data_2m9k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m9k _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.439 ' HB ' ' CD1' ' A' ' 105' ' ' PHE . 40.6 t . . . . . 0 N--CA 1.426 -1.667 0 N-CA-C 108.289 -1.004 . . . . 53.340000000000003 108.289 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -88.53 12.8 13.54 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.676 -0.693 . . . . 72.219999999999999 111.458 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.9 m -136.99 132.74 34.74 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 121.415 0.626 . . . . 60.310000000000002 112.462 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.4 mt -112.11 145.3 40.02 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.358 -0.979 . . . . 71.400000000000006 108.358 173.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -103.42 114.8 29.36 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 106.956 -1.498 . . . . 73.310000000000002 106.956 172.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG23 ' HG ' ' A' ' 103' ' ' LEU . 33.5 t -101.05 113.87 38.46 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 CA-C-N 114.144 -1.389 . . . . 64.230000000000004 108.643 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.6 p -111.4 171.61 7.38 Favored 'General case' 0 N--CA 1.41 -2.438 0 N-CA-C 109.104 -0.702 . . . . 64.519999999999996 109.104 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 88.04 29.13 21.27 Favored Glycine 0 N--CA 1.431 -1.652 0 C-N-CA 120.911 -0.661 . . . . 37.799999999999997 112.493 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 96.5 mt -93.07 125.83 53.39 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.671 -1.233 . . . . 72.230000000000004 107.671 173.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -50.21 153.41 6.91 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.484 2.123 . . . . 70.209999999999994 110.783 172.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.3 p -65.94 -12.91 14.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 123.152 0.581 . . . . 62.420000000000002 112.09 -172.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -126.77 41.67 3.47 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.904 0.859 . . . . 53.350000000000001 109.373 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 pp -59.17 145.5 10.84 Favored 'Isoleucine or valine' 0 C--O 1.25 1.115 0 C-N-CA 119.271 -0.972 . . . . 72.310000000000002 112.52 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.424 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 70.6 mmtt -98.94 146.22 31.3 Favored Pre-proline 0 C--N 1.271 -2.813 0 N-CA-C 107.31 -1.367 . . . . 72.030000000000001 107.31 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -59.45 -24.53 75.15 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.381 2.054 . . . . 74.019999999999996 111.866 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.532 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 13.9 ptt180 -78.13 -20.58 51.83 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.692 -0.686 . . . . 75.129999999999995 112.736 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 42.6 mt-10 -64.6 -38.74 92.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.221 0.534 . . . . 63.43 110.368 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -76.1 -22.17 55.86 Favored 'General case' 0 C--O 1.212 -0.907 0 CA-C-O 121.628 0.727 . . . . 65.450000000000003 109.934 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.532 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 62.9 t80 -73.5 -47.96 37.11 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.065 -0.97 . . . . 72.200000000000003 109.04 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.39 -38.84 74.75 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.655 -0.702 . . . . 75.430000000000007 110.175 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.9 tp -78.52 -37.08 43.92 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.46 -0.791 . . . . 61.420000000000002 112.719 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -97.05 1.04 49.65 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 118.898 -1.121 . . . . 63.229999999999997 113.598 -175.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -67.82 -42.93 36.44 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 114.049 1.129 . . . . 72.200000000000003 114.049 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -63.76 -20.11 68.17 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 121.478 1.452 . . . . 72.120000000000005 111.807 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -90.02 101.11 13.82 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 121.638 0.732 . . . . 74.200000000000003 110.834 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -64.41 110.4 2.26 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.345 -1.298 . . . . 65.200000000000003 110.642 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.47 -17.26 3.1 Favored Glycine 0 N--CA 1.425 -2.087 0 CA-C-N 115.015 -0.993 . . . . 62.149999999999999 113.326 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -62.4 107.9 1.01 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 118.001 0.901 . . . . 74.209999999999994 112.317 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -90.72 -43.92 9.8 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.49 -0.777 . . . . 74.409999999999997 110.648 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.91 171.88 43.29 Favored Glycine 0 C--N 1.301 -1.376 0 C-N-CA 120.797 -0.716 . . . . 54.439999999999998 111.674 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.8 p -138.57 137.34 36.91 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.85 0.325 . . . . 74.239999999999995 111.659 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.6 mp -112.83 121.63 45.27 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.561 -0.903 . . . . 65.349999999999994 108.561 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.5 mm -94.27 133.03 36.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 120.892 0.377 . . . . 74.319999999999993 110.14 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -118.06 106.88 13.35 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.708 -1.59 . . . . 73.519999999999996 106.708 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.73 131.19 42.77 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.893 -0.594 . . . . 73.150000000000006 109.663 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 18.8 m -129.7 153.01 48.58 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 104.486 -2.412 . . . . 72.310000000000002 104.486 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.5 -26.87 45.24 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 114.381 1.252 . . . . 42.450000000000003 114.381 -172.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -104.48 -25.64 12.71 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 113.268 0.84 . . . . 73.430000000000007 113.268 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.599 ' O ' ' HB ' ' A' ' 65' ' ' THR . 14.3 pt20 -172.55 136.54 0.82 Allowed Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.398 -0.593 . . . . 72.430000000000007 109.398 -173.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 44.8 Cg_endo -74.58 133.39 17.2 Favored 'Trans proline' 0 N--CA 1.43 -2.232 0 C-N-CA 121.956 1.771 . . . . 70.120000000000005 110.449 170.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m -101.78 143.54 14.5 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 N-CA-C 108.126 -1.065 . . . . 74.310000000000002 108.126 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.5 120.96 4.88 Favored Glycine 0 CA--C 1.479 -2.161 0 C-N-CA 119.807 -1.187 . . . . 73.109999999999999 112.719 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -87.69 102.8 14.99 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.769 -1.567 . . . . 72.519999999999996 106.769 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.9 t -97.69 123.8 50.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-N 114.984 -1.007 . . . . 65.319999999999993 110.036 -175.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.9 tt -95.86 131.51 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.108 0 CA-C-N 115.04 -0.982 . . . . 75.129999999999995 109.274 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.45 159.71 18.48 Favored 'General case' 0 N--CA 1.414 -2.25 0 CA-C-N 114.977 -1.01 . . . . 71.329999999999998 110.839 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -53.63 -44.93 69.93 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 125.646 1.578 . . . . 75.010000000000005 110.808 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.3 p -150.8 153.86 36.22 Favored 'General case' 0 N--CA 1.398 -3.067 0 CA-C-N 115.403 -0.817 . . . . 64.329999999999998 111.293 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -58.74 -42.58 89.12 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 125.158 1.383 . . . . 74.340000000000003 110.2 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.66 -18.73 64.26 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.897 -1.047 . . . . 74.510000000000005 109.394 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.25 -45.26 5.37 Favored Glycine 0 C--N 1.294 -1.766 0 CA-C-N 113.626 -1.625 . . . . 61.299999999999997 110.455 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.54 -45.02 95.39 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.998 0.919 . . . . 51.039999999999999 111.584 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.08 -26.92 68.76 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.286 -0.416 . . . . 63.439999999999998 111.844 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.5 -39.52 27.81 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.16 0.505 . . . . 72.010000000000005 109.878 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.95 85.96 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.684 -0.689 . . . . 43.149999999999999 111.021 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.412 ' CE ' ' HA ' ' A' ' 104' ' ' GLU . 14.0 ptmm? -68.38 -28.08 66.79 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.281 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -64.43 -36.23 83.5 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.658 0.599 . . . . 73.439999999999998 110.904 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.25 -38.64 17.38 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 120.977 0.418 . . . . 63.119999999999997 111.916 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 91' ' ' ILE . 95.6 mt -96.94 -5.43 37.98 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 115.571 1.693 . . . . 60.140000000000001 115.571 -171.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -78.75 114.93 18.1 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 117.086 -1.845 . . . . 54.329999999999998 110.889 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.34 14.65 29.86 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 110.746 -0.942 . . . . 64.239999999999995 110.746 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.534 HG23 ' O ' ' A' ' 88' ' ' LEU . 10.2 tt -84.7 126.04 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.875 0 CA-C-O 121.632 0.73 . . . . 55.140000000000001 109.413 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -63.93 111.78 2.64 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 105.84 -1.911 . . . . 73.310000000000002 105.84 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -71.71 -25.78 62.22 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.947 0.88 . . . . 73.109999999999999 109.262 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -161.29 117.8 1.37 Allowed Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 106.583 -1.636 . . . . 72.310000000000002 106.583 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.08 -28.81 86.39 Favored 'Trans proline' 0 N--CA 1.474 0.349 0 C-N-CA 122.161 1.907 . . . . 74.439999999999998 112.862 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -74.71 -24.7 58.79 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.275 0.56 . . . . 71.129999999999995 110.899 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.431 ' C ' ' H ' ' A' ' 99' ' ' GLN . 46.4 t-20 -102.96 135.64 19.38 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.023 -1.473 . . . . 63.119999999999997 107.023 -177.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.97 15.06 0.62 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.306 2.004 . . . . 72.400000000000006 112.341 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 97' ' ' ASN . 5.9 tp60 -89.96 121.4 32.02 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.922 0.889 . . . . 72.439999999999998 110.334 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.497 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 66.2 p -114.59 142.47 46.39 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.128 -0.693 . . . . 73.010000000000005 109.128 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.9 tp -89.18 135.95 33.29 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.933 -0.766 . . . . 71.150000000000006 108.933 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -135.0 124.79 25.39 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.57 -0.529 . . . . 61.229999999999997 109.57 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.441 ' HG ' HG23 ' A' ' 35' ' ' VAL . 6.6 mp -110.84 118.33 35.84 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.059 -0.519 . . . . 63.439999999999998 109.866 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.412 ' HA ' ' CE ' ' A' ' 85' ' ' LYS . 7.7 mm-40 -126.61 161.29 28.39 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.936 -0.765 . . . . 72.019999999999996 108.936 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.439 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 27.1 m-85 -69.94 139.17 52.84 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.36 -0.536 . . . . 54.539999999999999 109.922 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.52 160.66 29.28 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 121.121 0.486 . . . . 65.019999999999996 110.004 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -77.16 -13.65 59.91 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.454 -0.794 . . . . 73.540000000000006 110.127 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.38 136.67 16.64 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.025 -0.989 . . . . 62.229999999999997 109.449 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -70.96 113.0 7.56 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.239 -1.393 . . . . 43.32 107.239 173.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.432 -1.359 0 N-CA-C 108.486 -0.931 . . . . 64.230000000000004 108.486 -177.639 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.421 -1.883 0 N-CA-C 105.105 -2.183 . . . . 75.200000000000003 105.105 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -84.86 8.2 18.25 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 112.417 0.525 . . . . 61.340000000000003 112.417 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 28.9 m -127.85 129.27 46.66 Favored 'General case' 0 C--N 1.27 -2.857 0 C-N-CA 119.963 -0.695 . . . . 72.409999999999997 112.065 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -104.77 134.39 48.0 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.517 -1.29 . . . . 72.230000000000004 107.517 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.56 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 33.7 p90 -91.75 118.3 30.55 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 107.784 -1.191 . . . . 74.040000000000006 107.784 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG23 ' HG ' ' B' ' 103' ' ' LEU . 39.6 t -97.44 115.68 37.86 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 114.198 -1.364 . . . . 61.229999999999997 108.137 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 24.0 p -129.44 171.12 12.87 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 115.101 -0.954 . . . . 64.420000000000002 109.224 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 82.03 51.92 4.27 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 110.44 -1.064 . . . . 70.030000000000001 110.44 -173.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 95.7 mt -122.44 129.25 25.14 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.868 -1.16 . . . . 53.240000000000002 107.868 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -52.85 159.59 4.92 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 122.412 2.074 . . . . 72.109999999999999 110.978 171.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.68 -10.54 14.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.628 0.727 . . . . 74.120000000000005 111.301 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -127.02 40.83 3.64 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 122.158 0.98 . . . . 73.329999999999998 109.441 -176.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.443 HD11 ' O ' ' B' ' 42' ' ' ILE . 2.7 pp -64.46 134.19 29.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 118.686 -1.205 . . . . 71.530000000000001 110.666 170.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.42 141.99 26.55 Favored Pre-proline 0 C--N 1.273 -2.734 0 N-CA-C 108.672 -0.862 . . . . 71.430000000000007 108.672 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -51.78 -32.16 44.94 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.85 2.367 . . . . 74.519999999999996 112.429 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.492 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 12.0 ptt180 -68.44 -26.57 65.58 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 112.426 0.528 . . . . 62.240000000000002 112.426 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -65.13 -42.7 93.63 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.327 0.584 . . . . 71.209999999999994 109.539 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.38 -36.6 81.68 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 115.397 -0.82 . . . . 74.200000000000003 109.489 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.492 ' HB3' ' O ' ' B' ' 45' ' ' ARG . 76.2 t80 -61.01 -46.82 89.19 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.822 -1.081 . . . . 63.420000000000002 110.867 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 89.0 mt -66.62 -41.66 88.02 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.241 0.544 . . . . 55.049999999999997 109.826 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 29.2 tp -69.73 -44.2 70.77 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.667 -1.151 . . . . 72.329999999999998 112.117 -175.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -94.53 4.42 53.87 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 113.167 0.803 . . . . 61.329999999999998 113.167 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 28.2 ttt180 -69.5 -43.77 23.55 Favored Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 112.976 0.732 . . . . 75.150000000000006 112.976 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -76.23 -2.47 12.66 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 121.45 1.434 . . . . 74.439999999999998 112.033 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -94.6 103.12 15.06 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 121.833 0.825 . . . . 70.319999999999993 111.556 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -68.19 118.17 10.97 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 114.103 -1.408 . . . . 65.150000000000006 110.793 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.07 -19.7 4.33 Favored Glycine 0 C--N 1.281 -2.472 0 CA-C-N 115.005 -0.998 . . . . 73.519999999999996 112.695 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -58.4 113.22 1.87 Allowed 'General case' 0 C--O 1.242 0.672 0 CA-C-N 117.301 0.55 . . . . 70.420000000000002 111.663 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -95.46 -58.97 1.98 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.58 -0.736 . . . . 74.010000000000005 110.344 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.6 160.2 32.92 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 120.041 -1.076 . . . . 72.200000000000003 113.095 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.3 p -119.33 137.95 53.37 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 122.702 0.401 . . . . 62.420000000000002 110.814 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 66.9 tp -111.31 111.3 22.25 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.882 -1.155 . . . . 75.540000000000006 107.882 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 51.0 mm -94.61 136.38 26.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 109.732 -0.47 . . . . 63.409999999999997 109.732 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -133.19 114.84 14.3 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.477 -0.935 . . . . 74.439999999999998 108.477 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.06 113.95 8.63 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.959 -1.126 . . . . 75.150000000000006 107.959 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.9 m -105.93 167.56 9.71 Favored 'General case' 0 N--CA 1.403 -2.807 0 N-CA-C 107.023 -1.473 . . . . 72.530000000000001 107.023 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.76 -33.42 23.11 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.675 0.991 . . . . 71.120000000000005 113.675 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -105.18 -37.78 6.78 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 119.724 -0.79 . . . . 71.530000000000001 112.424 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -155.25 159.68 31.53 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 110.203 -0.295 . . . . 73.430000000000007 110.203 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.24 123.29 7.09 Favored 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.218 1.945 . . . . 65.329999999999998 109.636 167.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 35.9 m -97.58 156.84 3.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 107.461 -1.311 . . . . 64.239999999999995 107.461 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.03 121.94 2.58 Favored Glycine 0 C--O 1.203 -1.798 0 C-N-CA 118.237 -1.935 . . . . 50.329999999999998 113.492 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -88.42 108.36 19.33 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.78 -1.193 . . . . 60.539999999999999 107.78 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.62 120.11 53.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-N 116.184 -0.462 . . . . 74.109999999999999 110.473 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 11.8 tt -96.32 134.8 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 115.559 -0.746 . . . . 73.409999999999997 110.478 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -111.29 149.58 30.87 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 114.621 -1.172 . . . . 74.200000000000003 109.821 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -56.27 -34.35 66.34 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.727 1.211 . . . . 61.32 111.453 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 9.9 p -144.56 138.3 27.4 Favored 'General case' 0 N--CA 1.398 -3.027 0 CA-C-O 121.953 0.883 . . . . 73.400000000000006 110.634 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -25.57 59.03 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 114.494 -1.23 . . . . 75.209999999999994 110.453 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.1 -19.68 64.06 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.532 1.158 . . . . 73.329999999999998 108.654 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.26 -43.2 5.66 Favored Glycine 0 C--N 1.308 -1.0 0 CA-C-N 113.786 -1.552 . . . . 51.200000000000003 109.922 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.41 -37.64 78.55 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.989 0.916 . . . . 52.210000000000001 112.02 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.04 -34.53 76.41 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.864 0.364 . . . . 62.329999999999998 111.44 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.25 -38.12 27.43 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.295 0.569 . . . . 72.430000000000007 109.804 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.2 93.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.872 -1.058 . . . . 61.439999999999998 111.202 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -65.6 -41.01 93.28 Favored 'General case' 0 C--O 1.195 -1.815 0 CA-C-N 116.258 -0.428 . . . . 75.200000000000003 110.647 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -63.68 -24.73 67.9 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 112.359 0.503 . . . . 74.239999999999995 112.359 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.54 -36.02 33.67 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 120.811 0.339 . . . . 64.420000000000002 111.156 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.489 ' O ' HG21 ' B' ' 91' ' ' ILE . 98.6 mt -102.14 -19.92 14.93 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 115.222 1.564 . . . . 74.040000000000006 115.222 -174.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . 0.259 0.2 OUTLIER -75.65 113.95 13.67 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 118.92 -1.112 . . . . 62.350000000000001 112.616 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.04 14.99 13.51 Favored Glycine 0 N--CA 1.41 -3.035 0 CA-C-N 115.554 -0.748 . . . . 61.399999999999999 111.74 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.489 HG21 ' O ' ' B' ' 88' ' ' LEU . 15.7 tt -95.93 133.89 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.977 0 N-CA-C 108.964 -0.754 . . . . 74.349999999999994 108.964 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -62.82 119.3 9.09 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 105.117 -2.179 . . . . 74.329999999999998 105.117 172.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -68.18 -31.12 70.44 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 108.418 -0.956 . . . . 74.310000000000002 108.418 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.481 ' CB ' ' HB3' ' A' ' 45' ' ' ARG . 1.0 OUTLIER -166.47 137.42 2.76 Favored Pre-proline 0 N--CA 1.427 -1.616 0 N-CA-C 106.709 -1.589 . . . . 74.420000000000002 106.709 174.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.1 -2.81 12.88 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.132 1.888 . . . . 71.230000000000004 113.237 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -85.63 -24.92 26.91 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.75 0.786 . . . . 71.540000000000006 109.532 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' ASN . . . . . 0.533 ' OD1' ' HB2' ' B' ' 99' ' ' GLN . 6.6 t-20 -110.45 148.17 37.88 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 106.004 -1.85 . . . . 73.439999999999998 106.004 174.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.05 22.1 0.77 Allowed 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 122.529 2.153 . . . . 65.129999999999995 112.045 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' GLN . . . . . 0.533 ' HB2' ' OD1' ' B' ' 97' ' ' ASN . 5.5 tp60 -89.41 129.29 35.95 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.948 0.899 . . . . 63.219999999999999 110.802 -176.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.564 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 36.8 p -116.52 138.32 51.49 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.731 -0.47 . . . . 54.229999999999997 109.731 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 49.3 tp -86.09 131.1 34.33 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.045 -0.724 . . . . 73.120000000000005 109.045 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -135.82 122.63 21.15 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-O 120.834 0.35 . . . . 74.019999999999996 110.31 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.408 ' HG ' HG23 ' B' ' 35' ' ' VAL . 6.2 mp -108.27 116.27 31.66 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.841 -1.17 . . . . 74.219999999999999 107.841 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.56 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 7.4 tp10 -131.72 159.6 37.94 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.625 -1.62 . . . . 61.409999999999997 106.625 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -68.93 137.19 53.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 119.561 1.073 . . . . 71.319999999999993 110.859 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.63 164.28 26.46 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.92 -0.582 . . . . 74.439999999999998 110.232 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -84.72 -9.86 57.81 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.76 0.791 . . . . 71.310000000000002 109.114 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.44 130.09 19.09 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.208 -0.905 . . . . 63.240000000000002 109.892 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -70.26 104.55 2.69 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.854 -1.165 . . . . 64.409999999999997 107.854 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.423 -1.819 0 CA-C-N 115.665 -0.698 . . . . 62.310000000000002 109.57 -172.969 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.3 t . . . . . 0 N--CA 1.436 -1.126 0 N-CA-C 103.859 -2.645 . . . . 54.009999999999998 103.859 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 75' ' ' PHE . 26.6 ptt180 -129.64 7.97 5.32 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.793 -0.64 . . . . 73.519999999999996 112.461 -168.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.3 m -104.89 124.48 49.55 Favored 'General case' 0 C--N 1.266 -3.04 0 C-N-CA 119.77 -0.772 . . . . 70.120000000000005 109.236 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 93.7 mt -104.75 136.78 43.63 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.745 -1.205 . . . . 64.140000000000001 107.745 176.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 20.4 p90 -98.32 118.98 36.18 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.27 -1.382 . . . . 74.239999999999995 107.27 174.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.431 HG22 ' HG ' ' A' ' 103' ' ' LEU . 19.5 t -99.79 111.01 28.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 114.531 -1.213 . . . . 61.530000000000001 108.365 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.7 p -110.01 175.33 5.48 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 108.57 -0.9 . . . . 73.109999999999999 108.57 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 97.42 1.33 59.2 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.757 -0.735 . . . . 54.210000000000001 111.659 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.5 mt -77.06 139.05 65.03 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 108.373 -0.973 . . . . 42.32 108.373 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.415 ' C ' ' H ' ' A' ' 41' ' ' ASP . 54.7 Cg_endo -69.74 170.38 16.69 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.726 1.617 . . . . 75.530000000000001 111.383 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 p -78.69 7.54 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-O 122.67 1.224 . . . . 60.409999999999997 109.403 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 39' ' ' PRO . 24.4 t70 -115.93 7.94 14.55 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.042 -1.436 . . . . 75.519999999999996 109.481 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.32 125.3 18.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.962 0.887 . . . . 55.25 110.813 -176.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -109.96 142.04 25.05 Favored Pre-proline 0 C--N 1.289 -2.043 0 CA-C-N 114.198 -1.365 . . . . 75.049999999999997 109.356 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.48 -25.08 30.72 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.63 2.886 . . . . 51.240000000000002 113.56 -176.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.525 ' HB3' ' OD2' ' B' ' 94' ' ' ASP . 23.7 ptt180 -66.63 -28.17 68.26 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 121.067 0.461 . . . . 75.420000000000002 111.464 -178.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -71.48 -38.2 71.23 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.143 0.497 . . . . 70.510000000000005 110.666 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.76 -38.65 73.47 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 108.544 -0.91 . . . . 73.010000000000005 108.544 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.547 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 12.2 t80 -57.93 -49.05 78.08 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.756 -1.111 . . . . 73.409999999999997 111.087 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 97.1 mt -62.84 -41.31 99.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.075 0.464 . . . . 54.310000000000002 110.707 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.9 tp -73.46 -40.92 63.78 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.315 -0.857 . . . . 62.539999999999999 111.609 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -90.79 -5.69 55.31 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 114.543 1.312 . . . . 73.109999999999999 114.543 -175.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 13.1 mtp180 -58.36 -48.38 97.09 Favored Pre-proline 0 N--CA 1.481 1.091 0 N-CA-C 113.417 0.895 . . . . 73.239999999999995 113.417 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.57 -16.84 52.05 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 121.472 1.448 . . . . 72.549999999999997 112.494 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -91.03 86.31 6.21 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.327 0.584 . . . . 63.25 110.147 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -70.48 115.99 10.29 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 122.213 1.006 . . . . 71.109999999999999 109.544 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.14 -23.08 2.08 Favored Glycine 0 C--N 1.287 -2.172 0 CA-C-N 113.81 -1.541 . . . . 70.340000000000003 109.556 -173.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -57.37 109.55 0.7 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.206 1.002 . . . . 62.310000000000002 111.343 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -88.15 -47.52 8.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.525 0.679 . . . . 54.229999999999997 109.679 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.46 170.95 44.08 Favored Glycine 0 C--N 1.297 -1.618 0 C-N-CA 120.147 -1.025 . . . . 71.120000000000005 112.833 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.4 p -131.59 138.03 48.68 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 122.653 0.381 . . . . 75.329999999999998 110.144 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -115.66 118.29 32.66 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.468 -1.678 . . . . 72.319999999999993 106.468 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -93.52 133.84 33.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.881 -1.155 . . . . 73.209999999999994 107.881 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -127.97 117.74 22.29 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.191 -1.04 . . . . 73.230000000000004 108.191 -175.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.37 111.31 4.56 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.055 -1.091 . . . . 75.109999999999999 108.055 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.8 m -116.03 168.24 10.26 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.826 -0.805 . . . . 53.32 108.826 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.28 -29.93 10.76 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.789 1.235 . . . . 72.219999999999999 114.196 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -104.11 -47.2 4.23 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.989 -0.684 . . . . 74.540000000000006 111.16 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -155.93 153.24 25.41 Favored Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-N 115.48 -0.782 . . . . 65.109999999999999 109.527 -167.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -68.72 105.65 1.34 Allowed 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 122.047 1.832 . . . . 74.010000000000005 108.765 167.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -86.08 162.8 2.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 108.206 -1.035 . . . . 71.129999999999995 108.206 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.33 120.2 3.3 Favored Glycine 0 CA--C 1.486 -1.751 0 C-N-CA 117.91 -2.091 . . . . 64.230000000000004 113.072 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -89.0 104.8 17.32 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.39 -1.337 . . . . 72.230000000000004 107.39 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.3 t -99.9 118.34 46.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 115.765 -0.652 . . . . 73.409999999999997 110.289 -176.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 tt -97.69 127.6 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 CA-C-O 121.909 0.861 . . . . 64.5 110.32 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.417 ' O ' ' HD2' ' A' ' 31' ' ' ARG . 73.2 m-85 -102.86 166.18 10.62 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 114.515 -1.22 . . . . 73.239999999999995 110.144 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.03 -47.73 74.34 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.972 -1.013 . . . . 73.329999999999998 112.565 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 p -146.13 165.12 30.06 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.615 -0.721 . . . . 51.340000000000003 111.082 -172.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.35 -32.12 69.69 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.628 -0.508 . . . . 74.019999999999996 109.628 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.63 -20.41 65.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 122.199 1.0 . . . . 53.130000000000003 109.552 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.06 -42.43 6.3 Favored Glycine 0 C--N 1.299 -1.492 0 CA-C-N 114.253 -1.34 . . . . 75.299999999999997 110.417 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.22 -42.86 88.12 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 123.167 0.587 . . . . 75.120000000000005 111.48 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.18 -42.76 91.59 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 111.637 0.236 . . . . 74.109999999999999 111.637 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.4 -36.85 68.77 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-O 121.031 0.444 . . . . 72.019999999999996 111.098 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.42 -39.64 77.75 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.491 -0.777 . . . . 54.119999999999997 111.346 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -68.18 -37.13 80.63 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 120.1 -0.64 . . . . 74.299999999999997 110.147 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -58.27 -38.16 76.41 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 123.47 0.481 . . . . 73.340000000000003 111.286 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.66 -41.66 26.42 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 116.387 -0.37 . . . . 64.109999999999999 111.601 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.476 ' O ' HG22 ' A' ' 91' ' ' ILE . 99.0 mt -88.97 -22.17 23.17 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 116.212 1.93 . . . . 73.420000000000002 116.212 -173.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.78 113.15 8.52 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 117.904 -1.519 . . . . 65.239999999999995 109.888 176.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.77 11.98 13.53 Favored Glycine 0 N--CA 1.408 -3.222 0 CA-C-N 115.411 -0.813 . . . . 44.119999999999997 111.478 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.5 tt -94.45 133.75 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 N-CA-C 107.441 -1.318 . . . . 63.329999999999998 107.441 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 59.5 ttt180 -97.43 126.86 42.93 Favored 'General case' 0 C--N 1.251 -3.696 0 N-CA-C 109.15 -0.685 . . . . 72.109999999999999 109.15 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.13 -32.84 74.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.593 -1.185 . . . . 75.530000000000001 110.418 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' B' ' 45' ' ' ARG . 1.5 m-20 -147.73 126.49 6.2 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 103.938 -2.616 . . . . 61.530000000000001 103.938 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.613 ' HD3' ' CZ ' ' B' ' 48' ' ' TYR . 30.6 Cg_endo -67.69 -12.76 36.63 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 CA-C-N 121.279 1.492 . . . . 75.519999999999996 111.217 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -91.46 -0.65 57.65 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.194 -0.912 . . . . 73.310000000000002 111.01 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.494 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 18.7 t30 -117.41 127.14 26.87 Favored Pre-proline 0 C--O 1.213 -0.853 0 N-CA-C 108.387 -0.968 . . . . 65.120000000000005 108.387 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.07 -12.18 33.42 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.398 2.732 . . . . 62.219999999999999 114.927 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -94.68 158.63 15.43 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 119.804 -0.758 . . . . 73.430000000000007 110.209 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.404 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 49.6 p -135.95 161.09 36.62 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.712 -1.218 . . . . 74.420000000000002 107.712 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 mp -90.43 129.74 36.58 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.186 0.517 . . . . 74.129999999999995 110.42 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -124.37 110.52 14.67 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.178 -1.416 . . . . 64.109999999999999 107.178 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.431 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.6 mp -98.58 122.51 41.88 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.405 -0.816 . . . . 74.019999999999996 109.846 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.496 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 37.3 tt0 -130.94 157.57 42.6 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.864 -1.532 . . . . 64.109999999999999 106.864 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -65.71 139.97 58.42 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 118.458 0.572 . . . . 73.519999999999996 109.586 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.14 157.27 32.98 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.958 -0.756 . . . . 73.310000000000002 108.958 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -88.61 0.69 56.13 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 122.124 0.964 . . . . 75.319999999999993 109.216 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.35 124.97 3.76 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.749 -1.114 . . . . 64.310000000000002 108.113 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -64.78 124.15 21.21 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.463 0.649 . . . . 63.450000000000003 110.891 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.8 m . . . . . 0 N--CA 1.418 -2.072 0 N-CA-C 108.097 -1.075 . . . . 71.430000000000007 108.097 -178.956 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 97.5 t . . . . . 0 CA--C 1.5 -0.965 0 N-CA-C 103.692 -2.707 . . . . 70.349999999999994 103.692 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.587 ' HB2' ' O ' ' B' ' 75' ' ' PHE . 16.1 ptm180 -123.53 17.9 9.65 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-N 114.655 -1.157 . . . . 63.310000000000002 110.974 -164.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 29.9 m -124.67 121.56 35.04 Favored 'General case' 0 C--N 1.273 -2.739 0 C-N-CA 119.554 -0.858 . . . . 73.219999999999999 110.104 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 87.9 mt -103.48 137.23 41.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.196 -1.039 . . . . 75.340000000000003 108.196 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -98.88 113.99 26.37 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 106.762 -1.57 . . . . 73.219999999999999 106.762 175.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.422 HG21 ' HG ' ' B' ' 103' ' ' LEU . 22.0 t -99.69 112.56 32.42 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.665 0 CA-C-N 114.429 -1.259 . . . . 55.340000000000003 108.4 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' B' ' 101' ' ' LEU . 48.9 p -111.48 169.46 8.79 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 108.626 -0.879 . . . . 73.140000000000001 108.626 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.526 ' HA2' ' CD ' ' B' ' 99' ' ' GLN . . . 109.68 -6.65 31.49 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 120.421 -0.895 . . . . 70.049999999999997 111.655 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 55.1 mt -75.8 133.71 72.84 Favored Pre-proline 0 N--CA 1.428 -1.572 0 CA-C-N 114.253 -0.974 . . . . 64.530000000000001 108.812 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.49 170.68 16.87 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.095 1.863 . . . . 51.009999999999998 110.715 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.496 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 8.2 p -70.92 -11.51 15.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.446 0.641 . . . . 73.340000000000003 111.623 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.471 ' CG ' ' HZ3' ' B' ' 43' ' ' LYS . 21.9 t70 -112.55 27.28 9.77 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.961 0.886 . . . . 65.129999999999995 108.894 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.58 126.59 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-O 121.566 0.698 . . . . 73.530000000000001 109.4 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.471 ' HZ3' ' CG ' ' B' ' 41' ' ' ASP . 9.8 mptt -101.34 141.53 22.78 Favored Pre-proline 0 C--N 1.299 -1.608 0 CA-C-N 115.707 -0.678 . . . . 60.43 111.08 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -51.0 -25.42 16.18 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.628 2.886 . . . . 61.229999999999997 114.199 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.499 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 15.3 ptt-85 -66.35 -32.27 73.57 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 120.864 0.364 . . . . 75.049999999999997 111.019 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -69.24 -34.48 74.88 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.923 -0.58 . . . . 72.349999999999994 109.973 -174.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.411 ' O ' ' HD2' ' B' ' 51' ' ' PHE . 97.3 mt -74.65 -44.07 52.2 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.47 0.652 . . . . 62.109999999999999 109.454 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.613 ' CZ ' ' HD3' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -57.81 -43.32 85.61 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.976 -1.011 . . . . 74.040000000000006 112.071 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.55 -42.81 98.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.891 0.377 . . . . 73.310000000000002 111.015 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.3 tp -71.65 -42.68 67.25 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.284 -0.871 . . . . 65.049999999999997 111.657 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . 0.411 ' HD2' ' O ' ' B' ' 47' ' ' LEU . 81.4 m-85 -85.42 -4.74 59.25 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.993 1.479 . . . . 73.329999999999998 114.993 -175.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.605 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 26.2 mtp180 -51.81 -50.05 80.01 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 114.16 1.17 . . . . 75.25 114.16 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.51 -0.88 10.64 Favored 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 121.873 1.715 . . . . 74.120000000000005 114.046 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . 0.264 69.8 m-85 -87.67 134.92 33.57 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 115.519 1.674 . . . . 71.120000000000005 115.519 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -67.12 109.24 2.96 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.262 -1.79 . . . . 72.519999999999996 112.455 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' B' ' 75' ' ' PHE . . . 106.38 -7.59 40.14 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 115.531 -0.759 . . . . 44.520000000000003 113.467 171.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -59.94 106.98 0.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.406 0.622 . . . . 72.409999999999997 112.54 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -99.24 -44.58 6.19 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.692 -0.686 . . . . 72.209999999999994 110.849 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.91 -178.88 41.78 Favored Glycine 0 C--N 1.302 -1.318 0 C-N-CA 119.429 -1.367 . . . . 71.25 113.569 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.7 p -139.86 137.67 35.09 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.162 0.585 . . . . 74.25 111.158 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.51 116.51 28.31 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.301 -1.0 . . . . 73.310000000000002 108.301 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.51 133.27 35.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.663 -0.866 . . . . 37.899999999999999 108.663 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' B' ' 69' ' ' PRO . 12.1 tmtt? -125.31 115.29 20.12 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.364 -1.347 . . . . 53.329999999999998 107.364 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.15 130.74 39.71 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.09 -0.504 . . . . 73.109999999999999 109.872 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 3.4 m -124.52 164.82 18.97 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.885 -1.154 . . . . 74.329999999999998 107.885 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.58 -31.5 36.49 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.53 0.937 . . . . 63.229999999999997 113.53 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -99.22 -52.41 3.53 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.897 -0.721 . . . . 74.230000000000004 111.484 176.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -154.16 145.86 16.85 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 115.781 -0.645 . . . . 75.120000000000005 111.156 -170.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.496 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 60.2 Cg_endo -75.62 124.8 8.49 Favored 'Trans proline' 0 N--CA 1.436 -1.88 0 C-N-CA 122.93 2.42 . . . . 60.219999999999999 111.621 174.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 m -93.84 155.11 3.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 114.977 -1.011 . . . . 65.120000000000005 108.442 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.32 120.51 4.23 Favored Glycine 0 CA--C 1.486 -1.756 0 C-N-CA 119.032 -1.556 . . . . 61.420000000000002 112.811 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -89.7 102.77 15.46 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.608 -1.256 . . . . 72.209999999999994 107.608 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 68.8 t -92.67 123.94 44.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 115.79 -0.641 . . . . 64.430000000000007 109.584 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 13.7 tt -101.53 129.21 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.328 0 CA-C-O 122.297 1.046 . . . . 75.150000000000006 111.074 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' B' ' 31' ' ' ARG . 91.9 m-85 -109.81 160.43 16.35 Favored 'General case' 0 N--CA 1.404 -2.759 0 CA-C-N 113.217 -1.81 . . . . 71.099999999999994 107.993 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . 0.465 ' HA ' ' NH2' ' B' ' 31' ' ' ARG . 34.7 t70 -73.09 -33.31 65.53 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.276 0.56 . . . . 72.400000000000006 111.843 176.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 12.4 p -128.73 158.81 37.56 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 116.258 -0.428 . . . . 52.310000000000002 111.641 -174.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.48 -27.78 37.73 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.476 -0.889 . . . . 63.450000000000003 108.662 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.07 -24.91 61.58 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.977 0.894 . . . . 61.219999999999999 108.764 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.12 -44.75 28.3 Favored Glycine 0 C--N 1.31 -0.895 0 N-CA-C 109.62 -1.392 . . . . 37.899999999999999 109.62 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.6 -44.95 95.03 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.766 -0.717 . . . . 73.319999999999993 111.736 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -66.96 -28.28 68.15 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.495 0.554 . . . . 74.109999999999999 112.495 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.95 -46.84 32.9 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.119 -0.491 . . . . 71.099999999999994 110.172 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.97 92.6 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.53 -0.759 . . . . 74.040000000000006 111.678 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.467 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 14.2 ptmm? -69.49 -34.38 74.24 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 120.024 -0.67 . . . . 74.109999999999999 110.147 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -62.84 -32.24 73.42 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 121.129 0.49 . . . . 74.420000000000002 110.405 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.78 -32.48 19.07 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 112.541 0.571 . . . . 74.400000000000006 112.541 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.454 ' O ' HG22 ' B' ' 91' ' ' ILE . 91.7 mt -101.66 -25.19 13.95 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 116.603 2.075 . . . . 72.310000000000002 116.603 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . 0.268 0.2 OUTLIER -68.69 113.92 6.6 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 118.06 -1.456 . . . . 61.530000000000001 112.615 -176.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.2 6.47 15.82 Favored Glycine 0 N--CA 1.419 -2.451 0 C-N-CA 120.791 -0.719 . . . . 54.409999999999997 111.872 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.454 HG22 ' O ' ' B' ' 88' ' ' LEU . 12.2 tt -96.61 146.73 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.361 0 N-CA-C 107.735 -1.209 . . . . 42.409999999999997 107.735 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.425 ' CG ' HG23 ' B' ' 100' ' ' THR . 97.7 mtt180 -89.47 140.89 29.07 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-O 121.333 0.587 . . . . 72.319999999999993 112.342 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -73.27 -31.41 64.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.834 -1.53 . . . . 73.120000000000005 109.182 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.525 ' OD2' ' HB3' ' A' ' 45' ' ' ARG 0.266 4.8 m-20 -142.67 137.27 15.1 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 104.113 -2.551 . . . . 74.140000000000001 104.113 176.343 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . 0.545 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 19.0 Cg_endo -64.09 -19.51 66.32 Favored 'Trans proline' 0 CA--C 1.55 1.291 0 CA-C-N 121.064 1.416 . . . . 72.040000000000006 109.631 168.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -72.14 -24.98 61.54 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.109 1.764 . . . . 74.209999999999994 109.609 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -94.91 126.84 45.37 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 115.189 -0.914 . . . . 73.239999999999995 109.769 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.19 -6.25 14.76 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.937 2.425 . . . . 74.510000000000005 112.689 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' GLN . . . . . 0.526 ' CD ' ' HA2' ' B' ' 37' ' ' GLY . 8.7 tt0 -99.0 162.11 13.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.571 -0.9 . . . . 74.030000000000001 108.571 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.448 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 82.6 p -125.64 164.25 21.0 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.513 -0.551 . . . . 74.430000000000007 109.513 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' B' ' 36' ' ' SER . 5.3 mp -85.8 117.33 24.6 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 107.012 -1.477 . . . . 54.43 107.012 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -113.44 107.34 15.71 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 107.725 -1.213 . . . . 73.310000000000002 107.725 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.422 ' HG ' HG21 ' B' ' 35' ' ' VAL . 5.0 mp -90.22 116.45 28.21 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.572 -1.27 . . . . 61.119999999999997 107.572 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.467 ' HA ' ' CE ' ' B' ' 85' ' ' LYS . 12.1 tp10 -135.22 162.88 31.29 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.88 -1.156 . . . . 72.329999999999998 107.88 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -69.07 137.28 53.41 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 118.71 0.687 . . . . 75.010000000000005 111.84 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.95 156.03 32.27 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 109.169 -0.678 . . . . 71.030000000000001 109.169 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -78.13 -8.61 58.48 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.908 0.861 . . . . 42.450000000000003 109.624 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.2 130.98 9.95 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.164 -0.925 . . . . 75.239999999999995 108.77 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.403 ' ND2' ' HG2' ' B' ' 31' ' ' ARG . 6.5 m-20 -63.74 132.49 51.16 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.549 -0.75 . . . . 62.229999999999997 110.003 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 C--N 1.299 -1.589 0 N-CA-C 108.357 -0.979 . . . . 53.219999999999999 108.357 -179.507 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.465 ' HA ' HD22 ' A' ' 109' ' ' ASN . 17.8 t . . . . . 0 C--O 1.215 -0.724 0 N-CA-C 113.184 0.809 . . . . 74.329999999999998 113.184 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 42.4 mtt180 -99.43 -25.16 14.55 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-O 122.363 1.078 . . . . 71.230000000000004 109.349 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.4 m -98.11 138.24 35.7 Favored 'General case' 0 C--N 1.26 -3.291 0 CA-C-N 113.549 -1.659 . . . . 71.450000000000003 113.6 -167.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.8 mt -124.57 142.8 51.08 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 114.018 -1.447 . . . . 74.140000000000001 108.325 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.474 ' CE1' ' HB3' ' A' ' 104' ' ' GLU . 32.0 p90 -101.48 112.23 24.71 Favored 'General case' 0 N--CA 1.423 -1.825 0 C-N-CA 118.956 -1.097 . . . . 75.040000000000006 108.074 172.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.7 t -97.05 114.01 32.89 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.828 0 N-CA-C 106.898 -1.519 . . . . 55.439999999999998 106.898 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.6 p -124.46 154.44 40.48 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.288 -0.869 . . . . 74.209999999999994 111.177 -175.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.62 4.65 34.44 Favored Glycine 0 N--CA 1.425 -2.07 0 CA-C-N 115.939 -0.573 . . . . 38.039999999999999 111.856 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 94.4 mt -66.28 131.67 94.35 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.23 -0.655 . . . . 54.310000000000002 109.23 175.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.04 157.55 3.92 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.416 2.077 . . . . 70.409999999999997 110.283 171.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.483 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 9.8 p -83.44 6.97 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 122.787 1.28 . . . . 72.439999999999998 109.847 -170.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -127.87 17.04 6.82 Favored 'General case' 0 N--CA 1.406 -2.659 0 CA-C-N 114.323 -1.308 . . . . 54.420000000000002 110.322 -175.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 pp -54.06 133.75 16.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 114.62 1.341 . . . . 71.230000000000004 114.62 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.461 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.33 143.03 26.03 Favored Pre-proline 0 C--N 1.285 -2.199 0 CA-C-N 114.174 -1.376 . . . . 54.219999999999999 108.279 177.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.88 -24.64 65.58 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.913 2.408 . . . . 73.019999999999996 113.853 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.547 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -82.35 -15.34 53.16 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 118.094 -1.442 . . . . 70.109999999999999 111.882 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 30.0 mt-10 -69.66 -37.76 76.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.803 0.811 . . . . 74.129999999999995 108.932 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.9 mt -65.67 -35.92 82.16 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 114.773 -1.103 . . . . 75.209999999999994 108.828 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 73.7 t80 -63.95 -47.37 80.76 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.572 -1.194 . . . . 74.519999999999996 110.227 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 81.9 mt -65.02 -35.68 81.95 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.815 0.341 . . . . 71.510000000000005 111.809 -176.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.0 tp -86.23 -36.25 19.53 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 112.581 0.585 . . . . 65.140000000000001 112.581 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -98.56 -11.12 22.5 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 114.337 1.236 . . . . 73.510000000000005 114.337 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.5 ttt-85 -66.79 -42.71 45.67 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 119.987 -0.685 . . . . 71.329999999999998 111.693 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -58.11 -25.35 70.74 Favored 'Trans proline' 0 C--N 1.398 3.167 0 C-N-CA 121.711 1.608 . . . . 72.120000000000005 111.553 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -84.8 84.42 7.7 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.777 0.799 . . . . 72.200000000000003 110.112 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -67.93 108.74 3.15 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.333 -1.303 . . . . 75.099999999999994 109.905 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.94 -25.5 1.29 Allowed Glycine 0 N--CA 1.424 -2.133 0 CA-C-N 113.996 -1.457 . . . . 64.209999999999994 109.67 -172.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -55.45 118.72 4.71 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.085 0.554 . . . . 72.430000000000007 110.538 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -93.65 -60.09 1.85 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 120.121 -0.632 . . . . 61.229999999999997 109.363 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.56 175.15 38.15 Favored Glycine 0 C--N 1.298 -1.546 0 C-N-CA 120.848 -0.691 . . . . 65.310000000000002 112.075 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.3 p -134.79 143.88 47.34 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 122.488 0.315 . . . . 75.530000000000001 111.002 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.5 mt -115.98 119.91 37.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.09 -0.707 . . . . 74.209999999999994 109.09 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.17 133.3 35.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 110.137 -0.319 . . . . 71.540000000000006 110.137 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -117.82 106.66 13.23 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.27 -1.381 . . . . 72.239999999999995 107.27 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.4 124.6 25.48 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.246 -1.02 . . . . 71.219999999999999 108.246 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 5.9 m -128.89 150.79 50.2 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 105.155 -2.165 . . . . 72.239999999999995 105.155 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.05 -40.34 10.53 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 114.42 1.267 . . . . 63.32 114.42 -173.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -96.01 -26.76 15.42 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.877 1.065 . . . . 73.439999999999998 113.877 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -172.23 143.05 1.27 Allowed Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 110.202 -0.296 . . . . 70.439999999999998 110.202 -177.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.483 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 59.5 Cg_endo -77.37 124.64 7.23 Favored 'Trans proline' 0 N--CA 1.432 -2.092 0 C-N-CA 122.491 2.127 . . . . 65.019999999999996 110.102 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.7 m -96.36 147.49 6.1 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 N-CA-C 108.222 -1.029 . . . . 53.240000000000002 108.222 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.22 120.86 4.59 Favored Glycine 0 CA--C 1.479 -2.204 0 C-N-CA 118.879 -1.629 . . . . 71.129999999999995 112.907 -175.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.44 103.65 15.71 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 106.849 -1.538 . . . . 75.409999999999997 106.849 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.5 t -94.34 128.07 45.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.363 0 CA-C-N 115.071 -0.968 . . . . 74.129999999999995 110.284 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.67 114.24 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.369 0 N-CA-C 107.991 -1.114 . . . . 62.219999999999999 107.991 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 36.1 m-85 -93.96 162.65 13.81 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.329 -0.85 . . . . 74.200000000000003 109.584 174.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.36 -41.21 51.31 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 124.317 1.011 . . . . 75.510000000000005 111.876 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.6 p -164.9 166.08 19.85 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.571 -0.741 . . . . 70.540000000000006 111.986 -174.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.593 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -56.05 -39.5 72.11 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.236 1.014 . . . . 72.120000000000005 112.105 177.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.82 -28.17 69.38 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.625 0.726 . . . . 73.319999999999993 109.731 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.56 -38.71 9.46 Favored Glycine 0 C--N 1.309 -0.922 0 CA-C-N 114.648 -1.16 . . . . 65.310000000000002 110.897 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.67 -45.87 77.48 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.546 0.738 . . . . 52.219999999999999 112.032 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -34.82 78.8 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.007 0.432 . . . . 75.150000000000006 111.439 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.6 -41.21 65.84 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.992 -0.549 . . . . 62.109999999999999 110.563 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.89 -41.72 86.73 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.747 -0.66 . . . . 62.5 110.821 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -69.42 -28.46 66.16 Favored 'General case' 0 C--O 1.199 -1.585 0 CA-C-N 116.292 -0.413 . . . . 70.019999999999996 111.297 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -78.11 -21.07 50.99 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.27 0.557 . . . . 75.349999999999994 111.751 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.91 -44.02 11.36 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.278 -0.419 . . . . 72.439999999999998 111.378 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 91' ' ' ILE . 96.0 mt -93.78 -12.64 28.66 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 115.456 1.65 . . . . 74.519999999999996 115.456 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -67.56 114.6 6.34 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 119.559 1.072 . . . . 55.020000000000003 112.169 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.37 16.37 14.86 Favored Glycine 0 N--CA 1.429 -1.83 0 C-N-CA 119.73 -1.224 . . . . 63.340000000000003 111.789 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 88' ' ' LEU . 11.4 tt -90.81 128.19 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.73 0 N-CA-C 107.669 -1.234 . . . . 75.230000000000004 107.669 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -75.1 121.73 22.5 Favored 'General case' 0 C--N 1.269 -2.898 0 N-CA-C 107.87 -1.159 . . . . 71.099999999999994 107.87 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.43 -32.81 69.03 Favored 'General case' 0 C--N 1.312 -1.033 0 O-C-N 124.357 1.036 . . . . 70.150000000000006 109.04 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -148.06 115.18 3.99 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 107.077 -1.453 . . . . 75.430000000000007 107.077 171.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -62.37 -9.59 15.89 Favored 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 122.685 2.257 . . . . 70.239999999999995 113.185 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -74.46 -19.21 60.47 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.483 0.658 . . . . 74.510000000000005 109.453 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -118.08 146.52 39.4 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.202 -1.036 . . . . 74.019999999999996 108.202 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.19 -16.61 52.53 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.182 1.921 . . . . 74.230000000000004 113.159 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -52.83 125.35 16.62 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.199 1.4 . . . . 73.120000000000005 111.823 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.3 p -112.26 150.3 31.13 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 120.153 -0.619 . . . . 45.420000000000002 110.823 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.2 tp -98.34 127.01 44.08 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.469 -0.938 . . . . 73.420000000000002 108.469 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -122.38 136.03 54.82 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.09 0.471 . . . . 74.349999999999994 109.822 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -110.38 116.25 31.11 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.378 -0.828 . . . . 73.040000000000006 108.965 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 5.3 tp10 -127.19 161.99 27.22 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.73 -0.841 . . . . 73.519999999999996 108.73 -177.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -70.75 139.29 51.03 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 118.514 0.597 . . . . 65.25 110.436 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.16 150.5 31.7 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 109.233 -0.655 . . . . 60.340000000000003 109.233 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -74.18 -6.65 49.03 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.589 -0.732 . . . . 74.530000000000001 111.961 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.16 133.65 7.88 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.772 -0.825 . . . . 38.039999999999999 108.772 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.465 HD22 ' HA ' ' A' ' 30' ' ' VAL . 84.1 m-20 -74.78 108.31 7.44 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.99 -1.115 . . . . 72.239999999999995 107.99 172.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 C--N 1.289 -2.054 0 C-N-CA 119.11 -1.036 . . . . 41.020000000000003 109.823 -179.303 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 32.2 t . . . . . 0 C--O 1.216 -0.687 0 CA-C-O 121.003 0.43 . . . . 71.329999999999998 111.754 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 86.6 mtt180 -91.64 -3.52 56.26 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.124 0.488 . . . . 75.239999999999995 111.634 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.9 m -115.55 128.2 55.81 Favored 'General case' 0 C--N 1.263 -3.16 0 CA-C-O 121.675 0.75 . . . . 53.240000000000002 112.759 -172.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 71.3 mt -110.1 142.41 41.6 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.184 -0.916 . . . . 71.099999999999994 108.697 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -99.38 113.69 26.17 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 106.992 -1.484 . . . . 74.430000000000007 106.992 173.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.405 HG22 ' HG ' ' B' ' 103' ' ' LEU . 53.4 t -102.49 125.67 56.73 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.984 0 CA-C-N 113.953 -1.476 . . . . 72.439999999999998 107.509 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.2 p -139.17 169.56 17.55 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.732 -0.667 . . . . 74.030000000000001 110.219 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 90.56 42.66 5.08 Favored Glycine 0 N--CA 1.422 -2.295 0 N-CA-C 109.465 -1.454 . . . . 71.219999999999999 109.465 -172.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.33 138.25 20.13 Favored Pre-proline 0 N--CA 1.418 -2.066 0 CA-C-N 114.039 -1.08 . . . . 75.310000000000002 108.437 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -54.53 155.83 15.87 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.401 2.068 . . . . 55.149999999999999 110.094 171.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.445 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 8.1 p -83.06 3.93 2.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 122.627 1.203 . . . . 65.030000000000001 108.796 -174.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.93 21.93 6.3 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 114.136 -1.393 . . . . 64.150000000000006 111.056 -173.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 35.2 pt -54.0 137.03 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 113.88 1.067 . . . . 75.310000000000002 113.88 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.485 ' HA ' ' HE3' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -93.36 141.38 23.88 Favored Pre-proline 0 C--N 1.279 -2.467 0 N-CA-C 107.054 -1.461 . . . . 73.420000000000002 107.054 174.425 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.24 -25.53 78.53 Favored 'Trans proline' 0 N--CA 1.478 0.616 0 C-N-CA 122.644 2.229 . . . . 71.129999999999995 113.093 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.461 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 16.7 ptt180 -79.7 -18.0 52.3 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 112.166 0.432 . . . . 63.030000000000001 112.166 -176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . 0.431 ' HG2' ' HG2' ' A' ' 46' ' ' GLU . 31.2 mt-10 -65.31 -40.29 93.56 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.815 0.817 . . . . 75.140000000000001 108.993 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 74.2 mt -67.92 -35.93 79.28 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.556 -1.202 . . . . 73.439999999999998 109.634 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' B' ' 45' ' ' ARG . 50.4 t80 -61.16 -48.18 82.79 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.43 -0.804 . . . . 74.099999999999994 111.144 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 79.8 mt -63.1 -44.31 96.04 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 123.837 0.71 . . . . 63.100000000000001 110.054 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.9 tp -73.02 -41.55 64.11 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.894 -1.048 . . . . 71.239999999999995 111.861 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -96.03 10.03 38.83 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.323 0.861 . . . . 73.010000000000005 113.323 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -70.48 -48.65 17.3 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 120.615 -0.434 . . . . 64.219999999999999 111.725 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.75 -3.85 14.42 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 121.376 1.384 . . . . 72.439999999999998 112.128 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -91.42 94.69 9.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.416 1.103 . . . . 74.319999999999993 111.439 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -64.2 113.24 3.43 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 112.922 -1.944 . . . . 55.409999999999997 110.047 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.88 -21.97 3.68 Favored Glycine 0 C--N 1.287 -2.156 0 CA-C-N 115.097 -0.956 . . . . 63.009999999999998 111.403 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -62.26 105.8 0.65 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.329 0.585 . . . . 73.519999999999996 111.99 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -87.52 -48.6 7.8 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.787 -0.642 . . . . 63.420000000000002 109.609 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.57 170.93 43.55 Favored Glycine 0 C--N 1.298 -1.529 0 C-N-CA 120.741 -0.742 . . . . 53.229999999999997 112.0 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.7 p -128.8 138.1 51.89 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 122.684 0.394 . . . . 63.439999999999998 110.432 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 87.6 mt -112.99 112.88 24.64 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.526 -0.916 . . . . 71.310000000000002 108.526 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 50.4 mm -93.81 133.05 36.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.651 -0.499 . . . . 74.230000000000004 109.651 -176.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -128.3 126.69 41.32 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.097 -1.446 . . . . 74.5 107.097 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.72 125.88 29.93 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.698 0.761 . . . . 65.129999999999995 112.758 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.3 m -113.6 155.89 24.65 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 103.811 -2.663 . . . . 54.229999999999997 103.811 173.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.88 -35.15 31.36 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 114.322 1.23 . . . . 54.130000000000003 114.322 -172.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -104.91 -14.57 15.42 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 113.237 0.829 . . . . 75.019999999999996 113.237 -175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -172.81 147.85 1.65 Allowed Pre-proline 0 N--CA 1.468 0.473 0 CA-C-O 120.753 0.311 . . . . 61.119999999999997 110.258 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.445 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 46.2 Cg_endo -78.63 122.85 5.65 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 C-N-CA 122.347 2.032 . . . . 74.129999999999995 110.263 169.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 35.2 m -94.03 155.05 3.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.082 -1.081 . . . . 71.219999999999999 108.082 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.49 121.65 3.55 Favored Glycine 0 CA--C 1.474 -2.501 0 C-N-CA 118.868 -1.634 . . . . 63.329999999999998 113.301 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -88.17 102.46 14.82 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.754 -1.572 . . . . 75.329999999999998 106.754 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.18 122.9 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 CA-C-N 115.195 -0.911 . . . . 64.030000000000001 109.539 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 62.6 mt -102.68 120.71 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.418 0 CA-C-N 113.846 -1.525 . . . . 53.43 109.448 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . 0.405 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 71.5 m-85 -105.06 161.21 14.43 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 114.112 -1.404 . . . . 73.219999999999999 109.846 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.57 -29.97 71.0 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.21 -0.904 . . . . 73.439999999999998 111.807 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 29.7 p -161.67 165.87 27.58 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.045 0.538 . . . . 73.519999999999996 110.072 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -22.58 62.51 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.529 -0.468 . . . . 43.439999999999998 110.314 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.15 -28.12 69.54 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.452 0.644 . . . . 54.409999999999997 110.383 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.38 -39.91 7.1 Favored Glycine 0 C--N 1.308 -1.023 0 N-CA-C 110.2 -1.16 . . . . 53.039999999999999 110.2 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.49 -43.68 98.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.503 -0.849 . . . . 62.5 111.825 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.93 -39.69 90.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 74.310000000000002 111.472 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.11 -37.83 64.01 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.082 0.468 . . . . 74.109999999999999 110.135 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.36 -40.54 77.43 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.48 -0.782 . . . . 53.310000000000002 111.083 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.522 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 14.5 ptmm? -68.18 -40.77 82.15 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 120.303 -0.559 . . . . 74.239999999999995 110.668 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -66.79 -25.26 66.38 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 120.71 -0.396 . . . . 74.239999999999995 111.925 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.67 -41.51 17.67 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 120.839 0.352 . . . . 75.519999999999996 111.281 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.541 ' O ' HG23 ' B' ' 91' ' ' ILE . 96.9 mt -96.26 -14.0 22.98 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 115.623 1.712 . . . . 62.100000000000001 115.623 -173.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.43 116.06 12.42 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 118.803 -1.159 . . . . 74.25 112.523 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.82 26.64 7.45 Favored Glycine 0 N--CA 1.428 -1.877 0 C-N-CA 120.49 -0.862 . . . . 71.239999999999995 111.373 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.541 HG23 ' O ' ' B' ' 88' ' ' LEU . 16.5 tt -114.95 133.71 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.551 0 N-CA-C 107.325 -1.361 . . . . 74.219999999999999 107.325 174.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.66 134.47 51.18 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-O 121.086 0.469 . . . . 72.540000000000006 110.634 172.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -70.8 -30.35 66.78 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.529 -1.214 . . . . 63.030000000000001 109.039 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' B' ' 97' ' ' ASN . 8.5 t70 -144.31 118.97 5.93 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 104.544 -2.391 . . . . 74.010000000000005 104.544 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . 0.52 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 31.8 Cg_endo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.907 2.405 . . . . 74.319999999999993 113.819 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -94.21 4.46 53.86 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.609 0.719 . . . . 74.530000000000001 111.123 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . 56.2 t30 -118.84 130.34 24.88 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 107.514 -1.291 . . . . 74.310000000000002 107.514 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.44 -13.43 33.01 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 123.046 2.497 . . . . 75.549999999999997 113.972 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -67.33 116.53 8.19 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-O 121.379 0.609 . . . . 75.010000000000005 110.28 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.591 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 58.2 p -106.48 145.17 32.14 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.824 -0.625 . . . . 54.310000000000002 109.916 -176.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 33.4 tp -94.13 128.97 40.85 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 110.025 -0.361 . . . . 71.329999999999998 110.025 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' B' ' 104' ' ' GLU . 6.0 ptm180 -129.02 127.44 41.61 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.914 -0.402 . . . . 54.109999999999999 109.914 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.405 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.7 mp -115.06 118.84 34.51 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.608 -0.723 . . . . 74.540000000000006 110.034 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.522 ' HA ' ' CE ' ' B' ' 85' ' ' LYS . 34.3 mt-10 -137.81 162.0 35.1 Favored 'General case' 0 C--O 1.199 -1.574 0 C-N-CA 122.739 0.415 . . . . 74.140000000000001 110.378 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -69.39 132.91 47.12 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 118.295 0.498 . . . . 74.510000000000005 111.355 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.59 154.47 34.39 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.413 -0.588 . . . . 65.310000000000002 109.413 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -84.28 9.15 13.73 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 120.876 0.369 . . . . 75.430000000000007 111.567 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.81 130.41 11.5 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.638 -0.504 . . . . 60.530000000000001 109.638 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -76.68 121.45 23.28 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 108.676 -0.861 . . . . 70.329999999999998 108.676 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 C--N 1.287 -2.141 0 N-CA-C 109.225 -0.657 . . . . 74.140000000000001 109.225 -177.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.5 t . . . . . 0 C--O 1.214 -0.769 0 CA-C-O 121.363 0.602 . . . . 71.120000000000005 110.917 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.632 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 69.0 mtt180 -91.93 -22.63 19.93 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 122.352 1.072 . . . . 73.340000000000003 109.518 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 18.1 m -96.07 122.7 39.18 Favored 'General case' 0 C--N 1.258 -3.396 0 CA-C-N 113.471 -1.695 . . . . 73.340000000000003 112.018 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.414 HD22 ' O ' ' A' ' 73' ' ' VAL . 2.1 pt? -115.59 142.11 47.17 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 107.554 -1.276 . . . . 75.540000000000006 107.554 175.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 104' ' ' GLU . 26.2 p90 -96.57 122.18 39.2 Favored 'General case' 0 N--CA 1.417 -2.091 0 C-N-CA 118.779 -1.168 . . . . 71.230000000000004 109.272 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.27 108.78 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.586 0 N-CA-C 106.419 -1.697 . . . . 62.399999999999999 106.419 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 32.2 p -115.76 172.95 6.81 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 108.93 -0.767 . . . . 74.030000000000001 108.93 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 87.13 41.38 6.64 Favored Glycine 0 N--CA 1.418 -2.56 0 N-CA-C 109.897 -1.281 . . . . 74.099999999999994 109.897 -174.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.9 mt -114.81 145.14 33.32 Favored Pre-proline 0 N--CA 1.423 -1.777 0 N-CA-C 107.201 -1.407 . . . . 72.129999999999995 107.201 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.43 171.26 15.01 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.558 1.505 . . . . 72.430000000000007 110.199 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.5 p -71.31 -7.53 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 CA-C-O 122.574 1.178 . . . . 71.349999999999994 109.932 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -103.3 20.02 18.55 Favored 'General case' 0 C--O 1.203 -1.392 0 CA-C-N 114.035 -1.439 . . . . 65.200000000000003 109.386 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.98 123.51 27.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.261 0 CA-C-O 121.622 0.725 . . . . 73.219999999999999 110.715 178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -101.18 145.76 30.98 Favored Pre-proline 0 C--N 1.307 -1.244 0 C-N-CA 124.831 1.252 . . . . 74.019999999999996 111.44 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.56 -17.86 60.55 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.295 2.664 . . . . 70.450000000000003 114.557 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.548 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -86.73 -17.24 34.1 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 117.71 -1.596 . . . . 71.319999999999993 110.961 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -66.7 -42.16 86.86 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.133 0.492 . . . . 74.010000000000005 110.155 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.19 -37.35 87.04 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.191 -0.67 . . . . 55.420000000000002 109.191 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.683 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 61.0 t80 -59.38 -48.72 80.56 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.13 -0.941 . . . . 61.420000000000002 110.732 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 86.6 mt -61.59 -41.61 97.68 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.918 0.761 . . . . 73.510000000000005 110.32 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.9 tp -70.61 -42.19 71.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.286 -0.87 . . . . 71.329999999999998 111.79 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -86.72 7.13 28.03 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.851 1.056 . . . . 75.549999999999997 113.851 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.489 ' HA ' ' NE ' ' A' ' 52' ' ' ARG . 3.9 mmp_? -52.83 -50.33 81.94 Favored Pre-proline 0 N--CA 1.486 1.326 0 N-CA-C 113.924 1.083 . . . . 74.420000000000002 113.924 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -76.5 -0.91 10.92 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 121.914 1.743 . . . . 54.340000000000003 113.863 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.417 ' CE2' ' HA ' ' A' ' 84' ' ' ALA . 60.6 m-85 -98.76 115.33 28.53 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 121.945 0.879 . . . . 64.530000000000001 112.364 -174.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.08 120.93 24.89 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 113.814 -1.539 . . . . 61.240000000000002 109.511 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.7 -14.0 6.09 Favored Glycine 0 C--N 1.276 -2.791 0 CA-C-N 114.958 -1.019 . . . . 73.319999999999993 113.037 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -58.33 107.31 0.48 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.044 0.422 . . . . 73.010000000000005 111.003 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.478 ' OE2' ' HA ' ' A' ' 76' ' ' ASP . 22.5 mt-10 -96.21 -33.96 11.83 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 120.579 -0.449 . . . . 74.430000000000007 110.987 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.77 -179.22 48.39 Favored Glycine 0 C--N 1.302 -1.334 0 C-N-CA 120.131 -1.033 . . . . 38.07 112.418 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.7 p -145.74 138.17 25.63 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.201 0.6 . . . . 73.040000000000006 110.409 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.0 mp -120.5 124.75 46.16 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.373 -0.973 . . . . 75.510000000000005 108.373 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.2 mm -93.96 138.02 21.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.983 -0.747 . . . . 65.209999999999994 108.983 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -126.39 112.09 15.24 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.091 -1.077 . . . . 75.150000000000006 108.091 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.92 116.41 13.39 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.671 -0.695 . . . . 75.109999999999999 110.746 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -109.03 152.2 25.32 Favored 'General case' 0 N--CA 1.396 -3.156 0 N-CA-C 102.296 -3.224 . . . . 74.549999999999997 102.296 171.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.82 -40.53 29.58 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.981 0.734 . . . . 42.299999999999997 112.981 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -85.16 -49.24 8.4 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.31 0.576 . . . . 74.349999999999994 112.019 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -138.47 127.07 14.18 Favored Pre-proline 0 C--N 1.283 -2.297 0 CA-C-N 115.718 -0.674 . . . . 71.409999999999997 112.334 -168.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.84 101.5 1.2 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.585 2.19 . . . . 64.329999999999998 108.689 166.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.39 152.16 3.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.773 -0.825 . . . . 71.329999999999998 108.773 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.76 119.99 4.53 Favored Glycine 0 CA--C 1.473 -2.555 0 C-N-CA 118.632 -1.746 . . . . 61.100000000000001 111.989 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -87.83 106.18 17.91 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 106.675 -1.602 . . . . 75.549999999999997 106.675 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.414 ' O ' HD22 ' A' ' 33' ' ' LEU . 98.5 t -96.14 130.56 44.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 115.326 -0.852 . . . . 74.120000000000005 109.659 -177.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.8 mp -102.95 117.91 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.606 0 CA-C-N 115.079 -0.964 . . . . 63.109999999999999 108.945 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.632 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 7.4 m-85 -98.48 163.38 12.71 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.854 -1.066 . . . . 75.340000000000003 108.992 172.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.478 ' HA ' ' OE2' ' A' ' 58' ' ' GLU . 10.7 t70 -51.27 -39.27 56.37 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 123.944 0.778 . . . . 74.019999999999996 111.65 176.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.8 m -160.7 166.17 29.24 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.181 -0.918 . . . . 43.009999999999998 110.428 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.591 ' HD3' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -55.28 -32.66 62.57 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.975 0.91 . . . . 74.109999999999999 111.029 176.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.438 ' HA ' ' OE2' ' A' ' 82' ' ' GLU . . . -64.35 -26.07 68.31 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.825 0.821 . . . . 53.039999999999999 110.534 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.77 -44.27 5.51 Favored Glycine 0 C--N 1.285 -2.284 0 N-CA-C 109.855 -1.298 . . . . 62.439999999999998 109.855 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.95 -39.23 91.4 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.379 -0.91 . . . . 71.030000000000001 110.932 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.438 ' OE2' ' HA ' ' A' ' 79' ' ' ALA . 14.8 pt-20 -62.75 -41.48 99.23 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 123.139 0.274 . . . . 64.340000000000003 110.764 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.32 -37.41 80.53 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-O 121.28 0.562 . . . . 73.049999999999997 110.673 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.417 ' HA ' ' CE2' ' A' ' 54' ' ' PHE . . . -69.54 -42.7 74.26 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.618 -0.719 . . . . 74.25 111.411 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.41 ' HG2' ' HA ' ' A' ' 82' ' ' GLU . 14.9 ptmm? -70.08 -33.45 71.92 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.331 -0.548 . . . . 73.049999999999997 110.8 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.12 -44.11 95.14 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 123.432 0.458 . . . . 72.340000000000003 110.921 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.72 -41.5 23.5 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 120.288 -0.565 . . . . 72.219999999999999 112.009 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.42 ' O ' HG21 ' A' ' 91' ' ' ILE . 94.3 mt -89.08 -20.66 24.04 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 116.335 1.976 . . . . 75.430000000000007 116.335 -170.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -67.58 115.01 6.69 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 120.1 1.318 . . . . 55.310000000000002 110.083 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.43 13.72 16.32 Favored Glycine 0 N--CA 1.415 -2.75 0 CA-C-N 115.69 -0.686 . . . . 75.540000000000006 111.472 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.42 HG21 ' O ' ' A' ' 88' ' ' LEU . 14.5 tt -92.12 132.86 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.652 0 CA-C-O 121.411 0.624 . . . . 72.200000000000003 110.068 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 94' ' ' ASP . 30.2 mmt180 -63.81 137.23 57.96 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.854 -1.066 . . . . 65.219999999999999 108.248 172.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.447 ' CD1' HD12 ' A' ' 101' ' ' LEU . 7.1 t80 -77.32 -30.77 54.2 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.872 -1.529 . . . . 72.140000000000001 106.872 174.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.61 ' OD2' ' HB3' ' B' ' 45' ' ' ARG 0.294 5.0 m-20 -144.66 136.92 13.24 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 100.823 -3.769 . . . . 61.520000000000003 100.823 171.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.572 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 49.3 Cg_endo -71.88 -5.9 18.02 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 CA-C-N 121.943 1.729 . . . . 74.230000000000004 109.815 172.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -94.94 6.43 49.07 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.986 1.314 . . . . 75.420000000000002 109.154 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.487 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 48.4 t-20 -129.21 131.25 23.56 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 108.825 -0.806 . . . . 74.319999999999993 108.825 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -70.44 -6.46 18.98 Favored 'Trans proline' 0 C--O 1.25 1.121 0 C-N-CA 123.361 2.707 . . . . 75.450000000000003 113.082 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -84.54 118.72 24.5 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 108.927 -0.768 . . . . 73.0 108.927 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.472 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 37.0 p -120.4 146.39 46.24 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.558 -0.746 . . . . 73.019999999999996 109.138 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 36' ' ' SER . 7.5 mp -80.8 137.79 36.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.442 0.639 . . . . 64.040000000000006 111.637 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -129.63 105.75 8.26 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 107.263 -1.384 . . . . 73.409999999999997 107.263 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -97.94 117.17 31.69 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.047 -0.978 . . . . 63.539999999999999 108.784 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.551 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 32.9 tt0 -136.61 160.43 38.83 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.572 -1.64 . . . . 71.040000000000006 106.572 -177.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -70.0 139.43 52.75 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 119.263 0.938 . . . . 74.230000000000004 110.492 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.28 145.07 46.36 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.337 -0.616 . . . . 71.549999999999997 109.337 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.52 2.19 14.54 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.78 -0.645 . . . . 73.230000000000004 111.536 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.26 115.78 4.78 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.162 -1.051 . . . . 61.210000000000001 108.162 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -69.13 123.21 20.48 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 107.876 -1.157 . . . . 74.510000000000005 107.876 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.6 m . . . . . 0 C--N 1.295 -1.767 0 C-N-CA 120.99 -0.284 . . . . 72.140000000000001 110.636 -174.167 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--O 1.224 -0.246 0 CA-C-O 121.52 0.676 . . . . 75.439999999999998 112.155 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -96.3 -17.38 20.74 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 115.066 -0.97 . . . . 64.219999999999999 110.363 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 13.6 m -99.2 129.65 45.45 Favored 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 114.991 -1.004 . . . . 71.340000000000003 112.83 -170.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.409 HD23 ' O ' ' B' ' 73' ' ' VAL . 2.4 pt? -123.87 151.39 43.52 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 107.241 -1.392 . . . . 71.340000000000003 107.241 174.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.594 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 18.3 p90 -105.4 123.98 48.78 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 121.896 0.855 . . . . 74.439999999999998 109.585 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.435 HG21 ' HG ' ' B' ' 103' ' ' LEU . 43.5 t -97.79 115.41 37.67 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 107.004 -1.48 . . . . 73.140000000000001 107.004 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 23.8 p -119.04 168.36 10.9 Favored 'General case' 0 C--N 1.274 -2.703 0 CA-C-N 115.309 -0.86 . . . . 61.520000000000003 108.786 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 89.69 31.13 11.7 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.749 -0.94 . . . . 72.420000000000002 110.749 -175.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 88.9 mt -104.2 114.31 64.44 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.076 -1.453 . . . . 63.450000000000003 107.076 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.15 156.85 19.09 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.102 1.868 . . . . 74.219999999999999 110.43 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.22 -10.51 9.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 122.174 0.988 . . . . 74.409999999999997 111.27 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -98.04 8.3 44.98 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 114.869 -1.059 . . . . 72.010000000000005 110.054 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.49 121.53 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 CA-C-O 121.583 0.706 . . . . 64.420000000000002 111.489 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.444 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 3.2 mptp? -85.58 145.81 42.79 Favored Pre-proline 0 C--N 1.315 -0.906 0 C-N-CA 124.39 1.076 . . . . 74.209999999999994 109.923 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.19 -23.53 74.16 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.526 2.151 . . . . 64.549999999999997 112.972 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.61 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 13.2 ptt180 -77.46 -24.48 50.24 Favored 'General case' 0 N--CA 1.425 -1.681 0 O-C-N 122.279 -0.263 . . . . 63.119999999999997 111.126 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 43.3 mt-10 -68.09 -33.63 74.9 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.276 0.56 . . . . 74.209999999999994 110.001 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 48.8 mt -63.09 -47.11 84.25 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.281 -1.007 . . . . 70.230000000000004 108.281 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.587 ' O ' ' HG3' ' B' ' 52' ' ' ARG . 11.5 t80 -58.83 -44.62 90.95 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.431 -1.259 . . . . 74.329999999999998 111.175 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 93.5 mt -65.24 -39.14 92.31 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.007 0.432 . . . . 73.319999999999993 110.884 -178.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 34.7 tp -78.97 -40.52 31.49 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 115.931 -0.577 . . . . 71.319999999999993 112.121 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -89.88 0.91 56.78 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 115.519 1.674 . . . . 64.040000000000006 115.519 -174.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 14.3 mtp180 -61.36 -47.52 93.62 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 114.459 1.281 . . . . 73.219999999999999 114.459 176.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -72.08 -4.24 14.79 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.257 1.305 . . . . 73.209999999999994 112.377 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -92.42 93.4 8.57 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.915 0.864 . . . . 72.120000000000005 111.428 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . 0.461 ' HD3' ' H ' ' B' ' 55' ' ' LYS . 0.1 OUTLIER -65.35 111.76 3.19 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.085 -1.416 . . . . 72.049999999999997 110.143 178.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.14 -15.54 4.24 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.331 -0.85 . . . . 75.099999999999994 112.702 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -61.9 109.39 1.24 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 117.099 0.45 . . . . 75.329999999999998 110.747 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -86.56 -38.2 17.4 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.175 -1.046 . . . . 72.239999999999995 108.175 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.7 178.9 40.58 Favored Glycine 0 C--N 1.311 -0.826 0 CA-C-N 115.014 -0.994 . . . . 38.07 112.023 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.6 p -135.1 148.74 49.9 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 122.456 0.302 . . . . 63.020000000000003 110.973 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 54.3 tp -126.31 111.74 14.89 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.974 -1.121 . . . . 72.400000000000006 107.974 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.418 ' CG2' ' HB2' ' B' ' 69' ' ' PRO . 46.5 mm -94.24 134.34 32.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 110.228 -0.286 . . . . 73.5 110.228 -175.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -124.35 114.91 20.16 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.219 -0.66 . . . . 52.219999999999999 109.219 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.08 125.34 26.36 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.216 0.531 . . . . 74.010000000000005 109.58 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 16.0 m -125.04 159.38 31.48 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 106.145 -1.798 . . . . 61.219999999999999 106.145 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.04 -40.54 15.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.17 0.988 . . . . 44.219999999999999 112.946 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -88.93 -47.7 7.97 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.857 0.688 . . . . 50.299999999999997 112.857 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.458 ' O ' ' HB ' ' B' ' 65' ' ' THR . 26.4 pt20 -155.68 149.0 18.49 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 116.041 -0.527 . . . . 72.400000000000006 110.048 -170.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.418 ' HB2' ' CG2' ' B' ' 62' ' ' ILE . 49.9 Cg_endo -79.07 108.58 2.41 Favored 'Trans proline' 0 N--CA 1.436 -1.899 0 C-N-CA 122.146 1.898 . . . . 55.119999999999997 109.981 170.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.03 151.32 4.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.5 -0.773 . . . . 53.439999999999998 109.061 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.13 120.69 4.73 Favored Glycine 0 CA--C 1.478 -2.244 0 C-N-CA 118.162 -1.97 . . . . 51.310000000000002 113.681 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -88.41 105.44 17.6 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 106.467 -1.679 . . . . 63.43 106.467 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.409 ' O ' HD23 ' B' ' 33' ' ' LEU . 74.6 t -100.15 130.67 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 CA-C-O 121.421 0.629 . . . . 74.219999999999999 110.3 -176.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.52 119.77 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 CA-C-N 114.708 -1.133 . . . . 74.430000000000007 108.724 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -102.78 168.37 9.28 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 115.208 -0.906 . . . . 62.539999999999999 111.358 174.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.96 -43.67 50.28 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.289 -1.323 . . . . 75.109999999999999 110.792 172.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 11.5 p -166.03 169.68 14.35 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.045 -0.98 . . . . 75.510000000000005 110.894 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -30.53 71.65 Favored 'General case' 0 C--O 1.213 -0.822 0 O-C-N 123.194 0.309 . . . . 75.310000000000002 110.182 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.98 67.38 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 122.361 1.077 . . . . 71.0 109.469 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.5 -43.69 5.45 Favored Glycine 0 C--N 1.294 -1.791 0 CA-C-N 113.536 -1.665 . . . . 64.340000000000003 110.678 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.79 -36.9 85.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.556 -0.822 . . . . 72.540000000000006 111.798 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 9.9 pt-20 -60.75 -41.23 94.99 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 120.747 0.308 . . . . 73.329999999999998 110.64 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.72 -39.4 80.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.998 0.428 . . . . 63.229999999999997 110.162 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.29 82.39 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.371 -0.831 . . . . 75.030000000000001 111.198 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' B' ' 82' ' ' GLU . 13.1 ptmm? -69.54 -32.19 70.86 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 116.233 -0.44 . . . . 65.310000000000002 110.861 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -70.95 -28.83 64.76 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 111.987 0.366 . . . . 74.439999999999998 111.987 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.71 -32.8 25.33 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 120.436 -0.505 . . . . 65.439999999999998 111.694 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.548 ' O ' HG22 ' B' ' 91' ' ' ILE . 92.7 mt -107.8 -4.39 18.11 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 115.443 1.645 . . . . 74.530000000000001 115.443 -173.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -79.03 114.78 18.25 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 117.786 -1.566 . . . . 74.209999999999994 110.272 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.9 3.96 48.64 Favored Glycine 0 CA--C 1.479 -2.211 0 C-N-CA 120.564 -0.827 . . . . 73.099999999999994 111.911 174.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.548 HG22 ' O ' ' B' ' 88' ' ' LEU . 15.5 tt -96.5 137.61 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.056 0 N-CA-C 107.312 -1.366 . . . . 73.239999999999995 107.312 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.28 142.14 39.62 Favored 'General case' 0 C--N 1.265 -3.071 0 CA-C-O 121.35 0.595 . . . . 62.229999999999997 112.537 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.444 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 39.8 t80 -67.69 -37.0 81.72 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.798 -1.546 . . . . 71.409999999999997 108.991 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.547 ' HB2' ' CB ' ' B' ' 97' ' ' ASN 0.277 3.9 m-20 -131.13 133.81 25.1 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 101.831 -3.396 . . . . 60.340000000000003 101.831 174.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . 0.683 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 18.7 Cg_endo -61.04 -29.9 88.56 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 CA-C-N 121.993 1.748 . . . . 62.509999999999998 112.026 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -94.91 15.93 17.38 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.544 -0.753 . . . . 52.399999999999999 111.133 -175.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' ASN . . . . . 0.547 ' CB ' ' HB2' ' B' ' 94' ' ' ASP . 57.7 t-20 -122.82 131.86 24.33 Favored Pre-proline 0 C--N 1.312 -1.054 0 N-CA-C 107.225 -1.398 . . . . 60.409999999999997 107.225 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.91 -3.42 13.58 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.279 1.986 . . . . 73.200000000000003 112.57 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' GLN . . . . . 0.425 ' HA ' ' OE1' ' B' ' 99' ' ' GLN . 5.8 tp60 -76.59 112.23 12.92 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.958 -0.756 . . . . 74.329999999999998 108.958 177.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.508 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 81.6 p -105.49 144.85 31.68 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.647 -0.706 . . . . 65.109999999999999 110.278 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 81.0 mt -79.53 135.97 36.76 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.431 -0.952 . . . . 64.120000000000005 108.431 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -131.42 112.79 13.01 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.744 -1.206 . . . . 73.420000000000002 107.744 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.435 ' HG ' HG21 ' B' ' 35' ' ' VAL . 7.6 mp -103.12 118.21 36.28 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.601 -0.727 . . . . 64.140000000000001 109.61 177.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.594 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 6.5 tp10 -135.29 157.12 47.71 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 105.684 -1.969 . . . . 74.0 105.684 -177.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -69.33 142.24 54.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 119.74 1.154 . . . . 65.420000000000002 110.961 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.47 153.11 25.79 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.888 -1.153 . . . . 53.520000000000003 107.888 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -94.3 13.01 24.89 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.908 -1.117 . . . . 73.219999999999999 109.235 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.4 114.86 10.44 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.71 -1.218 . . . . 55.509999999999998 107.71 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -85.01 104.44 14.94 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.236 -1.394 . . . . 74.409999999999997 107.236 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 16.3 m . . . . . 0 C--N 1.288 -2.099 0 CA-C-N 116.07 -0.514 . . . . 74.230000000000004 110.895 -170.521 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 105.941 -1.874 . . . . 74.340000000000003 105.941 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 24.2 mtt180 -104.02 0.88 30.41 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.778 -0.769 . . . . 64.409999999999997 111.066 -172.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.1 m -104.69 125.49 50.84 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-O 121.391 0.615 . . . . 73.25 112.597 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.414 HD13 ' CE1' ' A' ' 75' ' ' PHE . 73.5 mt -109.73 138.03 46.68 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.554 -0.906 . . . . 55.530000000000001 108.554 173.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -96.31 110.55 22.86 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 107.345 -1.354 . . . . 74.030000000000001 107.345 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -97.67 124.51 50.68 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.767 0 CA-C-N 114.168 -1.378 . . . . 72.530000000000001 108.623 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.7 p -129.45 164.72 23.08 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.166 -0.924 . . . . 75.150000000000006 110.111 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 92.85 29.89 10.13 Favored Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.924 -0.87 . . . . 50.549999999999997 110.924 -173.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.9 mt -95.23 122.19 60.32 Favored Pre-proline 0 N--CA 1.425 -1.699 0 N-CA-C 106.04 -1.837 . . . . 71.209999999999994 106.04 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -55.41 153.32 28.73 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.161 1.908 . . . . 74.239999999999995 111.7 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.5 p -61.34 -12.91 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.918 0.887 . . . . 74.120000000000005 111.423 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -127.94 40.74 3.63 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.623 -0.88 . . . . 74.120000000000005 108.623 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.7 tt -72.08 132.02 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.459 -0.791 . . . . 72.519999999999996 109.087 172.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -90.26 145.8 33.47 Favored Pre-proline 0 C--N 1.276 -2.619 0 N-CA-C 108.584 -0.895 . . . . 71.230000000000004 108.584 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.66 -29.3 84.92 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.478 2.119 . . . . 73.239999999999995 111.728 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.509 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 13.2 ptt180 -70.85 -22.06 62.36 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 115.44 -0.8 . . . . 72.409999999999997 111.738 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.47 -38.27 77.66 Favored 'General case' 0 CA--C 1.506 -0.729 0 O-C-N 122.058 -0.401 . . . . 45.109999999999999 110.451 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.22 -34.0 76.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 122.042 0.925 . . . . 55.149999999999999 108.768 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.569 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 56.5 t80 -65.46 -48.83 71.34 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.573 -1.194 . . . . 71.129999999999995 110.169 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 95.5 mt -65.17 -43.57 91.32 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 123.606 0.566 . . . . 71.099999999999994 110.045 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.2 tp -65.59 -43.14 90.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.034 -0.985 . . . . 54.299999999999997 111.147 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -95.73 14.88 21.71 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 113.156 0.799 . . . . 72.239999999999995 113.156 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 3.2 mmp_? -55.37 -51.14 82.4 Favored Pre-proline 0 N--CA 1.486 1.351 0 N-CA-C 112.452 0.538 . . . . 62.020000000000003 112.452 174.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.33 -1.61 11.17 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 121.859 1.706 . . . . 65.439999999999998 112.918 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -93.63 89.74 6.35 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.52 0.676 . . . . 73.209999999999994 111.867 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -65.45 112.22 3.45 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.716 -1.129 . . . . 64.230000000000004 108.597 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 75' ' ' PHE . . . 132.96 -10.56 5.14 Favored Glycine 0 C--N 1.286 -2.206 0 C-N-CA 119.306 -1.426 . . . . 73.409999999999997 112.943 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -69.09 94.81 0.69 Allowed 'General case' 0 C--O 1.243 0.712 0 CA-C-N 117.626 0.713 . . . . 74.310000000000002 109.162 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -84.59 -44.35 13.6 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.032 -0.531 . . . . 62.25 109.879 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -168.8 179.43 41.64 Favored Glycine 0 C--N 1.296 -1.658 0 C-N-CA 120.645 -0.788 . . . . 73.099999999999994 111.867 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.8 p -151.44 140.72 21.37 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 122.801 0.44 . . . . 72.329999999999998 109.844 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.1 tp -111.96 109.56 19.41 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.322 -0.992 . . . . 72.219999999999999 108.322 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.41 129.65 44.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.563 -0.532 . . . . 74.409999999999997 109.563 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -123.4 123.09 39.89 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.37 -0.974 . . . . 74.099999999999994 108.37 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.69 118.06 21.17 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.406 0.622 . . . . 71.109999999999999 110.56 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 14.2 m -107.99 155.41 20.37 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 104.577 -2.379 . . . . 75.109999999999999 104.577 175.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.38 -33.71 31.11 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.265 1.209 . . . . 70.25 114.265 -172.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -105.07 -17.45 14.49 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 118.923 -1.111 . . . . 64.319999999999993 113.138 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.419 ' O ' ' HB ' ' A' ' 65' ' ' THR . 28.9 pt20 -164.56 148.73 7.99 Favored Pre-proline 0 C--N 1.321 -0.654 0 C-N-CA 120.662 -0.415 . . . . 72.340000000000003 110.725 -173.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -80.94 121.7 4.1 Favored 'Trans proline' 0 N--CA 1.429 -2.292 0 C-N-CA 121.856 1.704 . . . . 70.530000000000001 109.671 168.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.82 146.94 5.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 107.676 -1.231 . . . . 72.209999999999994 107.676 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.33 120.77 3.13 Favored Glycine 0 CA--C 1.48 -2.13 0 C-N-CA 118.363 -1.875 . . . . 65.239999999999995 113.238 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -88.0 101.82 14.14 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.534 -1.654 . . . . 62.210000000000001 106.534 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.6 t -92.18 126.23 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 CA-C-N 115.688 -0.687 . . . . 65.329999999999998 110.031 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.6 mt -100.83 111.28 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.406 0 CA-C-N 114.287 -1.324 . . . . 55.229999999999997 108.32 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.514 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 80.8 m-85 -95.84 169.17 10.19 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 114.926 -1.034 . . . . 62.140000000000001 110.994 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.6 -44.13 97.08 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.304 -1.316 . . . . 72.230000000000004 112.561 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.9 p -152.78 165.71 34.5 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 122.427 -0.171 . . . . 72.420000000000002 111.016 -172.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -27.95 47.51 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.246 -1.02 . . . . 74.030000000000001 108.246 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.44 -26.18 65.38 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.245 -0.888 . . . . 63.130000000000003 108.766 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.46 -40.46 8.38 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.324 -1.11 . . . . 61.439999999999998 110.324 176.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.15 92.92 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.286 0.635 . . . . 54.200000000000003 112.528 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.47 -31.47 70.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 119.769 -0.772 . . . . 64.430000000000007 112.11 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.4 -42.52 68.23 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.148 0.499 . . . . 52.240000000000002 110.018 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.01 -42.36 97.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.651 -0.704 . . . . 74.319999999999993 111.295 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.449 ' CE ' ' HA ' ' A' ' 104' ' ' GLU . 13.8 ptmm? -67.97 -36.9 80.84 Favored 'General case' 0 C--O 1.198 -1.648 0 C-N-CA 120.248 -0.581 . . . . 73.409999999999997 109.85 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -67.15 -19.79 65.65 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 112.974 0.731 . . . . 74.540000000000006 112.974 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.34 -45.57 10.45 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-O 121.276 0.56 . . . . 65.409999999999997 110.236 175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.518 ' O ' HG22 ' A' ' 91' ' ' ILE . 93.8 mt -94.13 -19.16 21.05 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 116.17 1.915 . . . . 73.209999999999994 116.17 -171.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.293 0.2 OUTLIER -76.55 116.99 17.75 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 120.662 -1.273 . . . . 54.130000000000003 113.335 -177.196 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.75 19.83 9.39 Favored Glycine 0 N--CA 1.423 -2.225 0 C-N-CA 120.689 -0.767 . . . . 62.329999999999998 112.142 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 88' ' ' LEU . 18.1 tt -112.91 135.84 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.212 0 N-CA-C 108.166 -1.05 . . . . 72.129999999999995 108.166 176.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.424 ' NH1' ' HA ' ' A' ' 98' ' ' PRO . 63.5 mtt180 -72.75 128.11 34.57 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 116.242 -0.435 . . . . 73.209999999999994 109.901 174.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -57.57 -32.26 66.97 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 124.983 1.427 . . . . 70.420000000000002 109.932 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.595 ' OD2' ' HB3' ' B' ' 45' ' ' ARG 0.284 8.8 m-20 -133.53 140.27 36.39 Favored Pre-proline 0 CA--C 1.496 -1.132 0 N-CA-C 103.326 -2.842 . . . . 54.0 103.326 170.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.506 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 34.7 Cg_endo -70.89 -17.28 32.57 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 CA-C-N 121.229 1.475 . . . . 74.420000000000002 111.771 173.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -86.66 -12.47 48.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.132 0.491 . . . . 62.350000000000001 110.096 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.59 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 44.7 t-20 -103.76 131.98 21.49 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 109.078 -0.712 . . . . 72.219999999999999 109.078 -172.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.424 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 45.1 Cg_endo -70.43 -14.56 34.09 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.465 2.11 . . . . 71.230000000000004 112.407 176.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -65.24 115.89 6.03 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 109.458 -0.571 . . . . 61.219999999999999 109.458 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.483 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 60.6 p -102.62 139.92 37.57 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 119.946 -0.701 . . . . 72.519999999999996 110.026 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.9 tp -94.78 123.25 38.13 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.669 -0.864 . . . . 64.120000000000005 108.669 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -137.32 128.4 27.67 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 119.607 -0.837 . . . . 74.120000000000005 110.473 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.65 125.29 50.81 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.315 -1.312 . . . . 63.530000000000001 108.38 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.449 ' HA ' ' CE ' ' A' ' 85' ' ' LYS . 26.0 tt0 -136.32 155.36 50.18 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.818 -1.179 . . . . 60.009999999999998 107.818 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -66.57 132.13 47.53 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 119.028 0.831 . . . . 73.329999999999998 111.822 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.09 152.6 36.76 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.19 -1.041 . . . . 73.019999999999996 108.19 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -93.24 15.59 15.12 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.66 1.219 . . . . 73.239999999999995 110.319 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -153.86 125.83 7.8 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.738 -1.119 . . . . 72.439999999999998 108.373 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.12 123.56 21.0 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.033 -1.099 . . . . 75.129999999999995 108.033 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 C--N 1.269 -2.916 0 N-CA-C 107.327 -1.361 . . . . 61.420000000000002 107.327 -179.862 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.432 -1.328 0 N-CA-C 106.203 -1.777 . . . . 65.400000000000006 106.203 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.518 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 66.5 mtt180 -99.47 -15.7 18.6 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-N 115.567 -0.742 . . . . 62.409999999999997 111.427 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' B' ' 73' ' ' VAL . 31.0 m -105.4 129.16 53.78 Favored 'General case' 1 C--N 1.243 -4.026 0 N-CA-C 113.581 0.956 . . . . 53.340000000000003 113.581 -170.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.481 HD12 ' O ' ' B' ' 81' ' ' ALA . 79.2 mt -106.64 145.78 31.53 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.479 -1.237 . . . . 73.329999999999998 107.883 171.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' B' ' 104' ' ' GLU . 25.5 p90 -104.15 116.28 31.91 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 119.077 -1.049 . . . . 62.32 108.346 173.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.37 118.09 43.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 114.03 -1.441 . . . . 53.299999999999997 107.602 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.5 p -126.37 163.15 23.91 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 109.44 -0.578 . . . . 72.109999999999999 109.44 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 99.5 19.99 18.77 Favored Glycine 0 N--CA 1.423 -2.215 0 N-CA-C 111.826 -0.51 . . . . 41.0 111.826 -172.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 72.4 mt -93.89 120.21 66.1 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 107.915 -1.143 . . . . 73.239999999999995 107.915 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.34 159.6 22.48 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.576 2.184 . . . . 53.240000000000002 111.643 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.04 -6.11 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-O 121.94 0.876 . . . . 62.420000000000002 110.922 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -114.48 30.08 7.56 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.108 -1.071 . . . . 72.530000000000001 108.108 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 tt -58.8 140.32 17.28 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 CA-C-O 121.745 0.783 . . . . 72.329999999999998 111.627 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.62 ' HG2' ' CZ ' ' B' ' 45' ' ' ARG . 0.1 OUTLIER -101.18 143.34 26.4 Favored Pre-proline 0 C--N 1.293 -1.872 0 C-N-CA 125.712 1.605 . . . . 74.239999999999995 108.525 175.056 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -61.79 -27.91 81.15 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.451 2.1 . . . . 63.020000000000003 113.437 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.62 ' CZ ' ' HG2' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -82.7 -10.65 58.82 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 118.228 -1.389 . . . . 65.150000000000006 111.909 -177.244 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -65.09 -39.4 93.14 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 120.101 -0.639 . . . . 72.510000000000005 109.708 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.31 -33.71 74.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.538 -0.755 . . . . 71.049999999999997 109.806 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.506 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 66.5 t80 -61.94 -50.81 70.63 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.674 -0.694 . . . . 74.230000000000004 110.184 177.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 81.4 mt -62.04 -44.17 97.27 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 124.085 0.865 . . . . 44.009999999999998 109.548 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 20.6 tp -63.17 -44.64 94.88 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.45 -1.25 . . . . 71.019999999999996 110.965 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -93.59 11.39 28.96 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 113.902 1.075 . . . . 74.329999999999998 113.902 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.47 ' HA ' ' NE ' ' B' ' 52' ' ' ARG . 5.2 mmp_? -55.25 -51.86 76.21 Favored Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 113.276 0.843 . . . . 75.319999999999993 113.276 175.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -79.26 -1.0 11.2 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.011 1.808 . . . . 74.420000000000002 112.937 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -99.81 99.76 10.61 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-O 122.5 1.143 . . . . 65.109999999999999 112.516 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -73.67 116.09 13.85 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 113.02 -1.9 . . . . 61.219999999999999 109.076 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.19 -24.73 2.22 Favored Glycine 0 C--N 1.284 -2.312 0 CA-C-N 114.822 -1.081 . . . . 60.520000000000003 112.103 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -55.67 110.07 0.66 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.512 0.725 . . . . 61.039999999999999 112.488 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -96.11 -49.27 5.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.489 -0.778 . . . . 50.130000000000003 110.368 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -169.68 172.41 43.65 Favored Glycine 0 C--N 1.299 -1.477 0 CA-C-N 115.162 -0.926 . . . . 71.219999999999999 111.413 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.9 p -141.17 137.63 32.83 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 122.531 0.332 . . . . 74.25 110.627 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 28.5 tp -120.33 115.35 23.37 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.897 -1.149 . . . . 75.129999999999995 107.897 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.95 131.47 42.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 109.684 -0.488 . . . . 72.030000000000001 109.684 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -118.55 114.35 22.68 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.309 -0.997 . . . . 72.0 108.309 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.6 119.74 12.86 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.956 -0.757 . . . . 64.319999999999993 108.956 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 25.6 m -114.65 155.25 26.93 Favored 'General case' 0 N--CA 1.401 -2.913 0 N-CA-C 104.662 -2.347 . . . . 64.340000000000003 104.662 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.78 -38.01 14.73 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.69 0.996 . . . . 71.439999999999998 113.69 -173.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -104.29 -15.78 15.36 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 113.239 0.829 . . . . 72.299999999999997 113.239 -174.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.51 ' O ' ' HB ' ' B' ' 65' ' ' THR . 29.4 pt20 -172.64 140.05 0.97 Allowed Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 110.135 -0.32 . . . . 71.530000000000001 110.135 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.54 112.99 3.68 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.846 2.364 . . . . 71.310000000000002 109.672 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -90.8 145.31 7.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.648 -0.871 . . . . 75.400000000000006 108.648 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.19 120.1 4.43 Favored Glycine 0 CA--C 1.483 -1.914 0 C-N-CA 118.917 -1.611 . . . . 60.219999999999999 112.775 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.91 103.06 15.82 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.579 -1.267 . . . . 75.219999999999999 107.579 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' B' ' 32' ' ' THR . 59.3 t -98.25 127.36 50.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-N 115.725 -0.67 . . . . 71.299999999999997 110.687 -175.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 53.3 mt -98.44 128.76 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 CA-C-N 114.842 -1.072 . . . . 63.130000000000003 108.814 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . 0.518 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 85.3 m-85 -109.03 159.47 16.82 Favored 'General case' 0 C--N 1.271 -2.837 0 N-CA-C 107.799 -1.185 . . . . 64.209999999999994 107.799 174.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.13 -40.09 94.77 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 112.469 0.544 . . . . 75.340000000000003 112.469 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 2.9 p -143.69 155.61 44.27 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 116.046 -0.524 . . . . 63.030000000000001 111.707 -174.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . 0.504 ' HD3' ' N ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -59.69 -35.18 73.98 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 123.398 0.436 . . . . 73.030000000000001 110.898 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.6 -32.31 73.74 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 122.008 0.909 . . . . 64.439999999999998 109.49 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.47 -37.44 35.76 Favored Glycine 0 C--N 1.31 -0.864 0 CA-C-N 114.021 -1.445 . . . . 73.230000000000004 110.493 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.481 ' O ' HD12 ' B' ' 33' ' ' LEU . . . -70.03 -45.3 67.47 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.848 -0.676 . . . . 55.119999999999997 111.517 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.94 -37.19 85.37 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.289 -0.564 . . . . 71.140000000000001 111.425 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.46 -35.99 81.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.853 0.359 . . . . 44.219999999999999 110.268 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.65 74.74 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.716 -0.675 . . . . 73.310000000000002 111.464 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.411 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 13.8 ptmm? -66.65 -40.18 88.56 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 119.743 -0.783 . . . . 72.239999999999995 110.619 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -60.53 -30.62 69.87 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.173 0.435 . . . . 53.299999999999997 112.173 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.18 -36.36 19.54 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.33 -0.548 . . . . 41.229999999999997 111.969 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.449 ' O ' HG23 ' B' ' 91' ' ' ILE . 91.2 mt -96.97 -23.38 16.33 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 116.042 1.867 . . . . 53.399999999999999 116.042 -172.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.34 123.11 25.43 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.202 1.186 . . . . 73.409999999999997 114.202 -175.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.34 27.13 6.27 Favored Glycine 0 CA--C 1.483 -1.907 0 C-N-CA 120.316 -0.945 . . . . 74.019999999999996 111.582 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.449 HG23 ' O ' ' B' ' 88' ' ' LEU . 18.8 tt -124.44 142.96 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.395 0 N-CA-C 106.316 -1.735 . . . . 74.349999999999994 106.316 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.458 ' HG2' HG22 ' B' ' 100' ' ' THR . 96.3 mtt180 -74.21 145.82 43.83 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-O 121.098 0.475 . . . . 73.129999999999995 111.164 176.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -74.03 -33.24 63.68 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.166 -1.379 . . . . 74.140000000000001 108.199 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.558 ' HB2' ' CB ' ' B' ' 97' ' ' ASN . 4.8 m-20 -136.08 130.32 18.37 Favored Pre-proline 0 CA--C 1.511 -0.533 0 N-CA-C 103.456 -2.794 . . . . 75.430000000000007 103.456 173.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . 0.569 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 17.5 Cg_endo -58.26 -34.82 98.97 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.024 1.816 . . . . 52.119999999999997 112.479 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.17 1.57 39.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.816 -0.629 . . . . 75.209999999999994 111.782 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' ASN . . . . . 0.558 ' CB ' ' HB2' ' B' ' 94' ' ' ASP . 48.1 t30 -114.12 128.07 26.18 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 109.575 -0.528 . . . . 74.450000000000003 109.575 -175.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.12 -7.16 20.48 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 122.82 2.347 . . . . 71.319999999999993 112.016 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' GLN . . . . . 0.531 ' HB3' ' ND2' ' B' ' 97' ' ' ASN . 6.4 tp60 -75.01 112.12 10.91 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.099 -1.074 . . . . 71.25 108.099 174.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.48 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 82.2 p -101.96 151.88 21.6 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.76 -0.655 . . . . 74.209999999999994 109.398 -174.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 42.0 tp -98.81 121.0 40.19 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.958 -1.127 . . . . 71.329999999999998 107.958 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -131.93 138.53 48.4 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-O 121.344 0.593 . . . . 64.329999999999998 109.511 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 5.9 mp -122.36 118.41 28.36 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.944 -1.026 . . . . 71.420000000000002 109.137 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' B' ' 34' ' ' PHE . 9.3 mm-40 -124.21 168.43 12.94 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.966 -1.124 . . . . 43.219999999999999 107.966 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -74.35 141.95 45.15 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 109.191 -0.67 . . . . 60.439999999999998 109.191 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.46 144.22 42.22 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 108.163 -1.051 . . . . 64.140000000000001 108.163 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -80.44 6.74 11.45 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.787 0.803 . . . . 71.049999999999997 110.827 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -167.26 131.93 1.95 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.856 -1.905 . . . . 63.32 105.856 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -66.34 145.65 55.48 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 109.041 -0.725 . . . . 73.439999999999998 109.041 176.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.411 -2.412 0 C-N-CA 119.059 -1.056 . . . . 71.540000000000006 109.15 179.822 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 17.2 t . . . . . 0 N--CA 1.447 -0.59 0 CA-C-O 121.56 0.695 . . . . 74.200000000000003 109.84 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.493 ' NH2' ' HA ' ' A' ' 76' ' ' ASP . 17.1 ptm180 -111.08 9.68 22.01 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.215 -0.902 . . . . 71.319999999999993 111.459 -172.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.1 m -121.0 125.83 48.37 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.652 -0.704 . . . . 74.430000000000007 109.85 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.7 mt -107.35 152.85 23.6 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.239 -0.891 . . . . 73.519999999999996 108.846 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 104' ' ' GLU . 21.8 p90 -115.18 118.16 32.53 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 117.883 -1.527 . . . . 75.319999999999993 109.056 172.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.8 t -97.63 123.08 49.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 113.797 -1.547 . . . . 74.319999999999993 107.679 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 60.0 p -124.31 175.37 7.12 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.986 -1.116 . . . . 71.030000000000001 107.986 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 88.5 27.21 25.5 Favored Glycine 0 N--CA 1.422 -2.279 0 N-CA-C 111.169 -0.772 . . . . 74.310000000000002 111.169 -176.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.4 mt -103.68 131.64 21.83 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 107.623 -1.251 . . . . 71.340000000000003 107.623 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.86 168.01 21.56 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.791 1.661 . . . . 72.319999999999993 111.094 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.71 -6.2 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-O 122.063 0.935 . . . . 60.509999999999998 110.524 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -124.78 40.4 3.75 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.176 -1.046 . . . . 52.439999999999998 108.176 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.49 125.03 34.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 106.589 -1.634 . . . . 62.420000000000002 106.589 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -93.91 142.24 24.77 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 109.223 -0.658 . . . . 72.010000000000005 109.223 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.24 -21.16 50.71 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.887 2.391 . . . . 62.240000000000002 113.217 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.591 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 11.3 ptt180 -77.21 -24.48 51.31 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 116.233 -0.439 . . . . 74.519999999999996 110.743 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -70.41 -41.27 73.18 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.0 0.428 . . . . 64.25 110.513 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.47 -39.97 94.82 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 108.728 -0.842 . . . . 74.150000000000006 108.728 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.644 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 30.7 t80 -57.13 -48.24 79.15 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.408 -1.269 . . . . 64.310000000000002 111.292 178.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 88.1 mt -61.53 -40.77 95.88 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.238 0.542 . . . . 73.540000000000006 110.77 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.8 tp -77.23 -40.93 43.13 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.0 -1.0 . . . . 72.019999999999996 111.926 -176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -88.3 -8.13 55.64 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 115.398 1.629 . . . . 74.409999999999997 115.398 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 54.8 mtp85 -57.79 -43.78 98.94 Favored Pre-proline 0 N--CA 1.48 1.075 0 N-CA-C 114.896 1.443 . . . . 72.040000000000006 114.896 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -67.91 -17.45 46.6 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 121.344 1.362 . . . . 75.129999999999995 112.101 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -86.32 89.6 7.91 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.923 0.868 . . . . 74.230000000000004 110.962 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -65.03 110.76 2.6 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.367 -1.288 . . . . 74.310000000000002 109.769 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.88 -24.72 2.42 Favored Glycine 0 C--N 1.281 -2.522 0 CA-C-N 114.682 -1.144 . . . . 61.409999999999997 111.193 -176.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -58.29 113.03 1.76 Allowed 'General case' 0 C--O 1.242 0.664 0 C-N-CA 122.799 0.44 . . . . 72.340000000000003 111.355 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -91.65 -59.76 2.05 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.37 -0.832 . . . . 51.350000000000001 109.614 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.43 -178.45 39.64 Favored Glycine 0 C--N 1.298 -1.583 0 CA-C-N 115.276 -0.874 . . . . 55.329999999999998 111.449 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.2 p -135.66 137.97 42.36 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 122.532 0.333 . . . . 74.409999999999997 111.345 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.6 tt -107.7 119.97 40.93 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.742 -1.577 . . . . 53.329999999999998 106.742 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -95.66 128.97 46.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 109.661 -0.496 . . . . 64.439999999999998 109.661 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -119.06 109.35 15.81 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 106.51 -1.663 . . . . 73.239999999999995 106.51 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.84 127.78 33.66 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.514 -0.767 . . . . 74.540000000000006 109.777 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 7.1 m -130.32 151.04 51.25 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 105.54 -2.022 . . . . 63.43 105.54 175.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.74 -41.65 10.94 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 114.529 1.307 . . . . 72.420000000000002 114.529 -172.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -105.41 -11.58 16.38 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 114.988 1.477 . . . . 74.150000000000006 114.988 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' A' ' 65' ' ' THR . 29.1 pt20 -166.1 125.69 1.19 Allowed Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 120.95 0.405 . . . . 55.310000000000002 111.671 -175.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.81 108.17 2.64 Favored 'Trans proline' 0 N--CA 1.439 -1.682 0 C-N-CA 122.371 2.047 . . . . 65.540000000000006 108.945 169.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.16 146.92 5.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.639 -0.874 . . . . 62.039999999999999 108.639 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.77 120.72 4.59 Favored Glycine 0 CA--C 1.486 -1.732 0 C-N-CA 118.868 -1.634 . . . . 61.530000000000001 113.499 -176.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -87.74 103.77 15.92 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.999 -1.482 . . . . 74.420000000000002 106.999 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.9 t -94.68 121.8 45.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 114.781 -1.1 . . . . 60.350000000000001 110.818 -174.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 tt -93.33 124.92 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.962 0 CA-C-N 114.822 -1.081 . . . . 74.420000000000002 109.978 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -103.59 155.57 18.44 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 114.817 -1.083 . . . . 72.140000000000001 108.424 173.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.493 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 22.5 t70 -67.98 -34.52 76.69 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.815 -0.63 . . . . 74.319999999999993 110.4 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.7 m -132.49 145.87 51.49 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 107.984 -1.117 . . . . 73.019999999999996 107.984 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.665 ' HB2' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -78.22 -24.38 47.07 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.66 -0.866 . . . . 71.239999999999995 108.66 -179.178 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.13 -25.45 68.36 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.028 0.918 . . . . 53.229999999999997 109.098 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.7 -42.59 6.78 Favored Glycine 0 C--N 1.297 -1.627 0 CA-C-N 113.533 -1.667 . . . . 64.5 109.724 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.28 -49.01 79.48 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.306 0.642 . . . . 70.120000000000005 111.239 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.19 -35.58 73.84 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.264 0.626 . . . . 62.299999999999997 112.234 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.05 -32.23 39.42 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.166 0.508 . . . . 63.399999999999999 111.014 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.73 -46.05 69.91 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.147 -0.479 . . . . 72.420000000000002 111.052 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -28.08 66.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.135 -0.484 . . . . 64.150000000000006 111.525 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -70.28 -40.7 74.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.212 -0.449 . . . . 74.209999999999994 110.496 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.66 -36.99 36.89 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.279 0.474 . . . . 37.170000000000002 112.279 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 91' ' ' ILE . 98.5 mt -89.39 -4.48 58.02 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 115.484 1.661 . . . . 71.319999999999993 115.484 -175.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -78.55 118.05 20.3 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 117.86 -1.536 . . . . 74.340000000000003 110.803 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.13 6.53 31.82 Favored Glycine 0 CA--C 1.483 -1.934 0 CA-C-N 115.73 -0.668 . . . . 63.32 112.729 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 88' ' ' LEU . 13.9 tt -88.36 121.43 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 109.244 -0.651 . . . . 72.219999999999999 109.244 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.5 ' CG ' HG22 ' A' ' 100' ' ' THR . 71.3 mtt180 -74.53 135.28 42.16 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 116.166 -0.47 . . . . 72.230000000000004 110.311 173.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.492 ' CD1' HD11 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -63.54 -39.23 93.86 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.367 -1.288 . . . . 54.039999999999999 107.697 177.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' B' ' 45' ' ' ARG . 8.2 m-20 -135.41 128.47 18.24 Favored Pre-proline 0 CA--C 1.485 -1.547 0 N-CA-C 104.413 -2.44 . . . . 62.43 104.413 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -56.96 -26.24 66.9 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 121.748 1.632 . . . . 52.039999999999999 111.07 173.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -74.88 -20.68 59.63 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.544 1.138 . . . . 72.310000000000002 110.569 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.485 ' ND2' ' HB3' ' A' ' 99' ' ' GLN . 36.4 t30 -106.69 124.59 35.06 Favored Pre-proline 0 C--N 1.308 -1.217 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 110.491 -173.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.65 -12.04 33.33 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 123.248 2.632 . . . . 74.340000000000003 113.25 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.485 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 6.5 tp60 -74.09 113.49 11.34 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.31 -0.996 . . . . 72.439999999999998 108.31 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.501 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 68.0 p -110.76 145.18 38.55 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.518 -0.764 . . . . 62.149999999999999 110.2 -173.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.1 mp -78.39 120.51 23.23 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.431 0.634 . . . . 55.43 109.652 175.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.417 ' HD3' ' OE2' ' A' ' 104' ' ' GLU . 0.3 OUTLIER -123.43 112.56 17.68 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 107.224 -1.399 . . . . 74.109999999999999 107.224 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -106.94 127.31 53.33 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.2 -0.909 . . . . 72.129999999999995 110.31 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 47.3 mt-10 -132.67 174.07 10.68 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.351 -1.351 . . . . 75.409999999999997 107.351 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.402 ' HB3' HG13 ' A' ' 30' ' ' VAL . 61.8 m-85 -79.51 138.62 37.59 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.34 -0.615 . . . . 73.030000000000001 109.34 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.36 152.28 40.93 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.256 -0.646 . . . . 52.329999999999998 109.256 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.539 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 14.0 tmtt? -74.29 -8.15 55.22 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.45 0.643 . . . . 75.140000000000001 110.198 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.54 131.23 9.82 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.733 -0.667 . . . . 73.420000000000002 109.722 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.423 HD22 ' HA ' ' A' ' 30' ' ' VAL . 93.0 m-20 -75.68 143.27 42.24 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.925 -0.579 . . . . 71.230000000000004 110.217 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 C--N 1.296 -1.761 0 N-CA-C 108.855 -0.794 . . . . 75.510000000000005 108.855 178.541 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' B' ' 105' ' ' PHE . 16.0 t . . . . . 0 N--CA 1.442 -0.841 0 CA-C-O 121.48 0.657 . . . . 74.030000000000001 110.157 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -104.08 -2.62 25.64 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.446 -0.797 . . . . 75.209999999999994 110.59 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 23.2 m -113.54 127.62 56.15 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 115.507 -0.769 . . . . 71.420000000000002 110.645 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.42 HD11 ' O ' ' B' ' 81' ' ' ALA . 94.9 mt -104.96 148.3 26.86 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.735 -0.839 . . . . 73.430000000000007 108.735 176.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 37.1 p90 -105.01 115.66 30.65 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 118.126 -1.429 . . . . 64.25 107.757 171.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 43.5 t -97.05 114.75 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-N 113.99 -1.459 . . . . 65.230000000000004 107.812 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 21.3 p -123.72 174.34 7.54 Favored 'General case' 0 N--CA 1.401 -2.908 0 CA-C-N 114.704 -1.134 . . . . 73.439999999999998 108.72 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 87.92 32.98 11.55 Favored Glycine 0 N--CA 1.421 -2.325 0 N-CA-C 110.241 -1.143 . . . . 61.340000000000003 110.241 -172.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 85.9 mt -105.68 142.87 25.69 Favored Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 107.767 -1.198 . . . . 61.25 107.767 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -75.68 164.3 32.35 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.977 1.784 . . . . 72.140000000000001 110.151 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.433 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 13.8 p -71.23 -8.51 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-O 122.457 1.123 . . . . 63.420000000000002 109.869 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.419 ' O ' ' HD2' ' B' ' 43' ' ' LYS . 13.0 t70 -99.43 10.95 40.43 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.24 -1.345 . . . . 73.129999999999995 109.472 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.65 125.01 23.05 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 CA-C-O 121.886 0.851 . . . . 72.430000000000007 109.79 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.51 ' HG3' ' NE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -105.53 142.55 24.98 Favored Pre-proline 0 C--N 1.291 -1.976 0 CA-C-N 114.65 -1.159 . . . . 71.319999999999993 109.517 177.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.75 -26.67 24.3 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 123.762 2.975 . . . . 73.349999999999994 113.632 -174.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.548 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 19.2 ptt180 -66.74 -26.17 66.86 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.879 -0.6 . . . . 73.319999999999993 112.057 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . 0.43 ' HG3' ' HG2' ' B' ' 43' ' ' LYS . 42.3 mt-10 -70.3 -42.85 71.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.784 0.326 . . . . 61.509999999999998 110.945 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -68.01 -33.83 75.35 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 108.71 -0.848 . . . . 72.510000000000005 108.71 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.538 ' HB3' ' O ' ' B' ' 45' ' ' ARG . 62.8 t80 -60.97 -51.38 69.49 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.653 -1.158 . . . . 61.020000000000003 110.098 175.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 92.7 mt -62.84 -40.95 99.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.321 0.582 . . . . 64.099999999999994 110.216 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 25.4 tp -69.63 -41.59 75.42 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.781 -1.1 . . . . 61.340000000000003 111.674 -176.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -94.69 -2.25 51.55 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 114.954 1.464 . . . . 73.109999999999999 114.954 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 30.6 mtp180 -60.94 -43.25 90.71 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.292 0.849 . . . . 60.450000000000003 113.292 173.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.93 -19.93 70.17 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 121.378 1.385 . . . . 74.019999999999996 112.188 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -92.53 90.11 7.02 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 122.364 1.078 . . . . 74.25 110.191 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -76.45 109.35 10.1 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.684 -1.144 . . . . 75.420000000000002 110.05 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.42 -27.51 1.36 Allowed Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 108.986 -1.645 . . . . 65.340000000000003 108.986 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -51.86 123.32 9.99 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.542 1.137 . . . . 73.019999999999996 111.789 173.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -97.2 -60.39 1.59 Allowed 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 109.719 -0.475 . . . . 72.129999999999995 109.719 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.42 168.46 36.64 Favored Glycine 0 C--N 1.292 -1.915 0 C-N-CA 119.567 -1.301 . . . . 51.030000000000001 113.141 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.5 p -126.15 138.06 53.64 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.33 0.586 . . . . 71.450000000000003 110.747 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 49.5 tp -116.27 116.67 28.19 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.47 -0.937 . . . . 51.32 108.47 176.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mp -94.33 131.89 39.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 109.154 -0.684 . . . . 63.039999999999999 109.154 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -130.47 125.96 35.7 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.546 -0.909 . . . . 74.510000000000005 108.546 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -77.39 130.5 37.16 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.013 0.435 . . . . 41.119999999999997 110.774 -175.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.7 m -129.71 151.74 49.97 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 104.244 -2.502 . . . . 75.420000000000002 104.244 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.17 -45.46 8.35 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.376 1.07 . . . . 63.32 113.541 -174.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -88.96 -29.2 19.71 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.624 0.972 . . . . 74.409999999999997 113.624 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -165.06 132.56 2.39 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-O 120.871 0.367 . . . . 72.319999999999993 111.797 -169.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.433 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 12.0 Cg_exo -71.89 109.96 2.8 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.659 2.24 . . . . 73.329999999999998 108.747 167.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 33.3 m -87.21 151.56 3.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.2 -0.667 . . . . 71.340000000000003 109.2 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.98 121.09 4.59 Favored Glycine 0 C--N 1.297 -1.638 0 C-N-CA 119.271 -1.442 . . . . 54.310000000000002 112.726 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -87.91 104.32 16.5 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.818 -1.549 . . . . 55.509999999999998 106.818 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 98.9 t -100.31 117.35 45.38 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-N 115.028 -0.987 . . . . 64.439999999999998 109.697 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 tt -101.83 131.61 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 115.37 -0.832 . . . . 74.430000000000007 110.466 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -108.7 158.12 17.9 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.438 -1.255 . . . . 74.310000000000002 109.174 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -59.26 -27.12 65.52 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 123.758 0.661 . . . . 75.519999999999996 112.055 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 21.3 m -154.43 157.26 38.19 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.625 -0.672 . . . . 73.340000000000003 110.943 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . 0.622 ' HD3' ' N ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -57.97 -32.24 67.67 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.113 0.565 . . . . 73.510000000000005 110.623 175.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.25 -27.69 67.43 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.804 0.812 . . . . 74.219999999999999 110.062 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.88 -37.19 8.64 Favored Glycine 0 C--N 1.301 -1.374 0 N-CA-C 110.244 -1.142 . . . . 72.099999999999994 110.244 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.42 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -67.16 -47.3 71.43 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.455 -0.872 . . . . 51.030000000000001 111.182 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -57.52 -40.7 79.34 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.948 0.351 . . . . 71.310000000000002 111.948 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.05 -35.31 66.69 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 120.944 0.402 . . . . 61.130000000000003 110.945 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.93 -44.19 73.57 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.104 -0.498 . . . . 70.439999999999998 111.254 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.42 ' HE2' ' O ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER -71.2 -32.14 68.49 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.146 -0.479 . . . . 71.109999999999999 110.648 -177.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -64.46 -38.78 92.22 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.797 -0.638 . . . . 70.200000000000003 111.092 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.97 -40.06 25.01 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 120.573 -0.451 . . . . 72.140000000000001 112.053 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.562 ' O ' HG23 ' B' ' 91' ' ' ILE . 94.5 mt -93.12 -11.99 31.53 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 116.593 2.072 . . . . 73.439999999999998 116.593 -172.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -78.66 117.64 20.01 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 117.911 -1.516 . . . . 64.319999999999993 110.488 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.04 7.83 37.46 Favored Glycine 0 CA--C 1.485 -1.836 0 C-N-CA 120.434 -0.889 . . . . 53.350000000000001 112.188 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.562 HG23 ' O ' ' B' ' 88' ' ' LEU . 13.5 tt -105.46 140.2 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 107.907 -1.146 . . . . 71.25 107.907 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.475 ' HG3' HG22 ' B' ' 100' ' ' THR . 43.7 mtt85 -70.65 139.9 51.43 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 113.843 1.053 . . . . 74.420000000000002 113.843 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.461 ' CD1' HD21 ' B' ' 101' ' ' LEU . 54.6 t80 -83.43 -25.07 31.58 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.141 -1.845 . . . . 73.319999999999993 108.321 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -149.31 122.71 4.52 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 106.883 -1.525 . . . . 73.519999999999996 106.883 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . 0.644 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 36.8 Cg_endo -62.84 -23.44 74.33 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.057 2.505 . . . . 63.119999999999997 113.993 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -98.18 1.7 47.67 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.266 0.555 . . . . 62.219999999999999 112.126 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -116.71 133.76 23.0 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 108.059 -1.089 . . . . 64.329999999999998 108.059 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.0 -9.46 19.29 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.796 2.331 . . . . 65.409999999999997 113.061 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' GLN . . . . . 0.422 ' HA ' ' OE1' ' B' ' 99' ' ' GLN . 6.1 tp60 -69.81 111.38 5.52 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.795 0.807 . . . . 72.239999999999995 109.934 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.475 HG22 ' HG3' ' B' ' 92' ' ' ARG . 41.7 p -110.43 145.31 37.84 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.181 -0.918 . . . . 73.040000000000006 109.34 -176.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.461 HD21 ' CD1' ' B' ' 93' ' ' PHE . 91.7 mt -71.18 146.55 49.03 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.295 0.569 . . . . 55.420000000000002 110.521 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -143.84 106.26 4.41 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.338 -1.356 . . . . 74.450000000000003 107.338 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.42 ' O ' ' HE2' ' B' ' 85' ' ' LYS . 6.7 mp -107.67 116.26 31.63 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.486 -0.779 . . . . 73.230000000000004 109.608 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.432 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 9.6 tp10 -129.26 161.55 29.93 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.231 -1.396 . . . . 70.540000000000006 107.231 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.403 ' HB3' HG13 ' B' ' 30' ' ' VAL . 72.3 m-85 -70.06 136.37 50.23 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 118.262 0.483 . . . . 74.030000000000001 110.687 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.48 153.7 43.12 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.068 -0.515 . . . . 73.349999999999994 110.571 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -82.37 5.09 21.44 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 122.184 0.993 . . . . 62.310000000000002 110.054 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -169.6 131.62 1.14 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.507 -1.664 . . . . 62.219999999999999 106.507 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -65.6 97.79 0.33 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.434 -0.58 . . . . 75.349999999999994 109.434 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.418 -2.032 0 CA-C-N 114.792 -1.095 . . . . 55.030000000000001 108.545 -176.708 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.581 ' HA ' ' ND2' ' A' ' 109' ' ' ASN . 47.6 t . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 113.048 0.758 . . . . 74.140000000000001 113.048 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 75' ' ' PHE . 6.6 mpt_? -106.04 6.08 30.85 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-N 115.859 -0.609 . . . . 63.310000000000002 112.104 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.1 m -135.82 132.46 36.7 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 114.35 1.241 . . . . 72.099999999999994 114.35 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.456 HD13 ' O ' ' A' ' 81' ' ' ALA . 68.9 mt -110.42 151.56 27.35 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.043 -1.095 . . . . 74.329999999999998 108.043 171.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -107.39 114.21 28.08 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 118.808 -1.157 . . . . 63.43 108.036 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.433 HG21 ' HG ' ' A' ' 103' ' ' LEU . 42.2 t -97.99 119.96 46.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.749 0 CA-C-N 113.791 -1.55 . . . . 44.049999999999997 107.9 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.7 p -123.26 165.1 17.5 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 115.204 -0.907 . . . . 73.5 109.628 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 96.36 18.67 30.19 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 111.5 -0.64 . . . . 71.319999999999993 111.5 -174.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.3 mt -89.83 128.87 48.57 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 107.337 -1.357 . . . . 65.439999999999998 107.337 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.41 165.22 32.43 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.684 1.589 . . . . 54.130000000000003 110.991 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.32 -5.42 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 122.151 0.976 . . . . 64.340000000000003 110.751 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.556 ' OD2' ' HE2' ' B' ' 43' ' ' LYS . 24.5 t70 -113.56 13.8 18.84 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.207 -0.906 . . . . 74.310000000000002 109.647 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.414 HD11 ' N ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -61.08 129.23 23.57 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 CA-C-O 121.693 0.758 . . . . 75.209999999999994 109.38 -178.221 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.414 ' N ' HD11 ' A' ' 42' ' ' ILE . 46.1 mmtm -93.59 145.8 30.62 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 115.477 -0.783 . . . . 71.329999999999998 113.031 -176.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.34 -29.02 87.95 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.589 2.193 . . . . 63.299999999999997 112.202 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.638 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -86.37 -12.11 50.15 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 118.885 -1.126 . . . . 64.450000000000003 110.491 177.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 43' ' ' LYS . 43.7 tt0 -77.1 -40.57 45.41 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.377 -0.601 . . . . 71.519999999999996 109.377 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.34 -33.23 75.36 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.684 0.754 . . . . 71.430000000000007 109.221 172.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.638 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 57.2 t80 -61.17 -48.87 79.59 Favored 'General case' 0 C--O 1.202 -1.432 0 CA-C-N 114.467 -1.242 . . . . 73.540000000000006 110.467 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 83.2 mt -66.88 -35.78 80.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.582 0.706 . . . . 60.119999999999997 110.031 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 tp -67.25 -51.31 54.64 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.787 -1.097 . . . . 71.230000000000004 111.287 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -96.41 11.95 33.05 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.493 0.923 . . . . 73.540000000000006 113.493 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 31.8 ttt-85 -70.36 -42.79 16.31 Favored Pre-proline 0 C--N 1.312 -1.061 0 C-N-CA 120.653 -0.419 . . . . 73.109999999999999 112.052 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -77.29 -4.39 14.7 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 121.521 1.48 . . . . 61.210000000000001 111.879 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -89.73 107.18 18.94 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 122.076 0.941 . . . . 60.219999999999999 111.533 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -75.29 110.56 9.74 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 113.707 -1.588 . . . . 54.310000000000002 108.905 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.22 -10.83 5.33 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.457 -0.878 . . . . 72.439999999999998 113.339 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -66.7 112.52 4.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.553 0.677 . . . . 71.439999999999998 111.141 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -90.1 -41.49 11.63 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.238 0.542 . . . . 62.140000000000001 110.424 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.46 -176.93 42.7 Favored Glycine 0 C--N 1.307 -1.066 0 CA-C-N 115.186 -0.915 . . . . 51.439999999999998 111.325 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.6 p -148.03 137.9 22.55 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.475 0.546 . . . . 45.200000000000003 112.475 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.4 mp -111.24 126.35 54.78 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.741 -0.837 . . . . 64.430000000000007 108.741 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.2 mm -94.97 143.57 11.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 C-N-CA 122.301 0.24 . . . . 55.340000000000003 110.637 -174.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 69' ' ' PRO . 64.0 tttp -125.95 106.19 9.46 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.847 -0.797 . . . . 71.209999999999994 108.847 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.36 112.79 9.76 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.49 -0.777 . . . . 75.319999999999993 110.443 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -110.99 173.21 6.44 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 107.912 -1.144 . . . . 53.32 107.912 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.87 -38.51 49.81 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.099 0.959 . . . . 73.109999999999999 112.911 -177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -104.19 -49.1 3.68 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.48 0.657 . . . . 64.219999999999999 111.467 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -136.92 136.05 20.75 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 114.789 -1.096 . . . . 65.030000000000001 112.316 -166.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 55.7 Cg_endo -81.1 102.36 1.35 Allowed 'Trans proline' 0 N--CA 1.429 -2.287 0 C-N-CA 122.723 2.282 . . . . 72.019999999999996 109.43 168.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -80.22 157.1 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 N-CA-C 109.291 -0.633 . . . . 75.409999999999997 109.291 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.09 123.49 4.83 Favored Glycine 0 CA--C 1.48 -2.144 0 C-N-CA 118.536 -1.792 . . . . 72.510000000000005 113.294 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -87.23 103.01 15.03 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 105.621 -1.992 . . . . 73.209999999999994 105.621 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 76.1 t -97.8 127.12 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 CA-C-N 115.084 -0.962 . . . . 72.219999999999999 110.495 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 3.0 mp -94.46 129.77 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 CA-C-N 114.482 -1.235 . . . . 74.319999999999993 108.575 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.455 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 89.4 m-85 -117.7 152.24 35.63 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.483 -0.932 . . . . 64.439999999999998 108.483 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -49.89 -38.05 34.05 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 124.548 1.139 . . . . 54.25 112.697 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.5 p -157.04 163.74 38.72 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.528 -0.76 . . . . 61.100000000000001 110.346 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -28.54 63.48 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.208 -0.597 . . . . 73.200000000000003 109.925 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.83 -29.71 70.22 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-O 121.793 0.806 . . . . 74.150000000000006 109.424 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.08 -32.14 26.87 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.585 -1.006 . . . . 74.310000000000002 110.585 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.456 ' O ' HD13 ' A' ' 33' ' ' LEU . . . -67.05 -48.61 67.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 123.506 0.723 . . . . 74.010000000000005 110.976 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.01 -28.68 69.96 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.345 -0.222 . . . . 71.010000000000005 111.301 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.31 -41.02 73.84 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.965 0.412 . . . . 72.310000000000002 110.032 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.99 -42.22 90.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.813 -0.631 . . . . 42.200000000000003 109.64 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.534 ' HE2' ' HA ' ' A' ' 104' ' ' GLU . 34.7 ttmt -59.92 -45.62 92.0 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.558 -0.746 . . . . 75.299999999999997 110.269 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.59 -31.58 69.59 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.819 -0.628 . . . . 72.530000000000001 111.871 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.16 -35.18 17.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 113.025 0.75 . . . . 64.540000000000006 113.025 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 91' ' ' ILE . 97.9 mt -110.72 -5.31 15.02 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 116.724 2.12 . . . . 62.439999999999998 116.724 -170.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -78.7 114.57 17.74 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 117.358 -1.737 . . . . 74.349999999999994 111.199 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.65 12.93 33.78 Favored Glycine 0 CA--C 1.48 -2.132 0 N-CA-C 110.509 -1.036 . . . . 41.409999999999997 110.509 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 88' ' ' LEU . 9.6 tt -90.76 141.08 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.004 0 N-CA-C 108.969 -0.752 . . . . 75.109999999999999 108.969 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -63.21 117.05 6.01 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 108.122 -1.066 . . . . 74.209999999999994 108.122 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' B' ' 45' ' ' ARG . 64.9 t80 -73.86 -28.65 61.69 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.648 -1.612 . . . . 72.129999999999995 106.648 176.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 97' ' ' ASN . 20.8 t0 -144.27 117.03 5.63 Favored Pre-proline 0 N--CA 1.422 -1.843 0 N-CA-C 102.833 -3.025 . . . . 74.540000000000006 102.833 176.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.464 ' HD3' ' CZ ' ' B' ' 48' ' ' TYR . 74.2 Cg_endo -71.81 -20.76 25.75 Favored 'Trans proline' 0 C--N 1.327 -0.554 0 CA-C-N 120.608 1.253 . . . . 64.209999999999994 113.5 -177.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -87.06 -21.1 26.28 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 121.634 0.73 . . . . 64.120000000000005 109.134 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 46.8 t-20 -99.19 137.02 20.34 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 107.428 -1.323 . . . . 55.009999999999998 107.428 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.38 -13.94 31.83 Favored 'Trans proline' 0 CA--C 1.553 1.454 0 C-N-CA 122.556 2.171 . . . . 62.32 113.623 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -61.71 119.35 8.54 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.857 0.863 . . . . 74.230000000000004 110.593 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.41 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 24.7 p -119.22 147.21 44.5 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.249 -0.432 . . . . 75.200000000000003 110.811 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 24.5 tp -89.87 129.41 36.24 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.551 -0.749 . . . . 73.340000000000003 109.132 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -134.89 128.51 32.77 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.524 -0.547 . . . . 72.299999999999997 109.524 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.433 ' HG ' HG21 ' A' ' 35' ' ' VAL . 5.6 mp -113.8 128.01 56.24 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.722 -0.672 . . . . 72.140000000000001 109.439 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.534 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 9.3 tp10 -137.3 163.55 30.7 Favored 'General case' 0 C--O 1.195 -1.785 0 N-CA-C 107.618 -1.253 . . . . 61.340000000000003 107.618 177.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -73.24 133.58 44.02 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 119.229 0.922 . . . . 74.120000000000005 110.498 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.36 155.13 39.7 Favored 'General case' 0 N--CA 1.438 -1.051 0 O-C-N 123.688 0.618 . . . . 45.240000000000002 109.739 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -87.48 7.18 30.47 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.784 0.802 . . . . 73.420000000000002 109.88 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.42 126.05 12.54 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.609 -0.723 . . . . 55.409999999999997 109.45 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.581 ' ND2' ' HA ' ' A' ' 30' ' ' VAL . 3.4 m-20 -79.62 124.89 28.95 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.473 -0.936 . . . . 74.519999999999996 108.473 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.9 m . . . . . 0 C--N 1.276 -2.592 0 N-CA-C 106.854 -1.536 . . . . 74.239999999999995 106.854 179.405 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.453 ' HA ' ' ND2' ' B' ' 109' ' ' ASN . 34.8 t . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 121.763 0.792 . . . . 63.450000000000003 112.572 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -90.24 6.45 42.78 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.402 -0.817 . . . . 71.129999999999995 112.188 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 18.3 m -129.42 128.42 42.94 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 113.4 0.889 . . . . 61.130000000000003 113.4 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.49 HD13 ' O ' ' B' ' 81' ' ' ALA . 76.3 mt -104.0 148.16 26.53 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.633 -1.247 . . . . 70.140000000000001 107.633 172.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 28.2 p90 -105.98 118.02 35.53 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 118.477 -1.289 . . . . 74.519999999999996 107.565 172.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.443 HG21 ' HG ' ' B' ' 103' ' ' LEU . 39.1 t -100.58 124.32 54.07 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.564 0 CA-C-N 114.157 -1.383 . . . . 44.310000000000002 107.849 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 35.7 p -129.16 168.43 16.15 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 115.339 -0.846 . . . . 50.409999999999997 109.89 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.82 12.07 57.14 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 110.543 -1.023 . . . . 37.109999999999999 110.543 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' B' ' 39' ' ' PRO . 89.8 mt -80.95 123.59 82.03 Favored Pre-proline 0 N--CA 1.432 -1.328 0 C-N-CA 123.634 0.774 . . . . 72.510000000000005 110.046 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 38' ' ' LEU . 51.5 Cg_exo -58.11 155.29 34.9 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.738 2.292 . . . . 72.329999999999998 111.649 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 7.4 p -70.32 -4.42 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-O 121.906 0.86 . . . . 74.209999999999994 111.046 -177.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -120.19 22.66 11.31 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.883 -0.784 . . . . 71.129999999999995 108.883 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 6.6 tt -50.44 132.08 10.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-N 115.077 -0.965 . . . . 44.210000000000001 111.609 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.556 ' HE2' ' OD2' ' A' ' 41' ' ' ASP . 39.6 mmtm -108.54 140.1 21.46 Favored Pre-proline 0 C--N 1.29 -1.994 0 CA-C-N 115.316 -0.857 . . . . 70.329999999999998 112.632 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -53.31 -41.75 70.39 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.73 2.287 . . . . 65.340000000000003 112.401 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.564 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -74.42 -22.76 58.99 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 117.718 -1.593 . . . . 72.200000000000003 111.356 -178.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' B' ' 43' ' ' LYS . 36.4 tt0 -66.46 -41.62 88.77 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.628 -0.879 . . . . 74.140000000000001 108.628 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.42 -41.75 88.76 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.616 -0.72 . . . . 72.140000000000001 110.011 173.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.575 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 71.6 t80 -52.8 -47.74 67.37 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 124.496 1.118 . . . . 75.420000000000002 111.121 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 88.5 mt -64.47 -37.36 87.26 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 123.31 0.381 . . . . 75.450000000000003 111.118 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 tp -75.87 -46.44 30.21 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.824 -0.626 . . . . 72.049999999999997 112.054 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -92.03 4.14 53.71 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.413 0.894 . . . . 71.340000000000003 113.413 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.575 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 53.0 ttt-85 -61.03 -48.44 92.42 Favored Pre-proline 0 CA--C 1.563 1.469 0 N-CA-C 112.656 0.613 . . . . 74.530000000000001 112.656 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.76 -1.71 11.83 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.133 1.889 . . . . 73.310000000000002 112.707 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -84.6 98.72 10.32 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.867 0.842 . . . . 72.140000000000001 110.779 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -66.39 113.84 4.96 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 113.783 -1.553 . . . . 74.120000000000005 109.401 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.15 -16.71 5.72 Favored Glycine 0 C--N 1.285 -2.27 0 CA-C-N 115.105 -0.952 . . . . 42.409999999999997 111.905 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -63.56 103.73 0.57 Allowed 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.246 0.546 . . . . 75.099999999999994 110.937 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -84.26 -45.61 12.68 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.746 -0.835 . . . . 61.549999999999997 108.746 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.25 173.63 42.95 Favored Glycine 0 C--N 1.305 -1.18 0 CA-C-N 114.814 -1.085 . . . . 53.409999999999997 111.768 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.3 p -128.68 141.37 51.36 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 122.542 0.337 . . . . 62.420000000000002 110.61 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 61.7 tp -114.5 110.94 20.6 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.919 -1.141 . . . . 52.020000000000003 107.919 175.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 50.9 mm -94.06 131.4 41.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 109.882 -0.414 . . . . 75.439999999999998 109.882 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -124.38 115.08 20.39 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.159 0.504 . . . . 73.209999999999994 110.178 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.57 124.67 23.88 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.731 -0.668 . . . . 74.409999999999997 110.748 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 11.2 m -130.26 155.34 46.46 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 103.835 -2.654 . . . . 74.439999999999998 103.835 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.45 -35.17 51.81 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.617 0.969 . . . . 71.030000000000001 113.617 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -87.02 -45.92 10.3 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 119.838 -0.745 . . . . 60.039999999999999 112.537 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -155.35 134.79 7.87 Favored Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 114.921 -1.036 . . . . 65.049999999999997 109.654 -168.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 14.3 Cg_exo -72.19 105.0 1.76 Allowed 'Trans proline' 0 C--N 1.298 -2.09 0 C-N-CA 122.283 1.989 . . . . 64.25 108.076 166.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 36.0 m -77.15 151.2 5.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.594 -0.891 . . . . 73.340000000000003 108.594 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.64 120.88 4.31 Favored Glycine 0 CA--C 1.474 -2.492 0 C-N-CA 117.791 -2.147 . . . . 71.299999999999997 113.124 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -88.29 102.52 14.92 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 105.999 -1.852 . . . . 71.340000000000003 105.999 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 70.6 t -95.2 120.25 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.544 0 CA-C-O 122.089 0.947 . . . . 71.439999999999998 109.761 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 58.3 mt -98.0 123.44 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.723 0 CA-C-N 113.099 -1.864 . . . . 65.409999999999997 109.021 -172.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -114.16 161.21 18.09 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-N 114.6 -1.182 . . . . 71.409999999999997 109.894 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -55.7 -41.39 73.72 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 124.684 1.194 . . . . 72.030000000000001 112.667 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 4.0 p -155.81 162.99 40.39 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.92 -0.582 . . . . 74.430000000000007 110.534 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -28.22 64.57 Favored 'General case' 0 C--O 1.202 -1.408 0 C-N-CA 119.865 -0.734 . . . . 74.540000000000006 109.889 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.0 -27.77 69.05 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.491 0.663 . . . . 52.049999999999997 110.196 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.46 -41.21 6.57 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.995 -1.242 . . . . 74.120000000000005 109.995 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.49 ' O ' HD13 ' B' ' 33' ' ' LEU . . . -61.91 -41.26 97.7 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 114.702 -0.749 . . . . 54.149999999999999 111.827 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.8 -36.24 83.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.548 0.213 . . . . 64.329999999999998 111.168 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.71 -39.28 73.52 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.381 -0.599 . . . . 74.340000000000003 109.381 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.86 -42.2 86.04 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.125 -0.943 . . . . 60.149999999999999 110.286 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.433 ' HE2' ' HA ' ' B' ' 104' ' ' GLU . 13.3 ttmt -60.71 -47.89 84.26 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.426 -0.806 . . . . 64.230000000000004 109.636 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -60.14 -38.49 83.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.009 -0.541 . . . . 71.310000000000002 111.11 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.42 -30.95 62.13 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 112.538 0.57 . . . . 71.0 112.538 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.596 ' O ' HG21 ' B' ' 91' ' ' ILE . 98.4 mt -108.52 -12.54 14.98 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 116.002 1.853 . . . . 75.340000000000003 116.002 -174.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -79.56 114.55 18.57 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 120.188 -1.57 . . . . 61.310000000000002 112.024 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.98 9.18 28.59 Favored Glycine 0 CA--C 1.485 -1.829 0 C-N-CA 120.619 -0.8 . . . . 73.439999999999998 111.381 173.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.596 HG21 ' O ' ' B' ' 88' ' ' LEU . 13.6 tt -104.81 149.79 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.803 0 N-CA-C 106.904 -1.517 . . . . 75.340000000000003 106.904 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.425 ' CZ ' ' HA ' ' B' ' 98' ' ' PRO . 99.3 mtt180 -81.39 138.71 35.58 Favored 'General case' 0 C--N 1.267 -2.989 0 CA-C-O 121.523 0.677 . . . . 74.409999999999997 112.192 175.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -77.97 -28.54 49.43 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.219 -1.355 . . . . 53.210000000000001 108.117 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.23 127.62 14.76 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 106.106 -1.812 . . . . 75.140000000000001 106.106 175.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . 0.53 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 72.7 Cg_endo -71.58 -21.72 25.34 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.089 1.859 . . . . 72.209999999999994 114.761 -176.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.99 -25.43 29.99 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.527 0.679 . . . . 74.109999999999999 109.717 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -97.2 128.77 33.98 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.475 -0.784 . . . . 72.129999999999995 108.983 -176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.425 ' HA ' ' CZ ' ' B' ' 92' ' ' ARG . 38.1 Cg_exo -60.64 -16.82 45.55 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 123.241 2.627 . . . . 54.299999999999997 113.179 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -55.46 118.86 4.83 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 124.707 1.203 . . . . 71.230000000000004 110.138 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 33.7 p -104.67 157.97 16.82 Favored 'General case' 0 N--CA 1.413 -2.323 0 C-N-CA 120.115 -0.634 . . . . 70.319999999999993 110.505 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 35.5 tp -96.25 124.66 40.33 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.507 -1.664 . . . . 75.409999999999997 106.507 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -129.62 127.46 40.67 Favored 'General case' 0 N--CA 1.422 -1.84 0 C-N-CA 120.161 -0.616 . . . . 71.329999999999998 109.758 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.443 ' HG ' HG21 ' B' ' 35' ' ' VAL . 5.8 mp -114.8 140.92 48.53 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.271 -1.011 . . . . 71.129999999999995 108.271 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.472 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 39.1 tt0 -152.24 165.64 34.24 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.535 -1.654 . . . . 75.510000000000005 106.535 176.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -71.32 138.46 49.31 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 120.077 1.308 . . . . 55.329999999999998 110.983 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.47 154.42 30.56 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.434 -0.58 . . . . 75.25 109.434 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -84.43 1.46 45.31 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 122.126 0.965 . . . . 73.230000000000004 109.432 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.82 118.72 12.52 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.302 -0.863 . . . . 65.120000000000005 109.481 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.453 ' ND2' ' HA ' ' B' ' 30' ' ' VAL . 3.8 m-20 -73.42 112.59 9.63 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.549 -1.278 . . . . 43.299999999999997 107.549 175.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 C--N 1.278 -2.52 0 N-CA-C 108.97 -0.752 . . . . 65.530000000000001 108.97 -176.56 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.434 -1.232 0 N-CA-C 104.108 -2.553 . . . . 54.0 104.108 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -121.29 -4.15 9.44 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 115.174 -0.921 . . . . 64.319999999999993 110.322 -168.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.7 m -101.99 124.54 47.79 Favored 'General case' 0 C--N 1.264 -3.117 0 CA-C-N 115.132 -0.94 . . . . 54.119999999999997 109.213 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 33' ' ' LEU . 3.2 mp -108.13 137.59 45.85 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 107.308 -1.367 . . . . 75.099999999999994 107.308 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -103.77 109.16 20.77 Favored 'General case' 0 N--CA 1.412 -2.355 0 C-N-CA 118.473 -1.291 . . . . 74.019999999999996 107.621 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.438 HG22 ' HG ' ' A' ' 103' ' ' LEU . 25.0 t -96.57 120.17 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.752 0 CA-C-N 113.772 -1.558 . . . . 72.109999999999999 107.677 -174.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 20.1 p -126.51 166.78 16.63 Favored 'General case' 0 N--CA 1.4 -2.935 0 CA-C-N 114.644 -1.162 . . . . 63.310000000000002 108.305 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 94.89 32.08 7.36 Favored Glycine 0 N--CA 1.417 -2.619 0 N-CA-C 110.671 -0.972 . . . . 64.099999999999994 110.671 -173.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.4 mt -101.0 145.27 30.11 Favored Pre-proline 0 N--CA 1.428 -1.566 0 N-CA-C 109.081 -0.711 . . . . 54.409999999999997 109.081 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.04 157.69 33.17 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.208 1.939 . . . . 62.340000000000003 110.022 173.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.474 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 7.7 p -76.29 -2.15 4.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-O 122.362 1.077 . . . . 61.030000000000001 109.66 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -128.28 35.13 4.46 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 114.437 -1.256 . . . . 65.209999999999994 108.564 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.98 123.86 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 N-CA-C 108.097 -1.075 . . . . 54.049999999999997 108.097 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -93.65 143.98 27.45 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-N 115.358 -0.837 . . . . 61.100000000000001 110.153 -175.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.09 -19.95 35.5 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.472 2.781 . . . . 73.120000000000005 114.617 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.578 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -87.34 -15.67 37.26 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 118.435 -1.306 . . . . 74.310000000000002 111.644 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -67.32 -41.21 85.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.102 0.477 . . . . 62.32 110.244 -177.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.13 -30.31 67.45 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 116.153 -0.476 . . . . 70.340000000000003 109.833 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.701 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 41.2 t80 -61.88 -51.17 69.28 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.484 -0.78 . . . . 72.140000000000001 110.246 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.94 -38.31 90.51 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.073 -0.512 . . . . 75.200000000000003 110.973 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.8 tp -77.91 -43.02 31.27 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.507 -0.77 . . . . 74.530000000000001 112.289 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -97.62 -2.06 42.4 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 114.441 1.274 . . . . 54.43 114.441 -172.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 32.3 ttt-85 -60.69 -46.09 97.07 Favored Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 112.89 0.7 . . . . 64.219999999999999 112.89 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -75.05 -2.68 12.86 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.095 1.863 . . . . 75.25 112.769 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -83.88 106.21 15.38 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.627 0.727 . . . . 74.409999999999997 110.871 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -68.76 109.95 4.08 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.254 -1.339 . . . . 74.239999999999995 110.115 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.24 -14.28 6.97 Favored Glycine 0 N--CA 1.421 -2.306 0 CA-C-N 114.908 -1.042 . . . . 72.349999999999994 111.576 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -65.93 102.89 0.84 Allowed 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.173 0.511 . . . . 54.210000000000001 110.852 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -81.16 -57.48 3.49 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.543 -0.91 . . . . 75.299999999999997 108.543 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.08 -174.37 35.45 Favored Glycine 0 C--N 1.303 -1.251 0 CA-C-N 114.911 -1.04 . . . . 52.439999999999998 112.439 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.7 p -146.39 137.88 24.61 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 123.407 0.683 . . . . 65.239999999999995 110.297 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.2 tp -112.06 120.05 40.54 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.558 -0.534 . . . . 61.32 109.558 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 mm -94.01 134.49 31.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.851 -0.796 . . . . 62.109999999999999 108.851 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -134.74 114.13 12.36 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 110.006 -0.368 . . . . 72.310000000000002 110.006 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.82 112.82 2.45 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.36 0.6 . . . . 65.310000000000002 109.514 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -113.86 164.32 13.92 Favored 'General case' 0 N--CA 1.404 -2.756 0 N-CA-C 105.479 -2.045 . . . . 75.140000000000001 105.479 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.97 -38.25 10.39 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.246 1.202 . . . . 54.450000000000003 114.246 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.74 -27.73 13.5 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.455 0.539 . . . . 74.329999999999998 112.455 -174.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -169.93 148.49 3.16 Favored Pre-proline 0 N--CA 1.423 -1.822 0 CA-C-N 115.921 -0.581 . . . . 61.109999999999999 110.7 -168.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.474 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 13.8 Cg_exo -70.24 106.2 1.71 Allowed 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 121.999 1.8 . . . . 63.210000000000001 108.417 165.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.1 m -81.48 158.76 4.08 Favored 'Isoleucine or valine' 0 C--O 1.25 1.081 0 N-CA-C 107.883 -1.155 . . . . 53.109999999999999 107.883 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.88 120.9 2.91 Favored Glycine 0 CA--C 1.484 -1.853 0 C-N-CA 117.668 -2.206 . . . . 73.109999999999999 113.077 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -88.03 102.02 14.35 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.532 -1.285 . . . . 72.0 107.532 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 78.4 t -91.34 123.79 43.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 108.814 -0.81 . . . . 54.509999999999998 108.814 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.9 pt -107.83 123.73 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.329 0 CA-C-O 122.05 0.929 . . . . 63.450000000000003 111.564 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -100.25 163.82 12.23 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 114.243 -1.344 . . . . 72.0 109.84 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -64.52 -39.86 94.55 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.111 -0.95 . . . . 65.109999999999999 112.461 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 56.0 m -145.21 166.0 26.74 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.742 -0.208 . . . . 62.119999999999997 110.48 -172.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -29.49 64.33 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 120.591 -0.444 . . . . 73.239999999999995 112.081 -176.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.23 -18.98 64.7 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 122.222 1.01 . . . . 65.340000000000003 108.88 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.1 -41.29 10.46 Favored Glycine 0 C--N 1.305 -1.184 0 CA-C-N 114.392 -1.276 . . . . 51.100000000000001 110.033 176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.62 -46.17 76.71 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.684 -0.758 . . . . 73.519999999999996 111.6 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -29.41 70.15 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 111.887 0.329 . . . . 71.129999999999995 111.887 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.55 -40.45 56.84 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 111.304 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.18 -43.23 87.47 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.915 -0.584 . . . . 74.510000000000005 110.953 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 103' ' ' LEU . 14.5 ptmm? -72.08 -31.81 66.45 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.93 -0.708 . . . . 74.209999999999994 110.414 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -58.73 -36.72 74.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.038 0.447 . . . . 74.140000000000001 110.453 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.23 -42.2 16.15 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 120.999 0.428 . . . . 61.219999999999999 111.606 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.436 ' O ' HG22 ' A' ' 91' ' ' ILE . 92.3 mt -98.52 -18.61 18.09 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 117.18 2.289 . . . . 72.510000000000005 117.18 -169.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.335 0.2 OUTLIER -72.42 114.63 10.75 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 117.167 -1.813 . . . . 53.049999999999997 111.946 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.68 14.92 10.71 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 110.461 -1.056 . . . . 64.310000000000002 110.461 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.1 tt -93.2 128.19 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 CA-C-O 121.26 0.553 . . . . 74.450000000000003 109.788 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.468 ' HG3' HG21 ' A' ' 100' ' ' THR . 5.9 ttt180 -83.79 124.82 31.32 Favored 'General case' 0 N--CA 1.402 -2.873 0 N-CA-C 107.68 -1.23 . . . . 72.030000000000001 107.68 173.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.434 ' HB2' ' CD1' ' A' ' 101' ' ' LEU . 3.5 t80 -64.18 -34.25 77.66 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 124.572 1.17 . . . . 73.120000000000005 110.012 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' B' ' 45' ' ' ARG . 2.8 p-10 -151.64 136.92 10.72 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 105.901 -1.889 . . . . 73.25 105.901 175.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.428 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 73.8 Cg_endo -75.48 -1.27 11.11 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.336 2.024 . . . . 65.140000000000001 114.118 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -92.35 -25.17 18.66 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.285 0.564 . . . . 73.129999999999995 110.019 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -99.29 133.77 21.78 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 108.065 -1.087 . . . . 72.420000000000002 108.065 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.63 -16.74 56.53 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.167 1.911 . . . . 42.020000000000003 112.398 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -62.16 122.33 15.32 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.573 1.149 . . . . 55.100000000000001 110.466 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.527 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 26.0 p -119.33 149.71 41.36 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.21 -0.663 . . . . 74.239999999999995 109.21 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.8 mp -88.67 124.09 33.76 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-O 120.789 0.328 . . . . 72.519999999999996 110.715 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -120.37 112.9 19.59 Favored 'General case' 0 N--CA 1.4 -2.964 0 N-CA-C 107.518 -1.29 . . . . 74.099999999999994 107.518 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.461 ' O ' ' HE2' ' A' ' 85' ' ' LYS . 6.4 mp -87.15 116.22 25.07 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.512 -1.222 . . . . 72.319999999999993 107.822 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -118.13 164.74 14.7 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.374 -1.343 . . . . 74.540000000000006 107.374 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -81.7 132.16 35.28 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 118.694 0.679 . . . . 73.420000000000002 109.568 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.41 137.79 48.6 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.837 -1.172 . . . . 73.319999999999993 107.837 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -82.95 12.02 5.43 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.215 1.007 . . . . 61.409999999999997 109.892 -175.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -157.5 118.73 3.61 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 114.421 -1.263 . . . . 73.239999999999995 107.614 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -70.68 138.63 50.81 Favored 'General case' 0 CA--C 1.475 -1.935 0 C-N-CA 120.019 -0.672 . . . . 72.129999999999995 110.329 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.281 -2.372 0 CA-C-N 115.567 -0.742 . . . . 72.209999999999994 110.168 -174.037 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 81.0 t . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 103.748 -2.686 . . . . 74.209999999999994 103.748 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -129.02 7.39 5.52 Favored 'General case' 0 CA--C 1.471 -2.078 0 CA-C-N 115.435 -0.802 . . . . 74.530000000000001 111.803 -169.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 56.6 m -109.58 132.34 54.23 Favored 'General case' 0 C--N 1.264 -3.151 0 N-CA-C 107.554 -1.276 . . . . 64.349999999999994 107.554 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' B' ' 72' ' ' PHE . 3.4 mp -121.98 151.46 40.77 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.482 -0.933 . . . . 72.239999999999995 108.482 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' B' ' 104' ' ' GLU . 17.9 p90 -108.13 111.47 23.5 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.787 -1.19 . . . . 75.010000000000005 107.787 175.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 57.2 t -97.57 122.16 48.86 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 CA-C-N 114.094 -1.412 . . . . 71.120000000000005 108.197 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 65.4 p -130.05 174.8 9.44 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.532 -0.758 . . . . 64.310000000000002 110.128 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 88.66 22.87 38.14 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.029 -1.228 . . . . 61.229999999999997 110.029 -172.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 88.4 mt -92.37 132.52 31.8 Favored Pre-proline 0 N--CA 1.412 -2.336 0 N-CA-C 106.179 -1.785 . . . . 53.219999999999999 106.179 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.88 160.24 30.2 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 121.639 1.559 . . . . 74.109999999999999 110.95 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.62 -7.92 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-O 122.588 1.185 . . . . 63.200000000000003 109.774 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -121.46 31.92 6.11 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 114.042 -1.435 . . . . 51.049999999999997 108.576 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.25 131.65 33.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 109.091 -0.707 . . . . 74.230000000000004 109.091 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -100.52 136.54 19.92 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-N 115.302 -0.863 . . . . 72.319999999999993 109.655 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -54.62 -24.61 37.65 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 C-N-CA 123.716 2.944 . . . . 74.209999999999994 114.121 -173.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.516 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 10.6 ptt180 -82.5 -15.24 53.16 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 122.081 -0.387 . . . . 61.149999999999999 111.954 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.13 -40.83 82.39 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.31 -0.626 . . . . 71.140000000000001 109.31 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 90.8 mt -68.76 -32.26 71.89 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.463 -0.79 . . . . 63.240000000000002 109.633 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.577 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 75.6 t80 -63.53 -48.17 78.62 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.135 -0.939 . . . . 73.239999999999995 110.033 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 84.9 mt -67.16 -39.93 86.58 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.196 0.522 . . . . 73.409999999999997 110.31 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 tp -74.01 -40.39 62.96 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.954 -1.021 . . . . 71.510000000000005 112.473 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -97.97 -4.18 36.8 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.639 0.978 . . . . 72.450000000000003 113.639 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 67.7 ttt180 -61.55 -45.07 93.78 Favored Pre-proline 0 CA--C 1.555 1.141 0 N-CA-C 112.665 0.617 . . . . 75.310000000000002 112.665 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.62 -12.99 20.3 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 121.373 1.382 . . . . 63.119999999999997 113.021 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -78.01 110.73 13.21 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 121.953 0.882 . . . . 64.439999999999998 111.48 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -72.38 109.46 6.11 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 113.945 -1.479 . . . . 65.129999999999995 109.363 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.69 -13.78 5.83 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-N 115.522 -0.763 . . . . 52.219999999999999 112.317 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -61.57 117.03 5.23 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.33 0.586 . . . . 73.209999999999994 111.638 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.47 -47.47 5.95 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.487 -0.779 . . . . 63.43 111.034 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.23 177.13 46.73 Favored Glycine 0 C--N 1.294 -1.802 0 C-N-CA 120.015 -1.088 . . . . 65.329999999999998 112.457 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.5 p -135.47 137.78 42.5 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 122.852 0.461 . . . . 62.229999999999997 110.999 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 5.5 mp -117.35 124.4 48.84 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.423 -1.325 . . . . 72.420000000000002 107.423 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 47.2 mm -94.28 146.98 5.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 109.671 -0.492 . . . . 71.25 109.671 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -129.59 106.57 8.83 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.234 -1.395 . . . . 53.32 107.234 176.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -72.44 116.57 13.05 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.99 -1.115 . . . . 71.010000000000005 107.99 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 11.5 m -122.84 155.16 37.19 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 104.98 -2.23 . . . . 62.240000000000002 104.98 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.94 -25.79 65.45 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.905 0.383 . . . . 60.399999999999999 111.698 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -82.11 -45.8 14.7 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 116.062 -0.517 . . . . 70.519999999999996 111.695 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -172.34 145.97 1.57 Allowed Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 108.183 -1.044 . . . . 71.519999999999996 108.183 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.06 106.38 2.02 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.299 2.0 . . . . 71.150000000000006 109.087 168.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 35.8 m -87.6 157.67 3.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.721 -0.844 . . . . 70.239999999999995 108.721 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.31 120.89 3.33 Favored Glycine 0 CA--C 1.481 -2.067 0 C-N-CA 118.62 -1.753 . . . . 73.120000000000005 112.791 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' B' ' 33' ' ' LEU . 98.0 m-85 -88.16 102.37 14.74 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.342 -1.355 . . . . 73.5 107.342 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 88.4 t -94.13 130.15 43.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.298 0 CA-C-N 114.678 -1.146 . . . . 53.119999999999997 109.703 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 48.6 pt -106.99 138.64 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.241 0 CA-C-O 121.848 0.832 . . . . 72.319999999999993 110.596 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -119.21 166.08 13.42 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 114.116 -1.402 . . . . 72.120000000000005 111.553 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.75 -40.87 80.73 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.023 -1.444 . . . . 72.340000000000003 112.362 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 5.0 p -157.95 167.64 29.38 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.145 -0.48 . . . . 72.129999999999995 111.399 -170.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.58 -30.11 62.82 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 120.219 -0.593 . . . . 71.430000000000007 109.845 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.48 -24.19 63.75 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.766 0.793 . . . . 43.009999999999998 109.579 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.89 -36.85 9.79 Favored Glycine 0 C--N 1.309 -0.963 0 CA-C-N 114.63 -1.168 . . . . 72.430000000000007 110.581 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.07 71.44 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.717 0.807 . . . . 50.539999999999999 111.002 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.29 -38.66 77.47 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 116.092 -0.504 . . . . 74.140000000000001 111.207 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.6 -40.8 72.99 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.716 -0.674 . . . . 52.329999999999998 111.322 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.82 -41.38 83.15 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 116.161 -0.472 . . . . 73.540000000000006 111.459 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.451 ' HE2' ' O ' ' B' ' 103' ' ' LEU . 15.1 ptmm? -72.02 -36.42 69.68 Favored 'General case' 0 C--O 1.2 -1.533 0 C-N-CA 120.153 -0.619 . . . . 52.140000000000001 109.521 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -58.95 -39.22 81.0 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.316 0.646 . . . . 52.409999999999997 110.081 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.45 -31.37 37.47 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 112.615 0.598 . . . . 71.129999999999995 112.615 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.41 ' O ' HG23 ' B' ' 91' ' ' ILE . 96.2 mt -100.21 -31.49 11.35 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.201 1.926 . . . . 72.109999999999999 116.201 -174.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . 0.251 0.2 OUTLIER -65.91 121.96 16.27 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.448 1.277 . . . . 71.230000000000004 114.448 -173.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.23 14.94 15.21 Favored Glycine 0 N--CA 1.428 -1.874 0 C-N-CA 120.744 -0.741 . . . . 73.239999999999995 112.104 174.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.41 HG23 ' O ' ' B' ' 88' ' ' LEU . 13.5 tt -103.98 140.04 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.909 0 N-CA-C 107.123 -1.436 . . . . 64.099999999999994 107.123 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' B' ' 94' ' ' ASP . 89.4 mtt180 -74.15 134.91 42.83 Favored 'General case' 0 C--N 1.263 -3.163 0 CA-C-O 120.869 0.366 . . . . 65.010000000000005 110.051 171.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.466 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.0 t80 -65.49 -34.76 79.02 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.436 -1.256 . . . . 75.5 109.171 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.472 ' HB2' ' CB ' ' B' ' 97' ' ' ASN . 3.0 m-20 -131.4 138.35 32.57 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 102.055 -3.313 . . . . 52.219999999999999 102.055 173.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . 0.701 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 22.1 Cg_endo -63.21 -29.25 73.51 Favored 'Trans proline' 0 N--CA 1.486 1.041 0 CA-C-N 121.911 1.718 . . . . 53.229999999999997 111.001 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.5 -17.36 42.21 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.965 -1.47 . . . . 50.399999999999999 110.916 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' ASN . . . . . 0.472 ' CB ' ' HB2' ' B' ' 94' ' ' ASP . 39.5 t30 -100.43 125.67 38.54 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 109.573 -0.528 . . . . 64.519999999999996 109.573 -175.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.72 -10.71 28.35 Favored 'Trans proline' 0 C--O 1.239 0.554 0 C-N-CA 122.795 2.33 . . . . 74.409999999999997 112.586 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' GLN . . . . . 0.423 ' HB3' ' ND2' ' B' ' 97' ' ' ASN . 6.6 tp60 -70.29 113.06 7.08 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.446 -0.946 . . . . 72.140000000000001 108.446 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.498 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 69.6 p -97.37 145.8 25.79 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.03 -0.532 . . . . 70.349999999999994 109.919 -175.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 52.2 tp -87.85 123.71 32.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.881 -1.155 . . . . 71.049999999999997 107.881 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -136.88 123.33 20.8 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-O 121.669 0.747 . . . . 74.319999999999993 110.337 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.451 ' O ' ' HE2' ' B' ' 85' ' ' LYS . 5.4 mp -107.19 122.52 46.69 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.199 -1.364 . . . . 71.340000000000003 109.391 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.419 ' HB2' ' CE1' ' B' ' 34' ' ' PHE . 48.6 mt-10 -126.29 165.56 18.75 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.206 -1.035 . . . . 65.530000000000001 108.206 174.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -73.81 141.15 46.2 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.807 -0.357 . . . . 74.349999999999994 110.039 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.03 158.8 26.4 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.563 -0.903 . . . . 37.460000000000001 108.563 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -92.26 7.75 41.3 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.956 0.884 . . . . 75.0 109.946 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -157.66 132.67 8.72 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.252 -0.885 . . . . 55.520000000000003 108.916 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -85.32 141.28 30.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.574 -0.528 . . . . 53.530000000000001 109.574 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.292 -1.904 0 N-CA-C 108.498 -0.927 . . . . 74.439999999999998 108.498 175.946 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.411 -2.42 0 N-CA-C 105.669 -1.975 . . . . 74.510000000000005 105.669 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 16.8 ptm180 -114.65 7.09 15.9 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.327 -0.851 . . . . 70.329999999999998 110.42 -175.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.9 m -116.41 117.73 30.75 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.919 0.866 . . . . 64.510000000000005 110.686 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 mp -98.13 140.73 32.01 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.774 -1.565 . . . . 74.200000000000003 106.774 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.516 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 6.8 p90 -107.54 114.64 28.77 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 117.578 -1.649 . . . . 72.140000000000001 107.979 173.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.41 HG23 ' HG ' ' A' ' 103' ' ' LEU . 43.8 t -97.29 121.05 47.41 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.879 0 CA-C-N 114.375 -1.284 . . . . 72.120000000000005 108.492 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.5 p -124.26 170.77 10.44 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 115.544 -0.753 . . . . 64.140000000000001 109.608 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 82.35 41.42 9.24 Favored Glycine 0 N--CA 1.43 -1.725 0 N-CA-C 110.103 -1.199 . . . . 36.850000000000001 110.103 -173.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.4 mt -111.31 123.06 35.98 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 114.23 -0.985 . . . . 73.219999999999999 110.16 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.5 144.08 19.61 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.857 2.372 . . . . 71.329999999999998 110.664 173.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.494 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 7.6 p -73.24 4.75 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 CA-C-O 122.475 1.131 . . . . 71.209999999999994 112.088 -173.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -125.66 13.12 8.04 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.885 -1.052 . . . . 70.5 110.904 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.0 pt -53.65 135.68 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 113.453 0.909 . . . . 62.119999999999997 113.453 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -97.18 146.0 30.59 Favored Pre-proline 0 C--N 1.292 -1.894 0 CA-C-N 114.625 -1.17 . . . . 72.540000000000006 109.119 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.13 -26.7 52.03 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.171 2.581 . . . . 72.319999999999993 112.861 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.525 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 9.8 ptt180 -70.86 -23.91 62.41 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 120.858 0.361 . . . . 72.420000000000002 111.328 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -72.63 -40.47 66.39 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.633 -0.877 . . . . 41.340000000000003 108.633 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.2 mt -66.73 -36.78 83.28 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.802 -0.814 . . . . 65.340000000000003 108.802 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.525 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 87.8 t80 -58.62 -47.54 84.04 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-N 114.708 -1.133 . . . . 74.140000000000001 110.253 175.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 97.6 mt -70.91 -30.14 66.4 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.072 0.463 . . . . 71.519999999999996 110.563 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.7 tp -68.62 -51.56 40.95 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.213 -0.903 . . . . 65.010000000000005 110.667 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -95.2 10.59 35.43 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.682 0.623 . . . . 72.420000000000002 112.682 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 10.6 ttp180 -52.65 -50.02 83.01 Favored Pre-proline 0 CA--C 1.565 1.539 0 C-N-CA 124.471 1.108 . . . . 74.349999999999994 113.696 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -85.35 -0.88 9.07 Favored 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 121.588 1.525 . . . . 64.049999999999997 112.74 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -88.72 96.04 10.51 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 122.629 1.204 . . . . 70.219999999999999 112.104 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -69.85 113.54 7.18 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 113.068 -1.878 . . . . 65.230000000000004 109.44 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.99 -24.82 3.25 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 114.956 -1.02 . . . . 63.420000000000002 110.661 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -56.62 115.81 2.76 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.251 0.62 . . . . 51.310000000000002 111.352 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -94.26 -56.58 2.78 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 109.209 -0.663 . . . . 55.399999999999999 109.209 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.22 169.93 40.63 Favored Glycine 0 C--N 1.295 -1.743 0 CA-C-N 115.214 -0.903 . . . . 45.299999999999997 111.6 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.4 p -130.55 137.36 49.66 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 120.93 0.395 . . . . 72.230000000000004 110.543 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -121.02 109.73 15.4 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.52 -0.919 . . . . 53.020000000000003 108.52 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -93.92 130.84 42.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.098 0.475 . . . . 72.530000000000001 111.287 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 69' ' ' PRO . 87.2 tttt -108.84 112.37 24.59 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.505 -0.924 . . . . 55.049999999999997 108.505 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.1 122.77 15.21 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.789 -0.642 . . . . 73.109999999999999 110.226 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.594 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 15.5 m -130.39 159.67 36.3 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 105.669 -1.975 . . . . 65.299999999999997 105.669 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -42.64 -41.78 3.21 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.177 1.391 . . . . 72.030000000000001 114.356 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -105.62 -36.47 7.08 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.331 0.586 . . . . 71.030000000000001 112.542 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.594 ' O ' ' HB ' ' A' ' 65' ' ' THR . 8.3 pt20 -147.3 132.29 8.98 Favored Pre-proline 0 C--N 1.291 -1.953 0 CA-C-N 115.357 -0.838 . . . . 75.299999999999997 111.697 -168.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 40' ' ' VAL . 32.3 Cg_endo -73.06 101.87 1.39 Allowed 'Trans proline' 0 N--CA 1.433 -2.082 0 C-N-CA 121.649 1.566 . . . . 72.430000000000007 108.18 167.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.7 m -70.77 139.12 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 108.685 -0.857 . . . . 63.350000000000001 108.685 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -108.82 119.79 5.7 Favored Glycine 0 CA--C 1.465 -3.056 0 C-N-CA 118.236 -1.935 . . . . 72.329999999999998 112.939 -174.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -88.73 101.91 14.47 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 105.865 -1.902 . . . . 64.439999999999998 105.865 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -96.78 121.55 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.504 0 CA-C-N 114.735 -1.12 . . . . 63.030000000000001 108.888 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.7 mt -102.02 119.85 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.763 0 CA-C-N 114.601 -1.181 . . . . 72.109999999999999 109.854 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.521 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 5.2 m-85 -102.07 156.35 17.6 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 114.373 -1.285 . . . . 72.340000000000003 109.916 176.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -64.47 -30.53 71.56 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.201 -1.363 . . . . 62.530000000000001 112.112 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m -156.27 155.84 33.03 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 121.804 -0.56 . . . . 74.109999999999999 112.205 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.611 ' HD3' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -54.16 -39.15 66.29 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 123.953 0.783 . . . . 72.340000000000003 110.91 175.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.71 -29.56 69.42 Favored 'General case' 0 CA--C 1.493 -1.249 0 O-C-N 123.889 0.743 . . . . 75.310000000000002 110.369 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.01 -45.4 5.1 Favored Glycine 0 C--N 1.295 -1.733 0 CA-C-N 114.469 -1.241 . . . . 73.329999999999998 110.69 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.1 -46.32 88.6 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.479 1.112 . . . . 70.120000000000005 113.137 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 10.0 pt-20 -62.51 -37.11 84.77 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.384 -0.371 . . . . 64.340000000000003 111.327 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.31 -37.63 52.21 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 116.267 -0.424 . . . . 65.430000000000007 110.638 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.76 90.37 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.721 -0.672 . . . . 63.130000000000003 111.661 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -75.36 -33.71 61.08 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 118.552 -1.259 . . . . 64.219999999999999 111.85 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.6 -17.15 61.21 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.229 0.538 . . . . 55.32 111.509 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.22 -45.03 14.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 120.998 0.427 . . . . 62.210000000000001 110.285 175.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.546 ' O ' HG23 ' A' ' 91' ' ' ILE . 91.9 mt -91.04 -5.42 55.31 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 114.749 1.389 . . . . 73.219999999999999 114.749 -173.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -78.99 114.77 18.21 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.055 -1.028 . . . . 74.310000000000002 112.627 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.13 20.37 10.56 Favored Glycine 0 CA--C 1.479 -2.216 0 C-N-CA 120.408 -0.901 . . . . 55.530000000000001 111.64 174.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 88' ' ' LEU . 16.0 tt -114.3 142.32 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.276 0 N-CA-C 105.461 -2.051 . . . . 70.540000000000006 105.461 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.471 ' CD ' ' HA ' ' A' ' 95' ' ' PRO . 33.3 ptt180 -87.02 130.09 34.61 Favored 'General case' 0 C--N 1.262 -3.227 0 C-N-CA 119.424 -0.91 . . . . 55.039999999999999 111.335 175.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -60.75 -31.48 70.81 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.701 -1.59 . . . . 71.409999999999997 110.207 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -142.28 113.27 6.18 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 105.512 -2.033 . . . . 74.0 105.512 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.471 ' HA ' ' CD ' ' A' ' 92' ' ' ARG . 53.0 Cg_exo -61.38 -12.85 25.81 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 122.99 2.46 . . . . 43.43 114.846 -178.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -98.21 -14.45 20.33 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.704 -0.623 . . . . 74.010000000000005 110.177 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -94.79 141.97 24.07 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.705 -0.85 . . . . 64.519999999999996 108.705 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.09 2.35 7.25 Favored 'Trans proline' 0 CA--C 1.549 1.248 0 C-N-CA 122.619 2.213 . . . . 75.019999999999996 114.314 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -92.87 127.78 38.5 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 121.558 -0.714 . . . . 72.510000000000005 109.259 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.561 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 50.6 p -107.08 143.64 34.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.916 -0.401 . . . . 55.119999999999997 109.916 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 34.7 tp -89.37 127.98 35.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.382 -0.97 . . . . 74.519999999999996 108.382 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -136.96 124.01 21.56 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 108.545 -0.909 . . . . 64.450000000000003 108.545 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.41 ' HG ' HG23 ' A' ' 35' ' ' VAL . 5.9 mp -112.83 122.72 48.5 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 115.732 -0.667 . . . . 60.530000000000001 109.85 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.516 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 43.3 mt-10 -127.89 177.43 6.85 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.603 -1.258 . . . . 75.140000000000001 107.603 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -91.02 138.57 31.5 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 118.753 0.706 . . . . 64.019999999999996 111.424 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.75 158.79 33.98 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.443 -0.799 . . . . 60.310000000000002 108.865 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -84.8 -1.98 57.11 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.764 0.792 . . . . 75.450000000000003 109.643 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -151.43 132.56 14.4 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.321 -0.854 . . . . 72.109999999999999 109.623 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -78.11 124.29 27.88 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.645 -0.502 . . . . 70.400000000000006 109.645 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 C--N 1.287 -2.15 0 N-CA-C 108.07 -1.085 . . . . 75.439999999999998 108.07 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.472 ' HA ' HD22 ' B' ' 109' ' ' ASN . 48.5 t . . . . . 0 N--CA 1.43 -1.443 0 N-CA-C 108.816 -0.809 . . . . 75.340000000000003 108.816 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' B' ' 75' ' ' PHE . 15.0 ptm180 -114.49 11.65 17.19 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.208 -0.905 . . . . 72.510000000000005 111.232 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 29.6 m -122.19 122.93 40.31 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.514 0.673 . . . . 71.109999999999999 111.096 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 mp -101.63 144.75 29.97 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.075 -1.454 . . . . 62.32 107.075 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' B' ' 104' ' ' GLU . 9.9 p90 -109.2 116.43 31.9 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 117.412 -1.715 . . . . 62.340000000000003 108.179 171.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.46 120.06 46.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 CA-C-N 113.946 -1.479 . . . . 73.439999999999998 108.225 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' SER . . . . . 0.441 ' OG ' ' HG3' ' B' ' 102' ' ' ARG . 11.0 p -128.72 163.03 26.02 Favored 'General case' 0 N--CA 1.408 -2.557 0 CA-C-N 115.505 -0.771 . . . . 73.400000000000006 109.984 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 88.83 37.79 7.19 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 110.648 -0.981 . . . . 42.100000000000001 110.648 -173.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.89 135.79 19.37 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 108.069 -1.086 . . . . 73.430000000000007 108.069 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.06 150.64 23.46 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.081 1.854 . . . . 73.040000000000006 110.194 172.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.451 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 8.1 p -76.75 1.73 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 121.999 0.904 . . . . 62.409999999999997 110.5 -174.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -127.73 20.85 6.53 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.509 -0.769 . . . . 50.340000000000003 110.032 -173.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 24.9 pt -52.6 133.77 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 113.871 1.063 . . . . 74.0 113.871 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' B' ' 43' ' ' LYS . 3.2 mptp? -90.86 147.12 35.26 Favored Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 114.58 -1.191 . . . . 75.400000000000006 109.458 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.84 -28.65 59.21 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.855 2.37 . . . . 64.450000000000003 113.286 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.525 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -79.54 -14.38 58.9 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 117.642 -1.623 . . . . 63.25 111.898 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -69.93 -40.53 75.46 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.818 -0.808 . . . . 72.049999999999997 108.818 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 88.6 mt -66.4 -34.03 77.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.376 -0.829 . . . . 72.349999999999994 109.072 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.525 ' HB3' ' O ' ' B' ' 45' ' ' ARG . 78.9 t80 -60.94 -49.28 78.08 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-N 115.112 -0.949 . . . . 72.310000000000002 110.065 176.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 92.0 mt -70.01 -29.14 66.12 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-O 121.117 0.484 . . . . 74.430000000000007 110.677 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 tp -71.78 -51.03 24.7 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.113 -0.949 . . . . 64.010000000000005 111.121 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -96.8 7.5 46.45 Favored 'General case' 0 C--O 1.217 -0.608 0 N-CA-C 113.674 0.99 . . . . 71.239999999999995 113.674 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 10.0 ttp180 -47.93 -50.83 51.53 Favored Pre-proline 0 CA--C 1.568 1.639 0 N-CA-C 114.505 1.298 . . . . 72.120000000000005 114.505 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -87.62 -1.39 7.46 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 121.685 1.59 . . . . 73.209999999999994 112.98 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -86.96 97.17 10.55 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.929 1.347 . . . . 71.450000000000003 111.878 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -69.39 113.25 6.53 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 112.169 -2.287 . . . . 72.340000000000003 109.637 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.26 -20.28 4.23 Favored Glycine 0 N--CA 1.422 -2.295 0 CA-C-N 114.72 -1.127 . . . . 71.150000000000006 111.29 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -57.05 114.98 2.36 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.249 0.62 . . . . 73.409999999999997 112.075 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.36 -51.24 4.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.607 0.718 . . . . 65.299999999999997 109.363 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.17 178.59 42.88 Favored Glycine 0 C--N 1.298 -1.55 0 CA-C-N 115.208 -0.905 . . . . 53.43 112.198 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 6.7 p -134.39 141.08 46.73 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 123.508 0.723 . . . . 64.209999999999994 110.082 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -122.91 112.93 18.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.736 -1.579 . . . . 36.850000000000001 106.736 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -93.84 137.92 21.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.13 0.49 . . . . 72.340000000000003 111.254 -176.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -124.46 112.14 16.54 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.129 -1.063 . . . . 61.210000000000001 108.129 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.48 116.61 7.66 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.661 -0.496 . . . . 70.239999999999995 109.661 -177.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 8.5 m -111.53 167.38 10.37 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.523 -1.658 . . . . 75.540000000000006 106.523 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.78 -33.11 6.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.231 1.197 . . . . 71.439999999999998 114.231 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 58.7 mtt-85 -104.72 -28.68 11.05 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.665 0.987 . . . . 74.319999999999993 113.665 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -170.7 152.86 3.93 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 116.439 -0.346 . . . . 73.439999999999998 110.155 -165.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.451 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 51.4 Cg_endo -77.72 108.24 2.52 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 C-N-CA 122.27 1.98 . . . . 54.149999999999999 109.927 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 31.7 m -76.03 140.23 17.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.372 -1.344 . . . . 71.099999999999994 107.372 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.16 120.84 5.46 Favored Glycine 0 C--N 1.282 -2.438 0 C-N-CA 118.753 -1.689 . . . . 74.310000000000002 112.912 -175.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.4 102.29 14.39 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 105.883 -1.895 . . . . 61.43 105.883 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 83.3 t -94.94 124.76 47.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 114.789 -1.096 . . . . 55.439999999999998 109.279 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 60.7 mt -107.35 122.08 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.567 0 CA-C-N 114.41 -1.268 . . . . 75.239999999999995 109.81 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . 0.447 ' O ' ' HB2' ' B' ' 31' ' ' ARG . 4.0 m-85 -105.95 157.2 17.67 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.666 -1.152 . . . . 75.430000000000007 109.697 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.76 -36.26 67.64 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.125 -0.943 . . . . 61.409999999999997 109.868 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.91 134.31 54.85 Favored 'General case' 0 N--CA 1.389 -3.485 0 CA-C-N 115.173 -0.921 . . . . 72.530000000000001 109.406 -170.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -25.09 56.71 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.425 -0.807 . . . . 61.210000000000001 111.218 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.3 -19.81 49.54 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 107.451 -1.315 . . . . 73.25 107.451 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.34 -41.98 8.18 Favored Glycine 0 C--N 1.295 -1.705 0 CA-C-N 113.312 -1.767 . . . . 64.409999999999997 109.22 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.23 -46.91 88.16 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.201 1.0 . . . . 65.420000000000002 112.16 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -58.81 -44.72 90.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.257 -0.429 . . . . 73.519999999999996 111.305 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.71 -36.16 75.68 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.705 -0.68 . . . . 60.0 110.578 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.68 -42.37 91.36 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.881 -0.6 . . . . 53.130000000000003 111.444 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -74.27 -36.03 63.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 118.171 -1.412 . . . . 63.32 111.147 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -63.49 -27.47 69.29 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.547 0.529 . . . . 74.349999999999994 111.321 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.31 -43.69 17.18 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 120.672 0.272 . . . . 74.109999999999999 111.388 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.529 ' O ' HG23 ' B' ' 91' ' ' ILE . 95.7 mt -86.22 -8.57 57.69 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.164 1.542 . . . . 53.310000000000002 115.164 -174.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.22 114.59 15.06 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.049 -1.06 . . . . 65.219999999999999 112.813 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.49 14.79 26.86 Favored Glycine 0 N--CA 1.428 -1.851 0 C-N-CA 120.301 -0.952 . . . . 53.520000000000003 112.278 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.529 HG23 ' O ' ' B' ' 88' ' ' LEU . 16.3 tt -106.59 134.43 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.211 0 N-CA-C 106.127 -1.805 . . . . 52.240000000000002 106.127 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.529 ' NE ' ' HA ' ' B' ' 95' ' ' PRO . 39.4 ptt180 -78.9 133.11 36.97 Favored 'General case' 0 C--N 1.262 -3.223 0 C-N-CA 119.651 -0.82 . . . . 74.230000000000004 111.168 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -69.13 -28.63 66.63 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.769 -1.559 . . . . 74.340000000000003 110.206 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' A' ' 45' ' ' ARG . 10.6 t70 -146.57 118.25 4.83 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 106.389 -1.708 . . . . 63.130000000000003 106.389 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . 0.529 ' HA ' ' NE ' ' B' ' 92' ' ' ARG . 21.0 Cg_endo -60.69 -21.45 69.58 Favored 'Trans proline' 0 N--CA 1.48 0.726 0 C-N-CA 123.039 2.493 . . . . 72.310000000000002 114.409 -176.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -85.97 -23.25 26.97 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.508 0.671 . . . . 65.340000000000003 110.27 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -100.62 132.29 22.51 Favored Pre-proline 0 C--N 1.29 -2.002 0 CA-C-N 115.499 -0.773 . . . . 73.299999999999997 109.13 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.08 -0.72 6.74 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.852 2.368 . . . . 72.400000000000006 112.505 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -69.72 112.23 6.04 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.888 -0.782 . . . . 72.530000000000001 108.888 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.476 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 70.3 p -103.48 145.57 29.81 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.903 -0.777 . . . . 73.219999999999999 108.903 -177.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 36.7 tp -89.9 130.67 36.09 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.663 -1.236 . . . . 61.450000000000003 107.663 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.441 ' HG3' ' OG ' ' B' ' 36' ' ' SER . 7.7 ptm180 -138.14 122.53 18.32 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 108.694 -0.854 . . . . 70.340000000000003 108.694 -175.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -117.47 132.37 56.56 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.82 -0.627 . . . . 73.540000000000006 110.18 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.577 ' HB2' ' CE2' ' B' ' 34' ' ' PHE . 36.0 mt-10 -136.43 174.28 10.79 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.19 -1.781 . . . . 73.099999999999994 106.19 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -81.84 145.02 30.62 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 119.128 -1.029 . . . . 74.439999999999998 110.941 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.14 151.73 40.0 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 107.906 -1.146 . . . . 72.019999999999996 107.906 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -75.95 -9.66 58.79 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.004 0.907 . . . . 62.509999999999998 109.888 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.8 127.29 9.33 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.076 -0.965 . . . . 73.010000000000005 108.827 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.472 HD22 ' HA ' ' B' ' 30' ' ' VAL . 93.0 m-20 -71.71 143.73 49.55 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.912 -0.585 . . . . 65.310000000000002 110.976 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 N--CA 1.413 -2.291 0 N-CA-C 108.075 -1.083 . . . . 64.420000000000002 108.075 178.55 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 CA--C 1.502 -0.889 0 N-CA-C 107.465 -1.309 . . . . 63.409999999999997 107.465 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 17.0 ptp180 -113.99 -1.7 13.72 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.069 -0.969 . . . . 74.439999999999998 111.172 -172.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.4 m -111.07 130.57 55.57 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 115.538 -0.755 . . . . 44.109999999999999 110.679 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -127.78 153.31 46.72 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.903 -0.777 . . . . 75.510000000000005 108.903 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -103.0 120.68 41.08 Favored 'General case' 0 N--CA 1.418 -2.075 0 CA-C-O 121.924 0.869 . . . . 74.040000000000006 108.97 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.0 t -97.59 120.94 47.58 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 CA-C-N 114.388 -1.278 . . . . 71.140000000000001 107.659 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.8 p -128.9 157.44 41.58 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 116.295 -0.411 . . . . 64.209999999999994 110.564 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 98.91 17.44 27.84 Favored Glycine 0 C--N 1.299 -1.525 0 O-C-N 123.675 0.609 . . . . 54.340000000000003 112.734 -178.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.452 ' O ' ' HD2' ' A' ' 69' ' ' PRO . 96.1 mt -78.72 125.65 83.9 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 106.9 -1.519 . . . . 74.319999999999993 106.9 173.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 41' ' ' ASP . 10.8 Cg_endo -58.63 154.57 41.88 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.244 1.296 . . . . 52.32 110.117 176.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.3 p -73.44 4.8 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 CA-C-O 122.33 1.062 . . . . 74.310000000000002 110.785 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.442 ' O ' ' HE2' ' A' ' 43' ' ' LYS . 18.3 t70 -110.34 13.29 22.95 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 114.574 -1.194 . . . . 60.329999999999998 109.155 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.266 2.4 pp -58.09 141.43 15.08 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 N-CA-C 114.939 1.459 . . . . 74.430000000000007 114.939 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 41' ' ' ASP . 61.1 mmtt -106.5 145.93 32.0 Favored Pre-proline 0 C--N 1.283 -2.313 0 CA-C-N 113.548 -1.66 . . . . 73.430000000000007 106.736 176.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.14 -25.93 65.38 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.223 1.949 . . . . 54.240000000000002 111.94 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.494 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 13.9 ptt180 -69.82 -24.73 63.51 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.574 -0.739 . . . . 70.040000000000006 111.521 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.413 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 40.6 mt-10 -69.99 -42.89 72.47 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 120.986 0.422 . . . . 75.430000000000007 110.28 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.01 -37.3 86.91 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.85 0.833 . . . . 63.450000000000003 109.099 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.559 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 23.2 t80 -60.88 -50.47 73.29 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.462 -1.245 . . . . 72.340000000000003 110.905 176.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 95.7 mt -64.16 -41.41 97.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.174 0.511 . . . . 64.109999999999999 110.065 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 tp -67.33 -41.96 84.4 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.741 -1.118 . . . . 74.150000000000006 111.52 -176.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -92.07 -1.32 57.27 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 115.194 1.553 . . . . 63.039999999999999 115.194 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.559 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 12.6 mtp180 -61.51 -45.97 94.11 Favored Pre-proline 0 N--CA 1.479 0.992 0 N-CA-C 113.794 1.035 . . . . 74.239999999999995 113.794 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.28 -16.28 43.66 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 121.166 1.244 . . . . 74.120000000000005 112.513 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -92.65 92.33 7.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.296 1.046 . . . . 64.329999999999998 110.203 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -73.35 113.92 10.98 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 113.753 -1.567 . . . . 74.040000000000006 109.544 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.98 -20.93 2.49 Favored Glycine 0 C--N 1.288 -2.123 0 CA-C-N 114.754 -1.112 . . . . 44.200000000000003 111.657 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -54.47 112.73 1.06 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.553 0.741 . . . . 75.299999999999997 111.969 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -94.26 -45.21 7.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.639 -0.71 . . . . 74.329999999999998 110.932 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.43 178.35 48.32 Favored Glycine 0 C--N 1.298 -1.563 0 C-N-CA 120.27 -0.967 . . . . 65.230000000000004 112.791 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.0 p -143.08 142.17 31.45 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 123.069 0.548 . . . . 45.109999999999999 111.297 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.424 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 5.4 mp -118.8 130.21 55.65 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.247 -1.39 . . . . 74.209999999999994 107.247 173.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.5 mm -109.26 131.92 58.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 118.043 0.383 . . . . 70.430000000000007 111.26 -173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -120.13 106.83 12.34 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.479 -0.934 . . . . 73.409999999999997 108.479 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -63.21 126.24 26.75 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.802 -1.09 . . . . 60.210000000000001 109.517 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 14.8 m -130.1 153.98 47.93 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 105.565 -2.013 . . . . 72.420000000000002 105.565 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.41 -33.64 31.18 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.164 1.172 . . . . 64.439999999999998 114.164 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -104.19 -35.67 7.94 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 112.768 0.655 . . . . 75.109999999999999 112.768 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.537 ' O ' ' HB ' ' A' ' 65' ' ' THR . 5.4 pm0 -156.88 129.45 4.23 Favored Pre-proline 0 C--N 1.302 -1.477 0 C-N-CA 121.071 -0.251 . . . . 75.420000000000002 110.434 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 38' ' ' LEU . 29.0 Cg_exo -64.15 118.64 5.59 Favored 'Trans proline' 0 N--CA 1.441 -1.577 0 C-N-CA 122.305 2.003 . . . . 65.409999999999997 108.99 167.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.0 140.33 15.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.383 -0.969 . . . . 63.520000000000003 108.383 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 61' ' ' LEU . . . -122.33 122.22 4.98 Favored Glycine 0 C--N 1.289 -2.05 0 C-N-CA 119.775 -1.203 . . . . 64.519999999999996 112.699 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -87.89 103.16 15.4 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.429 -1.693 . . . . 75.299999999999997 106.429 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.44 132.19 47.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 CA-C-N 115.118 -0.947 . . . . 74.230000000000004 110.545 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.4 HD11 ' O ' ' A' ' 110' ' ' THR . 4.7 tt -107.68 129.69 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 CA-C-N 114.893 -1.049 . . . . 71.299999999999997 109.98 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.502 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 14.2 m-85 -108.76 158.33 17.73 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 114.897 -1.047 . . . . 73.25 109.22 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.97 -31.95 73.44 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.872 -0.604 . . . . 72.140000000000001 111.256 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.7 p -133.32 152.13 51.91 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 112.492 0.553 . . . . 45.140000000000001 112.492 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.445 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.89 -35.46 80.06 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 108.591 -0.892 . . . . 63.539999999999999 108.591 175.106 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.419 ' N ' ' HG2' ' A' ' 78' ' ' ARG . . . -71.61 -19.52 62.11 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 122.556 1.169 . . . . 74.120000000000005 108.316 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.96 -45.64 8.93 Favored Glycine 0 C--N 1.294 -1.779 0 CA-C-N 113.937 -1.483 . . . . 70.420000000000002 110.153 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.29 -42.89 74.87 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.99 -0.605 . . . . 64.530000000000001 111.593 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.443 ' HA ' ' HG2' ' A' ' 85' ' ' LYS 0.27 1.4 pp20? -69.67 -30.24 67.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 112.937 0.717 . . . . 74.5 112.937 -177.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.62 -32.81 68.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.316 0.579 . . . . 38.049999999999997 109.992 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.87 -44.87 68.91 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.438 -0.801 . . . . 72.120000000000005 110.828 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 104' ' ' GLU . 14.1 ptmm? -68.88 -33.11 73.25 Favored 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 120.792 -0.363 . . . . 75.409999999999997 110.209 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -59.73 -41.77 91.66 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.403 0.681 . . . . 63.140000000000001 109.913 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.59 -33.39 18.9 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 112.196 0.443 . . . . 64.140000000000001 112.196 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.585 ' O ' HG23 ' A' ' 91' ' ' ILE . 97.1 mt -94.05 -13.25 27.1 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 115.934 1.827 . . . . 54.329999999999998 115.934 -172.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.313 0.2 OUTLIER -78.79 114.39 17.68 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 116.771 -1.972 . . . . 73.430000000000007 112.633 177.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.26 6.85 25.36 Favored Glycine 0 CA--C 1.492 -1.401 0 C-N-CA 120.746 -0.74 . . . . 74.510000000000005 112.335 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 88' ' ' LEU . 9.1 tt -91.96 130.39 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 N-CA-C 107.844 -1.169 . . . . 74.510000000000005 107.844 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -74.9 130.25 39.07 Favored 'General case' 0 C--N 1.275 -2.631 0 C-N-CA 119.523 -0.871 . . . . 65.200000000000003 109.772 171.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -66.73 -30.04 70.16 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.336 -1.302 . . . . 73.540000000000006 108.284 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -141.58 124.9 9.78 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 104.556 -2.387 . . . . 74.450000000000003 104.556 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.469 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 43.1 Cg_endo -65.01 -27.17 58.04 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 122.197 1.931 . . . . 61.039999999999999 114.454 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -81.92 -24.79 35.42 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.422 -0.955 . . . . 63.310000000000002 108.422 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -84.12 129.45 58.42 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.852 -1.166 . . . . 64.530000000000001 107.852 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.08 -18.49 51.48 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.196 1.931 . . . . 73.400000000000006 112.275 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.416 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 6.1 tp60 -66.48 114.83 5.77 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.261 0.553 . . . . 62.200000000000003 110.485 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.472 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 32.8 p -98.23 161.78 13.53 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 115.678 -0.692 . . . . 74.019999999999996 109.772 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.5 tp -100.8 126.97 47.41 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.53 -1.285 . . . . 74.349999999999994 107.53 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.466 ' HD2' ' OG1' ' A' ' 100' ' ' THR . 0.1 OUTLIER -127.13 117.16 21.84 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.513 -0.921 . . . . 73.349999999999994 108.513 -176.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.15 123.84 49.86 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.814 -0.63 . . . . 64.329999999999998 110.101 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.466 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 9.1 tp10 -140.52 158.02 44.62 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.45 -1.315 . . . . 64.510000000000005 107.45 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -66.14 140.91 58.24 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 118.715 0.689 . . . . 71.420000000000002 112.847 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.71 158.46 24.21 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 108.375 -0.972 . . . . 71.540000000000006 108.375 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -82.35 -7.56 59.63 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.283 0.563 . . . . 74.120000000000005 110.472 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.0 136.41 28.43 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.958 -0.564 . . . . 44.020000000000003 110.905 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -81.88 124.41 29.68 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.779 -0.646 . . . . 73.519999999999996 109.631 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.4 ' O ' HD11 ' A' ' 74' ' ' ILE . 11.3 t . . . . . 0 N--CA 1.416 -2.163 0 N-CA-C 107.338 -1.356 . . . . 63.520000000000003 107.338 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' B' ' 78' ' ' ARG . 55.0 t . . . . . 0 CA--C 1.502 -0.897 0 N-CA-C 108.71 -0.848 . . . . 72.450000000000003 108.71 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -118.71 4.13 11.62 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.985 0.898 . . . . 73.510000000000005 110.325 -172.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' THR . . . . . 0.438 ' HB ' ' HA ' ' B' ' 109' ' ' ASN . 63.5 m -111.52 136.06 51.23 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.688 -1.142 . . . . 62.240000000000002 108.345 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -131.53 154.37 48.87 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.443 -0.577 . . . . 61.039999999999999 109.443 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 30.6 p90 -101.97 118.1 36.2 Favored 'General case' 0 N--CA 1.416 -2.171 0 CA-C-O 122.04 0.924 . . . . 61.229999999999997 108.718 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 51.0 t -98.42 122.25 49.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 113.901 -1.5 . . . . 73.319999999999993 107.553 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 22.5 p -127.42 164.57 21.58 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.666 -0.697 . . . . 64.349999999999994 109.603 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 93.95 27.81 11.92 Favored Glycine 0 N--CA 1.424 -2.143 0 O-C-N 123.523 0.514 . . . . 71.510000000000005 111.896 -175.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 98.2 mt -96.55 117.78 65.77 Favored Pre-proline 0 C--N 1.292 -1.91 0 N-CA-C 108.629 -0.878 . . . . 73.420000000000002 108.629 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.76 151.74 14.56 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.882 2.388 . . . . 61.229999999999997 112.001 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.466 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 11.9 p -63.62 -6.69 2.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 123.876 0.87 . . . . 74.319999999999993 112.781 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -121.39 26.31 8.93 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.618 -0.676 . . . . 74.150000000000006 109.775 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.412 HD12 ' O ' ' B' ' 42' ' ' ILE . 2.5 pp -58.43 135.76 22.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 113.203 0.816 . . . . 73.239999999999995 113.203 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -102.31 143.34 26.41 Favored Pre-proline 0 C--N 1.278 -2.53 0 CA-C-N 114.718 -1.128 . . . . 64.540000000000006 109.187 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -51.87 -32.18 45.91 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.79 2.327 . . . . 61.43 112.666 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.56 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 10.7 ptt180 -68.44 -25.44 65.02 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 111.886 0.328 . . . . 64.439999999999998 111.886 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -70.5 -39.63 74.02 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.602 0.715 . . . . 71.439999999999998 109.365 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 77.7 mt -67.71 -34.71 77.41 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 115.007 -0.997 . . . . 72.540000000000006 108.637 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.608 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 51.0 t80 -62.49 -48.44 79.56 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.745 -1.116 . . . . 73.239999999999995 110.102 176.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 93.6 mt -66.22 -40.77 90.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.131 0.491 . . . . 64.319999999999993 110.294 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.3 tp -71.57 -43.42 66.36 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.278 -0.874 . . . . 73.439999999999998 112.048 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -100.07 8.24 44.09 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 113.301 0.852 . . . . 74.209999999999994 113.301 -174.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 28.5 ttt180 -70.54 -43.34 16.14 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-O 119.349 -0.358 . . . . 74.010000000000005 111.798 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -74.96 -12.73 21.61 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 121.532 1.488 . . . . 73.329999999999998 112.623 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -85.72 110.82 19.59 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.655 0.741 . . . . 75.140000000000001 111.668 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -74.55 112.59 10.89 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.489 -1.232 . . . . 74.329999999999998 111.304 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.13 -19.84 3.84 Favored Glycine 0 N--CA 1.429 -1.77 0 CA-C-N 115.018 -0.992 . . . . 62.009999999999998 112.97 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -56.64 112.6 1.33 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.209 0.528 . . . . 75.439999999999998 112.369 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -93.75 -55.03 3.4 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.751 -0.659 . . . . 72.299999999999997 110.756 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.29 170.71 43.72 Favored Glycine 0 C--N 1.296 -1.667 0 C-N-CA 120.309 -0.948 . . . . 51.439999999999998 112.304 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 12.6 p -132.3 137.12 47.34 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.388 0.514 . . . . 75.409999999999997 112.388 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . 0.408 ' O ' ' HA2' ' B' ' 71' ' ' GLY . 54.8 mt -104.3 113.5 27.1 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.353 -0.98 . . . . 73.049999999999997 108.353 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 43.2 mm -94.38 127.02 46.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 109.208 -0.664 . . . . 62.219999999999999 109.208 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -120.2 114.7 22.31 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.517 -0.92 . . . . 71.209999999999994 108.517 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.37 123.23 19.06 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.866 -0.607 . . . . 55.420000000000002 109.638 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.1 m -128.04 150.44 49.94 Favored 'General case' 0 N--CA 1.402 -2.851 0 N-CA-C 103.923 -2.621 . . . . 74.019999999999996 103.923 174.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.09 -40.16 4.71 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.5 1.296 . . . . 73.430000000000007 114.5 -173.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -100.61 -18.52 16.54 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 112.373 0.509 . . . . 74.129999999999995 112.373 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -169.05 127.32 0.88 Allowed Pre-proline 0 C--N 1.308 -1.234 0 C-N-CA 120.878 -0.329 . . . . 73.150000000000006 111.628 -169.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 10.5 Cg_exo -73.33 101.21 1.32 Allowed 'Trans proline' 0 N--CA 1.437 -1.798 0 C-N-CA 122.363 2.042 . . . . 75.530000000000001 107.99 167.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.97 150.36 4.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.022 -0.536 . . . . 64.040000000000006 109.712 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' B' ' 61' ' ' LEU . . . -123.23 120.65 4.29 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 118.402 -1.856 . . . . 74.409999999999997 112.959 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -88.11 102.52 14.86 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.192 -1.781 . . . . 74.120000000000005 106.192 175.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.86 130.21 49.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-N 114.677 -1.147 . . . . 75.129999999999995 110.863 -172.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . 0.494 HD12 ' O ' ' B' ' 110' ' ' THR . 3.7 tt -104.05 127.61 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 0 CA-C-N 115.204 -0.907 . . . . 70.010000000000005 109.613 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . 0.404 ' HB2' ' HB1' ' B' ' 81' ' ' ALA . 8.9 m-85 -105.33 154.13 20.69 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.43 -1.322 . . . . 73.239999999999995 107.43 171.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -65.19 -37.04 86.08 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.64 -0.504 . . . . 70.540000000000006 109.64 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 4.2 p -114.86 133.21 56.15 Favored 'General case' 0 N--CA 1.386 -3.673 0 CA-C-O 121.722 0.772 . . . . 75.209999999999994 111.304 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' B' ' 30' ' ' VAL . 0.0 OUTLIER -75.65 -24.46 56.39 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 115.241 -0.891 . . . . 72.140000000000001 110.785 177.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.12 -19.82 39.32 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.906 -1.516 . . . . 63.039999999999999 106.906 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.08 -43.43 10.8 Favored Glycine 0 C--N 1.299 -1.507 0 CA-C-N 113.277 -1.783 . . . . 62.340000000000003 109.637 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' B' ' 75' ' ' PHE . . . -62.41 -35.13 78.26 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.52 -0.84 . . . . 53.439999999999998 110.977 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 1.4 pp20? -69.42 -38.28 77.83 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.29 -0.964 . . . . 73.519999999999996 110.405 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.52 78.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.091 0.472 . . . . 74.140000000000001 110.4 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.03 -44.46 72.65 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.824 -0.625 . . . . 38.049999999999997 111.402 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' B' ' 82' ' ' GLU . 13.2 ptmm? -68.45 -34.71 76.44 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.787 -0.365 . . . . 74.299999999999997 110.475 -177.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -62.51 -28.85 70.13 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.063 -0.517 . . . . 73.019999999999996 110.91 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.75 -41.3 13.41 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 112.305 0.483 . . . . 63.299999999999997 112.305 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.539 ' O ' HG22 ' B' ' 91' ' ' ILE . 97.5 mt -98.62 -8.17 26.79 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 116.192 1.923 . . . . 74.340000000000003 116.192 -169.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 36.0 p30 -69.99 116.11 9.98 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 119.504 1.047 . . . . 72.430000000000007 113.208 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.87 7.07 48.31 Favored Glycine 0 CA--C 1.482 -1.994 0 C-N-CA 120.843 -0.694 . . . . 75.129999999999995 113.068 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.539 HG22 ' O ' ' B' ' 88' ' ' LEU . 14.4 tt -101.58 137.24 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.929 0 N-CA-C 108.168 -1.049 . . . . 74.319999999999993 108.168 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -68.78 132.82 47.43 Favored 'General case' 0 C--N 1.266 -3.036 0 CA-C-O 121.776 0.798 . . . . 71.040000000000006 112.161 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -73.42 -28.35 61.94 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.672 -1.604 . . . . 73.230000000000004 107.848 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 45' ' ' ARG . 9.4 t0 -146.14 114.73 4.59 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 105.417 -2.068 . . . . 62.229999999999997 105.417 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . 0.502 ' HD3' ' CZ ' ' A' ' 48' ' ' TYR . 56.7 Cg_endo -68.74 -19.06 41.83 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.328 2.019 . . . . 62.229999999999997 113.961 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -83.14 -24.69 32.44 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.794 -0.817 . . . . 74.099999999999994 108.794 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -95.54 143.35 25.96 Favored Pre-proline 0 C--N 1.309 -1.174 0 N-CA-C 108.57 -0.9 . . . . 71.140000000000001 108.57 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.11 -3.47 13.84 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 122.068 1.845 . . . . 71.420000000000002 114.224 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -75.87 120.65 21.51 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.992 0.425 . . . . 73.450000000000003 110.893 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.545 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 82.4 p -99.44 154.88 17.87 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 109.202 -0.666 . . . . 73.329999999999998 109.202 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 28.8 tp -94.78 127.92 41.12 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.686 -1.227 . . . . 71.540000000000006 107.686 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -125.63 130.28 51.31 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.567 -1.271 . . . . 74.409999999999997 107.567 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -123.61 116.31 22.9 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 123.366 0.416 . . . . 75.310000000000002 110.317 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.554 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 5.0 tp10 -134.37 156.64 48.15 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.918 -1.512 . . . . 73.209999999999994 106.918 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -66.8 143.43 56.9 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.35 0.977 . . . . 73.109999999999999 111.879 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.86 157.36 24.42 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.896 -0.593 . . . . 61.539999999999999 109.903 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.469 ' HB3' ' HZ3' ' B' ' 107' ' ' LYS . 5.9 ttpm? -85.65 7.82 21.89 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.626 0.727 . . . . 71.120000000000005 110.712 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.64 138.88 11.13 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.348 -0.982 . . . . 51.420000000000002 108.348 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.438 ' HA ' ' HB ' ' B' ' 32' ' ' THR . 94.3 m-20 -82.88 158.56 22.63 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-O 121.228 0.537 . . . . 63.420000000000002 109.928 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.494 ' O ' HD12 ' B' ' 74' ' ' ILE . 14.2 t . . . . . 0 C--N 1.285 -2.216 0 N-CA-C 106.939 -1.504 . . . . 75.430000000000007 106.939 174.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.566 ' HA ' HD22 ' A' ' 109' ' ' ASN . 98.6 t . . . . . 0 N--CA 1.431 -1.388 0 N-CA-C 105.745 -1.946 . . . . 73.549999999999997 105.745 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.587 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 13.7 ptm180 -127.57 15.89 7.04 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.004 -1.453 . . . . 72.420000000000002 110.497 -167.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.4 m -124.7 124.63 42.59 Favored 'General case' 0 C--N 1.272 -2.784 0 C-N-CA 119.467 -0.893 . . . . 73.150000000000006 110.666 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.2 mt -107.16 141.17 38.86 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.352 -0.981 . . . . 63.109999999999999 108.352 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 16.7 p90 -102.73 115.8 31.31 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 107.088 -1.449 . . . . 64.129999999999995 107.088 173.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.4 t -97.65 120.03 46.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 CA-C-N 114.23 -1.35 . . . . 75.099999999999994 108.418 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.9 p -123.8 165.76 16.75 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 116.246 -0.433 . . . . 75.349999999999994 110.008 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.14 11.96 44.05 Favored Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 111.065 -0.814 . . . . 63.109999999999999 111.065 -173.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.6 mt -83.07 130.23 58.11 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 107.608 -1.256 . . . . 74.5 107.608 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.12 161.43 10.98 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.099 1.866 . . . . 71.319999999999993 111.204 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.408 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 7.5 p -62.53 -15.69 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.681 0.753 . . . . 73.099999999999994 110.79 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -121.56 35.69 4.82 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.04 -0.982 . . . . 55.149999999999999 109.231 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.416 HG23 ' HG2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -66.43 131.2 32.22 Favored 'Isoleucine or valine' 0 C--O 1.256 1.44 0 N-CA-C 108.422 -0.955 . . . . 73.219999999999999 108.422 175.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -99.25 143.94 27.33 Favored Pre-proline 0 C--N 1.291 -1.957 0 CA-C-N 115.111 -0.949 . . . . 72.209999999999994 111.627 -177.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.53 -26.53 37.01 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.634 2.889 . . . . 71.319999999999993 114.194 -176.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.548 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -86.5 -10.52 53.94 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 117.159 -1.816 . . . . 71.030000000000001 112.109 -177.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.42 -40.21 85.52 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.005 -0.739 . . . . 75.319999999999993 109.005 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.38 -27.27 65.17 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.588 -0.733 . . . . 74.010000000000005 110.123 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.548 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 46.9 t80 -65.3 -47.59 76.08 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.371 -0.831 . . . . 70.450000000000003 109.823 176.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.44 -40.37 81.16 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.365 -0.605 . . . . 71.349999999999994 109.365 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 tp -64.34 -47.61 78.67 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.819 -1.082 . . . . 74.329999999999998 112.164 -178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -98.91 0.94 45.14 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 114.609 1.337 . . . . 72.140000000000001 114.609 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.1 ttt85 -63.63 -44.2 79.94 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 112.829 0.677 . . . . 74.439999999999998 112.829 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.77 -6.97 20.3 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 121.28 1.32 . . . . 72.450000000000003 112.713 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -96.59 90.02 5.19 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.516 0.674 . . . . 74.019999999999996 110.698 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -67.65 109.59 3.36 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.969 0.89 . . . . 71.209999999999994 109.882 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.1 -27.01 1.42 Allowed Glycine 0 C--N 1.285 -2.267 0 CA-C-N 114.406 -1.27 . . . . 60.520000000000003 110.155 -173.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -54.91 127.31 28.13 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.139 0.576 . . . . 74.430000000000007 111.934 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -105.92 -53.89 2.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.175 0.512 . . . . 71.109999999999999 110.568 174.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.64 178.12 41.17 Favored Glycine 0 C--N 1.294 -1.793 0 CA-C-N 115.492 -0.776 . . . . 71.209999999999994 111.822 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.4 p -146.72 137.69 24.07 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.64 0.22 . . . . 74.439999999999998 111.054 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.0 mt -115.98 134.64 54.76 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.458 0.703 . . . . 74.319999999999993 109.128 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.9 mm -95.0 144.71 9.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 110.15 -0.315 . . . . 64.540000000000006 110.15 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -136.97 118.88 15.23 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.833 -0.432 . . . . 75.430000000000007 109.833 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.29 110.59 6.02 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.349 0.595 . . . . 75.420000000000002 111.022 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.3 m -99.44 162.76 12.84 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 105.578 -2.008 . . . . 72.420000000000002 105.578 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -43.91 -37.87 3.09 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 114.037 1.125 . . . . 74.439999999999998 114.037 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -103.87 -26.72 12.57 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.211 1.189 . . . . 64.230000000000004 114.211 -177.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -166.79 153.38 8.18 Favored Pre-proline 0 C--N 1.307 -1.261 0 C-N-CA 120.783 -0.367 . . . . 71.420000000000002 110.346 -168.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.416 ' HG2' HG23 ' A' ' 42' ' ' ILE . 56.9 Cg_endo -76.66 118.89 4.98 Favored 'Trans proline' 0 N--CA 1.438 -1.766 0 C-N-CA 122.459 2.106 . . . . 74.329999999999998 110.949 172.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 m -93.93 162.17 2.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.837 -1.171 . . . . 65.430000000000007 107.837 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.41 121.59 3.54 Favored Glycine 0 C--N 1.297 -1.633 0 C-N-CA 118.934 -1.603 . . . . 72.530000000000001 113.332 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -87.8 105.53 17.46 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.414 -1.328 . . . . 65.129999999999995 107.414 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.68 127.43 52.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 115.053 -0.976 . . . . 62.219999999999999 110.164 -176.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 tt -99.79 130.06 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 CA-C-O 121.704 0.764 . . . . 64.019999999999996 110.219 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 82.0 m-85 -112.01 152.8 27.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 114.228 -1.351 . . . . 74.450000000000003 109.172 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.45 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 35.0 t70 -68.02 -30.1 69.26 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 114.839 -1.073 . . . . 53.539999999999999 112.712 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.4 m -131.95 150.09 52.25 Favored 'General case' 0 N--CA 1.417 -2.1 0 O-C-N 121.776 -0.577 . . . . 73.209999999999994 109.961 -174.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.519 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -80.38 -27.87 38.07 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.499 -0.926 . . . . 74.140000000000001 108.499 178.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.44 -19.46 60.39 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 114.377 -1.283 . . . . 72.349999999999994 107.591 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.41 -42.13 7.09 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 113.393 -1.73 . . . . 37.289999999999999 110.095 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.04 -43.41 98.89 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.135 0.574 . . . . 74.030000000000001 111.599 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.0 -38.26 90.48 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 121.027 -0.269 . . . . 74.439999999999998 111.706 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.08 -38.53 72.44 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 120.701 0.286 . . . . 74.340000000000003 110.478 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.58 90.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.568 -0.742 . . . . 44.32 111.202 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -67.08 -37.78 84.59 Favored 'General case' 0 C--O 1.206 -1.237 0 C-N-CA 120.378 -0.529 . . . . 55.310000000000002 111.262 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -72.91 -17.08 61.54 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 120.853 0.359 . . . . 71.209999999999994 111.753 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.57 -45.93 11.29 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 116.364 -0.38 . . . . 71.239999999999995 110.76 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 91' ' ' ILE . 92.7 mt -98.38 -9.05 25.86 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 115.291 1.589 . . . . 72.040000000000006 115.291 -172.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.55 126.34 30.61 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.075 -1.016 . . . . 74.430000000000007 110.657 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.19 3.37 54.22 Favored Glycine 0 CA--C 1.475 -2.445 0 C-N-CA 120.599 -0.81 . . . . 60.240000000000002 112.5 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 88' ' ' LEU . 16.1 tt -111.18 144.45 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.343 0 N-CA-C 107.058 -1.46 . . . . 75.519999999999996 107.058 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -70.21 135.41 49.02 Favored 'General case' 0 C--N 1.272 -2.786 0 CA-C-O 121.557 0.694 . . . . 73.109999999999999 112.394 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -74.06 -28.54 61.46 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 113.677 -1.601 . . . . 61.109999999999999 109.069 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -144.36 120.26 6.19 Favored Pre-proline 0 C--N 1.314 -0.973 0 N-CA-C 105.906 -1.887 . . . . 64.439999999999998 105.906 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.53 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 57.6 Cg_endo -67.33 -21.63 47.21 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.522 2.148 . . . . 73.150000000000006 114.241 -176.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -82.61 -26.11 32.58 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.5 0.667 . . . . 64.239999999999995 109.255 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -90.27 134.08 32.02 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 108.012 -1.106 . . . . 60.039999999999999 108.012 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -70.18 -9.26 25.56 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 122.351 2.034 . . . . 71.230000000000004 112.181 176.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -68.96 125.69 27.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.559 -0.746 . . . . 60.119999999999997 110.061 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 39.5 p -102.63 156.35 17.68 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 116.496 -0.32 . . . . 72.040000000000006 110.207 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.4 tp -95.54 126.11 40.6 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.798 -0.815 . . . . 74.219999999999999 108.798 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -120.66 127.04 51.7 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.205 -1.035 . . . . 75.099999999999994 108.205 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -116.37 116.54 27.9 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 123.51 0.506 . . . . 73.109999999999999 109.683 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.457 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 39.1 tt0 -128.52 162.88 26.19 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.782 -1.192 . . . . 62.229999999999997 107.782 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -71.36 145.36 49.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 118.728 0.694 . . . . 73.439999999999998 109.23 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.58 157.89 34.65 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.694 -0.854 . . . . 52.539999999999999 108.694 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 13.1 tmtt? -80.24 -9.85 59.74 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.092 0.948 . . . . 75.430000000000007 108.6 -176.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -157.14 126.13 5.88 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.184 -1.371 . . . . 54.039999999999999 107.567 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.566 HD22 ' HA ' ' A' ' 30' ' ' VAL . 91.5 m-20 -72.26 141.15 48.93 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.241 -0.436 . . . . 74.030000000000001 110.243 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.1 t . . . . . 0 C--N 1.295 -1.787 0 C-N-CA 120.367 -0.533 . . . . 74.439999999999998 109.979 -178.659 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.42 ' HA ' HD22 ' B' ' 109' ' ' ASN . 68.3 t . . . . . 0 N--CA 1.42 -1.973 0 N-CA-C 104.766 -2.309 . . . . 37.289999999999999 104.766 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -116.18 10.68 14.98 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.636 -0.711 . . . . 73.120000000000005 110.743 -171.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 57.9 m -120.46 129.8 54.02 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-O 121.5 0.667 . . . . 60.350000000000001 110.657 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 mp -112.34 143.25 43.76 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.611 -1.255 . . . . 75.25 107.611 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.541 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 26.3 p90 -101.3 116.85 33.74 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 107.437 -1.32 . . . . 73.409999999999997 107.437 172.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.411 HG22 ' HG ' ' B' ' 103' ' ' LEU . 41.2 t -98.81 114.98 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.329 0 CA-C-N 114.21 -1.359 . . . . 73.109999999999999 107.468 -177.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.8 p -124.53 154.18 40.97 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 116.285 -0.416 . . . . 73.230000000000004 110.295 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.51 4.29 32.51 Favored Glycine 0 N--CA 1.431 -1.685 0 O-C-N 123.561 0.538 . . . . 42.32 111.969 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.521 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 86.3 mt -71.66 132.58 85.21 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 107.372 -1.344 . . . . 74.120000000000005 107.372 175.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' B' ' 41' ' ' ASP . 37.4 Cg_endo -65.99 160.89 42.16 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.62 1.546 . . . . 54.539999999999999 111.677 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.461 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 9.4 p -69.91 4.99 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.6 0 CA-C-O 122.148 0.975 . . . . 54.030000000000001 111.274 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' B' ' 39' ' ' PRO . 27.9 t70 -125.51 19.01 8.1 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.616 1.166 . . . . 72.040000000000006 109.19 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.12 127.5 20.87 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 CA-C-O 121.843 0.83 . . . . 62.520000000000003 111.086 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.431 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 70.1 mmtt -98.71 137.35 20.58 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.07 -0.968 . . . . 75.340000000000003 108.936 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -53.74 -32.48 65.93 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.857 2.372 . . . . 73.340000000000003 113.236 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.562 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 0.0 OUTLIER -73.15 -15.8 61.46 Favored 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 119.374 -0.931 . . . . 74.340000000000003 112.324 -179.157 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . 0.431 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 47.6 mt-10 -69.55 -36.06 75.98 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.893 -0.504 . . . . 75.109999999999999 110.23 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.88 -26.38 64.16 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 121.732 0.777 . . . . 73.5 108.919 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.53 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 58.3 t80 -73.33 -34.91 65.93 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.911 -1.041 . . . . 75.200000000000003 110.215 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 67.1 mt -78.48 -41.51 32.39 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.271 -0.64 . . . . 73.010000000000005 109.271 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.6 tp -66.09 -46.52 77.35 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.21 -0.904 . . . . 62.109999999999999 111.482 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -95.03 14.92 20.28 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 112.221 0.452 . . . . 75.319999999999993 112.221 -176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.471 ' CZ ' ' HA ' ' B' ' 52' ' ' ARG . 0.8 OUTLIER -59.46 -52.12 76.44 Favored Pre-proline 0 CA--C 1.56 1.349 0 CA-C-N 115.864 -0.607 . . . . 63.439999999999998 111.743 178.466 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.3 -1.48 11.12 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 121.607 1.538 . . . . 61.409999999999997 112.728 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -89.54 91.6 8.76 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 122.024 0.916 . . . . 74.530000000000001 110.673 -177.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -75.4 109.85 9.28 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.21 -1.359 . . . . 74.099999999999994 108.785 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.65 -14.04 4.19 Favored Glycine 0 C--N 1.293 -1.813 0 CA-C-N 115.058 -0.974 . . . . 64.099999999999994 111.753 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -59.93 109.89 1.05 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.191 0.52 . . . . 74.510000000000005 110.527 175.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -86.09 -49.35 7.85 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.737 -0.665 . . . . 54.030000000000001 110.435 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.11 -175.69 45.46 Favored Glycine 0 C--N 1.294 -1.797 0 C-N-CA 120.13 -1.033 . . . . 37.289999999999999 112.175 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 21.5 p -148.17 143.27 26.96 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 122.377 0.271 . . . . 60.240000000000002 111.335 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . 0.4 ' O ' ' HA2' ' B' ' 71' ' ' GLY . 85.3 mt -116.83 127.21 54.08 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.474 -0.936 . . . . 74.040000000000006 108.474 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 47.4 mm -94.56 136.46 25.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.198 -0.667 . . . . 53.009999999999998 109.198 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -127.58 115.4 18.75 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.016 -0.735 . . . . 74.129999999999995 109.016 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.21 109.46 5.26 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.235 -0.654 . . . . 62.219999999999999 109.235 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 19.6 m -100.6 156.23 17.42 Favored 'General case' 0 N--CA 1.407 -2.611 0 N-CA-C 104.458 -2.423 . . . . 71.319999999999993 104.458 175.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.41 -37.58 17.38 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 113.65 0.981 . . . . 62.32 113.65 -173.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -102.78 -16.54 15.93 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.191 1.182 . . . . 63.43 114.191 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 4.4 pt20 -173.77 142.45 0.92 Allowed Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 118.167 0.44 . . . . 63.240000000000002 111.731 -174.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.461 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 14.9 Cg_exo -68.77 115.19 3.82 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 123.05 2.5 . . . . 74.019999999999996 111.096 170.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -92.55 167.35 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.038 -1.097 . . . . 70.340000000000003 108.038 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' B' ' 61' ' ' LEU . . . -138.62 122.68 2.43 Favored Glycine 0 C--O 1.207 -1.585 0 C-N-CA 118.87 -1.633 . . . . 54.509999999999998 113.621 -176.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -88.11 107.73 18.9 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.636 -1.246 . . . . 72.510000000000005 107.636 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 90.2 t -101.17 129.16 52.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 115.185 -0.916 . . . . 73.120000000000005 110.978 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . 0.484 HD12 ' O ' ' B' ' 110' ' ' THR . 3.4 tt -101.85 134.33 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 115.253 -0.885 . . . . 62.210000000000001 110.351 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -113.57 158.35 20.89 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.97 -1.014 . . . . 64.239999999999995 110.738 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.1 -34.66 78.08 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.823 -1.535 . . . . 74.340000000000003 112.4 175.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 46.4 m -135.75 152.14 50.83 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 120.757 -0.377 . . . . 70.019999999999996 110.736 -173.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . 0.416 ' HD3' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -80.08 -26.6 39.52 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.393 0.616 . . . . 63.310000000000002 109.343 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.05 -21.14 51.11 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 107.726 -1.212 . . . . 52.240000000000002 107.726 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.47 -39.58 14.67 Favored Glycine 0 C--N 1.31 -0.884 0 N-CA-C 109.276 -1.529 . . . . 37.289999999999999 109.276 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.02 -42.61 97.06 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.322 -0.939 . . . . 62.329999999999998 111.501 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.84 -37.64 88.29 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.782 0.325 . . . . 61.240000000000002 111.556 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.15 -37.21 69.43 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.054 0.454 . . . . 70.140000000000001 110.336 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.84 -42.96 80.62 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.497 -0.774 . . . . 62.049999999999997 111.027 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.448 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 14.9 ptmm? -68.2 -37.1 80.54 Favored 'General case' 0 C--O 1.206 -1.189 0 C-N-CA 120.585 -0.446 . . . . 73.019999999999996 110.744 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -66.68 -29.53 69.55 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 120.863 0.363 . . . . 62.0 111.427 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.34 -44.42 25.21 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 116.166 -0.47 . . . . 70.310000000000002 111.252 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.571 ' O ' HG22 ' B' ' 91' ' ' ILE . 99.3 mt -94.75 -11.96 28.05 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 115.356 1.613 . . . . 72.400000000000006 115.356 -173.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -76.2 115.64 16.12 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 118.257 -1.377 . . . . 71.219999999999999 109.825 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.99 11.56 24.07 Favored Glycine 0 CA--C 1.482 -2.01 0 C-N-CA 120.463 -0.875 . . . . 74.329999999999998 111.767 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.571 HG22 ' O ' ' B' ' 88' ' ' LEU . 14.4 tt -99.66 140.54 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.624 0 N-CA-C 107.665 -1.235 . . . . 54.509999999999998 107.665 175.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.409 ' CG ' HG23 ' B' ' 100' ' ' THR . 79.3 mtt180 -81.75 128.67 34.23 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-O 120.985 0.421 . . . . 74.219999999999999 110.175 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.74 -34.39 77.77 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.55 -1.205 . . . . 75.109999999999999 110.063 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -144.5 126.1 7.98 Favored Pre-proline 0 C--N 1.312 -1.047 0 N-CA-C 106.405 -1.702 . . . . 70.239999999999995 106.405 174.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . 0.46 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 60.4 Cg_endo -69.84 -0.41 6.93 Favored 'Trans proline' 0 N--CA 1.486 1.031 0 C-N-CA 123.266 2.644 . . . . 74.510000000000005 114.386 -173.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -91.75 -25.65 18.95 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.54 0.686 . . . . 73.409999999999997 109.542 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -91.81 139.16 24.68 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 108.144 -1.058 . . . . 74.400000000000006 108.144 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -69.6 -20.78 35.16 Favored 'Trans proline' 0 C--O 1.247 0.932 0 C-N-CA 121.763 1.642 . . . . 60.130000000000003 111.014 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -55.57 131.17 45.61 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.502 1.121 . . . . 62.43 110.621 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.409 HG23 ' CG ' ' B' ' 92' ' ' ARG . 75.2 p -112.76 160.03 18.36 Favored 'General case' 0 N--CA 1.418 -2.061 0 C-N-CA 120.177 -0.609 . . . . 72.400000000000006 109.78 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 20.2 tp -96.8 121.23 38.43 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.261 -1.014 . . . . 54.509999999999998 108.261 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -112.51 123.13 49.61 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.242 -1.022 . . . . 74.430000000000007 108.242 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.411 ' HG ' HG22 ' B' ' 35' ' ' VAL . 7.1 mp -110.5 115.7 30.1 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 109.381 -0.6 . . . . 74.219999999999999 109.381 172.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.541 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 34.2 tt0 -129.87 157.58 41.86 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.321 -1.362 . . . . 74.329999999999998 107.321 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -66.7 138.46 57.42 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 118.602 0.637 . . . . 75.540000000000006 110.693 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.36 152.26 30.52 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 108.902 -0.777 . . . . 74.129999999999995 108.902 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' B' ' 107' ' ' LYS . 14.4 tmtt? -78.49 -6.93 56.79 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.4 -0.818 . . . . 54.240000000000002 110.053 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.18 132.87 21.0 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.127 -0.942 . . . . 73.219999999999999 108.824 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.42 HD22 ' HA ' ' B' ' 30' ' ' VAL . 91.2 m-20 -87.13 143.09 27.46 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.326 -0.397 . . . . 72.349999999999994 110.249 177.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.484 ' O ' HD12 ' B' ' 74' ' ' ILE . 12.8 t . . . . . 0 N--CA 1.416 -2.132 0 N-CA-C 107.572 -1.27 . . . . 71.540000000000006 107.572 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.4 t . . . . . 0 N--CA 1.431 -1.381 0 CA-C-O 122.252 1.025 . . . . 72.099999999999994 109.636 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -102.52 13.45 34.5 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.194 -1.366 . . . . 73.299999999999997 111.244 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.412 ' HB ' ' HA ' ' A' ' 109' ' ' ASN . 23.8 m -139.02 132.51 30.29 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.917 -0.713 . . . . 70.519999999999996 111.576 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.7 mt -110.73 145.88 37.27 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.341 -0.985 . . . . 73.239999999999995 108.341 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -101.65 111.2 23.37 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 107.29 -1.374 . . . . 62.520000000000003 107.29 173.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.44 120.92 47.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.178 -1.374 . . . . 73.040000000000006 108.013 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 p -126.98 168.64 14.27 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 115.335 -0.848 . . . . 72.420000000000002 109.217 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 88.58 39.64 6.62 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 111.085 -0.806 . . . . 71.019999999999996 111.085 -177.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 99.6 mt -105.37 137.97 19.42 Favored Pre-proline 0 N--CA 1.418 -2.041 0 N-CA-C 108.325 -0.991 . . . . 73.510000000000005 108.325 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -56.76 159.43 14.16 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.941 1.761 . . . . 75.439999999999998 109.183 171.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.55 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 8.9 p -80.86 -0.75 4.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 122.435 1.112 . . . . 64.310000000000002 110.677 -168.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -117.42 16.25 14.71 Favored 'General case' 0 N--CA 1.413 -2.276 0 CA-C-N 114.552 -1.204 . . . . 72.140000000000001 110.809 -172.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.47 ' HA ' ' OE1' ' A' ' 46' ' ' GLU 0.272 2.7 pp -55.82 136.38 18.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 114.47 1.285 . . . . 71.129999999999995 114.47 -177.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.533 ' HD3' ' CD ' ' A' ' 46' ' ' GLU . 6.6 mptt -103.1 149.8 37.24 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 106.689 -1.597 . . . . 74.319999999999993 106.689 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.19 -28.68 88.41 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.361 2.04 . . . . 73.349999999999994 112.0 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.655 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 20.3 ptt180 -68.16 -30.38 69.49 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 116.165 -0.47 . . . . 75.120000000000005 111.712 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.533 ' CD ' ' HD3' ' A' ' 43' ' ' LYS . 46.5 mt-10 -69.0 -42.41 76.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.022 0.439 . . . . 74.519999999999996 110.185 -175.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.56 -43.11 94.94 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.508 -0.923 . . . . 72.219999999999999 108.508 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.551 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 37.4 t80 -57.79 -45.1 86.54 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.414 -1.266 . . . . 72.310000000000002 111.626 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 88.4 mt -64.73 -40.46 95.36 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.366 0.603 . . . . 65.409999999999997 110.305 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 tp -70.08 -43.67 70.65 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.897 -1.047 . . . . 74.340000000000003 111.106 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -84.99 6.82 23.58 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 114.065 1.135 . . . . 64.430000000000007 114.065 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.463 ' HA ' ' NE ' ' A' ' 52' ' ' ARG . 3.2 mmp_? -50.59 -52.23 57.84 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 113.482 0.919 . . . . 74.239999999999995 113.482 177.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.38 -1.36 9.71 Favored 'Trans proline' 0 C--N 1.365 1.436 0 C-N-CA 121.795 1.663 . . . . 72.209999999999994 113.248 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -89.5 107.82 19.29 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 122.1 0.953 . . . . 71.129999999999995 112.38 -175.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -76.78 112.16 13.07 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 113.852 -1.522 . . . . 75.310000000000002 111.054 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.4 -32.04 1.99 Allowed Glycine 0 N--CA 1.424 -2.147 0 CA-C-N 114.653 -1.158 . . . . 73.230000000000004 111.19 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.05 118.25 4.49 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.667 0.787 . . . . 74.349999999999994 112.705 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -108.1 -35.71 6.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.272 0.558 . . . . 61.329999999999998 110.652 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.56 -178.38 48.37 Favored Glycine 0 C--N 1.306 -1.084 0 C-N-CA 120.154 -1.022 . . . . 75.230000000000004 112.441 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.6 p -144.29 137.56 27.31 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.613 0.206 . . . . 70.430000000000007 111.43 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -107.83 114.32 28.19 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 107.725 -1.213 . . . . 73.349999999999994 107.725 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.53 136.59 26.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 110.334 -0.247 . . . . 74.319999999999993 110.334 -175.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 69' ' ' PRO . 63.4 tttp -124.99 106.94 10.33 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 109.353 -0.61 . . . . 62.340000000000003 109.353 176.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.87 109.17 7.16 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.707 -0.849 . . . . 72.450000000000003 108.707 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.4 m -104.97 164.11 12.03 Favored 'General case' 0 N--CA 1.41 -2.455 0 N-CA-C 105.373 -2.084 . . . . 65.200000000000003 105.373 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.02 -33.76 62.9 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.704 0.683 . . . . 70.109999999999999 111.903 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.448 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 1.5 tpm_? -82.18 -52.28 7.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 112.201 0.445 . . . . 71.230000000000004 112.201 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -160.22 152.55 17.28 Favored Pre-proline 0 C--N 1.289 -2.033 0 CA-C-N 115.878 -0.601 . . . . 63.32 109.853 -171.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.55 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 58.3 Cg_endo -80.16 108.73 2.24 Favored 'Trans proline' 0 N--CA 1.431 -2.187 0 C-N-CA 122.546 2.164 . . . . 72.430000000000007 110.051 168.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.5 m -83.04 160.33 3.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.109 -1.071 . . . . 64.439999999999998 108.109 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.41 120.71 2.25 Favored Glycine 0 CA--C 1.474 -2.504 0 C-N-CA 118.042 -2.028 . . . . 55.240000000000002 112.747 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -88.37 102.52 14.95 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 106.622 -1.622 . . . . 75.209999999999994 106.622 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.07 127.28 47.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-N 115.429 -0.805 . . . . 74.209999999999994 109.948 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.9 pt -98.0 135.24 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.301 0 CA-C-N 115.155 -0.929 . . . . 75.129999999999995 110.722 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -121.98 149.53 43.33 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.341 -1.3 . . . . 72.510000000000005 108.559 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -52.64 -44.23 65.97 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 124.486 1.116 . . . . 74.349999999999994 111.585 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.1 m -145.34 158.09 43.9 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.72 -0.673 . . . . 74.329999999999998 110.235 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.489 ' HD3' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.24 -26.68 67.48 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.857 -0.61 . . . . 72.519999999999996 109.872 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.02 -28.05 69.54 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.366 -0.834 . . . . 62.539999999999999 110.15 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.01 -37.07 8.58 Favored Glycine 0 C--N 1.311 -0.812 0 N-CA-C 109.774 -1.33 . . . . 37.57 109.774 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.67 -44.45 93.73 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.491 -0.854 . . . . 72.25 111.728 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.4 -35.98 82.2 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.862 0.363 . . . . 61.329999999999998 111.832 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.35 -42.04 69.01 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.027 0.441 . . . . 65.420000000000002 110.052 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.62 95.76 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.666 -0.697 . . . . 71.430000000000007 111.258 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.419 ' CE ' ' HA ' ' A' ' 104' ' ' GLU . 14.8 ptmm? -70.56 -33.57 71.27 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 120.538 -0.465 . . . . 64.010000000000005 110.657 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -69.48 -36.49 76.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.887 0.375 . . . . 74.140000000000001 110.839 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.85 -41.93 42.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.07 0.462 . . . . 40.43 111.859 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.574 ' O ' HG21 ' A' ' 91' ' ' ILE . 85.8 mt -93.95 -9.75 36.0 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 115.085 1.513 . . . . 73.230000000000004 115.085 -172.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -74.95 118.39 17.86 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 117.898 -1.521 . . . . 72.040000000000006 108.828 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.23 12.56 48.48 Favored Glycine 0 N--CA 1.424 -2.152 0 CA-C-N 115.468 -0.787 . . . . 40.229999999999997 111.794 176.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.574 HG21 ' O ' ' A' ' 88' ' ' LEU . 13.7 tt -100.84 134.46 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.965 0 N-CA-C 108.185 -1.042 . . . . 71.319999999999993 108.185 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.491 ' CG ' HG23 ' A' ' 100' ' ' THR . 82.7 mtt180 -79.41 142.31 36.07 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 115.445 -0.798 . . . . 71.329999999999998 112.448 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -75.88 -28.89 58.29 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.548 -1.66 . . . . 74.209999999999994 108.394 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.587 ' OD2' ' HB3' ' B' ' 45' ' ' ARG . 6.2 m-20 -138.22 127.76 14.83 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 104.138 -2.542 . . . . 71.030000000000001 104.138 173.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.609 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 18.0 Cg_endo -58.92 -26.73 82.26 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.093 1.862 . . . . 73.450000000000003 112.444 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -90.76 -5.14 56.08 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.461 -0.79 . . . . 72.409999999999997 111.82 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.443 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 52.7 t-20 -104.17 125.96 32.95 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 108.171 -1.048 . . . . 73.310000000000002 108.171 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -64.53 -7.07 13.36 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 123.15 2.567 . . . . 62.5 113.349 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -77.44 115.32 17.11 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.691 -0.855 . . . . 65.099999999999994 108.691 176.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.51 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 27.7 p -116.12 153.05 32.46 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.158 -1.053 . . . . 71.230000000000004 108.158 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.6 mp -82.85 140.52 32.87 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 118.417 0.553 . . . . 71.549999999999997 111.102 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.6 108.81 10.19 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.659 -1.608 . . . . 75.340000000000003 106.659 176.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.61 123.26 46.01 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.951 -0.568 . . . . 60.450000000000003 111.818 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HA ' ' CE ' ' A' ' 85' ' ' LYS . 17.2 mm-40 -132.34 164.32 26.72 Favored 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 123.435 0.694 . . . . 75.340000000000003 109.807 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -73.68 143.32 46.27 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.468 -0.567 . . . . 64.109999999999999 109.468 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.46 157.07 37.53 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.146 -1.057 . . . . 75.239999999999995 108.146 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -72.73 -13.32 61.31 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.383 1.087 . . . . 71.549999999999997 110.503 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.81 127.01 3.98 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 105.985 -1.857 . . . . 55.329999999999998 105.985 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.412 ' HA ' ' HB ' ' A' ' 32' ' ' THR . 7.1 p30 -79.19 144.42 34.44 Favored 'General case' 0 CA--C 1.47 -2.104 0 C-N-CA 118.517 -1.273 . . . . 63.420000000000002 108.918 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.395 -3.213 0 C-N-CA 118.544 -1.262 . . . . 74.530000000000001 112.548 -173.234 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--O 1.214 -0.81 0 CA-C-O 121.348 0.594 . . . . 63.109999999999999 110.991 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.687 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 72.2 mtt180 -95.44 -2.59 48.51 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.287 -0.87 . . . . 72.530000000000001 109.921 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 16.0 m -101.03 137.92 38.76 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 114.977 -1.01 . . . . 52.130000000000003 112.265 -174.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 77.2 mt -117.52 146.24 43.69 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.696 -1.224 . . . . 73.209999999999994 107.696 173.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -99.53 118.98 37.29 Favored 'General case' 0 N--CA 1.42 -1.974 0 C-N-CA 118.486 -1.286 . . . . 71.430000000000007 107.811 173.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.44 HG23 ' HG ' ' B' ' 103' ' ' LEU . 35.2 t -97.32 109.09 22.66 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 N-CA-C 106.318 -1.734 . . . . 60.43 106.318 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' B' ' 101' ' ' LEU . 22.3 p -116.54 170.34 8.65 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-N 115.094 -0.957 . . . . 64.329999999999998 108.867 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 81.23 46.33 7.04 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.705 -0.958 . . . . 75.099999999999994 110.705 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 91.3 mt -114.37 141.44 26.51 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 107.573 -1.269 . . . . 74.430000000000007 107.573 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -59.99 161.4 19.1 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 121.585 1.523 . . . . 72.349999999999994 110.395 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.549 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 8.8 p -86.07 7.89 2.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 122.477 1.132 . . . . 74.329999999999998 109.752 -171.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -127.9 19.13 6.61 Favored 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 114.79 -1.095 . . . . 72.099999999999994 111.402 -174.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 32.6 pt -58.07 134.81 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 114.424 1.268 . . . . 74.109999999999999 114.424 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -101.44 145.85 31.17 Favored Pre-proline 0 C--N 1.297 -1.707 0 CA-C-N 113.908 -1.496 . . . . 73.140000000000001 110.066 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -55.97 -27.98 66.48 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.258 2.639 . . . . 74.109999999999999 113.484 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.587 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 23.9 ptt180 -70.36 -28.67 65.3 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 121.179 0.514 . . . . 73.010000000000005 111.051 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -69.84 -40.01 76.09 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.839 -0.619 . . . . 75.140000000000001 110.204 -176.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.97 -41.59 95.32 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 108.708 -0.849 . . . . 71.319999999999993 108.708 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.609 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 7.3 t80 -57.1 -47.1 81.87 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.73 -1.123 . . . . 72.25 111.32 177.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 82.5 mt -61.1 -42.7 99.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.11 0.481 . . . . 73.409999999999997 110.789 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 37.9 tp -73.86 -42.99 60.0 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.198 -0.91 . . . . 64.200000000000003 111.936 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -89.02 -10.49 47.36 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 115.623 1.712 . . . . 75.409999999999997 115.623 -173.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 14.1 mtp180 -54.28 -52.41 69.26 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 113.603 0.964 . . . . 70.319999999999993 113.603 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.3 -21.18 71.03 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 121.668 1.578 . . . . 73.019999999999996 112.304 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -88.42 86.59 7.07 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.662 0.744 . . . . 64.510000000000005 109.564 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -68.5 112.87 5.58 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.282 -1.326 . . . . 70.150000000000006 108.464 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 149.39 -28.52 1.21 Allowed Glycine 0 C--N 1.288 -2.087 0 CA-C-N 114.186 -1.37 . . . . 60.439999999999998 110.16 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -58.83 117.12 4.26 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.471 0.708 . . . . 64.209999999999994 111.568 176.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -102.02 -59.85 1.63 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.995 0.426 . . . . 72.140000000000001 111.212 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.78 172.37 31.17 Favored Glycine 0 C--N 1.295 -1.702 0 C-N-CA 120.559 -0.829 . . . . 71.109999999999999 112.181 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.1 p -135.39 137.04 41.92 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 122.903 0.481 . . . . 54.420000000000002 110.622 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.56 110.17 17.04 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.382 -1.34 . . . . 73.439999999999998 107.382 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.35 138.03 21.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 120.748 0.308 . . . . 73.430000000000007 110.923 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' B' ' 69' ' ' PRO . 0.6 OUTLIER -117.14 106.77 13.69 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.662 -1.607 . . . . 71.239999999999995 106.662 176.548 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.75 124.17 24.79 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.182 -0.917 . . . . 72.219999999999999 109.04 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 7.8 m -127.09 151.94 47.96 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 103.214 -2.884 . . . . 61.310000000000002 103.214 177.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.33 -33.36 65.54 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.063 0.764 . . . . 74.239999999999995 113.063 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -86.98 -38.7 16.37 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 120.19 -0.604 . . . . 71.0 112.294 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.494 ' O ' ' HB ' ' B' ' 65' ' ' THR . 28.4 pt20 -161.53 135.3 4.91 Favored Pre-proline 0 C--N 1.297 -1.691 0 CA-C-O 120.495 0.188 . . . . 71.510000000000005 111.485 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.549 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 18.0 Cg_endo -80.55 109.8 2.33 Favored 'Trans proline' 0 N--CA 1.427 -2.411 0 C-N-CA 122.064 1.842 . . . . 62.130000000000003 109.508 168.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -84.68 147.9 5.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.436 -0.95 . . . . 51.240000000000002 108.436 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.28 120.56 4.58 Favored Glycine 0 CA--C 1.481 -2.056 0 C-N-CA 118.647 -1.74 . . . . 74.329999999999998 112.847 -175.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -87.74 102.72 14.93 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.628 -1.619 . . . . 70.439999999999998 106.628 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 69.2 t -100.11 128.73 51.75 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 114.923 -1.035 . . . . 70.120000000000005 110.117 -174.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 45.8 pt -101.76 132.67 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 CA-C-O 122.165 0.983 . . . . 65.540000000000006 110.865 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . 0.687 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 79.9 m-85 -111.15 142.64 43.06 Favored 'General case' 0 C--N 1.266 -3.028 0 CA-C-N 113.744 -1.571 . . . . 75.209999999999994 107.9 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.95 -24.92 67.66 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.308 0.575 . . . . 75.349999999999994 110.704 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 3.1 m -129.75 131.82 46.39 Favored 'General case' 0 N--CA 1.386 -3.67 0 N-CA-C 107.429 -1.323 . . . . 74.200000000000003 107.429 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . 0.625 ' NE ' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -80.93 -24.11 38.39 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.952 -0.567 . . . . 73.109999999999999 110.301 179.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.16 -20.52 57.49 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.316 -2.105 . . . . 70.219999999999999 105.316 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.81 -40.31 15.01 Favored Glycine 0 C--N 1.314 -0.65 0 CA-C-N 112.672 -2.058 . . . . 61.119999999999997 109.282 177.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.31 -47.27 86.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.111 -1.045 . . . . 51.420000000000002 110.912 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 10.9 pt-20 -63.7 -31.2 72.3 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.54 -0.464 . . . . 71.010000000000005 112.124 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.64 -42.15 67.92 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.712 0.291 . . . . 70.209999999999994 110.545 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.28 -39.29 82.16 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.55 -0.75 . . . . 63.140000000000001 111.105 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' B' ' 82' ' ' GLU . 14.4 ptmm? -66.06 -37.34 85.59 Favored 'General case' 0 C--O 1.199 -1.554 0 C-N-CA 120.606 -0.438 . . . . 73.129999999999995 110.288 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -55.79 -32.82 63.82 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 120.961 0.41 . . . . 73.420000000000002 111.772 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.09 -36.45 19.62 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 112.406 0.521 . . . . 54.130000000000003 112.406 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.594 ' O ' HG22 ' B' ' 91' ' ' ILE . 97.5 mt -95.69 -22.14 17.74 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 116.019 1.859 . . . . 74.530000000000001 116.019 -173.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.99 113.3 12.15 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 118.441 -1.304 . . . . 75.209999999999994 110.514 178.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.46 16.17 16.94 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 120.761 -0.733 . . . . 72.049999999999997 111.344 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.594 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.3 tt -113.37 145.31 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.81 0 N-CA-C 107.844 -1.169 . . . . 74.319999999999993 107.844 175.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.522 ' CG ' HG21 ' B' ' 100' ' ' THR . 97.7 mtt180 -82.31 145.02 30.19 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 113.325 0.861 . . . . 74.519999999999996 113.325 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -77.24 -34.87 55.81 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.405 -1.725 . . . . 74.409999999999997 107.264 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' A' ' 45' ' ' ARG . 5.2 m-20 -134.34 120.62 14.91 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 105.249 -2.13 . . . . 73.340000000000003 105.249 176.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . 0.551 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 18.1 Cg_endo -60.78 -24.22 78.38 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 121.897 1.731 . . . . 73.109999999999999 112.21 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -84.71 -14.62 47.84 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 123.725 0.81 . . . . 74.5 110.776 -176.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -104.52 133.44 20.19 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 107.538 -1.282 . . . . 55.439999999999998 107.538 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.52 -5.39 15.09 Favored 'Trans proline' 0 CA--C 1.55 1.294 0 C-N-CA 122.524 2.149 . . . . 74.439999999999998 112.916 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -72.01 116.97 13.04 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 109.244 -0.65 . . . . 42.109999999999999 109.244 177.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.624 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 67.2 p -115.87 152.17 33.88 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.974 -0.75 . . . . 62.439999999999998 108.974 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' B' ' 36' ' ' SER . 6.4 mp -84.08 139.69 32.31 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.11 0.481 . . . . 71.310000000000002 110.487 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -125.3 109.49 12.86 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 107.134 -1.432 . . . . 71.209999999999994 107.134 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.44 ' HG ' HG23 ' B' ' 35' ' ' VAL . 6.8 mp -99.39 119.56 38.16 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 108.467 -0.938 . . . . 74.239999999999995 108.467 173.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.412 ' HA ' ' CE ' ' B' ' 85' ' ' LYS . 36.7 mm-40 -136.22 165.37 25.89 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.101 -1.074 . . . . 62.32 108.101 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -71.17 137.04 48.43 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 118.727 0.694 . . . . 74.420000000000002 110.544 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.63 152.92 29.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 116.216 -0.447 . . . . 53.420000000000002 110.032 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -73.17 -12.85 61.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.859 0.838 . . . . 62.439999999999998 110.086 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.97 123.29 20.64 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.243 -0.889 . . . . 72.010000000000005 109.625 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -83.53 100.81 11.01 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.688 -1.597 . . . . 61.299999999999997 106.688 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.6 t . . . . . 0 C--N 1.288 -2.071 0 CA-C-O 121.862 0.839 . . . . 65.239999999999995 112.517 -172.588 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.473 ' HA ' ' ND2' ' A' ' 109' ' ' ASN . 37.5 t . . . . . 0 N--CA 1.437 -1.112 0 N-CA-C 108.106 -1.072 . . . . 71.140000000000001 108.106 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 13.1 ptm180 -92.65 8.58 38.48 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.3 0.571 . . . . 75.409999999999997 110.294 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.7 m -122.45 129.66 52.27 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.804 0.811 . . . . 62.32 111.972 -177.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.408 HD13 ' N ' ' A' ' 33' ' ' LEU . 2.8 mp -110.46 141.29 43.77 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.339 -1.356 . . . . 74.120000000000005 107.339 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.661 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 11.4 p90 -101.51 128.01 47.94 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.252 -1.388 . . . . 63.0 107.252 172.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.4 t -106.76 118.32 54.27 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.623 0 N-CA-C 107.783 -1.191 . . . . 62.310000000000002 107.783 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.8 p -127.46 163.05 24.94 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.106 -0.702 . . . . 51.32 109.106 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.22 33.58 10.51 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.709 -0.956 . . . . 61.210000000000001 110.709 -174.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.7 mt -96.4 140.39 22.18 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.988 -1.116 . . . . 70.319999999999993 107.988 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -65.37 161.4 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 C-N-CA 121.315 1.344 . . . . 64.219999999999999 109.952 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -70.46 -8.77 11.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.79 0.805 . . . . 72.239999999999995 110.315 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -124.27 40.45 3.73 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 108.224 -1.028 . . . . 72.230000000000004 108.224 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.9 tp -60.53 125.34 16.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.115 -0.948 . . . . 74.340000000000003 109.451 173.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.509 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 26.1 mmmt -90.48 138.04 27.08 Favored Pre-proline 0 C--N 1.296 -1.757 0 N-CA-C 106.8 -1.555 . . . . 71.510000000000005 106.8 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.5 -25.07 77.48 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.485 2.123 . . . . 74.120000000000005 112.784 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -74.21 -27.66 60.9 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 116.012 -0.54 . . . . 74.530000000000001 111.396 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 30.5 mt-10 -62.87 -47.44 83.32 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.129 0.49 . . . . 73.239999999999995 109.964 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 99.7 mt -62.16 -45.3 94.05 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.283 -0.871 . . . . 63.140000000000001 109.803 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.669 ' CZ ' ' HD3' ' B' ' 95' ' ' PRO . 0.0 OUTLIER -60.01 -43.4 95.24 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.494 -0.776 . . . . 75.409999999999997 112.123 178.616 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 98.6 mt -64.36 -44.24 92.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.071 0.462 . . . . 74.329999999999998 110.221 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.412 ' O ' ' HD2' ' A' ' 53' ' ' PRO . 27.9 tp -66.72 -39.37 87.97 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.92 -1.036 . . . . 71.010000000000005 110.976 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -86.9 -4.49 59.18 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 114.566 1.321 . . . . 74.340000000000003 114.566 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 17.7 mtp180 -60.15 -42.87 92.08 Favored Pre-proline 0 N--CA 1.485 1.29 0 N-CA-C 113.447 0.906 . . . . 74.450000000000003 113.447 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 50' ' ' LEU . 24.5 Cg_exo -69.04 -18.36 40.4 Favored 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 121.693 1.595 . . . . 63.509999999999998 112.018 173.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -89.73 92.26 8.98 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 122.097 0.951 . . . . 74.239999999999995 110.967 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -69.4 111.79 5.51 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.177 -1.374 . . . . 63.539999999999999 109.589 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.84 -26.56 2.07 Favored Glycine 0 C--N 1.291 -1.963 0 CA-C-N 115.469 -0.787 . . . . 72.219999999999999 111.143 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -57.69 116.34 3.36 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.544 0.738 . . . . 74.219999999999999 111.698 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -96.7 -48.85 5.33 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.151 0.5 . . . . 51.149999999999999 110.323 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.69 167.23 40.27 Favored Glycine 0 C--N 1.302 -1.307 0 C-N-CA 120.014 -1.089 . . . . 75.120000000000005 113.246 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.5 p -127.27 137.66 52.9 Favored 'General case' 0 C--O 1.251 1.145 0 C-N-CA 123.12 0.568 . . . . 62.030000000000001 111.652 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.1 mp -112.42 150.44 31.14 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.904 -1.147 . . . . 64.200000000000003 107.904 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.0 mm -125.35 142.0 43.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 117.975 0.352 . . . . 73.120000000000005 110.091 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -133.99 107.73 7.96 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.52 -0.918 . . . . 72.019999999999996 108.52 178.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.2 130.37 43.62 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.315 -0.624 . . . . 75.230000000000004 109.315 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.9 m -129.38 164.0 24.57 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 106.405 -1.702 . . . . 75.340000000000003 106.405 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.41 -37.24 16.53 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.008 1.114 . . . . 74.129999999999995 114.008 -176.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -94.56 -41.6 9.25 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.285 0.565 . . . . 72.310000000000002 112.071 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -163.86 153.88 12.89 Favored Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 115.456 -0.793 . . . . 64.430000000000007 109.367 -170.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -78.27 118.2 4.27 Favored 'Trans proline' 0 N--CA 1.429 -2.309 0 C-N-CA 121.992 1.795 . . . . 71.239999999999995 109.939 170.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.37 159.58 2.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.973 -1.121 . . . . 71.219999999999999 107.973 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.72 157.46 20.45 Favored Glycine 0 C--N 1.298 -1.555 0 C-N-CA 118.688 -1.72 . . . . 61.43 113.683 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.68 109.73 15.56 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.948 -1.501 . . . . 73.439999999999998 106.948 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.7 t -103.23 128.98 55.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 CA-C-N 116.044 -0.525 . . . . 64.349999999999994 110.155 -177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 mp -105.85 128.43 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 115.799 -0.637 . . . . 74.239999999999995 109.964 -178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 4.7 m-85 -109.07 153.41 23.7 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.682 -1.145 . . . . 73.340000000000003 110.242 175.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -67.09 -27.98 67.8 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.867 -1.061 . . . . 71.329999999999998 112.066 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.3 m -134.88 144.86 47.76 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 109.537 -0.542 . . . . 64.140000000000001 109.537 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -24.75 55.79 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.959 -0.564 . . . . 73.349999999999994 110.11 -178.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.37 -36.56 71.49 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.817 -0.808 . . . . 64.209999999999994 108.817 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.41 -37.05 62.84 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 114.261 -1.336 . . . . 74.439999999999998 110.195 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.64 78.1 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.012 -0.594 . . . . 63.140000000000001 111.177 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.75 -33.15 74.28 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.698 -0.401 . . . . 74.409999999999997 111.758 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.83 -39.82 66.27 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 120.637 0.256 . . . . 75.319999999999993 111.195 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.31 -43.11 92.08 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 116.275 -0.421 . . . . 74.209999999999994 110.896 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.439 ' CD ' ' HA ' ' A' ' 104' ' ' GLU . 20.3 pttp -70.84 -30.28 66.65 Favored 'General case' 0 C--O 1.198 -1.631 0 C-N-CA 119.03 -1.068 . . . . 72.409999999999997 111.945 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -62.82 -31.4 72.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.381 0.61 . . . . 72.340000000000003 110.096 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.83 -36.57 21.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 116.041 -0.527 . . . . 55.119999999999997 111.427 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.547 ' O ' HG21 ' A' ' 91' ' ' ILE . 96.5 mt -93.98 -10.83 32.36 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 115.361 1.615 . . . . 54.420000000000002 115.361 -174.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -78.77 115.08 18.23 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 118.502 -1.279 . . . . 73.540000000000006 111.202 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.51 19.4 13.92 Favored Glycine 0 N--CA 1.421 -2.331 0 C-N-CA 120.515 -0.85 . . . . 73.219999999999999 111.211 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.547 HG21 ' O ' ' A' ' 88' ' ' LEU . 16.5 tt -102.04 125.33 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.04 0 N-CA-C 106.86 -1.533 . . . . 75.329999999999998 106.86 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -78.28 129.04 34.58 Favored 'General case' 0 C--N 1.257 -3.422 0 N-CA-C 109.303 -0.629 . . . . 55.030000000000001 109.303 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -72.68 -30.22 64.06 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.714 -1.13 . . . . 74.540000000000006 109.824 -172.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' B' ' 45' ' ' ARG 0.277 9.7 m-20 -150.62 124.63 4.47 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 105.765 -1.939 . . . . 37.859999999999999 105.765 177.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.474 ' HD3' ' CZ ' ' B' ' 48' ' ' TYR . 52.3 Cg_exo -63.0 -19.01 68.09 Favored 'Trans proline' 0 CA--C 1.555 1.535 0 CA-C-N 121.127 1.438 . . . . 72.5 111.272 170.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -78.12 -23.53 47.8 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.272 1.029 . . . . 73.430000000000007 110.707 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.568 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 22.0 t-20 -107.6 141.38 22.92 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 107.336 -1.357 . . . . 75.310000000000002 107.336 -172.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.436 ' HD2' ' OD1' ' A' ' 97' ' ' ASN . 73.5 Cg_endo -76.07 7.25 3.36 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 122.522 2.148 . . . . 72.010000000000005 111.726 176.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -88.31 126.18 35.05 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.141 -0.936 . . . . 74.200000000000003 109.921 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.2 p -115.25 141.92 47.38 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.529 -0.915 . . . . 54.109999999999999 108.529 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.3 tp -89.14 132.58 34.75 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.411 -0.589 . . . . 43.5 109.411 -176.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -134.56 122.53 22.5 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.095 0.558 . . . . 74.519999999999996 109.727 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -116.02 132.82 56.54 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.273 -0.64 . . . . 71.310000000000002 109.273 177.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.661 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 34.7 tt0 -146.24 168.49 20.93 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.223 -1.769 . . . . 71.519999999999996 106.223 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -68.02 138.2 55.66 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 120.133 1.333 . . . . 74.340000000000003 110.646 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.07 160.22 31.42 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.298 -0.864 . . . . 74.299999999999997 111.491 -176.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -63.29 -25.39 68.29 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.521 -1.218 . . . . 64.140000000000001 110.379 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.1 130.66 29.39 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 114.554 -1.203 . . . . 62.350000000000001 108.948 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.473 ' ND2' ' HA ' ' A' ' 30' ' ' VAL . 1.7 m-20 -82.44 121.35 26.62 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.322 -1.732 . . . . 73.400000000000006 106.322 176.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.287 -2.124 0 C-N-CA 119.46 -0.896 . . . . 61.240000000000002 111.293 -178.838 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.504 ' HB ' ' CD1' ' B' ' 105' ' ' PHE . 40.8 t . . . . . 1 N--CA 1.369 -4.513 0 N-CA-C 105.005 -2.22 . . . . 74.239999999999995 105.005 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.438 ' NH2' ' HA ' ' B' ' 76' ' ' ASP . 17.1 ptm180 -101.05 11.72 39.03 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 122.019 0.914 . . . . 72.310000000000002 109.221 -177.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 51.9 m -124.13 114.92 20.31 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.959 -1.019 . . . . 74.25 109.348 172.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mp -96.87 140.48 31.36 Favored 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 107.857 -1.164 . . . . 74.230000000000004 107.857 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' B' ' 104' ' ' GLU 0.262 28.0 p90 -102.83 110.63 22.61 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 117.534 -1.666 . . . . 73.329999999999998 109.127 175.005 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.425 HG22 ' HG ' ' B' ' 103' ' ' LEU . 40.5 t -97.49 125.88 50.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-N 113.736 -1.574 . . . . 74.530000000000001 108.634 -176.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 19.1 p -131.32 170.76 14.19 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.945 -0.571 . . . . 60.409999999999997 109.658 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.36 5.2 57.11 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.721 -0.952 . . . . 41.229999999999997 110.721 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.706 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 63.8 mt -84.34 120.01 73.86 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 106.515 -1.661 . . . . 74.129999999999995 106.515 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.56 175.84 6.56 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.577 1.518 . . . . 75.140000000000001 111.425 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.433 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 13.2 p -65.54 -19.82 26.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.957 0.884 . . . . 37.859999999999999 110.149 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -107.32 39.51 1.88 Allowed 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.141 -0.936 . . . . 74.109999999999999 108.599 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 tp -68.62 121.32 17.67 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 N-CA-C 109.044 -0.724 . . . . 74.109999999999999 109.044 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.404 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 16.3 mmmt -89.11 138.55 28.95 Favored Pre-proline 0 C--N 1.287 -2.112 0 N-CA-C 106.545 -1.65 . . . . 71.0 106.545 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.29 -29.48 86.2 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 122.333 2.022 . . . . 64.040000000000006 112.065 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.569 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 14.2 ptt180 -63.49 -31.94 73.25 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 114.818 -1.083 . . . . 63.43 112.17 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . 0.404 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 36.9 mt-10 -63.02 -49.26 75.31 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.824 0.345 . . . . 74.049999999999997 110.374 -177.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.15 -43.46 91.75 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.724 -0.671 . . . . 75.319999999999993 109.969 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.685 ' O ' ' HG3' ' B' ' 52' ' ' ARG . 0.4 OUTLIER -59.94 -43.38 94.99 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.031 -0.986 . . . . 75.120000000000005 112.298 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.39 -42.51 75.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.854 0.359 . . . . 70.019999999999996 110.274 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 24.6 tp -64.93 -41.45 95.52 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.108 -0.951 . . . . 72.439999999999998 111.087 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -88.67 1.87 54.29 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 113.944 1.09 . . . . 73.549999999999997 113.944 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.685 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 17.4 mtp180 -62.19 -46.38 90.95 Favored Pre-proline 0 CA--C 1.558 1.262 0 N-CA-C 113.593 0.96 . . . . 75.010000000000005 113.593 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -68.0 -19.46 45.75 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 121.853 1.702 . . . . 62.539999999999999 112.421 175.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -81.89 98.15 8.38 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.007 0.908 . . . . 73.530000000000001 110.789 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -70.91 110.11 5.44 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 113.898 -1.501 . . . . 75.120000000000005 110.764 -177.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.38 -15.42 4.18 Favored Glycine 0 N--CA 1.423 -2.233 0 CA-C-N 114.401 -1.272 . . . . 74.200000000000003 111.537 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -56.47 115.66 2.64 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.155 0.502 . . . . 71.120000000000005 111.424 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -93.49 -50.79 5.26 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-N 115.634 -0.712 . . . . 70.319999999999993 109.864 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.33 -179.17 47.5 Favored Glycine 0 C--N 1.29 -2.007 0 C-N-CA 120.527 -0.844 . . . . 53.149999999999999 111.671 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.2 p -136.9 137.99 40.21 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 123.311 0.644 . . . . 61.009999999999998 109.836 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 52.8 tp -120.36 123.81 43.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.591 -1.263 . . . . 73.049999999999997 107.591 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.63 144.96 8.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 109.929 -0.397 . . . . 54.119999999999997 109.929 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -133.43 108.56 8.74 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.039 -1.097 . . . . 74.120000000000005 108.039 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.19 108.85 3.31 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.91 -0.587 . . . . 74.129999999999995 109.603 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 20.9 m -100.06 156.71 17.03 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 105.872 -1.899 . . . . 53.520000000000003 105.872 175.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.09 -37.35 3.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.597 1.159 . . . . 74.099999999999994 113.885 -174.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -101.34 -46.12 5.12 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 119.677 -0.809 . . . . 70.540000000000006 112.469 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.706 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 4.0 pt20 -142.55 136.66 14.72 Favored Pre-proline 0 C--N 1.288 -2.095 0 CA-C-O 120.985 0.422 . . . . 73.340000000000003 112.035 -170.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.433 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 19.1 Cg_exo -64.34 108.88 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.393 2.729 . . . . 55.439999999999998 110.537 170.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 33.8 m -87.64 160.63 2.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.251 -1.018 . . . . 64.340000000000003 108.251 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.55 121.19 2.89 Favored Glycine 0 CA--C 1.481 -2.062 0 C-N-CA 119.163 -1.494 . . . . 64.120000000000005 112.68 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.12 108.83 19.46 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.198 -1.408 . . . . 73.109999999999999 107.198 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 86.0 t -95.9 125.23 48.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-N 115.72 -0.673 . . . . 72.439999999999998 110.396 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 3.5 mp -96.91 127.32 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 CA-C-N 115.064 -0.971 . . . . 73.310000000000002 108.907 -176.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -109.38 158.14 18.22 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.426 -0.806 . . . . 75.310000000000002 110.647 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . 0.438 ' HA ' ' NH2' ' B' ' 31' ' ' ARG . 18.0 t70 -79.93 -29.53 39.77 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 113.941 -1.482 . . . . 73.010000000000005 111.777 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 9.2 m -135.57 153.9 51.53 Favored 'General case' 0 N--CA 1.417 -2.098 0 C-N-CA 119.238 -0.985 . . . . 75.349999999999994 112.107 -168.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 7.3 tpt85 -63.51 -42.62 98.47 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.477 -1.238 . . . . 75.5 109.856 177.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.11 -17.61 62.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.191 -1.368 . . . . 75.340000000000003 109.679 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.69 -47.5 4.52 Favored Glycine 0 CA--C 1.488 -1.646 0 CA-C-N 114.113 -1.403 . . . . 52.240000000000002 109.902 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.22 -46.68 87.81 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 114.498 -0.851 . . . . 70.549999999999997 111.752 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.16 -31.33 72.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.602 0.593 . . . . 74.329999999999998 112.602 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.74 -39.47 24.15 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 120.804 -0.358 . . . . 70.129999999999995 110.691 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.95 -42.36 85.37 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.059 -0.519 . . . . 72.239999999999995 111.427 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' B' ' 104' ' ' GLU . 0.0 OUTLIER -73.51 -27.67 61.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 120.308 -0.557 . . . . 73.409999999999997 110.9 -177.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -76.15 -39.73 54.3 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.239 -0.437 . . . . 54.130000000000003 110.362 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.08 -43.89 61.23 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 120.848 0.356 . . . . 52.509999999999998 111.874 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.505 ' O ' HG21 ' B' ' 91' ' ' ILE . 97.1 mt -87.05 -14.11 42.46 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 115.684 1.735 . . . . 74.049999999999997 115.684 -172.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -78.5 113.92 16.95 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 117.729 -1.588 . . . . 73.439999999999998 111.57 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.95 18.22 9.0 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.383 -0.913 . . . . 63.340000000000003 111.353 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.505 HG21 ' O ' ' B' ' 88' ' ' LEU . 15.1 tt -101.59 136.92 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.91 0 N-CA-C 108.086 -1.079 . . . . 61.350000000000001 108.086 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.443 ' NH1' ' HA ' ' B' ' 98' ' ' PRO . 15.6 mmt180 -64.97 130.21 42.56 Favored 'General case' 0 C--N 1.278 -2.541 0 C-N-CA 124.109 0.964 . . . . 61.020000000000003 108.602 175.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -75.13 -27.51 59.8 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.01 -1.478 . . . . 63.310000000000002 107.01 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.62 126.43 3.51 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 103.375 -2.824 . . . . 52.140000000000001 103.375 168.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . 0.669 ' HD3' ' CZ ' ' A' ' 48' ' ' TYR . 69.6 Cg_endo -71.88 -8.4 22.93 Favored 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 122.235 1.957 . . . . 73.140000000000001 114.342 -171.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -84.49 -21.81 30.47 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.05 -0.722 . . . . 64.040000000000006 109.05 -177.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -108.98 142.44 25.52 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.329 -0.989 . . . . 65.340000000000003 108.329 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.443 ' HA ' ' NH1' ' B' ' 92' ' ' ARG . 49.1 Cg_exo -62.25 -3.92 4.63 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 123.151 2.567 . . . . 42.299999999999997 113.525 172.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.93 117.03 6.99 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-O 121.653 0.74 . . . . 75.120000000000005 109.855 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 42.5 p -121.56 150.07 42.19 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.566 -0.743 . . . . 71.319999999999993 109.906 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 22.7 tp -85.95 123.42 31.26 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 106.411 -1.7 . . . . 72.319999999999993 106.411 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.97 113.17 16.14 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.842 -1.17 . . . . 75.409999999999997 107.842 -172.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.425 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.7 mp -112.59 136.62 51.92 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.537 -0.756 . . . . 72.319999999999993 110.271 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.489 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 42.4 tt0 -144.94 167.52 22.44 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.937 -1.505 . . . . 72.25 106.937 175.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.504 ' CD1' ' HB ' ' B' ' 30' ' ' VAL . 40.1 m-85 -76.64 135.07 39.14 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.277 -0.638 . . . . 74.120000000000005 109.277 177.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.53 163.48 26.87 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.462 0.649 . . . . 65.109999999999999 111.194 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -76.57 -20.64 56.6 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 122.187 0.994 . . . . 44.109999999999999 108.895 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.06 124.3 27.36 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.879 -1.055 . . . . 74.430000000000007 110.956 -174.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.453 HD22 ' HA ' ' B' ' 30' ' ' VAL . 81.7 m-20 -82.94 136.21 34.64 Favored 'General case' 0 CA--C 1.475 -1.904 0 N-CA-C 107.68 -1.23 . . . . 74.109999999999999 107.68 173.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 12.0 t . . . . . 0 C--N 1.268 -2.978 0 N-CA-C 108.652 -0.87 . . . . 72.129999999999995 108.652 178.93 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.413 ' HA ' HD22 ' A' ' 109' ' ' ASN . 96.1 t . . . . . 0 N--CA 1.444 -0.773 0 N-CA-C 103.169 -2.901 . . . . 72.430000000000007 103.169 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 75' ' ' PHE . 20.4 ptt180 -133.27 9.81 4.08 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 119.788 -0.765 . . . . 73.530000000000001 112.016 -167.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 75.0 m -105.36 119.98 40.43 Favored 'General case' 0 C--N 1.264 -3.149 0 C-N-CA 119.744 -0.782 . . . . 73.430000000000007 109.536 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 81' ' ' ALA . 76.1 mt -99.28 142.11 31.19 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.418 -1.327 . . . . 71.230000000000004 107.418 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.576 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 15.8 p90 -103.54 116.79 33.04 Favored 'General case' 0 C--N 1.281 -2.4 0 C-N-CA 117.994 -1.482 . . . . 74.019999999999996 107.989 175.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.405 HG21 ' HG ' ' A' ' 103' ' ' LEU . 29.7 t -97.36 118.98 44.8 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.311 -1.366 . . . . 54.109999999999999 107.311 -178.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 32.7 p -120.92 166.08 14.31 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 109.041 -0.725 . . . . 72.329999999999998 109.041 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.413 ' HA2' ' NE2' ' A' ' 99' ' ' GLN . . . 97.0 18.5 29.19 Favored Glycine 0 N--CA 1.425 -2.038 0 C-N-CA 120.524 -0.846 . . . . 72.310000000000002 111.643 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -93.89 112.0 55.24 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.456 -0.942 . . . . 51.329999999999998 108.456 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.71 156.97 25.15 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.402 2.068 . . . . 72.099999999999994 110.774 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.99 -4.24 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 CA-C-O 122.109 0.957 . . . . 73.420000000000002 112.141 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -100.93 14.19 32.66 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.85 -0.796 . . . . 64.310000000000002 108.85 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.25 129.18 11.95 Favored 'Isoleucine or valine' 0 C--O 1.254 1.297 0 C-N-CA 124.859 1.263 . . . . 64.549999999999997 110.122 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -126.85 104.77 23.19 Favored Pre-proline 0 C--N 1.286 -2.19 0 N-CA-C 106.705 -1.591 . . . . 74.319999999999993 106.705 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -39.98 -17.49 0.05 OUTLIER 'Trans proline' 0 N--CA 1.515 2.777 1 C-N-CA 126.53 4.82 . . . . 62.340000000000003 118.14 -165.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.516 ' HG3' ' CE2' ' B' ' 93' ' ' PHE . 0.0 OUTLIER -60.59 -32.56 71.67 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 112.892 0.701 . . . . 71.109999999999999 112.892 176.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.628 ' HG3' ' CZ ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -69.39 -42.84 74.59 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.371 -0.931 . . . . 75.430000000000007 109.605 -177.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.37 -45.25 94.03 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 115.817 -0.628 . . . . 64.209999999999994 109.394 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.65 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 72.9 t80 -56.52 -49.13 75.67 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.952 -1.022 . . . . 72.310000000000002 111.42 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 93.2 mt -66.8 -35.97 81.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.915 0.388 . . . . 62.100000000000001 110.772 -176.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.5 tp -73.83 -41.97 61.54 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.279 -0.873 . . . . 63.530000000000001 112.327 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -87.81 -11.39 48.11 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 115.936 1.828 . . . . 73.150000000000006 115.936 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.628 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 52.8 mtp180 -60.58 -41.97 85.8 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 113.793 1.034 . . . . 75.299999999999997 113.793 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -64.82 -19.23 64.18 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.696 1.597 . . . . 54.340000000000003 112.387 175.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -81.76 89.65 6.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.233 0.539 . . . . 64.239999999999995 110.214 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.29 109.79 1.68 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.746 -0.835 . . . . 64.329999999999998 108.746 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.6 -17.67 3.7 Favored Glycine 0 N--CA 1.419 -2.485 0 CA-C-N 114.823 -1.081 . . . . 71.310000000000002 110.759 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -63.38 112.74 2.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.821 0.31 . . . . 63.409999999999997 110.538 175.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -90.55 -48.07 7.31 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.09 0.471 . . . . 73.409999999999997 110.437 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.8 179.21 48.78 Favored Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.203 -0.999 . . . . 74.439999999999998 112.558 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 p -138.33 136.84 36.8 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.803 0.335 . . . . 73.540000000000006 110.933 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 mp -123.02 121.16 35.39 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.558 -0.904 . . . . 73.530000000000001 108.558 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.76 138.56 20.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 120.853 0.358 . . . . 64.409999999999997 111.204 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -121.14 135.64 55.13 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.527 1.131 . . . . 71.230000000000004 108.254 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.63 126.89 33.31 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.74 0.781 . . . . 75.299999999999997 112.913 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 18.9 m -130.12 148.56 51.97 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 104.254 -2.499 . . . . 65.329999999999998 104.254 172.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -42.24 -48.86 4.99 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.849 1.26 . . . . 72.409999999999997 114.366 -169.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -105.3 -5.05 20.87 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.187 -1.005 . . . . 71.010000000000005 113.184 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.48 ' O ' ' HB ' ' A' ' 65' ' ' THR . 11.2 pt20 -161.79 117.1 1.28 Allowed Pre-proline 0 C--N 1.312 -1.03 0 C-N-CA 120.114 -0.634 . . . . 71.230000000000004 112.515 -171.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -73.53 105.52 2.01 Favored 'Trans proline' 0 N--CA 1.432 -2.089 0 C-N-CA 122.243 1.962 . . . . 72.030000000000001 108.107 169.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.5 152.16 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.119 -0.697 . . . . 71.140000000000001 109.119 -176.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.53 120.4 4.4 Favored Glycine 0 CA--C 1.477 -2.293 0 C-N-CA 118.642 -1.742 . . . . 61.229999999999997 112.805 -175.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.52 103.72 16.15 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.454 -1.313 . . . . 71.409999999999997 107.454 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.2 t -98.09 120.96 48.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 114.888 -1.051 . . . . 72.299999999999997 110.097 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.416 HD12 ' O ' ' A' ' 110' ' ' THR . 5.9 tt -94.96 127.74 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.258 0 CA-C-N 115.019 -0.991 . . . . 71.439999999999998 110.187 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.556 ' O ' ' HD2' ' A' ' 31' ' ' ARG . 84.4 m-85 -107.46 165.86 11.09 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 114.616 -1.175 . . . . 72.340000000000003 110.086 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.95 -48.21 78.88 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 125.209 1.404 . . . . 75.420000000000002 112.48 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 p -143.65 163.88 32.0 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 111.755 0.28 . . . . 74.439999999999998 111.755 -172.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.455 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -68.44 -36.05 78.48 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.216 0.531 . . . . 74.430000000000007 110.65 -177.685 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.64 -28.87 63.0 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.228 -0.896 . . . . 73.420000000000002 108.962 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.11 -39.5 37.17 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.443 -1.253 . . . . 70.310000000000002 110.407 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.503 ' O ' HD12 ' A' ' 33' ' ' LEU . . . -65.35 -46.1 81.56 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.878 -0.661 . . . . 65.430000000000007 111.534 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -63.38 -37.63 88.03 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.448 -0.501 . . . . 74.239999999999995 112.082 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.2 -38.47 85.38 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.249 -0.432 . . . . 72.120000000000005 110.106 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.86 -39.52 83.77 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.808 -0.633 . . . . 45.009999999999998 110.56 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.412 ' CD ' ' HA ' ' A' ' 104' ' ' GLU . 21.4 ttpp -59.09 -47.97 83.32 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.685 -0.689 . . . . 62.420000000000002 111.836 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -66.1 -25.16 66.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.194 0.521 . . . . 61.43 111.864 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.17 -39.72 32.72 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.872 -0.604 . . . . 43.310000000000002 111.514 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 91' ' ' ILE . 98.2 mt -102.2 -25.33 13.73 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 116.896 2.184 . . . . 73.409999999999997 116.896 -173.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -65.46 114.75 5.06 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-N 120.327 1.421 . . . . 75.25 110.18 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.58 10.18 19.87 Favored Glycine 0 N--CA 1.421 -2.32 0 CA-C-N 115.405 -0.816 . . . . 45.020000000000003 111.606 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 88' ' ' LEU . 14.7 tt -93.9 130.33 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.41 0 N-CA-C 109.107 -0.701 . . . . 64.319999999999993 109.107 177.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.524 ' CG ' HG21 ' A' ' 100' ' ' THR . 79.0 mtt180 -76.15 141.35 41.92 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-O 121.396 0.617 . . . . 73.140000000000001 111.757 173.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.628 ' CZ ' ' HG3' ' A' ' 46' ' ' GLU . 26.3 t80 -70.74 -34.46 71.9 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.509 -1.678 . . . . 60.329999999999998 109.108 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.546 ' OD2' ' HB3' ' B' ' 45' ' ' ARG . 6.5 m-20 -140.41 142.14 28.32 Favored Pre-proline 0 C--N 1.294 -1.821 0 N-CA-C 102.666 -3.087 . . . . 52.329999999999998 102.666 175.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.682 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 28.1 Cg_endo -64.03 -22.7 67.9 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 121.469 1.446 . . . . 75.049999999999997 110.898 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -92.08 -8.16 46.62 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.65 -1.159 . . . . 74.129999999999995 110.545 -176.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.542 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 34.2 t30 -103.51 120.66 51.03 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 108.977 -0.749 . . . . 64.099999999999994 108.977 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.89 -19.55 35.38 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.669 2.246 . . . . 74.120000000000005 111.858 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.413 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 6.9 tp60 -68.09 114.65 6.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.337 -0.986 . . . . 72.450000000000003 108.337 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.524 HG21 ' CG ' ' A' ' 92' ' ' ARG . 69.1 p -107.56 154.83 20.84 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.066 -0.716 . . . . 74.010000000000005 109.066 -175.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.7 mp -86.29 118.29 25.64 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.803 -0.443 . . . . 74.109999999999999 109.803 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -110.76 121.25 44.87 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.725 -1.954 . . . . 74.109999999999999 105.725 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.405 ' HG ' HG21 ' A' ' 35' ' ' VAL . 6.5 mp -105.27 138.17 41.89 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.151 -1.055 . . . . 71.25 108.151 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.576 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 32.6 tt0 -146.02 163.38 35.41 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.843 -1.91 . . . . 64.200000000000003 105.843 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -70.55 137.91 50.5 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 119.22 0.918 . . . . 74.439999999999998 110.37 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.9 141.15 40.66 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 108.15 -1.056 . . . . 73.209999999999994 108.15 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -80.19 10.04 4.93 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 122.233 1.016 . . . . 74.200000000000003 110.692 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -162.38 132.17 4.54 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.986 -1.857 . . . . 75.450000000000003 105.986 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.413 HD22 ' HA ' ' A' ' 30' ' ' VAL . 79.4 m-20 -78.36 158.54 28.75 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.413 0.625 . . . . 62.329999999999998 111.648 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.416 ' O ' HD12 ' A' ' 74' ' ' ILE . 6.7 t . . . . . 0 N--CA 1.399 -2.977 0 N-CA-C 104.35 -2.463 . . . . 51.520000000000003 104.35 169.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.448 ' HA ' HD22 ' B' ' 109' ' ' ASN . 57.8 t . . . . . 0 CA--C 1.5 -0.976 0 N-CA-C 106.49 -1.67 . . . . 73.129999999999995 106.49 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -140.04 15.06 2.45 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 115.042 -0.981 . . . . 64.230000000000004 111.855 -171.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' B' ' 74' ' ' ILE . 35.3 m -105.84 125.76 51.37 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 108.727 -0.842 . . . . 65.230000000000004 108.727 174.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.44 HD11 ' O ' ' B' ' 81' ' ' ALA . 85.4 mt -100.83 143.11 31.38 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.75 -0.833 . . . . 71.129999999999995 108.75 178.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.606 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 4.6 p90 -104.44 118.47 36.68 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 106.798 -1.556 . . . . 71.239999999999995 106.798 171.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 39.8 t -97.27 111.95 28.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 N-CA-C 107.206 -1.405 . . . . 64.319999999999993 107.206 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 36.2 p -109.92 162.47 14.48 Favored 'General case' 0 C--N 1.276 -2.59 0 N-CA-C 109.07 -0.715 . . . . 63.350000000000001 109.07 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.83 24.82 12.47 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.428 -0.891 . . . . 70.030000000000001 111.887 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 83.4 mt -101.78 113.59 65.81 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 107.757 -1.201 . . . . 75.430000000000007 107.757 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.49 169.79 2.14 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.856 2.371 . . . . 54.350000000000001 112.35 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 6.6 p -72.96 -2.41 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 122.115 0.959 . . . . 63.420000000000002 110.458 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' B' ' 43' ' ' LYS . 22.3 t0 -105.01 10.65 34.03 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 114.954 -1.021 . . . . 55.329999999999998 109.563 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.94 129.88 19.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-O 121.811 0.815 . . . . 72.420000000000002 109.449 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 45' ' ' ARG . 47.7 mmtm -130.0 107.05 16.56 Favored Pre-proline 0 C--N 1.277 -2.564 0 N-CA-C 106.449 -1.686 . . . . 64.049999999999997 106.449 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -41.48 -16.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.478 1 C-N-CA 126.372 4.715 . . . . 52.420000000000002 117.774 -165.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.546 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 9.8 ptt180 -65.51 -24.72 67.2 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 122.642 0.377 . . . . 75.230000000000004 111.855 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . 0.515 ' HG3' ' CE1' ' B' ' 93' ' ' PHE . 0.0 OUTLIER -76.03 -41.83 49.72 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 119.214 -0.994 . . . . 75.120000000000005 108.888 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.17 -37.19 84.28 Favored 'General case' 0 C--O 1.211 -0.939 0 N-CA-C 108.859 -0.793 . . . . 74.219999999999999 108.859 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.682 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 63.1 t80 -58.53 -49.78 76.15 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.846 -1.07 . . . . 55.130000000000003 110.488 176.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.62 -33.98 74.97 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.862 0.363 . . . . 64.219999999999999 110.738 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 36.5 tp -74.58 -45.92 42.08 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.566 -0.743 . . . . 72.239999999999995 112.467 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -92.13 -7.31 48.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.951 1.093 . . . . 70.010000000000005 113.951 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 20.6 ttt180 -65.99 -43.13 56.29 Favored Pre-proline 0 CA--C 1.56 1.333 0 N-CA-C 112.416 0.525 . . . . 71.409999999999997 112.416 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.22 -15.43 46.09 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 121.76 1.64 . . . . 53.420000000000002 111.862 175.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -85.68 88.87 7.6 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.419 -0.585 . . . . 71.409999999999997 109.419 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.1 112.85 5.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.453 -0.794 . . . . 73.109999999999999 109.978 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.84 -26.5 1.62 Allowed Glycine 0 N--CA 1.426 -1.985 0 CA-C-N 113.578 -1.646 . . . . 72.409999999999997 109.49 -174.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -50.89 119.03 3.54 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.413 1.085 . . . . 72.140000000000001 111.905 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.413 ' HB2' HG22 ' B' ' 74' ' ' ILE . 6.6 mm-40 -93.06 -46.69 7.33 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 115.928 -0.578 . . . . 52.420000000000002 109.443 176.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.85 171.99 37.4 Favored Glycine 0 C--N 1.297 -1.614 0 C-N-CA 120.455 -0.879 . . . . 72.200000000000003 112.325 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.9 p -127.11 137.34 52.98 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.192 0.52 . . . . 61.109999999999999 111.061 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.87 109.72 16.88 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.376 -0.972 . . . . 72.219999999999999 108.376 175.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.74 131.95 39.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.729 -0.841 . . . . 60.329999999999998 108.729 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -130.97 119.57 22.27 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 109.293 -0.632 . . . . 75.239999999999995 109.293 -176.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.51 134.63 57.26 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.213 1.005 . . . . 73.409999999999997 110.873 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 2.5 m -130.08 158.58 39.24 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 105.663 -1.977 . . . . 71.040000000000006 105.663 175.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.89 -40.66 10.36 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.065 0.946 . . . . 72.109999999999999 113.29 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 -104.75 -41.66 5.6 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 119.58 -0.848 . . . . 72.349999999999994 112.735 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.558 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 14.1 pt20 -153.36 126.44 4.13 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 120.717 -0.393 . . . . 74.099999999999994 111.55 -173.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' B' ' 38' ' ' LEU . 51.9 Cg_exo -56.85 124.37 16.09 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.004 2.469 . . . . 63.109999999999999 111.393 171.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.24 141.22 14.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 115.114 -0.948 . . . . 72.329999999999998 108.679 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.73 120.31 5.21 Favored Glycine 0 C--O 1.205 -1.702 0 C-N-CA 119.139 -1.505 . . . . 74.239999999999995 112.46 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -90.37 102.94 15.67 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.642 -1.244 . . . . 74.310000000000002 107.642 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.17 112.38 37.49 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 CA-C-N 115.569 -0.741 . . . . 70.310000000000002 109.182 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . 0.413 HG22 ' HB2' ' B' ' 58' ' ' GLU . 12.4 tt -97.18 138.01 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 CA-C-N 115.528 -0.76 . . . . 71.209999999999994 110.549 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -112.61 160.04 18.26 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.04 -0.982 . . . . 75.430000000000007 109.341 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.24 -31.61 72.53 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.863 -0.608 . . . . 63.219999999999999 112.224 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 26.4 p -128.88 152.56 48.38 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 121.74 0.781 . . . . 61.509999999999998 111.904 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . 0.599 ' HD3' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -63.09 -39.05 93.57 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.514 -1.221 . . . . 73.430000000000007 109.954 177.255 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . 0.416 ' N ' ' HG2' ' B' ' 78' ' ' ARG . . . -79.51 -19.9 48.52 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.184 -1.043 . . . . 63.020000000000003 108.184 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.56 -44.75 31.76 Favored Glycine 0 C--N 1.307 -1.067 0 N-CA-C 109.227 -1.549 . . . . 72.400000000000006 109.227 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.44 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -67.97 -37.4 81.48 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.381 -0.909 . . . . 50.310000000000002 109.476 176.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -55.42 -52.51 63.33 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.066 -0.97 . . . . 65.230000000000004 110.576 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.08 89.76 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.525 -0.761 . . . . 74.230000000000004 110.994 -176.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.21 -39.96 82.28 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.351 -0.84 . . . . 44.409999999999997 110.563 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -62.84 -42.49 99.76 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.603 -0.726 . . . . 44.119999999999997 111.841 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -62.37 -37.37 85.42 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.257 0.551 . . . . 74.230000000000004 111.25 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.19 -45.34 33.7 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 115.581 -0.736 . . . . 63.149999999999999 111.767 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.462 ' O ' HG23 ' B' ' 91' ' ' ILE . 90.7 mt -93.33 -21.05 19.8 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 117.477 2.399 . . . . 72.010000000000005 117.477 -170.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -69.86 114.01 7.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 120.787 1.631 . . . . 73.219999999999999 112.343 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 113.9 1.56 24.01 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.885 -0.598 . . . . 64.040000000000006 112.255 176.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.462 HG23 ' O ' ' B' ' 88' ' ' LEU . 13.2 tt -86.02 136.15 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 CA-C-O 121.137 0.494 . . . . 61.240000000000002 110.184 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.414 ' HA ' HG22 ' B' ' 100' ' ' THR . 22.2 mmt180 -59.26 139.02 57.38 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 125.17 1.388 . . . . 72.519999999999996 110.045 173.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.516 ' CE2' ' HG3' ' A' ' 45' ' ' ARG . 34.9 t80 -80.77 -32.28 35.54 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.491 -1.67 . . . . 74.140000000000001 106.491 173.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.531 ' HB2' ' HB3' ' B' ' 97' ' ' ASN . 9.5 m-20 -147.47 143.31 17.83 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 101.493 -3.521 . . . . 73.530000000000001 101.493 174.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . 0.65 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 74.0 Cg_endo -78.33 -15.88 13.98 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 CA-C-N 121.952 1.733 . . . . 61.200000000000003 109.619 175.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -79.63 -25.34 41.43 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.299 -1.319 . . . . 74.129999999999995 109.629 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' ASN . . . . . 0.531 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . 38.0 t30 -109.69 129.9 23.4 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 107.744 -1.206 . . . . 75.109999999999999 107.744 -174.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.73 -2.81 6.97 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 123.156 2.57 . . . . 61.310000000000002 113.241 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -77.45 122.41 25.16 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.723 0.773 . . . . 73.319999999999993 110.267 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.414 HG22 ' HA ' ' B' ' 92' ' ' ARG . 17.9 p -121.72 159.81 25.82 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 115.045 -0.979 . . . . 75.200000000000003 108.582 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.427 HD12 ' N ' ' B' ' 101' ' ' LEU . 4.4 mp -93.05 134.81 34.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.405 -0.961 . . . . 75.530000000000001 108.405 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -123.99 116.85 23.52 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.044 -1.836 . . . . 71.219999999999999 106.044 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mp -106.49 136.37 46.38 Favored 'General case' 0 C--N 1.289 -2.034 0 O-C-N 123.752 0.657 . . . . 72.409999999999997 110.354 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.606 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 37.1 tt0 -145.4 163.97 32.95 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 105.744 -1.947 . . . . 74.150000000000006 105.744 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -70.47 144.93 51.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 119.493 1.042 . . . . 71.450000000000003 110.133 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.69 158.18 27.03 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 107.996 -1.113 . . . . 73.120000000000005 107.996 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -81.91 -11.32 58.96 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.009 0.909 . . . . 63.009999999999998 109.523 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -149.06 130.49 14.77 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.664 -1.153 . . . . 52.229999999999997 107.948 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.448 HD22 ' HA ' ' B' ' 30' ' ' VAL . 54.2 m-80 -74.15 113.99 11.98 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.432 0.634 . . . . 72.420000000000002 110.479 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.419 -2.023 0 N-CA-C 107.336 -1.357 . . . . 70.030000000000001 107.336 -179.158 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.492 ' HB ' ' CD1' ' A' ' 105' ' ' PHE . 26.1 t . . . . . 0 N--CA 1.429 -1.51 0 N-CA-C 109.691 -0.485 . . . . 71.030000000000001 109.691 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.412 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 40.9 mtm180 -85.97 7.38 24.6 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-O 120.926 0.393 . . . . 72.209999999999994 110.507 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.6 m -134.2 129.77 36.23 Favored 'General case' 0 C--N 1.259 -3.363 0 CA-C-O 121.821 0.82 . . . . 64.530000000000001 112.054 -173.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 81' ' ' ALA . 88.4 mt -103.7 139.07 39.46 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.73 -1.211 . . . . 52.350000000000001 107.73 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -98.76 112.14 24.31 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.773 -1.566 . . . . 74.310000000000002 106.773 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.43 HG23 ' HG ' ' A' ' 103' ' ' LEU . 29.1 t -96.99 120.63 46.58 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 CA-C-N 113.79 -1.55 . . . . 71.109999999999999 107.739 -174.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 p -126.38 163.71 22.68 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 115.228 -0.896 . . . . 62.229999999999997 109.548 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.64 27.84 10.14 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.927 -0.869 . . . . 73.25 110.927 -173.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.551 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 96.8 mt -97.26 119.35 63.27 Favored Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 107.96 -1.126 . . . . 73.420000000000002 107.96 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.99 153.22 6.57 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.734 2.289 . . . . 72.140000000000001 111.283 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.499 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 8.6 p -70.07 -1.98 2.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.875 0.845 . . . . 70.109999999999999 112.013 -172.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -127.2 31.34 5.25 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-O 121.553 0.692 . . . . 65.150000000000006 109.974 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.14 149.06 6.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 N-CA-C 113.613 0.968 . . . . 74.019999999999996 113.613 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.514 ' HG2' ' CZ ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -102.74 144.53 28.8 Favored Pre-proline 0 C--N 1.279 -2.476 0 CA-C-N 113.883 -1.508 . . . . 73.409999999999997 109.615 176.091 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.45 -24.98 79.21 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 122.63 2.22 . . . . 74.319999999999993 113.325 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.536 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -84.14 -11.42 56.63 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 118.441 -1.304 . . . . 72.310000000000002 111.427 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.437 ' HG2' ' HG2' ' B' ' 46' ' ' GLU . 35.7 mt-10 -63.77 -39.92 95.44 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.703 0.763 . . . . 75.299999999999997 109.358 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.3 mt -67.32 -31.53 71.88 Favored 'General case' 0 C--O 1.209 -1.064 0 CA-C-N 115.226 -0.897 . . . . 73.450000000000003 110.077 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.61 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 42.0 t80 -65.32 -46.81 78.82 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.786 -0.643 . . . . 74.219999999999999 110.863 178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 69.0 mt -64.92 -40.01 94.39 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.114 -0.494 . . . . 64.310000000000002 110.884 -176.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.6 tp -81.42 -38.96 25.65 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.43 -0.804 . . . . 61.549999999999997 112.543 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -95.43 -3.52 46.79 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.285 1.217 . . . . 72.430000000000007 114.285 -173.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -61.49 -44.55 92.56 Favored Pre-proline 0 CA--C 1.563 1.452 0 N-CA-C 112.799 0.666 . . . . 64.329999999999998 112.799 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.68 -2.39 12.39 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 121.393 1.395 . . . . 53.25 112.854 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -91.53 95.35 9.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 122.336 1.065 . . . . 72.400000000000006 110.945 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -63.79 109.63 1.8 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 113.078 -1.874 . . . . 74.230000000000004 110.519 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.72 -23.56 3.23 Favored Glycine 0 N--CA 1.422 -2.252 0 CA-C-N 114.858 -1.065 . . . . 70.549999999999997 111.002 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -55.32 114.85 1.97 Allowed 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.498 0.719 . . . . 74.519999999999996 111.959 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -97.86 -58.91 1.87 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.661 -0.699 . . . . 75.109999999999999 110.376 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -158.26 -177.0 30.94 Favored Glycine 0 C--N 1.295 -1.726 0 C-N-CA 120.898 -0.668 . . . . 73.450000000000003 111.869 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.7 p -148.76 140.65 23.76 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 123.032 0.533 . . . . 64.340000000000003 110.349 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.3 tp -120.87 122.01 39.33 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.41 -0.589 . . . . 75.239999999999995 109.41 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.4 mm -93.57 133.76 33.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 109.233 -0.654 . . . . 74.430000000000007 109.233 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -135.3 113.27 11.1 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 121.021 0.438 . . . . 62.25 110.374 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -67.97 124.43 23.34 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.362 0.601 . . . . 61.399999999999999 110.897 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.8 m -116.7 162.05 18.27 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 105.637 -1.986 . . . . 71.209999999999994 105.637 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.51 -34.95 3.53 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.163 1.172 . . . . 74.109999999999999 114.163 -175.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -95.62 -46.79 6.49 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 112.75 0.648 . . . . 70.430000000000007 112.75 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.551 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 4.2 pt20 -156.82 157.08 30.62 Favored Pre-proline 0 C--N 1.295 -1.773 0 CA-C-N 115.792 -0.64 . . . . 64.019999999999996 109.459 -170.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.499 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 74.5 Cg_endo -80.46 120.64 4.05 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 122.667 2.245 . . . . 72.299999999999997 110.711 171.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.91 161.62 2.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.239 -1.022 . . . . 71.540000000000006 108.239 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.91 120.93 2.92 Favored Glycine 0 CA--C 1.484 -1.85 0 C-N-CA 118.762 -1.685 . . . . 74.109999999999999 112.579 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -88.11 104.62 16.85 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.519 -1.289 . . . . 75.409999999999997 107.519 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.6 t -99.25 123.26 51.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 CA-C-N 115.922 -0.581 . . . . 62.32 109.799 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 tt -101.54 131.85 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 115.38 -0.827 . . . . 73.140000000000001 110.962 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.412 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 74.2 m-85 -115.51 146.83 41.34 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.434 -1.257 . . . . 74.010000000000005 107.639 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -79.23 -24.07 43.31 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.708 0.766 . . . . 74.420000000000002 110.493 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.6 m -109.96 140.65 43.73 Favored 'General case' 0 N--CA 1.392 -3.373 0 CA-C-N 115.498 -0.774 . . . . 73.239999999999995 108.964 -175.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.1 mmt-85 -73.38 -33.15 64.87 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.417 -1.327 . . . . 73.140000000000001 107.417 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.2 -19.23 61.77 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.499 -1.682 . . . . 44.119999999999997 109.071 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.91 -42.34 6.39 Favored Glycine 0 CA--C 1.487 -1.661 0 N-CA-C 109.606 -1.398 . . . . 63.439999999999998 109.606 -177.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.425 ' O ' HD12 ' A' ' 33' ' ' LEU . . . -64.71 -47.45 78.27 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 114.902 -0.649 . . . . 73.349999999999994 111.115 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.56 -36.11 82.82 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.147 -0.621 . . . . 73.450000000000003 111.991 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.37 78.12 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 120.737 0.303 . . . . 44.350000000000001 110.854 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.36 -42.28 79.45 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.947 -0.569 . . . . 73.430000000000007 110.843 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -28.78 64.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 120.245 -0.582 . . . . 73.510000000000005 111.801 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -71.31 -41.38 69.97 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 120.592 0.234 . . . . 64.340000000000003 111.542 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.05 -41.42 50.74 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.252 0.464 . . . . 75.239999999999995 112.252 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 91' ' ' ILE . 97.4 mt -95.93 1.71 53.06 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 115.646 1.721 . . . . 70.239999999999995 115.646 -173.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -79.09 114.39 18.0 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 116.822 -1.951 . . . . 75.310000000000002 111.066 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.17 12.18 34.58 Favored Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 110.27 -1.132 . . . . 61.119999999999997 110.27 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 88' ' ' LEU . 13.3 tt -82.38 134.46 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.911 0 N-CA-C 109.116 -0.698 . . . . 52.420000000000002 109.116 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.439 ' NH1' ' HA ' ' A' ' 98' ' ' PRO . 26.2 mmt180 -60.91 121.07 11.44 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 107.954 -1.128 . . . . 72.400000000000006 107.954 171.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -75.37 -27.06 58.99 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.856 -1.535 . . . . 73.140000000000001 106.856 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 97' ' ' ASN . 12.0 t70 -148.07 126.1 5.91 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 103.212 -2.884 . . . . 70.239999999999995 103.212 174.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.569 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 69.2 Cg_endo -71.81 -16.44 29.62 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.426 1.417 . . . . 61.32 114.732 -175.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -93.07 -22.14 19.3 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.34 0.591 . . . . 74.129999999999995 110.174 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 48.9 t-20 -91.27 132.49 33.77 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.158 -1.423 . . . . 65.430000000000007 107.158 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.439 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 35.6 Cg_endo -67.75 -1.8 7.43 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.587 2.192 . . . . 70.329999999999998 113.0 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.75 113.74 10.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.793 -0.817 . . . . 62.450000000000003 108.793 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.9 p -115.7 147.53 40.77 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.915 -0.584 . . . . 74.129999999999995 109.687 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.6 tp -94.83 125.04 39.23 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 116.073 -0.512 . . . . 73.439999999999998 109.84 -174.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -120.54 126.35 50.11 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.194 -0.669 . . . . 75.010000000000005 109.194 176.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.43 ' HG ' HG23 ' A' ' 35' ' ' VAL . 7.0 mp -104.5 127.18 52.15 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 107.841 -1.17 . . . . 62.420000000000002 107.841 176.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -136.04 163.29 30.66 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 107.731 -1.211 . . . . 71.030000000000001 107.731 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.492 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 33.0 m-85 -78.7 134.83 37.06 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 119.048 0.84 . . . . 74.439999999999998 110.323 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.39 165.0 25.42 Favored 'General case' 0 N--CA 1.428 -1.532 0 O-C-N 123.668 0.605 . . . . 43.350000000000001 109.403 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -86.79 -6.87 58.68 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-O 121.946 0.879 . . . . 53.109999999999999 109.661 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.5 134.22 23.61 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.073 -0.967 . . . . 75.329999999999998 108.83 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' A' ' 30' ' ' VAL . 3.3 m-20 -76.72 124.97 28.46 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.165 -1.421 . . . . 53.119999999999997 107.165 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.409 -2.476 0 C-N-CA 118.113 -1.435 . . . . 75.530000000000001 108.907 179.326 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 17.5 t . . . . . 0 N--CA 1.444 -0.727 0 N-CA-C 110.345 -0.243 . . . . 74.430000000000007 110.345 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.56 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 82.8 mtm180 -96.22 0.04 50.52 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-O 121.286 0.565 . . . . 53.340000000000003 110.74 175.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 25.0 m -111.24 128.72 56.02 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-O 121.511 0.672 . . . . 72.430000000000007 112.549 -176.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.492 HD11 ' O ' ' B' ' 81' ' ' ALA . 91.1 mt -104.57 146.37 29.0 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.43 -0.952 . . . . 73.420000000000002 108.43 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' B' ' 104' ' ' GLU . 27.9 p90 -104.6 115.18 29.89 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.187 -1.412 . . . . 51.200000000000003 107.187 172.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.53 115.45 37.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 CA-C-N 113.917 -1.492 . . . . 62.310000000000002 107.859 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 35.7 p -119.53 171.4 8.38 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.272 -0.876 . . . . 74.239999999999995 109.272 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 86.93 25.01 35.83 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.38 -1.088 . . . . 52.509999999999998 110.38 -173.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.585 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 95.7 mt -94.77 114.71 64.2 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 107.701 -1.222 . . . . 60.229999999999997 107.701 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.23 157.62 1.86 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.762 2.308 . . . . 74.329999999999998 111.968 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.435 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 7.2 p -63.35 -17.52 19.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.424 0.63 . . . . 75.209999999999994 112.111 -173.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -120.35 42.38 2.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.682 0.753 . . . . 62.340000000000003 109.948 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.402 HD11 ' O ' ' B' ' 42' ' ' ILE . 2.5 pp -60.89 135.02 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.563 -1.255 . . . . 73.299999999999997 110.801 169.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -94.19 144.14 27.55 Favored Pre-proline 0 C--N 1.266 -3.025 0 N-CA-C 106.68 -1.6 . . . . 71.150000000000006 106.68 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.38 -20.7 69.44 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.352 2.035 . . . . 70.109999999999999 113.176 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.513 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -87.34 -10.74 51.38 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 118.966 -1.094 . . . . 71.019999999999996 111.999 -179.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . 0.437 ' HG2' ' HG2' ' A' ' 46' ' ' GLU . 33.5 mt-10 -67.07 -39.0 86.74 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.426 0.631 . . . . 53.229999999999997 109.811 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 90.9 mt -68.86 -29.97 68.39 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-N 115.445 -0.798 . . . . 54.43 109.393 176.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.569 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 39.9 t80 -66.99 -47.99 69.83 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.438 -0.801 . . . . 74.200000000000003 110.682 177.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 82.3 mt -63.69 -39.77 95.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.29 0.567 . . . . 72.209999999999994 110.327 -177.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 33.6 tp -76.82 -39.49 51.16 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.106 -0.952 . . . . 73.0 112.489 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -95.25 -0.87 52.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 114.175 1.176 . . . . 74.409999999999997 114.175 -176.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -63.13 -42.98 79.83 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 112.479 0.548 . . . . 53.450000000000003 112.479 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -65.93 -21.63 56.82 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.09 1.86 . . . . 42.210000000000001 112.226 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -92.24 88.23 6.39 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 121.753 0.787 . . . . 75.209999999999994 109.57 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -80.51 115.49 20.06 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 122.439 1.114 . . . . 71.239999999999995 111.361 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.01 -28.41 0.73 Allowed Glycine 0 C--N 1.284 -2.354 0 CA-C-N 112.657 -2.065 . . . . 71.200000000000003 108.742 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -48.6 121.88 4.99 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.818 1.247 . . . . 75.230000000000004 111.775 174.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -92.83 -56.71 2.9 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.546 -0.909 . . . . 72.299999999999997 108.546 174.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.54 -175.88 39.57 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 115.063 -0.971 . . . . 72.150000000000006 112.035 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 12.5 p -136.99 138.17 40.24 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 122.735 0.414 . . . . 61.100000000000001 111.086 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 57.8 tp -114.39 127.22 55.73 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.289 -1.004 . . . . 63.340000000000003 108.289 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 50.8 mm -93.99 143.37 11.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.232 -0.655 . . . . 61.450000000000003 109.232 -176.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -137.96 108.23 6.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.645 -0.872 . . . . 63.310000000000002 108.645 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -66.94 128.98 38.4 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.312 0.577 . . . . 74.150000000000006 109.834 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.8 m -125.72 158.15 35.57 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 104.584 -2.376 . . . . 73.140000000000001 104.584 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.68 -29.24 59.02 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.554 0.946 . . . . 74.239999999999995 113.554 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -85.92 -39.28 17.12 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.729 0.64 . . . . 75.400000000000006 112.729 177.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 3.7 pt20 -174.32 155.1 2.16 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 115.886 -0.597 . . . . 74.340000000000003 109.691 -169.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.435 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 58.4 Cg_endo -80.28 115.82 3.25 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 C-N-CA 122.357 2.038 . . . . 74.239999999999995 110.657 171.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -87.92 162.63 2.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.405 -0.961 . . . . 53.039999999999999 108.405 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.06 122.7 3.4 Favored Glycine 0 CA--C 1.491 -1.464 0 C-N-CA 118.689 -1.72 . . . . 73.409999999999997 113.555 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -87.93 108.99 19.46 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.541 -1.281 . . . . 72.120000000000005 107.541 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 67.9 t -103.54 120.66 53.9 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 115.698 -0.683 . . . . 74.329999999999998 110.285 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . 0.515 HD12 ' O ' ' B' ' 110' ' ' THR . 3.6 tt -96.54 130.82 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 115.169 -0.923 . . . . 75.319999999999993 110.06 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . 0.56 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 90.0 m-85 -111.13 156.56 21.18 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.906 -1.043 . . . . 65.439999999999998 108.326 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.74 -36.15 82.91 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.015 0.436 . . . . 60.539999999999999 112.089 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 33.0 p -131.84 163.41 28.33 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.411 0.624 . . . . 73.019999999999996 112.64 -175.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' B' ' 82' ' ' GLU . 4.4 mpt_? -73.94 -34.06 64.17 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 108.734 -0.839 . . . . 75.140000000000001 108.734 176.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.82 -19.84 64.29 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.01 -0.996 . . . . 72.409999999999997 109.564 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.16 -46.12 6.0 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.224 -1.151 . . . . 54.109999999999999 110.224 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.492 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -62.88 -45.1 94.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.3 -0.45 . . . . 63.240000000000002 111.705 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' B' ' 78' ' ' ARG . 9.6 pt-20 -63.56 -36.11 82.71 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 120.916 -0.314 . . . . 72.150000000000006 111.299 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.43 -41.85 79.72 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 120.839 0.352 . . . . 52.140000000000001 110.312 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.44 -42.31 87.84 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.72 -0.673 . . . . 63.409999999999997 111.227 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -70.96 -39.29 72.63 Favored 'General case' 0 C--O 1.203 -1.35 0 C-N-CA 119.407 -0.917 . . . . 72.409999999999997 110.999 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -65.68 -31.9 73.16 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.174 0.511 . . . . 61.43 110.764 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.06 -40.27 17.02 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 112.309 0.485 . . . . 71.0 112.309 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.521 ' O ' HG22 ' B' ' 91' ' ' ILE . 87.3 mt -100.99 -13.11 18.4 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 116.348 1.981 . . . . 70.030000000000001 116.348 -172.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -76.17 113.69 14.0 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 117.401 -1.72 . . . . 73.129999999999995 112.043 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 113.36 6.46 21.91 Favored Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 120.545 -0.836 . . . . 65.310000000000002 112.055 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.521 HG22 ' O ' ' B' ' 88' ' ' LEU . 14.9 tt -97.95 144.67 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.954 0 N-CA-C 107.117 -1.438 . . . . 72.329999999999998 107.117 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -79.42 138.36 37.6 Favored 'General case' 0 C--N 1.26 -3.296 0 CA-C-O 121.244 0.545 . . . . 71.230000000000004 111.471 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -69.17 -35.51 76.37 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 113.811 -1.54 . . . . 74.549999999999997 108.599 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.423 ' OD2' ' HD2' ' A' ' 45' ' ' ARG . 1.1 m-20 -129.36 130.13 23.3 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 102.306 -3.22 . . . . 73.040000000000006 102.306 172.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . 0.61 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 27.9 Cg_endo -61.29 -30.66 88.32 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.316 2.011 . . . . 75.329999999999998 113.39 -177.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -94.19 15.21 17.85 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 123.339 0.656 . . . . 65.239999999999995 111.276 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' ASN . . . . . 0.4 ' CB ' ' HB2' ' B' ' 94' ' ' ASP . 46.3 t30 -127.18 128.14 24.16 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.698 -0.853 . . . . 72.340000000000003 108.698 -177.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.55 9.82 1.15 Allowed 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.927 2.418 . . . . 53.329999999999998 113.25 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -83.83 110.34 18.28 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.894 -1.521 . . . . 70.319999999999993 106.894 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.469 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 65.5 p -102.72 141.09 36.11 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.798 -0.761 . . . . 74.299999999999997 110.365 -175.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 24.7 tp -86.17 126.1 33.99 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.272 -1.01 . . . . 72.140000000000001 108.272 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -131.05 121.68 25.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 109.437 -0.579 . . . . 62.439999999999998 109.437 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.68 116.59 32.27 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.126 -0.943 . . . . 72.510000000000005 109.829 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' GLU . . . . . 0.577 ' HB2' ' CE1' ' B' ' 34' ' ' PHE . 40.2 mm-40 -122.51 170.33 10.09 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.545 -1.65 . . . . 73.109999999999999 106.545 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -81.72 137.43 35.38 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 119.184 0.902 . . . . 72.349999999999994 109.738 176.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.66 151.13 27.72 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.176 0.512 . . . . 74.510000000000005 111.41 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -87.23 12.09 12.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.715 0.769 . . . . 41.229999999999997 109.996 177.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -137.69 115.42 11.38 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 107.524 -1.287 . . . . 70.25 107.524 177.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -84.05 106.96 16.11 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.464 -1.68 . . . . 71.340000000000003 106.464 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.515 ' O ' HD12 ' B' ' 74' ' ' ILE . 28.8 m . . . . . 0 C--N 1.3 -1.544 0 CA-C-N 116.245 -0.434 . . . . 51.32 110.834 -173.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 CA--C 1.508 -0.64 0 N-CA-C 109.288 -0.634 . . . . 75.310000000000002 109.288 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.87 136.35 50.6 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.382 -0.969 . . . . 74.430000000000007 108.382 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -52.29 144.45 12.78 Favored 'General case' 0 C--O 1.25 1.083 0 O-C-N 124.229 0.955 . . . . 73.209999999999994 112.842 -175.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.446 ' HA ' ' CD ' ' A' ' 78' ' ' ARG . 1.4 pp20? -78.04 96.01 4.99 Favored 'General case' 0 N--CA 1.385 -3.683 0 CA-C-O 122.318 1.056 . . . . 75.400000000000006 109.685 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.439 ' HB ' ' CD1' ' A' ' 105' ' ' PHE . 40.6 t -82.28 111.82 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 114.826 -1.079 . . . . 53.340000000000003 108.289 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -88.53 12.8 13.54 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.676 -0.693 . . . . 72.219999999999999 111.458 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.9 m -136.99 132.74 34.74 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 121.415 0.626 . . . . 60.310000000000002 112.462 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.4 mt -112.11 145.3 40.02 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.358 -0.979 . . . . 71.400000000000006 108.358 173.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -103.42 114.8 29.36 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 106.956 -1.498 . . . . 73.310000000000002 106.956 172.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG23 ' HG ' ' A' ' 103' ' ' LEU . 33.5 t -101.05 113.87 38.46 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 CA-C-N 114.144 -1.389 . . . . 64.230000000000004 108.643 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.6 p -111.4 171.61 7.38 Favored 'General case' 0 N--CA 1.41 -2.438 0 N-CA-C 109.104 -0.702 . . . . 64.519999999999996 109.104 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 88.04 29.13 21.27 Favored Glycine 0 N--CA 1.431 -1.652 0 C-N-CA 120.911 -0.661 . . . . 37.799999999999997 112.493 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 96.5 mt -93.07 125.83 53.39 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.671 -1.233 . . . . 72.230000000000004 107.671 173.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -50.21 153.41 6.91 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.484 2.123 . . . . 70.209999999999994 110.783 172.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.3 p -65.94 -12.91 14.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 123.152 0.581 . . . . 62.420000000000002 112.09 -172.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -126.77 41.67 3.47 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.904 0.859 . . . . 53.350000000000001 109.373 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 pp -59.17 145.5 10.84 Favored 'Isoleucine or valine' 0 C--O 1.25 1.115 0 C-N-CA 119.271 -0.972 . . . . 72.310000000000002 112.52 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.424 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 70.6 mmtt -98.94 146.22 31.3 Favored Pre-proline 0 C--N 1.271 -2.813 0 N-CA-C 107.31 -1.367 . . . . 72.030000000000001 107.31 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -59.45 -24.53 75.15 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.381 2.054 . . . . 74.019999999999996 111.866 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.532 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 13.9 ptt180 -78.13 -20.58 51.83 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.692 -0.686 . . . . 75.129999999999995 112.736 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 42.6 mt-10 -64.6 -38.74 92.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.221 0.534 . . . . 63.43 110.368 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -76.1 -22.17 55.86 Favored 'General case' 0 C--O 1.212 -0.907 0 CA-C-O 121.628 0.727 . . . . 65.450000000000003 109.934 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.532 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 62.9 t80 -73.5 -47.96 37.11 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.065 -0.97 . . . . 72.200000000000003 109.04 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.39 -38.84 74.75 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.655 -0.702 . . . . 75.430000000000007 110.175 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.9 tp -78.52 -37.08 43.92 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.46 -0.791 . . . . 61.420000000000002 112.719 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -97.05 1.04 49.65 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 118.898 -1.121 . . . . 63.229999999999997 113.598 -175.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -67.82 -42.93 36.44 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 114.049 1.129 . . . . 72.200000000000003 114.049 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -63.76 -20.11 68.17 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 121.478 1.452 . . . . 72.120000000000005 111.807 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -90.02 101.11 13.82 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 121.638 0.732 . . . . 74.200000000000003 110.834 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -64.41 110.4 2.26 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.345 -1.298 . . . . 65.200000000000003 110.642 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.47 -17.26 3.1 Favored Glycine 0 N--CA 1.425 -2.087 0 CA-C-N 115.015 -0.993 . . . . 62.149999999999999 113.326 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -62.4 107.9 1.01 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 118.001 0.901 . . . . 74.209999999999994 112.317 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -90.72 -43.92 9.8 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.49 -0.777 . . . . 74.409999999999997 110.648 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.91 171.88 43.29 Favored Glycine 0 C--N 1.301 -1.376 0 C-N-CA 120.797 -0.716 . . . . 54.439999999999998 111.674 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.8 p -138.57 137.34 36.91 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.85 0.325 . . . . 74.239999999999995 111.659 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.6 mp -112.83 121.63 45.27 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.561 -0.903 . . . . 65.349999999999994 108.561 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.5 mm -94.27 133.03 36.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 120.892 0.377 . . . . 74.319999999999993 110.14 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -118.06 106.88 13.35 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.708 -1.59 . . . . 73.519999999999996 106.708 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.73 131.19 42.77 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.893 -0.594 . . . . 73.150000000000006 109.663 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 18.8 m -129.7 153.01 48.58 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 104.486 -2.412 . . . . 72.310000000000002 104.486 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.5 -26.87 45.24 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 114.381 1.252 . . . . 42.450000000000003 114.381 -172.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -104.48 -25.64 12.71 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 113.268 0.84 . . . . 73.430000000000007 113.268 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.599 ' O ' ' HB ' ' A' ' 65' ' ' THR . 14.3 pt20 -172.55 136.54 0.82 Allowed Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.398 -0.593 . . . . 72.430000000000007 109.398 -173.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 44.8 Cg_endo -74.58 133.39 17.2 Favored 'Trans proline' 0 N--CA 1.43 -2.232 0 C-N-CA 121.956 1.771 . . . . 70.120000000000005 110.449 170.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m -101.78 143.54 14.5 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 N-CA-C 108.126 -1.065 . . . . 74.310000000000002 108.126 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.5 120.96 4.88 Favored Glycine 0 CA--C 1.479 -2.161 0 C-N-CA 119.807 -1.187 . . . . 73.109999999999999 112.719 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -87.69 102.8 14.99 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.769 -1.567 . . . . 72.519999999999996 106.769 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.9 t -97.69 123.8 50.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-N 114.984 -1.007 . . . . 65.319999999999993 110.036 -175.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.9 tt -95.86 131.51 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.108 0 CA-C-N 115.04 -0.982 . . . . 75.129999999999995 109.274 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.45 159.71 18.48 Favored 'General case' 0 N--CA 1.414 -2.25 0 CA-C-N 114.977 -1.01 . . . . 71.329999999999998 110.839 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -53.63 -44.93 69.93 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 125.646 1.578 . . . . 75.010000000000005 110.808 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.3 p -150.8 153.86 36.22 Favored 'General case' 0 N--CA 1.398 -3.067 0 CA-C-N 115.403 -0.817 . . . . 64.329999999999998 111.293 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.446 ' CD ' ' HA ' ' A' ' 29' ' ' GLU . 7.2 ttt-85 -58.74 -42.58 89.12 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 125.158 1.383 . . . . 74.340000000000003 110.2 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.66 -18.73 64.26 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.897 -1.047 . . . . 74.510000000000005 109.394 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.25 -45.26 5.37 Favored Glycine 0 C--N 1.294 -1.766 0 CA-C-N 113.626 -1.625 . . . . 61.299999999999997 110.455 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.54 -45.02 95.39 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.998 0.919 . . . . 51.039999999999999 111.584 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.08 -26.92 68.76 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.286 -0.416 . . . . 63.439999999999998 111.844 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.5 -39.52 27.81 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.16 0.505 . . . . 72.010000000000005 109.878 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.95 85.96 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.684 -0.689 . . . . 43.149999999999999 111.021 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.412 ' CE ' ' HA ' ' A' ' 104' ' ' GLU . 14.0 ptmm? -68.38 -28.08 66.79 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.281 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -64.43 -36.23 83.5 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.658 0.599 . . . . 73.439999999999998 110.904 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.25 -38.64 17.38 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 120.977 0.418 . . . . 63.119999999999997 111.916 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 91' ' ' ILE . 95.6 mt -96.94 -5.43 37.98 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 115.571 1.693 . . . . 60.140000000000001 115.571 -171.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -78.75 114.93 18.1 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 117.086 -1.845 . . . . 54.329999999999998 110.889 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.34 14.65 29.86 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 110.746 -0.942 . . . . 64.239999999999995 110.746 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.534 HG23 ' O ' ' A' ' 88' ' ' LEU . 10.2 tt -84.7 126.04 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.875 0 CA-C-O 121.632 0.73 . . . . 55.140000000000001 109.413 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -63.93 111.78 2.64 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 105.84 -1.911 . . . . 73.310000000000002 105.84 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -71.71 -25.78 62.22 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.947 0.88 . . . . 73.109999999999999 109.262 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -161.29 117.8 1.37 Allowed Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 106.583 -1.636 . . . . 72.310000000000002 106.583 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.08 -28.81 86.39 Favored 'Trans proline' 0 N--CA 1.474 0.349 0 C-N-CA 122.161 1.907 . . . . 74.439999999999998 112.862 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -74.71 -24.7 58.79 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.275 0.56 . . . . 71.129999999999995 110.899 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.431 ' C ' ' H ' ' A' ' 99' ' ' GLN . 46.4 t-20 -102.96 135.64 19.38 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.023 -1.473 . . . . 63.119999999999997 107.023 -177.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.97 15.06 0.62 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.306 2.004 . . . . 72.400000000000006 112.341 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 97' ' ' ASN . 5.9 tp60 -89.96 121.4 32.02 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.922 0.889 . . . . 72.439999999999998 110.334 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.497 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 66.2 p -114.59 142.47 46.39 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.128 -0.693 . . . . 73.010000000000005 109.128 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.9 tp -89.18 135.95 33.29 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.933 -0.766 . . . . 71.150000000000006 108.933 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -135.0 124.79 25.39 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.57 -0.529 . . . . 61.229999999999997 109.57 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.441 ' HG ' HG23 ' A' ' 35' ' ' VAL . 6.6 mp -110.84 118.33 35.84 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.059 -0.519 . . . . 63.439999999999998 109.866 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.412 ' HA ' ' CE ' ' A' ' 85' ' ' LYS . 7.7 mm-40 -126.61 161.29 28.39 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.936 -0.765 . . . . 72.019999999999996 108.936 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.439 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 27.1 m-85 -69.94 139.17 52.84 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.36 -0.536 . . . . 54.539999999999999 109.922 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.52 160.66 29.28 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 121.121 0.486 . . . . 65.019999999999996 110.004 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -77.16 -13.65 59.91 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.454 -0.794 . . . . 73.540000000000006 110.127 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.38 136.67 16.64 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.025 -0.989 . . . . 62.229999999999997 109.449 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -70.96 113.0 7.56 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.239 -1.393 . . . . 43.32 107.239 173.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.4 t -89.29 126.57 35.57 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.486 -0.931 . . . . 64.230000000000004 108.486 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 54.5 mtmt -90.39 81.88 5.97 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 113.098 0.777 . . . . 72.430000000000007 113.098 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 14.1 tpt -74.77 -53.19 9.64 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 105.439 -2.06 . . . . 70.430000000000007 105.439 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.61 115.81 28.01 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 103.707 -2.701 . . . . 70.510000000000005 103.707 168.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 111' ' ' LYS . 95.4 mttt -69.57 110.99 5.1 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 112.863 0.69 . . . . 70.519999999999996 112.863 -170.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.2 m -62.16 113.99 3.18 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.464 -1.244 . . . . 75.319999999999993 112.709 -176.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.03 140.08 6.4 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.408 -1.701 . . . . 71.400000000000006 106.408 172.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.8 tp -114.54 13.53 17.56 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.305 -0.958 . . . . 74.140000000000001 112.624 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 . . . . . 0 C--N 1.305 -1.346 0 N-CA-C 108.243 -1.021 . . . . 71.230000000000004 108.243 175.692 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 12.4 tpt . . . . . 0 CA--C 1.515 -0.404 0 N-CA-C 107.183 -1.414 . . . . 74.209999999999994 107.183 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -105.03 -73.13 0.69 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.802 -0.814 . . . . 54.340000000000003 108.802 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -123.22 105.41 9.86 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.842 -0.617 . . . . 65.120000000000005 109.696 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.426 ' HA ' ' HD2' ' B' ' 78' ' ' ARG . 7.9 pt-20 -70.17 96.23 1.06 Allowed 'General case' 0 N--CA 1.387 -3.615 0 CA-C-O 121.142 0.496 . . . . 74.219999999999999 112.238 175.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 60.1 t -79.45 110.05 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 N-CA-C 105.105 -2.183 . . . . 75.200000000000003 105.105 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -84.86 8.2 18.25 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 112.417 0.525 . . . . 61.340000000000003 112.417 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 28.9 m -127.85 129.27 46.66 Favored 'General case' 0 C--N 1.27 -2.857 0 C-N-CA 119.963 -0.695 . . . . 72.409999999999997 112.065 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -104.77 134.39 48.0 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.517 -1.29 . . . . 72.230000000000004 107.517 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.56 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 33.7 p90 -91.75 118.3 30.55 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 107.784 -1.191 . . . . 74.040000000000006 107.784 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG23 ' HG ' ' B' ' 103' ' ' LEU . 39.6 t -97.44 115.68 37.86 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 114.198 -1.364 . . . . 61.229999999999997 108.137 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 24.0 p -129.44 171.12 12.87 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 115.101 -0.954 . . . . 64.420000000000002 109.224 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 82.03 51.92 4.27 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 110.44 -1.064 . . . . 70.030000000000001 110.44 -173.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 95.7 mt -122.44 129.25 25.14 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.868 -1.16 . . . . 53.240000000000002 107.868 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -52.85 159.59 4.92 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 122.412 2.074 . . . . 72.109999999999999 110.978 171.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.68 -10.54 14.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.628 0.727 . . . . 74.120000000000005 111.301 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -127.02 40.83 3.64 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 122.158 0.98 . . . . 73.329999999999998 109.441 -176.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.443 HD11 ' O ' ' B' ' 42' ' ' ILE . 2.7 pp -64.46 134.19 29.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 118.686 -1.205 . . . . 71.530000000000001 110.666 170.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.42 141.99 26.55 Favored Pre-proline 0 C--N 1.273 -2.734 0 N-CA-C 108.672 -0.862 . . . . 71.430000000000007 108.672 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -51.78 -32.16 44.94 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.85 2.367 . . . . 74.519999999999996 112.429 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.492 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 12.0 ptt180 -68.44 -26.57 65.58 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 112.426 0.528 . . . . 62.240000000000002 112.426 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -65.13 -42.7 93.63 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.327 0.584 . . . . 71.209999999999994 109.539 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.38 -36.6 81.68 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 115.397 -0.82 . . . . 74.200000000000003 109.489 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.492 ' HB3' ' O ' ' B' ' 45' ' ' ARG . 76.2 t80 -61.01 -46.82 89.19 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.822 -1.081 . . . . 63.420000000000002 110.867 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 89.0 mt -66.62 -41.66 88.02 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.241 0.544 . . . . 55.049999999999997 109.826 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 29.2 tp -69.73 -44.2 70.77 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.667 -1.151 . . . . 72.329999999999998 112.117 -175.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -94.53 4.42 53.87 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 113.167 0.803 . . . . 61.329999999999998 113.167 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 28.2 ttt180 -69.5 -43.77 23.55 Favored Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 112.976 0.732 . . . . 75.150000000000006 112.976 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -76.23 -2.47 12.66 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 121.45 1.434 . . . . 74.439999999999998 112.033 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -94.6 103.12 15.06 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 121.833 0.825 . . . . 70.319999999999993 111.556 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -68.19 118.17 10.97 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 114.103 -1.408 . . . . 65.150000000000006 110.793 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.07 -19.7 4.33 Favored Glycine 0 C--N 1.281 -2.472 0 CA-C-N 115.005 -0.998 . . . . 73.519999999999996 112.695 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -58.4 113.22 1.87 Allowed 'General case' 0 C--O 1.242 0.672 0 CA-C-N 117.301 0.55 . . . . 70.420000000000002 111.663 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -95.46 -58.97 1.98 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.58 -0.736 . . . . 74.010000000000005 110.344 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.6 160.2 32.92 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 120.041 -1.076 . . . . 72.200000000000003 113.095 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.3 p -119.33 137.95 53.37 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 122.702 0.401 . . . . 62.420000000000002 110.814 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 66.9 tp -111.31 111.3 22.25 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.882 -1.155 . . . . 75.540000000000006 107.882 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 51.0 mm -94.61 136.38 26.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 109.732 -0.47 . . . . 63.409999999999997 109.732 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -133.19 114.84 14.3 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.477 -0.935 . . . . 74.439999999999998 108.477 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.06 113.95 8.63 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.959 -1.126 . . . . 75.150000000000006 107.959 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.9 m -105.93 167.56 9.71 Favored 'General case' 0 N--CA 1.403 -2.807 0 N-CA-C 107.023 -1.473 . . . . 72.530000000000001 107.023 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.76 -33.42 23.11 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.675 0.991 . . . . 71.120000000000005 113.675 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -105.18 -37.78 6.78 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 119.724 -0.79 . . . . 71.530000000000001 112.424 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -155.25 159.68 31.53 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 110.203 -0.295 . . . . 73.430000000000007 110.203 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.24 123.29 7.09 Favored 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.218 1.945 . . . . 65.329999999999998 109.636 167.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 35.9 m -97.58 156.84 3.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 107.461 -1.311 . . . . 64.239999999999995 107.461 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.03 121.94 2.58 Favored Glycine 0 C--O 1.203 -1.798 0 C-N-CA 118.237 -1.935 . . . . 50.329999999999998 113.492 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -88.42 108.36 19.33 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.78 -1.193 . . . . 60.539999999999999 107.78 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.62 120.11 53.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-N 116.184 -0.462 . . . . 74.109999999999999 110.473 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 11.8 tt -96.32 134.8 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 115.559 -0.746 . . . . 73.409999999999997 110.478 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -111.29 149.58 30.87 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 114.621 -1.172 . . . . 74.200000000000003 109.821 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -56.27 -34.35 66.34 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.727 1.211 . . . . 61.32 111.453 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 9.9 p -144.56 138.3 27.4 Favored 'General case' 0 N--CA 1.398 -3.027 0 CA-C-O 121.953 0.883 . . . . 73.400000000000006 110.634 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -74.9 -25.57 59.03 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 114.494 -1.23 . . . . 75.209999999999994 110.453 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.1 -19.68 64.06 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.532 1.158 . . . . 73.329999999999998 108.654 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.26 -43.2 5.66 Favored Glycine 0 C--N 1.308 -1.0 0 CA-C-N 113.786 -1.552 . . . . 51.200000000000003 109.922 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.41 -37.64 78.55 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.989 0.916 . . . . 52.210000000000001 112.02 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.04 -34.53 76.41 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.864 0.364 . . . . 62.329999999999998 111.44 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.25 -38.12 27.43 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.295 0.569 . . . . 72.430000000000007 109.804 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.2 93.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.872 -1.058 . . . . 61.439999999999998 111.202 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -65.6 -41.01 93.28 Favored 'General case' 0 C--O 1.195 -1.815 0 CA-C-N 116.258 -0.428 . . . . 75.200000000000003 110.647 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -63.68 -24.73 67.9 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 112.359 0.503 . . . . 74.239999999999995 112.359 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.54 -36.02 33.67 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 120.811 0.339 . . . . 64.420000000000002 111.156 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.489 ' O ' HG21 ' B' ' 91' ' ' ILE . 98.6 mt -102.14 -19.92 14.93 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 115.222 1.564 . . . . 74.040000000000006 115.222 -174.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . 0.259 0.2 OUTLIER -75.65 113.95 13.67 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 118.92 -1.112 . . . . 62.350000000000001 112.616 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.04 14.99 13.51 Favored Glycine 0 N--CA 1.41 -3.035 0 CA-C-N 115.554 -0.748 . . . . 61.399999999999999 111.74 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.489 HG21 ' O ' ' B' ' 88' ' ' LEU . 15.7 tt -95.93 133.89 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.977 0 N-CA-C 108.964 -0.754 . . . . 74.349999999999994 108.964 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -62.82 119.3 9.09 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 105.117 -2.179 . . . . 74.329999999999998 105.117 172.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -68.18 -31.12 70.44 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 108.418 -0.956 . . . . 74.310000000000002 108.418 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.481 ' CB ' ' HB3' ' A' ' 45' ' ' ARG . 1.0 OUTLIER -166.47 137.42 2.76 Favored Pre-proline 0 N--CA 1.427 -1.616 0 N-CA-C 106.709 -1.589 . . . . 74.420000000000002 106.709 174.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.1 -2.81 12.88 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.132 1.888 . . . . 71.230000000000004 113.237 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -85.63 -24.92 26.91 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.75 0.786 . . . . 71.540000000000006 109.532 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' ASN . . . . . 0.533 ' OD1' ' HB2' ' B' ' 99' ' ' GLN . 6.6 t-20 -110.45 148.17 37.88 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 106.004 -1.85 . . . . 73.439999999999998 106.004 174.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.05 22.1 0.77 Allowed 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 122.529 2.153 . . . . 65.129999999999995 112.045 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLN . . . . . 0.533 ' HB2' ' OD1' ' B' ' 97' ' ' ASN . 5.5 tp60 -89.41 129.29 35.95 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.948 0.899 . . . . 63.219999999999999 110.802 -176.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.564 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 36.8 p -116.52 138.32 51.49 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.731 -0.47 . . . . 54.229999999999997 109.731 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 49.3 tp -86.09 131.1 34.33 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.045 -0.724 . . . . 73.120000000000005 109.045 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -135.82 122.63 21.15 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-O 120.834 0.35 . . . . 74.019999999999996 110.31 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.408 ' HG ' HG23 ' B' ' 35' ' ' VAL . 6.2 mp -108.27 116.27 31.66 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.841 -1.17 . . . . 74.219999999999999 107.841 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.56 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 7.4 tp10 -131.72 159.6 37.94 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.625 -1.62 . . . . 61.409999999999997 106.625 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -68.93 137.19 53.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 119.561 1.073 . . . . 71.319999999999993 110.859 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.63 164.28 26.46 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.92 -0.582 . . . . 74.439999999999998 110.232 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -84.72 -9.86 57.81 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.76 0.791 . . . . 71.310000000000002 109.114 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.44 130.09 19.09 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.208 -0.905 . . . . 63.240000000000002 109.892 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -70.26 104.55 2.69 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.854 -1.165 . . . . 64.409999999999997 107.854 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 13.0 m -92.37 101.99 14.46 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.665 -0.698 . . . . 62.310000000000002 109.57 -172.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -77.93 83.62 4.24 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.029 0.919 . . . . 72.25 111.284 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 14.7 tpt -96.68 24.04 6.41 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.533 -1.212 . . . . 72.219999999999999 107.888 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -140.31 119.08 12.45 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.491 -1.231 . . . . 63.130000000000003 107.791 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -71.99 108.51 5.27 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.642 0.589 . . . . 73.430000000000007 109.977 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 41.9 p -142.14 139.55 32.18 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.405 -0.361 . . . . 54.149999999999999 110.263 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -130.89 159.13 38.32 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.468 -0.938 . . . . 74.519999999999996 108.468 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 33.3 tp -108.13 20.05 19.18 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.922 -0.77 . . . . 72.150000000000006 108.922 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 . . . . . 0 C--N 1.318 -0.794 0 N-CA-C 108.038 -1.097 . . . . 52.310000000000002 108.038 177.024 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.578 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 96.2 mmm . . . . . 0 C--O 1.207 -1.153 0 N-CA-C 110.472 -0.196 . . . . 75.310000000000002 110.472 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.528 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 44.6 mt-10 -89.57 62.04 5.75 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 121.067 -1.021 . . . . 54.140000000000001 112.197 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 27' ' ' GLU . 15.1 mt-10 -171.12 30.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 126.304 1.842 . . . . 64.200000000000003 110.572 175.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.58 ' OE1' ' HD3' ' A' ' 78' ' ' ARG . 43.0 mm-40 -70.61 106.74 3.61 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.603 -1.18 . . . . 72.109999999999999 108.934 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.3 t -77.49 109.02 11.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 103.859 -2.645 . . . . 54.009999999999998 103.859 167.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 75' ' ' PHE . 26.6 ptt180 -129.64 7.97 5.32 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.793 -0.64 . . . . 73.519999999999996 112.461 -168.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.3 m -104.89 124.48 49.55 Favored 'General case' 0 C--N 1.266 -3.04 0 C-N-CA 119.77 -0.772 . . . . 70.120000000000005 109.236 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 93.7 mt -104.75 136.78 43.63 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.745 -1.205 . . . . 64.140000000000001 107.745 176.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 20.4 p90 -98.32 118.98 36.18 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.27 -1.382 . . . . 74.239999999999995 107.27 174.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.431 HG22 ' HG ' ' A' ' 103' ' ' LEU . 19.5 t -99.79 111.01 28.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 114.531 -1.213 . . . . 61.530000000000001 108.365 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.7 p -110.01 175.33 5.48 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 108.57 -0.9 . . . . 73.109999999999999 108.57 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 97.42 1.33 59.2 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.757 -0.735 . . . . 54.210000000000001 111.659 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.5 mt -77.06 139.05 65.03 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 108.373 -0.973 . . . . 42.32 108.373 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.415 ' C ' ' H ' ' A' ' 41' ' ' ASP . 54.7 Cg_endo -69.74 170.38 16.69 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.726 1.617 . . . . 75.530000000000001 111.383 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 p -78.69 7.54 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-O 122.67 1.224 . . . . 60.409999999999997 109.403 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 39' ' ' PRO . 24.4 t70 -115.93 7.94 14.55 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.042 -1.436 . . . . 75.519999999999996 109.481 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.32 125.3 18.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.962 0.887 . . . . 55.25 110.813 -176.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -109.96 142.04 25.05 Favored Pre-proline 0 C--N 1.289 -2.043 0 CA-C-N 114.198 -1.365 . . . . 75.049999999999997 109.356 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.48 -25.08 30.72 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.63 2.886 . . . . 51.240000000000002 113.56 -176.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.525 ' HB3' ' OD2' ' B' ' 94' ' ' ASP . 23.7 ptt180 -66.63 -28.17 68.26 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 121.067 0.461 . . . . 75.420000000000002 111.464 -178.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -71.48 -38.2 71.23 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.143 0.497 . . . . 70.510000000000005 110.666 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.76 -38.65 73.47 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 108.544 -0.91 . . . . 73.010000000000005 108.544 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.547 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 12.2 t80 -57.93 -49.05 78.08 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.756 -1.111 . . . . 73.409999999999997 111.087 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 97.1 mt -62.84 -41.31 99.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.075 0.464 . . . . 54.310000000000002 110.707 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.9 tp -73.46 -40.92 63.78 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.315 -0.857 . . . . 62.539999999999999 111.609 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -90.79 -5.69 55.31 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 114.543 1.312 . . . . 73.109999999999999 114.543 -175.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 13.1 mtp180 -58.36 -48.38 97.09 Favored Pre-proline 0 N--CA 1.481 1.091 0 N-CA-C 113.417 0.895 . . . . 73.239999999999995 113.417 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.57 -16.84 52.05 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 121.472 1.448 . . . . 72.549999999999997 112.494 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -91.03 86.31 6.21 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.327 0.584 . . . . 63.25 110.147 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -70.48 115.99 10.29 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 122.213 1.006 . . . . 71.109999999999999 109.544 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.14 -23.08 2.08 Favored Glycine 0 C--N 1.287 -2.172 0 CA-C-N 113.81 -1.541 . . . . 70.340000000000003 109.556 -173.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -57.37 109.55 0.7 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.206 1.002 . . . . 62.310000000000002 111.343 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -88.15 -47.52 8.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.525 0.679 . . . . 54.229999999999997 109.679 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.46 170.95 44.08 Favored Glycine 0 C--N 1.297 -1.618 0 C-N-CA 120.147 -1.025 . . . . 71.120000000000005 112.833 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.4 p -131.59 138.03 48.68 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 122.653 0.381 . . . . 75.329999999999998 110.144 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -115.66 118.29 32.66 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.468 -1.678 . . . . 72.319999999999993 106.468 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -93.52 133.84 33.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.881 -1.155 . . . . 73.209999999999994 107.881 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -127.97 117.74 22.29 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.191 -1.04 . . . . 73.230000000000004 108.191 -175.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.37 111.31 4.56 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.055 -1.091 . . . . 75.109999999999999 108.055 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.8 m -116.03 168.24 10.26 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.826 -0.805 . . . . 53.32 108.826 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.28 -29.93 10.76 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.789 1.235 . . . . 72.219999999999999 114.196 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -104.11 -47.2 4.23 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.989 -0.684 . . . . 74.540000000000006 111.16 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -155.93 153.24 25.41 Favored Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-N 115.48 -0.782 . . . . 65.109999999999999 109.527 -167.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -68.72 105.65 1.34 Allowed 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 122.047 1.832 . . . . 74.010000000000005 108.765 167.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -86.08 162.8 2.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 108.206 -1.035 . . . . 71.129999999999995 108.206 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.33 120.2 3.3 Favored Glycine 0 CA--C 1.486 -1.751 0 C-N-CA 117.91 -2.091 . . . . 64.230000000000004 113.072 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -89.0 104.8 17.32 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.39 -1.337 . . . . 72.230000000000004 107.39 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.3 t -99.9 118.34 46.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 115.765 -0.652 . . . . 73.409999999999997 110.289 -176.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 tt -97.69 127.6 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 CA-C-O 121.909 0.861 . . . . 64.5 110.32 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.417 ' O ' ' HD2' ' A' ' 31' ' ' ARG . 73.2 m-85 -102.86 166.18 10.62 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 114.515 -1.22 . . . . 73.239999999999995 110.144 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.03 -47.73 74.34 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.972 -1.013 . . . . 73.329999999999998 112.565 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 p -146.13 165.12 30.06 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.615 -0.721 . . . . 51.340000000000003 111.082 -172.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.58 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -70.35 -32.12 69.69 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.628 -0.508 . . . . 74.019999999999996 109.628 -178.016 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.63 -20.41 65.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 122.199 1.0 . . . . 53.130000000000003 109.552 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.06 -42.43 6.3 Favored Glycine 0 C--N 1.299 -1.492 0 CA-C-N 114.253 -1.34 . . . . 75.299999999999997 110.417 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.22 -42.86 88.12 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 123.167 0.587 . . . . 75.120000000000005 111.48 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.18 -42.76 91.59 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 111.637 0.236 . . . . 74.109999999999999 111.637 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.4 -36.85 68.77 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-O 121.031 0.444 . . . . 72.019999999999996 111.098 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.42 -39.64 77.75 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.491 -0.777 . . . . 54.119999999999997 111.346 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -68.18 -37.13 80.63 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 120.1 -0.64 . . . . 74.299999999999997 110.147 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -58.27 -38.16 76.41 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 123.47 0.481 . . . . 73.340000000000003 111.286 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.66 -41.66 26.42 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 116.387 -0.37 . . . . 64.109999999999999 111.601 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.476 ' O ' HG22 ' A' ' 91' ' ' ILE . 99.0 mt -88.97 -22.17 23.17 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 116.212 1.93 . . . . 73.420000000000002 116.212 -173.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.78 113.15 8.52 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 117.904 -1.519 . . . . 65.239999999999995 109.888 176.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.77 11.98 13.53 Favored Glycine 0 N--CA 1.408 -3.222 0 CA-C-N 115.411 -0.813 . . . . 44.119999999999997 111.478 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.5 tt -94.45 133.75 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 N-CA-C 107.441 -1.318 . . . . 63.329999999999998 107.441 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 59.5 ttt180 -97.43 126.86 42.93 Favored 'General case' 0 C--N 1.251 -3.696 0 N-CA-C 109.15 -0.685 . . . . 72.109999999999999 109.15 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.13 -32.84 74.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.593 -1.185 . . . . 75.530000000000001 110.418 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.499 ' OD2' ' HB3' ' B' ' 45' ' ' ARG . 1.5 m-20 -147.73 126.49 6.2 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 103.938 -2.616 . . . . 61.530000000000001 103.938 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.613 ' HD3' ' CZ ' ' B' ' 48' ' ' TYR . 30.6 Cg_endo -67.69 -12.76 36.63 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 CA-C-N 121.279 1.492 . . . . 75.519999999999996 111.217 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -91.46 -0.65 57.65 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.194 -0.912 . . . . 73.310000000000002 111.01 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.494 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 18.7 t30 -117.41 127.14 26.87 Favored Pre-proline 0 C--O 1.213 -0.853 0 N-CA-C 108.387 -0.968 . . . . 65.120000000000005 108.387 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.07 -12.18 33.42 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.398 2.732 . . . . 62.219999999999999 114.927 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -94.68 158.63 15.43 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 119.804 -0.758 . . . . 73.430000000000007 110.209 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.404 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 49.6 p -135.95 161.09 36.62 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.712 -1.218 . . . . 74.420000000000002 107.712 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 mp -90.43 129.74 36.58 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.186 0.517 . . . . 74.129999999999995 110.42 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -124.37 110.52 14.67 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.178 -1.416 . . . . 64.109999999999999 107.178 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.431 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.6 mp -98.58 122.51 41.88 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.405 -0.816 . . . . 74.019999999999996 109.846 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.496 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 37.3 tt0 -130.94 157.57 42.6 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.864 -1.532 . . . . 64.109999999999999 106.864 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -65.71 139.97 58.42 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 118.458 0.572 . . . . 73.519999999999996 109.586 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.14 157.27 32.98 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.958 -0.756 . . . . 73.310000000000002 108.958 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -88.61 0.69 56.13 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 122.124 0.964 . . . . 75.319999999999993 109.216 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.35 124.97 3.76 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.749 -1.114 . . . . 64.310000000000002 108.113 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -64.78 124.15 21.21 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.463 0.649 . . . . 63.450000000000003 110.891 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.8 m -103.26 102.57 12.54 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 108.097 -1.075 . . . . 71.430000000000007 108.097 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -72.88 154.48 40.57 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.612 -1.177 . . . . 62.530000000000001 113.231 -174.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -84.54 169.28 14.6 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 104.876 -2.268 . . . . 74.5 104.876 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.76 102.75 0.07 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.182 0.901 . . . . 40.229999999999997 110.673 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -144.82 116.67 8.24 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.7 -0.852 . . . . 74.019999999999996 108.7 -174.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 37.1 t -88.25 106.06 17.96 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.775 -0.824 . . . . 71.109999999999999 108.775 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -90.24 -20.34 23.1 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.028 -0.73 . . . . 75.219999999999999 109.028 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.6 tp 67.32 99.12 0.05 Allowed 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.775 1.23 . . . . 63.219999999999999 110.723 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 . . . . . 0 C--N 1.321 -0.65 0 C-N-CA 124.612 1.165 . . . . 52.25 109.877 -179.924 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 110.384 -0.228 . . . . 73.099999999999994 110.384 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -89.97 104.52 17.08 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.217 -0.66 . . . . 63.32 109.217 -174.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 56.72 61.81 2.5 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.931 0.892 . . . . 73.030000000000001 113.363 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.416 ' CD ' HH11 ' B' ' 78' ' ' ARG . 9.6 mm-40 -66.01 115.11 5.72 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 105.644 -1.984 . . . . 74.010000000000005 105.644 170.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 97.5 t -70.81 109.07 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 103.692 -2.707 . . . . 70.349999999999994 103.692 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.587 ' HB2' ' O ' ' B' ' 75' ' ' PHE . 16.1 ptm180 -123.53 17.9 9.65 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-N 114.655 -1.157 . . . . 63.310000000000002 110.974 -164.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 29.9 m -124.67 121.56 35.04 Favored 'General case' 0 C--N 1.273 -2.739 0 C-N-CA 119.554 -0.858 . . . . 73.219999999999999 110.104 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 87.9 mt -103.48 137.23 41.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.196 -1.039 . . . . 75.340000000000003 108.196 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -98.88 113.99 26.37 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 106.762 -1.57 . . . . 73.219999999999999 106.762 175.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.422 HG21 ' HG ' ' B' ' 103' ' ' LEU . 22.0 t -99.69 112.56 32.42 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.665 0 CA-C-N 114.429 -1.259 . . . . 55.340000000000003 108.4 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' B' ' 101' ' ' LEU . 48.9 p -111.48 169.46 8.79 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 108.626 -0.879 . . . . 73.140000000000001 108.626 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.526 ' HA2' ' CD ' ' B' ' 99' ' ' GLN . . . 109.68 -6.65 31.49 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 120.421 -0.895 . . . . 70.049999999999997 111.655 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 55.1 mt -75.8 133.71 72.84 Favored Pre-proline 0 N--CA 1.428 -1.572 0 CA-C-N 114.253 -0.974 . . . . 64.530000000000001 108.812 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.49 170.68 16.87 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.095 1.863 . . . . 51.009999999999998 110.715 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.496 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 8.2 p -70.92 -11.51 15.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.446 0.641 . . . . 73.340000000000003 111.623 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.471 ' CG ' ' HZ3' ' B' ' 43' ' ' LYS . 21.9 t70 -112.55 27.28 9.77 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.961 0.886 . . . . 65.129999999999995 108.894 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.58 126.59 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-O 121.566 0.698 . . . . 73.530000000000001 109.4 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.471 ' HZ3' ' CG ' ' B' ' 41' ' ' ASP . 9.8 mptt -101.34 141.53 22.78 Favored Pre-proline 0 C--N 1.299 -1.608 0 CA-C-N 115.707 -0.678 . . . . 60.43 111.08 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -51.0 -25.42 16.18 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.628 2.886 . . . . 61.229999999999997 114.199 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.499 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 15.3 ptt-85 -66.35 -32.27 73.57 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 120.864 0.364 . . . . 75.049999999999997 111.019 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -69.24 -34.48 74.88 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.923 -0.58 . . . . 72.349999999999994 109.973 -174.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.411 ' O ' ' HD2' ' B' ' 51' ' ' PHE . 97.3 mt -74.65 -44.07 52.2 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.47 0.652 . . . . 62.109999999999999 109.454 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.613 ' CZ ' ' HD3' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -57.81 -43.32 85.61 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.976 -1.011 . . . . 74.040000000000006 112.071 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.55 -42.81 98.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.891 0.377 . . . . 73.310000000000002 111.015 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.3 tp -71.65 -42.68 67.25 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.284 -0.871 . . . . 65.049999999999997 111.657 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . 0.411 ' HD2' ' O ' ' B' ' 47' ' ' LEU . 81.4 m-85 -85.42 -4.74 59.25 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.993 1.479 . . . . 73.329999999999998 114.993 -175.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.605 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 26.2 mtp180 -51.81 -50.05 80.01 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 114.16 1.17 . . . . 75.25 114.16 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.51 -0.88 10.64 Favored 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 121.873 1.715 . . . . 74.120000000000005 114.046 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . 0.264 69.8 m-85 -87.67 134.92 33.57 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 115.519 1.674 . . . . 71.120000000000005 115.519 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -67.12 109.24 2.96 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.262 -1.79 . . . . 72.519999999999996 112.455 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' B' ' 75' ' ' PHE . . . 106.38 -7.59 40.14 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 115.531 -0.759 . . . . 44.520000000000003 113.467 171.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -59.94 106.98 0.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.406 0.622 . . . . 72.409999999999997 112.54 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -99.24 -44.58 6.19 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.692 -0.686 . . . . 72.209999999999994 110.849 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.91 -178.88 41.78 Favored Glycine 0 C--N 1.302 -1.318 0 C-N-CA 119.429 -1.367 . . . . 71.25 113.569 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.7 p -139.86 137.67 35.09 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.162 0.585 . . . . 74.25 111.158 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.51 116.51 28.31 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.301 -1.0 . . . . 73.310000000000002 108.301 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.51 133.27 35.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.663 -0.866 . . . . 37.899999999999999 108.663 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' B' ' 69' ' ' PRO . 12.1 tmtt? -125.31 115.29 20.12 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.364 -1.347 . . . . 53.329999999999998 107.364 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.15 130.74 39.71 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.09 -0.504 . . . . 73.109999999999999 109.872 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 3.4 m -124.52 164.82 18.97 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.885 -1.154 . . . . 74.329999999999998 107.885 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.58 -31.5 36.49 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.53 0.937 . . . . 63.229999999999997 113.53 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -99.22 -52.41 3.53 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.897 -0.721 . . . . 74.230000000000004 111.484 176.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -154.16 145.86 16.85 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 115.781 -0.645 . . . . 75.120000000000005 111.156 -170.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.496 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 60.2 Cg_endo -75.62 124.8 8.49 Favored 'Trans proline' 0 N--CA 1.436 -1.88 0 C-N-CA 122.93 2.42 . . . . 60.219999999999999 111.621 174.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 m -93.84 155.11 3.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 114.977 -1.011 . . . . 65.120000000000005 108.442 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.32 120.51 4.23 Favored Glycine 0 CA--C 1.486 -1.756 0 C-N-CA 119.032 -1.556 . . . . 61.420000000000002 112.811 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -89.7 102.77 15.46 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.608 -1.256 . . . . 72.209999999999994 107.608 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 68.8 t -92.67 123.94 44.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 115.79 -0.641 . . . . 64.430000000000007 109.584 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 13.7 tt -101.53 129.21 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.328 0 CA-C-O 122.297 1.046 . . . . 75.150000000000006 111.074 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' B' ' 31' ' ' ARG . 91.9 m-85 -109.81 160.43 16.35 Favored 'General case' 0 N--CA 1.404 -2.759 0 CA-C-N 113.217 -1.81 . . . . 71.099999999999994 107.993 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . 0.465 ' HA ' ' NH2' ' B' ' 31' ' ' ARG . 34.7 t70 -73.09 -33.31 65.53 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.276 0.56 . . . . 72.400000000000006 111.843 176.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 12.4 p -128.73 158.81 37.56 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 116.258 -0.428 . . . . 52.310000000000002 111.641 -174.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . 0.416 HH11 ' CD ' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -80.48 -27.78 37.73 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.476 -0.889 . . . . 63.450000000000003 108.662 177.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.07 -24.91 61.58 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.977 0.894 . . . . 61.219999999999999 108.764 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.12 -44.75 28.3 Favored Glycine 0 C--N 1.31 -0.895 0 N-CA-C 109.62 -1.392 . . . . 37.899999999999999 109.62 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.6 -44.95 95.03 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.766 -0.717 . . . . 73.319999999999993 111.736 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -66.96 -28.28 68.15 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.495 0.554 . . . . 74.109999999999999 112.495 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.95 -46.84 32.9 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.119 -0.491 . . . . 71.099999999999994 110.172 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.97 92.6 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.53 -0.759 . . . . 74.040000000000006 111.678 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.467 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 14.2 ptmm? -69.49 -34.38 74.24 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 120.024 -0.67 . . . . 74.109999999999999 110.147 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -62.84 -32.24 73.42 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 121.129 0.49 . . . . 74.420000000000002 110.405 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.78 -32.48 19.07 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 112.541 0.571 . . . . 74.400000000000006 112.541 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.454 ' O ' HG22 ' B' ' 91' ' ' ILE . 91.7 mt -101.66 -25.19 13.95 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 116.603 2.075 . . . . 72.310000000000002 116.603 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . 0.268 0.2 OUTLIER -68.69 113.92 6.6 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 118.06 -1.456 . . . . 61.530000000000001 112.615 -176.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.2 6.47 15.82 Favored Glycine 0 N--CA 1.419 -2.451 0 C-N-CA 120.791 -0.719 . . . . 54.409999999999997 111.872 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.454 HG22 ' O ' ' B' ' 88' ' ' LEU . 12.2 tt -96.61 146.73 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.361 0 N-CA-C 107.735 -1.209 . . . . 42.409999999999997 107.735 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.425 ' CG ' HG23 ' B' ' 100' ' ' THR . 97.7 mtt180 -89.47 140.89 29.07 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-O 121.333 0.587 . . . . 72.319999999999993 112.342 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -73.27 -31.41 64.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.834 -1.53 . . . . 73.120000000000005 109.182 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.525 ' OD2' ' HB3' ' A' ' 45' ' ' ARG 0.266 4.8 m-20 -142.67 137.27 15.1 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 104.113 -2.551 . . . . 74.140000000000001 104.113 176.343 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . 0.545 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 19.0 Cg_endo -64.09 -19.51 66.32 Favored 'Trans proline' 0 CA--C 1.55 1.291 0 CA-C-N 121.064 1.416 . . . . 72.040000000000006 109.631 168.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -72.14 -24.98 61.54 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.109 1.764 . . . . 74.209999999999994 109.609 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -94.91 126.84 45.37 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 115.189 -0.914 . . . . 73.239999999999995 109.769 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.19 -6.25 14.76 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.937 2.425 . . . . 74.510000000000005 112.689 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' GLN . . . . . 0.526 ' CD ' ' HA2' ' B' ' 37' ' ' GLY . 8.7 tt0 -99.0 162.11 13.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.571 -0.9 . . . . 74.030000000000001 108.571 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.448 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 82.6 p -125.64 164.25 21.0 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.513 -0.551 . . . . 74.430000000000007 109.513 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' B' ' 36' ' ' SER . 5.3 mp -85.8 117.33 24.6 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 107.012 -1.477 . . . . 54.43 107.012 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -113.44 107.34 15.71 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 107.725 -1.213 . . . . 73.310000000000002 107.725 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.422 ' HG ' HG21 ' B' ' 35' ' ' VAL . 5.0 mp -90.22 116.45 28.21 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.572 -1.27 . . . . 61.119999999999997 107.572 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.467 ' HA ' ' CE ' ' B' ' 85' ' ' LYS . 12.1 tp10 -135.22 162.88 31.29 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.88 -1.156 . . . . 72.329999999999998 107.88 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -69.07 137.28 53.41 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 118.71 0.687 . . . . 75.010000000000005 111.84 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.95 156.03 32.27 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 109.169 -0.678 . . . . 71.030000000000001 109.169 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -78.13 -8.61 58.48 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.908 0.861 . . . . 42.450000000000003 109.624 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.2 130.98 9.95 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.164 -0.925 . . . . 75.239999999999995 108.77 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.403 ' ND2' ' HG2' ' B' ' 31' ' ' ARG . 6.5 m-20 -63.74 132.49 51.16 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.549 -0.75 . . . . 62.229999999999997 110.003 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 33.4 m -120.4 116.36 25.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.357 -0.979 . . . . 53.219999999999999 108.357 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' B' ' 111' ' ' LYS . 0.0 OUTLIER -89.21 158.15 17.98 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.66 -0.7 . . . . 73.129999999999995 110.543 -177.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -93.03 99.76 12.31 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 110.014 -0.365 . . . . 73.530000000000001 110.014 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . 39.5 72.28 0.15 Allowed 'General case' 0 C--O 1.246 0.921 0 C-N-CA 125.347 1.459 . . . . 72.400000000000006 113.247 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -130.48 130.91 44.81 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 116.112 -0.495 . . . . 74.319999999999993 109.671 -173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 33.1 t -126.65 104.46 8.11 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.127 -1.434 . . . . 73.319999999999993 107.127 175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . 0.415 ' HZ1' ' C ' ' B' ' 118' ' ' GLU . 18.9 pttp -83.08 -16.1 48.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.093 -0.503 . . . . 54.420000000000002 112.236 -175.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 tt 58.74 32.58 22.34 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.567 1.147 . . . . 72.319999999999993 109.922 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . 0.415 ' C ' ' HZ1' ' B' ' 116' ' ' LYS . 53.9 tp10 . . . . . 0 C--N 1.317 -0.807 0 N-CA-C 106.603 -1.629 . . . . 74.439999999999998 106.603 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 CA--C 1.501 -0.917 0 CA-C-O 121.212 0.53 . . . . 75.310000000000002 109.928 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -117.64 141.34 48.49 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 106.144 -1.798 . . . . 71.319999999999993 106.144 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -84.2 78.0 9.86 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.389 1.09 . . . . 72.150000000000006 111.066 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -96.33 -177.41 3.95 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.717 -1.583 . . . . 74.140000000000001 110.373 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.465 ' HA ' HD22 ' A' ' 109' ' ' ASN . 17.8 t -56.66 111.39 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 113.184 0.809 . . . . 74.329999999999998 113.184 -164.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 42.4 mtt180 -99.43 -25.16 14.55 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-O 122.363 1.078 . . . . 71.230000000000004 109.349 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.4 m -98.11 138.24 35.7 Favored 'General case' 0 C--N 1.26 -3.291 0 CA-C-N 113.549 -1.659 . . . . 71.450000000000003 113.6 -167.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.8 mt -124.57 142.8 51.08 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 114.018 -1.447 . . . . 74.140000000000001 108.325 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.474 ' CE1' ' HB3' ' A' ' 104' ' ' GLU . 32.0 p90 -101.48 112.23 24.71 Favored 'General case' 0 N--CA 1.423 -1.825 0 C-N-CA 118.956 -1.097 . . . . 75.040000000000006 108.074 172.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.7 t -97.05 114.01 32.89 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.828 0 N-CA-C 106.898 -1.519 . . . . 55.439999999999998 106.898 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.6 p -124.46 154.44 40.48 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.288 -0.869 . . . . 74.209999999999994 111.177 -175.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.62 4.65 34.44 Favored Glycine 0 N--CA 1.425 -2.07 0 CA-C-N 115.939 -0.573 . . . . 38.039999999999999 111.856 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 94.4 mt -66.28 131.67 94.35 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.23 -0.655 . . . . 54.310000000000002 109.23 175.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.04 157.55 3.92 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.416 2.077 . . . . 70.409999999999997 110.283 171.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.483 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 9.8 p -83.44 6.97 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 122.787 1.28 . . . . 72.439999999999998 109.847 -170.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -127.87 17.04 6.82 Favored 'General case' 0 N--CA 1.406 -2.659 0 CA-C-N 114.323 -1.308 . . . . 54.420000000000002 110.322 -175.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 pp -54.06 133.75 16.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 114.62 1.341 . . . . 71.230000000000004 114.62 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.461 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.33 143.03 26.03 Favored Pre-proline 0 C--N 1.285 -2.199 0 CA-C-N 114.174 -1.376 . . . . 54.219999999999999 108.279 177.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.88 -24.64 65.58 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.913 2.408 . . . . 73.019999999999996 113.853 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.547 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -82.35 -15.34 53.16 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 118.094 -1.442 . . . . 70.109999999999999 111.882 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 30.0 mt-10 -69.66 -37.76 76.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.803 0.811 . . . . 74.129999999999995 108.932 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.9 mt -65.67 -35.92 82.16 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 114.773 -1.103 . . . . 75.209999999999994 108.828 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 73.7 t80 -63.95 -47.37 80.76 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.572 -1.194 . . . . 74.519999999999996 110.227 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 81.9 mt -65.02 -35.68 81.95 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.815 0.341 . . . . 71.510000000000005 111.809 -176.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.0 tp -86.23 -36.25 19.53 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 112.581 0.585 . . . . 65.140000000000001 112.581 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -98.56 -11.12 22.5 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 114.337 1.236 . . . . 73.510000000000005 114.337 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.5 ttt-85 -66.79 -42.71 45.67 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 119.987 -0.685 . . . . 71.329999999999998 111.693 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -58.11 -25.35 70.74 Favored 'Trans proline' 0 C--N 1.398 3.167 0 C-N-CA 121.711 1.608 . . . . 72.120000000000005 111.553 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -84.8 84.42 7.7 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.777 0.799 . . . . 72.200000000000003 110.112 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -67.93 108.74 3.15 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.333 -1.303 . . . . 75.099999999999994 109.905 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.94 -25.5 1.29 Allowed Glycine 0 N--CA 1.424 -2.133 0 CA-C-N 113.996 -1.457 . . . . 64.209999999999994 109.67 -172.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -55.45 118.72 4.71 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.085 0.554 . . . . 72.430000000000007 110.538 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -93.65 -60.09 1.85 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 120.121 -0.632 . . . . 61.229999999999997 109.363 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.56 175.15 38.15 Favored Glycine 0 C--N 1.298 -1.546 0 C-N-CA 120.848 -0.691 . . . . 65.310000000000002 112.075 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.3 p -134.79 143.88 47.34 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 122.488 0.315 . . . . 75.530000000000001 111.002 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.424 HD21 ' O ' ' A' ' 112' ' ' MET . 80.5 mt -115.98 119.91 37.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.09 -0.707 . . . . 74.209999999999994 109.09 174.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.17 133.3 35.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 110.137 -0.319 . . . . 71.540000000000006 110.137 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -117.82 106.66 13.23 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.27 -1.381 . . . . 72.239999999999995 107.27 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.4 124.6 25.48 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.246 -1.02 . . . . 71.219999999999999 108.246 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 5.9 m -128.89 150.79 50.2 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 105.155 -2.165 . . . . 72.239999999999995 105.155 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.05 -40.34 10.53 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 114.42 1.267 . . . . 63.32 114.42 -173.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -96.01 -26.76 15.42 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.877 1.065 . . . . 73.439999999999998 113.877 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -172.23 143.05 1.27 Allowed Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 110.202 -0.296 . . . . 70.439999999999998 110.202 -177.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.483 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 59.5 Cg_endo -77.37 124.64 7.23 Favored 'Trans proline' 0 N--CA 1.432 -2.092 0 C-N-CA 122.491 2.127 . . . . 65.019999999999996 110.102 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.7 m -96.36 147.49 6.1 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 N-CA-C 108.222 -1.029 . . . . 53.240000000000002 108.222 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.22 120.86 4.59 Favored Glycine 0 CA--C 1.479 -2.204 0 C-N-CA 118.879 -1.629 . . . . 71.129999999999995 112.907 -175.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.44 103.65 15.71 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 106.849 -1.538 . . . . 75.409999999999997 106.849 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.5 t -94.34 128.07 45.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.363 0 CA-C-N 115.071 -0.968 . . . . 74.129999999999995 110.284 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.67 114.24 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.369 0 N-CA-C 107.991 -1.114 . . . . 62.219999999999999 107.991 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 36.1 m-85 -93.96 162.65 13.81 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.329 -0.85 . . . . 74.200000000000003 109.584 174.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.36 -41.21 51.31 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 124.317 1.011 . . . . 75.510000000000005 111.876 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.6 p -164.9 166.08 19.85 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.571 -0.741 . . . . 70.540000000000006 111.986 -174.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.593 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -56.05 -39.5 72.11 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.236 1.014 . . . . 72.120000000000005 112.105 177.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.82 -28.17 69.38 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.625 0.726 . . . . 73.319999999999993 109.731 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.56 -38.71 9.46 Favored Glycine 0 C--N 1.309 -0.922 0 CA-C-N 114.648 -1.16 . . . . 65.310000000000002 110.897 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.67 -45.87 77.48 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.546 0.738 . . . . 52.219999999999999 112.032 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -34.82 78.8 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.007 0.432 . . . . 75.150000000000006 111.439 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.6 -41.21 65.84 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.992 -0.549 . . . . 62.109999999999999 110.563 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.89 -41.72 86.73 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.747 -0.66 . . . . 62.5 110.821 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -69.42 -28.46 66.16 Favored 'General case' 0 C--O 1.199 -1.585 0 CA-C-N 116.292 -0.413 . . . . 70.019999999999996 111.297 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -78.11 -21.07 50.99 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.27 0.557 . . . . 75.349999999999994 111.751 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.91 -44.02 11.36 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.278 -0.419 . . . . 72.439999999999998 111.378 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 91' ' ' ILE . 96.0 mt -93.78 -12.64 28.66 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 115.456 1.65 . . . . 74.519999999999996 115.456 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -67.56 114.6 6.34 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 119.559 1.072 . . . . 55.020000000000003 112.169 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.37 16.37 14.86 Favored Glycine 0 N--CA 1.429 -1.83 0 C-N-CA 119.73 -1.224 . . . . 63.340000000000003 111.789 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 88' ' ' LEU . 11.4 tt -90.81 128.19 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.73 0 N-CA-C 107.669 -1.234 . . . . 75.230000000000004 107.669 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -75.1 121.73 22.5 Favored 'General case' 0 C--N 1.269 -2.898 0 N-CA-C 107.87 -1.159 . . . . 71.099999999999994 107.87 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.43 -32.81 69.03 Favored 'General case' 0 C--N 1.312 -1.033 0 O-C-N 124.357 1.036 . . . . 70.150000000000006 109.04 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -148.06 115.18 3.99 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 107.077 -1.453 . . . . 75.430000000000007 107.077 171.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -62.37 -9.59 15.89 Favored 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 122.685 2.257 . . . . 70.239999999999995 113.185 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -74.46 -19.21 60.47 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.483 0.658 . . . . 74.510000000000005 109.453 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -118.08 146.52 39.4 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.202 -1.036 . . . . 74.019999999999996 108.202 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.19 -16.61 52.53 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.182 1.921 . . . . 74.230000000000004 113.159 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -52.83 125.35 16.62 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.199 1.4 . . . . 73.120000000000005 111.823 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.3 p -112.26 150.3 31.13 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 120.153 -0.619 . . . . 45.420000000000002 110.823 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.2 tp -98.34 127.01 44.08 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.469 -0.938 . . . . 73.420000000000002 108.469 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -122.38 136.03 54.82 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.09 0.471 . . . . 74.349999999999994 109.822 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -110.38 116.25 31.11 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.378 -0.828 . . . . 73.040000000000006 108.965 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 5.3 tp10 -127.19 161.99 27.22 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.73 -0.841 . . . . 73.519999999999996 108.73 -177.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -70.75 139.29 51.03 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 118.514 0.597 . . . . 65.25 110.436 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.16 150.5 31.7 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 109.233 -0.655 . . . . 60.340000000000003 109.233 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -74.18 -6.65 49.03 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.589 -0.732 . . . . 74.530000000000001 111.961 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.16 133.65 7.88 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.772 -0.825 . . . . 38.039999999999999 108.772 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.465 HD22 ' HA ' ' A' ' 30' ' ' VAL . 84.1 m-20 -74.78 108.31 7.44 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.99 -1.115 . . . . 72.239999999999995 107.99 172.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.7 t -101.05 126.76 47.76 Favored 'General case' 0 C--N 1.289 -2.054 0 C-N-CA 119.11 -1.036 . . . . 41.020000000000003 109.823 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.552 ' HE2' ' N ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -60.99 138.28 58.19 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.927 -0.397 . . . . 63.340000000000003 109.927 175.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.424 ' O ' HD21 ' A' ' 61' ' ' LEU . 1.3 tmt? -69.13 -25.95 64.65 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.591 -0.732 . . . . 73.219999999999999 110.599 -176.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.03 93.14 2.69 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.309 -0.626 . . . . 65.120000000000005 109.309 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -78.0 123.92 27.39 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.587 -0.733 . . . . 73.150000000000006 110.258 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 75.1 m -86.3 144.61 27.3 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.341 0.591 . . . . 72.129999999999995 112.542 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -139.44 118.96 12.97 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.977 -1.49 . . . . 72.239999999999995 106.977 174.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.51 ' HG ' ' OE2' ' A' ' 118' ' ' GLU . 22.3 tp -102.11 -68.38 0.83 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.549 -0.908 . . . . 73.450000000000003 108.549 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.51 ' OE2' ' HG ' ' A' ' 117' ' ' LEU . 9.3 mp0 . . . . . 0 C--N 1.307 -1.249 0 N-CA-C 106.399 -1.704 . . . . 73.25 106.399 168.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.293 0 CA-C-O 120.83 0.348 . . . . 62.509999999999998 110.166 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -135.91 163.37 30.4 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.739 -1.208 . . . . 64.409999999999997 107.739 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -87.94 47.58 1.52 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.777 0.798 . . . . 71.510000000000005 110.944 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.45 ' HB2' ' HD2' ' B' ' 78' ' ' ARG . 26.9 mm-40 -81.72 -179.97 7.6 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 114.561 -1.199 . . . . 64.019999999999996 110.948 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 32.2 t -83.0 111.66 19.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.003 0.43 . . . . 71.329999999999998 111.754 -166.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 86.6 mtt180 -91.64 -3.52 56.26 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.124 0.488 . . . . 75.239999999999995 111.634 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.9 m -115.55 128.2 55.81 Favored 'General case' 0 C--N 1.263 -3.16 0 CA-C-O 121.675 0.75 . . . . 53.240000000000002 112.759 -172.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 71.3 mt -110.1 142.41 41.6 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.184 -0.916 . . . . 71.099999999999994 108.697 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -99.38 113.69 26.17 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 106.992 -1.484 . . . . 74.430000000000007 106.992 173.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.405 HG22 ' HG ' ' B' ' 103' ' ' LEU . 53.4 t -102.49 125.67 56.73 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.984 0 CA-C-N 113.953 -1.476 . . . . 72.439999999999998 107.509 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.2 p -139.17 169.56 17.55 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.732 -0.667 . . . . 74.030000000000001 110.219 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 90.56 42.66 5.08 Favored Glycine 0 N--CA 1.422 -2.295 0 N-CA-C 109.465 -1.454 . . . . 71.219999999999999 109.465 -172.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.33 138.25 20.13 Favored Pre-proline 0 N--CA 1.418 -2.066 0 CA-C-N 114.039 -1.08 . . . . 75.310000000000002 108.437 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -54.53 155.83 15.87 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.401 2.068 . . . . 55.149999999999999 110.094 171.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.445 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 8.1 p -83.06 3.93 2.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 122.627 1.203 . . . . 65.030000000000001 108.796 -174.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.93 21.93 6.3 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 114.136 -1.393 . . . . 64.150000000000006 111.056 -173.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 35.2 pt -54.0 137.03 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 113.88 1.067 . . . . 75.310000000000002 113.88 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.485 ' HA ' ' HE3' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -93.36 141.38 23.88 Favored Pre-proline 0 C--N 1.279 -2.467 0 N-CA-C 107.054 -1.461 . . . . 73.420000000000002 107.054 174.425 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.24 -25.53 78.53 Favored 'Trans proline' 0 N--CA 1.478 0.616 0 C-N-CA 122.644 2.229 . . . . 71.129999999999995 113.093 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.461 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 16.7 ptt180 -79.7 -18.0 52.3 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 112.166 0.432 . . . . 63.030000000000001 112.166 -176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.431 ' HG2' ' HG2' ' A' ' 46' ' ' GLU . 31.2 mt-10 -65.31 -40.29 93.56 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.815 0.817 . . . . 75.140000000000001 108.993 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 74.2 mt -67.92 -35.93 79.28 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.556 -1.202 . . . . 73.439999999999998 109.634 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' B' ' 45' ' ' ARG . 50.4 t80 -61.16 -48.18 82.79 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.43 -0.804 . . . . 74.099999999999994 111.144 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 79.8 mt -63.1 -44.31 96.04 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 123.837 0.71 . . . . 63.100000000000001 110.054 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.9 tp -73.02 -41.55 64.11 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.894 -1.048 . . . . 71.239999999999995 111.861 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -96.03 10.03 38.83 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.323 0.861 . . . . 73.010000000000005 113.323 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -70.48 -48.65 17.3 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 120.615 -0.434 . . . . 64.219999999999999 111.725 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.75 -3.85 14.42 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 121.376 1.384 . . . . 72.439999999999998 112.128 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -91.42 94.69 9.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.416 1.103 . . . . 74.319999999999993 111.439 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -64.2 113.24 3.43 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 112.922 -1.944 . . . . 55.409999999999997 110.047 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.88 -21.97 3.68 Favored Glycine 0 C--N 1.287 -2.156 0 CA-C-N 115.097 -0.956 . . . . 63.009999999999998 111.403 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -62.26 105.8 0.65 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.329 0.585 . . . . 73.519999999999996 111.99 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -87.52 -48.6 7.8 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.787 -0.642 . . . . 63.420000000000002 109.609 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.57 170.93 43.55 Favored Glycine 0 C--N 1.298 -1.529 0 C-N-CA 120.741 -0.742 . . . . 53.229999999999997 112.0 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.7 p -128.8 138.1 51.89 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 122.684 0.394 . . . . 63.439999999999998 110.432 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 87.6 mt -112.99 112.88 24.64 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.526 -0.916 . . . . 71.310000000000002 108.526 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 50.4 mm -93.81 133.05 36.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.651 -0.499 . . . . 74.230000000000004 109.651 -176.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -128.3 126.69 41.32 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.097 -1.446 . . . . 74.5 107.097 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.72 125.88 29.93 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.698 0.761 . . . . 65.129999999999995 112.758 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.3 m -113.6 155.89 24.65 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 103.811 -2.663 . . . . 54.229999999999997 103.811 173.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.88 -35.15 31.36 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 114.322 1.23 . . . . 54.130000000000003 114.322 -172.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -104.91 -14.57 15.42 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 113.237 0.829 . . . . 75.019999999999996 113.237 -175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -172.81 147.85 1.65 Allowed Pre-proline 0 N--CA 1.468 0.473 0 CA-C-O 120.753 0.311 . . . . 61.119999999999997 110.258 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.445 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 46.2 Cg_endo -78.63 122.85 5.65 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 C-N-CA 122.347 2.032 . . . . 74.129999999999995 110.263 169.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 35.2 m -94.03 155.05 3.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.082 -1.081 . . . . 71.219999999999999 108.082 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.49 121.65 3.55 Favored Glycine 0 CA--C 1.474 -2.501 0 C-N-CA 118.868 -1.634 . . . . 63.329999999999998 113.301 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -88.17 102.46 14.82 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.754 -1.572 . . . . 75.329999999999998 106.754 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.18 122.9 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 CA-C-N 115.195 -0.911 . . . . 64.030000000000001 109.539 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 62.6 mt -102.68 120.71 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.418 0 CA-C-N 113.846 -1.525 . . . . 53.43 109.448 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.405 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 71.5 m-85 -105.06 161.21 14.43 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 114.112 -1.404 . . . . 73.219999999999999 109.846 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.57 -29.97 71.0 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.21 -0.904 . . . . 73.439999999999998 111.807 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 29.7 p -161.67 165.87 27.58 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.045 0.538 . . . . 73.519999999999996 110.072 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . 0.45 ' HD2' ' HB2' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -70.63 -22.58 62.51 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.529 -0.468 . . . . 43.439999999999998 110.314 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.15 -28.12 69.54 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.452 0.644 . . . . 54.409999999999997 110.383 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.38 -39.91 7.1 Favored Glycine 0 C--N 1.308 -1.023 0 N-CA-C 110.2 -1.16 . . . . 53.039999999999999 110.2 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.49 -43.68 98.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.503 -0.849 . . . . 62.5 111.825 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.93 -39.69 90.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 74.310000000000002 111.472 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.11 -37.83 64.01 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.082 0.468 . . . . 74.109999999999999 110.135 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.36 -40.54 77.43 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.48 -0.782 . . . . 53.310000000000002 111.083 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.522 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 14.5 ptmm? -68.18 -40.77 82.15 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 120.303 -0.559 . . . . 74.239999999999995 110.668 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -66.79 -25.26 66.38 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 120.71 -0.396 . . . . 74.239999999999995 111.925 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.67 -41.51 17.67 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 120.839 0.352 . . . . 75.519999999999996 111.281 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.541 ' O ' HG23 ' B' ' 91' ' ' ILE . 96.9 mt -96.26 -14.0 22.98 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 115.623 1.712 . . . . 62.100000000000001 115.623 -173.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.43 116.06 12.42 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 118.803 -1.159 . . . . 74.25 112.523 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.82 26.64 7.45 Favored Glycine 0 N--CA 1.428 -1.877 0 C-N-CA 120.49 -0.862 . . . . 71.239999999999995 111.373 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.541 HG23 ' O ' ' B' ' 88' ' ' LEU . 16.5 tt -114.95 133.71 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.551 0 N-CA-C 107.325 -1.361 . . . . 74.219999999999999 107.325 174.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.66 134.47 51.18 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-O 121.086 0.469 . . . . 72.540000000000006 110.634 172.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -70.8 -30.35 66.78 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.529 -1.214 . . . . 63.030000000000001 109.039 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' B' ' 97' ' ' ASN . 8.5 t70 -144.31 118.97 5.93 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 104.544 -2.391 . . . . 74.010000000000005 104.544 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . 0.52 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 31.8 Cg_endo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.907 2.405 . . . . 74.319999999999993 113.819 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -94.21 4.46 53.86 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.609 0.719 . . . . 74.530000000000001 111.123 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . 56.2 t30 -118.84 130.34 24.88 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 107.514 -1.291 . . . . 74.310000000000002 107.514 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.44 -13.43 33.01 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 123.046 2.497 . . . . 75.549999999999997 113.972 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -67.33 116.53 8.19 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-O 121.379 0.609 . . . . 75.010000000000005 110.28 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.591 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 58.2 p -106.48 145.17 32.14 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.824 -0.625 . . . . 54.310000000000002 109.916 -176.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 33.4 tp -94.13 128.97 40.85 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 110.025 -0.361 . . . . 71.329999999999998 110.025 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' B' ' 104' ' ' GLU . 6.0 ptm180 -129.02 127.44 41.61 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.914 -0.402 . . . . 54.109999999999999 109.914 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.405 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.7 mp -115.06 118.84 34.51 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.608 -0.723 . . . . 74.540000000000006 110.034 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.522 ' HA ' ' CE ' ' B' ' 85' ' ' LYS . 34.3 mt-10 -137.81 162.0 35.1 Favored 'General case' 0 C--O 1.199 -1.574 0 C-N-CA 122.739 0.415 . . . . 74.140000000000001 110.378 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -69.39 132.91 47.12 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 118.295 0.498 . . . . 74.510000000000005 111.355 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.59 154.47 34.39 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.413 -0.588 . . . . 65.310000000000002 109.413 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -84.28 9.15 13.73 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 120.876 0.369 . . . . 75.430000000000007 111.567 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.81 130.41 11.5 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.638 -0.504 . . . . 60.530000000000001 109.638 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -76.68 121.45 23.28 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 108.676 -0.861 . . . . 70.329999999999998 108.676 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 7.0 m -113.3 134.33 54.66 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.225 -0.657 . . . . 74.140000000000001 109.225 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.16 153.62 21.1 Favored 'General case' 0 C--O 1.247 0.948 0 N-CA-C 107.612 -1.255 . . . . 72.209999999999994 107.612 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.31 77.39 8.96 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.856 0.836 . . . . 62.229999999999997 109.3 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -163.62 103.84 0.93 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.34 -1.3 . . . . 64.219999999999999 109.8 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -86.06 81.5 8.45 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 122.454 1.121 . . . . 73.120000000000005 108.491 173.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 41.8 m -120.76 127.17 51.72 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 114.459 -1.246 . . . . 44.229999999999997 110.524 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -140.67 158.49 43.91 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.677 -0.86 . . . . 72.519999999999996 108.677 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 53.7 tp -80.87 -45.28 17.08 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.847 -0.798 . . . . 73.420000000000002 108.847 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.431 -1.39 0 CA-C-N 115.646 -0.707 . . . . 73.530000000000001 109.912 -178.673 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 C--O 1.224 -0.251 0 CA-C-O 121.005 0.431 . . . . 75.310000000000002 110.362 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -115.15 177.64 4.58 Favored 'General case' 0 C--O 1.252 1.194 0 CA-C-N 116.461 -0.336 . . . . 73.310000000000002 110.738 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -75.34 104.89 6.1 Favored 'General case' 0 N--CA 1.432 -1.365 0 O-C-N 124.233 0.958 . . . . 73.329999999999998 111.722 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.407 ' HB2' ' HD2' ' A' ' 78' ' ' ARG . 34.4 mt-10 -150.75 179.86 7.85 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.791 -1.929 . . . . 74.040000000000006 105.791 174.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.58 111.1 12.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 121.363 0.602 . . . . 71.120000000000005 110.917 -170.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.632 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 69.0 mtt180 -91.93 -22.63 19.93 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 122.352 1.072 . . . . 73.340000000000003 109.518 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 18.1 m -96.07 122.7 39.18 Favored 'General case' 0 C--N 1.258 -3.396 0 CA-C-N 113.471 -1.695 . . . . 73.340000000000003 112.018 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.414 HD22 ' O ' ' A' ' 73' ' ' VAL . 2.1 pt? -115.59 142.11 47.17 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 107.554 -1.276 . . . . 75.540000000000006 107.554 175.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 104' ' ' GLU . 26.2 p90 -96.57 122.18 39.2 Favored 'General case' 0 N--CA 1.417 -2.091 0 C-N-CA 118.779 -1.168 . . . . 71.230000000000004 109.272 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.27 108.78 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.586 0 N-CA-C 106.419 -1.697 . . . . 62.399999999999999 106.419 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 32.2 p -115.76 172.95 6.81 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 108.93 -0.767 . . . . 74.030000000000001 108.93 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 87.13 41.38 6.64 Favored Glycine 0 N--CA 1.418 -2.56 0 N-CA-C 109.897 -1.281 . . . . 74.099999999999994 109.897 -174.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.9 mt -114.81 145.14 33.32 Favored Pre-proline 0 N--CA 1.423 -1.777 0 N-CA-C 107.201 -1.407 . . . . 72.129999999999995 107.201 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.43 171.26 15.01 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.558 1.505 . . . . 72.430000000000007 110.199 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.5 p -71.31 -7.53 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 CA-C-O 122.574 1.178 . . . . 71.349999999999994 109.932 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -103.3 20.02 18.55 Favored 'General case' 0 C--O 1.203 -1.392 0 CA-C-N 114.035 -1.439 . . . . 65.200000000000003 109.386 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.98 123.51 27.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.261 0 CA-C-O 121.622 0.725 . . . . 73.219999999999999 110.715 178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -101.18 145.76 30.98 Favored Pre-proline 0 C--N 1.307 -1.244 0 C-N-CA 124.831 1.252 . . . . 74.019999999999996 111.44 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.56 -17.86 60.55 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.295 2.664 . . . . 70.450000000000003 114.557 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.548 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -86.73 -17.24 34.1 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 117.71 -1.596 . . . . 71.319999999999993 110.961 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -66.7 -42.16 86.86 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.133 0.492 . . . . 74.010000000000005 110.155 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.19 -37.35 87.04 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.191 -0.67 . . . . 55.420000000000002 109.191 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.683 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 61.0 t80 -59.38 -48.72 80.56 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.13 -0.941 . . . . 61.420000000000002 110.732 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 86.6 mt -61.59 -41.61 97.68 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.918 0.761 . . . . 73.510000000000005 110.32 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.9 tp -70.61 -42.19 71.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.286 -0.87 . . . . 71.329999999999998 111.79 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -86.72 7.13 28.03 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.851 1.056 . . . . 75.549999999999997 113.851 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.489 ' HA ' ' NE ' ' A' ' 52' ' ' ARG . 3.9 mmp_? -52.83 -50.33 81.94 Favored Pre-proline 0 N--CA 1.486 1.326 0 N-CA-C 113.924 1.083 . . . . 74.420000000000002 113.924 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -76.5 -0.91 10.92 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 121.914 1.743 . . . . 54.340000000000003 113.863 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.417 ' CE2' ' HA ' ' A' ' 84' ' ' ALA . 60.6 m-85 -98.76 115.33 28.53 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 121.945 0.879 . . . . 64.530000000000001 112.364 -174.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.08 120.93 24.89 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 113.814 -1.539 . . . . 61.240000000000002 109.511 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.7 -14.0 6.09 Favored Glycine 0 C--N 1.276 -2.791 0 CA-C-N 114.958 -1.019 . . . . 73.319999999999993 113.037 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -58.33 107.31 0.48 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.044 0.422 . . . . 73.010000000000005 111.003 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.478 ' OE2' ' HA ' ' A' ' 76' ' ' ASP . 22.5 mt-10 -96.21 -33.96 11.83 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 120.579 -0.449 . . . . 74.430000000000007 110.987 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.77 -179.22 48.39 Favored Glycine 0 C--N 1.302 -1.334 0 C-N-CA 120.131 -1.033 . . . . 38.07 112.418 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.7 p -145.74 138.17 25.63 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.201 0.6 . . . . 73.040000000000006 110.409 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.0 mp -120.5 124.75 46.16 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.373 -0.973 . . . . 75.510000000000005 108.373 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.2 mm -93.96 138.02 21.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.983 -0.747 . . . . 65.209999999999994 108.983 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -126.39 112.09 15.24 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.091 -1.077 . . . . 75.150000000000006 108.091 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.92 116.41 13.39 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.671 -0.695 . . . . 75.109999999999999 110.746 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -109.03 152.2 25.32 Favored 'General case' 0 N--CA 1.396 -3.156 0 N-CA-C 102.296 -3.224 . . . . 74.549999999999997 102.296 171.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.82 -40.53 29.58 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.981 0.734 . . . . 42.299999999999997 112.981 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -85.16 -49.24 8.4 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.31 0.576 . . . . 74.349999999999994 112.019 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -138.47 127.07 14.18 Favored Pre-proline 0 C--N 1.283 -2.297 0 CA-C-N 115.718 -0.674 . . . . 71.409999999999997 112.334 -168.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.84 101.5 1.2 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.585 2.19 . . . . 64.329999999999998 108.689 166.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.39 152.16 3.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.773 -0.825 . . . . 71.329999999999998 108.773 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.76 119.99 4.53 Favored Glycine 0 CA--C 1.473 -2.555 0 C-N-CA 118.632 -1.746 . . . . 61.100000000000001 111.989 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -87.83 106.18 17.91 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 106.675 -1.602 . . . . 75.549999999999997 106.675 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.414 ' O ' HD22 ' A' ' 33' ' ' LEU . 98.5 t -96.14 130.56 44.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 115.326 -0.852 . . . . 74.120000000000005 109.659 -177.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.8 mp -102.95 117.91 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.606 0 CA-C-N 115.079 -0.964 . . . . 63.109999999999999 108.945 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.632 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 7.4 m-85 -98.48 163.38 12.71 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.854 -1.066 . . . . 75.340000000000003 108.992 172.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.478 ' HA ' ' OE2' ' A' ' 58' ' ' GLU . 10.7 t70 -51.27 -39.27 56.37 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 123.944 0.778 . . . . 74.019999999999996 111.65 176.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.8 m -160.7 166.17 29.24 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.181 -0.918 . . . . 43.009999999999998 110.428 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.591 ' HD3' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -55.28 -32.66 62.57 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.975 0.91 . . . . 74.109999999999999 111.029 176.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.438 ' HA ' ' OE2' ' A' ' 82' ' ' GLU . . . -64.35 -26.07 68.31 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.825 0.821 . . . . 53.039999999999999 110.534 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.77 -44.27 5.51 Favored Glycine 0 C--N 1.285 -2.284 0 N-CA-C 109.855 -1.298 . . . . 62.439999999999998 109.855 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.95 -39.23 91.4 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.379 -0.91 . . . . 71.030000000000001 110.932 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.438 ' OE2' ' HA ' ' A' ' 79' ' ' ALA . 14.8 pt-20 -62.75 -41.48 99.23 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 123.139 0.274 . . . . 64.340000000000003 110.764 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.32 -37.41 80.53 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-O 121.28 0.562 . . . . 73.049999999999997 110.673 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.417 ' HA ' ' CE2' ' A' ' 54' ' ' PHE . . . -69.54 -42.7 74.26 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.618 -0.719 . . . . 74.25 111.411 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.41 ' HG2' ' HA ' ' A' ' 82' ' ' GLU . 14.9 ptmm? -70.08 -33.45 71.92 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.331 -0.548 . . . . 73.049999999999997 110.8 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.12 -44.11 95.14 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 123.432 0.458 . . . . 72.340000000000003 110.921 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.72 -41.5 23.5 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 120.288 -0.565 . . . . 72.219999999999999 112.009 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.42 ' O ' HG21 ' A' ' 91' ' ' ILE . 94.3 mt -89.08 -20.66 24.04 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 116.335 1.976 . . . . 75.430000000000007 116.335 -170.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -67.58 115.01 6.69 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 120.1 1.318 . . . . 55.310000000000002 110.083 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.43 13.72 16.32 Favored Glycine 0 N--CA 1.415 -2.75 0 CA-C-N 115.69 -0.686 . . . . 75.540000000000006 111.472 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.42 HG21 ' O ' ' A' ' 88' ' ' LEU . 14.5 tt -92.12 132.86 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.652 0 CA-C-O 121.411 0.624 . . . . 72.200000000000003 110.068 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 94' ' ' ASP . 30.2 mmt180 -63.81 137.23 57.96 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.854 -1.066 . . . . 65.219999999999999 108.248 172.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.447 ' CD1' HD12 ' A' ' 101' ' ' LEU . 7.1 t80 -77.32 -30.77 54.2 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.872 -1.529 . . . . 72.140000000000001 106.872 174.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.61 ' OD2' ' HB3' ' B' ' 45' ' ' ARG 0.294 5.0 m-20 -144.66 136.92 13.24 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 100.823 -3.769 . . . . 61.520000000000003 100.823 171.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.572 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 49.3 Cg_endo -71.88 -5.9 18.02 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 CA-C-N 121.943 1.729 . . . . 74.230000000000004 109.815 172.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -94.94 6.43 49.07 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.986 1.314 . . . . 75.420000000000002 109.154 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.487 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 48.4 t-20 -129.21 131.25 23.56 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 108.825 -0.806 . . . . 74.319999999999993 108.825 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -70.44 -6.46 18.98 Favored 'Trans proline' 0 C--O 1.25 1.121 0 C-N-CA 123.361 2.707 . . . . 75.450000000000003 113.082 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -84.54 118.72 24.5 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 108.927 -0.768 . . . . 73.0 108.927 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.472 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 37.0 p -120.4 146.39 46.24 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.558 -0.746 . . . . 73.019999999999996 109.138 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 36' ' ' SER . 7.5 mp -80.8 137.79 36.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.442 0.639 . . . . 64.040000000000006 111.637 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -129.63 105.75 8.26 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 107.263 -1.384 . . . . 73.409999999999997 107.263 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -97.94 117.17 31.69 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.047 -0.978 . . . . 63.539999999999999 108.784 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.551 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 32.9 tt0 -136.61 160.43 38.83 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.572 -1.64 . . . . 71.040000000000006 106.572 -177.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -70.0 139.43 52.75 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 119.263 0.938 . . . . 74.230000000000004 110.492 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.28 145.07 46.36 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.337 -0.616 . . . . 71.549999999999997 109.337 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.52 2.19 14.54 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.78 -0.645 . . . . 73.230000000000004 111.536 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.26 115.78 4.78 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.162 -1.051 . . . . 61.210000000000001 108.162 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -69.13 123.21 20.48 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 107.876 -1.157 . . . . 74.510000000000005 107.876 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.6 m -103.97 101.53 11.31 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 120.99 -0.284 . . . . 72.140000000000001 110.636 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -68.02 128.77 37.75 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.202 -0.666 . . . . 74.430000000000007 109.202 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 84.0 mtp -68.56 -42.1 78.8 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.042 -0.725 . . . . 71.329999999999998 109.042 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.45 117.88 27.69 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.005 -0.998 . . . . 75.129999999999995 108.668 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -83.19 104.53 13.45 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.099 -0.5 . . . . 73.120000000000005 110.065 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.8 m -70.69 100.59 1.89 Allowed 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.721 -0.672 . . . . 62.420000000000002 110.201 177.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -122.61 101.2 7.33 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 105.058 -2.201 . . . . 65.239999999999995 105.058 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.0 tp -76.66 76.55 3.32 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.585 0.957 . . . . 51.149999999999999 113.585 -171.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--N 1.316 -0.877 0 C-N-CA 126.424 1.89 . . . . 64.329999999999998 107.064 171.891 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 19.8 mmt . . . . . 0 CA--C 1.494 -1.184 0 N-CA-C 107.363 -1.347 . . . . 38.07 107.363 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -104.23 155.2 18.93 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.681 -0.408 . . . . 63.549999999999997 110.109 -174.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -86.41 100.45 12.35 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.174 -1.788 . . . . 63.039999999999999 106.174 168.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.64 -179.45 6.57 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 106.894 -1.521 . . . . 74.109999999999999 106.894 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.26 111.91 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.52 0.676 . . . . 75.439999999999998 112.155 -169.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -96.3 -17.38 20.74 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 115.066 -0.97 . . . . 64.219999999999999 110.363 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 13.6 m -99.2 129.65 45.45 Favored 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 114.991 -1.004 . . . . 71.340000000000003 112.83 -170.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.409 HD23 ' O ' ' B' ' 73' ' ' VAL . 2.4 pt? -123.87 151.39 43.52 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 107.241 -1.392 . . . . 71.340000000000003 107.241 174.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.594 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 18.3 p90 -105.4 123.98 48.78 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 121.896 0.855 . . . . 74.439999999999998 109.585 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.435 HG21 ' HG ' ' B' ' 103' ' ' LEU . 43.5 t -97.79 115.41 37.67 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 107.004 -1.48 . . . . 73.140000000000001 107.004 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 23.8 p -119.04 168.36 10.9 Favored 'General case' 0 C--N 1.274 -2.703 0 CA-C-N 115.309 -0.86 . . . . 61.520000000000003 108.786 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 89.69 31.13 11.7 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.749 -0.94 . . . . 72.420000000000002 110.749 -175.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 88.9 mt -104.2 114.31 64.44 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.076 -1.453 . . . . 63.450000000000003 107.076 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.15 156.85 19.09 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.102 1.868 . . . . 74.219999999999999 110.43 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.22 -10.51 9.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 122.174 0.988 . . . . 74.409999999999997 111.27 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -98.04 8.3 44.98 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 114.869 -1.059 . . . . 72.010000000000005 110.054 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.49 121.53 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 CA-C-O 121.583 0.706 . . . . 64.420000000000002 111.489 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.444 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 3.2 mptp? -85.58 145.81 42.79 Favored Pre-proline 0 C--N 1.315 -0.906 0 C-N-CA 124.39 1.076 . . . . 74.209999999999994 109.923 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.19 -23.53 74.16 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.526 2.151 . . . . 64.549999999999997 112.972 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.61 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 13.2 ptt180 -77.46 -24.48 50.24 Favored 'General case' 0 N--CA 1.425 -1.681 0 O-C-N 122.279 -0.263 . . . . 63.119999999999997 111.126 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 43.3 mt-10 -68.09 -33.63 74.9 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.276 0.56 . . . . 74.209999999999994 110.001 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 48.8 mt -63.09 -47.11 84.25 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.281 -1.007 . . . . 70.230000000000004 108.281 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.587 ' O ' ' HG3' ' B' ' 52' ' ' ARG . 11.5 t80 -58.83 -44.62 90.95 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.431 -1.259 . . . . 74.329999999999998 111.175 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 93.5 mt -65.24 -39.14 92.31 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.007 0.432 . . . . 73.319999999999993 110.884 -178.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 34.7 tp -78.97 -40.52 31.49 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 115.931 -0.577 . . . . 71.319999999999993 112.121 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -89.88 0.91 56.78 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 115.519 1.674 . . . . 64.040000000000006 115.519 -174.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 14.3 mtp180 -61.36 -47.52 93.62 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 114.459 1.281 . . . . 73.219999999999999 114.459 176.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -72.08 -4.24 14.79 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.257 1.305 . . . . 73.209999999999994 112.377 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -92.42 93.4 8.57 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.915 0.864 . . . . 72.120000000000005 111.428 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . 0.461 ' HD3' ' H ' ' B' ' 55' ' ' LYS . 0.1 OUTLIER -65.35 111.76 3.19 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.085 -1.416 . . . . 72.049999999999997 110.143 178.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.14 -15.54 4.24 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.331 -0.85 . . . . 75.099999999999994 112.702 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -61.9 109.39 1.24 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 117.099 0.45 . . . . 75.329999999999998 110.747 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -86.56 -38.2 17.4 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.175 -1.046 . . . . 72.239999999999995 108.175 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.7 178.9 40.58 Favored Glycine 0 C--N 1.311 -0.826 0 CA-C-N 115.014 -0.994 . . . . 38.07 112.023 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.6 p -135.1 148.74 49.9 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 122.456 0.302 . . . . 63.020000000000003 110.973 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 54.3 tp -126.31 111.74 14.89 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.974 -1.121 . . . . 72.400000000000006 107.974 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.418 ' CG2' ' HB2' ' B' ' 69' ' ' PRO . 46.5 mm -94.24 134.34 32.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 110.228 -0.286 . . . . 73.5 110.228 -175.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -124.35 114.91 20.16 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.219 -0.66 . . . . 52.219999999999999 109.219 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.08 125.34 26.36 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.216 0.531 . . . . 74.010000000000005 109.58 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 16.0 m -125.04 159.38 31.48 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 106.145 -1.798 . . . . 61.219999999999999 106.145 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.04 -40.54 15.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.17 0.988 . . . . 44.219999999999999 112.946 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -88.93 -47.7 7.97 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.857 0.688 . . . . 50.299999999999997 112.857 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.458 ' O ' ' HB ' ' B' ' 65' ' ' THR . 26.4 pt20 -155.68 149.0 18.49 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 116.041 -0.527 . . . . 72.400000000000006 110.048 -170.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.418 ' HB2' ' CG2' ' B' ' 62' ' ' ILE . 49.9 Cg_endo -79.07 108.58 2.41 Favored 'Trans proline' 0 N--CA 1.436 -1.899 0 C-N-CA 122.146 1.898 . . . . 55.119999999999997 109.981 170.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.03 151.32 4.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.5 -0.773 . . . . 53.439999999999998 109.061 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.13 120.69 4.73 Favored Glycine 0 CA--C 1.478 -2.244 0 C-N-CA 118.162 -1.97 . . . . 51.310000000000002 113.681 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -88.41 105.44 17.6 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 106.467 -1.679 . . . . 63.43 106.467 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.409 ' O ' HD23 ' B' ' 33' ' ' LEU . 74.6 t -100.15 130.67 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 CA-C-O 121.421 0.629 . . . . 74.219999999999999 110.3 -176.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.52 119.77 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 CA-C-N 114.708 -1.133 . . . . 74.430000000000007 108.724 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -102.78 168.37 9.28 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 115.208 -0.906 . . . . 62.539999999999999 111.358 174.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.96 -43.67 50.28 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.289 -1.323 . . . . 75.109999999999999 110.792 172.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 11.5 p -166.03 169.68 14.35 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.045 -0.98 . . . . 75.510000000000005 110.894 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -30.53 71.65 Favored 'General case' 0 C--O 1.213 -0.822 0 O-C-N 123.194 0.309 . . . . 75.310000000000002 110.182 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.98 67.38 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 122.361 1.077 . . . . 71.0 109.469 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.5 -43.69 5.45 Favored Glycine 0 C--N 1.294 -1.791 0 CA-C-N 113.536 -1.665 . . . . 64.340000000000003 110.678 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.79 -36.9 85.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.556 -0.822 . . . . 72.540000000000006 111.798 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 9.9 pt-20 -60.75 -41.23 94.99 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 120.747 0.308 . . . . 73.329999999999998 110.64 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.72 -39.4 80.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.998 0.428 . . . . 63.229999999999997 110.162 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.29 82.39 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.371 -0.831 . . . . 75.030000000000001 111.198 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' B' ' 82' ' ' GLU . 13.1 ptmm? -69.54 -32.19 70.86 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 116.233 -0.44 . . . . 65.310000000000002 110.861 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -70.95 -28.83 64.76 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 111.987 0.366 . . . . 74.439999999999998 111.987 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.71 -32.8 25.33 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 120.436 -0.505 . . . . 65.439999999999998 111.694 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.548 ' O ' HG22 ' B' ' 91' ' ' ILE . 92.7 mt -107.8 -4.39 18.11 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 115.443 1.645 . . . . 74.530000000000001 115.443 -173.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -79.03 114.78 18.25 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 117.786 -1.566 . . . . 74.209999999999994 110.272 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.9 3.96 48.64 Favored Glycine 0 CA--C 1.479 -2.211 0 C-N-CA 120.564 -0.827 . . . . 73.099999999999994 111.911 174.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.548 HG22 ' O ' ' B' ' 88' ' ' LEU . 15.5 tt -96.5 137.61 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.056 0 N-CA-C 107.312 -1.366 . . . . 73.239999999999995 107.312 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.28 142.14 39.62 Favored 'General case' 0 C--N 1.265 -3.071 0 CA-C-O 121.35 0.595 . . . . 62.229999999999997 112.537 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.444 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 39.8 t80 -67.69 -37.0 81.72 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.798 -1.546 . . . . 71.409999999999997 108.991 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.547 ' HB2' ' CB ' ' B' ' 97' ' ' ASN 0.277 3.9 m-20 -131.13 133.81 25.1 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 101.831 -3.396 . . . . 60.340000000000003 101.831 174.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . 0.683 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 18.7 Cg_endo -61.04 -29.9 88.56 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 CA-C-N 121.993 1.748 . . . . 62.509999999999998 112.026 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -94.91 15.93 17.38 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.544 -0.753 . . . . 52.399999999999999 111.133 -175.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' ASN . . . . . 0.547 ' CB ' ' HB2' ' B' ' 94' ' ' ASP . 57.7 t-20 -122.82 131.86 24.33 Favored Pre-proline 0 C--N 1.312 -1.054 0 N-CA-C 107.225 -1.398 . . . . 60.409999999999997 107.225 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.91 -3.42 13.58 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.279 1.986 . . . . 73.200000000000003 112.57 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' GLN . . . . . 0.425 ' HA ' ' OE1' ' B' ' 99' ' ' GLN . 5.8 tp60 -76.59 112.23 12.92 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.958 -0.756 . . . . 74.329999999999998 108.958 177.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.508 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 81.6 p -105.49 144.85 31.68 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.647 -0.706 . . . . 65.109999999999999 110.278 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 81.0 mt -79.53 135.97 36.76 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.431 -0.952 . . . . 64.120000000000005 108.431 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -131.42 112.79 13.01 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.744 -1.206 . . . . 73.420000000000002 107.744 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.435 ' HG ' HG21 ' B' ' 35' ' ' VAL . 7.6 mp -103.12 118.21 36.28 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.601 -0.727 . . . . 64.140000000000001 109.61 177.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.594 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 6.5 tp10 -135.29 157.12 47.71 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 105.684 -1.969 . . . . 74.0 105.684 -177.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -69.33 142.24 54.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 119.74 1.154 . . . . 65.420000000000002 110.961 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.47 153.11 25.79 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.888 -1.153 . . . . 53.520000000000003 107.888 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -94.3 13.01 24.89 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.908 -1.117 . . . . 73.219999999999999 109.235 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.4 114.86 10.44 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.71 -1.218 . . . . 55.509999999999998 107.71 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -85.01 104.44 14.94 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.236 -1.394 . . . . 74.409999999999997 107.236 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 16.3 m -102.38 96.79 7.17 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 116.07 -0.514 . . . . 74.230000000000004 110.895 -170.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -61.74 141.67 57.73 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 116.451 -0.34 . . . . 71.219999999999999 110.094 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 89.0 mtp -88.55 -57.6 2.86 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.71 -0.848 . . . . 73.439999999999998 108.71 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.34 116.59 32.68 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.033 -1.469 . . . . 71.150000000000006 107.033 175.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -109.59 137.99 46.61 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 116.241 -0.436 . . . . 72.439999999999998 109.975 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 10.5 p -68.35 126.79 30.71 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.544 -0.539 . . . . 72.230000000000004 109.544 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -75.11 150.54 38.77 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.426 -0.583 . . . . 73.230000000000004 109.426 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 40.4 tp -78.58 65.95 3.99 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.29 -1.004 . . . . 73.209999999999994 108.29 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.446 -0.653 0 C-N-CA 125.941 1.696 . . . . 72.450000000000003 107.577 -177.856 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 CA--C 1.487 -1.457 0 N-CA-C 107.2 -1.407 . . . . 75.310000000000002 107.2 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -111.25 -167.9 1.24 Allowed 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.928 -0.767 . . . . 73.129999999999995 108.928 -169.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.24 62.39 3.6 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.981 0.896 . . . . 74.530000000000001 109.099 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.532 ' OE1' ' HD3' ' A' ' 78' ' ' ARG . 39.5 mt-10 -72.13 150.31 43.94 Favored 'General case' 0 N--CA 1.4 -2.933 0 C-N-CA 126.09 1.756 . . . . 71.439999999999998 108.531 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.7 110.0 8.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 105.941 -1.874 . . . . 74.340000000000003 105.941 173.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 24.2 mtt180 -104.02 0.88 30.41 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.778 -0.769 . . . . 64.409999999999997 111.066 -172.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.1 m -104.69 125.49 50.84 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-O 121.391 0.615 . . . . 73.25 112.597 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.414 HD13 ' CE1' ' A' ' 75' ' ' PHE . 73.5 mt -109.73 138.03 46.68 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.554 -0.906 . . . . 55.530000000000001 108.554 173.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -96.31 110.55 22.86 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 107.345 -1.354 . . . . 74.030000000000001 107.345 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -97.67 124.51 50.68 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.767 0 CA-C-N 114.168 -1.378 . . . . 72.530000000000001 108.623 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.7 p -129.45 164.72 23.08 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.166 -0.924 . . . . 75.150000000000006 110.111 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 92.85 29.89 10.13 Favored Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.924 -0.87 . . . . 50.549999999999997 110.924 -173.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.9 mt -95.23 122.19 60.32 Favored Pre-proline 0 N--CA 1.425 -1.699 0 N-CA-C 106.04 -1.837 . . . . 71.209999999999994 106.04 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -55.41 153.32 28.73 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.161 1.908 . . . . 74.239999999999995 111.7 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.5 p -61.34 -12.91 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.918 0.887 . . . . 74.120000000000005 111.423 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -127.94 40.74 3.63 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.623 -0.88 . . . . 74.120000000000005 108.623 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.7 tt -72.08 132.02 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.459 -0.791 . . . . 72.519999999999996 109.087 172.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -90.26 145.8 33.47 Favored Pre-proline 0 C--N 1.276 -2.619 0 N-CA-C 108.584 -0.895 . . . . 71.230000000000004 108.584 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.66 -29.3 84.92 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.478 2.119 . . . . 73.239999999999995 111.728 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.509 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 13.2 ptt180 -70.85 -22.06 62.36 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 115.44 -0.8 . . . . 72.409999999999997 111.738 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.47 -38.27 77.66 Favored 'General case' 0 CA--C 1.506 -0.729 0 O-C-N 122.058 -0.401 . . . . 45.109999999999999 110.451 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.22 -34.0 76.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 122.042 0.925 . . . . 55.149999999999999 108.768 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.569 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 56.5 t80 -65.46 -48.83 71.34 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.573 -1.194 . . . . 71.129999999999995 110.169 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 95.5 mt -65.17 -43.57 91.32 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 123.606 0.566 . . . . 71.099999999999994 110.045 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.2 tp -65.59 -43.14 90.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.034 -0.985 . . . . 54.299999999999997 111.147 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -95.73 14.88 21.71 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 113.156 0.799 . . . . 72.239999999999995 113.156 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 3.2 mmp_? -55.37 -51.14 82.4 Favored Pre-proline 0 N--CA 1.486 1.351 0 N-CA-C 112.452 0.538 . . . . 62.020000000000003 112.452 174.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.33 -1.61 11.17 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 121.859 1.706 . . . . 65.439999999999998 112.918 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -93.63 89.74 6.35 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.52 0.676 . . . . 73.209999999999994 111.867 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -65.45 112.22 3.45 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.716 -1.129 . . . . 64.230000000000004 108.597 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 75' ' ' PHE . . . 132.96 -10.56 5.14 Favored Glycine 0 C--N 1.286 -2.206 0 C-N-CA 119.306 -1.426 . . . . 73.409999999999997 112.943 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -69.09 94.81 0.69 Allowed 'General case' 0 C--O 1.243 0.712 0 CA-C-N 117.626 0.713 . . . . 74.310000000000002 109.162 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -84.59 -44.35 13.6 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.032 -0.531 . . . . 62.25 109.879 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -168.8 179.43 41.64 Favored Glycine 0 C--N 1.296 -1.658 0 C-N-CA 120.645 -0.788 . . . . 73.099999999999994 111.867 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.8 p -151.44 140.72 21.37 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 122.801 0.44 . . . . 72.329999999999998 109.844 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.1 tp -111.96 109.56 19.41 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.322 -0.992 . . . . 72.219999999999999 108.322 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.41 129.65 44.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.563 -0.532 . . . . 74.409999999999997 109.563 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -123.4 123.09 39.89 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.37 -0.974 . . . . 74.099999999999994 108.37 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.69 118.06 21.17 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.406 0.622 . . . . 71.109999999999999 110.56 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 14.2 m -107.99 155.41 20.37 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 104.577 -2.379 . . . . 75.109999999999999 104.577 175.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.38 -33.71 31.11 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.265 1.209 . . . . 70.25 114.265 -172.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -105.07 -17.45 14.49 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 118.923 -1.111 . . . . 64.319999999999993 113.138 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.419 ' O ' ' HB ' ' A' ' 65' ' ' THR . 28.9 pt20 -164.56 148.73 7.99 Favored Pre-proline 0 C--N 1.321 -0.654 0 C-N-CA 120.662 -0.415 . . . . 72.340000000000003 110.725 -173.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -80.94 121.7 4.1 Favored 'Trans proline' 0 N--CA 1.429 -2.292 0 C-N-CA 121.856 1.704 . . . . 70.530000000000001 109.671 168.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.82 146.94 5.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 107.676 -1.231 . . . . 72.209999999999994 107.676 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.33 120.77 3.13 Favored Glycine 0 CA--C 1.48 -2.13 0 C-N-CA 118.363 -1.875 . . . . 65.239999999999995 113.238 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -88.0 101.82 14.14 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.534 -1.654 . . . . 62.210000000000001 106.534 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.6 t -92.18 126.23 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 CA-C-N 115.688 -0.687 . . . . 65.329999999999998 110.031 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.6 mt -100.83 111.28 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.406 0 CA-C-N 114.287 -1.324 . . . . 55.229999999999997 108.32 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.514 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 80.8 m-85 -95.84 169.17 10.19 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 114.926 -1.034 . . . . 62.140000000000001 110.994 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.6 -44.13 97.08 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.304 -1.316 . . . . 72.230000000000004 112.561 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.9 p -152.78 165.71 34.5 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 122.427 -0.171 . . . . 72.420000000000002 111.016 -172.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -78.28 -27.95 47.51 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.246 -1.02 . . . . 74.030000000000001 108.246 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.44 -26.18 65.38 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.245 -0.888 . . . . 63.130000000000003 108.766 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.46 -40.46 8.38 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.324 -1.11 . . . . 61.439999999999998 110.324 176.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.15 92.92 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.286 0.635 . . . . 54.200000000000003 112.528 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.47 -31.47 70.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 119.769 -0.772 . . . . 64.430000000000007 112.11 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.4 -42.52 68.23 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.148 0.499 . . . . 52.240000000000002 110.018 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.01 -42.36 97.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.651 -0.704 . . . . 74.319999999999993 111.295 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.449 ' CE ' ' HA ' ' A' ' 104' ' ' GLU . 13.8 ptmm? -67.97 -36.9 80.84 Favored 'General case' 0 C--O 1.198 -1.648 0 C-N-CA 120.248 -0.581 . . . . 73.409999999999997 109.85 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -67.15 -19.79 65.65 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 112.974 0.731 . . . . 74.540000000000006 112.974 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.34 -45.57 10.45 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-O 121.276 0.56 . . . . 65.409999999999997 110.236 175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.518 ' O ' HG22 ' A' ' 91' ' ' ILE . 93.8 mt -94.13 -19.16 21.05 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 116.17 1.915 . . . . 73.209999999999994 116.17 -171.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.293 0.2 OUTLIER -76.55 116.99 17.75 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 120.662 -1.273 . . . . 54.130000000000003 113.335 -177.196 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.75 19.83 9.39 Favored Glycine 0 N--CA 1.423 -2.225 0 C-N-CA 120.689 -0.767 . . . . 62.329999999999998 112.142 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 88' ' ' LEU . 18.1 tt -112.91 135.84 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.212 0 N-CA-C 108.166 -1.05 . . . . 72.129999999999995 108.166 176.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.424 ' NH1' ' HA ' ' A' ' 98' ' ' PRO . 63.5 mtt180 -72.75 128.11 34.57 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 116.242 -0.435 . . . . 73.209999999999994 109.901 174.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -57.57 -32.26 66.97 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 124.983 1.427 . . . . 70.420000000000002 109.932 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.595 ' OD2' ' HB3' ' B' ' 45' ' ' ARG 0.284 8.8 m-20 -133.53 140.27 36.39 Favored Pre-proline 0 CA--C 1.496 -1.132 0 N-CA-C 103.326 -2.842 . . . . 54.0 103.326 170.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.506 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 34.7 Cg_endo -70.89 -17.28 32.57 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 CA-C-N 121.229 1.475 . . . . 74.420000000000002 111.771 173.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -86.66 -12.47 48.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.132 0.491 . . . . 62.350000000000001 110.096 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.59 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 44.7 t-20 -103.76 131.98 21.49 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 109.078 -0.712 . . . . 72.219999999999999 109.078 -172.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.424 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 45.1 Cg_endo -70.43 -14.56 34.09 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.465 2.11 . . . . 71.230000000000004 112.407 176.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -65.24 115.89 6.03 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 109.458 -0.571 . . . . 61.219999999999999 109.458 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.483 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 60.6 p -102.62 139.92 37.57 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 119.946 -0.701 . . . . 72.519999999999996 110.026 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.9 tp -94.78 123.25 38.13 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.669 -0.864 . . . . 64.120000000000005 108.669 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -137.32 128.4 27.67 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 119.607 -0.837 . . . . 74.120000000000005 110.473 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.65 125.29 50.81 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.315 -1.312 . . . . 63.530000000000001 108.38 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.449 ' HA ' ' CE ' ' A' ' 85' ' ' LYS . 26.0 tt0 -136.32 155.36 50.18 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.818 -1.179 . . . . 60.009999999999998 107.818 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -66.57 132.13 47.53 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 119.028 0.831 . . . . 73.329999999999998 111.822 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.09 152.6 36.76 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.19 -1.041 . . . . 73.019999999999996 108.19 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -93.24 15.59 15.12 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.66 1.219 . . . . 73.239999999999995 110.319 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -153.86 125.83 7.8 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.738 -1.119 . . . . 72.439999999999998 108.373 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.12 123.56 21.0 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.033 -1.099 . . . . 75.129999999999995 108.033 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.0 m -105.88 138.3 42.31 Favored 'General case' 0 C--N 1.269 -2.916 0 N-CA-C 107.327 -1.361 . . . . 61.420000000000002 107.327 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -111.7 167.71 10.13 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.294 -1.002 . . . . 74.239999999999995 108.294 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 85.6 mtp -77.39 177.21 8.15 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.047 -0.723 . . . . 61.039999999999999 109.047 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.02 85.32 4.25 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.178 0.513 . . . . 45.200000000000003 111.087 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -112.69 98.34 7.16 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.638 -1.616 . . . . 73.0 106.638 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.0 m -83.35 107.74 16.07 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.228 0.537 . . . . 72.140000000000001 110.708 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -83.11 78.04 9.66 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.014 -1.476 . . . . 71.049999999999997 107.014 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.7 tp -101.72 -35.65 9.0 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.346 -1.353 . . . . 51.450000000000003 107.346 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 . . . . . 0 N--CA 1.413 -2.309 0 N-CA-C 106.19 -1.782 . . . . 75.230000000000004 106.19 179.044 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.465 0.307 0 N-CA-C 111.965 0.357 . . . . 52.420000000000002 111.965 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -107.72 -163.1 0.87 Allowed 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.312 -0.995 . . . . 71.109999999999999 108.312 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -78.83 76.58 5.32 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 122.55 1.167 . . . . 71.420000000000002 112.217 177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.528 ' OE1' ' HD3' ' B' ' 78' ' ' ARG . 32.6 mt-10 -77.29 163.72 26.23 Favored 'General case' 0 N--CA 1.399 -2.977 0 CA-C-N 113.675 -1.602 . . . . 74.209999999999994 107.956 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 45.6 t -78.78 110.47 14.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 106.203 -1.777 . . . . 65.400000000000006 106.203 173.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.518 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 66.5 mtt180 -99.47 -15.7 18.6 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-N 115.567 -0.742 . . . . 62.409999999999997 111.427 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' B' ' 73' ' ' VAL . 31.0 m -105.4 129.16 53.78 Favored 'General case' 1 C--N 1.243 -4.026 0 N-CA-C 113.581 0.956 . . . . 53.340000000000003 113.581 -170.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.481 HD12 ' O ' ' B' ' 81' ' ' ALA . 79.2 mt -106.64 145.78 31.53 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.479 -1.237 . . . . 73.329999999999998 107.883 171.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' B' ' 104' ' ' GLU . 25.5 p90 -104.15 116.28 31.91 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 119.077 -1.049 . . . . 62.32 108.346 173.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.37 118.09 43.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 114.03 -1.441 . . . . 53.299999999999997 107.602 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.5 p -126.37 163.15 23.91 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 109.44 -0.578 . . . . 72.109999999999999 109.44 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 99.5 19.99 18.77 Favored Glycine 0 N--CA 1.423 -2.215 0 N-CA-C 111.826 -0.51 . . . . 41.0 111.826 -172.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 72.4 mt -93.89 120.21 66.1 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 107.915 -1.143 . . . . 73.239999999999995 107.915 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.34 159.6 22.48 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.576 2.184 . . . . 53.240000000000002 111.643 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.04 -6.11 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-O 121.94 0.876 . . . . 62.420000000000002 110.922 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -114.48 30.08 7.56 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.108 -1.071 . . . . 72.530000000000001 108.108 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 tt -58.8 140.32 17.28 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 CA-C-O 121.745 0.783 . . . . 72.329999999999998 111.627 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.62 ' HG2' ' CZ ' ' B' ' 45' ' ' ARG . 0.1 OUTLIER -101.18 143.34 26.4 Favored Pre-proline 0 C--N 1.293 -1.872 0 C-N-CA 125.712 1.605 . . . . 74.239999999999995 108.525 175.056 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -61.79 -27.91 81.15 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.451 2.1 . . . . 63.020000000000003 113.437 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.62 ' CZ ' ' HG2' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -82.7 -10.65 58.82 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 118.228 -1.389 . . . . 65.150000000000006 111.909 -177.244 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -65.09 -39.4 93.14 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 120.101 -0.639 . . . . 72.510000000000005 109.708 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.31 -33.71 74.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.538 -0.755 . . . . 71.049999999999997 109.806 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.506 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 66.5 t80 -61.94 -50.81 70.63 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.674 -0.694 . . . . 74.230000000000004 110.184 177.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 81.4 mt -62.04 -44.17 97.27 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 124.085 0.865 . . . . 44.009999999999998 109.548 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 20.6 tp -63.17 -44.64 94.88 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.45 -1.25 . . . . 71.019999999999996 110.965 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -93.59 11.39 28.96 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 113.902 1.075 . . . . 74.329999999999998 113.902 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.47 ' HA ' ' NE ' ' B' ' 52' ' ' ARG . 5.2 mmp_? -55.25 -51.86 76.21 Favored Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 113.276 0.843 . . . . 75.319999999999993 113.276 175.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -79.26 -1.0 11.2 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.011 1.808 . . . . 74.420000000000002 112.937 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -99.81 99.76 10.61 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-O 122.5 1.143 . . . . 65.109999999999999 112.516 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -73.67 116.09 13.85 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 113.02 -1.9 . . . . 61.219999999999999 109.076 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.19 -24.73 2.22 Favored Glycine 0 C--N 1.284 -2.312 0 CA-C-N 114.822 -1.081 . . . . 60.520000000000003 112.103 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -55.67 110.07 0.66 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.512 0.725 . . . . 61.039999999999999 112.488 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -96.11 -49.27 5.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.489 -0.778 . . . . 50.130000000000003 110.368 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -169.68 172.41 43.65 Favored Glycine 0 C--N 1.299 -1.477 0 CA-C-N 115.162 -0.926 . . . . 71.219999999999999 111.413 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.9 p -141.17 137.63 32.83 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 122.531 0.332 . . . . 74.25 110.627 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 28.5 tp -120.33 115.35 23.37 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.897 -1.149 . . . . 75.129999999999995 107.897 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.95 131.47 42.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 109.684 -0.488 . . . . 72.030000000000001 109.684 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -118.55 114.35 22.68 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.309 -0.997 . . . . 72.0 108.309 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.6 119.74 12.86 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.956 -0.757 . . . . 64.319999999999993 108.956 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 25.6 m -114.65 155.25 26.93 Favored 'General case' 0 N--CA 1.401 -2.913 0 N-CA-C 104.662 -2.347 . . . . 64.340000000000003 104.662 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.78 -38.01 14.73 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.69 0.996 . . . . 71.439999999999998 113.69 -173.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -104.29 -15.78 15.36 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 113.239 0.829 . . . . 72.299999999999997 113.239 -174.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.51 ' O ' ' HB ' ' B' ' 65' ' ' THR . 29.4 pt20 -172.64 140.05 0.97 Allowed Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 110.135 -0.32 . . . . 71.530000000000001 110.135 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.54 112.99 3.68 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.846 2.364 . . . . 71.310000000000002 109.672 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -90.8 145.31 7.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.648 -0.871 . . . . 75.400000000000006 108.648 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.19 120.1 4.43 Favored Glycine 0 CA--C 1.483 -1.914 0 C-N-CA 118.917 -1.611 . . . . 60.219999999999999 112.775 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.91 103.06 15.82 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.579 -1.267 . . . . 75.219999999999999 107.579 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' B' ' 32' ' ' THR . 59.3 t -98.25 127.36 50.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-N 115.725 -0.67 . . . . 71.299999999999997 110.687 -175.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 53.3 mt -98.44 128.76 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 CA-C-N 114.842 -1.072 . . . . 63.130000000000003 108.814 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.518 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 85.3 m-85 -109.03 159.47 16.82 Favored 'General case' 0 C--N 1.271 -2.837 0 N-CA-C 107.799 -1.185 . . . . 64.209999999999994 107.799 174.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.13 -40.09 94.77 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 112.469 0.544 . . . . 75.340000000000003 112.469 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 2.9 p -143.69 155.61 44.27 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 116.046 -0.524 . . . . 63.030000000000001 111.707 -174.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . 0.528 ' HD3' ' OE1' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -59.69 -35.18 73.98 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 123.398 0.436 . . . . 73.030000000000001 110.898 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.6 -32.31 73.74 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 122.008 0.909 . . . . 64.439999999999998 109.49 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.47 -37.44 35.76 Favored Glycine 0 C--N 1.31 -0.864 0 CA-C-N 114.021 -1.445 . . . . 73.230000000000004 110.493 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.481 ' O ' HD12 ' B' ' 33' ' ' LEU . . . -70.03 -45.3 67.47 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.848 -0.676 . . . . 55.119999999999997 111.517 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.94 -37.19 85.37 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.289 -0.564 . . . . 71.140000000000001 111.425 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.46 -35.99 81.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.853 0.359 . . . . 44.219999999999999 110.268 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.65 74.74 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.716 -0.675 . . . . 73.310000000000002 111.464 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.411 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 13.8 ptmm? -66.65 -40.18 88.56 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 119.743 -0.783 . . . . 72.239999999999995 110.619 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -60.53 -30.62 69.87 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.173 0.435 . . . . 53.299999999999997 112.173 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.18 -36.36 19.54 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.33 -0.548 . . . . 41.229999999999997 111.969 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.449 ' O ' HG23 ' B' ' 91' ' ' ILE . 91.2 mt -96.97 -23.38 16.33 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 116.042 1.867 . . . . 53.399999999999999 116.042 -172.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.34 123.11 25.43 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.202 1.186 . . . . 73.409999999999997 114.202 -175.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.34 27.13 6.27 Favored Glycine 0 CA--C 1.483 -1.907 0 C-N-CA 120.316 -0.945 . . . . 74.019999999999996 111.582 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.449 HG23 ' O ' ' B' ' 88' ' ' LEU . 18.8 tt -124.44 142.96 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.395 0 N-CA-C 106.316 -1.735 . . . . 74.349999999999994 106.316 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.458 ' HG2' HG22 ' B' ' 100' ' ' THR . 96.3 mtt180 -74.21 145.82 43.83 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-O 121.098 0.475 . . . . 73.129999999999995 111.164 176.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -74.03 -33.24 63.68 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.166 -1.379 . . . . 74.140000000000001 108.199 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.558 ' HB2' ' CB ' ' B' ' 97' ' ' ASN . 4.8 m-20 -136.08 130.32 18.37 Favored Pre-proline 0 CA--C 1.511 -0.533 0 N-CA-C 103.456 -2.794 . . . . 75.430000000000007 103.456 173.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . 0.569 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 17.5 Cg_endo -58.26 -34.82 98.97 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.024 1.816 . . . . 52.119999999999997 112.479 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.17 1.57 39.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.816 -0.629 . . . . 75.209999999999994 111.782 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' ASN . . . . . 0.558 ' CB ' ' HB2' ' B' ' 94' ' ' ASP . 48.1 t30 -114.12 128.07 26.18 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 109.575 -0.528 . . . . 74.450000000000003 109.575 -175.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.12 -7.16 20.48 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 122.82 2.347 . . . . 71.319999999999993 112.016 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' GLN . . . . . 0.531 ' HB3' ' ND2' ' B' ' 97' ' ' ASN . 6.4 tp60 -75.01 112.12 10.91 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.099 -1.074 . . . . 71.25 108.099 174.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.48 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 82.2 p -101.96 151.88 21.6 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.76 -0.655 . . . . 74.209999999999994 109.398 -174.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 42.0 tp -98.81 121.0 40.19 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.958 -1.127 . . . . 71.329999999999998 107.958 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -131.93 138.53 48.4 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-O 121.344 0.593 . . . . 64.329999999999998 109.511 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 5.9 mp -122.36 118.41 28.36 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.944 -1.026 . . . . 71.420000000000002 109.137 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' B' ' 34' ' ' PHE . 9.3 mm-40 -124.21 168.43 12.94 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.966 -1.124 . . . . 43.219999999999999 107.966 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -74.35 141.95 45.15 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 109.191 -0.67 . . . . 60.439999999999998 109.191 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.46 144.22 42.22 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 108.163 -1.051 . . . . 64.140000000000001 108.163 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -80.44 6.74 11.45 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.787 0.803 . . . . 71.049999999999997 110.827 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -167.26 131.93 1.95 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.856 -1.905 . . . . 63.32 105.856 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -66.34 145.65 55.48 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 109.041 -0.725 . . . . 73.439999999999998 109.041 176.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 7.6 t -102.03 156.13 17.74 Favored 'General case' 0 N--CA 1.411 -2.412 0 C-N-CA 119.059 -1.056 . . . . 71.540000000000006 109.15 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -111.01 154.89 23.53 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 107.826 -1.176 . . . . 72.010000000000005 107.826 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 86.5 mtp -90.15 155.46 19.02 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.169 -1.419 . . . . 71.409999999999997 107.169 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.66 94.14 1.32 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.045 0.45 . . . . 75.299999999999997 111.07 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -119.27 125.76 49.88 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 107.268 -1.382 . . . . 73.209999999999994 107.268 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 17.9 m -74.87 104.32 5.44 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 123.499 0.5 . . . . 62.409999999999997 110.623 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . 0.414 ' HE3' ' C ' ' B' ' 116' ' ' LYS . 0.1 OUTLIER -107.92 78.72 1.21 Allowed 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 122.132 0.967 . . . . 74.109999999999999 109.805 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 33.2 tp -118.72 -61.11 1.69 Allowed 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 104.806 -2.294 . . . . 73.510000000000005 104.806 171.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 . . . . . 0 N--CA 1.437 -1.115 0 N-CA-C 105.425 -2.065 . . . . 73.439999999999998 105.425 170.389 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 110.691 -0.114 . . . . 75.310000000000002 110.691 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.58 -47.21 10.07 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.357 0.599 . . . . 50.32 110.113 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.49 101.44 11.32 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.688 0.756 . . . . 74.310000000000002 111.867 -175.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.538 ' OE1' ' HG3' ' A' ' 78' ' ' ARG . 1.6 tm-20 -117.16 -179.1 3.61 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 105.117 -2.179 . . . . 55.229999999999997 105.117 173.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 17.2 t -92.59 109.76 22.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 C-N-CA 118.324 -1.351 . . . . 74.200000000000003 109.84 -171.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.493 ' NH2' ' HA ' ' A' ' 76' ' ' ASP . 17.1 ptm180 -111.08 9.68 22.01 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.215 -0.902 . . . . 71.319999999999993 111.459 -172.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.1 m -121.0 125.83 48.37 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.652 -0.704 . . . . 74.430000000000007 109.85 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.7 mt -107.35 152.85 23.6 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.239 -0.891 . . . . 73.519999999999996 108.846 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 104' ' ' GLU . 21.8 p90 -115.18 118.16 32.53 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 117.883 -1.527 . . . . 75.319999999999993 109.056 172.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.8 t -97.63 123.08 49.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 113.797 -1.547 . . . . 74.319999999999993 107.679 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 60.0 p -124.31 175.37 7.12 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.986 -1.116 . . . . 71.030000000000001 107.986 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 88.5 27.21 25.5 Favored Glycine 0 N--CA 1.422 -2.279 0 N-CA-C 111.169 -0.772 . . . . 74.310000000000002 111.169 -176.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.4 mt -103.68 131.64 21.83 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 107.623 -1.251 . . . . 71.340000000000003 107.623 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.86 168.01 21.56 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.791 1.661 . . . . 72.319999999999993 111.094 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.71 -6.2 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-O 122.063 0.935 . . . . 60.509999999999998 110.524 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -124.78 40.4 3.75 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.176 -1.046 . . . . 52.439999999999998 108.176 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.49 125.03 34.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 106.589 -1.634 . . . . 62.420000000000002 106.589 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -93.91 142.24 24.77 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 109.223 -0.658 . . . . 72.010000000000005 109.223 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.24 -21.16 50.71 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.887 2.391 . . . . 62.240000000000002 113.217 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.591 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 11.3 ptt180 -77.21 -24.48 51.31 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 116.233 -0.439 . . . . 74.519999999999996 110.743 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -70.41 -41.27 73.18 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.0 0.428 . . . . 64.25 110.513 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.47 -39.97 94.82 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 108.728 -0.842 . . . . 74.150000000000006 108.728 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.644 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 30.7 t80 -57.13 -48.24 79.15 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.408 -1.269 . . . . 64.310000000000002 111.292 178.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 88.1 mt -61.53 -40.77 95.88 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.238 0.542 . . . . 73.540000000000006 110.77 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.8 tp -77.23 -40.93 43.13 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.0 -1.0 . . . . 72.019999999999996 111.926 -176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -88.3 -8.13 55.64 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 115.398 1.629 . . . . 74.409999999999997 115.398 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 54.8 mtp85 -57.79 -43.78 98.94 Favored Pre-proline 0 N--CA 1.48 1.075 0 N-CA-C 114.896 1.443 . . . . 72.040000000000006 114.896 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -67.91 -17.45 46.6 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 121.344 1.362 . . . . 75.129999999999995 112.101 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -86.32 89.6 7.91 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.923 0.868 . . . . 74.230000000000004 110.962 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -65.03 110.76 2.6 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.367 -1.288 . . . . 74.310000000000002 109.769 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.88 -24.72 2.42 Favored Glycine 0 C--N 1.281 -2.522 0 CA-C-N 114.682 -1.144 . . . . 61.409999999999997 111.193 -176.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -58.29 113.03 1.76 Allowed 'General case' 0 C--O 1.242 0.664 0 C-N-CA 122.799 0.44 . . . . 72.340000000000003 111.355 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -91.65 -59.76 2.05 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.37 -0.832 . . . . 51.350000000000001 109.614 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.43 -178.45 39.64 Favored Glycine 0 C--N 1.298 -1.583 0 CA-C-N 115.276 -0.874 . . . . 55.329999999999998 111.449 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.2 p -135.66 137.97 42.36 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 122.532 0.333 . . . . 74.409999999999997 111.345 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.6 tt -107.7 119.97 40.93 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.742 -1.577 . . . . 53.329999999999998 106.742 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -95.66 128.97 46.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 109.661 -0.496 . . . . 64.439999999999998 109.661 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -119.06 109.35 15.81 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 106.51 -1.663 . . . . 73.239999999999995 106.51 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.84 127.78 33.66 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.514 -0.767 . . . . 74.540000000000006 109.777 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 7.1 m -130.32 151.04 51.25 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 105.54 -2.022 . . . . 63.43 105.54 175.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.74 -41.65 10.94 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 114.529 1.307 . . . . 72.420000000000002 114.529 -172.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -105.41 -11.58 16.38 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 114.988 1.477 . . . . 74.150000000000006 114.988 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' A' ' 65' ' ' THR . 29.1 pt20 -166.1 125.69 1.19 Allowed Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 120.95 0.405 . . . . 55.310000000000002 111.671 -175.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.81 108.17 2.64 Favored 'Trans proline' 0 N--CA 1.439 -1.682 0 C-N-CA 122.371 2.047 . . . . 65.540000000000006 108.945 169.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.16 146.92 5.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.639 -0.874 . . . . 62.039999999999999 108.639 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.77 120.72 4.59 Favored Glycine 0 CA--C 1.486 -1.732 0 C-N-CA 118.868 -1.634 . . . . 61.530000000000001 113.499 -176.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -87.74 103.77 15.92 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.999 -1.482 . . . . 74.420000000000002 106.999 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.9 t -94.68 121.8 45.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 114.781 -1.1 . . . . 60.350000000000001 110.818 -174.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 tt -93.33 124.92 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.962 0 CA-C-N 114.822 -1.081 . . . . 74.420000000000002 109.978 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -103.59 155.57 18.44 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 114.817 -1.083 . . . . 72.140000000000001 108.424 173.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.493 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 22.5 t70 -67.98 -34.52 76.69 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.815 -0.63 . . . . 74.319999999999993 110.4 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.7 m -132.49 145.87 51.49 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 107.984 -1.117 . . . . 73.019999999999996 107.984 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.665 ' HB2' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -78.22 -24.38 47.07 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.66 -0.866 . . . . 71.239999999999995 108.66 -179.178 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.13 -25.45 68.36 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.028 0.918 . . . . 53.229999999999997 109.098 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.7 -42.59 6.78 Favored Glycine 0 C--N 1.297 -1.627 0 CA-C-N 113.533 -1.667 . . . . 64.5 109.724 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.28 -49.01 79.48 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.306 0.642 . . . . 70.120000000000005 111.239 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.19 -35.58 73.84 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.264 0.626 . . . . 62.299999999999997 112.234 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.05 -32.23 39.42 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.166 0.508 . . . . 63.399999999999999 111.014 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.73 -46.05 69.91 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.147 -0.479 . . . . 72.420000000000002 111.052 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -28.08 66.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.135 -0.484 . . . . 64.150000000000006 111.525 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -70.28 -40.7 74.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.212 -0.449 . . . . 74.209999999999994 110.496 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.66 -36.99 36.89 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.279 0.474 . . . . 37.170000000000002 112.279 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 91' ' ' ILE . 98.5 mt -89.39 -4.48 58.02 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 115.484 1.661 . . . . 71.319999999999993 115.484 -175.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -78.55 118.05 20.3 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 117.86 -1.536 . . . . 74.340000000000003 110.803 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.13 6.53 31.82 Favored Glycine 0 CA--C 1.483 -1.934 0 CA-C-N 115.73 -0.668 . . . . 63.32 112.729 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 88' ' ' LEU . 13.9 tt -88.36 121.43 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 109.244 -0.651 . . . . 72.219999999999999 109.244 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.5 ' CG ' HG22 ' A' ' 100' ' ' THR . 71.3 mtt180 -74.53 135.28 42.16 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 116.166 -0.47 . . . . 72.230000000000004 110.311 173.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.492 ' CD1' HD11 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -63.54 -39.23 93.86 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.367 -1.288 . . . . 54.039999999999999 107.697 177.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' B' ' 45' ' ' ARG . 8.2 m-20 -135.41 128.47 18.24 Favored Pre-proline 0 CA--C 1.485 -1.547 0 N-CA-C 104.413 -2.44 . . . . 62.43 104.413 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -56.96 -26.24 66.9 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 121.748 1.632 . . . . 52.039999999999999 111.07 173.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -74.88 -20.68 59.63 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.544 1.138 . . . . 72.310000000000002 110.569 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.485 ' ND2' ' HB3' ' A' ' 99' ' ' GLN . 36.4 t30 -106.69 124.59 35.06 Favored Pre-proline 0 C--N 1.308 -1.217 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 110.491 -173.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.65 -12.04 33.33 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 123.248 2.632 . . . . 74.340000000000003 113.25 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.485 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 6.5 tp60 -74.09 113.49 11.34 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.31 -0.996 . . . . 72.439999999999998 108.31 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.501 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 68.0 p -110.76 145.18 38.55 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.518 -0.764 . . . . 62.149999999999999 110.2 -173.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.1 mp -78.39 120.51 23.23 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.431 0.634 . . . . 55.43 109.652 175.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.417 ' HD3' ' OE2' ' A' ' 104' ' ' GLU . 0.3 OUTLIER -123.43 112.56 17.68 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 107.224 -1.399 . . . . 74.109999999999999 107.224 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -106.94 127.31 53.33 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.2 -0.909 . . . . 72.129999999999995 110.31 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 47.3 mt-10 -132.67 174.07 10.68 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.351 -1.351 . . . . 75.409999999999997 107.351 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.402 ' HB3' HG13 ' A' ' 30' ' ' VAL . 61.8 m-85 -79.51 138.62 37.59 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.34 -0.615 . . . . 73.030000000000001 109.34 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.36 152.28 40.93 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.256 -0.646 . . . . 52.329999999999998 109.256 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.539 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 14.0 tmtt? -74.29 -8.15 55.22 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.45 0.643 . . . . 75.140000000000001 110.198 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.54 131.23 9.82 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.733 -0.667 . . . . 73.420000000000002 109.722 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.423 HD22 ' HA ' ' A' ' 30' ' ' VAL . 93.0 m-20 -75.68 143.27 42.24 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.925 -0.579 . . . . 71.230000000000004 110.217 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 t -117.1 146.81 42.91 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.855 -0.794 . . . . 75.510000000000005 108.855 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -110.4 157.34 19.65 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.269 -0.641 . . . . 64.219999999999999 109.269 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 15.9 mmt -87.8 -17.4 31.66 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.376 0.608 . . . . 74.420000000000002 109.876 173.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.1 99.86 2.89 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.617 -1.623 . . . . 64.040000000000006 106.617 170.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -159.87 146.99 16.45 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.588 -0.523 . . . . 75.25 109.588 -172.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.5 m 61.42 39.8 14.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.007 0.923 . . . . 60.409999999999997 113.236 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -71.92 102.27 2.87 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.911 -0.774 . . . . 71.400000000000006 108.911 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.02 73.44 6.82 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.345 -0.983 . . . . 53.109999999999999 108.345 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.426 -1.652 0 N-CA-C 105.569 -2.012 . . . . 73.409999999999997 105.569 -179.471 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 40.4 tpp . . . . . 0 CA--C 1.543 0.697 0 CA-C-O 121.842 0.83 . . . . 74.030000000000001 110.82 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -111.15 20.97 16.87 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.097 -1.075 . . . . 70.549999999999997 108.097 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -112.32 22.69 14.44 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.696 -1.594 . . . . 74.319999999999993 106.696 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -94.8 -179.76 4.97 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 112.354 -2.203 . . . . 71.319999999999993 109.803 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' B' ' 105' ' ' PHE . 16.0 t -97.52 111.77 28.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-O 121.48 0.657 . . . . 74.030000000000001 110.157 -168.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -104.08 -2.62 25.64 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.446 -0.797 . . . . 75.209999999999994 110.59 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 23.2 m -113.54 127.62 56.15 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 115.507 -0.769 . . . . 71.420000000000002 110.645 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.42 HD11 ' O ' ' B' ' 81' ' ' ALA . 94.9 mt -104.96 148.3 26.86 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.735 -0.839 . . . . 73.430000000000007 108.735 176.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 37.1 p90 -105.01 115.66 30.65 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 118.126 -1.429 . . . . 64.25 107.757 171.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 43.5 t -97.05 114.75 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-N 113.99 -1.459 . . . . 65.230000000000004 107.812 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 21.3 p -123.72 174.34 7.54 Favored 'General case' 0 N--CA 1.401 -2.908 0 CA-C-N 114.704 -1.134 . . . . 73.439999999999998 108.72 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 87.92 32.98 11.55 Favored Glycine 0 N--CA 1.421 -2.325 0 N-CA-C 110.241 -1.143 . . . . 61.340000000000003 110.241 -172.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 85.9 mt -105.68 142.87 25.69 Favored Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 107.767 -1.198 . . . . 61.25 107.767 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -75.68 164.3 32.35 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.977 1.784 . . . . 72.140000000000001 110.151 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.433 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 13.8 p -71.23 -8.51 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-O 122.457 1.123 . . . . 63.420000000000002 109.869 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.419 ' O ' ' HD2' ' B' ' 43' ' ' LYS . 13.0 t70 -99.43 10.95 40.43 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.24 -1.345 . . . . 73.129999999999995 109.472 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.65 125.01 23.05 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 CA-C-O 121.886 0.851 . . . . 72.430000000000007 109.79 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.51 ' HG3' ' NE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -105.53 142.55 24.98 Favored Pre-proline 0 C--N 1.291 -1.976 0 CA-C-N 114.65 -1.159 . . . . 71.319999999999993 109.517 177.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.75 -26.67 24.3 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 123.762 2.975 . . . . 73.349999999999994 113.632 -174.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.548 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 19.2 ptt180 -66.74 -26.17 66.86 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.879 -0.6 . . . . 73.319999999999993 112.057 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.43 ' HG3' ' HG2' ' B' ' 43' ' ' LYS . 42.3 mt-10 -70.3 -42.85 71.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.784 0.326 . . . . 61.509999999999998 110.945 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -68.01 -33.83 75.35 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 108.71 -0.848 . . . . 72.510000000000005 108.71 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.538 ' HB3' ' O ' ' B' ' 45' ' ' ARG . 62.8 t80 -60.97 -51.38 69.49 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.653 -1.158 . . . . 61.020000000000003 110.098 175.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 92.7 mt -62.84 -40.95 99.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.321 0.582 . . . . 64.099999999999994 110.216 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 25.4 tp -69.63 -41.59 75.42 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.781 -1.1 . . . . 61.340000000000003 111.674 -176.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -94.69 -2.25 51.55 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 114.954 1.464 . . . . 73.109999999999999 114.954 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 30.6 mtp180 -60.94 -43.25 90.71 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.292 0.849 . . . . 60.450000000000003 113.292 173.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.93 -19.93 70.17 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 121.378 1.385 . . . . 74.019999999999996 112.188 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -92.53 90.11 7.02 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 122.364 1.078 . . . . 74.25 110.191 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -76.45 109.35 10.1 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.684 -1.144 . . . . 75.420000000000002 110.05 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.42 -27.51 1.36 Allowed Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 108.986 -1.645 . . . . 65.340000000000003 108.986 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -51.86 123.32 9.99 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.542 1.137 . . . . 73.019999999999996 111.789 173.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -97.2 -60.39 1.59 Allowed 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 109.719 -0.475 . . . . 72.129999999999995 109.719 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.42 168.46 36.64 Favored Glycine 0 C--N 1.292 -1.915 0 C-N-CA 119.567 -1.301 . . . . 51.030000000000001 113.141 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.5 p -126.15 138.06 53.64 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.33 0.586 . . . . 71.450000000000003 110.747 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 49.5 tp -116.27 116.67 28.19 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.47 -0.937 . . . . 51.32 108.47 176.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mp -94.33 131.89 39.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 109.154 -0.684 . . . . 63.039999999999999 109.154 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -130.47 125.96 35.7 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.546 -0.909 . . . . 74.510000000000005 108.546 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -77.39 130.5 37.16 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.013 0.435 . . . . 41.119999999999997 110.774 -175.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.7 m -129.71 151.74 49.97 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 104.244 -2.502 . . . . 75.420000000000002 104.244 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.17 -45.46 8.35 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.376 1.07 . . . . 63.32 113.541 -174.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -88.96 -29.2 19.71 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.624 0.972 . . . . 74.409999999999997 113.624 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -165.06 132.56 2.39 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-O 120.871 0.367 . . . . 72.319999999999993 111.797 -169.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.433 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 12.0 Cg_exo -71.89 109.96 2.8 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.659 2.24 . . . . 73.329999999999998 108.747 167.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 33.3 m -87.21 151.56 3.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.2 -0.667 . . . . 71.340000000000003 109.2 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.98 121.09 4.59 Favored Glycine 0 C--N 1.297 -1.638 0 C-N-CA 119.271 -1.442 . . . . 54.310000000000002 112.726 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -87.91 104.32 16.5 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.818 -1.549 . . . . 55.509999999999998 106.818 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 98.9 t -100.31 117.35 45.38 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-N 115.028 -0.987 . . . . 64.439999999999998 109.697 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 tt -101.83 131.61 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 115.37 -0.832 . . . . 74.430000000000007 110.466 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -108.7 158.12 17.9 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.438 -1.255 . . . . 74.310000000000002 109.174 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -59.26 -27.12 65.52 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 123.758 0.661 . . . . 75.519999999999996 112.055 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 21.3 m -154.43 157.26 38.19 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.625 -0.672 . . . . 73.340000000000003 110.943 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . 0.622 ' HD3' ' N ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -57.97 -32.24 67.67 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.113 0.565 . . . . 73.510000000000005 110.623 175.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.25 -27.69 67.43 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.804 0.812 . . . . 74.219999999999999 110.062 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.88 -37.19 8.64 Favored Glycine 0 C--N 1.301 -1.374 0 N-CA-C 110.244 -1.142 . . . . 72.099999999999994 110.244 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.42 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -67.16 -47.3 71.43 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.455 -0.872 . . . . 51.030000000000001 111.182 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -57.52 -40.7 79.34 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.948 0.351 . . . . 71.310000000000002 111.948 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.05 -35.31 66.69 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 120.944 0.402 . . . . 61.130000000000003 110.945 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.93 -44.19 73.57 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.104 -0.498 . . . . 70.439999999999998 111.254 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.42 ' HE2' ' O ' ' B' ' 103' ' ' LEU . 0.0 OUTLIER -71.2 -32.14 68.49 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.146 -0.479 . . . . 71.109999999999999 110.648 -177.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -64.46 -38.78 92.22 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.797 -0.638 . . . . 70.200000000000003 111.092 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.97 -40.06 25.01 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 120.573 -0.451 . . . . 72.140000000000001 112.053 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.562 ' O ' HG23 ' B' ' 91' ' ' ILE . 94.5 mt -93.12 -11.99 31.53 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 116.593 2.072 . . . . 73.439999999999998 116.593 -172.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -78.66 117.64 20.01 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 117.911 -1.516 . . . . 64.319999999999993 110.488 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.04 7.83 37.46 Favored Glycine 0 CA--C 1.485 -1.836 0 C-N-CA 120.434 -0.889 . . . . 53.350000000000001 112.188 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.562 HG23 ' O ' ' B' ' 88' ' ' LEU . 13.5 tt -105.46 140.2 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 107.907 -1.146 . . . . 71.25 107.907 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.475 ' HG3' HG22 ' B' ' 100' ' ' THR . 43.7 mtt85 -70.65 139.9 51.43 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 113.843 1.053 . . . . 74.420000000000002 113.843 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.461 ' CD1' HD21 ' B' ' 101' ' ' LEU . 54.6 t80 -83.43 -25.07 31.58 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.141 -1.845 . . . . 73.319999999999993 108.321 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -149.31 122.71 4.52 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 106.883 -1.525 . . . . 73.519999999999996 106.883 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . 0.644 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 36.8 Cg_endo -62.84 -23.44 74.33 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.057 2.505 . . . . 63.119999999999997 113.993 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -98.18 1.7 47.67 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.266 0.555 . . . . 62.219999999999999 112.126 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -116.71 133.76 23.0 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 108.059 -1.089 . . . . 64.329999999999998 108.059 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.0 -9.46 19.29 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.796 2.331 . . . . 65.409999999999997 113.061 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' GLN . . . . . 0.422 ' HA ' ' OE1' ' B' ' 99' ' ' GLN . 6.1 tp60 -69.81 111.38 5.52 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.795 0.807 . . . . 72.239999999999995 109.934 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.475 HG22 ' HG3' ' B' ' 92' ' ' ARG . 41.7 p -110.43 145.31 37.84 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.181 -0.918 . . . . 73.040000000000006 109.34 -176.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.461 HD21 ' CD1' ' B' ' 93' ' ' PHE . 91.7 mt -71.18 146.55 49.03 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.295 0.569 . . . . 55.420000000000002 110.521 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -143.84 106.26 4.41 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.338 -1.356 . . . . 74.450000000000003 107.338 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.42 ' O ' ' HE2' ' B' ' 85' ' ' LYS . 6.7 mp -107.67 116.26 31.63 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.486 -0.779 . . . . 73.230000000000004 109.608 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.432 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 9.6 tp10 -129.26 161.55 29.93 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.231 -1.396 . . . . 70.540000000000006 107.231 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.403 ' HB3' HG13 ' B' ' 30' ' ' VAL . 72.3 m-85 -70.06 136.37 50.23 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 118.262 0.483 . . . . 74.030000000000001 110.687 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.48 153.7 43.12 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.068 -0.515 . . . . 73.349999999999994 110.571 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -82.37 5.09 21.44 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 122.184 0.993 . . . . 62.310000000000002 110.054 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -169.6 131.62 1.14 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.507 -1.664 . . . . 62.219999999999999 106.507 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -65.6 97.79 0.33 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.434 -0.58 . . . . 75.349999999999994 109.434 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 9.5 m -85.88 120.01 26.82 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 114.792 -1.095 . . . . 55.030000000000001 108.545 -176.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -84.31 141.94 30.56 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.706 -0.679 . . . . 60.340000000000003 110.286 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -82.28 -37.36 25.97 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.323 -1.362 . . . . 73.519999999999996 107.323 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.74 104.72 17.26 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.291 -1.322 . . . . 37.170000000000002 108.325 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.522 ' HG2' ' H ' ' B' ' 115' ' ' SER . 33.1 ttpt -145.67 -174.8 4.5 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.304 -1.739 . . . . 65.409999999999997 106.304 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.522 ' H ' ' HG2' ' B' ' 114' ' ' LYS . 19.5 m 79.62 20.96 0.61 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.686 1.195 . . . . 64.340000000000003 110.529 177.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -87.34 95.83 10.14 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.344 -0.984 . . . . 71.540000000000006 108.344 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 tt -88.3 81.46 7.28 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.37 -0.974 . . . . 73.030000000000001 108.37 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 . . . . . 0 N--CA 1.472 0.668 0 C-N-CA 129.678 3.191 . . . . 63.219999999999999 106.28 178.712 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 108.394 -0.965 . . . . 75.310000000000002 108.394 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -167.11 121.4 1.02 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.275 -1.009 . . . . 63.329999999999998 108.275 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -131.14 104.01 6.83 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.518 0.675 . . . . 73.329999999999998 110.311 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.482 ' HB3' ' HD2' ' A' ' 78' ' ' ARG . 1.9 tm-20 -141.99 -178.32 5.64 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 105.169 -2.16 . . . . 65.030000000000001 105.169 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.581 ' HA ' ' ND2' ' A' ' 109' ' ' ASN . 47.6 t -58.34 125.62 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 113.048 0.758 . . . . 74.140000000000001 113.048 -169.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 75' ' ' PHE . 6.6 mpt_? -106.04 6.08 30.85 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-N 115.859 -0.609 . . . . 63.310000000000002 112.104 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.1 m -135.82 132.46 36.7 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 114.35 1.241 . . . . 72.099999999999994 114.35 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.456 HD13 ' O ' ' A' ' 81' ' ' ALA . 68.9 mt -110.42 151.56 27.35 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.043 -1.095 . . . . 74.329999999999998 108.043 171.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -107.39 114.21 28.08 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 118.808 -1.157 . . . . 63.43 108.036 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.433 HG21 ' HG ' ' A' ' 103' ' ' LEU . 42.2 t -97.99 119.96 46.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.749 0 CA-C-N 113.791 -1.55 . . . . 44.049999999999997 107.9 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.7 p -123.26 165.1 17.5 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 115.204 -0.907 . . . . 73.5 109.628 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 96.36 18.67 30.19 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 111.5 -0.64 . . . . 71.319999999999993 111.5 -174.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.3 mt -89.83 128.87 48.57 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 107.337 -1.357 . . . . 65.439999999999998 107.337 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.41 165.22 32.43 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.684 1.589 . . . . 54.130000000000003 110.991 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.32 -5.42 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 122.151 0.976 . . . . 64.340000000000003 110.751 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.556 ' OD2' ' HE2' ' B' ' 43' ' ' LYS . 24.5 t70 -113.56 13.8 18.84 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.207 -0.906 . . . . 74.310000000000002 109.647 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.414 HD11 ' N ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -61.08 129.23 23.57 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 CA-C-O 121.693 0.758 . . . . 75.209999999999994 109.38 -178.221 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.414 ' N ' HD11 ' A' ' 42' ' ' ILE . 46.1 mmtm -93.59 145.8 30.62 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 115.477 -0.783 . . . . 71.329999999999998 113.031 -176.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.34 -29.02 87.95 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.589 2.193 . . . . 63.299999999999997 112.202 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.638 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -86.37 -12.11 50.15 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 118.885 -1.126 . . . . 64.450000000000003 110.491 177.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 43' ' ' LYS . 43.7 tt0 -77.1 -40.57 45.41 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.377 -0.601 . . . . 71.519999999999996 109.377 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.34 -33.23 75.36 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.684 0.754 . . . . 71.430000000000007 109.221 172.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.638 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 57.2 t80 -61.17 -48.87 79.59 Favored 'General case' 0 C--O 1.202 -1.432 0 CA-C-N 114.467 -1.242 . . . . 73.540000000000006 110.467 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 83.2 mt -66.88 -35.78 80.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.582 0.706 . . . . 60.119999999999997 110.031 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 tp -67.25 -51.31 54.64 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.787 -1.097 . . . . 71.230000000000004 111.287 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -96.41 11.95 33.05 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.493 0.923 . . . . 73.540000000000006 113.493 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 31.8 ttt-85 -70.36 -42.79 16.31 Favored Pre-proline 0 C--N 1.312 -1.061 0 C-N-CA 120.653 -0.419 . . . . 73.109999999999999 112.052 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -77.29 -4.39 14.7 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 121.521 1.48 . . . . 61.210000000000001 111.879 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -89.73 107.18 18.94 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 122.076 0.941 . . . . 60.219999999999999 111.533 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -75.29 110.56 9.74 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 113.707 -1.588 . . . . 54.310000000000002 108.905 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.22 -10.83 5.33 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.457 -0.878 . . . . 72.439999999999998 113.339 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -66.7 112.52 4.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.553 0.677 . . . . 71.439999999999998 111.141 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -90.1 -41.49 11.63 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.238 0.542 . . . . 62.140000000000001 110.424 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.46 -176.93 42.7 Favored Glycine 0 C--N 1.307 -1.066 0 CA-C-N 115.186 -0.915 . . . . 51.439999999999998 111.325 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.6 p -148.03 137.9 22.55 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.475 0.546 . . . . 45.200000000000003 112.475 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.4 mp -111.24 126.35 54.78 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.741 -0.837 . . . . 64.430000000000007 108.741 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.2 mm -94.97 143.57 11.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 C-N-CA 122.301 0.24 . . . . 55.340000000000003 110.637 -174.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 69' ' ' PRO . 64.0 tttp -125.95 106.19 9.46 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.847 -0.797 . . . . 71.209999999999994 108.847 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.36 112.79 9.76 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.49 -0.777 . . . . 75.319999999999993 110.443 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -110.99 173.21 6.44 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 107.912 -1.144 . . . . 53.32 107.912 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.87 -38.51 49.81 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.099 0.959 . . . . 73.109999999999999 112.911 -177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -104.19 -49.1 3.68 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.48 0.657 . . . . 64.219999999999999 111.467 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -136.92 136.05 20.75 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 114.789 -1.096 . . . . 65.030000000000001 112.316 -166.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 55.7 Cg_endo -81.1 102.36 1.35 Allowed 'Trans proline' 0 N--CA 1.429 -2.287 0 C-N-CA 122.723 2.282 . . . . 72.019999999999996 109.43 168.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -80.22 157.1 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 N-CA-C 109.291 -0.633 . . . . 75.409999999999997 109.291 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.09 123.49 4.83 Favored Glycine 0 CA--C 1.48 -2.144 0 C-N-CA 118.536 -1.792 . . . . 72.510000000000005 113.294 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -87.23 103.01 15.03 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 105.621 -1.992 . . . . 73.209999999999994 105.621 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 76.1 t -97.8 127.12 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 CA-C-N 115.084 -0.962 . . . . 72.219999999999999 110.495 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 3.0 mp -94.46 129.77 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 CA-C-N 114.482 -1.235 . . . . 74.319999999999993 108.575 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.455 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 89.4 m-85 -117.7 152.24 35.63 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.483 -0.932 . . . . 64.439999999999998 108.483 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -49.89 -38.05 34.05 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 124.548 1.139 . . . . 54.25 112.697 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.5 p -157.04 163.74 38.72 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.528 -0.76 . . . . 61.100000000000001 110.346 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.482 ' HD2' ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -71.99 -28.54 63.48 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.208 -0.597 . . . . 73.200000000000003 109.925 -178.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.83 -29.71 70.22 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-O 121.793 0.806 . . . . 74.150000000000006 109.424 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.08 -32.14 26.87 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.585 -1.006 . . . . 74.310000000000002 110.585 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.456 ' O ' HD13 ' A' ' 33' ' ' LEU . . . -67.05 -48.61 67.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 123.506 0.723 . . . . 74.010000000000005 110.976 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.01 -28.68 69.96 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.345 -0.222 . . . . 71.010000000000005 111.301 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.31 -41.02 73.84 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.965 0.412 . . . . 72.310000000000002 110.032 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.99 -42.22 90.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.813 -0.631 . . . . 42.200000000000003 109.64 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.534 ' HE2' ' HA ' ' A' ' 104' ' ' GLU . 34.7 ttmt -59.92 -45.62 92.0 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.558 -0.746 . . . . 75.299999999999997 110.269 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.59 -31.58 69.59 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.819 -0.628 . . . . 72.530000000000001 111.871 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.16 -35.18 17.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 113.025 0.75 . . . . 64.540000000000006 113.025 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 91' ' ' ILE . 97.9 mt -110.72 -5.31 15.02 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 116.724 2.12 . . . . 62.439999999999998 116.724 -170.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -78.7 114.57 17.74 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 117.358 -1.737 . . . . 74.349999999999994 111.199 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.65 12.93 33.78 Favored Glycine 0 CA--C 1.48 -2.132 0 N-CA-C 110.509 -1.036 . . . . 41.409999999999997 110.509 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 88' ' ' LEU . 9.6 tt -90.76 141.08 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.004 0 N-CA-C 108.969 -0.752 . . . . 75.109999999999999 108.969 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -63.21 117.05 6.01 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 108.122 -1.066 . . . . 74.209999999999994 108.122 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' B' ' 45' ' ' ARG . 64.9 t80 -73.86 -28.65 61.69 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.648 -1.612 . . . . 72.129999999999995 106.648 176.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 97' ' ' ASN . 20.8 t0 -144.27 117.03 5.63 Favored Pre-proline 0 N--CA 1.422 -1.843 0 N-CA-C 102.833 -3.025 . . . . 74.540000000000006 102.833 176.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.464 ' HD3' ' CZ ' ' B' ' 48' ' ' TYR . 74.2 Cg_endo -71.81 -20.76 25.75 Favored 'Trans proline' 0 C--N 1.327 -0.554 0 CA-C-N 120.608 1.253 . . . . 64.209999999999994 113.5 -177.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -87.06 -21.1 26.28 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 121.634 0.73 . . . . 64.120000000000005 109.134 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 46.8 t-20 -99.19 137.02 20.34 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 107.428 -1.323 . . . . 55.009999999999998 107.428 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.38 -13.94 31.83 Favored 'Trans proline' 0 CA--C 1.553 1.454 0 C-N-CA 122.556 2.171 . . . . 62.32 113.623 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -61.71 119.35 8.54 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.857 0.863 . . . . 74.230000000000004 110.593 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.41 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 24.7 p -119.22 147.21 44.5 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.249 -0.432 . . . . 75.200000000000003 110.811 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 24.5 tp -89.87 129.41 36.24 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.551 -0.749 . . . . 73.340000000000003 109.132 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -134.89 128.51 32.77 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.524 -0.547 . . . . 72.299999999999997 109.524 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.433 ' HG ' HG21 ' A' ' 35' ' ' VAL . 5.6 mp -113.8 128.01 56.24 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.722 -0.672 . . . . 72.140000000000001 109.439 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.534 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 9.3 tp10 -137.3 163.55 30.7 Favored 'General case' 0 C--O 1.195 -1.785 0 N-CA-C 107.618 -1.253 . . . . 61.340000000000003 107.618 177.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -73.24 133.58 44.02 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 119.229 0.922 . . . . 74.120000000000005 110.498 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.36 155.13 39.7 Favored 'General case' 0 N--CA 1.438 -1.051 0 O-C-N 123.688 0.618 . . . . 45.240000000000002 109.739 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -87.48 7.18 30.47 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.784 0.802 . . . . 73.420000000000002 109.88 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.42 126.05 12.54 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.609 -0.723 . . . . 55.409999999999997 109.45 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.581 ' ND2' ' HA ' ' A' ' 30' ' ' VAL . 3.4 m-20 -79.62 124.89 28.95 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.473 -0.936 . . . . 74.519999999999996 108.473 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.9 m -122.18 143.24 49.69 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 106.854 -1.536 . . . . 74.239999999999995 106.854 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -129.66 147.87 51.49 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.306 -0.558 . . . . 60.43 111.629 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 94.2 mmm -81.98 -57.62 3.33 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.504 -0.771 . . . . 73.319999999999993 109.239 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.1 106.41 5.76 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.627 -1.249 . . . . 50.409999999999997 107.627 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -124.5 113.18 17.77 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.491 -0.777 . . . . 71.519999999999996 109.54 -173.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.6 m -93.22 128.08 39.05 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.106 -0.497 . . . . 74.310000000000002 109.88 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -68.18 103.71 1.63 Allowed 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 109.162 -0.681 . . . . 64.129999999999995 109.162 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.53 14.49 9.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.769 0.795 . . . . 71.099999999999994 110.692 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 N--CA 1.403 -2.82 0 N-CA-C 105.955 -1.869 . . . . 65.439999999999998 105.955 174.224 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 108.893 -0.78 . . . . 63.25 108.893 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -106.69 130.13 54.47 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.566 -0.902 . . . . 65.230000000000004 108.566 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.405 ' HA ' ' NH1' ' B' ' 31' ' ' ARG . 41.3 tt0 -79.93 80.62 6.32 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 118.671 -1.212 . . . . 74.450000000000003 110.075 174.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.506 ' CB ' ' HD2' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -94.18 -179.64 5.01 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.612 -1.631 . . . . 72.030000000000001 107.693 177.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.453 ' HA ' ' ND2' ' B' ' 109' ' ' ASN . 34.8 t -76.38 112.78 14.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-O 121.763 0.792 . . . . 63.450000000000003 112.572 -170.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.405 ' NH1' ' HA ' ' B' ' 28' ' ' GLU . 6.3 mpt_? -90.24 6.45 42.78 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.402 -0.817 . . . . 71.129999999999995 112.188 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 18.3 m -129.42 128.42 42.94 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 113.4 0.889 . . . . 61.130000000000003 113.4 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.49 HD13 ' O ' ' B' ' 81' ' ' ALA . 76.3 mt -104.0 148.16 26.53 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.633 -1.247 . . . . 70.140000000000001 107.633 172.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 28.2 p90 -105.98 118.02 35.53 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 118.477 -1.289 . . . . 74.519999999999996 107.565 172.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.443 HG21 ' HG ' ' B' ' 103' ' ' LEU . 39.1 t -100.58 124.32 54.07 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.564 0 CA-C-N 114.157 -1.383 . . . . 44.310000000000002 107.849 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 35.7 p -129.16 168.43 16.15 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 115.339 -0.846 . . . . 50.409999999999997 109.89 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.82 12.07 57.14 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 110.543 -1.023 . . . . 37.109999999999999 110.543 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' B' ' 39' ' ' PRO . 89.8 mt -80.95 123.59 82.03 Favored Pre-proline 0 N--CA 1.432 -1.328 0 C-N-CA 123.634 0.774 . . . . 72.510000000000005 110.046 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 38' ' ' LEU . 51.5 Cg_exo -58.11 155.29 34.9 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.738 2.292 . . . . 72.329999999999998 111.649 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 7.4 p -70.32 -4.42 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-O 121.906 0.86 . . . . 74.209999999999994 111.046 -177.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -120.19 22.66 11.31 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.883 -0.784 . . . . 71.129999999999995 108.883 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 6.6 tt -50.44 132.08 10.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-N 115.077 -0.965 . . . . 44.210000000000001 111.609 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.556 ' HE2' ' OD2' ' A' ' 41' ' ' ASP . 39.6 mmtm -108.54 140.1 21.46 Favored Pre-proline 0 C--N 1.29 -1.994 0 CA-C-N 115.316 -0.857 . . . . 70.329999999999998 112.632 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -53.31 -41.75 70.39 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.73 2.287 . . . . 65.340000000000003 112.401 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.564 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -74.42 -22.76 58.99 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 117.718 -1.593 . . . . 72.200000000000003 111.356 -178.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' B' ' 43' ' ' LYS . 36.4 tt0 -66.46 -41.62 88.77 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.628 -0.879 . . . . 74.140000000000001 108.628 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.42 -41.75 88.76 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.616 -0.72 . . . . 72.140000000000001 110.011 173.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.575 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 71.6 t80 -52.8 -47.74 67.37 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 124.496 1.118 . . . . 75.420000000000002 111.121 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 88.5 mt -64.47 -37.36 87.26 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 123.31 0.381 . . . . 75.450000000000003 111.118 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 tp -75.87 -46.44 30.21 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.824 -0.626 . . . . 72.049999999999997 112.054 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -92.03 4.14 53.71 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.413 0.894 . . . . 71.340000000000003 113.413 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.575 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 53.0 ttt-85 -61.03 -48.44 92.42 Favored Pre-proline 0 CA--C 1.563 1.469 0 N-CA-C 112.656 0.613 . . . . 74.530000000000001 112.656 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.76 -1.71 11.83 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.133 1.889 . . . . 73.310000000000002 112.707 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -84.6 98.72 10.32 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.867 0.842 . . . . 72.140000000000001 110.779 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -66.39 113.84 4.96 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 113.783 -1.553 . . . . 74.120000000000005 109.401 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.15 -16.71 5.72 Favored Glycine 0 C--N 1.285 -2.27 0 CA-C-N 115.105 -0.952 . . . . 42.409999999999997 111.905 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -63.56 103.73 0.57 Allowed 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.246 0.546 . . . . 75.099999999999994 110.937 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -84.26 -45.61 12.68 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.746 -0.835 . . . . 61.549999999999997 108.746 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.25 173.63 42.95 Favored Glycine 0 C--N 1.305 -1.18 0 CA-C-N 114.814 -1.085 . . . . 53.409999999999997 111.768 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.3 p -128.68 141.37 51.36 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 122.542 0.337 . . . . 62.420000000000002 110.61 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 61.7 tp -114.5 110.94 20.6 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.919 -1.141 . . . . 52.020000000000003 107.919 175.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 50.9 mm -94.06 131.4 41.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 109.882 -0.414 . . . . 75.439999999999998 109.882 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -124.38 115.08 20.39 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.159 0.504 . . . . 73.209999999999994 110.178 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.57 124.67 23.88 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.731 -0.668 . . . . 74.409999999999997 110.748 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 11.2 m -130.26 155.34 46.46 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 103.835 -2.654 . . . . 74.439999999999998 103.835 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.45 -35.17 51.81 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.617 0.969 . . . . 71.030000000000001 113.617 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -87.02 -45.92 10.3 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 119.838 -0.745 . . . . 60.039999999999999 112.537 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -155.35 134.79 7.87 Favored Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 114.921 -1.036 . . . . 65.049999999999997 109.654 -168.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 14.3 Cg_exo -72.19 105.0 1.76 Allowed 'Trans proline' 0 C--N 1.298 -2.09 0 C-N-CA 122.283 1.989 . . . . 64.25 108.076 166.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 36.0 m -77.15 151.2 5.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.594 -0.891 . . . . 73.340000000000003 108.594 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.64 120.88 4.31 Favored Glycine 0 CA--C 1.474 -2.492 0 C-N-CA 117.791 -2.147 . . . . 71.299999999999997 113.124 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -88.29 102.52 14.92 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 105.999 -1.852 . . . . 71.340000000000003 105.999 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 70.6 t -95.2 120.25 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.544 0 CA-C-O 122.089 0.947 . . . . 71.439999999999998 109.761 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 58.3 mt -98.0 123.44 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.723 0 CA-C-N 113.099 -1.864 . . . . 65.409999999999997 109.021 -172.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -114.16 161.21 18.09 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-N 114.6 -1.182 . . . . 71.409999999999997 109.894 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -55.7 -41.39 73.72 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 124.684 1.194 . . . . 72.030000000000001 112.667 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 4.0 p -155.81 162.99 40.39 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.92 -0.582 . . . . 74.430000000000007 110.534 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . 0.506 ' HD2' ' CB ' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -70.71 -28.22 64.57 Favored 'General case' 0 C--O 1.202 -1.408 0 C-N-CA 119.865 -0.734 . . . . 74.540000000000006 109.889 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.0 -27.77 69.05 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.491 0.663 . . . . 52.049999999999997 110.196 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.46 -41.21 6.57 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.995 -1.242 . . . . 74.120000000000005 109.995 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.49 ' O ' HD13 ' B' ' 33' ' ' LEU . . . -61.91 -41.26 97.7 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 114.702 -0.749 . . . . 54.149999999999999 111.827 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.8 -36.24 83.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.548 0.213 . . . . 64.329999999999998 111.168 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.71 -39.28 73.52 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.381 -0.599 . . . . 74.340000000000003 109.381 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.86 -42.2 86.04 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.125 -0.943 . . . . 60.149999999999999 110.286 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.433 ' HE2' ' HA ' ' B' ' 104' ' ' GLU . 13.3 ttmt -60.71 -47.89 84.26 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.426 -0.806 . . . . 64.230000000000004 109.636 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -60.14 -38.49 83.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.009 -0.541 . . . . 71.310000000000002 111.11 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.42 -30.95 62.13 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 112.538 0.57 . . . . 71.0 112.538 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.596 ' O ' HG21 ' B' ' 91' ' ' ILE . 98.4 mt -108.52 -12.54 14.98 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 116.002 1.853 . . . . 75.340000000000003 116.002 -174.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -79.56 114.55 18.57 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 120.188 -1.57 . . . . 61.310000000000002 112.024 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.98 9.18 28.59 Favored Glycine 0 CA--C 1.485 -1.829 0 C-N-CA 120.619 -0.8 . . . . 73.439999999999998 111.381 173.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.596 HG21 ' O ' ' B' ' 88' ' ' LEU . 13.6 tt -104.81 149.79 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.803 0 N-CA-C 106.904 -1.517 . . . . 75.340000000000003 106.904 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.425 ' CZ ' ' HA ' ' B' ' 98' ' ' PRO . 99.3 mtt180 -81.39 138.71 35.58 Favored 'General case' 0 C--N 1.267 -2.989 0 CA-C-O 121.523 0.677 . . . . 74.409999999999997 112.192 175.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -77.97 -28.54 49.43 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.219 -1.355 . . . . 53.210000000000001 108.117 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.23 127.62 14.76 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 106.106 -1.812 . . . . 75.140000000000001 106.106 175.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . 0.53 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 72.7 Cg_endo -71.58 -21.72 25.34 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.089 1.859 . . . . 72.209999999999994 114.761 -176.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.99 -25.43 29.99 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.527 0.679 . . . . 74.109999999999999 109.717 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -97.2 128.77 33.98 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.475 -0.784 . . . . 72.129999999999995 108.983 -176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.425 ' HA ' ' CZ ' ' B' ' 92' ' ' ARG . 38.1 Cg_exo -60.64 -16.82 45.55 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 123.241 2.627 . . . . 54.299999999999997 113.179 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -55.46 118.86 4.83 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 124.707 1.203 . . . . 71.230000000000004 110.138 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 33.7 p -104.67 157.97 16.82 Favored 'General case' 0 N--CA 1.413 -2.323 0 C-N-CA 120.115 -0.634 . . . . 70.319999999999993 110.505 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 35.5 tp -96.25 124.66 40.33 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.507 -1.664 . . . . 75.409999999999997 106.507 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -129.62 127.46 40.67 Favored 'General case' 0 N--CA 1.422 -1.84 0 C-N-CA 120.161 -0.616 . . . . 71.329999999999998 109.758 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.443 ' HG ' HG21 ' B' ' 35' ' ' VAL . 5.8 mp -114.8 140.92 48.53 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.271 -1.011 . . . . 71.129999999999995 108.271 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.472 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 39.1 tt0 -152.24 165.64 34.24 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.535 -1.654 . . . . 75.510000000000005 106.535 176.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -71.32 138.46 49.31 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 120.077 1.308 . . . . 55.329999999999998 110.983 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.47 154.42 30.56 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.434 -0.58 . . . . 75.25 109.434 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -84.43 1.46 45.31 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 122.126 0.965 . . . . 73.230000000000004 109.432 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.82 118.72 12.52 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.302 -0.863 . . . . 65.120000000000005 109.481 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.453 ' ND2' ' HA ' ' B' ' 30' ' ' VAL . 3.8 m-20 -73.42 112.59 9.63 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.549 -1.278 . . . . 43.299999999999997 107.549 175.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 20.0 m -105.07 126.43 52.06 Favored 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 108.97 -0.752 . . . . 65.530000000000001 108.97 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -84.03 148.96 26.57 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.928 -0.768 . . . . 72.510000000000005 108.928 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -86.34 -37.14 18.77 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.268 -0.641 . . . . 74.319999999999993 109.268 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.24 112.95 25.08 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.345 -0.843 . . . . 72.109999999999999 110.032 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -111.77 116.07 30.11 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.262 -1.755 . . . . 73.340000000000003 106.262 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 7.9 t -150.63 158.95 44.75 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 109.511 -0.552 . . . . 40.520000000000003 109.511 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -102.87 101.14 11.17 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.756 -1.201 . . . . 74.450000000000003 107.756 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 89.3 mt -73.31 -23.31 60.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.087 0.47 . . . . 70.299999999999997 111.482 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.42 -1.961 0 N-CA-C 107.706 -1.22 . . . . 72.129999999999995 107.706 176.434 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 CA--C 1.498 -1.048 0 N-CA-C 108.986 -0.746 . . . . 75.310000000000002 108.986 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.09 -48.17 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.408 0.623 . . . . 70.430000000000007 110.029 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -109.78 80.92 1.36 Allowed 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 107.817 -1.179 . . . . 75.329999999999998 107.817 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.456 ' HA ' ' HD2' ' A' ' 78' ' ' ARG . 8.7 mm-40 -113.77 101.71 9.55 Favored 'General case' 0 N--CA 1.4 -2.954 0 CA-C-N 114.376 -1.283 . . . . 72.349999999999994 107.655 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.3 t -74.59 108.83 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 104.108 -2.553 . . . . 54.0 104.108 168.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -121.29 -4.15 9.44 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 115.174 -0.921 . . . . 64.319999999999993 110.322 -168.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.7 m -101.99 124.54 47.79 Favored 'General case' 0 C--N 1.264 -3.117 0 CA-C-N 115.132 -0.94 . . . . 54.119999999999997 109.213 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 33' ' ' LEU . 3.2 mp -108.13 137.59 45.85 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 107.308 -1.367 . . . . 75.099999999999994 107.308 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -103.77 109.16 20.77 Favored 'General case' 0 N--CA 1.412 -2.355 0 C-N-CA 118.473 -1.291 . . . . 74.019999999999996 107.621 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.438 HG22 ' HG ' ' A' ' 103' ' ' LEU . 25.0 t -96.57 120.17 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.752 0 CA-C-N 113.772 -1.558 . . . . 72.109999999999999 107.677 -174.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 20.1 p -126.51 166.78 16.63 Favored 'General case' 0 N--CA 1.4 -2.935 0 CA-C-N 114.644 -1.162 . . . . 63.310000000000002 108.305 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 94.89 32.08 7.36 Favored Glycine 0 N--CA 1.417 -2.619 0 N-CA-C 110.671 -0.972 . . . . 64.099999999999994 110.671 -173.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.4 mt -101.0 145.27 30.11 Favored Pre-proline 0 N--CA 1.428 -1.566 0 N-CA-C 109.081 -0.711 . . . . 54.409999999999997 109.081 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.04 157.69 33.17 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.208 1.939 . . . . 62.340000000000003 110.022 173.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.474 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 7.7 p -76.29 -2.15 4.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-O 122.362 1.077 . . . . 61.030000000000001 109.66 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -128.28 35.13 4.46 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 114.437 -1.256 . . . . 65.209999999999994 108.564 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.98 123.86 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 N-CA-C 108.097 -1.075 . . . . 54.049999999999997 108.097 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -93.65 143.98 27.45 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-N 115.358 -0.837 . . . . 61.100000000000001 110.153 -175.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.09 -19.95 35.5 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.472 2.781 . . . . 73.120000000000005 114.617 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.578 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -87.34 -15.67 37.26 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 118.435 -1.306 . . . . 74.310000000000002 111.644 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -67.32 -41.21 85.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.102 0.477 . . . . 62.32 110.244 -177.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.13 -30.31 67.45 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 116.153 -0.476 . . . . 70.340000000000003 109.833 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.701 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 41.2 t80 -61.88 -51.17 69.28 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.484 -0.78 . . . . 72.140000000000001 110.246 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.94 -38.31 90.51 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.073 -0.512 . . . . 75.200000000000003 110.973 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.8 tp -77.91 -43.02 31.27 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.507 -0.77 . . . . 74.530000000000001 112.289 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -97.62 -2.06 42.4 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 114.441 1.274 . . . . 54.43 114.441 -172.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 32.3 ttt-85 -60.69 -46.09 97.07 Favored Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 112.89 0.7 . . . . 64.219999999999999 112.89 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -75.05 -2.68 12.86 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.095 1.863 . . . . 75.25 112.769 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -83.88 106.21 15.38 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.627 0.727 . . . . 74.409999999999997 110.871 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -68.76 109.95 4.08 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.254 -1.339 . . . . 74.239999999999995 110.115 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.24 -14.28 6.97 Favored Glycine 0 N--CA 1.421 -2.306 0 CA-C-N 114.908 -1.042 . . . . 72.349999999999994 111.576 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -65.93 102.89 0.84 Allowed 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.173 0.511 . . . . 54.210000000000001 110.852 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -81.16 -57.48 3.49 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.543 -0.91 . . . . 75.299999999999997 108.543 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.08 -174.37 35.45 Favored Glycine 0 C--N 1.303 -1.251 0 CA-C-N 114.911 -1.04 . . . . 52.439999999999998 112.439 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.7 p -146.39 137.88 24.61 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 123.407 0.683 . . . . 65.239999999999995 110.297 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.403 ' HB2' ' SD ' ' A' ' 112' ' ' MET . 65.2 tp -112.06 120.05 40.54 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.558 -0.534 . . . . 61.32 109.558 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 mm -94.01 134.49 31.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.851 -0.796 . . . . 62.109999999999999 108.851 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -134.74 114.13 12.36 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 110.006 -0.368 . . . . 72.310000000000002 110.006 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.82 112.82 2.45 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.36 0.6 . . . . 65.310000000000002 109.514 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -113.86 164.32 13.92 Favored 'General case' 0 N--CA 1.404 -2.756 0 N-CA-C 105.479 -2.045 . . . . 75.140000000000001 105.479 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.97 -38.25 10.39 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.246 1.202 . . . . 54.450000000000003 114.246 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.74 -27.73 13.5 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.455 0.539 . . . . 74.329999999999998 112.455 -174.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -169.93 148.49 3.16 Favored Pre-proline 0 N--CA 1.423 -1.822 0 CA-C-N 115.921 -0.581 . . . . 61.109999999999999 110.7 -168.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.474 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 13.8 Cg_exo -70.24 106.2 1.71 Allowed 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 121.999 1.8 . . . . 63.210000000000001 108.417 165.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.1 m -81.48 158.76 4.08 Favored 'Isoleucine or valine' 0 C--O 1.25 1.081 0 N-CA-C 107.883 -1.155 . . . . 53.109999999999999 107.883 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.88 120.9 2.91 Favored Glycine 0 CA--C 1.484 -1.853 0 C-N-CA 117.668 -2.206 . . . . 73.109999999999999 113.077 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -88.03 102.02 14.35 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.532 -1.285 . . . . 72.0 107.532 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 78.4 t -91.34 123.79 43.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 108.814 -0.81 . . . . 54.509999999999998 108.814 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.9 pt -107.83 123.73 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.329 0 CA-C-O 122.05 0.929 . . . . 63.450000000000003 111.564 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -100.25 163.82 12.23 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 114.243 -1.344 . . . . 72.0 109.84 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -64.52 -39.86 94.55 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.111 -0.95 . . . . 65.109999999999999 112.461 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 56.0 m -145.21 166.0 26.74 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.742 -0.208 . . . . 62.119999999999997 110.48 -172.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.456 ' HD2' ' HA ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -71.94 -29.49 64.33 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 120.591 -0.444 . . . . 73.239999999999995 112.081 -176.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.23 -18.98 64.7 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 122.222 1.01 . . . . 65.340000000000003 108.88 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.1 -41.29 10.46 Favored Glycine 0 C--N 1.305 -1.184 0 CA-C-N 114.392 -1.276 . . . . 51.100000000000001 110.033 176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.62 -46.17 76.71 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.684 -0.758 . . . . 73.519999999999996 111.6 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -29.41 70.15 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 111.887 0.329 . . . . 71.129999999999995 111.887 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.55 -40.45 56.84 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 111.304 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.18 -43.23 87.47 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.915 -0.584 . . . . 74.510000000000005 110.953 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 103' ' ' LEU . 14.5 ptmm? -72.08 -31.81 66.45 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.93 -0.708 . . . . 74.209999999999994 110.414 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -58.73 -36.72 74.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.038 0.447 . . . . 74.140000000000001 110.453 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.23 -42.2 16.15 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 120.999 0.428 . . . . 61.219999999999999 111.606 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.436 ' O ' HG22 ' A' ' 91' ' ' ILE . 92.3 mt -98.52 -18.61 18.09 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 117.18 2.289 . . . . 72.510000000000005 117.18 -169.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.335 0.2 OUTLIER -72.42 114.63 10.75 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 117.167 -1.813 . . . . 53.049999999999997 111.946 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.68 14.92 10.71 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 110.461 -1.056 . . . . 64.310000000000002 110.461 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.1 tt -93.2 128.19 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 CA-C-O 121.26 0.553 . . . . 74.450000000000003 109.788 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.468 ' HG3' HG21 ' A' ' 100' ' ' THR . 5.9 ttt180 -83.79 124.82 31.32 Favored 'General case' 0 N--CA 1.402 -2.873 0 N-CA-C 107.68 -1.23 . . . . 72.030000000000001 107.68 173.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.434 ' HB2' ' CD1' ' A' ' 101' ' ' LEU . 3.5 t80 -64.18 -34.25 77.66 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 124.572 1.17 . . . . 73.120000000000005 110.012 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' B' ' 45' ' ' ARG . 2.8 p-10 -151.64 136.92 10.72 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 105.901 -1.889 . . . . 73.25 105.901 175.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.428 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 73.8 Cg_endo -75.48 -1.27 11.11 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.336 2.024 . . . . 65.140000000000001 114.118 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -92.35 -25.17 18.66 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.285 0.564 . . . . 73.129999999999995 110.019 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -99.29 133.77 21.78 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 108.065 -1.087 . . . . 72.420000000000002 108.065 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.63 -16.74 56.53 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.167 1.911 . . . . 42.020000000000003 112.398 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -62.16 122.33 15.32 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.573 1.149 . . . . 55.100000000000001 110.466 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.527 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 26.0 p -119.33 149.71 41.36 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.21 -0.663 . . . . 74.239999999999995 109.21 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.8 mp -88.67 124.09 33.76 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-O 120.789 0.328 . . . . 72.519999999999996 110.715 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -120.37 112.9 19.59 Favored 'General case' 0 N--CA 1.4 -2.964 0 N-CA-C 107.518 -1.29 . . . . 74.099999999999994 107.518 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.461 ' O ' ' HE2' ' A' ' 85' ' ' LYS . 6.4 mp -87.15 116.22 25.07 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.512 -1.222 . . . . 72.319999999999993 107.822 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -118.13 164.74 14.7 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.374 -1.343 . . . . 74.540000000000006 107.374 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -81.7 132.16 35.28 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 118.694 0.679 . . . . 73.420000000000002 109.568 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.41 137.79 48.6 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.837 -1.172 . . . . 73.319999999999993 107.837 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -82.95 12.02 5.43 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.215 1.007 . . . . 61.409999999999997 109.892 -175.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -157.5 118.73 3.61 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 114.421 -1.263 . . . . 73.239999999999995 107.614 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -70.68 138.63 50.81 Favored 'General case' 0 CA--C 1.475 -1.935 0 C-N-CA 120.019 -0.672 . . . . 72.129999999999995 110.329 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.3 m -118.37 142.84 47.13 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.567 -0.742 . . . . 72.209999999999994 110.168 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -115.44 158.32 22.69 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.03 -1.1 . . . . 71.310000000000002 108.03 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.403 ' SD ' ' HB2' ' A' ' 61' ' ' LEU . 96.7 mmm -89.17 -33.75 16.93 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.893 -0.78 . . . . 73.129999999999995 108.893 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -115.26 114.84 25.73 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.335 -0.848 . . . . 65.530000000000001 110.073 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -128.3 118.87 24.0 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.323 -0.991 . . . . 62.0 108.323 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.1 m -132.69 109.17 9.51 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.259 -0.645 . . . . 73.25 109.259 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -85.84 127.71 34.64 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.871 -1.159 . . . . 74.120000000000005 107.871 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.3 tp -84.02 -40.87 17.87 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.32 -0.4 . . . . 73.310000000000002 111.331 -174.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.3 -1.556 0 N-CA-C 107.051 -1.462 . . . . 65.540000000000006 107.051 -175.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 121.123 0.487 . . . . 55.439999999999998 111.166 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.44 -53.68 2.64 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 123.341 0.657 . . . . 75.129999999999995 110.886 -172.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -130.77 86.25 2.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.191 -1.04 . . . . 75.040000000000006 108.191 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 23.0 mm-40 -76.3 102.32 5.83 Favored 'General case' 0 N--CA 1.399 -3.014 0 CA-C-N 114.243 -1.344 . . . . 74.420000000000002 109.989 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 81.0 t -72.38 109.02 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 103.748 -2.686 . . . . 74.209999999999994 103.748 168.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' B' ' 29' ' ' GLU . 16.4 ptt180 -129.02 7.39 5.52 Favored 'General case' 0 CA--C 1.471 -2.078 0 CA-C-N 115.435 -0.802 . . . . 74.530000000000001 111.803 -169.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 56.6 m -109.58 132.34 54.23 Favored 'General case' 0 C--N 1.264 -3.151 0 N-CA-C 107.554 -1.276 . . . . 64.349999999999994 107.554 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' B' ' 72' ' ' PHE . 3.4 mp -121.98 151.46 40.77 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.482 -0.933 . . . . 72.239999999999995 108.482 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' B' ' 104' ' ' GLU . 17.9 p90 -108.13 111.47 23.5 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.787 -1.19 . . . . 75.010000000000005 107.787 175.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 57.2 t -97.57 122.16 48.86 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 CA-C-N 114.094 -1.412 . . . . 71.120000000000005 108.197 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 65.4 p -130.05 174.8 9.44 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.532 -0.758 . . . . 64.310000000000002 110.128 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 88.66 22.87 38.14 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.029 -1.228 . . . . 61.229999999999997 110.029 -172.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 88.4 mt -92.37 132.52 31.8 Favored Pre-proline 0 N--CA 1.412 -2.336 0 N-CA-C 106.179 -1.785 . . . . 53.219999999999999 106.179 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.88 160.24 30.2 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 121.639 1.559 . . . . 74.109999999999999 110.95 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.62 -7.92 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-O 122.588 1.185 . . . . 63.200000000000003 109.774 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -121.46 31.92 6.11 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 114.042 -1.435 . . . . 51.049999999999997 108.576 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.25 131.65 33.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 109.091 -0.707 . . . . 74.230000000000004 109.091 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -100.52 136.54 19.92 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-N 115.302 -0.863 . . . . 72.319999999999993 109.655 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -54.62 -24.61 37.65 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 C-N-CA 123.716 2.944 . . . . 74.209999999999994 114.121 -173.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.516 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 10.6 ptt180 -82.5 -15.24 53.16 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 122.081 -0.387 . . . . 61.149999999999999 111.954 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.13 -40.83 82.39 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.31 -0.626 . . . . 71.140000000000001 109.31 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 90.8 mt -68.76 -32.26 71.89 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.463 -0.79 . . . . 63.240000000000002 109.633 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.577 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 75.6 t80 -63.53 -48.17 78.62 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.135 -0.939 . . . . 73.239999999999995 110.033 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 84.9 mt -67.16 -39.93 86.58 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.196 0.522 . . . . 73.409999999999997 110.31 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 tp -74.01 -40.39 62.96 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.954 -1.021 . . . . 71.510000000000005 112.473 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -97.97 -4.18 36.8 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.639 0.978 . . . . 72.450000000000003 113.639 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 67.7 ttt180 -61.55 -45.07 93.78 Favored Pre-proline 0 CA--C 1.555 1.141 0 N-CA-C 112.665 0.617 . . . . 75.310000000000002 112.665 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.62 -12.99 20.3 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 121.373 1.382 . . . . 63.119999999999997 113.021 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -78.01 110.73 13.21 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 121.953 0.882 . . . . 64.439999999999998 111.48 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -72.38 109.46 6.11 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 113.945 -1.479 . . . . 65.129999999999995 109.363 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.69 -13.78 5.83 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-N 115.522 -0.763 . . . . 52.219999999999999 112.317 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -61.57 117.03 5.23 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.33 0.586 . . . . 73.209999999999994 111.638 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.47 -47.47 5.95 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.487 -0.779 . . . . 63.43 111.034 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.23 177.13 46.73 Favored Glycine 0 C--N 1.294 -1.802 0 C-N-CA 120.015 -1.088 . . . . 65.329999999999998 112.457 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.5 p -135.47 137.78 42.5 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 122.852 0.461 . . . . 62.229999999999997 110.999 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 5.5 mp -117.35 124.4 48.84 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.423 -1.325 . . . . 72.420000000000002 107.423 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 47.2 mm -94.28 146.98 5.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 109.671 -0.492 . . . . 71.25 109.671 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -129.59 106.57 8.83 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.234 -1.395 . . . . 53.32 107.234 176.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -72.44 116.57 13.05 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.99 -1.115 . . . . 71.010000000000005 107.99 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 11.5 m -122.84 155.16 37.19 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 104.98 -2.23 . . . . 62.240000000000002 104.98 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.94 -25.79 65.45 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.905 0.383 . . . . 60.399999999999999 111.698 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -82.11 -45.8 14.7 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 116.062 -0.517 . . . . 70.519999999999996 111.695 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -172.34 145.97 1.57 Allowed Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 108.183 -1.044 . . . . 71.519999999999996 108.183 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.06 106.38 2.02 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.299 2.0 . . . . 71.150000000000006 109.087 168.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 35.8 m -87.6 157.67 3.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.721 -0.844 . . . . 70.239999999999995 108.721 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.31 120.89 3.33 Favored Glycine 0 CA--C 1.481 -2.067 0 C-N-CA 118.62 -1.753 . . . . 73.120000000000005 112.791 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' B' ' 33' ' ' LEU . 98.0 m-85 -88.16 102.37 14.74 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.342 -1.355 . . . . 73.5 107.342 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 88.4 t -94.13 130.15 43.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.298 0 CA-C-N 114.678 -1.146 . . . . 53.119999999999997 109.703 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 48.6 pt -106.99 138.64 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.241 0 CA-C-O 121.848 0.832 . . . . 72.319999999999993 110.596 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -119.21 166.08 13.42 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 114.116 -1.402 . . . . 72.120000000000005 111.553 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.75 -40.87 80.73 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.023 -1.444 . . . . 72.340000000000003 112.362 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 5.0 p -157.95 167.64 29.38 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.145 -0.48 . . . . 72.129999999999995 111.399 -170.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.58 -30.11 62.82 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 120.219 -0.593 . . . . 71.430000000000007 109.845 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.48 -24.19 63.75 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.766 0.793 . . . . 43.009999999999998 109.579 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.89 -36.85 9.79 Favored Glycine 0 C--N 1.309 -0.963 0 CA-C-N 114.63 -1.168 . . . . 72.430000000000007 110.581 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.07 71.44 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.717 0.807 . . . . 50.539999999999999 111.002 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.29 -38.66 77.47 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 116.092 -0.504 . . . . 74.140000000000001 111.207 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.6 -40.8 72.99 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.716 -0.674 . . . . 52.329999999999998 111.322 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.82 -41.38 83.15 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 116.161 -0.472 . . . . 73.540000000000006 111.459 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.451 ' HE2' ' O ' ' B' ' 103' ' ' LEU . 15.1 ptmm? -72.02 -36.42 69.68 Favored 'General case' 0 C--O 1.2 -1.533 0 C-N-CA 120.153 -0.619 . . . . 52.140000000000001 109.521 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -58.95 -39.22 81.0 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.316 0.646 . . . . 52.409999999999997 110.081 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.45 -31.37 37.47 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 112.615 0.598 . . . . 71.129999999999995 112.615 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.41 ' O ' HG23 ' B' ' 91' ' ' ILE . 96.2 mt -100.21 -31.49 11.35 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.201 1.926 . . . . 72.109999999999999 116.201 -174.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . 0.251 0.2 OUTLIER -65.91 121.96 16.27 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.448 1.277 . . . . 71.230000000000004 114.448 -173.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.23 14.94 15.21 Favored Glycine 0 N--CA 1.428 -1.874 0 C-N-CA 120.744 -0.741 . . . . 73.239999999999995 112.104 174.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.41 HG23 ' O ' ' B' ' 88' ' ' LEU . 13.5 tt -103.98 140.04 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.909 0 N-CA-C 107.123 -1.436 . . . . 64.099999999999994 107.123 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' B' ' 94' ' ' ASP . 89.4 mtt180 -74.15 134.91 42.83 Favored 'General case' 0 C--N 1.263 -3.163 0 CA-C-O 120.869 0.366 . . . . 65.010000000000005 110.051 171.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.466 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.0 t80 -65.49 -34.76 79.02 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.436 -1.256 . . . . 75.5 109.171 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.472 ' HB2' ' CB ' ' B' ' 97' ' ' ASN . 3.0 m-20 -131.4 138.35 32.57 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 102.055 -3.313 . . . . 52.219999999999999 102.055 173.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . 0.701 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 22.1 Cg_endo -63.21 -29.25 73.51 Favored 'Trans proline' 0 N--CA 1.486 1.041 0 CA-C-N 121.911 1.718 . . . . 53.229999999999997 111.001 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.5 -17.36 42.21 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.965 -1.47 . . . . 50.399999999999999 110.916 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' ASN . . . . . 0.472 ' CB ' ' HB2' ' B' ' 94' ' ' ASP . 39.5 t30 -100.43 125.67 38.54 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 109.573 -0.528 . . . . 64.519999999999996 109.573 -175.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.72 -10.71 28.35 Favored 'Trans proline' 0 C--O 1.239 0.554 0 C-N-CA 122.795 2.33 . . . . 74.409999999999997 112.586 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' GLN . . . . . 0.423 ' HB3' ' ND2' ' B' ' 97' ' ' ASN . 6.6 tp60 -70.29 113.06 7.08 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.446 -0.946 . . . . 72.140000000000001 108.446 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.498 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 69.6 p -97.37 145.8 25.79 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.03 -0.532 . . . . 70.349999999999994 109.919 -175.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 52.2 tp -87.85 123.71 32.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.881 -1.155 . . . . 71.049999999999997 107.881 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -136.88 123.33 20.8 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-O 121.669 0.747 . . . . 74.319999999999993 110.337 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.451 ' O ' ' HE2' ' B' ' 85' ' ' LYS . 5.4 mp -107.19 122.52 46.69 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.199 -1.364 . . . . 71.340000000000003 109.391 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.419 ' HB2' ' CE1' ' B' ' 34' ' ' PHE . 48.6 mt-10 -126.29 165.56 18.75 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.206 -1.035 . . . . 65.530000000000001 108.206 174.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -73.81 141.15 46.2 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.807 -0.357 . . . . 74.349999999999994 110.039 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.03 158.8 26.4 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.563 -0.903 . . . . 37.460000000000001 108.563 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -92.26 7.75 41.3 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.956 0.884 . . . . 75.0 109.946 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -157.66 132.67 8.72 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.252 -0.885 . . . . 55.520000000000003 108.916 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -85.32 141.28 30.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.574 -0.528 . . . . 53.530000000000001 109.574 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -123.25 145.8 48.38 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.498 -0.927 . . . . 74.439999999999998 108.498 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -114.08 160.37 18.99 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 120.732 0.301 . . . . 73.420000000000002 110.754 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 14.1 mmt -94.01 -31.48 14.23 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.869 -0.605 . . . . 60.149999999999999 111.03 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -127.54 114.62 17.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 116.004 -0.543 . . . . 75.299999999999997 110.596 -177.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -160.32 94.42 1.08 Allowed 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.664 -1.236 . . . . 60.009999999999998 107.664 175.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.2 m -86.39 101.22 12.92 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.856 0.836 . . . . 73.439999999999998 111.229 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -93.6 90.66 6.73 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.177 -1.416 . . . . 73.120000000000005 107.177 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 51.7 tp -64.64 -32.59 74.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.825 0.821 . . . . 72.129999999999995 109.191 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 N--CA 1.404 -2.736 0 N-CA-C 107.096 -1.446 . . . . 74.040000000000006 107.096 177.915 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 CA--C 1.51 -0.571 0 N-CA-C 108.959 -0.756 . . . . 75.310000000000002 108.959 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -175.44 -167.34 0.25 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 101.874 -3.38 . . . . 73.319999999999993 101.874 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -98.58 36.93 1.55 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.561 -2.014 . . . . 74.340000000000003 105.561 172.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 9.6 pt-20 -55.43 151.68 9.82 Favored 'General case' 0 N--CA 1.397 -3.078 0 CA-C-N 112.395 -2.184 . . . . 73.450000000000003 114.777 -173.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.5 t -104.58 114.64 44.72 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.549 0 N-CA-C 105.669 -1.975 . . . . 74.510000000000005 105.669 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 16.8 ptm180 -114.65 7.09 15.9 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.327 -0.851 . . . . 70.329999999999998 110.42 -175.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.9 m -116.41 117.73 30.75 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.919 0.866 . . . . 64.510000000000005 110.686 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 mp -98.13 140.73 32.01 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.774 -1.565 . . . . 74.200000000000003 106.774 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.516 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 6.8 p90 -107.54 114.64 28.77 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 117.578 -1.649 . . . . 72.140000000000001 107.979 173.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.41 HG23 ' HG ' ' A' ' 103' ' ' LEU . 43.8 t -97.29 121.05 47.41 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.879 0 CA-C-N 114.375 -1.284 . . . . 72.120000000000005 108.492 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.5 p -124.26 170.77 10.44 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 115.544 -0.753 . . . . 64.140000000000001 109.608 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 82.35 41.42 9.24 Favored Glycine 0 N--CA 1.43 -1.725 0 N-CA-C 110.103 -1.199 . . . . 36.850000000000001 110.103 -173.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.4 mt -111.31 123.06 35.98 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 114.23 -0.985 . . . . 73.219999999999999 110.16 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.5 144.08 19.61 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.857 2.372 . . . . 71.329999999999998 110.664 173.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.494 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 7.6 p -73.24 4.75 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 CA-C-O 122.475 1.131 . . . . 71.209999999999994 112.088 -173.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -125.66 13.12 8.04 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.885 -1.052 . . . . 70.5 110.904 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.0 pt -53.65 135.68 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 113.453 0.909 . . . . 62.119999999999997 113.453 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -97.18 146.0 30.59 Favored Pre-proline 0 C--N 1.292 -1.894 0 CA-C-N 114.625 -1.17 . . . . 72.540000000000006 109.119 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.13 -26.7 52.03 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.171 2.581 . . . . 72.319999999999993 112.861 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.525 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 9.8 ptt180 -70.86 -23.91 62.41 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 120.858 0.361 . . . . 72.420000000000002 111.328 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -72.63 -40.47 66.39 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.633 -0.877 . . . . 41.340000000000003 108.633 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.2 mt -66.73 -36.78 83.28 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.802 -0.814 . . . . 65.340000000000003 108.802 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.525 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 87.8 t80 -58.62 -47.54 84.04 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-N 114.708 -1.133 . . . . 74.140000000000001 110.253 175.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 97.6 mt -70.91 -30.14 66.4 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.072 0.463 . . . . 71.519999999999996 110.563 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.7 tp -68.62 -51.56 40.95 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.213 -0.903 . . . . 65.010000000000005 110.667 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -95.2 10.59 35.43 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.682 0.623 . . . . 72.420000000000002 112.682 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 10.6 ttp180 -52.65 -50.02 83.01 Favored Pre-proline 0 CA--C 1.565 1.539 0 C-N-CA 124.471 1.108 . . . . 74.349999999999994 113.696 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -85.35 -0.88 9.07 Favored 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 121.588 1.525 . . . . 64.049999999999997 112.74 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -88.72 96.04 10.51 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 122.629 1.204 . . . . 70.219999999999999 112.104 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -69.85 113.54 7.18 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 113.068 -1.878 . . . . 65.230000000000004 109.44 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.99 -24.82 3.25 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 114.956 -1.02 . . . . 63.420000000000002 110.661 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -56.62 115.81 2.76 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.251 0.62 . . . . 51.310000000000002 111.352 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -94.26 -56.58 2.78 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 109.209 -0.663 . . . . 55.399999999999999 109.209 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.22 169.93 40.63 Favored Glycine 0 C--N 1.295 -1.743 0 CA-C-N 115.214 -0.903 . . . . 45.299999999999997 111.6 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.4 p -130.55 137.36 49.66 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 120.93 0.395 . . . . 72.230000000000004 110.543 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -121.02 109.73 15.4 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.52 -0.919 . . . . 53.020000000000003 108.52 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -93.92 130.84 42.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.098 0.475 . . . . 72.530000000000001 111.287 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 69' ' ' PRO . 87.2 tttt -108.84 112.37 24.59 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.505 -0.924 . . . . 55.049999999999997 108.505 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.1 122.77 15.21 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.789 -0.642 . . . . 73.109999999999999 110.226 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.594 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 15.5 m -130.39 159.67 36.3 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 105.669 -1.975 . . . . 65.299999999999997 105.669 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -42.64 -41.78 3.21 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.177 1.391 . . . . 72.030000000000001 114.356 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -105.62 -36.47 7.08 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.331 0.586 . . . . 71.030000000000001 112.542 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.594 ' O ' ' HB ' ' A' ' 65' ' ' THR . 8.3 pt20 -147.3 132.29 8.98 Favored Pre-proline 0 C--N 1.291 -1.953 0 CA-C-N 115.357 -0.838 . . . . 75.299999999999997 111.697 -168.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 40' ' ' VAL . 32.3 Cg_endo -73.06 101.87 1.39 Allowed 'Trans proline' 0 N--CA 1.433 -2.082 0 C-N-CA 121.649 1.566 . . . . 72.430000000000007 108.18 167.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.7 m -70.77 139.12 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 108.685 -0.857 . . . . 63.350000000000001 108.685 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -108.82 119.79 5.7 Favored Glycine 0 CA--C 1.465 -3.056 0 C-N-CA 118.236 -1.935 . . . . 72.329999999999998 112.939 -174.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -88.73 101.91 14.47 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 105.865 -1.902 . . . . 64.439999999999998 105.865 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -96.78 121.55 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.504 0 CA-C-N 114.735 -1.12 . . . . 63.030000000000001 108.888 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.7 mt -102.02 119.85 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.763 0 CA-C-N 114.601 -1.181 . . . . 72.109999999999999 109.854 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.521 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 5.2 m-85 -102.07 156.35 17.6 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 114.373 -1.285 . . . . 72.340000000000003 109.916 176.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -64.47 -30.53 71.56 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.201 -1.363 . . . . 62.530000000000001 112.112 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m -156.27 155.84 33.03 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 121.804 -0.56 . . . . 74.109999999999999 112.205 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.611 ' HD3' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -54.16 -39.15 66.29 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 123.953 0.783 . . . . 72.340000000000003 110.91 175.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.71 -29.56 69.42 Favored 'General case' 0 CA--C 1.493 -1.249 0 O-C-N 123.889 0.743 . . . . 75.310000000000002 110.369 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.01 -45.4 5.1 Favored Glycine 0 C--N 1.295 -1.733 0 CA-C-N 114.469 -1.241 . . . . 73.329999999999998 110.69 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.1 -46.32 88.6 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.479 1.112 . . . . 70.120000000000005 113.137 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 10.0 pt-20 -62.51 -37.11 84.77 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.384 -0.371 . . . . 64.340000000000003 111.327 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.31 -37.63 52.21 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 116.267 -0.424 . . . . 65.430000000000007 110.638 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.76 90.37 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.721 -0.672 . . . . 63.130000000000003 111.661 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -75.36 -33.71 61.08 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 118.552 -1.259 . . . . 64.219999999999999 111.85 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.6 -17.15 61.21 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.229 0.538 . . . . 55.32 111.509 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.22 -45.03 14.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 120.998 0.427 . . . . 62.210000000000001 110.285 175.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.546 ' O ' HG23 ' A' ' 91' ' ' ILE . 91.9 mt -91.04 -5.42 55.31 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 114.749 1.389 . . . . 73.219999999999999 114.749 -173.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -78.99 114.77 18.21 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.055 -1.028 . . . . 74.310000000000002 112.627 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.13 20.37 10.56 Favored Glycine 0 CA--C 1.479 -2.216 0 C-N-CA 120.408 -0.901 . . . . 55.530000000000001 111.64 174.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 88' ' ' LEU . 16.0 tt -114.3 142.32 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.276 0 N-CA-C 105.461 -2.051 . . . . 70.540000000000006 105.461 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.471 ' CD ' ' HA ' ' A' ' 95' ' ' PRO . 33.3 ptt180 -87.02 130.09 34.61 Favored 'General case' 0 C--N 1.262 -3.227 0 C-N-CA 119.424 -0.91 . . . . 55.039999999999999 111.335 175.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -60.75 -31.48 70.81 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.701 -1.59 . . . . 71.409999999999997 110.207 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -142.28 113.27 6.18 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 105.512 -2.033 . . . . 74.0 105.512 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.471 ' HA ' ' CD ' ' A' ' 92' ' ' ARG . 53.0 Cg_exo -61.38 -12.85 25.81 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 122.99 2.46 . . . . 43.43 114.846 -178.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -98.21 -14.45 20.33 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.704 -0.623 . . . . 74.010000000000005 110.177 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -94.79 141.97 24.07 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.705 -0.85 . . . . 64.519999999999996 108.705 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.09 2.35 7.25 Favored 'Trans proline' 0 CA--C 1.549 1.248 0 C-N-CA 122.619 2.213 . . . . 75.019999999999996 114.314 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -92.87 127.78 38.5 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 121.558 -0.714 . . . . 72.510000000000005 109.259 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.561 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 50.6 p -107.08 143.64 34.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.916 -0.401 . . . . 55.119999999999997 109.916 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 34.7 tp -89.37 127.98 35.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.382 -0.97 . . . . 74.519999999999996 108.382 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -136.96 124.01 21.56 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 108.545 -0.909 . . . . 64.450000000000003 108.545 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.41 ' HG ' HG23 ' A' ' 35' ' ' VAL . 5.9 mp -112.83 122.72 48.5 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 115.732 -0.667 . . . . 60.530000000000001 109.85 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.516 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 43.3 mt-10 -127.89 177.43 6.85 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.603 -1.258 . . . . 75.140000000000001 107.603 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -91.02 138.57 31.5 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 118.753 0.706 . . . . 64.019999999999996 111.424 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.75 158.79 33.98 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.443 -0.799 . . . . 60.310000000000002 108.865 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -84.8 -1.98 57.11 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.764 0.792 . . . . 75.450000000000003 109.643 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -151.43 132.56 14.4 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.321 -0.854 . . . . 72.109999999999999 109.623 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -78.11 124.29 27.88 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.645 -0.502 . . . . 70.400000000000006 109.645 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.7 m -92.68 139.14 30.87 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.07 -1.085 . . . . 75.439999999999998 108.07 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -86.07 123.08 30.98 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.868 -0.79 . . . . 75.400000000000006 108.868 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -86.52 -63.72 1.27 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.433 -0.951 . . . . 74.209999999999994 108.433 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -150.28 93.31 1.98 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.218 0.533 . . . . 45.5 110.331 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -143.47 117.89 9.68 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.752 -0.658 . . . . 72.010000000000005 109.483 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 m -85.41 89.85 7.79 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.67 -0.492 . . . . 62.039999999999999 109.67 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -94.17 76.38 4.03 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.267 -1.753 . . . . 74.040000000000006 106.267 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 tt -87.61 127.31 35.27 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.058 -1.83 . . . . 60.109999999999999 106.058 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 . . . . . 0 N--CA 1.475 0.81 0 C-N-CA 124.928 1.291 . . . . 75.209999999999994 109.765 -175.454 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 67.1 mtm . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 120.925 0.393 . . . . 72.409999999999997 109.968 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . 0.467 ' C ' ' H ' ' B' ' 29' ' ' GLU . 2.1 mp0 -108.15 -170.69 1.72 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.994 -0.743 . . . . 65.200000000000003 108.994 -174.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -83.58 43.69 0.92 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.425 -1.324 . . . . 62.109999999999999 107.425 172.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' B' ' 27' ' ' GLU . 8.3 pt-20 -64.7 127.59 32.21 Favored 'General case' 0 N--CA 1.41 -2.467 0 C-N-CA 125.969 1.707 . . . . 74.010000000000005 111.217 -176.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.472 ' HA ' HD22 ' B' ' 109' ' ' ASN . 48.5 t -95.72 110.55 24.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.816 -0.809 . . . . 75.340000000000003 108.816 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' B' ' 75' ' ' PHE . 15.0 ptm180 -114.49 11.65 17.19 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.208 -0.905 . . . . 72.510000000000005 111.232 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 29.6 m -122.19 122.93 40.31 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.514 0.673 . . . . 71.109999999999999 111.096 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 mp -101.63 144.75 29.97 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.075 -1.454 . . . . 62.32 107.075 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' B' ' 104' ' ' GLU . 9.9 p90 -109.2 116.43 31.9 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 117.412 -1.715 . . . . 62.340000000000003 108.179 171.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.46 120.06 46.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 CA-C-N 113.946 -1.479 . . . . 73.439999999999998 108.225 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.441 ' OG ' ' HG3' ' B' ' 102' ' ' ARG . 11.0 p -128.72 163.03 26.02 Favored 'General case' 0 N--CA 1.408 -2.557 0 CA-C-N 115.505 -0.771 . . . . 73.400000000000006 109.984 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 88.83 37.79 7.19 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 110.648 -0.981 . . . . 42.100000000000001 110.648 -173.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.89 135.79 19.37 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 108.069 -1.086 . . . . 73.430000000000007 108.069 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.06 150.64 23.46 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.081 1.854 . . . . 73.040000000000006 110.194 172.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.451 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 8.1 p -76.75 1.73 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 121.999 0.904 . . . . 62.409999999999997 110.5 -174.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -127.73 20.85 6.53 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.509 -0.769 . . . . 50.340000000000003 110.032 -173.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 24.9 pt -52.6 133.77 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 113.871 1.063 . . . . 74.0 113.871 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' B' ' 43' ' ' LYS . 3.2 mptp? -90.86 147.12 35.26 Favored Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 114.58 -1.191 . . . . 75.400000000000006 109.458 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.84 -28.65 59.21 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.855 2.37 . . . . 64.450000000000003 113.286 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.525 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -79.54 -14.38 58.9 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 117.642 -1.623 . . . . 63.25 111.898 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -69.93 -40.53 75.46 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.818 -0.808 . . . . 72.049999999999997 108.818 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 88.6 mt -66.4 -34.03 77.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.376 -0.829 . . . . 72.349999999999994 109.072 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.525 ' HB3' ' O ' ' B' ' 45' ' ' ARG . 78.9 t80 -60.94 -49.28 78.08 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-N 115.112 -0.949 . . . . 72.310000000000002 110.065 176.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 92.0 mt -70.01 -29.14 66.12 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-O 121.117 0.484 . . . . 74.430000000000007 110.677 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 tp -71.78 -51.03 24.7 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.113 -0.949 . . . . 64.010000000000005 111.121 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -96.8 7.5 46.45 Favored 'General case' 0 C--O 1.217 -0.608 0 N-CA-C 113.674 0.99 . . . . 71.239999999999995 113.674 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 10.0 ttp180 -47.93 -50.83 51.53 Favored Pre-proline 0 CA--C 1.568 1.639 0 N-CA-C 114.505 1.298 . . . . 72.120000000000005 114.505 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -87.62 -1.39 7.46 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 121.685 1.59 . . . . 73.209999999999994 112.98 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -86.96 97.17 10.55 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.929 1.347 . . . . 71.450000000000003 111.878 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -69.39 113.25 6.53 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 112.169 -2.287 . . . . 72.340000000000003 109.637 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.26 -20.28 4.23 Favored Glycine 0 N--CA 1.422 -2.295 0 CA-C-N 114.72 -1.127 . . . . 71.150000000000006 111.29 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -57.05 114.98 2.36 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.249 0.62 . . . . 73.409999999999997 112.075 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.36 -51.24 4.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.607 0.718 . . . . 65.299999999999997 109.363 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.17 178.59 42.88 Favored Glycine 0 C--N 1.298 -1.55 0 CA-C-N 115.208 -0.905 . . . . 53.43 112.198 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 6.7 p -134.39 141.08 46.73 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 123.508 0.723 . . . . 64.209999999999994 110.082 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -122.91 112.93 18.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.736 -1.579 . . . . 36.850000000000001 106.736 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -93.84 137.92 21.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.13 0.49 . . . . 72.340000000000003 111.254 -176.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -124.46 112.14 16.54 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.129 -1.063 . . . . 61.210000000000001 108.129 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.48 116.61 7.66 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.661 -0.496 . . . . 70.239999999999995 109.661 -177.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 8.5 m -111.53 167.38 10.37 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.523 -1.658 . . . . 75.540000000000006 106.523 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.78 -33.11 6.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.231 1.197 . . . . 71.439999999999998 114.231 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 58.7 mtt-85 -104.72 -28.68 11.05 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.665 0.987 . . . . 74.319999999999993 113.665 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -170.7 152.86 3.93 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 116.439 -0.346 . . . . 73.439999999999998 110.155 -165.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.451 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 51.4 Cg_endo -77.72 108.24 2.52 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 C-N-CA 122.27 1.98 . . . . 54.149999999999999 109.927 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 31.7 m -76.03 140.23 17.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.372 -1.344 . . . . 71.099999999999994 107.372 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.16 120.84 5.46 Favored Glycine 0 C--N 1.282 -2.438 0 C-N-CA 118.753 -1.689 . . . . 74.310000000000002 112.912 -175.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.4 102.29 14.39 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 105.883 -1.895 . . . . 61.43 105.883 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 83.3 t -94.94 124.76 47.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 114.789 -1.096 . . . . 55.439999999999998 109.279 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 60.7 mt -107.35 122.08 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.567 0 CA-C-N 114.41 -1.268 . . . . 75.239999999999995 109.81 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.447 ' O ' ' HB2' ' B' ' 31' ' ' ARG . 4.0 m-85 -105.95 157.2 17.67 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.666 -1.152 . . . . 75.430000000000007 109.697 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.76 -36.26 67.64 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.125 -0.943 . . . . 61.409999999999997 109.868 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.91 134.31 54.85 Favored 'General case' 0 N--CA 1.389 -3.485 0 CA-C-N 115.173 -0.921 . . . . 72.530000000000001 109.406 -170.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -25.09 56.71 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.425 -0.807 . . . . 61.210000000000001 111.218 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.3 -19.81 49.54 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 107.451 -1.315 . . . . 73.25 107.451 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.34 -41.98 8.18 Favored Glycine 0 C--N 1.295 -1.705 0 CA-C-N 113.312 -1.767 . . . . 64.409999999999997 109.22 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.23 -46.91 88.16 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.201 1.0 . . . . 65.420000000000002 112.16 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -58.81 -44.72 90.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.257 -0.429 . . . . 73.519999999999996 111.305 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.71 -36.16 75.68 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.705 -0.68 . . . . 60.0 110.578 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.68 -42.37 91.36 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.881 -0.6 . . . . 53.130000000000003 111.444 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -74.27 -36.03 63.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 118.171 -1.412 . . . . 63.32 111.147 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -63.49 -27.47 69.29 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.547 0.529 . . . . 74.349999999999994 111.321 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.31 -43.69 17.18 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 120.672 0.272 . . . . 74.109999999999999 111.388 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.529 ' O ' HG23 ' B' ' 91' ' ' ILE . 95.7 mt -86.22 -8.57 57.69 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.164 1.542 . . . . 53.310000000000002 115.164 -174.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.22 114.59 15.06 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.049 -1.06 . . . . 65.219999999999999 112.813 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.49 14.79 26.86 Favored Glycine 0 N--CA 1.428 -1.851 0 C-N-CA 120.301 -0.952 . . . . 53.520000000000003 112.278 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.529 HG23 ' O ' ' B' ' 88' ' ' LEU . 16.3 tt -106.59 134.43 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.211 0 N-CA-C 106.127 -1.805 . . . . 52.240000000000002 106.127 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.529 ' NE ' ' HA ' ' B' ' 95' ' ' PRO . 39.4 ptt180 -78.9 133.11 36.97 Favored 'General case' 0 C--N 1.262 -3.223 0 C-N-CA 119.651 -0.82 . . . . 74.230000000000004 111.168 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -69.13 -28.63 66.63 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.769 -1.559 . . . . 74.340000000000003 110.206 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' A' ' 45' ' ' ARG . 10.6 t70 -146.57 118.25 4.83 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 106.389 -1.708 . . . . 63.130000000000003 106.389 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . 0.529 ' HA ' ' NE ' ' B' ' 92' ' ' ARG . 21.0 Cg_endo -60.69 -21.45 69.58 Favored 'Trans proline' 0 N--CA 1.48 0.726 0 C-N-CA 123.039 2.493 . . . . 72.310000000000002 114.409 -176.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -85.97 -23.25 26.97 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.508 0.671 . . . . 65.340000000000003 110.27 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -100.62 132.29 22.51 Favored Pre-proline 0 C--N 1.29 -2.002 0 CA-C-N 115.499 -0.773 . . . . 73.299999999999997 109.13 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.08 -0.72 6.74 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.852 2.368 . . . . 72.400000000000006 112.505 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -69.72 112.23 6.04 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.888 -0.782 . . . . 72.530000000000001 108.888 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.476 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 70.3 p -103.48 145.57 29.81 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.903 -0.777 . . . . 73.219999999999999 108.903 -177.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 36.7 tp -89.9 130.67 36.09 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.663 -1.236 . . . . 61.450000000000003 107.663 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.441 ' HG3' ' OG ' ' B' ' 36' ' ' SER . 7.7 ptm180 -138.14 122.53 18.32 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 108.694 -0.854 . . . . 70.340000000000003 108.694 -175.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -117.47 132.37 56.56 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.82 -0.627 . . . . 73.540000000000006 110.18 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.577 ' HB2' ' CE2' ' B' ' 34' ' ' PHE . 36.0 mt-10 -136.43 174.28 10.79 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.19 -1.781 . . . . 73.099999999999994 106.19 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -81.84 145.02 30.62 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 119.128 -1.029 . . . . 74.439999999999998 110.941 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.14 151.73 40.0 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 107.906 -1.146 . . . . 72.019999999999996 107.906 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -75.95 -9.66 58.79 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.004 0.907 . . . . 62.509999999999998 109.888 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.8 127.29 9.33 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.076 -0.965 . . . . 73.010000000000005 108.827 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.472 HD22 ' HA ' ' B' ' 30' ' ' VAL . 93.0 m-20 -71.71 143.73 49.55 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.912 -0.585 . . . . 65.310000000000002 110.976 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 22.5 m -110.33 129.58 55.72 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 108.075 -1.083 . . . . 64.420000000000002 108.075 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -92.13 110.73 22.11 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.178 -1.045 . . . . 64.239999999999995 108.178 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -67.98 -60.62 2.36 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.672 -0.694 . . . . 60.43 111.361 -171.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -147.27 101.24 3.37 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.221 -0.592 . . . . 72.150000000000006 112.133 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -154.62 129.11 9.15 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.235 -1.024 . . . . 63.229999999999997 108.235 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 48.4 m -80.1 109.82 14.92 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.337 0.589 . . . . 63.5 109.43 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -144.47 83.39 1.72 Allowed 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 106.222 -1.77 . . . . 71.340000000000003 106.222 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 4.6 tt -110.08 76.59 1.0 Allowed 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.548 -0.751 . . . . 65.510000000000005 109.71 -175.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 C--N 1.306 -1.294 0 N-CA-C 105.476 -2.046 . . . . 74.0 105.476 175.503 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.368 0.128 . . . . 75.310000000000002 111.012 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -149.09 -70.58 0.2 Allowed 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.519 -1.289 . . . . 38.049999999999997 107.519 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -141.67 105.33 4.7 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.789 -1.189 . . . . 73.439999999999998 107.789 175.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -86.66 137.86 32.13 Favored 'General case' 0 N--CA 1.394 -3.23 0 N-CA-C 106.861 -1.533 . . . . 53.119999999999997 106.861 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.86 110.12 14.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.465 -1.309 . . . . 63.409999999999997 107.465 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 17.0 ptp180 -113.99 -1.7 13.72 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.069 -0.969 . . . . 74.439999999999998 111.172 -172.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.4 m -111.07 130.57 55.57 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 115.538 -0.755 . . . . 44.109999999999999 110.679 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -127.78 153.31 46.72 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.903 -0.777 . . . . 75.510000000000005 108.903 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -103.0 120.68 41.08 Favored 'General case' 0 N--CA 1.418 -2.075 0 CA-C-O 121.924 0.869 . . . . 74.040000000000006 108.97 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.0 t -97.59 120.94 47.58 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 CA-C-N 114.388 -1.278 . . . . 71.140000000000001 107.659 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.8 p -128.9 157.44 41.58 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 116.295 -0.411 . . . . 64.209999999999994 110.564 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 98.91 17.44 27.84 Favored Glycine 0 C--N 1.299 -1.525 0 O-C-N 123.675 0.609 . . . . 54.340000000000003 112.734 -178.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.452 ' O ' ' HD2' ' A' ' 69' ' ' PRO . 96.1 mt -78.72 125.65 83.9 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 106.9 -1.519 . . . . 74.319999999999993 106.9 173.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 41' ' ' ASP . 10.8 Cg_endo -58.63 154.57 41.88 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.244 1.296 . . . . 52.32 110.117 176.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.3 p -73.44 4.8 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 CA-C-O 122.33 1.062 . . . . 74.310000000000002 110.785 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.442 ' O ' ' HE2' ' A' ' 43' ' ' LYS . 18.3 t70 -110.34 13.29 22.95 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 114.574 -1.194 . . . . 60.329999999999998 109.155 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.266 2.4 pp -58.09 141.43 15.08 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 N-CA-C 114.939 1.459 . . . . 74.430000000000007 114.939 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 41' ' ' ASP . 61.1 mmtt -106.5 145.93 32.0 Favored Pre-proline 0 C--N 1.283 -2.313 0 CA-C-N 113.548 -1.66 . . . . 73.430000000000007 106.736 176.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.14 -25.93 65.38 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.223 1.949 . . . . 54.240000000000002 111.94 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.494 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 13.9 ptt180 -69.82 -24.73 63.51 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.574 -0.739 . . . . 70.040000000000006 111.521 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.413 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 40.6 mt-10 -69.99 -42.89 72.47 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 120.986 0.422 . . . . 75.430000000000007 110.28 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.01 -37.3 86.91 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.85 0.833 . . . . 63.450000000000003 109.099 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.559 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 23.2 t80 -60.88 -50.47 73.29 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.462 -1.245 . . . . 72.340000000000003 110.905 176.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 95.7 mt -64.16 -41.41 97.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.174 0.511 . . . . 64.109999999999999 110.065 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 tp -67.33 -41.96 84.4 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.741 -1.118 . . . . 74.150000000000006 111.52 -176.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -92.07 -1.32 57.27 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 115.194 1.553 . . . . 63.039999999999999 115.194 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.559 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 12.6 mtp180 -61.51 -45.97 94.11 Favored Pre-proline 0 N--CA 1.479 0.992 0 N-CA-C 113.794 1.035 . . . . 74.239999999999995 113.794 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.28 -16.28 43.66 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 121.166 1.244 . . . . 74.120000000000005 112.513 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -92.65 92.33 7.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.296 1.046 . . . . 64.329999999999998 110.203 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -73.35 113.92 10.98 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 113.753 -1.567 . . . . 74.040000000000006 109.544 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.98 -20.93 2.49 Favored Glycine 0 C--N 1.288 -2.123 0 CA-C-N 114.754 -1.112 . . . . 44.200000000000003 111.657 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -54.47 112.73 1.06 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.553 0.741 . . . . 75.299999999999997 111.969 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -94.26 -45.21 7.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.639 -0.71 . . . . 74.329999999999998 110.932 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.43 178.35 48.32 Favored Glycine 0 C--N 1.298 -1.563 0 C-N-CA 120.27 -0.967 . . . . 65.230000000000004 112.791 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.0 p -143.08 142.17 31.45 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 123.069 0.548 . . . . 45.109999999999999 111.297 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.424 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 5.4 mp -118.8 130.21 55.65 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.247 -1.39 . . . . 74.209999999999994 107.247 173.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.5 mm -109.26 131.92 58.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 118.043 0.383 . . . . 70.430000000000007 111.26 -173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -120.13 106.83 12.34 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.479 -0.934 . . . . 73.409999999999997 108.479 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -63.21 126.24 26.75 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.802 -1.09 . . . . 60.210000000000001 109.517 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 14.8 m -130.1 153.98 47.93 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 105.565 -2.013 . . . . 72.420000000000002 105.565 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.41 -33.64 31.18 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.164 1.172 . . . . 64.439999999999998 114.164 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -104.19 -35.67 7.94 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 112.768 0.655 . . . . 75.109999999999999 112.768 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.537 ' O ' ' HB ' ' A' ' 65' ' ' THR . 5.4 pm0 -156.88 129.45 4.23 Favored Pre-proline 0 C--N 1.302 -1.477 0 C-N-CA 121.071 -0.251 . . . . 75.420000000000002 110.434 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 38' ' ' LEU . 29.0 Cg_exo -64.15 118.64 5.59 Favored 'Trans proline' 0 N--CA 1.441 -1.577 0 C-N-CA 122.305 2.003 . . . . 65.409999999999997 108.99 167.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.0 140.33 15.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.383 -0.969 . . . . 63.520000000000003 108.383 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 61' ' ' LEU . . . -122.33 122.22 4.98 Favored Glycine 0 C--N 1.289 -2.05 0 C-N-CA 119.775 -1.203 . . . . 64.519999999999996 112.699 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -87.89 103.16 15.4 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.429 -1.693 . . . . 75.299999999999997 106.429 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.44 132.19 47.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 CA-C-N 115.118 -0.947 . . . . 74.230000000000004 110.545 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.4 HD11 ' O ' ' A' ' 110' ' ' THR . 4.7 tt -107.68 129.69 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 CA-C-N 114.893 -1.049 . . . . 71.299999999999997 109.98 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.502 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 14.2 m-85 -108.76 158.33 17.73 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 114.897 -1.047 . . . . 73.25 109.22 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.97 -31.95 73.44 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.872 -0.604 . . . . 72.140000000000001 111.256 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.7 p -133.32 152.13 51.91 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 112.492 0.553 . . . . 45.140000000000001 112.492 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.445 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.89 -35.46 80.06 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 108.591 -0.892 . . . . 63.539999999999999 108.591 175.106 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.419 ' N ' ' HG2' ' A' ' 78' ' ' ARG . . . -71.61 -19.52 62.11 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 122.556 1.169 . . . . 74.120000000000005 108.316 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.96 -45.64 8.93 Favored Glycine 0 C--N 1.294 -1.779 0 CA-C-N 113.937 -1.483 . . . . 70.420000000000002 110.153 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.29 -42.89 74.87 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.99 -0.605 . . . . 64.530000000000001 111.593 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.443 ' HA ' ' HG2' ' A' ' 85' ' ' LYS 0.27 1.4 pp20? -69.67 -30.24 67.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 112.937 0.717 . . . . 74.5 112.937 -177.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.62 -32.81 68.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.316 0.579 . . . . 38.049999999999997 109.992 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.87 -44.87 68.91 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.438 -0.801 . . . . 72.120000000000005 110.828 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 104' ' ' GLU . 14.1 ptmm? -68.88 -33.11 73.25 Favored 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 120.792 -0.363 . . . . 75.409999999999997 110.209 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -59.73 -41.77 91.66 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.403 0.681 . . . . 63.140000000000001 109.913 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.59 -33.39 18.9 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 112.196 0.443 . . . . 64.140000000000001 112.196 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.585 ' O ' HG23 ' A' ' 91' ' ' ILE . 97.1 mt -94.05 -13.25 27.1 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 115.934 1.827 . . . . 54.329999999999998 115.934 -172.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.313 0.2 OUTLIER -78.79 114.39 17.68 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 116.771 -1.972 . . . . 73.430000000000007 112.633 177.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.26 6.85 25.36 Favored Glycine 0 CA--C 1.492 -1.401 0 C-N-CA 120.746 -0.74 . . . . 74.510000000000005 112.335 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 88' ' ' LEU . 9.1 tt -91.96 130.39 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 N-CA-C 107.844 -1.169 . . . . 74.510000000000005 107.844 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -74.9 130.25 39.07 Favored 'General case' 0 C--N 1.275 -2.631 0 C-N-CA 119.523 -0.871 . . . . 65.200000000000003 109.772 171.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -66.73 -30.04 70.16 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.336 -1.302 . . . . 73.540000000000006 108.284 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -141.58 124.9 9.78 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 104.556 -2.387 . . . . 74.450000000000003 104.556 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.469 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 43.1 Cg_endo -65.01 -27.17 58.04 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 122.197 1.931 . . . . 61.039999999999999 114.454 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -81.92 -24.79 35.42 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.422 -0.955 . . . . 63.310000000000002 108.422 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -84.12 129.45 58.42 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.852 -1.166 . . . . 64.530000000000001 107.852 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.08 -18.49 51.48 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.196 1.931 . . . . 73.400000000000006 112.275 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.416 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 6.1 tp60 -66.48 114.83 5.77 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.261 0.553 . . . . 62.200000000000003 110.485 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.472 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 32.8 p -98.23 161.78 13.53 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 115.678 -0.692 . . . . 74.019999999999996 109.772 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.5 tp -100.8 126.97 47.41 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.53 -1.285 . . . . 74.349999999999994 107.53 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.466 ' HD2' ' OG1' ' A' ' 100' ' ' THR . 0.1 OUTLIER -127.13 117.16 21.84 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.513 -0.921 . . . . 73.349999999999994 108.513 -176.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.15 123.84 49.86 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.814 -0.63 . . . . 64.329999999999998 110.101 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.466 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 9.1 tp10 -140.52 158.02 44.62 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.45 -1.315 . . . . 64.510000000000005 107.45 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -66.14 140.91 58.24 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 118.715 0.689 . . . . 71.420000000000002 112.847 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.71 158.46 24.21 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 108.375 -0.972 . . . . 71.540000000000006 108.375 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -82.35 -7.56 59.63 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.283 0.563 . . . . 74.120000000000005 110.472 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.0 136.41 28.43 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.958 -0.564 . . . . 44.020000000000003 110.905 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -81.88 124.41 29.68 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.779 -0.646 . . . . 73.519999999999996 109.631 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.4 ' O ' HD11 ' A' ' 74' ' ' ILE . 11.3 t -87.77 138.98 30.99 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 107.338 -1.356 . . . . 63.520000000000003 107.338 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -112.35 109.97 19.91 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.28 0.562 . . . . 64.430000000000007 111.875 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 14.7 mmt -87.89 -32.94 18.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.566 -0.743 . . . . 74.349999999999994 109.631 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -129.13 107.89 9.93 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.199 -0.91 . . . . 60.450000000000003 109.622 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -101.86 90.3 3.95 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.151 -0.685 . . . . 65.340000000000003 109.151 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.2 m -88.88 80.72 7.06 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.911 0.862 . . . . 60.240000000000002 108.999 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 154.2 24.69 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.864 -1.062 . . . . 61.020000000000003 112.994 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.8 mt -85.48 125.67 33.22 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.506 -0.924 . . . . 65.329999999999998 108.506 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--N 1.293 -1.889 0 N-CA-C 107.763 -1.199 . . . . 73.420000000000002 107.763 -177.708 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 109.897 -0.408 . . . . 62.009999999999998 109.897 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -68.88 -73.01 0.16 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.422 -0.354 . . . . 75.319999999999993 111.556 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -122.27 91.67 3.56 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.039 0.755 . . . . 70.400000000000006 113.039 -173.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -95.45 122.28 38.01 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 106.06 -1.83 . . . . 55.119999999999997 106.06 170.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' B' ' 78' ' ' ARG . 55.0 t -78.4 109.48 13.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.71 -0.848 . . . . 72.450000000000003 108.71 -174.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -118.71 4.13 11.62 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.985 0.898 . . . . 73.510000000000005 110.325 -172.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' THR . . . . . 0.438 ' HB ' ' HA ' ' B' ' 109' ' ' ASN . 63.5 m -111.52 136.06 51.23 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.688 -1.142 . . . . 62.240000000000002 108.345 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -131.53 154.37 48.87 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.443 -0.577 . . . . 61.039999999999999 109.443 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 30.6 p90 -101.97 118.1 36.2 Favored 'General case' 0 N--CA 1.416 -2.171 0 CA-C-O 122.04 0.924 . . . . 61.229999999999997 108.718 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 51.0 t -98.42 122.25 49.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 113.901 -1.5 . . . . 73.319999999999993 107.553 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 22.5 p -127.42 164.57 21.58 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.666 -0.697 . . . . 64.349999999999994 109.603 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 93.95 27.81 11.92 Favored Glycine 0 N--CA 1.424 -2.143 0 O-C-N 123.523 0.514 . . . . 71.510000000000005 111.896 -175.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 98.2 mt -96.55 117.78 65.77 Favored Pre-proline 0 C--N 1.292 -1.91 0 N-CA-C 108.629 -0.878 . . . . 73.420000000000002 108.629 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.76 151.74 14.56 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.882 2.388 . . . . 61.229999999999997 112.001 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.466 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 11.9 p -63.62 -6.69 2.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 123.876 0.87 . . . . 74.319999999999993 112.781 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -121.39 26.31 8.93 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.618 -0.676 . . . . 74.150000000000006 109.775 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.412 HD12 ' O ' ' B' ' 42' ' ' ILE . 2.5 pp -58.43 135.76 22.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 113.203 0.816 . . . . 73.239999999999995 113.203 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -102.31 143.34 26.41 Favored Pre-proline 0 C--N 1.278 -2.53 0 CA-C-N 114.718 -1.128 . . . . 64.540000000000006 109.187 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -51.87 -32.18 45.91 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.79 2.327 . . . . 61.43 112.666 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.56 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 10.7 ptt180 -68.44 -25.44 65.02 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 111.886 0.328 . . . . 64.439999999999998 111.886 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -70.5 -39.63 74.02 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.602 0.715 . . . . 71.439999999999998 109.365 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 77.7 mt -67.71 -34.71 77.41 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 115.007 -0.997 . . . . 72.540000000000006 108.637 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.608 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 51.0 t80 -62.49 -48.44 79.56 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.745 -1.116 . . . . 73.239999999999995 110.102 176.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 93.6 mt -66.22 -40.77 90.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.131 0.491 . . . . 64.319999999999993 110.294 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.3 tp -71.57 -43.42 66.36 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.278 -0.874 . . . . 73.439999999999998 112.048 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -100.07 8.24 44.09 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 113.301 0.852 . . . . 74.209999999999994 113.301 -174.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 28.5 ttt180 -70.54 -43.34 16.14 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-O 119.349 -0.358 . . . . 74.010000000000005 111.798 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -74.96 -12.73 21.61 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 121.532 1.488 . . . . 73.329999999999998 112.623 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -85.72 110.82 19.59 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.655 0.741 . . . . 75.140000000000001 111.668 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -74.55 112.59 10.89 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.489 -1.232 . . . . 74.329999999999998 111.304 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.13 -19.84 3.84 Favored Glycine 0 N--CA 1.429 -1.77 0 CA-C-N 115.018 -0.992 . . . . 62.009999999999998 112.97 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -56.64 112.6 1.33 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.209 0.528 . . . . 75.439999999999998 112.369 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -93.75 -55.03 3.4 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.751 -0.659 . . . . 72.299999999999997 110.756 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.29 170.71 43.72 Favored Glycine 0 C--N 1.296 -1.667 0 C-N-CA 120.309 -0.948 . . . . 51.439999999999998 112.304 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 12.6 p -132.3 137.12 47.34 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.388 0.514 . . . . 75.409999999999997 112.388 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . 0.408 ' O ' ' HA2' ' B' ' 71' ' ' GLY . 54.8 mt -104.3 113.5 27.1 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.353 -0.98 . . . . 73.049999999999997 108.353 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 43.2 mm -94.38 127.02 46.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 109.208 -0.664 . . . . 62.219999999999999 109.208 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -120.2 114.7 22.31 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.517 -0.92 . . . . 71.209999999999994 108.517 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.37 123.23 19.06 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.866 -0.607 . . . . 55.420000000000002 109.638 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.1 m -128.04 150.44 49.94 Favored 'General case' 0 N--CA 1.402 -2.851 0 N-CA-C 103.923 -2.621 . . . . 74.019999999999996 103.923 174.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.09 -40.16 4.71 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.5 1.296 . . . . 73.430000000000007 114.5 -173.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -100.61 -18.52 16.54 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 112.373 0.509 . . . . 74.129999999999995 112.373 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -169.05 127.32 0.88 Allowed Pre-proline 0 C--N 1.308 -1.234 0 C-N-CA 120.878 -0.329 . . . . 73.150000000000006 111.628 -169.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 10.5 Cg_exo -73.33 101.21 1.32 Allowed 'Trans proline' 0 N--CA 1.437 -1.798 0 C-N-CA 122.363 2.042 . . . . 75.530000000000001 107.99 167.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.97 150.36 4.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.022 -0.536 . . . . 64.040000000000006 109.712 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' B' ' 61' ' ' LEU . . . -123.23 120.65 4.29 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 118.402 -1.856 . . . . 74.409999999999997 112.959 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -88.11 102.52 14.86 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.192 -1.781 . . . . 74.120000000000005 106.192 175.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.86 130.21 49.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-N 114.677 -1.147 . . . . 75.129999999999995 110.863 -172.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.494 HD12 ' O ' ' B' ' 110' ' ' THR . 3.7 tt -104.05 127.61 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 0 CA-C-N 115.204 -0.907 . . . . 70.010000000000005 109.613 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.404 ' HB2' ' HB1' ' B' ' 81' ' ' ALA . 8.9 m-85 -105.33 154.13 20.69 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.43 -1.322 . . . . 73.239999999999995 107.43 171.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -65.19 -37.04 86.08 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.64 -0.504 . . . . 70.540000000000006 109.64 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 4.2 p -114.86 133.21 56.15 Favored 'General case' 0 N--CA 1.386 -3.673 0 CA-C-O 121.722 0.772 . . . . 75.209999999999994 111.304 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' B' ' 30' ' ' VAL . 0.0 OUTLIER -75.65 -24.46 56.39 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 115.241 -0.891 . . . . 72.140000000000001 110.785 177.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.12 -19.82 39.32 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.906 -1.516 . . . . 63.039999999999999 106.906 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.08 -43.43 10.8 Favored Glycine 0 C--N 1.299 -1.507 0 CA-C-N 113.277 -1.783 . . . . 62.340000000000003 109.637 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' B' ' 75' ' ' PHE . . . -62.41 -35.13 78.26 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.52 -0.84 . . . . 53.439999999999998 110.977 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 1.4 pp20? -69.42 -38.28 77.83 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.29 -0.964 . . . . 73.519999999999996 110.405 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.52 78.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.091 0.472 . . . . 74.140000000000001 110.4 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.03 -44.46 72.65 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.824 -0.625 . . . . 38.049999999999997 111.402 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' B' ' 82' ' ' GLU . 13.2 ptmm? -68.45 -34.71 76.44 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.787 -0.365 . . . . 74.299999999999997 110.475 -177.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -62.51 -28.85 70.13 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.063 -0.517 . . . . 73.019999999999996 110.91 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.75 -41.3 13.41 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 112.305 0.483 . . . . 63.299999999999997 112.305 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.539 ' O ' HG22 ' B' ' 91' ' ' ILE . 97.5 mt -98.62 -8.17 26.79 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 116.192 1.923 . . . . 74.340000000000003 116.192 -169.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 36.0 p30 -69.99 116.11 9.98 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 119.504 1.047 . . . . 72.430000000000007 113.208 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.87 7.07 48.31 Favored Glycine 0 CA--C 1.482 -1.994 0 C-N-CA 120.843 -0.694 . . . . 75.129999999999995 113.068 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.539 HG22 ' O ' ' B' ' 88' ' ' LEU . 14.4 tt -101.58 137.24 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.929 0 N-CA-C 108.168 -1.049 . . . . 74.319999999999993 108.168 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -68.78 132.82 47.43 Favored 'General case' 0 C--N 1.266 -3.036 0 CA-C-O 121.776 0.798 . . . . 71.040000000000006 112.161 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -73.42 -28.35 61.94 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.672 -1.604 . . . . 73.230000000000004 107.848 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 45' ' ' ARG . 9.4 t0 -146.14 114.73 4.59 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 105.417 -2.068 . . . . 62.229999999999997 105.417 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . 0.502 ' HD3' ' CZ ' ' A' ' 48' ' ' TYR . 56.7 Cg_endo -68.74 -19.06 41.83 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.328 2.019 . . . . 62.229999999999997 113.961 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -83.14 -24.69 32.44 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.794 -0.817 . . . . 74.099999999999994 108.794 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -95.54 143.35 25.96 Favored Pre-proline 0 C--N 1.309 -1.174 0 N-CA-C 108.57 -0.9 . . . . 71.140000000000001 108.57 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.11 -3.47 13.84 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 122.068 1.845 . . . . 71.420000000000002 114.224 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -75.87 120.65 21.51 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.992 0.425 . . . . 73.450000000000003 110.893 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.545 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 82.4 p -99.44 154.88 17.87 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 109.202 -0.666 . . . . 73.329999999999998 109.202 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 28.8 tp -94.78 127.92 41.12 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.686 -1.227 . . . . 71.540000000000006 107.686 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -125.63 130.28 51.31 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.567 -1.271 . . . . 74.409999999999997 107.567 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -123.61 116.31 22.9 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 123.366 0.416 . . . . 75.310000000000002 110.317 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.554 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 5.0 tp10 -134.37 156.64 48.15 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.918 -1.512 . . . . 73.209999999999994 106.918 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -66.8 143.43 56.9 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.35 0.977 . . . . 73.109999999999999 111.879 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.86 157.36 24.42 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.896 -0.593 . . . . 61.539999999999999 109.903 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.469 ' HB3' ' HZ3' ' B' ' 107' ' ' LYS . 5.9 ttpm? -85.65 7.82 21.89 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.626 0.727 . . . . 71.120000000000005 110.712 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.64 138.88 11.13 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.348 -0.982 . . . . 51.420000000000002 108.348 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.438 ' HA ' ' HB ' ' B' ' 32' ' ' THR . 94.3 m-20 -82.88 158.56 22.63 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-O 121.228 0.537 . . . . 63.420000000000002 109.928 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.494 ' O ' HD12 ' B' ' 74' ' ' ILE . 14.2 t -123.47 164.06 19.66 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.939 -1.504 . . . . 75.430000000000007 106.939 174.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.96 144.66 47.54 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.427 -0.953 . . . . 71.319999999999993 108.427 177.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 26.0 mmt -104.6 -58.72 1.84 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.253 -0.647 . . . . 73.329999999999998 109.253 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.39 94.02 6.82 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.617 -0.72 . . . . 61.450000000000003 109.951 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -83.85 116.13 22.6 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.034 -0.728 . . . . 63.350000000000001 109.034 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 6.7 m -107.11 135.83 47.99 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 106.855 -1.535 . . . . 74.409999999999997 106.855 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -86.57 102.64 14.32 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 119.056 -1.058 . . . . 70.010000000000005 110.021 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 67.5 mt -104.79 88.74 2.98 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.362 -1.718 . . . . 70.109999999999999 106.362 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 . . . . . 0 C--N 1.297 -1.689 0 N-CA-C 108.431 -0.951 . . . . 73.530000000000001 108.431 -175.917 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.47 0.538 0 CA-C-O 120.487 0.184 . . . . 75.310000000000002 111.313 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -74.2 -67.67 0.59 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.206 -1.035 . . . . 61.350000000000001 108.206 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -116.37 147.1 41.95 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.838 -1.912 . . . . 71.209999999999994 105.838 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.1 mp0 -62.76 109.46 1.43 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 105.363 -2.088 . . . . 71.420000000000002 105.363 171.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.566 ' HA ' HD22 ' A' ' 109' ' ' ASN . 98.6 t -69.63 109.28 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 105.745 -1.946 . . . . 73.549999999999997 105.745 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.587 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 13.7 ptm180 -127.57 15.89 7.04 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.004 -1.453 . . . . 72.420000000000002 110.497 -167.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.4 m -124.7 124.63 42.59 Favored 'General case' 0 C--N 1.272 -2.784 0 C-N-CA 119.467 -0.893 . . . . 73.150000000000006 110.666 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.2 mt -107.16 141.17 38.86 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.352 -0.981 . . . . 63.109999999999999 108.352 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 16.7 p90 -102.73 115.8 31.31 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 107.088 -1.449 . . . . 64.129999999999995 107.088 173.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.4 t -97.65 120.03 46.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 CA-C-N 114.23 -1.35 . . . . 75.099999999999994 108.418 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.9 p -123.8 165.76 16.75 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 116.246 -0.433 . . . . 75.349999999999994 110.008 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.14 11.96 44.05 Favored Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 111.065 -0.814 . . . . 63.109999999999999 111.065 -173.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.6 mt -83.07 130.23 58.11 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 107.608 -1.256 . . . . 74.5 107.608 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.12 161.43 10.98 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.099 1.866 . . . . 71.319999999999993 111.204 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.408 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 7.5 p -62.53 -15.69 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.681 0.753 . . . . 73.099999999999994 110.79 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -121.56 35.69 4.82 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.04 -0.982 . . . . 55.149999999999999 109.231 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.416 HG23 ' HG2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -66.43 131.2 32.22 Favored 'Isoleucine or valine' 0 C--O 1.256 1.44 0 N-CA-C 108.422 -0.955 . . . . 73.219999999999999 108.422 175.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -99.25 143.94 27.33 Favored Pre-proline 0 C--N 1.291 -1.957 0 CA-C-N 115.111 -0.949 . . . . 72.209999999999994 111.627 -177.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.53 -26.53 37.01 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.634 2.889 . . . . 71.319999999999993 114.194 -176.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.548 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -86.5 -10.52 53.94 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 117.159 -1.816 . . . . 71.030000000000001 112.109 -177.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.42 -40.21 85.52 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.005 -0.739 . . . . 75.319999999999993 109.005 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.38 -27.27 65.17 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.588 -0.733 . . . . 74.010000000000005 110.123 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.548 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 46.9 t80 -65.3 -47.59 76.08 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.371 -0.831 . . . . 70.450000000000003 109.823 176.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.44 -40.37 81.16 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.365 -0.605 . . . . 71.349999999999994 109.365 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 tp -64.34 -47.61 78.67 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.819 -1.082 . . . . 74.329999999999998 112.164 -178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -98.91 0.94 45.14 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 114.609 1.337 . . . . 72.140000000000001 114.609 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.1 ttt85 -63.63 -44.2 79.94 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 112.829 0.677 . . . . 74.439999999999998 112.829 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.77 -6.97 20.3 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 121.28 1.32 . . . . 72.450000000000003 112.713 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -96.59 90.02 5.19 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.516 0.674 . . . . 74.019999999999996 110.698 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -67.65 109.59 3.36 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.969 0.89 . . . . 71.209999999999994 109.882 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.1 -27.01 1.42 Allowed Glycine 0 C--N 1.285 -2.267 0 CA-C-N 114.406 -1.27 . . . . 60.520000000000003 110.155 -173.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -54.91 127.31 28.13 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.139 0.576 . . . . 74.430000000000007 111.934 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -105.92 -53.89 2.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.175 0.512 . . . . 71.109999999999999 110.568 174.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.64 178.12 41.17 Favored Glycine 0 C--N 1.294 -1.793 0 CA-C-N 115.492 -0.776 . . . . 71.209999999999994 111.822 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.4 p -146.72 137.69 24.07 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.64 0.22 . . . . 74.439999999999998 111.054 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.0 mt -115.98 134.64 54.76 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.458 0.703 . . . . 74.319999999999993 109.128 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.9 mm -95.0 144.71 9.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 110.15 -0.315 . . . . 64.540000000000006 110.15 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -136.97 118.88 15.23 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.833 -0.432 . . . . 75.430000000000007 109.833 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.29 110.59 6.02 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.349 0.595 . . . . 75.420000000000002 111.022 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.3 m -99.44 162.76 12.84 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 105.578 -2.008 . . . . 72.420000000000002 105.578 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -43.91 -37.87 3.09 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 114.037 1.125 . . . . 74.439999999999998 114.037 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -103.87 -26.72 12.57 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.211 1.189 . . . . 64.230000000000004 114.211 -177.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -166.79 153.38 8.18 Favored Pre-proline 0 C--N 1.307 -1.261 0 C-N-CA 120.783 -0.367 . . . . 71.420000000000002 110.346 -168.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.416 ' HG2' HG23 ' A' ' 42' ' ' ILE . 56.9 Cg_endo -76.66 118.89 4.98 Favored 'Trans proline' 0 N--CA 1.438 -1.766 0 C-N-CA 122.459 2.106 . . . . 74.329999999999998 110.949 172.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 m -93.93 162.17 2.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.837 -1.171 . . . . 65.430000000000007 107.837 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.41 121.59 3.54 Favored Glycine 0 C--N 1.297 -1.633 0 C-N-CA 118.934 -1.603 . . . . 72.530000000000001 113.332 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -87.8 105.53 17.46 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.414 -1.328 . . . . 65.129999999999995 107.414 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.68 127.43 52.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 115.053 -0.976 . . . . 62.219999999999999 110.164 -176.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 tt -99.79 130.06 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 CA-C-O 121.704 0.764 . . . . 64.019999999999996 110.219 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 82.0 m-85 -112.01 152.8 27.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 114.228 -1.351 . . . . 74.450000000000003 109.172 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.45 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 35.0 t70 -68.02 -30.1 69.26 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 114.839 -1.073 . . . . 53.539999999999999 112.712 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.4 m -131.95 150.09 52.25 Favored 'General case' 0 N--CA 1.417 -2.1 0 O-C-N 121.776 -0.577 . . . . 73.209999999999994 109.961 -174.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.519 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -80.38 -27.87 38.07 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.499 -0.926 . . . . 74.140000000000001 108.499 178.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.44 -19.46 60.39 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 114.377 -1.283 . . . . 72.349999999999994 107.591 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.41 -42.13 7.09 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 113.393 -1.73 . . . . 37.289999999999999 110.095 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.04 -43.41 98.89 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.135 0.574 . . . . 74.030000000000001 111.599 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.0 -38.26 90.48 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 121.027 -0.269 . . . . 74.439999999999998 111.706 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.08 -38.53 72.44 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 120.701 0.286 . . . . 74.340000000000003 110.478 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.58 90.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.568 -0.742 . . . . 44.32 111.202 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -67.08 -37.78 84.59 Favored 'General case' 0 C--O 1.206 -1.237 0 C-N-CA 120.378 -0.529 . . . . 55.310000000000002 111.262 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -72.91 -17.08 61.54 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 120.853 0.359 . . . . 71.209999999999994 111.753 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.57 -45.93 11.29 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 116.364 -0.38 . . . . 71.239999999999995 110.76 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 91' ' ' ILE . 92.7 mt -98.38 -9.05 25.86 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 115.291 1.589 . . . . 72.040000000000006 115.291 -172.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.55 126.34 30.61 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.075 -1.016 . . . . 74.430000000000007 110.657 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.19 3.37 54.22 Favored Glycine 0 CA--C 1.475 -2.445 0 C-N-CA 120.599 -0.81 . . . . 60.240000000000002 112.5 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 88' ' ' LEU . 16.1 tt -111.18 144.45 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.343 0 N-CA-C 107.058 -1.46 . . . . 75.519999999999996 107.058 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -70.21 135.41 49.02 Favored 'General case' 0 C--N 1.272 -2.786 0 CA-C-O 121.557 0.694 . . . . 73.109999999999999 112.394 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -74.06 -28.54 61.46 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 113.677 -1.601 . . . . 61.109999999999999 109.069 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -144.36 120.26 6.19 Favored Pre-proline 0 C--N 1.314 -0.973 0 N-CA-C 105.906 -1.887 . . . . 64.439999999999998 105.906 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.53 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 57.6 Cg_endo -67.33 -21.63 47.21 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.522 2.148 . . . . 73.150000000000006 114.241 -176.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -82.61 -26.11 32.58 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.5 0.667 . . . . 64.239999999999995 109.255 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -90.27 134.08 32.02 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 108.012 -1.106 . . . . 60.039999999999999 108.012 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -70.18 -9.26 25.56 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 122.351 2.034 . . . . 71.230000000000004 112.181 176.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -68.96 125.69 27.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.559 -0.746 . . . . 60.119999999999997 110.061 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 39.5 p -102.63 156.35 17.68 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 116.496 -0.32 . . . . 72.040000000000006 110.207 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.4 tp -95.54 126.11 40.6 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.798 -0.815 . . . . 74.219999999999999 108.798 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -120.66 127.04 51.7 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.205 -1.035 . . . . 75.099999999999994 108.205 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -116.37 116.54 27.9 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 123.51 0.506 . . . . 73.109999999999999 109.683 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.457 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 39.1 tt0 -128.52 162.88 26.19 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.782 -1.192 . . . . 62.229999999999997 107.782 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -71.36 145.36 49.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 118.728 0.694 . . . . 73.439999999999998 109.23 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.58 157.89 34.65 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.694 -0.854 . . . . 52.539999999999999 108.694 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 13.1 tmtt? -80.24 -9.85 59.74 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.092 0.948 . . . . 75.430000000000007 108.6 -176.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -157.14 126.13 5.88 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.184 -1.371 . . . . 54.039999999999999 107.567 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.566 HD22 ' HA ' ' A' ' 30' ' ' VAL . 91.5 m-20 -72.26 141.15 48.93 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.241 -0.436 . . . . 74.030000000000001 110.243 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.1 t -94.96 134.43 37.64 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.367 -0.533 . . . . 74.439999999999998 109.979 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -94.85 92.02 6.73 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.575 -0.898 . . . . 72.409999999999997 108.575 175.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.1 tpt -67.24 -57.66 6.27 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.799 -1.091 . . . . 53.310000000000002 110.545 -176.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -112.79 89.88 3.19 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 121.288 0.566 . . . . 71.409999999999997 111.001 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -152.31 97.98 2.35 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.959 -0.756 . . . . 62.509999999999998 108.959 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.3 m -107.05 114.85 29.18 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.865 -1.531 . . . . 75.109999999999999 106.865 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -134.46 137.69 44.16 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 110.355 -0.239 . . . . 73.430000000000007 110.355 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.9 tp -73.67 -69.73 0.42 Allowed 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.825 -0.625 . . . . 75.109999999999999 109.522 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 C--N 1.307 -1.258 0 CA-C-N 116.135 -0.484 . . . . 54.439999999999998 110.459 -178.297 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 21.7 ptp . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 110.301 -0.259 . . . . 71.150000000000006 110.301 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.29 -49.15 58.62 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 112.38 0.511 . . . . 60.409999999999997 112.38 -171.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -126.9 131.02 51.24 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 120.843 0.354 . . . . 74.340000000000003 110.082 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.502 ' H ' ' CD ' ' B' ' 29' ' ' GLU . 1.3 mp0 -68.07 96.05 0.6 Allowed 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 108.241 -1.022 . . . . 75.140000000000001 108.241 173.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.42 ' HA ' HD22 ' B' ' 109' ' ' ASN . 68.3 t -84.49 109.52 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 104.766 -2.309 . . . . 37.289999999999999 104.766 171.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -116.18 10.68 14.98 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.636 -0.711 . . . . 73.120000000000005 110.743 -171.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 57.9 m -120.46 129.8 54.02 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-O 121.5 0.667 . . . . 60.350000000000001 110.657 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 mp -112.34 143.25 43.76 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.611 -1.255 . . . . 75.25 107.611 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.541 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 26.3 p90 -101.3 116.85 33.74 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 107.437 -1.32 . . . . 73.409999999999997 107.437 172.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.411 HG22 ' HG ' ' B' ' 103' ' ' LEU . 41.2 t -98.81 114.98 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.329 0 CA-C-N 114.21 -1.359 . . . . 73.109999999999999 107.468 -177.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.8 p -124.53 154.18 40.97 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 116.285 -0.416 . . . . 73.230000000000004 110.295 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.51 4.29 32.51 Favored Glycine 0 N--CA 1.431 -1.685 0 O-C-N 123.561 0.538 . . . . 42.32 111.969 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.521 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 86.3 mt -71.66 132.58 85.21 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 107.372 -1.344 . . . . 74.120000000000005 107.372 175.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' B' ' 41' ' ' ASP . 37.4 Cg_endo -65.99 160.89 42.16 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.62 1.546 . . . . 54.539999999999999 111.677 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.461 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 9.4 p -69.91 4.99 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.6 0 CA-C-O 122.148 0.975 . . . . 54.030000000000001 111.274 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' B' ' 39' ' ' PRO . 27.9 t70 -125.51 19.01 8.1 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.616 1.166 . . . . 72.040000000000006 109.19 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.12 127.5 20.87 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 CA-C-O 121.843 0.83 . . . . 62.520000000000003 111.086 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.431 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 70.1 mmtt -98.71 137.35 20.58 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.07 -0.968 . . . . 75.340000000000003 108.936 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -53.74 -32.48 65.93 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.857 2.372 . . . . 73.340000000000003 113.236 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.562 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 0.0 OUTLIER -73.15 -15.8 61.46 Favored 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 119.374 -0.931 . . . . 74.340000000000003 112.324 -179.157 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.431 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 47.6 mt-10 -69.55 -36.06 75.98 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.893 -0.504 . . . . 75.109999999999999 110.23 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.88 -26.38 64.16 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 121.732 0.777 . . . . 73.5 108.919 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.53 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 58.3 t80 -73.33 -34.91 65.93 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.911 -1.041 . . . . 75.200000000000003 110.215 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 67.1 mt -78.48 -41.51 32.39 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.271 -0.64 . . . . 73.010000000000005 109.271 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.6 tp -66.09 -46.52 77.35 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.21 -0.904 . . . . 62.109999999999999 111.482 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -95.03 14.92 20.28 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 112.221 0.452 . . . . 75.319999999999993 112.221 -176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.471 ' CZ ' ' HA ' ' B' ' 52' ' ' ARG . 0.8 OUTLIER -59.46 -52.12 76.44 Favored Pre-proline 0 CA--C 1.56 1.349 0 CA-C-N 115.864 -0.607 . . . . 63.439999999999998 111.743 178.466 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.3 -1.48 11.12 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 121.607 1.538 . . . . 61.409999999999997 112.728 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -89.54 91.6 8.76 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 122.024 0.916 . . . . 74.530000000000001 110.673 -177.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -75.4 109.85 9.28 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.21 -1.359 . . . . 74.099999999999994 108.785 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.65 -14.04 4.19 Favored Glycine 0 C--N 1.293 -1.813 0 CA-C-N 115.058 -0.974 . . . . 64.099999999999994 111.753 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -59.93 109.89 1.05 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.191 0.52 . . . . 74.510000000000005 110.527 175.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -86.09 -49.35 7.85 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.737 -0.665 . . . . 54.030000000000001 110.435 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.11 -175.69 45.46 Favored Glycine 0 C--N 1.294 -1.797 0 C-N-CA 120.13 -1.033 . . . . 37.289999999999999 112.175 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 21.5 p -148.17 143.27 26.96 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 122.377 0.271 . . . . 60.240000000000002 111.335 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . 0.4 ' O ' ' HA2' ' B' ' 71' ' ' GLY . 85.3 mt -116.83 127.21 54.08 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.474 -0.936 . . . . 74.040000000000006 108.474 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 47.4 mm -94.56 136.46 25.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.198 -0.667 . . . . 53.009999999999998 109.198 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -127.58 115.4 18.75 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.016 -0.735 . . . . 74.129999999999995 109.016 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.21 109.46 5.26 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.235 -0.654 . . . . 62.219999999999999 109.235 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 19.6 m -100.6 156.23 17.42 Favored 'General case' 0 N--CA 1.407 -2.611 0 N-CA-C 104.458 -2.423 . . . . 71.319999999999993 104.458 175.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.41 -37.58 17.38 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 113.65 0.981 . . . . 62.32 113.65 -173.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -102.78 -16.54 15.93 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.191 1.182 . . . . 63.43 114.191 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 4.4 pt20 -173.77 142.45 0.92 Allowed Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 118.167 0.44 . . . . 63.240000000000002 111.731 -174.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.461 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 14.9 Cg_exo -68.77 115.19 3.82 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 123.05 2.5 . . . . 74.019999999999996 111.096 170.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -92.55 167.35 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.038 -1.097 . . . . 70.340000000000003 108.038 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' B' ' 61' ' ' LEU . . . -138.62 122.68 2.43 Favored Glycine 0 C--O 1.207 -1.585 0 C-N-CA 118.87 -1.633 . . . . 54.509999999999998 113.621 -176.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -88.11 107.73 18.9 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.636 -1.246 . . . . 72.510000000000005 107.636 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 90.2 t -101.17 129.16 52.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 115.185 -0.916 . . . . 73.120000000000005 110.978 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.484 HD12 ' O ' ' B' ' 110' ' ' THR . 3.4 tt -101.85 134.33 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 115.253 -0.885 . . . . 62.210000000000001 110.351 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -113.57 158.35 20.89 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.97 -1.014 . . . . 64.239999999999995 110.738 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.1 -34.66 78.08 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.823 -1.535 . . . . 74.340000000000003 112.4 175.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 46.4 m -135.75 152.14 50.83 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 120.757 -0.377 . . . . 70.019999999999996 110.736 -173.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -80.08 -26.6 39.52 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.393 0.616 . . . . 63.310000000000002 109.343 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.05 -21.14 51.11 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 107.726 -1.212 . . . . 52.240000000000002 107.726 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.47 -39.58 14.67 Favored Glycine 0 C--N 1.31 -0.884 0 N-CA-C 109.276 -1.529 . . . . 37.289999999999999 109.276 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.02 -42.61 97.06 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.322 -0.939 . . . . 62.329999999999998 111.501 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.84 -37.64 88.29 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.782 0.325 . . . . 61.240000000000002 111.556 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.15 -37.21 69.43 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.054 0.454 . . . . 70.140000000000001 110.336 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.84 -42.96 80.62 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.497 -0.774 . . . . 62.049999999999997 111.027 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.448 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 14.9 ptmm? -68.2 -37.1 80.54 Favored 'General case' 0 C--O 1.206 -1.189 0 C-N-CA 120.585 -0.446 . . . . 73.019999999999996 110.744 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -66.68 -29.53 69.55 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 120.863 0.363 . . . . 62.0 111.427 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.34 -44.42 25.21 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 116.166 -0.47 . . . . 70.310000000000002 111.252 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.571 ' O ' HG22 ' B' ' 91' ' ' ILE . 99.3 mt -94.75 -11.96 28.05 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 115.356 1.613 . . . . 72.400000000000006 115.356 -173.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -76.2 115.64 16.12 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 118.257 -1.377 . . . . 71.219999999999999 109.825 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.99 11.56 24.07 Favored Glycine 0 CA--C 1.482 -2.01 0 C-N-CA 120.463 -0.875 . . . . 74.329999999999998 111.767 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.571 HG22 ' O ' ' B' ' 88' ' ' LEU . 14.4 tt -99.66 140.54 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.624 0 N-CA-C 107.665 -1.235 . . . . 54.509999999999998 107.665 175.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.409 ' CG ' HG23 ' B' ' 100' ' ' THR . 79.3 mtt180 -81.75 128.67 34.23 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-O 120.985 0.421 . . . . 74.219999999999999 110.175 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.74 -34.39 77.77 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.55 -1.205 . . . . 75.109999999999999 110.063 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -144.5 126.1 7.98 Favored Pre-proline 0 C--N 1.312 -1.047 0 N-CA-C 106.405 -1.702 . . . . 70.239999999999995 106.405 174.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . 0.46 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 60.4 Cg_endo -69.84 -0.41 6.93 Favored 'Trans proline' 0 N--CA 1.486 1.031 0 C-N-CA 123.266 2.644 . . . . 74.510000000000005 114.386 -173.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -91.75 -25.65 18.95 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.54 0.686 . . . . 73.409999999999997 109.542 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -91.81 139.16 24.68 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 108.144 -1.058 . . . . 74.400000000000006 108.144 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -69.6 -20.78 35.16 Favored 'Trans proline' 0 C--O 1.247 0.932 0 C-N-CA 121.763 1.642 . . . . 60.130000000000003 111.014 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -55.57 131.17 45.61 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.502 1.121 . . . . 62.43 110.621 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.409 HG23 ' CG ' ' B' ' 92' ' ' ARG . 75.2 p -112.76 160.03 18.36 Favored 'General case' 0 N--CA 1.418 -2.061 0 C-N-CA 120.177 -0.609 . . . . 72.400000000000006 109.78 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 20.2 tp -96.8 121.23 38.43 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.261 -1.014 . . . . 54.509999999999998 108.261 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -112.51 123.13 49.61 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.242 -1.022 . . . . 74.430000000000007 108.242 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.411 ' HG ' HG22 ' B' ' 35' ' ' VAL . 7.1 mp -110.5 115.7 30.1 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 109.381 -0.6 . . . . 74.219999999999999 109.381 172.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.541 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 34.2 tt0 -129.87 157.58 41.86 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.321 -1.362 . . . . 74.329999999999998 107.321 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -66.7 138.46 57.42 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 118.602 0.637 . . . . 75.540000000000006 110.693 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.36 152.26 30.52 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 108.902 -0.777 . . . . 74.129999999999995 108.902 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' B' ' 107' ' ' LYS . 14.4 tmtt? -78.49 -6.93 56.79 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.4 -0.818 . . . . 54.240000000000002 110.053 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.18 132.87 21.0 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.127 -0.942 . . . . 73.219999999999999 108.824 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.42 HD22 ' HA ' ' B' ' 30' ' ' VAL . 91.2 m-20 -87.13 143.09 27.46 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.326 -0.397 . . . . 72.349999999999994 110.249 177.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.484 ' O ' HD12 ' B' ' 74' ' ' ILE . 12.8 t -112.15 151.63 29.26 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 107.572 -1.27 . . . . 71.540000000000006 107.572 176.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -107.01 140.82 39.2 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.972 -1.121 . . . . 74.230000000000004 107.972 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -64.93 1.08 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.958 -1.497 . . . . 64.209999999999994 106.958 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.34 97.07 6.11 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.902 -0.59 . . . . 52.549999999999997 110.642 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -153.79 100.61 2.39 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.287 -0.635 . . . . 71.209999999999994 109.287 175.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 18.9 m -112.28 90.2 3.28 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.79 -0.819 . . . . 62.439999999999998 108.79 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . 0.419 ' HZ3' ' C ' ' B' ' 118' ' ' GLU . 64.4 tttm -106.62 104.64 14.37 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.918 -1.141 . . . . 62.25 107.918 -177.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 56.9 tp -78.11 -37.48 46.23 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.62 0.724 . . . . 62.109999999999999 109.194 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . 0.419 ' C ' ' HZ3' ' B' ' 116' ' ' LYS . 8.5 pt-20 . . . . . 0 N--CA 1.418 -2.046 0 CA-C-N 114.904 -1.044 . . . . 55.350000000000001 108.883 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 48.6 ttm . . . . . 0 C--O 1.222 -0.391 0 CA-C-O 120.491 0.186 . . . . 75.310000000000002 111.29 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -123.48 27.94 7.22 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 110.349 -0.241 . . . . 75.019999999999996 110.349 -172.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 65.82 84.11 0.16 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.228 0.955 . . . . 73.430000000000007 109.594 -173.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -80.03 -178.63 6.6 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.974 -1.012 . . . . 74.400000000000006 108.867 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.4 t -74.74 110.3 8.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 118.942 -1.103 . . . . 72.099999999999994 109.636 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -102.52 13.45 34.5 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.194 -1.366 . . . . 73.299999999999997 111.244 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.412 ' HB ' ' HA ' ' A' ' 109' ' ' ASN . 23.8 m -139.02 132.51 30.29 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.917 -0.713 . . . . 70.519999999999996 111.576 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.7 mt -110.73 145.88 37.27 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.341 -0.985 . . . . 73.239999999999995 108.341 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -101.65 111.2 23.37 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 107.29 -1.374 . . . . 62.520000000000003 107.29 173.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.44 120.92 47.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.178 -1.374 . . . . 73.040000000000006 108.013 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 p -126.98 168.64 14.27 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 115.335 -0.848 . . . . 72.420000000000002 109.217 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 88.58 39.64 6.62 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 111.085 -0.806 . . . . 71.019999999999996 111.085 -177.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 99.6 mt -105.37 137.97 19.42 Favored Pre-proline 0 N--CA 1.418 -2.041 0 N-CA-C 108.325 -0.991 . . . . 73.510000000000005 108.325 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -56.76 159.43 14.16 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.941 1.761 . . . . 75.439999999999998 109.183 171.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.55 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 8.9 p -80.86 -0.75 4.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 122.435 1.112 . . . . 64.310000000000002 110.677 -168.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -117.42 16.25 14.71 Favored 'General case' 0 N--CA 1.413 -2.276 0 CA-C-N 114.552 -1.204 . . . . 72.140000000000001 110.809 -172.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.47 ' HA ' ' OE1' ' A' ' 46' ' ' GLU 0.272 2.7 pp -55.82 136.38 18.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 114.47 1.285 . . . . 71.129999999999995 114.47 -177.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' HD3' ' CD ' ' A' ' 46' ' ' GLU . 6.6 mptt -103.1 149.8 37.24 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 106.689 -1.597 . . . . 74.319999999999993 106.689 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.19 -28.68 88.41 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.361 2.04 . . . . 73.349999999999994 112.0 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.655 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 20.3 ptt180 -68.16 -30.38 69.49 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 116.165 -0.47 . . . . 75.120000000000005 111.712 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.533 ' CD ' ' HD3' ' A' ' 43' ' ' LYS . 46.5 mt-10 -69.0 -42.41 76.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.022 0.439 . . . . 74.519999999999996 110.185 -175.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.56 -43.11 94.94 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.508 -0.923 . . . . 72.219999999999999 108.508 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.551 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 37.4 t80 -57.79 -45.1 86.54 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.414 -1.266 . . . . 72.310000000000002 111.626 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 88.4 mt -64.73 -40.46 95.36 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.366 0.603 . . . . 65.409999999999997 110.305 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 tp -70.08 -43.67 70.65 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.897 -1.047 . . . . 74.340000000000003 111.106 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -84.99 6.82 23.58 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 114.065 1.135 . . . . 64.430000000000007 114.065 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.463 ' HA ' ' NE ' ' A' ' 52' ' ' ARG . 3.2 mmp_? -50.59 -52.23 57.84 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 113.482 0.919 . . . . 74.239999999999995 113.482 177.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.38 -1.36 9.71 Favored 'Trans proline' 0 C--N 1.365 1.436 0 C-N-CA 121.795 1.663 . . . . 72.209999999999994 113.248 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -89.5 107.82 19.29 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 122.1 0.953 . . . . 71.129999999999995 112.38 -175.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -76.78 112.16 13.07 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 113.852 -1.522 . . . . 75.310000000000002 111.054 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.4 -32.04 1.99 Allowed Glycine 0 N--CA 1.424 -2.147 0 CA-C-N 114.653 -1.158 . . . . 73.230000000000004 111.19 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.05 118.25 4.49 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.667 0.787 . . . . 74.349999999999994 112.705 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -108.1 -35.71 6.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.272 0.558 . . . . 61.329999999999998 110.652 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.56 -178.38 48.37 Favored Glycine 0 C--N 1.306 -1.084 0 C-N-CA 120.154 -1.022 . . . . 75.230000000000004 112.441 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.6 p -144.29 137.56 27.31 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.613 0.206 . . . . 70.430000000000007 111.43 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -107.83 114.32 28.19 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 107.725 -1.213 . . . . 73.349999999999994 107.725 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.53 136.59 26.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 110.334 -0.247 . . . . 74.319999999999993 110.334 -175.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 69' ' ' PRO . 63.4 tttp -124.99 106.94 10.33 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 109.353 -0.61 . . . . 62.340000000000003 109.353 176.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.87 109.17 7.16 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.707 -0.849 . . . . 72.450000000000003 108.707 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.4 m -104.97 164.11 12.03 Favored 'General case' 0 N--CA 1.41 -2.455 0 N-CA-C 105.373 -2.084 . . . . 65.200000000000003 105.373 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.02 -33.76 62.9 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.704 0.683 . . . . 70.109999999999999 111.903 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.448 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 1.5 tpm_? -82.18 -52.28 7.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 112.201 0.445 . . . . 71.230000000000004 112.201 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -160.22 152.55 17.28 Favored Pre-proline 0 C--N 1.289 -2.033 0 CA-C-N 115.878 -0.601 . . . . 63.32 109.853 -171.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.55 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 58.3 Cg_endo -80.16 108.73 2.24 Favored 'Trans proline' 0 N--CA 1.431 -2.187 0 C-N-CA 122.546 2.164 . . . . 72.430000000000007 110.051 168.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.5 m -83.04 160.33 3.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.109 -1.071 . . . . 64.439999999999998 108.109 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.41 120.71 2.25 Favored Glycine 0 CA--C 1.474 -2.504 0 C-N-CA 118.042 -2.028 . . . . 55.240000000000002 112.747 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -88.37 102.52 14.95 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 106.622 -1.622 . . . . 75.209999999999994 106.622 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.07 127.28 47.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-N 115.429 -0.805 . . . . 74.209999999999994 109.948 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.9 pt -98.0 135.24 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.301 0 CA-C-N 115.155 -0.929 . . . . 75.129999999999995 110.722 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -121.98 149.53 43.33 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.341 -1.3 . . . . 72.510000000000005 108.559 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -52.64 -44.23 65.97 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 124.486 1.116 . . . . 74.349999999999994 111.585 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.1 m -145.34 158.09 43.9 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.72 -0.673 . . . . 74.329999999999998 110.235 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.489 ' HD3' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.24 -26.68 67.48 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.857 -0.61 . . . . 72.519999999999996 109.872 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.02 -28.05 69.54 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.366 -0.834 . . . . 62.539999999999999 110.15 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.01 -37.07 8.58 Favored Glycine 0 C--N 1.311 -0.812 0 N-CA-C 109.774 -1.33 . . . . 37.57 109.774 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.67 -44.45 93.73 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.491 -0.854 . . . . 72.25 111.728 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.4 -35.98 82.2 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.862 0.363 . . . . 61.329999999999998 111.832 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.35 -42.04 69.01 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.027 0.441 . . . . 65.420000000000002 110.052 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.62 95.76 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.666 -0.697 . . . . 71.430000000000007 111.258 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.419 ' CE ' ' HA ' ' A' ' 104' ' ' GLU . 14.8 ptmm? -70.56 -33.57 71.27 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 120.538 -0.465 . . . . 64.010000000000005 110.657 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -69.48 -36.49 76.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.887 0.375 . . . . 74.140000000000001 110.839 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.85 -41.93 42.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.07 0.462 . . . . 40.43 111.859 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.574 ' O ' HG21 ' A' ' 91' ' ' ILE . 85.8 mt -93.95 -9.75 36.0 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 115.085 1.513 . . . . 73.230000000000004 115.085 -172.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -74.95 118.39 17.86 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 117.898 -1.521 . . . . 72.040000000000006 108.828 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.23 12.56 48.48 Favored Glycine 0 N--CA 1.424 -2.152 0 CA-C-N 115.468 -0.787 . . . . 40.229999999999997 111.794 176.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.574 HG21 ' O ' ' A' ' 88' ' ' LEU . 13.7 tt -100.84 134.46 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.965 0 N-CA-C 108.185 -1.042 . . . . 71.319999999999993 108.185 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.491 ' CG ' HG23 ' A' ' 100' ' ' THR . 82.7 mtt180 -79.41 142.31 36.07 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 115.445 -0.798 . . . . 71.329999999999998 112.448 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -75.88 -28.89 58.29 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.548 -1.66 . . . . 74.209999999999994 108.394 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.587 ' OD2' ' HB3' ' B' ' 45' ' ' ARG . 6.2 m-20 -138.22 127.76 14.83 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 104.138 -2.542 . . . . 71.030000000000001 104.138 173.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.609 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 18.0 Cg_endo -58.92 -26.73 82.26 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.093 1.862 . . . . 73.450000000000003 112.444 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -90.76 -5.14 56.08 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.461 -0.79 . . . . 72.409999999999997 111.82 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.443 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 52.7 t-20 -104.17 125.96 32.95 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 108.171 -1.048 . . . . 73.310000000000002 108.171 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -64.53 -7.07 13.36 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 123.15 2.567 . . . . 62.5 113.349 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -77.44 115.32 17.11 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.691 -0.855 . . . . 65.099999999999994 108.691 176.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.51 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 27.7 p -116.12 153.05 32.46 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.158 -1.053 . . . . 71.230000000000004 108.158 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.6 mp -82.85 140.52 32.87 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 118.417 0.553 . . . . 71.549999999999997 111.102 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.6 108.81 10.19 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.659 -1.608 . . . . 75.340000000000003 106.659 176.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.61 123.26 46.01 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.951 -0.568 . . . . 60.450000000000003 111.818 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HA ' ' CE ' ' A' ' 85' ' ' LYS . 17.2 mm-40 -132.34 164.32 26.72 Favored 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 123.435 0.694 . . . . 75.340000000000003 109.807 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -73.68 143.32 46.27 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.468 -0.567 . . . . 64.109999999999999 109.468 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.46 157.07 37.53 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.146 -1.057 . . . . 75.239999999999995 108.146 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -72.73 -13.32 61.31 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.383 1.087 . . . . 71.549999999999997 110.503 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.81 127.01 3.98 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 105.985 -1.857 . . . . 55.329999999999998 105.985 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.412 ' HA ' ' HB ' ' A' ' 32' ' ' THR . 7.1 p30 -79.19 144.42 34.44 Favored 'General case' 0 CA--C 1.47 -2.104 0 C-N-CA 118.517 -1.273 . . . . 63.420000000000002 108.918 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.0 t -124.1 115.11 20.61 Favored 'General case' 0 N--CA 1.395 -3.213 0 C-N-CA 118.544 -1.262 . . . . 74.530000000000001 112.548 -173.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -41.83 124.45 2.6 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.045 -1.889 . . . . 65.329999999999998 109.02 168.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -45.79 -60.53 2.17 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.335 1.054 . . . . 74.549999999999997 110.357 -175.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -99.27 92.39 5.41 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 107.87 -1.159 . . . . 73.019999999999996 107.87 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.1 102.79 0.53 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.38 -0.827 . . . . 71.450000000000003 109.613 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.5 t -92.58 -164.75 1.22 Allowed 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 114.702 -1.135 . . . . 64.540000000000006 108.186 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.2 tttm 69.32 67.88 0.26 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.899 1.333 . . . . 63.409999999999997 109.177 -174.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.8 tp -134.58 -31.49 1.06 Allowed 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 113.046 -1.888 . . . . 64.409999999999997 107.271 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 N--CA 1.429 -1.511 0 N-CA-C 108.177 -1.046 . . . . 74.129999999999995 108.177 177.623 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 94.1 mmm . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 114.038 1.125 . . . . 71.319999999999993 114.038 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -69.33 102.97 1.85 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.665 0.617 . . . . 45.409999999999997 112.665 -170.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 56.18 37.85 29.25 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.707 0.803 . . . . 71.0 109.406 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -85.44 154.45 21.81 Favored 'General case' 0 N--CA 1.409 -2.51 0 CA-C-N 114.883 -1.053 . . . . 63.340000000000003 111.396 -171.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.0 112.1 4.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-N 114.441 -1.254 . . . . 63.109999999999999 110.991 -171.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.687 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 72.2 mtt180 -95.44 -2.59 48.51 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.287 -0.87 . . . . 72.530000000000001 109.921 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 16.0 m -101.03 137.92 38.76 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 114.977 -1.01 . . . . 52.130000000000003 112.265 -174.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 77.2 mt -117.52 146.24 43.69 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.696 -1.224 . . . . 73.209999999999994 107.696 173.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -99.53 118.98 37.29 Favored 'General case' 0 N--CA 1.42 -1.974 0 C-N-CA 118.486 -1.286 . . . . 71.430000000000007 107.811 173.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.44 HG23 ' HG ' ' B' ' 103' ' ' LEU . 35.2 t -97.32 109.09 22.66 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 N-CA-C 106.318 -1.734 . . . . 60.43 106.318 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' B' ' 101' ' ' LEU . 22.3 p -116.54 170.34 8.65 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-N 115.094 -0.957 . . . . 64.329999999999998 108.867 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 81.23 46.33 7.04 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.705 -0.958 . . . . 75.099999999999994 110.705 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 91.3 mt -114.37 141.44 26.51 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 107.573 -1.269 . . . . 74.430000000000007 107.573 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -59.99 161.4 19.1 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 121.585 1.523 . . . . 72.349999999999994 110.395 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.549 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 8.8 p -86.07 7.89 2.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 122.477 1.132 . . . . 74.329999999999998 109.752 -171.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -127.9 19.13 6.61 Favored 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 114.79 -1.095 . . . . 72.099999999999994 111.402 -174.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 32.6 pt -58.07 134.81 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 114.424 1.268 . . . . 74.109999999999999 114.424 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -101.44 145.85 31.17 Favored Pre-proline 0 C--N 1.297 -1.707 0 CA-C-N 113.908 -1.496 . . . . 73.140000000000001 110.066 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -55.97 -27.98 66.48 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.258 2.639 . . . . 74.109999999999999 113.484 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.587 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 23.9 ptt180 -70.36 -28.67 65.3 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 121.179 0.514 . . . . 73.010000000000005 111.051 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -69.84 -40.01 76.09 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.839 -0.619 . . . . 75.140000000000001 110.204 -176.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.97 -41.59 95.32 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 108.708 -0.849 . . . . 71.319999999999993 108.708 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.609 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 7.3 t80 -57.1 -47.1 81.87 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.73 -1.123 . . . . 72.25 111.32 177.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 82.5 mt -61.1 -42.7 99.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.11 0.481 . . . . 73.409999999999997 110.789 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 37.9 tp -73.86 -42.99 60.0 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.198 -0.91 . . . . 64.200000000000003 111.936 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -89.02 -10.49 47.36 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 115.623 1.712 . . . . 75.409999999999997 115.623 -173.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 14.1 mtp180 -54.28 -52.41 69.26 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 113.603 0.964 . . . . 70.319999999999993 113.603 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.3 -21.18 71.03 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 121.668 1.578 . . . . 73.019999999999996 112.304 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -88.42 86.59 7.07 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.662 0.744 . . . . 64.510000000000005 109.564 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -68.5 112.87 5.58 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.282 -1.326 . . . . 70.150000000000006 108.464 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 149.39 -28.52 1.21 Allowed Glycine 0 C--N 1.288 -2.087 0 CA-C-N 114.186 -1.37 . . . . 60.439999999999998 110.16 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -58.83 117.12 4.26 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.471 0.708 . . . . 64.209999999999994 111.568 176.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -102.02 -59.85 1.63 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.995 0.426 . . . . 72.140000000000001 111.212 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.78 172.37 31.17 Favored Glycine 0 C--N 1.295 -1.702 0 C-N-CA 120.559 -0.829 . . . . 71.109999999999999 112.181 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.1 p -135.39 137.04 41.92 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 122.903 0.481 . . . . 54.420000000000002 110.622 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.56 110.17 17.04 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.382 -1.34 . . . . 73.439999999999998 107.382 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.35 138.03 21.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 120.748 0.308 . . . . 73.430000000000007 110.923 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' B' ' 69' ' ' PRO . 0.6 OUTLIER -117.14 106.77 13.69 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.662 -1.607 . . . . 71.239999999999995 106.662 176.548 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.75 124.17 24.79 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.182 -0.917 . . . . 72.219999999999999 109.04 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 7.8 m -127.09 151.94 47.96 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 103.214 -2.884 . . . . 61.310000000000002 103.214 177.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.33 -33.36 65.54 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.063 0.764 . . . . 74.239999999999995 113.063 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -86.98 -38.7 16.37 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 120.19 -0.604 . . . . 71.0 112.294 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.494 ' O ' ' HB ' ' B' ' 65' ' ' THR . 28.4 pt20 -161.53 135.3 4.91 Favored Pre-proline 0 C--N 1.297 -1.691 0 CA-C-O 120.495 0.188 . . . . 71.510000000000005 111.485 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.549 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 18.0 Cg_endo -80.55 109.8 2.33 Favored 'Trans proline' 0 N--CA 1.427 -2.411 0 C-N-CA 122.064 1.842 . . . . 62.130000000000003 109.508 168.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -84.68 147.9 5.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.436 -0.95 . . . . 51.240000000000002 108.436 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.28 120.56 4.58 Favored Glycine 0 CA--C 1.481 -2.056 0 C-N-CA 118.647 -1.74 . . . . 74.329999999999998 112.847 -175.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -87.74 102.72 14.93 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.628 -1.619 . . . . 70.439999999999998 106.628 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 69.2 t -100.11 128.73 51.75 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 114.923 -1.035 . . . . 70.120000000000005 110.117 -174.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 45.8 pt -101.76 132.67 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 CA-C-O 122.165 0.983 . . . . 65.540000000000006 110.865 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.687 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 79.9 m-85 -111.15 142.64 43.06 Favored 'General case' 0 C--N 1.266 -3.028 0 CA-C-N 113.744 -1.571 . . . . 75.209999999999994 107.9 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.95 -24.92 67.66 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.308 0.575 . . . . 75.349999999999994 110.704 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 3.1 m -129.75 131.82 46.39 Favored 'General case' 0 N--CA 1.386 -3.67 0 N-CA-C 107.429 -1.323 . . . . 74.200000000000003 107.429 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . 0.625 ' NE ' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -80.93 -24.11 38.39 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.952 -0.567 . . . . 73.109999999999999 110.301 179.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.16 -20.52 57.49 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.316 -2.105 . . . . 70.219999999999999 105.316 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.81 -40.31 15.01 Favored Glycine 0 C--N 1.314 -0.65 0 CA-C-N 112.672 -2.058 . . . . 61.119999999999997 109.282 177.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.31 -47.27 86.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.111 -1.045 . . . . 51.420000000000002 110.912 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 10.9 pt-20 -63.7 -31.2 72.3 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.54 -0.464 . . . . 71.010000000000005 112.124 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.64 -42.15 67.92 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.712 0.291 . . . . 70.209999999999994 110.545 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.28 -39.29 82.16 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.55 -0.75 . . . . 63.140000000000001 111.105 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' B' ' 82' ' ' GLU . 14.4 ptmm? -66.06 -37.34 85.59 Favored 'General case' 0 C--O 1.199 -1.554 0 C-N-CA 120.606 -0.438 . . . . 73.129999999999995 110.288 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -55.79 -32.82 63.82 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 120.961 0.41 . . . . 73.420000000000002 111.772 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.09 -36.45 19.62 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 112.406 0.521 . . . . 54.130000000000003 112.406 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.594 ' O ' HG22 ' B' ' 91' ' ' ILE . 97.5 mt -95.69 -22.14 17.74 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 116.019 1.859 . . . . 74.530000000000001 116.019 -173.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.99 113.3 12.15 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 118.441 -1.304 . . . . 75.209999999999994 110.514 178.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.46 16.17 16.94 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 120.761 -0.733 . . . . 72.049999999999997 111.344 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.594 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.3 tt -113.37 145.31 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.81 0 N-CA-C 107.844 -1.169 . . . . 74.319999999999993 107.844 175.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.522 ' CG ' HG21 ' B' ' 100' ' ' THR . 97.7 mtt180 -82.31 145.02 30.19 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 113.325 0.861 . . . . 74.519999999999996 113.325 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -77.24 -34.87 55.81 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.405 -1.725 . . . . 74.409999999999997 107.264 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' A' ' 45' ' ' ARG . 5.2 m-20 -134.34 120.62 14.91 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 105.249 -2.13 . . . . 73.340000000000003 105.249 176.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . 0.551 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 18.1 Cg_endo -60.78 -24.22 78.38 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 121.897 1.731 . . . . 73.109999999999999 112.21 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -84.71 -14.62 47.84 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 123.725 0.81 . . . . 74.5 110.776 -176.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -104.52 133.44 20.19 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 107.538 -1.282 . . . . 55.439999999999998 107.538 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.52 -5.39 15.09 Favored 'Trans proline' 0 CA--C 1.55 1.294 0 C-N-CA 122.524 2.149 . . . . 74.439999999999998 112.916 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -72.01 116.97 13.04 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 109.244 -0.65 . . . . 42.109999999999999 109.244 177.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.624 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 67.2 p -115.87 152.17 33.88 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.974 -0.75 . . . . 62.439999999999998 108.974 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' B' ' 36' ' ' SER . 6.4 mp -84.08 139.69 32.31 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.11 0.481 . . . . 71.310000000000002 110.487 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -125.3 109.49 12.86 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 107.134 -1.432 . . . . 71.209999999999994 107.134 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.44 ' HG ' HG23 ' B' ' 35' ' ' VAL . 6.8 mp -99.39 119.56 38.16 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 108.467 -0.938 . . . . 74.239999999999995 108.467 173.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.412 ' HA ' ' CE ' ' B' ' 85' ' ' LYS . 36.7 mm-40 -136.22 165.37 25.89 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.101 -1.074 . . . . 62.32 108.101 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -71.17 137.04 48.43 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 118.727 0.694 . . . . 74.420000000000002 110.544 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.63 152.92 29.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 116.216 -0.447 . . . . 53.420000000000002 110.032 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -73.17 -12.85 61.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.859 0.838 . . . . 62.439999999999998 110.086 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.97 123.29 20.64 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.243 -0.889 . . . . 72.010000000000005 109.625 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -83.53 100.81 11.01 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.688 -1.597 . . . . 61.299999999999997 106.688 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.6 t -100.77 92.97 5.32 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.862 0.839 . . . . 65.239999999999995 112.517 -172.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -61.03 129.92 43.82 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.566 -1.197 . . . . 72.439999999999998 108.843 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.53 -48.42 67.05 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.422 -0.955 . . . . 73.010000000000005 108.422 -177.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.84 71.38 10.66 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.523 -0.917 . . . . 75.439999999999998 108.523 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -74.28 123.72 25.08 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.337 -1.301 . . . . 75.230000000000004 108.262 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.2 t -90.22 -166.62 1.63 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.183 -0.673 . . . . 71.420000000000002 109.183 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 57.6 tttm 74.73 81.33 0.11 Allowed 'General case' 0 C--O 1.244 0.764 0 C-N-CA 125.308 1.443 . . . . 75.040000000000006 110.886 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 41.4 tp -159.44 -48.55 0.05 Allowed 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.061 -1.829 . . . . 74.400000000000006 106.061 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 N--CA 1.436 -1.15 0 CA-C-N 114.208 -1.36 . . . . 74.200000000000003 107.645 174.333 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 47.2 ttp . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 107.094 -1.447 . . . . 75.310000000000002 107.094 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 74.07 155.28 0.16 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.583 1.153 . . . . 55.520000000000003 112.264 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.441 ' O ' HG22 ' A' ' 30' ' ' VAL . 43.7 mt-10 61.12 -164.99 0.23 Allowed 'General case' 0 C--N 1.341 0.215 0 O-C-N 124.325 1.016 . . . . 70.430000000000007 110.092 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.556 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -49.09 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 125.766 1.627 . . . . 75.140000000000001 110.254 168.263 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.473 ' HA ' ' ND2' ' A' ' 109' ' ' ASN . 37.5 t -104.41 113.76 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 108.106 -1.072 . . . . 71.140000000000001 108.106 177.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 13.1 ptm180 -92.65 8.58 38.48 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.3 0.571 . . . . 75.409999999999997 110.294 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.7 m -122.45 129.66 52.27 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.804 0.811 . . . . 62.32 111.972 -177.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.408 HD13 ' N ' ' A' ' 33' ' ' LEU . 2.8 mp -110.46 141.29 43.77 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.339 -1.356 . . . . 74.120000000000005 107.339 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.661 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 11.4 p90 -101.51 128.01 47.94 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.252 -1.388 . . . . 63.0 107.252 172.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.4 t -106.76 118.32 54.27 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.623 0 N-CA-C 107.783 -1.191 . . . . 62.310000000000002 107.783 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.8 p -127.46 163.05 24.94 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.106 -0.702 . . . . 51.32 109.106 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.22 33.58 10.51 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.709 -0.956 . . . . 61.210000000000001 110.709 -174.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.7 mt -96.4 140.39 22.18 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.988 -1.116 . . . . 70.319999999999993 107.988 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -65.37 161.4 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 C-N-CA 121.315 1.344 . . . . 64.219999999999999 109.952 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -70.46 -8.77 11.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.79 0.805 . . . . 72.239999999999995 110.315 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -124.27 40.45 3.73 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 108.224 -1.028 . . . . 72.230000000000004 108.224 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.9 tp -60.53 125.34 16.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.115 -0.948 . . . . 74.340000000000003 109.451 173.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.509 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 26.1 mmmt -90.48 138.04 27.08 Favored Pre-proline 0 C--N 1.296 -1.757 0 N-CA-C 106.8 -1.555 . . . . 71.510000000000005 106.8 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.5 -25.07 77.48 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.485 2.123 . . . . 74.120000000000005 112.784 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -74.21 -27.66 60.9 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 116.012 -0.54 . . . . 74.530000000000001 111.396 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 30.5 mt-10 -62.87 -47.44 83.32 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.129 0.49 . . . . 73.239999999999995 109.964 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 99.7 mt -62.16 -45.3 94.05 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.283 -0.871 . . . . 63.140000000000001 109.803 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.669 ' CZ ' ' HD3' ' B' ' 95' ' ' PRO . 0.0 OUTLIER -60.01 -43.4 95.24 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.494 -0.776 . . . . 75.409999999999997 112.123 178.616 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 98.6 mt -64.36 -44.24 92.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.071 0.462 . . . . 74.329999999999998 110.221 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.412 ' O ' ' HD2' ' A' ' 53' ' ' PRO . 27.9 tp -66.72 -39.37 87.97 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.92 -1.036 . . . . 71.010000000000005 110.976 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -86.9 -4.49 59.18 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 114.566 1.321 . . . . 74.340000000000003 114.566 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 17.7 mtp180 -60.15 -42.87 92.08 Favored Pre-proline 0 N--CA 1.485 1.29 0 N-CA-C 113.447 0.906 . . . . 74.450000000000003 113.447 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 50' ' ' LEU . 24.5 Cg_exo -69.04 -18.36 40.4 Favored 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 121.693 1.595 . . . . 63.509999999999998 112.018 173.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -89.73 92.26 8.98 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 122.097 0.951 . . . . 74.239999999999995 110.967 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -69.4 111.79 5.51 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.177 -1.374 . . . . 63.539999999999999 109.589 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.84 -26.56 2.07 Favored Glycine 0 C--N 1.291 -1.963 0 CA-C-N 115.469 -0.787 . . . . 72.219999999999999 111.143 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -57.69 116.34 3.36 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.544 0.738 . . . . 74.219999999999999 111.698 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -96.7 -48.85 5.33 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.151 0.5 . . . . 51.149999999999999 110.323 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.69 167.23 40.27 Favored Glycine 0 C--N 1.302 -1.307 0 C-N-CA 120.014 -1.089 . . . . 75.120000000000005 113.246 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.5 p -127.27 137.66 52.9 Favored 'General case' 0 C--O 1.251 1.145 0 C-N-CA 123.12 0.568 . . . . 62.030000000000001 111.652 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.1 mp -112.42 150.44 31.14 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.904 -1.147 . . . . 64.200000000000003 107.904 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.0 mm -125.35 142.0 43.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 117.975 0.352 . . . . 73.120000000000005 110.091 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -133.99 107.73 7.96 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.52 -0.918 . . . . 72.019999999999996 108.52 178.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.2 130.37 43.62 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.315 -0.624 . . . . 75.230000000000004 109.315 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.9 m -129.38 164.0 24.57 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 106.405 -1.702 . . . . 75.340000000000003 106.405 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.41 -37.24 16.53 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.008 1.114 . . . . 74.129999999999995 114.008 -176.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -94.56 -41.6 9.25 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.285 0.565 . . . . 72.310000000000002 112.071 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -163.86 153.88 12.89 Favored Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 115.456 -0.793 . . . . 64.430000000000007 109.367 -170.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -78.27 118.2 4.27 Favored 'Trans proline' 0 N--CA 1.429 -2.309 0 C-N-CA 121.992 1.795 . . . . 71.239999999999995 109.939 170.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.37 159.58 2.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.973 -1.121 . . . . 71.219999999999999 107.973 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.72 157.46 20.45 Favored Glycine 0 C--N 1.298 -1.555 0 C-N-CA 118.688 -1.72 . . . . 61.43 113.683 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.68 109.73 15.56 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.948 -1.501 . . . . 73.439999999999998 106.948 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.7 t -103.23 128.98 55.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 CA-C-N 116.044 -0.525 . . . . 64.349999999999994 110.155 -177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 mp -105.85 128.43 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 115.799 -0.637 . . . . 74.239999999999995 109.964 -178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 4.7 m-85 -109.07 153.41 23.7 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.682 -1.145 . . . . 73.340000000000003 110.242 175.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -67.09 -27.98 67.8 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.867 -1.061 . . . . 71.329999999999998 112.066 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.3 m -134.88 144.86 47.76 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 109.537 -0.542 . . . . 64.140000000000001 109.537 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.556 ' NE ' ' HA ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -75.85 -24.75 55.79 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.959 -0.564 . . . . 73.349999999999994 110.11 -178.045 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.37 -36.56 71.49 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.817 -0.808 . . . . 64.209999999999994 108.817 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.41 -37.05 62.84 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 114.261 -1.336 . . . . 74.439999999999998 110.195 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.64 78.1 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.012 -0.594 . . . . 63.140000000000001 111.177 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.75 -33.15 74.28 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.698 -0.401 . . . . 74.409999999999997 111.758 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.83 -39.82 66.27 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 120.637 0.256 . . . . 75.319999999999993 111.195 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.31 -43.11 92.08 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 116.275 -0.421 . . . . 74.209999999999994 110.896 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.439 ' CD ' ' HA ' ' A' ' 104' ' ' GLU . 20.3 pttp -70.84 -30.28 66.65 Favored 'General case' 0 C--O 1.198 -1.631 0 C-N-CA 119.03 -1.068 . . . . 72.409999999999997 111.945 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -62.82 -31.4 72.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.381 0.61 . . . . 72.340000000000003 110.096 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.83 -36.57 21.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 116.041 -0.527 . . . . 55.119999999999997 111.427 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.547 ' O ' HG21 ' A' ' 91' ' ' ILE . 96.5 mt -93.98 -10.83 32.36 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 115.361 1.615 . . . . 54.420000000000002 115.361 -174.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -78.77 115.08 18.23 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 118.502 -1.279 . . . . 73.540000000000006 111.202 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.51 19.4 13.92 Favored Glycine 0 N--CA 1.421 -2.331 0 C-N-CA 120.515 -0.85 . . . . 73.219999999999999 111.211 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.547 HG21 ' O ' ' A' ' 88' ' ' LEU . 16.5 tt -102.04 125.33 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.04 0 N-CA-C 106.86 -1.533 . . . . 75.329999999999998 106.86 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -78.28 129.04 34.58 Favored 'General case' 0 C--N 1.257 -3.422 0 N-CA-C 109.303 -0.629 . . . . 55.030000000000001 109.303 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -72.68 -30.22 64.06 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.714 -1.13 . . . . 74.540000000000006 109.824 -172.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' B' ' 45' ' ' ARG 0.277 9.7 m-20 -150.62 124.63 4.47 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 105.765 -1.939 . . . . 37.859999999999999 105.765 177.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.474 ' HD3' ' CZ ' ' B' ' 48' ' ' TYR . 52.3 Cg_exo -63.0 -19.01 68.09 Favored 'Trans proline' 0 CA--C 1.555 1.535 0 CA-C-N 121.127 1.438 . . . . 72.5 111.272 170.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -78.12 -23.53 47.8 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.272 1.029 . . . . 73.430000000000007 110.707 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.568 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 22.0 t-20 -107.6 141.38 22.92 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 107.336 -1.357 . . . . 75.310000000000002 107.336 -172.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.436 ' HD2' ' OD1' ' A' ' 97' ' ' ASN . 73.5 Cg_endo -76.07 7.25 3.36 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 122.522 2.148 . . . . 72.010000000000005 111.726 176.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -88.31 126.18 35.05 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.141 -0.936 . . . . 74.200000000000003 109.921 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.2 p -115.25 141.92 47.38 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.529 -0.915 . . . . 54.109999999999999 108.529 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.3 tp -89.14 132.58 34.75 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.411 -0.589 . . . . 43.5 109.411 -176.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -134.56 122.53 22.5 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.095 0.558 . . . . 74.519999999999996 109.727 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -116.02 132.82 56.54 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.273 -0.64 . . . . 71.310000000000002 109.273 177.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.661 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 34.7 tt0 -146.24 168.49 20.93 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.223 -1.769 . . . . 71.519999999999996 106.223 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -68.02 138.2 55.66 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 120.133 1.333 . . . . 74.340000000000003 110.646 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.07 160.22 31.42 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.298 -0.864 . . . . 74.299999999999997 111.491 -176.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -63.29 -25.39 68.29 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.521 -1.218 . . . . 64.140000000000001 110.379 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.1 130.66 29.39 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 114.554 -1.203 . . . . 62.350000000000001 108.948 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.473 ' ND2' ' HA ' ' A' ' 30' ' ' VAL . 1.7 m-20 -82.44 121.35 26.62 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.322 -1.732 . . . . 73.400000000000006 106.322 176.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.4 t -132.91 151.99 51.96 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 119.46 -0.896 . . . . 61.240000000000002 111.293 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -77.55 153.99 32.81 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.841 -1.54 . . . . 75.5 106.841 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.13 -40.2 86.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.051 -0.722 . . . . 72.420000000000002 109.051 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.89 100.54 8.09 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.493 -0.776 . . . . 53.25 110.38 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.7 107.11 4.99 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 105.668 -1.975 . . . . 63.329999999999998 105.668 174.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.1 m -70.87 126.31 29.22 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 123.615 0.572 . . . . 72.219999999999999 110.529 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.83 145.21 40.79 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.146 -0.479 . . . . 72.019999999999996 110.042 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.0 mt -123.03 145.11 48.8 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.79 -0.641 . . . . 64.430000000000007 109.729 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--N 1.301 -1.51 0 N-CA-C 108.615 -0.883 . . . . 54.149999999999999 108.615 178.604 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 49.1 ttm . . . . . 0 CA--C 1.51 -0.565 0 N-CA-C 107.72 -1.215 . . . . 73.019999999999996 107.72 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -104.5 112.01 24.9 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 114.026 1.121 . . . . 61.020000000000003 114.026 -168.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -149.13 -173.99 4.52 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 103.316 -2.846 . . . . 72.140000000000001 103.316 173.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' B' ' 78' ' ' ARG . 33.3 mt-10 -74.55 91.92 2.34 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 105.907 -1.886 . . . . 71.209999999999994 105.907 171.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.504 ' HB ' ' CD1' ' B' ' 105' ' ' PHE . 40.8 t -105.77 110.19 30.39 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.513 0 N-CA-C 105.005 -2.22 . . . . 74.239999999999995 105.005 176.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.438 ' NH2' ' HA ' ' B' ' 76' ' ' ASP . 17.1 ptm180 -101.05 11.72 39.03 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 122.019 0.914 . . . . 72.310000000000002 109.221 -177.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 51.9 m -124.13 114.92 20.31 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.959 -1.019 . . . . 74.25 109.348 172.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 mp -96.87 140.48 31.36 Favored 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 107.857 -1.164 . . . . 74.230000000000004 107.857 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' B' ' 104' ' ' GLU 0.262 28.0 p90 -102.83 110.63 22.61 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 117.534 -1.666 . . . . 73.329999999999998 109.127 175.005 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.425 HG22 ' HG ' ' B' ' 103' ' ' LEU . 40.5 t -97.49 125.88 50.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-N 113.736 -1.574 . . . . 74.530000000000001 108.634 -176.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 19.1 p -131.32 170.76 14.19 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.945 -0.571 . . . . 60.409999999999997 109.658 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.36 5.2 57.11 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.721 -0.952 . . . . 41.229999999999997 110.721 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.706 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 63.8 mt -84.34 120.01 73.86 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 106.515 -1.661 . . . . 74.129999999999995 106.515 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.56 175.84 6.56 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.577 1.518 . . . . 75.140000000000001 111.425 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.433 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 13.2 p -65.54 -19.82 26.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.957 0.884 . . . . 37.859999999999999 110.149 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -107.32 39.51 1.88 Allowed 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.141 -0.936 . . . . 74.109999999999999 108.599 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 tp -68.62 121.32 17.67 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 N-CA-C 109.044 -0.724 . . . . 74.109999999999999 109.044 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.404 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 16.3 mmmt -89.11 138.55 28.95 Favored Pre-proline 0 C--N 1.287 -2.112 0 N-CA-C 106.545 -1.65 . . . . 71.0 106.545 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.29 -29.48 86.2 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 122.333 2.022 . . . . 64.040000000000006 112.065 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.569 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 14.2 ptt180 -63.49 -31.94 73.25 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 114.818 -1.083 . . . . 63.43 112.17 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.404 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 36.9 mt-10 -63.02 -49.26 75.31 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.824 0.345 . . . . 74.049999999999997 110.374 -177.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.15 -43.46 91.75 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.724 -0.671 . . . . 75.319999999999993 109.969 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.685 ' O ' ' HG3' ' B' ' 52' ' ' ARG . 0.4 OUTLIER -59.94 -43.38 94.99 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.031 -0.986 . . . . 75.120000000000005 112.298 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.39 -42.51 75.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.854 0.359 . . . . 70.019999999999996 110.274 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 24.6 tp -64.93 -41.45 95.52 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.108 -0.951 . . . . 72.439999999999998 111.087 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -88.67 1.87 54.29 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 113.944 1.09 . . . . 73.549999999999997 113.944 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.685 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 17.4 mtp180 -62.19 -46.38 90.95 Favored Pre-proline 0 CA--C 1.558 1.262 0 N-CA-C 113.593 0.96 . . . . 75.010000000000005 113.593 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -68.0 -19.46 45.75 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 121.853 1.702 . . . . 62.539999999999999 112.421 175.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -81.89 98.15 8.38 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.007 0.908 . . . . 73.530000000000001 110.789 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -70.91 110.11 5.44 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 113.898 -1.501 . . . . 75.120000000000005 110.764 -177.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.38 -15.42 4.18 Favored Glycine 0 N--CA 1.423 -2.233 0 CA-C-N 114.401 -1.272 . . . . 74.200000000000003 111.537 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -56.47 115.66 2.64 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.155 0.502 . . . . 71.120000000000005 111.424 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -93.49 -50.79 5.26 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-N 115.634 -0.712 . . . . 70.319999999999993 109.864 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.33 -179.17 47.5 Favored Glycine 0 C--N 1.29 -2.007 0 C-N-CA 120.527 -0.844 . . . . 53.149999999999999 111.671 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.2 p -136.9 137.99 40.21 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 123.311 0.644 . . . . 61.009999999999998 109.836 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 52.8 tp -120.36 123.81 43.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.591 -1.263 . . . . 73.049999999999997 107.591 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.63 144.96 8.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 109.929 -0.397 . . . . 54.119999999999997 109.929 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -133.43 108.56 8.74 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.039 -1.097 . . . . 74.120000000000005 108.039 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.19 108.85 3.31 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.91 -0.587 . . . . 74.129999999999995 109.603 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 20.9 m -100.06 156.71 17.03 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 105.872 -1.899 . . . . 53.520000000000003 105.872 175.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.09 -37.35 3.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.597 1.159 . . . . 74.099999999999994 113.885 -174.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -101.34 -46.12 5.12 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 119.677 -0.809 . . . . 70.540000000000006 112.469 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.706 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 4.0 pt20 -142.55 136.66 14.72 Favored Pre-proline 0 C--N 1.288 -2.095 0 CA-C-O 120.985 0.422 . . . . 73.340000000000003 112.035 -170.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.433 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 19.1 Cg_exo -64.34 108.88 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.393 2.729 . . . . 55.439999999999998 110.537 170.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 33.8 m -87.64 160.63 2.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.251 -1.018 . . . . 64.340000000000003 108.251 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.55 121.19 2.89 Favored Glycine 0 CA--C 1.481 -2.062 0 C-N-CA 119.163 -1.494 . . . . 64.120000000000005 112.68 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.12 108.83 19.46 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.198 -1.408 . . . . 73.109999999999999 107.198 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 86.0 t -95.9 125.23 48.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-N 115.72 -0.673 . . . . 72.439999999999998 110.396 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 3.5 mp -96.91 127.32 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 CA-C-N 115.064 -0.971 . . . . 73.310000000000002 108.907 -176.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -109.38 158.14 18.22 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.426 -0.806 . . . . 75.310000000000002 110.647 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . 0.438 ' HA ' ' NH2' ' B' ' 31' ' ' ARG . 18.0 t70 -79.93 -29.53 39.77 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 113.941 -1.482 . . . . 73.010000000000005 111.777 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 9.2 m -135.57 153.9 51.53 Favored 'General case' 0 N--CA 1.417 -2.098 0 C-N-CA 119.238 -0.985 . . . . 75.349999999999994 112.107 -168.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . 0.461 ' HD3' ' HA ' ' B' ' 29' ' ' GLU . 7.3 tpt85 -63.51 -42.62 98.47 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.477 -1.238 . . . . 75.5 109.856 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.11 -17.61 62.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.191 -1.368 . . . . 75.340000000000003 109.679 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.69 -47.5 4.52 Favored Glycine 0 CA--C 1.488 -1.646 0 CA-C-N 114.113 -1.403 . . . . 52.240000000000002 109.902 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.22 -46.68 87.81 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 114.498 -0.851 . . . . 70.549999999999997 111.752 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.16 -31.33 72.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.602 0.593 . . . . 74.329999999999998 112.602 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.74 -39.47 24.15 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 120.804 -0.358 . . . . 70.129999999999995 110.691 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.95 -42.36 85.37 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.059 -0.519 . . . . 72.239999999999995 111.427 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' B' ' 104' ' ' GLU . 0.0 OUTLIER -73.51 -27.67 61.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 120.308 -0.557 . . . . 73.409999999999997 110.9 -177.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -76.15 -39.73 54.3 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.239 -0.437 . . . . 54.130000000000003 110.362 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.08 -43.89 61.23 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 120.848 0.356 . . . . 52.509999999999998 111.874 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.505 ' O ' HG21 ' B' ' 91' ' ' ILE . 97.1 mt -87.05 -14.11 42.46 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 115.684 1.735 . . . . 74.049999999999997 115.684 -172.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -78.5 113.92 16.95 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 117.729 -1.588 . . . . 73.439999999999998 111.57 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.95 18.22 9.0 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.383 -0.913 . . . . 63.340000000000003 111.353 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.505 HG21 ' O ' ' B' ' 88' ' ' LEU . 15.1 tt -101.59 136.92 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.91 0 N-CA-C 108.086 -1.079 . . . . 61.350000000000001 108.086 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.443 ' NH1' ' HA ' ' B' ' 98' ' ' PRO . 15.6 mmt180 -64.97 130.21 42.56 Favored 'General case' 0 C--N 1.278 -2.541 0 C-N-CA 124.109 0.964 . . . . 61.020000000000003 108.602 175.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -75.13 -27.51 59.8 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.01 -1.478 . . . . 63.310000000000002 107.01 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.62 126.43 3.51 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 103.375 -2.824 . . . . 52.140000000000001 103.375 168.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . 0.669 ' HD3' ' CZ ' ' A' ' 48' ' ' TYR . 69.6 Cg_endo -71.88 -8.4 22.93 Favored 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 122.235 1.957 . . . . 73.140000000000001 114.342 -171.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -84.49 -21.81 30.47 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.05 -0.722 . . . . 64.040000000000006 109.05 -177.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -108.98 142.44 25.52 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.329 -0.989 . . . . 65.340000000000003 108.329 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.443 ' HA ' ' NH1' ' B' ' 92' ' ' ARG . 49.1 Cg_exo -62.25 -3.92 4.63 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 123.151 2.567 . . . . 42.299999999999997 113.525 172.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.93 117.03 6.99 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-O 121.653 0.74 . . . . 75.120000000000005 109.855 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 42.5 p -121.56 150.07 42.19 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.566 -0.743 . . . . 71.319999999999993 109.906 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 22.7 tp -85.95 123.42 31.26 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 106.411 -1.7 . . . . 72.319999999999993 106.411 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.97 113.17 16.14 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.842 -1.17 . . . . 75.409999999999997 107.842 -172.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.425 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.7 mp -112.59 136.62 51.92 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.537 -0.756 . . . . 72.319999999999993 110.271 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.489 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 42.4 tt0 -144.94 167.52 22.44 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.937 -1.505 . . . . 72.25 106.937 175.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.504 ' CD1' ' HB ' ' B' ' 30' ' ' VAL . 40.1 m-85 -76.64 135.07 39.14 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.277 -0.638 . . . . 74.120000000000005 109.277 177.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.53 163.48 26.87 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.462 0.649 . . . . 65.109999999999999 111.194 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -76.57 -20.64 56.6 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 122.187 0.994 . . . . 44.109999999999999 108.895 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.06 124.3 27.36 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.879 -1.055 . . . . 74.430000000000007 110.956 -174.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.453 HD22 ' HA ' ' B' ' 30' ' ' VAL . 81.7 m-20 -82.94 136.21 34.64 Favored 'General case' 0 CA--C 1.475 -1.904 0 N-CA-C 107.68 -1.23 . . . . 74.109999999999999 107.68 173.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 12.0 t -135.25 152.51 51.6 Favored 'General case' 0 C--N 1.268 -2.978 0 N-CA-C 108.652 -0.87 . . . . 72.129999999999995 108.652 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -93.65 147.82 22.67 Favored 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 104.867 -2.271 . . . . 74.099999999999994 104.867 169.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -43.65 97.35 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.763 -0.829 . . . . 43.439999999999998 108.763 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.16 93.97 9.52 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.296 -1.372 . . . . 73.409999999999997 107.296 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -93.93 113.05 24.98 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.57 -1.641 . . . . 72.340000000000003 106.57 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -62.74 125.75 25.0 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-O 121.317 0.579 . . . . 54.520000000000003 111.458 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . 0.413 ' N ' ' HD2' ' B' ' 116' ' ' LYS . 0.1 OUTLIER -83.89 112.9 20.56 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.518 -0.764 . . . . 71.310000000000002 109.582 -177.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 71.3 mt -86.79 95.64 9.91 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.987 -1.116 . . . . 71.519999999999996 107.987 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--N 1.297 -1.702 0 CA-C-N 115.535 -0.757 . . . . 71.439999999999998 109.255 -175.436 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.511 -0.553 0 CA-C-O 121.009 0.433 . . . . 75.310000000000002 109.958 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -108.53 -69.04 0.87 Allowed 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 116.41 -0.359 . . . . 73.319999999999993 111.067 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.251 32.8 mt-10 -92.23 71.59 5.33 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 118.355 -1.338 . . . . 71.219999999999999 113.539 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.501 ' OE1' ' HD3' ' A' ' 78' ' ' ARG 0.311 9.2 mm-40 -57.72 135.3 56.75 Favored 'General case' 0 N--CA 1.406 -2.643 0 CA-C-N 113.321 -1.763 . . . . 74.099999999999994 106.457 169.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.413 ' HA ' HD22 ' A' ' 109' ' ' ASN . 96.1 t -72.89 107.89 3.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 103.169 -2.901 . . . . 72.430000000000007 103.169 168.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 75' ' ' PHE . 20.4 ptt180 -133.27 9.81 4.08 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 119.788 -0.765 . . . . 73.530000000000001 112.016 -167.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 75.0 m -105.36 119.98 40.43 Favored 'General case' 0 C--N 1.264 -3.149 0 C-N-CA 119.744 -0.782 . . . . 73.430000000000007 109.536 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 81' ' ' ALA . 76.1 mt -99.28 142.11 31.19 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.418 -1.327 . . . . 71.230000000000004 107.418 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.576 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 15.8 p90 -103.54 116.79 33.04 Favored 'General case' 0 C--N 1.281 -2.4 0 C-N-CA 117.994 -1.482 . . . . 74.019999999999996 107.989 175.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.405 HG21 ' HG ' ' A' ' 103' ' ' LEU . 29.7 t -97.36 118.98 44.8 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.311 -1.366 . . . . 54.109999999999999 107.311 -178.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 32.7 p -120.92 166.08 14.31 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 109.041 -0.725 . . . . 72.329999999999998 109.041 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.413 ' HA2' ' NE2' ' A' ' 99' ' ' GLN . . . 97.0 18.5 29.19 Favored Glycine 0 N--CA 1.425 -2.038 0 C-N-CA 120.524 -0.846 . . . . 72.310000000000002 111.643 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -93.89 112.0 55.24 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.456 -0.942 . . . . 51.329999999999998 108.456 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.71 156.97 25.15 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.402 2.068 . . . . 72.099999999999994 110.774 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.99 -4.24 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 CA-C-O 122.109 0.957 . . . . 73.420000000000002 112.141 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -100.93 14.19 32.66 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.85 -0.796 . . . . 64.310000000000002 108.85 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.25 129.18 11.95 Favored 'Isoleucine or valine' 0 C--O 1.254 1.297 0 C-N-CA 124.859 1.263 . . . . 64.549999999999997 110.122 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -126.85 104.77 23.19 Favored Pre-proline 0 C--N 1.286 -2.19 0 N-CA-C 106.705 -1.591 . . . . 74.319999999999993 106.705 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -39.98 -17.49 0.05 OUTLIER 'Trans proline' 0 N--CA 1.515 2.777 1 C-N-CA 126.53 4.82 . . . . 62.340000000000003 118.14 -165.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.516 ' HG3' ' CE2' ' B' ' 93' ' ' PHE . 0.0 OUTLIER -60.59 -32.56 71.67 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 112.892 0.701 . . . . 71.109999999999999 112.892 176.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.628 ' HG3' ' CZ ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -69.39 -42.84 74.59 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.371 -0.931 . . . . 75.430000000000007 109.605 -177.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.37 -45.25 94.03 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 115.817 -0.628 . . . . 64.209999999999994 109.394 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.65 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 72.9 t80 -56.52 -49.13 75.67 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.952 -1.022 . . . . 72.310000000000002 111.42 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 93.2 mt -66.8 -35.97 81.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.915 0.388 . . . . 62.100000000000001 110.772 -176.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.5 tp -73.83 -41.97 61.54 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.279 -0.873 . . . . 63.530000000000001 112.327 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -87.81 -11.39 48.11 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 115.936 1.828 . . . . 73.150000000000006 115.936 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.628 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 52.8 mtp180 -60.58 -41.97 85.8 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 113.793 1.034 . . . . 75.299999999999997 113.793 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -64.82 -19.23 64.18 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.696 1.597 . . . . 54.340000000000003 112.387 175.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -81.76 89.65 6.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.233 0.539 . . . . 64.239999999999995 110.214 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.29 109.79 1.68 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.746 -0.835 . . . . 64.329999999999998 108.746 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.6 -17.67 3.7 Favored Glycine 0 N--CA 1.419 -2.485 0 CA-C-N 114.823 -1.081 . . . . 71.310000000000002 110.759 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -63.38 112.74 2.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.821 0.31 . . . . 63.409999999999997 110.538 175.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -90.55 -48.07 7.31 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.09 0.471 . . . . 73.409999999999997 110.437 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.8 179.21 48.78 Favored Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.203 -0.999 . . . . 74.439999999999998 112.558 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 p -138.33 136.84 36.8 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.803 0.335 . . . . 73.540000000000006 110.933 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 mp -123.02 121.16 35.39 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.558 -0.904 . . . . 73.530000000000001 108.558 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.76 138.56 20.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 120.853 0.358 . . . . 64.409999999999997 111.204 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -121.14 135.64 55.13 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.527 1.131 . . . . 71.230000000000004 108.254 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.63 126.89 33.31 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.74 0.781 . . . . 75.299999999999997 112.913 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 18.9 m -130.12 148.56 51.97 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 104.254 -2.499 . . . . 65.329999999999998 104.254 172.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -42.24 -48.86 4.99 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.849 1.26 . . . . 72.409999999999997 114.366 -169.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -105.3 -5.05 20.87 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.187 -1.005 . . . . 71.010000000000005 113.184 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.48 ' O ' ' HB ' ' A' ' 65' ' ' THR . 11.2 pt20 -161.79 117.1 1.28 Allowed Pre-proline 0 C--N 1.312 -1.03 0 C-N-CA 120.114 -0.634 . . . . 71.230000000000004 112.515 -171.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -73.53 105.52 2.01 Favored 'Trans proline' 0 N--CA 1.432 -2.089 0 C-N-CA 122.243 1.962 . . . . 72.030000000000001 108.107 169.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.5 152.16 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.119 -0.697 . . . . 71.140000000000001 109.119 -176.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.53 120.4 4.4 Favored Glycine 0 CA--C 1.477 -2.293 0 C-N-CA 118.642 -1.742 . . . . 61.229999999999997 112.805 -175.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.52 103.72 16.15 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.454 -1.313 . . . . 71.409999999999997 107.454 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.2 t -98.09 120.96 48.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 114.888 -1.051 . . . . 72.299999999999997 110.097 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.416 HD12 ' O ' ' A' ' 110' ' ' THR . 5.9 tt -94.96 127.74 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.258 0 CA-C-N 115.019 -0.991 . . . . 71.439999999999998 110.187 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.556 ' O ' ' HD2' ' A' ' 31' ' ' ARG . 84.4 m-85 -107.46 165.86 11.09 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 114.616 -1.175 . . . . 72.340000000000003 110.086 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.95 -48.21 78.88 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 125.209 1.404 . . . . 75.420000000000002 112.48 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 p -143.65 163.88 32.0 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 111.755 0.28 . . . . 74.439999999999998 111.755 -172.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.501 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -68.44 -36.05 78.48 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.216 0.531 . . . . 74.430000000000007 110.65 -177.685 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.64 -28.87 63.0 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.228 -0.896 . . . . 73.420000000000002 108.962 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.11 -39.5 37.17 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.443 -1.253 . . . . 70.310000000000002 110.407 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.503 ' O ' HD12 ' A' ' 33' ' ' LEU . . . -65.35 -46.1 81.56 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.878 -0.661 . . . . 65.430000000000007 111.534 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -63.38 -37.63 88.03 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.448 -0.501 . . . . 74.239999999999995 112.082 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.2 -38.47 85.38 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.249 -0.432 . . . . 72.120000000000005 110.106 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.86 -39.52 83.77 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.808 -0.633 . . . . 45.009999999999998 110.56 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.412 ' CD ' ' HA ' ' A' ' 104' ' ' GLU . 21.4 ttpp -59.09 -47.97 83.32 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.685 -0.689 . . . . 62.420000000000002 111.836 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -66.1 -25.16 66.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.194 0.521 . . . . 61.43 111.864 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.17 -39.72 32.72 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.872 -0.604 . . . . 43.310000000000002 111.514 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 91' ' ' ILE . 98.2 mt -102.2 -25.33 13.73 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 116.896 2.184 . . . . 73.409999999999997 116.896 -173.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -65.46 114.75 5.06 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-N 120.327 1.421 . . . . 75.25 110.18 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.58 10.18 19.87 Favored Glycine 0 N--CA 1.421 -2.32 0 CA-C-N 115.405 -0.816 . . . . 45.020000000000003 111.606 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 88' ' ' LEU . 14.7 tt -93.9 130.33 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.41 0 N-CA-C 109.107 -0.701 . . . . 64.319999999999993 109.107 177.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.524 ' CG ' HG21 ' A' ' 100' ' ' THR . 79.0 mtt180 -76.15 141.35 41.92 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-O 121.396 0.617 . . . . 73.140000000000001 111.757 173.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.628 ' CZ ' ' HG3' ' A' ' 46' ' ' GLU . 26.3 t80 -70.74 -34.46 71.9 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.509 -1.678 . . . . 60.329999999999998 109.108 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.546 ' OD2' ' HB3' ' B' ' 45' ' ' ARG . 6.5 m-20 -140.41 142.14 28.32 Favored Pre-proline 0 C--N 1.294 -1.821 0 N-CA-C 102.666 -3.087 . . . . 52.329999999999998 102.666 175.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.682 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 28.1 Cg_endo -64.03 -22.7 67.9 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 121.469 1.446 . . . . 75.049999999999997 110.898 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -92.08 -8.16 46.62 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.65 -1.159 . . . . 74.129999999999995 110.545 -176.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.542 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 34.2 t30 -103.51 120.66 51.03 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 108.977 -0.749 . . . . 64.099999999999994 108.977 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.89 -19.55 35.38 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.669 2.246 . . . . 74.120000000000005 111.858 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.413 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 6.9 tp60 -68.09 114.65 6.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.337 -0.986 . . . . 72.450000000000003 108.337 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.524 HG21 ' CG ' ' A' ' 92' ' ' ARG . 69.1 p -107.56 154.83 20.84 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.066 -0.716 . . . . 74.010000000000005 109.066 -175.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.7 mp -86.29 118.29 25.64 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.803 -0.443 . . . . 74.109999999999999 109.803 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -110.76 121.25 44.87 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.725 -1.954 . . . . 74.109999999999999 105.725 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.405 ' HG ' HG21 ' A' ' 35' ' ' VAL . 6.5 mp -105.27 138.17 41.89 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.151 -1.055 . . . . 71.25 108.151 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.576 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 32.6 tt0 -146.02 163.38 35.41 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.843 -1.91 . . . . 64.200000000000003 105.843 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -70.55 137.91 50.5 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 119.22 0.918 . . . . 74.439999999999998 110.37 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.9 141.15 40.66 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 108.15 -1.056 . . . . 73.209999999999994 108.15 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -80.19 10.04 4.93 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 122.233 1.016 . . . . 74.200000000000003 110.692 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -162.38 132.17 4.54 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.986 -1.857 . . . . 75.450000000000003 105.986 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.413 HD22 ' HA ' ' A' ' 30' ' ' VAL . 79.4 m-20 -78.36 158.54 28.75 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.413 0.625 . . . . 62.329999999999998 111.648 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.416 ' O ' HD12 ' A' ' 74' ' ' ILE . 6.7 t -110.47 149.53 30.17 Favored 'General case' 0 N--CA 1.399 -2.977 0 N-CA-C 104.35 -2.463 . . . . 51.520000000000003 104.35 169.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -133.11 137.68 46.41 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 108.935 -0.765 . . . . 62.5 108.935 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 92.3 mmm -79.6 -15.56 57.42 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.017 0.437 . . . . 73.140000000000001 110.897 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.48 112.35 22.84 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.196 -0.911 . . . . 54.020000000000003 109.247 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.38 110.23 1.38 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.162 -1.051 . . . . 74.409999999999997 108.162 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.8 m -68.87 99.96 1.12 Allowed 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 123.697 0.623 . . . . 55.200000000000003 110.148 -176.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -66.87 141.49 57.64 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.183 -0.917 . . . . 51.149999999999999 111.779 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.9 mt -87.83 -20.32 26.23 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.094 -0.957 . . . . 74.219999999999999 108.47 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.422 -1.833 0 CA-C-N 114.912 -1.04 . . . . 60.020000000000003 108.241 178.052 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 48.8 ttm . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.851 0.358 . . . . 73.540000000000006 110.773 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -95.5 -77.6 0.47 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.339 0.59 . . . . 63.409999999999997 111.696 -175.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -116.14 99.51 7.29 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.103 -0.499 . . . . 64.040000000000006 111.047 -176.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -88.8 132.9 34.44 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 105.189 -2.152 . . . . 72.010000000000005 105.189 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.448 ' HA ' HD22 ' B' ' 109' ' ' ASN . 57.8 t -80.41 109.09 14.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.49 -1.67 . . . . 73.129999999999995 106.49 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -140.04 15.06 2.45 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 115.042 -0.981 . . . . 64.230000000000004 111.855 -171.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' B' ' 74' ' ' ILE . 35.3 m -105.84 125.76 51.37 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 108.727 -0.842 . . . . 65.230000000000004 108.727 174.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.44 HD11 ' O ' ' B' ' 81' ' ' ALA . 85.4 mt -100.83 143.11 31.38 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.75 -0.833 . . . . 71.129999999999995 108.75 178.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.606 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 4.6 p90 -104.44 118.47 36.68 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 106.798 -1.556 . . . . 71.239999999999995 106.798 171.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 39.8 t -97.27 111.95 28.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 N-CA-C 107.206 -1.405 . . . . 64.319999999999993 107.206 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 36.2 p -109.92 162.47 14.48 Favored 'General case' 0 C--N 1.276 -2.59 0 N-CA-C 109.07 -0.715 . . . . 63.350000000000001 109.07 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.83 24.82 12.47 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.428 -0.891 . . . . 70.030000000000001 111.887 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 83.4 mt -101.78 113.59 65.81 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 107.757 -1.201 . . . . 75.430000000000007 107.757 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.49 169.79 2.14 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.856 2.371 . . . . 54.350000000000001 112.35 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 6.6 p -72.96 -2.41 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 122.115 0.959 . . . . 63.420000000000002 110.458 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' B' ' 43' ' ' LYS . 22.3 t0 -105.01 10.65 34.03 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 114.954 -1.021 . . . . 55.329999999999998 109.563 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.94 129.88 19.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-O 121.811 0.815 . . . . 72.420000000000002 109.449 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 45' ' ' ARG . 47.7 mmtm -130.0 107.05 16.56 Favored Pre-proline 0 C--N 1.277 -2.564 0 N-CA-C 106.449 -1.686 . . . . 64.049999999999997 106.449 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -41.48 -16.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.478 1 C-N-CA 126.372 4.715 . . . . 52.420000000000002 117.774 -165.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.546 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 9.8 ptt180 -65.51 -24.72 67.2 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 122.642 0.377 . . . . 75.230000000000004 111.855 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.515 ' HG3' ' CE1' ' B' ' 93' ' ' PHE . 0.0 OUTLIER -76.03 -41.83 49.72 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 119.214 -0.994 . . . . 75.120000000000005 108.888 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.17 -37.19 84.28 Favored 'General case' 0 C--O 1.211 -0.939 0 N-CA-C 108.859 -0.793 . . . . 74.219999999999999 108.859 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.682 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 63.1 t80 -58.53 -49.78 76.15 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.846 -1.07 . . . . 55.130000000000003 110.488 176.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.62 -33.98 74.97 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.862 0.363 . . . . 64.219999999999999 110.738 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 36.5 tp -74.58 -45.92 42.08 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.566 -0.743 . . . . 72.239999999999995 112.467 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -92.13 -7.31 48.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.951 1.093 . . . . 70.010000000000005 113.951 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 20.6 ttt180 -65.99 -43.13 56.29 Favored Pre-proline 0 CA--C 1.56 1.333 0 N-CA-C 112.416 0.525 . . . . 71.409999999999997 112.416 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.22 -15.43 46.09 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 121.76 1.64 . . . . 53.420000000000002 111.862 175.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -85.68 88.87 7.6 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.419 -0.585 . . . . 71.409999999999997 109.419 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.1 112.85 5.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.453 -0.794 . . . . 73.109999999999999 109.978 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.84 -26.5 1.62 Allowed Glycine 0 N--CA 1.426 -1.985 0 CA-C-N 113.578 -1.646 . . . . 72.409999999999997 109.49 -174.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -50.89 119.03 3.54 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.413 1.085 . . . . 72.140000000000001 111.905 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.413 ' HB2' HG22 ' B' ' 74' ' ' ILE . 6.6 mm-40 -93.06 -46.69 7.33 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 115.928 -0.578 . . . . 52.420000000000002 109.443 176.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.85 171.99 37.4 Favored Glycine 0 C--N 1.297 -1.614 0 C-N-CA 120.455 -0.879 . . . . 72.200000000000003 112.325 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.9 p -127.11 137.34 52.98 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.192 0.52 . . . . 61.109999999999999 111.061 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.87 109.72 16.88 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.376 -0.972 . . . . 72.219999999999999 108.376 175.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.74 131.95 39.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.729 -0.841 . . . . 60.329999999999998 108.729 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -130.97 119.57 22.27 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 109.293 -0.632 . . . . 75.239999999999995 109.293 -176.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.51 134.63 57.26 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.213 1.005 . . . . 73.409999999999997 110.873 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 2.5 m -130.08 158.58 39.24 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 105.663 -1.977 . . . . 71.040000000000006 105.663 175.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.89 -40.66 10.36 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.065 0.946 . . . . 72.109999999999999 113.29 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 -104.75 -41.66 5.6 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 119.58 -0.848 . . . . 72.349999999999994 112.735 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.558 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 14.1 pt20 -153.36 126.44 4.13 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 120.717 -0.393 . . . . 74.099999999999994 111.55 -173.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' B' ' 38' ' ' LEU . 51.9 Cg_exo -56.85 124.37 16.09 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.004 2.469 . . . . 63.109999999999999 111.393 171.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.24 141.22 14.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 115.114 -0.948 . . . . 72.329999999999998 108.679 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.73 120.31 5.21 Favored Glycine 0 C--O 1.205 -1.702 0 C-N-CA 119.139 -1.505 . . . . 74.239999999999995 112.46 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -90.37 102.94 15.67 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.642 -1.244 . . . . 74.310000000000002 107.642 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.17 112.38 37.49 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 CA-C-N 115.569 -0.741 . . . . 70.310000000000002 109.182 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.413 HG22 ' HB2' ' B' ' 58' ' ' GLU . 12.4 tt -97.18 138.01 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 CA-C-N 115.528 -0.76 . . . . 71.209999999999994 110.549 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -112.61 160.04 18.26 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.04 -0.982 . . . . 75.430000000000007 109.341 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.24 -31.61 72.53 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.863 -0.608 . . . . 63.219999999999999 112.224 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 26.4 p -128.88 152.56 48.38 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 121.74 0.781 . . . . 61.509999999999998 111.904 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . 0.599 ' HD3' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -63.09 -39.05 93.57 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.514 -1.221 . . . . 73.430000000000007 109.954 177.255 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . 0.416 ' N ' ' HG2' ' B' ' 78' ' ' ARG . . . -79.51 -19.9 48.52 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.184 -1.043 . . . . 63.020000000000003 108.184 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.56 -44.75 31.76 Favored Glycine 0 C--N 1.307 -1.067 0 N-CA-C 109.227 -1.549 . . . . 72.400000000000006 109.227 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.44 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -67.97 -37.4 81.48 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.381 -0.909 . . . . 50.310000000000002 109.476 176.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -55.42 -52.51 63.33 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.066 -0.97 . . . . 65.230000000000004 110.576 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.08 89.76 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.525 -0.761 . . . . 74.230000000000004 110.994 -176.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.21 -39.96 82.28 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.351 -0.84 . . . . 44.409999999999997 110.563 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -62.84 -42.49 99.76 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.603 -0.726 . . . . 44.119999999999997 111.841 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -62.37 -37.37 85.42 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.257 0.551 . . . . 74.230000000000004 111.25 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.19 -45.34 33.7 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 115.581 -0.736 . . . . 63.149999999999999 111.767 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.462 ' O ' HG23 ' B' ' 91' ' ' ILE . 90.7 mt -93.33 -21.05 19.8 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 117.477 2.399 . . . . 72.010000000000005 117.477 -170.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -69.86 114.01 7.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 120.787 1.631 . . . . 73.219999999999999 112.343 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 113.9 1.56 24.01 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.885 -0.598 . . . . 64.040000000000006 112.255 176.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.462 HG23 ' O ' ' B' ' 88' ' ' LEU . 13.2 tt -86.02 136.15 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 CA-C-O 121.137 0.494 . . . . 61.240000000000002 110.184 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.414 ' HA ' HG22 ' B' ' 100' ' ' THR . 22.2 mmt180 -59.26 139.02 57.38 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 125.17 1.388 . . . . 72.519999999999996 110.045 173.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.516 ' CE2' ' HG3' ' A' ' 45' ' ' ARG . 34.9 t80 -80.77 -32.28 35.54 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.491 -1.67 . . . . 74.140000000000001 106.491 173.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.531 ' HB2' ' HB3' ' B' ' 97' ' ' ASN . 9.5 m-20 -147.47 143.31 17.83 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 101.493 -3.521 . . . . 73.530000000000001 101.493 174.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . 0.65 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 74.0 Cg_endo -78.33 -15.88 13.98 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 CA-C-N 121.952 1.733 . . . . 61.200000000000003 109.619 175.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -79.63 -25.34 41.43 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.299 -1.319 . . . . 74.129999999999995 109.629 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' ASN . . . . . 0.531 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . 38.0 t30 -109.69 129.9 23.4 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 107.744 -1.206 . . . . 75.109999999999999 107.744 -174.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.73 -2.81 6.97 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 123.156 2.57 . . . . 61.310000000000002 113.241 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -77.45 122.41 25.16 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.723 0.773 . . . . 73.319999999999993 110.267 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.414 HG22 ' HA ' ' B' ' 92' ' ' ARG . 17.9 p -121.72 159.81 25.82 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 115.045 -0.979 . . . . 75.200000000000003 108.582 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.427 HD12 ' N ' ' B' ' 101' ' ' LEU . 4.4 mp -93.05 134.81 34.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.405 -0.961 . . . . 75.530000000000001 108.405 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -123.99 116.85 23.52 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.044 -1.836 . . . . 71.219999999999999 106.044 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mp -106.49 136.37 46.38 Favored 'General case' 0 C--N 1.289 -2.034 0 O-C-N 123.752 0.657 . . . . 72.409999999999997 110.354 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.606 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 37.1 tt0 -145.4 163.97 32.95 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 105.744 -1.947 . . . . 74.150000000000006 105.744 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -70.47 144.93 51.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 119.493 1.042 . . . . 71.450000000000003 110.133 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.69 158.18 27.03 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 107.996 -1.113 . . . . 73.120000000000005 107.996 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -81.91 -11.32 58.96 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.009 0.909 . . . . 63.009999999999998 109.523 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -149.06 130.49 14.77 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.664 -1.153 . . . . 52.229999999999997 107.948 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.448 HD22 ' HA ' ' B' ' 30' ' ' VAL . 54.2 m-80 -74.15 113.99 11.98 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.432 0.634 . . . . 72.420000000000002 110.479 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 23.5 m -96.2 102.17 13.92 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.336 -1.357 . . . . 70.030000000000001 107.336 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -93.73 146.59 23.74 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.964 -1.016 . . . . 75.109999999999999 111.196 -169.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 92.3 mmm -73.15 -53.3 11.34 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.25 -1.018 . . . . 36.740000000000002 108.25 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.9 90.14 8.22 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 107.738 -1.208 . . . . 72.109999999999999 107.738 176.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -53.31 122.87 10.44 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.265 -0.88 . . . . 74.019999999999996 111.263 -175.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 39.3 m -58.61 119.84 7.79 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.555 0.693 . . . . 70.430000000000007 109.531 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -101.48 121.5 42.07 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.713 -1.13 . . . . 73.209999999999994 111.139 -167.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 4.5 tt -71.85 -59.27 2.84 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 106.714 -1.588 . . . . 73.340000000000003 106.714 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 C--N 1.306 -1.313 0 N-CA-C 107.785 -1.191 . . . . 54.420000000000002 107.785 175.767 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 109.211 -0.662 . . . . 75.310000000000002 109.211 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -69.0 -56.77 6.75 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 113.596 0.961 . . . . 74.420000000000002 113.596 -162.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -103.05 31.97 3.96 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.797 0.808 . . . . 65.299999999999997 112.101 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -90.97 151.38 21.1 Favored 'General case' 0 N--CA 1.411 -2.39 0 N-CA-C 107.072 -1.455 . . . . 74.310000000000002 107.072 175.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.492 ' HB ' ' CD1' ' A' ' 105' ' ' PHE . 26.1 t -91.61 121.88 42.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.693 0 CA-C-N 116.13 -0.486 . . . . 71.030000000000001 109.691 -170.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.504 ' NH2' ' HG2' ' A' ' 111' ' ' LYS . 40.9 mtm180 -85.97 7.38 24.6 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-O 120.926 0.393 . . . . 72.209999999999994 110.507 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.6 m -134.2 129.77 36.23 Favored 'General case' 0 C--N 1.259 -3.363 0 CA-C-O 121.821 0.82 . . . . 64.530000000000001 112.054 -173.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 81' ' ' ALA . 88.4 mt -103.7 139.07 39.46 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.73 -1.211 . . . . 52.350000000000001 107.73 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -98.76 112.14 24.31 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.773 -1.566 . . . . 74.310000000000002 106.773 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.43 HG23 ' HG ' ' A' ' 103' ' ' LEU . 29.1 t -96.99 120.63 46.58 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 CA-C-N 113.79 -1.55 . . . . 71.109999999999999 107.739 -174.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 p -126.38 163.71 22.68 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 115.228 -0.896 . . . . 62.229999999999997 109.548 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.64 27.84 10.14 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.927 -0.869 . . . . 73.25 110.927 -173.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.551 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 96.8 mt -97.26 119.35 63.27 Favored Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 107.96 -1.126 . . . . 73.420000000000002 107.96 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.99 153.22 6.57 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.734 2.289 . . . . 72.140000000000001 111.283 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.499 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 8.6 p -70.07 -1.98 2.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.875 0.845 . . . . 70.109999999999999 112.013 -172.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -127.2 31.34 5.25 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-O 121.553 0.692 . . . . 65.150000000000006 109.974 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.14 149.06 6.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 N-CA-C 113.613 0.968 . . . . 74.019999999999996 113.613 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.514 ' HG2' ' CZ ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -102.74 144.53 28.8 Favored Pre-proline 0 C--N 1.279 -2.476 0 CA-C-N 113.883 -1.508 . . . . 73.409999999999997 109.615 176.091 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.45 -24.98 79.21 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 122.63 2.22 . . . . 74.319999999999993 113.325 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.536 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -84.14 -11.42 56.63 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 118.441 -1.304 . . . . 72.310000000000002 111.427 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.437 ' HG2' ' HG2' ' B' ' 46' ' ' GLU . 35.7 mt-10 -63.77 -39.92 95.44 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.703 0.763 . . . . 75.299999999999997 109.358 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.3 mt -67.32 -31.53 71.88 Favored 'General case' 0 C--O 1.209 -1.064 0 CA-C-N 115.226 -0.897 . . . . 73.450000000000003 110.077 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.61 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 42.0 t80 -65.32 -46.81 78.82 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.786 -0.643 . . . . 74.219999999999999 110.863 178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 69.0 mt -64.92 -40.01 94.39 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.114 -0.494 . . . . 64.310000000000002 110.884 -176.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.6 tp -81.42 -38.96 25.65 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.43 -0.804 . . . . 61.549999999999997 112.543 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -95.43 -3.52 46.79 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.285 1.217 . . . . 72.430000000000007 114.285 -173.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -61.49 -44.55 92.56 Favored Pre-proline 0 CA--C 1.563 1.452 0 N-CA-C 112.799 0.666 . . . . 64.329999999999998 112.799 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.68 -2.39 12.39 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 121.393 1.395 . . . . 53.25 112.854 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -91.53 95.35 9.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 122.336 1.065 . . . . 72.400000000000006 110.945 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -63.79 109.63 1.8 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 113.078 -1.874 . . . . 74.230000000000004 110.519 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.72 -23.56 3.23 Favored Glycine 0 N--CA 1.422 -2.252 0 CA-C-N 114.858 -1.065 . . . . 70.549999999999997 111.002 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -55.32 114.85 1.97 Allowed 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.498 0.719 . . . . 74.519999999999996 111.959 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -97.86 -58.91 1.87 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.661 -0.699 . . . . 75.109999999999999 110.376 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -158.26 -177.0 30.94 Favored Glycine 0 C--N 1.295 -1.726 0 C-N-CA 120.898 -0.668 . . . . 73.450000000000003 111.869 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.7 p -148.76 140.65 23.76 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 123.032 0.533 . . . . 64.340000000000003 110.349 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.3 tp -120.87 122.01 39.33 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.41 -0.589 . . . . 75.239999999999995 109.41 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.4 mm -93.57 133.76 33.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 109.233 -0.654 . . . . 74.430000000000007 109.233 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -135.3 113.27 11.1 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 121.021 0.438 . . . . 62.25 110.374 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -67.97 124.43 23.34 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.362 0.601 . . . . 61.399999999999999 110.897 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.8 m -116.7 162.05 18.27 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 105.637 -1.986 . . . . 71.209999999999994 105.637 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.51 -34.95 3.53 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.163 1.172 . . . . 74.109999999999999 114.163 -175.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -95.62 -46.79 6.49 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 112.75 0.648 . . . . 70.430000000000007 112.75 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.551 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 4.2 pt20 -156.82 157.08 30.62 Favored Pre-proline 0 C--N 1.295 -1.773 0 CA-C-N 115.792 -0.64 . . . . 64.019999999999996 109.459 -170.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.499 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 74.5 Cg_endo -80.46 120.64 4.05 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 122.667 2.245 . . . . 72.299999999999997 110.711 171.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.91 161.62 2.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.239 -1.022 . . . . 71.540000000000006 108.239 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.91 120.93 2.92 Favored Glycine 0 CA--C 1.484 -1.85 0 C-N-CA 118.762 -1.685 . . . . 74.109999999999999 112.579 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -88.11 104.62 16.85 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.519 -1.289 . . . . 75.409999999999997 107.519 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.6 t -99.25 123.26 51.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 CA-C-N 115.922 -0.581 . . . . 62.32 109.799 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 tt -101.54 131.85 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 115.38 -0.827 . . . . 73.140000000000001 110.962 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.412 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 74.2 m-85 -115.51 146.83 41.34 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.434 -1.257 . . . . 74.010000000000005 107.639 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -79.23 -24.07 43.31 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.708 0.766 . . . . 74.420000000000002 110.493 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.6 m -109.96 140.65 43.73 Favored 'General case' 0 N--CA 1.392 -3.373 0 CA-C-N 115.498 -0.774 . . . . 73.239999999999995 108.964 -175.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.1 mmt-85 -73.38 -33.15 64.87 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.417 -1.327 . . . . 73.140000000000001 107.417 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.2 -19.23 61.77 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.499 -1.682 . . . . 44.119999999999997 109.071 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.91 -42.34 6.39 Favored Glycine 0 CA--C 1.487 -1.661 0 N-CA-C 109.606 -1.398 . . . . 63.439999999999998 109.606 -177.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.425 ' O ' HD12 ' A' ' 33' ' ' LEU . . . -64.71 -47.45 78.27 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 114.902 -0.649 . . . . 73.349999999999994 111.115 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.56 -36.11 82.82 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.147 -0.621 . . . . 73.450000000000003 111.991 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.37 78.12 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 120.737 0.303 . . . . 44.350000000000001 110.854 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.36 -42.28 79.45 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.947 -0.569 . . . . 73.430000000000007 110.843 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -28.78 64.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 120.245 -0.582 . . . . 73.510000000000005 111.801 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -71.31 -41.38 69.97 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 120.592 0.234 . . . . 64.340000000000003 111.542 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.05 -41.42 50.74 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.252 0.464 . . . . 75.239999999999995 112.252 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 91' ' ' ILE . 97.4 mt -95.93 1.71 53.06 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 115.646 1.721 . . . . 70.239999999999995 115.646 -173.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -79.09 114.39 18.0 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 116.822 -1.951 . . . . 75.310000000000002 111.066 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.17 12.18 34.58 Favored Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 110.27 -1.132 . . . . 61.119999999999997 110.27 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 88' ' ' LEU . 13.3 tt -82.38 134.46 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.911 0 N-CA-C 109.116 -0.698 . . . . 52.420000000000002 109.116 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.439 ' NH1' ' HA ' ' A' ' 98' ' ' PRO . 26.2 mmt180 -60.91 121.07 11.44 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 107.954 -1.128 . . . . 72.400000000000006 107.954 171.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -75.37 -27.06 58.99 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.856 -1.535 . . . . 73.140000000000001 106.856 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 97' ' ' ASN . 12.0 t70 -148.07 126.1 5.91 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 103.212 -2.884 . . . . 70.239999999999995 103.212 174.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.569 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 69.2 Cg_endo -71.81 -16.44 29.62 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.426 1.417 . . . . 61.32 114.732 -175.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -93.07 -22.14 19.3 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.34 0.591 . . . . 74.129999999999995 110.174 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 48.9 t-20 -91.27 132.49 33.77 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.158 -1.423 . . . . 65.430000000000007 107.158 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.439 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 35.6 Cg_endo -67.75 -1.8 7.43 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.587 2.192 . . . . 70.329999999999998 113.0 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.75 113.74 10.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.793 -0.817 . . . . 62.450000000000003 108.793 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.9 p -115.7 147.53 40.77 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.915 -0.584 . . . . 74.129999999999995 109.687 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.6 tp -94.83 125.04 39.23 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 116.073 -0.512 . . . . 73.439999999999998 109.84 -174.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -120.54 126.35 50.11 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.194 -0.669 . . . . 75.010000000000005 109.194 176.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.43 ' HG ' HG23 ' A' ' 35' ' ' VAL . 7.0 mp -104.5 127.18 52.15 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 107.841 -1.17 . . . . 62.420000000000002 107.841 176.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -136.04 163.29 30.66 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 107.731 -1.211 . . . . 71.030000000000001 107.731 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.492 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 33.0 m-85 -78.7 134.83 37.06 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 119.048 0.84 . . . . 74.439999999999998 110.323 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.39 165.0 25.42 Favored 'General case' 0 N--CA 1.428 -1.532 0 O-C-N 123.668 0.605 . . . . 43.350000000000001 109.403 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -86.79 -6.87 58.68 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-O 121.946 0.879 . . . . 53.109999999999999 109.661 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.5 134.22 23.61 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.073 -0.967 . . . . 75.329999999999998 108.83 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' A' ' 30' ' ' VAL . 3.3 m-20 -76.72 124.97 28.46 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.165 -1.421 . . . . 53.119999999999997 107.165 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.9 t -88.01 163.22 16.41 Favored 'General case' 0 N--CA 1.409 -2.476 0 C-N-CA 118.113 -1.435 . . . . 75.530000000000001 108.907 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.504 ' HG2' ' NH2' ' A' ' 31' ' ' ARG . 51.3 mtmt -130.09 132.16 46.04 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.303 -1.369 . . . . 72.329999999999998 107.303 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 91.9 mtp -67.32 116.13 7.75 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.374 -0.602 . . . . 73.120000000000005 109.374 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.69 104.11 15.78 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.685 -0.689 . . . . 61.340000000000003 111.369 -175.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -88.67 93.77 9.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 107.429 -1.323 . . . . 71.299999999999997 107.429 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.2 m -61.11 133.0 55.55 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.609 -1.178 . . . . 71.25 112.782 -173.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -111.3 70.17 0.71 Allowed 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 114.909 -1.041 . . . . 64.140000000000001 110.327 175.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.7 tp -88.35 -33.08 18.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.026 -1.842 . . . . 65.230000000000004 106.026 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.416 -2.153 0 N-CA-C 104.857 -2.275 . . . . 65.109999999999999 104.857 173.272 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.565 0.222 . . . . 73.409999999999997 110.412 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.84 -34.15 51.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.442 0.639 . . . . 63.240000000000002 111.009 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -95.86 74.79 3.12 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.807 -0.812 . . . . 74.540000000000006 108.807 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.529 ' HB3' ' CG ' ' B' ' 78' ' ' ARG . 2.6 mm-40 -161.04 -179.36 7.45 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.551 -0.907 . . . . 62.43 108.551 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 17.5 t -105.74 127.53 60.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 123.132 0.27 . . . . 74.430000000000007 110.345 -169.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.56 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 82.8 mtm180 -96.22 0.04 50.52 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-O 121.286 0.565 . . . . 53.340000000000003 110.74 175.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 25.0 m -111.24 128.72 56.02 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-O 121.511 0.672 . . . . 72.430000000000007 112.549 -176.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.492 HD11 ' O ' ' B' ' 81' ' ' ALA . 91.1 mt -104.57 146.37 29.0 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.43 -0.952 . . . . 73.420000000000002 108.43 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' B' ' 104' ' ' GLU . 27.9 p90 -104.6 115.18 29.89 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.187 -1.412 . . . . 51.200000000000003 107.187 172.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.53 115.45 37.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 CA-C-N 113.917 -1.492 . . . . 62.310000000000002 107.859 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 35.7 p -119.53 171.4 8.38 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.272 -0.876 . . . . 74.239999999999995 109.272 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 86.93 25.01 35.83 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.38 -1.088 . . . . 52.509999999999998 110.38 -173.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.585 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 95.7 mt -94.77 114.71 64.2 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 107.701 -1.222 . . . . 60.229999999999997 107.701 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.23 157.62 1.86 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.762 2.308 . . . . 74.329999999999998 111.968 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.435 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 7.2 p -63.35 -17.52 19.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.424 0.63 . . . . 75.209999999999994 112.111 -173.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -120.35 42.38 2.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.682 0.753 . . . . 62.340000000000003 109.948 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.402 HD11 ' O ' ' B' ' 42' ' ' ILE . 2.5 pp -60.89 135.02 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.563 -1.255 . . . . 73.299999999999997 110.801 169.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -94.19 144.14 27.55 Favored Pre-proline 0 C--N 1.266 -3.025 0 N-CA-C 106.68 -1.6 . . . . 71.150000000000006 106.68 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.38 -20.7 69.44 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.352 2.035 . . . . 70.109999999999999 113.176 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.513 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -87.34 -10.74 51.38 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 118.966 -1.094 . . . . 71.019999999999996 111.999 -179.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.437 ' HG2' ' HG2' ' A' ' 46' ' ' GLU . 33.5 mt-10 -67.07 -39.0 86.74 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.426 0.631 . . . . 53.229999999999997 109.811 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 90.9 mt -68.86 -29.97 68.39 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-N 115.445 -0.798 . . . . 54.43 109.393 176.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.569 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 39.9 t80 -66.99 -47.99 69.83 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.438 -0.801 . . . . 74.200000000000003 110.682 177.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 82.3 mt -63.69 -39.77 95.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.29 0.567 . . . . 72.209999999999994 110.327 -177.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 33.6 tp -76.82 -39.49 51.16 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.106 -0.952 . . . . 73.0 112.489 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -95.25 -0.87 52.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 114.175 1.176 . . . . 74.409999999999997 114.175 -176.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -63.13 -42.98 79.83 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 112.479 0.548 . . . . 53.450000000000003 112.479 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -65.93 -21.63 56.82 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.09 1.86 . . . . 42.210000000000001 112.226 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -92.24 88.23 6.39 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 121.753 0.787 . . . . 75.209999999999994 109.57 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -80.51 115.49 20.06 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 122.439 1.114 . . . . 71.239999999999995 111.361 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.01 -28.41 0.73 Allowed Glycine 0 C--N 1.284 -2.354 0 CA-C-N 112.657 -2.065 . . . . 71.200000000000003 108.742 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -48.6 121.88 4.99 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.818 1.247 . . . . 75.230000000000004 111.775 174.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -92.83 -56.71 2.9 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.546 -0.909 . . . . 72.299999999999997 108.546 174.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.54 -175.88 39.57 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 115.063 -0.971 . . . . 72.150000000000006 112.035 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 12.5 p -136.99 138.17 40.24 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 122.735 0.414 . . . . 61.100000000000001 111.086 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 57.8 tp -114.39 127.22 55.73 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.289 -1.004 . . . . 63.340000000000003 108.289 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 50.8 mm -93.99 143.37 11.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.232 -0.655 . . . . 61.450000000000003 109.232 -176.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -137.96 108.23 6.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.645 -0.872 . . . . 63.310000000000002 108.645 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -66.94 128.98 38.4 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.312 0.577 . . . . 74.150000000000006 109.834 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.8 m -125.72 158.15 35.57 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 104.584 -2.376 . . . . 73.140000000000001 104.584 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.68 -29.24 59.02 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.554 0.946 . . . . 74.239999999999995 113.554 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -85.92 -39.28 17.12 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.729 0.64 . . . . 75.400000000000006 112.729 177.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 3.7 pt20 -174.32 155.1 2.16 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 115.886 -0.597 . . . . 74.340000000000003 109.691 -169.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.435 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 58.4 Cg_endo -80.28 115.82 3.25 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 C-N-CA 122.357 2.038 . . . . 74.239999999999995 110.657 171.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -87.92 162.63 2.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.405 -0.961 . . . . 53.039999999999999 108.405 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.06 122.7 3.4 Favored Glycine 0 CA--C 1.491 -1.464 0 C-N-CA 118.689 -1.72 . . . . 73.409999999999997 113.555 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -87.93 108.99 19.46 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.541 -1.281 . . . . 72.120000000000005 107.541 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 67.9 t -103.54 120.66 53.9 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 115.698 -0.683 . . . . 74.329999999999998 110.285 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.515 HD12 ' O ' ' B' ' 110' ' ' THR . 3.6 tt -96.54 130.82 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 115.169 -0.923 . . . . 75.319999999999993 110.06 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . 0.56 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 90.0 m-85 -111.13 156.56 21.18 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.906 -1.043 . . . . 65.439999999999998 108.326 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.74 -36.15 82.91 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.015 0.436 . . . . 60.539999999999999 112.089 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 33.0 p -131.84 163.41 28.33 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.411 0.624 . . . . 73.019999999999996 112.64 -175.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' ARG . . . . . 0.529 ' CG ' ' HB3' ' B' ' 29' ' ' GLU . 4.4 mpt_? -73.94 -34.06 64.17 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 108.734 -0.839 . . . . 75.140000000000001 108.734 176.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.82 -19.84 64.29 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.01 -0.996 . . . . 72.409999999999997 109.564 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.16 -46.12 6.0 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.224 -1.151 . . . . 54.109999999999999 110.224 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.492 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -62.88 -45.1 94.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.3 -0.45 . . . . 63.240000000000002 111.705 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' B' ' 78' ' ' ARG . 9.6 pt-20 -63.56 -36.11 82.71 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 120.916 -0.314 . . . . 72.150000000000006 111.299 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.43 -41.85 79.72 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 120.839 0.352 . . . . 52.140000000000001 110.312 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.44 -42.31 87.84 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.72 -0.673 . . . . 63.409999999999997 111.227 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -70.96 -39.29 72.63 Favored 'General case' 0 C--O 1.203 -1.35 0 C-N-CA 119.407 -0.917 . . . . 72.409999999999997 110.999 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -65.68 -31.9 73.16 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.174 0.511 . . . . 61.43 110.764 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.06 -40.27 17.02 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 112.309 0.485 . . . . 71.0 112.309 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.521 ' O ' HG22 ' B' ' 91' ' ' ILE . 87.3 mt -100.99 -13.11 18.4 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 116.348 1.981 . . . . 70.030000000000001 116.348 -172.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -76.17 113.69 14.0 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 117.401 -1.72 . . . . 73.129999999999995 112.043 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 113.36 6.46 21.91 Favored Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 120.545 -0.836 . . . . 65.310000000000002 112.055 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.521 HG22 ' O ' ' B' ' 88' ' ' LEU . 14.9 tt -97.95 144.67 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.954 0 N-CA-C 107.117 -1.438 . . . . 72.329999999999998 107.117 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -79.42 138.36 37.6 Favored 'General case' 0 C--N 1.26 -3.296 0 CA-C-O 121.244 0.545 . . . . 71.230000000000004 111.471 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -69.17 -35.51 76.37 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 113.811 -1.54 . . . . 74.549999999999997 108.599 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.423 ' OD2' ' HD2' ' A' ' 45' ' ' ARG . 1.1 m-20 -129.36 130.13 23.3 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 102.306 -3.22 . . . . 73.040000000000006 102.306 172.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . 0.61 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 27.9 Cg_endo -61.29 -30.66 88.32 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.316 2.011 . . . . 75.329999999999998 113.39 -177.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -94.19 15.21 17.85 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 123.339 0.656 . . . . 65.239999999999995 111.276 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' ASN . . . . . 0.4 ' CB ' ' HB2' ' B' ' 94' ' ' ASP . 46.3 t30 -127.18 128.14 24.16 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.698 -0.853 . . . . 72.340000000000003 108.698 -177.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.55 9.82 1.15 Allowed 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.927 2.418 . . . . 53.329999999999998 113.25 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -83.83 110.34 18.28 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.894 -1.521 . . . . 70.319999999999993 106.894 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.469 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 65.5 p -102.72 141.09 36.11 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.798 -0.761 . . . . 74.299999999999997 110.365 -175.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 24.7 tp -86.17 126.1 33.99 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.272 -1.01 . . . . 72.140000000000001 108.272 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -131.05 121.68 25.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 109.437 -0.579 . . . . 62.439999999999998 109.437 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.68 116.59 32.27 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.126 -0.943 . . . . 72.510000000000005 109.829 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.577 ' HB2' ' CE1' ' B' ' 34' ' ' PHE . 40.2 mm-40 -122.51 170.33 10.09 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.545 -1.65 . . . . 73.109999999999999 106.545 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -81.72 137.43 35.38 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 119.184 0.902 . . . . 72.349999999999994 109.738 176.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.66 151.13 27.72 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.176 0.512 . . . . 74.510000000000005 111.41 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -87.23 12.09 12.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.715 0.769 . . . . 41.229999999999997 109.996 177.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -137.69 115.42 11.38 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 107.524 -1.287 . . . . 70.25 107.524 177.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -84.05 106.96 16.11 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.464 -1.68 . . . . 71.340000000000003 106.464 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.515 ' O ' HD12 ' B' ' 74' ' ' ILE . 28.8 m -75.82 139.23 41.64 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.245 -0.434 . . . . 51.32 110.834 -173.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -114.55 90.73 3.41 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.053 0.454 . . . . 61.030000000000001 110.64 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 86.4 mtp -85.09 90.28 7.82 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.901 -0.59 . . . . 64.239999999999995 110.633 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.41 148.85 22.54 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.722 -1.214 . . . . 71.530000000000001 107.722 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.485 ' HZ3' ' HB2' ' B' ' 114' ' ' LYS . 10.0 mtmp? -73.75 112.0 9.44 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.177 -0.675 . . . . 72.219999999999999 109.177 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 36.1 t -81.87 111.03 17.7 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 115.836 -0.62 . . . . 72.0 109.932 -177.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -71.69 133.38 45.6 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.275 -0.875 . . . . 63.329999999999998 111.231 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 48.2 tp -73.84 -54.94 6.88 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 104.856 -2.275 . . . . 72.209999999999994 104.856 172.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 N--CA 1.431 -1.388 0 C-N-CA 127.447 2.299 . . . . 75.530000000000001 105.86 170.08 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' A' ' 105' ' ' PHE . 40.6 t . . . . . 0 N--CA 1.426 -1.667 0 N-CA-C 108.289 -1.004 . . . . 53.34 108.289 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 88.4 mtt180 -88.53 12.8 13.54 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.676 -0.693 . . . . 72.22 111.458 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.9 m -136.99 132.74 34.74 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 121.415 0.626 . . . . 60.31 112.462 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.4 mt -112.11 145.3 40.02 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.358 -0.979 . . . . 71.4 108.358 173.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.403 ' CE1' ' HB2' ' A' ' 104' ' ' GLU . 21.5 p90 -103.42 114.8 29.36 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 106.956 -1.498 . . . . 73.31 106.956 172.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.59 HG22 ' HG ' ' A' ' 103' ' ' LEU . 33.5 t -101.05 113.87 38.46 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 CA-C-N 114.144 -1.389 . . . . 64.23 108.643 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.6 p -111.4 171.61 7.38 Favored 'General case' 0 N--CA 1.41 -2.438 0 N-CA-C 109.104 -0.702 . . . . 64.52 109.104 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 88.04 29.13 21.27 Favored Glycine 0 N--CA 1.431 -1.652 0 C-N-CA 120.911 -0.661 . . . . 33.24 112.493 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 96.5 mt -93.07 125.83 53.39 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.671 -1.233 . . . . 72.23 107.671 173.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -50.21 153.41 6.91 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.484 2.123 . . . . 70.21 110.783 172.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.453 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 11.3 p -65.94 -12.91 14.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 123.152 0.581 . . . . 62.42 112.09 -172.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -126.77 41.67 3.47 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.904 0.859 . . . . 53.35 109.373 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 pp -59.17 145.5 10.84 Favored 'Isoleucine or valine' 0 C--O 1.25 1.115 0 C-N-CA 119.271 -0.972 . . . . 72.31 112.52 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.451 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 70.6 mmtt -98.94 146.22 31.3 Favored Pre-proline 0 C--N 1.271 -2.813 0 N-CA-C 107.31 -1.367 . . . . 72.03 107.31 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -59.45 -24.53 75.15 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.381 2.054 . . . . 74.02 111.866 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.548 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . 13.9 ptt180 -78.13 -20.58 51.83 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.692 -0.686 . . . . 75.13 112.736 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 42.6 mt-10 -64.6 -38.74 92.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.221 0.534 . . . . 63.43 110.368 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -76.1 -22.17 55.86 Favored 'General case' 0 C--O 1.212 -0.907 0 CA-C-O 121.628 0.727 . . . . 65.45 109.934 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.508 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 62.9 t80 -73.5 -47.96 37.11 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.065 -0.97 . . . . 72.2 109.04 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.39 -38.84 74.75 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.655 -0.702 . . . . 75.43 110.175 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.9 tp -78.52 -37.08 43.92 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.46 -0.791 . . . . 61.42 112.719 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -97.05 1.04 49.65 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 118.898 -1.121 . . . . 63.23 113.598 -175.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -67.82 -42.93 36.44 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 114.049 1.129 . . . . 72.2 114.049 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -63.76 -20.11 68.17 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 121.478 1.452 . . . . 72.12 111.807 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -90.02 101.11 13.82 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 121.638 0.732 . . . . 74.2 110.834 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -64.41 110.4 2.26 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.345 -1.298 . . . . 65.2 110.642 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.47 -17.26 3.1 Favored Glycine 0 N--CA 1.425 -2.087 0 CA-C-N 115.015 -0.993 . . . . 62.15 113.326 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -62.4 107.9 1.01 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 118.001 0.901 . . . . 74.21 112.317 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -90.72 -43.92 9.8 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.49 -0.777 . . . . 74.41 110.648 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.91 171.88 43.29 Favored Glycine 0 C--N 1.301 -1.376 0 C-N-CA 120.797 -0.716 . . . . 54.44 111.674 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.8 p -138.57 137.34 36.91 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.85 0.325 . . . . 74.24 111.659 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.6 mp -112.83 121.63 45.27 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.561 -0.903 . . . . 65.35 108.561 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.5 mm -94.27 133.03 36.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 120.892 0.377 . . . . 74.32 110.14 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -118.06 106.88 13.35 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.708 -1.59 . . . . 73.52 106.708 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.73 131.19 42.77 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.893 -0.594 . . . . 73.15 109.663 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.591 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 18.8 m -129.7 153.01 48.58 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 104.486 -2.412 . . . . 72.31 104.486 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.5 -26.87 45.24 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 114.381 1.252 . . . . 42.45 114.381 -172.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 30.8 mmt180 -104.48 -25.64 12.71 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 113.268 0.84 . . . . 73.43 113.268 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.591 ' O ' ' HB ' ' A' ' 65' ' ' THR . 14.3 pt20 -172.55 136.54 0.82 Allowed Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.398 -0.593 . . . . 72.43 109.398 -173.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.455 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 44.8 Cg_endo -74.58 133.39 17.2 Favored 'Trans proline' 0 N--CA 1.43 -2.232 0 C-N-CA 121.956 1.771 . . . . 70.12 110.449 170.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m -101.78 143.54 14.5 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 N-CA-C 108.126 -1.065 . . . . 74.31 108.126 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.5 120.96 4.88 Favored Glycine 0 CA--C 1.479 -2.161 0 C-N-CA 119.807 -1.187 . . . . 73.11 112.719 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -87.69 102.8 14.99 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.769 -1.567 . . . . 72.52 106.769 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.9 t -97.69 123.8 50.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-N 114.984 -1.007 . . . . 65.32 110.036 -175.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 10.9 tt -95.86 131.51 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.108 0 CA-C-N 115.04 -0.982 . . . . 75.13 109.274 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.45 159.71 18.48 Favored 'General case' 0 N--CA 1.414 -2.25 0 CA-C-N 114.977 -1.01 . . . . 71.33 110.839 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -53.63 -44.93 69.93 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 125.646 1.578 . . . . 75.01 110.808 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.3 p -150.8 153.86 36.22 Favored 'General case' 0 N--CA 1.398 -3.067 0 CA-C-N 115.403 -0.817 . . . . 64.33 111.293 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -58.74 -42.58 89.12 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 125.158 1.383 . . . . 74.34 110.2 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.66 -18.73 64.26 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.897 -1.047 . . . . 74.51 109.394 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.25 -45.26 5.37 Favored Glycine 0 C--N 1.294 -1.766 0 CA-C-N 113.626 -1.625 . . . . 61.3 110.455 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.54 -45.02 95.39 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.998 0.919 . . . . 51.04 111.584 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.08 -26.92 68.76 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.286 -0.416 . . . . 63.44 111.844 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.5 -39.52 27.81 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.16 0.505 . . . . 72.01 109.878 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.95 85.96 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.684 -0.689 . . . . 43.15 111.021 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.419 ' CE ' ' HA ' ' A' ' 104' ' ' GLU . 14.0 ptmm? -68.38 -28.08 66.79 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 116.201 -0.454 . . . . 71.12 110.281 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -64.43 -36.23 83.5 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.658 0.599 . . . . 73.44 110.904 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.25 -38.64 17.38 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 120.977 0.418 . . . . 63.12 111.916 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.532 ' O ' HG22 ' A' ' 91' ' ' ILE . 95.6 mt -96.94 -5.43 37.98 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 115.571 1.693 . . . . 60.14 115.571 -171.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -78.75 114.93 18.1 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 117.086 -1.845 . . . . 54.33 110.889 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.34 14.65 29.86 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 110.746 -0.942 . . . . 64.24 110.746 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 88' ' ' LEU . 10.2 tt -84.7 126.04 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.875 0 CA-C-O 121.632 0.73 . . . . 55.14 109.413 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -63.93 111.78 2.64 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 105.84 -1.911 . . . . 73.31 105.84 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -71.71 -25.78 62.22 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.947 0.88 . . . . 73.11 109.262 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -161.29 117.8 1.37 Allowed Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 106.583 -1.636 . . . . 72.31 106.583 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.08 -28.81 86.39 Favored 'Trans proline' 0 N--CA 1.474 0.349 0 C-N-CA 122.161 1.907 . . . . 74.44 112.862 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -74.71 -24.7 58.79 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.275 0.56 . . . . 71.13 110.899 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -102.96 135.64 19.38 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.023 -1.473 . . . . 63.12 107.023 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.97 15.06 0.62 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.306 2.004 . . . . 72.4 112.341 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.404 ' HA ' ' OE1' ' A' ' 99' ' ' GLN . 5.9 tp60 -89.96 121.4 32.02 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.922 0.889 . . . . 72.44 110.334 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.483 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 66.2 p -114.59 142.47 46.39 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.128 -0.693 . . . . 73.01 109.128 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.9 tp -89.18 135.95 33.29 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.933 -0.766 . . . . 71.15 108.933 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -135.0 124.79 25.39 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.57 -0.529 . . . . 61.23 109.57 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.59 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.6 mp -110.84 118.33 35.84 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.059 -0.519 . . . . 63.44 109.866 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HA ' ' CE ' ' A' ' 85' ' ' LYS . 7.7 mm-40 -126.61 161.29 28.39 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.936 -0.765 . . . . 72.02 108.936 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.447 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 27.1 m-85 -69.94 139.17 52.84 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.36 -0.536 . . . . 54.54 109.922 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.52 160.66 29.28 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 121.121 0.486 . . . . 65.02 110.004 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -77.16 -13.65 59.91 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.454 -0.794 . . . . 73.54 110.127 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.38 136.67 16.64 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.025 -0.989 . . . . 62.23 109.449 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -70.96 113.0 7.56 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.239 -1.393 . . . . 43.32 107.239 173.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.432 -1.359 0 N-CA-C 108.486 -0.931 . . . . 64.23 108.486 -177.639 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.421 -1.883 0 N-CA-C 105.105 -2.183 . . . . 75.2 105.105 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -84.86 8.2 18.25 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 112.417 0.525 . . . . 61.34 112.417 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 28.9 m -127.85 129.27 46.66 Favored 'General case' 0 C--N 1.27 -2.857 0 C-N-CA 119.963 -0.695 . . . . 72.41 112.065 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -104.77 134.39 48.0 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.517 -1.29 . . . . 72.23 107.517 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.567 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 33.7 p90 -91.75 118.3 30.55 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 107.784 -1.191 . . . . 74.04 107.784 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.446 HG22 ' HG ' ' B' ' 103' ' ' LEU . 39.6 t -97.44 115.68 37.86 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 114.198 -1.364 . . . . 61.23 108.137 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 24.0 p -129.44 171.12 12.87 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 115.101 -0.954 . . . . 64.42 109.224 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 82.03 51.92 4.27 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 110.44 -1.064 . . . . 70.03 110.44 -173.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 95.7 mt -122.44 129.25 25.14 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.868 -1.16 . . . . 53.24 107.868 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -52.85 159.59 4.92 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 122.412 2.074 . . . . 72.11 110.978 171.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.68 -10.54 14.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.628 0.727 . . . . 74.12 111.301 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -127.02 40.83 3.64 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 122.158 0.98 . . . . 73.33 109.441 -176.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.451 ' O ' HD12 ' B' ' 42' ' ' ILE . 2.7 pp -64.46 134.19 29.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 118.686 -1.205 . . . . 71.53 110.666 170.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.416 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 74.1 mmtt -91.42 141.99 26.55 Favored Pre-proline 0 C--N 1.273 -2.734 0 N-CA-C 108.672 -0.862 . . . . 71.43 108.672 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -51.78 -32.16 44.94 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.85 2.367 . . . . 74.52 112.429 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.48 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 12.0 ptt180 -68.44 -26.57 65.58 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 112.426 0.528 . . . . 62.24 112.426 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.416 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 32.7 mt-10 -65.13 -42.7 93.63 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.327 0.584 . . . . 71.21 109.539 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.38 -36.6 81.68 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 115.397 -0.82 . . . . 74.2 109.489 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.486 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 76.2 t80 -61.01 -46.82 89.19 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.822 -1.081 . . . . 63.42 110.867 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 89.0 mt -66.62 -41.66 88.02 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.241 0.544 . . . . 55.05 109.826 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 29.2 tp -69.73 -44.2 70.77 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.667 -1.151 . . . . 72.33 112.117 -175.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -94.53 4.42 53.87 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 113.167 0.803 . . . . 61.33 113.167 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 28.2 ttt180 -69.5 -43.77 23.55 Favored Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 112.976 0.732 . . . . 75.15 112.976 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -76.23 -2.47 12.66 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 121.45 1.434 . . . . 74.44 112.033 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -94.6 103.12 15.06 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 121.833 0.825 . . . . 70.32 111.556 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -68.19 118.17 10.97 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 114.103 -1.408 . . . . 65.15 110.793 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' B' ' 75' ' ' PHE . . . 133.07 -19.7 4.33 Favored Glycine 0 C--N 1.281 -2.472 0 CA-C-N 115.005 -0.998 . . . . 73.52 112.695 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -58.4 113.22 1.87 Allowed 'General case' 0 C--O 1.242 0.672 0 CA-C-N 117.301 0.55 . . . . 70.42 111.663 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -95.46 -58.97 1.98 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.58 -0.736 . . . . 74.01 110.344 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.6 160.2 32.92 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 120.041 -1.076 . . . . 72.2 113.095 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.3 p -119.33 137.95 53.37 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 122.702 0.401 . . . . 62.42 110.814 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 66.9 tp -111.31 111.3 22.25 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.882 -1.155 . . . . 75.54 107.882 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 51.0 mm -94.61 136.38 26.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 109.732 -0.47 . . . . 63.41 109.732 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -133.19 114.84 14.3 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.477 -0.935 . . . . 74.44 108.477 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.06 113.95 8.63 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.959 -1.126 . . . . 75.15 107.959 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.9 m -105.93 167.56 9.71 Favored 'General case' 0 N--CA 1.403 -2.807 0 N-CA-C 107.023 -1.473 . . . . 72.53 107.023 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.76 -33.42 23.11 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.675 0.991 . . . . 71.12 113.675 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -105.18 -37.78 6.78 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 119.724 -0.79 . . . . 71.53 112.424 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -155.25 159.68 31.53 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 110.203 -0.295 . . . . 73.43 110.203 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.24 123.29 7.09 Favored 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.218 1.945 . . . . 65.33 109.636 167.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 35.9 m -97.58 156.84 3.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 107.461 -1.311 . . . . 64.24 107.461 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.03 121.94 2.58 Favored Glycine 0 C--O 1.203 -1.798 0 C-N-CA 118.237 -1.935 . . . . 50.33 113.492 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -88.42 108.36 19.33 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.78 -1.193 . . . . 60.54 107.78 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.62 120.11 53.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-N 116.184 -0.462 . . . . 74.11 110.473 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 11.8 tt -96.32 134.8 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 115.559 -0.746 . . . . 73.41 110.478 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' B' ' 56' ' ' GLY . 60.1 m-85 -111.29 149.58 30.87 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 114.621 -1.172 . . . . 74.2 109.821 179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -56.27 -34.35 66.34 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.727 1.211 . . . . 61.32 111.453 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 9.9 p -144.56 138.3 27.4 Favored 'General case' 0 N--CA 1.398 -3.027 0 CA-C-O 121.953 0.883 . . . . 73.4 110.634 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -25.57 59.03 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 114.494 -1.23 . . . . 75.21 110.453 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.1 -19.68 64.06 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.532 1.158 . . . . 73.33 108.654 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.26 -43.2 5.66 Favored Glycine 0 C--N 1.308 -1.0 0 CA-C-N 113.786 -1.552 . . . . 51.2 109.922 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.41 -37.64 78.55 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.989 0.916 . . . . 52.21 112.02 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.04 -34.53 76.41 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.864 0.364 . . . . 62.33 111.44 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.25 -38.12 27.43 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.295 0.569 . . . . 72.43 109.804 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.2 93.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.872 -1.058 . . . . 61.44 111.202 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -65.6 -41.01 93.28 Favored 'General case' 0 C--O 1.195 -1.815 0 CA-C-N 116.258 -0.428 . . . . 75.2 110.647 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -63.68 -24.73 67.9 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 112.359 0.503 . . . . 74.24 112.359 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.54 -36.02 33.67 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 120.811 0.339 . . . . 64.42 111.156 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.497 ' O ' HG22 ' B' ' 91' ' ' ILE . 98.6 mt -102.14 -19.92 14.93 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 115.222 1.564 . . . . 74.04 115.222 -174.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ASN . . . . . 0.436 ' HB3' ' H ' ' B' ' 103' ' ' LEU 0.259 0.2 OUTLIER -75.65 113.95 13.67 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 118.92 -1.112 . . . . 62.35 112.616 -178.807 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.04 14.99 13.51 Favored Glycine 0 N--CA 1.41 -3.035 0 CA-C-N 115.554 -0.748 . . . . 61.4 111.74 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.497 HG22 ' O ' ' B' ' 88' ' ' LEU . 15.7 tt -95.93 133.89 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.977 0 N-CA-C 108.964 -0.754 . . . . 74.35 108.964 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' B' ' 92' ' ' ARG . 7.3 tpt180 -62.82 119.3 9.09 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 105.117 -2.179 . . . . 74.33 105.117 172.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -68.18 -31.12 70.44 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 108.418 -0.956 . . . . 74.31 108.418 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 45' ' ' ARG . 1.0 OUTLIER -166.47 137.42 2.76 Favored Pre-proline 0 N--CA 1.427 -1.616 0 N-CA-C 106.709 -1.589 . . . . 74.42 106.709 174.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.1 -2.81 12.88 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.132 1.888 . . . . 71.23 113.237 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -85.63 -24.92 26.91 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.75 0.786 . . . . 71.54 109.532 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' ASN . . . . . 0.544 ' OD1' ' HB2' ' B' ' 99' ' ' GLN . 6.6 t-20 -110.45 148.17 37.88 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 106.004 -1.85 . . . . 73.44 106.004 174.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.05 22.1 0.77 Allowed 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 122.529 2.153 . . . . 65.13 112.045 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' GLN . . . . . 0.544 ' HB2' ' OD1' ' B' ' 97' ' ' ASN . 5.5 tp60 -89.41 129.29 35.95 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.948 0.899 . . . . 63.22 110.802 -176.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.544 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 36.8 p -116.52 138.32 51.49 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.731 -0.47 . . . . 54.23 109.731 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 49.3 tp -86.09 131.1 34.33 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.045 -0.724 . . . . 73.12 109.045 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -135.82 122.63 21.15 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-O 120.834 0.35 . . . . 74.02 110.31 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.446 ' HG ' HG22 ' B' ' 35' ' ' VAL . 6.2 mp -108.27 116.27 31.66 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.841 -1.17 . . . . 74.22 107.841 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.567 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 7.4 tp10 -131.72 159.6 37.94 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.625 -1.62 . . . . 61.41 106.625 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -68.93 137.19 53.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 119.561 1.073 . . . . 71.32 110.859 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.63 164.28 26.46 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.92 -0.582 . . . . 74.44 110.232 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -84.72 -9.86 57.81 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.76 0.791 . . . . 71.31 109.114 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.44 130.09 19.09 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.208 -0.905 . . . . 63.24 109.892 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -70.26 104.55 2.69 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.854 -1.165 . . . . 64.41 107.854 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.423 -1.819 0 CA-C-N 115.665 -0.698 . . . . 62.31 109.57 -172.969 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.3 t . . . . . 0 N--CA 1.436 -1.126 0 N-CA-C 103.859 -2.645 . . . . 54.01 103.859 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 75' ' ' PHE . 26.6 ptt180 -129.64 7.97 5.32 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.793 -0.64 . . . . 73.52 112.461 -168.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.3 m -104.89 124.48 49.55 Favored 'General case' 0 C--N 1.266 -3.04 0 C-N-CA 119.77 -0.772 . . . . 70.12 109.236 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 93.7 mt -104.75 136.78 43.63 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.745 -1.205 . . . . 64.14 107.745 176.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.501 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 20.4 p90 -98.32 118.98 36.18 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.27 -1.382 . . . . 74.24 107.27 174.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.461 HG22 ' HG ' ' A' ' 103' ' ' LEU . 19.5 t -99.79 111.01 28.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 114.531 -1.213 . . . . 61.53 108.365 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.7 p -110.01 175.33 5.48 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 108.57 -0.9 . . . . 73.11 108.57 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 97.42 1.33 59.2 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.757 -0.735 . . . . 54.21 111.659 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.5 mt -77.06 139.05 65.03 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 108.373 -0.973 . . . . 42.32 108.373 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 170.38 16.69 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.726 1.617 . . . . 75.53 111.383 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 p -78.69 7.54 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-O 122.67 1.224 . . . . 60.41 109.403 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -115.93 7.94 14.55 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.042 -1.436 . . . . 75.52 109.481 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.32 125.3 18.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.962 0.887 . . . . 55.25 110.813 -176.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -109.96 142.04 25.05 Favored Pre-proline 0 C--N 1.289 -2.043 0 CA-C-N 114.198 -1.365 . . . . 75.05 109.356 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.48 -25.08 30.72 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.63 2.886 . . . . 51.24 113.56 -176.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' HB3' ' OD2' ' B' ' 94' ' ' ASP . 23.7 ptt180 -66.63 -28.17 68.26 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 121.067 0.461 . . . . 75.42 111.464 -178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -71.48 -38.2 71.23 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.143 0.497 . . . . 70.51 110.666 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.76 -38.65 73.47 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 108.544 -0.91 . . . . 73.01 108.544 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.573 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 12.2 t80 -57.93 -49.05 78.08 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.756 -1.111 . . . . 73.41 111.087 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 97.1 mt -62.84 -41.31 99.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.075 0.464 . . . . 54.31 110.707 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.9 tp -73.46 -40.92 63.78 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.315 -0.857 . . . . 62.54 111.609 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -90.79 -5.69 55.31 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 114.543 1.312 . . . . 73.11 114.543 -175.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 13.1 mtp180 -58.36 -48.38 97.09 Favored Pre-proline 0 N--CA 1.481 1.091 0 N-CA-C 113.417 0.895 . . . . 73.24 113.417 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.57 -16.84 52.05 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 121.472 1.448 . . . . 72.55 112.494 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -91.03 86.31 6.21 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.327 0.584 . . . . 63.25 110.147 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -70.48 115.99 10.29 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 122.213 1.006 . . . . 71.11 109.544 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.14 -23.08 2.08 Favored Glycine 0 C--N 1.287 -2.172 0 CA-C-N 113.81 -1.541 . . . . 70.34 109.556 -173.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -57.37 109.55 0.7 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.206 1.002 . . . . 62.31 111.343 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -88.15 -47.52 8.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.525 0.679 . . . . 54.23 109.679 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.46 170.95 44.08 Favored Glycine 0 C--N 1.297 -1.618 0 C-N-CA 120.147 -1.025 . . . . 71.12 112.833 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.4 p -131.59 138.03 48.68 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 122.653 0.381 . . . . 75.33 110.144 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -115.66 118.29 32.66 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.468 -1.678 . . . . 72.32 106.468 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -93.52 133.84 33.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.881 -1.155 . . . . 73.21 107.881 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -127.97 117.74 22.29 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.191 -1.04 . . . . 73.23 108.191 -175.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.37 111.31 4.56 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.055 -1.091 . . . . 75.11 108.055 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.8 m -116.03 168.24 10.26 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.826 -0.805 . . . . 53.32 108.826 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.28 -29.93 10.76 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.789 1.235 . . . . 72.22 114.196 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -104.11 -47.2 4.23 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.989 -0.684 . . . . 74.54 111.16 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -155.93 153.24 25.41 Favored Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-N 115.48 -0.782 . . . . 65.11 109.527 -167.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -68.72 105.65 1.34 Allowed 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 122.047 1.832 . . . . 74.01 108.765 167.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -86.08 162.8 2.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 108.206 -1.035 . . . . 71.13 108.206 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.33 120.2 3.3 Favored Glycine 0 CA--C 1.486 -1.751 0 C-N-CA 117.91 -2.091 . . . . 64.23 113.072 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -89.0 104.8 17.32 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.39 -1.337 . . . . 72.23 107.39 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.3 t -99.9 118.34 46.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 115.765 -0.652 . . . . 73.41 110.289 -176.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 tt -97.69 127.6 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 CA-C-O 121.909 0.861 . . . . 64.5 110.32 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.421 ' O ' ' HD2' ' A' ' 31' ' ' ARG . 73.2 m-85 -102.86 166.18 10.62 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 114.515 -1.22 . . . . 73.24 110.144 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.03 -47.73 74.34 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.972 -1.013 . . . . 73.33 112.565 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 p -146.13 165.12 30.06 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.615 -0.721 . . . . 51.34 111.082 -172.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.411 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -70.35 -32.12 69.69 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.628 -0.508 . . . . 74.02 109.628 -178.016 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.63 -20.41 65.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 122.199 1.0 . . . . 53.13 109.552 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.06 -42.43 6.3 Favored Glycine 0 C--N 1.299 -1.492 0 CA-C-N 114.253 -1.34 . . . . 75.3 110.417 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.22 -42.86 88.12 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 123.167 0.587 . . . . 75.12 111.48 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.18 -42.76 91.59 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 111.637 0.236 . . . . 74.11 111.637 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.4 -36.85 68.77 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-O 121.031 0.444 . . . . 72.02 111.098 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.42 -39.64 77.75 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.491 -0.777 . . . . 54.12 111.346 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -68.18 -37.13 80.63 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 120.1 -0.64 . . . . 74.3 110.147 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -58.27 -38.16 76.41 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 123.47 0.481 . . . . 73.34 111.286 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.66 -41.66 26.42 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 116.387 -0.37 . . . . 64.11 111.601 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.48 ' O ' HG22 ' A' ' 91' ' ' ILE . 99.0 mt -88.97 -22.17 23.17 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 116.212 1.93 . . . . 73.42 116.212 -173.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.436 ' HB3' ' H ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -71.78 113.15 8.52 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 117.904 -1.519 . . . . 65.24 109.888 176.069 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.77 11.98 13.53 Favored Glycine 0 N--CA 1.408 -3.222 0 CA-C-N 115.411 -0.813 . . . . 44.12 111.478 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.5 tt -94.45 133.75 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 N-CA-C 107.441 -1.318 . . . . 63.33 107.441 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 59.5 ttt180 -97.43 126.86 42.93 Favored 'General case' 0 C--N 1.251 -3.696 0 N-CA-C 109.15 -0.685 . . . . 72.11 109.15 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.13 -32.84 74.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.593 -1.185 . . . . 75.53 110.418 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.62 ' HB2' ' HB3' ' A' ' 97' ' ' ASN . 1.5 m-20 -147.73 126.49 6.2 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 103.938 -2.616 . . . . 61.53 103.938 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.649 ' HD3' ' CZ ' ' B' ' 48' ' ' TYR . 30.6 Cg_endo -67.69 -12.76 36.63 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 CA-C-N 121.279 1.492 . . . . 75.52 111.217 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -91.46 -0.65 57.65 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.194 -0.912 . . . . 73.31 111.01 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 18.7 t30 -117.41 127.14 26.87 Favored Pre-proline 0 C--O 1.213 -0.853 0 N-CA-C 108.387 -0.968 . . . . 65.12 108.387 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.07 -12.18 33.42 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.398 2.732 . . . . 62.22 114.927 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -94.68 158.63 15.43 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 119.804 -0.758 . . . . 73.43 110.209 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.439 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 49.6 p -135.95 161.09 36.62 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.712 -1.218 . . . . 74.42 107.712 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 mp -90.43 129.74 36.58 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.186 0.517 . . . . 74.13 110.42 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -124.37 110.52 14.67 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.178 -1.416 . . . . 64.11 107.178 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.6 mp -98.58 122.51 41.88 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.405 -0.816 . . . . 74.02 109.846 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.501 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 37.3 tt0 -130.94 157.57 42.6 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.864 -1.532 . . . . 64.11 106.864 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -65.71 139.97 58.42 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 118.458 0.572 . . . . 73.52 109.586 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.14 157.27 32.98 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.958 -0.756 . . . . 73.31 108.958 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -88.61 0.69 56.13 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 122.124 0.964 . . . . 75.32 109.216 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.35 124.97 3.76 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.749 -1.114 . . . . 64.31 108.113 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -64.78 124.15 21.21 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.463 0.649 . . . . 63.45 110.891 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.8 m . . . . . 0 N--CA 1.418 -2.072 0 N-CA-C 108.097 -1.075 . . . . 71.43 108.097 -178.956 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 97.5 t . . . . . 0 CA--C 1.5 -0.965 0 N-CA-C 103.692 -2.707 . . . . 70.35 103.692 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.596 ' HB2' ' O ' ' B' ' 75' ' ' PHE . 16.1 ptm180 -123.53 17.9 9.65 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-N 114.655 -1.157 . . . . 63.31 110.974 -164.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 29.9 m -124.67 121.56 35.04 Favored 'General case' 0 C--N 1.273 -2.739 0 C-N-CA 119.554 -0.858 . . . . 73.22 110.104 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 87.9 mt -103.48 137.23 41.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.196 -1.039 . . . . 75.34 108.196 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -98.88 113.99 26.37 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 106.762 -1.57 . . . . 73.22 106.762 175.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.595 HG22 ' HG ' ' B' ' 103' ' ' LEU . 22.0 t -99.69 112.56 32.42 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.665 0 CA-C-N 114.429 -1.259 . . . . 55.34 108.4 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' B' ' 101' ' ' LEU . 48.9 p -111.48 169.46 8.79 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 108.626 -0.879 . . . . 73.14 108.626 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.541 ' HA2' ' CD ' ' B' ' 99' ' ' GLN . . . 109.68 -6.65 31.49 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 120.421 -0.895 . . . . 70.05 111.655 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 55.1 mt -75.8 133.71 72.84 Favored Pre-proline 0 N--CA 1.428 -1.572 0 CA-C-N 114.253 -0.974 . . . . 64.53 108.812 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.49 170.68 16.87 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.095 1.863 . . . . 51.01 110.715 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.508 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 8.2 p -70.92 -11.51 15.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.446 0.641 . . . . 73.34 111.623 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -112.55 27.28 9.77 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.961 0.886 . . . . 65.13 108.894 -177.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.513 HG22 ' HG2' ' B' ' 69' ' ' PRO . 0.1 OUTLIER -74.58 126.59 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-O 121.566 0.698 . . . . 73.53 109.4 179.578 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -101.34 141.53 22.78 Favored Pre-proline 0 C--N 1.299 -1.608 0 CA-C-N 115.707 -0.678 . . . . 60.43 111.08 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -51.0 -25.42 16.18 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.628 2.886 . . . . 61.23 114.199 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.508 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 15.3 ptt-85 -66.35 -32.27 73.57 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 120.864 0.364 . . . . 75.05 111.019 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -69.24 -34.48 74.88 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.923 -0.58 . . . . 72.35 109.973 -174.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.407 ' O ' ' HD2' ' B' ' 51' ' ' PHE . 97.3 mt -74.65 -44.07 52.2 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.47 0.652 . . . . 62.11 109.454 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.649 ' CZ ' ' HD3' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -57.81 -43.32 85.61 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.976 -1.011 . . . . 74.04 112.071 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 96.9 mt -63.55 -42.81 98.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.891 0.377 . . . . 73.31 111.015 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.3 tp -71.65 -42.68 67.25 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.284 -0.871 . . . . 65.05 111.657 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' PHE . . . . . 0.407 ' HD2' ' O ' ' B' ' 47' ' ' LEU . 81.4 m-85 -85.42 -4.74 59.25 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.993 1.479 . . . . 73.33 114.993 -175.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 26.2 mtp180 -51.81 -50.05 80.01 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 114.16 1.17 . . . . 75.25 114.16 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.51 -0.88 10.64 Favored 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 121.873 1.715 . . . . 74.12 114.046 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . 0.264 69.8 m-85 -87.67 134.92 33.57 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 115.519 1.674 . . . . 71.12 115.519 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -67.12 109.24 2.96 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.262 -1.79 . . . . 72.52 112.455 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' B' ' 75' ' ' PHE . . . 106.38 -7.59 40.14 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 115.531 -0.759 . . . . 44.52 113.467 171.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -59.94 106.98 0.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.406 0.622 . . . . 72.41 112.54 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -99.24 -44.58 6.19 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.692 -0.686 . . . . 72.21 110.849 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.91 -178.88 41.78 Favored Glycine 0 C--N 1.302 -1.318 0 C-N-CA 119.429 -1.367 . . . . 71.25 113.569 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.7 p -139.86 137.67 35.09 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.162 0.585 . . . . 74.25 111.158 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.51 116.51 28.31 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.301 -1.0 . . . . 73.31 108.301 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.51 133.27 35.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.663 -0.866 . . . . 33.34 108.663 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' B' ' 69' ' ' PRO . 12.1 tmtt? -125.31 115.29 20.12 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.364 -1.347 . . . . 53.33 107.364 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.15 130.74 39.71 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.09 -0.504 . . . . 73.11 109.872 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 3.4 m -124.52 164.82 18.97 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.885 -1.154 . . . . 74.33 107.885 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.58 -31.5 36.49 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.53 0.937 . . . . 63.23 113.53 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -99.22 -52.41 3.53 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.897 -0.721 . . . . 74.23 111.484 176.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -154.16 145.86 16.85 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 115.781 -0.645 . . . . 75.12 111.156 -170.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.513 ' HG2' HG22 ' B' ' 42' ' ' ILE . 60.2 Cg_endo -75.62 124.8 8.49 Favored 'Trans proline' 0 N--CA 1.436 -1.88 0 C-N-CA 122.93 2.42 . . . . 60.22 111.621 174.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 m -93.84 155.11 3.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 114.977 -1.011 . . . . 65.12 108.442 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.32 120.51 4.23 Favored Glycine 0 CA--C 1.486 -1.756 0 C-N-CA 119.032 -1.556 . . . . 61.42 112.811 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -89.7 102.77 15.46 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.608 -1.256 . . . . 72.21 107.608 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 68.8 t -92.67 123.94 44.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 115.79 -0.641 . . . . 64.43 109.584 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 13.7 tt -101.53 129.21 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.328 0 CA-C-O 122.297 1.046 . . . . 75.15 111.074 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' PHE . . . . . 0.596 ' O ' ' HB2' ' B' ' 31' ' ' ARG . 91.9 m-85 -109.81 160.43 16.35 Favored 'General case' 0 N--CA 1.404 -2.759 0 CA-C-N 113.217 -1.81 . . . . 71.1 107.993 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' ASP . . . . . 0.479 ' HA ' ' NH2' ' B' ' 31' ' ' ARG . 34.7 t70 -73.09 -33.31 65.53 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.276 0.56 . . . . 72.4 111.843 176.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 12.4 p -128.73 158.81 37.56 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 116.258 -0.428 . . . . 52.31 111.641 -174.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ARG . . . . . 0.436 ' H ' ' HD3' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -80.48 -27.78 37.73 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.476 -0.889 . . . . 63.45 108.662 177.37 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' B' ' 82' ' ' GLU . . . -72.07 -24.91 61.58 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.977 0.894 . . . . 61.22 108.764 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.12 -44.75 28.3 Favored Glycine 0 C--N 1.31 -0.895 0 N-CA-C 109.62 -1.392 . . . . 35.23 109.62 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.6 -44.95 95.03 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.766 -0.717 . . . . 73.32 111.736 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' B' ' 79' ' ' ALA . 2.0 pp20? -66.96 -28.28 68.15 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.495 0.554 . . . . 74.11 112.495 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.95 -46.84 32.9 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.119 -0.491 . . . . 71.1 110.172 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.97 92.6 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.53 -0.759 . . . . 74.04 111.678 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.457 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 14.2 ptmm? -69.49 -34.38 74.24 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 120.024 -0.67 . . . . 74.11 110.147 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -62.84 -32.24 73.42 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 121.129 0.49 . . . . 74.42 110.405 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.78 -32.48 19.07 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 112.541 0.571 . . . . 74.4 112.541 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.47 ' O ' HG22 ' B' ' 91' ' ' ILE . 91.7 mt -101.66 -25.19 13.95 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 116.603 2.075 . . . . 72.31 116.603 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . 0.268 0.2 OUTLIER -68.69 113.92 6.6 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 118.06 -1.456 . . . . 61.53 112.615 -176.608 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.2 6.47 15.82 Favored Glycine 0 N--CA 1.419 -2.451 0 C-N-CA 120.791 -0.719 . . . . 54.41 111.872 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.47 HG22 ' O ' ' B' ' 88' ' ' LEU . 12.2 tt -96.61 146.73 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.361 0 N-CA-C 107.735 -1.209 . . . . 42.41 107.735 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.451 ' HG3' HG22 ' B' ' 100' ' ' THR . 97.7 mtt180 -89.47 140.89 29.07 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-O 121.333 0.587 . . . . 72.32 112.342 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -73.27 -31.41 64.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.834 -1.53 . . . . 73.12 109.182 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.537 ' OD2' ' HB3' ' A' ' 45' ' ' ARG 0.266 4.8 m-20 -142.67 137.27 15.1 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 104.113 -2.551 . . . . 74.14 104.113 176.343 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 95' ' ' PRO . . . . . 0.573 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 19.0 Cg_endo -64.09 -19.51 66.32 Favored 'Trans proline' 0 CA--C 1.55 1.291 0 CA-C-N 121.064 1.416 . . . . 72.04 109.631 168.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -72.14 -24.98 61.54 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.109 1.764 . . . . 74.21 109.609 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -94.91 126.84 45.37 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 115.189 -0.914 . . . . 73.24 109.769 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.19 -6.25 14.76 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.937 2.425 . . . . 74.51 112.689 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' GLN . . . . . 0.541 ' CD ' ' HA2' ' B' ' 37' ' ' GLY . 8.7 tt0 -99.0 162.11 13.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.571 -0.9 . . . . 74.03 108.571 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.5 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 82.6 p -125.64 164.25 21.0 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.513 -0.551 . . . . 74.43 109.513 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' B' ' 36' ' ' SER . 5.3 mp -85.8 117.33 24.6 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 107.012 -1.477 . . . . 54.43 107.012 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -113.44 107.34 15.71 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 107.725 -1.213 . . . . 73.31 107.725 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.595 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.0 mp -90.22 116.45 28.21 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.572 -1.27 . . . . 61.12 107.572 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.457 ' HA ' ' CE ' ' B' ' 85' ' ' LYS . 12.1 tp10 -135.22 162.88 31.29 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.88 -1.156 . . . . 72.33 107.88 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -69.07 137.28 53.41 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 118.71 0.687 . . . . 75.01 111.84 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.95 156.03 32.27 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 109.169 -0.678 . . . . 71.03 109.169 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -78.13 -8.61 58.48 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.908 0.861 . . . . 42.45 109.624 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.2 130.98 9.95 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.164 -0.925 . . . . 75.24 108.77 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.411 ' ND2' ' HG2' ' B' ' 31' ' ' ARG . 6.5 m-20 -63.74 132.49 51.16 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.549 -0.75 . . . . 62.23 110.003 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 C--N 1.299 -1.589 0 N-CA-C 108.357 -0.979 . . . . 53.22 108.357 -179.507 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.529 ' HA ' HD21 ' A' ' 109' ' ' ASN . 17.8 t . . . . . 0 C--O 1.215 -0.724 0 N-CA-C 113.184 0.809 . . . . 74.33 113.184 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 42.4 mtt180 -99.43 -25.16 14.55 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-O 122.363 1.078 . . . . 71.23 109.349 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.4 m -98.11 138.24 35.7 Favored 'General case' 0 C--N 1.26 -3.291 0 CA-C-N 113.549 -1.659 . . . . 71.45 113.6 -167.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.8 mt -124.57 142.8 51.08 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 114.018 -1.447 . . . . 74.14 108.325 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 104' ' ' GLU . 32.0 p90 -101.48 112.23 24.71 Favored 'General case' 0 N--CA 1.423 -1.825 0 C-N-CA 118.956 -1.097 . . . . 75.04 108.074 172.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.481 HG12 HD11 ' A' ' 101' ' ' LEU . 41.7 t -97.05 114.01 32.89 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.828 0 N-CA-C 106.898 -1.519 . . . . 55.44 106.898 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.6 p -124.46 154.44 40.48 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.288 -0.869 . . . . 74.21 111.177 -175.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.62 4.65 34.44 Favored Glycine 0 N--CA 1.425 -2.07 0 CA-C-N 115.939 -0.573 . . . . 33.54 111.856 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.56 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 94.4 mt -66.28 131.67 94.35 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.23 -0.655 . . . . 54.31 109.23 175.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.04 157.55 3.92 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.416 2.077 . . . . 70.41 110.283 171.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.496 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 9.8 p -83.44 6.97 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 122.787 1.28 . . . . 72.44 109.847 -170.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -127.87 17.04 6.82 Favored 'General case' 0 N--CA 1.406 -2.659 0 CA-C-N 114.323 -1.308 . . . . 54.42 110.322 -175.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 pp -54.06 133.75 16.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 114.62 1.341 . . . . 71.23 114.62 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.539 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.33 143.03 26.03 Favored Pre-proline 0 C--N 1.285 -2.199 0 CA-C-N 114.174 -1.376 . . . . 54.22 108.279 177.196 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.88 -24.64 65.58 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.913 2.408 . . . . 73.02 113.853 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.545 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -82.35 -15.34 53.16 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 118.094 -1.442 . . . . 70.11 111.882 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.49 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 30.0 mt-10 -69.66 -37.76 76.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.803 0.811 . . . . 74.13 108.932 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.9 mt -65.67 -35.92 82.16 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 114.773 -1.103 . . . . 75.21 108.828 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.545 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 73.7 t80 -63.95 -47.37 80.76 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.572 -1.194 . . . . 74.52 110.227 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 81.9 mt -65.02 -35.68 81.95 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.815 0.341 . . . . 71.51 111.809 -176.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.0 tp -86.23 -36.25 19.53 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 112.581 0.585 . . . . 65.14 112.581 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -98.56 -11.12 22.5 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 114.337 1.236 . . . . 73.51 114.337 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.5 ttt-85 -66.79 -42.71 45.67 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 119.987 -0.685 . . . . 71.33 111.693 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -58.11 -25.35 70.74 Favored 'Trans proline' 0 C--N 1.398 3.167 0 C-N-CA 121.711 1.608 . . . . 72.12 111.553 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -84.8 84.42 7.7 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.777 0.799 . . . . 72.2 110.112 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -67.93 108.74 3.15 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.333 -1.303 . . . . 75.1 109.905 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.94 -25.5 1.29 Allowed Glycine 0 N--CA 1.424 -2.133 0 CA-C-N 113.996 -1.457 . . . . 64.21 109.67 -172.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -55.45 118.72 4.71 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.085 0.554 . . . . 72.43 110.538 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -93.65 -60.09 1.85 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 120.121 -0.632 . . . . 61.23 109.363 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.56 175.15 38.15 Favored Glycine 0 C--N 1.298 -1.546 0 C-N-CA 120.848 -0.691 . . . . 65.31 112.075 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.3 p -134.79 143.88 47.34 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 122.488 0.315 . . . . 75.53 111.002 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.5 mt -115.98 119.91 37.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.09 -0.707 . . . . 74.21 109.09 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.17 133.3 35.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 110.137 -0.319 . . . . 71.54 110.137 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -117.82 106.66 13.23 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.27 -1.381 . . . . 72.24 107.27 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.4 124.6 25.48 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.246 -1.02 . . . . 71.22 108.246 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 5.9 m -128.89 150.79 50.2 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 105.155 -2.165 . . . . 72.24 105.155 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.05 -40.34 10.53 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 114.42 1.267 . . . . 63.32 114.42 -173.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -96.01 -26.76 15.42 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.877 1.065 . . . . 73.44 113.877 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.56 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -172.23 143.05 1.27 Allowed Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 110.202 -0.296 . . . . 70.44 110.202 -177.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.496 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 59.5 Cg_endo -77.37 124.64 7.23 Favored 'Trans proline' 0 N--CA 1.432 -2.092 0 C-N-CA 122.491 2.127 . . . . 65.02 110.102 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.7 m -96.36 147.49 6.1 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 N-CA-C 108.222 -1.029 . . . . 53.24 108.222 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.22 120.86 4.59 Favored Glycine 0 CA--C 1.479 -2.204 0 C-N-CA 118.879 -1.629 . . . . 71.13 112.907 -175.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.44 103.65 15.71 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 106.849 -1.538 . . . . 75.41 106.849 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.5 t -94.34 128.07 45.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.363 0 CA-C-N 115.071 -0.968 . . . . 74.13 110.284 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.67 114.24 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.369 0 N-CA-C 107.991 -1.114 . . . . 62.22 107.991 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.476 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 36.1 m-85 -93.96 162.65 13.81 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.329 -0.85 . . . . 74.2 109.584 174.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.36 -41.21 51.31 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 124.317 1.011 . . . . 75.51 111.876 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.6 p -164.9 166.08 19.85 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.571 -0.741 . . . . 70.54 111.986 -174.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.687 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -56.05 -39.5 72.11 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.236 1.014 . . . . 72.12 112.105 177.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.82 -28.17 69.38 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.625 0.726 . . . . 73.32 109.731 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.56 -38.71 9.46 Favored Glycine 0 C--N 1.309 -0.922 0 CA-C-N 114.648 -1.16 . . . . 65.31 110.897 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.67 -45.87 77.48 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.546 0.738 . . . . 52.22 112.032 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -34.82 78.8 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.007 0.432 . . . . 75.15 111.439 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.6 -41.21 65.84 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.992 -0.549 . . . . 62.11 110.563 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.89 -41.72 86.73 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.747 -0.66 . . . . 62.5 110.821 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -69.42 -28.46 66.16 Favored 'General case' 0 C--O 1.199 -1.585 0 CA-C-N 116.292 -0.413 . . . . 70.02 111.297 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -78.11 -21.07 50.99 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.27 0.557 . . . . 75.35 111.751 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.91 -44.02 11.36 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.278 -0.419 . . . . 72.44 111.378 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.467 ' O ' HG22 ' A' ' 91' ' ' ILE . 96.0 mt -93.78 -12.64 28.66 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 115.456 1.65 . . . . 74.52 115.456 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -67.56 114.6 6.34 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 119.559 1.072 . . . . 55.02 112.169 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.37 16.37 14.86 Favored Glycine 0 N--CA 1.429 -1.83 0 C-N-CA 119.73 -1.224 . . . . 63.34 111.789 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 88' ' ' LEU . 11.4 tt -90.81 128.19 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.73 0 N-CA-C 107.669 -1.234 . . . . 75.23 107.669 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -75.1 121.73 22.5 Favored 'General case' 0 C--N 1.269 -2.898 0 N-CA-C 107.87 -1.159 . . . . 71.1 107.87 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.43 -32.81 69.03 Favored 'General case' 0 C--N 1.312 -1.033 0 O-C-N 124.357 1.036 . . . . 70.15 109.04 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.419 ' HB3' ' HB3' ' B' ' 45' ' ' ARG . 3.1 p-10 -148.06 115.18 3.99 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 107.077 -1.453 . . . . 75.43 107.077 171.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -62.37 -9.59 15.89 Favored 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 122.685 2.257 . . . . 70.24 113.185 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -74.46 -19.21 60.47 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.483 0.658 . . . . 74.51 109.453 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -118.08 146.52 39.4 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.202 -1.036 . . . . 74.02 108.202 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.19 -16.61 52.53 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.182 1.921 . . . . 74.23 113.159 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -52.83 125.35 16.62 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.199 1.4 . . . . 73.12 111.823 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.3 p -112.26 150.3 31.13 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 120.153 -0.619 . . . . 45.42 110.823 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.481 HD11 HG12 ' A' ' 35' ' ' VAL . 22.2 tp -98.34 127.01 44.08 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.469 -0.938 . . . . 73.42 108.469 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -122.38 136.03 54.82 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.09 0.471 . . . . 74.35 109.822 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.448 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.6 mp -110.38 116.25 31.11 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.378 -0.828 . . . . 73.04 108.965 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.478 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 5.3 tp10 -127.19 161.99 27.22 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.73 -0.841 . . . . 73.52 108.73 -177.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -70.75 139.29 51.03 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 118.514 0.597 . . . . 65.25 110.436 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.16 150.5 31.7 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 109.233 -0.655 . . . . 60.34 109.233 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -74.18 -6.65 49.03 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.589 -0.732 . . . . 74.53 111.961 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.16 133.65 7.88 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.772 -0.825 . . . . 31.41 108.772 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.529 HD21 ' HA ' ' A' ' 30' ' ' VAL . 84.1 m-20 -74.78 108.31 7.44 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.99 -1.115 . . . . 72.24 107.99 172.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 C--N 1.289 -2.054 0 C-N-CA 119.11 -1.036 . . . . 41.02 109.823 -179.303 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 32.2 t . . . . . 0 C--O 1.216 -0.687 0 CA-C-O 121.003 0.43 . . . . 71.33 111.754 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 86.6 mtt180 -91.64 -3.52 56.26 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.124 0.488 . . . . 75.24 111.634 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.9 m -115.55 128.2 55.81 Favored 'General case' 0 C--N 1.263 -3.16 0 CA-C-O 121.675 0.75 . . . . 53.24 112.759 -172.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 71.3 mt -110.1 142.41 41.6 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.184 -0.916 . . . . 71.1 108.697 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -99.38 113.69 26.17 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 106.992 -1.484 . . . . 74.43 106.992 173.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.478 HG22 ' HG ' ' B' ' 103' ' ' LEU . 53.4 t -102.49 125.67 56.73 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.984 0 CA-C-N 113.953 -1.476 . . . . 72.44 107.509 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.2 p -139.17 169.56 17.55 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.732 -0.667 . . . . 74.03 110.219 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 90.56 42.66 5.08 Favored Glycine 0 N--CA 1.422 -2.295 0 N-CA-C 109.465 -1.454 . . . . 71.22 109.465 -172.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.33 138.25 20.13 Favored Pre-proline 0 N--CA 1.418 -2.066 0 CA-C-N 114.039 -1.08 . . . . 75.31 108.437 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -54.53 155.83 15.87 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.401 2.068 . . . . 55.15 110.094 171.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.498 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 8.1 p -83.06 3.93 2.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 122.627 1.203 . . . . 65.03 108.796 -174.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.93 21.93 6.3 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 114.136 -1.393 . . . . 64.15 111.056 -173.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 35.2 pt -54.0 137.03 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 113.88 1.067 . . . . 75.31 113.88 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.583 ' HE3' ' HA ' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -93.36 141.38 23.88 Favored Pre-proline 0 C--N 1.279 -2.467 0 N-CA-C 107.054 -1.461 . . . . 73.42 107.054 174.425 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.24 -25.53 78.53 Favored 'Trans proline' 0 N--CA 1.478 0.616 0 C-N-CA 122.644 2.229 . . . . 71.13 113.093 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.471 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 16.7 ptt180 -79.7 -18.0 52.3 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 112.166 0.432 . . . . 63.03 112.166 -176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.503 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 31.2 mt-10 -65.31 -40.29 93.56 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.815 0.817 . . . . 75.14 108.993 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 74.2 mt -67.92 -35.93 79.28 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.556 -1.202 . . . . 73.44 109.634 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -61.16 -48.18 82.79 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.43 -0.804 . . . . 74.1 111.144 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 79.8 mt -63.1 -44.31 96.04 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 123.837 0.71 . . . . 63.1 110.054 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.9 tp -73.02 -41.55 64.11 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.894 -1.048 . . . . 71.24 111.861 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -96.03 10.03 38.83 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.323 0.861 . . . . 73.01 113.323 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -70.48 -48.65 17.3 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 120.615 -0.434 . . . . 64.22 111.725 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.75 -3.85 14.42 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 121.376 1.384 . . . . 72.44 112.128 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -91.42 94.69 9.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.416 1.103 . . . . 74.32 111.439 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -64.2 113.24 3.43 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 112.922 -1.944 . . . . 55.41 110.047 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.88 -21.97 3.68 Favored Glycine 0 C--N 1.287 -2.156 0 CA-C-N 115.097 -0.956 . . . . 63.01 111.403 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -62.26 105.8 0.65 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.329 0.585 . . . . 73.52 111.99 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -87.52 -48.6 7.8 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.787 -0.642 . . . . 63.42 109.609 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.57 170.93 43.55 Favored Glycine 0 C--N 1.298 -1.529 0 C-N-CA 120.741 -0.742 . . . . 53.23 112.0 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.7 p -128.8 138.1 51.89 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 122.684 0.394 . . . . 63.44 110.432 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 87.6 mt -112.99 112.88 24.64 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.526 -0.916 . . . . 71.31 108.526 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 50.4 mm -93.81 133.05 36.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.651 -0.499 . . . . 74.23 109.651 -176.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -128.3 126.69 41.32 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.097 -1.446 . . . . 74.5 107.097 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.72 125.88 29.93 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.698 0.761 . . . . 65.13 112.758 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.3 m -113.6 155.89 24.65 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 103.811 -2.663 . . . . 54.23 103.811 173.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.88 -35.15 31.36 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 114.322 1.23 . . . . 54.13 114.322 -172.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -104.91 -14.57 15.42 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 113.237 0.829 . . . . 75.02 113.237 -175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -172.81 147.85 1.65 Allowed Pre-proline 0 N--CA 1.468 0.473 0 CA-C-O 120.753 0.311 . . . . 61.12 110.258 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 46.2 Cg_endo -78.63 122.85 5.65 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 C-N-CA 122.347 2.032 . . . . 74.13 110.263 169.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 35.2 m -94.03 155.05 3.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.082 -1.081 . . . . 71.22 108.082 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.49 121.65 3.55 Favored Glycine 0 CA--C 1.474 -2.501 0 C-N-CA 118.868 -1.634 . . . . 63.33 113.301 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -88.17 102.46 14.82 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.754 -1.572 . . . . 75.33 106.754 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.18 122.9 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 CA-C-N 115.195 -0.911 . . . . 64.03 109.539 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 62.6 mt -102.68 120.71 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.418 0 CA-C-N 113.846 -1.525 . . . . 53.43 109.448 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' PHE . . . . . 0.42 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 71.5 m-85 -105.06 161.21 14.43 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 114.112 -1.404 . . . . 73.22 109.846 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.57 -29.97 71.0 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.21 -0.904 . . . . 73.44 111.807 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 29.7 p -161.67 165.87 27.58 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.045 0.538 . . . . 73.52 110.072 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -22.58 62.51 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.529 -0.468 . . . . 43.44 110.314 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.15 -28.12 69.54 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.452 0.644 . . . . 54.41 110.383 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.38 -39.91 7.1 Favored Glycine 0 C--N 1.308 -1.023 0 N-CA-C 110.2 -1.16 . . . . 53.04 110.2 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.49 -43.68 98.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.503 -0.849 . . . . 62.5 111.825 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.93 -39.69 90.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 74.31 111.472 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.11 -37.83 64.01 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.082 0.468 . . . . 74.11 110.135 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.36 -40.54 77.43 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.48 -0.782 . . . . 53.31 111.083 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.528 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 14.5 ptmm? -68.18 -40.77 82.15 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 120.303 -0.559 . . . . 74.24 110.668 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -66.79 -25.26 66.38 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 120.71 -0.396 . . . . 74.24 111.925 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.67 -41.51 17.67 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 120.839 0.352 . . . . 75.52 111.281 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.548 ' O ' HG22 ' B' ' 91' ' ' ILE . 96.9 mt -96.26 -14.0 22.98 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 115.623 1.712 . . . . 62.1 115.623 -173.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.43 116.06 12.42 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 118.803 -1.159 . . . . 74.25 112.523 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.82 26.64 7.45 Favored Glycine 0 N--CA 1.428 -1.877 0 C-N-CA 120.49 -0.862 . . . . 71.24 111.373 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.548 HG22 ' O ' ' B' ' 88' ' ' LEU . 16.5 tt -114.95 133.71 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.551 0 N-CA-C 107.325 -1.361 . . . . 74.22 107.325 174.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.414 ' HG2' HG22 ' B' ' 100' ' ' THR . 99.2 mtt180 -67.66 134.47 51.18 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-O 121.086 0.469 . . . . 72.54 110.634 172.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -70.8 -30.35 66.78 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.529 -1.214 . . . . 63.03 109.039 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' B' ' 97' ' ' ASN . 8.5 t70 -144.31 118.97 5.93 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 104.544 -2.391 . . . . 74.01 104.544 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' PRO . . . . . 0.516 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 31.8 Cg_endo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.907 2.405 . . . . 74.32 113.819 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -94.21 4.46 53.86 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.609 0.719 . . . . 74.53 111.123 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' ASN . . . . . 0.474 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . 56.2 t30 -118.84 130.34 24.88 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 107.514 -1.291 . . . . 74.31 107.514 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.44 -13.43 33.01 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 123.046 2.497 . . . . 75.55 113.972 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -67.33 116.53 8.19 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-O 121.379 0.609 . . . . 75.01 110.28 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.595 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 58.2 p -106.48 145.17 32.14 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.824 -0.625 . . . . 54.31 109.916 -176.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 33.4 tp -94.13 128.97 40.85 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 110.025 -0.361 . . . . 71.33 110.025 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.447 HH21 ' CD ' ' B' ' 104' ' ' GLU . 6.0 ptm180 -129.02 127.44 41.61 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.914 -0.402 . . . . 54.11 109.914 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.478 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.7 mp -115.06 118.84 34.51 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.608 -0.723 . . . . 74.54 110.034 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.528 ' HA ' ' CE ' ' B' ' 85' ' ' LYS . 34.3 mt-10 -137.81 162.0 35.1 Favored 'General case' 0 C--O 1.199 -1.574 0 C-N-CA 122.739 0.415 . . . . 74.14 110.378 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -69.39 132.91 47.12 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 118.295 0.498 . . . . 74.51 111.355 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.59 154.47 34.39 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.413 -0.588 . . . . 65.31 109.413 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -84.28 9.15 13.73 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 120.876 0.369 . . . . 75.43 111.567 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.81 130.41 11.5 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.638 -0.504 . . . . 60.53 109.638 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -76.68 121.45 23.28 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 108.676 -0.861 . . . . 70.33 108.676 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 C--N 1.287 -2.141 0 N-CA-C 109.225 -0.657 . . . . 74.14 109.225 -177.974 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.5 t . . . . . 0 C--O 1.214 -0.769 0 CA-C-O 121.363 0.602 . . . . 71.12 110.917 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.644 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 69.0 mtt180 -91.93 -22.63 19.93 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 122.352 1.072 . . . . 73.34 109.518 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 18.1 m -96.07 122.7 39.18 Favored 'General case' 0 C--N 1.258 -3.396 0 CA-C-N 113.471 -1.695 . . . . 73.34 112.018 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.544 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.1 pt? -115.59 142.11 47.17 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 107.554 -1.276 . . . . 75.54 107.554 175.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 104' ' ' GLU . 26.2 p90 -96.57 122.18 39.2 Favored 'General case' 0 N--CA 1.417 -2.091 0 C-N-CA 118.779 -1.168 . . . . 71.23 109.272 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.415 HG22 ' HG ' ' A' ' 103' ' ' LEU . 41.6 t -97.27 108.78 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.586 0 N-CA-C 106.419 -1.697 . . . . 62.4 106.419 178.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 32.2 p -115.76 172.95 6.81 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 108.93 -0.767 . . . . 74.03 108.93 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 87.13 41.38 6.64 Favored Glycine 0 N--CA 1.418 -2.56 0 N-CA-C 109.897 -1.281 . . . . 74.1 109.897 -174.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.9 mt -114.81 145.14 33.32 Favored Pre-proline 0 N--CA 1.423 -1.777 0 N-CA-C 107.201 -1.407 . . . . 72.13 107.201 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.43 171.26 15.01 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.558 1.505 . . . . 72.43 110.199 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.5 p -71.31 -7.53 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 CA-C-O 122.574 1.178 . . . . 71.35 109.932 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -103.3 20.02 18.55 Favored 'General case' 0 C--O 1.203 -1.392 0 CA-C-N 114.035 -1.439 . . . . 65.2 109.386 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.98 123.51 27.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.261 0 CA-C-O 121.622 0.725 . . . . 73.22 110.715 178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -101.18 145.76 30.98 Favored Pre-proline 0 C--N 1.307 -1.244 0 C-N-CA 124.831 1.252 . . . . 74.02 111.44 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.56 -17.86 60.55 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.295 2.664 . . . . 70.45 114.557 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.555 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -86.73 -17.24 34.1 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 117.71 -1.596 . . . . 71.32 110.961 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -66.7 -42.16 86.86 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.133 0.492 . . . . 74.01 110.155 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.19 -37.35 87.04 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.191 -0.67 . . . . 55.42 109.191 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.667 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 61.0 t80 -59.38 -48.72 80.56 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.13 -0.941 . . . . 61.42 110.732 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 86.6 mt -61.59 -41.61 97.68 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.918 0.761 . . . . 73.51 110.32 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.9 tp -70.61 -42.19 71.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.286 -0.87 . . . . 71.33 111.79 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -86.72 7.13 28.03 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.851 1.056 . . . . 75.55 113.851 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.523 ' NE ' ' HA ' ' A' ' 52' ' ' ARG . 3.9 mmp_? -52.83 -50.33 81.94 Favored Pre-proline 0 N--CA 1.486 1.326 0 N-CA-C 113.924 1.083 . . . . 74.42 113.924 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -76.5 -0.91 10.92 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 121.914 1.743 . . . . 54.34 113.863 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.434 ' CE2' ' HA ' ' A' ' 84' ' ' ALA . 60.6 m-85 -98.76 115.33 28.53 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 121.945 0.879 . . . . 64.53 112.364 -174.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HD3' ' H ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -80.08 120.93 24.89 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 113.814 -1.539 . . . . 61.24 109.511 179.068 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.7 -14.0 6.09 Favored Glycine 0 C--N 1.276 -2.791 0 CA-C-N 114.958 -1.019 . . . . 73.32 113.037 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -58.33 107.31 0.48 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.044 0.422 . . . . 73.01 111.003 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.497 ' OE2' ' HA ' ' A' ' 76' ' ' ASP . 22.5 mt-10 -96.21 -33.96 11.83 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 120.579 -0.449 . . . . 74.43 110.987 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.77 -179.22 48.39 Favored Glycine 0 C--N 1.302 -1.334 0 C-N-CA 120.131 -1.033 . . . . 30.4 112.418 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.7 p -145.74 138.17 25.63 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.201 0.6 . . . . 73.04 110.409 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.0 mp -120.5 124.75 46.16 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.373 -0.973 . . . . 75.51 108.373 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.2 mm -93.96 138.02 21.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.983 -0.747 . . . . 65.21 108.983 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -126.39 112.09 15.24 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.091 -1.077 . . . . 75.15 108.091 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.92 116.41 13.39 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.671 -0.695 . . . . 75.11 110.746 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -109.03 152.2 25.32 Favored 'General case' 0 N--CA 1.396 -3.156 0 N-CA-C 102.296 -3.224 . . . . 74.55 102.296 171.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.82 -40.53 29.58 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.981 0.734 . . . . 42.3 112.981 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -85.16 -49.24 8.4 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.31 0.576 . . . . 74.35 112.019 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -138.47 127.07 14.18 Favored Pre-proline 0 C--N 1.283 -2.297 0 CA-C-N 115.718 -0.674 . . . . 71.41 112.334 -168.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.84 101.5 1.2 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.585 2.19 . . . . 64.33 108.689 166.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.39 152.16 3.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.773 -0.825 . . . . 71.33 108.773 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.76 119.99 4.53 Favored Glycine 0 CA--C 1.473 -2.555 0 C-N-CA 118.632 -1.746 . . . . 61.1 111.989 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -87.83 106.18 17.91 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 106.675 -1.602 . . . . 75.55 106.675 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.5 t -96.14 130.56 44.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 115.326 -0.852 . . . . 74.12 109.659 -177.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.8 mp -102.95 117.91 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.606 0 CA-C-N 115.079 -0.964 . . . . 63.11 108.945 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.644 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 7.4 m-85 -98.48 163.38 12.71 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.854 -1.066 . . . . 75.34 108.992 172.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.497 ' HA ' ' OE2' ' A' ' 58' ' ' GLU . 10.7 t70 -51.27 -39.27 56.37 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 123.944 0.778 . . . . 74.02 111.65 176.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.8 m -160.7 166.17 29.24 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.181 -0.918 . . . . 43.01 110.428 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.572 ' N ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -55.28 -32.66 62.57 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.975 0.91 . . . . 74.11 111.029 176.531 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.45 ' HA ' ' OE2' ' A' ' 82' ' ' GLU . . . -64.35 -26.07 68.31 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.825 0.821 . . . . 53.04 110.534 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.77 -44.27 5.51 Favored Glycine 0 C--N 1.285 -2.284 0 N-CA-C 109.855 -1.298 . . . . 62.44 109.855 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.95 -39.23 91.4 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.379 -0.91 . . . . 71.03 110.932 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.45 ' OE2' ' HA ' ' A' ' 79' ' ' ALA . 14.8 pt-20 -62.75 -41.48 99.23 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 123.139 0.274 . . . . 64.34 110.764 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.32 -37.41 80.53 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-O 121.28 0.562 . . . . 73.05 110.673 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HA ' ' CE2' ' A' ' 54' ' ' PHE . . . -69.54 -42.7 74.26 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.618 -0.719 . . . . 74.25 111.411 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 82' ' ' GLU . 14.9 ptmm? -70.08 -33.45 71.92 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.331 -0.548 . . . . 73.05 110.8 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.12 -44.11 95.14 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 123.432 0.458 . . . . 72.34 110.921 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.72 -41.5 23.5 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 120.288 -0.565 . . . . 72.22 112.009 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.411 ' O ' HG22 ' A' ' 91' ' ' ILE . 94.3 mt -89.08 -20.66 24.04 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 116.335 1.976 . . . . 75.43 116.335 -170.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -67.58 115.01 6.69 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 120.1 1.318 . . . . 55.31 110.083 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.43 13.72 16.32 Favored Glycine 0 N--CA 1.415 -2.75 0 CA-C-N 115.69 -0.686 . . . . 75.54 111.472 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 88' ' ' LEU . 14.5 tt -92.12 132.86 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.652 0 CA-C-O 121.411 0.624 . . . . 72.2 110.068 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.435 ' HB3' ' O ' ' A' ' 94' ' ' ASP . 30.2 mmt180 -63.81 137.23 57.96 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.854 -1.066 . . . . 65.22 108.248 172.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.499 ' CD1' HD11 ' A' ' 101' ' ' LEU . 7.1 t80 -77.32 -30.77 54.2 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.872 -1.529 . . . . 72.14 106.872 174.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.617 ' OD2' ' HB3' ' B' ' 45' ' ' ARG 0.294 5.0 m-20 -144.66 136.92 13.24 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 100.823 -3.769 . . . . 61.52 100.823 171.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.586 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 49.3 Cg_endo -71.88 -5.9 18.02 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 CA-C-N 121.943 1.729 . . . . 74.23 109.815 172.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -94.94 6.43 49.07 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.986 1.314 . . . . 75.42 109.154 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.611 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 48.4 t-20 -129.21 131.25 23.56 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 108.825 -0.806 . . . . 74.32 108.825 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -70.44 -6.46 18.98 Favored 'Trans proline' 0 C--O 1.25 1.121 0 C-N-CA 123.361 2.707 . . . . 75.45 113.082 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.414 ' HA ' ' OE1' ' A' ' 99' ' ' GLN . 5.9 tp60 -84.54 118.72 24.5 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 108.927 -0.768 . . . . 73.0 108.927 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.474 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 37.0 p -120.4 146.39 46.24 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.558 -0.746 . . . . 73.02 109.138 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.499 HD11 ' CD1' ' A' ' 93' ' ' PHE . 7.5 mp -80.8 137.79 36.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.442 0.639 . . . . 64.04 111.637 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -129.63 105.75 8.26 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 107.263 -1.384 . . . . 73.41 107.263 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.1 mp -97.94 117.17 31.69 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.047 -0.978 . . . . 63.54 108.784 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.558 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 32.9 tt0 -136.61 160.43 38.83 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.572 -1.64 . . . . 71.04 106.572 -177.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -70.0 139.43 52.75 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 119.263 0.938 . . . . 74.23 110.492 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.28 145.07 46.36 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.337 -0.616 . . . . 71.55 109.337 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.52 2.19 14.54 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.78 -0.645 . . . . 73.23 111.536 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.26 115.78 4.78 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.162 -1.051 . . . . 61.21 108.162 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -69.13 123.21 20.48 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 107.876 -1.157 . . . . 74.51 107.876 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.6 m . . . . . 0 C--N 1.295 -1.767 0 C-N-CA 120.99 -0.284 . . . . 72.14 110.636 -174.167 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--O 1.224 -0.246 0 CA-C-O 121.52 0.676 . . . . 75.44 112.155 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -96.3 -17.38 20.74 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 115.066 -0.97 . . . . 64.22 110.363 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 13.6 m -99.2 129.65 45.45 Favored 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 114.991 -1.004 . . . . 71.34 112.83 -170.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.466 ' H ' HD23 ' B' ' 33' ' ' LEU . 2.4 pt? -123.87 151.39 43.52 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 107.241 -1.392 . . . . 71.34 107.241 174.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.603 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 18.3 p90 -105.4 123.98 48.78 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 121.896 0.855 . . . . 74.44 109.585 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.463 HG22 ' HG ' ' B' ' 103' ' ' LEU . 43.5 t -97.79 115.41 37.67 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 107.004 -1.48 . . . . 73.14 107.004 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 23.8 p -119.04 168.36 10.9 Favored 'General case' 0 C--N 1.274 -2.703 0 CA-C-N 115.309 -0.86 . . . . 61.52 108.786 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 89.69 31.13 11.7 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.749 -0.94 . . . . 72.42 110.749 -175.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 88.9 mt -104.2 114.31 64.44 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.076 -1.453 . . . . 63.45 107.076 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.15 156.85 19.09 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.102 1.868 . . . . 74.22 110.43 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 11.9 p -65.22 -10.51 9.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 122.174 0.988 . . . . 74.41 111.27 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -98.04 8.3 44.98 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 114.869 -1.059 . . . . 72.01 110.054 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.49 121.53 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 CA-C-O 121.583 0.706 . . . . 64.42 111.489 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.48 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 3.2 mptp? -85.58 145.81 42.79 Favored Pre-proline 0 C--N 1.315 -0.906 0 C-N-CA 124.39 1.076 . . . . 74.21 109.923 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.19 -23.53 74.16 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.526 2.151 . . . . 64.55 112.972 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.617 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 13.2 ptt180 -77.46 -24.48 50.24 Favored 'General case' 0 N--CA 1.425 -1.681 0 O-C-N 122.279 -0.263 . . . . 63.12 111.126 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.48 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 43.3 mt-10 -68.09 -33.63 74.9 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.276 0.56 . . . . 74.21 110.001 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 48.8 mt -63.09 -47.11 84.25 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.281 -1.007 . . . . 70.23 108.281 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.594 ' O ' ' HG3' ' B' ' 52' ' ' ARG . 11.5 t80 -58.83 -44.62 90.95 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.431 -1.259 . . . . 74.33 111.175 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 93.5 mt -65.24 -39.14 92.31 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.007 0.432 . . . . 73.32 110.884 -178.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 34.7 tp -78.97 -40.52 31.49 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 115.931 -0.577 . . . . 71.32 112.121 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -89.88 0.91 56.78 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 115.519 1.674 . . . . 64.04 115.519 -174.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 14.3 mtp180 -61.36 -47.52 93.62 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 114.459 1.281 . . . . 73.22 114.459 176.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -72.08 -4.24 14.79 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.257 1.305 . . . . 73.21 112.377 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -92.42 93.4 8.57 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.915 0.864 . . . . 72.12 111.428 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' LYS . . . . . 0.567 ' HD3' ' H ' ' B' ' 55' ' ' LYS . 0.1 OUTLIER -65.35 111.76 3.19 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.085 -1.416 . . . . 72.05 110.143 178.373 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.14 -15.54 4.24 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.331 -0.85 . . . . 75.1 112.702 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -61.9 109.39 1.24 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 117.099 0.45 . . . . 75.33 110.747 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -86.56 -38.2 17.4 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.175 -1.046 . . . . 72.24 108.175 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.7 178.9 40.58 Favored Glycine 0 C--N 1.311 -0.826 0 CA-C-N 115.014 -0.994 . . . . 34.24 112.023 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.6 p -135.1 148.74 49.9 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 122.456 0.302 . . . . 63.02 110.973 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 54.3 tp -126.31 111.74 14.89 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.974 -1.121 . . . . 72.4 107.974 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.43 ' CG2' ' HB2' ' B' ' 69' ' ' PRO . 46.5 mm -94.24 134.34 32.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 110.228 -0.286 . . . . 73.5 110.228 -175.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -124.35 114.91 20.16 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.219 -0.66 . . . . 52.22 109.219 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.08 125.34 26.36 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.216 0.531 . . . . 74.01 109.58 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 16.0 m -125.04 159.38 31.48 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 106.145 -1.798 . . . . 61.22 106.145 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.04 -40.54 15.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.17 0.988 . . . . 44.22 112.946 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -88.93 -47.7 7.97 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.857 0.688 . . . . 50.3 112.857 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 26.4 pt20 -155.68 149.0 18.49 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 116.041 -0.527 . . . . 72.4 110.048 -170.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 49.9 Cg_endo -79.07 108.58 2.41 Favored 'Trans proline' 0 N--CA 1.436 -1.899 0 C-N-CA 122.146 1.898 . . . . 55.12 109.981 170.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.03 151.32 4.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.5 -0.773 . . . . 53.44 109.061 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.13 120.69 4.73 Favored Glycine 0 CA--C 1.478 -2.244 0 C-N-CA 118.162 -1.97 . . . . 51.31 113.681 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -88.41 105.44 17.6 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 106.467 -1.679 . . . . 63.43 106.467 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.417 ' O ' HD23 ' B' ' 33' ' ' LEU . 74.6 t -100.15 130.67 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 CA-C-O 121.421 0.629 . . . . 74.22 110.3 -176.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.52 119.77 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 CA-C-N 114.708 -1.133 . . . . 74.43 108.724 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -102.78 168.37 9.28 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 115.208 -0.906 . . . . 62.54 111.358 174.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.96 -43.67 50.28 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.289 -1.323 . . . . 75.11 110.792 172.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 11.5 p -166.03 169.68 14.35 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.045 -0.98 . . . . 75.51 110.894 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ARG . . . . . 0.507 ' H ' ' HD3' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -63.24 -30.53 71.65 Favored 'General case' 0 C--O 1.213 -0.822 0 O-C-N 123.194 0.309 . . . . 75.31 110.182 176.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.98 67.38 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 122.361 1.077 . . . . 71.0 109.469 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.5 -43.69 5.45 Favored Glycine 0 C--N 1.294 -1.791 0 CA-C-N 113.536 -1.665 . . . . 64.34 110.678 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.79 -36.9 85.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.556 -0.822 . . . . 72.54 111.798 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 9.9 pt-20 -60.75 -41.23 94.99 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 120.747 0.308 . . . . 73.33 110.64 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.72 -39.4 80.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.998 0.428 . . . . 63.23 110.162 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.29 82.39 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.371 -0.831 . . . . 75.03 111.198 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' B' ' 82' ' ' GLU . 13.1 ptmm? -69.54 -32.19 70.86 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 116.233 -0.44 . . . . 65.31 110.861 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -70.95 -28.83 64.76 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 111.987 0.366 . . . . 74.44 111.987 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.71 -32.8 25.33 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 120.436 -0.505 . . . . 65.44 111.694 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.558 ' O ' HG22 ' B' ' 91' ' ' ILE . 92.7 mt -107.8 -4.39 18.11 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 115.443 1.645 . . . . 74.53 115.443 -173.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -79.03 114.78 18.25 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 117.786 -1.566 . . . . 74.21 110.272 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.9 3.96 48.64 Favored Glycine 0 CA--C 1.479 -2.211 0 C-N-CA 120.564 -0.827 . . . . 73.1 111.911 174.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.558 HG22 ' O ' ' B' ' 88' ' ' LEU . 15.5 tt -96.5 137.61 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.056 0 N-CA-C 107.312 -1.366 . . . . 73.24 107.312 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.428 ' HG2' HG22 ' B' ' 100' ' ' THR . 99.4 mtt180 -77.28 142.14 39.62 Favored 'General case' 0 C--N 1.265 -3.071 0 CA-C-O 121.35 0.595 . . . . 62.23 112.537 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.459 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 39.8 t80 -67.69 -37.0 81.72 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.798 -1.546 . . . . 71.41 108.991 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.57 ' HB2' ' HB2' ' B' ' 97' ' ' ASN 0.277 3.9 m-20 -131.13 133.81 25.1 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 101.831 -3.396 . . . . 60.34 101.831 174.32 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 95' ' ' PRO . . . . . 0.667 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 18.7 Cg_endo -61.04 -29.9 88.56 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 CA-C-N 121.993 1.748 . . . . 62.51 112.026 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -94.91 15.93 17.38 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.544 -0.753 . . . . 52.4 111.133 -175.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' B' ' 94' ' ' ASP . 57.7 t-20 -122.82 131.86 24.33 Favored Pre-proline 0 C--N 1.312 -1.054 0 N-CA-C 107.225 -1.398 . . . . 60.41 107.225 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.91 -3.42 13.58 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.279 1.986 . . . . 73.2 112.57 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' GLN . . . . . 0.471 ' HA ' ' OE1' ' B' ' 99' ' ' GLN . 5.8 tp60 -76.59 112.23 12.92 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.958 -0.756 . . . . 74.33 108.958 177.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.508 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 81.6 p -105.49 144.85 31.68 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.647 -0.706 . . . . 65.11 110.278 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 81.0 mt -79.53 135.97 36.76 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.431 -0.952 . . . . 64.12 108.431 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -131.42 112.79 13.01 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.744 -1.206 . . . . 73.42 107.744 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.463 ' HG ' HG22 ' B' ' 35' ' ' VAL . 7.6 mp -103.12 118.21 36.28 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.601 -0.727 . . . . 64.14 109.61 177.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.603 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 6.5 tp10 -135.29 157.12 47.71 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 105.684 -1.969 . . . . 74.0 105.684 -177.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -69.33 142.24 54.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 119.74 1.154 . . . . 65.42 110.961 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.47 153.11 25.79 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.888 -1.153 . . . . 53.52 107.888 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -94.3 13.01 24.89 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.908 -1.117 . . . . 73.22 109.235 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.4 114.86 10.44 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.71 -1.218 . . . . 55.51 107.71 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -85.01 104.44 14.94 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.236 -1.394 . . . . 74.41 107.236 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 16.3 m . . . . . 0 C--N 1.288 -2.099 0 CA-C-N 116.07 -0.514 . . . . 74.23 110.895 -170.521 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 105.941 -1.874 . . . . 74.34 105.941 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 24.2 mtt180 -104.02 0.88 30.41 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.778 -0.769 . . . . 64.41 111.066 -172.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.1 m -104.69 125.49 50.84 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-O 121.391 0.615 . . . . 73.25 112.597 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.413 HD12 ' CE1' ' A' ' 75' ' ' PHE . 73.5 mt -109.73 138.03 46.68 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.554 -0.906 . . . . 55.53 108.554 173.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -96.31 110.55 22.86 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 107.345 -1.354 . . . . 74.03 107.345 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.523 HG22 ' HG ' ' A' ' 103' ' ' LEU . 40.5 t -97.67 124.51 50.68 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.767 0 CA-C-N 114.168 -1.378 . . . . 72.53 108.623 -176.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.7 p -129.45 164.72 23.08 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.166 -0.924 . . . . 75.15 110.111 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 92.85 29.89 10.13 Favored Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.924 -0.87 . . . . 50.55 110.924 -173.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.9 mt -95.23 122.19 60.32 Favored Pre-proline 0 N--CA 1.425 -1.699 0 N-CA-C 106.04 -1.837 . . . . 71.21 106.04 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -55.41 153.32 28.73 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.161 1.908 . . . . 74.24 111.7 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.5 p -61.34 -12.91 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.918 0.887 . . . . 74.12 111.423 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -127.94 40.74 3.63 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.623 -0.88 . . . . 74.12 108.623 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.7 tt -72.08 132.02 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.459 -0.791 . . . . 72.52 109.087 172.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.444 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 29.3 mmmt -90.26 145.8 33.47 Favored Pre-proline 0 C--N 1.276 -2.619 0 N-CA-C 108.584 -0.895 . . . . 71.23 108.584 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.66 -29.3 84.92 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.478 2.119 . . . . 73.24 111.728 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.522 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 13.2 ptt180 -70.85 -22.06 62.36 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 115.44 -0.8 . . . . 72.41 111.738 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 38.8 mt-10 -69.47 -38.27 77.66 Favored 'General case' 0 CA--C 1.506 -0.729 0 O-C-N 122.058 -0.401 . . . . 45.11 110.451 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.22 -34.0 76.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 122.042 0.925 . . . . 55.15 108.768 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.576 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 56.5 t80 -65.46 -48.83 71.34 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.573 -1.194 . . . . 71.13 110.169 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 95.5 mt -65.17 -43.57 91.32 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 123.606 0.566 . . . . 71.1 110.045 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.407 HD13 HD22 ' B' ' 49' ' ' LEU . 34.2 tp -65.59 -43.14 90.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.034 -0.985 . . . . 54.3 111.147 -176.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -95.73 14.88 21.71 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 113.156 0.799 . . . . 72.24 113.156 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 3.2 mmp_? -55.37 -51.14 82.4 Favored Pre-proline 0 N--CA 1.486 1.351 0 N-CA-C 112.452 0.538 . . . . 62.02 112.452 174.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 52' ' ' ARG . 5.4 Cg_exo -81.33 -1.61 11.17 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 121.859 1.706 . . . . 65.44 112.918 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -93.63 89.74 6.35 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.52 0.676 . . . . 73.21 111.867 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -65.45 112.22 3.45 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.716 -1.129 . . . . 64.23 108.597 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 75' ' ' PHE . . . 132.96 -10.56 5.14 Favored Glycine 0 C--N 1.286 -2.206 0 C-N-CA 119.306 -1.426 . . . . 73.41 112.943 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -69.09 94.81 0.69 Allowed 'General case' 0 C--O 1.243 0.712 0 CA-C-N 117.626 0.713 . . . . 74.31 109.162 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -84.59 -44.35 13.6 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.032 -0.531 . . . . 62.25 109.879 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -168.8 179.43 41.64 Favored Glycine 0 C--N 1.296 -1.658 0 C-N-CA 120.645 -0.788 . . . . 73.1 111.867 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.8 p -151.44 140.72 21.37 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 122.801 0.44 . . . . 72.33 109.844 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.1 tp -111.96 109.56 19.41 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.322 -0.992 . . . . 72.22 108.322 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.41 129.65 44.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.563 -0.532 . . . . 74.41 109.563 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -123.4 123.09 39.89 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.37 -0.974 . . . . 74.1 108.37 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.69 118.06 21.17 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.406 0.622 . . . . 71.11 110.56 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.2 m -107.99 155.41 20.37 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 104.577 -2.379 . . . . 75.11 104.577 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.38 -33.71 31.11 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.265 1.209 . . . . 70.25 114.265 -172.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -105.07 -17.45 14.49 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 118.923 -1.111 . . . . 64.32 113.138 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -164.56 148.73 7.99 Favored Pre-proline 0 C--N 1.321 -0.654 0 C-N-CA 120.662 -0.415 . . . . 72.34 110.725 -173.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -80.94 121.7 4.1 Favored 'Trans proline' 0 N--CA 1.429 -2.292 0 C-N-CA 121.856 1.704 . . . . 70.53 109.671 168.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.82 146.94 5.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 107.676 -1.231 . . . . 72.21 107.676 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.33 120.77 3.13 Favored Glycine 0 CA--C 1.48 -2.13 0 C-N-CA 118.363 -1.875 . . . . 65.24 113.238 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -88.0 101.82 14.14 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.534 -1.654 . . . . 62.21 106.534 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.6 t -92.18 126.23 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 CA-C-N 115.688 -0.687 . . . . 65.33 110.031 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.6 mt -100.83 111.28 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.406 0 CA-C-N 114.287 -1.324 . . . . 55.23 108.32 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 80.8 m-85 -95.84 169.17 10.19 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 114.926 -1.034 . . . . 62.14 110.994 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.6 -44.13 97.08 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.304 -1.316 . . . . 72.23 112.561 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.9 p -152.78 165.71 34.5 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 122.427 -0.171 . . . . 72.42 111.016 -172.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -27.95 47.51 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.246 -1.02 . . . . 74.03 108.246 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.44 -26.18 65.38 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.245 -0.888 . . . . 63.13 108.766 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.46 -40.46 8.38 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.324 -1.11 . . . . 61.44 110.324 176.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.15 92.92 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.286 0.635 . . . . 54.2 112.528 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.47 -31.47 70.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 119.769 -0.772 . . . . 64.43 112.11 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.4 -42.52 68.23 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.148 0.499 . . . . 52.24 110.018 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.01 -42.36 97.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.651 -0.704 . . . . 74.32 111.295 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.441 ' CE ' ' HA ' ' A' ' 104' ' ' GLU . 13.8 ptmm? -67.97 -36.9 80.84 Favored 'General case' 0 C--O 1.198 -1.648 0 C-N-CA 120.248 -0.581 . . . . 73.41 109.85 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -67.15 -19.79 65.65 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 112.974 0.731 . . . . 74.54 112.974 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.34 -45.57 10.45 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-O 121.276 0.56 . . . . 65.41 110.236 175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.526 ' O ' HG22 ' A' ' 91' ' ' ILE . 93.8 mt -94.13 -19.16 21.05 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 116.17 1.915 . . . . 73.21 116.17 -171.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.439 ' HB3' ' H ' ' A' ' 103' ' ' LEU 0.293 0.2 OUTLIER -76.55 116.99 17.75 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 120.662 -1.273 . . . . 54.13 113.335 -177.196 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.75 19.83 9.39 Favored Glycine 0 N--CA 1.423 -2.225 0 C-N-CA 120.689 -0.767 . . . . 62.33 112.142 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 88' ' ' LEU . 18.1 tt -112.91 135.84 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.212 0 N-CA-C 108.166 -1.05 . . . . 72.13 108.166 176.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.486 ' HG2' HG22 ' A' ' 100' ' ' THR . 63.5 mtt180 -72.75 128.11 34.57 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 116.242 -0.435 . . . . 73.21 109.901 174.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.4 ' CD2' ' HG3' ' B' ' 45' ' ' ARG . 8.6 t80 -57.57 -32.26 66.97 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 124.983 1.427 . . . . 70.42 109.932 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.611 ' HB2' ' HB2' ' A' ' 97' ' ' ASN 0.284 8.8 m-20 -133.53 140.27 36.39 Favored Pre-proline 0 CA--C 1.496 -1.132 0 N-CA-C 103.326 -2.842 . . . . 54.0 103.326 170.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.513 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 34.7 Cg_endo -70.89 -17.28 32.57 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 CA-C-N 121.229 1.475 . . . . 74.42 111.771 173.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -86.66 -12.47 48.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.132 0.491 . . . . 62.35 110.096 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.611 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 44.7 t-20 -103.76 131.98 21.49 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 109.078 -0.712 . . . . 72.22 109.078 -172.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.421 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 45.1 Cg_endo -70.43 -14.56 34.09 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.465 2.11 . . . . 71.23 112.407 176.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -65.24 115.89 6.03 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 109.458 -0.571 . . . . 61.22 109.458 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.486 HG22 ' HG2' ' A' ' 92' ' ' ARG . 60.6 p -102.62 139.92 37.57 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 119.946 -0.701 . . . . 72.52 110.026 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.9 tp -94.78 123.25 38.13 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.669 -0.864 . . . . 64.12 108.669 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 102' ' ' ARG . 0.3 OUTLIER -137.32 128.4 27.67 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 119.607 -0.837 . . . . 74.12 110.473 178.473 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.523 ' HG ' HG22 ' A' ' 35' ' ' VAL . 5.3 mp -106.65 125.29 50.81 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.315 -1.312 . . . . 63.53 108.38 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.441 ' HA ' ' CE ' ' A' ' 85' ' ' LYS . 26.0 tt0 -136.32 155.36 50.18 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.818 -1.179 . . . . 60.01 107.818 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -66.57 132.13 47.53 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 119.028 0.831 . . . . 73.33 111.822 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.09 152.6 36.76 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.19 -1.041 . . . . 73.02 108.19 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -93.24 15.59 15.12 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.66 1.219 . . . . 73.24 110.319 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -153.86 125.83 7.8 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.738 -1.119 . . . . 72.44 108.373 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.12 123.56 21.0 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.033 -1.099 . . . . 75.13 108.033 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 C--N 1.269 -2.916 0 N-CA-C 107.327 -1.361 . . . . 61.42 107.327 -179.862 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.432 -1.328 0 N-CA-C 106.203 -1.777 . . . . 65.4 106.203 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.523 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 66.5 mtt180 -99.47 -15.7 18.6 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-N 115.567 -0.742 . . . . 62.41 111.427 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' B' ' 73' ' ' VAL . 31.0 m -105.4 129.16 53.78 Favored 'General case' 1 C--N 1.243 -4.026 0 N-CA-C 113.581 0.956 . . . . 53.34 113.581 -170.482 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.492 HD11 ' O ' ' B' ' 81' ' ' ALA . 79.2 mt -106.64 145.78 31.53 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.479 -1.237 . . . . 73.33 107.883 171.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' B' ' 104' ' ' GLU . 25.5 p90 -104.15 116.28 31.91 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 119.077 -1.049 . . . . 62.32 108.346 173.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.37 118.09 43.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 114.03 -1.441 . . . . 53.3 107.602 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.5 p -126.37 163.15 23.91 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 109.44 -0.578 . . . . 72.11 109.44 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 99.5 19.99 18.77 Favored Glycine 0 N--CA 1.423 -2.215 0 N-CA-C 111.826 -0.51 . . . . 41.0 111.826 -172.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 72.4 mt -93.89 120.21 66.1 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 107.915 -1.143 . . . . 73.24 107.915 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.34 159.6 22.48 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.576 2.184 . . . . 53.24 111.643 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 7.9 p -70.04 -6.11 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-O 121.94 0.876 . . . . 62.42 110.922 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -114.48 30.08 7.56 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.108 -1.071 . . . . 72.53 108.108 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.402 HG22 ' HG2' ' B' ' 69' ' ' PRO . 9.4 tt -58.8 140.32 17.28 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 CA-C-O 121.745 0.783 . . . . 72.33 111.627 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.636 ' HG2' ' CZ ' ' B' ' 45' ' ' ARG . 0.1 OUTLIER -101.18 143.34 26.4 Favored Pre-proline 0 C--N 1.293 -1.872 0 C-N-CA 125.712 1.605 . . . . 74.24 108.525 175.056 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -61.79 -27.91 81.15 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.451 2.1 . . . . 63.02 113.437 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.636 ' CZ ' ' HG2' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -82.7 -10.65 58.82 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 118.228 -1.389 . . . . 65.15 111.909 -177.244 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -65.09 -39.4 93.14 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 120.101 -0.639 . . . . 72.51 109.708 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.31 -33.71 74.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.538 -0.755 . . . . 71.05 109.806 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.513 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 66.5 t80 -61.94 -50.81 70.63 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.674 -0.694 . . . . 74.23 110.184 177.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 81.4 mt -62.04 -44.17 97.27 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 124.085 0.865 . . . . 44.01 109.548 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 20.6 tp -63.17 -44.64 94.88 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.45 -1.25 . . . . 71.02 110.965 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -93.59 11.39 28.96 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 113.902 1.075 . . . . 74.33 113.902 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' B' ' 52' ' ' ARG . 5.2 mmp_? -55.25 -51.86 76.21 Favored Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 113.276 0.843 . . . . 75.32 113.276 175.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' B' ' 52' ' ' ARG . 2.9 Cg_exo -79.26 -1.0 11.2 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.011 1.808 . . . . 74.42 112.937 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -99.81 99.76 10.61 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-O 122.5 1.143 . . . . 65.11 112.516 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -73.67 116.09 13.85 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 113.02 -1.9 . . . . 61.22 109.076 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' B' ' 75' ' ' PHE . . . 143.19 -24.73 2.22 Favored Glycine 0 C--N 1.284 -2.312 0 CA-C-N 114.822 -1.081 . . . . 60.52 112.103 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -55.67 110.07 0.66 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.512 0.725 . . . . 61.04 112.488 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -96.11 -49.27 5.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.489 -0.778 . . . . 50.13 110.368 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -169.68 172.41 43.65 Favored Glycine 0 C--N 1.299 -1.477 0 CA-C-N 115.162 -0.926 . . . . 71.22 111.413 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.9 p -141.17 137.63 32.83 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 122.531 0.332 . . . . 74.25 110.627 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 28.5 tp -120.33 115.35 23.37 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.897 -1.149 . . . . 75.13 107.897 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.95 131.47 42.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 109.684 -0.488 . . . . 72.03 109.684 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -118.55 114.35 22.68 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.309 -0.997 . . . . 72.0 108.309 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.6 119.74 12.86 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.956 -0.757 . . . . 64.32 108.956 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 25.6 m -114.65 155.25 26.93 Favored 'General case' 0 N--CA 1.401 -2.913 0 N-CA-C 104.662 -2.347 . . . . 64.34 104.662 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.78 -38.01 14.73 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.69 0.996 . . . . 71.44 113.69 -173.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -104.29 -15.78 15.36 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 113.239 0.829 . . . . 72.3 113.239 -174.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.493 ' O ' ' HB ' ' B' ' 65' ' ' THR . 29.4 pt20 -172.64 140.05 0.97 Allowed Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 110.135 -0.32 . . . . 71.53 110.135 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 68' ' ' GLN . 6.4 Cg_exo -74.54 112.99 3.68 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.846 2.364 . . . . 71.31 109.672 168.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -90.8 145.31 7.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.648 -0.871 . . . . 75.4 108.648 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.19 120.1 4.43 Favored Glycine 0 CA--C 1.483 -1.914 0 C-N-CA 118.917 -1.611 . . . . 60.22 112.775 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.91 103.06 15.82 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.579 -1.267 . . . . 75.22 107.579 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' B' ' 32' ' ' THR . 59.3 t -98.25 127.36 50.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-N 115.725 -0.67 . . . . 71.3 110.687 -175.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 53.3 mt -98.44 128.76 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 CA-C-N 114.842 -1.072 . . . . 63.13 108.814 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' PHE . . . . . 0.523 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 85.3 m-85 -109.03 159.47 16.82 Favored 'General case' 0 C--N 1.271 -2.837 0 N-CA-C 107.799 -1.185 . . . . 64.21 107.799 174.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.13 -40.09 94.77 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 112.469 0.544 . . . . 75.34 112.469 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 2.9 p -143.69 155.61 44.27 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 116.046 -0.524 . . . . 63.03 111.707 -174.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ARG . . . . . 0.597 ' H ' ' HD3' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -59.69 -35.18 73.98 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 123.398 0.436 . . . . 73.03 110.898 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.6 -32.31 73.74 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 122.008 0.909 . . . . 64.44 109.49 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.47 -37.44 35.76 Favored Glycine 0 C--N 1.31 -0.864 0 CA-C-N 114.021 -1.445 . . . . 73.23 110.493 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.492 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -70.03 -45.3 67.47 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.848 -0.676 . . . . 55.12 111.517 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.94 -37.19 85.37 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.289 -0.564 . . . . 71.14 111.425 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.46 -35.99 81.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.853 0.359 . . . . 44.22 110.268 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.65 74.74 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.716 -0.675 . . . . 73.31 111.464 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.407 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 13.8 ptmm? -66.65 -40.18 88.56 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 119.743 -0.783 . . . . 72.24 110.619 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -60.53 -30.62 69.87 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.173 0.435 . . . . 53.3 112.173 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.18 -36.36 19.54 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.33 -0.548 . . . . 41.23 111.969 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.457 ' O ' HG22 ' B' ' 91' ' ' ILE . 91.2 mt -96.97 -23.38 16.33 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 116.042 1.867 . . . . 53.4 116.042 -172.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ASN . . . . . 0.48 ' HB3' ' H ' ' B' ' 103' ' ' LEU . 0.2 OUTLIER -76.34 123.11 25.43 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.202 1.186 . . . . 73.41 114.202 -175.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.34 27.13 6.27 Favored Glycine 0 CA--C 1.483 -1.907 0 C-N-CA 120.316 -0.945 . . . . 74.02 111.582 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.457 HG22 ' O ' ' B' ' 88' ' ' LEU . 18.8 tt -124.44 142.96 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.395 0 N-CA-C 106.316 -1.735 . . . . 74.35 106.316 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.587 ' HG2' HG22 ' B' ' 100' ' ' THR . 96.3 mtt180 -74.21 145.82 43.83 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-O 121.098 0.475 . . . . 73.13 111.164 176.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -74.03 -33.24 63.68 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.166 -1.379 . . . . 74.14 108.199 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.575 ' HB2' ' CB ' ' B' ' 97' ' ' ASN . 4.8 m-20 -136.08 130.32 18.37 Favored Pre-proline 0 CA--C 1.511 -0.533 0 N-CA-C 103.456 -2.794 . . . . 75.43 103.456 173.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' PRO . . . . . 0.576 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 17.5 Cg_endo -58.26 -34.82 98.97 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.024 1.816 . . . . 52.12 112.479 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.17 1.57 39.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.816 -0.629 . . . . 75.21 111.782 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' ASN . . . . . 0.575 ' CB ' ' HB2' ' B' ' 94' ' ' ASP . 48.1 t30 -114.12 128.07 26.18 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 109.575 -0.528 . . . . 74.45 109.575 -175.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.12 -7.16 20.48 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 122.82 2.347 . . . . 71.32 112.016 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' GLN . . . . . 0.543 ' HB3' ' ND2' ' B' ' 97' ' ' ASN . 6.4 tp60 -75.01 112.12 10.91 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.099 -1.074 . . . . 71.25 108.099 174.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.587 HG22 ' HG2' ' B' ' 92' ' ' ARG . 82.2 p -101.96 151.88 21.6 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.76 -0.655 . . . . 74.21 109.398 -174.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 42.0 tp -98.81 121.0 40.19 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.958 -1.127 . . . . 71.33 107.958 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -131.93 138.53 48.4 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-O 121.344 0.593 . . . . 64.33 109.511 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' B' ' 89' ' ' ASN . 5.9 mp -122.36 118.41 28.36 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.944 -1.026 . . . . 71.42 109.137 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.451 ' HB2' ' CE2' ' B' ' 34' ' ' PHE . 9.3 mm-40 -124.21 168.43 12.94 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.966 -1.124 . . . . 43.22 107.966 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -74.35 141.95 45.15 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 109.191 -0.67 . . . . 60.44 109.191 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.46 144.22 42.22 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 108.163 -1.051 . . . . 64.14 108.163 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -80.44 6.74 11.45 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.787 0.803 . . . . 71.05 110.827 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -167.26 131.93 1.95 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.856 -1.905 . . . . 63.32 105.856 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -66.34 145.65 55.48 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 109.041 -0.725 . . . . 73.44 109.041 176.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.411 -2.412 0 C-N-CA 119.059 -1.056 . . . . 71.54 109.15 179.822 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 17.2 t . . . . . 0 N--CA 1.447 -0.59 0 CA-C-O 121.56 0.695 . . . . 74.2 109.84 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NH2' ' HA ' ' A' ' 76' ' ' ASP . 17.1 ptm180 -111.08 9.68 22.01 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.215 -0.902 . . . . 71.32 111.459 -172.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.1 m -121.0 125.83 48.37 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.652 -0.704 . . . . 74.43 109.85 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' A' ' 85' ' ' LYS . 89.7 mt -107.35 152.85 23.6 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.239 -0.891 . . . . 73.52 108.846 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.59 ' CE1' ' HB2' ' A' ' 104' ' ' GLU . 21.8 p90 -115.18 118.16 32.53 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 117.883 -1.527 . . . . 75.32 109.056 172.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.8 t -97.63 123.08 49.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 113.797 -1.547 . . . . 74.32 107.679 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 60.0 p -124.31 175.37 7.12 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.986 -1.116 . . . . 71.03 107.986 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 88.5 27.21 25.5 Favored Glycine 0 N--CA 1.422 -2.279 0 N-CA-C 111.169 -0.772 . . . . 74.31 111.169 -176.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.4 mt -103.68 131.64 21.83 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 107.623 -1.251 . . . . 71.34 107.623 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.86 168.01 21.56 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.791 1.661 . . . . 72.32 111.094 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.71 -6.2 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-O 122.063 0.935 . . . . 60.51 110.524 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -124.78 40.4 3.75 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.176 -1.046 . . . . 52.44 108.176 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.49 125.03 34.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 106.589 -1.634 . . . . 62.42 106.589 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -93.91 142.24 24.77 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 109.223 -0.658 . . . . 72.01 109.223 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.24 -21.16 50.71 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.887 2.391 . . . . 62.24 113.217 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.576 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.3 ptt180 -77.21 -24.48 51.31 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 116.233 -0.439 . . . . 74.52 110.743 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -70.41 -41.27 73.18 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.0 0.428 . . . . 64.25 110.513 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.47 -39.97 94.82 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 108.728 -0.842 . . . . 74.15 108.728 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.65 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 30.7 t80 -57.13 -48.24 79.15 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.408 -1.269 . . . . 64.31 111.292 178.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 88.1 mt -61.53 -40.77 95.88 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.238 0.542 . . . . 73.54 110.77 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.8 tp -77.23 -40.93 43.13 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.0 -1.0 . . . . 72.02 111.926 -176.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -88.3 -8.13 55.64 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 115.398 1.629 . . . . 74.41 115.398 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 54.8 mtp85 -57.79 -43.78 98.94 Favored Pre-proline 0 N--CA 1.48 1.075 0 N-CA-C 114.896 1.443 . . . . 72.04 114.896 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -67.91 -17.45 46.6 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 121.344 1.362 . . . . 75.13 112.101 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -86.32 89.6 7.91 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.923 0.868 . . . . 74.23 110.962 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -65.03 110.76 2.6 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.367 -1.288 . . . . 74.31 109.769 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.88 -24.72 2.42 Favored Glycine 0 C--N 1.281 -2.522 0 CA-C-N 114.682 -1.144 . . . . 61.41 111.193 -176.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -58.29 113.03 1.76 Allowed 'General case' 0 C--O 1.242 0.664 0 C-N-CA 122.799 0.44 . . . . 72.34 111.355 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -91.65 -59.76 2.05 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.37 -0.832 . . . . 51.35 109.614 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.43 -178.45 39.64 Favored Glycine 0 C--N 1.298 -1.583 0 CA-C-N 115.276 -0.874 . . . . 55.33 111.449 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.2 p -135.66 137.97 42.36 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 122.532 0.333 . . . . 74.41 111.345 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.6 tt -107.7 119.97 40.93 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.742 -1.577 . . . . 53.33 106.742 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -95.66 128.97 46.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 109.661 -0.496 . . . . 64.44 109.661 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -119.06 109.35 15.81 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 106.51 -1.663 . . . . 73.24 106.51 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.84 127.78 33.66 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.514 -0.767 . . . . 74.54 109.777 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 7.1 m -130.32 151.04 51.25 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 105.54 -2.022 . . . . 63.43 105.54 175.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.74 -41.65 10.94 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 114.529 1.307 . . . . 72.42 114.529 -172.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -105.41 -11.58 16.38 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 114.988 1.477 . . . . 74.15 114.988 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.417 ' O ' ' HB ' ' A' ' 65' ' ' THR . 29.1 pt20 -166.1 125.69 1.19 Allowed Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 120.95 0.405 . . . . 55.31 111.671 -175.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.81 108.17 2.64 Favored 'Trans proline' 0 N--CA 1.439 -1.682 0 C-N-CA 122.371 2.047 . . . . 65.54 108.945 169.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.16 146.92 5.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.639 -0.874 . . . . 62.04 108.639 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.77 120.72 4.59 Favored Glycine 0 CA--C 1.486 -1.732 0 C-N-CA 118.868 -1.634 . . . . 61.53 113.499 -176.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -87.74 103.77 15.92 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.999 -1.482 . . . . 74.42 106.999 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.9 t -94.68 121.8 45.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 114.781 -1.1 . . . . 60.35 110.818 -174.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 tt -93.33 124.92 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.962 0 CA-C-N 114.822 -1.081 . . . . 74.42 109.978 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -103.59 155.57 18.44 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 114.817 -1.083 . . . . 72.14 108.424 173.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.499 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 22.5 t70 -67.98 -34.52 76.69 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.815 -0.63 . . . . 74.32 110.4 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.7 m -132.49 145.87 51.49 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 107.984 -1.117 . . . . 73.02 107.984 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.676 ' HB2' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -78.22 -24.38 47.07 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.66 -0.866 . . . . 71.24 108.66 -179.178 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.13 -25.45 68.36 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.028 0.918 . . . . 53.23 109.098 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.7 -42.59 6.78 Favored Glycine 0 C--N 1.297 -1.627 0 CA-C-N 113.533 -1.667 . . . . 64.5 109.724 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.28 -49.01 79.48 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.306 0.642 . . . . 70.12 111.239 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.19 -35.58 73.84 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.264 0.626 . . . . 62.3 112.234 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.05 -32.23 39.42 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.166 0.508 . . . . 63.4 111.014 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.73 -46.05 69.91 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.147 -0.479 . . . . 72.42 111.052 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HB3' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -68.8 -28.08 66.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.135 -0.484 . . . . 64.15 111.525 -177.2 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -70.28 -40.7 74.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.212 -0.449 . . . . 74.21 110.496 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.66 -36.99 36.89 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.279 0.474 . . . . 31.32 112.279 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.55 ' O ' HG22 ' A' ' 91' ' ' ILE . 98.5 mt -89.39 -4.48 58.02 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 115.484 1.661 . . . . 71.32 115.484 -175.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -78.55 118.05 20.3 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 117.86 -1.536 . . . . 74.34 110.803 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.13 6.53 31.82 Favored Glycine 0 CA--C 1.483 -1.934 0 CA-C-N 115.73 -0.668 . . . . 63.32 112.729 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.9 tt -88.36 121.43 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 109.244 -0.651 . . . . 72.22 109.244 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.529 ' CG ' HG22 ' A' ' 100' ' ' THR . 71.3 mtt180 -74.53 135.28 42.16 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 116.166 -0.47 . . . . 72.23 110.311 173.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.516 ' CD1' HD11 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -63.54 -39.23 93.86 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.367 -1.288 . . . . 54.04 107.697 177.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' A' ' 97' ' ' ASN . 8.2 m-20 -135.41 128.47 18.24 Favored Pre-proline 0 CA--C 1.485 -1.547 0 N-CA-C 104.413 -2.44 . . . . 62.43 104.413 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -56.96 -26.24 66.9 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 121.748 1.632 . . . . 52.04 111.07 173.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -74.88 -20.68 59.63 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.544 1.138 . . . . 72.31 110.569 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 36.4 t30 -106.69 124.59 35.06 Favored Pre-proline 0 C--N 1.308 -1.217 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.491 -173.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.65 -12.04 33.33 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 123.248 2.632 . . . . 74.34 113.25 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.497 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 6.5 tp60 -74.09 113.49 11.34 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.31 -0.996 . . . . 72.44 108.31 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.529 HG22 ' CG ' ' A' ' 92' ' ' ARG . 68.0 p -110.76 145.18 38.55 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.518 -0.764 . . . . 62.15 110.2 -173.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.561 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.1 mp -78.39 120.51 23.23 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.431 0.634 . . . . 55.43 109.652 175.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 104' ' ' GLU . 0.3 OUTLIER -123.43 112.56 17.68 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 107.224 -1.399 . . . . 74.11 107.224 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -106.94 127.31 53.33 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.2 -0.909 . . . . 72.13 110.31 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.59 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 47.3 mt-10 -132.67 174.07 10.68 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.351 -1.351 . . . . 75.41 107.351 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.469 ' HB3' HG11 ' A' ' 30' ' ' VAL . 61.8 m-85 -79.51 138.62 37.59 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.34 -0.615 . . . . 73.03 109.34 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.36 152.28 40.93 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.256 -0.646 . . . . 52.33 109.256 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.539 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 14.0 tmtt? -74.29 -8.15 55.22 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.45 0.643 . . . . 75.14 110.198 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.54 131.23 9.82 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.733 -0.667 . . . . 73.42 109.722 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.46 HD21 ' HA ' ' A' ' 30' ' ' VAL . 93.0 m-20 -75.68 143.27 42.24 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.925 -0.579 . . . . 71.23 110.217 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 C--N 1.296 -1.761 0 N-CA-C 108.855 -0.794 . . . . 75.51 108.855 178.541 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.472 HG11 ' HB3' ' B' ' 105' ' ' PHE . 16.0 t . . . . . 0 N--CA 1.442 -0.841 0 CA-C-O 121.48 0.657 . . . . 74.03 110.157 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -104.08 -2.62 25.64 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.446 -0.797 . . . . 75.21 110.59 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 23.2 m -113.54 127.62 56.15 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 115.507 -0.769 . . . . 71.42 110.645 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.469 HD13 ' HB3' ' B' ' 85' ' ' LYS . 94.9 mt -104.96 148.3 26.86 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.735 -0.839 . . . . 73.43 108.735 176.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.435 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 37.1 p90 -105.01 115.66 30.65 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 118.126 -1.429 . . . . 64.25 107.757 171.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.414 HG22 ' HG ' ' B' ' 103' ' ' LEU . 43.5 t -97.05 114.75 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-N 113.99 -1.459 . . . . 65.23 107.812 -177.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 21.3 p -123.72 174.34 7.54 Favored 'General case' 0 N--CA 1.401 -2.908 0 CA-C-N 114.704 -1.134 . . . . 73.44 108.72 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 87.92 32.98 11.55 Favored Glycine 0 N--CA 1.421 -2.325 0 N-CA-C 110.241 -1.143 . . . . 61.34 110.241 -172.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 85.9 mt -105.68 142.87 25.69 Favored Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 107.767 -1.198 . . . . 61.25 107.767 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -75.68 164.3 32.35 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.977 1.784 . . . . 72.14 110.151 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.432 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 13.8 p -71.23 -8.51 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-O 122.457 1.123 . . . . 63.42 109.869 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.429 ' O ' ' HD2' ' B' ' 43' ' ' LYS . 13.0 t70 -99.43 10.95 40.43 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.24 -1.345 . . . . 73.13 109.472 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.402 ' HA ' ' OE2' ' B' ' 46' ' ' GLU . 0.0 OUTLIER -66.65 125.01 23.05 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 CA-C-O 121.886 0.851 . . . . 72.43 109.79 -178.274 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.519 ' HG3' ' NE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -105.53 142.55 24.98 Favored Pre-proline 0 C--N 1.291 -1.976 0 CA-C-N 114.65 -1.159 . . . . 71.32 109.517 177.156 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.75 -26.67 24.3 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 123.762 2.975 . . . . 73.35 113.632 -174.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.559 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 19.2 ptt180 -66.74 -26.17 66.86 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.879 -0.6 . . . . 73.32 112.057 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.478 ' HG3' ' HG2' ' B' ' 43' ' ' LYS . 42.3 mt-10 -70.3 -42.85 71.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.784 0.326 . . . . 61.51 110.945 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -68.01 -33.83 75.35 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 108.71 -0.848 . . . . 72.51 108.71 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.528 ' O ' ' HG3' ' B' ' 52' ' ' ARG . 62.8 t80 -60.97 -51.38 69.49 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.653 -1.158 . . . . 61.02 110.098 175.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 92.7 mt -62.84 -40.95 99.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.321 0.582 . . . . 64.1 110.216 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 25.4 tp -69.63 -41.59 75.42 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.781 -1.1 . . . . 61.34 111.674 -176.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -94.69 -2.25 51.55 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 114.954 1.464 . . . . 73.11 114.954 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 30.6 mtp180 -60.94 -43.25 90.71 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.292 0.849 . . . . 60.45 113.292 173.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.93 -19.93 70.17 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 121.378 1.385 . . . . 74.02 112.188 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -92.53 90.11 7.02 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 122.364 1.078 . . . . 74.25 110.191 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -76.45 109.35 10.1 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.684 -1.144 . . . . 75.42 110.05 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.42 -27.51 1.36 Allowed Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 108.986 -1.645 . . . . 65.34 108.986 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -51.86 123.32 9.99 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.542 1.137 . . . . 73.02 111.789 173.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -97.2 -60.39 1.59 Allowed 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 109.719 -0.475 . . . . 72.13 109.719 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.42 168.46 36.64 Favored Glycine 0 C--N 1.292 -1.915 0 C-N-CA 119.567 -1.301 . . . . 51.03 113.141 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.5 p -126.15 138.06 53.64 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.33 0.586 . . . . 71.45 110.747 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 49.5 tp -116.27 116.67 28.19 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.47 -0.937 . . . . 51.32 108.47 176.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mp -94.33 131.89 39.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 109.154 -0.684 . . . . 63.04 109.154 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -130.47 125.96 35.7 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.546 -0.909 . . . . 74.51 108.546 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -77.39 130.5 37.16 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.013 0.435 . . . . 41.12 110.774 -175.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.7 m -129.71 151.74 49.97 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 104.244 -2.502 . . . . 75.42 104.244 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.17 -45.46 8.35 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.376 1.07 . . . . 63.32 113.541 -174.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -88.96 -29.2 19.71 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.624 0.972 . . . . 74.41 113.624 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.407 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 26.1 pt20 -165.06 132.56 2.39 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-O 120.871 0.367 . . . . 72.32 111.797 -169.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.432 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 12.0 Cg_exo -71.89 109.96 2.8 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.659 2.24 . . . . 73.33 108.747 167.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 33.3 m -87.21 151.56 3.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.2 -0.667 . . . . 71.34 109.2 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.98 121.09 4.59 Favored Glycine 0 C--N 1.297 -1.638 0 C-N-CA 119.271 -1.442 . . . . 54.31 112.726 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -87.91 104.32 16.5 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.818 -1.549 . . . . 55.51 106.818 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 98.9 t -100.31 117.35 45.38 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-N 115.028 -0.987 . . . . 64.44 109.697 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 tt -101.83 131.61 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 115.37 -0.832 . . . . 74.43 110.466 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -108.7 158.12 17.9 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.438 -1.255 . . . . 74.31 109.174 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -59.26 -27.12 65.52 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 123.758 0.661 . . . . 75.52 112.055 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 21.3 m -154.43 157.26 38.19 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.625 -0.672 . . . . 73.34 110.943 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ARG . . . . . 0.627 ' H ' ' HD3' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -57.97 -32.24 67.67 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.113 0.565 . . . . 73.51 110.623 175.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.25 -27.69 67.43 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.804 0.812 . . . . 74.22 110.062 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.88 -37.19 8.64 Favored Glycine 0 C--N 1.301 -1.374 0 N-CA-C 110.244 -1.142 . . . . 72.1 110.244 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.413 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -67.16 -47.3 71.43 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.455 -0.872 . . . . 51.03 111.182 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -57.52 -40.7 79.34 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.948 0.351 . . . . 71.31 111.948 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.05 -35.31 66.69 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 120.944 0.402 . . . . 61.13 110.945 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.93 -44.19 73.57 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.104 -0.498 . . . . 70.44 111.254 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.469 ' HB3' HD13 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -71.2 -32.14 68.49 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.146 -0.479 . . . . 71.11 110.648 -177.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -64.46 -38.78 92.22 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.797 -0.638 . . . . 70.2 111.092 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.97 -40.06 25.01 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 120.573 -0.451 . . . . 72.14 112.053 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.575 ' O ' HG22 ' B' ' 91' ' ' ILE . 94.5 mt -93.12 -11.99 31.53 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 116.593 2.072 . . . . 73.44 116.593 -172.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -78.66 117.64 20.01 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 117.911 -1.516 . . . . 64.32 110.488 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.04 7.83 37.46 Favored Glycine 0 CA--C 1.485 -1.836 0 C-N-CA 120.434 -0.889 . . . . 53.35 112.188 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.575 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.5 tt -105.46 140.2 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 107.907 -1.146 . . . . 71.25 107.907 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.559 ' HG3' HG22 ' B' ' 100' ' ' THR . 43.7 mtt85 -70.65 139.9 51.43 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 113.843 1.053 . . . . 74.42 113.843 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.475 ' CD1' HD21 ' B' ' 101' ' ' LEU . 54.6 t80 -83.43 -25.07 31.58 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.141 -1.845 . . . . 73.32 108.321 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -149.31 122.71 4.52 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 106.883 -1.525 . . . . 73.52 106.883 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' PRO . . . . . 0.65 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 36.8 Cg_endo -62.84 -23.44 74.33 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.057 2.505 . . . . 63.12 113.993 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -98.18 1.7 47.67 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.266 0.555 . . . . 62.22 112.126 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -116.71 133.76 23.0 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 108.059 -1.089 . . . . 64.33 108.059 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.421 ' HA ' HH21 ' B' ' 92' ' ' ARG . 31.8 Cg_exo -64.0 -9.46 19.29 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.796 2.331 . . . . 65.41 113.061 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' GLN . . . . . 0.455 ' HA ' ' OE1' ' B' ' 99' ' ' GLN . 6.1 tp60 -69.81 111.38 5.52 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.795 0.807 . . . . 72.24 109.934 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.559 HG22 ' HG3' ' B' ' 92' ' ' ARG . 41.7 p -110.43 145.31 37.84 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.181 -0.918 . . . . 73.04 109.34 -176.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.475 HD21 ' CD1' ' B' ' 93' ' ' PHE . 91.7 mt -71.18 146.55 49.03 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.295 0.569 . . . . 55.42 110.521 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -143.84 106.26 4.41 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.338 -1.356 . . . . 74.45 107.338 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.426 ' O ' ' HE2' ' B' ' 85' ' ' LYS . 6.7 mp -107.67 116.26 31.63 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.486 -0.779 . . . . 73.23 109.608 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.435 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 9.6 tp10 -129.26 161.55 29.93 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.231 -1.396 . . . . 70.54 107.231 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' PHE . . . . . 0.472 ' HB3' HG11 ' B' ' 30' ' ' VAL . 72.3 m-85 -70.06 136.37 50.23 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 118.262 0.483 . . . . 74.03 110.687 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.48 153.7 43.12 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.068 -0.515 . . . . 73.35 110.571 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -82.37 5.09 21.44 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 122.184 0.993 . . . . 62.31 110.054 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -169.6 131.62 1.14 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.507 -1.664 . . . . 62.22 106.507 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -65.6 97.79 0.33 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.434 -0.58 . . . . 75.35 109.434 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.418 -2.032 0 CA-C-N 114.792 -1.095 . . . . 55.03 108.545 -176.708 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.593 ' HA ' ' ND2' ' A' ' 109' ' ' ASN . 47.6 t . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 113.048 0.758 . . . . 74.14 113.048 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 75' ' ' PHE . 6.6 mpt_? -106.04 6.08 30.85 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-N 115.859 -0.609 . . . . 63.31 112.104 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.459 ' H ' HG12 ' A' ' 30' ' ' VAL . 18.1 m -135.82 132.46 36.7 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 114.35 1.241 . . . . 72.1 114.35 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.467 HD11 ' O ' ' A' ' 81' ' ' ALA . 68.9 mt -110.42 151.56 27.35 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.043 -1.095 . . . . 74.33 108.043 171.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -107.39 114.21 28.08 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 118.808 -1.157 . . . . 63.43 108.036 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.489 HG22 ' HG ' ' A' ' 103' ' ' LEU . 42.2 t -97.99 119.96 46.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.749 0 CA-C-N 113.791 -1.55 . . . . 44.05 107.9 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.7 p -123.26 165.1 17.5 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 115.204 -0.907 . . . . 73.5 109.628 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 96.36 18.67 30.19 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 111.5 -0.64 . . . . 71.32 111.5 -174.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.451 HD22 HG13 ' A' ' 42' ' ' ILE . 82.3 mt -89.83 128.87 48.57 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 107.337 -1.357 . . . . 65.44 107.337 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.41 165.22 32.43 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.684 1.589 . . . . 54.13 110.991 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 8.9 p -69.32 -5.42 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 122.151 0.976 . . . . 64.34 110.751 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.555 ' OD2' ' HE2' ' B' ' 43' ' ' LYS . 24.5 t70 -113.56 13.8 18.84 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.207 -0.906 . . . . 74.31 109.647 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.451 HG13 HD22 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -61.08 129.23 23.57 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 CA-C-O 121.693 0.758 . . . . 75.21 109.38 -178.221 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 46.1 mmtm -93.59 145.8 30.62 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 115.477 -0.783 . . . . 71.33 113.031 -176.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.34 -29.02 87.95 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.589 2.193 . . . . 63.3 112.202 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.623 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -86.37 -12.11 50.15 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 118.885 -1.126 . . . . 64.45 110.491 177.691 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 43' ' ' LYS . 43.7 tt0 -77.1 -40.57 45.41 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.377 -0.601 . . . . 71.52 109.377 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.34 -33.23 75.36 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.684 0.754 . . . . 71.43 109.221 172.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.623 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 57.2 t80 -61.17 -48.87 79.59 Favored 'General case' 0 C--O 1.202 -1.432 0 CA-C-N 114.467 -1.242 . . . . 73.54 110.467 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 83.2 mt -66.88 -35.78 80.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.582 0.706 . . . . 60.12 110.031 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 tp -67.25 -51.31 54.64 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.787 -1.097 . . . . 71.23 111.287 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -96.41 11.95 33.05 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.493 0.923 . . . . 73.54 113.493 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 31.8 ttt-85 -70.36 -42.79 16.31 Favored Pre-proline 0 C--N 1.312 -1.061 0 C-N-CA 120.653 -0.419 . . . . 73.11 112.052 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -77.29 -4.39 14.7 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 121.521 1.48 . . . . 61.21 111.879 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -89.73 107.18 18.94 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 122.076 0.941 . . . . 60.22 111.533 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -75.29 110.56 9.74 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 113.707 -1.588 . . . . 54.31 108.905 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.22 -10.83 5.33 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.457 -0.878 . . . . 72.44 113.339 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -66.7 112.52 4.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.553 0.677 . . . . 71.44 111.141 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -90.1 -41.49 11.63 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.238 0.542 . . . . 62.14 110.424 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.46 -176.93 42.7 Favored Glycine 0 C--N 1.307 -1.066 0 CA-C-N 115.186 -0.915 . . . . 51.44 111.325 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.467 ' HB3' HG22 ' A' ' 73' ' ' VAL . 20.6 p -148.03 137.9 22.55 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.475 0.546 . . . . 45.2 112.475 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.4 mp -111.24 126.35 54.78 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.741 -0.837 . . . . 64.43 108.741 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.2 mm -94.97 143.57 11.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 C-N-CA 122.301 0.24 . . . . 55.34 110.637 -174.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 69' ' ' PRO . 64.0 tttp -125.95 106.19 9.46 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.847 -0.797 . . . . 71.21 108.847 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.36 112.79 9.76 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.49 -0.777 . . . . 75.32 110.443 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 66' ' ' ALA . 2.3 m -110.99 173.21 6.44 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 107.912 -1.144 . . . . 53.32 107.912 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.427 ' H ' HG22 ' A' ' 65' ' ' THR . . . -50.87 -38.51 49.81 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.099 0.959 . . . . 73.11 112.911 -177.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -104.19 -49.1 3.68 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.48 0.657 . . . . 64.22 111.467 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -136.92 136.05 20.75 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 114.789 -1.096 . . . . 65.03 112.316 -166.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 55.7 Cg_endo -81.1 102.36 1.35 Allowed 'Trans proline' 0 N--CA 1.429 -2.287 0 C-N-CA 122.723 2.282 . . . . 72.02 109.43 168.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -80.22 157.1 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 N-CA-C 109.291 -0.633 . . . . 75.41 109.291 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.09 123.49 4.83 Favored Glycine 0 CA--C 1.48 -2.144 0 C-N-CA 118.536 -1.792 . . . . 72.51 113.294 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -87.23 103.01 15.03 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 105.621 -1.992 . . . . 73.21 105.621 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 60' ' ' SER . 76.1 t -97.8 127.12 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 CA-C-N 115.084 -0.962 . . . . 72.22 110.495 -174.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 3.0 mp -94.46 129.77 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 CA-C-N 114.482 -1.235 . . . . 74.32 108.575 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.459 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 89.4 m-85 -117.7 152.24 35.63 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.483 -0.932 . . . . 64.44 108.483 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -49.89 -38.05 34.05 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 124.548 1.139 . . . . 54.25 112.697 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.5 p -157.04 163.74 38.72 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.528 -0.76 . . . . 61.1 110.346 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -28.54 63.48 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.208 -0.597 . . . . 73.2 109.925 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.83 -29.71 70.22 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-O 121.793 0.806 . . . . 74.15 109.424 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.08 -32.14 26.87 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.585 -1.006 . . . . 74.31 110.585 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.467 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -67.05 -48.61 67.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 123.506 0.723 . . . . 74.01 110.976 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.01 -28.68 69.96 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.345 -0.222 . . . . 71.01 111.301 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.31 -41.02 73.84 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.965 0.412 . . . . 72.31 110.032 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.99 -42.22 90.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.813 -0.631 . . . . 42.2 109.64 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 104' ' ' GLU . 34.7 ttmt -59.92 -45.62 92.0 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.558 -0.746 . . . . 75.3 110.269 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.59 -31.58 69.59 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.819 -0.628 . . . . 72.53 111.871 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.16 -35.18 17.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 113.025 0.75 . . . . 64.54 113.025 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 91' ' ' ILE . 97.9 mt -110.72 -5.31 15.02 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 116.724 2.12 . . . . 62.44 116.724 -170.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -78.7 114.57 17.74 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 117.358 -1.737 . . . . 74.35 111.199 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.65 12.93 33.78 Favored Glycine 0 CA--C 1.48 -2.132 0 N-CA-C 110.509 -1.036 . . . . 41.41 110.509 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 88' ' ' LEU . 9.6 tt -90.76 141.08 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.004 0 N-CA-C 108.969 -0.752 . . . . 75.11 108.969 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -63.21 117.05 6.01 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 108.122 -1.066 . . . . 74.21 108.122 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' B' ' 45' ' ' ARG . 64.9 t80 -73.86 -28.65 61.69 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.648 -1.612 . . . . 72.13 106.648 176.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 97' ' ' ASN . 20.8 t0 -144.27 117.03 5.63 Favored Pre-proline 0 N--CA 1.422 -1.843 0 N-CA-C 102.833 -3.025 . . . . 74.54 102.833 176.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.459 ' HD3' ' CZ ' ' B' ' 48' ' ' TYR . 74.2 Cg_endo -71.81 -20.76 25.75 Favored 'Trans proline' 0 C--N 1.327 -0.554 0 CA-C-N 120.608 1.253 . . . . 64.21 113.5 -177.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -87.06 -21.1 26.28 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 121.634 0.73 . . . . 64.12 109.134 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.491 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 46.8 t-20 -99.19 137.02 20.34 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 107.428 -1.323 . . . . 55.01 107.428 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.38 -13.94 31.83 Favored 'Trans proline' 0 CA--C 1.553 1.454 0 C-N-CA 122.556 2.171 . . . . 62.32 113.623 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -61.71 119.35 8.54 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.857 0.863 . . . . 74.23 110.593 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.423 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 24.7 p -119.22 147.21 44.5 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.249 -0.432 . . . . 75.2 110.811 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 24.5 tp -89.87 129.41 36.24 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.551 -0.749 . . . . 73.34 109.132 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -134.89 128.51 32.77 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.524 -0.547 . . . . 72.3 109.524 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 35' ' ' VAL . 5.6 mp -113.8 128.01 56.24 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.722 -0.672 . . . . 72.14 109.439 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.538 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 9.3 tp10 -137.3 163.55 30.7 Favored 'General case' 0 C--O 1.195 -1.785 0 N-CA-C 107.618 -1.253 . . . . 61.34 107.618 177.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -73.24 133.58 44.02 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 119.229 0.922 . . . . 74.12 110.498 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.36 155.13 39.7 Favored 'General case' 0 N--CA 1.438 -1.051 0 O-C-N 123.688 0.618 . . . . 45.24 109.739 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -87.48 7.18 30.47 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.784 0.802 . . . . 73.42 109.88 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.42 126.05 12.54 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.609 -0.723 . . . . 55.41 109.45 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.593 ' ND2' ' HA ' ' A' ' 30' ' ' VAL . 3.4 m-20 -79.62 124.89 28.95 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.473 -0.936 . . . . 74.52 108.473 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.9 m . . . . . 0 C--N 1.276 -2.592 0 N-CA-C 106.854 -1.536 . . . . 74.24 106.854 179.405 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.459 HG12 ' H ' ' B' ' 32' ' ' THR . 34.8 t . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 121.763 0.792 . . . . 63.45 112.572 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -90.24 6.45 42.78 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.402 -0.817 . . . . 71.13 112.188 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' THR . . . . . 0.459 ' H ' HG12 ' B' ' 30' ' ' VAL . 18.3 m -129.42 128.42 42.94 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 113.4 0.889 . . . . 61.13 113.4 -175.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.502 HD11 ' O ' ' B' ' 81' ' ' ALA . 76.3 mt -104.0 148.16 26.53 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.633 -1.247 . . . . 70.14 107.633 172.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 28.2 p90 -105.98 118.02 35.53 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 118.477 -1.289 . . . . 74.52 107.565 172.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.485 HG22 ' HG ' ' B' ' 103' ' ' LEU . 39.1 t -100.58 124.32 54.07 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.564 0 CA-C-N 114.157 -1.383 . . . . 44.31 107.849 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 35.7 p -129.16 168.43 16.15 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 115.339 -0.846 . . . . 50.41 109.89 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.82 12.07 57.14 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 110.543 -1.023 . . . . 25.41 110.543 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 89.8 mt -80.95 123.59 82.03 Favored Pre-proline 0 N--CA 1.432 -1.328 0 C-N-CA 123.634 0.774 . . . . 72.51 110.046 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.11 155.29 34.9 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.738 2.292 . . . . 72.33 111.649 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.481 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 7.4 p -70.32 -4.42 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-O 121.906 0.86 . . . . 74.21 111.046 -177.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -120.19 22.66 11.31 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.883 -0.784 . . . . 71.13 108.883 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.41 HD11 HD21 ' B' ' 47' ' ' LEU . 6.6 tt -50.44 132.08 10.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-N 115.077 -0.965 . . . . 44.21 111.609 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.555 ' HE2' ' OD2' ' A' ' 41' ' ' ASP . 39.6 mmtm -108.54 140.1 21.46 Favored Pre-proline 0 C--N 1.29 -1.994 0 CA-C-N 115.316 -0.857 . . . . 70.33 112.632 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -53.31 -41.75 70.39 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.73 2.287 . . . . 65.34 112.401 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.542 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -74.42 -22.76 58.99 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 117.718 -1.593 . . . . 72.2 111.356 -178.239 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' B' ' 43' ' ' LYS . 36.4 tt0 -66.46 -41.62 88.77 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.628 -0.879 . . . . 74.14 108.628 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.439 HD11 HD11 ' B' ' 62' ' ' ILE . 90.1 mt -66.42 -41.75 88.76 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.616 -0.72 . . . . 72.14 110.011 173.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.583 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 71.6 t80 -52.8 -47.74 67.37 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 124.496 1.118 . . . . 75.42 111.121 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 88.5 mt -64.47 -37.36 87.26 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 123.31 0.381 . . . . 75.45 111.118 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.452 HD13 HD22 ' A' ' 49' ' ' LEU . 39.3 tp -75.87 -46.44 30.21 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.824 -0.626 . . . . 72.05 112.054 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -92.03 4.14 53.71 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.413 0.894 . . . . 71.34 113.413 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.583 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 53.0 ttt-85 -61.03 -48.44 92.42 Favored Pre-proline 0 CA--C 1.563 1.469 0 N-CA-C 112.656 0.613 . . . . 74.53 112.656 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.76 -1.71 11.83 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.133 1.889 . . . . 73.31 112.707 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -84.6 98.72 10.32 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.867 0.842 . . . . 72.14 110.779 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -66.39 113.84 4.96 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 113.783 -1.553 . . . . 74.12 109.401 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.15 -16.71 5.72 Favored Glycine 0 C--N 1.285 -2.27 0 CA-C-N 115.105 -0.952 . . . . 42.41 111.905 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -63.56 103.73 0.57 Allowed 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.246 0.546 . . . . 75.1 110.937 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -84.26 -45.61 12.68 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.746 -0.835 . . . . 61.55 108.746 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.25 173.63 42.95 Favored Glycine 0 C--N 1.305 -1.18 0 CA-C-N 114.814 -1.085 . . . . 53.41 111.768 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.3 p -128.68 141.37 51.36 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 122.542 0.337 . . . . 62.42 110.61 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 61.7 tp -114.5 110.94 20.6 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.919 -1.141 . . . . 52.02 107.919 175.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.439 HD11 HD11 ' B' ' 47' ' ' LEU . 50.9 mm -94.06 131.4 41.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 109.882 -0.414 . . . . 75.44 109.882 -176.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' B' ' 69' ' ' PRO . 60.5 tttp -124.38 115.08 20.39 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.159 0.504 . . . . 73.21 110.178 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.57 124.67 23.88 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.731 -0.668 . . . . 74.41 110.748 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 11.2 m -130.26 155.34 46.46 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 103.835 -2.654 . . . . 74.44 103.835 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.45 -35.17 51.81 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.617 0.969 . . . . 71.03 113.617 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -87.02 -45.92 10.3 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 119.838 -0.745 . . . . 60.04 112.537 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -155.35 134.79 7.87 Favored Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 114.921 -1.036 . . . . 65.05 109.654 -168.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 14.3 Cg_exo -72.19 105.0 1.76 Allowed 'Trans proline' 0 C--N 1.298 -2.09 0 C-N-CA 122.283 1.989 . . . . 64.25 108.076 166.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 36.0 m -77.15 151.2 5.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.594 -0.891 . . . . 73.34 108.594 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.64 120.88 4.31 Favored Glycine 0 CA--C 1.474 -2.492 0 C-N-CA 117.791 -2.147 . . . . 71.3 113.124 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -88.29 102.52 14.92 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 105.999 -1.852 . . . . 71.34 105.999 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 70.6 t -95.2 120.25 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.544 0 CA-C-O 122.089 0.947 . . . . 71.44 109.761 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 58.3 mt -98.0 123.44 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.723 0 CA-C-N 113.099 -1.864 . . . . 65.41 109.021 -172.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -114.16 161.21 18.09 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-N 114.6 -1.182 . . . . 71.41 109.894 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -55.7 -41.39 73.72 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 124.684 1.194 . . . . 72.03 112.667 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 4.0 p -155.81 162.99 40.39 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.92 -0.582 . . . . 74.43 110.534 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -28.22 64.57 Favored 'General case' 0 C--O 1.202 -1.408 0 C-N-CA 119.865 -0.734 . . . . 74.54 109.889 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.0 -27.77 69.05 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.491 0.663 . . . . 52.05 110.196 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.46 -41.21 6.57 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.995 -1.242 . . . . 74.12 109.995 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.502 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -61.91 -41.26 97.7 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 114.702 -0.749 . . . . 54.15 111.827 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.8 -36.24 83.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.548 0.213 . . . . 64.33 111.168 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.71 -39.28 73.52 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.381 -0.599 . . . . 74.34 109.381 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.86 -42.2 86.04 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.125 -0.943 . . . . 60.15 110.286 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' B' ' 104' ' ' GLU . 13.3 ttmt -60.71 -47.89 84.26 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.426 -0.806 . . . . 64.23 109.636 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -60.14 -38.49 83.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.009 -0.541 . . . . 71.31 111.11 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.42 -30.95 62.13 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 112.538 0.57 . . . . 71.0 112.538 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.604 ' O ' HG22 ' B' ' 91' ' ' ILE . 98.4 mt -108.52 -12.54 14.98 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 116.002 1.853 . . . . 75.34 116.002 -174.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -79.56 114.55 18.57 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 120.188 -1.57 . . . . 61.31 112.024 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.98 9.18 28.59 Favored Glycine 0 CA--C 1.485 -1.829 0 C-N-CA 120.619 -0.8 . . . . 73.44 111.381 173.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.604 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.6 tt -104.81 149.79 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.803 0 N-CA-C 106.904 -1.517 . . . . 75.34 106.904 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.44 ' CZ ' ' HA ' ' B' ' 98' ' ' PRO . 99.3 mtt180 -81.39 138.71 35.58 Favored 'General case' 0 C--N 1.267 -2.989 0 CA-C-O 121.523 0.677 . . . . 74.41 112.192 175.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 43.5 t80 -77.97 -28.54 49.43 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.219 -1.355 . . . . 53.21 108.117 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.23 127.62 14.76 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 106.106 -1.812 . . . . 75.14 106.106 175.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' PRO . . . . . 0.506 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 72.7 Cg_endo -71.58 -21.72 25.34 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.089 1.859 . . . . 72.21 114.761 -176.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.99 -25.43 29.99 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.527 0.679 . . . . 74.11 109.717 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -97.2 128.77 33.98 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.475 -0.784 . . . . 72.13 108.983 -176.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.44 ' HA ' ' CZ ' ' B' ' 92' ' ' ARG . 38.1 Cg_exo -60.64 -16.82 45.55 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 123.241 2.627 . . . . 54.3 113.179 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -55.46 118.86 4.83 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 124.707 1.203 . . . . 71.23 110.138 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 33.7 p -104.67 157.97 16.82 Favored 'General case' 0 N--CA 1.413 -2.323 0 C-N-CA 120.115 -0.634 . . . . 70.32 110.505 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 35.5 tp -96.25 124.66 40.33 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.507 -1.664 . . . . 75.41 106.507 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -129.62 127.46 40.67 Favored 'General case' 0 N--CA 1.422 -1.84 0 C-N-CA 120.161 -0.616 . . . . 71.33 109.758 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.485 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.8 mp -114.8 140.92 48.53 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.271 -1.011 . . . . 71.13 108.271 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.477 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 39.1 tt0 -152.24 165.64 34.24 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.535 -1.654 . . . . 75.51 106.535 176.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -71.32 138.46 49.31 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 120.077 1.308 . . . . 55.33 110.983 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.47 154.42 30.56 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.434 -0.58 . . . . 75.25 109.434 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -84.43 1.46 45.31 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 122.126 0.965 . . . . 73.23 109.432 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.82 118.72 12.52 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.302 -0.863 . . . . 65.12 109.481 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' B' ' 30' ' ' VAL . 3.8 m-20 -73.42 112.59 9.63 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.549 -1.278 . . . . 43.3 107.549 175.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 C--N 1.278 -2.52 0 N-CA-C 108.97 -0.752 . . . . 65.53 108.97 -176.56 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.462 ' HA ' HD21 ' A' ' 109' ' ' ASN . 57.3 t . . . . . 0 N--CA 1.434 -1.232 0 N-CA-C 104.108 -2.553 . . . . 54.0 104.108 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -121.29 -4.15 9.44 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 115.174 -0.921 . . . . 64.32 110.322 -168.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.7 m -101.99 124.54 47.79 Favored 'General case' 0 C--N 1.264 -3.117 0 CA-C-N 115.132 -0.94 . . . . 54.12 109.213 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 33' ' ' LEU . 3.2 mp -108.13 137.59 45.85 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 107.308 -1.367 . . . . 75.1 107.308 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 104' ' ' GLU . 24.2 p90 -103.77 109.16 20.77 Favored 'General case' 0 N--CA 1.412 -2.355 0 C-N-CA 118.473 -1.291 . . . . 74.02 107.621 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.536 HG22 ' HG ' ' A' ' 103' ' ' LEU . 25.0 t -96.57 120.17 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.752 0 CA-C-N 113.772 -1.558 . . . . 72.11 107.677 -174.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 20.1 p -126.51 166.78 16.63 Favored 'General case' 0 N--CA 1.4 -2.935 0 CA-C-N 114.644 -1.162 . . . . 63.31 108.305 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 94.89 32.08 7.36 Favored Glycine 0 N--CA 1.417 -2.619 0 N-CA-C 110.671 -0.972 . . . . 64.1 110.671 -173.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.4 mt -101.0 145.27 30.11 Favored Pre-proline 0 N--CA 1.428 -1.566 0 N-CA-C 109.081 -0.711 . . . . 54.41 109.081 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.04 157.69 33.17 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.208 1.939 . . . . 62.34 110.022 173.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.486 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 7.7 p -76.29 -2.15 4.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-O 122.362 1.077 . . . . 61.03 109.66 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -128.28 35.13 4.46 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 114.437 -1.256 . . . . 65.21 108.564 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.98 123.86 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 N-CA-C 108.097 -1.075 . . . . 54.05 108.097 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 43' ' ' LYS . 4.8 mmpt? -93.65 143.98 27.45 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-N 115.358 -0.837 . . . . 61.1 110.153 -175.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.09 -19.95 35.5 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.472 2.781 . . . . 73.12 114.617 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.551 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -87.34 -15.67 37.26 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 118.435 -1.306 . . . . 74.31 111.644 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -67.32 -41.21 85.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.102 0.477 . . . . 62.32 110.244 -177.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.13 -30.31 67.45 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 116.153 -0.476 . . . . 70.34 109.833 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.692 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 41.2 t80 -61.88 -51.17 69.28 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.484 -0.78 . . . . 72.14 110.246 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.94 -38.31 90.51 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.073 -0.512 . . . . 75.2 110.973 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.8 tp -77.91 -43.02 31.27 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.507 -0.77 . . . . 74.53 112.289 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -97.62 -2.06 42.4 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 114.441 1.274 . . . . 54.43 114.441 -172.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 32.3 ttt-85 -60.69 -46.09 97.07 Favored Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 112.89 0.7 . . . . 64.22 112.89 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -75.05 -2.68 12.86 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.095 1.863 . . . . 75.25 112.769 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -83.88 106.21 15.38 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.627 0.727 . . . . 74.41 110.871 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -68.76 109.95 4.08 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.254 -1.339 . . . . 74.24 110.115 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.24 -14.28 6.97 Favored Glycine 0 N--CA 1.421 -2.306 0 CA-C-N 114.908 -1.042 . . . . 72.35 111.576 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -65.93 102.89 0.84 Allowed 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.173 0.511 . . . . 54.21 110.852 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.417 ' HB2' HG13 ' A' ' 74' ' ' ILE . 7.9 mm-40 -81.16 -57.48 3.49 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.543 -0.91 . . . . 75.3 108.543 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.08 -174.37 35.45 Favored Glycine 0 C--N 1.303 -1.251 0 CA-C-N 114.911 -1.04 . . . . 52.44 112.439 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.7 p -146.39 137.88 24.61 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 123.407 0.683 . . . . 65.24 110.297 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.2 tp -112.06 120.05 40.54 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.558 -0.534 . . . . 61.32 109.558 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 mm -94.01 134.49 31.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.851 -0.796 . . . . 62.11 108.851 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -134.74 114.13 12.36 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 110.006 -0.368 . . . . 72.31 110.006 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.82 112.82 2.45 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.36 0.6 . . . . 65.31 109.514 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -113.86 164.32 13.92 Favored 'General case' 0 N--CA 1.404 -2.756 0 N-CA-C 105.479 -2.045 . . . . 75.14 105.479 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.97 -38.25 10.39 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.246 1.202 . . . . 54.45 114.246 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.74 -27.73 13.5 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.455 0.539 . . . . 74.33 112.455 -174.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -169.93 148.49 3.16 Favored Pre-proline 0 N--CA 1.423 -1.822 0 CA-C-N 115.921 -0.581 . . . . 61.11 110.7 -168.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.486 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 13.8 Cg_exo -70.24 106.2 1.71 Allowed 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 121.999 1.8 . . . . 63.21 108.417 165.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.1 m -81.48 158.76 4.08 Favored 'Isoleucine or valine' 0 C--O 1.25 1.081 0 N-CA-C 107.883 -1.155 . . . . 53.11 107.883 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.88 120.9 2.91 Favored Glycine 0 CA--C 1.484 -1.853 0 C-N-CA 117.668 -2.206 . . . . 73.11 113.077 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -88.03 102.02 14.35 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.532 -1.285 . . . . 72.0 107.532 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 78.4 t -91.34 123.79 43.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 108.814 -0.81 . . . . 54.51 108.814 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 58' ' ' GLU . 46.9 pt -107.83 123.73 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.329 0 CA-C-O 122.05 0.929 . . . . 63.45 111.564 -175.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -100.25 163.82 12.23 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 114.243 -1.344 . . . . 72.0 109.84 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -64.52 -39.86 94.55 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.111 -0.95 . . . . 65.11 112.461 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 56.0 m -145.21 166.0 26.74 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.742 -0.208 . . . . 62.12 110.48 -172.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -29.49 64.33 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 120.591 -0.444 . . . . 73.24 112.081 -176.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.23 -18.98 64.7 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 122.222 1.01 . . . . 65.34 108.88 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.1 -41.29 10.46 Favored Glycine 0 C--N 1.305 -1.184 0 CA-C-N 114.392 -1.276 . . . . 51.1 110.033 176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.62 -46.17 76.71 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.684 -0.758 . . . . 73.52 111.6 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -29.41 70.15 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 111.887 0.329 . . . . 71.13 111.887 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.55 -40.45 56.84 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 116.193 -0.458 . . . . 72.13 111.304 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.18 -43.23 87.47 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.915 -0.584 . . . . 74.51 110.953 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 103' ' ' LEU . 14.5 ptmm? -72.08 -31.81 66.45 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.93 -0.708 . . . . 74.21 110.414 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -58.73 -36.72 74.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.038 0.447 . . . . 74.14 110.453 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.23 -42.2 16.15 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 120.999 0.428 . . . . 61.22 111.606 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.433 ' O ' HG22 ' A' ' 91' ' ' ILE . 92.3 mt -98.52 -18.61 18.09 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 117.18 2.289 . . . . 72.51 117.18 -169.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.335 0.2 OUTLIER -72.42 114.63 10.75 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 117.167 -1.813 . . . . 53.05 111.946 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.68 14.92 10.71 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 110.461 -1.056 . . . . 64.31 110.461 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.1 tt -93.2 128.19 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 CA-C-O 121.26 0.553 . . . . 74.45 109.788 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.714 ' HG3' HG22 ' A' ' 100' ' ' THR . 5.9 ttt180 -83.79 124.82 31.32 Favored 'General case' 0 N--CA 1.402 -2.873 0 N-CA-C 107.68 -1.23 . . . . 72.03 107.68 173.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.44 ' HB2' ' CD1' ' A' ' 101' ' ' LEU . 3.5 t80 -64.18 -34.25 77.66 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 124.572 1.17 . . . . 73.12 110.012 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.502 ' HB3' ' HB3' ' B' ' 45' ' ' ARG . 2.8 p-10 -151.64 136.92 10.72 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 105.901 -1.889 . . . . 73.25 105.901 175.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.437 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 73.8 Cg_endo -75.48 -1.27 11.11 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.336 2.024 . . . . 65.14 114.118 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -92.35 -25.17 18.66 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.285 0.564 . . . . 73.13 110.019 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -99.29 133.77 21.78 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 108.065 -1.087 . . . . 72.42 108.065 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.63 -16.74 56.53 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.167 1.911 . . . . 42.02 112.398 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -62.16 122.33 15.32 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.573 1.149 . . . . 55.1 110.466 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.714 HG22 ' HG3' ' A' ' 92' ' ' ARG . 26.0 p -119.33 149.71 41.36 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.21 -0.663 . . . . 74.24 109.21 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.8 mp -88.67 124.09 33.76 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-O 120.789 0.328 . . . . 72.52 110.715 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -120.37 112.9 19.59 Favored 'General case' 0 N--CA 1.4 -2.964 0 N-CA-C 107.518 -1.29 . . . . 74.1 107.518 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.536 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.4 mp -87.15 116.22 25.07 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.512 -1.222 . . . . 72.32 107.822 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.416 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 37.7 mt-10 -118.13 164.74 14.7 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.374 -1.343 . . . . 74.54 107.374 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -81.7 132.16 35.28 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 118.694 0.679 . . . . 73.42 109.568 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.41 137.79 48.6 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.837 -1.172 . . . . 73.32 107.837 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -82.95 12.02 5.43 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.215 1.007 . . . . 61.41 109.892 -175.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -157.5 118.73 3.61 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 114.421 -1.263 . . . . 73.24 107.614 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.462 HD21 ' HA ' ' A' ' 30' ' ' VAL . 44.9 m-80 -70.68 138.63 50.81 Favored 'General case' 0 CA--C 1.475 -1.935 0 C-N-CA 120.019 -0.672 . . . . 72.13 110.329 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.281 -2.372 0 CA-C-N 115.567 -0.742 . . . . 72.21 110.168 -174.037 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 81.0 t . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 103.748 -2.686 . . . . 74.21 103.748 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -129.02 7.39 5.52 Favored 'General case' 0 CA--C 1.471 -2.078 0 CA-C-N 115.435 -0.802 . . . . 74.53 111.803 -169.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 56.6 m -109.58 132.34 54.23 Favored 'General case' 0 C--N 1.264 -3.151 0 N-CA-C 107.554 -1.276 . . . . 64.35 107.554 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 72' ' ' PHE . 3.4 mp -121.98 151.46 40.77 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.482 -0.933 . . . . 72.24 108.482 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.438 ' CE1' ' HB2' ' B' ' 104' ' ' GLU . 17.9 p90 -108.13 111.47 23.5 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.787 -1.19 . . . . 75.01 107.787 175.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 57.2 t -97.57 122.16 48.86 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 CA-C-N 114.094 -1.412 . . . . 71.12 108.197 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 65.4 p -130.05 174.8 9.44 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.532 -0.758 . . . . 64.31 110.128 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 88.66 22.87 38.14 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.029 -1.228 . . . . 61.23 110.029 -172.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 88.4 mt -92.37 132.52 31.8 Favored Pre-proline 0 N--CA 1.412 -2.336 0 N-CA-C 106.179 -1.785 . . . . 53.22 106.179 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.88 160.24 30.2 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 121.639 1.559 . . . . 74.11 110.95 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 9.4 p -68.62 -7.92 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-O 122.588 1.185 . . . . 63.2 109.774 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -121.46 31.92 6.11 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 114.042 -1.435 . . . . 51.05 108.576 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.25 131.65 33.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 109.091 -0.707 . . . . 74.23 109.091 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -100.52 136.54 19.92 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-N 115.302 -0.863 . . . . 72.32 109.655 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -54.62 -24.61 37.65 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 C-N-CA 123.716 2.944 . . . . 74.21 114.121 -173.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.507 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 10.6 ptt180 -82.5 -15.24 53.16 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 122.081 -0.387 . . . . 61.15 111.954 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.13 -40.83 82.39 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.31 -0.626 . . . . 71.14 109.31 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 90.8 mt -68.76 -32.26 71.89 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.463 -0.79 . . . . 63.24 109.633 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.592 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 75.6 t80 -63.53 -48.17 78.62 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.135 -0.939 . . . . 73.24 110.033 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 84.9 mt -67.16 -39.93 86.58 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.196 0.522 . . . . 73.41 110.31 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 tp -74.01 -40.39 62.96 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.954 -1.021 . . . . 71.51 112.473 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -97.97 -4.18 36.8 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.639 0.978 . . . . 72.45 113.639 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.592 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 67.7 ttt180 -61.55 -45.07 93.78 Favored Pre-proline 0 CA--C 1.555 1.141 0 N-CA-C 112.665 0.617 . . . . 75.31 112.665 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.62 -12.99 20.3 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 121.373 1.382 . . . . 63.12 113.021 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -78.01 110.73 13.21 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 121.953 0.882 . . . . 64.44 111.48 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -72.38 109.46 6.11 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 113.945 -1.479 . . . . 65.13 109.363 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.69 -13.78 5.83 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-N 115.522 -0.763 . . . . 52.22 112.317 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -61.57 117.03 5.23 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.33 0.586 . . . . 73.21 111.638 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.427 ' HB2' HG13 ' B' ' 74' ' ' ILE . 5.7 mm-40 -96.47 -47.47 5.95 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.487 -0.779 . . . . 63.43 111.034 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.23 177.13 46.73 Favored Glycine 0 C--N 1.294 -1.802 0 C-N-CA 120.015 -1.088 . . . . 65.33 112.457 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.5 p -135.47 137.78 42.5 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 122.852 0.461 . . . . 62.23 110.999 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 5.5 mp -117.35 124.4 48.84 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.423 -1.325 . . . . 72.42 107.423 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 47.2 mm -94.28 146.98 5.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 109.671 -0.492 . . . . 71.25 109.671 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -129.59 106.57 8.83 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.234 -1.395 . . . . 53.32 107.234 176.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -72.44 116.57 13.05 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.99 -1.115 . . . . 71.01 107.99 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 11.5 m -122.84 155.16 37.19 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 104.98 -2.23 . . . . 62.24 104.98 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.94 -25.79 65.45 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.905 0.383 . . . . 60.4 111.698 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -82.11 -45.8 14.7 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 116.062 -0.517 . . . . 70.52 111.695 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -172.34 145.97 1.57 Allowed Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 108.183 -1.044 . . . . 71.52 108.183 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 8.2 Cg_exo -72.06 106.38 2.02 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.299 2.0 . . . . 71.15 109.087 168.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 35.8 m -87.6 157.67 3.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.721 -0.844 . . . . 70.24 108.721 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.31 120.89 3.33 Favored Glycine 0 CA--C 1.481 -2.067 0 C-N-CA 118.62 -1.753 . . . . 73.12 112.791 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' B' ' 33' ' ' LEU . 98.0 m-85 -88.16 102.37 14.74 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.342 -1.355 . . . . 73.5 107.342 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 88.4 t -94.13 130.15 43.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.298 0 CA-C-N 114.678 -1.146 . . . . 53.12 109.703 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' B' ' 58' ' ' GLU . 48.6 pt -106.99 138.64 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.241 0 CA-C-O 121.848 0.832 . . . . 72.32 110.596 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -119.21 166.08 13.42 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 114.116 -1.402 . . . . 72.12 111.553 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.75 -40.87 80.73 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.023 -1.444 . . . . 72.34 112.362 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 5.0 p -157.95 167.64 29.38 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.145 -0.48 . . . . 72.13 111.399 -170.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.58 -30.11 62.82 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 120.219 -0.593 . . . . 71.43 109.845 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.48 -24.19 63.75 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.766 0.793 . . . . 43.01 109.579 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.89 -36.85 9.79 Favored Glycine 0 C--N 1.309 -0.963 0 CA-C-N 114.63 -1.168 . . . . 72.43 110.581 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.444 ' HB1' HD11 ' B' ' 33' ' ' LEU . . . -65.1 -49.07 71.44 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.717 0.807 . . . . 50.54 111.002 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.29 -38.66 77.47 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 116.092 -0.504 . . . . 74.14 111.207 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.6 -40.8 72.99 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.716 -0.674 . . . . 52.33 111.322 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.82 -41.38 83.15 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 116.161 -0.472 . . . . 73.54 111.459 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' B' ' 103' ' ' LEU . 15.1 ptmm? -72.02 -36.42 69.68 Favored 'General case' 0 C--O 1.2 -1.533 0 C-N-CA 120.153 -0.619 . . . . 52.14 109.521 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -58.95 -39.22 81.0 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.316 0.646 . . . . 52.41 110.081 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.45 -31.37 37.47 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 112.615 0.598 . . . . 71.13 112.615 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.418 ' O ' HG22 ' B' ' 91' ' ' ILE . 96.2 mt -100.21 -31.49 11.35 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.201 1.926 . . . . 72.11 116.201 -174.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . 0.251 0.2 OUTLIER -65.91 121.96 16.27 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.448 1.277 . . . . 71.23 114.448 -173.338 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.23 14.94 15.21 Favored Glycine 0 N--CA 1.428 -1.874 0 C-N-CA 120.744 -0.741 . . . . 73.24 112.104 174.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.418 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.5 tt -103.98 140.04 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.909 0 N-CA-C 107.123 -1.436 . . . . 64.1 107.123 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' B' ' 94' ' ' ASP . 89.4 mtt180 -74.15 134.91 42.83 Favored 'General case' 0 C--N 1.263 -3.163 0 CA-C-O 120.869 0.366 . . . . 65.01 110.051 171.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.0 t80 -65.49 -34.76 79.02 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.436 -1.256 . . . . 75.5 109.171 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.562 ' HB2' ' HB3' ' B' ' 97' ' ' ASN . 3.0 m-20 -131.4 138.35 32.57 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 102.055 -3.313 . . . . 52.22 102.055 173.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' PRO . . . . . 0.692 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 22.1 Cg_endo -63.21 -29.25 73.51 Favored 'Trans proline' 0 N--CA 1.486 1.041 0 CA-C-N 121.911 1.718 . . . . 53.23 111.001 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.5 -17.36 42.21 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.965 -1.47 . . . . 50.4 110.916 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' ASN . . . . . 0.562 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . 39.5 t30 -100.43 125.67 38.54 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 109.573 -0.528 . . . . 64.52 109.573 -175.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.72 -10.71 28.35 Favored 'Trans proline' 0 C--O 1.239 0.554 0 C-N-CA 122.795 2.33 . . . . 74.41 112.586 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' GLN . . . . . 0.433 ' HB3' ' ND2' ' B' ' 97' ' ' ASN . 6.6 tp60 -70.29 113.06 7.08 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.446 -0.946 . . . . 72.14 108.446 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.492 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 69.6 p -97.37 145.8 25.79 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.03 -0.532 . . . . 70.35 109.919 -175.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 52.2 tp -87.85 123.71 32.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.881 -1.155 . . . . 71.05 107.881 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -136.88 123.33 20.8 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-O 121.669 0.747 . . . . 74.32 110.337 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.469 ' O ' ' HE2' ' B' ' 85' ' ' LYS . 5.4 mp -107.19 122.52 46.69 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.199 -1.364 . . . . 71.34 109.391 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.438 ' HB2' ' CE1' ' B' ' 34' ' ' PHE . 48.6 mt-10 -126.29 165.56 18.75 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.206 -1.035 . . . . 65.53 108.206 174.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -73.81 141.15 46.2 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.807 -0.357 . . . . 74.35 110.039 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.03 158.8 26.4 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.563 -0.903 . . . . 35.01 108.563 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -92.26 7.75 41.3 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.956 0.884 . . . . 75.0 109.946 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -157.66 132.67 8.72 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.252 -0.885 . . . . 55.52 108.916 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -85.32 141.28 30.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.574 -0.528 . . . . 53.53 109.574 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.292 -1.904 0 N-CA-C 108.498 -0.927 . . . . 74.44 108.498 175.946 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.411 -2.42 0 N-CA-C 105.669 -1.975 . . . . 74.51 105.669 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 16.8 ptm180 -114.65 7.09 15.9 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.327 -0.851 . . . . 70.33 110.42 -175.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.9 m -116.41 117.73 30.75 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.919 0.866 . . . . 64.51 110.686 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.481 HD23 ' HB3' ' A' ' 85' ' ' LYS . 2.9 mp -98.13 140.73 32.01 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.774 -1.565 . . . . 74.2 106.774 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.538 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 6.8 p90 -107.54 114.64 28.77 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 117.578 -1.649 . . . . 72.14 107.979 173.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.447 HG22 ' HG ' ' A' ' 103' ' ' LEU . 43.8 t -97.29 121.05 47.41 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.879 0 CA-C-N 114.375 -1.284 . . . . 72.12 108.492 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.5 p -124.26 170.77 10.44 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 115.544 -0.753 . . . . 64.14 109.608 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 82.35 41.42 9.24 Favored Glycine 0 N--CA 1.43 -1.725 0 N-CA-C 110.103 -1.199 . . . . 21.44 110.103 -173.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.451 ' HB3' HD13 ' A' ' 42' ' ' ILE . 96.4 mt -111.31 123.06 35.98 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 114.23 -0.985 . . . . 73.22 110.16 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.5 144.08 19.61 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.857 2.372 . . . . 71.33 110.664 173.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.572 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 7.6 p -73.24 4.75 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 CA-C-O 122.475 1.131 . . . . 71.21 112.088 -173.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -125.66 13.12 8.04 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.885 -1.052 . . . . 70.5 110.904 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.451 HD13 ' HB3' ' A' ' 38' ' ' LEU . 28.0 pt -53.65 135.68 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 113.453 0.909 . . . . 62.12 113.453 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -97.18 146.0 30.59 Favored Pre-proline 0 C--N 1.292 -1.894 0 CA-C-N 114.625 -1.17 . . . . 72.54 109.119 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.13 -26.7 52.03 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.171 2.581 . . . . 72.32 112.861 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.525 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 9.8 ptt180 -70.86 -23.91 62.41 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 120.858 0.361 . . . . 72.42 111.328 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -72.63 -40.47 66.39 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.633 -0.877 . . . . 41.34 108.633 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.2 mt -66.73 -36.78 83.28 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.802 -0.814 . . . . 65.34 108.802 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.525 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 87.8 t80 -58.62 -47.54 84.04 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-N 114.708 -1.133 . . . . 74.14 110.253 175.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 97.6 mt -70.91 -30.14 66.4 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.072 0.463 . . . . 71.52 110.563 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.7 tp -68.62 -51.56 40.95 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.213 -0.903 . . . . 65.01 110.667 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -95.2 10.59 35.43 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.682 0.623 . . . . 72.42 112.682 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 10.6 ttp180 -52.65 -50.02 83.01 Favored Pre-proline 0 CA--C 1.565 1.539 0 C-N-CA 124.471 1.108 . . . . 74.35 113.696 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -85.35 -0.88 9.07 Favored 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 121.588 1.525 . . . . 64.05 112.74 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -88.72 96.04 10.51 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 122.629 1.204 . . . . 70.22 112.104 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -69.85 113.54 7.18 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 113.068 -1.878 . . . . 65.23 109.44 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.99 -24.82 3.25 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 114.956 -1.02 . . . . 63.42 110.661 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -56.62 115.81 2.76 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.251 0.62 . . . . 51.31 111.352 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -94.26 -56.58 2.78 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 109.209 -0.663 . . . . 55.4 109.209 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.22 169.93 40.63 Favored Glycine 0 C--N 1.295 -1.743 0 CA-C-N 115.214 -0.903 . . . . 45.3 111.6 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.411 ' HB3' HG22 ' A' ' 73' ' ' VAL . 10.4 p -130.55 137.36 49.66 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 120.93 0.395 . . . . 72.23 110.543 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -121.02 109.73 15.4 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.52 -0.919 . . . . 53.02 108.52 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.587 HD13 ' H ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -93.92 130.84 42.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.098 0.475 . . . . 72.53 111.287 -177.554 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 69' ' ' PRO . 87.2 tttt -108.84 112.37 24.59 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.505 -0.924 . . . . 55.05 108.505 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.1 122.77 15.21 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.789 -0.642 . . . . 73.11 110.226 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 15.5 m -130.39 159.67 36.3 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 105.669 -1.975 . . . . 65.3 105.669 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -42.64 -41.78 3.21 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.177 1.391 . . . . 72.03 114.356 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -105.62 -36.47 7.08 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.331 0.586 . . . . 71.03 112.542 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.574 ' O ' ' HB ' ' A' ' 65' ' ' THR . 8.3 pt20 -147.3 132.29 8.98 Favored Pre-proline 0 C--N 1.291 -1.953 0 CA-C-N 115.357 -0.838 . . . . 75.3 111.697 -168.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.572 ' HD3' ' HA ' ' A' ' 40' ' ' VAL . 32.3 Cg_endo -73.06 101.87 1.39 Allowed 'Trans proline' 0 N--CA 1.433 -2.082 0 C-N-CA 121.649 1.566 . . . . 72.43 108.18 167.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.7 m -70.77 139.12 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 108.685 -0.857 . . . . 63.35 108.685 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 62' ' ' ILE . . . -108.82 119.79 5.7 Favored Glycine 0 CA--C 1.465 -3.056 0 C-N-CA 118.236 -1.935 . . . . 72.33 112.939 -174.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -88.73 101.91 14.47 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 105.865 -1.902 . . . . 64.44 105.865 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 60' ' ' SER . 92.4 t -96.78 121.55 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.504 0 CA-C-N 114.735 -1.12 . . . . 63.03 108.888 -176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.7 mt -102.02 119.85 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.763 0 CA-C-N 114.601 -1.181 . . . . 72.11 109.854 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 5.2 m-85 -102.07 156.35 17.6 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 114.373 -1.285 . . . . 72.34 109.916 176.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -64.47 -30.53 71.56 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.201 -1.363 . . . . 62.53 112.112 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m -156.27 155.84 33.03 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 121.804 -0.56 . . . . 74.11 112.205 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.641 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -54.16 -39.15 66.29 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 123.953 0.783 . . . . 72.34 110.91 175.285 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.71 -29.56 69.42 Favored 'General case' 0 CA--C 1.493 -1.249 0 O-C-N 123.889 0.743 . . . . 75.31 110.369 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.01 -45.4 5.1 Favored Glycine 0 C--N 1.295 -1.733 0 CA-C-N 114.469 -1.241 . . . . 73.33 110.69 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.1 -46.32 88.6 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.479 1.112 . . . . 70.12 113.137 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 10.0 pt-20 -62.51 -37.11 84.77 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.384 -0.371 . . . . 64.34 111.327 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.31 -37.63 52.21 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 116.267 -0.424 . . . . 65.43 110.638 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.76 90.37 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.721 -0.672 . . . . 63.13 111.661 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.481 ' HB3' HD23 ' A' ' 33' ' ' LEU . 16.1 pttp -75.36 -33.71 61.08 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 118.552 -1.259 . . . . 64.22 111.85 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.6 -17.15 61.21 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.229 0.538 . . . . 55.32 111.509 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.22 -45.03 14.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 120.998 0.427 . . . . 62.21 110.285 175.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.555 ' O ' HG22 ' A' ' 91' ' ' ILE . 91.9 mt -91.04 -5.42 55.31 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 114.749 1.389 . . . . 73.22 114.749 -173.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -78.99 114.77 18.21 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.055 -1.028 . . . . 74.31 112.627 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.13 20.37 10.56 Favored Glycine 0 CA--C 1.479 -2.216 0 C-N-CA 120.408 -0.901 . . . . 55.53 111.64 174.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 88' ' ' LEU . 16.0 tt -114.3 142.32 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.276 0 N-CA-C 105.461 -2.051 . . . . 70.54 105.461 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.49 ' CD ' ' HA ' ' A' ' 95' ' ' PRO . 33.3 ptt180 -87.02 130.09 34.61 Favored 'General case' 0 C--N 1.262 -3.227 0 C-N-CA 119.424 -0.91 . . . . 55.04 111.335 175.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -60.75 -31.48 70.81 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.701 -1.59 . . . . 71.41 110.207 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.404 ' OD2' ' HB3' ' B' ' 45' ' ' ARG . 9.4 t0 -142.28 113.27 6.18 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 105.512 -2.033 . . . . 74.0 105.512 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.49 ' HA ' ' CD ' ' A' ' 92' ' ' ARG . 53.0 Cg_exo -61.38 -12.85 25.81 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 122.99 2.46 . . . . 43.43 114.846 -178.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -98.21 -14.45 20.33 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.704 -0.623 . . . . 74.01 110.177 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -94.79 141.97 24.07 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.705 -0.85 . . . . 64.52 108.705 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.09 2.35 7.25 Favored 'Trans proline' 0 CA--C 1.549 1.248 0 C-N-CA 122.619 2.213 . . . . 75.02 114.314 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -92.87 127.78 38.5 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 121.558 -0.714 . . . . 72.51 109.259 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.556 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 50.6 p -107.08 143.64 34.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.916 -0.401 . . . . 55.12 109.916 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 34.7 tp -89.37 127.98 35.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.382 -0.97 . . . . 74.52 108.382 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -136.96 124.01 21.56 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 108.545 -0.909 . . . . 64.45 108.545 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.447 ' HG ' HG22 ' A' ' 35' ' ' VAL . 5.9 mp -112.83 122.72 48.5 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 115.732 -0.667 . . . . 60.53 109.85 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.538 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 43.3 mt-10 -127.89 177.43 6.85 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.603 -1.258 . . . . 75.14 107.603 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -91.02 138.57 31.5 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 118.753 0.706 . . . . 64.02 111.424 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.75 158.79 33.98 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.443 -0.799 . . . . 60.31 108.865 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -84.8 -1.98 57.11 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.764 0.792 . . . . 75.45 109.643 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -151.43 132.56 14.4 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.321 -0.854 . . . . 72.11 109.623 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -78.11 124.29 27.88 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.645 -0.502 . . . . 70.4 109.645 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 C--N 1.287 -2.15 0 N-CA-C 108.07 -1.085 . . . . 75.44 108.07 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.522 ' HA ' HD21 ' B' ' 109' ' ' ASN . 48.5 t . . . . . 0 N--CA 1.43 -1.443 0 N-CA-C 108.816 -0.809 . . . . 75.34 108.816 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' B' ' 75' ' ' PHE . 15.0 ptm180 -114.49 11.65 17.19 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.208 -0.905 . . . . 72.51 111.232 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 29.6 m -122.19 122.93 40.31 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.514 0.673 . . . . 71.11 111.096 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' B' ' 85' ' ' LYS . 2.2 mp -101.63 144.75 29.97 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.075 -1.454 . . . . 62.32 107.075 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.591 ' CE2' ' HB2' ' B' ' 104' ' ' GLU . 9.9 p90 -109.2 116.43 31.9 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 117.412 -1.715 . . . . 62.34 108.179 171.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.46 120.06 46.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 CA-C-N 113.946 -1.479 . . . . 73.44 108.225 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' SER . . . . . 0.459 ' OG ' ' HG3' ' B' ' 102' ' ' ARG . 11.0 p -128.72 163.03 26.02 Favored 'General case' 0 N--CA 1.408 -2.557 0 CA-C-N 115.505 -0.771 . . . . 73.4 109.984 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 88.83 37.79 7.19 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 110.648 -0.981 . . . . 42.1 110.648 -173.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.89 135.79 19.37 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 108.069 -1.086 . . . . 73.43 108.069 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.06 150.64 23.46 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.081 1.854 . . . . 73.04 110.194 172.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.527 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 8.1 p -76.75 1.73 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 121.999 0.904 . . . . 62.41 110.5 -174.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -127.73 20.85 6.53 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.509 -0.769 . . . . 50.34 110.032 -173.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 24.9 pt -52.6 133.77 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 113.871 1.063 . . . . 74.0 113.871 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' B' ' 43' ' ' LYS . 3.2 mptp? -90.86 147.12 35.26 Favored Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 114.58 -1.191 . . . . 75.4 109.458 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.84 -28.65 59.21 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.855 2.37 . . . . 64.45 113.286 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.523 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -79.54 -14.38 58.9 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 117.642 -1.623 . . . . 63.25 111.898 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -69.93 -40.53 75.46 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.818 -0.808 . . . . 72.05 108.818 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 88.6 mt -66.4 -34.03 77.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.376 -0.829 . . . . 72.35 109.072 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.523 ' HB3' ' O ' ' B' ' 45' ' ' ARG . 78.9 t80 -60.94 -49.28 78.08 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-N 115.112 -0.949 . . . . 72.31 110.065 176.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 92.0 mt -70.01 -29.14 66.12 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-O 121.117 0.484 . . . . 74.43 110.677 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 tp -71.78 -51.03 24.7 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.113 -0.949 . . . . 64.01 111.121 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -96.8 7.5 46.45 Favored 'General case' 0 C--O 1.217 -0.608 0 N-CA-C 113.674 0.99 . . . . 71.24 113.674 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 10.0 ttp180 -47.93 -50.83 51.53 Favored Pre-proline 0 CA--C 1.568 1.639 0 N-CA-C 114.505 1.298 . . . . 72.12 114.505 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' B' ' 52' ' ' ARG . 1.0 OUTLIER -87.62 -1.39 7.46 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 121.685 1.59 . . . . 73.21 112.98 177.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -86.96 97.17 10.55 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.929 1.347 . . . . 71.45 111.878 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -69.39 113.25 6.53 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 112.169 -2.287 . . . . 72.34 109.637 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.26 -20.28 4.23 Favored Glycine 0 N--CA 1.422 -2.295 0 CA-C-N 114.72 -1.127 . . . . 71.15 111.29 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -57.05 114.98 2.36 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.249 0.62 . . . . 73.41 112.075 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.36 -51.24 4.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.607 0.718 . . . . 65.3 109.363 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.17 178.59 42.88 Favored Glycine 0 C--N 1.298 -1.55 0 CA-C-N 115.208 -0.905 . . . . 53.43 112.198 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.414 ' HB3' HG22 ' B' ' 73' ' ' VAL . 6.7 p -134.39 141.08 46.73 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 123.508 0.723 . . . . 64.21 110.082 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -122.91 112.93 18.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.736 -1.579 . . . . 34.42 106.736 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.579 HD13 ' H ' ' B' ' 62' ' ' ILE . 0.2 OUTLIER -93.84 137.92 21.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.13 0.49 . . . . 72.34 111.254 -176.821 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -124.46 112.14 16.54 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.129 -1.063 . . . . 61.21 108.129 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.48 116.61 7.66 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.661 -0.496 . . . . 70.24 109.661 -177.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 8.5 m -111.53 167.38 10.37 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.523 -1.658 . . . . 75.54 106.523 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.78 -33.11 6.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.231 1.197 . . . . 71.44 114.231 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 58.7 mtt-85 -104.72 -28.68 11.05 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.665 0.987 . . . . 74.32 113.665 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -170.7 152.86 3.93 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 116.439 -0.346 . . . . 73.44 110.155 -165.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 51.4 Cg_endo -77.72 108.24 2.52 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 C-N-CA 122.27 1.98 . . . . 54.15 109.927 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 31.7 m -76.03 140.23 17.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.372 -1.344 . . . . 71.1 107.372 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.16 120.84 5.46 Favored Glycine 0 C--N 1.282 -2.438 0 C-N-CA 118.753 -1.689 . . . . 74.31 112.912 -175.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.4 102.29 14.39 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 105.883 -1.895 . . . . 61.43 105.883 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.414 HG22 ' HB3' ' B' ' 60' ' ' SER . 83.3 t -94.94 124.76 47.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 114.789 -1.096 . . . . 55.44 109.279 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 60.7 mt -107.35 122.08 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.567 0 CA-C-N 114.41 -1.268 . . . . 75.24 109.81 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' B' ' 31' ' ' ARG . 4.0 m-85 -105.95 157.2 17.67 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.666 -1.152 . . . . 75.43 109.697 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.76 -36.26 67.64 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.125 -0.943 . . . . 61.41 109.868 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.91 134.31 54.85 Favored 'General case' 0 N--CA 1.389 -3.485 0 CA-C-N 115.173 -0.921 . . . . 72.53 109.406 -170.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -25.09 56.71 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.425 -0.807 . . . . 61.21 111.218 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.3 -19.81 49.54 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 107.451 -1.315 . . . . 73.25 107.451 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.34 -41.98 8.18 Favored Glycine 0 C--N 1.295 -1.705 0 CA-C-N 113.312 -1.767 . . . . 64.41 109.22 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.23 -46.91 88.16 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.201 1.0 . . . . 65.42 112.16 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -58.81 -44.72 90.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.257 -0.429 . . . . 73.52 111.305 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.71 -36.16 75.68 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.705 -0.68 . . . . 60.0 110.578 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.68 -42.37 91.36 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.881 -0.6 . . . . 53.13 111.444 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.444 ' HB3' HD23 ' B' ' 33' ' ' LEU . 17.1 pttp -74.27 -36.03 63.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 118.171 -1.412 . . . . 63.32 111.147 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -63.49 -27.47 69.29 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.547 0.529 . . . . 74.35 111.321 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.31 -43.69 17.18 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 120.672 0.272 . . . . 74.11 111.388 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.538 ' O ' HG22 ' B' ' 91' ' ' ILE . 95.7 mt -86.22 -8.57 57.69 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.164 1.542 . . . . 53.31 115.164 -174.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.22 114.59 15.06 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.049 -1.06 . . . . 65.22 112.813 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.49 14.79 26.86 Favored Glycine 0 N--CA 1.428 -1.851 0 C-N-CA 120.301 -0.952 . . . . 53.52 112.278 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.538 HG22 ' O ' ' B' ' 88' ' ' LEU . 16.3 tt -106.59 134.43 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.211 0 N-CA-C 106.127 -1.805 . . . . 52.24 106.127 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' B' ' 95' ' ' PRO . 39.4 ptt180 -78.9 133.11 36.97 Favored 'General case' 0 C--N 1.262 -3.223 0 C-N-CA 119.651 -0.82 . . . . 74.23 111.168 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -69.13 -28.63 66.63 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.769 -1.559 . . . . 74.34 110.206 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.435 ' OD2' ' HB3' ' A' ' 45' ' ' ARG . 10.6 t70 -146.57 118.25 4.83 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 106.389 -1.708 . . . . 63.13 106.389 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 95' ' ' PRO . . . . . 0.496 ' HA ' ' NE ' ' B' ' 92' ' ' ARG . 21.0 Cg_endo -60.69 -21.45 69.58 Favored 'Trans proline' 0 N--CA 1.48 0.726 0 C-N-CA 123.039 2.493 . . . . 72.31 114.409 -176.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -85.97 -23.25 26.97 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.508 0.671 . . . . 65.34 110.27 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -100.62 132.29 22.51 Favored Pre-proline 0 C--N 1.29 -2.002 0 CA-C-N 115.499 -0.773 . . . . 73.3 109.13 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.08 -0.72 6.74 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.852 2.368 . . . . 72.4 112.505 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -69.72 112.23 6.04 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.888 -0.782 . . . . 72.53 108.888 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.47 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 70.3 p -103.48 145.57 29.81 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.903 -0.777 . . . . 73.22 108.903 -177.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 36.7 tp -89.9 130.67 36.09 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.663 -1.236 . . . . 61.45 107.663 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.459 ' HG3' ' OG ' ' B' ' 36' ' ' SER . 7.7 ptm180 -138.14 122.53 18.32 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 108.694 -0.854 . . . . 70.34 108.694 -175.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -117.47 132.37 56.56 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.82 -0.627 . . . . 73.54 110.18 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.591 ' HB2' ' CE2' ' B' ' 34' ' ' PHE . 36.0 mt-10 -136.43 174.28 10.79 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.19 -1.781 . . . . 73.1 106.19 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -81.84 145.02 30.62 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 119.128 -1.029 . . . . 74.44 110.941 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.14 151.73 40.0 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 107.906 -1.146 . . . . 72.02 107.906 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -75.95 -9.66 58.79 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.004 0.907 . . . . 62.51 109.888 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.8 127.29 9.33 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.076 -0.965 . . . . 73.01 108.827 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.522 HD21 ' HA ' ' B' ' 30' ' ' VAL . 93.0 m-20 -71.71 143.73 49.55 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.912 -0.585 . . . . 65.31 110.976 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 N--CA 1.413 -2.291 0 N-CA-C 108.075 -1.083 . . . . 64.42 108.075 178.55 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 CA--C 1.502 -0.889 0 N-CA-C 107.465 -1.309 . . . . 63.41 107.465 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 17.0 ptp180 -113.99 -1.7 13.72 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.069 -0.969 . . . . 74.44 111.172 -172.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.4 m -111.07 130.57 55.57 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 115.538 -0.755 . . . . 44.11 110.679 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.451 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.0 pt? -127.78 153.31 46.72 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.903 -0.777 . . . . 75.51 108.903 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -103.0 120.68 41.08 Favored 'General case' 0 N--CA 1.418 -2.075 0 CA-C-O 121.924 0.869 . . . . 74.04 108.97 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.0 t -97.59 120.94 47.58 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 CA-C-N 114.388 -1.278 . . . . 71.14 107.659 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.8 p -128.9 157.44 41.58 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 116.295 -0.411 . . . . 64.21 110.564 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 98.91 17.44 27.84 Favored Glycine 0 C--N 1.299 -1.525 0 O-C-N 123.675 0.609 . . . . 54.34 112.734 -178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.467 ' HB3' HG21 ' A' ' 42' ' ' ILE . 96.1 mt -78.72 125.65 83.9 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 106.9 -1.519 . . . . 74.32 106.9 173.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -58.63 154.57 41.88 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.244 1.296 . . . . 52.32 110.117 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.3 p -73.44 4.8 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 CA-C-O 122.33 1.062 . . . . 74.31 110.785 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.43 ' O ' ' HE2' ' A' ' 43' ' ' LYS . 18.3 t70 -110.34 13.29 22.95 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 114.574 -1.194 . . . . 60.33 109.155 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.467 HG21 ' HB3' ' A' ' 38' ' ' LEU 0.266 2.4 pp -58.09 141.43 15.08 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 N-CA-C 114.939 1.459 . . . . 74.43 114.939 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.435 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 61.1 mmtt -106.5 145.93 32.0 Favored Pre-proline 0 C--N 1.283 -2.313 0 CA-C-N 113.548 -1.66 . . . . 73.43 106.736 176.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.14 -25.93 65.38 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.223 1.949 . . . . 54.24 111.94 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.501 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 13.9 ptt180 -69.82 -24.73 63.51 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.574 -0.739 . . . . 70.04 111.521 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 40.6 mt-10 -69.99 -42.89 72.47 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 120.986 0.422 . . . . 75.43 110.28 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.01 -37.3 86.91 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.85 0.833 . . . . 63.45 109.099 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.572 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 23.2 t80 -60.88 -50.47 73.29 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.462 -1.245 . . . . 72.34 110.905 176.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 95.7 mt -64.16 -41.41 97.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.174 0.511 . . . . 64.11 110.065 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 tp -67.33 -41.96 84.4 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.741 -1.118 . . . . 74.15 111.52 -176.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -92.07 -1.32 57.27 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 115.194 1.553 . . . . 63.04 115.194 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.572 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 12.6 mtp180 -61.51 -45.97 94.11 Favored Pre-proline 0 N--CA 1.479 0.992 0 N-CA-C 113.794 1.035 . . . . 74.24 113.794 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.28 -16.28 43.66 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 121.166 1.244 . . . . 74.12 112.513 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -92.65 92.33 7.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.296 1.046 . . . . 64.33 110.203 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -73.35 113.92 10.98 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 113.753 -1.567 . . . . 74.04 109.544 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.98 -20.93 2.49 Favored Glycine 0 C--N 1.288 -2.123 0 CA-C-N 114.754 -1.112 . . . . 44.2 111.657 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -54.47 112.73 1.06 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.553 0.741 . . . . 75.3 111.969 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -94.26 -45.21 7.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.639 -0.71 . . . . 74.33 110.932 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.43 178.35 48.32 Favored Glycine 0 C--N 1.298 -1.563 0 C-N-CA 120.27 -0.967 . . . . 65.23 112.791 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.0 p -143.08 142.17 31.45 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 123.069 0.548 . . . . 45.11 111.297 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.426 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 5.4 mp -118.8 130.21 55.65 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.247 -1.39 . . . . 74.21 107.247 173.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.5 mm -109.26 131.92 58.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 118.043 0.383 . . . . 70.43 111.26 -173.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -120.13 106.83 12.34 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.479 -0.934 . . . . 73.41 108.479 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -63.21 126.24 26.75 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.802 -1.09 . . . . 60.21 109.517 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 14.8 m -130.1 153.98 47.93 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 105.565 -2.013 . . . . 72.42 105.565 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.41 -33.64 31.18 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.164 1.172 . . . . 64.44 114.164 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -104.19 -35.67 7.94 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 112.768 0.655 . . . . 75.11 112.768 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.532 ' O ' ' HB ' ' A' ' 65' ' ' THR . 5.4 pm0 -156.88 129.45 4.23 Favored Pre-proline 0 C--N 1.302 -1.477 0 C-N-CA 121.071 -0.251 . . . . 75.42 110.434 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 38' ' ' LEU . 29.0 Cg_exo -64.15 118.64 5.59 Favored 'Trans proline' 0 N--CA 1.441 -1.577 0 C-N-CA 122.305 2.003 . . . . 65.41 108.99 167.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.0 140.33 15.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.383 -0.969 . . . . 63.52 108.383 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 61' ' ' LEU . . . -122.33 122.22 4.98 Favored Glycine 0 C--N 1.289 -2.05 0 C-N-CA 119.775 -1.203 . . . . 64.52 112.699 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -87.89 103.16 15.4 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.429 -1.693 . . . . 75.3 106.429 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.44 132.19 47.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 CA-C-N 115.118 -0.947 . . . . 74.23 110.545 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 110' ' ' THR . 4.7 tt -107.68 129.69 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 CA-C-N 114.893 -1.049 . . . . 71.3 109.98 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.51 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 14.2 m-85 -108.76 158.33 17.73 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 114.897 -1.047 . . . . 73.25 109.22 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.97 -31.95 73.44 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.872 -0.604 . . . . 72.14 111.256 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.7 p -133.32 152.13 51.91 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 112.492 0.553 . . . . 45.14 112.492 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.633 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.89 -35.46 80.06 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 108.591 -0.892 . . . . 63.54 108.591 175.106 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.61 -19.52 62.11 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 122.556 1.169 . . . . 74.12 108.316 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.96 -45.64 8.93 Favored Glycine 0 C--N 1.294 -1.779 0 CA-C-N 113.937 -1.483 . . . . 70.42 110.153 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.29 -42.89 74.87 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.99 -0.605 . . . . 64.53 111.593 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.477 ' HA ' ' HG2' ' A' ' 85' ' ' LYS 0.27 1.4 pp20? -69.67 -30.24 67.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 112.937 0.717 . . . . 74.5 112.937 -177.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.62 -32.81 68.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.316 0.579 . . . . 32.41 109.992 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.87 -44.87 68.91 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.438 -0.801 . . . . 72.12 110.828 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 104' ' ' GLU . 14.1 ptmm? -68.88 -33.11 73.25 Favored 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 120.792 -0.363 . . . . 75.41 110.209 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -59.73 -41.77 91.66 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.403 0.681 . . . . 63.14 109.913 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.59 -33.39 18.9 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 112.196 0.443 . . . . 64.14 112.196 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.596 ' O ' HG22 ' A' ' 91' ' ' ILE . 97.1 mt -94.05 -13.25 27.1 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 115.934 1.827 . . . . 54.33 115.934 -172.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.313 0.2 OUTLIER -78.79 114.39 17.68 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 116.771 -1.972 . . . . 73.43 112.633 177.372 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.26 6.85 25.36 Favored Glycine 0 CA--C 1.492 -1.401 0 C-N-CA 120.746 -0.74 . . . . 74.51 112.335 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 88' ' ' LEU . 9.1 tt -91.96 130.39 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 N-CA-C 107.844 -1.169 . . . . 74.51 107.844 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.47 ' HG2' HG22 ' A' ' 100' ' ' THR . 98.6 mtt180 -74.9 130.25 39.07 Favored 'General case' 0 C--N 1.275 -2.631 0 C-N-CA 119.523 -0.871 . . . . 65.2 109.772 171.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -66.73 -30.04 70.16 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.336 -1.302 . . . . 73.54 108.284 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -141.58 124.9 9.78 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 104.556 -2.387 . . . . 74.45 104.556 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.472 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 43.1 Cg_endo -65.01 -27.17 58.04 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 122.197 1.931 . . . . 61.04 114.454 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -81.92 -24.79 35.42 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.422 -0.955 . . . . 63.31 108.422 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -84.12 129.45 58.42 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.852 -1.166 . . . . 64.53 107.852 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.08 -18.49 51.48 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.196 1.931 . . . . 73.4 112.275 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.425 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 6.1 tp60 -66.48 114.83 5.77 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.261 0.553 . . . . 62.2 110.485 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.481 ' OG1' ' HD2' ' A' ' 102' ' ' ARG . 32.8 p -98.23 161.78 13.53 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 115.678 -0.692 . . . . 74.02 109.772 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.5 tp -100.8 126.97 47.41 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.53 -1.285 . . . . 74.35 107.53 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.481 ' HD2' ' OG1' ' A' ' 100' ' ' THR . 0.1 OUTLIER -127.13 117.16 21.84 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.513 -0.921 . . . . 73.35 108.513 -176.809 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.15 123.84 49.86 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.814 -0.63 . . . . 64.33 110.101 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.5 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 9.1 tp10 -140.52 158.02 44.62 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.45 -1.315 . . . . 64.51 107.45 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -66.14 140.91 58.24 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 118.715 0.689 . . . . 71.42 112.847 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.71 158.46 24.21 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 108.375 -0.972 . . . . 71.54 108.375 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -82.35 -7.56 59.63 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.283 0.563 . . . . 74.12 110.472 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.0 136.41 28.43 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.958 -0.564 . . . . 44.02 110.905 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -81.88 124.41 29.68 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.779 -0.646 . . . . 73.52 109.631 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.411 ' O ' HD12 ' A' ' 74' ' ' ILE . 11.3 t . . . . . 0 N--CA 1.416 -2.163 0 N-CA-C 107.338 -1.356 . . . . 63.52 107.338 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' B' ' 78' ' ' ARG . 55.0 t . . . . . 0 CA--C 1.502 -0.897 0 N-CA-C 108.71 -0.848 . . . . 72.45 108.71 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -118.71 4.13 11.62 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.985 0.898 . . . . 73.51 110.325 -172.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' THR . . . . . 0.483 ' HB ' ' HA ' ' B' ' 109' ' ' ASN . 63.5 m -111.52 136.06 51.23 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.688 -1.142 . . . . 62.24 108.345 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.441 ' H ' HD23 ' B' ' 33' ' ' LEU . 2.1 pt? -131.53 154.37 48.87 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.443 -0.577 . . . . 61.04 109.443 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.563 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 30.6 p90 -101.97 118.1 36.2 Favored 'General case' 0 N--CA 1.416 -2.171 0 CA-C-O 122.04 0.924 . . . . 61.23 108.718 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 51.0 t -98.42 122.25 49.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 113.901 -1.5 . . . . 73.32 107.553 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 22.5 p -127.42 164.57 21.58 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.666 -0.697 . . . . 64.35 109.603 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 93.95 27.81 11.92 Favored Glycine 0 N--CA 1.424 -2.143 0 O-C-N 123.523 0.514 . . . . 71.51 111.896 -175.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.405 ' HB3' HG12 ' B' ' 42' ' ' ILE . 98.2 mt -96.55 117.78 65.77 Favored Pre-proline 0 C--N 1.292 -1.91 0 N-CA-C 108.629 -0.878 . . . . 73.42 108.629 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.76 151.74 14.56 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.882 2.388 . . . . 61.23 112.001 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.49 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 11.9 p -63.62 -6.69 2.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 123.876 0.87 . . . . 74.32 112.781 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -121.39 26.31 8.93 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.618 -0.676 . . . . 74.15 109.775 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.411 HD12 ' O ' ' B' ' 42' ' ' ILE . 2.5 pp -58.43 135.76 22.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 113.203 0.816 . . . . 73.24 113.203 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -102.31 143.34 26.41 Favored Pre-proline 0 C--N 1.278 -2.53 0 CA-C-N 114.718 -1.128 . . . . 64.54 109.187 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -51.87 -32.18 45.91 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.79 2.327 . . . . 61.43 112.666 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.524 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 10.7 ptt180 -68.44 -25.44 65.02 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 111.886 0.328 . . . . 64.44 111.886 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -70.5 -39.63 74.02 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.602 0.715 . . . . 71.44 109.365 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 77.7 mt -67.71 -34.71 77.41 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 115.007 -0.997 . . . . 72.54 108.637 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.623 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 51.0 t80 -62.49 -48.44 79.56 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.745 -1.116 . . . . 73.24 110.102 176.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 93.6 mt -66.22 -40.77 90.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.131 0.491 . . . . 64.32 110.294 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.3 tp -71.57 -43.42 66.36 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.278 -0.874 . . . . 73.44 112.048 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -100.07 8.24 44.09 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 113.301 0.852 . . . . 74.21 113.301 -174.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.623 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 28.5 ttt180 -70.54 -43.34 16.14 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-O 119.349 -0.358 . . . . 74.01 111.798 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -74.96 -12.73 21.61 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 121.532 1.488 . . . . 73.33 112.623 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -85.72 110.82 19.59 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.655 0.741 . . . . 75.14 111.668 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -74.55 112.59 10.89 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.489 -1.232 . . . . 74.33 111.304 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.13 -19.84 3.84 Favored Glycine 0 N--CA 1.429 -1.77 0 CA-C-N 115.018 -0.992 . . . . 62.01 112.97 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -56.64 112.6 1.33 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.209 0.528 . . . . 75.44 112.369 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -93.75 -55.03 3.4 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.751 -0.659 . . . . 72.3 110.756 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.29 170.71 43.72 Favored Glycine 0 C--N 1.296 -1.667 0 C-N-CA 120.309 -0.948 . . . . 51.44 112.304 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.417 ' HB3' HG22 ' B' ' 73' ' ' VAL . 12.6 p -132.3 137.12 47.34 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.388 0.514 . . . . 75.41 112.388 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.408 ' O ' ' HA2' ' B' ' 71' ' ' GLY . 54.8 mt -104.3 113.5 27.1 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.353 -0.98 . . . . 73.05 108.353 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 43.2 mm -94.38 127.02 46.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 109.208 -0.664 . . . . 62.22 109.208 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -120.2 114.7 22.31 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.517 -0.92 . . . . 71.21 108.517 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.37 123.23 19.06 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.866 -0.607 . . . . 55.42 109.638 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.1 m -128.04 150.44 49.94 Favored 'General case' 0 N--CA 1.402 -2.851 0 N-CA-C 103.923 -2.621 . . . . 74.02 103.923 174.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.09 -40.16 4.71 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.5 1.296 . . . . 73.43 114.5 -173.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -100.61 -18.52 16.54 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 112.373 0.509 . . . . 74.13 112.373 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 24.4 pt20 -169.05 127.32 0.88 Allowed Pre-proline 0 C--N 1.308 -1.234 0 C-N-CA 120.878 -0.329 . . . . 73.15 111.628 -169.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 10.5 Cg_exo -73.33 101.21 1.32 Allowed 'Trans proline' 0 N--CA 1.437 -1.798 0 C-N-CA 122.363 2.042 . . . . 75.53 107.99 167.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.97 150.36 4.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.022 -0.536 . . . . 64.04 109.712 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' B' ' 61' ' ' LEU . . . -123.23 120.65 4.29 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 118.402 -1.856 . . . . 74.41 112.959 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -88.11 102.52 14.86 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.192 -1.781 . . . . 74.12 106.192 175.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' B' ' 60' ' ' SER . 60.1 t -99.86 130.21 49.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-N 114.677 -1.147 . . . . 75.13 110.863 -172.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.502 HD12 ' O ' ' B' ' 110' ' ' THR . 3.7 tt -104.05 127.61 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 0 CA-C-N 115.204 -0.907 . . . . 70.01 109.613 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' B' ' 81' ' ' ALA . 8.9 m-85 -105.33 154.13 20.69 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.43 -1.322 . . . . 73.24 107.43 171.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -65.19 -37.04 86.08 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.64 -0.504 . . . . 70.54 109.64 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 4.2 p -114.86 133.21 56.15 Favored 'General case' 0 N--CA 1.386 -3.673 0 CA-C-O 121.722 0.772 . . . . 75.21 111.304 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' B' ' 30' ' ' VAL . 0.0 OUTLIER -75.65 -24.46 56.39 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 115.241 -0.891 . . . . 72.14 110.785 177.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.12 -19.82 39.32 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.906 -1.516 . . . . 63.04 106.906 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.08 -43.43 10.8 Favored Glycine 0 C--N 1.299 -1.507 0 CA-C-N 113.277 -1.783 . . . . 62.34 109.637 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' B' ' 75' ' ' PHE . . . -62.41 -35.13 78.26 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.52 -0.84 . . . . 53.44 110.977 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 1.4 pp20? -69.42 -38.28 77.83 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.29 -0.964 . . . . 73.52 110.405 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.52 78.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.091 0.472 . . . . 74.14 110.4 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.03 -44.46 72.65 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.824 -0.625 . . . . 24.31 111.402 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' B' ' 82' ' ' GLU . 13.2 ptmm? -68.45 -34.71 76.44 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.787 -0.365 . . . . 74.3 110.475 -177.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -62.51 -28.85 70.13 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.063 -0.517 . . . . 73.02 110.91 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.75 -41.3 13.41 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 112.305 0.483 . . . . 63.3 112.305 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.548 ' O ' HG22 ' B' ' 91' ' ' ILE . 97.5 mt -98.62 -8.17 26.79 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 116.192 1.923 . . . . 74.34 116.192 -169.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.99 116.11 9.98 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 119.504 1.047 . . . . 72.43 113.208 177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.87 7.07 48.31 Favored Glycine 0 CA--C 1.482 -1.994 0 C-N-CA 120.843 -0.694 . . . . 75.13 113.068 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.548 HG22 ' O ' ' B' ' 88' ' ' LEU . 14.4 tt -101.58 137.24 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.929 0 N-CA-C 108.168 -1.049 . . . . 74.32 108.168 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -68.78 132.82 47.43 Favored 'General case' 0 C--N 1.266 -3.036 0 CA-C-O 121.776 0.798 . . . . 71.04 112.161 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -73.42 -28.35 61.94 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.672 -1.604 . . . . 73.23 107.848 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.446 ' OD2' ' HB3' ' A' ' 45' ' ' ARG . 9.4 t0 -146.14 114.73 4.59 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 105.417 -2.068 . . . . 62.23 105.417 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 95' ' ' PRO . . . . . 0.516 ' HD3' ' CZ ' ' A' ' 48' ' ' TYR . 56.7 Cg_endo -68.74 -19.06 41.83 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.328 2.019 . . . . 62.23 113.961 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -83.14 -24.69 32.44 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.794 -0.817 . . . . 74.1 108.794 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -95.54 143.35 25.96 Favored Pre-proline 0 C--N 1.309 -1.174 0 N-CA-C 108.57 -0.9 . . . . 71.14 108.57 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.11 -3.47 13.84 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 122.068 1.845 . . . . 71.42 114.224 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -75.87 120.65 21.51 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.992 0.425 . . . . 73.45 110.893 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.544 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 82.4 p -99.44 154.88 17.87 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 109.202 -0.666 . . . . 73.33 109.202 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 28.8 tp -94.78 127.92 41.12 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.686 -1.227 . . . . 71.54 107.686 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -125.63 130.28 51.31 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.567 -1.271 . . . . 74.41 107.567 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -123.61 116.31 22.9 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 123.366 0.416 . . . . 75.31 110.317 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.563 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 5.0 tp10 -134.37 156.64 48.15 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.918 -1.512 . . . . 73.21 106.918 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -66.8 143.43 56.9 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.35 0.977 . . . . 73.11 111.879 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.86 157.36 24.42 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.896 -0.593 . . . . 61.54 109.903 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -85.65 7.82 21.89 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.626 0.727 . . . . 71.12 110.712 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.64 138.88 11.13 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.348 -0.982 . . . . 51.42 108.348 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.483 ' HA ' ' HB ' ' B' ' 32' ' ' THR . 94.3 m-20 -82.88 158.56 22.63 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-O 121.228 0.537 . . . . 63.42 109.928 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.502 ' O ' HD12 ' B' ' 74' ' ' ILE . 14.2 t . . . . . 0 C--N 1.285 -2.216 0 N-CA-C 106.939 -1.504 . . . . 75.43 106.939 174.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.663 ' HA ' HD21 ' A' ' 109' ' ' ASN . 98.6 t . . . . . 0 N--CA 1.431 -1.388 0 N-CA-C 105.745 -1.946 . . . . 73.55 105.745 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 13.7 ptm180 -127.57 15.89 7.04 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.004 -1.453 . . . . 72.42 110.497 -167.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.4 m -124.7 124.63 42.59 Favored 'General case' 0 C--N 1.272 -2.784 0 C-N-CA 119.467 -0.893 . . . . 73.15 110.666 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.2 mt -107.16 141.17 38.86 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.352 -0.981 . . . . 63.11 108.352 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.463 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 16.7 p90 -102.73 115.8 31.31 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 107.088 -1.449 . . . . 64.13 107.088 173.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.416 HG22 ' HG ' ' A' ' 103' ' ' LEU . 35.4 t -97.65 120.03 46.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 CA-C-N 114.23 -1.35 . . . . 75.1 108.418 -177.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.9 p -123.8 165.76 16.75 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 116.246 -0.433 . . . . 75.35 110.008 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.14 11.96 44.05 Favored Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 111.065 -0.814 . . . . 63.11 111.065 -173.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.6 mt -83.07 130.23 58.11 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 107.608 -1.256 . . . . 74.5 107.608 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.12 161.43 10.98 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.099 1.866 . . . . 71.32 111.204 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.407 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 7.5 p -62.53 -15.69 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.681 0.753 . . . . 73.1 110.79 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -121.56 35.69 4.82 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.04 -0.982 . . . . 55.15 109.231 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.594 HG22 ' HG2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -66.43 131.2 32.22 Favored 'Isoleucine or valine' 0 C--O 1.256 1.44 0 N-CA-C 108.422 -0.955 . . . . 73.22 108.422 175.293 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -99.25 143.94 27.33 Favored Pre-proline 0 C--N 1.291 -1.957 0 CA-C-N 115.111 -0.949 . . . . 72.21 111.627 -177.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.53 -26.53 37.01 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.634 2.889 . . . . 71.32 114.194 -176.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.54 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -86.5 -10.52 53.94 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 117.159 -1.816 . . . . 71.03 112.109 -177.66 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' HG2' ' HG2' ' B' ' 46' ' ' GLU . 35.6 mt-10 -67.42 -40.21 85.52 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.005 -0.739 . . . . 75.32 109.005 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.38 -27.27 65.17 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.588 -0.733 . . . . 74.01 110.123 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.54 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 46.9 t80 -65.3 -47.59 76.08 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.371 -0.831 . . . . 70.45 109.823 176.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.44 -40.37 81.16 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.365 -0.605 . . . . 71.35 109.365 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.456 HD13 HD22 ' B' ' 49' ' ' LEU . 32.3 tp -64.34 -47.61 78.67 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.819 -1.082 . . . . 74.33 112.164 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -98.91 0.94 45.14 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 114.609 1.337 . . . . 72.14 114.609 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.1 ttt85 -63.63 -44.2 79.94 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 112.829 0.677 . . . . 74.44 112.829 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.77 -6.97 20.3 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 121.28 1.32 . . . . 72.45 112.713 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -96.59 90.02 5.19 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.516 0.674 . . . . 74.02 110.698 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -67.65 109.59 3.36 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.969 0.89 . . . . 71.21 109.882 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.1 -27.01 1.42 Allowed Glycine 0 C--N 1.285 -2.267 0 CA-C-N 114.406 -1.27 . . . . 60.52 110.155 -173.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -54.91 127.31 28.13 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.139 0.576 . . . . 74.43 111.934 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -105.92 -53.89 2.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.175 0.512 . . . . 71.11 110.568 174.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.64 178.12 41.17 Favored Glycine 0 C--N 1.294 -1.793 0 CA-C-N 115.492 -0.776 . . . . 71.21 111.822 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.4 p -146.72 137.69 24.07 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.64 0.22 . . . . 74.44 111.054 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.0 mt -115.98 134.64 54.76 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.458 0.703 . . . . 74.32 109.128 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.9 mm -95.0 144.71 9.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 110.15 -0.315 . . . . 64.54 110.15 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -136.97 118.88 15.23 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.833 -0.432 . . . . 75.43 109.833 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.29 110.59 6.02 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.349 0.595 . . . . 75.42 111.022 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.3 m -99.44 162.76 12.84 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 105.578 -2.008 . . . . 72.42 105.578 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -43.91 -37.87 3.09 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 114.037 1.125 . . . . 74.44 114.037 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -103.87 -26.72 12.57 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.211 1.189 . . . . 64.23 114.211 -177.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -166.79 153.38 8.18 Favored Pre-proline 0 C--N 1.307 -1.261 0 C-N-CA 120.783 -0.367 . . . . 71.42 110.346 -168.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.594 ' HG2' HG22 ' A' ' 42' ' ' ILE . 56.9 Cg_endo -76.66 118.89 4.98 Favored 'Trans proline' 0 N--CA 1.438 -1.766 0 C-N-CA 122.459 2.106 . . . . 74.33 110.949 172.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 m -93.93 162.17 2.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.837 -1.171 . . . . 65.43 107.837 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.41 121.59 3.54 Favored Glycine 0 C--N 1.297 -1.633 0 C-N-CA 118.934 -1.603 . . . . 72.53 113.332 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -87.8 105.53 17.46 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.414 -1.328 . . . . 65.13 107.414 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.68 127.43 52.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 115.053 -0.976 . . . . 62.22 110.164 -176.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 tt -99.79 130.06 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 CA-C-O 121.704 0.764 . . . . 64.02 110.219 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.598 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 82.0 m-85 -112.01 152.8 27.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 114.228 -1.351 . . . . 74.45 109.172 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.477 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 35.0 t70 -68.02 -30.1 69.26 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 114.839 -1.073 . . . . 53.54 112.712 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.4 m -131.95 150.09 52.25 Favored 'General case' 0 N--CA 1.417 -2.1 0 O-C-N 121.776 -0.577 . . . . 73.21 109.961 -174.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.635 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -80.38 -27.87 38.07 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.499 -0.926 . . . . 74.14 108.499 178.322 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.44 -19.46 60.39 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 114.377 -1.283 . . . . 72.35 107.591 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.41 -42.13 7.09 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 113.393 -1.73 . . . . 34.4 110.095 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.04 -43.41 98.89 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.135 0.574 . . . . 74.03 111.599 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.0 -38.26 90.48 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 121.027 -0.269 . . . . 74.44 111.706 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.08 -38.53 72.44 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 120.701 0.286 . . . . 74.34 110.478 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.58 90.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.568 -0.742 . . . . 44.32 111.202 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -67.08 -37.78 84.59 Favored 'General case' 0 C--O 1.206 -1.237 0 C-N-CA 120.378 -0.529 . . . . 55.31 111.262 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -72.91 -17.08 61.54 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 120.853 0.359 . . . . 71.21 111.753 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.57 -45.93 11.29 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 116.364 -0.38 . . . . 71.24 110.76 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.476 ' O ' HG22 ' A' ' 91' ' ' ILE . 92.7 mt -98.38 -9.05 25.86 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 115.291 1.589 . . . . 72.04 115.291 -172.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.55 126.34 30.61 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.075 -1.016 . . . . 74.43 110.657 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.19 3.37 54.22 Favored Glycine 0 CA--C 1.475 -2.445 0 C-N-CA 120.599 -0.81 . . . . 60.24 112.5 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 88' ' ' LEU . 16.1 tt -111.18 144.45 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.343 0 N-CA-C 107.058 -1.46 . . . . 75.52 107.058 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -70.21 135.41 49.02 Favored 'General case' 0 C--N 1.272 -2.786 0 CA-C-O 121.557 0.694 . . . . 73.11 112.394 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -74.06 -28.54 61.46 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 113.677 -1.601 . . . . 61.11 109.069 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -144.36 120.26 6.19 Favored Pre-proline 0 C--N 1.314 -0.973 0 N-CA-C 105.906 -1.887 . . . . 64.44 105.906 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.511 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 57.6 Cg_endo -67.33 -21.63 47.21 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.522 2.148 . . . . 73.15 114.241 -176.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -82.61 -26.11 32.58 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.5 0.667 . . . . 64.24 109.255 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -90.27 134.08 32.02 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 108.012 -1.106 . . . . 60.04 108.012 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -70.18 -9.26 25.56 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 122.351 2.034 . . . . 71.23 112.181 176.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -68.96 125.69 27.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.559 -0.746 . . . . 60.12 110.061 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 39.5 p -102.63 156.35 17.68 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 116.496 -0.32 . . . . 72.04 110.207 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.4 tp -95.54 126.11 40.6 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.798 -0.815 . . . . 74.22 108.798 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -120.66 127.04 51.7 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.205 -1.035 . . . . 75.1 108.205 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.416 ' HG ' HG22 ' A' ' 35' ' ' VAL . 7.3 mp -116.37 116.54 27.9 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 123.51 0.506 . . . . 73.11 109.683 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 39.1 tt0 -128.52 162.88 26.19 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.782 -1.192 . . . . 62.23 107.782 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -71.36 145.36 49.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 118.728 0.694 . . . . 73.44 109.23 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.58 157.89 34.65 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.694 -0.854 . . . . 52.54 108.694 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 13.1 tmtt? -80.24 -9.85 59.74 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.092 0.948 . . . . 75.43 108.6 -176.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -157.14 126.13 5.88 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.184 -1.371 . . . . 54.04 107.567 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.663 HD21 ' HA ' ' A' ' 30' ' ' VAL . 91.5 m-20 -72.26 141.15 48.93 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.241 -0.436 . . . . 74.03 110.243 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.1 t . . . . . 0 C--N 1.295 -1.787 0 C-N-CA 120.367 -0.533 . . . . 74.44 109.979 -178.659 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.429 ' HA ' HD21 ' B' ' 109' ' ' ASN . 68.3 t . . . . . 0 N--CA 1.42 -1.973 0 N-CA-C 104.766 -2.309 . . . . 23.24 104.766 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -116.18 10.68 14.98 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.636 -0.711 . . . . 73.12 110.743 -171.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 57.9 m -120.46 129.8 54.02 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-O 121.5 0.667 . . . . 60.35 110.657 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.432 ' N ' HD12 ' B' ' 33' ' ' LEU . 2.4 mp -112.34 143.25 43.76 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.611 -1.255 . . . . 75.25 107.611 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.545 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 26.3 p90 -101.3 116.85 33.74 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 107.437 -1.32 . . . . 73.41 107.437 172.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.444 HG22 ' HG ' ' B' ' 103' ' ' LEU . 41.2 t -98.81 114.98 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.329 0 CA-C-N 114.21 -1.359 . . . . 73.11 107.468 -177.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.8 p -124.53 154.18 40.97 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 116.285 -0.416 . . . . 73.23 110.295 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.51 4.29 32.51 Favored Glycine 0 N--CA 1.431 -1.685 0 O-C-N 123.561 0.538 . . . . 42.32 111.969 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 86.3 mt -71.66 132.58 85.21 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 107.372 -1.344 . . . . 74.12 107.372 175.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' PRO . . . . . 0.403 ' C ' ' H ' ' B' ' 41' ' ' ASP . 37.4 Cg_endo -65.99 160.89 42.16 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.62 1.546 . . . . 54.54 111.677 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.467 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 9.4 p -69.91 4.99 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.6 0 CA-C-O 122.148 0.975 . . . . 54.03 111.274 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' B' ' 39' ' ' PRO . 27.9 t70 -125.51 19.01 8.1 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.616 1.166 . . . . 72.04 109.19 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.12 127.5 20.87 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 CA-C-O 121.843 0.83 . . . . 62.52 111.086 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.462 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 70.1 mmtt -98.71 137.35 20.58 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.07 -0.968 . . . . 75.34 108.936 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -53.74 -32.48 65.93 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.857 2.372 . . . . 73.34 113.236 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.575 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 0.0 OUTLIER -73.15 -15.8 61.46 Favored 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 119.374 -0.931 . . . . 74.34 112.324 -179.157 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.462 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 47.6 mt-10 -69.55 -36.06 75.98 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.893 -0.504 . . . . 75.11 110.23 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.88 -26.38 64.16 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 121.732 0.777 . . . . 73.5 108.919 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.511 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 58.3 t80 -73.33 -34.91 65.93 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.911 -1.041 . . . . 75.2 110.215 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 67.1 mt -78.48 -41.51 32.39 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.271 -0.64 . . . . 73.01 109.271 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.6 tp -66.09 -46.52 77.35 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.21 -0.904 . . . . 62.11 111.482 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -95.03 14.92 20.28 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 112.221 0.452 . . . . 75.32 112.221 -176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.486 ' HA ' ' CZ ' ' B' ' 52' ' ' ARG . 0.8 OUTLIER -59.46 -52.12 76.44 Favored Pre-proline 0 CA--C 1.56 1.349 0 CA-C-N 115.864 -0.607 . . . . 63.44 111.743 178.466 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.3 -1.48 11.12 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 121.607 1.538 . . . . 61.41 112.728 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -89.54 91.6 8.76 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 122.024 0.916 . . . . 74.53 110.673 -177.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -75.4 109.85 9.28 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.21 -1.359 . . . . 74.1 108.785 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.65 -14.04 4.19 Favored Glycine 0 C--N 1.293 -1.813 0 CA-C-N 115.058 -0.974 . . . . 64.1 111.753 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -59.93 109.89 1.05 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.191 0.52 . . . . 74.51 110.527 175.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -86.09 -49.35 7.85 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.737 -0.665 . . . . 54.03 110.435 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.11 -175.69 45.46 Favored Glycine 0 C--N 1.294 -1.797 0 C-N-CA 120.13 -1.033 . . . . 23.51 112.175 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 21.5 p -148.17 143.27 26.96 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 122.377 0.271 . . . . 60.24 111.335 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 85.3 mt -116.83 127.21 54.08 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.474 -0.936 . . . . 74.04 108.474 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 47.4 mm -94.56 136.46 25.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.198 -0.667 . . . . 53.01 109.198 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -127.58 115.4 18.75 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.016 -0.735 . . . . 74.13 109.016 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.21 109.46 5.26 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.235 -0.654 . . . . 62.22 109.235 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 19.6 m -100.6 156.23 17.42 Favored 'General case' 0 N--CA 1.407 -2.611 0 N-CA-C 104.458 -2.423 . . . . 71.32 104.458 175.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.41 -37.58 17.38 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 113.65 0.981 . . . . 62.32 113.65 -173.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -102.78 -16.54 15.93 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.191 1.182 . . . . 63.43 114.191 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.532 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 4.4 pt20 -173.77 142.45 0.92 Allowed Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 118.167 0.44 . . . . 63.24 111.731 -174.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.467 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 14.9 Cg_exo -68.77 115.19 3.82 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 123.05 2.5 . . . . 74.02 111.096 170.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -92.55 167.35 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.038 -1.097 . . . . 70.34 108.038 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.62 122.68 2.43 Favored Glycine 0 C--O 1.207 -1.585 0 C-N-CA 118.87 -1.633 . . . . 54.51 113.621 -176.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -88.11 107.73 18.9 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.636 -1.246 . . . . 72.51 107.636 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 90.2 t -101.17 129.16 52.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 115.185 -0.916 . . . . 73.12 110.978 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.49 HD12 ' O ' ' B' ' 110' ' ' THR . 3.4 tt -101.85 134.33 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 115.253 -0.885 . . . . 62.21 110.351 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -113.57 158.35 20.89 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.97 -1.014 . . . . 64.24 110.738 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.1 -34.66 78.08 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.823 -1.535 . . . . 74.34 112.4 175.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 46.4 m -135.75 152.14 50.83 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 120.757 -0.377 . . . . 70.02 110.736 -173.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' ARG . . . . . 0.567 ' H ' ' HD3' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -80.08 -26.6 39.52 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.393 0.616 . . . . 63.31 109.343 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.05 -21.14 51.11 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 107.726 -1.212 . . . . 52.24 107.726 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.47 -39.58 14.67 Favored Glycine 0 C--N 1.31 -0.884 0 N-CA-C 109.276 -1.529 . . . . 32.01 109.276 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.02 -42.61 97.06 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.322 -0.939 . . . . 62.33 111.501 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.84 -37.64 88.29 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.782 0.325 . . . . 61.24 111.556 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.15 -37.21 69.43 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.054 0.454 . . . . 70.14 110.336 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.84 -42.96 80.62 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.497 -0.774 . . . . 62.05 111.027 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.43 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 14.9 ptmm? -68.2 -37.1 80.54 Favored 'General case' 0 C--O 1.206 -1.189 0 C-N-CA 120.585 -0.446 . . . . 73.02 110.744 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -66.68 -29.53 69.55 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 120.863 0.363 . . . . 62.0 111.427 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.34 -44.42 25.21 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 116.166 -0.47 . . . . 70.31 111.252 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.581 ' O ' HG22 ' B' ' 91' ' ' ILE . 99.3 mt -94.75 -11.96 28.05 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 115.356 1.613 . . . . 72.4 115.356 -173.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -76.2 115.64 16.12 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 118.257 -1.377 . . . . 71.22 109.825 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.99 11.56 24.07 Favored Glycine 0 CA--C 1.482 -2.01 0 C-N-CA 120.463 -0.875 . . . . 74.33 111.767 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.581 HG22 ' O ' ' B' ' 88' ' ' LEU . 14.4 tt -99.66 140.54 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.624 0 N-CA-C 107.665 -1.235 . . . . 54.51 107.665 175.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.44 ' CG ' HG22 ' B' ' 100' ' ' THR . 79.3 mtt180 -81.75 128.67 34.23 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-O 120.985 0.421 . . . . 74.22 110.175 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.74 -34.39 77.77 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.55 -1.205 . . . . 75.11 110.063 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -144.5 126.1 7.98 Favored Pre-proline 0 C--N 1.312 -1.047 0 N-CA-C 106.405 -1.702 . . . . 70.24 106.405 174.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 95' ' ' PRO . . . . . 0.457 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 60.4 Cg_endo -69.84 -0.41 6.93 Favored 'Trans proline' 0 N--CA 1.486 1.031 0 C-N-CA 123.266 2.644 . . . . 74.51 114.386 -173.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -91.75 -25.65 18.95 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.54 0.686 . . . . 73.41 109.542 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -91.81 139.16 24.68 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 108.144 -1.058 . . . . 74.4 108.144 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -69.6 -20.78 35.16 Favored 'Trans proline' 0 C--O 1.247 0.932 0 C-N-CA 121.763 1.642 . . . . 60.13 111.014 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -55.57 131.17 45.61 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.502 1.121 . . . . 62.43 110.621 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.44 HG22 ' CG ' ' B' ' 92' ' ' ARG . 75.2 p -112.76 160.03 18.36 Favored 'General case' 0 N--CA 1.418 -2.061 0 C-N-CA 120.177 -0.609 . . . . 72.4 109.78 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 20.2 tp -96.8 121.23 38.43 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.261 -1.014 . . . . 54.51 108.261 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -112.51 123.13 49.61 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.242 -1.022 . . . . 74.43 108.242 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.444 ' HG ' HG22 ' B' ' 35' ' ' VAL . 7.1 mp -110.5 115.7 30.1 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 109.381 -0.6 . . . . 74.22 109.381 172.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.545 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 34.2 tt0 -129.87 157.58 41.86 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.321 -1.362 . . . . 74.33 107.321 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 105' ' ' PHE . . . . . 0.417 ' HB3' HG11 ' B' ' 30' ' ' VAL . 25.6 m-85 -66.7 138.46 57.42 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 118.602 0.637 . . . . 75.54 110.693 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.36 152.26 30.52 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 108.902 -0.777 . . . . 74.13 108.902 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' B' ' 107' ' ' LYS . 14.4 tmtt? -78.49 -6.93 56.79 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.4 -0.818 . . . . 54.24 110.053 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.18 132.87 21.0 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.127 -0.942 . . . . 73.22 108.824 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.429 HD21 ' HA ' ' B' ' 30' ' ' VAL . 91.2 m-20 -87.13 143.09 27.46 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.326 -0.397 . . . . 72.35 110.249 177.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.49 ' O ' HD12 ' B' ' 74' ' ' ILE . 12.8 t . . . . . 0 N--CA 1.416 -2.132 0 N-CA-C 107.572 -1.27 . . . . 71.54 107.572 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.4 t . . . . . 0 N--CA 1.431 -1.381 0 CA-C-O 122.252 1.025 . . . . 72.1 109.636 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -102.52 13.45 34.5 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.194 -1.366 . . . . 73.3 111.244 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 109' ' ' ASN . 23.8 m -139.02 132.51 30.29 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.917 -0.713 . . . . 70.52 111.576 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.7 mt -110.73 145.88 37.27 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.341 -0.985 . . . . 73.24 108.341 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -101.65 111.2 23.37 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 107.29 -1.374 . . . . 62.52 107.29 173.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.45 HG22 ' HG ' ' A' ' 103' ' ' LEU . 47.2 t -97.44 120.92 47.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.178 -1.374 . . . . 73.04 108.013 -177.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 p -126.98 168.64 14.27 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 115.335 -0.848 . . . . 72.42 109.217 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 88.58 39.64 6.62 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 111.085 -0.806 . . . . 71.02 111.085 -177.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 99.6 mt -105.37 137.97 19.42 Favored Pre-proline 0 N--CA 1.418 -2.041 0 N-CA-C 108.325 -0.991 . . . . 73.51 108.325 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -56.76 159.43 14.16 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.941 1.761 . . . . 75.44 109.183 171.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.574 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 8.9 p -80.86 -0.75 4.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 122.435 1.112 . . . . 64.31 110.677 -168.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -117.42 16.25 14.71 Favored 'General case' 0 N--CA 1.413 -2.276 0 CA-C-N 114.552 -1.204 . . . . 72.14 110.809 -172.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.482 HG13 ' HG2' ' A' ' 69' ' ' PRO 0.272 2.7 pp -55.82 136.38 18.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 114.47 1.285 . . . . 71.13 114.47 -177.73 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.546 ' HD3' ' CD ' ' A' ' 46' ' ' GLU . 6.6 mptt -103.1 149.8 37.24 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 106.689 -1.597 . . . . 74.32 106.689 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.19 -28.68 88.41 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.361 2.04 . . . . 73.35 112.0 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.662 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 20.3 ptt180 -68.16 -30.38 69.49 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 116.165 -0.47 . . . . 75.12 111.712 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.546 ' CD ' ' HD3' ' A' ' 43' ' ' LYS . 46.5 mt-10 -69.0 -42.41 76.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.022 0.439 . . . . 74.52 110.185 -175.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.56 -43.11 94.94 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.508 -0.923 . . . . 72.22 108.508 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.544 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 37.4 t80 -57.79 -45.1 86.54 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.414 -1.266 . . . . 72.31 111.626 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 88.4 mt -64.73 -40.46 95.36 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.366 0.603 . . . . 65.41 110.305 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 tp -70.08 -43.67 70.65 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.897 -1.047 . . . . 74.34 111.106 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -84.99 6.82 23.58 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 114.065 1.135 . . . . 64.43 114.065 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.491 ' NE ' ' HA ' ' A' ' 52' ' ' ARG . 3.2 mmp_? -50.59 -52.23 57.84 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 113.482 0.919 . . . . 74.24 113.482 177.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.38 -1.36 9.71 Favored 'Trans proline' 0 C--N 1.365 1.436 0 C-N-CA 121.795 1.663 . . . . 72.21 113.248 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -89.5 107.82 19.29 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 122.1 0.953 . . . . 71.13 112.38 -175.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -76.78 112.16 13.07 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 113.852 -1.522 . . . . 75.31 111.054 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 75' ' ' PHE . . . 142.4 -32.04 1.99 Allowed Glycine 0 N--CA 1.424 -2.147 0 CA-C-N 114.653 -1.158 . . . . 73.23 111.19 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.05 118.25 4.49 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.667 0.787 . . . . 74.35 112.705 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -108.1 -35.71 6.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.272 0.558 . . . . 61.33 110.652 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.56 -178.38 48.37 Favored Glycine 0 C--N 1.306 -1.084 0 C-N-CA 120.154 -1.022 . . . . 75.23 112.441 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.6 p -144.29 137.56 27.31 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.613 0.206 . . . . 70.43 111.43 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -107.83 114.32 28.19 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 107.725 -1.213 . . . . 73.35 107.725 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.53 136.59 26.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 110.334 -0.247 . . . . 74.32 110.334 -175.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 69' ' ' PRO . 63.4 tttp -124.99 106.94 10.33 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 109.353 -0.61 . . . . 62.34 109.353 176.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.87 109.17 7.16 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.707 -0.849 . . . . 72.45 108.707 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.4 m -104.97 164.11 12.03 Favored 'General case' 0 N--CA 1.41 -2.455 0 N-CA-C 105.373 -2.084 . . . . 65.2 105.373 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.02 -33.76 62.9 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.704 0.683 . . . . 70.11 111.903 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.494 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 1.5 tpm_? -82.18 -52.28 7.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 112.201 0.445 . . . . 71.23 112.201 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -160.22 152.55 17.28 Favored Pre-proline 0 C--N 1.289 -2.033 0 CA-C-N 115.878 -0.601 . . . . 63.32 109.853 -171.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.574 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 58.3 Cg_endo -80.16 108.73 2.24 Favored 'Trans proline' 0 N--CA 1.431 -2.187 0 C-N-CA 122.546 2.164 . . . . 72.43 110.051 168.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.5 m -83.04 160.33 3.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.109 -1.071 . . . . 64.44 108.109 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.41 120.71 2.25 Favored Glycine 0 CA--C 1.474 -2.504 0 C-N-CA 118.042 -2.028 . . . . 55.24 112.747 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -88.37 102.52 14.95 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 106.622 -1.622 . . . . 75.21 106.622 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.07 127.28 47.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-N 115.429 -0.805 . . . . 74.21 109.948 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.9 pt -98.0 135.24 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.301 0 CA-C-N 115.155 -0.929 . . . . 75.13 110.722 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 87.9 m-85 -121.98 149.53 43.33 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.341 -1.3 . . . . 72.51 108.559 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -52.64 -44.23 65.97 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 124.486 1.116 . . . . 74.35 111.585 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.1 m -145.34 158.09 43.9 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.72 -0.673 . . . . 74.33 110.235 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.456 ' N ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.24 -26.68 67.48 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.857 -0.61 . . . . 72.52 109.872 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.02 -28.05 69.54 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.366 -0.834 . . . . 62.54 110.15 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.01 -37.07 8.58 Favored Glycine 0 C--N 1.311 -0.812 0 N-CA-C 109.774 -1.33 . . . . 23.21 109.774 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.67 -44.45 93.73 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.491 -0.854 . . . . 72.25 111.728 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.4 -35.98 82.2 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.862 0.363 . . . . 61.33 111.832 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.35 -42.04 69.01 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.027 0.441 . . . . 65.42 110.052 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.62 95.76 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.666 -0.697 . . . . 71.43 111.258 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.421 ' CE ' ' HA ' ' A' ' 104' ' ' GLU . 14.8 ptmm? -70.56 -33.57 71.27 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 120.538 -0.465 . . . . 64.01 110.657 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -69.48 -36.49 76.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.887 0.375 . . . . 74.14 110.839 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.85 -41.93 42.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.07 0.462 . . . . 40.43 111.859 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 91' ' ' ILE . 85.8 mt -93.95 -9.75 36.0 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 115.085 1.513 . . . . 73.23 115.085 -172.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -74.95 118.39 17.86 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 117.898 -1.521 . . . . 72.04 108.828 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.23 12.56 48.48 Favored Glycine 0 N--CA 1.424 -2.152 0 CA-C-N 115.468 -0.787 . . . . 40.23 111.794 176.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.7 tt -100.84 134.46 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.965 0 N-CA-C 108.185 -1.042 . . . . 71.32 108.185 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.542 ' HG2' HG22 ' A' ' 100' ' ' THR . 82.7 mtt180 -79.41 142.31 36.07 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 115.445 -0.798 . . . . 71.33 112.448 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -75.88 -28.89 58.29 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.548 -1.66 . . . . 74.21 108.394 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.597 ' OD2' ' HB3' ' B' ' 45' ' ' ARG . 6.2 m-20 -138.22 127.76 14.83 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 104.138 -2.542 . . . . 71.03 104.138 173.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.61 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 18.0 Cg_endo -58.92 -26.73 82.26 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.093 1.862 . . . . 73.45 112.444 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -90.76 -5.14 56.08 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.461 -0.79 . . . . 72.41 111.82 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.464 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 52.7 t-20 -104.17 125.96 32.95 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 108.171 -1.048 . . . . 73.31 108.171 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -64.53 -7.07 13.36 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 123.15 2.567 . . . . 62.5 113.349 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -77.44 115.32 17.11 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.691 -0.855 . . . . 65.1 108.691 176.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.542 HG22 ' HG2' ' A' ' 92' ' ' ARG . 27.7 p -116.12 153.05 32.46 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.158 -1.053 . . . . 71.23 108.158 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.6 mp -82.85 140.52 32.87 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 118.417 0.553 . . . . 71.55 111.102 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.6 108.81 10.19 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.659 -1.608 . . . . 75.34 106.659 176.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.45 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.8 mp -102.61 123.26 46.01 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.951 -0.568 . . . . 60.45 111.818 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.421 ' HA ' ' CE ' ' A' ' 85' ' ' LYS . 17.2 mm-40 -132.34 164.32 26.72 Favored 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 123.435 0.694 . . . . 75.34 109.807 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -73.68 143.32 46.27 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.468 -0.567 . . . . 64.11 109.468 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.46 157.07 37.53 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.146 -1.057 . . . . 75.24 108.146 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -72.73 -13.32 61.31 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.383 1.087 . . . . 71.55 110.503 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.81 127.01 3.98 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 105.985 -1.857 . . . . 55.33 105.985 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.476 ' HA ' ' HB ' ' A' ' 32' ' ' THR . 7.1 p30 -79.19 144.42 34.44 Favored 'General case' 0 CA--C 1.47 -2.104 0 C-N-CA 118.517 -1.273 . . . . 63.42 108.918 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.395 -3.213 0 C-N-CA 118.544 -1.262 . . . . 74.53 112.548 -173.234 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--O 1.214 -0.81 0 CA-C-O 121.348 0.594 . . . . 63.11 110.991 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.697 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 72.2 mtt180 -95.44 -2.59 48.51 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.287 -0.87 . . . . 72.53 109.921 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 16.0 m -101.03 137.92 38.76 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 114.977 -1.01 . . . . 52.13 112.265 -174.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 77.2 mt -117.52 146.24 43.69 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.696 -1.224 . . . . 73.21 107.696 173.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -99.53 118.98 37.29 Favored 'General case' 0 N--CA 1.42 -1.974 0 C-N-CA 118.486 -1.286 . . . . 71.43 107.811 173.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.467 HG22 ' HG ' ' B' ' 103' ' ' LEU . 35.2 t -97.32 109.09 22.66 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 N-CA-C 106.318 -1.734 . . . . 60.43 106.318 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -116.54 170.34 8.65 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-N 115.094 -0.957 . . . . 64.33 108.867 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 81.23 46.33 7.04 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.705 -0.958 . . . . 75.1 110.705 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 91.3 mt -114.37 141.44 26.51 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 107.573 -1.269 . . . . 74.43 107.573 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -59.99 161.4 19.1 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 121.585 1.523 . . . . 72.35 110.395 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.618 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 8.8 p -86.07 7.89 2.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 122.477 1.132 . . . . 74.33 109.752 -171.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -127.9 19.13 6.61 Favored 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 114.79 -1.095 . . . . 72.1 111.402 -174.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.427 HG12 ' HG2' ' B' ' 69' ' ' PRO . 32.6 pt -58.07 134.81 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 114.424 1.268 . . . . 74.11 114.424 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -101.44 145.85 31.17 Favored Pre-proline 0 C--N 1.297 -1.707 0 CA-C-N 113.908 -1.496 . . . . 73.14 110.066 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -55.97 -27.98 66.48 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.258 2.639 . . . . 74.11 113.484 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.597 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 23.9 ptt180 -70.36 -28.67 65.3 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 121.179 0.514 . . . . 73.01 111.051 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -69.84 -40.01 76.09 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.839 -0.619 . . . . 75.14 110.204 -176.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.97 -41.59 95.32 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 108.708 -0.849 . . . . 71.32 108.708 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.61 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 7.3 t80 -57.1 -47.1 81.87 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.73 -1.123 . . . . 72.25 111.32 177.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 82.5 mt -61.1 -42.7 99.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.11 0.481 . . . . 73.41 110.789 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.412 HD13 HD22 ' A' ' 49' ' ' LEU . 37.9 tp -73.86 -42.99 60.0 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.198 -0.91 . . . . 64.2 111.936 -176.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -89.02 -10.49 47.36 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 115.623 1.712 . . . . 75.41 115.623 -173.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 14.1 mtp180 -54.28 -52.41 69.26 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 113.603 0.964 . . . . 70.32 113.603 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.3 -21.18 71.03 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 121.668 1.578 . . . . 73.02 112.304 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -88.42 86.59 7.07 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.662 0.744 . . . . 64.51 109.564 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -68.5 112.87 5.58 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.282 -1.326 . . . . 70.15 108.464 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 149.39 -28.52 1.21 Allowed Glycine 0 C--N 1.288 -2.087 0 CA-C-N 114.186 -1.37 . . . . 60.44 110.16 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -58.83 117.12 4.26 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.471 0.708 . . . . 64.21 111.568 176.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -102.02 -59.85 1.63 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.995 0.426 . . . . 72.14 111.212 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.78 172.37 31.17 Favored Glycine 0 C--N 1.295 -1.702 0 C-N-CA 120.559 -0.829 . . . . 71.11 112.181 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.1 p -135.39 137.04 41.92 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 122.903 0.481 . . . . 54.42 110.622 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.56 110.17 17.04 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.382 -1.34 . . . . 73.44 107.382 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.35 138.03 21.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 120.748 0.308 . . . . 73.43 110.923 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' B' ' 69' ' ' PRO . 0.6 OUTLIER -117.14 106.77 13.69 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.662 -1.607 . . . . 71.24 106.662 176.548 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.75 124.17 24.79 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.182 -0.917 . . . . 72.22 109.04 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 7.8 m -127.09 151.94 47.96 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 103.214 -2.884 . . . . 61.31 103.214 177.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.33 -33.36 65.54 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.063 0.764 . . . . 74.24 113.063 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -86.98 -38.7 16.37 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 120.19 -0.604 . . . . 71.0 112.294 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' B' ' 65' ' ' THR . 28.4 pt20 -161.53 135.3 4.91 Favored Pre-proline 0 C--N 1.297 -1.691 0 CA-C-O 120.495 0.188 . . . . 71.51 111.485 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.618 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 18.0 Cg_endo -80.55 109.8 2.33 Favored 'Trans proline' 0 N--CA 1.427 -2.411 0 C-N-CA 122.064 1.842 . . . . 62.13 109.508 168.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -84.68 147.9 5.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.436 -0.95 . . . . 51.24 108.436 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.28 120.56 4.58 Favored Glycine 0 CA--C 1.481 -2.056 0 C-N-CA 118.647 -1.74 . . . . 74.33 112.847 -175.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -87.74 102.72 14.93 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.628 -1.619 . . . . 70.44 106.628 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 69.2 t -100.11 128.73 51.75 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 114.923 -1.035 . . . . 70.12 110.117 -174.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 45.8 pt -101.76 132.67 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 CA-C-O 122.165 0.983 . . . . 65.54 110.865 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' PHE . . . . . 0.697 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 79.9 m-85 -111.15 142.64 43.06 Favored 'General case' 0 C--N 1.266 -3.028 0 CA-C-N 113.744 -1.571 . . . . 75.21 107.9 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.95 -24.92 67.66 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.308 0.575 . . . . 75.35 110.704 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 3.1 m -129.75 131.82 46.39 Favored 'General case' 0 N--CA 1.386 -3.67 0 N-CA-C 107.429 -1.323 . . . . 74.2 107.429 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' ARG . . . . . 0.702 ' H ' ' NE ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -80.93 -24.11 38.39 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.952 -0.567 . . . . 73.11 110.301 179.33 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.16 -20.52 57.49 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.316 -2.105 . . . . 70.22 105.316 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.81 -40.31 15.01 Favored Glycine 0 C--N 1.314 -0.65 0 CA-C-N 112.672 -2.058 . . . . 61.12 109.282 177.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.31 -47.27 86.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.111 -1.045 . . . . 51.42 110.912 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 10.9 pt-20 -63.7 -31.2 72.3 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.54 -0.464 . . . . 71.01 112.124 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.64 -42.15 67.92 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.712 0.291 . . . . 70.21 110.545 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.28 -39.29 82.16 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.55 -0.75 . . . . 63.14 111.105 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' B' ' 82' ' ' GLU . 14.4 ptmm? -66.06 -37.34 85.59 Favored 'General case' 0 C--O 1.199 -1.554 0 C-N-CA 120.606 -0.438 . . . . 73.13 110.288 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -55.79 -32.82 63.82 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 120.961 0.41 . . . . 73.42 111.772 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.09 -36.45 19.62 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 112.406 0.521 . . . . 54.13 112.406 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.604 ' O ' HG22 ' B' ' 91' ' ' ILE . 97.5 mt -95.69 -22.14 17.74 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 116.019 1.859 . . . . 74.53 116.019 -173.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ASN . . . . . 0.459 ' HB3' ' H ' ' B' ' 103' ' ' LEU . 0.3 OUTLIER -74.99 113.3 12.15 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 118.441 -1.304 . . . . 75.21 110.514 178.351 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.46 16.17 16.94 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 120.761 -0.733 . . . . 72.05 111.344 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.604 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.3 tt -113.37 145.31 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.81 0 N-CA-C 107.844 -1.169 . . . . 74.32 107.844 175.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.554 ' CG ' HG22 ' B' ' 100' ' ' THR . 97.7 mtt180 -82.31 145.02 30.19 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 113.325 0.861 . . . . 74.52 113.325 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.411 ' HB2' HD11 ' B' ' 101' ' ' LEU . 22.0 t80 -77.24 -34.87 55.81 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.405 -1.725 . . . . 74.41 107.264 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' A' ' 45' ' ' ARG . 5.2 m-20 -134.34 120.62 14.91 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 105.249 -2.13 . . . . 73.34 105.249 176.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 95' ' ' PRO . . . . . 0.544 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 18.1 Cg_endo -60.78 -24.22 78.38 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 121.897 1.731 . . . . 73.11 112.21 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -84.71 -14.62 47.84 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 123.725 0.81 . . . . 74.5 110.776 -176.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 97' ' ' ASN . . . . . 0.445 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . 53.7 t-20 -104.52 133.44 20.19 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 107.538 -1.282 . . . . 55.44 107.538 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.52 -5.39 15.09 Favored 'Trans proline' 0 CA--C 1.55 1.294 0 C-N-CA 122.524 2.149 . . . . 74.44 112.916 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -72.01 116.97 13.04 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 109.244 -0.65 . . . . 42.11 109.244 177.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.618 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 67.2 p -115.87 152.17 33.88 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.974 -0.75 . . . . 62.44 108.974 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' B' ' 93' ' ' PHE . 6.4 mp -84.08 139.69 32.31 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.11 0.481 . . . . 71.31 110.487 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -125.3 109.49 12.86 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 107.134 -1.432 . . . . 71.21 107.134 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.467 ' HG ' HG22 ' B' ' 35' ' ' VAL . 6.8 mp -99.39 119.56 38.16 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 108.467 -0.938 . . . . 74.24 108.467 173.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.406 ' HA ' ' CE ' ' B' ' 85' ' ' LYS . 36.7 mm-40 -136.22 165.37 25.89 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.101 -1.074 . . . . 62.32 108.101 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -71.17 137.04 48.43 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 118.727 0.694 . . . . 74.42 110.544 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.63 152.92 29.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 116.216 -0.447 . . . . 53.42 110.032 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -73.17 -12.85 61.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.859 0.838 . . . . 62.44 110.086 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.97 123.29 20.64 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.243 -0.889 . . . . 72.01 109.625 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -83.53 100.81 11.01 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.688 -1.597 . . . . 61.3 106.688 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.6 t . . . . . 0 C--N 1.288 -2.071 0 CA-C-O 121.862 0.839 . . . . 65.24 112.517 -172.588 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.536 HG12 ' H ' ' A' ' 32' ' ' THR . 37.5 t . . . . . 0 N--CA 1.437 -1.112 0 N-CA-C 108.106 -1.072 . . . . 71.14 108.106 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 13.1 ptm180 -92.65 8.58 38.48 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.3 0.571 . . . . 75.41 110.294 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.536 ' H ' HG12 ' A' ' 30' ' ' VAL . 8.7 m -122.45 129.66 52.27 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.804 0.811 . . . . 62.32 111.972 -177.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 33' ' ' LEU . 2.8 mp -110.46 141.29 43.77 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.339 -1.356 . . . . 74.12 107.339 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.671 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 11.4 p90 -101.51 128.01 47.94 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.252 -1.388 . . . . 63.0 107.252 172.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.4 t -106.76 118.32 54.27 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.623 0 N-CA-C 107.783 -1.191 . . . . 62.31 107.783 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.8 p -127.46 163.05 24.94 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.106 -0.702 . . . . 51.32 109.106 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.22 33.58 10.51 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.709 -0.956 . . . . 61.21 110.709 -174.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.7 mt -96.4 140.39 22.18 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.988 -1.116 . . . . 70.32 107.988 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -65.37 161.4 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 C-N-CA 121.315 1.344 . . . . 64.22 109.952 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -70.46 -8.77 11.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.79 0.805 . . . . 72.24 110.315 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -124.27 40.45 3.73 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 108.224 -1.028 . . . . 72.23 108.224 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.9 tp -60.53 125.34 16.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.115 -0.948 . . . . 74.34 109.451 173.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.606 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 26.1 mmmt -90.48 138.04 27.08 Favored Pre-proline 0 C--N 1.296 -1.757 0 N-CA-C 106.8 -1.555 . . . . 71.51 106.8 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.5 -25.07 77.48 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.485 2.123 . . . . 74.12 112.784 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.4 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 14.5 ptt180 -74.21 -27.66 60.9 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 116.012 -0.54 . . . . 74.53 111.396 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 30.5 mt-10 -62.87 -47.44 83.32 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.129 0.49 . . . . 73.24 109.964 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 99.7 mt -62.16 -45.3 94.05 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.283 -0.871 . . . . 63.14 109.803 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.682 ' CZ ' ' HD3' ' B' ' 95' ' ' PRO . 0.0 OUTLIER -60.01 -43.4 95.24 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.494 -0.776 . . . . 75.41 112.123 178.616 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 98.6 mt -64.36 -44.24 92.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.071 0.462 . . . . 74.33 110.221 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.429 ' O ' ' HD2' ' A' ' 53' ' ' PRO . 27.9 tp -66.72 -39.37 87.97 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.92 -1.036 . . . . 71.01 110.976 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -86.9 -4.49 59.18 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 114.566 1.321 . . . . 74.34 114.566 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 17.7 mtp180 -60.15 -42.87 92.08 Favored Pre-proline 0 N--CA 1.485 1.29 0 N-CA-C 113.447 0.906 . . . . 74.45 113.447 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 50' ' ' LEU . 24.5 Cg_exo -69.04 -18.36 40.4 Favored 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 121.693 1.595 . . . . 63.51 112.018 173.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -89.73 92.26 8.98 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 122.097 0.951 . . . . 74.24 110.967 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -69.4 111.79 5.51 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.177 -1.374 . . . . 63.54 109.589 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.84 -26.56 2.07 Favored Glycine 0 C--N 1.291 -1.963 0 CA-C-N 115.469 -0.787 . . . . 72.22 111.143 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -57.69 116.34 3.36 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.544 0.738 . . . . 74.22 111.698 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -96.7 -48.85 5.33 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.151 0.5 . . . . 51.15 110.323 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.69 167.23 40.27 Favored Glycine 0 C--N 1.302 -1.307 0 C-N-CA 120.014 -1.089 . . . . 75.12 113.246 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.418 ' HB3' HG22 ' A' ' 73' ' ' VAL . 11.5 p -127.27 137.66 52.9 Favored 'General case' 0 C--O 1.251 1.145 0 C-N-CA 123.12 0.568 . . . . 62.03 111.652 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.1 mp -112.42 150.44 31.14 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.904 -1.147 . . . . 64.2 107.904 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.0 mm -125.35 142.0 43.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 117.975 0.352 . . . . 73.12 110.091 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.561 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -133.99 107.73 7.96 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.52 -0.918 . . . . 72.02 108.52 178.307 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.2 130.37 43.62 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.315 -0.624 . . . . 75.23 109.315 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.9 m -129.38 164.0 24.57 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 106.405 -1.702 . . . . 75.34 106.405 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.41 -37.24 16.53 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.008 1.114 . . . . 74.13 114.008 -176.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -94.56 -41.6 9.25 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.285 0.565 . . . . 72.31 112.071 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -163.86 153.88 12.89 Favored Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 115.456 -0.793 . . . . 64.43 109.367 -170.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -78.27 118.2 4.27 Favored 'Trans proline' 0 N--CA 1.429 -2.309 0 C-N-CA 121.992 1.795 . . . . 71.24 109.939 170.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.37 159.58 2.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.973 -1.121 . . . . 71.22 107.973 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.72 157.46 20.45 Favored Glycine 0 C--N 1.298 -1.555 0 C-N-CA 118.688 -1.72 . . . . 61.43 113.683 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.68 109.73 15.56 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.948 -1.501 . . . . 73.44 106.948 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.418 HG22 ' HB3' ' A' ' 60' ' ' SER . 72.7 t -103.23 128.98 55.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 CA-C-N 116.044 -0.525 . . . . 64.35 110.155 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 mp -105.85 128.43 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 115.799 -0.637 . . . . 74.24 109.964 -178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 4.7 m-85 -109.07 153.41 23.7 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.682 -1.145 . . . . 73.34 110.242 175.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -67.09 -27.98 67.8 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.867 -1.061 . . . . 71.33 112.066 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.3 m -134.88 144.86 47.76 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 109.537 -0.542 . . . . 64.14 109.537 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -24.75 55.79 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.959 -0.564 . . . . 73.35 110.11 -178.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.37 -36.56 71.49 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.817 -0.808 . . . . 64.21 108.817 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.41 -37.05 62.84 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 114.261 -1.336 . . . . 74.44 110.195 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.64 78.1 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.012 -0.594 . . . . 63.14 111.177 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.75 -33.15 74.28 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.698 -0.401 . . . . 74.41 111.758 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.83 -39.82 66.27 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 120.637 0.256 . . . . 75.32 111.195 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.31 -43.11 92.08 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 116.275 -0.421 . . . . 74.21 110.896 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.402 ' CD ' ' HA ' ' A' ' 104' ' ' GLU . 20.3 pttp -70.84 -30.28 66.65 Favored 'General case' 0 C--O 1.198 -1.631 0 C-N-CA 119.03 -1.068 . . . . 72.41 111.945 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -62.82 -31.4 72.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.381 0.61 . . . . 72.34 110.096 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.83 -36.57 21.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 116.041 -0.527 . . . . 55.12 111.427 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.556 ' O ' HG22 ' A' ' 91' ' ' ILE . 96.5 mt -93.98 -10.83 32.36 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 115.361 1.615 . . . . 54.42 115.361 -174.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.77 115.08 18.23 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 118.502 -1.279 . . . . 73.54 111.202 176.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.51 19.4 13.92 Favored Glycine 0 N--CA 1.421 -2.331 0 C-N-CA 120.515 -0.85 . . . . 73.22 111.211 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 88' ' ' LEU . 16.5 tt -102.04 125.33 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.04 0 N-CA-C 106.86 -1.533 . . . . 75.33 106.86 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -78.28 129.04 34.58 Favored 'General case' 0 C--N 1.257 -3.422 0 N-CA-C 109.303 -0.629 . . . . 55.03 109.303 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -72.68 -30.22 64.06 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.714 -1.13 . . . . 74.54 109.824 -172.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.597 ' HB2' ' CB ' ' A' ' 97' ' ' ASN 0.277 9.7 m-20 -150.62 124.63 4.47 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 105.765 -1.939 . . . . 24.45 105.765 177.674 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.466 ' HD3' ' CZ ' ' B' ' 48' ' ' TYR . 52.3 Cg_exo -63.0 -19.01 68.09 Favored 'Trans proline' 0 CA--C 1.555 1.535 0 CA-C-N 121.127 1.438 . . . . 72.5 111.272 170.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -78.12 -23.53 47.8 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.272 1.029 . . . . 73.43 110.707 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.597 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 22.0 t-20 -107.6 141.38 22.92 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 107.336 -1.357 . . . . 75.31 107.336 -172.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.429 ' HD2' ' OD1' ' A' ' 97' ' ' ASN . 73.5 Cg_endo -76.07 7.25 3.36 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 122.522 2.148 . . . . 72.01 111.726 176.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -88.31 126.18 35.05 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.141 -0.936 . . . . 74.2 109.921 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.2 p -115.25 141.92 47.38 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.529 -0.915 . . . . 54.11 108.529 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.3 tp -89.14 132.58 34.75 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.411 -0.589 . . . . 43.5 109.411 -176.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -134.56 122.53 22.5 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.095 0.558 . . . . 74.52 109.727 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -116.02 132.82 56.54 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.273 -0.64 . . . . 71.31 109.273 177.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.671 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 34.7 tt0 -146.24 168.49 20.93 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.223 -1.769 . . . . 71.52 106.223 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -68.02 138.2 55.66 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 120.133 1.333 . . . . 74.34 110.646 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.07 160.22 31.42 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.298 -0.864 . . . . 74.3 111.491 -176.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -63.29 -25.39 68.29 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.521 -1.218 . . . . 64.14 110.379 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.1 130.66 29.39 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 114.554 -1.203 . . . . 62.35 108.948 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 30' ' ' VAL . 1.7 m-20 -82.44 121.35 26.62 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.322 -1.732 . . . . 73.4 106.322 176.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.287 -2.124 0 C-N-CA 119.46 -0.896 . . . . 61.24 111.293 -178.838 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.512 ' HB ' ' CD1' ' B' ' 105' ' ' PHE . 40.8 t . . . . . 1 N--CA 1.369 -4.513 0 N-CA-C 105.005 -2.22 . . . . 74.24 105.005 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.468 ' NH2' ' HA ' ' B' ' 76' ' ' ASP . 17.1 ptm180 -101.05 11.72 39.03 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 122.019 0.914 . . . . 72.31 109.221 -177.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' THR . . . . . 0.473 HG21 HG22 ' B' ' 110' ' ' THR . 51.9 m -124.13 114.92 20.31 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.959 -1.019 . . . . 74.25 109.348 172.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' B' ' 85' ' ' LYS . 4.4 mp -96.87 140.48 31.36 Favored 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 107.857 -1.164 . . . . 74.23 107.857 -176.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' B' ' 104' ' ' GLU 0.262 28.0 p90 -102.83 110.63 22.61 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 117.534 -1.666 . . . . 73.33 109.127 175.005 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.444 HG22 ' HG ' ' B' ' 103' ' ' LEU . 40.5 t -97.49 125.88 50.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-N 113.736 -1.574 . . . . 74.53 108.634 -176.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 19.1 p -131.32 170.76 14.19 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.945 -0.571 . . . . 60.41 109.658 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.36 5.2 57.11 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.721 -0.952 . . . . 41.23 110.721 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.719 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 63.8 mt -84.34 120.01 73.86 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 106.515 -1.661 . . . . 74.13 106.515 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.56 175.84 6.56 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.577 1.518 . . . . 75.14 111.425 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.436 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 13.2 p -65.54 -19.82 26.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.957 0.884 . . . . 31.12 110.149 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -107.32 39.51 1.88 Allowed 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.141 -0.936 . . . . 74.11 108.599 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 tp -68.62 121.32 17.67 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 N-CA-C 109.044 -0.724 . . . . 74.11 109.044 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.418 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 16.3 mmmt -89.11 138.55 28.95 Favored Pre-proline 0 C--N 1.287 -2.112 0 N-CA-C 106.545 -1.65 . . . . 71.0 106.545 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.29 -29.48 86.2 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 122.333 2.022 . . . . 64.04 112.065 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.576 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 14.2 ptt180 -63.49 -31.94 73.25 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 114.818 -1.083 . . . . 63.43 112.17 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.418 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 36.9 mt-10 -63.02 -49.26 75.31 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.824 0.345 . . . . 74.05 110.374 -177.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.15 -43.46 91.75 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.724 -0.671 . . . . 75.32 109.969 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.69 ' O ' ' HG3' ' B' ' 52' ' ' ARG . 0.4 OUTLIER -59.94 -43.38 94.99 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.031 -0.986 . . . . 75.12 112.298 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.39 -42.51 75.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.854 0.359 . . . . 70.02 110.274 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 24.6 tp -64.93 -41.45 95.52 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.108 -0.951 . . . . 72.44 111.087 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -88.67 1.87 54.29 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 113.944 1.09 . . . . 73.55 113.944 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.69 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 17.4 mtp180 -62.19 -46.38 90.95 Favored Pre-proline 0 CA--C 1.558 1.262 0 N-CA-C 113.593 0.96 . . . . 75.01 113.593 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -68.0 -19.46 45.75 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 121.853 1.702 . . . . 62.54 112.421 175.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -81.89 98.15 8.38 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.007 0.908 . . . . 73.53 110.789 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -70.91 110.11 5.44 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 113.898 -1.501 . . . . 75.12 110.764 -177.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.38 -15.42 4.18 Favored Glycine 0 N--CA 1.423 -2.233 0 CA-C-N 114.401 -1.272 . . . . 74.2 111.537 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -56.47 115.66 2.64 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.155 0.502 . . . . 71.12 111.424 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -93.49 -50.79 5.26 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-N 115.634 -0.712 . . . . 70.32 109.864 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.33 -179.17 47.5 Favored Glycine 0 C--N 1.29 -2.007 0 C-N-CA 120.527 -0.844 . . . . 53.15 111.671 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.2 p -136.9 137.99 40.21 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 123.311 0.644 . . . . 61.01 109.836 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 52.8 tp -120.36 123.81 43.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.591 -1.263 . . . . 73.05 107.591 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.63 144.96 8.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 109.929 -0.397 . . . . 54.12 109.929 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.456 ' HA ' ' HE3' ' B' ' 63' ' ' LYS . 1.6 tpmt? -133.43 108.56 8.74 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.039 -1.097 . . . . 74.12 108.039 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.19 108.85 3.31 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.91 -0.587 . . . . 74.13 109.603 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 20.9 m -100.06 156.71 17.03 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 105.872 -1.899 . . . . 53.52 105.872 175.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.09 -37.35 3.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.597 1.159 . . . . 74.1 113.885 -174.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -101.34 -46.12 5.12 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 119.677 -0.809 . . . . 70.54 112.469 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.719 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 4.0 pt20 -142.55 136.66 14.72 Favored Pre-proline 0 C--N 1.288 -2.095 0 CA-C-O 120.985 0.422 . . . . 73.34 112.035 -170.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.436 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 19.1 Cg_exo -64.34 108.88 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.393 2.729 . . . . 55.44 110.537 170.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 33.8 m -87.64 160.63 2.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.251 -1.018 . . . . 64.34 108.251 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.55 121.19 2.89 Favored Glycine 0 CA--C 1.481 -2.062 0 C-N-CA 119.163 -1.494 . . . . 64.12 112.68 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.12 108.83 19.46 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.198 -1.408 . . . . 73.11 107.198 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 86.0 t -95.9 125.23 48.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-N 115.72 -0.673 . . . . 72.44 110.396 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 3.5 mp -96.91 127.32 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 CA-C-N 115.064 -0.971 . . . . 73.31 108.907 -176.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -109.38 158.14 18.22 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.426 -0.806 . . . . 75.31 110.647 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' ASP . . . . . 0.468 ' HA ' ' NH2' ' B' ' 31' ' ' ARG . 18.0 t70 -79.93 -29.53 39.77 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 113.941 -1.482 . . . . 73.01 111.777 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 9.2 m -135.57 153.9 51.53 Favored 'General case' 0 N--CA 1.417 -2.098 0 C-N-CA 119.238 -0.985 . . . . 75.35 112.107 -168.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 7.3 tpt85 -63.51 -42.62 98.47 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.477 -1.238 . . . . 75.5 109.856 177.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.11 -17.61 62.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.191 -1.368 . . . . 75.34 109.679 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.69 -47.5 4.52 Favored Glycine 0 CA--C 1.488 -1.646 0 CA-C-N 114.113 -1.403 . . . . 52.24 109.902 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.22 -46.68 87.81 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 114.498 -0.851 . . . . 70.55 111.752 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.16 -31.33 72.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.602 0.593 . . . . 74.33 112.602 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.74 -39.47 24.15 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 120.804 -0.358 . . . . 70.13 110.691 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.95 -42.36 85.37 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.059 -0.519 . . . . 72.24 111.427 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.431 ' HB3' HD23 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -73.51 -27.67 61.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 120.308 -0.557 . . . . 73.41 110.9 -177.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -76.15 -39.73 54.3 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.239 -0.437 . . . . 54.13 110.362 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.08 -43.89 61.23 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 120.848 0.356 . . . . 52.51 111.874 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.507 ' O ' HG22 ' B' ' 91' ' ' ILE . 97.1 mt -87.05 -14.11 42.46 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 115.684 1.735 . . . . 74.05 115.684 -172.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -78.5 113.92 16.95 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 117.729 -1.588 . . . . 73.44 111.57 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.95 18.22 9.0 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.383 -0.913 . . . . 63.34 111.353 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.507 HG22 ' O ' ' B' ' 88' ' ' LEU . 15.1 tt -101.59 136.92 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.91 0 N-CA-C 108.086 -1.079 . . . . 61.35 108.086 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.468 ' NH1' ' HA ' ' B' ' 98' ' ' PRO . 15.6 mmt180 -64.97 130.21 42.56 Favored 'General case' 0 C--N 1.278 -2.541 0 C-N-CA 124.109 0.964 . . . . 61.02 108.602 175.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -75.13 -27.51 59.8 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.01 -1.478 . . . . 63.31 107.01 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.62 126.43 3.51 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 103.375 -2.824 . . . . 52.14 103.375 168.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 95' ' ' PRO . . . . . 0.682 ' HD3' ' CZ ' ' A' ' 48' ' ' TYR . 69.6 Cg_endo -71.88 -8.4 22.93 Favored 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 122.235 1.957 . . . . 73.14 114.342 -171.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -84.49 -21.81 30.47 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.05 -0.722 . . . . 64.04 109.05 -177.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -108.98 142.44 25.52 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.329 -0.989 . . . . 65.34 108.329 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.468 ' HA ' ' NH1' ' B' ' 92' ' ' ARG . 49.1 Cg_exo -62.25 -3.92 4.63 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 123.151 2.567 . . . . 42.3 113.525 172.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.93 117.03 6.99 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-O 121.653 0.74 . . . . 75.12 109.855 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 42.5 p -121.56 150.07 42.19 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.566 -0.743 . . . . 71.32 109.906 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 22.7 tp -85.95 123.42 31.26 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 106.411 -1.7 . . . . 72.32 106.411 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.97 113.17 16.14 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.842 -1.17 . . . . 75.41 107.842 -172.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.444 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.7 mp -112.59 136.62 51.92 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.537 -0.756 . . . . 72.32 110.271 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.489 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 42.4 tt0 -144.94 167.52 22.44 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.937 -1.505 . . . . 72.25 106.937 175.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 105' ' ' PHE . . . . . 0.512 ' CD1' ' HB ' ' B' ' 30' ' ' VAL . 40.1 m-85 -76.64 135.07 39.14 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.277 -0.638 . . . . 74.12 109.277 177.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.53 163.48 26.87 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.462 0.649 . . . . 65.11 111.194 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -76.57 -20.64 56.6 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 122.187 0.994 . . . . 44.11 108.895 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.06 124.3 27.36 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.879 -1.055 . . . . 74.43 110.956 -174.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.479 HD21 ' HA ' ' B' ' 30' ' ' VAL . 81.7 m-20 -82.94 136.21 34.64 Favored 'General case' 0 CA--C 1.475 -1.904 0 N-CA-C 107.68 -1.23 . . . . 74.11 107.68 173.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.473 HG22 HG21 ' B' ' 32' ' ' THR . 12.0 t . . . . . 0 C--N 1.268 -2.978 0 N-CA-C 108.652 -0.87 . . . . 72.13 108.652 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.1 t . . . . . 0 N--CA 1.444 -0.773 0 N-CA-C 103.169 -2.901 . . . . 72.43 103.169 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' A' ' 75' ' ' PHE . 20.4 ptt180 -133.27 9.81 4.08 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 119.788 -0.765 . . . . 73.53 112.016 -167.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 75.0 m -105.36 119.98 40.43 Favored 'General case' 0 C--N 1.264 -3.149 0 C-N-CA 119.744 -0.782 . . . . 73.43 109.536 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.512 HD11 ' O ' ' A' ' 81' ' ' ALA . 76.1 mt -99.28 142.11 31.19 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.418 -1.327 . . . . 71.23 107.418 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 15.8 p90 -103.54 116.79 33.04 Favored 'General case' 0 C--N 1.281 -2.4 0 C-N-CA 117.994 -1.482 . . . . 74.02 107.989 175.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.423 HG22 ' HG ' ' A' ' 103' ' ' LEU . 29.7 t -97.36 118.98 44.8 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.311 -1.366 . . . . 54.11 107.311 -178.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 32.7 p -120.92 166.08 14.31 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 109.041 -0.725 . . . . 72.33 109.041 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA2' ' NE2' ' A' ' 99' ' ' GLN . . . 97.0 18.5 29.19 Favored Glycine 0 N--CA 1.425 -2.038 0 C-N-CA 120.524 -0.846 . . . . 72.31 111.643 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -93.89 112.0 55.24 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.456 -0.942 . . . . 51.33 108.456 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.71 156.97 25.15 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.402 2.068 . . . . 72.1 110.774 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.99 -4.24 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 CA-C-O 122.109 0.957 . . . . 73.42 112.141 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -100.93 14.19 32.66 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.85 -0.796 . . . . 64.31 108.85 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.25 129.18 11.95 Favored 'Isoleucine or valine' 0 C--O 1.254 1.297 0 C-N-CA 124.859 1.263 . . . . 64.55 110.122 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -126.85 104.77 23.19 Favored Pre-proline 0 C--N 1.286 -2.19 0 N-CA-C 106.705 -1.591 . . . . 74.32 106.705 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -39.98 -17.49 0.05 OUTLIER 'Trans proline' 0 N--CA 1.515 2.777 1 C-N-CA 126.53 4.82 . . . . 62.34 118.14 -165.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.503 ' HG3' ' CE2' ' B' ' 93' ' ' PHE . 0.0 OUTLIER -60.59 -32.56 71.67 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 112.892 0.701 . . . . 71.11 112.892 176.586 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.645 ' HG3' ' CZ ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -69.39 -42.84 74.59 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.371 -0.931 . . . . 75.43 109.605 -177.063 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.37 -45.25 94.03 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 115.817 -0.628 . . . . 64.21 109.394 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.642 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 72.9 t80 -56.52 -49.13 75.67 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.952 -1.022 . . . . 72.31 111.42 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 93.2 mt -66.8 -35.97 81.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.915 0.388 . . . . 62.1 110.772 -176.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.5 tp -73.83 -41.97 61.54 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.279 -0.873 . . . . 63.53 112.327 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -87.81 -11.39 48.11 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 115.936 1.828 . . . . 73.15 115.936 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 52.8 mtp180 -60.58 -41.97 85.8 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 113.793 1.034 . . . . 75.3 113.793 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -64.82 -19.23 64.18 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.696 1.597 . . . . 54.34 112.387 175.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -81.76 89.65 6.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.233 0.539 . . . . 64.24 110.214 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.29 109.79 1.68 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.746 -0.835 . . . . 64.33 108.746 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.6 -17.67 3.7 Favored Glycine 0 N--CA 1.419 -2.485 0 CA-C-N 114.823 -1.081 . . . . 71.31 110.759 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -63.38 112.74 2.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.821 0.31 . . . . 63.41 110.538 175.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -90.55 -48.07 7.31 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.09 0.471 . . . . 73.41 110.437 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.8 179.21 48.78 Favored Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.203 -0.999 . . . . 74.44 112.558 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 p -138.33 136.84 36.8 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.803 0.335 . . . . 73.54 110.933 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 mp -123.02 121.16 35.39 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.558 -0.904 . . . . 73.53 108.558 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.76 138.56 20.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 120.853 0.358 . . . . 64.41 111.204 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -121.14 135.64 55.13 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.527 1.131 . . . . 71.23 108.254 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.63 126.89 33.31 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.74 0.781 . . . . 75.3 112.913 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 18.9 m -130.12 148.56 51.97 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 104.254 -2.499 . . . . 65.33 104.254 172.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -42.24 -48.86 4.99 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.849 1.26 . . . . 72.41 114.366 -169.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 67' ' ' ARG . 24.1 mtm180 -105.3 -5.05 20.87 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.187 -1.005 . . . . 71.01 113.184 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.476 ' O ' ' HB ' ' A' ' 65' ' ' THR . 11.2 pt20 -161.79 117.1 1.28 Allowed Pre-proline 0 C--N 1.312 -1.03 0 C-N-CA 120.114 -0.634 . . . . 71.23 112.515 -171.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -73.53 105.52 2.01 Favored 'Trans proline' 0 N--CA 1.432 -2.089 0 C-N-CA 122.243 1.962 . . . . 72.03 108.107 169.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.5 152.16 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.119 -0.697 . . . . 71.14 109.119 -176.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.53 120.4 4.4 Favored Glycine 0 CA--C 1.477 -2.293 0 C-N-CA 118.642 -1.742 . . . . 61.23 112.805 -175.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.52 103.72 16.15 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.454 -1.313 . . . . 71.41 107.454 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.2 t -98.09 120.96 48.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 114.888 -1.051 . . . . 72.3 110.097 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 110' ' ' THR . 5.9 tt -94.96 127.74 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.258 0 CA-C-N 115.019 -0.991 . . . . 71.44 110.187 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.532 ' O ' ' HD2' ' A' ' 31' ' ' ARG . 84.4 m-85 -107.46 165.86 11.09 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 114.616 -1.175 . . . . 72.34 110.086 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.95 -48.21 78.88 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 125.209 1.404 . . . . 75.42 112.48 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 p -143.65 163.88 32.0 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 111.755 0.28 . . . . 74.44 111.755 -172.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.509 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -68.44 -36.05 78.48 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.216 0.531 . . . . 74.43 110.65 -177.685 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.64 -28.87 63.0 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.228 -0.896 . . . . 73.42 108.962 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.11 -39.5 37.17 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.443 -1.253 . . . . 70.31 110.407 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.512 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -65.35 -46.1 81.56 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.878 -0.661 . . . . 65.43 111.534 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -63.38 -37.63 88.03 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.448 -0.501 . . . . 74.24 112.082 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.2 -38.47 85.38 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.249 -0.432 . . . . 72.12 110.106 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.86 -39.52 83.77 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.808 -0.633 . . . . 45.01 110.56 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -59.09 -47.97 83.32 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.685 -0.689 . . . . 62.42 111.836 177.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -66.1 -25.16 66.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.194 0.521 . . . . 61.43 111.864 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.17 -39.72 32.72 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.872 -0.604 . . . . 43.31 111.514 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.472 ' O ' HG22 ' A' ' 91' ' ' ILE . 98.2 mt -102.2 -25.33 13.73 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 116.896 2.184 . . . . 73.41 116.896 -173.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -65.46 114.75 5.06 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-N 120.327 1.421 . . . . 75.25 110.18 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.58 10.18 19.87 Favored Glycine 0 N--CA 1.421 -2.32 0 CA-C-N 115.405 -0.816 . . . . 45.02 111.606 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 88' ' ' LEU . 14.7 tt -93.9 130.33 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.41 0 N-CA-C 109.107 -0.701 . . . . 64.32 109.107 177.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.536 ' CG ' HG22 ' A' ' 100' ' ' THR . 79.0 mtt180 -76.15 141.35 41.92 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-O 121.396 0.617 . . . . 73.14 111.757 173.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.645 ' CZ ' ' HG3' ' A' ' 46' ' ' GLU . 26.3 t80 -70.74 -34.46 71.9 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.509 -1.678 . . . . 60.33 109.108 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.558 ' HB2' ' CB ' ' A' ' 97' ' ' ASN . 6.5 m-20 -140.41 142.14 28.32 Favored Pre-proline 0 C--N 1.294 -1.821 0 N-CA-C 102.666 -3.087 . . . . 52.33 102.666 175.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.67 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 28.1 Cg_endo -64.03 -22.7 67.9 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 121.469 1.446 . . . . 75.05 110.898 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -92.08 -8.16 46.62 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.65 -1.159 . . . . 74.13 110.545 -176.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.558 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 34.2 t30 -103.51 120.66 51.03 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 108.977 -0.749 . . . . 64.1 108.977 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.89 -19.55 35.38 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.669 2.246 . . . . 74.12 111.858 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.429 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 6.9 tp60 -68.09 114.65 6.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.337 -0.986 . . . . 72.45 108.337 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.536 HG22 ' CG ' ' A' ' 92' ' ' ARG . 69.1 p -107.56 154.83 20.84 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.066 -0.716 . . . . 74.01 109.066 -175.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.7 mp -86.29 118.29 25.64 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.803 -0.443 . . . . 74.11 109.803 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -110.76 121.25 44.87 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.725 -1.954 . . . . 74.11 105.725 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.423 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.5 mp -105.27 138.17 41.89 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.151 -1.055 . . . . 71.25 108.151 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.579 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 32.6 tt0 -146.02 163.38 35.41 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.843 -1.91 . . . . 64.2 105.843 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -70.55 137.91 50.5 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 119.22 0.918 . . . . 74.44 110.37 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.9 141.15 40.66 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 108.15 -1.056 . . . . 73.21 108.15 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -80.19 10.04 4.93 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 122.233 1.016 . . . . 74.2 110.692 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -162.38 132.17 4.54 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.986 -1.857 . . . . 75.45 105.986 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -78.36 158.54 28.75 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.413 0.625 . . . . 62.33 111.648 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.422 ' O ' HD12 ' A' ' 74' ' ' ILE . 6.7 t . . . . . 0 N--CA 1.399 -2.977 0 N-CA-C 104.35 -2.463 . . . . 51.52 104.35 169.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.526 ' HA ' HD21 ' B' ' 109' ' ' ASN . 57.8 t . . . . . 0 CA--C 1.5 -0.976 0 N-CA-C 106.49 -1.67 . . . . 73.13 106.49 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -140.04 15.06 2.45 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 115.042 -0.981 . . . . 64.23 111.855 -171.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' B' ' 74' ' ' ILE . 35.3 m -105.84 125.76 51.37 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 108.727 -0.842 . . . . 65.23 108.727 174.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.455 HD11 ' O ' ' B' ' 81' ' ' ALA . 85.4 mt -100.83 143.11 31.38 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.75 -0.833 . . . . 71.13 108.75 178.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.615 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 4.6 p90 -104.44 118.47 36.68 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 106.798 -1.556 . . . . 71.24 106.798 171.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 39.8 t -97.27 111.95 28.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 N-CA-C 107.206 -1.405 . . . . 64.32 107.206 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 36.2 p -109.92 162.47 14.48 Favored 'General case' 0 C--N 1.276 -2.59 0 N-CA-C 109.07 -0.715 . . . . 63.35 109.07 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.83 24.82 12.47 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.428 -0.891 . . . . 70.03 111.887 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.573 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 83.4 mt -101.78 113.59 65.81 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 107.757 -1.201 . . . . 75.43 107.757 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.49 169.79 2.14 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.856 2.371 . . . . 54.35 112.35 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 6.6 p -72.96 -2.41 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 122.115 0.959 . . . . 63.42 110.458 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' B' ' 43' ' ' LYS . 22.3 t0 -105.01 10.65 34.03 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 114.954 -1.021 . . . . 55.33 109.563 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.94 129.88 19.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-O 121.811 0.815 . . . . 72.42 109.449 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' B' ' 45' ' ' ARG . 47.7 mmtm -130.0 107.05 16.56 Favored Pre-proline 0 C--N 1.277 -2.564 0 N-CA-C 106.449 -1.686 . . . . 64.05 106.449 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -41.48 -16.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.478 1 C-N-CA 126.372 4.715 . . . . 52.42 117.774 -165.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.557 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 9.8 ptt180 -65.51 -24.72 67.2 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 122.642 0.377 . . . . 75.23 111.855 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.553 ' HG3' ' CE1' ' B' ' 93' ' ' PHE . 0.0 OUTLIER -76.03 -41.83 49.72 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 119.214 -0.994 . . . . 75.12 108.888 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.41 ' HG ' ' OE1' ' B' ' 46' ' ' GLU . 96.4 mt -62.17 -37.19 84.28 Favored 'General case' 0 C--O 1.211 -0.939 0 N-CA-C 108.859 -0.793 . . . . 74.22 108.859 175.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.67 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 63.1 t80 -58.53 -49.78 76.15 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.846 -1.07 . . . . 55.13 110.488 176.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.62 -33.98 74.97 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.862 0.363 . . . . 64.22 110.738 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 36.5 tp -74.58 -45.92 42.08 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.566 -0.743 . . . . 72.24 112.467 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -92.13 -7.31 48.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.951 1.093 . . . . 70.01 113.951 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.594 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 20.6 ttt180 -65.99 -43.13 56.29 Favored Pre-proline 0 CA--C 1.56 1.333 0 N-CA-C 112.416 0.525 . . . . 71.41 112.416 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.22 -15.43 46.09 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 121.76 1.64 . . . . 53.42 111.862 175.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -85.68 88.87 7.6 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.419 -0.585 . . . . 71.41 109.419 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.1 112.85 5.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.453 -0.794 . . . . 73.11 109.978 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.84 -26.5 1.62 Allowed Glycine 0 N--CA 1.426 -1.985 0 CA-C-N 113.578 -1.646 . . . . 72.41 109.49 -174.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -50.89 119.03 3.54 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.413 1.085 . . . . 72.14 111.905 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.493 ' HB2' HG23 ' B' ' 74' ' ' ILE . 6.6 mm-40 -93.06 -46.69 7.33 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 115.928 -0.578 . . . . 52.42 109.443 176.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.85 171.99 37.4 Favored Glycine 0 C--N 1.297 -1.614 0 C-N-CA 120.455 -0.879 . . . . 72.2 112.325 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.9 p -127.11 137.34 52.98 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.192 0.52 . . . . 61.11 111.061 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' LEU . . . . . 0.409 HD22 HG22 ' B' ' 110' ' ' THR . 5.1 mp -117.87 109.72 16.88 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.376 -0.972 . . . . 72.22 108.376 175.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.74 131.95 39.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.729 -0.841 . . . . 60.33 108.729 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -130.97 119.57 22.27 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 109.293 -0.632 . . . . 75.24 109.293 -176.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.51 134.63 57.26 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.213 1.005 . . . . 73.41 110.873 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 2.5 m -130.08 158.58 39.24 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 105.663 -1.977 . . . . 71.04 105.663 175.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.89 -40.66 10.36 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.065 0.946 . . . . 72.11 113.29 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 -104.75 -41.66 5.6 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 119.58 -0.848 . . . . 72.35 112.735 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.573 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 14.1 pt20 -153.36 126.44 4.13 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 120.717 -0.393 . . . . 74.1 111.55 -173.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' B' ' 38' ' ' LEU . 51.9 Cg_exo -56.85 124.37 16.09 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.004 2.469 . . . . 63.11 111.393 171.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.24 141.22 14.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 115.114 -0.948 . . . . 72.33 108.679 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.73 120.31 5.21 Favored Glycine 0 C--O 1.205 -1.702 0 C-N-CA 119.139 -1.505 . . . . 74.24 112.46 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -90.37 102.94 15.67 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.642 -1.244 . . . . 74.31 107.642 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.17 112.38 37.49 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 CA-C-N 115.569 -0.741 . . . . 70.31 109.182 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.493 HG23 ' HB2' ' B' ' 58' ' ' GLU . 12.4 tt -97.18 138.01 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 CA-C-N 115.528 -0.76 . . . . 71.21 110.549 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -112.61 160.04 18.26 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.04 -0.982 . . . . 75.43 109.341 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.24 -31.61 72.53 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.863 -0.608 . . . . 63.22 112.224 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 26.4 p -128.88 152.56 48.38 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 121.74 0.781 . . . . 61.51 111.904 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 78' ' ' ARG . . . . . 0.832 ' H ' ' HD3' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -63.09 -39.05 93.57 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.514 -1.221 . . . . 73.43 109.954 177.255 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 79' ' ' ALA . . . . . 0.404 ' N ' ' HG2' ' B' ' 78' ' ' ARG . . . -79.51 -19.9 48.52 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.184 -1.043 . . . . 63.02 108.184 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.56 -44.75 31.76 Favored Glycine 0 C--N 1.307 -1.067 0 N-CA-C 109.227 -1.549 . . . . 72.4 109.227 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.455 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -67.97 -37.4 81.48 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.381 -0.909 . . . . 50.31 109.476 176.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -55.42 -52.51 63.33 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.066 -0.97 . . . . 65.23 110.576 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.08 89.76 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.525 -0.761 . . . . 74.23 110.994 -176.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.21 -39.96 82.28 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.351 -0.84 . . . . 44.41 110.563 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -62.84 -42.49 99.76 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.603 -0.726 . . . . 44.12 111.841 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -62.37 -37.37 85.42 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.257 0.551 . . . . 74.23 111.25 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.19 -45.34 33.7 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 115.581 -0.736 . . . . 63.15 111.767 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.497 ' O ' HG22 ' B' ' 91' ' ' ILE . 90.7 mt -93.33 -21.05 19.8 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 117.477 2.399 . . . . 72.01 117.477 -170.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.86 114.01 7.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 120.787 1.631 . . . . 73.22 112.343 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 113.9 1.56 24.01 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.885 -0.598 . . . . 64.04 112.255 176.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.497 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.2 tt -86.02 136.15 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 CA-C-O 121.137 0.494 . . . . 61.24 110.184 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.516 ' HA ' HG22 ' B' ' 100' ' ' THR . 22.2 mmt180 -59.26 139.02 57.38 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 125.17 1.388 . . . . 72.52 110.045 173.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.553 ' CE1' ' HG3' ' B' ' 46' ' ' GLU . 34.9 t80 -80.77 -32.28 35.54 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.491 -1.67 . . . . 74.14 106.491 173.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.667 ' HB2' ' HB3' ' B' ' 97' ' ' ASN . 9.5 m-20 -147.47 143.31 17.83 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 101.493 -3.521 . . . . 73.53 101.493 174.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 95' ' ' PRO . . . . . 0.632 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 74.0 Cg_endo -78.33 -15.88 13.98 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 CA-C-N 121.952 1.733 . . . . 61.2 109.619 175.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -79.63 -25.34 41.43 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.299 -1.319 . . . . 74.13 109.629 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 97' ' ' ASN . . . . . 0.667 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . 38.0 t30 -109.69 129.9 23.4 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 107.744 -1.206 . . . . 75.11 107.744 -174.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.73 -2.81 6.97 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 123.156 2.57 . . . . 61.31 113.241 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -77.45 122.41 25.16 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.723 0.773 . . . . 73.32 110.267 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.516 HG22 ' HA ' ' B' ' 92' ' ' ARG . 17.9 p -121.72 159.81 25.82 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 115.045 -0.979 . . . . 75.2 108.582 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.406 HD13 HG23 ' B' ' 91' ' ' ILE . 4.4 mp -93.05 134.81 34.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.405 -0.961 . . . . 75.53 108.405 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -123.99 116.85 23.52 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.044 -1.836 . . . . 71.22 106.044 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mp -106.49 136.37 46.38 Favored 'General case' 0 C--N 1.289 -2.034 0 O-C-N 123.752 0.657 . . . . 72.41 110.354 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.615 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 37.1 tt0 -145.4 163.97 32.95 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 105.744 -1.947 . . . . 74.15 105.744 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -70.47 144.93 51.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 119.493 1.042 . . . . 71.45 110.133 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.69 158.18 27.03 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 107.996 -1.113 . . . . 73.12 107.996 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -81.91 -11.32 58.96 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.009 0.909 . . . . 63.01 109.523 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -149.06 130.49 14.77 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.664 -1.153 . . . . 52.23 107.948 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.526 HD21 ' HA ' ' B' ' 30' ' ' VAL . 54.2 m-80 -74.15 113.99 11.98 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.432 0.634 . . . . 72.42 110.479 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.409 HG22 HD22 ' B' ' 61' ' ' LEU . 23.5 m . . . . . 0 N--CA 1.419 -2.023 0 N-CA-C 107.336 -1.357 . . . . 70.03 107.336 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 32' ' ' THR . 26.1 t . . . . . 0 N--CA 1.429 -1.51 0 N-CA-C 109.691 -0.485 . . . . 71.03 109.691 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 40.9 mtm180 -85.97 7.38 24.6 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-O 120.926 0.393 . . . . 72.21 110.507 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.531 ' H ' HG12 ' A' ' 30' ' ' VAL . 33.6 m -134.2 129.77 36.23 Favored 'General case' 0 C--N 1.259 -3.363 0 CA-C-O 121.821 0.82 . . . . 64.53 112.054 -173.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.429 HD13 ' HB3' ' A' ' 85' ' ' LYS . 88.4 mt -103.7 139.07 39.46 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.73 -1.211 . . . . 52.35 107.73 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -98.76 112.14 24.31 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.773 -1.566 . . . . 74.31 106.773 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.515 HG22 ' HG ' ' A' ' 103' ' ' LEU . 29.1 t -96.99 120.63 46.58 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 CA-C-N 113.79 -1.55 . . . . 71.11 107.739 -174.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 p -126.38 163.71 22.68 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 115.228 -0.896 . . . . 62.23 109.548 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.64 27.84 10.14 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.927 -0.869 . . . . 73.25 110.927 -173.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.563 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 96.8 mt -97.26 119.35 63.27 Favored Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 107.96 -1.126 . . . . 73.42 107.96 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.99 153.22 6.57 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.734 2.289 . . . . 72.14 111.283 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.512 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 8.6 p -70.07 -1.98 2.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.875 0.845 . . . . 70.11 112.013 -172.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -127.2 31.34 5.25 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-O 121.553 0.692 . . . . 65.15 109.974 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.14 149.06 6.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 N-CA-C 113.613 0.968 . . . . 74.02 113.613 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.529 ' HG2' ' CZ ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -102.74 144.53 28.8 Favored Pre-proline 0 C--N 1.279 -2.476 0 CA-C-N 113.883 -1.508 . . . . 73.41 109.615 176.091 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.45 -24.98 79.21 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 122.63 2.22 . . . . 74.32 113.325 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.529 ' CZ ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -84.14 -11.42 56.63 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 118.441 -1.304 . . . . 72.31 111.427 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.475 ' HG2' ' HG2' ' B' ' 46' ' ' GLU . 35.7 mt-10 -63.77 -39.92 95.44 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.703 0.763 . . . . 75.3 109.358 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.3 mt -67.32 -31.53 71.88 Favored 'General case' 0 C--O 1.209 -1.064 0 CA-C-N 115.226 -0.897 . . . . 73.45 110.077 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.6 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 42.0 t80 -65.32 -46.81 78.82 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.786 -0.643 . . . . 74.22 110.863 178.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 69.0 mt -64.92 -40.01 94.39 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.114 -0.494 . . . . 64.31 110.884 -176.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.6 tp -81.42 -38.96 25.65 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.43 -0.804 . . . . 61.55 112.543 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -95.43 -3.52 46.79 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.285 1.217 . . . . 72.43 114.285 -173.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -61.49 -44.55 92.56 Favored Pre-proline 0 CA--C 1.563 1.452 0 N-CA-C 112.799 0.666 . . . . 64.33 112.799 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.68 -2.39 12.39 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 121.393 1.395 . . . . 53.25 112.854 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -91.53 95.35 9.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 122.336 1.065 . . . . 72.4 110.945 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -63.79 109.63 1.8 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 113.078 -1.874 . . . . 74.23 110.519 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.72 -23.56 3.23 Favored Glycine 0 N--CA 1.422 -2.252 0 CA-C-N 114.858 -1.065 . . . . 70.55 111.002 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -55.32 114.85 1.97 Allowed 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.498 0.719 . . . . 74.52 111.959 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -97.86 -58.91 1.87 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.661 -0.699 . . . . 75.11 110.376 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -158.26 -177.0 30.94 Favored Glycine 0 C--N 1.295 -1.726 0 C-N-CA 120.898 -0.668 . . . . 73.45 111.869 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.7 p -148.76 140.65 23.76 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 123.032 0.533 . . . . 64.34 110.349 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.3 tp -120.87 122.01 39.33 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.41 -0.589 . . . . 75.24 109.41 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.403 HG23 ' HB2' ' A' ' 69' ' ' PRO . 44.4 mm -93.57 133.76 33.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 109.233 -0.654 . . . . 74.43 109.233 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -135.3 113.27 11.1 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 121.021 0.438 . . . . 62.25 110.374 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -67.97 124.43 23.34 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.362 0.601 . . . . 61.4 110.897 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.8 m -116.7 162.05 18.27 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 105.637 -1.986 . . . . 71.21 105.637 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.51 -34.95 3.53 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.163 1.172 . . . . 74.11 114.163 -175.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -95.62 -46.79 6.49 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 112.75 0.648 . . . . 70.43 112.75 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 4.2 pt20 -156.82 157.08 30.62 Favored Pre-proline 0 C--N 1.295 -1.773 0 CA-C-N 115.792 -0.64 . . . . 64.02 109.459 -170.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.512 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 74.5 Cg_endo -80.46 120.64 4.05 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 122.667 2.245 . . . . 72.3 110.711 171.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.91 161.62 2.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.239 -1.022 . . . . 71.54 108.239 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.91 120.93 2.92 Favored Glycine 0 CA--C 1.484 -1.85 0 C-N-CA 118.762 -1.685 . . . . 74.11 112.579 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -88.11 104.62 16.85 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.519 -1.289 . . . . 75.41 107.519 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.6 t -99.25 123.26 51.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 CA-C-N 115.922 -0.581 . . . . 62.32 109.799 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 tt -101.54 131.85 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 115.38 -0.827 . . . . 73.14 110.962 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 74.2 m-85 -115.51 146.83 41.34 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.434 -1.257 . . . . 74.01 107.639 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -79.23 -24.07 43.31 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.708 0.766 . . . . 74.42 110.493 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.6 m -109.96 140.65 43.73 Favored 'General case' 0 N--CA 1.392 -3.373 0 CA-C-N 115.498 -0.774 . . . . 73.24 108.964 -175.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.1 mmt-85 -73.38 -33.15 64.87 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.417 -1.327 . . . . 73.14 107.417 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.2 -19.23 61.77 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.499 -1.682 . . . . 44.12 109.071 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.91 -42.34 6.39 Favored Glycine 0 CA--C 1.487 -1.661 0 N-CA-C 109.606 -1.398 . . . . 63.44 109.606 -177.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.413 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -64.71 -47.45 78.27 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 114.902 -0.649 . . . . 73.35 111.115 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.56 -36.11 82.82 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.147 -0.621 . . . . 73.45 111.991 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.37 78.12 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 120.737 0.303 . . . . 44.35 110.854 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.36 -42.28 79.45 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.947 -0.569 . . . . 73.43 110.843 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.429 ' HB3' HD13 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -71.62 -28.78 64.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 120.245 -0.582 . . . . 73.51 111.801 -178.395 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -71.31 -41.38 69.97 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 120.592 0.234 . . . . 64.34 111.542 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.05 -41.42 50.74 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.252 0.464 . . . . 75.24 112.252 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.477 ' O ' HG22 ' A' ' 91' ' ' ILE . 97.4 mt -95.93 1.71 53.06 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 115.646 1.721 . . . . 70.24 115.646 -173.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -79.09 114.39 18.0 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 116.822 -1.951 . . . . 75.31 111.066 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.17 12.18 34.58 Favored Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 110.27 -1.132 . . . . 61.12 110.27 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.3 tt -82.38 134.46 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.911 0 N-CA-C 109.116 -0.698 . . . . 52.42 109.116 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.461 ' NH1' ' HA ' ' A' ' 98' ' ' PRO . 26.2 mmt180 -60.91 121.07 11.44 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 107.954 -1.128 . . . . 72.4 107.954 171.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -75.37 -27.06 58.99 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.856 -1.535 . . . . 73.14 106.856 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 97' ' ' ASN . 12.0 t70 -148.07 126.1 5.91 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 103.212 -2.884 . . . . 70.24 103.212 174.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.561 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 69.2 Cg_endo -71.81 -16.44 29.62 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.426 1.417 . . . . 61.32 114.732 -175.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -93.07 -22.14 19.3 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.34 0.591 . . . . 74.13 110.174 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 48.9 t-20 -91.27 132.49 33.77 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.158 -1.423 . . . . 65.43 107.158 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.461 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 35.6 Cg_endo -67.75 -1.8 7.43 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.587 2.192 . . . . 70.33 113.0 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.75 113.74 10.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.793 -0.817 . . . . 62.45 108.793 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.9 p -115.7 147.53 40.77 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.915 -0.584 . . . . 74.13 109.687 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.6 tp -94.83 125.04 39.23 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 116.073 -0.512 . . . . 73.44 109.84 -174.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -120.54 126.35 50.11 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.194 -0.669 . . . . 75.01 109.194 176.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.515 ' HG ' HG22 ' A' ' 35' ' ' VAL . 7.0 mp -104.5 127.18 52.15 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 107.841 -1.17 . . . . 62.42 107.841 176.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -136.04 163.29 30.66 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 107.731 -1.211 . . . . 71.03 107.731 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.505 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 33.0 m-85 -78.7 134.83 37.06 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 119.048 0.84 . . . . 74.44 110.323 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.39 165.0 25.42 Favored 'General case' 0 N--CA 1.428 -1.532 0 O-C-N 123.668 0.605 . . . . 43.35 109.403 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -86.79 -6.87 58.68 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-O 121.946 0.879 . . . . 53.11 109.661 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.5 134.22 23.61 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.073 -0.967 . . . . 75.33 108.83 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' A' ' 30' ' ' VAL . 3.3 m-20 -76.72 124.97 28.46 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.165 -1.421 . . . . 53.12 107.165 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.409 -2.476 0 C-N-CA 118.113 -1.435 . . . . 75.53 108.907 179.326 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.56 HG12 ' H ' ' B' ' 32' ' ' THR . 17.5 t . . . . . 0 N--CA 1.444 -0.727 0 N-CA-C 110.345 -0.243 . . . . 74.43 110.345 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.572 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 82.8 mtm180 -96.22 0.04 50.52 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-O 121.286 0.565 . . . . 53.34 110.74 175.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' THR . . . . . 0.56 ' H ' HG12 ' B' ' 30' ' ' VAL . 25.0 m -111.24 128.72 56.02 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-O 121.511 0.672 . . . . 72.43 112.549 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.5 HD11 ' O ' ' B' ' 81' ' ' ALA . 91.1 mt -104.57 146.37 29.0 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.43 -0.952 . . . . 73.42 108.43 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.6 ' CE1' ' HB2' ' B' ' 104' ' ' GLU . 27.9 p90 -104.6 115.18 29.89 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.187 -1.412 . . . . 51.2 107.187 172.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.53 115.45 37.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 CA-C-N 113.917 -1.492 . . . . 62.31 107.859 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 35.7 p -119.53 171.4 8.38 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.272 -0.876 . . . . 74.24 109.272 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 86.93 25.01 35.83 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.38 -1.088 . . . . 52.51 110.38 -173.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 95.7 mt -94.77 114.71 64.2 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 107.701 -1.222 . . . . 60.23 107.701 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.23 157.62 1.86 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.762 2.308 . . . . 74.33 111.968 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 7.2 p -63.35 -17.52 19.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.424 0.63 . . . . 75.21 112.111 -173.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -120.35 42.38 2.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.682 0.753 . . . . 62.34 109.948 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.421 HG12 ' HB3' ' B' ' 38' ' ' LEU . 2.5 pp -60.89 135.02 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.563 -1.255 . . . . 73.3 110.801 169.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.41 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 23.4 mmmt -94.19 144.14 27.55 Favored Pre-proline 0 C--N 1.266 -3.025 0 N-CA-C 106.68 -1.6 . . . . 71.15 106.68 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.38 -20.7 69.44 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.352 2.035 . . . . 70.11 113.176 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.487 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 0.0 OUTLIER -87.34 -10.74 51.38 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 118.966 -1.094 . . . . 71.02 111.999 -179.403 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.475 ' HG2' ' HG2' ' A' ' 46' ' ' GLU . 33.5 mt-10 -67.07 -39.0 86.74 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.426 0.631 . . . . 53.23 109.811 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 90.9 mt -68.86 -29.97 68.39 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-N 115.445 -0.798 . . . . 54.43 109.393 176.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.561 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 39.9 t80 -66.99 -47.99 69.83 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.438 -0.801 . . . . 74.2 110.682 177.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 82.3 mt -63.69 -39.77 95.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.29 0.567 . . . . 72.21 110.327 -177.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 33.6 tp -76.82 -39.49 51.16 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.106 -0.952 . . . . 73.0 112.489 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -95.25 -0.87 52.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 114.175 1.176 . . . . 74.41 114.175 -176.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -63.13 -42.98 79.83 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 112.479 0.548 . . . . 53.45 112.479 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -65.93 -21.63 56.82 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.09 1.86 . . . . 42.21 112.226 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -92.24 88.23 6.39 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 121.753 0.787 . . . . 75.21 109.57 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -80.51 115.49 20.06 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 122.439 1.114 . . . . 71.24 111.361 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.01 -28.41 0.73 Allowed Glycine 0 C--N 1.284 -2.354 0 CA-C-N 112.657 -2.065 . . . . 71.2 108.742 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -48.6 121.88 4.99 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.818 1.247 . . . . 75.23 111.775 174.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.47 ' HB2' HG23 ' B' ' 74' ' ' ILE . 12.0 mm-40 -92.83 -56.71 2.9 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.546 -0.909 . . . . 72.3 108.546 174.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.54 -175.88 39.57 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 115.063 -0.971 . . . . 72.15 112.035 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 12.5 p -136.99 138.17 40.24 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 122.735 0.414 . . . . 61.1 111.086 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 57.8 tp -114.39 127.22 55.73 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.289 -1.004 . . . . 63.34 108.289 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 50.8 mm -93.99 143.37 11.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.232 -0.655 . . . . 61.45 109.232 -176.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -137.96 108.23 6.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.645 -0.872 . . . . 63.31 108.645 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -66.94 128.98 38.4 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.312 0.577 . . . . 74.15 109.834 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.8 m -125.72 158.15 35.57 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 104.584 -2.376 . . . . 73.14 104.584 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.68 -29.24 59.02 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.554 0.946 . . . . 74.24 113.554 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -85.92 -39.28 17.12 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.729 0.64 . . . . 75.4 112.729 177.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 3.7 pt20 -174.32 155.1 2.16 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 115.886 -0.597 . . . . 74.34 109.691 -169.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.447 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 58.4 Cg_endo -80.28 115.82 3.25 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 C-N-CA 122.357 2.038 . . . . 74.24 110.657 171.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -87.92 162.63 2.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.405 -0.961 . . . . 53.04 108.405 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.06 122.7 3.4 Favored Glycine 0 CA--C 1.491 -1.464 0 C-N-CA 118.689 -1.72 . . . . 73.41 113.555 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -87.93 108.99 19.46 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.541 -1.281 . . . . 72.12 107.541 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 67.9 t -103.54 120.66 53.9 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 115.698 -0.683 . . . . 74.33 110.285 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.526 HD12 ' O ' ' B' ' 110' ' ' THR . 3.6 tt -96.54 130.82 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 115.169 -0.923 . . . . 75.32 110.06 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 75' ' ' PHE . . . . . 0.572 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 90.0 m-85 -111.13 156.56 21.18 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.906 -1.043 . . . . 65.44 108.326 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.74 -36.15 82.91 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.015 0.436 . . . . 60.54 112.089 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 33.0 p -131.84 163.41 28.33 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.411 0.624 . . . . 73.02 112.64 -175.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' B' ' 82' ' ' GLU . 4.4 mpt_? -73.94 -34.06 64.17 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 108.734 -0.839 . . . . 75.14 108.734 176.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.82 -19.84 64.29 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.01 -0.996 . . . . 72.41 109.564 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.16 -46.12 6.0 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.224 -1.151 . . . . 54.11 110.224 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.5 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -62.88 -45.1 94.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.3 -0.45 . . . . 63.24 111.705 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' B' ' 78' ' ' ARG . 9.6 pt-20 -63.56 -36.11 82.71 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 120.916 -0.314 . . . . 72.15 111.299 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.43 -41.85 79.72 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 120.839 0.352 . . . . 52.14 110.312 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.44 -42.31 87.84 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.72 -0.673 . . . . 63.41 111.227 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -70.96 -39.29 72.63 Favored 'General case' 0 C--O 1.203 -1.35 0 C-N-CA 119.407 -0.917 . . . . 72.41 110.999 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -65.68 -31.9 73.16 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.174 0.511 . . . . 61.43 110.764 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.06 -40.27 17.02 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 112.309 0.485 . . . . 71.0 112.309 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.529 ' O ' HG22 ' B' ' 91' ' ' ILE . 87.3 mt -100.99 -13.11 18.4 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 116.348 1.981 . . . . 70.03 116.348 -172.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -76.17 113.69 14.0 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 117.401 -1.72 . . . . 73.13 112.043 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 113.36 6.46 21.91 Favored Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 120.545 -0.836 . . . . 65.31 112.055 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.529 HG22 ' O ' ' B' ' 88' ' ' LEU . 14.9 tt -97.95 144.67 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.954 0 N-CA-C 107.117 -1.438 . . . . 72.33 107.117 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.418 ' HG2' HG22 ' B' ' 100' ' ' THR . 81.6 mtt180 -79.42 138.36 37.6 Favored 'General case' 0 C--N 1.26 -3.296 0 CA-C-O 121.244 0.545 . . . . 71.23 111.471 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -69.17 -35.51 76.37 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 113.811 -1.54 . . . . 74.55 108.599 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' B' ' 97' ' ' ASN . 1.1 m-20 -129.36 130.13 23.3 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 102.306 -3.22 . . . . 73.04 102.306 172.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 95' ' ' PRO . . . . . 0.6 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 27.9 Cg_endo -61.29 -30.66 88.32 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.316 2.011 . . . . 75.33 113.39 -177.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -94.19 15.21 17.85 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 123.339 0.656 . . . . 65.24 111.276 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 97' ' ' ASN . . . . . 0.495 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . 46.3 t30 -127.18 128.14 24.16 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.698 -0.853 . . . . 72.34 108.698 -177.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.55 9.82 1.15 Allowed 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.927 2.418 . . . . 53.33 113.25 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -83.83 110.34 18.28 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.894 -1.521 . . . . 70.32 106.894 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.462 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 65.5 p -102.72 141.09 36.11 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.798 -0.761 . . . . 74.3 110.365 -175.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 24.7 tp -86.17 126.1 33.99 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.272 -1.01 . . . . 72.14 108.272 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -131.05 121.68 25.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 109.437 -0.579 . . . . 62.44 109.437 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.68 116.59 32.27 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.126 -0.943 . . . . 72.51 109.829 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 104' ' ' GLU . . . . . 0.6 ' HB2' ' CE1' ' B' ' 34' ' ' PHE . 40.2 mm-40 -122.51 170.33 10.09 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.545 -1.65 . . . . 73.11 106.545 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -81.72 137.43 35.38 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 119.184 0.902 . . . . 72.35 109.738 176.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.66 151.13 27.72 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.176 0.512 . . . . 74.51 111.41 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -87.23 12.09 12.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.715 0.769 . . . . 41.23 109.996 177.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -137.69 115.42 11.38 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 107.524 -1.287 . . . . 70.25 107.524 177.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -84.05 106.96 16.11 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.464 -1.68 . . . . 71.34 106.464 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.526 ' O ' HD12 ' B' ' 74' ' ' ILE . 28.8 m . . . . . 0 C--N 1.3 -1.544 0 CA-C-N 116.245 -0.434 . . . . 51.32 110.834 -173.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 CA--C 1.508 -0.64 0 N-CA-C 109.288 -0.634 . . . . 75.31 109.288 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.87 136.35 50.6 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.382 -0.969 . . . . 74.43 108.382 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -52.29 144.45 12.78 Favored 'General case' 0 C--O 1.25 1.083 0 O-C-N 124.229 0.955 . . . . 73.21 112.842 -175.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.497 ' HA ' ' CD ' ' A' ' 78' ' ' ARG . 1.4 pp20? -78.04 96.01 4.99 Favored 'General case' 0 N--CA 1.385 -3.683 0 CA-C-O 122.318 1.056 . . . . 75.4 109.685 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' A' ' 105' ' ' PHE . 40.6 t -82.28 111.82 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 114.826 -1.079 . . . . 53.34 108.289 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 88.4 mtt180 -88.53 12.8 13.54 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.676 -0.693 . . . . 72.22 111.458 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.9 m -136.99 132.74 34.74 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 121.415 0.626 . . . . 60.31 112.462 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.4 mt -112.11 145.3 40.02 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.358 -0.979 . . . . 71.4 108.358 173.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.403 ' CE1' ' HB2' ' A' ' 104' ' ' GLU . 21.5 p90 -103.42 114.8 29.36 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 106.956 -1.498 . . . . 73.31 106.956 172.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.59 HG22 ' HG ' ' A' ' 103' ' ' LEU . 33.5 t -101.05 113.87 38.46 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 CA-C-N 114.144 -1.389 . . . . 64.23 108.643 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.6 p -111.4 171.61 7.38 Favored 'General case' 0 N--CA 1.41 -2.438 0 N-CA-C 109.104 -0.702 . . . . 64.52 109.104 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 88.04 29.13 21.27 Favored Glycine 0 N--CA 1.431 -1.652 0 C-N-CA 120.911 -0.661 . . . . 33.24 112.493 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 96.5 mt -93.07 125.83 53.39 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.671 -1.233 . . . . 72.23 107.671 173.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -50.21 153.41 6.91 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.484 2.123 . . . . 70.21 110.783 172.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.453 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 11.3 p -65.94 -12.91 14.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 123.152 0.581 . . . . 62.42 112.09 -172.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -126.77 41.67 3.47 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.904 0.859 . . . . 53.35 109.373 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 pp -59.17 145.5 10.84 Favored 'Isoleucine or valine' 0 C--O 1.25 1.115 0 C-N-CA 119.271 -0.972 . . . . 72.31 112.52 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.451 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 70.6 mmtt -98.94 146.22 31.3 Favored Pre-proline 0 C--N 1.271 -2.813 0 N-CA-C 107.31 -1.367 . . . . 72.03 107.31 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -59.45 -24.53 75.15 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.381 2.054 . . . . 74.02 111.866 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.548 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . 13.9 ptt180 -78.13 -20.58 51.83 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.692 -0.686 . . . . 75.13 112.736 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 42.6 mt-10 -64.6 -38.74 92.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.221 0.534 . . . . 63.43 110.368 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -76.1 -22.17 55.86 Favored 'General case' 0 C--O 1.212 -0.907 0 CA-C-O 121.628 0.727 . . . . 65.45 109.934 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.508 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 62.9 t80 -73.5 -47.96 37.11 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.065 -0.97 . . . . 72.2 109.04 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.39 -38.84 74.75 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.655 -0.702 . . . . 75.43 110.175 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.9 tp -78.52 -37.08 43.92 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.46 -0.791 . . . . 61.42 112.719 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -97.05 1.04 49.65 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 118.898 -1.121 . . . . 63.23 113.598 -175.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -67.82 -42.93 36.44 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 114.049 1.129 . . . . 72.2 114.049 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -63.76 -20.11 68.17 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 121.478 1.452 . . . . 72.12 111.807 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -90.02 101.11 13.82 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 121.638 0.732 . . . . 74.2 110.834 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -64.41 110.4 2.26 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.345 -1.298 . . . . 65.2 110.642 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.47 -17.26 3.1 Favored Glycine 0 N--CA 1.425 -2.087 0 CA-C-N 115.015 -0.993 . . . . 62.15 113.326 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -62.4 107.9 1.01 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 118.001 0.901 . . . . 74.21 112.317 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -90.72 -43.92 9.8 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.49 -0.777 . . . . 74.41 110.648 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.91 171.88 43.29 Favored Glycine 0 C--N 1.301 -1.376 0 C-N-CA 120.797 -0.716 . . . . 54.44 111.674 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.8 p -138.57 137.34 36.91 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.85 0.325 . . . . 74.24 111.659 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 112' ' ' MET . 6.6 mp -112.83 121.63 45.27 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.561 -0.903 . . . . 65.35 108.561 177.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.5 mm -94.27 133.03 36.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 120.892 0.377 . . . . 74.32 110.14 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -118.06 106.88 13.35 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.708 -1.59 . . . . 73.52 106.708 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.73 131.19 42.77 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.893 -0.594 . . . . 73.15 109.663 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.591 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 18.8 m -129.7 153.01 48.58 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 104.486 -2.412 . . . . 72.31 104.486 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.5 -26.87 45.24 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 114.381 1.252 . . . . 42.45 114.381 -172.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 30.8 mmt180 -104.48 -25.64 12.71 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 113.268 0.84 . . . . 73.43 113.268 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.591 ' O ' ' HB ' ' A' ' 65' ' ' THR . 14.3 pt20 -172.55 136.54 0.82 Allowed Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.398 -0.593 . . . . 72.43 109.398 -173.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.455 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 44.8 Cg_endo -74.58 133.39 17.2 Favored 'Trans proline' 0 N--CA 1.43 -2.232 0 C-N-CA 121.956 1.771 . . . . 70.12 110.449 170.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m -101.78 143.54 14.5 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 N-CA-C 108.126 -1.065 . . . . 74.31 108.126 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.5 120.96 4.88 Favored Glycine 0 CA--C 1.479 -2.161 0 C-N-CA 119.807 -1.187 . . . . 73.11 112.719 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -87.69 102.8 14.99 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.769 -1.567 . . . . 72.52 106.769 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.9 t -97.69 123.8 50.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-N 114.984 -1.007 . . . . 65.32 110.036 -175.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' A' ' 112' ' ' MET . 10.9 tt -95.86 131.51 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.108 0 CA-C-N 115.04 -0.982 . . . . 75.13 109.274 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.45 159.71 18.48 Favored 'General case' 0 N--CA 1.414 -2.25 0 CA-C-N 114.977 -1.01 . . . . 71.33 110.839 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -53.63 -44.93 69.93 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 125.646 1.578 . . . . 75.01 110.808 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.3 p -150.8 153.86 36.22 Favored 'General case' 0 N--CA 1.398 -3.067 0 CA-C-N 115.403 -0.817 . . . . 64.33 111.293 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.497 ' CD ' ' HA ' ' A' ' 29' ' ' GLU . 7.2 ttt-85 -58.74 -42.58 89.12 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 125.158 1.383 . . . . 74.34 110.2 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.66 -18.73 64.26 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.897 -1.047 . . . . 74.51 109.394 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.25 -45.26 5.37 Favored Glycine 0 C--N 1.294 -1.766 0 CA-C-N 113.626 -1.625 . . . . 61.3 110.455 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.54 -45.02 95.39 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.998 0.919 . . . . 51.04 111.584 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.08 -26.92 68.76 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.286 -0.416 . . . . 63.44 111.844 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.5 -39.52 27.81 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.16 0.505 . . . . 72.01 109.878 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.95 85.96 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.684 -0.689 . . . . 43.15 111.021 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.419 ' CE ' ' HA ' ' A' ' 104' ' ' GLU . 14.0 ptmm? -68.38 -28.08 66.79 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 116.201 -0.454 . . . . 71.12 110.281 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -64.43 -36.23 83.5 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.658 0.599 . . . . 73.44 110.904 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.25 -38.64 17.38 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 120.977 0.418 . . . . 63.12 111.916 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.532 ' O ' HG22 ' A' ' 91' ' ' ILE . 95.6 mt -96.94 -5.43 37.98 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 115.571 1.693 . . . . 60.14 115.571 -171.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -78.75 114.93 18.1 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 117.086 -1.845 . . . . 54.33 110.889 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.34 14.65 29.86 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 110.746 -0.942 . . . . 64.24 110.746 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 88' ' ' LEU . 10.2 tt -84.7 126.04 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.875 0 CA-C-O 121.632 0.73 . . . . 55.14 109.413 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -63.93 111.78 2.64 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 105.84 -1.911 . . . . 73.31 105.84 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -71.71 -25.78 62.22 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.947 0.88 . . . . 73.11 109.262 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -161.29 117.8 1.37 Allowed Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 106.583 -1.636 . . . . 72.31 106.583 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.08 -28.81 86.39 Favored 'Trans proline' 0 N--CA 1.474 0.349 0 C-N-CA 122.161 1.907 . . . . 74.44 112.862 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -74.71 -24.7 58.79 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.275 0.56 . . . . 71.13 110.899 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -102.96 135.64 19.38 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.023 -1.473 . . . . 63.12 107.023 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.97 15.06 0.62 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.306 2.004 . . . . 72.4 112.341 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.404 ' HA ' ' OE1' ' A' ' 99' ' ' GLN . 5.9 tp60 -89.96 121.4 32.02 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.922 0.889 . . . . 72.44 110.334 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.483 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 66.2 p -114.59 142.47 46.39 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.128 -0.693 . . . . 73.01 109.128 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.9 tp -89.18 135.95 33.29 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.933 -0.766 . . . . 71.15 108.933 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -135.0 124.79 25.39 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.57 -0.529 . . . . 61.23 109.57 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.59 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.6 mp -110.84 118.33 35.84 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.059 -0.519 . . . . 63.44 109.866 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HA ' ' CE ' ' A' ' 85' ' ' LYS . 7.7 mm-40 -126.61 161.29 28.39 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.936 -0.765 . . . . 72.02 108.936 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.447 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 27.1 m-85 -69.94 139.17 52.84 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.36 -0.536 . . . . 54.54 109.922 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.52 160.66 29.28 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 121.121 0.486 . . . . 65.02 110.004 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -77.16 -13.65 59.91 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.454 -0.794 . . . . 73.54 110.127 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.38 136.67 16.64 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.025 -0.989 . . . . 62.23 109.449 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -70.96 113.0 7.56 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.239 -1.393 . . . . 43.32 107.239 173.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.4 t -89.29 126.57 35.57 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.486 -0.931 . . . . 64.23 108.486 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.457 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 54.5 mtmt -90.39 81.88 5.97 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 113.098 0.777 . . . . 72.43 113.098 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.444 ' HB3' HG21 ' A' ' 74' ' ' ILE . 14.1 tpt -74.77 -53.19 9.64 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 105.439 -2.06 . . . . 70.43 105.439 171.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.61 115.81 28.01 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 103.707 -2.701 . . . . 70.51 103.707 168.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 111' ' ' LYS . 95.4 mttt -69.57 110.99 5.1 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 112.863 0.69 . . . . 70.52 112.863 -170.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.2 m -62.16 113.99 3.18 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.464 -1.244 . . . . 75.32 112.709 -176.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.03 140.08 6.4 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.408 -1.701 . . . . 71.4 106.408 172.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.8 tp -114.54 13.53 17.56 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.305 -0.958 . . . . 74.14 112.624 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 . . . . . 0 C--N 1.305 -1.346 0 N-CA-C 108.243 -1.021 . . . . 71.23 108.243 175.692 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 12.4 tpt . . . . . 0 CA--C 1.515 -0.404 0 N-CA-C 107.183 -1.414 . . . . 74.21 107.183 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -105.03 -73.13 0.69 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.802 -0.814 . . . . 54.34 108.802 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -123.22 105.41 9.86 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.842 -0.617 . . . . 65.12 109.696 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' B' ' 78' ' ' ARG . 7.9 pt-20 -70.17 96.23 1.06 Allowed 'General case' 0 N--CA 1.387 -3.615 0 CA-C-O 121.142 0.496 . . . . 74.22 112.238 175.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 60.1 t -79.45 110.05 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 N-CA-C 105.105 -2.183 . . . . 75.2 105.105 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -84.86 8.2 18.25 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 112.417 0.525 . . . . 61.34 112.417 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 28.9 m -127.85 129.27 46.66 Favored 'General case' 0 C--N 1.27 -2.857 0 C-N-CA 119.963 -0.695 . . . . 72.41 112.065 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -104.77 134.39 48.0 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.517 -1.29 . . . . 72.23 107.517 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.567 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 33.7 p90 -91.75 118.3 30.55 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 107.784 -1.191 . . . . 74.04 107.784 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.446 HG22 ' HG ' ' B' ' 103' ' ' LEU . 39.6 t -97.44 115.68 37.86 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 114.198 -1.364 . . . . 61.23 108.137 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 24.0 p -129.44 171.12 12.87 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 115.101 -0.954 . . . . 64.42 109.224 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 82.03 51.92 4.27 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 110.44 -1.064 . . . . 70.03 110.44 -173.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 95.7 mt -122.44 129.25 25.14 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.868 -1.16 . . . . 53.24 107.868 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -52.85 159.59 4.92 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 122.412 2.074 . . . . 72.11 110.978 171.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.68 -10.54 14.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.628 0.727 . . . . 74.12 111.301 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -127.02 40.83 3.64 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 122.158 0.98 . . . . 73.33 109.441 -176.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.451 ' O ' HD12 ' B' ' 42' ' ' ILE . 2.7 pp -64.46 134.19 29.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 118.686 -1.205 . . . . 71.53 110.666 170.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.416 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 74.1 mmtt -91.42 141.99 26.55 Favored Pre-proline 0 C--N 1.273 -2.734 0 N-CA-C 108.672 -0.862 . . . . 71.43 108.672 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -51.78 -32.16 44.94 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.85 2.367 . . . . 74.52 112.429 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.48 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 12.0 ptt180 -68.44 -26.57 65.58 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 112.426 0.528 . . . . 62.24 112.426 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.416 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 32.7 mt-10 -65.13 -42.7 93.63 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.327 0.584 . . . . 71.21 109.539 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.38 -36.6 81.68 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 115.397 -0.82 . . . . 74.2 109.489 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.486 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 76.2 t80 -61.01 -46.82 89.19 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.822 -1.081 . . . . 63.42 110.867 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 89.0 mt -66.62 -41.66 88.02 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.241 0.544 . . . . 55.05 109.826 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 29.2 tp -69.73 -44.2 70.77 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.667 -1.151 . . . . 72.33 112.117 -175.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -94.53 4.42 53.87 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 113.167 0.803 . . . . 61.33 113.167 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 28.2 ttt180 -69.5 -43.77 23.55 Favored Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 112.976 0.732 . . . . 75.15 112.976 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -76.23 -2.47 12.66 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 121.45 1.434 . . . . 74.44 112.033 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -94.6 103.12 15.06 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 121.833 0.825 . . . . 70.32 111.556 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -68.19 118.17 10.97 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 114.103 -1.408 . . . . 65.15 110.793 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' B' ' 75' ' ' PHE . . . 133.07 -19.7 4.33 Favored Glycine 0 C--N 1.281 -2.472 0 CA-C-N 115.005 -0.998 . . . . 73.52 112.695 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -58.4 113.22 1.87 Allowed 'General case' 0 C--O 1.242 0.672 0 CA-C-N 117.301 0.55 . . . . 70.42 111.663 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -95.46 -58.97 1.98 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.58 -0.736 . . . . 74.01 110.344 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.6 160.2 32.92 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 120.041 -1.076 . . . . 72.2 113.095 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.3 p -119.33 137.95 53.37 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 122.702 0.401 . . . . 62.42 110.814 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 66.9 tp -111.31 111.3 22.25 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.882 -1.155 . . . . 75.54 107.882 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 51.0 mm -94.61 136.38 26.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 109.732 -0.47 . . . . 63.41 109.732 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -133.19 114.84 14.3 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.477 -0.935 . . . . 74.44 108.477 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.06 113.95 8.63 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.959 -1.126 . . . . 75.15 107.959 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.9 m -105.93 167.56 9.71 Favored 'General case' 0 N--CA 1.403 -2.807 0 N-CA-C 107.023 -1.473 . . . . 72.53 107.023 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.76 -33.42 23.11 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.675 0.991 . . . . 71.12 113.675 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -105.18 -37.78 6.78 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 119.724 -0.79 . . . . 71.53 112.424 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -155.25 159.68 31.53 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 110.203 -0.295 . . . . 73.43 110.203 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.24 123.29 7.09 Favored 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.218 1.945 . . . . 65.33 109.636 167.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 35.9 m -97.58 156.84 3.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 107.461 -1.311 . . . . 64.24 107.461 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.03 121.94 2.58 Favored Glycine 0 C--O 1.203 -1.798 0 C-N-CA 118.237 -1.935 . . . . 50.33 113.492 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -88.42 108.36 19.33 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.78 -1.193 . . . . 60.54 107.78 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.62 120.11 53.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-N 116.184 -0.462 . . . . 74.11 110.473 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' B' ' 111' ' ' LYS . 11.8 tt -96.32 134.8 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 115.559 -0.746 . . . . 73.41 110.478 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' B' ' 56' ' ' GLY . 60.1 m-85 -111.29 149.58 30.87 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 114.621 -1.172 . . . . 74.2 109.821 179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -56.27 -34.35 66.34 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.727 1.211 . . . . 61.32 111.453 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 9.9 p -144.56 138.3 27.4 Favored 'General case' 0 N--CA 1.398 -3.027 0 CA-C-O 121.953 0.883 . . . . 73.4 110.634 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -74.9 -25.57 59.03 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 114.494 -1.23 . . . . 75.21 110.453 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.1 -19.68 64.06 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.532 1.158 . . . . 73.33 108.654 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.26 -43.2 5.66 Favored Glycine 0 C--N 1.308 -1.0 0 CA-C-N 113.786 -1.552 . . . . 51.2 109.922 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.41 -37.64 78.55 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.989 0.916 . . . . 52.21 112.02 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.04 -34.53 76.41 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.864 0.364 . . . . 62.33 111.44 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.25 -38.12 27.43 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.295 0.569 . . . . 72.43 109.804 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.2 93.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.872 -1.058 . . . . 61.44 111.202 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -65.6 -41.01 93.28 Favored 'General case' 0 C--O 1.195 -1.815 0 CA-C-N 116.258 -0.428 . . . . 75.2 110.647 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -63.68 -24.73 67.9 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 112.359 0.503 . . . . 74.24 112.359 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.54 -36.02 33.67 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 120.811 0.339 . . . . 64.42 111.156 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.497 ' O ' HG22 ' B' ' 91' ' ' ILE . 98.6 mt -102.14 -19.92 14.93 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 115.222 1.564 . . . . 74.04 115.222 -174.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ASN . . . . . 0.436 ' HB3' ' H ' ' B' ' 103' ' ' LEU 0.259 0.2 OUTLIER -75.65 113.95 13.67 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 118.92 -1.112 . . . . 62.35 112.616 -178.807 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.04 14.99 13.51 Favored Glycine 0 N--CA 1.41 -3.035 0 CA-C-N 115.554 -0.748 . . . . 61.4 111.74 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.497 HG22 ' O ' ' B' ' 88' ' ' LEU . 15.7 tt -95.93 133.89 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.977 0 N-CA-C 108.964 -0.754 . . . . 74.35 108.964 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' B' ' 92' ' ' ARG . 7.3 tpt180 -62.82 119.3 9.09 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 105.117 -2.179 . . . . 74.33 105.117 172.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -68.18 -31.12 70.44 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 108.418 -0.956 . . . . 74.31 108.418 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 45' ' ' ARG . 1.0 OUTLIER -166.47 137.42 2.76 Favored Pre-proline 0 N--CA 1.427 -1.616 0 N-CA-C 106.709 -1.589 . . . . 74.42 106.709 174.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.1 -2.81 12.88 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.132 1.888 . . . . 71.23 113.237 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -85.63 -24.92 26.91 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.75 0.786 . . . . 71.54 109.532 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' ASN . . . . . 0.544 ' OD1' ' HB2' ' B' ' 99' ' ' GLN . 6.6 t-20 -110.45 148.17 37.88 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 106.004 -1.85 . . . . 73.44 106.004 174.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.05 22.1 0.77 Allowed 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 122.529 2.153 . . . . 65.13 112.045 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLN . . . . . 0.544 ' HB2' ' OD1' ' B' ' 97' ' ' ASN . 5.5 tp60 -89.41 129.29 35.95 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.948 0.899 . . . . 63.22 110.802 -176.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.544 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 36.8 p -116.52 138.32 51.49 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.731 -0.47 . . . . 54.23 109.731 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 49.3 tp -86.09 131.1 34.33 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.045 -0.724 . . . . 73.12 109.045 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -135.82 122.63 21.15 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-O 120.834 0.35 . . . . 74.02 110.31 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.446 ' HG ' HG22 ' B' ' 35' ' ' VAL . 6.2 mp -108.27 116.27 31.66 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.841 -1.17 . . . . 74.22 107.841 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.567 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 7.4 tp10 -131.72 159.6 37.94 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.625 -1.62 . . . . 61.41 106.625 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -68.93 137.19 53.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 119.561 1.073 . . . . 71.32 110.859 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.63 164.28 26.46 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.92 -0.582 . . . . 74.44 110.232 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -84.72 -9.86 57.81 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.76 0.791 . . . . 71.31 109.114 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.44 130.09 19.09 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.208 -0.905 . . . . 63.24 109.892 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -70.26 104.55 2.69 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.854 -1.165 . . . . 64.41 107.854 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 13.0 m -92.37 101.99 14.46 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.665 -0.698 . . . . 62.31 109.57 -172.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' LYS . . . . . 0.475 ' HA ' HD12 ' B' ' 74' ' ' ILE . 53.3 mtmt -77.93 83.62 4.24 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.029 0.919 . . . . 72.25 111.284 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 14.7 tpt -96.68 24.04 6.41 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.533 -1.212 . . . . 72.22 107.888 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -140.31 119.08 12.45 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.491 -1.231 . . . . 63.13 107.791 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -71.99 108.51 5.27 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.642 0.589 . . . . 73.43 109.977 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 41.9 p -142.14 139.55 32.18 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.405 -0.361 . . . . 54.15 110.263 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -130.89 159.13 38.32 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.468 -0.938 . . . . 74.52 108.468 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 33.3 tp -108.13 20.05 19.18 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.922 -0.77 . . . . 72.15 108.922 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 . . . . . 0 C--N 1.318 -0.794 0 N-CA-C 108.038 -1.097 . . . . 52.31 108.038 177.024 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.583 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 96.2 mmm . . . . . 0 C--O 1.207 -1.153 0 N-CA-C 110.472 -0.196 . . . . 75.31 110.472 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 44.6 mt-10 -89.57 62.04 5.75 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 121.067 -1.021 . . . . 54.14 112.197 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 27' ' ' GLU . 15.1 mt-10 -171.12 30.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 126.304 1.842 . . . . 64.2 110.572 175.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 26' ' ' MET . 43.0 mm-40 -70.61 106.74 3.61 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.603 -1.18 . . . . 72.11 108.934 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.3 t -77.49 109.02 11.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 103.859 -2.645 . . . . 54.01 103.859 167.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 75' ' ' PHE . 26.6 ptt180 -129.64 7.97 5.32 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.793 -0.64 . . . . 73.52 112.461 -168.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.3 m -104.89 124.48 49.55 Favored 'General case' 0 C--N 1.266 -3.04 0 C-N-CA 119.77 -0.772 . . . . 70.12 109.236 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 93.7 mt -104.75 136.78 43.63 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.745 -1.205 . . . . 64.14 107.745 176.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.501 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 20.4 p90 -98.32 118.98 36.18 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.27 -1.382 . . . . 74.24 107.27 174.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.461 HG22 ' HG ' ' A' ' 103' ' ' LEU . 19.5 t -99.79 111.01 28.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 114.531 -1.213 . . . . 61.53 108.365 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.7 p -110.01 175.33 5.48 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 108.57 -0.9 . . . . 73.11 108.57 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 97.42 1.33 59.2 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.757 -0.735 . . . . 54.21 111.659 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.5 mt -77.06 139.05 65.03 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 108.373 -0.973 . . . . 42.32 108.373 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 170.38 16.69 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.726 1.617 . . . . 75.53 111.383 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 p -78.69 7.54 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-O 122.67 1.224 . . . . 60.41 109.403 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -115.93 7.94 14.55 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.042 -1.436 . . . . 75.52 109.481 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.32 125.3 18.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.962 0.887 . . . . 55.25 110.813 -176.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -109.96 142.04 25.05 Favored Pre-proline 0 C--N 1.289 -2.043 0 CA-C-N 114.198 -1.365 . . . . 75.05 109.356 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.48 -25.08 30.72 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.63 2.886 . . . . 51.24 113.56 -176.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' HB3' ' OD2' ' B' ' 94' ' ' ASP . 23.7 ptt180 -66.63 -28.17 68.26 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 121.067 0.461 . . . . 75.42 111.464 -178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -71.48 -38.2 71.23 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.143 0.497 . . . . 70.51 110.666 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.76 -38.65 73.47 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 108.544 -0.91 . . . . 73.01 108.544 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.573 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 12.2 t80 -57.93 -49.05 78.08 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.756 -1.111 . . . . 73.41 111.087 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 97.1 mt -62.84 -41.31 99.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.075 0.464 . . . . 54.31 110.707 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.9 tp -73.46 -40.92 63.78 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.315 -0.857 . . . . 62.54 111.609 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -90.79 -5.69 55.31 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 114.543 1.312 . . . . 73.11 114.543 -175.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 13.1 mtp180 -58.36 -48.38 97.09 Favored Pre-proline 0 N--CA 1.481 1.091 0 N-CA-C 113.417 0.895 . . . . 73.24 113.417 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.57 -16.84 52.05 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 121.472 1.448 . . . . 72.55 112.494 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -91.03 86.31 6.21 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.327 0.584 . . . . 63.25 110.147 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -70.48 115.99 10.29 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 122.213 1.006 . . . . 71.11 109.544 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.14 -23.08 2.08 Favored Glycine 0 C--N 1.287 -2.172 0 CA-C-N 113.81 -1.541 . . . . 70.34 109.556 -173.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -57.37 109.55 0.7 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.206 1.002 . . . . 62.31 111.343 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -88.15 -47.52 8.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.525 0.679 . . . . 54.23 109.679 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.46 170.95 44.08 Favored Glycine 0 C--N 1.297 -1.618 0 C-N-CA 120.147 -1.025 . . . . 71.12 112.833 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.4 p -131.59 138.03 48.68 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 122.653 0.381 . . . . 75.33 110.144 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -115.66 118.29 32.66 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.468 -1.678 . . . . 72.32 106.468 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -93.52 133.84 33.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.881 -1.155 . . . . 73.21 107.881 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -127.97 117.74 22.29 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.191 -1.04 . . . . 73.23 108.191 -175.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.37 111.31 4.56 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.055 -1.091 . . . . 75.11 108.055 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.8 m -116.03 168.24 10.26 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.826 -0.805 . . . . 53.32 108.826 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.28 -29.93 10.76 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.789 1.235 . . . . 72.22 114.196 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -104.11 -47.2 4.23 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.989 -0.684 . . . . 74.54 111.16 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -155.93 153.24 25.41 Favored Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-N 115.48 -0.782 . . . . 65.11 109.527 -167.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -68.72 105.65 1.34 Allowed 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 122.047 1.832 . . . . 74.01 108.765 167.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -86.08 162.8 2.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 108.206 -1.035 . . . . 71.13 108.206 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.33 120.2 3.3 Favored Glycine 0 CA--C 1.486 -1.751 0 C-N-CA 117.91 -2.091 . . . . 64.23 113.072 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -89.0 104.8 17.32 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.39 -1.337 . . . . 72.23 107.39 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.3 t -99.9 118.34 46.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 115.765 -0.652 . . . . 73.41 110.289 -176.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 tt -97.69 127.6 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 CA-C-O 121.909 0.861 . . . . 64.5 110.32 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.421 ' O ' ' HD2' ' A' ' 31' ' ' ARG . 73.2 m-85 -102.86 166.18 10.62 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 114.515 -1.22 . . . . 73.24 110.144 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.03 -47.73 74.34 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.972 -1.013 . . . . 73.33 112.565 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 p -146.13 165.12 30.06 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.615 -0.721 . . . . 51.34 111.082 -172.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.504 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -70.35 -32.12 69.69 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.628 -0.508 . . . . 74.02 109.628 -178.016 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.63 -20.41 65.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 122.199 1.0 . . . . 53.13 109.552 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.06 -42.43 6.3 Favored Glycine 0 C--N 1.299 -1.492 0 CA-C-N 114.253 -1.34 . . . . 75.3 110.417 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.22 -42.86 88.12 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 123.167 0.587 . . . . 75.12 111.48 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.18 -42.76 91.59 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 111.637 0.236 . . . . 74.11 111.637 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.4 -36.85 68.77 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-O 121.031 0.444 . . . . 72.02 111.098 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.42 -39.64 77.75 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.491 -0.777 . . . . 54.12 111.346 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -68.18 -37.13 80.63 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 120.1 -0.64 . . . . 74.3 110.147 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -58.27 -38.16 76.41 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 123.47 0.481 . . . . 73.34 111.286 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.66 -41.66 26.42 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 116.387 -0.37 . . . . 64.11 111.601 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.48 ' O ' HG22 ' A' ' 91' ' ' ILE . 99.0 mt -88.97 -22.17 23.17 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 116.212 1.93 . . . . 73.42 116.212 -173.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.436 ' HB3' ' H ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -71.78 113.15 8.52 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 117.904 -1.519 . . . . 65.24 109.888 176.069 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.77 11.98 13.53 Favored Glycine 0 N--CA 1.408 -3.222 0 CA-C-N 115.411 -0.813 . . . . 44.12 111.478 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.5 tt -94.45 133.75 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 N-CA-C 107.441 -1.318 . . . . 63.33 107.441 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 59.5 ttt180 -97.43 126.86 42.93 Favored 'General case' 0 C--N 1.251 -3.696 0 N-CA-C 109.15 -0.685 . . . . 72.11 109.15 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.13 -32.84 74.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.593 -1.185 . . . . 75.53 110.418 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.62 ' HB2' ' HB3' ' A' ' 97' ' ' ASN . 1.5 m-20 -147.73 126.49 6.2 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 103.938 -2.616 . . . . 61.53 103.938 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.649 ' HD3' ' CZ ' ' B' ' 48' ' ' TYR . 30.6 Cg_endo -67.69 -12.76 36.63 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 CA-C-N 121.279 1.492 . . . . 75.52 111.217 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -91.46 -0.65 57.65 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.194 -0.912 . . . . 73.31 111.01 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 18.7 t30 -117.41 127.14 26.87 Favored Pre-proline 0 C--O 1.213 -0.853 0 N-CA-C 108.387 -0.968 . . . . 65.12 108.387 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.07 -12.18 33.42 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.398 2.732 . . . . 62.22 114.927 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -94.68 158.63 15.43 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 119.804 -0.758 . . . . 73.43 110.209 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.439 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 49.6 p -135.95 161.09 36.62 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.712 -1.218 . . . . 74.42 107.712 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 mp -90.43 129.74 36.58 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.186 0.517 . . . . 74.13 110.42 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -124.37 110.52 14.67 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.178 -1.416 . . . . 64.11 107.178 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.6 mp -98.58 122.51 41.88 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.405 -0.816 . . . . 74.02 109.846 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.501 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 37.3 tt0 -130.94 157.57 42.6 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.864 -1.532 . . . . 64.11 106.864 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -65.71 139.97 58.42 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 118.458 0.572 . . . . 73.52 109.586 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.14 157.27 32.98 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.958 -0.756 . . . . 73.31 108.958 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -88.61 0.69 56.13 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 122.124 0.964 . . . . 75.32 109.216 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.35 124.97 3.76 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.749 -1.114 . . . . 64.31 108.113 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -64.78 124.15 21.21 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.463 0.649 . . . . 63.45 110.891 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.8 m -103.26 102.57 12.54 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 108.097 -1.075 . . . . 71.43 108.097 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -72.88 154.48 40.57 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.612 -1.177 . . . . 62.53 113.231 -174.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -84.54 169.28 14.6 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 104.876 -2.268 . . . . 74.5 104.876 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.76 102.75 0.07 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.182 0.901 . . . . 40.23 110.673 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -144.82 116.67 8.24 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.7 -0.852 . . . . 74.02 108.7 -174.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 37.1 t -88.25 106.06 17.96 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.775 -0.824 . . . . 71.11 108.775 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -90.24 -20.34 23.1 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.028 -0.73 . . . . 75.22 109.028 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.6 tp 67.32 99.12 0.05 Allowed 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.775 1.23 . . . . 63.22 110.723 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 . . . . . 0 C--N 1.321 -0.65 0 C-N-CA 124.612 1.165 . . . . 52.25 109.877 -179.924 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 110.384 -0.228 . . . . 73.1 110.384 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -89.97 104.52 17.08 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.217 -0.66 . . . . 63.32 109.217 -174.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 56.72 61.81 2.5 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.931 0.892 . . . . 73.03 113.363 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.42 ' CD ' HH11 ' B' ' 78' ' ' ARG . 9.6 mm-40 -66.01 115.11 5.72 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 105.644 -1.984 . . . . 74.01 105.644 170.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 97.5 t -70.81 109.07 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 103.692 -2.707 . . . . 70.35 103.692 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.596 ' HB2' ' O ' ' B' ' 75' ' ' PHE . 16.1 ptm180 -123.53 17.9 9.65 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-N 114.655 -1.157 . . . . 63.31 110.974 -164.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 29.9 m -124.67 121.56 35.04 Favored 'General case' 0 C--N 1.273 -2.739 0 C-N-CA 119.554 -0.858 . . . . 73.22 110.104 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 87.9 mt -103.48 137.23 41.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.196 -1.039 . . . . 75.34 108.196 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -98.88 113.99 26.37 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 106.762 -1.57 . . . . 73.22 106.762 175.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.595 HG22 ' HG ' ' B' ' 103' ' ' LEU . 22.0 t -99.69 112.56 32.42 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.665 0 CA-C-N 114.429 -1.259 . . . . 55.34 108.4 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' B' ' 101' ' ' LEU . 48.9 p -111.48 169.46 8.79 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 108.626 -0.879 . . . . 73.14 108.626 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.541 ' HA2' ' CD ' ' B' ' 99' ' ' GLN . . . 109.68 -6.65 31.49 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 120.421 -0.895 . . . . 70.05 111.655 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 55.1 mt -75.8 133.71 72.84 Favored Pre-proline 0 N--CA 1.428 -1.572 0 CA-C-N 114.253 -0.974 . . . . 64.53 108.812 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.49 170.68 16.87 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.095 1.863 . . . . 51.01 110.715 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.508 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 8.2 p -70.92 -11.51 15.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.446 0.641 . . . . 73.34 111.623 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -112.55 27.28 9.77 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.961 0.886 . . . . 65.13 108.894 -177.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.513 HG22 ' HG2' ' B' ' 69' ' ' PRO . 0.1 OUTLIER -74.58 126.59 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-O 121.566 0.698 . . . . 73.53 109.4 179.578 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -101.34 141.53 22.78 Favored Pre-proline 0 C--N 1.299 -1.608 0 CA-C-N 115.707 -0.678 . . . . 60.43 111.08 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -51.0 -25.42 16.18 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.628 2.886 . . . . 61.23 114.199 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.508 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 15.3 ptt-85 -66.35 -32.27 73.57 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 120.864 0.364 . . . . 75.05 111.019 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -69.24 -34.48 74.88 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.923 -0.58 . . . . 72.35 109.973 -174.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.407 ' O ' ' HD2' ' B' ' 51' ' ' PHE . 97.3 mt -74.65 -44.07 52.2 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.47 0.652 . . . . 62.11 109.454 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.649 ' CZ ' ' HD3' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -57.81 -43.32 85.61 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.976 -1.011 . . . . 74.04 112.071 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 96.9 mt -63.55 -42.81 98.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.891 0.377 . . . . 73.31 111.015 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.3 tp -71.65 -42.68 67.25 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.284 -0.871 . . . . 65.05 111.657 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' PHE . . . . . 0.407 ' HD2' ' O ' ' B' ' 47' ' ' LEU . 81.4 m-85 -85.42 -4.74 59.25 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.993 1.479 . . . . 73.33 114.993 -175.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 26.2 mtp180 -51.81 -50.05 80.01 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 114.16 1.17 . . . . 75.25 114.16 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.51 -0.88 10.64 Favored 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 121.873 1.715 . . . . 74.12 114.046 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . 0.264 69.8 m-85 -87.67 134.92 33.57 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 115.519 1.674 . . . . 71.12 115.519 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -67.12 109.24 2.96 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.262 -1.79 . . . . 72.52 112.455 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' B' ' 75' ' ' PHE . . . 106.38 -7.59 40.14 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 115.531 -0.759 . . . . 44.52 113.467 171.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -59.94 106.98 0.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.406 0.622 . . . . 72.41 112.54 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -99.24 -44.58 6.19 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.692 -0.686 . . . . 72.21 110.849 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.91 -178.88 41.78 Favored Glycine 0 C--N 1.302 -1.318 0 C-N-CA 119.429 -1.367 . . . . 71.25 113.569 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.7 p -139.86 137.67 35.09 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.162 0.585 . . . . 74.25 111.158 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.51 116.51 28.31 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.301 -1.0 . . . . 73.31 108.301 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.51 133.27 35.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.663 -0.866 . . . . 33.34 108.663 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' B' ' 69' ' ' PRO . 12.1 tmtt? -125.31 115.29 20.12 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.364 -1.347 . . . . 53.33 107.364 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.15 130.74 39.71 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.09 -0.504 . . . . 73.11 109.872 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 3.4 m -124.52 164.82 18.97 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.885 -1.154 . . . . 74.33 107.885 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.58 -31.5 36.49 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.53 0.937 . . . . 63.23 113.53 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -99.22 -52.41 3.53 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.897 -0.721 . . . . 74.23 111.484 176.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -154.16 145.86 16.85 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 115.781 -0.645 . . . . 75.12 111.156 -170.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.513 ' HG2' HG22 ' B' ' 42' ' ' ILE . 60.2 Cg_endo -75.62 124.8 8.49 Favored 'Trans proline' 0 N--CA 1.436 -1.88 0 C-N-CA 122.93 2.42 . . . . 60.22 111.621 174.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 m -93.84 155.11 3.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 114.977 -1.011 . . . . 65.12 108.442 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.32 120.51 4.23 Favored Glycine 0 CA--C 1.486 -1.756 0 C-N-CA 119.032 -1.556 . . . . 61.42 112.811 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -89.7 102.77 15.46 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.608 -1.256 . . . . 72.21 107.608 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 68.8 t -92.67 123.94 44.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 115.79 -0.641 . . . . 64.43 109.584 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' B' ' 111' ' ' LYS . 13.7 tt -101.53 129.21 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.328 0 CA-C-O 122.297 1.046 . . . . 75.15 111.074 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.596 ' O ' ' HB2' ' B' ' 31' ' ' ARG . 91.9 m-85 -109.81 160.43 16.35 Favored 'General case' 0 N--CA 1.404 -2.759 0 CA-C-N 113.217 -1.81 . . . . 71.1 107.993 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ASP . . . . . 0.479 ' HA ' ' NH2' ' B' ' 31' ' ' ARG . 34.7 t70 -73.09 -33.31 65.53 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.276 0.56 . . . . 72.4 111.843 176.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 12.4 p -128.73 158.81 37.56 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 116.258 -0.428 . . . . 52.31 111.641 -174.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ARG . . . . . 0.436 ' H ' ' HD3' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -80.48 -27.78 37.73 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.476 -0.889 . . . . 63.45 108.662 177.37 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' B' ' 82' ' ' GLU . . . -72.07 -24.91 61.58 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.977 0.894 . . . . 61.22 108.764 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.12 -44.75 28.3 Favored Glycine 0 C--N 1.31 -0.895 0 N-CA-C 109.62 -1.392 . . . . 35.23 109.62 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.6 -44.95 95.03 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.766 -0.717 . . . . 73.32 111.736 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' B' ' 79' ' ' ALA . 2.0 pp20? -66.96 -28.28 68.15 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.495 0.554 . . . . 74.11 112.495 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.95 -46.84 32.9 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.119 -0.491 . . . . 71.1 110.172 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.97 92.6 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.53 -0.759 . . . . 74.04 111.678 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.457 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 14.2 ptmm? -69.49 -34.38 74.24 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 120.024 -0.67 . . . . 74.11 110.147 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -62.84 -32.24 73.42 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 121.129 0.49 . . . . 74.42 110.405 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.78 -32.48 19.07 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 112.541 0.571 . . . . 74.4 112.541 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.47 ' O ' HG22 ' B' ' 91' ' ' ILE . 91.7 mt -101.66 -25.19 13.95 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 116.603 2.075 . . . . 72.31 116.603 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . 0.268 0.2 OUTLIER -68.69 113.92 6.6 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 118.06 -1.456 . . . . 61.53 112.615 -176.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.2 6.47 15.82 Favored Glycine 0 N--CA 1.419 -2.451 0 C-N-CA 120.791 -0.719 . . . . 54.41 111.872 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.47 HG22 ' O ' ' B' ' 88' ' ' LEU . 12.2 tt -96.61 146.73 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.361 0 N-CA-C 107.735 -1.209 . . . . 42.41 107.735 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.451 ' HG3' HG22 ' B' ' 100' ' ' THR . 97.7 mtt180 -89.47 140.89 29.07 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-O 121.333 0.587 . . . . 72.32 112.342 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -73.27 -31.41 64.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.834 -1.53 . . . . 73.12 109.182 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.537 ' OD2' ' HB3' ' A' ' 45' ' ' ARG 0.266 4.8 m-20 -142.67 137.27 15.1 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 104.113 -2.551 . . . . 74.14 104.113 176.343 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 95' ' ' PRO . . . . . 0.573 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 19.0 Cg_endo -64.09 -19.51 66.32 Favored 'Trans proline' 0 CA--C 1.55 1.291 0 CA-C-N 121.064 1.416 . . . . 72.04 109.631 168.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -72.14 -24.98 61.54 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.109 1.764 . . . . 74.21 109.609 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -94.91 126.84 45.37 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 115.189 -0.914 . . . . 73.24 109.769 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.19 -6.25 14.76 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.937 2.425 . . . . 74.51 112.689 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' GLN . . . . . 0.541 ' CD ' ' HA2' ' B' ' 37' ' ' GLY . 8.7 tt0 -99.0 162.11 13.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.571 -0.9 . . . . 74.03 108.571 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.5 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 82.6 p -125.64 164.25 21.0 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.513 -0.551 . . . . 74.43 109.513 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' B' ' 36' ' ' SER . 5.3 mp -85.8 117.33 24.6 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 107.012 -1.477 . . . . 54.43 107.012 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -113.44 107.34 15.71 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 107.725 -1.213 . . . . 73.31 107.725 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.595 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.0 mp -90.22 116.45 28.21 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.572 -1.27 . . . . 61.12 107.572 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.457 ' HA ' ' CE ' ' B' ' 85' ' ' LYS . 12.1 tp10 -135.22 162.88 31.29 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.88 -1.156 . . . . 72.33 107.88 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -69.07 137.28 53.41 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 118.71 0.687 . . . . 75.01 111.84 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.95 156.03 32.27 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 109.169 -0.678 . . . . 71.03 109.169 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -78.13 -8.61 58.48 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.908 0.861 . . . . 42.45 109.624 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.2 130.98 9.95 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.164 -0.925 . . . . 75.24 108.77 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.411 ' ND2' ' HG2' ' B' ' 31' ' ' ARG . 6.5 m-20 -63.74 132.49 51.16 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.549 -0.75 . . . . 62.23 110.003 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 33.4 m -120.4 116.36 25.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.357 -0.979 . . . . 53.22 108.357 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' LYS . . . . . 0.593 ' H ' ' HD3' ' B' ' 111' ' ' LYS . 0.0 OUTLIER -89.21 158.15 17.98 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.66 -0.7 . . . . 73.13 110.543 -177.215 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -93.03 99.76 12.31 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 110.014 -0.365 . . . . 73.53 110.014 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . 39.5 72.28 0.15 Allowed 'General case' 0 C--O 1.246 0.921 0 C-N-CA 125.347 1.459 . . . . 72.4 113.247 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -130.48 130.91 44.81 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 116.112 -0.495 . . . . 74.32 109.671 -173.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 33.1 t -126.65 104.46 8.11 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.127 -1.434 . . . . 73.32 107.127 175.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -83.08 -16.1 48.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.093 -0.503 . . . . 54.42 112.236 -175.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 tt 58.74 32.58 22.34 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.567 1.147 . . . . 72.32 109.922 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 . . . . . 0 C--N 1.317 -0.807 0 N-CA-C 106.603 -1.629 . . . . 74.44 106.603 179.275 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 CA--C 1.501 -0.917 0 CA-C-O 121.212 0.53 . . . . 75.31 109.928 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -117.64 141.34 48.49 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 106.144 -1.798 . . . . 71.32 106.144 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -84.2 78.0 9.86 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.389 1.09 . . . . 72.15 111.066 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -96.33 -177.41 3.95 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.717 -1.583 . . . . 74.14 110.373 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.529 ' HA ' HD21 ' A' ' 109' ' ' ASN . 17.8 t -56.66 111.39 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 113.184 0.809 . . . . 74.33 113.184 -164.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 42.4 mtt180 -99.43 -25.16 14.55 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-O 122.363 1.078 . . . . 71.23 109.349 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.4 m -98.11 138.24 35.7 Favored 'General case' 0 C--N 1.26 -3.291 0 CA-C-N 113.549 -1.659 . . . . 71.45 113.6 -167.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.8 mt -124.57 142.8 51.08 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 114.018 -1.447 . . . . 74.14 108.325 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 104' ' ' GLU . 32.0 p90 -101.48 112.23 24.71 Favored 'General case' 0 N--CA 1.423 -1.825 0 C-N-CA 118.956 -1.097 . . . . 75.04 108.074 172.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.481 HG12 HD11 ' A' ' 101' ' ' LEU . 41.7 t -97.05 114.01 32.89 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.828 0 N-CA-C 106.898 -1.519 . . . . 55.44 106.898 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.6 p -124.46 154.44 40.48 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.288 -0.869 . . . . 74.21 111.177 -175.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.62 4.65 34.44 Favored Glycine 0 N--CA 1.425 -2.07 0 CA-C-N 115.939 -0.573 . . . . 33.54 111.856 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.56 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 94.4 mt -66.28 131.67 94.35 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.23 -0.655 . . . . 54.31 109.23 175.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.04 157.55 3.92 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.416 2.077 . . . . 70.41 110.283 171.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.496 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 9.8 p -83.44 6.97 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 122.787 1.28 . . . . 72.44 109.847 -170.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -127.87 17.04 6.82 Favored 'General case' 0 N--CA 1.406 -2.659 0 CA-C-N 114.323 -1.308 . . . . 54.42 110.322 -175.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 pp -54.06 133.75 16.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 114.62 1.341 . . . . 71.23 114.62 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.539 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.33 143.03 26.03 Favored Pre-proline 0 C--N 1.285 -2.199 0 CA-C-N 114.174 -1.376 . . . . 54.22 108.279 177.196 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.88 -24.64 65.58 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.913 2.408 . . . . 73.02 113.853 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.545 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -82.35 -15.34 53.16 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 118.094 -1.442 . . . . 70.11 111.882 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.49 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 30.0 mt-10 -69.66 -37.76 76.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.803 0.811 . . . . 74.13 108.932 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.9 mt -65.67 -35.92 82.16 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 114.773 -1.103 . . . . 75.21 108.828 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.545 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 73.7 t80 -63.95 -47.37 80.76 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.572 -1.194 . . . . 74.52 110.227 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 81.9 mt -65.02 -35.68 81.95 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.815 0.341 . . . . 71.51 111.809 -176.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.0 tp -86.23 -36.25 19.53 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 112.581 0.585 . . . . 65.14 112.581 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -98.56 -11.12 22.5 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 114.337 1.236 . . . . 73.51 114.337 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.5 ttt-85 -66.79 -42.71 45.67 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 119.987 -0.685 . . . . 71.33 111.693 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -58.11 -25.35 70.74 Favored 'Trans proline' 0 C--N 1.398 3.167 0 C-N-CA 121.711 1.608 . . . . 72.12 111.553 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -84.8 84.42 7.7 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.777 0.799 . . . . 72.2 110.112 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -67.93 108.74 3.15 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.333 -1.303 . . . . 75.1 109.905 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.94 -25.5 1.29 Allowed Glycine 0 N--CA 1.424 -2.133 0 CA-C-N 113.996 -1.457 . . . . 64.21 109.67 -172.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -55.45 118.72 4.71 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.085 0.554 . . . . 72.43 110.538 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -93.65 -60.09 1.85 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 120.121 -0.632 . . . . 61.23 109.363 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.56 175.15 38.15 Favored Glycine 0 C--N 1.298 -1.546 0 C-N-CA 120.848 -0.691 . . . . 65.31 112.075 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.3 p -134.79 143.88 47.34 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 122.488 0.315 . . . . 75.53 111.002 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.437 HD21 ' O ' ' A' ' 112' ' ' MET . 80.5 mt -115.98 119.91 37.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.09 -0.707 . . . . 74.21 109.09 174.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.17 133.3 35.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 110.137 -0.319 . . . . 71.54 110.137 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -117.82 106.66 13.23 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.27 -1.381 . . . . 72.24 107.27 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.4 124.6 25.48 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.246 -1.02 . . . . 71.22 108.246 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 5.9 m -128.89 150.79 50.2 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 105.155 -2.165 . . . . 72.24 105.155 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.05 -40.34 10.53 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 114.42 1.267 . . . . 63.32 114.42 -173.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -96.01 -26.76 15.42 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.877 1.065 . . . . 73.44 113.877 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.56 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -172.23 143.05 1.27 Allowed Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 110.202 -0.296 . . . . 70.44 110.202 -177.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.496 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 59.5 Cg_endo -77.37 124.64 7.23 Favored 'Trans proline' 0 N--CA 1.432 -2.092 0 C-N-CA 122.491 2.127 . . . . 65.02 110.102 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.7 m -96.36 147.49 6.1 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 N-CA-C 108.222 -1.029 . . . . 53.24 108.222 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.22 120.86 4.59 Favored Glycine 0 CA--C 1.479 -2.204 0 C-N-CA 118.879 -1.629 . . . . 71.13 112.907 -175.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.44 103.65 15.71 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 106.849 -1.538 . . . . 75.41 106.849 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.5 t -94.34 128.07 45.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.363 0 CA-C-N 115.071 -0.968 . . . . 74.13 110.284 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.67 114.24 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.369 0 N-CA-C 107.991 -1.114 . . . . 62.22 107.991 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.476 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 36.1 m-85 -93.96 162.65 13.81 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.329 -0.85 . . . . 74.2 109.584 174.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.36 -41.21 51.31 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 124.317 1.011 . . . . 75.51 111.876 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.6 p -164.9 166.08 19.85 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.571 -0.741 . . . . 70.54 111.986 -174.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.687 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -56.05 -39.5 72.11 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.236 1.014 . . . . 72.12 112.105 177.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.82 -28.17 69.38 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.625 0.726 . . . . 73.32 109.731 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.56 -38.71 9.46 Favored Glycine 0 C--N 1.309 -0.922 0 CA-C-N 114.648 -1.16 . . . . 65.31 110.897 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.67 -45.87 77.48 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.546 0.738 . . . . 52.22 112.032 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -34.82 78.8 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.007 0.432 . . . . 75.15 111.439 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.6 -41.21 65.84 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.992 -0.549 . . . . 62.11 110.563 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.89 -41.72 86.73 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.747 -0.66 . . . . 62.5 110.821 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -69.42 -28.46 66.16 Favored 'General case' 0 C--O 1.199 -1.585 0 CA-C-N 116.292 -0.413 . . . . 70.02 111.297 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -78.11 -21.07 50.99 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.27 0.557 . . . . 75.35 111.751 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.91 -44.02 11.36 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.278 -0.419 . . . . 72.44 111.378 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.467 ' O ' HG22 ' A' ' 91' ' ' ILE . 96.0 mt -93.78 -12.64 28.66 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 115.456 1.65 . . . . 74.52 115.456 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -67.56 114.6 6.34 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 119.559 1.072 . . . . 55.02 112.169 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.37 16.37 14.86 Favored Glycine 0 N--CA 1.429 -1.83 0 C-N-CA 119.73 -1.224 . . . . 63.34 111.789 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 88' ' ' LEU . 11.4 tt -90.81 128.19 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.73 0 N-CA-C 107.669 -1.234 . . . . 75.23 107.669 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -75.1 121.73 22.5 Favored 'General case' 0 C--N 1.269 -2.898 0 N-CA-C 107.87 -1.159 . . . . 71.1 107.87 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.43 -32.81 69.03 Favored 'General case' 0 C--N 1.312 -1.033 0 O-C-N 124.357 1.036 . . . . 70.15 109.04 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.419 ' HB3' ' HB3' ' B' ' 45' ' ' ARG . 3.1 p-10 -148.06 115.18 3.99 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 107.077 -1.453 . . . . 75.43 107.077 171.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -62.37 -9.59 15.89 Favored 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 122.685 2.257 . . . . 70.24 113.185 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -74.46 -19.21 60.47 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.483 0.658 . . . . 74.51 109.453 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -118.08 146.52 39.4 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.202 -1.036 . . . . 74.02 108.202 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.19 -16.61 52.53 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.182 1.921 . . . . 74.23 113.159 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -52.83 125.35 16.62 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.199 1.4 . . . . 73.12 111.823 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.3 p -112.26 150.3 31.13 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 120.153 -0.619 . . . . 45.42 110.823 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.481 HD11 HG12 ' A' ' 35' ' ' VAL . 22.2 tp -98.34 127.01 44.08 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.469 -0.938 . . . . 73.42 108.469 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -122.38 136.03 54.82 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.09 0.471 . . . . 74.35 109.822 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.448 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.6 mp -110.38 116.25 31.11 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.378 -0.828 . . . . 73.04 108.965 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.478 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 5.3 tp10 -127.19 161.99 27.22 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.73 -0.841 . . . . 73.52 108.73 -177.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -70.75 139.29 51.03 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 118.514 0.597 . . . . 65.25 110.436 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.16 150.5 31.7 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 109.233 -0.655 . . . . 60.34 109.233 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -74.18 -6.65 49.03 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.589 -0.732 . . . . 74.53 111.961 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.16 133.65 7.88 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.772 -0.825 . . . . 31.41 108.772 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.529 HD21 ' HA ' ' A' ' 30' ' ' VAL . 84.1 m-20 -74.78 108.31 7.44 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.99 -1.115 . . . . 72.24 107.99 172.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.7 t -101.05 126.76 47.76 Favored 'General case' 0 C--N 1.289 -2.054 0 C-N-CA 119.11 -1.036 . . . . 41.02 109.823 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.556 ' N ' ' HE2' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -60.99 138.28 58.19 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.927 -0.397 . . . . 63.34 109.927 175.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.437 ' O ' HD21 ' A' ' 61' ' ' LEU . 1.3 tmt? -69.13 -25.95 64.65 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.591 -0.732 . . . . 73.22 110.599 -176.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.03 93.14 2.69 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.309 -0.626 . . . . 65.12 109.309 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -78.0 123.92 27.39 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.587 -0.733 . . . . 73.15 110.258 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 75.1 m -86.3 144.61 27.3 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.341 0.591 . . . . 72.13 112.542 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -139.44 118.96 12.97 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.977 -1.49 . . . . 72.24 106.977 174.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.513 ' HG ' ' OE2' ' A' ' 118' ' ' GLU . 22.3 tp -102.11 -68.38 0.83 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.549 -0.908 . . . . 73.45 108.549 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.513 ' OE2' ' HG ' ' A' ' 117' ' ' LEU . 9.3 mp0 . . . . . 0 C--N 1.307 -1.249 0 N-CA-C 106.399 -1.704 . . . . 73.25 106.399 168.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.293 0 CA-C-O 120.83 0.348 . . . . 62.51 110.166 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -135.91 163.37 30.4 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.739 -1.208 . . . . 64.41 107.739 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -87.94 47.58 1.52 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.777 0.798 . . . . 71.51 110.944 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.584 ' HB2' ' HD2' ' B' ' 78' ' ' ARG . 26.9 mm-40 -81.72 -179.97 7.6 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 114.561 -1.199 . . . . 64.02 110.948 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 32.2 t -83.0 111.66 19.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.003 0.43 . . . . 71.33 111.754 -166.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 86.6 mtt180 -91.64 -3.52 56.26 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.124 0.488 . . . . 75.24 111.634 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.9 m -115.55 128.2 55.81 Favored 'General case' 0 C--N 1.263 -3.16 0 CA-C-O 121.675 0.75 . . . . 53.24 112.759 -172.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 71.3 mt -110.1 142.41 41.6 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.184 -0.916 . . . . 71.1 108.697 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -99.38 113.69 26.17 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 106.992 -1.484 . . . . 74.43 106.992 173.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.478 HG22 ' HG ' ' B' ' 103' ' ' LEU . 53.4 t -102.49 125.67 56.73 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.984 0 CA-C-N 113.953 -1.476 . . . . 72.44 107.509 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.2 p -139.17 169.56 17.55 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.732 -0.667 . . . . 74.03 110.219 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 90.56 42.66 5.08 Favored Glycine 0 N--CA 1.422 -2.295 0 N-CA-C 109.465 -1.454 . . . . 71.22 109.465 -172.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.33 138.25 20.13 Favored Pre-proline 0 N--CA 1.418 -2.066 0 CA-C-N 114.039 -1.08 . . . . 75.31 108.437 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -54.53 155.83 15.87 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.401 2.068 . . . . 55.15 110.094 171.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.498 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 8.1 p -83.06 3.93 2.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 122.627 1.203 . . . . 65.03 108.796 -174.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.93 21.93 6.3 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 114.136 -1.393 . . . . 64.15 111.056 -173.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 35.2 pt -54.0 137.03 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 113.88 1.067 . . . . 75.31 113.88 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.583 ' HE3' ' HA ' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -93.36 141.38 23.88 Favored Pre-proline 0 C--N 1.279 -2.467 0 N-CA-C 107.054 -1.461 . . . . 73.42 107.054 174.425 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.24 -25.53 78.53 Favored 'Trans proline' 0 N--CA 1.478 0.616 0 C-N-CA 122.644 2.229 . . . . 71.13 113.093 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.471 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 16.7 ptt180 -79.7 -18.0 52.3 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 112.166 0.432 . . . . 63.03 112.166 -176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.503 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 31.2 mt-10 -65.31 -40.29 93.56 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.815 0.817 . . . . 75.14 108.993 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 74.2 mt -67.92 -35.93 79.28 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.556 -1.202 . . . . 73.44 109.634 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -61.16 -48.18 82.79 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.43 -0.804 . . . . 74.1 111.144 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 79.8 mt -63.1 -44.31 96.04 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 123.837 0.71 . . . . 63.1 110.054 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.9 tp -73.02 -41.55 64.11 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.894 -1.048 . . . . 71.24 111.861 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -96.03 10.03 38.83 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.323 0.861 . . . . 73.01 113.323 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -70.48 -48.65 17.3 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 120.615 -0.434 . . . . 64.22 111.725 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.75 -3.85 14.42 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 121.376 1.384 . . . . 72.44 112.128 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -91.42 94.69 9.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.416 1.103 . . . . 74.32 111.439 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -64.2 113.24 3.43 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 112.922 -1.944 . . . . 55.41 110.047 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.88 -21.97 3.68 Favored Glycine 0 C--N 1.287 -2.156 0 CA-C-N 115.097 -0.956 . . . . 63.01 111.403 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -62.26 105.8 0.65 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.329 0.585 . . . . 73.52 111.99 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -87.52 -48.6 7.8 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.787 -0.642 . . . . 63.42 109.609 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.57 170.93 43.55 Favored Glycine 0 C--N 1.298 -1.529 0 C-N-CA 120.741 -0.742 . . . . 53.23 112.0 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.7 p -128.8 138.1 51.89 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 122.684 0.394 . . . . 63.44 110.432 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 87.6 mt -112.99 112.88 24.64 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.526 -0.916 . . . . 71.31 108.526 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 50.4 mm -93.81 133.05 36.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.651 -0.499 . . . . 74.23 109.651 -176.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -128.3 126.69 41.32 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.097 -1.446 . . . . 74.5 107.097 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.72 125.88 29.93 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.698 0.761 . . . . 65.13 112.758 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.3 m -113.6 155.89 24.65 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 103.811 -2.663 . . . . 54.23 103.811 173.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.88 -35.15 31.36 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 114.322 1.23 . . . . 54.13 114.322 -172.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -104.91 -14.57 15.42 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 113.237 0.829 . . . . 75.02 113.237 -175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -172.81 147.85 1.65 Allowed Pre-proline 0 N--CA 1.468 0.473 0 CA-C-O 120.753 0.311 . . . . 61.12 110.258 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 46.2 Cg_endo -78.63 122.85 5.65 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 C-N-CA 122.347 2.032 . . . . 74.13 110.263 169.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 35.2 m -94.03 155.05 3.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.082 -1.081 . . . . 71.22 108.082 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.49 121.65 3.55 Favored Glycine 0 CA--C 1.474 -2.501 0 C-N-CA 118.868 -1.634 . . . . 63.33 113.301 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -88.17 102.46 14.82 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.754 -1.572 . . . . 75.33 106.754 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.18 122.9 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 CA-C-N 115.195 -0.911 . . . . 64.03 109.539 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 62.6 mt -102.68 120.71 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.418 0 CA-C-N 113.846 -1.525 . . . . 53.43 109.448 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.42 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 71.5 m-85 -105.06 161.21 14.43 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 114.112 -1.404 . . . . 73.22 109.846 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.57 -29.97 71.0 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.21 -0.904 . . . . 73.44 111.807 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 29.7 p -161.67 165.87 27.58 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.045 0.538 . . . . 73.52 110.072 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ARG . . . . . 0.584 ' HD2' ' HB2' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -70.63 -22.58 62.51 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.529 -0.468 . . . . 43.44 110.314 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.15 -28.12 69.54 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.452 0.644 . . . . 54.41 110.383 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.38 -39.91 7.1 Favored Glycine 0 C--N 1.308 -1.023 0 N-CA-C 110.2 -1.16 . . . . 53.04 110.2 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.49 -43.68 98.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.503 -0.849 . . . . 62.5 111.825 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.93 -39.69 90.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 74.31 111.472 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.11 -37.83 64.01 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.082 0.468 . . . . 74.11 110.135 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.36 -40.54 77.43 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.48 -0.782 . . . . 53.31 111.083 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.528 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 14.5 ptmm? -68.18 -40.77 82.15 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 120.303 -0.559 . . . . 74.24 110.668 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -66.79 -25.26 66.38 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 120.71 -0.396 . . . . 74.24 111.925 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.67 -41.51 17.67 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 120.839 0.352 . . . . 75.52 111.281 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.548 ' O ' HG22 ' B' ' 91' ' ' ILE . 96.9 mt -96.26 -14.0 22.98 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 115.623 1.712 . . . . 62.1 115.623 -173.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.43 116.06 12.42 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 118.803 -1.159 . . . . 74.25 112.523 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.82 26.64 7.45 Favored Glycine 0 N--CA 1.428 -1.877 0 C-N-CA 120.49 -0.862 . . . . 71.24 111.373 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.548 HG22 ' O ' ' B' ' 88' ' ' LEU . 16.5 tt -114.95 133.71 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.551 0 N-CA-C 107.325 -1.361 . . . . 74.22 107.325 174.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.414 ' HG2' HG22 ' B' ' 100' ' ' THR . 99.2 mtt180 -67.66 134.47 51.18 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-O 121.086 0.469 . . . . 72.54 110.634 172.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -70.8 -30.35 66.78 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.529 -1.214 . . . . 63.03 109.039 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' B' ' 97' ' ' ASN . 8.5 t70 -144.31 118.97 5.93 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 104.544 -2.391 . . . . 74.01 104.544 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' PRO . . . . . 0.516 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 31.8 Cg_endo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.907 2.405 . . . . 74.32 113.819 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -94.21 4.46 53.86 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.609 0.719 . . . . 74.53 111.123 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' ASN . . . . . 0.474 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . 56.2 t30 -118.84 130.34 24.88 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 107.514 -1.291 . . . . 74.31 107.514 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.44 -13.43 33.01 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 123.046 2.497 . . . . 75.55 113.972 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -67.33 116.53 8.19 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-O 121.379 0.609 . . . . 75.01 110.28 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.595 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 58.2 p -106.48 145.17 32.14 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.824 -0.625 . . . . 54.31 109.916 -176.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 33.4 tp -94.13 128.97 40.85 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 110.025 -0.361 . . . . 71.33 110.025 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.447 HH21 ' CD ' ' B' ' 104' ' ' GLU . 6.0 ptm180 -129.02 127.44 41.61 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.914 -0.402 . . . . 54.11 109.914 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.478 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.7 mp -115.06 118.84 34.51 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.608 -0.723 . . . . 74.54 110.034 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.528 ' HA ' ' CE ' ' B' ' 85' ' ' LYS . 34.3 mt-10 -137.81 162.0 35.1 Favored 'General case' 0 C--O 1.199 -1.574 0 C-N-CA 122.739 0.415 . . . . 74.14 110.378 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -69.39 132.91 47.12 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 118.295 0.498 . . . . 74.51 111.355 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.59 154.47 34.39 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.413 -0.588 . . . . 65.31 109.413 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -84.28 9.15 13.73 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 120.876 0.369 . . . . 75.43 111.567 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.81 130.41 11.5 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.638 -0.504 . . . . 60.53 109.638 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -76.68 121.45 23.28 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 108.676 -0.861 . . . . 70.33 108.676 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 7.0 m -113.3 134.33 54.66 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.225 -0.657 . . . . 74.14 109.225 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.16 153.62 21.1 Favored 'General case' 0 C--O 1.247 0.948 0 N-CA-C 107.612 -1.255 . . . . 72.21 107.612 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.31 77.39 8.96 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.856 0.836 . . . . 62.23 109.3 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -163.62 103.84 0.93 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.34 -1.3 . . . . 64.22 109.8 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -86.06 81.5 8.45 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 122.454 1.121 . . . . 73.12 108.491 173.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 41.8 m -120.76 127.17 51.72 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 114.459 -1.246 . . . . 44.23 110.524 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -140.67 158.49 43.91 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.677 -0.86 . . . . 72.52 108.677 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 53.7 tp -80.87 -45.28 17.08 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.847 -0.798 . . . . 73.42 108.847 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.431 -1.39 0 CA-C-N 115.646 -0.707 . . . . 73.53 109.912 -178.673 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.417 ' N ' ' HG ' ' A' ' 77' ' ' SER . 1.8 mpt? . . . . . 0 C--O 1.224 -0.251 0 CA-C-O 121.005 0.431 . . . . 75.31 110.362 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -115.15 177.64 4.58 Favored 'General case' 0 C--O 1.252 1.194 0 CA-C-N 116.461 -0.336 . . . . 73.31 110.738 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -75.34 104.89 6.1 Favored 'General case' 0 N--CA 1.432 -1.365 0 O-C-N 124.233 0.958 . . . . 73.33 111.722 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.445 ' HB2' ' HD2' ' A' ' 78' ' ' ARG . 34.4 mt-10 -150.75 179.86 7.85 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.791 -1.929 . . . . 74.04 105.791 174.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.58 111.1 12.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 121.363 0.602 . . . . 71.12 110.917 -170.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.644 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 69.0 mtt180 -91.93 -22.63 19.93 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 122.352 1.072 . . . . 73.34 109.518 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 18.1 m -96.07 122.7 39.18 Favored 'General case' 0 C--N 1.258 -3.396 0 CA-C-N 113.471 -1.695 . . . . 73.34 112.018 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.544 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.1 pt? -115.59 142.11 47.17 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 107.554 -1.276 . . . . 75.54 107.554 175.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 104' ' ' GLU . 26.2 p90 -96.57 122.18 39.2 Favored 'General case' 0 N--CA 1.417 -2.091 0 C-N-CA 118.779 -1.168 . . . . 71.23 109.272 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.415 HG22 ' HG ' ' A' ' 103' ' ' LEU . 41.6 t -97.27 108.78 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.586 0 N-CA-C 106.419 -1.697 . . . . 62.4 106.419 178.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 32.2 p -115.76 172.95 6.81 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 108.93 -0.767 . . . . 74.03 108.93 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 87.13 41.38 6.64 Favored Glycine 0 N--CA 1.418 -2.56 0 N-CA-C 109.897 -1.281 . . . . 74.1 109.897 -174.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.9 mt -114.81 145.14 33.32 Favored Pre-proline 0 N--CA 1.423 -1.777 0 N-CA-C 107.201 -1.407 . . . . 72.13 107.201 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.43 171.26 15.01 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.558 1.505 . . . . 72.43 110.199 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.5 p -71.31 -7.53 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 CA-C-O 122.574 1.178 . . . . 71.35 109.932 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -103.3 20.02 18.55 Favored 'General case' 0 C--O 1.203 -1.392 0 CA-C-N 114.035 -1.439 . . . . 65.2 109.386 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.98 123.51 27.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.261 0 CA-C-O 121.622 0.725 . . . . 73.22 110.715 178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -101.18 145.76 30.98 Favored Pre-proline 0 C--N 1.307 -1.244 0 C-N-CA 124.831 1.252 . . . . 74.02 111.44 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.56 -17.86 60.55 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.295 2.664 . . . . 70.45 114.557 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.555 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -86.73 -17.24 34.1 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 117.71 -1.596 . . . . 71.32 110.961 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -66.7 -42.16 86.86 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.133 0.492 . . . . 74.01 110.155 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.19 -37.35 87.04 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.191 -0.67 . . . . 55.42 109.191 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.667 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 61.0 t80 -59.38 -48.72 80.56 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.13 -0.941 . . . . 61.42 110.732 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 86.6 mt -61.59 -41.61 97.68 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.918 0.761 . . . . 73.51 110.32 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.9 tp -70.61 -42.19 71.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.286 -0.87 . . . . 71.33 111.79 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -86.72 7.13 28.03 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.851 1.056 . . . . 75.55 113.851 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.523 ' NE ' ' HA ' ' A' ' 52' ' ' ARG . 3.9 mmp_? -52.83 -50.33 81.94 Favored Pre-proline 0 N--CA 1.486 1.326 0 N-CA-C 113.924 1.083 . . . . 74.42 113.924 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -76.5 -0.91 10.92 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 121.914 1.743 . . . . 54.34 113.863 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' CE2' ' HA ' ' A' ' 84' ' ' ALA . 60.6 m-85 -98.76 115.33 28.53 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 121.945 0.879 . . . . 64.53 112.364 -174.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HD3' ' H ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -80.08 120.93 24.89 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 113.814 -1.539 . . . . 61.24 109.511 179.068 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.7 -14.0 6.09 Favored Glycine 0 C--N 1.276 -2.791 0 CA-C-N 114.958 -1.019 . . . . 73.32 113.037 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -58.33 107.31 0.48 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.044 0.422 . . . . 73.01 111.003 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.497 ' OE2' ' HA ' ' A' ' 76' ' ' ASP . 22.5 mt-10 -96.21 -33.96 11.83 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 120.579 -0.449 . . . . 74.43 110.987 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.77 -179.22 48.39 Favored Glycine 0 C--N 1.302 -1.334 0 C-N-CA 120.131 -1.033 . . . . 30.4 112.418 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.7 p -145.74 138.17 25.63 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.201 0.6 . . . . 73.04 110.409 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.0 mp -120.5 124.75 46.16 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.373 -0.973 . . . . 75.51 108.373 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.2 mm -93.96 138.02 21.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.983 -0.747 . . . . 65.21 108.983 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -126.39 112.09 15.24 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.091 -1.077 . . . . 75.15 108.091 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.92 116.41 13.39 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.671 -0.695 . . . . 75.11 110.746 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -109.03 152.2 25.32 Favored 'General case' 0 N--CA 1.396 -3.156 0 N-CA-C 102.296 -3.224 . . . . 74.55 102.296 171.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.82 -40.53 29.58 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.981 0.734 . . . . 42.3 112.981 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -85.16 -49.24 8.4 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.31 0.576 . . . . 74.35 112.019 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -138.47 127.07 14.18 Favored Pre-proline 0 C--N 1.283 -2.297 0 CA-C-N 115.718 -0.674 . . . . 71.41 112.334 -168.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.84 101.5 1.2 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.585 2.19 . . . . 64.33 108.689 166.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.39 152.16 3.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.773 -0.825 . . . . 71.33 108.773 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.76 119.99 4.53 Favored Glycine 0 CA--C 1.473 -2.555 0 C-N-CA 118.632 -1.746 . . . . 61.1 111.989 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -87.83 106.18 17.91 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 106.675 -1.602 . . . . 75.55 106.675 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.5 t -96.14 130.56 44.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 115.326 -0.852 . . . . 74.12 109.659 -177.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.8 mp -102.95 117.91 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.606 0 CA-C-N 115.079 -0.964 . . . . 63.11 108.945 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.644 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 7.4 m-85 -98.48 163.38 12.71 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.854 -1.066 . . . . 75.34 108.992 172.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.497 ' HA ' ' OE2' ' A' ' 58' ' ' GLU . 10.7 t70 -51.27 -39.27 56.37 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 123.944 0.778 . . . . 74.02 111.65 176.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.417 ' HG ' ' N ' ' A' ' 26' ' ' MET . 66.8 m -160.7 166.17 29.24 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.181 -0.918 . . . . 43.01 110.428 -175.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.572 ' N ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -55.28 -32.66 62.57 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.975 0.91 . . . . 74.11 111.029 176.531 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.45 ' HA ' ' OE2' ' A' ' 82' ' ' GLU . . . -64.35 -26.07 68.31 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.825 0.821 . . . . 53.04 110.534 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.77 -44.27 5.51 Favored Glycine 0 C--N 1.285 -2.284 0 N-CA-C 109.855 -1.298 . . . . 62.44 109.855 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.95 -39.23 91.4 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.379 -0.91 . . . . 71.03 110.932 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.45 ' OE2' ' HA ' ' A' ' 79' ' ' ALA . 14.8 pt-20 -62.75 -41.48 99.23 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 123.139 0.274 . . . . 64.34 110.764 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.32 -37.41 80.53 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-O 121.28 0.562 . . . . 73.05 110.673 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HA ' ' CE2' ' A' ' 54' ' ' PHE . . . -69.54 -42.7 74.26 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.618 -0.719 . . . . 74.25 111.411 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 82' ' ' GLU . 14.9 ptmm? -70.08 -33.45 71.92 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.331 -0.548 . . . . 73.05 110.8 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.12 -44.11 95.14 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 123.432 0.458 . . . . 72.34 110.921 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.72 -41.5 23.5 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 120.288 -0.565 . . . . 72.22 112.009 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.411 ' O ' HG22 ' A' ' 91' ' ' ILE . 94.3 mt -89.08 -20.66 24.04 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 116.335 1.976 . . . . 75.43 116.335 -170.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -67.58 115.01 6.69 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 120.1 1.318 . . . . 55.31 110.083 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.43 13.72 16.32 Favored Glycine 0 N--CA 1.415 -2.75 0 CA-C-N 115.69 -0.686 . . . . 75.54 111.472 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 88' ' ' LEU . 14.5 tt -92.12 132.86 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.652 0 CA-C-O 121.411 0.624 . . . . 72.2 110.068 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.435 ' HB3' ' O ' ' A' ' 94' ' ' ASP . 30.2 mmt180 -63.81 137.23 57.96 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.854 -1.066 . . . . 65.22 108.248 172.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.499 ' CD1' HD11 ' A' ' 101' ' ' LEU . 7.1 t80 -77.32 -30.77 54.2 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.872 -1.529 . . . . 72.14 106.872 174.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.617 ' OD2' ' HB3' ' B' ' 45' ' ' ARG 0.294 5.0 m-20 -144.66 136.92 13.24 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 100.823 -3.769 . . . . 61.52 100.823 171.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.586 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 49.3 Cg_endo -71.88 -5.9 18.02 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 CA-C-N 121.943 1.729 . . . . 74.23 109.815 172.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -94.94 6.43 49.07 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.986 1.314 . . . . 75.42 109.154 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.611 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 48.4 t-20 -129.21 131.25 23.56 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 108.825 -0.806 . . . . 74.32 108.825 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -70.44 -6.46 18.98 Favored 'Trans proline' 0 C--O 1.25 1.121 0 C-N-CA 123.361 2.707 . . . . 75.45 113.082 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.414 ' HA ' ' OE1' ' A' ' 99' ' ' GLN . 5.9 tp60 -84.54 118.72 24.5 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 108.927 -0.768 . . . . 73.0 108.927 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.474 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 37.0 p -120.4 146.39 46.24 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.558 -0.746 . . . . 73.02 109.138 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.499 HD11 ' CD1' ' A' ' 93' ' ' PHE . 7.5 mp -80.8 137.79 36.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.442 0.639 . . . . 64.04 111.637 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -129.63 105.75 8.26 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 107.263 -1.384 . . . . 73.41 107.263 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.1 mp -97.94 117.17 31.69 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.047 -0.978 . . . . 63.54 108.784 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.558 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 32.9 tt0 -136.61 160.43 38.83 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.572 -1.64 . . . . 71.04 106.572 -177.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -70.0 139.43 52.75 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 119.263 0.938 . . . . 74.23 110.492 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.28 145.07 46.36 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.337 -0.616 . . . . 71.55 109.337 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.52 2.19 14.54 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.78 -0.645 . . . . 73.23 111.536 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.26 115.78 4.78 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.162 -1.051 . . . . 61.21 108.162 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -69.13 123.21 20.48 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 107.876 -1.157 . . . . 74.51 107.876 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.6 m -103.97 101.53 11.31 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 120.99 -0.284 . . . . 72.14 110.636 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -68.02 128.77 37.75 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.202 -0.666 . . . . 74.43 109.202 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 84.0 mtp -68.56 -42.1 78.8 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.042 -0.725 . . . . 71.33 109.042 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.45 117.88 27.69 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.005 -0.998 . . . . 75.13 108.668 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -83.19 104.53 13.45 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.099 -0.5 . . . . 73.12 110.065 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.8 m -70.69 100.59 1.89 Allowed 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.721 -0.672 . . . . 62.42 110.201 177.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -122.61 101.2 7.33 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 105.058 -2.201 . . . . 65.24 105.058 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.0 tp -76.66 76.55 3.32 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.585 0.957 . . . . 51.15 113.585 -171.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--N 1.316 -0.877 0 C-N-CA 126.424 1.89 . . . . 64.33 107.064 171.891 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 19.8 mmt . . . . . 0 CA--C 1.494 -1.184 0 N-CA-C 107.363 -1.347 . . . . 38.04 107.363 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -104.23 155.2 18.93 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.681 -0.408 . . . . 63.55 110.109 -174.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -86.41 100.45 12.35 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.174 -1.788 . . . . 63.04 106.174 168.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.64 -179.45 6.57 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 106.894 -1.521 . . . . 74.11 106.894 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.26 111.91 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.52 0.676 . . . . 75.44 112.155 -169.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -96.3 -17.38 20.74 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 115.066 -0.97 . . . . 64.22 110.363 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 13.6 m -99.2 129.65 45.45 Favored 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 114.991 -1.004 . . . . 71.34 112.83 -170.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.466 ' H ' HD23 ' B' ' 33' ' ' LEU . 2.4 pt? -123.87 151.39 43.52 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 107.241 -1.392 . . . . 71.34 107.241 174.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.603 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 18.3 p90 -105.4 123.98 48.78 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 121.896 0.855 . . . . 74.44 109.585 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.463 HG22 ' HG ' ' B' ' 103' ' ' LEU . 43.5 t -97.79 115.41 37.67 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 107.004 -1.48 . . . . 73.14 107.004 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 23.8 p -119.04 168.36 10.9 Favored 'General case' 0 C--N 1.274 -2.703 0 CA-C-N 115.309 -0.86 . . . . 61.52 108.786 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 89.69 31.13 11.7 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.749 -0.94 . . . . 72.42 110.749 -175.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 88.9 mt -104.2 114.31 64.44 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.076 -1.453 . . . . 63.45 107.076 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.15 156.85 19.09 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.102 1.868 . . . . 74.22 110.43 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 11.9 p -65.22 -10.51 9.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 122.174 0.988 . . . . 74.41 111.27 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -98.04 8.3 44.98 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 114.869 -1.059 . . . . 72.01 110.054 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.49 121.53 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 CA-C-O 121.583 0.706 . . . . 64.42 111.489 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.48 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 3.2 mptp? -85.58 145.81 42.79 Favored Pre-proline 0 C--N 1.315 -0.906 0 C-N-CA 124.39 1.076 . . . . 74.21 109.923 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.19 -23.53 74.16 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.526 2.151 . . . . 64.55 112.972 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.617 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 13.2 ptt180 -77.46 -24.48 50.24 Favored 'General case' 0 N--CA 1.425 -1.681 0 O-C-N 122.279 -0.263 . . . . 63.12 111.126 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.48 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 43.3 mt-10 -68.09 -33.63 74.9 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.276 0.56 . . . . 74.21 110.001 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 48.8 mt -63.09 -47.11 84.25 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.281 -1.007 . . . . 70.23 108.281 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.594 ' O ' ' HG3' ' B' ' 52' ' ' ARG . 11.5 t80 -58.83 -44.62 90.95 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.431 -1.259 . . . . 74.33 111.175 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 93.5 mt -65.24 -39.14 92.31 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.007 0.432 . . . . 73.32 110.884 -178.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 34.7 tp -78.97 -40.52 31.49 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 115.931 -0.577 . . . . 71.32 112.121 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -89.88 0.91 56.78 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 115.519 1.674 . . . . 64.04 115.519 -174.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 14.3 mtp180 -61.36 -47.52 93.62 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 114.459 1.281 . . . . 73.22 114.459 176.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -72.08 -4.24 14.79 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.257 1.305 . . . . 73.21 112.377 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -92.42 93.4 8.57 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.915 0.864 . . . . 72.12 111.428 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.567 ' HD3' ' H ' ' B' ' 55' ' ' LYS . 0.1 OUTLIER -65.35 111.76 3.19 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.085 -1.416 . . . . 72.05 110.143 178.373 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.14 -15.54 4.24 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.331 -0.85 . . . . 75.1 112.702 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -61.9 109.39 1.24 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 117.099 0.45 . . . . 75.33 110.747 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -86.56 -38.2 17.4 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.175 -1.046 . . . . 72.24 108.175 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.7 178.9 40.58 Favored Glycine 0 C--N 1.311 -0.826 0 CA-C-N 115.014 -0.994 . . . . 34.24 112.023 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.6 p -135.1 148.74 49.9 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 122.456 0.302 . . . . 63.02 110.973 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 54.3 tp -126.31 111.74 14.89 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.974 -1.121 . . . . 72.4 107.974 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.43 ' CG2' ' HB2' ' B' ' 69' ' ' PRO . 46.5 mm -94.24 134.34 32.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 110.228 -0.286 . . . . 73.5 110.228 -175.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -124.35 114.91 20.16 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.219 -0.66 . . . . 52.22 109.219 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.08 125.34 26.36 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.216 0.531 . . . . 74.01 109.58 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 16.0 m -125.04 159.38 31.48 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 106.145 -1.798 . . . . 61.22 106.145 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.04 -40.54 15.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.17 0.988 . . . . 44.22 112.946 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -88.93 -47.7 7.97 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.857 0.688 . . . . 50.3 112.857 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 26.4 pt20 -155.68 149.0 18.49 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 116.041 -0.527 . . . . 72.4 110.048 -170.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 49.9 Cg_endo -79.07 108.58 2.41 Favored 'Trans proline' 0 N--CA 1.436 -1.899 0 C-N-CA 122.146 1.898 . . . . 55.12 109.981 170.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.03 151.32 4.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.5 -0.773 . . . . 53.44 109.061 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.13 120.69 4.73 Favored Glycine 0 CA--C 1.478 -2.244 0 C-N-CA 118.162 -1.97 . . . . 51.31 113.681 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -88.41 105.44 17.6 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 106.467 -1.679 . . . . 63.43 106.467 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.417 ' O ' HD23 ' B' ' 33' ' ' LEU . 74.6 t -100.15 130.67 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 CA-C-O 121.421 0.629 . . . . 74.22 110.3 -176.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.52 119.77 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 CA-C-N 114.708 -1.133 . . . . 74.43 108.724 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -102.78 168.37 9.28 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 115.208 -0.906 . . . . 62.54 111.358 174.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.96 -43.67 50.28 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.289 -1.323 . . . . 75.11 110.792 172.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 11.5 p -166.03 169.68 14.35 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.045 -0.98 . . . . 75.51 110.894 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ARG . . . . . 0.507 ' H ' ' HD3' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -63.24 -30.53 71.65 Favored 'General case' 0 C--O 1.213 -0.822 0 O-C-N 123.194 0.309 . . . . 75.31 110.182 176.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.98 67.38 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 122.361 1.077 . . . . 71.0 109.469 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.5 -43.69 5.45 Favored Glycine 0 C--N 1.294 -1.791 0 CA-C-N 113.536 -1.665 . . . . 64.34 110.678 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.79 -36.9 85.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.556 -0.822 . . . . 72.54 111.798 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 9.9 pt-20 -60.75 -41.23 94.99 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 120.747 0.308 . . . . 73.33 110.64 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.72 -39.4 80.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.998 0.428 . . . . 63.23 110.162 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.29 82.39 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.371 -0.831 . . . . 75.03 111.198 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' B' ' 82' ' ' GLU . 13.1 ptmm? -69.54 -32.19 70.86 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 116.233 -0.44 . . . . 65.31 110.861 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -70.95 -28.83 64.76 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 111.987 0.366 . . . . 74.44 111.987 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.71 -32.8 25.33 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 120.436 -0.505 . . . . 65.44 111.694 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.558 ' O ' HG22 ' B' ' 91' ' ' ILE . 92.7 mt -107.8 -4.39 18.11 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 115.443 1.645 . . . . 74.53 115.443 -173.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -79.03 114.78 18.25 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 117.786 -1.566 . . . . 74.21 110.272 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.9 3.96 48.64 Favored Glycine 0 CA--C 1.479 -2.211 0 C-N-CA 120.564 -0.827 . . . . 73.1 111.911 174.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.558 HG22 ' O ' ' B' ' 88' ' ' LEU . 15.5 tt -96.5 137.61 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.056 0 N-CA-C 107.312 -1.366 . . . . 73.24 107.312 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.428 ' HG2' HG22 ' B' ' 100' ' ' THR . 99.4 mtt180 -77.28 142.14 39.62 Favored 'General case' 0 C--N 1.265 -3.071 0 CA-C-O 121.35 0.595 . . . . 62.23 112.537 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.459 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 39.8 t80 -67.69 -37.0 81.72 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.798 -1.546 . . . . 71.41 108.991 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.57 ' HB2' ' HB2' ' B' ' 97' ' ' ASN 0.277 3.9 m-20 -131.13 133.81 25.1 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 101.831 -3.396 . . . . 60.34 101.831 174.32 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 95' ' ' PRO . . . . . 0.667 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 18.7 Cg_endo -61.04 -29.9 88.56 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 CA-C-N 121.993 1.748 . . . . 62.51 112.026 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -94.91 15.93 17.38 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.544 -0.753 . . . . 52.4 111.133 -175.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' B' ' 94' ' ' ASP . 57.7 t-20 -122.82 131.86 24.33 Favored Pre-proline 0 C--N 1.312 -1.054 0 N-CA-C 107.225 -1.398 . . . . 60.41 107.225 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.91 -3.42 13.58 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.279 1.986 . . . . 73.2 112.57 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' GLN . . . . . 0.471 ' HA ' ' OE1' ' B' ' 99' ' ' GLN . 5.8 tp60 -76.59 112.23 12.92 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.958 -0.756 . . . . 74.33 108.958 177.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.508 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 81.6 p -105.49 144.85 31.68 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.647 -0.706 . . . . 65.11 110.278 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 81.0 mt -79.53 135.97 36.76 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.431 -0.952 . . . . 64.12 108.431 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -131.42 112.79 13.01 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.744 -1.206 . . . . 73.42 107.744 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.463 ' HG ' HG22 ' B' ' 35' ' ' VAL . 7.6 mp -103.12 118.21 36.28 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.601 -0.727 . . . . 64.14 109.61 177.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.603 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 6.5 tp10 -135.29 157.12 47.71 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 105.684 -1.969 . . . . 74.0 105.684 -177.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -69.33 142.24 54.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 119.74 1.154 . . . . 65.42 110.961 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.47 153.11 25.79 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.888 -1.153 . . . . 53.52 107.888 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -94.3 13.01 24.89 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.908 -1.117 . . . . 73.22 109.235 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.4 114.86 10.44 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.71 -1.218 . . . . 55.51 107.71 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -85.01 104.44 14.94 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.236 -1.394 . . . . 74.41 107.236 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 16.3 m -102.38 96.79 7.17 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 116.07 -0.514 . . . . 74.23 110.895 -170.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -61.74 141.67 57.73 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 116.451 -0.34 . . . . 71.22 110.094 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 89.0 mtp -88.55 -57.6 2.86 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.71 -0.848 . . . . 73.44 108.71 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.34 116.59 32.68 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.033 -1.469 . . . . 71.15 107.033 175.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -109.59 137.99 46.61 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 116.241 -0.436 . . . . 72.44 109.975 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 10.5 p -68.35 126.79 30.71 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.544 -0.539 . . . . 72.23 109.544 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -75.11 150.54 38.77 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.426 -0.583 . . . . 73.23 109.426 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 40.4 tp -78.58 65.95 3.99 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.29 -1.004 . . . . 73.21 108.29 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.446 -0.653 0 C-N-CA 125.941 1.696 . . . . 72.45 107.577 -177.856 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 CA--C 1.487 -1.457 0 N-CA-C 107.2 -1.407 . . . . 75.31 107.2 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -111.25 -167.9 1.24 Allowed 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.928 -0.767 . . . . 73.13 108.928 -169.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.24 62.39 3.6 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.981 0.896 . . . . 74.53 109.099 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.483 ' OE1' ' HD3' ' A' ' 78' ' ' ARG . 39.5 mt-10 -72.13 150.31 43.94 Favored 'General case' 0 N--CA 1.4 -2.933 0 C-N-CA 126.09 1.756 . . . . 71.44 108.531 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.7 110.0 8.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 105.941 -1.874 . . . . 74.34 105.941 173.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 24.2 mtt180 -104.02 0.88 30.41 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.778 -0.769 . . . . 64.41 111.066 -172.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.1 m -104.69 125.49 50.84 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-O 121.391 0.615 . . . . 73.25 112.597 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.413 HD12 ' CE1' ' A' ' 75' ' ' PHE . 73.5 mt -109.73 138.03 46.68 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.554 -0.906 . . . . 55.53 108.554 173.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -96.31 110.55 22.86 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 107.345 -1.354 . . . . 74.03 107.345 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.523 HG22 ' HG ' ' A' ' 103' ' ' LEU . 40.5 t -97.67 124.51 50.68 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.767 0 CA-C-N 114.168 -1.378 . . . . 72.53 108.623 -176.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.7 p -129.45 164.72 23.08 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.166 -0.924 . . . . 75.15 110.111 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 92.85 29.89 10.13 Favored Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.924 -0.87 . . . . 50.55 110.924 -173.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.9 mt -95.23 122.19 60.32 Favored Pre-proline 0 N--CA 1.425 -1.699 0 N-CA-C 106.04 -1.837 . . . . 71.21 106.04 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -55.41 153.32 28.73 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.161 1.908 . . . . 74.24 111.7 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.5 p -61.34 -12.91 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.918 0.887 . . . . 74.12 111.423 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -127.94 40.74 3.63 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.623 -0.88 . . . . 74.12 108.623 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.7 tt -72.08 132.02 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.459 -0.791 . . . . 72.52 109.087 172.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.444 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 29.3 mmmt -90.26 145.8 33.47 Favored Pre-proline 0 C--N 1.276 -2.619 0 N-CA-C 108.584 -0.895 . . . . 71.23 108.584 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.66 -29.3 84.92 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.478 2.119 . . . . 73.24 111.728 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.522 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 13.2 ptt180 -70.85 -22.06 62.36 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 115.44 -0.8 . . . . 72.41 111.738 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 38.8 mt-10 -69.47 -38.27 77.66 Favored 'General case' 0 CA--C 1.506 -0.729 0 O-C-N 122.058 -0.401 . . . . 45.11 110.451 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.22 -34.0 76.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 122.042 0.925 . . . . 55.15 108.768 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.576 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 56.5 t80 -65.46 -48.83 71.34 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.573 -1.194 . . . . 71.13 110.169 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 95.5 mt -65.17 -43.57 91.32 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 123.606 0.566 . . . . 71.1 110.045 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.407 HD13 HD22 ' B' ' 49' ' ' LEU . 34.2 tp -65.59 -43.14 90.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.034 -0.985 . . . . 54.3 111.147 -176.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -95.73 14.88 21.71 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 113.156 0.799 . . . . 72.24 113.156 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 3.2 mmp_? -55.37 -51.14 82.4 Favored Pre-proline 0 N--CA 1.486 1.351 0 N-CA-C 112.452 0.538 . . . . 62.02 112.452 174.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 52' ' ' ARG . 5.4 Cg_exo -81.33 -1.61 11.17 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 121.859 1.706 . . . . 65.44 112.918 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -93.63 89.74 6.35 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.52 0.676 . . . . 73.21 111.867 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -65.45 112.22 3.45 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.716 -1.129 . . . . 64.23 108.597 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 75' ' ' PHE . . . 132.96 -10.56 5.14 Favored Glycine 0 C--N 1.286 -2.206 0 C-N-CA 119.306 -1.426 . . . . 73.41 112.943 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -69.09 94.81 0.69 Allowed 'General case' 0 C--O 1.243 0.712 0 CA-C-N 117.626 0.713 . . . . 74.31 109.162 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -84.59 -44.35 13.6 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.032 -0.531 . . . . 62.25 109.879 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -168.8 179.43 41.64 Favored Glycine 0 C--N 1.296 -1.658 0 C-N-CA 120.645 -0.788 . . . . 73.1 111.867 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.8 p -151.44 140.72 21.37 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 122.801 0.44 . . . . 72.33 109.844 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.1 tp -111.96 109.56 19.41 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.322 -0.992 . . . . 72.22 108.322 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.41 129.65 44.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.563 -0.532 . . . . 74.41 109.563 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -123.4 123.09 39.89 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.37 -0.974 . . . . 74.1 108.37 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.69 118.06 21.17 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.406 0.622 . . . . 71.11 110.56 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.2 m -107.99 155.41 20.37 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 104.577 -2.379 . . . . 75.11 104.577 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.38 -33.71 31.11 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.265 1.209 . . . . 70.25 114.265 -172.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -105.07 -17.45 14.49 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 118.923 -1.111 . . . . 64.32 113.138 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -164.56 148.73 7.99 Favored Pre-proline 0 C--N 1.321 -0.654 0 C-N-CA 120.662 -0.415 . . . . 72.34 110.725 -173.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -80.94 121.7 4.1 Favored 'Trans proline' 0 N--CA 1.429 -2.292 0 C-N-CA 121.856 1.704 . . . . 70.53 109.671 168.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.82 146.94 5.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 107.676 -1.231 . . . . 72.21 107.676 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.33 120.77 3.13 Favored Glycine 0 CA--C 1.48 -2.13 0 C-N-CA 118.363 -1.875 . . . . 65.24 113.238 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -88.0 101.82 14.14 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.534 -1.654 . . . . 62.21 106.534 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.6 t -92.18 126.23 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 CA-C-N 115.688 -0.687 . . . . 65.33 110.031 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.6 mt -100.83 111.28 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.406 0 CA-C-N 114.287 -1.324 . . . . 55.23 108.32 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.533 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 80.8 m-85 -95.84 169.17 10.19 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 114.926 -1.034 . . . . 62.14 110.994 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.6 -44.13 97.08 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.304 -1.316 . . . . 72.23 112.561 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.9 p -152.78 165.71 34.5 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 122.427 -0.171 . . . . 72.42 111.016 -172.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.483 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -78.28 -27.95 47.51 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.246 -1.02 . . . . 74.03 108.246 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.44 -26.18 65.38 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.245 -0.888 . . . . 63.13 108.766 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.46 -40.46 8.38 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.324 -1.11 . . . . 61.44 110.324 176.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.15 92.92 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.286 0.635 . . . . 54.2 112.528 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.47 -31.47 70.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 119.769 -0.772 . . . . 64.43 112.11 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.4 -42.52 68.23 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.148 0.499 . . . . 52.24 110.018 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.01 -42.36 97.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.651 -0.704 . . . . 74.32 111.295 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.441 ' CE ' ' HA ' ' A' ' 104' ' ' GLU . 13.8 ptmm? -67.97 -36.9 80.84 Favored 'General case' 0 C--O 1.198 -1.648 0 C-N-CA 120.248 -0.581 . . . . 73.41 109.85 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -67.15 -19.79 65.65 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 112.974 0.731 . . . . 74.54 112.974 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.34 -45.57 10.45 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-O 121.276 0.56 . . . . 65.41 110.236 175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.526 ' O ' HG22 ' A' ' 91' ' ' ILE . 93.8 mt -94.13 -19.16 21.05 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 116.17 1.915 . . . . 73.21 116.17 -171.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.439 ' HB3' ' H ' ' A' ' 103' ' ' LEU 0.293 0.2 OUTLIER -76.55 116.99 17.75 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 120.662 -1.273 . . . . 54.13 113.335 -177.196 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.75 19.83 9.39 Favored Glycine 0 N--CA 1.423 -2.225 0 C-N-CA 120.689 -0.767 . . . . 62.33 112.142 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 88' ' ' LEU . 18.1 tt -112.91 135.84 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.212 0 N-CA-C 108.166 -1.05 . . . . 72.13 108.166 176.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.486 ' HG2' HG22 ' A' ' 100' ' ' THR . 63.5 mtt180 -72.75 128.11 34.57 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 116.242 -0.435 . . . . 73.21 109.901 174.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.4 ' CD2' ' HG3' ' B' ' 45' ' ' ARG . 8.6 t80 -57.57 -32.26 66.97 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 124.983 1.427 . . . . 70.42 109.932 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.611 ' HB2' ' HB2' ' A' ' 97' ' ' ASN 0.284 8.8 m-20 -133.53 140.27 36.39 Favored Pre-proline 0 CA--C 1.496 -1.132 0 N-CA-C 103.326 -2.842 . . . . 54.0 103.326 170.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.513 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 34.7 Cg_endo -70.89 -17.28 32.57 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 CA-C-N 121.229 1.475 . . . . 74.42 111.771 173.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -86.66 -12.47 48.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.132 0.491 . . . . 62.35 110.096 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.611 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 44.7 t-20 -103.76 131.98 21.49 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 109.078 -0.712 . . . . 72.22 109.078 -172.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.421 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 45.1 Cg_endo -70.43 -14.56 34.09 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.465 2.11 . . . . 71.23 112.407 176.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -65.24 115.89 6.03 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 109.458 -0.571 . . . . 61.22 109.458 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.486 HG22 ' HG2' ' A' ' 92' ' ' ARG . 60.6 p -102.62 139.92 37.57 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 119.946 -0.701 . . . . 72.52 110.026 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.9 tp -94.78 123.25 38.13 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.669 -0.864 . . . . 64.12 108.669 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 102' ' ' ARG . 0.3 OUTLIER -137.32 128.4 27.67 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 119.607 -0.837 . . . . 74.12 110.473 178.473 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.523 ' HG ' HG22 ' A' ' 35' ' ' VAL . 5.3 mp -106.65 125.29 50.81 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.315 -1.312 . . . . 63.53 108.38 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.441 ' HA ' ' CE ' ' A' ' 85' ' ' LYS . 26.0 tt0 -136.32 155.36 50.18 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.818 -1.179 . . . . 60.01 107.818 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -66.57 132.13 47.53 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 119.028 0.831 . . . . 73.33 111.822 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.09 152.6 36.76 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.19 -1.041 . . . . 73.02 108.19 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -93.24 15.59 15.12 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.66 1.219 . . . . 73.24 110.319 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -153.86 125.83 7.8 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.738 -1.119 . . . . 72.44 108.373 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.12 123.56 21.0 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.033 -1.099 . . . . 75.13 108.033 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.0 m -105.88 138.3 42.31 Favored 'General case' 0 C--N 1.269 -2.916 0 N-CA-C 107.327 -1.361 . . . . 61.42 107.327 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -111.7 167.71 10.13 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.294 -1.002 . . . . 74.24 108.294 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 85.6 mtp -77.39 177.21 8.15 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.047 -0.723 . . . . 61.04 109.047 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.02 85.32 4.25 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.178 0.513 . . . . 45.2 111.087 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -112.69 98.34 7.16 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.638 -1.616 . . . . 73.0 106.638 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.0 m -83.35 107.74 16.07 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.228 0.537 . . . . 72.14 110.708 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -83.11 78.04 9.66 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.014 -1.476 . . . . 71.05 107.014 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.7 tp -101.72 -35.65 9.0 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.346 -1.353 . . . . 51.45 107.346 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 . . . . . 0 N--CA 1.413 -2.309 0 N-CA-C 106.19 -1.782 . . . . 75.23 106.19 179.044 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.465 0.307 0 N-CA-C 111.965 0.357 . . . . 52.42 111.965 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -107.72 -163.1 0.87 Allowed 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.312 -0.995 . . . . 71.11 108.312 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -78.83 76.58 5.32 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 122.55 1.167 . . . . 71.42 112.217 177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.464 ' OE1' ' HD3' ' B' ' 78' ' ' ARG . 32.6 mt-10 -77.29 163.72 26.23 Favored 'General case' 0 N--CA 1.399 -2.977 0 CA-C-N 113.675 -1.602 . . . . 74.21 107.956 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 45.6 t -78.78 110.47 14.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 106.203 -1.777 . . . . 65.4 106.203 173.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.523 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 66.5 mtt180 -99.47 -15.7 18.6 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-N 115.567 -0.742 . . . . 62.41 111.427 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' B' ' 73' ' ' VAL . 31.0 m -105.4 129.16 53.78 Favored 'General case' 1 C--N 1.243 -4.026 0 N-CA-C 113.581 0.956 . . . . 53.34 113.581 -170.482 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.492 HD11 ' O ' ' B' ' 81' ' ' ALA . 79.2 mt -106.64 145.78 31.53 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.479 -1.237 . . . . 73.33 107.883 171.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' B' ' 104' ' ' GLU . 25.5 p90 -104.15 116.28 31.91 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 119.077 -1.049 . . . . 62.32 108.346 173.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.37 118.09 43.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 114.03 -1.441 . . . . 53.3 107.602 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.5 p -126.37 163.15 23.91 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 109.44 -0.578 . . . . 72.11 109.44 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 99.5 19.99 18.77 Favored Glycine 0 N--CA 1.423 -2.215 0 N-CA-C 111.826 -0.51 . . . . 41.0 111.826 -172.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 72.4 mt -93.89 120.21 66.1 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 107.915 -1.143 . . . . 73.24 107.915 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.34 159.6 22.48 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.576 2.184 . . . . 53.24 111.643 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 7.9 p -70.04 -6.11 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-O 121.94 0.876 . . . . 62.42 110.922 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -114.48 30.08 7.56 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.108 -1.071 . . . . 72.53 108.108 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.402 HG22 ' HG2' ' B' ' 69' ' ' PRO . 9.4 tt -58.8 140.32 17.28 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 CA-C-O 121.745 0.783 . . . . 72.33 111.627 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.636 ' HG2' ' CZ ' ' B' ' 45' ' ' ARG . 0.1 OUTLIER -101.18 143.34 26.4 Favored Pre-proline 0 C--N 1.293 -1.872 0 C-N-CA 125.712 1.605 . . . . 74.24 108.525 175.056 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -61.79 -27.91 81.15 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.451 2.1 . . . . 63.02 113.437 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.636 ' CZ ' ' HG2' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -82.7 -10.65 58.82 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 118.228 -1.389 . . . . 65.15 111.909 -177.244 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -65.09 -39.4 93.14 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 120.101 -0.639 . . . . 72.51 109.708 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.31 -33.71 74.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.538 -0.755 . . . . 71.05 109.806 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.513 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 66.5 t80 -61.94 -50.81 70.63 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.674 -0.694 . . . . 74.23 110.184 177.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 81.4 mt -62.04 -44.17 97.27 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 124.085 0.865 . . . . 44.01 109.548 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 20.6 tp -63.17 -44.64 94.88 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.45 -1.25 . . . . 71.02 110.965 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -93.59 11.39 28.96 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 113.902 1.075 . . . . 74.33 113.902 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' B' ' 52' ' ' ARG . 5.2 mmp_? -55.25 -51.86 76.21 Favored Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 113.276 0.843 . . . . 75.32 113.276 175.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' B' ' 52' ' ' ARG . 2.9 Cg_exo -79.26 -1.0 11.2 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.011 1.808 . . . . 74.42 112.937 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -99.81 99.76 10.61 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-O 122.5 1.143 . . . . 65.11 112.516 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -73.67 116.09 13.85 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 113.02 -1.9 . . . . 61.22 109.076 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' B' ' 75' ' ' PHE . . . 143.19 -24.73 2.22 Favored Glycine 0 C--N 1.284 -2.312 0 CA-C-N 114.822 -1.081 . . . . 60.52 112.103 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -55.67 110.07 0.66 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.512 0.725 . . . . 61.04 112.488 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -96.11 -49.27 5.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.489 -0.778 . . . . 50.13 110.368 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -169.68 172.41 43.65 Favored Glycine 0 C--N 1.299 -1.477 0 CA-C-N 115.162 -0.926 . . . . 71.22 111.413 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.9 p -141.17 137.63 32.83 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 122.531 0.332 . . . . 74.25 110.627 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 28.5 tp -120.33 115.35 23.37 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.897 -1.149 . . . . 75.13 107.897 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.95 131.47 42.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 109.684 -0.488 . . . . 72.03 109.684 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -118.55 114.35 22.68 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.309 -0.997 . . . . 72.0 108.309 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.6 119.74 12.86 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.956 -0.757 . . . . 64.32 108.956 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 25.6 m -114.65 155.25 26.93 Favored 'General case' 0 N--CA 1.401 -2.913 0 N-CA-C 104.662 -2.347 . . . . 64.34 104.662 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.78 -38.01 14.73 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.69 0.996 . . . . 71.44 113.69 -173.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -104.29 -15.78 15.36 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 113.239 0.829 . . . . 72.3 113.239 -174.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.493 ' O ' ' HB ' ' B' ' 65' ' ' THR . 29.4 pt20 -172.64 140.05 0.97 Allowed Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 110.135 -0.32 . . . . 71.53 110.135 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 68' ' ' GLN . 6.4 Cg_exo -74.54 112.99 3.68 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.846 2.364 . . . . 71.31 109.672 168.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -90.8 145.31 7.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.648 -0.871 . . . . 75.4 108.648 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.19 120.1 4.43 Favored Glycine 0 CA--C 1.483 -1.914 0 C-N-CA 118.917 -1.611 . . . . 60.22 112.775 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.91 103.06 15.82 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.579 -1.267 . . . . 75.22 107.579 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' B' ' 32' ' ' THR . 59.3 t -98.25 127.36 50.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-N 115.725 -0.67 . . . . 71.3 110.687 -175.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 53.3 mt -98.44 128.76 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 CA-C-N 114.842 -1.072 . . . . 63.13 108.814 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.523 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 85.3 m-85 -109.03 159.47 16.82 Favored 'General case' 0 C--N 1.271 -2.837 0 N-CA-C 107.799 -1.185 . . . . 64.21 107.799 174.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.13 -40.09 94.77 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 112.469 0.544 . . . . 75.34 112.469 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 2.9 p -143.69 155.61 44.27 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 116.046 -0.524 . . . . 63.03 111.707 -174.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ARG . . . . . 0.597 ' H ' ' HD3' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -59.69 -35.18 73.98 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 123.398 0.436 . . . . 73.03 110.898 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.6 -32.31 73.74 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 122.008 0.909 . . . . 64.44 109.49 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.47 -37.44 35.76 Favored Glycine 0 C--N 1.31 -0.864 0 CA-C-N 114.021 -1.445 . . . . 73.23 110.493 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.492 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -70.03 -45.3 67.47 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.848 -0.676 . . . . 55.12 111.517 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.94 -37.19 85.37 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.289 -0.564 . . . . 71.14 111.425 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.46 -35.99 81.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.853 0.359 . . . . 44.22 110.268 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.65 74.74 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.716 -0.675 . . . . 73.31 111.464 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.407 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 13.8 ptmm? -66.65 -40.18 88.56 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 119.743 -0.783 . . . . 72.24 110.619 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -60.53 -30.62 69.87 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.173 0.435 . . . . 53.3 112.173 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.18 -36.36 19.54 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.33 -0.548 . . . . 41.23 111.969 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.457 ' O ' HG22 ' B' ' 91' ' ' ILE . 91.2 mt -96.97 -23.38 16.33 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 116.042 1.867 . . . . 53.4 116.042 -172.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ASN . . . . . 0.48 ' HB3' ' H ' ' B' ' 103' ' ' LEU . 0.2 OUTLIER -76.34 123.11 25.43 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.202 1.186 . . . . 73.41 114.202 -175.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.34 27.13 6.27 Favored Glycine 0 CA--C 1.483 -1.907 0 C-N-CA 120.316 -0.945 . . . . 74.02 111.582 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.457 HG22 ' O ' ' B' ' 88' ' ' LEU . 18.8 tt -124.44 142.96 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.395 0 N-CA-C 106.316 -1.735 . . . . 74.35 106.316 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.587 ' HG2' HG22 ' B' ' 100' ' ' THR . 96.3 mtt180 -74.21 145.82 43.83 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-O 121.098 0.475 . . . . 73.13 111.164 176.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -74.03 -33.24 63.68 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.166 -1.379 . . . . 74.14 108.199 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.575 ' HB2' ' CB ' ' B' ' 97' ' ' ASN . 4.8 m-20 -136.08 130.32 18.37 Favored Pre-proline 0 CA--C 1.511 -0.533 0 N-CA-C 103.456 -2.794 . . . . 75.43 103.456 173.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' PRO . . . . . 0.576 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 17.5 Cg_endo -58.26 -34.82 98.97 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.024 1.816 . . . . 52.12 112.479 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.17 1.57 39.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.816 -0.629 . . . . 75.21 111.782 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' ASN . . . . . 0.575 ' CB ' ' HB2' ' B' ' 94' ' ' ASP . 48.1 t30 -114.12 128.07 26.18 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 109.575 -0.528 . . . . 74.45 109.575 -175.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.12 -7.16 20.48 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 122.82 2.347 . . . . 71.32 112.016 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' GLN . . . . . 0.543 ' HB3' ' ND2' ' B' ' 97' ' ' ASN . 6.4 tp60 -75.01 112.12 10.91 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.099 -1.074 . . . . 71.25 108.099 174.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.587 HG22 ' HG2' ' B' ' 92' ' ' ARG . 82.2 p -101.96 151.88 21.6 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.76 -0.655 . . . . 74.21 109.398 -174.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 42.0 tp -98.81 121.0 40.19 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.958 -1.127 . . . . 71.33 107.958 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -131.93 138.53 48.4 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-O 121.344 0.593 . . . . 64.33 109.511 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' B' ' 89' ' ' ASN . 5.9 mp -122.36 118.41 28.36 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.944 -1.026 . . . . 71.42 109.137 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.451 ' HB2' ' CE2' ' B' ' 34' ' ' PHE . 9.3 mm-40 -124.21 168.43 12.94 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.966 -1.124 . . . . 43.22 107.966 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -74.35 141.95 45.15 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 109.191 -0.67 . . . . 60.44 109.191 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.46 144.22 42.22 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 108.163 -1.051 . . . . 64.14 108.163 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -80.44 6.74 11.45 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.787 0.803 . . . . 71.05 110.827 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -167.26 131.93 1.95 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.856 -1.905 . . . . 63.32 105.856 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -66.34 145.65 55.48 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 109.041 -0.725 . . . . 73.44 109.041 176.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 7.6 t -102.03 156.13 17.74 Favored 'General case' 0 N--CA 1.411 -2.412 0 C-N-CA 119.059 -1.056 . . . . 71.54 109.15 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -111.01 154.89 23.53 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 107.826 -1.176 . . . . 72.01 107.826 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 86.5 mtp -90.15 155.46 19.02 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.169 -1.419 . . . . 71.41 107.169 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.66 94.14 1.32 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.045 0.45 . . . . 75.3 111.07 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -119.27 125.76 49.88 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 107.268 -1.382 . . . . 73.21 107.268 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 17.9 m -74.87 104.32 5.44 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 123.499 0.5 . . . . 62.41 110.623 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' LYS . . . . . 0.42 ' C ' ' HE3' ' B' ' 116' ' ' LYS . 0.1 OUTLIER -107.92 78.72 1.21 Allowed 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 122.132 0.967 . . . . 74.11 109.805 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 33.2 tp -118.72 -61.11 1.69 Allowed 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 104.806 -2.294 . . . . 73.51 104.806 171.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 . . . . . 0 N--CA 1.437 -1.115 0 N-CA-C 105.425 -2.065 . . . . 73.44 105.425 170.389 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 110.691 -0.114 . . . . 75.31 110.691 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.58 -47.21 10.07 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.357 0.599 . . . . 50.32 110.113 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.49 101.44 11.32 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.688 0.756 . . . . 74.31 111.867 -175.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.543 ' OE1' ' HG3' ' A' ' 78' ' ' ARG . 1.6 tm-20 -117.16 -179.1 3.61 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 105.117 -2.179 . . . . 55.23 105.117 173.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 17.2 t -92.59 109.76 22.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 C-N-CA 118.324 -1.351 . . . . 74.2 109.84 -171.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NH2' ' HA ' ' A' ' 76' ' ' ASP . 17.1 ptm180 -111.08 9.68 22.01 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.215 -0.902 . . . . 71.32 111.459 -172.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.1 m -121.0 125.83 48.37 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.652 -0.704 . . . . 74.43 109.85 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' A' ' 85' ' ' LYS . 89.7 mt -107.35 152.85 23.6 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.239 -0.891 . . . . 73.52 108.846 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.59 ' CE1' ' HB2' ' A' ' 104' ' ' GLU . 21.8 p90 -115.18 118.16 32.53 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 117.883 -1.527 . . . . 75.32 109.056 172.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.8 t -97.63 123.08 49.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 113.797 -1.547 . . . . 74.32 107.679 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 60.0 p -124.31 175.37 7.12 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.986 -1.116 . . . . 71.03 107.986 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 88.5 27.21 25.5 Favored Glycine 0 N--CA 1.422 -2.279 0 N-CA-C 111.169 -0.772 . . . . 74.31 111.169 -176.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.4 mt -103.68 131.64 21.83 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 107.623 -1.251 . . . . 71.34 107.623 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.86 168.01 21.56 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.791 1.661 . . . . 72.32 111.094 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.71 -6.2 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-O 122.063 0.935 . . . . 60.51 110.524 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -124.78 40.4 3.75 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.176 -1.046 . . . . 52.44 108.176 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.49 125.03 34.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 106.589 -1.634 . . . . 62.42 106.589 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -93.91 142.24 24.77 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 109.223 -0.658 . . . . 72.01 109.223 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.24 -21.16 50.71 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.887 2.391 . . . . 62.24 113.217 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.576 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.3 ptt180 -77.21 -24.48 51.31 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 116.233 -0.439 . . . . 74.52 110.743 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -70.41 -41.27 73.18 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.0 0.428 . . . . 64.25 110.513 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.47 -39.97 94.82 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 108.728 -0.842 . . . . 74.15 108.728 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.65 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 30.7 t80 -57.13 -48.24 79.15 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.408 -1.269 . . . . 64.31 111.292 178.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 88.1 mt -61.53 -40.77 95.88 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.238 0.542 . . . . 73.54 110.77 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.8 tp -77.23 -40.93 43.13 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.0 -1.0 . . . . 72.02 111.926 -176.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -88.3 -8.13 55.64 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 115.398 1.629 . . . . 74.41 115.398 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 54.8 mtp85 -57.79 -43.78 98.94 Favored Pre-proline 0 N--CA 1.48 1.075 0 N-CA-C 114.896 1.443 . . . . 72.04 114.896 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -67.91 -17.45 46.6 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 121.344 1.362 . . . . 75.13 112.101 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -86.32 89.6 7.91 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.923 0.868 . . . . 74.23 110.962 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -65.03 110.76 2.6 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.367 -1.288 . . . . 74.31 109.769 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.88 -24.72 2.42 Favored Glycine 0 C--N 1.281 -2.522 0 CA-C-N 114.682 -1.144 . . . . 61.41 111.193 -176.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -58.29 113.03 1.76 Allowed 'General case' 0 C--O 1.242 0.664 0 C-N-CA 122.799 0.44 . . . . 72.34 111.355 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -91.65 -59.76 2.05 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.37 -0.832 . . . . 51.35 109.614 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.43 -178.45 39.64 Favored Glycine 0 C--N 1.298 -1.583 0 CA-C-N 115.276 -0.874 . . . . 55.33 111.449 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.2 p -135.66 137.97 42.36 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 122.532 0.333 . . . . 74.41 111.345 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.6 tt -107.7 119.97 40.93 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.742 -1.577 . . . . 53.33 106.742 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -95.66 128.97 46.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 109.661 -0.496 . . . . 64.44 109.661 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -119.06 109.35 15.81 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 106.51 -1.663 . . . . 73.24 106.51 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.84 127.78 33.66 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.514 -0.767 . . . . 74.54 109.777 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 7.1 m -130.32 151.04 51.25 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 105.54 -2.022 . . . . 63.43 105.54 175.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.74 -41.65 10.94 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 114.529 1.307 . . . . 72.42 114.529 -172.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -105.41 -11.58 16.38 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 114.988 1.477 . . . . 74.15 114.988 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.417 ' O ' ' HB ' ' A' ' 65' ' ' THR . 29.1 pt20 -166.1 125.69 1.19 Allowed Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 120.95 0.405 . . . . 55.31 111.671 -175.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.81 108.17 2.64 Favored 'Trans proline' 0 N--CA 1.439 -1.682 0 C-N-CA 122.371 2.047 . . . . 65.54 108.945 169.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.16 146.92 5.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.639 -0.874 . . . . 62.04 108.639 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.77 120.72 4.59 Favored Glycine 0 CA--C 1.486 -1.732 0 C-N-CA 118.868 -1.634 . . . . 61.53 113.499 -176.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -87.74 103.77 15.92 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.999 -1.482 . . . . 74.42 106.999 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.9 t -94.68 121.8 45.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 114.781 -1.1 . . . . 60.35 110.818 -174.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 tt -93.33 124.92 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.962 0 CA-C-N 114.822 -1.081 . . . . 74.42 109.978 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -103.59 155.57 18.44 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 114.817 -1.083 . . . . 72.14 108.424 173.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.499 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 22.5 t70 -67.98 -34.52 76.69 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.815 -0.63 . . . . 74.32 110.4 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.7 m -132.49 145.87 51.49 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 107.984 -1.117 . . . . 73.02 107.984 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.676 ' HB2' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -78.22 -24.38 47.07 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.66 -0.866 . . . . 71.24 108.66 -179.178 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.13 -25.45 68.36 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.028 0.918 . . . . 53.23 109.098 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.7 -42.59 6.78 Favored Glycine 0 C--N 1.297 -1.627 0 CA-C-N 113.533 -1.667 . . . . 64.5 109.724 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.28 -49.01 79.48 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.306 0.642 . . . . 70.12 111.239 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.19 -35.58 73.84 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.264 0.626 . . . . 62.3 112.234 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.05 -32.23 39.42 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.166 0.508 . . . . 63.4 111.014 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.73 -46.05 69.91 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.147 -0.479 . . . . 72.42 111.052 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HB3' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -68.8 -28.08 66.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.135 -0.484 . . . . 64.15 111.525 -177.2 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -70.28 -40.7 74.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.212 -0.449 . . . . 74.21 110.496 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.66 -36.99 36.89 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.279 0.474 . . . . 31.32 112.279 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.55 ' O ' HG22 ' A' ' 91' ' ' ILE . 98.5 mt -89.39 -4.48 58.02 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 115.484 1.661 . . . . 71.32 115.484 -175.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -78.55 118.05 20.3 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 117.86 -1.536 . . . . 74.34 110.803 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.13 6.53 31.82 Favored Glycine 0 CA--C 1.483 -1.934 0 CA-C-N 115.73 -0.668 . . . . 63.32 112.729 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.9 tt -88.36 121.43 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 109.244 -0.651 . . . . 72.22 109.244 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.529 ' CG ' HG22 ' A' ' 100' ' ' THR . 71.3 mtt180 -74.53 135.28 42.16 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 116.166 -0.47 . . . . 72.23 110.311 173.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.516 ' CD1' HD11 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -63.54 -39.23 93.86 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.367 -1.288 . . . . 54.04 107.697 177.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' A' ' 97' ' ' ASN . 8.2 m-20 -135.41 128.47 18.24 Favored Pre-proline 0 CA--C 1.485 -1.547 0 N-CA-C 104.413 -2.44 . . . . 62.43 104.413 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -56.96 -26.24 66.9 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 121.748 1.632 . . . . 52.04 111.07 173.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -74.88 -20.68 59.63 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.544 1.138 . . . . 72.31 110.569 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 36.4 t30 -106.69 124.59 35.06 Favored Pre-proline 0 C--N 1.308 -1.217 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.491 -173.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.65 -12.04 33.33 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 123.248 2.632 . . . . 74.34 113.25 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.497 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 6.5 tp60 -74.09 113.49 11.34 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.31 -0.996 . . . . 72.44 108.31 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.529 HG22 ' CG ' ' A' ' 92' ' ' ARG . 68.0 p -110.76 145.18 38.55 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.518 -0.764 . . . . 62.15 110.2 -173.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.561 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.1 mp -78.39 120.51 23.23 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.431 0.634 . . . . 55.43 109.652 175.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 104' ' ' GLU . 0.3 OUTLIER -123.43 112.56 17.68 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 107.224 -1.399 . . . . 74.11 107.224 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -106.94 127.31 53.33 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.2 -0.909 . . . . 72.13 110.31 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.59 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 47.3 mt-10 -132.67 174.07 10.68 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.351 -1.351 . . . . 75.41 107.351 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.469 ' HB3' HG11 ' A' ' 30' ' ' VAL . 61.8 m-85 -79.51 138.62 37.59 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.34 -0.615 . . . . 73.03 109.34 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.36 152.28 40.93 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.256 -0.646 . . . . 52.33 109.256 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.539 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 14.0 tmtt? -74.29 -8.15 55.22 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.45 0.643 . . . . 75.14 110.198 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.54 131.23 9.82 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.733 -0.667 . . . . 73.42 109.722 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.46 HD21 ' HA ' ' A' ' 30' ' ' VAL . 93.0 m-20 -75.68 143.27 42.24 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.925 -0.579 . . . . 71.23 110.217 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 t -117.1 146.81 42.91 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.855 -0.794 . . . . 75.51 108.855 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -110.4 157.34 19.65 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.269 -0.641 . . . . 64.22 109.269 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 15.9 mmt -87.8 -17.4 31.66 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.376 0.608 . . . . 74.42 109.876 173.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.1 99.86 2.89 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.617 -1.623 . . . . 64.04 106.617 170.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -159.87 146.99 16.45 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.588 -0.523 . . . . 75.25 109.588 -172.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.5 m 61.42 39.8 14.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.007 0.923 . . . . 60.41 113.236 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -71.92 102.27 2.87 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.911 -0.774 . . . . 71.4 108.911 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.02 73.44 6.82 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.345 -0.983 . . . . 53.11 108.345 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.426 -1.652 0 N-CA-C 105.569 -2.012 . . . . 73.41 105.569 -179.471 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 40.4 tpp . . . . . 0 CA--C 1.543 0.697 0 CA-C-O 121.842 0.83 . . . . 74.03 110.82 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -111.15 20.97 16.87 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.097 -1.075 . . . . 70.55 108.097 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -112.32 22.69 14.44 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.696 -1.594 . . . . 74.32 106.696 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.434 ' HB2' ' HD2' ' B' ' 78' ' ' ARG . 22.8 mm-40 -94.8 -179.76 4.97 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 112.354 -2.203 . . . . 71.32 109.803 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.472 HG11 ' HB3' ' B' ' 105' ' ' PHE . 16.0 t -97.52 111.77 28.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-O 121.48 0.657 . . . . 74.03 110.157 -168.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -104.08 -2.62 25.64 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.446 -0.797 . . . . 75.21 110.59 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 23.2 m -113.54 127.62 56.15 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 115.507 -0.769 . . . . 71.42 110.645 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.469 HD13 ' HB3' ' B' ' 85' ' ' LYS . 94.9 mt -104.96 148.3 26.86 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.735 -0.839 . . . . 73.43 108.735 176.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.435 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 37.1 p90 -105.01 115.66 30.65 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 118.126 -1.429 . . . . 64.25 107.757 171.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.414 HG22 ' HG ' ' B' ' 103' ' ' LEU . 43.5 t -97.05 114.75 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-N 113.99 -1.459 . . . . 65.23 107.812 -177.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 21.3 p -123.72 174.34 7.54 Favored 'General case' 0 N--CA 1.401 -2.908 0 CA-C-N 114.704 -1.134 . . . . 73.44 108.72 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 87.92 32.98 11.55 Favored Glycine 0 N--CA 1.421 -2.325 0 N-CA-C 110.241 -1.143 . . . . 61.34 110.241 -172.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 85.9 mt -105.68 142.87 25.69 Favored Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 107.767 -1.198 . . . . 61.25 107.767 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -75.68 164.3 32.35 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.977 1.784 . . . . 72.14 110.151 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.432 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 13.8 p -71.23 -8.51 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-O 122.457 1.123 . . . . 63.42 109.869 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.429 ' O ' ' HD2' ' B' ' 43' ' ' LYS . 13.0 t70 -99.43 10.95 40.43 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.24 -1.345 . . . . 73.13 109.472 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.402 ' HA ' ' OE2' ' B' ' 46' ' ' GLU . 0.0 OUTLIER -66.65 125.01 23.05 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 CA-C-O 121.886 0.851 . . . . 72.43 109.79 -178.274 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.519 ' HG3' ' NE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -105.53 142.55 24.98 Favored Pre-proline 0 C--N 1.291 -1.976 0 CA-C-N 114.65 -1.159 . . . . 71.32 109.517 177.156 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.75 -26.67 24.3 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 123.762 2.975 . . . . 73.35 113.632 -174.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.559 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 19.2 ptt180 -66.74 -26.17 66.86 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.879 -0.6 . . . . 73.32 112.057 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.478 ' HG3' ' HG2' ' B' ' 43' ' ' LYS . 42.3 mt-10 -70.3 -42.85 71.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.784 0.326 . . . . 61.51 110.945 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -68.01 -33.83 75.35 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 108.71 -0.848 . . . . 72.51 108.71 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.528 ' O ' ' HG3' ' B' ' 52' ' ' ARG . 62.8 t80 -60.97 -51.38 69.49 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.653 -1.158 . . . . 61.02 110.098 175.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 92.7 mt -62.84 -40.95 99.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.321 0.582 . . . . 64.1 110.216 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 25.4 tp -69.63 -41.59 75.42 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.781 -1.1 . . . . 61.34 111.674 -176.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -94.69 -2.25 51.55 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 114.954 1.464 . . . . 73.11 114.954 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 30.6 mtp180 -60.94 -43.25 90.71 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.292 0.849 . . . . 60.45 113.292 173.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.93 -19.93 70.17 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 121.378 1.385 . . . . 74.02 112.188 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -92.53 90.11 7.02 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 122.364 1.078 . . . . 74.25 110.191 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -76.45 109.35 10.1 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.684 -1.144 . . . . 75.42 110.05 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.42 -27.51 1.36 Allowed Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 108.986 -1.645 . . . . 65.34 108.986 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -51.86 123.32 9.99 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.542 1.137 . . . . 73.02 111.789 173.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -97.2 -60.39 1.59 Allowed 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 109.719 -0.475 . . . . 72.13 109.719 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.42 168.46 36.64 Favored Glycine 0 C--N 1.292 -1.915 0 C-N-CA 119.567 -1.301 . . . . 51.03 113.141 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.5 p -126.15 138.06 53.64 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.33 0.586 . . . . 71.45 110.747 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 49.5 tp -116.27 116.67 28.19 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.47 -0.937 . . . . 51.32 108.47 176.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mp -94.33 131.89 39.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 109.154 -0.684 . . . . 63.04 109.154 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -130.47 125.96 35.7 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.546 -0.909 . . . . 74.51 108.546 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -77.39 130.5 37.16 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.013 0.435 . . . . 41.12 110.774 -175.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.7 m -129.71 151.74 49.97 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 104.244 -2.502 . . . . 75.42 104.244 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.17 -45.46 8.35 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.376 1.07 . . . . 63.32 113.541 -174.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -88.96 -29.2 19.71 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.624 0.972 . . . . 74.41 113.624 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.407 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 26.1 pt20 -165.06 132.56 2.39 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-O 120.871 0.367 . . . . 72.32 111.797 -169.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.432 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 12.0 Cg_exo -71.89 109.96 2.8 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.659 2.24 . . . . 73.33 108.747 167.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 33.3 m -87.21 151.56 3.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.2 -0.667 . . . . 71.34 109.2 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.98 121.09 4.59 Favored Glycine 0 C--N 1.297 -1.638 0 C-N-CA 119.271 -1.442 . . . . 54.31 112.726 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -87.91 104.32 16.5 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.818 -1.549 . . . . 55.51 106.818 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 98.9 t -100.31 117.35 45.38 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-N 115.028 -0.987 . . . . 64.44 109.697 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 tt -101.83 131.61 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 115.37 -0.832 . . . . 74.43 110.466 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -108.7 158.12 17.9 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.438 -1.255 . . . . 74.31 109.174 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -59.26 -27.12 65.52 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 123.758 0.661 . . . . 75.52 112.055 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 21.3 m -154.43 157.26 38.19 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.625 -0.672 . . . . 73.34 110.943 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ARG . . . . . 0.627 ' H ' ' HD3' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -57.97 -32.24 67.67 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.113 0.565 . . . . 73.51 110.623 175.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.25 -27.69 67.43 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.804 0.812 . . . . 74.22 110.062 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.88 -37.19 8.64 Favored Glycine 0 C--N 1.301 -1.374 0 N-CA-C 110.244 -1.142 . . . . 72.1 110.244 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.413 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -67.16 -47.3 71.43 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.455 -0.872 . . . . 51.03 111.182 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -57.52 -40.7 79.34 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.948 0.351 . . . . 71.31 111.948 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.05 -35.31 66.69 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 120.944 0.402 . . . . 61.13 110.945 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.93 -44.19 73.57 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.104 -0.498 . . . . 70.44 111.254 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.469 ' HB3' HD13 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -71.2 -32.14 68.49 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.146 -0.479 . . . . 71.11 110.648 -177.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -64.46 -38.78 92.22 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.797 -0.638 . . . . 70.2 111.092 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.97 -40.06 25.01 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 120.573 -0.451 . . . . 72.14 112.053 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.575 ' O ' HG22 ' B' ' 91' ' ' ILE . 94.5 mt -93.12 -11.99 31.53 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 116.593 2.072 . . . . 73.44 116.593 -172.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -78.66 117.64 20.01 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 117.911 -1.516 . . . . 64.32 110.488 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.04 7.83 37.46 Favored Glycine 0 CA--C 1.485 -1.836 0 C-N-CA 120.434 -0.889 . . . . 53.35 112.188 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.575 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.5 tt -105.46 140.2 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 107.907 -1.146 . . . . 71.25 107.907 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.559 ' HG3' HG22 ' B' ' 100' ' ' THR . 43.7 mtt85 -70.65 139.9 51.43 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 113.843 1.053 . . . . 74.42 113.843 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.475 ' CD1' HD21 ' B' ' 101' ' ' LEU . 54.6 t80 -83.43 -25.07 31.58 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.141 -1.845 . . . . 73.32 108.321 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -149.31 122.71 4.52 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 106.883 -1.525 . . . . 73.52 106.883 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' PRO . . . . . 0.65 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 36.8 Cg_endo -62.84 -23.44 74.33 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.057 2.505 . . . . 63.12 113.993 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -98.18 1.7 47.67 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.266 0.555 . . . . 62.22 112.126 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -116.71 133.76 23.0 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 108.059 -1.089 . . . . 64.33 108.059 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.421 ' HA ' HH21 ' B' ' 92' ' ' ARG . 31.8 Cg_exo -64.0 -9.46 19.29 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.796 2.331 . . . . 65.41 113.061 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' GLN . . . . . 0.455 ' HA ' ' OE1' ' B' ' 99' ' ' GLN . 6.1 tp60 -69.81 111.38 5.52 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.795 0.807 . . . . 72.24 109.934 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.559 HG22 ' HG3' ' B' ' 92' ' ' ARG . 41.7 p -110.43 145.31 37.84 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.181 -0.918 . . . . 73.04 109.34 -176.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.475 HD21 ' CD1' ' B' ' 93' ' ' PHE . 91.7 mt -71.18 146.55 49.03 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.295 0.569 . . . . 55.42 110.521 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -143.84 106.26 4.41 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.338 -1.356 . . . . 74.45 107.338 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.426 ' O ' ' HE2' ' B' ' 85' ' ' LYS . 6.7 mp -107.67 116.26 31.63 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.486 -0.779 . . . . 73.23 109.608 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.435 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 9.6 tp10 -129.26 161.55 29.93 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.231 -1.396 . . . . 70.54 107.231 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' PHE . . . . . 0.472 ' HB3' HG11 ' B' ' 30' ' ' VAL . 72.3 m-85 -70.06 136.37 50.23 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 118.262 0.483 . . . . 74.03 110.687 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.48 153.7 43.12 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.068 -0.515 . . . . 73.35 110.571 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -82.37 5.09 21.44 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 122.184 0.993 . . . . 62.31 110.054 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -169.6 131.62 1.14 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.507 -1.664 . . . . 62.22 106.507 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -65.6 97.79 0.33 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.434 -0.58 . . . . 75.35 109.434 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 9.5 m -85.88 120.01 26.82 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 114.792 -1.095 . . . . 55.03 108.545 -176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -84.31 141.94 30.56 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.706 -0.679 . . . . 60.34 110.286 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -82.28 -37.36 25.97 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.323 -1.362 . . . . 73.52 107.323 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.74 104.72 17.26 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.291 -1.322 . . . . 23.53 108.325 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.552 ' HG2' ' H ' ' B' ' 115' ' ' SER . 33.1 ttpt -145.67 -174.8 4.5 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.304 -1.739 . . . . 65.41 106.304 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.552 ' H ' ' HG2' ' B' ' 114' ' ' LYS . 19.5 m 79.62 20.96 0.61 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.686 1.195 . . . . 64.34 110.529 177.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -87.34 95.83 10.14 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.344 -0.984 . . . . 71.54 108.344 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 tt -88.3 81.46 7.28 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.37 -0.974 . . . . 73.03 108.37 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 . . . . . 0 N--CA 1.472 0.668 0 C-N-CA 129.678 3.191 . . . . 63.22 106.28 178.712 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 108.394 -0.965 . . . . 75.31 108.394 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -167.11 121.4 1.02 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.275 -1.009 . . . . 63.33 108.275 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -131.14 104.01 6.83 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.518 0.675 . . . . 73.33 110.311 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.592 ' HB3' ' HD2' ' A' ' 78' ' ' ARG . 1.9 tm-20 -141.99 -178.32 5.64 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 105.169 -2.16 . . . . 65.03 105.169 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.593 ' HA ' ' ND2' ' A' ' 109' ' ' ASN . 47.6 t -58.34 125.62 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 113.048 0.758 . . . . 74.14 113.048 -169.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 75' ' ' PHE . 6.6 mpt_? -106.04 6.08 30.85 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-N 115.859 -0.609 . . . . 63.31 112.104 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.459 ' H ' HG12 ' A' ' 30' ' ' VAL . 18.1 m -135.82 132.46 36.7 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 114.35 1.241 . . . . 72.1 114.35 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.467 HD11 ' O ' ' A' ' 81' ' ' ALA . 68.9 mt -110.42 151.56 27.35 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.043 -1.095 . . . . 74.33 108.043 171.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -107.39 114.21 28.08 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 118.808 -1.157 . . . . 63.43 108.036 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.489 HG22 ' HG ' ' A' ' 103' ' ' LEU . 42.2 t -97.99 119.96 46.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.749 0 CA-C-N 113.791 -1.55 . . . . 44.05 107.9 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.7 p -123.26 165.1 17.5 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 115.204 -0.907 . . . . 73.5 109.628 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 96.36 18.67 30.19 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 111.5 -0.64 . . . . 71.32 111.5 -174.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.451 HD22 HG13 ' A' ' 42' ' ' ILE . 82.3 mt -89.83 128.87 48.57 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 107.337 -1.357 . . . . 65.44 107.337 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.41 165.22 32.43 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.684 1.589 . . . . 54.13 110.991 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 8.9 p -69.32 -5.42 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 122.151 0.976 . . . . 64.34 110.751 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.555 ' OD2' ' HE2' ' B' ' 43' ' ' LYS . 24.5 t70 -113.56 13.8 18.84 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.207 -0.906 . . . . 74.31 109.647 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.451 HG13 HD22 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -61.08 129.23 23.57 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 CA-C-O 121.693 0.758 . . . . 75.21 109.38 -178.221 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 46.1 mmtm -93.59 145.8 30.62 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 115.477 -0.783 . . . . 71.33 113.031 -176.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.34 -29.02 87.95 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.589 2.193 . . . . 63.3 112.202 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.623 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -86.37 -12.11 50.15 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 118.885 -1.126 . . . . 64.45 110.491 177.691 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 43' ' ' LYS . 43.7 tt0 -77.1 -40.57 45.41 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.377 -0.601 . . . . 71.52 109.377 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.34 -33.23 75.36 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.684 0.754 . . . . 71.43 109.221 172.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.623 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 57.2 t80 -61.17 -48.87 79.59 Favored 'General case' 0 C--O 1.202 -1.432 0 CA-C-N 114.467 -1.242 . . . . 73.54 110.467 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 83.2 mt -66.88 -35.78 80.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.582 0.706 . . . . 60.12 110.031 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 tp -67.25 -51.31 54.64 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.787 -1.097 . . . . 71.23 111.287 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -96.41 11.95 33.05 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.493 0.923 . . . . 73.54 113.493 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 31.8 ttt-85 -70.36 -42.79 16.31 Favored Pre-proline 0 C--N 1.312 -1.061 0 C-N-CA 120.653 -0.419 . . . . 73.11 112.052 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -77.29 -4.39 14.7 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 121.521 1.48 . . . . 61.21 111.879 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -89.73 107.18 18.94 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 122.076 0.941 . . . . 60.22 111.533 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -75.29 110.56 9.74 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 113.707 -1.588 . . . . 54.31 108.905 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.22 -10.83 5.33 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.457 -0.878 . . . . 72.44 113.339 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -66.7 112.52 4.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.553 0.677 . . . . 71.44 111.141 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -90.1 -41.49 11.63 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.238 0.542 . . . . 62.14 110.424 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.46 -176.93 42.7 Favored Glycine 0 C--N 1.307 -1.066 0 CA-C-N 115.186 -0.915 . . . . 51.44 111.325 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.467 ' HB3' HG22 ' A' ' 73' ' ' VAL . 20.6 p -148.03 137.9 22.55 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.475 0.546 . . . . 45.2 112.475 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.4 mp -111.24 126.35 54.78 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.741 -0.837 . . . . 64.43 108.741 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.2 mm -94.97 143.57 11.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 C-N-CA 122.301 0.24 . . . . 55.34 110.637 -174.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 69' ' ' PRO . 64.0 tttp -125.95 106.19 9.46 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.847 -0.797 . . . . 71.21 108.847 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.36 112.79 9.76 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.49 -0.777 . . . . 75.32 110.443 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 66' ' ' ALA . 2.3 m -110.99 173.21 6.44 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 107.912 -1.144 . . . . 53.32 107.912 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.427 ' H ' HG22 ' A' ' 65' ' ' THR . . . -50.87 -38.51 49.81 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.099 0.959 . . . . 73.11 112.911 -177.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -104.19 -49.1 3.68 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.48 0.657 . . . . 64.22 111.467 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -136.92 136.05 20.75 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 114.789 -1.096 . . . . 65.03 112.316 -166.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 55.7 Cg_endo -81.1 102.36 1.35 Allowed 'Trans proline' 0 N--CA 1.429 -2.287 0 C-N-CA 122.723 2.282 . . . . 72.02 109.43 168.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -80.22 157.1 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 N-CA-C 109.291 -0.633 . . . . 75.41 109.291 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.09 123.49 4.83 Favored Glycine 0 CA--C 1.48 -2.144 0 C-N-CA 118.536 -1.792 . . . . 72.51 113.294 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -87.23 103.01 15.03 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 105.621 -1.992 . . . . 73.21 105.621 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 60' ' ' SER . 76.1 t -97.8 127.12 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 CA-C-N 115.084 -0.962 . . . . 72.22 110.495 -174.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 3.0 mp -94.46 129.77 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 CA-C-N 114.482 -1.235 . . . . 74.32 108.575 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.459 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 89.4 m-85 -117.7 152.24 35.63 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.483 -0.932 . . . . 64.44 108.483 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -49.89 -38.05 34.05 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 124.548 1.139 . . . . 54.25 112.697 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.5 p -157.04 163.74 38.72 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.528 -0.76 . . . . 61.1 110.346 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.592 ' HD2' ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -71.99 -28.54 63.48 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.208 -0.597 . . . . 73.2 109.925 -178.582 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.83 -29.71 70.22 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-O 121.793 0.806 . . . . 74.15 109.424 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.08 -32.14 26.87 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.585 -1.006 . . . . 74.31 110.585 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.467 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -67.05 -48.61 67.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 123.506 0.723 . . . . 74.01 110.976 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.01 -28.68 69.96 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.345 -0.222 . . . . 71.01 111.301 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.31 -41.02 73.84 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.965 0.412 . . . . 72.31 110.032 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.99 -42.22 90.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.813 -0.631 . . . . 42.2 109.64 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 104' ' ' GLU . 34.7 ttmt -59.92 -45.62 92.0 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.558 -0.746 . . . . 75.3 110.269 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.59 -31.58 69.59 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.819 -0.628 . . . . 72.53 111.871 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.16 -35.18 17.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 113.025 0.75 . . . . 64.54 113.025 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 91' ' ' ILE . 97.9 mt -110.72 -5.31 15.02 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 116.724 2.12 . . . . 62.44 116.724 -170.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -78.7 114.57 17.74 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 117.358 -1.737 . . . . 74.35 111.199 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.65 12.93 33.78 Favored Glycine 0 CA--C 1.48 -2.132 0 N-CA-C 110.509 -1.036 . . . . 41.41 110.509 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 88' ' ' LEU . 9.6 tt -90.76 141.08 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.004 0 N-CA-C 108.969 -0.752 . . . . 75.11 108.969 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -63.21 117.05 6.01 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 108.122 -1.066 . . . . 74.21 108.122 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' B' ' 45' ' ' ARG . 64.9 t80 -73.86 -28.65 61.69 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.648 -1.612 . . . . 72.13 106.648 176.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 97' ' ' ASN . 20.8 t0 -144.27 117.03 5.63 Favored Pre-proline 0 N--CA 1.422 -1.843 0 N-CA-C 102.833 -3.025 . . . . 74.54 102.833 176.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.459 ' HD3' ' CZ ' ' B' ' 48' ' ' TYR . 74.2 Cg_endo -71.81 -20.76 25.75 Favored 'Trans proline' 0 C--N 1.327 -0.554 0 CA-C-N 120.608 1.253 . . . . 64.21 113.5 -177.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -87.06 -21.1 26.28 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 121.634 0.73 . . . . 64.12 109.134 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.491 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 46.8 t-20 -99.19 137.02 20.34 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 107.428 -1.323 . . . . 55.01 107.428 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.38 -13.94 31.83 Favored 'Trans proline' 0 CA--C 1.553 1.454 0 C-N-CA 122.556 2.171 . . . . 62.32 113.623 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -61.71 119.35 8.54 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.857 0.863 . . . . 74.23 110.593 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.423 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 24.7 p -119.22 147.21 44.5 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.249 -0.432 . . . . 75.2 110.811 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 24.5 tp -89.87 129.41 36.24 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.551 -0.749 . . . . 73.34 109.132 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -134.89 128.51 32.77 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.524 -0.547 . . . . 72.3 109.524 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 35' ' ' VAL . 5.6 mp -113.8 128.01 56.24 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.722 -0.672 . . . . 72.14 109.439 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.538 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 9.3 tp10 -137.3 163.55 30.7 Favored 'General case' 0 C--O 1.195 -1.785 0 N-CA-C 107.618 -1.253 . . . . 61.34 107.618 177.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -73.24 133.58 44.02 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 119.229 0.922 . . . . 74.12 110.498 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.36 155.13 39.7 Favored 'General case' 0 N--CA 1.438 -1.051 0 O-C-N 123.688 0.618 . . . . 45.24 109.739 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -87.48 7.18 30.47 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.784 0.802 . . . . 73.42 109.88 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.42 126.05 12.54 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.609 -0.723 . . . . 55.41 109.45 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.593 ' ND2' ' HA ' ' A' ' 30' ' ' VAL . 3.4 m-20 -79.62 124.89 28.95 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.473 -0.936 . . . . 74.52 108.473 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.9 m -122.18 143.24 49.69 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 106.854 -1.536 . . . . 74.24 106.854 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -129.66 147.87 51.49 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.306 -0.558 . . . . 60.43 111.629 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 94.2 mmm -81.98 -57.62 3.33 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.504 -0.771 . . . . 73.32 109.239 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.1 106.41 5.76 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.627 -1.249 . . . . 50.41 107.627 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -124.5 113.18 17.77 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.491 -0.777 . . . . 71.52 109.54 -173.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.6 m -93.22 128.08 39.05 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.106 -0.497 . . . . 74.31 109.88 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -68.18 103.71 1.63 Allowed 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 109.162 -0.681 . . . . 64.13 109.162 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.53 14.49 9.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.769 0.795 . . . . 71.1 110.692 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 N--CA 1.403 -2.82 0 N-CA-C 105.955 -1.869 . . . . 65.44 105.955 174.224 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 108.893 -0.78 . . . . 63.25 108.893 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -106.69 130.13 54.47 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.566 -0.902 . . . . 65.23 108.566 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.449 ' HA ' HH12 ' B' ' 31' ' ' ARG . 41.3 tt0 -79.93 80.62 6.32 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 118.671 -1.212 . . . . 74.45 110.075 174.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.52 ' CB ' ' HD2' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -94.18 -179.64 5.01 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.612 -1.631 . . . . 72.03 107.693 177.364 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.459 HG12 ' H ' ' B' ' 32' ' ' THR . 34.8 t -76.38 112.78 14.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-O 121.763 0.792 . . . . 63.45 112.572 -170.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.449 HH12 ' HA ' ' B' ' 28' ' ' GLU . 6.3 mpt_? -90.24 6.45 42.78 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.402 -0.817 . . . . 71.13 112.188 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' THR . . . . . 0.459 ' H ' HG12 ' B' ' 30' ' ' VAL . 18.3 m -129.42 128.42 42.94 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 113.4 0.889 . . . . 61.13 113.4 -175.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.502 HD11 ' O ' ' B' ' 81' ' ' ALA . 76.3 mt -104.0 148.16 26.53 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.633 -1.247 . . . . 70.14 107.633 172.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 28.2 p90 -105.98 118.02 35.53 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 118.477 -1.289 . . . . 74.52 107.565 172.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.485 HG22 ' HG ' ' B' ' 103' ' ' LEU . 39.1 t -100.58 124.32 54.07 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.564 0 CA-C-N 114.157 -1.383 . . . . 44.31 107.849 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 35.7 p -129.16 168.43 16.15 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 115.339 -0.846 . . . . 50.41 109.89 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.82 12.07 57.14 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 110.543 -1.023 . . . . 25.41 110.543 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 89.8 mt -80.95 123.59 82.03 Favored Pre-proline 0 N--CA 1.432 -1.328 0 C-N-CA 123.634 0.774 . . . . 72.51 110.046 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.11 155.29 34.9 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.738 2.292 . . . . 72.33 111.649 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.481 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 7.4 p -70.32 -4.42 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-O 121.906 0.86 . . . . 74.21 111.046 -177.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -120.19 22.66 11.31 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.883 -0.784 . . . . 71.13 108.883 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.41 HD11 HD21 ' B' ' 47' ' ' LEU . 6.6 tt -50.44 132.08 10.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-N 115.077 -0.965 . . . . 44.21 111.609 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.555 ' HE2' ' OD2' ' A' ' 41' ' ' ASP . 39.6 mmtm -108.54 140.1 21.46 Favored Pre-proline 0 C--N 1.29 -1.994 0 CA-C-N 115.316 -0.857 . . . . 70.33 112.632 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -53.31 -41.75 70.39 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.73 2.287 . . . . 65.34 112.401 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.542 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -74.42 -22.76 58.99 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 117.718 -1.593 . . . . 72.2 111.356 -178.239 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' B' ' 43' ' ' LYS . 36.4 tt0 -66.46 -41.62 88.77 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.628 -0.879 . . . . 74.14 108.628 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.439 HD11 HD11 ' B' ' 62' ' ' ILE . 90.1 mt -66.42 -41.75 88.76 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.616 -0.72 . . . . 72.14 110.011 173.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.583 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 71.6 t80 -52.8 -47.74 67.37 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 124.496 1.118 . . . . 75.42 111.121 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 88.5 mt -64.47 -37.36 87.26 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 123.31 0.381 . . . . 75.45 111.118 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.452 HD13 HD22 ' A' ' 49' ' ' LEU . 39.3 tp -75.87 -46.44 30.21 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.824 -0.626 . . . . 72.05 112.054 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -92.03 4.14 53.71 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.413 0.894 . . . . 71.34 113.413 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.583 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 53.0 ttt-85 -61.03 -48.44 92.42 Favored Pre-proline 0 CA--C 1.563 1.469 0 N-CA-C 112.656 0.613 . . . . 74.53 112.656 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.76 -1.71 11.83 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.133 1.889 . . . . 73.31 112.707 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -84.6 98.72 10.32 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.867 0.842 . . . . 72.14 110.779 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -66.39 113.84 4.96 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 113.783 -1.553 . . . . 74.12 109.401 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.15 -16.71 5.72 Favored Glycine 0 C--N 1.285 -2.27 0 CA-C-N 115.105 -0.952 . . . . 42.41 111.905 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -63.56 103.73 0.57 Allowed 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.246 0.546 . . . . 75.1 110.937 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -84.26 -45.61 12.68 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.746 -0.835 . . . . 61.55 108.746 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.25 173.63 42.95 Favored Glycine 0 C--N 1.305 -1.18 0 CA-C-N 114.814 -1.085 . . . . 53.41 111.768 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.3 p -128.68 141.37 51.36 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 122.542 0.337 . . . . 62.42 110.61 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 61.7 tp -114.5 110.94 20.6 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.919 -1.141 . . . . 52.02 107.919 175.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.439 HD11 HD11 ' B' ' 47' ' ' LEU . 50.9 mm -94.06 131.4 41.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 109.882 -0.414 . . . . 75.44 109.882 -176.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' B' ' 69' ' ' PRO . 60.5 tttp -124.38 115.08 20.39 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.159 0.504 . . . . 73.21 110.178 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.57 124.67 23.88 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.731 -0.668 . . . . 74.41 110.748 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 11.2 m -130.26 155.34 46.46 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 103.835 -2.654 . . . . 74.44 103.835 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.45 -35.17 51.81 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.617 0.969 . . . . 71.03 113.617 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -87.02 -45.92 10.3 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 119.838 -0.745 . . . . 60.04 112.537 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -155.35 134.79 7.87 Favored Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 114.921 -1.036 . . . . 65.05 109.654 -168.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 14.3 Cg_exo -72.19 105.0 1.76 Allowed 'Trans proline' 0 C--N 1.298 -2.09 0 C-N-CA 122.283 1.989 . . . . 64.25 108.076 166.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 36.0 m -77.15 151.2 5.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.594 -0.891 . . . . 73.34 108.594 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.64 120.88 4.31 Favored Glycine 0 CA--C 1.474 -2.492 0 C-N-CA 117.791 -2.147 . . . . 71.3 113.124 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -88.29 102.52 14.92 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 105.999 -1.852 . . . . 71.34 105.999 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 70.6 t -95.2 120.25 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.544 0 CA-C-O 122.089 0.947 . . . . 71.44 109.761 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 58.3 mt -98.0 123.44 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.723 0 CA-C-N 113.099 -1.864 . . . . 65.41 109.021 -172.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -114.16 161.21 18.09 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-N 114.6 -1.182 . . . . 71.41 109.894 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -55.7 -41.39 73.72 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 124.684 1.194 . . . . 72.03 112.667 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 4.0 p -155.81 162.99 40.39 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.92 -0.582 . . . . 74.43 110.534 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ARG . . . . . 0.52 ' HD2' ' CB ' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -70.71 -28.22 64.57 Favored 'General case' 0 C--O 1.202 -1.408 0 C-N-CA 119.865 -0.734 . . . . 74.54 109.889 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.0 -27.77 69.05 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.491 0.663 . . . . 52.05 110.196 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.46 -41.21 6.57 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.995 -1.242 . . . . 74.12 109.995 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.502 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -61.91 -41.26 97.7 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 114.702 -0.749 . . . . 54.15 111.827 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.8 -36.24 83.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.548 0.213 . . . . 64.33 111.168 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.71 -39.28 73.52 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.381 -0.599 . . . . 74.34 109.381 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.86 -42.2 86.04 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.125 -0.943 . . . . 60.15 110.286 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' B' ' 104' ' ' GLU . 13.3 ttmt -60.71 -47.89 84.26 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.426 -0.806 . . . . 64.23 109.636 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -60.14 -38.49 83.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.009 -0.541 . . . . 71.31 111.11 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.42 -30.95 62.13 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 112.538 0.57 . . . . 71.0 112.538 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.604 ' O ' HG22 ' B' ' 91' ' ' ILE . 98.4 mt -108.52 -12.54 14.98 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 116.002 1.853 . . . . 75.34 116.002 -174.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -79.56 114.55 18.57 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 120.188 -1.57 . . . . 61.31 112.024 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.98 9.18 28.59 Favored Glycine 0 CA--C 1.485 -1.829 0 C-N-CA 120.619 -0.8 . . . . 73.44 111.381 173.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.604 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.6 tt -104.81 149.79 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.803 0 N-CA-C 106.904 -1.517 . . . . 75.34 106.904 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.44 ' CZ ' ' HA ' ' B' ' 98' ' ' PRO . 99.3 mtt180 -81.39 138.71 35.58 Favored 'General case' 0 C--N 1.267 -2.989 0 CA-C-O 121.523 0.677 . . . . 74.41 112.192 175.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 43.5 t80 -77.97 -28.54 49.43 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.219 -1.355 . . . . 53.21 108.117 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.23 127.62 14.76 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 106.106 -1.812 . . . . 75.14 106.106 175.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' PRO . . . . . 0.506 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 72.7 Cg_endo -71.58 -21.72 25.34 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.089 1.859 . . . . 72.21 114.761 -176.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.99 -25.43 29.99 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.527 0.679 . . . . 74.11 109.717 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -97.2 128.77 33.98 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.475 -0.784 . . . . 72.13 108.983 -176.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.44 ' HA ' ' CZ ' ' B' ' 92' ' ' ARG . 38.1 Cg_exo -60.64 -16.82 45.55 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 123.241 2.627 . . . . 54.3 113.179 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -55.46 118.86 4.83 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 124.707 1.203 . . . . 71.23 110.138 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 33.7 p -104.67 157.97 16.82 Favored 'General case' 0 N--CA 1.413 -2.323 0 C-N-CA 120.115 -0.634 . . . . 70.32 110.505 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 35.5 tp -96.25 124.66 40.33 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.507 -1.664 . . . . 75.41 106.507 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -129.62 127.46 40.67 Favored 'General case' 0 N--CA 1.422 -1.84 0 C-N-CA 120.161 -0.616 . . . . 71.33 109.758 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.485 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.8 mp -114.8 140.92 48.53 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.271 -1.011 . . . . 71.13 108.271 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.477 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 39.1 tt0 -152.24 165.64 34.24 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.535 -1.654 . . . . 75.51 106.535 176.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -71.32 138.46 49.31 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 120.077 1.308 . . . . 55.33 110.983 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.47 154.42 30.56 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.434 -0.58 . . . . 75.25 109.434 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -84.43 1.46 45.31 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 122.126 0.965 . . . . 73.23 109.432 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.82 118.72 12.52 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.302 -0.863 . . . . 65.12 109.481 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' B' ' 30' ' ' VAL . 3.8 m-20 -73.42 112.59 9.63 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.549 -1.278 . . . . 43.3 107.549 175.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 20.0 m -105.07 126.43 52.06 Favored 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 108.97 -0.752 . . . . 65.53 108.97 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -84.03 148.96 26.57 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.928 -0.768 . . . . 72.51 108.928 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -86.34 -37.14 18.77 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.268 -0.641 . . . . 74.32 109.268 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.24 112.95 25.08 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.345 -0.843 . . . . 72.11 110.032 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -111.77 116.07 30.11 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.262 -1.755 . . . . 73.34 106.262 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 7.9 t -150.63 158.95 44.75 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 109.511 -0.552 . . . . 40.52 109.511 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -102.87 101.14 11.17 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.756 -1.201 . . . . 74.45 107.756 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 89.3 mt -73.31 -23.31 60.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.087 0.47 . . . . 70.3 111.482 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.42 -1.961 0 N-CA-C 107.706 -1.22 . . . . 72.13 107.706 176.434 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 CA--C 1.498 -1.048 0 N-CA-C 108.986 -0.746 . . . . 75.31 108.986 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.09 -48.17 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.408 0.623 . . . . 70.43 110.029 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -109.78 80.92 1.36 Allowed 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 107.817 -1.179 . . . . 75.33 107.817 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' HA ' ' HD2' ' A' ' 78' ' ' ARG . 8.7 mm-40 -113.77 101.71 9.55 Favored 'General case' 0 N--CA 1.4 -2.954 0 CA-C-N 114.376 -1.283 . . . . 72.35 107.655 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.462 ' HA ' HD21 ' A' ' 109' ' ' ASN . 57.3 t -74.59 108.83 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 104.108 -2.553 . . . . 54.0 104.108 168.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -121.29 -4.15 9.44 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 115.174 -0.921 . . . . 64.32 110.322 -168.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.7 m -101.99 124.54 47.79 Favored 'General case' 0 C--N 1.264 -3.117 0 CA-C-N 115.132 -0.94 . . . . 54.12 109.213 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 33' ' ' LEU . 3.2 mp -108.13 137.59 45.85 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 107.308 -1.367 . . . . 75.1 107.308 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 104' ' ' GLU . 24.2 p90 -103.77 109.16 20.77 Favored 'General case' 0 N--CA 1.412 -2.355 0 C-N-CA 118.473 -1.291 . . . . 74.02 107.621 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.536 HG22 ' HG ' ' A' ' 103' ' ' LEU . 25.0 t -96.57 120.17 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.752 0 CA-C-N 113.772 -1.558 . . . . 72.11 107.677 -174.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 20.1 p -126.51 166.78 16.63 Favored 'General case' 0 N--CA 1.4 -2.935 0 CA-C-N 114.644 -1.162 . . . . 63.31 108.305 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 94.89 32.08 7.36 Favored Glycine 0 N--CA 1.417 -2.619 0 N-CA-C 110.671 -0.972 . . . . 64.1 110.671 -173.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.4 mt -101.0 145.27 30.11 Favored Pre-proline 0 N--CA 1.428 -1.566 0 N-CA-C 109.081 -0.711 . . . . 54.41 109.081 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.04 157.69 33.17 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.208 1.939 . . . . 62.34 110.022 173.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.486 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 7.7 p -76.29 -2.15 4.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-O 122.362 1.077 . . . . 61.03 109.66 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -128.28 35.13 4.46 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 114.437 -1.256 . . . . 65.21 108.564 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.98 123.86 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 N-CA-C 108.097 -1.075 . . . . 54.05 108.097 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 43' ' ' LYS . 4.8 mmpt? -93.65 143.98 27.45 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-N 115.358 -0.837 . . . . 61.1 110.153 -175.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.09 -19.95 35.5 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.472 2.781 . . . . 73.12 114.617 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.551 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -87.34 -15.67 37.26 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 118.435 -1.306 . . . . 74.31 111.644 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -67.32 -41.21 85.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.102 0.477 . . . . 62.32 110.244 -177.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.13 -30.31 67.45 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 116.153 -0.476 . . . . 70.34 109.833 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.692 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 41.2 t80 -61.88 -51.17 69.28 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.484 -0.78 . . . . 72.14 110.246 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.94 -38.31 90.51 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.073 -0.512 . . . . 75.2 110.973 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.8 tp -77.91 -43.02 31.27 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.507 -0.77 . . . . 74.53 112.289 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -97.62 -2.06 42.4 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 114.441 1.274 . . . . 54.43 114.441 -172.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 32.3 ttt-85 -60.69 -46.09 97.07 Favored Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 112.89 0.7 . . . . 64.22 112.89 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -75.05 -2.68 12.86 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.095 1.863 . . . . 75.25 112.769 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -83.88 106.21 15.38 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.627 0.727 . . . . 74.41 110.871 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -68.76 109.95 4.08 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.254 -1.339 . . . . 74.24 110.115 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.24 -14.28 6.97 Favored Glycine 0 N--CA 1.421 -2.306 0 CA-C-N 114.908 -1.042 . . . . 72.35 111.576 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -65.93 102.89 0.84 Allowed 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.173 0.511 . . . . 54.21 110.852 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.417 ' HB2' HG13 ' A' ' 74' ' ' ILE . 7.9 mm-40 -81.16 -57.48 3.49 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.543 -0.91 . . . . 75.3 108.543 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.08 -174.37 35.45 Favored Glycine 0 C--N 1.303 -1.251 0 CA-C-N 114.911 -1.04 . . . . 52.44 112.439 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.7 p -146.39 137.88 24.61 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 123.407 0.683 . . . . 65.24 110.297 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.41 ' HB2' ' SD ' ' A' ' 112' ' ' MET . 65.2 tp -112.06 120.05 40.54 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.558 -0.534 . . . . 61.32 109.558 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 mm -94.01 134.49 31.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.851 -0.796 . . . . 62.11 108.851 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -134.74 114.13 12.36 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 110.006 -0.368 . . . . 72.31 110.006 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.82 112.82 2.45 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.36 0.6 . . . . 65.31 109.514 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -113.86 164.32 13.92 Favored 'General case' 0 N--CA 1.404 -2.756 0 N-CA-C 105.479 -2.045 . . . . 75.14 105.479 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.97 -38.25 10.39 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.246 1.202 . . . . 54.45 114.246 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.74 -27.73 13.5 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.455 0.539 . . . . 74.33 112.455 -174.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -169.93 148.49 3.16 Favored Pre-proline 0 N--CA 1.423 -1.822 0 CA-C-N 115.921 -0.581 . . . . 61.11 110.7 -168.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.486 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 13.8 Cg_exo -70.24 106.2 1.71 Allowed 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 121.999 1.8 . . . . 63.21 108.417 165.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.1 m -81.48 158.76 4.08 Favored 'Isoleucine or valine' 0 C--O 1.25 1.081 0 N-CA-C 107.883 -1.155 . . . . 53.11 107.883 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.88 120.9 2.91 Favored Glycine 0 CA--C 1.484 -1.853 0 C-N-CA 117.668 -2.206 . . . . 73.11 113.077 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -88.03 102.02 14.35 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.532 -1.285 . . . . 72.0 107.532 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 78.4 t -91.34 123.79 43.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 108.814 -0.81 . . . . 54.51 108.814 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 58' ' ' GLU . 46.9 pt -107.83 123.73 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.329 0 CA-C-O 122.05 0.929 . . . . 63.45 111.564 -175.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -100.25 163.82 12.23 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 114.243 -1.344 . . . . 72.0 109.84 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -64.52 -39.86 94.55 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.111 -0.95 . . . . 65.11 112.461 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 56.0 m -145.21 166.0 26.74 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.742 -0.208 . . . . 62.12 110.48 -172.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -71.94 -29.49 64.33 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 120.591 -0.444 . . . . 73.24 112.081 -176.415 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.23 -18.98 64.7 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 122.222 1.01 . . . . 65.34 108.88 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.1 -41.29 10.46 Favored Glycine 0 C--N 1.305 -1.184 0 CA-C-N 114.392 -1.276 . . . . 51.1 110.033 176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.62 -46.17 76.71 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.684 -0.758 . . . . 73.52 111.6 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -29.41 70.15 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 111.887 0.329 . . . . 71.13 111.887 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.55 -40.45 56.84 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 116.193 -0.458 . . . . 72.13 111.304 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.18 -43.23 87.47 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.915 -0.584 . . . . 74.51 110.953 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 103' ' ' LEU . 14.5 ptmm? -72.08 -31.81 66.45 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.93 -0.708 . . . . 74.21 110.414 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -58.73 -36.72 74.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.038 0.447 . . . . 74.14 110.453 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.23 -42.2 16.15 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 120.999 0.428 . . . . 61.22 111.606 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.433 ' O ' HG22 ' A' ' 91' ' ' ILE . 92.3 mt -98.52 -18.61 18.09 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 117.18 2.289 . . . . 72.51 117.18 -169.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.335 0.2 OUTLIER -72.42 114.63 10.75 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 117.167 -1.813 . . . . 53.05 111.946 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.68 14.92 10.71 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 110.461 -1.056 . . . . 64.31 110.461 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.1 tt -93.2 128.19 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 CA-C-O 121.26 0.553 . . . . 74.45 109.788 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.714 ' HG3' HG22 ' A' ' 100' ' ' THR . 5.9 ttt180 -83.79 124.82 31.32 Favored 'General case' 0 N--CA 1.402 -2.873 0 N-CA-C 107.68 -1.23 . . . . 72.03 107.68 173.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.44 ' HB2' ' CD1' ' A' ' 101' ' ' LEU . 3.5 t80 -64.18 -34.25 77.66 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 124.572 1.17 . . . . 73.12 110.012 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.502 ' HB3' ' HB3' ' B' ' 45' ' ' ARG . 2.8 p-10 -151.64 136.92 10.72 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 105.901 -1.889 . . . . 73.25 105.901 175.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.437 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 73.8 Cg_endo -75.48 -1.27 11.11 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.336 2.024 . . . . 65.14 114.118 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -92.35 -25.17 18.66 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.285 0.564 . . . . 73.13 110.019 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -99.29 133.77 21.78 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 108.065 -1.087 . . . . 72.42 108.065 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.63 -16.74 56.53 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.167 1.911 . . . . 42.02 112.398 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -62.16 122.33 15.32 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.573 1.149 . . . . 55.1 110.466 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.714 HG22 ' HG3' ' A' ' 92' ' ' ARG . 26.0 p -119.33 149.71 41.36 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.21 -0.663 . . . . 74.24 109.21 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.8 mp -88.67 124.09 33.76 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-O 120.789 0.328 . . . . 72.52 110.715 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -120.37 112.9 19.59 Favored 'General case' 0 N--CA 1.4 -2.964 0 N-CA-C 107.518 -1.29 . . . . 74.1 107.518 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.536 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.4 mp -87.15 116.22 25.07 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.512 -1.222 . . . . 72.32 107.822 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.416 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 37.7 mt-10 -118.13 164.74 14.7 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.374 -1.343 . . . . 74.54 107.374 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -81.7 132.16 35.28 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 118.694 0.679 . . . . 73.42 109.568 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.41 137.79 48.6 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.837 -1.172 . . . . 73.32 107.837 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -82.95 12.02 5.43 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.215 1.007 . . . . 61.41 109.892 -175.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -157.5 118.73 3.61 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 114.421 -1.263 . . . . 73.24 107.614 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.462 HD21 ' HA ' ' A' ' 30' ' ' VAL . 44.9 m-80 -70.68 138.63 50.81 Favored 'General case' 0 CA--C 1.475 -1.935 0 C-N-CA 120.019 -0.672 . . . . 72.13 110.329 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.3 m -118.37 142.84 47.13 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.567 -0.742 . . . . 72.21 110.168 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -115.44 158.32 22.69 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.03 -1.1 . . . . 71.31 108.03 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.41 ' SD ' ' HB2' ' A' ' 61' ' ' LEU . 96.7 mmm -89.17 -33.75 16.93 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.893 -0.78 . . . . 73.13 108.893 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -115.26 114.84 25.73 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.335 -0.848 . . . . 65.53 110.073 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -128.3 118.87 24.0 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.323 -0.991 . . . . 62.0 108.323 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.1 m -132.69 109.17 9.51 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.259 -0.645 . . . . 73.25 109.259 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -85.84 127.71 34.64 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.871 -1.159 . . . . 74.12 107.871 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.3 tp -84.02 -40.87 17.87 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.32 -0.4 . . . . 73.31 111.331 -174.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.3 -1.556 0 N-CA-C 107.051 -1.462 . . . . 65.54 107.051 -175.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 121.123 0.487 . . . . 55.44 111.166 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.44 -53.68 2.64 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 123.341 0.657 . . . . 75.13 110.886 -172.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -130.77 86.25 2.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.191 -1.04 . . . . 75.04 108.191 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 23.0 mm-40 -76.3 102.32 5.83 Favored 'General case' 0 N--CA 1.399 -3.014 0 CA-C-N 114.243 -1.344 . . . . 74.42 109.989 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 81.0 t -72.38 109.02 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 103.748 -2.686 . . . . 74.21 103.748 168.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' B' ' 29' ' ' GLU . 16.4 ptt180 -129.02 7.39 5.52 Favored 'General case' 0 CA--C 1.471 -2.078 0 CA-C-N 115.435 -0.802 . . . . 74.53 111.803 -169.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 56.6 m -109.58 132.34 54.23 Favored 'General case' 0 C--N 1.264 -3.151 0 N-CA-C 107.554 -1.276 . . . . 64.35 107.554 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 72' ' ' PHE . 3.4 mp -121.98 151.46 40.77 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.482 -0.933 . . . . 72.24 108.482 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.438 ' CE1' ' HB2' ' B' ' 104' ' ' GLU . 17.9 p90 -108.13 111.47 23.5 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.787 -1.19 . . . . 75.01 107.787 175.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 57.2 t -97.57 122.16 48.86 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 CA-C-N 114.094 -1.412 . . . . 71.12 108.197 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 65.4 p -130.05 174.8 9.44 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.532 -0.758 . . . . 64.31 110.128 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 88.66 22.87 38.14 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.029 -1.228 . . . . 61.23 110.029 -172.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 88.4 mt -92.37 132.52 31.8 Favored Pre-proline 0 N--CA 1.412 -2.336 0 N-CA-C 106.179 -1.785 . . . . 53.22 106.179 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.88 160.24 30.2 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 121.639 1.559 . . . . 74.11 110.95 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 9.4 p -68.62 -7.92 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-O 122.588 1.185 . . . . 63.2 109.774 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -121.46 31.92 6.11 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 114.042 -1.435 . . . . 51.05 108.576 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.25 131.65 33.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 109.091 -0.707 . . . . 74.23 109.091 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -100.52 136.54 19.92 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-N 115.302 -0.863 . . . . 72.32 109.655 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -54.62 -24.61 37.65 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 C-N-CA 123.716 2.944 . . . . 74.21 114.121 -173.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.507 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 10.6 ptt180 -82.5 -15.24 53.16 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 122.081 -0.387 . . . . 61.15 111.954 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.13 -40.83 82.39 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.31 -0.626 . . . . 71.14 109.31 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 90.8 mt -68.76 -32.26 71.89 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.463 -0.79 . . . . 63.24 109.633 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.592 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 75.6 t80 -63.53 -48.17 78.62 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.135 -0.939 . . . . 73.24 110.033 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 84.9 mt -67.16 -39.93 86.58 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.196 0.522 . . . . 73.41 110.31 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 tp -74.01 -40.39 62.96 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.954 -1.021 . . . . 71.51 112.473 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -97.97 -4.18 36.8 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.639 0.978 . . . . 72.45 113.639 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.592 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 67.7 ttt180 -61.55 -45.07 93.78 Favored Pre-proline 0 CA--C 1.555 1.141 0 N-CA-C 112.665 0.617 . . . . 75.31 112.665 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.62 -12.99 20.3 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 121.373 1.382 . . . . 63.12 113.021 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -78.01 110.73 13.21 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 121.953 0.882 . . . . 64.44 111.48 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -72.38 109.46 6.11 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 113.945 -1.479 . . . . 65.13 109.363 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.69 -13.78 5.83 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-N 115.522 -0.763 . . . . 52.22 112.317 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -61.57 117.03 5.23 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.33 0.586 . . . . 73.21 111.638 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.427 ' HB2' HG13 ' B' ' 74' ' ' ILE . 5.7 mm-40 -96.47 -47.47 5.95 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.487 -0.779 . . . . 63.43 111.034 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.23 177.13 46.73 Favored Glycine 0 C--N 1.294 -1.802 0 C-N-CA 120.015 -1.088 . . . . 65.33 112.457 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.5 p -135.47 137.78 42.5 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 122.852 0.461 . . . . 62.23 110.999 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 5.5 mp -117.35 124.4 48.84 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.423 -1.325 . . . . 72.42 107.423 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 47.2 mm -94.28 146.98 5.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 109.671 -0.492 . . . . 71.25 109.671 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -129.59 106.57 8.83 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.234 -1.395 . . . . 53.32 107.234 176.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -72.44 116.57 13.05 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.99 -1.115 . . . . 71.01 107.99 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 11.5 m -122.84 155.16 37.19 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 104.98 -2.23 . . . . 62.24 104.98 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.94 -25.79 65.45 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.905 0.383 . . . . 60.4 111.698 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -82.11 -45.8 14.7 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 116.062 -0.517 . . . . 70.52 111.695 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -172.34 145.97 1.57 Allowed Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 108.183 -1.044 . . . . 71.52 108.183 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 8.2 Cg_exo -72.06 106.38 2.02 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.299 2.0 . . . . 71.15 109.087 168.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 35.8 m -87.6 157.67 3.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.721 -0.844 . . . . 70.24 108.721 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.31 120.89 3.33 Favored Glycine 0 CA--C 1.481 -2.067 0 C-N-CA 118.62 -1.753 . . . . 73.12 112.791 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' B' ' 33' ' ' LEU . 98.0 m-85 -88.16 102.37 14.74 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.342 -1.355 . . . . 73.5 107.342 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 88.4 t -94.13 130.15 43.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.298 0 CA-C-N 114.678 -1.146 . . . . 53.12 109.703 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' B' ' 58' ' ' GLU . 48.6 pt -106.99 138.64 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.241 0 CA-C-O 121.848 0.832 . . . . 72.32 110.596 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -119.21 166.08 13.42 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 114.116 -1.402 . . . . 72.12 111.553 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.75 -40.87 80.73 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.023 -1.444 . . . . 72.34 112.362 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 5.0 p -157.95 167.64 29.38 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.145 -0.48 . . . . 72.13 111.399 -170.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.58 -30.11 62.82 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 120.219 -0.593 . . . . 71.43 109.845 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.48 -24.19 63.75 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.766 0.793 . . . . 43.01 109.579 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.89 -36.85 9.79 Favored Glycine 0 C--N 1.309 -0.963 0 CA-C-N 114.63 -1.168 . . . . 72.43 110.581 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.444 ' HB1' HD11 ' B' ' 33' ' ' LEU . . . -65.1 -49.07 71.44 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.717 0.807 . . . . 50.54 111.002 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.29 -38.66 77.47 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 116.092 -0.504 . . . . 74.14 111.207 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.6 -40.8 72.99 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.716 -0.674 . . . . 52.33 111.322 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.82 -41.38 83.15 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 116.161 -0.472 . . . . 73.54 111.459 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' B' ' 103' ' ' LEU . 15.1 ptmm? -72.02 -36.42 69.68 Favored 'General case' 0 C--O 1.2 -1.533 0 C-N-CA 120.153 -0.619 . . . . 52.14 109.521 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -58.95 -39.22 81.0 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.316 0.646 . . . . 52.41 110.081 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.45 -31.37 37.47 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 112.615 0.598 . . . . 71.13 112.615 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.418 ' O ' HG22 ' B' ' 91' ' ' ILE . 96.2 mt -100.21 -31.49 11.35 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.201 1.926 . . . . 72.11 116.201 -174.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . 0.251 0.2 OUTLIER -65.91 121.96 16.27 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.448 1.277 . . . . 71.23 114.448 -173.338 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.23 14.94 15.21 Favored Glycine 0 N--CA 1.428 -1.874 0 C-N-CA 120.744 -0.741 . . . . 73.24 112.104 174.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.418 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.5 tt -103.98 140.04 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.909 0 N-CA-C 107.123 -1.436 . . . . 64.1 107.123 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' B' ' 94' ' ' ASP . 89.4 mtt180 -74.15 134.91 42.83 Favored 'General case' 0 C--N 1.263 -3.163 0 CA-C-O 120.869 0.366 . . . . 65.01 110.051 171.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.0 t80 -65.49 -34.76 79.02 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.436 -1.256 . . . . 75.5 109.171 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.562 ' HB2' ' HB3' ' B' ' 97' ' ' ASN . 3.0 m-20 -131.4 138.35 32.57 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 102.055 -3.313 . . . . 52.22 102.055 173.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' PRO . . . . . 0.692 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 22.1 Cg_endo -63.21 -29.25 73.51 Favored 'Trans proline' 0 N--CA 1.486 1.041 0 CA-C-N 121.911 1.718 . . . . 53.23 111.001 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.5 -17.36 42.21 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.965 -1.47 . . . . 50.4 110.916 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' ASN . . . . . 0.562 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . 39.5 t30 -100.43 125.67 38.54 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 109.573 -0.528 . . . . 64.52 109.573 -175.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.72 -10.71 28.35 Favored 'Trans proline' 0 C--O 1.239 0.554 0 C-N-CA 122.795 2.33 . . . . 74.41 112.586 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' GLN . . . . . 0.433 ' HB3' ' ND2' ' B' ' 97' ' ' ASN . 6.6 tp60 -70.29 113.06 7.08 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.446 -0.946 . . . . 72.14 108.446 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.492 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 69.6 p -97.37 145.8 25.79 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.03 -0.532 . . . . 70.35 109.919 -175.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 52.2 tp -87.85 123.71 32.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.881 -1.155 . . . . 71.05 107.881 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -136.88 123.33 20.8 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-O 121.669 0.747 . . . . 74.32 110.337 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.469 ' O ' ' HE2' ' B' ' 85' ' ' LYS . 5.4 mp -107.19 122.52 46.69 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.199 -1.364 . . . . 71.34 109.391 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.438 ' HB2' ' CE1' ' B' ' 34' ' ' PHE . 48.6 mt-10 -126.29 165.56 18.75 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.206 -1.035 . . . . 65.53 108.206 174.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -73.81 141.15 46.2 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.807 -0.357 . . . . 74.35 110.039 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.03 158.8 26.4 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.563 -0.903 . . . . 35.01 108.563 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -92.26 7.75 41.3 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.956 0.884 . . . . 75.0 109.946 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -157.66 132.67 8.72 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.252 -0.885 . . . . 55.52 108.916 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -85.32 141.28 30.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.574 -0.528 . . . . 53.53 109.574 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -123.25 145.8 48.38 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.498 -0.927 . . . . 74.44 108.498 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -114.08 160.37 18.99 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 120.732 0.301 . . . . 73.42 110.754 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' MET . . . . . 0.404 ' HG2' HD11 ' B' ' 74' ' ' ILE . 14.1 mmt -94.01 -31.48 14.23 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.869 -0.605 . . . . 60.15 111.03 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -127.54 114.62 17.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 116.004 -0.543 . . . . 75.3 110.596 -177.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -160.32 94.42 1.08 Allowed 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.664 -1.236 . . . . 60.01 107.664 175.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.2 m -86.39 101.22 12.92 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.856 0.836 . . . . 73.44 111.229 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -93.6 90.66 6.73 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.177 -1.416 . . . . 73.12 107.177 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 51.7 tp -64.64 -32.59 74.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.825 0.821 . . . . 72.13 109.191 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 N--CA 1.404 -2.736 0 N-CA-C 107.096 -1.446 . . . . 74.04 107.096 177.915 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 CA--C 1.51 -0.571 0 N-CA-C 108.959 -0.756 . . . . 75.31 108.959 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -175.44 -167.34 0.25 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 101.874 -3.38 . . . . 73.32 101.874 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -98.58 36.93 1.55 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.561 -2.014 . . . . 74.34 105.561 172.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.714 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 9.6 pt-20 -55.43 151.68 9.82 Favored 'General case' 0 N--CA 1.397 -3.078 0 CA-C-N 112.395 -2.184 . . . . 73.45 114.777 -173.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.5 t -104.58 114.64 44.72 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.549 0 N-CA-C 105.669 -1.975 . . . . 74.51 105.669 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 16.8 ptm180 -114.65 7.09 15.9 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.327 -0.851 . . . . 70.33 110.42 -175.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.9 m -116.41 117.73 30.75 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.919 0.866 . . . . 64.51 110.686 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.481 HD23 ' HB3' ' A' ' 85' ' ' LYS . 2.9 mp -98.13 140.73 32.01 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.774 -1.565 . . . . 74.2 106.774 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.538 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 6.8 p90 -107.54 114.64 28.77 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 117.578 -1.649 . . . . 72.14 107.979 173.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.447 HG22 ' HG ' ' A' ' 103' ' ' LEU . 43.8 t -97.29 121.05 47.41 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.879 0 CA-C-N 114.375 -1.284 . . . . 72.12 108.492 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.5 p -124.26 170.77 10.44 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 115.544 -0.753 . . . . 64.14 109.608 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 82.35 41.42 9.24 Favored Glycine 0 N--CA 1.43 -1.725 0 N-CA-C 110.103 -1.199 . . . . 21.44 110.103 -173.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.451 ' HB3' HD13 ' A' ' 42' ' ' ILE . 96.4 mt -111.31 123.06 35.98 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 114.23 -0.985 . . . . 73.22 110.16 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.5 144.08 19.61 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.857 2.372 . . . . 71.33 110.664 173.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.572 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 7.6 p -73.24 4.75 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 CA-C-O 122.475 1.131 . . . . 71.21 112.088 -173.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -125.66 13.12 8.04 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.885 -1.052 . . . . 70.5 110.904 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.451 HD13 ' HB3' ' A' ' 38' ' ' LEU . 28.0 pt -53.65 135.68 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 113.453 0.909 . . . . 62.12 113.453 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -97.18 146.0 30.59 Favored Pre-proline 0 C--N 1.292 -1.894 0 CA-C-N 114.625 -1.17 . . . . 72.54 109.119 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.13 -26.7 52.03 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.171 2.581 . . . . 72.32 112.861 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.525 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 9.8 ptt180 -70.86 -23.91 62.41 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 120.858 0.361 . . . . 72.42 111.328 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -72.63 -40.47 66.39 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.633 -0.877 . . . . 41.34 108.633 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.2 mt -66.73 -36.78 83.28 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.802 -0.814 . . . . 65.34 108.802 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.525 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 87.8 t80 -58.62 -47.54 84.04 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-N 114.708 -1.133 . . . . 74.14 110.253 175.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 97.6 mt -70.91 -30.14 66.4 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.072 0.463 . . . . 71.52 110.563 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.7 tp -68.62 -51.56 40.95 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.213 -0.903 . . . . 65.01 110.667 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -95.2 10.59 35.43 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.682 0.623 . . . . 72.42 112.682 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 10.6 ttp180 -52.65 -50.02 83.01 Favored Pre-proline 0 CA--C 1.565 1.539 0 C-N-CA 124.471 1.108 . . . . 74.35 113.696 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -85.35 -0.88 9.07 Favored 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 121.588 1.525 . . . . 64.05 112.74 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -88.72 96.04 10.51 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 122.629 1.204 . . . . 70.22 112.104 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -69.85 113.54 7.18 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 113.068 -1.878 . . . . 65.23 109.44 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.99 -24.82 3.25 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 114.956 -1.02 . . . . 63.42 110.661 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -56.62 115.81 2.76 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.251 0.62 . . . . 51.31 111.352 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -94.26 -56.58 2.78 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 109.209 -0.663 . . . . 55.4 109.209 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.22 169.93 40.63 Favored Glycine 0 C--N 1.295 -1.743 0 CA-C-N 115.214 -0.903 . . . . 45.3 111.6 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.411 ' HB3' HG22 ' A' ' 73' ' ' VAL . 10.4 p -130.55 137.36 49.66 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 120.93 0.395 . . . . 72.23 110.543 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -121.02 109.73 15.4 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.52 -0.919 . . . . 53.02 108.52 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.587 HD13 ' H ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -93.92 130.84 42.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.098 0.475 . . . . 72.53 111.287 -177.554 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 69' ' ' PRO . 87.2 tttt -108.84 112.37 24.59 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.505 -0.924 . . . . 55.05 108.505 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.1 122.77 15.21 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.789 -0.642 . . . . 73.11 110.226 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 15.5 m -130.39 159.67 36.3 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 105.669 -1.975 . . . . 65.3 105.669 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -42.64 -41.78 3.21 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.177 1.391 . . . . 72.03 114.356 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -105.62 -36.47 7.08 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.331 0.586 . . . . 71.03 112.542 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.574 ' O ' ' HB ' ' A' ' 65' ' ' THR . 8.3 pt20 -147.3 132.29 8.98 Favored Pre-proline 0 C--N 1.291 -1.953 0 CA-C-N 115.357 -0.838 . . . . 75.3 111.697 -168.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.572 ' HD3' ' HA ' ' A' ' 40' ' ' VAL . 32.3 Cg_endo -73.06 101.87 1.39 Allowed 'Trans proline' 0 N--CA 1.433 -2.082 0 C-N-CA 121.649 1.566 . . . . 72.43 108.18 167.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.7 m -70.77 139.12 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 108.685 -0.857 . . . . 63.35 108.685 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 62' ' ' ILE . . . -108.82 119.79 5.7 Favored Glycine 0 CA--C 1.465 -3.056 0 C-N-CA 118.236 -1.935 . . . . 72.33 112.939 -174.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -88.73 101.91 14.47 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 105.865 -1.902 . . . . 64.44 105.865 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 60' ' ' SER . 92.4 t -96.78 121.55 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.504 0 CA-C-N 114.735 -1.12 . . . . 63.03 108.888 -176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.7 mt -102.02 119.85 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.763 0 CA-C-N 114.601 -1.181 . . . . 72.11 109.854 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 5.2 m-85 -102.07 156.35 17.6 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 114.373 -1.285 . . . . 72.34 109.916 176.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -64.47 -30.53 71.56 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.201 -1.363 . . . . 62.53 112.112 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m -156.27 155.84 33.03 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 121.804 -0.56 . . . . 74.11 112.205 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.714 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -54.16 -39.15 66.29 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 123.953 0.783 . . . . 72.34 110.91 175.285 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.71 -29.56 69.42 Favored 'General case' 0 CA--C 1.493 -1.249 0 O-C-N 123.889 0.743 . . . . 75.31 110.369 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.01 -45.4 5.1 Favored Glycine 0 C--N 1.295 -1.733 0 CA-C-N 114.469 -1.241 . . . . 73.33 110.69 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.1 -46.32 88.6 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.479 1.112 . . . . 70.12 113.137 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 10.0 pt-20 -62.51 -37.11 84.77 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.384 -0.371 . . . . 64.34 111.327 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.31 -37.63 52.21 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 116.267 -0.424 . . . . 65.43 110.638 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.76 90.37 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.721 -0.672 . . . . 63.13 111.661 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.481 ' HB3' HD23 ' A' ' 33' ' ' LEU . 16.1 pttp -75.36 -33.71 61.08 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 118.552 -1.259 . . . . 64.22 111.85 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.6 -17.15 61.21 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.229 0.538 . . . . 55.32 111.509 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.22 -45.03 14.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 120.998 0.427 . . . . 62.21 110.285 175.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.555 ' O ' HG22 ' A' ' 91' ' ' ILE . 91.9 mt -91.04 -5.42 55.31 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 114.749 1.389 . . . . 73.22 114.749 -173.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -78.99 114.77 18.21 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.055 -1.028 . . . . 74.31 112.627 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.13 20.37 10.56 Favored Glycine 0 CA--C 1.479 -2.216 0 C-N-CA 120.408 -0.901 . . . . 55.53 111.64 174.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 88' ' ' LEU . 16.0 tt -114.3 142.32 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.276 0 N-CA-C 105.461 -2.051 . . . . 70.54 105.461 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.49 ' CD ' ' HA ' ' A' ' 95' ' ' PRO . 33.3 ptt180 -87.02 130.09 34.61 Favored 'General case' 0 C--N 1.262 -3.227 0 C-N-CA 119.424 -0.91 . . . . 55.04 111.335 175.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -60.75 -31.48 70.81 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.701 -1.59 . . . . 71.41 110.207 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.404 ' OD2' ' HB3' ' B' ' 45' ' ' ARG . 9.4 t0 -142.28 113.27 6.18 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 105.512 -2.033 . . . . 74.0 105.512 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.49 ' HA ' ' CD ' ' A' ' 92' ' ' ARG . 53.0 Cg_exo -61.38 -12.85 25.81 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 122.99 2.46 . . . . 43.43 114.846 -178.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -98.21 -14.45 20.33 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.704 -0.623 . . . . 74.01 110.177 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -94.79 141.97 24.07 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.705 -0.85 . . . . 64.52 108.705 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.09 2.35 7.25 Favored 'Trans proline' 0 CA--C 1.549 1.248 0 C-N-CA 122.619 2.213 . . . . 75.02 114.314 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -92.87 127.78 38.5 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 121.558 -0.714 . . . . 72.51 109.259 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.556 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 50.6 p -107.08 143.64 34.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.916 -0.401 . . . . 55.12 109.916 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 34.7 tp -89.37 127.98 35.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.382 -0.97 . . . . 74.52 108.382 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -136.96 124.01 21.56 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 108.545 -0.909 . . . . 64.45 108.545 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.447 ' HG ' HG22 ' A' ' 35' ' ' VAL . 5.9 mp -112.83 122.72 48.5 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 115.732 -0.667 . . . . 60.53 109.85 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.538 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 43.3 mt-10 -127.89 177.43 6.85 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.603 -1.258 . . . . 75.14 107.603 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -91.02 138.57 31.5 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 118.753 0.706 . . . . 64.02 111.424 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.75 158.79 33.98 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.443 -0.799 . . . . 60.31 108.865 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -84.8 -1.98 57.11 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.764 0.792 . . . . 75.45 109.643 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -151.43 132.56 14.4 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.321 -0.854 . . . . 72.11 109.623 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -78.11 124.29 27.88 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.645 -0.502 . . . . 70.4 109.645 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.7 m -92.68 139.14 30.87 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.07 -1.085 . . . . 75.44 108.07 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -86.07 123.08 30.98 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.868 -0.79 . . . . 75.4 108.868 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -86.52 -63.72 1.27 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.433 -0.951 . . . . 74.21 108.433 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -150.28 93.31 1.98 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.218 0.533 . . . . 45.5 110.331 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -143.47 117.89 9.68 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.752 -0.658 . . . . 72.01 109.483 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 m -85.41 89.85 7.79 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.67 -0.492 . . . . 62.04 109.67 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -94.17 76.38 4.03 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.267 -1.753 . . . . 74.04 106.267 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.42 HD23 ' HG3' ' A' ' 118' ' ' GLU . 4.7 tt -87.61 127.31 35.27 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.058 -1.83 . . . . 60.11 106.058 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.42 ' HG3' HD23 ' A' ' 117' ' ' LEU . 47.8 mt-10 . . . . . 0 N--CA 1.475 0.81 0 C-N-CA 124.928 1.291 . . . . 75.21 109.765 -175.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 67.1 mtm . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 120.925 0.393 . . . . 72.41 109.968 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 27' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' B' ' 29' ' ' GLU . 2.1 mp0 -108.15 -170.69 1.72 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.994 -0.743 . . . . 65.2 108.994 -174.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -83.58 43.69 0.92 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.425 -1.324 . . . . 62.11 107.425 172.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' B' ' 27' ' ' GLU . 8.3 pt-20 -64.7 127.59 32.21 Favored 'General case' 0 N--CA 1.41 -2.467 0 C-N-CA 125.969 1.707 . . . . 74.01 111.217 -176.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.522 ' HA ' HD21 ' B' ' 109' ' ' ASN . 48.5 t -95.72 110.55 24.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.816 -0.809 . . . . 75.34 108.816 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' B' ' 75' ' ' PHE . 15.0 ptm180 -114.49 11.65 17.19 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.208 -0.905 . . . . 72.51 111.232 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 29.6 m -122.19 122.93 40.31 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.514 0.673 . . . . 71.11 111.096 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' B' ' 85' ' ' LYS . 2.2 mp -101.63 144.75 29.97 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.075 -1.454 . . . . 62.32 107.075 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.591 ' CE2' ' HB2' ' B' ' 104' ' ' GLU . 9.9 p90 -109.2 116.43 31.9 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 117.412 -1.715 . . . . 62.34 108.179 171.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.46 120.06 46.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 CA-C-N 113.946 -1.479 . . . . 73.44 108.225 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.459 ' OG ' ' HG3' ' B' ' 102' ' ' ARG . 11.0 p -128.72 163.03 26.02 Favored 'General case' 0 N--CA 1.408 -2.557 0 CA-C-N 115.505 -0.771 . . . . 73.4 109.984 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 88.83 37.79 7.19 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 110.648 -0.981 . . . . 42.1 110.648 -173.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.89 135.79 19.37 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 108.069 -1.086 . . . . 73.43 108.069 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.06 150.64 23.46 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.081 1.854 . . . . 73.04 110.194 172.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.527 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 8.1 p -76.75 1.73 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 121.999 0.904 . . . . 62.41 110.5 -174.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -127.73 20.85 6.53 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.509 -0.769 . . . . 50.34 110.032 -173.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 24.9 pt -52.6 133.77 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 113.871 1.063 . . . . 74.0 113.871 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' B' ' 43' ' ' LYS . 3.2 mptp? -90.86 147.12 35.26 Favored Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 114.58 -1.191 . . . . 75.4 109.458 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.84 -28.65 59.21 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.855 2.37 . . . . 64.45 113.286 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.523 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -79.54 -14.38 58.9 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 117.642 -1.623 . . . . 63.25 111.898 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -69.93 -40.53 75.46 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.818 -0.808 . . . . 72.05 108.818 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 88.6 mt -66.4 -34.03 77.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.376 -0.829 . . . . 72.35 109.072 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.523 ' HB3' ' O ' ' B' ' 45' ' ' ARG . 78.9 t80 -60.94 -49.28 78.08 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-N 115.112 -0.949 . . . . 72.31 110.065 176.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 92.0 mt -70.01 -29.14 66.12 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-O 121.117 0.484 . . . . 74.43 110.677 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 tp -71.78 -51.03 24.7 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.113 -0.949 . . . . 64.01 111.121 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -96.8 7.5 46.45 Favored 'General case' 0 C--O 1.217 -0.608 0 N-CA-C 113.674 0.99 . . . . 71.24 113.674 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 10.0 ttp180 -47.93 -50.83 51.53 Favored Pre-proline 0 CA--C 1.568 1.639 0 N-CA-C 114.505 1.298 . . . . 72.12 114.505 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' B' ' 52' ' ' ARG . 1.0 OUTLIER -87.62 -1.39 7.46 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 121.685 1.59 . . . . 73.21 112.98 177.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -86.96 97.17 10.55 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.929 1.347 . . . . 71.45 111.878 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -69.39 113.25 6.53 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 112.169 -2.287 . . . . 72.34 109.637 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.26 -20.28 4.23 Favored Glycine 0 N--CA 1.422 -2.295 0 CA-C-N 114.72 -1.127 . . . . 71.15 111.29 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -57.05 114.98 2.36 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.249 0.62 . . . . 73.41 112.075 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.36 -51.24 4.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.607 0.718 . . . . 65.3 109.363 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.17 178.59 42.88 Favored Glycine 0 C--N 1.298 -1.55 0 CA-C-N 115.208 -0.905 . . . . 53.43 112.198 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.414 ' HB3' HG22 ' B' ' 73' ' ' VAL . 6.7 p -134.39 141.08 46.73 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 123.508 0.723 . . . . 64.21 110.082 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -122.91 112.93 18.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.736 -1.579 . . . . 34.42 106.736 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.579 HD13 ' H ' ' B' ' 62' ' ' ILE . 0.2 OUTLIER -93.84 137.92 21.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.13 0.49 . . . . 72.34 111.254 -176.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -124.46 112.14 16.54 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.129 -1.063 . . . . 61.21 108.129 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.48 116.61 7.66 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.661 -0.496 . . . . 70.24 109.661 -177.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 8.5 m -111.53 167.38 10.37 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.523 -1.658 . . . . 75.54 106.523 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.78 -33.11 6.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.231 1.197 . . . . 71.44 114.231 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 58.7 mtt-85 -104.72 -28.68 11.05 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.665 0.987 . . . . 74.32 113.665 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -170.7 152.86 3.93 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 116.439 -0.346 . . . . 73.44 110.155 -165.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 51.4 Cg_endo -77.72 108.24 2.52 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 C-N-CA 122.27 1.98 . . . . 54.15 109.927 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 31.7 m -76.03 140.23 17.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.372 -1.344 . . . . 71.1 107.372 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.16 120.84 5.46 Favored Glycine 0 C--N 1.282 -2.438 0 C-N-CA 118.753 -1.689 . . . . 74.31 112.912 -175.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.4 102.29 14.39 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 105.883 -1.895 . . . . 61.43 105.883 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.414 HG22 ' HB3' ' B' ' 60' ' ' SER . 83.3 t -94.94 124.76 47.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 114.789 -1.096 . . . . 55.44 109.279 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 60.7 mt -107.35 122.08 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.567 0 CA-C-N 114.41 -1.268 . . . . 75.24 109.81 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' B' ' 31' ' ' ARG . 4.0 m-85 -105.95 157.2 17.67 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.666 -1.152 . . . . 75.43 109.697 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.76 -36.26 67.64 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.125 -0.943 . . . . 61.41 109.868 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.91 134.31 54.85 Favored 'General case' 0 N--CA 1.389 -3.485 0 CA-C-N 115.173 -0.921 . . . . 72.53 109.406 -170.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -25.09 56.71 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.425 -0.807 . . . . 61.21 111.218 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.3 -19.81 49.54 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 107.451 -1.315 . . . . 73.25 107.451 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.34 -41.98 8.18 Favored Glycine 0 C--N 1.295 -1.705 0 CA-C-N 113.312 -1.767 . . . . 64.41 109.22 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.23 -46.91 88.16 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.201 1.0 . . . . 65.42 112.16 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -58.81 -44.72 90.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.257 -0.429 . . . . 73.52 111.305 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.71 -36.16 75.68 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.705 -0.68 . . . . 60.0 110.578 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.68 -42.37 91.36 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.881 -0.6 . . . . 53.13 111.444 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.444 ' HB3' HD23 ' B' ' 33' ' ' LEU . 17.1 pttp -74.27 -36.03 63.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 118.171 -1.412 . . . . 63.32 111.147 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -63.49 -27.47 69.29 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.547 0.529 . . . . 74.35 111.321 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.31 -43.69 17.18 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 120.672 0.272 . . . . 74.11 111.388 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.538 ' O ' HG22 ' B' ' 91' ' ' ILE . 95.7 mt -86.22 -8.57 57.69 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.164 1.542 . . . . 53.31 115.164 -174.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.22 114.59 15.06 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.049 -1.06 . . . . 65.22 112.813 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.49 14.79 26.86 Favored Glycine 0 N--CA 1.428 -1.851 0 C-N-CA 120.301 -0.952 . . . . 53.52 112.278 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.538 HG22 ' O ' ' B' ' 88' ' ' LEU . 16.3 tt -106.59 134.43 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.211 0 N-CA-C 106.127 -1.805 . . . . 52.24 106.127 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' B' ' 95' ' ' PRO . 39.4 ptt180 -78.9 133.11 36.97 Favored 'General case' 0 C--N 1.262 -3.223 0 C-N-CA 119.651 -0.82 . . . . 74.23 111.168 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -69.13 -28.63 66.63 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.769 -1.559 . . . . 74.34 110.206 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.435 ' OD2' ' HB3' ' A' ' 45' ' ' ARG . 10.6 t70 -146.57 118.25 4.83 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 106.389 -1.708 . . . . 63.13 106.389 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' PRO . . . . . 0.496 ' HA ' ' NE ' ' B' ' 92' ' ' ARG . 21.0 Cg_endo -60.69 -21.45 69.58 Favored 'Trans proline' 0 N--CA 1.48 0.726 0 C-N-CA 123.039 2.493 . . . . 72.31 114.409 -176.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -85.97 -23.25 26.97 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.508 0.671 . . . . 65.34 110.27 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -100.62 132.29 22.51 Favored Pre-proline 0 C--N 1.29 -2.002 0 CA-C-N 115.499 -0.773 . . . . 73.3 109.13 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.08 -0.72 6.74 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.852 2.368 . . . . 72.4 112.505 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -69.72 112.23 6.04 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.888 -0.782 . . . . 72.53 108.888 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.47 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 70.3 p -103.48 145.57 29.81 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.903 -0.777 . . . . 73.22 108.903 -177.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 36.7 tp -89.9 130.67 36.09 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.663 -1.236 . . . . 61.45 107.663 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.459 ' HG3' ' OG ' ' B' ' 36' ' ' SER . 7.7 ptm180 -138.14 122.53 18.32 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 108.694 -0.854 . . . . 70.34 108.694 -175.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -117.47 132.37 56.56 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.82 -0.627 . . . . 73.54 110.18 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.591 ' HB2' ' CE2' ' B' ' 34' ' ' PHE . 36.0 mt-10 -136.43 174.28 10.79 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.19 -1.781 . . . . 73.1 106.19 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -81.84 145.02 30.62 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 119.128 -1.029 . . . . 74.44 110.941 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.14 151.73 40.0 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 107.906 -1.146 . . . . 72.02 107.906 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -75.95 -9.66 58.79 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.004 0.907 . . . . 62.51 109.888 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.8 127.29 9.33 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.076 -0.965 . . . . 73.01 108.827 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.522 HD21 ' HA ' ' B' ' 30' ' ' VAL . 93.0 m-20 -71.71 143.73 49.55 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.912 -0.585 . . . . 65.31 110.976 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 22.5 m -110.33 129.58 55.72 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 108.075 -1.083 . . . . 64.42 108.075 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -92.13 110.73 22.11 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.178 -1.045 . . . . 64.24 108.178 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -67.98 -60.62 2.36 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.672 -0.694 . . . . 60.43 111.361 -171.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -147.27 101.24 3.37 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.221 -0.592 . . . . 72.15 112.133 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -154.62 129.11 9.15 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.235 -1.024 . . . . 63.23 108.235 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 48.4 m -80.1 109.82 14.92 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.337 0.589 . . . . 63.5 109.43 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -144.47 83.39 1.72 Allowed 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 106.222 -1.77 . . . . 71.34 106.222 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 4.6 tt -110.08 76.59 1.0 Allowed 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.548 -0.751 . . . . 65.51 109.71 -175.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 C--N 1.306 -1.294 0 N-CA-C 105.476 -2.046 . . . . 74.0 105.476 175.503 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.368 0.128 . . . . 75.31 111.012 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -149.09 -70.58 0.2 Allowed 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.519 -1.289 . . . . 38.01 107.519 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -141.67 105.33 4.7 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.789 -1.189 . . . . 73.44 107.789 175.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.42 ' HB3' ' HD2' ' A' ' 78' ' ' ARG . 7.7 mp0 -86.66 137.86 32.13 Favored 'General case' 0 N--CA 1.394 -3.23 0 N-CA-C 106.861 -1.533 . . . . 53.12 106.861 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.86 110.12 14.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.465 -1.309 . . . . 63.41 107.465 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 17.0 ptp180 -113.99 -1.7 13.72 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.069 -0.969 . . . . 74.44 111.172 -172.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.4 m -111.07 130.57 55.57 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 115.538 -0.755 . . . . 44.11 110.679 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.451 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.0 pt? -127.78 153.31 46.72 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.903 -0.777 . . . . 75.51 108.903 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -103.0 120.68 41.08 Favored 'General case' 0 N--CA 1.418 -2.075 0 CA-C-O 121.924 0.869 . . . . 74.04 108.97 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.0 t -97.59 120.94 47.58 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 CA-C-N 114.388 -1.278 . . . . 71.14 107.659 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.8 p -128.9 157.44 41.58 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 116.295 -0.411 . . . . 64.21 110.564 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 98.91 17.44 27.84 Favored Glycine 0 C--N 1.299 -1.525 0 O-C-N 123.675 0.609 . . . . 54.34 112.734 -178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.467 ' HB3' HG21 ' A' ' 42' ' ' ILE . 96.1 mt -78.72 125.65 83.9 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 106.9 -1.519 . . . . 74.32 106.9 173.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -58.63 154.57 41.88 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.244 1.296 . . . . 52.32 110.117 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.3 p -73.44 4.8 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 CA-C-O 122.33 1.062 . . . . 74.31 110.785 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.43 ' O ' ' HE2' ' A' ' 43' ' ' LYS . 18.3 t70 -110.34 13.29 22.95 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 114.574 -1.194 . . . . 60.33 109.155 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.467 HG21 ' HB3' ' A' ' 38' ' ' LEU 0.266 2.4 pp -58.09 141.43 15.08 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 N-CA-C 114.939 1.459 . . . . 74.43 114.939 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.435 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 61.1 mmtt -106.5 145.93 32.0 Favored Pre-proline 0 C--N 1.283 -2.313 0 CA-C-N 113.548 -1.66 . . . . 73.43 106.736 176.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.14 -25.93 65.38 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.223 1.949 . . . . 54.24 111.94 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.501 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 13.9 ptt180 -69.82 -24.73 63.51 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.574 -0.739 . . . . 70.04 111.521 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 40.6 mt-10 -69.99 -42.89 72.47 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 120.986 0.422 . . . . 75.43 110.28 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.01 -37.3 86.91 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.85 0.833 . . . . 63.45 109.099 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.572 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 23.2 t80 -60.88 -50.47 73.29 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.462 -1.245 . . . . 72.34 110.905 176.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 95.7 mt -64.16 -41.41 97.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.174 0.511 . . . . 64.11 110.065 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 tp -67.33 -41.96 84.4 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.741 -1.118 . . . . 74.15 111.52 -176.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -92.07 -1.32 57.27 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 115.194 1.553 . . . . 63.04 115.194 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.572 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 12.6 mtp180 -61.51 -45.97 94.11 Favored Pre-proline 0 N--CA 1.479 0.992 0 N-CA-C 113.794 1.035 . . . . 74.24 113.794 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.28 -16.28 43.66 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 121.166 1.244 . . . . 74.12 112.513 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -92.65 92.33 7.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.296 1.046 . . . . 64.33 110.203 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -73.35 113.92 10.98 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 113.753 -1.567 . . . . 74.04 109.544 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.98 -20.93 2.49 Favored Glycine 0 C--N 1.288 -2.123 0 CA-C-N 114.754 -1.112 . . . . 44.2 111.657 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -54.47 112.73 1.06 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.553 0.741 . . . . 75.3 111.969 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -94.26 -45.21 7.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.639 -0.71 . . . . 74.33 110.932 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.43 178.35 48.32 Favored Glycine 0 C--N 1.298 -1.563 0 C-N-CA 120.27 -0.967 . . . . 65.23 112.791 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.0 p -143.08 142.17 31.45 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 123.069 0.548 . . . . 45.11 111.297 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.426 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 5.4 mp -118.8 130.21 55.65 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.247 -1.39 . . . . 74.21 107.247 173.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.5 mm -109.26 131.92 58.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 118.043 0.383 . . . . 70.43 111.26 -173.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -120.13 106.83 12.34 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.479 -0.934 . . . . 73.41 108.479 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -63.21 126.24 26.75 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.802 -1.09 . . . . 60.21 109.517 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 14.8 m -130.1 153.98 47.93 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 105.565 -2.013 . . . . 72.42 105.565 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.41 -33.64 31.18 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.164 1.172 . . . . 64.44 114.164 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -104.19 -35.67 7.94 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 112.768 0.655 . . . . 75.11 112.768 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.532 ' O ' ' HB ' ' A' ' 65' ' ' THR . 5.4 pm0 -156.88 129.45 4.23 Favored Pre-proline 0 C--N 1.302 -1.477 0 C-N-CA 121.071 -0.251 . . . . 75.42 110.434 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 38' ' ' LEU . 29.0 Cg_exo -64.15 118.64 5.59 Favored 'Trans proline' 0 N--CA 1.441 -1.577 0 C-N-CA 122.305 2.003 . . . . 65.41 108.99 167.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.0 140.33 15.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.383 -0.969 . . . . 63.52 108.383 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 61' ' ' LEU . . . -122.33 122.22 4.98 Favored Glycine 0 C--N 1.289 -2.05 0 C-N-CA 119.775 -1.203 . . . . 64.52 112.699 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -87.89 103.16 15.4 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.429 -1.693 . . . . 75.3 106.429 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.44 132.19 47.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 CA-C-N 115.118 -0.947 . . . . 74.23 110.545 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 110' ' ' THR . 4.7 tt -107.68 129.69 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 CA-C-N 114.893 -1.049 . . . . 71.3 109.98 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.51 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 14.2 m-85 -108.76 158.33 17.73 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 114.897 -1.047 . . . . 73.25 109.22 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.97 -31.95 73.44 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.872 -0.604 . . . . 72.14 111.256 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.7 p -133.32 152.13 51.91 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 112.492 0.553 . . . . 45.14 112.492 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.633 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.89 -35.46 80.06 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 108.591 -0.892 . . . . 63.54 108.591 175.106 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.61 -19.52 62.11 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 122.556 1.169 . . . . 74.12 108.316 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.96 -45.64 8.93 Favored Glycine 0 C--N 1.294 -1.779 0 CA-C-N 113.937 -1.483 . . . . 70.42 110.153 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.29 -42.89 74.87 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.99 -0.605 . . . . 64.53 111.593 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.477 ' HA ' ' HG2' ' A' ' 85' ' ' LYS 0.27 1.4 pp20? -69.67 -30.24 67.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 112.937 0.717 . . . . 74.5 112.937 -177.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.62 -32.81 68.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.316 0.579 . . . . 32.41 109.992 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.87 -44.87 68.91 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.438 -0.801 . . . . 72.12 110.828 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 104' ' ' GLU . 14.1 ptmm? -68.88 -33.11 73.25 Favored 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 120.792 -0.363 . . . . 75.41 110.209 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -59.73 -41.77 91.66 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.403 0.681 . . . . 63.14 109.913 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.59 -33.39 18.9 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 112.196 0.443 . . . . 64.14 112.196 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.596 ' O ' HG22 ' A' ' 91' ' ' ILE . 97.1 mt -94.05 -13.25 27.1 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 115.934 1.827 . . . . 54.33 115.934 -172.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.313 0.2 OUTLIER -78.79 114.39 17.68 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 116.771 -1.972 . . . . 73.43 112.633 177.372 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.26 6.85 25.36 Favored Glycine 0 CA--C 1.492 -1.401 0 C-N-CA 120.746 -0.74 . . . . 74.51 112.335 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 88' ' ' LEU . 9.1 tt -91.96 130.39 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 N-CA-C 107.844 -1.169 . . . . 74.51 107.844 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.47 ' HG2' HG22 ' A' ' 100' ' ' THR . 98.6 mtt180 -74.9 130.25 39.07 Favored 'General case' 0 C--N 1.275 -2.631 0 C-N-CA 119.523 -0.871 . . . . 65.2 109.772 171.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -66.73 -30.04 70.16 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.336 -1.302 . . . . 73.54 108.284 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -141.58 124.9 9.78 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 104.556 -2.387 . . . . 74.45 104.556 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.472 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 43.1 Cg_endo -65.01 -27.17 58.04 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 122.197 1.931 . . . . 61.04 114.454 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -81.92 -24.79 35.42 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.422 -0.955 . . . . 63.31 108.422 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -84.12 129.45 58.42 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.852 -1.166 . . . . 64.53 107.852 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.08 -18.49 51.48 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.196 1.931 . . . . 73.4 112.275 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.425 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 6.1 tp60 -66.48 114.83 5.77 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.261 0.553 . . . . 62.2 110.485 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.481 ' OG1' ' HD2' ' A' ' 102' ' ' ARG . 32.8 p -98.23 161.78 13.53 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 115.678 -0.692 . . . . 74.02 109.772 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.5 tp -100.8 126.97 47.41 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.53 -1.285 . . . . 74.35 107.53 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.481 ' HD2' ' OG1' ' A' ' 100' ' ' THR . 0.1 OUTLIER -127.13 117.16 21.84 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.513 -0.921 . . . . 73.35 108.513 -176.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.15 123.84 49.86 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.814 -0.63 . . . . 64.33 110.101 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.5 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 9.1 tp10 -140.52 158.02 44.62 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.45 -1.315 . . . . 64.51 107.45 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -66.14 140.91 58.24 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 118.715 0.689 . . . . 71.42 112.847 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.71 158.46 24.21 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 108.375 -0.972 . . . . 71.54 108.375 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -82.35 -7.56 59.63 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.283 0.563 . . . . 74.12 110.472 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.0 136.41 28.43 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.958 -0.564 . . . . 44.02 110.905 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -81.88 124.41 29.68 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.779 -0.646 . . . . 73.52 109.631 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.411 ' O ' HD12 ' A' ' 74' ' ' ILE . 11.3 t -87.77 138.98 30.99 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 107.338 -1.356 . . . . 63.52 107.338 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -112.35 109.97 19.91 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.28 0.562 . . . . 64.43 111.875 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 14.7 mmt -87.89 -32.94 18.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.566 -0.743 . . . . 74.35 109.631 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -129.13 107.89 9.93 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.199 -0.91 . . . . 60.45 109.622 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -101.86 90.3 3.95 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.151 -0.685 . . . . 65.34 109.151 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.2 m -88.88 80.72 7.06 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.911 0.862 . . . . 60.24 108.999 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 154.2 24.69 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.864 -1.062 . . . . 61.02 112.994 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.8 mt -85.48 125.67 33.22 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.506 -0.924 . . . . 65.33 108.506 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--N 1.293 -1.889 0 N-CA-C 107.763 -1.199 . . . . 73.42 107.763 -177.708 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 109.897 -0.408 . . . . 62.01 109.897 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -68.88 -73.01 0.16 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.422 -0.354 . . . . 75.32 111.556 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -122.27 91.67 3.56 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.039 0.755 . . . . 70.4 113.039 -173.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -95.45 122.28 38.01 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 106.06 -1.83 . . . . 55.12 106.06 170.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' B' ' 78' ' ' ARG . 55.0 t -78.4 109.48 13.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.71 -0.848 . . . . 72.45 108.71 -174.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -118.71 4.13 11.62 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.985 0.898 . . . . 73.51 110.325 -172.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' THR . . . . . 0.483 ' HB ' ' HA ' ' B' ' 109' ' ' ASN . 63.5 m -111.52 136.06 51.23 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.688 -1.142 . . . . 62.24 108.345 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.441 ' H ' HD23 ' B' ' 33' ' ' LEU . 2.1 pt? -131.53 154.37 48.87 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.443 -0.577 . . . . 61.04 109.443 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.563 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 30.6 p90 -101.97 118.1 36.2 Favored 'General case' 0 N--CA 1.416 -2.171 0 CA-C-O 122.04 0.924 . . . . 61.23 108.718 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 51.0 t -98.42 122.25 49.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 113.901 -1.5 . . . . 73.32 107.553 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 22.5 p -127.42 164.57 21.58 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.666 -0.697 . . . . 64.35 109.603 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 93.95 27.81 11.92 Favored Glycine 0 N--CA 1.424 -2.143 0 O-C-N 123.523 0.514 . . . . 71.51 111.896 -175.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.405 ' HB3' HG12 ' B' ' 42' ' ' ILE . 98.2 mt -96.55 117.78 65.77 Favored Pre-proline 0 C--N 1.292 -1.91 0 N-CA-C 108.629 -0.878 . . . . 73.42 108.629 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.76 151.74 14.56 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.882 2.388 . . . . 61.23 112.001 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.49 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 11.9 p -63.62 -6.69 2.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 123.876 0.87 . . . . 74.32 112.781 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -121.39 26.31 8.93 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.618 -0.676 . . . . 74.15 109.775 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.411 HD12 ' O ' ' B' ' 42' ' ' ILE . 2.5 pp -58.43 135.76 22.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 113.203 0.816 . . . . 73.24 113.203 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -102.31 143.34 26.41 Favored Pre-proline 0 C--N 1.278 -2.53 0 CA-C-N 114.718 -1.128 . . . . 64.54 109.187 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -51.87 -32.18 45.91 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.79 2.327 . . . . 61.43 112.666 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.524 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 10.7 ptt180 -68.44 -25.44 65.02 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 111.886 0.328 . . . . 64.44 111.886 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -70.5 -39.63 74.02 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.602 0.715 . . . . 71.44 109.365 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 77.7 mt -67.71 -34.71 77.41 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 115.007 -0.997 . . . . 72.54 108.637 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.623 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 51.0 t80 -62.49 -48.44 79.56 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.745 -1.116 . . . . 73.24 110.102 176.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 93.6 mt -66.22 -40.77 90.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.131 0.491 . . . . 64.32 110.294 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.3 tp -71.57 -43.42 66.36 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.278 -0.874 . . . . 73.44 112.048 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -100.07 8.24 44.09 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 113.301 0.852 . . . . 74.21 113.301 -174.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.623 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 28.5 ttt180 -70.54 -43.34 16.14 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-O 119.349 -0.358 . . . . 74.01 111.798 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -74.96 -12.73 21.61 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 121.532 1.488 . . . . 73.33 112.623 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -85.72 110.82 19.59 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.655 0.741 . . . . 75.14 111.668 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -74.55 112.59 10.89 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.489 -1.232 . . . . 74.33 111.304 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.13 -19.84 3.84 Favored Glycine 0 N--CA 1.429 -1.77 0 CA-C-N 115.018 -0.992 . . . . 62.01 112.97 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -56.64 112.6 1.33 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.209 0.528 . . . . 75.44 112.369 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -93.75 -55.03 3.4 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.751 -0.659 . . . . 72.3 110.756 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.29 170.71 43.72 Favored Glycine 0 C--N 1.296 -1.667 0 C-N-CA 120.309 -0.948 . . . . 51.44 112.304 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.417 ' HB3' HG22 ' B' ' 73' ' ' VAL . 12.6 p -132.3 137.12 47.34 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.388 0.514 . . . . 75.41 112.388 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.408 ' O ' ' HA2' ' B' ' 71' ' ' GLY . 54.8 mt -104.3 113.5 27.1 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.353 -0.98 . . . . 73.05 108.353 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 43.2 mm -94.38 127.02 46.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 109.208 -0.664 . . . . 62.22 109.208 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -120.2 114.7 22.31 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.517 -0.92 . . . . 71.21 108.517 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.37 123.23 19.06 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.866 -0.607 . . . . 55.42 109.638 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.1 m -128.04 150.44 49.94 Favored 'General case' 0 N--CA 1.402 -2.851 0 N-CA-C 103.923 -2.621 . . . . 74.02 103.923 174.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.09 -40.16 4.71 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.5 1.296 . . . . 73.43 114.5 -173.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -100.61 -18.52 16.54 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 112.373 0.509 . . . . 74.13 112.373 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 24.4 pt20 -169.05 127.32 0.88 Allowed Pre-proline 0 C--N 1.308 -1.234 0 C-N-CA 120.878 -0.329 . . . . 73.15 111.628 -169.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 10.5 Cg_exo -73.33 101.21 1.32 Allowed 'Trans proline' 0 N--CA 1.437 -1.798 0 C-N-CA 122.363 2.042 . . . . 75.53 107.99 167.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.97 150.36 4.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.022 -0.536 . . . . 64.04 109.712 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' B' ' 61' ' ' LEU . . . -123.23 120.65 4.29 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 118.402 -1.856 . . . . 74.41 112.959 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -88.11 102.52 14.86 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.192 -1.781 . . . . 74.12 106.192 175.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' B' ' 60' ' ' SER . 60.1 t -99.86 130.21 49.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-N 114.677 -1.147 . . . . 75.13 110.863 -172.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.502 HD12 ' O ' ' B' ' 110' ' ' THR . 3.7 tt -104.05 127.61 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 0 CA-C-N 115.204 -0.907 . . . . 70.01 109.613 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' B' ' 81' ' ' ALA . 8.9 m-85 -105.33 154.13 20.69 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.43 -1.322 . . . . 73.24 107.43 171.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -65.19 -37.04 86.08 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.64 -0.504 . . . . 70.54 109.64 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 4.2 p -114.86 133.21 56.15 Favored 'General case' 0 N--CA 1.386 -3.673 0 CA-C-O 121.722 0.772 . . . . 75.21 111.304 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' B' ' 30' ' ' VAL . 0.0 OUTLIER -75.65 -24.46 56.39 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 115.241 -0.891 . . . . 72.14 110.785 177.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.12 -19.82 39.32 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.906 -1.516 . . . . 63.04 106.906 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.08 -43.43 10.8 Favored Glycine 0 C--N 1.299 -1.507 0 CA-C-N 113.277 -1.783 . . . . 62.34 109.637 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' B' ' 75' ' ' PHE . . . -62.41 -35.13 78.26 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.52 -0.84 . . . . 53.44 110.977 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 1.4 pp20? -69.42 -38.28 77.83 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.29 -0.964 . . . . 73.52 110.405 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.52 78.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.091 0.472 . . . . 74.14 110.4 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.03 -44.46 72.65 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.824 -0.625 . . . . 24.31 111.402 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' B' ' 82' ' ' GLU . 13.2 ptmm? -68.45 -34.71 76.44 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.787 -0.365 . . . . 74.3 110.475 -177.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -62.51 -28.85 70.13 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.063 -0.517 . . . . 73.02 110.91 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.75 -41.3 13.41 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 112.305 0.483 . . . . 63.3 112.305 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.548 ' O ' HG22 ' B' ' 91' ' ' ILE . 97.5 mt -98.62 -8.17 26.79 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 116.192 1.923 . . . . 74.34 116.192 -169.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.99 116.11 9.98 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 119.504 1.047 . . . . 72.43 113.208 177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.87 7.07 48.31 Favored Glycine 0 CA--C 1.482 -1.994 0 C-N-CA 120.843 -0.694 . . . . 75.13 113.068 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.548 HG22 ' O ' ' B' ' 88' ' ' LEU . 14.4 tt -101.58 137.24 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.929 0 N-CA-C 108.168 -1.049 . . . . 74.32 108.168 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -68.78 132.82 47.43 Favored 'General case' 0 C--N 1.266 -3.036 0 CA-C-O 121.776 0.798 . . . . 71.04 112.161 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -73.42 -28.35 61.94 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.672 -1.604 . . . . 73.23 107.848 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.446 ' OD2' ' HB3' ' A' ' 45' ' ' ARG . 9.4 t0 -146.14 114.73 4.59 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 105.417 -2.068 . . . . 62.23 105.417 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' PRO . . . . . 0.516 ' HD3' ' CZ ' ' A' ' 48' ' ' TYR . 56.7 Cg_endo -68.74 -19.06 41.83 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.328 2.019 . . . . 62.23 113.961 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -83.14 -24.69 32.44 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.794 -0.817 . . . . 74.1 108.794 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -95.54 143.35 25.96 Favored Pre-proline 0 C--N 1.309 -1.174 0 N-CA-C 108.57 -0.9 . . . . 71.14 108.57 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.11 -3.47 13.84 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 122.068 1.845 . . . . 71.42 114.224 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -75.87 120.65 21.51 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.992 0.425 . . . . 73.45 110.893 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.544 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 82.4 p -99.44 154.88 17.87 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 109.202 -0.666 . . . . 73.33 109.202 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 28.8 tp -94.78 127.92 41.12 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.686 -1.227 . . . . 71.54 107.686 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -125.63 130.28 51.31 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.567 -1.271 . . . . 74.41 107.567 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -123.61 116.31 22.9 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 123.366 0.416 . . . . 75.31 110.317 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.563 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 5.0 tp10 -134.37 156.64 48.15 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.918 -1.512 . . . . 73.21 106.918 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -66.8 143.43 56.9 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.35 0.977 . . . . 73.11 111.879 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.86 157.36 24.42 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.896 -0.593 . . . . 61.54 109.903 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -85.65 7.82 21.89 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.626 0.727 . . . . 71.12 110.712 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.64 138.88 11.13 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.348 -0.982 . . . . 51.42 108.348 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.483 ' HA ' ' HB ' ' B' ' 32' ' ' THR . 94.3 m-20 -82.88 158.56 22.63 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-O 121.228 0.537 . . . . 63.42 109.928 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.502 ' O ' HD12 ' B' ' 74' ' ' ILE . 14.2 t -123.47 164.06 19.66 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.939 -1.504 . . . . 75.43 106.939 174.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' LYS . . . . . 0.466 ' H ' ' HD3' ' B' ' 111' ' ' LYS . 0.0 OUTLIER -134.96 144.66 47.54 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.427 -0.953 . . . . 71.32 108.427 177.132 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 26.0 mmt -104.6 -58.72 1.84 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.253 -0.647 . . . . 73.33 109.253 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.39 94.02 6.82 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.617 -0.72 . . . . 61.45 109.951 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -83.85 116.13 22.6 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.034 -0.728 . . . . 63.35 109.034 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 6.7 m -107.11 135.83 47.99 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 106.855 -1.535 . . . . 74.41 106.855 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -86.57 102.64 14.32 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 119.056 -1.058 . . . . 70.01 110.021 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 67.5 mt -104.79 88.74 2.98 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.362 -1.718 . . . . 70.11 106.362 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 . . . . . 0 C--N 1.297 -1.689 0 N-CA-C 108.431 -0.951 . . . . 73.53 108.431 -175.917 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.47 0.538 0 CA-C-O 120.487 0.184 . . . . 75.31 111.313 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -74.2 -67.67 0.59 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.206 -1.035 . . . . 61.35 108.206 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -116.37 147.1 41.95 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.838 -1.912 . . . . 71.21 105.838 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 1.1 mp0 -62.76 109.46 1.43 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 105.363 -2.088 . . . . 71.42 105.363 171.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.663 ' HA ' HD21 ' A' ' 109' ' ' ASN . 98.6 t -69.63 109.28 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 105.745 -1.946 . . . . 73.55 105.745 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 13.7 ptm180 -127.57 15.89 7.04 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.004 -1.453 . . . . 72.42 110.497 -167.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.4 m -124.7 124.63 42.59 Favored 'General case' 0 C--N 1.272 -2.784 0 C-N-CA 119.467 -0.893 . . . . 73.15 110.666 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.2 mt -107.16 141.17 38.86 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.352 -0.981 . . . . 63.11 108.352 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.463 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 16.7 p90 -102.73 115.8 31.31 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 107.088 -1.449 . . . . 64.13 107.088 173.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.416 HG22 ' HG ' ' A' ' 103' ' ' LEU . 35.4 t -97.65 120.03 46.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 CA-C-N 114.23 -1.35 . . . . 75.1 108.418 -177.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.9 p -123.8 165.76 16.75 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 116.246 -0.433 . . . . 75.35 110.008 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.14 11.96 44.05 Favored Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 111.065 -0.814 . . . . 63.11 111.065 -173.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.6 mt -83.07 130.23 58.11 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 107.608 -1.256 . . . . 74.5 107.608 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.12 161.43 10.98 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.099 1.866 . . . . 71.32 111.204 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.407 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 7.5 p -62.53 -15.69 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.681 0.753 . . . . 73.1 110.79 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -121.56 35.69 4.82 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.04 -0.982 . . . . 55.15 109.231 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.594 HG22 ' HG2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -66.43 131.2 32.22 Favored 'Isoleucine or valine' 0 C--O 1.256 1.44 0 N-CA-C 108.422 -0.955 . . . . 73.22 108.422 175.293 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -99.25 143.94 27.33 Favored Pre-proline 0 C--N 1.291 -1.957 0 CA-C-N 115.111 -0.949 . . . . 72.21 111.627 -177.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.53 -26.53 37.01 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.634 2.889 . . . . 71.32 114.194 -176.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.54 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -86.5 -10.52 53.94 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 117.159 -1.816 . . . . 71.03 112.109 -177.66 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' HG2' ' HG2' ' B' ' 46' ' ' GLU . 35.6 mt-10 -67.42 -40.21 85.52 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.005 -0.739 . . . . 75.32 109.005 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.38 -27.27 65.17 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.588 -0.733 . . . . 74.01 110.123 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.54 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 46.9 t80 -65.3 -47.59 76.08 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.371 -0.831 . . . . 70.45 109.823 176.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.44 -40.37 81.16 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.365 -0.605 . . . . 71.35 109.365 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.456 HD13 HD22 ' B' ' 49' ' ' LEU . 32.3 tp -64.34 -47.61 78.67 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.819 -1.082 . . . . 74.33 112.164 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -98.91 0.94 45.14 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 114.609 1.337 . . . . 72.14 114.609 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.1 ttt85 -63.63 -44.2 79.94 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 112.829 0.677 . . . . 74.44 112.829 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.77 -6.97 20.3 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 121.28 1.32 . . . . 72.45 112.713 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -96.59 90.02 5.19 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.516 0.674 . . . . 74.02 110.698 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -67.65 109.59 3.36 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.969 0.89 . . . . 71.21 109.882 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.1 -27.01 1.42 Allowed Glycine 0 C--N 1.285 -2.267 0 CA-C-N 114.406 -1.27 . . . . 60.52 110.155 -173.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -54.91 127.31 28.13 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.139 0.576 . . . . 74.43 111.934 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -105.92 -53.89 2.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.175 0.512 . . . . 71.11 110.568 174.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.64 178.12 41.17 Favored Glycine 0 C--N 1.294 -1.793 0 CA-C-N 115.492 -0.776 . . . . 71.21 111.822 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.4 p -146.72 137.69 24.07 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.64 0.22 . . . . 74.44 111.054 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.0 mt -115.98 134.64 54.76 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.458 0.703 . . . . 74.32 109.128 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.9 mm -95.0 144.71 9.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 110.15 -0.315 . . . . 64.54 110.15 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -136.97 118.88 15.23 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.833 -0.432 . . . . 75.43 109.833 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.29 110.59 6.02 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.349 0.595 . . . . 75.42 111.022 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.3 m -99.44 162.76 12.84 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 105.578 -2.008 . . . . 72.42 105.578 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -43.91 -37.87 3.09 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 114.037 1.125 . . . . 74.44 114.037 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -103.87 -26.72 12.57 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.211 1.189 . . . . 64.23 114.211 -177.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -166.79 153.38 8.18 Favored Pre-proline 0 C--N 1.307 -1.261 0 C-N-CA 120.783 -0.367 . . . . 71.42 110.346 -168.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.594 ' HG2' HG22 ' A' ' 42' ' ' ILE . 56.9 Cg_endo -76.66 118.89 4.98 Favored 'Trans proline' 0 N--CA 1.438 -1.766 0 C-N-CA 122.459 2.106 . . . . 74.33 110.949 172.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 m -93.93 162.17 2.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.837 -1.171 . . . . 65.43 107.837 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.41 121.59 3.54 Favored Glycine 0 C--N 1.297 -1.633 0 C-N-CA 118.934 -1.603 . . . . 72.53 113.332 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -87.8 105.53 17.46 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.414 -1.328 . . . . 65.13 107.414 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.68 127.43 52.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 115.053 -0.976 . . . . 62.22 110.164 -176.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 tt -99.79 130.06 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 CA-C-O 121.704 0.764 . . . . 64.02 110.219 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.598 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 82.0 m-85 -112.01 152.8 27.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 114.228 -1.351 . . . . 74.45 109.172 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.477 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 35.0 t70 -68.02 -30.1 69.26 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 114.839 -1.073 . . . . 53.54 112.712 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.4 m -131.95 150.09 52.25 Favored 'General case' 0 N--CA 1.417 -2.1 0 O-C-N 121.776 -0.577 . . . . 73.21 109.961 -174.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.635 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -80.38 -27.87 38.07 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.499 -0.926 . . . . 74.14 108.499 178.322 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.44 -19.46 60.39 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 114.377 -1.283 . . . . 72.35 107.591 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.41 -42.13 7.09 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 113.393 -1.73 . . . . 34.4 110.095 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.04 -43.41 98.89 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.135 0.574 . . . . 74.03 111.599 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.0 -38.26 90.48 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 121.027 -0.269 . . . . 74.44 111.706 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.08 -38.53 72.44 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 120.701 0.286 . . . . 74.34 110.478 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.58 90.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.568 -0.742 . . . . 44.32 111.202 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -67.08 -37.78 84.59 Favored 'General case' 0 C--O 1.206 -1.237 0 C-N-CA 120.378 -0.529 . . . . 55.31 111.262 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -72.91 -17.08 61.54 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 120.853 0.359 . . . . 71.21 111.753 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.57 -45.93 11.29 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 116.364 -0.38 . . . . 71.24 110.76 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.476 ' O ' HG22 ' A' ' 91' ' ' ILE . 92.7 mt -98.38 -9.05 25.86 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 115.291 1.589 . . . . 72.04 115.291 -172.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.55 126.34 30.61 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.075 -1.016 . . . . 74.43 110.657 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.19 3.37 54.22 Favored Glycine 0 CA--C 1.475 -2.445 0 C-N-CA 120.599 -0.81 . . . . 60.24 112.5 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 88' ' ' LEU . 16.1 tt -111.18 144.45 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.343 0 N-CA-C 107.058 -1.46 . . . . 75.52 107.058 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -70.21 135.41 49.02 Favored 'General case' 0 C--N 1.272 -2.786 0 CA-C-O 121.557 0.694 . . . . 73.11 112.394 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -74.06 -28.54 61.46 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 113.677 -1.601 . . . . 61.11 109.069 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -144.36 120.26 6.19 Favored Pre-proline 0 C--N 1.314 -0.973 0 N-CA-C 105.906 -1.887 . . . . 64.44 105.906 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.511 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 57.6 Cg_endo -67.33 -21.63 47.21 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.522 2.148 . . . . 73.15 114.241 -176.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -82.61 -26.11 32.58 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.5 0.667 . . . . 64.24 109.255 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -90.27 134.08 32.02 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 108.012 -1.106 . . . . 60.04 108.012 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -70.18 -9.26 25.56 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 122.351 2.034 . . . . 71.23 112.181 176.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -68.96 125.69 27.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.559 -0.746 . . . . 60.12 110.061 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 39.5 p -102.63 156.35 17.68 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 116.496 -0.32 . . . . 72.04 110.207 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.4 tp -95.54 126.11 40.6 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.798 -0.815 . . . . 74.22 108.798 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -120.66 127.04 51.7 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.205 -1.035 . . . . 75.1 108.205 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.416 ' HG ' HG22 ' A' ' 35' ' ' VAL . 7.3 mp -116.37 116.54 27.9 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 123.51 0.506 . . . . 73.11 109.683 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 39.1 tt0 -128.52 162.88 26.19 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.782 -1.192 . . . . 62.23 107.782 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -71.36 145.36 49.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 118.728 0.694 . . . . 73.44 109.23 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.58 157.89 34.65 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.694 -0.854 . . . . 52.54 108.694 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 13.1 tmtt? -80.24 -9.85 59.74 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.092 0.948 . . . . 75.43 108.6 -176.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -157.14 126.13 5.88 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.184 -1.371 . . . . 54.04 107.567 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.663 HD21 ' HA ' ' A' ' 30' ' ' VAL . 91.5 m-20 -72.26 141.15 48.93 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.241 -0.436 . . . . 74.03 110.243 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.1 t -94.96 134.43 37.64 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.367 -0.533 . . . . 74.44 109.979 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -94.85 92.02 6.73 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.575 -0.898 . . . . 72.41 108.575 175.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.1 tpt -67.24 -57.66 6.27 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.799 -1.091 . . . . 53.31 110.545 -176.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -112.79 89.88 3.19 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 121.288 0.566 . . . . 71.41 111.001 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -152.31 97.98 2.35 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.959 -0.756 . . . . 62.51 108.959 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.3 m -107.05 114.85 29.18 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.865 -1.531 . . . . 75.11 106.865 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -134.46 137.69 44.16 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 110.355 -0.239 . . . . 73.43 110.355 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.9 tp -73.67 -69.73 0.42 Allowed 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.825 -0.625 . . . . 75.11 109.522 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 C--N 1.307 -1.258 0 CA-C-N 116.135 -0.484 . . . . 54.44 110.459 -178.297 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 21.7 ptp . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 110.301 -0.259 . . . . 71.15 110.301 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.29 -49.15 58.62 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 112.38 0.511 . . . . 60.41 112.38 -171.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -126.9 131.02 51.24 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 120.843 0.354 . . . . 74.34 110.082 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.551 ' CD ' ' H ' ' B' ' 29' ' ' GLU . 1.3 mp0 -68.07 96.05 0.6 Allowed 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 108.241 -1.022 . . . . 75.14 108.241 173.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.429 ' HA ' HD21 ' B' ' 109' ' ' ASN . 68.3 t -84.49 109.52 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 104.766 -2.309 . . . . 23.24 104.766 171.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -116.18 10.68 14.98 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.636 -0.711 . . . . 73.12 110.743 -171.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 57.9 m -120.46 129.8 54.02 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-O 121.5 0.667 . . . . 60.35 110.657 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.432 ' N ' HD12 ' B' ' 33' ' ' LEU . 2.4 mp -112.34 143.25 43.76 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.611 -1.255 . . . . 75.25 107.611 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.545 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 26.3 p90 -101.3 116.85 33.74 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 107.437 -1.32 . . . . 73.41 107.437 172.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.444 HG22 ' HG ' ' B' ' 103' ' ' LEU . 41.2 t -98.81 114.98 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.329 0 CA-C-N 114.21 -1.359 . . . . 73.11 107.468 -177.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.8 p -124.53 154.18 40.97 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 116.285 -0.416 . . . . 73.23 110.295 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.51 4.29 32.51 Favored Glycine 0 N--CA 1.431 -1.685 0 O-C-N 123.561 0.538 . . . . 42.32 111.969 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 86.3 mt -71.66 132.58 85.21 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 107.372 -1.344 . . . . 74.12 107.372 175.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' PRO . . . . . 0.403 ' C ' ' H ' ' B' ' 41' ' ' ASP . 37.4 Cg_endo -65.99 160.89 42.16 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.62 1.546 . . . . 54.54 111.677 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.467 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 9.4 p -69.91 4.99 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.6 0 CA-C-O 122.148 0.975 . . . . 54.03 111.274 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' B' ' 39' ' ' PRO . 27.9 t70 -125.51 19.01 8.1 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.616 1.166 . . . . 72.04 109.19 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.12 127.5 20.87 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 CA-C-O 121.843 0.83 . . . . 62.52 111.086 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.462 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 70.1 mmtt -98.71 137.35 20.58 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.07 -0.968 . . . . 75.34 108.936 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -53.74 -32.48 65.93 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.857 2.372 . . . . 73.34 113.236 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.575 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 0.0 OUTLIER -73.15 -15.8 61.46 Favored 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 119.374 -0.931 . . . . 74.34 112.324 -179.157 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.462 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 47.6 mt-10 -69.55 -36.06 75.98 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.893 -0.504 . . . . 75.11 110.23 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.88 -26.38 64.16 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 121.732 0.777 . . . . 73.5 108.919 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.511 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 58.3 t80 -73.33 -34.91 65.93 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.911 -1.041 . . . . 75.2 110.215 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 67.1 mt -78.48 -41.51 32.39 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.271 -0.64 . . . . 73.01 109.271 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.6 tp -66.09 -46.52 77.35 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.21 -0.904 . . . . 62.11 111.482 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -95.03 14.92 20.28 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 112.221 0.452 . . . . 75.32 112.221 -176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.486 ' HA ' ' CZ ' ' B' ' 52' ' ' ARG . 0.8 OUTLIER -59.46 -52.12 76.44 Favored Pre-proline 0 CA--C 1.56 1.349 0 CA-C-N 115.864 -0.607 . . . . 63.44 111.743 178.466 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.3 -1.48 11.12 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 121.607 1.538 . . . . 61.41 112.728 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -89.54 91.6 8.76 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 122.024 0.916 . . . . 74.53 110.673 -177.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -75.4 109.85 9.28 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.21 -1.359 . . . . 74.1 108.785 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.65 -14.04 4.19 Favored Glycine 0 C--N 1.293 -1.813 0 CA-C-N 115.058 -0.974 . . . . 64.1 111.753 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -59.93 109.89 1.05 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.191 0.52 . . . . 74.51 110.527 175.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -86.09 -49.35 7.85 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.737 -0.665 . . . . 54.03 110.435 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.11 -175.69 45.46 Favored Glycine 0 C--N 1.294 -1.797 0 C-N-CA 120.13 -1.033 . . . . 23.51 112.175 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 21.5 p -148.17 143.27 26.96 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 122.377 0.271 . . . . 60.24 111.335 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 85.3 mt -116.83 127.21 54.08 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.474 -0.936 . . . . 74.04 108.474 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 47.4 mm -94.56 136.46 25.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.198 -0.667 . . . . 53.01 109.198 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -127.58 115.4 18.75 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.016 -0.735 . . . . 74.13 109.016 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.21 109.46 5.26 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.235 -0.654 . . . . 62.22 109.235 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 19.6 m -100.6 156.23 17.42 Favored 'General case' 0 N--CA 1.407 -2.611 0 N-CA-C 104.458 -2.423 . . . . 71.32 104.458 175.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.41 -37.58 17.38 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 113.65 0.981 . . . . 62.32 113.65 -173.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -102.78 -16.54 15.93 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.191 1.182 . . . . 63.43 114.191 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.532 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 4.4 pt20 -173.77 142.45 0.92 Allowed Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 118.167 0.44 . . . . 63.24 111.731 -174.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.467 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 14.9 Cg_exo -68.77 115.19 3.82 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 123.05 2.5 . . . . 74.02 111.096 170.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -92.55 167.35 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.038 -1.097 . . . . 70.34 108.038 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.62 122.68 2.43 Favored Glycine 0 C--O 1.207 -1.585 0 C-N-CA 118.87 -1.633 . . . . 54.51 113.621 -176.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -88.11 107.73 18.9 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.636 -1.246 . . . . 72.51 107.636 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 90.2 t -101.17 129.16 52.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 115.185 -0.916 . . . . 73.12 110.978 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.49 HD12 ' O ' ' B' ' 110' ' ' THR . 3.4 tt -101.85 134.33 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 115.253 -0.885 . . . . 62.21 110.351 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -113.57 158.35 20.89 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.97 -1.014 . . . . 64.24 110.738 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.1 -34.66 78.08 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.823 -1.535 . . . . 74.34 112.4 175.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 46.4 m -135.75 152.14 50.83 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 120.757 -0.377 . . . . 70.02 110.736 -173.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' ARG . . . . . 0.567 ' H ' ' HD3' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -80.08 -26.6 39.52 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.393 0.616 . . . . 63.31 109.343 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.05 -21.14 51.11 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 107.726 -1.212 . . . . 52.24 107.726 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.47 -39.58 14.67 Favored Glycine 0 C--N 1.31 -0.884 0 N-CA-C 109.276 -1.529 . . . . 32.01 109.276 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.02 -42.61 97.06 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.322 -0.939 . . . . 62.33 111.501 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.84 -37.64 88.29 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.782 0.325 . . . . 61.24 111.556 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.15 -37.21 69.43 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.054 0.454 . . . . 70.14 110.336 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.84 -42.96 80.62 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.497 -0.774 . . . . 62.05 111.027 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.43 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 14.9 ptmm? -68.2 -37.1 80.54 Favored 'General case' 0 C--O 1.206 -1.189 0 C-N-CA 120.585 -0.446 . . . . 73.02 110.744 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -66.68 -29.53 69.55 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 120.863 0.363 . . . . 62.0 111.427 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.34 -44.42 25.21 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 116.166 -0.47 . . . . 70.31 111.252 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.581 ' O ' HG22 ' B' ' 91' ' ' ILE . 99.3 mt -94.75 -11.96 28.05 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 115.356 1.613 . . . . 72.4 115.356 -173.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -76.2 115.64 16.12 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 118.257 -1.377 . . . . 71.22 109.825 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.99 11.56 24.07 Favored Glycine 0 CA--C 1.482 -2.01 0 C-N-CA 120.463 -0.875 . . . . 74.33 111.767 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.581 HG22 ' O ' ' B' ' 88' ' ' LEU . 14.4 tt -99.66 140.54 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.624 0 N-CA-C 107.665 -1.235 . . . . 54.51 107.665 175.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.44 ' CG ' HG22 ' B' ' 100' ' ' THR . 79.3 mtt180 -81.75 128.67 34.23 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-O 120.985 0.421 . . . . 74.22 110.175 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.74 -34.39 77.77 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.55 -1.205 . . . . 75.11 110.063 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -144.5 126.1 7.98 Favored Pre-proline 0 C--N 1.312 -1.047 0 N-CA-C 106.405 -1.702 . . . . 70.24 106.405 174.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' PRO . . . . . 0.457 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 60.4 Cg_endo -69.84 -0.41 6.93 Favored 'Trans proline' 0 N--CA 1.486 1.031 0 C-N-CA 123.266 2.644 . . . . 74.51 114.386 -173.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -91.75 -25.65 18.95 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.54 0.686 . . . . 73.41 109.542 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -91.81 139.16 24.68 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 108.144 -1.058 . . . . 74.4 108.144 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -69.6 -20.78 35.16 Favored 'Trans proline' 0 C--O 1.247 0.932 0 C-N-CA 121.763 1.642 . . . . 60.13 111.014 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -55.57 131.17 45.61 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.502 1.121 . . . . 62.43 110.621 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.44 HG22 ' CG ' ' B' ' 92' ' ' ARG . 75.2 p -112.76 160.03 18.36 Favored 'General case' 0 N--CA 1.418 -2.061 0 C-N-CA 120.177 -0.609 . . . . 72.4 109.78 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 20.2 tp -96.8 121.23 38.43 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.261 -1.014 . . . . 54.51 108.261 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -112.51 123.13 49.61 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.242 -1.022 . . . . 74.43 108.242 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.444 ' HG ' HG22 ' B' ' 35' ' ' VAL . 7.1 mp -110.5 115.7 30.1 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 109.381 -0.6 . . . . 74.22 109.381 172.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.545 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 34.2 tt0 -129.87 157.58 41.86 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.321 -1.362 . . . . 74.33 107.321 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 105' ' ' PHE . . . . . 0.417 ' HB3' HG11 ' B' ' 30' ' ' VAL . 25.6 m-85 -66.7 138.46 57.42 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 118.602 0.637 . . . . 75.54 110.693 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.36 152.26 30.52 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 108.902 -0.777 . . . . 74.13 108.902 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' B' ' 107' ' ' LYS . 14.4 tmtt? -78.49 -6.93 56.79 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.4 -0.818 . . . . 54.24 110.053 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.18 132.87 21.0 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.127 -0.942 . . . . 73.22 108.824 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.429 HD21 ' HA ' ' B' ' 30' ' ' VAL . 91.2 m-20 -87.13 143.09 27.46 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.326 -0.397 . . . . 72.35 110.249 177.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.49 ' O ' HD12 ' B' ' 74' ' ' ILE . 12.8 t -112.15 151.63 29.26 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 107.572 -1.27 . . . . 71.54 107.572 176.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -107.01 140.82 39.2 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.972 -1.121 . . . . 74.23 107.972 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -64.93 1.08 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.958 -1.497 . . . . 64.21 106.958 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.34 97.07 6.11 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.902 -0.59 . . . . 52.55 110.642 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -153.79 100.61 2.39 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.287 -0.635 . . . . 71.21 109.287 175.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 18.9 m -112.28 90.2 3.28 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.79 -0.819 . . . . 62.44 108.79 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -106.62 104.64 14.37 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.918 -1.141 . . . . 62.25 107.918 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 56.9 tp -78.11 -37.48 46.23 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.62 0.724 . . . . 62.11 109.194 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.418 -2.046 0 CA-C-N 114.904 -1.044 . . . . 55.35 108.883 177.327 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 48.6 ttm . . . . . 0 C--O 1.222 -0.391 0 CA-C-O 120.491 0.186 . . . . 75.31 111.29 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -123.48 27.94 7.22 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 110.349 -0.241 . . . . 75.02 110.349 -172.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 65.82 84.11 0.16 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.228 0.955 . . . . 73.43 109.594 -173.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -80.03 -178.63 6.6 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.974 -1.012 . . . . 74.4 108.867 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.4 t -74.74 110.3 8.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 118.942 -1.103 . . . . 72.1 109.636 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -102.52 13.45 34.5 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.194 -1.366 . . . . 73.3 111.244 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 109' ' ' ASN . 23.8 m -139.02 132.51 30.29 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.917 -0.713 . . . . 70.52 111.576 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.7 mt -110.73 145.88 37.27 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.341 -0.985 . . . . 73.24 108.341 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -101.65 111.2 23.37 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 107.29 -1.374 . . . . 62.52 107.29 173.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.45 HG22 ' HG ' ' A' ' 103' ' ' LEU . 47.2 t -97.44 120.92 47.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.178 -1.374 . . . . 73.04 108.013 -177.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 p -126.98 168.64 14.27 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 115.335 -0.848 . . . . 72.42 109.217 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 88.58 39.64 6.62 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 111.085 -0.806 . . . . 71.02 111.085 -177.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 99.6 mt -105.37 137.97 19.42 Favored Pre-proline 0 N--CA 1.418 -2.041 0 N-CA-C 108.325 -0.991 . . . . 73.51 108.325 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -56.76 159.43 14.16 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.941 1.761 . . . . 75.44 109.183 171.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.574 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 8.9 p -80.86 -0.75 4.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 122.435 1.112 . . . . 64.31 110.677 -168.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -117.42 16.25 14.71 Favored 'General case' 0 N--CA 1.413 -2.276 0 CA-C-N 114.552 -1.204 . . . . 72.14 110.809 -172.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.482 HG13 ' HG2' ' A' ' 69' ' ' PRO 0.272 2.7 pp -55.82 136.38 18.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 114.47 1.285 . . . . 71.13 114.47 -177.73 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.546 ' HD3' ' CD ' ' A' ' 46' ' ' GLU . 6.6 mptt -103.1 149.8 37.24 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 106.689 -1.597 . . . . 74.32 106.689 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.19 -28.68 88.41 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.361 2.04 . . . . 73.35 112.0 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.662 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 20.3 ptt180 -68.16 -30.38 69.49 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 116.165 -0.47 . . . . 75.12 111.712 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.546 ' CD ' ' HD3' ' A' ' 43' ' ' LYS . 46.5 mt-10 -69.0 -42.41 76.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.022 0.439 . . . . 74.52 110.185 -175.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.56 -43.11 94.94 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.508 -0.923 . . . . 72.22 108.508 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.544 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 37.4 t80 -57.79 -45.1 86.54 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.414 -1.266 . . . . 72.31 111.626 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 88.4 mt -64.73 -40.46 95.36 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.366 0.603 . . . . 65.41 110.305 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 tp -70.08 -43.67 70.65 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.897 -1.047 . . . . 74.34 111.106 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -84.99 6.82 23.58 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 114.065 1.135 . . . . 64.43 114.065 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.491 ' NE ' ' HA ' ' A' ' 52' ' ' ARG . 3.2 mmp_? -50.59 -52.23 57.84 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 113.482 0.919 . . . . 74.24 113.482 177.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.38 -1.36 9.71 Favored 'Trans proline' 0 C--N 1.365 1.436 0 C-N-CA 121.795 1.663 . . . . 72.21 113.248 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -89.5 107.82 19.29 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 122.1 0.953 . . . . 71.13 112.38 -175.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -76.78 112.16 13.07 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 113.852 -1.522 . . . . 75.31 111.054 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 75' ' ' PHE . . . 142.4 -32.04 1.99 Allowed Glycine 0 N--CA 1.424 -2.147 0 CA-C-N 114.653 -1.158 . . . . 73.23 111.19 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.05 118.25 4.49 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.667 0.787 . . . . 74.35 112.705 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -108.1 -35.71 6.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.272 0.558 . . . . 61.33 110.652 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.56 -178.38 48.37 Favored Glycine 0 C--N 1.306 -1.084 0 C-N-CA 120.154 -1.022 . . . . 75.23 112.441 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.6 p -144.29 137.56 27.31 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.613 0.206 . . . . 70.43 111.43 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -107.83 114.32 28.19 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 107.725 -1.213 . . . . 73.35 107.725 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.53 136.59 26.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 110.334 -0.247 . . . . 74.32 110.334 -175.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 69' ' ' PRO . 63.4 tttp -124.99 106.94 10.33 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 109.353 -0.61 . . . . 62.34 109.353 176.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.87 109.17 7.16 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.707 -0.849 . . . . 72.45 108.707 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.4 m -104.97 164.11 12.03 Favored 'General case' 0 N--CA 1.41 -2.455 0 N-CA-C 105.373 -2.084 . . . . 65.2 105.373 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.02 -33.76 62.9 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.704 0.683 . . . . 70.11 111.903 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.494 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 1.5 tpm_? -82.18 -52.28 7.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 112.201 0.445 . . . . 71.23 112.201 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -160.22 152.55 17.28 Favored Pre-proline 0 C--N 1.289 -2.033 0 CA-C-N 115.878 -0.601 . . . . 63.32 109.853 -171.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.574 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 58.3 Cg_endo -80.16 108.73 2.24 Favored 'Trans proline' 0 N--CA 1.431 -2.187 0 C-N-CA 122.546 2.164 . . . . 72.43 110.051 168.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.5 m -83.04 160.33 3.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.109 -1.071 . . . . 64.44 108.109 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.41 120.71 2.25 Favored Glycine 0 CA--C 1.474 -2.504 0 C-N-CA 118.042 -2.028 . . . . 55.24 112.747 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -88.37 102.52 14.95 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 106.622 -1.622 . . . . 75.21 106.622 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.07 127.28 47.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-N 115.429 -0.805 . . . . 74.21 109.948 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.9 pt -98.0 135.24 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.301 0 CA-C-N 115.155 -0.929 . . . . 75.13 110.722 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 87.9 m-85 -121.98 149.53 43.33 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.341 -1.3 . . . . 72.51 108.559 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -52.64 -44.23 65.97 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 124.486 1.116 . . . . 74.35 111.585 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.1 m -145.34 158.09 43.9 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.72 -0.673 . . . . 74.33 110.235 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.456 ' N ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.24 -26.68 67.48 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.857 -0.61 . . . . 72.52 109.872 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.02 -28.05 69.54 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.366 -0.834 . . . . 62.54 110.15 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.01 -37.07 8.58 Favored Glycine 0 C--N 1.311 -0.812 0 N-CA-C 109.774 -1.33 . . . . 23.21 109.774 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.67 -44.45 93.73 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.491 -0.854 . . . . 72.25 111.728 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.4 -35.98 82.2 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.862 0.363 . . . . 61.33 111.832 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.35 -42.04 69.01 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.027 0.441 . . . . 65.42 110.052 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.62 95.76 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.666 -0.697 . . . . 71.43 111.258 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.421 ' CE ' ' HA ' ' A' ' 104' ' ' GLU . 14.8 ptmm? -70.56 -33.57 71.27 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 120.538 -0.465 . . . . 64.01 110.657 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -69.48 -36.49 76.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.887 0.375 . . . . 74.14 110.839 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.85 -41.93 42.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.07 0.462 . . . . 40.43 111.859 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 91' ' ' ILE . 85.8 mt -93.95 -9.75 36.0 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 115.085 1.513 . . . . 73.23 115.085 -172.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -74.95 118.39 17.86 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 117.898 -1.521 . . . . 72.04 108.828 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.23 12.56 48.48 Favored Glycine 0 N--CA 1.424 -2.152 0 CA-C-N 115.468 -0.787 . . . . 40.23 111.794 176.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.7 tt -100.84 134.46 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.965 0 N-CA-C 108.185 -1.042 . . . . 71.32 108.185 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.542 ' HG2' HG22 ' A' ' 100' ' ' THR . 82.7 mtt180 -79.41 142.31 36.07 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 115.445 -0.798 . . . . 71.33 112.448 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -75.88 -28.89 58.29 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.548 -1.66 . . . . 74.21 108.394 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.597 ' OD2' ' HB3' ' B' ' 45' ' ' ARG . 6.2 m-20 -138.22 127.76 14.83 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 104.138 -2.542 . . . . 71.03 104.138 173.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.61 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 18.0 Cg_endo -58.92 -26.73 82.26 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.093 1.862 . . . . 73.45 112.444 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -90.76 -5.14 56.08 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.461 -0.79 . . . . 72.41 111.82 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.464 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 52.7 t-20 -104.17 125.96 32.95 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 108.171 -1.048 . . . . 73.31 108.171 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -64.53 -7.07 13.36 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 123.15 2.567 . . . . 62.5 113.349 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -77.44 115.32 17.11 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.691 -0.855 . . . . 65.1 108.691 176.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.542 HG22 ' HG2' ' A' ' 92' ' ' ARG . 27.7 p -116.12 153.05 32.46 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.158 -1.053 . . . . 71.23 108.158 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.6 mp -82.85 140.52 32.87 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 118.417 0.553 . . . . 71.55 111.102 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.6 108.81 10.19 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.659 -1.608 . . . . 75.34 106.659 176.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.45 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.8 mp -102.61 123.26 46.01 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.951 -0.568 . . . . 60.45 111.818 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.421 ' HA ' ' CE ' ' A' ' 85' ' ' LYS . 17.2 mm-40 -132.34 164.32 26.72 Favored 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 123.435 0.694 . . . . 75.34 109.807 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -73.68 143.32 46.27 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.468 -0.567 . . . . 64.11 109.468 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.46 157.07 37.53 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.146 -1.057 . . . . 75.24 108.146 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -72.73 -13.32 61.31 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.383 1.087 . . . . 71.55 110.503 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.81 127.01 3.98 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 105.985 -1.857 . . . . 55.33 105.985 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.476 ' HA ' ' HB ' ' A' ' 32' ' ' THR . 7.1 p30 -79.19 144.42 34.44 Favored 'General case' 0 CA--C 1.47 -2.104 0 C-N-CA 118.517 -1.273 . . . . 63.42 108.918 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.0 t -124.1 115.11 20.61 Favored 'General case' 0 N--CA 1.395 -3.213 0 C-N-CA 118.544 -1.262 . . . . 74.53 112.548 -173.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -41.83 124.45 2.6 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.045 -1.889 . . . . 65.33 109.02 168.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -45.79 -60.53 2.17 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.335 1.054 . . . . 74.55 110.357 -175.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -99.27 92.39 5.41 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 107.87 -1.159 . . . . 73.02 107.87 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.1 102.79 0.53 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.38 -0.827 . . . . 71.45 109.613 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.5 t -92.58 -164.75 1.22 Allowed 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 114.702 -1.135 . . . . 64.54 108.186 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.2 tttm 69.32 67.88 0.26 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.899 1.333 . . . . 63.41 109.177 -174.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.8 tp -134.58 -31.49 1.06 Allowed 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 113.046 -1.888 . . . . 64.41 107.271 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 N--CA 1.429 -1.511 0 N-CA-C 108.177 -1.046 . . . . 74.13 108.177 177.623 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 94.1 mmm . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 114.038 1.125 . . . . 71.32 114.038 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -69.33 102.97 1.85 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.665 0.617 . . . . 45.41 112.665 -170.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 56.18 37.85 29.25 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.707 0.803 . . . . 71.0 109.406 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -85.44 154.45 21.81 Favored 'General case' 0 N--CA 1.409 -2.51 0 CA-C-N 114.883 -1.053 . . . . 63.34 111.396 -171.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.0 112.1 4.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-N 114.441 -1.254 . . . . 63.11 110.991 -171.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.697 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 72.2 mtt180 -95.44 -2.59 48.51 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.287 -0.87 . . . . 72.53 109.921 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 16.0 m -101.03 137.92 38.76 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 114.977 -1.01 . . . . 52.13 112.265 -174.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 77.2 mt -117.52 146.24 43.69 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.696 -1.224 . . . . 73.21 107.696 173.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -99.53 118.98 37.29 Favored 'General case' 0 N--CA 1.42 -1.974 0 C-N-CA 118.486 -1.286 . . . . 71.43 107.811 173.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.467 HG22 ' HG ' ' B' ' 103' ' ' LEU . 35.2 t -97.32 109.09 22.66 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 N-CA-C 106.318 -1.734 . . . . 60.43 106.318 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -116.54 170.34 8.65 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-N 115.094 -0.957 . . . . 64.33 108.867 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 81.23 46.33 7.04 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.705 -0.958 . . . . 75.1 110.705 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 91.3 mt -114.37 141.44 26.51 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 107.573 -1.269 . . . . 74.43 107.573 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -59.99 161.4 19.1 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 121.585 1.523 . . . . 72.35 110.395 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.618 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 8.8 p -86.07 7.89 2.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 122.477 1.132 . . . . 74.33 109.752 -171.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -127.9 19.13 6.61 Favored 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 114.79 -1.095 . . . . 72.1 111.402 -174.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.427 HG12 ' HG2' ' B' ' 69' ' ' PRO . 32.6 pt -58.07 134.81 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 114.424 1.268 . . . . 74.11 114.424 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -101.44 145.85 31.17 Favored Pre-proline 0 C--N 1.297 -1.707 0 CA-C-N 113.908 -1.496 . . . . 73.14 110.066 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -55.97 -27.98 66.48 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.258 2.639 . . . . 74.11 113.484 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.597 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 23.9 ptt180 -70.36 -28.67 65.3 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 121.179 0.514 . . . . 73.01 111.051 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -69.84 -40.01 76.09 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.839 -0.619 . . . . 75.14 110.204 -176.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.97 -41.59 95.32 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 108.708 -0.849 . . . . 71.32 108.708 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.61 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 7.3 t80 -57.1 -47.1 81.87 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.73 -1.123 . . . . 72.25 111.32 177.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 82.5 mt -61.1 -42.7 99.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.11 0.481 . . . . 73.41 110.789 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.412 HD13 HD22 ' A' ' 49' ' ' LEU . 37.9 tp -73.86 -42.99 60.0 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.198 -0.91 . . . . 64.2 111.936 -176.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -89.02 -10.49 47.36 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 115.623 1.712 . . . . 75.41 115.623 -173.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 14.1 mtp180 -54.28 -52.41 69.26 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 113.603 0.964 . . . . 70.32 113.603 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.3 -21.18 71.03 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 121.668 1.578 . . . . 73.02 112.304 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -88.42 86.59 7.07 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.662 0.744 . . . . 64.51 109.564 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -68.5 112.87 5.58 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.282 -1.326 . . . . 70.15 108.464 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 149.39 -28.52 1.21 Allowed Glycine 0 C--N 1.288 -2.087 0 CA-C-N 114.186 -1.37 . . . . 60.44 110.16 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -58.83 117.12 4.26 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.471 0.708 . . . . 64.21 111.568 176.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -102.02 -59.85 1.63 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.995 0.426 . . . . 72.14 111.212 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.78 172.37 31.17 Favored Glycine 0 C--N 1.295 -1.702 0 C-N-CA 120.559 -0.829 . . . . 71.11 112.181 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.1 p -135.39 137.04 41.92 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 122.903 0.481 . . . . 54.42 110.622 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.56 110.17 17.04 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.382 -1.34 . . . . 73.44 107.382 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.35 138.03 21.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 120.748 0.308 . . . . 73.43 110.923 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' B' ' 69' ' ' PRO . 0.6 OUTLIER -117.14 106.77 13.69 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.662 -1.607 . . . . 71.24 106.662 176.548 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.75 124.17 24.79 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.182 -0.917 . . . . 72.22 109.04 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 7.8 m -127.09 151.94 47.96 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 103.214 -2.884 . . . . 61.31 103.214 177.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.33 -33.36 65.54 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.063 0.764 . . . . 74.24 113.063 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -86.98 -38.7 16.37 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 120.19 -0.604 . . . . 71.0 112.294 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' B' ' 65' ' ' THR . 28.4 pt20 -161.53 135.3 4.91 Favored Pre-proline 0 C--N 1.297 -1.691 0 CA-C-O 120.495 0.188 . . . . 71.51 111.485 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.618 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 18.0 Cg_endo -80.55 109.8 2.33 Favored 'Trans proline' 0 N--CA 1.427 -2.411 0 C-N-CA 122.064 1.842 . . . . 62.13 109.508 168.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -84.68 147.9 5.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.436 -0.95 . . . . 51.24 108.436 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.28 120.56 4.58 Favored Glycine 0 CA--C 1.481 -2.056 0 C-N-CA 118.647 -1.74 . . . . 74.33 112.847 -175.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -87.74 102.72 14.93 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.628 -1.619 . . . . 70.44 106.628 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 69.2 t -100.11 128.73 51.75 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 114.923 -1.035 . . . . 70.12 110.117 -174.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 45.8 pt -101.76 132.67 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 CA-C-O 122.165 0.983 . . . . 65.54 110.865 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.697 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 79.9 m-85 -111.15 142.64 43.06 Favored 'General case' 0 C--N 1.266 -3.028 0 CA-C-N 113.744 -1.571 . . . . 75.21 107.9 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.95 -24.92 67.66 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.308 0.575 . . . . 75.35 110.704 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 3.1 m -129.75 131.82 46.39 Favored 'General case' 0 N--CA 1.386 -3.67 0 N-CA-C 107.429 -1.323 . . . . 74.2 107.429 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' ARG . . . . . 0.702 ' H ' ' NE ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -80.93 -24.11 38.39 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.952 -0.567 . . . . 73.11 110.301 179.33 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.16 -20.52 57.49 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.316 -2.105 . . . . 70.22 105.316 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.81 -40.31 15.01 Favored Glycine 0 C--N 1.314 -0.65 0 CA-C-N 112.672 -2.058 . . . . 61.12 109.282 177.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.31 -47.27 86.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.111 -1.045 . . . . 51.42 110.912 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 10.9 pt-20 -63.7 -31.2 72.3 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.54 -0.464 . . . . 71.01 112.124 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.64 -42.15 67.92 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.712 0.291 . . . . 70.21 110.545 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.28 -39.29 82.16 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.55 -0.75 . . . . 63.14 111.105 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' B' ' 82' ' ' GLU . 14.4 ptmm? -66.06 -37.34 85.59 Favored 'General case' 0 C--O 1.199 -1.554 0 C-N-CA 120.606 -0.438 . . . . 73.13 110.288 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -55.79 -32.82 63.82 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 120.961 0.41 . . . . 73.42 111.772 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.09 -36.45 19.62 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 112.406 0.521 . . . . 54.13 112.406 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.604 ' O ' HG22 ' B' ' 91' ' ' ILE . 97.5 mt -95.69 -22.14 17.74 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 116.019 1.859 . . . . 74.53 116.019 -173.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ASN . . . . . 0.459 ' HB3' ' H ' ' B' ' 103' ' ' LEU . 0.3 OUTLIER -74.99 113.3 12.15 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 118.441 -1.304 . . . . 75.21 110.514 178.351 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.46 16.17 16.94 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 120.761 -0.733 . . . . 72.05 111.344 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.604 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.3 tt -113.37 145.31 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.81 0 N-CA-C 107.844 -1.169 . . . . 74.32 107.844 175.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.554 ' CG ' HG22 ' B' ' 100' ' ' THR . 97.7 mtt180 -82.31 145.02 30.19 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 113.325 0.861 . . . . 74.52 113.325 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.411 ' HB2' HD11 ' B' ' 101' ' ' LEU . 22.0 t80 -77.24 -34.87 55.81 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.405 -1.725 . . . . 74.41 107.264 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' A' ' 45' ' ' ARG . 5.2 m-20 -134.34 120.62 14.91 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 105.249 -2.13 . . . . 73.34 105.249 176.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' PRO . . . . . 0.544 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 18.1 Cg_endo -60.78 -24.22 78.38 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 121.897 1.731 . . . . 73.11 112.21 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -84.71 -14.62 47.84 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 123.725 0.81 . . . . 74.5 110.776 -176.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 97' ' ' ASN . . . . . 0.445 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . 53.7 t-20 -104.52 133.44 20.19 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 107.538 -1.282 . . . . 55.44 107.538 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.52 -5.39 15.09 Favored 'Trans proline' 0 CA--C 1.55 1.294 0 C-N-CA 122.524 2.149 . . . . 74.44 112.916 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -72.01 116.97 13.04 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 109.244 -0.65 . . . . 42.11 109.244 177.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.618 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 67.2 p -115.87 152.17 33.88 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.974 -0.75 . . . . 62.44 108.974 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' B' ' 93' ' ' PHE . 6.4 mp -84.08 139.69 32.31 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.11 0.481 . . . . 71.31 110.487 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -125.3 109.49 12.86 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 107.134 -1.432 . . . . 71.21 107.134 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.467 ' HG ' HG22 ' B' ' 35' ' ' VAL . 6.8 mp -99.39 119.56 38.16 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 108.467 -0.938 . . . . 74.24 108.467 173.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.406 ' HA ' ' CE ' ' B' ' 85' ' ' LYS . 36.7 mm-40 -136.22 165.37 25.89 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.101 -1.074 . . . . 62.32 108.101 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -71.17 137.04 48.43 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 118.727 0.694 . . . . 74.42 110.544 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.63 152.92 29.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 116.216 -0.447 . . . . 53.42 110.032 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -73.17 -12.85 61.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.859 0.838 . . . . 62.44 110.086 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.97 123.29 20.64 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.243 -0.889 . . . . 72.01 109.625 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -83.53 100.81 11.01 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.688 -1.597 . . . . 61.3 106.688 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.6 t -100.77 92.97 5.32 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.862 0.839 . . . . 65.24 112.517 -172.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -61.03 129.92 43.82 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.566 -1.197 . . . . 72.44 108.843 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.53 -48.42 67.05 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.422 -0.955 . . . . 73.01 108.422 -177.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.84 71.38 10.66 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.523 -0.917 . . . . 75.44 108.523 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -74.28 123.72 25.08 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.337 -1.301 . . . . 75.23 108.262 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.2 t -90.22 -166.62 1.63 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.183 -0.673 . . . . 71.42 109.183 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 57.6 tttm 74.73 81.33 0.11 Allowed 'General case' 0 C--O 1.244 0.764 0 C-N-CA 125.308 1.443 . . . . 75.04 110.886 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 41.4 tp -159.44 -48.55 0.05 Allowed 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.061 -1.829 . . . . 74.4 106.061 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 N--CA 1.436 -1.15 0 CA-C-N 114.208 -1.36 . . . . 74.2 107.645 174.333 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 47.2 ttp . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 107.094 -1.447 . . . . 75.31 107.094 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 74.07 155.28 0.16 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.583 1.153 . . . . 55.52 112.264 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 30' ' ' VAL . 43.7 mt-10 61.12 -164.99 0.23 Allowed 'General case' 0 C--N 1.341 0.215 0 O-C-N 124.325 1.016 . . . . 70.43 110.092 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.557 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -49.09 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 125.766 1.627 . . . . 75.14 110.254 168.263 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.536 HG12 ' H ' ' A' ' 32' ' ' THR . 37.5 t -104.41 113.76 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 108.106 -1.072 . . . . 71.14 108.106 177.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 13.1 ptm180 -92.65 8.58 38.48 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.3 0.571 . . . . 75.41 110.294 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.536 ' H ' HG12 ' A' ' 30' ' ' VAL . 8.7 m -122.45 129.66 52.27 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.804 0.811 . . . . 62.32 111.972 -177.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 33' ' ' LEU . 2.8 mp -110.46 141.29 43.77 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.339 -1.356 . . . . 74.12 107.339 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.671 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 11.4 p90 -101.51 128.01 47.94 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.252 -1.388 . . . . 63.0 107.252 172.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.4 t -106.76 118.32 54.27 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.623 0 N-CA-C 107.783 -1.191 . . . . 62.31 107.783 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.8 p -127.46 163.05 24.94 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.106 -0.702 . . . . 51.32 109.106 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.22 33.58 10.51 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.709 -0.956 . . . . 61.21 110.709 -174.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.7 mt -96.4 140.39 22.18 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.988 -1.116 . . . . 70.32 107.988 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -65.37 161.4 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 C-N-CA 121.315 1.344 . . . . 64.22 109.952 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -70.46 -8.77 11.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.79 0.805 . . . . 72.24 110.315 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -124.27 40.45 3.73 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 108.224 -1.028 . . . . 72.23 108.224 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.9 tp -60.53 125.34 16.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.115 -0.948 . . . . 74.34 109.451 173.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.606 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 26.1 mmmt -90.48 138.04 27.08 Favored Pre-proline 0 C--N 1.296 -1.757 0 N-CA-C 106.8 -1.555 . . . . 71.51 106.8 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.5 -25.07 77.48 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.485 2.123 . . . . 74.12 112.784 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 14.5 ptt180 -74.21 -27.66 60.9 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 116.012 -0.54 . . . . 74.53 111.396 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 30.5 mt-10 -62.87 -47.44 83.32 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.129 0.49 . . . . 73.24 109.964 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 99.7 mt -62.16 -45.3 94.05 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.283 -0.871 . . . . 63.14 109.803 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.682 ' CZ ' ' HD3' ' B' ' 95' ' ' PRO . 0.0 OUTLIER -60.01 -43.4 95.24 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.494 -0.776 . . . . 75.41 112.123 178.616 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 98.6 mt -64.36 -44.24 92.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.071 0.462 . . . . 74.33 110.221 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.429 ' O ' ' HD2' ' A' ' 53' ' ' PRO . 27.9 tp -66.72 -39.37 87.97 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.92 -1.036 . . . . 71.01 110.976 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -86.9 -4.49 59.18 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 114.566 1.321 . . . . 74.34 114.566 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 17.7 mtp180 -60.15 -42.87 92.08 Favored Pre-proline 0 N--CA 1.485 1.29 0 N-CA-C 113.447 0.906 . . . . 74.45 113.447 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 50' ' ' LEU . 24.5 Cg_exo -69.04 -18.36 40.4 Favored 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 121.693 1.595 . . . . 63.51 112.018 173.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -89.73 92.26 8.98 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 122.097 0.951 . . . . 74.24 110.967 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -69.4 111.79 5.51 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.177 -1.374 . . . . 63.54 109.589 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.84 -26.56 2.07 Favored Glycine 0 C--N 1.291 -1.963 0 CA-C-N 115.469 -0.787 . . . . 72.22 111.143 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -57.69 116.34 3.36 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.544 0.738 . . . . 74.22 111.698 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -96.7 -48.85 5.33 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.151 0.5 . . . . 51.15 110.323 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.69 167.23 40.27 Favored Glycine 0 C--N 1.302 -1.307 0 C-N-CA 120.014 -1.089 . . . . 75.12 113.246 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.418 ' HB3' HG22 ' A' ' 73' ' ' VAL . 11.5 p -127.27 137.66 52.9 Favored 'General case' 0 C--O 1.251 1.145 0 C-N-CA 123.12 0.568 . . . . 62.03 111.652 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.1 mp -112.42 150.44 31.14 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.904 -1.147 . . . . 64.2 107.904 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.0 mm -125.35 142.0 43.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 117.975 0.352 . . . . 73.12 110.091 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.561 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -133.99 107.73 7.96 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.52 -0.918 . . . . 72.02 108.52 178.307 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.2 130.37 43.62 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.315 -0.624 . . . . 75.23 109.315 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.9 m -129.38 164.0 24.57 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 106.405 -1.702 . . . . 75.34 106.405 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.41 -37.24 16.53 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.008 1.114 . . . . 74.13 114.008 -176.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -94.56 -41.6 9.25 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.285 0.565 . . . . 72.31 112.071 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -163.86 153.88 12.89 Favored Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 115.456 -0.793 . . . . 64.43 109.367 -170.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -78.27 118.2 4.27 Favored 'Trans proline' 0 N--CA 1.429 -2.309 0 C-N-CA 121.992 1.795 . . . . 71.24 109.939 170.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.37 159.58 2.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.973 -1.121 . . . . 71.22 107.973 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.72 157.46 20.45 Favored Glycine 0 C--N 1.298 -1.555 0 C-N-CA 118.688 -1.72 . . . . 61.43 113.683 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.68 109.73 15.56 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.948 -1.501 . . . . 73.44 106.948 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.418 HG22 ' HB3' ' A' ' 60' ' ' SER . 72.7 t -103.23 128.98 55.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 CA-C-N 116.044 -0.525 . . . . 64.35 110.155 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 mp -105.85 128.43 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 115.799 -0.637 . . . . 74.24 109.964 -178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 4.7 m-85 -109.07 153.41 23.7 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.682 -1.145 . . . . 73.34 110.242 175.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -67.09 -27.98 67.8 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.867 -1.061 . . . . 71.33 112.066 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.3 m -134.88 144.86 47.76 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 109.537 -0.542 . . . . 64.14 109.537 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.557 ' NE ' ' HA ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -75.85 -24.75 55.79 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.959 -0.564 . . . . 73.35 110.11 -178.045 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.37 -36.56 71.49 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.817 -0.808 . . . . 64.21 108.817 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.41 -37.05 62.84 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 114.261 -1.336 . . . . 74.44 110.195 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.64 78.1 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.012 -0.594 . . . . 63.14 111.177 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.75 -33.15 74.28 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.698 -0.401 . . . . 74.41 111.758 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.83 -39.82 66.27 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 120.637 0.256 . . . . 75.32 111.195 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.31 -43.11 92.08 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 116.275 -0.421 . . . . 74.21 110.896 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.402 ' CD ' ' HA ' ' A' ' 104' ' ' GLU . 20.3 pttp -70.84 -30.28 66.65 Favored 'General case' 0 C--O 1.198 -1.631 0 C-N-CA 119.03 -1.068 . . . . 72.41 111.945 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -62.82 -31.4 72.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.381 0.61 . . . . 72.34 110.096 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.83 -36.57 21.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 116.041 -0.527 . . . . 55.12 111.427 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.556 ' O ' HG22 ' A' ' 91' ' ' ILE . 96.5 mt -93.98 -10.83 32.36 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 115.361 1.615 . . . . 54.42 115.361 -174.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.77 115.08 18.23 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 118.502 -1.279 . . . . 73.54 111.202 176.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.51 19.4 13.92 Favored Glycine 0 N--CA 1.421 -2.331 0 C-N-CA 120.515 -0.85 . . . . 73.22 111.211 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 88' ' ' LEU . 16.5 tt -102.04 125.33 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.04 0 N-CA-C 106.86 -1.533 . . . . 75.33 106.86 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -78.28 129.04 34.58 Favored 'General case' 0 C--N 1.257 -3.422 0 N-CA-C 109.303 -0.629 . . . . 55.03 109.303 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -72.68 -30.22 64.06 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.714 -1.13 . . . . 74.54 109.824 -172.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.597 ' HB2' ' CB ' ' A' ' 97' ' ' ASN 0.277 9.7 m-20 -150.62 124.63 4.47 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 105.765 -1.939 . . . . 24.45 105.765 177.674 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.466 ' HD3' ' CZ ' ' B' ' 48' ' ' TYR . 52.3 Cg_exo -63.0 -19.01 68.09 Favored 'Trans proline' 0 CA--C 1.555 1.535 0 CA-C-N 121.127 1.438 . . . . 72.5 111.272 170.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -78.12 -23.53 47.8 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.272 1.029 . . . . 73.43 110.707 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.597 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 22.0 t-20 -107.6 141.38 22.92 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 107.336 -1.357 . . . . 75.31 107.336 -172.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.429 ' HD2' ' OD1' ' A' ' 97' ' ' ASN . 73.5 Cg_endo -76.07 7.25 3.36 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 122.522 2.148 . . . . 72.01 111.726 176.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -88.31 126.18 35.05 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.141 -0.936 . . . . 74.2 109.921 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.2 p -115.25 141.92 47.38 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.529 -0.915 . . . . 54.11 108.529 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.3 tp -89.14 132.58 34.75 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.411 -0.589 . . . . 43.5 109.411 -176.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -134.56 122.53 22.5 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.095 0.558 . . . . 74.52 109.727 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -116.02 132.82 56.54 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.273 -0.64 . . . . 71.31 109.273 177.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.671 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 34.7 tt0 -146.24 168.49 20.93 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.223 -1.769 . . . . 71.52 106.223 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -68.02 138.2 55.66 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 120.133 1.333 . . . . 74.34 110.646 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.07 160.22 31.42 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.298 -0.864 . . . . 74.3 111.491 -176.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -63.29 -25.39 68.29 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.521 -1.218 . . . . 64.14 110.379 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.1 130.66 29.39 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 114.554 -1.203 . . . . 62.35 108.948 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 30' ' ' VAL . 1.7 m-20 -82.44 121.35 26.62 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.322 -1.732 . . . . 73.4 106.322 176.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.4 t -132.91 151.99 51.96 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 119.46 -0.896 . . . . 61.24 111.293 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -77.55 153.99 32.81 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.841 -1.54 . . . . 75.5 106.841 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.13 -40.2 86.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.051 -0.722 . . . . 72.42 109.051 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.89 100.54 8.09 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.493 -0.776 . . . . 53.25 110.38 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.7 107.11 4.99 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 105.668 -1.975 . . . . 63.33 105.668 174.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.1 m -70.87 126.31 29.22 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 123.615 0.572 . . . . 72.22 110.529 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.83 145.21 40.79 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.146 -0.479 . . . . 72.02 110.042 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.0 mt -123.03 145.11 48.8 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.79 -0.641 . . . . 64.43 109.729 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--N 1.301 -1.51 0 N-CA-C 108.615 -0.883 . . . . 54.15 108.615 178.604 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 49.1 ttm . . . . . 0 CA--C 1.51 -0.565 0 N-CA-C 107.72 -1.215 . . . . 73.02 107.72 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -104.5 112.01 24.9 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 114.026 1.121 . . . . 61.02 114.026 -168.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -149.13 -173.99 4.52 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 103.316 -2.846 . . . . 72.14 103.316 173.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.608 ' HA ' ' HD3' ' B' ' 78' ' ' ARG . 33.3 mt-10 -74.55 91.92 2.34 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 105.907 -1.886 . . . . 71.21 105.907 171.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.512 ' HB ' ' CD1' ' B' ' 105' ' ' PHE . 40.8 t -105.77 110.19 30.39 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.513 0 N-CA-C 105.005 -2.22 . . . . 74.24 105.005 176.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.468 ' NH2' ' HA ' ' B' ' 76' ' ' ASP . 17.1 ptm180 -101.05 11.72 39.03 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 122.019 0.914 . . . . 72.31 109.221 -177.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' THR . . . . . 0.473 HG21 HG22 ' B' ' 110' ' ' THR . 51.9 m -124.13 114.92 20.31 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.959 -1.019 . . . . 74.25 109.348 172.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' B' ' 85' ' ' LYS . 4.4 mp -96.87 140.48 31.36 Favored 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 107.857 -1.164 . . . . 74.23 107.857 -176.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' B' ' 104' ' ' GLU 0.262 28.0 p90 -102.83 110.63 22.61 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 117.534 -1.666 . . . . 73.33 109.127 175.005 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.444 HG22 ' HG ' ' B' ' 103' ' ' LEU . 40.5 t -97.49 125.88 50.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-N 113.736 -1.574 . . . . 74.53 108.634 -176.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 19.1 p -131.32 170.76 14.19 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.945 -0.571 . . . . 60.41 109.658 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.36 5.2 57.11 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.721 -0.952 . . . . 41.23 110.721 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.719 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 63.8 mt -84.34 120.01 73.86 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 106.515 -1.661 . . . . 74.13 106.515 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.56 175.84 6.56 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.577 1.518 . . . . 75.14 111.425 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.436 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 13.2 p -65.54 -19.82 26.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.957 0.884 . . . . 31.12 110.149 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -107.32 39.51 1.88 Allowed 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.141 -0.936 . . . . 74.11 108.599 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 tp -68.62 121.32 17.67 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 N-CA-C 109.044 -0.724 . . . . 74.11 109.044 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.418 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 16.3 mmmt -89.11 138.55 28.95 Favored Pre-proline 0 C--N 1.287 -2.112 0 N-CA-C 106.545 -1.65 . . . . 71.0 106.545 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.29 -29.48 86.2 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 122.333 2.022 . . . . 64.04 112.065 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.576 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 14.2 ptt180 -63.49 -31.94 73.25 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 114.818 -1.083 . . . . 63.43 112.17 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.418 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 36.9 mt-10 -63.02 -49.26 75.31 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.824 0.345 . . . . 74.05 110.374 -177.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.15 -43.46 91.75 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.724 -0.671 . . . . 75.32 109.969 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.69 ' O ' ' HG3' ' B' ' 52' ' ' ARG . 0.4 OUTLIER -59.94 -43.38 94.99 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.031 -0.986 . . . . 75.12 112.298 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.39 -42.51 75.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.854 0.359 . . . . 70.02 110.274 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 24.6 tp -64.93 -41.45 95.52 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.108 -0.951 . . . . 72.44 111.087 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -88.67 1.87 54.29 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 113.944 1.09 . . . . 73.55 113.944 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.69 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 17.4 mtp180 -62.19 -46.38 90.95 Favored Pre-proline 0 CA--C 1.558 1.262 0 N-CA-C 113.593 0.96 . . . . 75.01 113.593 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -68.0 -19.46 45.75 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 121.853 1.702 . . . . 62.54 112.421 175.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -81.89 98.15 8.38 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.007 0.908 . . . . 73.53 110.789 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -70.91 110.11 5.44 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 113.898 -1.501 . . . . 75.12 110.764 -177.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.38 -15.42 4.18 Favored Glycine 0 N--CA 1.423 -2.233 0 CA-C-N 114.401 -1.272 . . . . 74.2 111.537 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -56.47 115.66 2.64 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.155 0.502 . . . . 71.12 111.424 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -93.49 -50.79 5.26 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-N 115.634 -0.712 . . . . 70.32 109.864 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.33 -179.17 47.5 Favored Glycine 0 C--N 1.29 -2.007 0 C-N-CA 120.527 -0.844 . . . . 53.15 111.671 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.2 p -136.9 137.99 40.21 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 123.311 0.644 . . . . 61.01 109.836 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 52.8 tp -120.36 123.81 43.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.591 -1.263 . . . . 73.05 107.591 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.63 144.96 8.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 109.929 -0.397 . . . . 54.12 109.929 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.456 ' HA ' ' HE3' ' B' ' 63' ' ' LYS . 1.6 tpmt? -133.43 108.56 8.74 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.039 -1.097 . . . . 74.12 108.039 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.19 108.85 3.31 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.91 -0.587 . . . . 74.13 109.603 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 20.9 m -100.06 156.71 17.03 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 105.872 -1.899 . . . . 53.52 105.872 175.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.09 -37.35 3.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.597 1.159 . . . . 74.1 113.885 -174.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -101.34 -46.12 5.12 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 119.677 -0.809 . . . . 70.54 112.469 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.719 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 4.0 pt20 -142.55 136.66 14.72 Favored Pre-proline 0 C--N 1.288 -2.095 0 CA-C-O 120.985 0.422 . . . . 73.34 112.035 -170.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.436 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 19.1 Cg_exo -64.34 108.88 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.393 2.729 . . . . 55.44 110.537 170.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 33.8 m -87.64 160.63 2.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.251 -1.018 . . . . 64.34 108.251 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.55 121.19 2.89 Favored Glycine 0 CA--C 1.481 -2.062 0 C-N-CA 119.163 -1.494 . . . . 64.12 112.68 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.12 108.83 19.46 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.198 -1.408 . . . . 73.11 107.198 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 86.0 t -95.9 125.23 48.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-N 115.72 -0.673 . . . . 72.44 110.396 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 3.5 mp -96.91 127.32 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 CA-C-N 115.064 -0.971 . . . . 73.31 108.907 -176.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -109.38 158.14 18.22 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.426 -0.806 . . . . 75.31 110.647 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' ASP . . . . . 0.468 ' HA ' ' NH2' ' B' ' 31' ' ' ARG . 18.0 t70 -79.93 -29.53 39.77 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 113.941 -1.482 . . . . 73.01 111.777 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 9.2 m -135.57 153.9 51.53 Favored 'General case' 0 N--CA 1.417 -2.098 0 C-N-CA 119.238 -0.985 . . . . 75.35 112.107 -168.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' ARG . . . . . 0.608 ' HD3' ' HA ' ' B' ' 29' ' ' GLU . 7.3 tpt85 -63.51 -42.62 98.47 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.477 -1.238 . . . . 75.5 109.856 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.11 -17.61 62.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.191 -1.368 . . . . 75.34 109.679 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.69 -47.5 4.52 Favored Glycine 0 CA--C 1.488 -1.646 0 CA-C-N 114.113 -1.403 . . . . 52.24 109.902 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.22 -46.68 87.81 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 114.498 -0.851 . . . . 70.55 111.752 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.16 -31.33 72.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.602 0.593 . . . . 74.33 112.602 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.74 -39.47 24.15 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 120.804 -0.358 . . . . 70.13 110.691 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.95 -42.36 85.37 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.059 -0.519 . . . . 72.24 111.427 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.431 ' HB3' HD23 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -73.51 -27.67 61.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 120.308 -0.557 . . . . 73.41 110.9 -177.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -76.15 -39.73 54.3 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.239 -0.437 . . . . 54.13 110.362 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.08 -43.89 61.23 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 120.848 0.356 . . . . 52.51 111.874 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.507 ' O ' HG22 ' B' ' 91' ' ' ILE . 97.1 mt -87.05 -14.11 42.46 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 115.684 1.735 . . . . 74.05 115.684 -172.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -78.5 113.92 16.95 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 117.729 -1.588 . . . . 73.44 111.57 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.95 18.22 9.0 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.383 -0.913 . . . . 63.34 111.353 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.507 HG22 ' O ' ' B' ' 88' ' ' LEU . 15.1 tt -101.59 136.92 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.91 0 N-CA-C 108.086 -1.079 . . . . 61.35 108.086 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.468 ' NH1' ' HA ' ' B' ' 98' ' ' PRO . 15.6 mmt180 -64.97 130.21 42.56 Favored 'General case' 0 C--N 1.278 -2.541 0 C-N-CA 124.109 0.964 . . . . 61.02 108.602 175.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -75.13 -27.51 59.8 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.01 -1.478 . . . . 63.31 107.01 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.62 126.43 3.51 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 103.375 -2.824 . . . . 52.14 103.375 168.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 95' ' ' PRO . . . . . 0.682 ' HD3' ' CZ ' ' A' ' 48' ' ' TYR . 69.6 Cg_endo -71.88 -8.4 22.93 Favored 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 122.235 1.957 . . . . 73.14 114.342 -171.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -84.49 -21.81 30.47 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.05 -0.722 . . . . 64.04 109.05 -177.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -108.98 142.44 25.52 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.329 -0.989 . . . . 65.34 108.329 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.468 ' HA ' ' NH1' ' B' ' 92' ' ' ARG . 49.1 Cg_exo -62.25 -3.92 4.63 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 123.151 2.567 . . . . 42.3 113.525 172.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.93 117.03 6.99 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-O 121.653 0.74 . . . . 75.12 109.855 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 42.5 p -121.56 150.07 42.19 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.566 -0.743 . . . . 71.32 109.906 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 22.7 tp -85.95 123.42 31.26 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 106.411 -1.7 . . . . 72.32 106.411 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.97 113.17 16.14 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.842 -1.17 . . . . 75.41 107.842 -172.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.444 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.7 mp -112.59 136.62 51.92 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.537 -0.756 . . . . 72.32 110.271 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.489 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 42.4 tt0 -144.94 167.52 22.44 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.937 -1.505 . . . . 72.25 106.937 175.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 105' ' ' PHE . . . . . 0.512 ' CD1' ' HB ' ' B' ' 30' ' ' VAL . 40.1 m-85 -76.64 135.07 39.14 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.277 -0.638 . . . . 74.12 109.277 177.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.53 163.48 26.87 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.462 0.649 . . . . 65.11 111.194 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -76.57 -20.64 56.6 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 122.187 0.994 . . . . 44.11 108.895 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.06 124.3 27.36 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.879 -1.055 . . . . 74.43 110.956 -174.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.479 HD21 ' HA ' ' B' ' 30' ' ' VAL . 81.7 m-20 -82.94 136.21 34.64 Favored 'General case' 0 CA--C 1.475 -1.904 0 N-CA-C 107.68 -1.23 . . . . 74.11 107.68 173.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.473 HG22 HG21 ' B' ' 32' ' ' THR . 12.0 t -135.25 152.51 51.6 Favored 'General case' 0 C--N 1.268 -2.978 0 N-CA-C 108.652 -0.87 . . . . 72.13 108.652 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -93.65 147.82 22.67 Favored 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 104.867 -2.271 . . . . 74.1 104.867 169.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -43.65 97.35 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.763 -0.829 . . . . 43.44 108.763 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.16 93.97 9.52 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.296 -1.372 . . . . 73.41 107.296 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -93.93 113.05 24.98 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.57 -1.641 . . . . 72.34 106.57 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -62.74 125.75 25.0 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-O 121.317 0.579 . . . . 54.52 111.458 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 116' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' B' ' 116' ' ' LYS . 0.1 OUTLIER -83.89 112.9 20.56 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.518 -0.764 . . . . 71.31 109.582 -177.588 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 71.3 mt -86.79 95.64 9.91 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.987 -1.116 . . . . 71.52 107.987 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--N 1.297 -1.702 0 CA-C-N 115.535 -0.757 . . . . 71.44 109.255 -175.436 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.511 -0.553 0 CA-C-O 121.009 0.433 . . . . 75.31 109.958 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -108.53 -69.04 0.87 Allowed 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 116.41 -0.359 . . . . 73.32 111.067 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.251 32.8 mt-10 -92.23 71.59 5.33 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 118.355 -1.338 . . . . 71.22 113.539 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.429 ' HB2' ' HD3' ' A' ' 31' ' ' ARG 0.311 9.2 mm-40 -57.72 135.3 56.75 Favored 'General case' 0 N--CA 1.406 -2.643 0 CA-C-N 113.321 -1.763 . . . . 74.1 106.457 169.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.89 107.89 3.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 103.169 -2.901 . . . . 72.43 103.169 168.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' A' ' 75' ' ' PHE . 20.4 ptt180 -133.27 9.81 4.08 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 119.788 -0.765 . . . . 73.53 112.016 -167.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 75.0 m -105.36 119.98 40.43 Favored 'General case' 0 C--N 1.264 -3.149 0 C-N-CA 119.744 -0.782 . . . . 73.43 109.536 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.512 HD11 ' O ' ' A' ' 81' ' ' ALA . 76.1 mt -99.28 142.11 31.19 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.418 -1.327 . . . . 71.23 107.418 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 15.8 p90 -103.54 116.79 33.04 Favored 'General case' 0 C--N 1.281 -2.4 0 C-N-CA 117.994 -1.482 . . . . 74.02 107.989 175.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.423 HG22 ' HG ' ' A' ' 103' ' ' LEU . 29.7 t -97.36 118.98 44.8 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.311 -1.366 . . . . 54.11 107.311 -178.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 32.7 p -120.92 166.08 14.31 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 109.041 -0.725 . . . . 72.33 109.041 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA2' ' NE2' ' A' ' 99' ' ' GLN . . . 97.0 18.5 29.19 Favored Glycine 0 N--CA 1.425 -2.038 0 C-N-CA 120.524 -0.846 . . . . 72.31 111.643 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -93.89 112.0 55.24 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.456 -0.942 . . . . 51.33 108.456 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.71 156.97 25.15 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.402 2.068 . . . . 72.1 110.774 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.99 -4.24 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 CA-C-O 122.109 0.957 . . . . 73.42 112.141 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -100.93 14.19 32.66 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.85 -0.796 . . . . 64.31 108.85 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.25 129.18 11.95 Favored 'Isoleucine or valine' 0 C--O 1.254 1.297 0 C-N-CA 124.859 1.263 . . . . 64.55 110.122 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -126.85 104.77 23.19 Favored Pre-proline 0 C--N 1.286 -2.19 0 N-CA-C 106.705 -1.591 . . . . 74.32 106.705 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -39.98 -17.49 0.05 OUTLIER 'Trans proline' 0 N--CA 1.515 2.777 1 C-N-CA 126.53 4.82 . . . . 62.34 118.14 -165.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.503 ' HG3' ' CE2' ' B' ' 93' ' ' PHE . 0.0 OUTLIER -60.59 -32.56 71.67 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 112.892 0.701 . . . . 71.11 112.892 176.586 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.645 ' HG3' ' CZ ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -69.39 -42.84 74.59 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.371 -0.931 . . . . 75.43 109.605 -177.063 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.37 -45.25 94.03 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 115.817 -0.628 . . . . 64.21 109.394 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.642 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 72.9 t80 -56.52 -49.13 75.67 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.952 -1.022 . . . . 72.31 111.42 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 93.2 mt -66.8 -35.97 81.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.915 0.388 . . . . 62.1 110.772 -176.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.5 tp -73.83 -41.97 61.54 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.279 -0.873 . . . . 63.53 112.327 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -87.81 -11.39 48.11 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 115.936 1.828 . . . . 73.15 115.936 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 52.8 mtp180 -60.58 -41.97 85.8 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 113.793 1.034 . . . . 75.3 113.793 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -64.82 -19.23 64.18 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.696 1.597 . . . . 54.34 112.387 175.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -81.76 89.65 6.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.233 0.539 . . . . 64.24 110.214 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.29 109.79 1.68 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.746 -0.835 . . . . 64.33 108.746 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.6 -17.67 3.7 Favored Glycine 0 N--CA 1.419 -2.485 0 CA-C-N 114.823 -1.081 . . . . 71.31 110.759 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -63.38 112.74 2.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.821 0.31 . . . . 63.41 110.538 175.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -90.55 -48.07 7.31 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.09 0.471 . . . . 73.41 110.437 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.8 179.21 48.78 Favored Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.203 -0.999 . . . . 74.44 112.558 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 p -138.33 136.84 36.8 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.803 0.335 . . . . 73.54 110.933 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 mp -123.02 121.16 35.39 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.558 -0.904 . . . . 73.53 108.558 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.76 138.56 20.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 120.853 0.358 . . . . 64.41 111.204 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -121.14 135.64 55.13 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.527 1.131 . . . . 71.23 108.254 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.63 126.89 33.31 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.74 0.781 . . . . 75.3 112.913 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 18.9 m -130.12 148.56 51.97 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 104.254 -2.499 . . . . 65.33 104.254 172.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -42.24 -48.86 4.99 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.849 1.26 . . . . 72.41 114.366 -169.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 67' ' ' ARG . 24.1 mtm180 -105.3 -5.05 20.87 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.187 -1.005 . . . . 71.01 113.184 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.476 ' O ' ' HB ' ' A' ' 65' ' ' THR . 11.2 pt20 -161.79 117.1 1.28 Allowed Pre-proline 0 C--N 1.312 -1.03 0 C-N-CA 120.114 -0.634 . . . . 71.23 112.515 -171.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -73.53 105.52 2.01 Favored 'Trans proline' 0 N--CA 1.432 -2.089 0 C-N-CA 122.243 1.962 . . . . 72.03 108.107 169.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.5 152.16 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.119 -0.697 . . . . 71.14 109.119 -176.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.53 120.4 4.4 Favored Glycine 0 CA--C 1.477 -2.293 0 C-N-CA 118.642 -1.742 . . . . 61.23 112.805 -175.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.52 103.72 16.15 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.454 -1.313 . . . . 71.41 107.454 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.2 t -98.09 120.96 48.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 114.888 -1.051 . . . . 72.3 110.097 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 110' ' ' THR . 5.9 tt -94.96 127.74 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.258 0 CA-C-N 115.019 -0.991 . . . . 71.44 110.187 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.532 ' O ' ' HD2' ' A' ' 31' ' ' ARG . 84.4 m-85 -107.46 165.86 11.09 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 114.616 -1.175 . . . . 72.34 110.086 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.95 -48.21 78.88 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 125.209 1.404 . . . . 75.42 112.48 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 p -143.65 163.88 32.0 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 111.755 0.28 . . . . 74.44 111.755 -172.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.509 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -68.44 -36.05 78.48 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.216 0.531 . . . . 74.43 110.65 -177.685 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.64 -28.87 63.0 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.228 -0.896 . . . . 73.42 108.962 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.11 -39.5 37.17 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.443 -1.253 . . . . 70.31 110.407 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.512 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -65.35 -46.1 81.56 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.878 -0.661 . . . . 65.43 111.534 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -63.38 -37.63 88.03 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.448 -0.501 . . . . 74.24 112.082 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.2 -38.47 85.38 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.249 -0.432 . . . . 72.12 110.106 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.86 -39.52 83.77 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.808 -0.633 . . . . 45.01 110.56 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -59.09 -47.97 83.32 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.685 -0.689 . . . . 62.42 111.836 177.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -66.1 -25.16 66.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.194 0.521 . . . . 61.43 111.864 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.17 -39.72 32.72 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.872 -0.604 . . . . 43.31 111.514 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.472 ' O ' HG22 ' A' ' 91' ' ' ILE . 98.2 mt -102.2 -25.33 13.73 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 116.896 2.184 . . . . 73.41 116.896 -173.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -65.46 114.75 5.06 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-N 120.327 1.421 . . . . 75.25 110.18 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.58 10.18 19.87 Favored Glycine 0 N--CA 1.421 -2.32 0 CA-C-N 115.405 -0.816 . . . . 45.02 111.606 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 88' ' ' LEU . 14.7 tt -93.9 130.33 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.41 0 N-CA-C 109.107 -0.701 . . . . 64.32 109.107 177.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.536 ' CG ' HG22 ' A' ' 100' ' ' THR . 79.0 mtt180 -76.15 141.35 41.92 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-O 121.396 0.617 . . . . 73.14 111.757 173.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.645 ' CZ ' ' HG3' ' A' ' 46' ' ' GLU . 26.3 t80 -70.74 -34.46 71.9 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.509 -1.678 . . . . 60.33 109.108 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.558 ' HB2' ' CB ' ' A' ' 97' ' ' ASN . 6.5 m-20 -140.41 142.14 28.32 Favored Pre-proline 0 C--N 1.294 -1.821 0 N-CA-C 102.666 -3.087 . . . . 52.33 102.666 175.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.67 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 28.1 Cg_endo -64.03 -22.7 67.9 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 121.469 1.446 . . . . 75.05 110.898 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -92.08 -8.16 46.62 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.65 -1.159 . . . . 74.13 110.545 -176.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.558 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 34.2 t30 -103.51 120.66 51.03 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 108.977 -0.749 . . . . 64.1 108.977 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.89 -19.55 35.38 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.669 2.246 . . . . 74.12 111.858 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.429 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 6.9 tp60 -68.09 114.65 6.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.337 -0.986 . . . . 72.45 108.337 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.536 HG22 ' CG ' ' A' ' 92' ' ' ARG . 69.1 p -107.56 154.83 20.84 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.066 -0.716 . . . . 74.01 109.066 -175.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.7 mp -86.29 118.29 25.64 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.803 -0.443 . . . . 74.11 109.803 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -110.76 121.25 44.87 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.725 -1.954 . . . . 74.11 105.725 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.423 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.5 mp -105.27 138.17 41.89 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.151 -1.055 . . . . 71.25 108.151 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.579 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 32.6 tt0 -146.02 163.38 35.41 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.843 -1.91 . . . . 64.2 105.843 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -70.55 137.91 50.5 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 119.22 0.918 . . . . 74.44 110.37 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.9 141.15 40.66 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 108.15 -1.056 . . . . 73.21 108.15 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -80.19 10.04 4.93 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 122.233 1.016 . . . . 74.2 110.692 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -162.38 132.17 4.54 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.986 -1.857 . . . . 75.45 105.986 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -78.36 158.54 28.75 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.413 0.625 . . . . 62.33 111.648 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.422 ' O ' HD12 ' A' ' 74' ' ' ILE . 6.7 t -110.47 149.53 30.17 Favored 'General case' 0 N--CA 1.399 -2.977 0 N-CA-C 104.35 -2.463 . . . . 51.52 104.35 169.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -133.11 137.68 46.41 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 108.935 -0.765 . . . . 62.5 108.935 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 92.3 mmm -79.6 -15.56 57.42 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.017 0.437 . . . . 73.14 110.897 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.48 112.35 22.84 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.196 -0.911 . . . . 54.02 109.247 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.38 110.23 1.38 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.162 -1.051 . . . . 74.41 108.162 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.8 m -68.87 99.96 1.12 Allowed 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 123.697 0.623 . . . . 55.2 110.148 -176.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -66.87 141.49 57.64 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.183 -0.917 . . . . 51.15 111.779 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.9 mt -87.83 -20.32 26.23 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.094 -0.957 . . . . 74.22 108.47 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.422 -1.833 0 CA-C-N 114.912 -1.04 . . . . 60.02 108.241 178.052 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 48.8 ttm . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.851 0.358 . . . . 73.54 110.773 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -95.5 -77.6 0.47 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.339 0.59 . . . . 63.41 111.696 -175.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -116.14 99.51 7.29 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.103 -0.499 . . . . 64.04 111.047 -176.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -88.8 132.9 34.44 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 105.189 -2.152 . . . . 72.01 105.189 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.526 ' HA ' HD21 ' B' ' 109' ' ' ASN . 57.8 t -80.41 109.09 14.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.49 -1.67 . . . . 73.13 106.49 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -140.04 15.06 2.45 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 115.042 -0.981 . . . . 64.23 111.855 -171.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' B' ' 74' ' ' ILE . 35.3 m -105.84 125.76 51.37 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 108.727 -0.842 . . . . 65.23 108.727 174.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.455 HD11 ' O ' ' B' ' 81' ' ' ALA . 85.4 mt -100.83 143.11 31.38 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.75 -0.833 . . . . 71.13 108.75 178.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.615 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 4.6 p90 -104.44 118.47 36.68 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 106.798 -1.556 . . . . 71.24 106.798 171.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 39.8 t -97.27 111.95 28.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 N-CA-C 107.206 -1.405 . . . . 64.32 107.206 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 36.2 p -109.92 162.47 14.48 Favored 'General case' 0 C--N 1.276 -2.59 0 N-CA-C 109.07 -0.715 . . . . 63.35 109.07 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.83 24.82 12.47 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.428 -0.891 . . . . 70.03 111.887 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.573 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 83.4 mt -101.78 113.59 65.81 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 107.757 -1.201 . . . . 75.43 107.757 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.49 169.79 2.14 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.856 2.371 . . . . 54.35 112.35 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 6.6 p -72.96 -2.41 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 122.115 0.959 . . . . 63.42 110.458 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' B' ' 43' ' ' LYS . 22.3 t0 -105.01 10.65 34.03 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 114.954 -1.021 . . . . 55.33 109.563 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.94 129.88 19.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-O 121.811 0.815 . . . . 72.42 109.449 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' B' ' 45' ' ' ARG . 47.7 mmtm -130.0 107.05 16.56 Favored Pre-proline 0 C--N 1.277 -2.564 0 N-CA-C 106.449 -1.686 . . . . 64.05 106.449 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -41.48 -16.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.478 1 C-N-CA 126.372 4.715 . . . . 52.42 117.774 -165.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.557 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 9.8 ptt180 -65.51 -24.72 67.2 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 122.642 0.377 . . . . 75.23 111.855 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.553 ' HG3' ' CE1' ' B' ' 93' ' ' PHE . 0.0 OUTLIER -76.03 -41.83 49.72 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 119.214 -0.994 . . . . 75.12 108.888 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.41 ' HG ' ' OE1' ' B' ' 46' ' ' GLU . 96.4 mt -62.17 -37.19 84.28 Favored 'General case' 0 C--O 1.211 -0.939 0 N-CA-C 108.859 -0.793 . . . . 74.22 108.859 175.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.67 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 63.1 t80 -58.53 -49.78 76.15 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.846 -1.07 . . . . 55.13 110.488 176.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.62 -33.98 74.97 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.862 0.363 . . . . 64.22 110.738 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 36.5 tp -74.58 -45.92 42.08 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.566 -0.743 . . . . 72.24 112.467 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -92.13 -7.31 48.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.951 1.093 . . . . 70.01 113.951 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.594 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 20.6 ttt180 -65.99 -43.13 56.29 Favored Pre-proline 0 CA--C 1.56 1.333 0 N-CA-C 112.416 0.525 . . . . 71.41 112.416 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.22 -15.43 46.09 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 121.76 1.64 . . . . 53.42 111.862 175.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -85.68 88.87 7.6 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.419 -0.585 . . . . 71.41 109.419 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.1 112.85 5.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.453 -0.794 . . . . 73.11 109.978 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.84 -26.5 1.62 Allowed Glycine 0 N--CA 1.426 -1.985 0 CA-C-N 113.578 -1.646 . . . . 72.41 109.49 -174.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -50.89 119.03 3.54 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.413 1.085 . . . . 72.14 111.905 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.493 ' HB2' HG23 ' B' ' 74' ' ' ILE . 6.6 mm-40 -93.06 -46.69 7.33 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 115.928 -0.578 . . . . 52.42 109.443 176.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.85 171.99 37.4 Favored Glycine 0 C--N 1.297 -1.614 0 C-N-CA 120.455 -0.879 . . . . 72.2 112.325 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.9 p -127.11 137.34 52.98 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.192 0.52 . . . . 61.11 111.061 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' LEU . . . . . 0.409 HD22 HG22 ' B' ' 110' ' ' THR . 5.1 mp -117.87 109.72 16.88 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.376 -0.972 . . . . 72.22 108.376 175.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.74 131.95 39.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.729 -0.841 . . . . 60.33 108.729 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -130.97 119.57 22.27 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 109.293 -0.632 . . . . 75.24 109.293 -176.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.51 134.63 57.26 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.213 1.005 . . . . 73.41 110.873 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 2.5 m -130.08 158.58 39.24 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 105.663 -1.977 . . . . 71.04 105.663 175.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.89 -40.66 10.36 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.065 0.946 . . . . 72.11 113.29 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 -104.75 -41.66 5.6 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 119.58 -0.848 . . . . 72.35 112.735 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.573 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 14.1 pt20 -153.36 126.44 4.13 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 120.717 -0.393 . . . . 74.1 111.55 -173.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' B' ' 38' ' ' LEU . 51.9 Cg_exo -56.85 124.37 16.09 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.004 2.469 . . . . 63.11 111.393 171.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.24 141.22 14.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 115.114 -0.948 . . . . 72.33 108.679 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.73 120.31 5.21 Favored Glycine 0 C--O 1.205 -1.702 0 C-N-CA 119.139 -1.505 . . . . 74.24 112.46 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -90.37 102.94 15.67 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.642 -1.244 . . . . 74.31 107.642 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.17 112.38 37.49 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 CA-C-N 115.569 -0.741 . . . . 70.31 109.182 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.493 HG23 ' HB2' ' B' ' 58' ' ' GLU . 12.4 tt -97.18 138.01 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 CA-C-N 115.528 -0.76 . . . . 71.21 110.549 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -112.61 160.04 18.26 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.04 -0.982 . . . . 75.43 109.341 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.24 -31.61 72.53 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.863 -0.608 . . . . 63.22 112.224 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 26.4 p -128.88 152.56 48.38 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 121.74 0.781 . . . . 61.51 111.904 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 78' ' ' ARG . . . . . 0.832 ' H ' ' HD3' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -63.09 -39.05 93.57 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.514 -1.221 . . . . 73.43 109.954 177.255 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 79' ' ' ALA . . . . . 0.404 ' N ' ' HG2' ' B' ' 78' ' ' ARG . . . -79.51 -19.9 48.52 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.184 -1.043 . . . . 63.02 108.184 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.56 -44.75 31.76 Favored Glycine 0 C--N 1.307 -1.067 0 N-CA-C 109.227 -1.549 . . . . 72.4 109.227 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.455 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -67.97 -37.4 81.48 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.381 -0.909 . . . . 50.31 109.476 176.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -55.42 -52.51 63.33 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.066 -0.97 . . . . 65.23 110.576 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.08 89.76 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.525 -0.761 . . . . 74.23 110.994 -176.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.21 -39.96 82.28 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.351 -0.84 . . . . 44.41 110.563 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -62.84 -42.49 99.76 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.603 -0.726 . . . . 44.12 111.841 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -62.37 -37.37 85.42 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.257 0.551 . . . . 74.23 111.25 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.19 -45.34 33.7 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 115.581 -0.736 . . . . 63.15 111.767 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.497 ' O ' HG22 ' B' ' 91' ' ' ILE . 90.7 mt -93.33 -21.05 19.8 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 117.477 2.399 . . . . 72.01 117.477 -170.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.86 114.01 7.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 120.787 1.631 . . . . 73.22 112.343 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 113.9 1.56 24.01 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.885 -0.598 . . . . 64.04 112.255 176.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.497 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.2 tt -86.02 136.15 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 CA-C-O 121.137 0.494 . . . . 61.24 110.184 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.516 ' HA ' HG22 ' B' ' 100' ' ' THR . 22.2 mmt180 -59.26 139.02 57.38 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 125.17 1.388 . . . . 72.52 110.045 173.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.553 ' CE1' ' HG3' ' B' ' 46' ' ' GLU . 34.9 t80 -80.77 -32.28 35.54 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.491 -1.67 . . . . 74.14 106.491 173.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.667 ' HB2' ' HB3' ' B' ' 97' ' ' ASN . 9.5 m-20 -147.47 143.31 17.83 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 101.493 -3.521 . . . . 73.53 101.493 174.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 95' ' ' PRO . . . . . 0.632 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 74.0 Cg_endo -78.33 -15.88 13.98 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 CA-C-N 121.952 1.733 . . . . 61.2 109.619 175.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -79.63 -25.34 41.43 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.299 -1.319 . . . . 74.13 109.629 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 97' ' ' ASN . . . . . 0.667 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . 38.0 t30 -109.69 129.9 23.4 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 107.744 -1.206 . . . . 75.11 107.744 -174.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.73 -2.81 6.97 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 123.156 2.57 . . . . 61.31 113.241 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -77.45 122.41 25.16 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.723 0.773 . . . . 73.32 110.267 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.516 HG22 ' HA ' ' B' ' 92' ' ' ARG . 17.9 p -121.72 159.81 25.82 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 115.045 -0.979 . . . . 75.2 108.582 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.406 HD13 HG23 ' B' ' 91' ' ' ILE . 4.4 mp -93.05 134.81 34.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.405 -0.961 . . . . 75.53 108.405 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -123.99 116.85 23.52 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.044 -1.836 . . . . 71.22 106.044 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mp -106.49 136.37 46.38 Favored 'General case' 0 C--N 1.289 -2.034 0 O-C-N 123.752 0.657 . . . . 72.41 110.354 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.615 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 37.1 tt0 -145.4 163.97 32.95 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 105.744 -1.947 . . . . 74.15 105.744 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -70.47 144.93 51.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 119.493 1.042 . . . . 71.45 110.133 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.69 158.18 27.03 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 107.996 -1.113 . . . . 73.12 107.996 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -81.91 -11.32 58.96 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.009 0.909 . . . . 63.01 109.523 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -149.06 130.49 14.77 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.664 -1.153 . . . . 52.23 107.948 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.526 HD21 ' HA ' ' B' ' 30' ' ' VAL . 54.2 m-80 -74.15 113.99 11.98 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.432 0.634 . . . . 72.42 110.479 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.409 HG22 HD22 ' B' ' 61' ' ' LEU . 23.5 m -96.2 102.17 13.92 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.336 -1.357 . . . . 70.03 107.336 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -93.73 146.59 23.74 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.964 -1.016 . . . . 75.11 111.196 -169.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 92.3 mmm -73.15 -53.3 11.34 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.25 -1.018 . . . . 23.35 108.25 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.9 90.14 8.22 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 107.738 -1.208 . . . . 72.11 107.738 176.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -53.31 122.87 10.44 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.265 -0.88 . . . . 74.02 111.263 -175.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 39.3 m -58.61 119.84 7.79 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.555 0.693 . . . . 70.43 109.531 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -101.48 121.5 42.07 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.713 -1.13 . . . . 73.21 111.139 -167.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 4.5 tt -71.85 -59.27 2.84 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 106.714 -1.588 . . . . 73.34 106.714 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 C--N 1.306 -1.313 0 N-CA-C 107.785 -1.191 . . . . 54.42 107.785 175.767 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 109.211 -0.662 . . . . 75.31 109.211 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -69.0 -56.77 6.75 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 113.596 0.961 . . . . 74.42 113.596 -162.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -103.05 31.97 3.96 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.797 0.808 . . . . 65.3 112.101 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -90.97 151.38 21.1 Favored 'General case' 0 N--CA 1.411 -2.39 0 N-CA-C 107.072 -1.455 . . . . 74.31 107.072 175.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 32' ' ' THR . 26.1 t -91.61 121.88 42.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.693 0 CA-C-N 116.13 -0.486 . . . . 71.03 109.691 -170.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.519 ' NH2' ' HG2' ' A' ' 111' ' ' LYS . 40.9 mtm180 -85.97 7.38 24.6 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-O 120.926 0.393 . . . . 72.21 110.507 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.531 ' H ' HG12 ' A' ' 30' ' ' VAL . 33.6 m -134.2 129.77 36.23 Favored 'General case' 0 C--N 1.259 -3.363 0 CA-C-O 121.821 0.82 . . . . 64.53 112.054 -173.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.429 HD13 ' HB3' ' A' ' 85' ' ' LYS . 88.4 mt -103.7 139.07 39.46 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.73 -1.211 . . . . 52.35 107.73 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -98.76 112.14 24.31 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.773 -1.566 . . . . 74.31 106.773 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.515 HG22 ' HG ' ' A' ' 103' ' ' LEU . 29.1 t -96.99 120.63 46.58 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 CA-C-N 113.79 -1.55 . . . . 71.11 107.739 -174.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 p -126.38 163.71 22.68 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 115.228 -0.896 . . . . 62.23 109.548 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.64 27.84 10.14 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.927 -0.869 . . . . 73.25 110.927 -173.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.563 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 96.8 mt -97.26 119.35 63.27 Favored Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 107.96 -1.126 . . . . 73.42 107.96 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.99 153.22 6.57 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.734 2.289 . . . . 72.14 111.283 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.512 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 8.6 p -70.07 -1.98 2.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.875 0.845 . . . . 70.11 112.013 -172.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -127.2 31.34 5.25 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-O 121.553 0.692 . . . . 65.15 109.974 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.14 149.06 6.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 N-CA-C 113.613 0.968 . . . . 74.02 113.613 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.529 ' HG2' ' CZ ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -102.74 144.53 28.8 Favored Pre-proline 0 C--N 1.279 -2.476 0 CA-C-N 113.883 -1.508 . . . . 73.41 109.615 176.091 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.45 -24.98 79.21 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 122.63 2.22 . . . . 74.32 113.325 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.529 ' CZ ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -84.14 -11.42 56.63 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 118.441 -1.304 . . . . 72.31 111.427 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.475 ' HG2' ' HG2' ' B' ' 46' ' ' GLU . 35.7 mt-10 -63.77 -39.92 95.44 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.703 0.763 . . . . 75.3 109.358 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.3 mt -67.32 -31.53 71.88 Favored 'General case' 0 C--O 1.209 -1.064 0 CA-C-N 115.226 -0.897 . . . . 73.45 110.077 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.6 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 42.0 t80 -65.32 -46.81 78.82 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.786 -0.643 . . . . 74.22 110.863 178.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 69.0 mt -64.92 -40.01 94.39 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.114 -0.494 . . . . 64.31 110.884 -176.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.6 tp -81.42 -38.96 25.65 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.43 -0.804 . . . . 61.55 112.543 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -95.43 -3.52 46.79 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.285 1.217 . . . . 72.43 114.285 -173.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -61.49 -44.55 92.56 Favored Pre-proline 0 CA--C 1.563 1.452 0 N-CA-C 112.799 0.666 . . . . 64.33 112.799 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.68 -2.39 12.39 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 121.393 1.395 . . . . 53.25 112.854 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -91.53 95.35 9.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 122.336 1.065 . . . . 72.4 110.945 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -63.79 109.63 1.8 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 113.078 -1.874 . . . . 74.23 110.519 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.72 -23.56 3.23 Favored Glycine 0 N--CA 1.422 -2.252 0 CA-C-N 114.858 -1.065 . . . . 70.55 111.002 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -55.32 114.85 1.97 Allowed 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.498 0.719 . . . . 74.52 111.959 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -97.86 -58.91 1.87 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.661 -0.699 . . . . 75.11 110.376 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -158.26 -177.0 30.94 Favored Glycine 0 C--N 1.295 -1.726 0 C-N-CA 120.898 -0.668 . . . . 73.45 111.869 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.7 p -148.76 140.65 23.76 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 123.032 0.533 . . . . 64.34 110.349 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.3 tp -120.87 122.01 39.33 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.41 -0.589 . . . . 75.24 109.41 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.403 HG23 ' HB2' ' A' ' 69' ' ' PRO . 44.4 mm -93.57 133.76 33.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 109.233 -0.654 . . . . 74.43 109.233 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -135.3 113.27 11.1 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 121.021 0.438 . . . . 62.25 110.374 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -67.97 124.43 23.34 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.362 0.601 . . . . 61.4 110.897 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.8 m -116.7 162.05 18.27 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 105.637 -1.986 . . . . 71.21 105.637 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.51 -34.95 3.53 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.163 1.172 . . . . 74.11 114.163 -175.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -95.62 -46.79 6.49 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 112.75 0.648 . . . . 70.43 112.75 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 4.2 pt20 -156.82 157.08 30.62 Favored Pre-proline 0 C--N 1.295 -1.773 0 CA-C-N 115.792 -0.64 . . . . 64.02 109.459 -170.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.512 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 74.5 Cg_endo -80.46 120.64 4.05 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 122.667 2.245 . . . . 72.3 110.711 171.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.91 161.62 2.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.239 -1.022 . . . . 71.54 108.239 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.91 120.93 2.92 Favored Glycine 0 CA--C 1.484 -1.85 0 C-N-CA 118.762 -1.685 . . . . 74.11 112.579 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -88.11 104.62 16.85 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.519 -1.289 . . . . 75.41 107.519 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.6 t -99.25 123.26 51.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 CA-C-N 115.922 -0.581 . . . . 62.32 109.799 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 tt -101.54 131.85 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 115.38 -0.827 . . . . 73.14 110.962 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 74.2 m-85 -115.51 146.83 41.34 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.434 -1.257 . . . . 74.01 107.639 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -79.23 -24.07 43.31 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.708 0.766 . . . . 74.42 110.493 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.6 m -109.96 140.65 43.73 Favored 'General case' 0 N--CA 1.392 -3.373 0 CA-C-N 115.498 -0.774 . . . . 73.24 108.964 -175.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.1 mmt-85 -73.38 -33.15 64.87 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.417 -1.327 . . . . 73.14 107.417 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.2 -19.23 61.77 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.499 -1.682 . . . . 44.12 109.071 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.91 -42.34 6.39 Favored Glycine 0 CA--C 1.487 -1.661 0 N-CA-C 109.606 -1.398 . . . . 63.44 109.606 -177.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.413 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -64.71 -47.45 78.27 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 114.902 -0.649 . . . . 73.35 111.115 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.56 -36.11 82.82 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.147 -0.621 . . . . 73.45 111.991 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.37 78.12 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 120.737 0.303 . . . . 44.35 110.854 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.36 -42.28 79.45 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.947 -0.569 . . . . 73.43 110.843 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.429 ' HB3' HD13 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -71.62 -28.78 64.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 120.245 -0.582 . . . . 73.51 111.801 -178.395 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -71.31 -41.38 69.97 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 120.592 0.234 . . . . 64.34 111.542 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.05 -41.42 50.74 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.252 0.464 . . . . 75.24 112.252 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.477 ' O ' HG22 ' A' ' 91' ' ' ILE . 97.4 mt -95.93 1.71 53.06 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 115.646 1.721 . . . . 70.24 115.646 -173.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -79.09 114.39 18.0 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 116.822 -1.951 . . . . 75.31 111.066 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.17 12.18 34.58 Favored Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 110.27 -1.132 . . . . 61.12 110.27 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.3 tt -82.38 134.46 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.911 0 N-CA-C 109.116 -0.698 . . . . 52.42 109.116 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.461 ' NH1' ' HA ' ' A' ' 98' ' ' PRO . 26.2 mmt180 -60.91 121.07 11.44 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 107.954 -1.128 . . . . 72.4 107.954 171.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -75.37 -27.06 58.99 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.856 -1.535 . . . . 73.14 106.856 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 97' ' ' ASN . 12.0 t70 -148.07 126.1 5.91 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 103.212 -2.884 . . . . 70.24 103.212 174.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.561 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 69.2 Cg_endo -71.81 -16.44 29.62 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.426 1.417 . . . . 61.32 114.732 -175.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -93.07 -22.14 19.3 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.34 0.591 . . . . 74.13 110.174 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 48.9 t-20 -91.27 132.49 33.77 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.158 -1.423 . . . . 65.43 107.158 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.461 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 35.6 Cg_endo -67.75 -1.8 7.43 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.587 2.192 . . . . 70.33 113.0 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.75 113.74 10.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.793 -0.817 . . . . 62.45 108.793 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.9 p -115.7 147.53 40.77 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.915 -0.584 . . . . 74.13 109.687 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.6 tp -94.83 125.04 39.23 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 116.073 -0.512 . . . . 73.44 109.84 -174.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -120.54 126.35 50.11 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.194 -0.669 . . . . 75.01 109.194 176.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.515 ' HG ' HG22 ' A' ' 35' ' ' VAL . 7.0 mp -104.5 127.18 52.15 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 107.841 -1.17 . . . . 62.42 107.841 176.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -136.04 163.29 30.66 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 107.731 -1.211 . . . . 71.03 107.731 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.505 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 33.0 m-85 -78.7 134.83 37.06 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 119.048 0.84 . . . . 74.44 110.323 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.39 165.0 25.42 Favored 'General case' 0 N--CA 1.428 -1.532 0 O-C-N 123.668 0.605 . . . . 43.35 109.403 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -86.79 -6.87 58.68 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-O 121.946 0.879 . . . . 53.11 109.661 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.5 134.22 23.61 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.073 -0.967 . . . . 75.33 108.83 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' A' ' 30' ' ' VAL . 3.3 m-20 -76.72 124.97 28.46 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.165 -1.421 . . . . 53.12 107.165 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.9 t -88.01 163.22 16.41 Favored 'General case' 0 N--CA 1.409 -2.476 0 C-N-CA 118.113 -1.435 . . . . 75.53 108.907 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.519 ' HG2' ' NH2' ' A' ' 31' ' ' ARG . 51.3 mtmt -130.09 132.16 46.04 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.303 -1.369 . . . . 72.33 107.303 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 91.9 mtp -67.32 116.13 7.75 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.374 -0.602 . . . . 73.12 109.374 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.69 104.11 15.78 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.685 -0.689 . . . . 61.34 111.369 -175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -88.67 93.77 9.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 107.429 -1.323 . . . . 71.3 107.429 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.2 m -61.11 133.0 55.55 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.609 -1.178 . . . . 71.25 112.782 -173.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -111.3 70.17 0.71 Allowed 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 114.909 -1.041 . . . . 64.14 110.327 175.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.7 tp -88.35 -33.08 18.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.026 -1.842 . . . . 65.23 106.026 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.416 -2.153 0 N-CA-C 104.857 -2.275 . . . . 65.11 104.857 173.272 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.565 0.222 . . . . 73.41 110.412 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.84 -34.15 51.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.442 0.639 . . . . 63.24 111.009 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -95.86 74.79 3.12 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.807 -0.812 . . . . 74.54 108.807 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.591 ' HB3' ' HG2' ' B' ' 78' ' ' ARG . 2.6 mm-40 -161.04 -179.36 7.45 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.551 -0.907 . . . . 62.43 108.551 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.56 HG12 ' H ' ' B' ' 32' ' ' THR . 17.5 t -105.74 127.53 60.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 123.132 0.27 . . . . 74.43 110.345 -169.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.572 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 82.8 mtm180 -96.22 0.04 50.52 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-O 121.286 0.565 . . . . 53.34 110.74 175.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' THR . . . . . 0.56 ' H ' HG12 ' B' ' 30' ' ' VAL . 25.0 m -111.24 128.72 56.02 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-O 121.511 0.672 . . . . 72.43 112.549 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.5 HD11 ' O ' ' B' ' 81' ' ' ALA . 91.1 mt -104.57 146.37 29.0 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.43 -0.952 . . . . 73.42 108.43 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.6 ' CE1' ' HB2' ' B' ' 104' ' ' GLU . 27.9 p90 -104.6 115.18 29.89 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.187 -1.412 . . . . 51.2 107.187 172.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.53 115.45 37.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 CA-C-N 113.917 -1.492 . . . . 62.31 107.859 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 35.7 p -119.53 171.4 8.38 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.272 -0.876 . . . . 74.24 109.272 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 86.93 25.01 35.83 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.38 -1.088 . . . . 52.51 110.38 -173.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 95.7 mt -94.77 114.71 64.2 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 107.701 -1.222 . . . . 60.23 107.701 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.23 157.62 1.86 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.762 2.308 . . . . 74.33 111.968 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 7.2 p -63.35 -17.52 19.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.424 0.63 . . . . 75.21 112.111 -173.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -120.35 42.38 2.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.682 0.753 . . . . 62.34 109.948 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.421 HG12 ' HB3' ' B' ' 38' ' ' LEU . 2.5 pp -60.89 135.02 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.563 -1.255 . . . . 73.3 110.801 169.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.41 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 23.4 mmmt -94.19 144.14 27.55 Favored Pre-proline 0 C--N 1.266 -3.025 0 N-CA-C 106.68 -1.6 . . . . 71.15 106.68 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.38 -20.7 69.44 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.352 2.035 . . . . 70.11 113.176 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.487 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 0.0 OUTLIER -87.34 -10.74 51.38 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 118.966 -1.094 . . . . 71.02 111.999 -179.403 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.475 ' HG2' ' HG2' ' A' ' 46' ' ' GLU . 33.5 mt-10 -67.07 -39.0 86.74 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.426 0.631 . . . . 53.23 109.811 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 90.9 mt -68.86 -29.97 68.39 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-N 115.445 -0.798 . . . . 54.43 109.393 176.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.561 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 39.9 t80 -66.99 -47.99 69.83 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.438 -0.801 . . . . 74.2 110.682 177.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 82.3 mt -63.69 -39.77 95.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.29 0.567 . . . . 72.21 110.327 -177.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 33.6 tp -76.82 -39.49 51.16 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.106 -0.952 . . . . 73.0 112.489 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -95.25 -0.87 52.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 114.175 1.176 . . . . 74.41 114.175 -176.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -63.13 -42.98 79.83 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 112.479 0.548 . . . . 53.45 112.479 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -65.93 -21.63 56.82 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.09 1.86 . . . . 42.21 112.226 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -92.24 88.23 6.39 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 121.753 0.787 . . . . 75.21 109.57 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -80.51 115.49 20.06 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 122.439 1.114 . . . . 71.24 111.361 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.01 -28.41 0.73 Allowed Glycine 0 C--N 1.284 -2.354 0 CA-C-N 112.657 -2.065 . . . . 71.2 108.742 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -48.6 121.88 4.99 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.818 1.247 . . . . 75.23 111.775 174.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.47 ' HB2' HG23 ' B' ' 74' ' ' ILE . 12.0 mm-40 -92.83 -56.71 2.9 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.546 -0.909 . . . . 72.3 108.546 174.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.54 -175.88 39.57 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 115.063 -0.971 . . . . 72.15 112.035 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 12.5 p -136.99 138.17 40.24 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 122.735 0.414 . . . . 61.1 111.086 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 57.8 tp -114.39 127.22 55.73 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.289 -1.004 . . . . 63.34 108.289 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 50.8 mm -93.99 143.37 11.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.232 -0.655 . . . . 61.45 109.232 -176.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -137.96 108.23 6.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.645 -0.872 . . . . 63.31 108.645 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -66.94 128.98 38.4 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.312 0.577 . . . . 74.15 109.834 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.8 m -125.72 158.15 35.57 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 104.584 -2.376 . . . . 73.14 104.584 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.68 -29.24 59.02 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.554 0.946 . . . . 74.24 113.554 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -85.92 -39.28 17.12 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.729 0.64 . . . . 75.4 112.729 177.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 3.7 pt20 -174.32 155.1 2.16 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 115.886 -0.597 . . . . 74.34 109.691 -169.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.447 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 58.4 Cg_endo -80.28 115.82 3.25 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 C-N-CA 122.357 2.038 . . . . 74.24 110.657 171.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -87.92 162.63 2.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.405 -0.961 . . . . 53.04 108.405 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.06 122.7 3.4 Favored Glycine 0 CA--C 1.491 -1.464 0 C-N-CA 118.689 -1.72 . . . . 73.41 113.555 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -87.93 108.99 19.46 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.541 -1.281 . . . . 72.12 107.541 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 67.9 t -103.54 120.66 53.9 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 115.698 -0.683 . . . . 74.33 110.285 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.526 HD12 ' O ' ' B' ' 110' ' ' THR . 3.6 tt -96.54 130.82 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 115.169 -0.923 . . . . 75.32 110.06 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 75' ' ' PHE . . . . . 0.572 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 90.0 m-85 -111.13 156.56 21.18 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.906 -1.043 . . . . 65.44 108.326 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.74 -36.15 82.91 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.015 0.436 . . . . 60.54 112.089 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 33.0 p -131.84 163.41 28.33 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.411 0.624 . . . . 73.02 112.64 -175.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' ARG . . . . . 0.591 ' HG2' ' HB3' ' B' ' 29' ' ' GLU . 4.4 mpt_? -73.94 -34.06 64.17 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 108.734 -0.839 . . . . 75.14 108.734 176.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.82 -19.84 64.29 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.01 -0.996 . . . . 72.41 109.564 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.16 -46.12 6.0 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.224 -1.151 . . . . 54.11 110.224 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.5 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -62.88 -45.1 94.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.3 -0.45 . . . . 63.24 111.705 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' B' ' 78' ' ' ARG . 9.6 pt-20 -63.56 -36.11 82.71 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 120.916 -0.314 . . . . 72.15 111.299 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.43 -41.85 79.72 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 120.839 0.352 . . . . 52.14 110.312 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.44 -42.31 87.84 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.72 -0.673 . . . . 63.41 111.227 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -70.96 -39.29 72.63 Favored 'General case' 0 C--O 1.203 -1.35 0 C-N-CA 119.407 -0.917 . . . . 72.41 110.999 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -65.68 -31.9 73.16 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.174 0.511 . . . . 61.43 110.764 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.06 -40.27 17.02 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 112.309 0.485 . . . . 71.0 112.309 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.529 ' O ' HG22 ' B' ' 91' ' ' ILE . 87.3 mt -100.99 -13.11 18.4 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 116.348 1.981 . . . . 70.03 116.348 -172.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -76.17 113.69 14.0 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 117.401 -1.72 . . . . 73.13 112.043 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 113.36 6.46 21.91 Favored Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 120.545 -0.836 . . . . 65.31 112.055 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.529 HG22 ' O ' ' B' ' 88' ' ' LEU . 14.9 tt -97.95 144.67 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.954 0 N-CA-C 107.117 -1.438 . . . . 72.33 107.117 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.418 ' HG2' HG22 ' B' ' 100' ' ' THR . 81.6 mtt180 -79.42 138.36 37.6 Favored 'General case' 0 C--N 1.26 -3.296 0 CA-C-O 121.244 0.545 . . . . 71.23 111.471 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -69.17 -35.51 76.37 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 113.811 -1.54 . . . . 74.55 108.599 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' B' ' 97' ' ' ASN . 1.1 m-20 -129.36 130.13 23.3 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 102.306 -3.22 . . . . 73.04 102.306 172.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 95' ' ' PRO . . . . . 0.6 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 27.9 Cg_endo -61.29 -30.66 88.32 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.316 2.011 . . . . 75.33 113.39 -177.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -94.19 15.21 17.85 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 123.339 0.656 . . . . 65.24 111.276 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' ASN . . . . . 0.495 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . 46.3 t30 -127.18 128.14 24.16 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.698 -0.853 . . . . 72.34 108.698 -177.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.55 9.82 1.15 Allowed 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.927 2.418 . . . . 53.33 113.25 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -83.83 110.34 18.28 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.894 -1.521 . . . . 70.32 106.894 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.462 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 65.5 p -102.72 141.09 36.11 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.798 -0.761 . . . . 74.3 110.365 -175.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 24.7 tp -86.17 126.1 33.99 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.272 -1.01 . . . . 72.14 108.272 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -131.05 121.68 25.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 109.437 -0.579 . . . . 62.44 109.437 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.68 116.59 32.27 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.126 -0.943 . . . . 72.51 109.829 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.6 ' HB2' ' CE1' ' B' ' 34' ' ' PHE . 40.2 mm-40 -122.51 170.33 10.09 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.545 -1.65 . . . . 73.11 106.545 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -81.72 137.43 35.38 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 119.184 0.902 . . . . 72.35 109.738 176.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.66 151.13 27.72 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.176 0.512 . . . . 74.51 111.41 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -87.23 12.09 12.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.715 0.769 . . . . 41.23 109.996 177.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -137.69 115.42 11.38 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 107.524 -1.287 . . . . 70.25 107.524 177.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -84.05 106.96 16.11 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.464 -1.68 . . . . 71.34 106.464 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.526 ' O ' HD12 ' B' ' 74' ' ' ILE . 28.8 m -75.82 139.23 41.64 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.245 -0.434 . . . . 51.32 110.834 -173.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -114.55 90.73 3.41 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.053 0.454 . . . . 61.03 110.64 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 86.4 mtp -85.09 90.28 7.82 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.901 -0.59 . . . . 64.24 110.633 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.41 148.85 22.54 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.722 -1.214 . . . . 71.53 107.722 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -73.75 112.0 9.44 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.177 -0.675 . . . . 72.22 109.177 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 36.1 t -81.87 111.03 17.7 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 115.836 -0.62 . . . . 72.0 109.932 -177.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -71.69 133.38 45.6 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.275 -0.875 . . . . 63.33 111.231 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 48.2 tp -73.84 -54.94 6.88 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 104.856 -2.275 . . . . 72.21 104.856 172.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 N--CA 1.431 -1.388 0 C-N-CA 127.447 2.299 . . . . 75.53 105.86 170.08 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' A' ' 105' ' ' PHE . 40.6 t . . . . . 0 N--CA 1.426 -1.667 0 N-CA-C 108.289 -1.004 . . . . 53.340000000000003 108.289 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 88.4 mtt180 -88.53 12.8 13.54 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.676 -0.693 . . . . 72.219999999999999 111.458 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.9 m -136.99 132.74 34.74 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 121.415 0.626 . . . . 60.310000000000002 112.462 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.4 mt -112.11 145.3 40.02 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.358 -0.979 . . . . 71.400000000000006 108.358 173.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.403 ' CE1' ' HB2' ' A' ' 104' ' ' GLU . 21.5 p90 -103.42 114.8 29.36 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 106.956 -1.498 . . . . 73.310000000000002 106.956 172.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.59 HG22 ' HG ' ' A' ' 103' ' ' LEU . 33.5 t -101.05 113.87 38.46 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 CA-C-N 114.144 -1.389 . . . . 64.230000000000004 108.643 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.6 p -111.4 171.61 7.38 Favored 'General case' 0 N--CA 1.41 -2.438 0 N-CA-C 109.104 -0.702 . . . . 64.519999999999996 109.104 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 88.04 29.13 21.27 Favored Glycine 0 N--CA 1.431 -1.652 0 C-N-CA 120.911 -0.661 . . . . 33.240000000000002 112.493 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 96.5 mt -93.07 125.83 53.39 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.671 -1.233 . . . . 72.230000000000004 107.671 173.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -50.21 153.41 6.91 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.484 2.123 . . . . 70.209999999999994 110.783 172.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.453 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 11.3 p -65.94 -12.91 14.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 123.152 0.581 . . . . 62.420000000000002 112.09 -172.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -126.77 41.67 3.47 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.904 0.859 . . . . 53.350000000000001 109.373 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 pp -59.17 145.5 10.84 Favored 'Isoleucine or valine' 0 C--O 1.25 1.115 0 C-N-CA 119.271 -0.972 . . . . 72.310000000000002 112.52 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.451 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 70.6 mmtt -98.94 146.22 31.3 Favored Pre-proline 0 C--N 1.271 -2.813 0 N-CA-C 107.31 -1.367 . . . . 72.030000000000001 107.31 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -59.45 -24.53 75.15 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.381 2.054 . . . . 74.019999999999996 111.866 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.548 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . 13.9 ptt180 -78.13 -20.58 51.83 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.692 -0.686 . . . . 75.129999999999995 112.736 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 42.6 mt-10 -64.6 -38.74 92.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.221 0.534 . . . . 63.43 110.368 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -76.1 -22.17 55.86 Favored 'General case' 0 C--O 1.212 -0.907 0 CA-C-O 121.628 0.727 . . . . 65.450000000000003 109.934 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.508 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 62.9 t80 -73.5 -47.96 37.11 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.065 -0.97 . . . . 72.200000000000003 109.04 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.39 -38.84 74.75 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.655 -0.702 . . . . 75.430000000000007 110.175 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.9 tp -78.52 -37.08 43.92 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.46 -0.791 . . . . 61.420000000000002 112.719 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -97.05 1.04 49.65 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 118.898 -1.121 . . . . 63.229999999999997 113.598 -175.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -67.82 -42.93 36.44 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 114.049 1.129 . . . . 72.200000000000003 114.049 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -63.76 -20.11 68.17 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 121.478 1.452 . . . . 72.120000000000005 111.807 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -90.02 101.11 13.82 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 121.638 0.732 . . . . 74.200000000000003 110.834 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -64.41 110.4 2.26 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.345 -1.298 . . . . 65.200000000000003 110.642 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.47 -17.26 3.1 Favored Glycine 0 N--CA 1.425 -2.087 0 CA-C-N 115.015 -0.993 . . . . 62.149999999999999 113.326 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -62.4 107.9 1.01 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 118.001 0.901 . . . . 74.209999999999994 112.317 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -90.72 -43.92 9.8 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.49 -0.777 . . . . 74.409999999999997 110.648 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.91 171.88 43.29 Favored Glycine 0 C--N 1.301 -1.376 0 C-N-CA 120.797 -0.716 . . . . 54.439999999999998 111.674 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.8 p -138.57 137.34 36.91 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.85 0.325 . . . . 74.239999999999995 111.659 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.6 mp -112.83 121.63 45.27 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.561 -0.903 . . . . 65.349999999999994 108.561 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.5 mm -94.27 133.03 36.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 120.892 0.377 . . . . 74.319999999999993 110.14 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -118.06 106.88 13.35 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.708 -1.59 . . . . 73.519999999999996 106.708 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.73 131.19 42.77 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.893 -0.594 . . . . 73.150000000000006 109.663 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.591 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 18.8 m -129.7 153.01 48.58 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 104.486 -2.412 . . . . 72.310000000000002 104.486 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.5 -26.87 45.24 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 114.381 1.252 . . . . 42.450000000000003 114.381 -172.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 30.8 mmt180 -104.48 -25.64 12.71 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 113.268 0.84 . . . . 73.430000000000007 113.268 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.591 ' O ' ' HB ' ' A' ' 65' ' ' THR . 14.3 pt20 -172.55 136.54 0.82 Allowed Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.398 -0.593 . . . . 72.430000000000007 109.398 -173.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.455 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 44.8 Cg_endo -74.58 133.39 17.2 Favored 'Trans proline' 0 N--CA 1.43 -2.232 0 C-N-CA 121.956 1.771 . . . . 70.120000000000005 110.449 170.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m -101.78 143.54 14.5 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 N-CA-C 108.126 -1.065 . . . . 74.310000000000002 108.126 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.5 120.96 4.88 Favored Glycine 0 CA--C 1.479 -2.161 0 C-N-CA 119.807 -1.187 . . . . 73.109999999999999 112.719 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -87.69 102.8 14.99 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.769 -1.567 . . . . 72.519999999999996 106.769 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.9 t -97.69 123.8 50.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-N 114.984 -1.007 . . . . 65.319999999999993 110.036 -175.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 10.9 tt -95.86 131.51 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.108 0 CA-C-N 115.04 -0.982 . . . . 75.129999999999995 109.274 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.45 159.71 18.48 Favored 'General case' 0 N--CA 1.414 -2.25 0 CA-C-N 114.977 -1.01 . . . . 71.329999999999998 110.839 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -53.63 -44.93 69.93 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 125.646 1.578 . . . . 75.010000000000005 110.808 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.3 p -150.8 153.86 36.22 Favored 'General case' 0 N--CA 1.398 -3.067 0 CA-C-N 115.403 -0.817 . . . . 64.329999999999998 111.293 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -58.74 -42.58 89.12 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 125.158 1.383 . . . . 74.340000000000003 110.2 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.66 -18.73 64.26 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.897 -1.047 . . . . 74.510000000000005 109.394 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.25 -45.26 5.37 Favored Glycine 0 C--N 1.294 -1.766 0 CA-C-N 113.626 -1.625 . . . . 61.299999999999997 110.455 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.54 -45.02 95.39 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.998 0.919 . . . . 51.039999999999999 111.584 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.08 -26.92 68.76 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.286 -0.416 . . . . 63.439999999999998 111.844 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.5 -39.52 27.81 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.16 0.505 . . . . 72.010000000000005 109.878 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.95 85.96 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.684 -0.689 . . . . 43.149999999999999 111.021 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.419 ' CE ' ' HA ' ' A' ' 104' ' ' GLU . 14.0 ptmm? -68.38 -28.08 66.79 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.281 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -64.43 -36.23 83.5 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.658 0.599 . . . . 73.439999999999998 110.904 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.25 -38.64 17.38 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 120.977 0.418 . . . . 63.119999999999997 111.916 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.532 ' O ' HG22 ' A' ' 91' ' ' ILE . 95.6 mt -96.94 -5.43 37.98 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 115.571 1.693 . . . . 60.140000000000001 115.571 -171.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -78.75 114.93 18.1 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 117.086 -1.845 . . . . 54.329999999999998 110.889 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.34 14.65 29.86 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 110.746 -0.942 . . . . 64.239999999999995 110.746 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 88' ' ' LEU . 10.2 tt -84.7 126.04 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.875 0 CA-C-O 121.632 0.73 . . . . 55.140000000000001 109.413 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -63.93 111.78 2.64 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 105.84 -1.911 . . . . 73.310000000000002 105.84 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -71.71 -25.78 62.22 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.947 0.88 . . . . 73.109999999999999 109.262 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -161.29 117.8 1.37 Allowed Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 106.583 -1.636 . . . . 72.310000000000002 106.583 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.08 -28.81 86.39 Favored 'Trans proline' 0 N--CA 1.474 0.349 0 C-N-CA 122.161 1.907 . . . . 74.439999999999998 112.862 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -74.71 -24.7 58.79 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.275 0.56 . . . . 71.129999999999995 110.899 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -102.96 135.64 19.38 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.023 -1.473 . . . . 63.119999999999997 107.023 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.97 15.06 0.62 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.306 2.004 . . . . 72.400000000000006 112.341 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.404 ' HA ' ' OE1' ' A' ' 99' ' ' GLN . 5.9 tp60 -89.96 121.4 32.02 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.922 0.889 . . . . 72.439999999999998 110.334 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.483 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 66.2 p -114.59 142.47 46.39 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.128 -0.693 . . . . 73.010000000000005 109.128 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.9 tp -89.18 135.95 33.29 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.933 -0.766 . . . . 71.150000000000006 108.933 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -135.0 124.79 25.39 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.57 -0.529 . . . . 61.229999999999997 109.57 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.59 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.6 mp -110.84 118.33 35.84 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.059 -0.519 . . . . 63.439999999999998 109.866 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HA ' ' CE ' ' A' ' 85' ' ' LYS . 7.7 mm-40 -126.61 161.29 28.39 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.936 -0.765 . . . . 72.019999999999996 108.936 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.447 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 27.1 m-85 -69.94 139.17 52.84 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.36 -0.536 . . . . 54.539999999999999 109.922 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.52 160.66 29.28 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 121.121 0.486 . . . . 65.019999999999996 110.004 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -77.16 -13.65 59.91 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.454 -0.794 . . . . 73.540000000000006 110.127 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.38 136.67 16.64 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.025 -0.989 . . . . 62.229999999999997 109.449 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -70.96 113.0 7.56 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.239 -1.393 . . . . 43.32 107.239 173.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.432 -1.359 0 N-CA-C 108.486 -0.931 . . . . 64.230000000000004 108.486 -177.639 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.421 -1.883 0 N-CA-C 105.105 -2.183 . . . . 75.200000000000003 105.105 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -84.86 8.2 18.25 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 112.417 0.525 . . . . 61.340000000000003 112.417 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 28.9 m -127.85 129.27 46.66 Favored 'General case' 0 C--N 1.27 -2.857 0 C-N-CA 119.963 -0.695 . . . . 72.409999999999997 112.065 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -104.77 134.39 48.0 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.517 -1.29 . . . . 72.230000000000004 107.517 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.567 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 33.7 p90 -91.75 118.3 30.55 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 107.784 -1.191 . . . . 74.040000000000006 107.784 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.446 HG22 ' HG ' ' B' ' 103' ' ' LEU . 39.6 t -97.44 115.68 37.86 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 114.198 -1.364 . . . . 61.229999999999997 108.137 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 24.0 p -129.44 171.12 12.87 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 115.101 -0.954 . . . . 64.420000000000002 109.224 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 82.03 51.92 4.27 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 110.44 -1.064 . . . . 70.030000000000001 110.44 -173.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 95.7 mt -122.44 129.25 25.14 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.868 -1.16 . . . . 53.240000000000002 107.868 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -52.85 159.59 4.92 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 122.412 2.074 . . . . 72.109999999999999 110.978 171.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.68 -10.54 14.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.628 0.727 . . . . 74.120000000000005 111.301 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -127.02 40.83 3.64 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 122.158 0.98 . . . . 73.329999999999998 109.441 -176.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.451 ' O ' HD12 ' B' ' 42' ' ' ILE . 2.7 pp -64.46 134.19 29.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 118.686 -1.205 . . . . 71.530000000000001 110.666 170.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.416 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 74.1 mmtt -91.42 141.99 26.55 Favored Pre-proline 0 C--N 1.273 -2.734 0 N-CA-C 108.672 -0.862 . . . . 71.430000000000007 108.672 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -51.78 -32.16 44.94 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.85 2.367 . . . . 74.519999999999996 112.429 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.48 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 12.0 ptt180 -68.44 -26.57 65.58 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 112.426 0.528 . . . . 62.240000000000002 112.426 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.416 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 32.7 mt-10 -65.13 -42.7 93.63 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.327 0.584 . . . . 71.209999999999994 109.539 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.38 -36.6 81.68 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 115.397 -0.82 . . . . 74.200000000000003 109.489 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.486 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 76.2 t80 -61.01 -46.82 89.19 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.822 -1.081 . . . . 63.420000000000002 110.867 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 89.0 mt -66.62 -41.66 88.02 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.241 0.544 . . . . 55.049999999999997 109.826 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 29.2 tp -69.73 -44.2 70.77 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.667 -1.151 . . . . 72.329999999999998 112.117 -175.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -94.53 4.42 53.87 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 113.167 0.803 . . . . 61.329999999999998 113.167 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 28.2 ttt180 -69.5 -43.77 23.55 Favored Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 112.976 0.732 . . . . 75.150000000000006 112.976 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -76.23 -2.47 12.66 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 121.45 1.434 . . . . 74.439999999999998 112.033 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -94.6 103.12 15.06 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 121.833 0.825 . . . . 70.319999999999993 111.556 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -68.19 118.17 10.97 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 114.103 -1.408 . . . . 65.150000000000006 110.793 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' B' ' 75' ' ' PHE . . . 133.07 -19.7 4.33 Favored Glycine 0 C--N 1.281 -2.472 0 CA-C-N 115.005 -0.998 . . . . 73.519999999999996 112.695 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -58.4 113.22 1.87 Allowed 'General case' 0 C--O 1.242 0.672 0 CA-C-N 117.301 0.55 . . . . 70.420000000000002 111.663 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -95.46 -58.97 1.98 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.58 -0.736 . . . . 74.010000000000005 110.344 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.6 160.2 32.92 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 120.041 -1.076 . . . . 72.200000000000003 113.095 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.3 p -119.33 137.95 53.37 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 122.702 0.401 . . . . 62.420000000000002 110.814 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 66.9 tp -111.31 111.3 22.25 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.882 -1.155 . . . . 75.540000000000006 107.882 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 51.0 mm -94.61 136.38 26.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 109.732 -0.47 . . . . 63.409999999999997 109.732 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -133.19 114.84 14.3 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.477 -0.935 . . . . 74.439999999999998 108.477 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.06 113.95 8.63 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.959 -1.126 . . . . 75.150000000000006 107.959 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.9 m -105.93 167.56 9.71 Favored 'General case' 0 N--CA 1.403 -2.807 0 N-CA-C 107.023 -1.473 . . . . 72.530000000000001 107.023 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.76 -33.42 23.11 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.675 0.991 . . . . 71.120000000000005 113.675 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -105.18 -37.78 6.78 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 119.724 -0.79 . . . . 71.530000000000001 112.424 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -155.25 159.68 31.53 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 110.203 -0.295 . . . . 73.430000000000007 110.203 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.24 123.29 7.09 Favored 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.218 1.945 . . . . 65.329999999999998 109.636 167.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 35.9 m -97.58 156.84 3.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 107.461 -1.311 . . . . 64.239999999999995 107.461 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.03 121.94 2.58 Favored Glycine 0 C--O 1.203 -1.798 0 C-N-CA 118.237 -1.935 . . . . 50.329999999999998 113.492 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -88.42 108.36 19.33 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.78 -1.193 . . . . 60.539999999999999 107.78 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.62 120.11 53.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-N 116.184 -0.462 . . . . 74.109999999999999 110.473 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 11.8 tt -96.32 134.8 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 115.559 -0.746 . . . . 73.409999999999997 110.478 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' B' ' 56' ' ' GLY . 60.1 m-85 -111.29 149.58 30.87 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 114.621 -1.172 . . . . 74.200000000000003 109.821 179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -56.27 -34.35 66.34 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.727 1.211 . . . . 61.32 111.453 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 9.9 p -144.56 138.3 27.4 Favored 'General case' 0 N--CA 1.398 -3.027 0 CA-C-O 121.953 0.883 . . . . 73.400000000000006 110.634 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -25.57 59.03 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 114.494 -1.23 . . . . 75.209999999999994 110.453 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.1 -19.68 64.06 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.532 1.158 . . . . 73.329999999999998 108.654 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.26 -43.2 5.66 Favored Glycine 0 C--N 1.308 -1.0 0 CA-C-N 113.786 -1.552 . . . . 51.200000000000003 109.922 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.41 -37.64 78.55 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.989 0.916 . . . . 52.210000000000001 112.02 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.04 -34.53 76.41 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.864 0.364 . . . . 62.329999999999998 111.44 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.25 -38.12 27.43 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.295 0.569 . . . . 72.430000000000007 109.804 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.2 93.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.872 -1.058 . . . . 61.439999999999998 111.202 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -65.6 -41.01 93.28 Favored 'General case' 0 C--O 1.195 -1.815 0 CA-C-N 116.258 -0.428 . . . . 75.200000000000003 110.647 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -63.68 -24.73 67.9 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 112.359 0.503 . . . . 74.239999999999995 112.359 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.54 -36.02 33.67 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 120.811 0.339 . . . . 64.420000000000002 111.156 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.497 ' O ' HG22 ' B' ' 91' ' ' ILE . 98.6 mt -102.14 -19.92 14.93 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 115.222 1.564 . . . . 74.040000000000006 115.222 -174.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . 0.436 ' HB3' ' H ' ' B' ' 103' ' ' LEU 0.259 0.2 OUTLIER -75.65 113.95 13.67 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 118.92 -1.112 . . . . 62.350000000000001 112.616 -178.807 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.04 14.99 13.51 Favored Glycine 0 N--CA 1.41 -3.035 0 CA-C-N 115.554 -0.748 . . . . 61.399999999999999 111.74 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.497 HG22 ' O ' ' B' ' 88' ' ' LEU . 15.7 tt -95.93 133.89 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.977 0 N-CA-C 108.964 -0.754 . . . . 74.349999999999994 108.964 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' B' ' 92' ' ' ARG . 7.3 tpt180 -62.82 119.3 9.09 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 105.117 -2.179 . . . . 74.329999999999998 105.117 172.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -68.18 -31.12 70.44 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 108.418 -0.956 . . . . 74.310000000000002 108.418 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 45' ' ' ARG . 1.0 OUTLIER -166.47 137.42 2.76 Favored Pre-proline 0 N--CA 1.427 -1.616 0 N-CA-C 106.709 -1.589 . . . . 74.420000000000002 106.709 174.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.1 -2.81 12.88 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.132 1.888 . . . . 71.230000000000004 113.237 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -85.63 -24.92 26.91 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.75 0.786 . . . . 71.540000000000006 109.532 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' ASN . . . . . 0.544 ' OD1' ' HB2' ' B' ' 99' ' ' GLN . 6.6 t-20 -110.45 148.17 37.88 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 106.004 -1.85 . . . . 73.439999999999998 106.004 174.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.05 22.1 0.77 Allowed 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 122.529 2.153 . . . . 65.129999999999995 112.045 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' GLN . . . . . 0.544 ' HB2' ' OD1' ' B' ' 97' ' ' ASN . 5.5 tp60 -89.41 129.29 35.95 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.948 0.899 . . . . 63.219999999999999 110.802 -176.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.544 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 36.8 p -116.52 138.32 51.49 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.731 -0.47 . . . . 54.229999999999997 109.731 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 49.3 tp -86.09 131.1 34.33 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.045 -0.724 . . . . 73.120000000000005 109.045 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -135.82 122.63 21.15 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-O 120.834 0.35 . . . . 74.019999999999996 110.31 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.446 ' HG ' HG22 ' B' ' 35' ' ' VAL . 6.2 mp -108.27 116.27 31.66 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.841 -1.17 . . . . 74.219999999999999 107.841 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.567 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 7.4 tp10 -131.72 159.6 37.94 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.625 -1.62 . . . . 61.409999999999997 106.625 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -68.93 137.19 53.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 119.561 1.073 . . . . 71.319999999999993 110.859 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.63 164.28 26.46 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.92 -0.582 . . . . 74.439999999999998 110.232 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -84.72 -9.86 57.81 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.76 0.791 . . . . 71.310000000000002 109.114 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.44 130.09 19.09 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.208 -0.905 . . . . 63.240000000000002 109.892 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -70.26 104.55 2.69 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.854 -1.165 . . . . 64.409999999999997 107.854 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.423 -1.819 0 CA-C-N 115.665 -0.698 . . . . 62.310000000000002 109.57 -172.969 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.3 t . . . . . 0 N--CA 1.436 -1.126 0 N-CA-C 103.859 -2.645 . . . . 54.009999999999998 103.859 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 75' ' ' PHE . 26.6 ptt180 -129.64 7.97 5.32 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.793 -0.64 . . . . 73.519999999999996 112.461 -168.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.3 m -104.89 124.48 49.55 Favored 'General case' 0 C--N 1.266 -3.04 0 C-N-CA 119.77 -0.772 . . . . 70.120000000000005 109.236 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 93.7 mt -104.75 136.78 43.63 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.745 -1.205 . . . . 64.140000000000001 107.745 176.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.501 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 20.4 p90 -98.32 118.98 36.18 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.27 -1.382 . . . . 74.239999999999995 107.27 174.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.461 HG22 ' HG ' ' A' ' 103' ' ' LEU . 19.5 t -99.79 111.01 28.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 114.531 -1.213 . . . . 61.530000000000001 108.365 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.7 p -110.01 175.33 5.48 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 108.57 -0.9 . . . . 73.109999999999999 108.57 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 97.42 1.33 59.2 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.757 -0.735 . . . . 54.210000000000001 111.659 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.5 mt -77.06 139.05 65.03 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 108.373 -0.973 . . . . 42.32 108.373 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 170.38 16.69 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.726 1.617 . . . . 75.530000000000001 111.383 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 p -78.69 7.54 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-O 122.67 1.224 . . . . 60.409999999999997 109.403 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -115.93 7.94 14.55 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.042 -1.436 . . . . 75.519999999999996 109.481 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.32 125.3 18.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.962 0.887 . . . . 55.25 110.813 -176.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -109.96 142.04 25.05 Favored Pre-proline 0 C--N 1.289 -2.043 0 CA-C-N 114.198 -1.365 . . . . 75.049999999999997 109.356 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.48 -25.08 30.72 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.63 2.886 . . . . 51.240000000000002 113.56 -176.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' HB3' ' OD2' ' B' ' 94' ' ' ASP . 23.7 ptt180 -66.63 -28.17 68.26 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 121.067 0.461 . . . . 75.420000000000002 111.464 -178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -71.48 -38.2 71.23 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.143 0.497 . . . . 70.510000000000005 110.666 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.76 -38.65 73.47 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 108.544 -0.91 . . . . 73.010000000000005 108.544 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.573 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 12.2 t80 -57.93 -49.05 78.08 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.756 -1.111 . . . . 73.409999999999997 111.087 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 97.1 mt -62.84 -41.31 99.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.075 0.464 . . . . 54.310000000000002 110.707 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.9 tp -73.46 -40.92 63.78 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.315 -0.857 . . . . 62.539999999999999 111.609 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -90.79 -5.69 55.31 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 114.543 1.312 . . . . 73.109999999999999 114.543 -175.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 13.1 mtp180 -58.36 -48.38 97.09 Favored Pre-proline 0 N--CA 1.481 1.091 0 N-CA-C 113.417 0.895 . . . . 73.239999999999995 113.417 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.57 -16.84 52.05 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 121.472 1.448 . . . . 72.549999999999997 112.494 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -91.03 86.31 6.21 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.327 0.584 . . . . 63.25 110.147 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -70.48 115.99 10.29 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 122.213 1.006 . . . . 71.109999999999999 109.544 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.14 -23.08 2.08 Favored Glycine 0 C--N 1.287 -2.172 0 CA-C-N 113.81 -1.541 . . . . 70.340000000000003 109.556 -173.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -57.37 109.55 0.7 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.206 1.002 . . . . 62.310000000000002 111.343 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -88.15 -47.52 8.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.525 0.679 . . . . 54.229999999999997 109.679 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.46 170.95 44.08 Favored Glycine 0 C--N 1.297 -1.618 0 C-N-CA 120.147 -1.025 . . . . 71.120000000000005 112.833 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.4 p -131.59 138.03 48.68 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 122.653 0.381 . . . . 75.329999999999998 110.144 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -115.66 118.29 32.66 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.468 -1.678 . . . . 72.319999999999993 106.468 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -93.52 133.84 33.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.881 -1.155 . . . . 73.209999999999994 107.881 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -127.97 117.74 22.29 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.191 -1.04 . . . . 73.230000000000004 108.191 -175.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.37 111.31 4.56 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.055 -1.091 . . . . 75.109999999999999 108.055 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.8 m -116.03 168.24 10.26 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.826 -0.805 . . . . 53.32 108.826 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.28 -29.93 10.76 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.789 1.235 . . . . 72.219999999999999 114.196 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -104.11 -47.2 4.23 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.989 -0.684 . . . . 74.540000000000006 111.16 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -155.93 153.24 25.41 Favored Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-N 115.48 -0.782 . . . . 65.109999999999999 109.527 -167.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -68.72 105.65 1.34 Allowed 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 122.047 1.832 . . . . 74.010000000000005 108.765 167.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -86.08 162.8 2.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 108.206 -1.035 . . . . 71.129999999999995 108.206 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.33 120.2 3.3 Favored Glycine 0 CA--C 1.486 -1.751 0 C-N-CA 117.91 -2.091 . . . . 64.230000000000004 113.072 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -89.0 104.8 17.32 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.39 -1.337 . . . . 72.230000000000004 107.39 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.3 t -99.9 118.34 46.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 115.765 -0.652 . . . . 73.409999999999997 110.289 -176.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 tt -97.69 127.6 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 CA-C-O 121.909 0.861 . . . . 64.5 110.32 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.421 ' O ' ' HD2' ' A' ' 31' ' ' ARG . 73.2 m-85 -102.86 166.18 10.62 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 114.515 -1.22 . . . . 73.239999999999995 110.144 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.03 -47.73 74.34 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.972 -1.013 . . . . 73.329999999999998 112.565 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 p -146.13 165.12 30.06 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.615 -0.721 . . . . 51.340000000000003 111.082 -172.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.411 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -70.35 -32.12 69.69 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.628 -0.508 . . . . 74.019999999999996 109.628 -178.016 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.63 -20.41 65.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 122.199 1.0 . . . . 53.130000000000003 109.552 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.06 -42.43 6.3 Favored Glycine 0 C--N 1.299 -1.492 0 CA-C-N 114.253 -1.34 . . . . 75.299999999999997 110.417 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.22 -42.86 88.12 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 123.167 0.587 . . . . 75.120000000000005 111.48 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.18 -42.76 91.59 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 111.637 0.236 . . . . 74.109999999999999 111.637 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.4 -36.85 68.77 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-O 121.031 0.444 . . . . 72.019999999999996 111.098 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.42 -39.64 77.75 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.491 -0.777 . . . . 54.119999999999997 111.346 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -68.18 -37.13 80.63 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 120.1 -0.64 . . . . 74.299999999999997 110.147 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -58.27 -38.16 76.41 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 123.47 0.481 . . . . 73.340000000000003 111.286 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.66 -41.66 26.42 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 116.387 -0.37 . . . . 64.109999999999999 111.601 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.48 ' O ' HG22 ' A' ' 91' ' ' ILE . 99.0 mt -88.97 -22.17 23.17 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 116.212 1.93 . . . . 73.420000000000002 116.212 -173.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.436 ' HB3' ' H ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -71.78 113.15 8.52 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 117.904 -1.519 . . . . 65.239999999999995 109.888 176.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.77 11.98 13.53 Favored Glycine 0 N--CA 1.408 -3.222 0 CA-C-N 115.411 -0.813 . . . . 44.119999999999997 111.478 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.5 tt -94.45 133.75 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 N-CA-C 107.441 -1.318 . . . . 63.329999999999998 107.441 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 59.5 ttt180 -97.43 126.86 42.93 Favored 'General case' 0 C--N 1.251 -3.696 0 N-CA-C 109.15 -0.685 . . . . 72.109999999999999 109.15 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.13 -32.84 74.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.593 -1.185 . . . . 75.530000000000001 110.418 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.62 ' HB2' ' HB3' ' A' ' 97' ' ' ASN . 1.5 m-20 -147.73 126.49 6.2 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 103.938 -2.616 . . . . 61.530000000000001 103.938 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.649 ' HD3' ' CZ ' ' B' ' 48' ' ' TYR . 30.6 Cg_endo -67.69 -12.76 36.63 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 CA-C-N 121.279 1.492 . . . . 75.519999999999996 111.217 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -91.46 -0.65 57.65 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.194 -0.912 . . . . 73.310000000000002 111.01 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 18.7 t30 -117.41 127.14 26.87 Favored Pre-proline 0 C--O 1.213 -0.853 0 N-CA-C 108.387 -0.968 . . . . 65.120000000000005 108.387 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.07 -12.18 33.42 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.398 2.732 . . . . 62.219999999999999 114.927 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -94.68 158.63 15.43 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 119.804 -0.758 . . . . 73.430000000000007 110.209 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.439 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 49.6 p -135.95 161.09 36.62 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.712 -1.218 . . . . 74.420000000000002 107.712 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 mp -90.43 129.74 36.58 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.186 0.517 . . . . 74.129999999999995 110.42 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -124.37 110.52 14.67 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.178 -1.416 . . . . 64.109999999999999 107.178 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.6 mp -98.58 122.51 41.88 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.405 -0.816 . . . . 74.019999999999996 109.846 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.501 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 37.3 tt0 -130.94 157.57 42.6 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.864 -1.532 . . . . 64.109999999999999 106.864 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -65.71 139.97 58.42 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 118.458 0.572 . . . . 73.519999999999996 109.586 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.14 157.27 32.98 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.958 -0.756 . . . . 73.310000000000002 108.958 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -88.61 0.69 56.13 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 122.124 0.964 . . . . 75.319999999999993 109.216 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.35 124.97 3.76 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.749 -1.114 . . . . 64.310000000000002 108.113 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -64.78 124.15 21.21 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.463 0.649 . . . . 63.450000000000003 110.891 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.8 m . . . . . 0 N--CA 1.418 -2.072 0 N-CA-C 108.097 -1.075 . . . . 71.430000000000007 108.097 -178.956 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 97.5 t . . . . . 0 CA--C 1.5 -0.965 0 N-CA-C 103.692 -2.707 . . . . 70.349999999999994 103.692 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.596 ' HB2' ' O ' ' B' ' 75' ' ' PHE . 16.1 ptm180 -123.53 17.9 9.65 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-N 114.655 -1.157 . . . . 63.310000000000002 110.974 -164.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 29.9 m -124.67 121.56 35.04 Favored 'General case' 0 C--N 1.273 -2.739 0 C-N-CA 119.554 -0.858 . . . . 73.219999999999999 110.104 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 87.9 mt -103.48 137.23 41.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.196 -1.039 . . . . 75.340000000000003 108.196 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -98.88 113.99 26.37 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 106.762 -1.57 . . . . 73.219999999999999 106.762 175.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.595 HG22 ' HG ' ' B' ' 103' ' ' LEU . 22.0 t -99.69 112.56 32.42 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.665 0 CA-C-N 114.429 -1.259 . . . . 55.340000000000003 108.4 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' B' ' 101' ' ' LEU . 48.9 p -111.48 169.46 8.79 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 108.626 -0.879 . . . . 73.140000000000001 108.626 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.541 ' HA2' ' CD ' ' B' ' 99' ' ' GLN . . . 109.68 -6.65 31.49 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 120.421 -0.895 . . . . 70.049999999999997 111.655 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 55.1 mt -75.8 133.71 72.84 Favored Pre-proline 0 N--CA 1.428 -1.572 0 CA-C-N 114.253 -0.974 . . . . 64.530000000000001 108.812 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.49 170.68 16.87 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.095 1.863 . . . . 51.009999999999998 110.715 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.508 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 8.2 p -70.92 -11.51 15.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.446 0.641 . . . . 73.340000000000003 111.623 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -112.55 27.28 9.77 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.961 0.886 . . . . 65.129999999999995 108.894 -177.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.513 HG22 ' HG2' ' B' ' 69' ' ' PRO . 0.1 OUTLIER -74.58 126.59 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-O 121.566 0.698 . . . . 73.530000000000001 109.4 179.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -101.34 141.53 22.78 Favored Pre-proline 0 C--N 1.299 -1.608 0 CA-C-N 115.707 -0.678 . . . . 60.43 111.08 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -51.0 -25.42 16.18 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.628 2.886 . . . . 61.229999999999997 114.199 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.508 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 15.3 ptt-85 -66.35 -32.27 73.57 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 120.864 0.364 . . . . 75.049999999999997 111.019 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -69.24 -34.48 74.88 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.923 -0.58 . . . . 72.349999999999994 109.973 -174.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.407 ' O ' ' HD2' ' B' ' 51' ' ' PHE . 97.3 mt -74.65 -44.07 52.2 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.47 0.652 . . . . 62.109999999999999 109.454 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.649 ' CZ ' ' HD3' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -57.81 -43.32 85.61 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.976 -1.011 . . . . 74.040000000000006 112.071 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 96.9 mt -63.55 -42.81 98.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.891 0.377 . . . . 73.310000000000002 111.015 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.3 tp -71.65 -42.68 67.25 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.284 -0.871 . . . . 65.049999999999997 111.657 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . 0.407 ' HD2' ' O ' ' B' ' 47' ' ' LEU . 81.4 m-85 -85.42 -4.74 59.25 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.993 1.479 . . . . 73.329999999999998 114.993 -175.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 26.2 mtp180 -51.81 -50.05 80.01 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 114.16 1.17 . . . . 75.25 114.16 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.51 -0.88 10.64 Favored 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 121.873 1.715 . . . . 74.120000000000005 114.046 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . 0.264 69.8 m-85 -87.67 134.92 33.57 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 115.519 1.674 . . . . 71.120000000000005 115.519 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -67.12 109.24 2.96 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.262 -1.79 . . . . 72.519999999999996 112.455 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' B' ' 75' ' ' PHE . . . 106.38 -7.59 40.14 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 115.531 -0.759 . . . . 44.520000000000003 113.467 171.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -59.94 106.98 0.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.406 0.622 . . . . 72.409999999999997 112.54 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -99.24 -44.58 6.19 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.692 -0.686 . . . . 72.209999999999994 110.849 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.91 -178.88 41.78 Favored Glycine 0 C--N 1.302 -1.318 0 C-N-CA 119.429 -1.367 . . . . 71.25 113.569 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.7 p -139.86 137.67 35.09 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.162 0.585 . . . . 74.25 111.158 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.51 116.51 28.31 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.301 -1.0 . . . . 73.310000000000002 108.301 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.51 133.27 35.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.663 -0.866 . . . . 33.340000000000003 108.663 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' B' ' 69' ' ' PRO . 12.1 tmtt? -125.31 115.29 20.12 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.364 -1.347 . . . . 53.329999999999998 107.364 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.15 130.74 39.71 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.09 -0.504 . . . . 73.109999999999999 109.872 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 3.4 m -124.52 164.82 18.97 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.885 -1.154 . . . . 74.329999999999998 107.885 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.58 -31.5 36.49 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.53 0.937 . . . . 63.229999999999997 113.53 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -99.22 -52.41 3.53 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.897 -0.721 . . . . 74.230000000000004 111.484 176.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -154.16 145.86 16.85 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 115.781 -0.645 . . . . 75.120000000000005 111.156 -170.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.513 ' HG2' HG22 ' B' ' 42' ' ' ILE . 60.2 Cg_endo -75.62 124.8 8.49 Favored 'Trans proline' 0 N--CA 1.436 -1.88 0 C-N-CA 122.93 2.42 . . . . 60.219999999999999 111.621 174.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 m -93.84 155.11 3.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 114.977 -1.011 . . . . 65.120000000000005 108.442 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.32 120.51 4.23 Favored Glycine 0 CA--C 1.486 -1.756 0 C-N-CA 119.032 -1.556 . . . . 61.420000000000002 112.811 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -89.7 102.77 15.46 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.608 -1.256 . . . . 72.209999999999994 107.608 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 68.8 t -92.67 123.94 44.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 115.79 -0.641 . . . . 64.430000000000007 109.584 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 13.7 tt -101.53 129.21 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.328 0 CA-C-O 122.297 1.046 . . . . 75.150000000000006 111.074 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . 0.596 ' O ' ' HB2' ' B' ' 31' ' ' ARG . 91.9 m-85 -109.81 160.43 16.35 Favored 'General case' 0 N--CA 1.404 -2.759 0 CA-C-N 113.217 -1.81 . . . . 71.099999999999994 107.993 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . 0.479 ' HA ' ' NH2' ' B' ' 31' ' ' ARG . 34.7 t70 -73.09 -33.31 65.53 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.276 0.56 . . . . 72.400000000000006 111.843 176.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 12.4 p -128.73 158.81 37.56 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 116.258 -0.428 . . . . 52.310000000000002 111.641 -174.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . 0.436 ' HD3' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -80.48 -27.78 37.73 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.476 -0.889 . . . . 63.450000000000003 108.662 177.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' B' ' 82' ' ' GLU . . . -72.07 -24.91 61.58 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.977 0.894 . . . . 61.219999999999999 108.764 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.12 -44.75 28.3 Favored Glycine 0 C--N 1.31 -0.895 0 N-CA-C 109.62 -1.392 . . . . 35.229999999999997 109.62 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.6 -44.95 95.03 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.766 -0.717 . . . . 73.319999999999993 111.736 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' B' ' 79' ' ' ALA . 2.0 pp20? -66.96 -28.28 68.15 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.495 0.554 . . . . 74.109999999999999 112.495 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.95 -46.84 32.9 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.119 -0.491 . . . . 71.099999999999994 110.172 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.97 92.6 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.53 -0.759 . . . . 74.040000000000006 111.678 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.457 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 14.2 ptmm? -69.49 -34.38 74.24 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 120.024 -0.67 . . . . 74.109999999999999 110.147 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -62.84 -32.24 73.42 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 121.129 0.49 . . . . 74.420000000000002 110.405 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.78 -32.48 19.07 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 112.541 0.571 . . . . 74.400000000000006 112.541 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.47 ' O ' HG22 ' B' ' 91' ' ' ILE . 91.7 mt -101.66 -25.19 13.95 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 116.603 2.075 . . . . 72.310000000000002 116.603 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . 0.268 0.2 OUTLIER -68.69 113.92 6.6 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 118.06 -1.456 . . . . 61.530000000000001 112.615 -176.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.2 6.47 15.82 Favored Glycine 0 N--CA 1.419 -2.451 0 C-N-CA 120.791 -0.719 . . . . 54.409999999999997 111.872 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.47 HG22 ' O ' ' B' ' 88' ' ' LEU . 12.2 tt -96.61 146.73 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.361 0 N-CA-C 107.735 -1.209 . . . . 42.409999999999997 107.735 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.451 ' HG3' HG22 ' B' ' 100' ' ' THR . 97.7 mtt180 -89.47 140.89 29.07 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-O 121.333 0.587 . . . . 72.319999999999993 112.342 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -73.27 -31.41 64.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.834 -1.53 . . . . 73.120000000000005 109.182 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.537 ' OD2' ' HB3' ' A' ' 45' ' ' ARG 0.266 4.8 m-20 -142.67 137.27 15.1 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 104.113 -2.551 . . . . 74.140000000000001 104.113 176.343 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . 0.573 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 19.0 Cg_endo -64.09 -19.51 66.32 Favored 'Trans proline' 0 CA--C 1.55 1.291 0 CA-C-N 121.064 1.416 . . . . 72.040000000000006 109.631 168.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -72.14 -24.98 61.54 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.109 1.764 . . . . 74.209999999999994 109.609 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -94.91 126.84 45.37 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 115.189 -0.914 . . . . 73.239999999999995 109.769 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.19 -6.25 14.76 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.937 2.425 . . . . 74.510000000000005 112.689 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' GLN . . . . . 0.541 ' CD ' ' HA2' ' B' ' 37' ' ' GLY . 8.7 tt0 -99.0 162.11 13.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.571 -0.9 . . . . 74.030000000000001 108.571 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.5 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 82.6 p -125.64 164.25 21.0 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.513 -0.551 . . . . 74.430000000000007 109.513 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' B' ' 36' ' ' SER . 5.3 mp -85.8 117.33 24.6 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 107.012 -1.477 . . . . 54.43 107.012 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -113.44 107.34 15.71 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 107.725 -1.213 . . . . 73.310000000000002 107.725 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.595 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.0 mp -90.22 116.45 28.21 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.572 -1.27 . . . . 61.119999999999997 107.572 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.457 ' HA ' ' CE ' ' B' ' 85' ' ' LYS . 12.1 tp10 -135.22 162.88 31.29 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.88 -1.156 . . . . 72.329999999999998 107.88 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -69.07 137.28 53.41 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 118.71 0.687 . . . . 75.010000000000005 111.84 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.95 156.03 32.27 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 109.169 -0.678 . . . . 71.030000000000001 109.169 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -78.13 -8.61 58.48 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.908 0.861 . . . . 42.450000000000003 109.624 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.2 130.98 9.95 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.164 -0.925 . . . . 75.239999999999995 108.77 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.411 ' ND2' ' HG2' ' B' ' 31' ' ' ARG . 6.5 m-20 -63.74 132.49 51.16 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.549 -0.75 . . . . 62.229999999999997 110.003 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 C--N 1.299 -1.589 0 N-CA-C 108.357 -0.979 . . . . 53.219999999999999 108.357 -179.507 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.529 ' HA ' HD21 ' A' ' 109' ' ' ASN . 17.8 t . . . . . 0 C--O 1.215 -0.724 0 N-CA-C 113.184 0.809 . . . . 74.329999999999998 113.184 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 42.4 mtt180 -99.43 -25.16 14.55 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-O 122.363 1.078 . . . . 71.230000000000004 109.349 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.4 m -98.11 138.24 35.7 Favored 'General case' 0 C--N 1.26 -3.291 0 CA-C-N 113.549 -1.659 . . . . 71.450000000000003 113.6 -167.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.8 mt -124.57 142.8 51.08 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 114.018 -1.447 . . . . 74.140000000000001 108.325 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 104' ' ' GLU . 32.0 p90 -101.48 112.23 24.71 Favored 'General case' 0 N--CA 1.423 -1.825 0 C-N-CA 118.956 -1.097 . . . . 75.040000000000006 108.074 172.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.481 HG12 HD11 ' A' ' 101' ' ' LEU . 41.7 t -97.05 114.01 32.89 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.828 0 N-CA-C 106.898 -1.519 . . . . 55.439999999999998 106.898 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.6 p -124.46 154.44 40.48 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.288 -0.869 . . . . 74.209999999999994 111.177 -175.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.62 4.65 34.44 Favored Glycine 0 N--CA 1.425 -2.07 0 CA-C-N 115.939 -0.573 . . . . 33.539999999999999 111.856 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.56 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 94.4 mt -66.28 131.67 94.35 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.23 -0.655 . . . . 54.310000000000002 109.23 175.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.04 157.55 3.92 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.416 2.077 . . . . 70.409999999999997 110.283 171.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.496 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 9.8 p -83.44 6.97 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 122.787 1.28 . . . . 72.439999999999998 109.847 -170.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -127.87 17.04 6.82 Favored 'General case' 0 N--CA 1.406 -2.659 0 CA-C-N 114.323 -1.308 . . . . 54.420000000000002 110.322 -175.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 pp -54.06 133.75 16.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 114.62 1.341 . . . . 71.230000000000004 114.62 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.539 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.33 143.03 26.03 Favored Pre-proline 0 C--N 1.285 -2.199 0 CA-C-N 114.174 -1.376 . . . . 54.219999999999999 108.279 177.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.88 -24.64 65.58 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.913 2.408 . . . . 73.019999999999996 113.853 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.545 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -82.35 -15.34 53.16 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 118.094 -1.442 . . . . 70.109999999999999 111.882 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.49 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 30.0 mt-10 -69.66 -37.76 76.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.803 0.811 . . . . 74.129999999999995 108.932 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.9 mt -65.67 -35.92 82.16 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 114.773 -1.103 . . . . 75.209999999999994 108.828 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.545 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 73.7 t80 -63.95 -47.37 80.76 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.572 -1.194 . . . . 74.519999999999996 110.227 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 81.9 mt -65.02 -35.68 81.95 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.815 0.341 . . . . 71.510000000000005 111.809 -176.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.0 tp -86.23 -36.25 19.53 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 112.581 0.585 . . . . 65.140000000000001 112.581 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -98.56 -11.12 22.5 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 114.337 1.236 . . . . 73.510000000000005 114.337 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.5 ttt-85 -66.79 -42.71 45.67 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 119.987 -0.685 . . . . 71.329999999999998 111.693 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -58.11 -25.35 70.74 Favored 'Trans proline' 0 C--N 1.398 3.167 0 C-N-CA 121.711 1.608 . . . . 72.120000000000005 111.553 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -84.8 84.42 7.7 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.777 0.799 . . . . 72.200000000000003 110.112 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -67.93 108.74 3.15 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.333 -1.303 . . . . 75.099999999999994 109.905 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.94 -25.5 1.29 Allowed Glycine 0 N--CA 1.424 -2.133 0 CA-C-N 113.996 -1.457 . . . . 64.209999999999994 109.67 -172.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -55.45 118.72 4.71 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.085 0.554 . . . . 72.430000000000007 110.538 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -93.65 -60.09 1.85 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 120.121 -0.632 . . . . 61.229999999999997 109.363 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.56 175.15 38.15 Favored Glycine 0 C--N 1.298 -1.546 0 C-N-CA 120.848 -0.691 . . . . 65.310000000000002 112.075 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.3 p -134.79 143.88 47.34 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 122.488 0.315 . . . . 75.530000000000001 111.002 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.5 mt -115.98 119.91 37.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.09 -0.707 . . . . 74.209999999999994 109.09 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.17 133.3 35.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 110.137 -0.319 . . . . 71.540000000000006 110.137 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -117.82 106.66 13.23 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.27 -1.381 . . . . 72.239999999999995 107.27 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.4 124.6 25.48 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.246 -1.02 . . . . 71.219999999999999 108.246 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 5.9 m -128.89 150.79 50.2 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 105.155 -2.165 . . . . 72.239999999999995 105.155 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.05 -40.34 10.53 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 114.42 1.267 . . . . 63.32 114.42 -173.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -96.01 -26.76 15.42 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.877 1.065 . . . . 73.439999999999998 113.877 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.56 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -172.23 143.05 1.27 Allowed Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 110.202 -0.296 . . . . 70.439999999999998 110.202 -177.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.496 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 59.5 Cg_endo -77.37 124.64 7.23 Favored 'Trans proline' 0 N--CA 1.432 -2.092 0 C-N-CA 122.491 2.127 . . . . 65.019999999999996 110.102 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.7 m -96.36 147.49 6.1 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 N-CA-C 108.222 -1.029 . . . . 53.240000000000002 108.222 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.22 120.86 4.59 Favored Glycine 0 CA--C 1.479 -2.204 0 C-N-CA 118.879 -1.629 . . . . 71.129999999999995 112.907 -175.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.44 103.65 15.71 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 106.849 -1.538 . . . . 75.409999999999997 106.849 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.5 t -94.34 128.07 45.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.363 0 CA-C-N 115.071 -0.968 . . . . 74.129999999999995 110.284 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.67 114.24 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.369 0 N-CA-C 107.991 -1.114 . . . . 62.219999999999999 107.991 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.476 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 36.1 m-85 -93.96 162.65 13.81 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.329 -0.85 . . . . 74.200000000000003 109.584 174.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.36 -41.21 51.31 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 124.317 1.011 . . . . 75.510000000000005 111.876 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.6 p -164.9 166.08 19.85 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.571 -0.741 . . . . 70.540000000000006 111.986 -174.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.687 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -56.05 -39.5 72.11 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.236 1.014 . . . . 72.120000000000005 112.105 177.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.82 -28.17 69.38 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.625 0.726 . . . . 73.319999999999993 109.731 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.56 -38.71 9.46 Favored Glycine 0 C--N 1.309 -0.922 0 CA-C-N 114.648 -1.16 . . . . 65.310000000000002 110.897 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.67 -45.87 77.48 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.546 0.738 . . . . 52.219999999999999 112.032 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -34.82 78.8 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.007 0.432 . . . . 75.150000000000006 111.439 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.6 -41.21 65.84 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.992 -0.549 . . . . 62.109999999999999 110.563 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.89 -41.72 86.73 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.747 -0.66 . . . . 62.5 110.821 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -69.42 -28.46 66.16 Favored 'General case' 0 C--O 1.199 -1.585 0 CA-C-N 116.292 -0.413 . . . . 70.019999999999996 111.297 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -78.11 -21.07 50.99 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.27 0.557 . . . . 75.349999999999994 111.751 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.91 -44.02 11.36 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.278 -0.419 . . . . 72.439999999999998 111.378 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.467 ' O ' HG22 ' A' ' 91' ' ' ILE . 96.0 mt -93.78 -12.64 28.66 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 115.456 1.65 . . . . 74.519999999999996 115.456 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -67.56 114.6 6.34 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 119.559 1.072 . . . . 55.020000000000003 112.169 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.37 16.37 14.86 Favored Glycine 0 N--CA 1.429 -1.83 0 C-N-CA 119.73 -1.224 . . . . 63.340000000000003 111.789 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 88' ' ' LEU . 11.4 tt -90.81 128.19 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.73 0 N-CA-C 107.669 -1.234 . . . . 75.230000000000004 107.669 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -75.1 121.73 22.5 Favored 'General case' 0 C--N 1.269 -2.898 0 N-CA-C 107.87 -1.159 . . . . 71.099999999999994 107.87 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.43 -32.81 69.03 Favored 'General case' 0 C--N 1.312 -1.033 0 O-C-N 124.357 1.036 . . . . 70.150000000000006 109.04 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.419 ' HB3' ' HB3' ' B' ' 45' ' ' ARG . 3.1 p-10 -148.06 115.18 3.99 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 107.077 -1.453 . . . . 75.430000000000007 107.077 171.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -62.37 -9.59 15.89 Favored 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 122.685 2.257 . . . . 70.239999999999995 113.185 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -74.46 -19.21 60.47 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.483 0.658 . . . . 74.510000000000005 109.453 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -118.08 146.52 39.4 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.202 -1.036 . . . . 74.019999999999996 108.202 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.19 -16.61 52.53 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.182 1.921 . . . . 74.230000000000004 113.159 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -52.83 125.35 16.62 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.199 1.4 . . . . 73.120000000000005 111.823 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.3 p -112.26 150.3 31.13 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 120.153 -0.619 . . . . 45.420000000000002 110.823 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.481 HD11 HG12 ' A' ' 35' ' ' VAL . 22.2 tp -98.34 127.01 44.08 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.469 -0.938 . . . . 73.420000000000002 108.469 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -122.38 136.03 54.82 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.09 0.471 . . . . 74.349999999999994 109.822 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.448 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.6 mp -110.38 116.25 31.11 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.378 -0.828 . . . . 73.040000000000006 108.965 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.478 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 5.3 tp10 -127.19 161.99 27.22 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.73 -0.841 . . . . 73.519999999999996 108.73 -177.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -70.75 139.29 51.03 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 118.514 0.597 . . . . 65.25 110.436 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.16 150.5 31.7 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 109.233 -0.655 . . . . 60.340000000000003 109.233 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -74.18 -6.65 49.03 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.589 -0.732 . . . . 74.530000000000001 111.961 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.16 133.65 7.88 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.772 -0.825 . . . . 31.41 108.772 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.529 HD21 ' HA ' ' A' ' 30' ' ' VAL . 84.1 m-20 -74.78 108.31 7.44 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.99 -1.115 . . . . 72.239999999999995 107.99 172.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 C--N 1.289 -2.054 0 C-N-CA 119.11 -1.036 . . . . 41.020000000000003 109.823 -179.303 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 32.2 t . . . . . 0 C--O 1.216 -0.687 0 CA-C-O 121.003 0.43 . . . . 71.329999999999998 111.754 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 86.6 mtt180 -91.64 -3.52 56.26 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.124 0.488 . . . . 75.239999999999995 111.634 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.9 m -115.55 128.2 55.81 Favored 'General case' 0 C--N 1.263 -3.16 0 CA-C-O 121.675 0.75 . . . . 53.240000000000002 112.759 -172.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 71.3 mt -110.1 142.41 41.6 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.184 -0.916 . . . . 71.099999999999994 108.697 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -99.38 113.69 26.17 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 106.992 -1.484 . . . . 74.430000000000007 106.992 173.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.478 HG22 ' HG ' ' B' ' 103' ' ' LEU . 53.4 t -102.49 125.67 56.73 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.984 0 CA-C-N 113.953 -1.476 . . . . 72.439999999999998 107.509 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.2 p -139.17 169.56 17.55 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.732 -0.667 . . . . 74.030000000000001 110.219 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 90.56 42.66 5.08 Favored Glycine 0 N--CA 1.422 -2.295 0 N-CA-C 109.465 -1.454 . . . . 71.219999999999999 109.465 -172.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.33 138.25 20.13 Favored Pre-proline 0 N--CA 1.418 -2.066 0 CA-C-N 114.039 -1.08 . . . . 75.310000000000002 108.437 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -54.53 155.83 15.87 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.401 2.068 . . . . 55.149999999999999 110.094 171.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.498 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 8.1 p -83.06 3.93 2.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 122.627 1.203 . . . . 65.030000000000001 108.796 -174.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.93 21.93 6.3 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 114.136 -1.393 . . . . 64.150000000000006 111.056 -173.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 35.2 pt -54.0 137.03 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 113.88 1.067 . . . . 75.310000000000002 113.88 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.583 ' HA ' ' HE3' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -93.36 141.38 23.88 Favored Pre-proline 0 C--N 1.279 -2.467 0 N-CA-C 107.054 -1.461 . . . . 73.420000000000002 107.054 174.425 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.24 -25.53 78.53 Favored 'Trans proline' 0 N--CA 1.478 0.616 0 C-N-CA 122.644 2.229 . . . . 71.129999999999995 113.093 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.471 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 16.7 ptt180 -79.7 -18.0 52.3 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 112.166 0.432 . . . . 63.030000000000001 112.166 -176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.503 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 31.2 mt-10 -65.31 -40.29 93.56 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.815 0.817 . . . . 75.140000000000001 108.993 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 74.2 mt -67.92 -35.93 79.28 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.556 -1.202 . . . . 73.439999999999998 109.634 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -61.16 -48.18 82.79 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.43 -0.804 . . . . 74.099999999999994 111.144 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 79.8 mt -63.1 -44.31 96.04 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 123.837 0.71 . . . . 63.100000000000001 110.054 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.9 tp -73.02 -41.55 64.11 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.894 -1.048 . . . . 71.239999999999995 111.861 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -96.03 10.03 38.83 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.323 0.861 . . . . 73.010000000000005 113.323 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -70.48 -48.65 17.3 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 120.615 -0.434 . . . . 64.219999999999999 111.725 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.75 -3.85 14.42 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 121.376 1.384 . . . . 72.439999999999998 112.128 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -91.42 94.69 9.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.416 1.103 . . . . 74.319999999999993 111.439 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -64.2 113.24 3.43 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 112.922 -1.944 . . . . 55.409999999999997 110.047 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.88 -21.97 3.68 Favored Glycine 0 C--N 1.287 -2.156 0 CA-C-N 115.097 -0.956 . . . . 63.009999999999998 111.403 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -62.26 105.8 0.65 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.329 0.585 . . . . 73.519999999999996 111.99 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -87.52 -48.6 7.8 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.787 -0.642 . . . . 63.420000000000002 109.609 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.57 170.93 43.55 Favored Glycine 0 C--N 1.298 -1.529 0 C-N-CA 120.741 -0.742 . . . . 53.229999999999997 112.0 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.7 p -128.8 138.1 51.89 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 122.684 0.394 . . . . 63.439999999999998 110.432 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 87.6 mt -112.99 112.88 24.64 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.526 -0.916 . . . . 71.310000000000002 108.526 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 50.4 mm -93.81 133.05 36.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.651 -0.499 . . . . 74.230000000000004 109.651 -176.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -128.3 126.69 41.32 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.097 -1.446 . . . . 74.5 107.097 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.72 125.88 29.93 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.698 0.761 . . . . 65.129999999999995 112.758 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.3 m -113.6 155.89 24.65 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 103.811 -2.663 . . . . 54.229999999999997 103.811 173.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.88 -35.15 31.36 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 114.322 1.23 . . . . 54.130000000000003 114.322 -172.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -104.91 -14.57 15.42 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 113.237 0.829 . . . . 75.019999999999996 113.237 -175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -172.81 147.85 1.65 Allowed Pre-proline 0 N--CA 1.468 0.473 0 CA-C-O 120.753 0.311 . . . . 61.119999999999997 110.258 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 46.2 Cg_endo -78.63 122.85 5.65 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 C-N-CA 122.347 2.032 . . . . 74.129999999999995 110.263 169.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 35.2 m -94.03 155.05 3.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.082 -1.081 . . . . 71.219999999999999 108.082 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.49 121.65 3.55 Favored Glycine 0 CA--C 1.474 -2.501 0 C-N-CA 118.868 -1.634 . . . . 63.329999999999998 113.301 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -88.17 102.46 14.82 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.754 -1.572 . . . . 75.329999999999998 106.754 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.18 122.9 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 CA-C-N 115.195 -0.911 . . . . 64.030000000000001 109.539 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 62.6 mt -102.68 120.71 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.418 0 CA-C-N 113.846 -1.525 . . . . 53.43 109.448 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . 0.42 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 71.5 m-85 -105.06 161.21 14.43 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 114.112 -1.404 . . . . 73.219999999999999 109.846 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.57 -29.97 71.0 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.21 -0.904 . . . . 73.439999999999998 111.807 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 29.7 p -161.67 165.87 27.58 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.045 0.538 . . . . 73.519999999999996 110.072 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -22.58 62.51 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.529 -0.468 . . . . 43.439999999999998 110.314 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.15 -28.12 69.54 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.452 0.644 . . . . 54.409999999999997 110.383 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.38 -39.91 7.1 Favored Glycine 0 C--N 1.308 -1.023 0 N-CA-C 110.2 -1.16 . . . . 53.039999999999999 110.2 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.49 -43.68 98.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.503 -0.849 . . . . 62.5 111.825 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.93 -39.69 90.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 74.310000000000002 111.472 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.11 -37.83 64.01 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.082 0.468 . . . . 74.109999999999999 110.135 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.36 -40.54 77.43 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.48 -0.782 . . . . 53.310000000000002 111.083 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.528 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 14.5 ptmm? -68.18 -40.77 82.15 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 120.303 -0.559 . . . . 74.239999999999995 110.668 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -66.79 -25.26 66.38 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 120.71 -0.396 . . . . 74.239999999999995 111.925 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.67 -41.51 17.67 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 120.839 0.352 . . . . 75.519999999999996 111.281 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.548 ' O ' HG22 ' B' ' 91' ' ' ILE . 96.9 mt -96.26 -14.0 22.98 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 115.623 1.712 . . . . 62.100000000000001 115.623 -173.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.43 116.06 12.42 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 118.803 -1.159 . . . . 74.25 112.523 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.82 26.64 7.45 Favored Glycine 0 N--CA 1.428 -1.877 0 C-N-CA 120.49 -0.862 . . . . 71.239999999999995 111.373 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.548 HG22 ' O ' ' B' ' 88' ' ' LEU . 16.5 tt -114.95 133.71 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.551 0 N-CA-C 107.325 -1.361 . . . . 74.219999999999999 107.325 174.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.414 ' HG2' HG22 ' B' ' 100' ' ' THR . 99.2 mtt180 -67.66 134.47 51.18 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-O 121.086 0.469 . . . . 72.540000000000006 110.634 172.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -70.8 -30.35 66.78 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.529 -1.214 . . . . 63.030000000000001 109.039 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' B' ' 97' ' ' ASN . 8.5 t70 -144.31 118.97 5.93 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 104.544 -2.391 . . . . 74.010000000000005 104.544 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . 0.516 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 31.8 Cg_endo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.907 2.405 . . . . 74.319999999999993 113.819 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -94.21 4.46 53.86 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.609 0.719 . . . . 74.530000000000001 111.123 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' ASN . . . . . 0.474 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . 56.2 t30 -118.84 130.34 24.88 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 107.514 -1.291 . . . . 74.310000000000002 107.514 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.44 -13.43 33.01 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 123.046 2.497 . . . . 75.549999999999997 113.972 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -67.33 116.53 8.19 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-O 121.379 0.609 . . . . 75.010000000000005 110.28 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.595 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 58.2 p -106.48 145.17 32.14 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.824 -0.625 . . . . 54.310000000000002 109.916 -176.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 33.4 tp -94.13 128.97 40.85 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 110.025 -0.361 . . . . 71.329999999999998 110.025 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.447 HH21 ' CD ' ' B' ' 104' ' ' GLU . 6.0 ptm180 -129.02 127.44 41.61 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.914 -0.402 . . . . 54.109999999999999 109.914 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.478 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.7 mp -115.06 118.84 34.51 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.608 -0.723 . . . . 74.540000000000006 110.034 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.528 ' HA ' ' CE ' ' B' ' 85' ' ' LYS . 34.3 mt-10 -137.81 162.0 35.1 Favored 'General case' 0 C--O 1.199 -1.574 0 C-N-CA 122.739 0.415 . . . . 74.140000000000001 110.378 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -69.39 132.91 47.12 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 118.295 0.498 . . . . 74.510000000000005 111.355 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.59 154.47 34.39 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.413 -0.588 . . . . 65.310000000000002 109.413 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -84.28 9.15 13.73 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 120.876 0.369 . . . . 75.430000000000007 111.567 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.81 130.41 11.5 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.638 -0.504 . . . . 60.530000000000001 109.638 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -76.68 121.45 23.28 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 108.676 -0.861 . . . . 70.329999999999998 108.676 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 C--N 1.287 -2.141 0 N-CA-C 109.225 -0.657 . . . . 74.140000000000001 109.225 -177.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.5 t . . . . . 0 C--O 1.214 -0.769 0 CA-C-O 121.363 0.602 . . . . 71.120000000000005 110.917 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.644 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 69.0 mtt180 -91.93 -22.63 19.93 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 122.352 1.072 . . . . 73.340000000000003 109.518 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 18.1 m -96.07 122.7 39.18 Favored 'General case' 0 C--N 1.258 -3.396 0 CA-C-N 113.471 -1.695 . . . . 73.340000000000003 112.018 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.544 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.1 pt? -115.59 142.11 47.17 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 107.554 -1.276 . . . . 75.540000000000006 107.554 175.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 104' ' ' GLU . 26.2 p90 -96.57 122.18 39.2 Favored 'General case' 0 N--CA 1.417 -2.091 0 C-N-CA 118.779 -1.168 . . . . 71.230000000000004 109.272 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.415 HG22 ' HG ' ' A' ' 103' ' ' LEU . 41.6 t -97.27 108.78 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.586 0 N-CA-C 106.419 -1.697 . . . . 62.399999999999999 106.419 178.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 32.2 p -115.76 172.95 6.81 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 108.93 -0.767 . . . . 74.030000000000001 108.93 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 87.13 41.38 6.64 Favored Glycine 0 N--CA 1.418 -2.56 0 N-CA-C 109.897 -1.281 . . . . 74.099999999999994 109.897 -174.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.9 mt -114.81 145.14 33.32 Favored Pre-proline 0 N--CA 1.423 -1.777 0 N-CA-C 107.201 -1.407 . . . . 72.129999999999995 107.201 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.43 171.26 15.01 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.558 1.505 . . . . 72.430000000000007 110.199 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.5 p -71.31 -7.53 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 CA-C-O 122.574 1.178 . . . . 71.349999999999994 109.932 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -103.3 20.02 18.55 Favored 'General case' 0 C--O 1.203 -1.392 0 CA-C-N 114.035 -1.439 . . . . 65.200000000000003 109.386 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.98 123.51 27.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.261 0 CA-C-O 121.622 0.725 . . . . 73.219999999999999 110.715 178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -101.18 145.76 30.98 Favored Pre-proline 0 C--N 1.307 -1.244 0 C-N-CA 124.831 1.252 . . . . 74.019999999999996 111.44 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.56 -17.86 60.55 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.295 2.664 . . . . 70.450000000000003 114.557 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.555 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -86.73 -17.24 34.1 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 117.71 -1.596 . . . . 71.319999999999993 110.961 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -66.7 -42.16 86.86 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.133 0.492 . . . . 74.010000000000005 110.155 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.19 -37.35 87.04 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.191 -0.67 . . . . 55.420000000000002 109.191 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.667 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 61.0 t80 -59.38 -48.72 80.56 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.13 -0.941 . . . . 61.420000000000002 110.732 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 86.6 mt -61.59 -41.61 97.68 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.918 0.761 . . . . 73.510000000000005 110.32 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.9 tp -70.61 -42.19 71.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.286 -0.87 . . . . 71.329999999999998 111.79 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -86.72 7.13 28.03 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.851 1.056 . . . . 75.549999999999997 113.851 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.523 ' HA ' ' NE ' ' A' ' 52' ' ' ARG . 3.9 mmp_? -52.83 -50.33 81.94 Favored Pre-proline 0 N--CA 1.486 1.326 0 N-CA-C 113.924 1.083 . . . . 74.420000000000002 113.924 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -76.5 -0.91 10.92 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 121.914 1.743 . . . . 54.340000000000003 113.863 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.434 ' CE2' ' HA ' ' A' ' 84' ' ' ALA . 60.6 m-85 -98.76 115.33 28.53 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 121.945 0.879 . . . . 64.530000000000001 112.364 -174.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HD3' ' H ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -80.08 120.93 24.89 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 113.814 -1.539 . . . . 61.240000000000002 109.511 179.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.7 -14.0 6.09 Favored Glycine 0 C--N 1.276 -2.791 0 CA-C-N 114.958 -1.019 . . . . 73.319999999999993 113.037 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -58.33 107.31 0.48 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.044 0.422 . . . . 73.010000000000005 111.003 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.497 ' OE2' ' HA ' ' A' ' 76' ' ' ASP . 22.5 mt-10 -96.21 -33.96 11.83 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 120.579 -0.449 . . . . 74.430000000000007 110.987 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.77 -179.22 48.39 Favored Glycine 0 C--N 1.302 -1.334 0 C-N-CA 120.131 -1.033 . . . . 30.399999999999999 112.418 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.7 p -145.74 138.17 25.63 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.201 0.6 . . . . 73.040000000000006 110.409 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.0 mp -120.5 124.75 46.16 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.373 -0.973 . . . . 75.510000000000005 108.373 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.2 mm -93.96 138.02 21.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.983 -0.747 . . . . 65.209999999999994 108.983 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -126.39 112.09 15.24 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.091 -1.077 . . . . 75.150000000000006 108.091 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.92 116.41 13.39 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.671 -0.695 . . . . 75.109999999999999 110.746 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -109.03 152.2 25.32 Favored 'General case' 0 N--CA 1.396 -3.156 0 N-CA-C 102.296 -3.224 . . . . 74.549999999999997 102.296 171.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.82 -40.53 29.58 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.981 0.734 . . . . 42.299999999999997 112.981 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -85.16 -49.24 8.4 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.31 0.576 . . . . 74.349999999999994 112.019 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -138.47 127.07 14.18 Favored Pre-proline 0 C--N 1.283 -2.297 0 CA-C-N 115.718 -0.674 . . . . 71.409999999999997 112.334 -168.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.84 101.5 1.2 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.585 2.19 . . . . 64.329999999999998 108.689 166.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.39 152.16 3.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.773 -0.825 . . . . 71.329999999999998 108.773 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.76 119.99 4.53 Favored Glycine 0 CA--C 1.473 -2.555 0 C-N-CA 118.632 -1.746 . . . . 61.100000000000001 111.989 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -87.83 106.18 17.91 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 106.675 -1.602 . . . . 75.549999999999997 106.675 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.5 t -96.14 130.56 44.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 115.326 -0.852 . . . . 74.120000000000005 109.659 -177.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.8 mp -102.95 117.91 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.606 0 CA-C-N 115.079 -0.964 . . . . 63.109999999999999 108.945 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.644 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 7.4 m-85 -98.48 163.38 12.71 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.854 -1.066 . . . . 75.340000000000003 108.992 172.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.497 ' HA ' ' OE2' ' A' ' 58' ' ' GLU . 10.7 t70 -51.27 -39.27 56.37 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 123.944 0.778 . . . . 74.019999999999996 111.65 176.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.8 m -160.7 166.17 29.24 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.181 -0.918 . . . . 43.009999999999998 110.428 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.572 ' HD3' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -55.28 -32.66 62.57 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.975 0.91 . . . . 74.109999999999999 111.029 176.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.45 ' HA ' ' OE2' ' A' ' 82' ' ' GLU . . . -64.35 -26.07 68.31 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.825 0.821 . . . . 53.039999999999999 110.534 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.77 -44.27 5.51 Favored Glycine 0 C--N 1.285 -2.284 0 N-CA-C 109.855 -1.298 . . . . 62.439999999999998 109.855 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.95 -39.23 91.4 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.379 -0.91 . . . . 71.030000000000001 110.932 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.45 ' OE2' ' HA ' ' A' ' 79' ' ' ALA . 14.8 pt-20 -62.75 -41.48 99.23 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 123.139 0.274 . . . . 64.340000000000003 110.764 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.32 -37.41 80.53 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-O 121.28 0.562 . . . . 73.049999999999997 110.673 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HA ' ' CE2' ' A' ' 54' ' ' PHE . . . -69.54 -42.7 74.26 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.618 -0.719 . . . . 74.25 111.411 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 82' ' ' GLU . 14.9 ptmm? -70.08 -33.45 71.92 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.331 -0.548 . . . . 73.049999999999997 110.8 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.12 -44.11 95.14 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 123.432 0.458 . . . . 72.340000000000003 110.921 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.72 -41.5 23.5 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 120.288 -0.565 . . . . 72.219999999999999 112.009 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.411 ' O ' HG22 ' A' ' 91' ' ' ILE . 94.3 mt -89.08 -20.66 24.04 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 116.335 1.976 . . . . 75.430000000000007 116.335 -170.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -67.58 115.01 6.69 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 120.1 1.318 . . . . 55.310000000000002 110.083 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.43 13.72 16.32 Favored Glycine 0 N--CA 1.415 -2.75 0 CA-C-N 115.69 -0.686 . . . . 75.540000000000006 111.472 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 88' ' ' LEU . 14.5 tt -92.12 132.86 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.652 0 CA-C-O 121.411 0.624 . . . . 72.200000000000003 110.068 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.435 ' HB3' ' O ' ' A' ' 94' ' ' ASP . 30.2 mmt180 -63.81 137.23 57.96 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.854 -1.066 . . . . 65.219999999999999 108.248 172.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.499 ' CD1' HD11 ' A' ' 101' ' ' LEU . 7.1 t80 -77.32 -30.77 54.2 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.872 -1.529 . . . . 72.140000000000001 106.872 174.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.617 ' OD2' ' HB3' ' B' ' 45' ' ' ARG 0.294 5.0 m-20 -144.66 136.92 13.24 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 100.823 -3.769 . . . . 61.520000000000003 100.823 171.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.586 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 49.3 Cg_endo -71.88 -5.9 18.02 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 CA-C-N 121.943 1.729 . . . . 74.230000000000004 109.815 172.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -94.94 6.43 49.07 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.986 1.314 . . . . 75.420000000000002 109.154 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.611 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 48.4 t-20 -129.21 131.25 23.56 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 108.825 -0.806 . . . . 74.319999999999993 108.825 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -70.44 -6.46 18.98 Favored 'Trans proline' 0 C--O 1.25 1.121 0 C-N-CA 123.361 2.707 . . . . 75.450000000000003 113.082 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.414 ' HA ' ' OE1' ' A' ' 99' ' ' GLN . 5.9 tp60 -84.54 118.72 24.5 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 108.927 -0.768 . . . . 73.0 108.927 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.474 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 37.0 p -120.4 146.39 46.24 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.558 -0.746 . . . . 73.019999999999996 109.138 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.499 HD11 ' CD1' ' A' ' 93' ' ' PHE . 7.5 mp -80.8 137.79 36.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.442 0.639 . . . . 64.040000000000006 111.637 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -129.63 105.75 8.26 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 107.263 -1.384 . . . . 73.409999999999997 107.263 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.1 mp -97.94 117.17 31.69 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.047 -0.978 . . . . 63.539999999999999 108.784 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.558 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 32.9 tt0 -136.61 160.43 38.83 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.572 -1.64 . . . . 71.040000000000006 106.572 -177.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -70.0 139.43 52.75 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 119.263 0.938 . . . . 74.230000000000004 110.492 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.28 145.07 46.36 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.337 -0.616 . . . . 71.549999999999997 109.337 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.52 2.19 14.54 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.78 -0.645 . . . . 73.230000000000004 111.536 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.26 115.78 4.78 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.162 -1.051 . . . . 61.210000000000001 108.162 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -69.13 123.21 20.48 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 107.876 -1.157 . . . . 74.510000000000005 107.876 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.6 m . . . . . 0 C--N 1.295 -1.767 0 C-N-CA 120.99 -0.284 . . . . 72.140000000000001 110.636 -174.167 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--O 1.224 -0.246 0 CA-C-O 121.52 0.676 . . . . 75.439999999999998 112.155 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -96.3 -17.38 20.74 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 115.066 -0.97 . . . . 64.219999999999999 110.363 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 13.6 m -99.2 129.65 45.45 Favored 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 114.991 -1.004 . . . . 71.340000000000003 112.83 -170.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.466 HD23 ' H ' ' B' ' 33' ' ' LEU . 2.4 pt? -123.87 151.39 43.52 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 107.241 -1.392 . . . . 71.340000000000003 107.241 174.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.603 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 18.3 p90 -105.4 123.98 48.78 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 121.896 0.855 . . . . 74.439999999999998 109.585 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.463 HG22 ' HG ' ' B' ' 103' ' ' LEU . 43.5 t -97.79 115.41 37.67 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 107.004 -1.48 . . . . 73.140000000000001 107.004 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 23.8 p -119.04 168.36 10.9 Favored 'General case' 0 C--N 1.274 -2.703 0 CA-C-N 115.309 -0.86 . . . . 61.520000000000003 108.786 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 89.69 31.13 11.7 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.749 -0.94 . . . . 72.420000000000002 110.749 -175.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 88.9 mt -104.2 114.31 64.44 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.076 -1.453 . . . . 63.450000000000003 107.076 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.15 156.85 19.09 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.102 1.868 . . . . 74.219999999999999 110.43 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 11.9 p -65.22 -10.51 9.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 122.174 0.988 . . . . 74.409999999999997 111.27 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -98.04 8.3 44.98 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 114.869 -1.059 . . . . 72.010000000000005 110.054 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.49 121.53 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 CA-C-O 121.583 0.706 . . . . 64.420000000000002 111.489 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.48 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 3.2 mptp? -85.58 145.81 42.79 Favored Pre-proline 0 C--N 1.315 -0.906 0 C-N-CA 124.39 1.076 . . . . 74.209999999999994 109.923 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.19 -23.53 74.16 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.526 2.151 . . . . 64.549999999999997 112.972 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.617 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 13.2 ptt180 -77.46 -24.48 50.24 Favored 'General case' 0 N--CA 1.425 -1.681 0 O-C-N 122.279 -0.263 . . . . 63.119999999999997 111.126 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.48 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 43.3 mt-10 -68.09 -33.63 74.9 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.276 0.56 . . . . 74.209999999999994 110.001 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 48.8 mt -63.09 -47.11 84.25 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.281 -1.007 . . . . 70.230000000000004 108.281 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.594 ' O ' ' HG3' ' B' ' 52' ' ' ARG . 11.5 t80 -58.83 -44.62 90.95 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.431 -1.259 . . . . 74.329999999999998 111.175 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 93.5 mt -65.24 -39.14 92.31 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.007 0.432 . . . . 73.319999999999993 110.884 -178.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 34.7 tp -78.97 -40.52 31.49 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 115.931 -0.577 . . . . 71.319999999999993 112.121 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -89.88 0.91 56.78 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 115.519 1.674 . . . . 64.040000000000006 115.519 -174.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 14.3 mtp180 -61.36 -47.52 93.62 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 114.459 1.281 . . . . 73.219999999999999 114.459 176.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -72.08 -4.24 14.79 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.257 1.305 . . . . 73.209999999999994 112.377 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -92.42 93.4 8.57 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.915 0.864 . . . . 72.120000000000005 111.428 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . 0.567 ' HD3' ' H ' ' B' ' 55' ' ' LYS . 0.1 OUTLIER -65.35 111.76 3.19 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.085 -1.416 . . . . 72.049999999999997 110.143 178.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.14 -15.54 4.24 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.331 -0.85 . . . . 75.099999999999994 112.702 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -61.9 109.39 1.24 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 117.099 0.45 . . . . 75.329999999999998 110.747 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -86.56 -38.2 17.4 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.175 -1.046 . . . . 72.239999999999995 108.175 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.7 178.9 40.58 Favored Glycine 0 C--N 1.311 -0.826 0 CA-C-N 115.014 -0.994 . . . . 34.240000000000002 112.023 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.6 p -135.1 148.74 49.9 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 122.456 0.302 . . . . 63.020000000000003 110.973 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 54.3 tp -126.31 111.74 14.89 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.974 -1.121 . . . . 72.400000000000006 107.974 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.43 ' CG2' ' HB2' ' B' ' 69' ' ' PRO . 46.5 mm -94.24 134.34 32.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 110.228 -0.286 . . . . 73.5 110.228 -175.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -124.35 114.91 20.16 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.219 -0.66 . . . . 52.219999999999999 109.219 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.08 125.34 26.36 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.216 0.531 . . . . 74.010000000000005 109.58 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 16.0 m -125.04 159.38 31.48 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 106.145 -1.798 . . . . 61.219999999999999 106.145 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.04 -40.54 15.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.17 0.988 . . . . 44.219999999999999 112.946 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -88.93 -47.7 7.97 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.857 0.688 . . . . 50.299999999999997 112.857 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 26.4 pt20 -155.68 149.0 18.49 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 116.041 -0.527 . . . . 72.400000000000006 110.048 -170.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 49.9 Cg_endo -79.07 108.58 2.41 Favored 'Trans proline' 0 N--CA 1.436 -1.899 0 C-N-CA 122.146 1.898 . . . . 55.119999999999997 109.981 170.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.03 151.32 4.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.5 -0.773 . . . . 53.439999999999998 109.061 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.13 120.69 4.73 Favored Glycine 0 CA--C 1.478 -2.244 0 C-N-CA 118.162 -1.97 . . . . 51.310000000000002 113.681 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -88.41 105.44 17.6 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 106.467 -1.679 . . . . 63.43 106.467 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.417 ' O ' HD23 ' B' ' 33' ' ' LEU . 74.6 t -100.15 130.67 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 CA-C-O 121.421 0.629 . . . . 74.219999999999999 110.3 -176.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.52 119.77 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 CA-C-N 114.708 -1.133 . . . . 74.430000000000007 108.724 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -102.78 168.37 9.28 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 115.208 -0.906 . . . . 62.539999999999999 111.358 174.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.96 -43.67 50.28 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.289 -1.323 . . . . 75.109999999999999 110.792 172.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 11.5 p -166.03 169.68 14.35 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.045 -0.98 . . . . 75.510000000000005 110.894 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . 0.507 ' HD3' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -63.24 -30.53 71.65 Favored 'General case' 0 C--O 1.213 -0.822 0 O-C-N 123.194 0.309 . . . . 75.310000000000002 110.182 176.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.98 67.38 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 122.361 1.077 . . . . 71.0 109.469 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.5 -43.69 5.45 Favored Glycine 0 C--N 1.294 -1.791 0 CA-C-N 113.536 -1.665 . . . . 64.340000000000003 110.678 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.79 -36.9 85.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.556 -0.822 . . . . 72.540000000000006 111.798 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 9.9 pt-20 -60.75 -41.23 94.99 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 120.747 0.308 . . . . 73.329999999999998 110.64 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.72 -39.4 80.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.998 0.428 . . . . 63.229999999999997 110.162 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.29 82.39 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.371 -0.831 . . . . 75.030000000000001 111.198 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' B' ' 82' ' ' GLU . 13.1 ptmm? -69.54 -32.19 70.86 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 116.233 -0.44 . . . . 65.310000000000002 110.861 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -70.95 -28.83 64.76 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 111.987 0.366 . . . . 74.439999999999998 111.987 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.71 -32.8 25.33 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 120.436 -0.505 . . . . 65.439999999999998 111.694 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.558 ' O ' HG22 ' B' ' 91' ' ' ILE . 92.7 mt -107.8 -4.39 18.11 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 115.443 1.645 . . . . 74.530000000000001 115.443 -173.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -79.03 114.78 18.25 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 117.786 -1.566 . . . . 74.209999999999994 110.272 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.9 3.96 48.64 Favored Glycine 0 CA--C 1.479 -2.211 0 C-N-CA 120.564 -0.827 . . . . 73.099999999999994 111.911 174.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.558 HG22 ' O ' ' B' ' 88' ' ' LEU . 15.5 tt -96.5 137.61 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.056 0 N-CA-C 107.312 -1.366 . . . . 73.239999999999995 107.312 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.428 ' HG2' HG22 ' B' ' 100' ' ' THR . 99.4 mtt180 -77.28 142.14 39.62 Favored 'General case' 0 C--N 1.265 -3.071 0 CA-C-O 121.35 0.595 . . . . 62.229999999999997 112.537 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.459 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 39.8 t80 -67.69 -37.0 81.72 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.798 -1.546 . . . . 71.409999999999997 108.991 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.57 ' HB2' ' HB2' ' B' ' 97' ' ' ASN 0.277 3.9 m-20 -131.13 133.81 25.1 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 101.831 -3.396 . . . . 60.340000000000003 101.831 174.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . 0.667 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 18.7 Cg_endo -61.04 -29.9 88.56 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 CA-C-N 121.993 1.748 . . . . 62.509999999999998 112.026 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -94.91 15.93 17.38 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.544 -0.753 . . . . 52.399999999999999 111.133 -175.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' B' ' 94' ' ' ASP . 57.7 t-20 -122.82 131.86 24.33 Favored Pre-proline 0 C--N 1.312 -1.054 0 N-CA-C 107.225 -1.398 . . . . 60.409999999999997 107.225 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.91 -3.42 13.58 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.279 1.986 . . . . 73.200000000000003 112.57 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' GLN . . . . . 0.471 ' HA ' ' OE1' ' B' ' 99' ' ' GLN . 5.8 tp60 -76.59 112.23 12.92 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.958 -0.756 . . . . 74.329999999999998 108.958 177.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.508 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 81.6 p -105.49 144.85 31.68 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.647 -0.706 . . . . 65.109999999999999 110.278 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 81.0 mt -79.53 135.97 36.76 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.431 -0.952 . . . . 64.120000000000005 108.431 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -131.42 112.79 13.01 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.744 -1.206 . . . . 73.420000000000002 107.744 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.463 ' HG ' HG22 ' B' ' 35' ' ' VAL . 7.6 mp -103.12 118.21 36.28 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.601 -0.727 . . . . 64.140000000000001 109.61 177.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.603 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 6.5 tp10 -135.29 157.12 47.71 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 105.684 -1.969 . . . . 74.0 105.684 -177.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -69.33 142.24 54.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 119.74 1.154 . . . . 65.420000000000002 110.961 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.47 153.11 25.79 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.888 -1.153 . . . . 53.520000000000003 107.888 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -94.3 13.01 24.89 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.908 -1.117 . . . . 73.219999999999999 109.235 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.4 114.86 10.44 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.71 -1.218 . . . . 55.509999999999998 107.71 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -85.01 104.44 14.94 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.236 -1.394 . . . . 74.409999999999997 107.236 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 16.3 m . . . . . 0 C--N 1.288 -2.099 0 CA-C-N 116.07 -0.514 . . . . 74.230000000000004 110.895 -170.521 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 105.941 -1.874 . . . . 74.340000000000003 105.941 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 24.2 mtt180 -104.02 0.88 30.41 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.778 -0.769 . . . . 64.409999999999997 111.066 -172.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.1 m -104.69 125.49 50.84 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-O 121.391 0.615 . . . . 73.25 112.597 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.413 HD12 ' CE1' ' A' ' 75' ' ' PHE . 73.5 mt -109.73 138.03 46.68 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.554 -0.906 . . . . 55.530000000000001 108.554 173.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -96.31 110.55 22.86 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 107.345 -1.354 . . . . 74.030000000000001 107.345 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.523 HG22 ' HG ' ' A' ' 103' ' ' LEU . 40.5 t -97.67 124.51 50.68 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.767 0 CA-C-N 114.168 -1.378 . . . . 72.530000000000001 108.623 -176.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.7 p -129.45 164.72 23.08 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.166 -0.924 . . . . 75.150000000000006 110.111 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 92.85 29.89 10.13 Favored Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.924 -0.87 . . . . 50.549999999999997 110.924 -173.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.9 mt -95.23 122.19 60.32 Favored Pre-proline 0 N--CA 1.425 -1.699 0 N-CA-C 106.04 -1.837 . . . . 71.209999999999994 106.04 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -55.41 153.32 28.73 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.161 1.908 . . . . 74.239999999999995 111.7 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.5 p -61.34 -12.91 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.918 0.887 . . . . 74.120000000000005 111.423 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -127.94 40.74 3.63 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.623 -0.88 . . . . 74.120000000000005 108.623 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.7 tt -72.08 132.02 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.459 -0.791 . . . . 72.519999999999996 109.087 172.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.444 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 29.3 mmmt -90.26 145.8 33.47 Favored Pre-proline 0 C--N 1.276 -2.619 0 N-CA-C 108.584 -0.895 . . . . 71.230000000000004 108.584 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.66 -29.3 84.92 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.478 2.119 . . . . 73.239999999999995 111.728 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.522 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 13.2 ptt180 -70.85 -22.06 62.36 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 115.44 -0.8 . . . . 72.409999999999997 111.738 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 38.8 mt-10 -69.47 -38.27 77.66 Favored 'General case' 0 CA--C 1.506 -0.729 0 O-C-N 122.058 -0.401 . . . . 45.109999999999999 110.451 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.22 -34.0 76.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 122.042 0.925 . . . . 55.149999999999999 108.768 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.576 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 56.5 t80 -65.46 -48.83 71.34 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.573 -1.194 . . . . 71.129999999999995 110.169 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 95.5 mt -65.17 -43.57 91.32 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 123.606 0.566 . . . . 71.099999999999994 110.045 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.407 HD13 HD22 ' B' ' 49' ' ' LEU . 34.2 tp -65.59 -43.14 90.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.034 -0.985 . . . . 54.299999999999997 111.147 -176.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -95.73 14.88 21.71 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 113.156 0.799 . . . . 72.239999999999995 113.156 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 3.2 mmp_? -55.37 -51.14 82.4 Favored Pre-proline 0 N--CA 1.486 1.351 0 N-CA-C 112.452 0.538 . . . . 62.020000000000003 112.452 174.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 52' ' ' ARG . 5.4 Cg_exo -81.33 -1.61 11.17 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 121.859 1.706 . . . . 65.439999999999998 112.918 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -93.63 89.74 6.35 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.52 0.676 . . . . 73.209999999999994 111.867 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -65.45 112.22 3.45 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.716 -1.129 . . . . 64.230000000000004 108.597 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 75' ' ' PHE . . . 132.96 -10.56 5.14 Favored Glycine 0 C--N 1.286 -2.206 0 C-N-CA 119.306 -1.426 . . . . 73.409999999999997 112.943 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -69.09 94.81 0.69 Allowed 'General case' 0 C--O 1.243 0.712 0 CA-C-N 117.626 0.713 . . . . 74.310000000000002 109.162 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -84.59 -44.35 13.6 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.032 -0.531 . . . . 62.25 109.879 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -168.8 179.43 41.64 Favored Glycine 0 C--N 1.296 -1.658 0 C-N-CA 120.645 -0.788 . . . . 73.099999999999994 111.867 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.8 p -151.44 140.72 21.37 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 122.801 0.44 . . . . 72.329999999999998 109.844 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.1 tp -111.96 109.56 19.41 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.322 -0.992 . . . . 72.219999999999999 108.322 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.41 129.65 44.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.563 -0.532 . . . . 74.409999999999997 109.563 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -123.4 123.09 39.89 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.37 -0.974 . . . . 74.099999999999994 108.37 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.69 118.06 21.17 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.406 0.622 . . . . 71.109999999999999 110.56 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.2 m -107.99 155.41 20.37 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 104.577 -2.379 . . . . 75.109999999999999 104.577 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.38 -33.71 31.11 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.265 1.209 . . . . 70.25 114.265 -172.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -105.07 -17.45 14.49 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 118.923 -1.111 . . . . 64.319999999999993 113.138 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -164.56 148.73 7.99 Favored Pre-proline 0 C--N 1.321 -0.654 0 C-N-CA 120.662 -0.415 . . . . 72.340000000000003 110.725 -173.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -80.94 121.7 4.1 Favored 'Trans proline' 0 N--CA 1.429 -2.292 0 C-N-CA 121.856 1.704 . . . . 70.530000000000001 109.671 168.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.82 146.94 5.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 107.676 -1.231 . . . . 72.209999999999994 107.676 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.33 120.77 3.13 Favored Glycine 0 CA--C 1.48 -2.13 0 C-N-CA 118.363 -1.875 . . . . 65.239999999999995 113.238 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -88.0 101.82 14.14 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.534 -1.654 . . . . 62.210000000000001 106.534 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.6 t -92.18 126.23 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 CA-C-N 115.688 -0.687 . . . . 65.329999999999998 110.031 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.6 mt -100.83 111.28 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.406 0 CA-C-N 114.287 -1.324 . . . . 55.229999999999997 108.32 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 80.8 m-85 -95.84 169.17 10.19 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 114.926 -1.034 . . . . 62.140000000000001 110.994 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.6 -44.13 97.08 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.304 -1.316 . . . . 72.230000000000004 112.561 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.9 p -152.78 165.71 34.5 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 122.427 -0.171 . . . . 72.420000000000002 111.016 -172.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -27.95 47.51 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.246 -1.02 . . . . 74.030000000000001 108.246 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.44 -26.18 65.38 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.245 -0.888 . . . . 63.130000000000003 108.766 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.46 -40.46 8.38 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.324 -1.11 . . . . 61.439999999999998 110.324 176.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.15 92.92 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.286 0.635 . . . . 54.200000000000003 112.528 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.47 -31.47 70.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 119.769 -0.772 . . . . 64.430000000000007 112.11 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.4 -42.52 68.23 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.148 0.499 . . . . 52.240000000000002 110.018 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.01 -42.36 97.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.651 -0.704 . . . . 74.319999999999993 111.295 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.441 ' CE ' ' HA ' ' A' ' 104' ' ' GLU . 13.8 ptmm? -67.97 -36.9 80.84 Favored 'General case' 0 C--O 1.198 -1.648 0 C-N-CA 120.248 -0.581 . . . . 73.409999999999997 109.85 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -67.15 -19.79 65.65 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 112.974 0.731 . . . . 74.540000000000006 112.974 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.34 -45.57 10.45 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-O 121.276 0.56 . . . . 65.409999999999997 110.236 175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.526 ' O ' HG22 ' A' ' 91' ' ' ILE . 93.8 mt -94.13 -19.16 21.05 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 116.17 1.915 . . . . 73.209999999999994 116.17 -171.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.439 ' HB3' ' H ' ' A' ' 103' ' ' LEU 0.293 0.2 OUTLIER -76.55 116.99 17.75 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 120.662 -1.273 . . . . 54.130000000000003 113.335 -177.196 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.75 19.83 9.39 Favored Glycine 0 N--CA 1.423 -2.225 0 C-N-CA 120.689 -0.767 . . . . 62.329999999999998 112.142 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 88' ' ' LEU . 18.1 tt -112.91 135.84 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.212 0 N-CA-C 108.166 -1.05 . . . . 72.129999999999995 108.166 176.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.486 ' HG2' HG22 ' A' ' 100' ' ' THR . 63.5 mtt180 -72.75 128.11 34.57 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 116.242 -0.435 . . . . 73.209999999999994 109.901 174.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.4 ' CD2' ' HG3' ' B' ' 45' ' ' ARG . 8.6 t80 -57.57 -32.26 66.97 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 124.983 1.427 . . . . 70.420000000000002 109.932 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.611 ' HB2' ' HB2' ' A' ' 97' ' ' ASN 0.284 8.8 m-20 -133.53 140.27 36.39 Favored Pre-proline 0 CA--C 1.496 -1.132 0 N-CA-C 103.326 -2.842 . . . . 54.0 103.326 170.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.513 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 34.7 Cg_endo -70.89 -17.28 32.57 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 CA-C-N 121.229 1.475 . . . . 74.420000000000002 111.771 173.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -86.66 -12.47 48.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.132 0.491 . . . . 62.350000000000001 110.096 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.611 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 44.7 t-20 -103.76 131.98 21.49 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 109.078 -0.712 . . . . 72.219999999999999 109.078 -172.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.421 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 45.1 Cg_endo -70.43 -14.56 34.09 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.465 2.11 . . . . 71.230000000000004 112.407 176.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -65.24 115.89 6.03 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 109.458 -0.571 . . . . 61.219999999999999 109.458 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.486 HG22 ' HG2' ' A' ' 92' ' ' ARG . 60.6 p -102.62 139.92 37.57 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 119.946 -0.701 . . . . 72.519999999999996 110.026 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.9 tp -94.78 123.25 38.13 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.669 -0.864 . . . . 64.120000000000005 108.669 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 102' ' ' ARG . 0.3 OUTLIER -137.32 128.4 27.67 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 119.607 -0.837 . . . . 74.120000000000005 110.473 178.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.523 ' HG ' HG22 ' A' ' 35' ' ' VAL . 5.3 mp -106.65 125.29 50.81 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.315 -1.312 . . . . 63.530000000000001 108.38 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.441 ' HA ' ' CE ' ' A' ' 85' ' ' LYS . 26.0 tt0 -136.32 155.36 50.18 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.818 -1.179 . . . . 60.009999999999998 107.818 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -66.57 132.13 47.53 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 119.028 0.831 . . . . 73.329999999999998 111.822 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.09 152.6 36.76 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.19 -1.041 . . . . 73.019999999999996 108.19 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -93.24 15.59 15.12 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.66 1.219 . . . . 73.239999999999995 110.319 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -153.86 125.83 7.8 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.738 -1.119 . . . . 72.439999999999998 108.373 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.12 123.56 21.0 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.033 -1.099 . . . . 75.129999999999995 108.033 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 C--N 1.269 -2.916 0 N-CA-C 107.327 -1.361 . . . . 61.420000000000002 107.327 -179.862 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.432 -1.328 0 N-CA-C 106.203 -1.777 . . . . 65.400000000000006 106.203 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.523 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 66.5 mtt180 -99.47 -15.7 18.6 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-N 115.567 -0.742 . . . . 62.409999999999997 111.427 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' B' ' 73' ' ' VAL . 31.0 m -105.4 129.16 53.78 Favored 'General case' 1 C--N 1.243 -4.026 0 N-CA-C 113.581 0.956 . . . . 53.340000000000003 113.581 -170.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.492 HD11 ' O ' ' B' ' 81' ' ' ALA . 79.2 mt -106.64 145.78 31.53 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.479 -1.237 . . . . 73.329999999999998 107.883 171.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' B' ' 104' ' ' GLU . 25.5 p90 -104.15 116.28 31.91 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 119.077 -1.049 . . . . 62.32 108.346 173.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.37 118.09 43.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 114.03 -1.441 . . . . 53.299999999999997 107.602 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.5 p -126.37 163.15 23.91 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 109.44 -0.578 . . . . 72.109999999999999 109.44 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 99.5 19.99 18.77 Favored Glycine 0 N--CA 1.423 -2.215 0 N-CA-C 111.826 -0.51 . . . . 41.0 111.826 -172.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 72.4 mt -93.89 120.21 66.1 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 107.915 -1.143 . . . . 73.239999999999995 107.915 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.34 159.6 22.48 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.576 2.184 . . . . 53.240000000000002 111.643 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 7.9 p -70.04 -6.11 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-O 121.94 0.876 . . . . 62.420000000000002 110.922 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -114.48 30.08 7.56 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.108 -1.071 . . . . 72.530000000000001 108.108 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.402 HG22 ' HG2' ' B' ' 69' ' ' PRO . 9.4 tt -58.8 140.32 17.28 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 CA-C-O 121.745 0.783 . . . . 72.329999999999998 111.627 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.636 ' HG2' ' CZ ' ' B' ' 45' ' ' ARG . 0.1 OUTLIER -101.18 143.34 26.4 Favored Pre-proline 0 C--N 1.293 -1.872 0 C-N-CA 125.712 1.605 . . . . 74.239999999999995 108.525 175.056 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -61.79 -27.91 81.15 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.451 2.1 . . . . 63.020000000000003 113.437 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.636 ' CZ ' ' HG2' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -82.7 -10.65 58.82 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 118.228 -1.389 . . . . 65.150000000000006 111.909 -177.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -65.09 -39.4 93.14 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 120.101 -0.639 . . . . 72.510000000000005 109.708 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.31 -33.71 74.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.538 -0.755 . . . . 71.049999999999997 109.806 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.513 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 66.5 t80 -61.94 -50.81 70.63 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.674 -0.694 . . . . 74.230000000000004 110.184 177.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 81.4 mt -62.04 -44.17 97.27 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 124.085 0.865 . . . . 44.009999999999998 109.548 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 20.6 tp -63.17 -44.64 94.88 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.45 -1.25 . . . . 71.019999999999996 110.965 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -93.59 11.39 28.96 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 113.902 1.075 . . . . 74.329999999999998 113.902 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' B' ' 52' ' ' ARG . 5.2 mmp_? -55.25 -51.86 76.21 Favored Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 113.276 0.843 . . . . 75.319999999999993 113.276 175.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' B' ' 52' ' ' ARG . 2.9 Cg_exo -79.26 -1.0 11.2 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.011 1.808 . . . . 74.420000000000002 112.937 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -99.81 99.76 10.61 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-O 122.5 1.143 . . . . 65.109999999999999 112.516 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -73.67 116.09 13.85 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 113.02 -1.9 . . . . 61.219999999999999 109.076 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' B' ' 75' ' ' PHE . . . 143.19 -24.73 2.22 Favored Glycine 0 C--N 1.284 -2.312 0 CA-C-N 114.822 -1.081 . . . . 60.520000000000003 112.103 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -55.67 110.07 0.66 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.512 0.725 . . . . 61.039999999999999 112.488 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -96.11 -49.27 5.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.489 -0.778 . . . . 50.130000000000003 110.368 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -169.68 172.41 43.65 Favored Glycine 0 C--N 1.299 -1.477 0 CA-C-N 115.162 -0.926 . . . . 71.219999999999999 111.413 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.9 p -141.17 137.63 32.83 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 122.531 0.332 . . . . 74.25 110.627 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 28.5 tp -120.33 115.35 23.37 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.897 -1.149 . . . . 75.129999999999995 107.897 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.95 131.47 42.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 109.684 -0.488 . . . . 72.030000000000001 109.684 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -118.55 114.35 22.68 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.309 -0.997 . . . . 72.0 108.309 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.6 119.74 12.86 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.956 -0.757 . . . . 64.319999999999993 108.956 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 25.6 m -114.65 155.25 26.93 Favored 'General case' 0 N--CA 1.401 -2.913 0 N-CA-C 104.662 -2.347 . . . . 64.340000000000003 104.662 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.78 -38.01 14.73 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.69 0.996 . . . . 71.439999999999998 113.69 -173.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -104.29 -15.78 15.36 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 113.239 0.829 . . . . 72.299999999999997 113.239 -174.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.493 ' O ' ' HB ' ' B' ' 65' ' ' THR . 29.4 pt20 -172.64 140.05 0.97 Allowed Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 110.135 -0.32 . . . . 71.530000000000001 110.135 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 68' ' ' GLN . 6.4 Cg_exo -74.54 112.99 3.68 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.846 2.364 . . . . 71.310000000000002 109.672 168.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -90.8 145.31 7.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.648 -0.871 . . . . 75.400000000000006 108.648 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.19 120.1 4.43 Favored Glycine 0 CA--C 1.483 -1.914 0 C-N-CA 118.917 -1.611 . . . . 60.219999999999999 112.775 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.91 103.06 15.82 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.579 -1.267 . . . . 75.219999999999999 107.579 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' B' ' 32' ' ' THR . 59.3 t -98.25 127.36 50.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-N 115.725 -0.67 . . . . 71.299999999999997 110.687 -175.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 53.3 mt -98.44 128.76 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 CA-C-N 114.842 -1.072 . . . . 63.130000000000003 108.814 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . 0.523 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 85.3 m-85 -109.03 159.47 16.82 Favored 'General case' 0 C--N 1.271 -2.837 0 N-CA-C 107.799 -1.185 . . . . 64.209999999999994 107.799 174.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.13 -40.09 94.77 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 112.469 0.544 . . . . 75.340000000000003 112.469 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 2.9 p -143.69 155.61 44.27 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 116.046 -0.524 . . . . 63.030000000000001 111.707 -174.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . 0.597 ' HD3' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -59.69 -35.18 73.98 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 123.398 0.436 . . . . 73.030000000000001 110.898 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.6 -32.31 73.74 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 122.008 0.909 . . . . 64.439999999999998 109.49 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.47 -37.44 35.76 Favored Glycine 0 C--N 1.31 -0.864 0 CA-C-N 114.021 -1.445 . . . . 73.230000000000004 110.493 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.492 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -70.03 -45.3 67.47 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.848 -0.676 . . . . 55.119999999999997 111.517 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.94 -37.19 85.37 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.289 -0.564 . . . . 71.140000000000001 111.425 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.46 -35.99 81.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.853 0.359 . . . . 44.219999999999999 110.268 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.65 74.74 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.716 -0.675 . . . . 73.310000000000002 111.464 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.407 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 13.8 ptmm? -66.65 -40.18 88.56 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 119.743 -0.783 . . . . 72.239999999999995 110.619 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -60.53 -30.62 69.87 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.173 0.435 . . . . 53.299999999999997 112.173 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.18 -36.36 19.54 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.33 -0.548 . . . . 41.229999999999997 111.969 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.457 ' O ' HG22 ' B' ' 91' ' ' ILE . 91.2 mt -96.97 -23.38 16.33 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 116.042 1.867 . . . . 53.399999999999999 116.042 -172.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . 0.48 ' HB3' ' H ' ' B' ' 103' ' ' LEU . 0.2 OUTLIER -76.34 123.11 25.43 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.202 1.186 . . . . 73.409999999999997 114.202 -175.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.34 27.13 6.27 Favored Glycine 0 CA--C 1.483 -1.907 0 C-N-CA 120.316 -0.945 . . . . 74.019999999999996 111.582 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.457 HG22 ' O ' ' B' ' 88' ' ' LEU . 18.8 tt -124.44 142.96 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.395 0 N-CA-C 106.316 -1.735 . . . . 74.349999999999994 106.316 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.587 ' HG2' HG22 ' B' ' 100' ' ' THR . 96.3 mtt180 -74.21 145.82 43.83 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-O 121.098 0.475 . . . . 73.129999999999995 111.164 176.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -74.03 -33.24 63.68 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.166 -1.379 . . . . 74.140000000000001 108.199 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.575 ' HB2' ' CB ' ' B' ' 97' ' ' ASN . 4.8 m-20 -136.08 130.32 18.37 Favored Pre-proline 0 CA--C 1.511 -0.533 0 N-CA-C 103.456 -2.794 . . . . 75.430000000000007 103.456 173.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . 0.576 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 17.5 Cg_endo -58.26 -34.82 98.97 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.024 1.816 . . . . 52.119999999999997 112.479 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.17 1.57 39.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.816 -0.629 . . . . 75.209999999999994 111.782 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' ASN . . . . . 0.575 ' CB ' ' HB2' ' B' ' 94' ' ' ASP . 48.1 t30 -114.12 128.07 26.18 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 109.575 -0.528 . . . . 74.450000000000003 109.575 -175.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.12 -7.16 20.48 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 122.82 2.347 . . . . 71.319999999999993 112.016 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' GLN . . . . . 0.543 ' HB3' ' ND2' ' B' ' 97' ' ' ASN . 6.4 tp60 -75.01 112.12 10.91 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.099 -1.074 . . . . 71.25 108.099 174.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.587 HG22 ' HG2' ' B' ' 92' ' ' ARG . 82.2 p -101.96 151.88 21.6 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.76 -0.655 . . . . 74.209999999999994 109.398 -174.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 42.0 tp -98.81 121.0 40.19 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.958 -1.127 . . . . 71.329999999999998 107.958 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -131.93 138.53 48.4 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-O 121.344 0.593 . . . . 64.329999999999998 109.511 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' B' ' 89' ' ' ASN . 5.9 mp -122.36 118.41 28.36 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.944 -1.026 . . . . 71.420000000000002 109.137 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.451 ' HB2' ' CE2' ' B' ' 34' ' ' PHE . 9.3 mm-40 -124.21 168.43 12.94 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.966 -1.124 . . . . 43.219999999999999 107.966 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -74.35 141.95 45.15 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 109.191 -0.67 . . . . 60.439999999999998 109.191 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.46 144.22 42.22 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 108.163 -1.051 . . . . 64.140000000000001 108.163 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -80.44 6.74 11.45 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.787 0.803 . . . . 71.049999999999997 110.827 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -167.26 131.93 1.95 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.856 -1.905 . . . . 63.32 105.856 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -66.34 145.65 55.48 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 109.041 -0.725 . . . . 73.439999999999998 109.041 176.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.411 -2.412 0 C-N-CA 119.059 -1.056 . . . . 71.540000000000006 109.15 179.822 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 17.2 t . . . . . 0 N--CA 1.447 -0.59 0 CA-C-O 121.56 0.695 . . . . 74.200000000000003 109.84 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NH2' ' HA ' ' A' ' 76' ' ' ASP . 17.1 ptm180 -111.08 9.68 22.01 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.215 -0.902 . . . . 71.319999999999993 111.459 -172.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.1 m -121.0 125.83 48.37 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.652 -0.704 . . . . 74.430000000000007 109.85 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' A' ' 85' ' ' LYS . 89.7 mt -107.35 152.85 23.6 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.239 -0.891 . . . . 73.519999999999996 108.846 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.59 ' CE1' ' HB2' ' A' ' 104' ' ' GLU . 21.8 p90 -115.18 118.16 32.53 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 117.883 -1.527 . . . . 75.319999999999993 109.056 172.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.8 t -97.63 123.08 49.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 113.797 -1.547 . . . . 74.319999999999993 107.679 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 60.0 p -124.31 175.37 7.12 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.986 -1.116 . . . . 71.030000000000001 107.986 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 88.5 27.21 25.5 Favored Glycine 0 N--CA 1.422 -2.279 0 N-CA-C 111.169 -0.772 . . . . 74.310000000000002 111.169 -176.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.4 mt -103.68 131.64 21.83 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 107.623 -1.251 . . . . 71.340000000000003 107.623 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.86 168.01 21.56 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.791 1.661 . . . . 72.319999999999993 111.094 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.71 -6.2 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-O 122.063 0.935 . . . . 60.509999999999998 110.524 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -124.78 40.4 3.75 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.176 -1.046 . . . . 52.439999999999998 108.176 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.49 125.03 34.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 106.589 -1.634 . . . . 62.420000000000002 106.589 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -93.91 142.24 24.77 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 109.223 -0.658 . . . . 72.010000000000005 109.223 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.24 -21.16 50.71 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.887 2.391 . . . . 62.240000000000002 113.217 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.576 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.3 ptt180 -77.21 -24.48 51.31 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 116.233 -0.439 . . . . 74.519999999999996 110.743 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -70.41 -41.27 73.18 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.0 0.428 . . . . 64.25 110.513 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.47 -39.97 94.82 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 108.728 -0.842 . . . . 74.150000000000006 108.728 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.65 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 30.7 t80 -57.13 -48.24 79.15 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.408 -1.269 . . . . 64.310000000000002 111.292 178.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 88.1 mt -61.53 -40.77 95.88 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.238 0.542 . . . . 73.540000000000006 110.77 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.8 tp -77.23 -40.93 43.13 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.0 -1.0 . . . . 72.019999999999996 111.926 -176.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -88.3 -8.13 55.64 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 115.398 1.629 . . . . 74.409999999999997 115.398 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 54.8 mtp85 -57.79 -43.78 98.94 Favored Pre-proline 0 N--CA 1.48 1.075 0 N-CA-C 114.896 1.443 . . . . 72.040000000000006 114.896 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -67.91 -17.45 46.6 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 121.344 1.362 . . . . 75.129999999999995 112.101 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -86.32 89.6 7.91 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.923 0.868 . . . . 74.230000000000004 110.962 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -65.03 110.76 2.6 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.367 -1.288 . . . . 74.310000000000002 109.769 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.88 -24.72 2.42 Favored Glycine 0 C--N 1.281 -2.522 0 CA-C-N 114.682 -1.144 . . . . 61.409999999999997 111.193 -176.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -58.29 113.03 1.76 Allowed 'General case' 0 C--O 1.242 0.664 0 C-N-CA 122.799 0.44 . . . . 72.340000000000003 111.355 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -91.65 -59.76 2.05 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.37 -0.832 . . . . 51.350000000000001 109.614 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.43 -178.45 39.64 Favored Glycine 0 C--N 1.298 -1.583 0 CA-C-N 115.276 -0.874 . . . . 55.329999999999998 111.449 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.2 p -135.66 137.97 42.36 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 122.532 0.333 . . . . 74.409999999999997 111.345 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.6 tt -107.7 119.97 40.93 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.742 -1.577 . . . . 53.329999999999998 106.742 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -95.66 128.97 46.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 109.661 -0.496 . . . . 64.439999999999998 109.661 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -119.06 109.35 15.81 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 106.51 -1.663 . . . . 73.239999999999995 106.51 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.84 127.78 33.66 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.514 -0.767 . . . . 74.540000000000006 109.777 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 7.1 m -130.32 151.04 51.25 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 105.54 -2.022 . . . . 63.43 105.54 175.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.74 -41.65 10.94 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 114.529 1.307 . . . . 72.420000000000002 114.529 -172.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -105.41 -11.58 16.38 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 114.988 1.477 . . . . 74.150000000000006 114.988 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.417 ' O ' ' HB ' ' A' ' 65' ' ' THR . 29.1 pt20 -166.1 125.69 1.19 Allowed Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 120.95 0.405 . . . . 55.310000000000002 111.671 -175.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.81 108.17 2.64 Favored 'Trans proline' 0 N--CA 1.439 -1.682 0 C-N-CA 122.371 2.047 . . . . 65.540000000000006 108.945 169.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.16 146.92 5.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.639 -0.874 . . . . 62.039999999999999 108.639 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.77 120.72 4.59 Favored Glycine 0 CA--C 1.486 -1.732 0 C-N-CA 118.868 -1.634 . . . . 61.530000000000001 113.499 -176.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -87.74 103.77 15.92 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.999 -1.482 . . . . 74.420000000000002 106.999 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.9 t -94.68 121.8 45.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 114.781 -1.1 . . . . 60.350000000000001 110.818 -174.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 tt -93.33 124.92 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.962 0 CA-C-N 114.822 -1.081 . . . . 74.420000000000002 109.978 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -103.59 155.57 18.44 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 114.817 -1.083 . . . . 72.140000000000001 108.424 173.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.499 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 22.5 t70 -67.98 -34.52 76.69 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.815 -0.63 . . . . 74.319999999999993 110.4 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.7 m -132.49 145.87 51.49 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 107.984 -1.117 . . . . 73.019999999999996 107.984 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.676 ' HB2' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -78.22 -24.38 47.07 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.66 -0.866 . . . . 71.239999999999995 108.66 -179.178 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.13 -25.45 68.36 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.028 0.918 . . . . 53.229999999999997 109.098 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.7 -42.59 6.78 Favored Glycine 0 C--N 1.297 -1.627 0 CA-C-N 113.533 -1.667 . . . . 64.5 109.724 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.28 -49.01 79.48 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.306 0.642 . . . . 70.120000000000005 111.239 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.19 -35.58 73.84 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.264 0.626 . . . . 62.299999999999997 112.234 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.05 -32.23 39.42 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.166 0.508 . . . . 63.399999999999999 111.014 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.73 -46.05 69.91 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.147 -0.479 . . . . 72.420000000000002 111.052 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HB3' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -68.8 -28.08 66.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.135 -0.484 . . . . 64.150000000000006 111.525 -177.2 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -70.28 -40.7 74.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.212 -0.449 . . . . 74.209999999999994 110.496 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.66 -36.99 36.89 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.279 0.474 . . . . 31.32 112.279 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.55 ' O ' HG22 ' A' ' 91' ' ' ILE . 98.5 mt -89.39 -4.48 58.02 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 115.484 1.661 . . . . 71.319999999999993 115.484 -175.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -78.55 118.05 20.3 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 117.86 -1.536 . . . . 74.340000000000003 110.803 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.13 6.53 31.82 Favored Glycine 0 CA--C 1.483 -1.934 0 CA-C-N 115.73 -0.668 . . . . 63.32 112.729 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.9 tt -88.36 121.43 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 109.244 -0.651 . . . . 72.219999999999999 109.244 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.529 ' CG ' HG22 ' A' ' 100' ' ' THR . 71.3 mtt180 -74.53 135.28 42.16 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 116.166 -0.47 . . . . 72.230000000000004 110.311 173.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.516 ' CD1' HD11 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -63.54 -39.23 93.86 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.367 -1.288 . . . . 54.039999999999999 107.697 177.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' A' ' 97' ' ' ASN . 8.2 m-20 -135.41 128.47 18.24 Favored Pre-proline 0 CA--C 1.485 -1.547 0 N-CA-C 104.413 -2.44 . . . . 62.43 104.413 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -56.96 -26.24 66.9 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 121.748 1.632 . . . . 52.039999999999999 111.07 173.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -74.88 -20.68 59.63 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.544 1.138 . . . . 72.310000000000002 110.569 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 36.4 t30 -106.69 124.59 35.06 Favored Pre-proline 0 C--N 1.308 -1.217 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 110.491 -173.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.65 -12.04 33.33 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 123.248 2.632 . . . . 74.340000000000003 113.25 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.497 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 6.5 tp60 -74.09 113.49 11.34 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.31 -0.996 . . . . 72.439999999999998 108.31 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.529 HG22 ' CG ' ' A' ' 92' ' ' ARG . 68.0 p -110.76 145.18 38.55 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.518 -0.764 . . . . 62.149999999999999 110.2 -173.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.561 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.1 mp -78.39 120.51 23.23 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.431 0.634 . . . . 55.43 109.652 175.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 104' ' ' GLU . 0.3 OUTLIER -123.43 112.56 17.68 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 107.224 -1.399 . . . . 74.109999999999999 107.224 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -106.94 127.31 53.33 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.2 -0.909 . . . . 72.129999999999995 110.31 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.59 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 47.3 mt-10 -132.67 174.07 10.68 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.351 -1.351 . . . . 75.409999999999997 107.351 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.469 ' HB3' HG11 ' A' ' 30' ' ' VAL . 61.8 m-85 -79.51 138.62 37.59 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.34 -0.615 . . . . 73.030000000000001 109.34 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.36 152.28 40.93 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.256 -0.646 . . . . 52.329999999999998 109.256 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.539 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 14.0 tmtt? -74.29 -8.15 55.22 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.45 0.643 . . . . 75.140000000000001 110.198 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.54 131.23 9.82 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.733 -0.667 . . . . 73.420000000000002 109.722 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.46 HD21 ' HA ' ' A' ' 30' ' ' VAL . 93.0 m-20 -75.68 143.27 42.24 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.925 -0.579 . . . . 71.230000000000004 110.217 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 C--N 1.296 -1.761 0 N-CA-C 108.855 -0.794 . . . . 75.510000000000005 108.855 178.541 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.472 HG11 ' HB3' ' B' ' 105' ' ' PHE . 16.0 t . . . . . 0 N--CA 1.442 -0.841 0 CA-C-O 121.48 0.657 . . . . 74.030000000000001 110.157 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -104.08 -2.62 25.64 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.446 -0.797 . . . . 75.209999999999994 110.59 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 23.2 m -113.54 127.62 56.15 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 115.507 -0.769 . . . . 71.420000000000002 110.645 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.469 HD13 ' HB3' ' B' ' 85' ' ' LYS . 94.9 mt -104.96 148.3 26.86 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.735 -0.839 . . . . 73.430000000000007 108.735 176.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.435 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 37.1 p90 -105.01 115.66 30.65 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 118.126 -1.429 . . . . 64.25 107.757 171.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.414 HG22 ' HG ' ' B' ' 103' ' ' LEU . 43.5 t -97.05 114.75 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-N 113.99 -1.459 . . . . 65.230000000000004 107.812 -177.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 21.3 p -123.72 174.34 7.54 Favored 'General case' 0 N--CA 1.401 -2.908 0 CA-C-N 114.704 -1.134 . . . . 73.439999999999998 108.72 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 87.92 32.98 11.55 Favored Glycine 0 N--CA 1.421 -2.325 0 N-CA-C 110.241 -1.143 . . . . 61.340000000000003 110.241 -172.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 85.9 mt -105.68 142.87 25.69 Favored Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 107.767 -1.198 . . . . 61.25 107.767 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -75.68 164.3 32.35 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.977 1.784 . . . . 72.140000000000001 110.151 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.432 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 13.8 p -71.23 -8.51 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-O 122.457 1.123 . . . . 63.420000000000002 109.869 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.429 ' O ' ' HD2' ' B' ' 43' ' ' LYS . 13.0 t70 -99.43 10.95 40.43 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.24 -1.345 . . . . 73.129999999999995 109.472 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.402 ' HA ' ' OE2' ' B' ' 46' ' ' GLU . 0.0 OUTLIER -66.65 125.01 23.05 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 CA-C-O 121.886 0.851 . . . . 72.430000000000007 109.79 -178.274 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.519 ' HG3' ' NE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -105.53 142.55 24.98 Favored Pre-proline 0 C--N 1.291 -1.976 0 CA-C-N 114.65 -1.159 . . . . 71.319999999999993 109.517 177.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.75 -26.67 24.3 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 123.762 2.975 . . . . 73.349999999999994 113.632 -174.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.559 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 19.2 ptt180 -66.74 -26.17 66.86 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.879 -0.6 . . . . 73.319999999999993 112.057 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.478 ' HG3' ' HG2' ' B' ' 43' ' ' LYS . 42.3 mt-10 -70.3 -42.85 71.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.784 0.326 . . . . 61.509999999999998 110.945 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -68.01 -33.83 75.35 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 108.71 -0.848 . . . . 72.510000000000005 108.71 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.528 ' O ' ' HG3' ' B' ' 52' ' ' ARG . 62.8 t80 -60.97 -51.38 69.49 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.653 -1.158 . . . . 61.020000000000003 110.098 175.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 92.7 mt -62.84 -40.95 99.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.321 0.582 . . . . 64.099999999999994 110.216 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 25.4 tp -69.63 -41.59 75.42 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.781 -1.1 . . . . 61.340000000000003 111.674 -176.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -94.69 -2.25 51.55 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 114.954 1.464 . . . . 73.109999999999999 114.954 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 30.6 mtp180 -60.94 -43.25 90.71 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.292 0.849 . . . . 60.450000000000003 113.292 173.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.93 -19.93 70.17 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 121.378 1.385 . . . . 74.019999999999996 112.188 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -92.53 90.11 7.02 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 122.364 1.078 . . . . 74.25 110.191 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -76.45 109.35 10.1 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.684 -1.144 . . . . 75.420000000000002 110.05 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.42 -27.51 1.36 Allowed Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 108.986 -1.645 . . . . 65.340000000000003 108.986 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -51.86 123.32 9.99 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.542 1.137 . . . . 73.019999999999996 111.789 173.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -97.2 -60.39 1.59 Allowed 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 109.719 -0.475 . . . . 72.129999999999995 109.719 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.42 168.46 36.64 Favored Glycine 0 C--N 1.292 -1.915 0 C-N-CA 119.567 -1.301 . . . . 51.030000000000001 113.141 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.5 p -126.15 138.06 53.64 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.33 0.586 . . . . 71.450000000000003 110.747 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 49.5 tp -116.27 116.67 28.19 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.47 -0.937 . . . . 51.32 108.47 176.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mp -94.33 131.89 39.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 109.154 -0.684 . . . . 63.039999999999999 109.154 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -130.47 125.96 35.7 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.546 -0.909 . . . . 74.510000000000005 108.546 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -77.39 130.5 37.16 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.013 0.435 . . . . 41.119999999999997 110.774 -175.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.7 m -129.71 151.74 49.97 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 104.244 -2.502 . . . . 75.420000000000002 104.244 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.17 -45.46 8.35 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.376 1.07 . . . . 63.32 113.541 -174.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -88.96 -29.2 19.71 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.624 0.972 . . . . 74.409999999999997 113.624 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.407 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 26.1 pt20 -165.06 132.56 2.39 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-O 120.871 0.367 . . . . 72.319999999999993 111.797 -169.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.432 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 12.0 Cg_exo -71.89 109.96 2.8 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.659 2.24 . . . . 73.329999999999998 108.747 167.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 33.3 m -87.21 151.56 3.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.2 -0.667 . . . . 71.340000000000003 109.2 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.98 121.09 4.59 Favored Glycine 0 C--N 1.297 -1.638 0 C-N-CA 119.271 -1.442 . . . . 54.310000000000002 112.726 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -87.91 104.32 16.5 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.818 -1.549 . . . . 55.509999999999998 106.818 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 98.9 t -100.31 117.35 45.38 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-N 115.028 -0.987 . . . . 64.439999999999998 109.697 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 tt -101.83 131.61 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 115.37 -0.832 . . . . 74.430000000000007 110.466 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -108.7 158.12 17.9 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.438 -1.255 . . . . 74.310000000000002 109.174 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -59.26 -27.12 65.52 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 123.758 0.661 . . . . 75.519999999999996 112.055 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 21.3 m -154.43 157.26 38.19 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.625 -0.672 . . . . 73.340000000000003 110.943 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . 0.627 ' HD3' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -57.97 -32.24 67.67 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.113 0.565 . . . . 73.510000000000005 110.623 175.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.25 -27.69 67.43 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.804 0.812 . . . . 74.219999999999999 110.062 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.88 -37.19 8.64 Favored Glycine 0 C--N 1.301 -1.374 0 N-CA-C 110.244 -1.142 . . . . 72.099999999999994 110.244 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.413 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -67.16 -47.3 71.43 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.455 -0.872 . . . . 51.030000000000001 111.182 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -57.52 -40.7 79.34 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.948 0.351 . . . . 71.310000000000002 111.948 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.05 -35.31 66.69 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 120.944 0.402 . . . . 61.130000000000003 110.945 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.93 -44.19 73.57 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.104 -0.498 . . . . 70.439999999999998 111.254 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.469 ' HB3' HD13 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -71.2 -32.14 68.49 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.146 -0.479 . . . . 71.109999999999999 110.648 -177.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -64.46 -38.78 92.22 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.797 -0.638 . . . . 70.200000000000003 111.092 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.97 -40.06 25.01 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 120.573 -0.451 . . . . 72.140000000000001 112.053 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.575 ' O ' HG22 ' B' ' 91' ' ' ILE . 94.5 mt -93.12 -11.99 31.53 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 116.593 2.072 . . . . 73.439999999999998 116.593 -172.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -78.66 117.64 20.01 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 117.911 -1.516 . . . . 64.319999999999993 110.488 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.04 7.83 37.46 Favored Glycine 0 CA--C 1.485 -1.836 0 C-N-CA 120.434 -0.889 . . . . 53.350000000000001 112.188 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.575 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.5 tt -105.46 140.2 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 107.907 -1.146 . . . . 71.25 107.907 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.559 ' HG3' HG22 ' B' ' 100' ' ' THR . 43.7 mtt85 -70.65 139.9 51.43 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 113.843 1.053 . . . . 74.420000000000002 113.843 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.475 ' CD1' HD21 ' B' ' 101' ' ' LEU . 54.6 t80 -83.43 -25.07 31.58 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.141 -1.845 . . . . 73.319999999999993 108.321 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -149.31 122.71 4.52 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 106.883 -1.525 . . . . 73.519999999999996 106.883 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . 0.65 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 36.8 Cg_endo -62.84 -23.44 74.33 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.057 2.505 . . . . 63.119999999999997 113.993 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -98.18 1.7 47.67 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.266 0.555 . . . . 62.219999999999999 112.126 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -116.71 133.76 23.0 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 108.059 -1.089 . . . . 64.329999999999998 108.059 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.421 ' HA ' HH21 ' B' ' 92' ' ' ARG . 31.8 Cg_exo -64.0 -9.46 19.29 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.796 2.331 . . . . 65.409999999999997 113.061 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' GLN . . . . . 0.455 ' HA ' ' OE1' ' B' ' 99' ' ' GLN . 6.1 tp60 -69.81 111.38 5.52 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.795 0.807 . . . . 72.239999999999995 109.934 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.559 HG22 ' HG3' ' B' ' 92' ' ' ARG . 41.7 p -110.43 145.31 37.84 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.181 -0.918 . . . . 73.040000000000006 109.34 -176.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.475 HD21 ' CD1' ' B' ' 93' ' ' PHE . 91.7 mt -71.18 146.55 49.03 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.295 0.569 . . . . 55.420000000000002 110.521 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -143.84 106.26 4.41 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.338 -1.356 . . . . 74.450000000000003 107.338 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.426 ' O ' ' HE2' ' B' ' 85' ' ' LYS . 6.7 mp -107.67 116.26 31.63 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.486 -0.779 . . . . 73.230000000000004 109.608 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.435 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 9.6 tp10 -129.26 161.55 29.93 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.231 -1.396 . . . . 70.540000000000006 107.231 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . 0.472 ' HB3' HG11 ' B' ' 30' ' ' VAL . 72.3 m-85 -70.06 136.37 50.23 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 118.262 0.483 . . . . 74.030000000000001 110.687 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.48 153.7 43.12 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.068 -0.515 . . . . 73.349999999999994 110.571 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -82.37 5.09 21.44 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 122.184 0.993 . . . . 62.310000000000002 110.054 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -169.6 131.62 1.14 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.507 -1.664 . . . . 62.219999999999999 106.507 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -65.6 97.79 0.33 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.434 -0.58 . . . . 75.349999999999994 109.434 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.418 -2.032 0 CA-C-N 114.792 -1.095 . . . . 55.030000000000001 108.545 -176.708 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.593 ' HA ' ' ND2' ' A' ' 109' ' ' ASN . 47.6 t . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 113.048 0.758 . . . . 74.140000000000001 113.048 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 75' ' ' PHE . 6.6 mpt_? -106.04 6.08 30.85 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-N 115.859 -0.609 . . . . 63.310000000000002 112.104 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.459 ' H ' HG12 ' A' ' 30' ' ' VAL . 18.1 m -135.82 132.46 36.7 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 114.35 1.241 . . . . 72.099999999999994 114.35 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.467 HD11 ' O ' ' A' ' 81' ' ' ALA . 68.9 mt -110.42 151.56 27.35 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.043 -1.095 . . . . 74.329999999999998 108.043 171.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -107.39 114.21 28.08 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 118.808 -1.157 . . . . 63.43 108.036 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.489 HG22 ' HG ' ' A' ' 103' ' ' LEU . 42.2 t -97.99 119.96 46.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.749 0 CA-C-N 113.791 -1.55 . . . . 44.049999999999997 107.9 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.7 p -123.26 165.1 17.5 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 115.204 -0.907 . . . . 73.5 109.628 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 96.36 18.67 30.19 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 111.5 -0.64 . . . . 71.319999999999993 111.5 -174.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.451 HD22 HG13 ' A' ' 42' ' ' ILE . 82.3 mt -89.83 128.87 48.57 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 107.337 -1.357 . . . . 65.439999999999998 107.337 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.41 165.22 32.43 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.684 1.589 . . . . 54.130000000000003 110.991 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 8.9 p -69.32 -5.42 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 122.151 0.976 . . . . 64.340000000000003 110.751 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.555 ' OD2' ' HE2' ' B' ' 43' ' ' LYS . 24.5 t70 -113.56 13.8 18.84 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.207 -0.906 . . . . 74.310000000000002 109.647 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.451 HG13 HD22 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -61.08 129.23 23.57 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 CA-C-O 121.693 0.758 . . . . 75.209999999999994 109.38 -178.221 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 46.1 mmtm -93.59 145.8 30.62 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 115.477 -0.783 . . . . 71.329999999999998 113.031 -176.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.34 -29.02 87.95 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.589 2.193 . . . . 63.299999999999997 112.202 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.623 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -86.37 -12.11 50.15 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 118.885 -1.126 . . . . 64.450000000000003 110.491 177.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 43' ' ' LYS . 43.7 tt0 -77.1 -40.57 45.41 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.377 -0.601 . . . . 71.519999999999996 109.377 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.34 -33.23 75.36 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.684 0.754 . . . . 71.430000000000007 109.221 172.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.623 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 57.2 t80 -61.17 -48.87 79.59 Favored 'General case' 0 C--O 1.202 -1.432 0 CA-C-N 114.467 -1.242 . . . . 73.540000000000006 110.467 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 83.2 mt -66.88 -35.78 80.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.582 0.706 . . . . 60.119999999999997 110.031 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 tp -67.25 -51.31 54.64 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.787 -1.097 . . . . 71.230000000000004 111.287 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -96.41 11.95 33.05 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.493 0.923 . . . . 73.540000000000006 113.493 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 31.8 ttt-85 -70.36 -42.79 16.31 Favored Pre-proline 0 C--N 1.312 -1.061 0 C-N-CA 120.653 -0.419 . . . . 73.109999999999999 112.052 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -77.29 -4.39 14.7 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 121.521 1.48 . . . . 61.210000000000001 111.879 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -89.73 107.18 18.94 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 122.076 0.941 . . . . 60.219999999999999 111.533 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -75.29 110.56 9.74 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 113.707 -1.588 . . . . 54.310000000000002 108.905 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.22 -10.83 5.33 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.457 -0.878 . . . . 72.439999999999998 113.339 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -66.7 112.52 4.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.553 0.677 . . . . 71.439999999999998 111.141 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -90.1 -41.49 11.63 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.238 0.542 . . . . 62.140000000000001 110.424 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.46 -176.93 42.7 Favored Glycine 0 C--N 1.307 -1.066 0 CA-C-N 115.186 -0.915 . . . . 51.439999999999998 111.325 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.467 ' HB3' HG22 ' A' ' 73' ' ' VAL . 20.6 p -148.03 137.9 22.55 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.475 0.546 . . . . 45.200000000000003 112.475 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.4 mp -111.24 126.35 54.78 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.741 -0.837 . . . . 64.430000000000007 108.741 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.2 mm -94.97 143.57 11.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 C-N-CA 122.301 0.24 . . . . 55.340000000000003 110.637 -174.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 69' ' ' PRO . 64.0 tttp -125.95 106.19 9.46 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.847 -0.797 . . . . 71.209999999999994 108.847 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.36 112.79 9.76 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.49 -0.777 . . . . 75.319999999999993 110.443 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 66' ' ' ALA . 2.3 m -110.99 173.21 6.44 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 107.912 -1.144 . . . . 53.32 107.912 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.427 ' H ' HG22 ' A' ' 65' ' ' THR . . . -50.87 -38.51 49.81 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.099 0.959 . . . . 73.109999999999999 112.911 -177.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -104.19 -49.1 3.68 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.48 0.657 . . . . 64.219999999999999 111.467 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -136.92 136.05 20.75 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 114.789 -1.096 . . . . 65.030000000000001 112.316 -166.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 55.7 Cg_endo -81.1 102.36 1.35 Allowed 'Trans proline' 0 N--CA 1.429 -2.287 0 C-N-CA 122.723 2.282 . . . . 72.019999999999996 109.43 168.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -80.22 157.1 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 N-CA-C 109.291 -0.633 . . . . 75.409999999999997 109.291 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.09 123.49 4.83 Favored Glycine 0 CA--C 1.48 -2.144 0 C-N-CA 118.536 -1.792 . . . . 72.510000000000005 113.294 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -87.23 103.01 15.03 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 105.621 -1.992 . . . . 73.209999999999994 105.621 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 60' ' ' SER . 76.1 t -97.8 127.12 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 CA-C-N 115.084 -0.962 . . . . 72.219999999999999 110.495 -174.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 3.0 mp -94.46 129.77 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 CA-C-N 114.482 -1.235 . . . . 74.319999999999993 108.575 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.459 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 89.4 m-85 -117.7 152.24 35.63 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.483 -0.932 . . . . 64.439999999999998 108.483 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -49.89 -38.05 34.05 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 124.548 1.139 . . . . 54.25 112.697 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.5 p -157.04 163.74 38.72 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.528 -0.76 . . . . 61.100000000000001 110.346 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -28.54 63.48 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.208 -0.597 . . . . 73.200000000000003 109.925 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.83 -29.71 70.22 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-O 121.793 0.806 . . . . 74.150000000000006 109.424 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.08 -32.14 26.87 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.585 -1.006 . . . . 74.310000000000002 110.585 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.467 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -67.05 -48.61 67.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 123.506 0.723 . . . . 74.010000000000005 110.976 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.01 -28.68 69.96 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.345 -0.222 . . . . 71.010000000000005 111.301 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.31 -41.02 73.84 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.965 0.412 . . . . 72.310000000000002 110.032 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.99 -42.22 90.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.813 -0.631 . . . . 42.200000000000003 109.64 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 104' ' ' GLU . 34.7 ttmt -59.92 -45.62 92.0 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.558 -0.746 . . . . 75.299999999999997 110.269 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.59 -31.58 69.59 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.819 -0.628 . . . . 72.530000000000001 111.871 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.16 -35.18 17.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 113.025 0.75 . . . . 64.540000000000006 113.025 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 91' ' ' ILE . 97.9 mt -110.72 -5.31 15.02 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 116.724 2.12 . . . . 62.439999999999998 116.724 -170.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -78.7 114.57 17.74 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 117.358 -1.737 . . . . 74.349999999999994 111.199 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.65 12.93 33.78 Favored Glycine 0 CA--C 1.48 -2.132 0 N-CA-C 110.509 -1.036 . . . . 41.409999999999997 110.509 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 88' ' ' LEU . 9.6 tt -90.76 141.08 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.004 0 N-CA-C 108.969 -0.752 . . . . 75.109999999999999 108.969 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -63.21 117.05 6.01 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 108.122 -1.066 . . . . 74.209999999999994 108.122 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' B' ' 45' ' ' ARG . 64.9 t80 -73.86 -28.65 61.69 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.648 -1.612 . . . . 72.129999999999995 106.648 176.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 97' ' ' ASN . 20.8 t0 -144.27 117.03 5.63 Favored Pre-proline 0 N--CA 1.422 -1.843 0 N-CA-C 102.833 -3.025 . . . . 74.540000000000006 102.833 176.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.459 ' HD3' ' CZ ' ' B' ' 48' ' ' TYR . 74.2 Cg_endo -71.81 -20.76 25.75 Favored 'Trans proline' 0 C--N 1.327 -0.554 0 CA-C-N 120.608 1.253 . . . . 64.209999999999994 113.5 -177.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -87.06 -21.1 26.28 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 121.634 0.73 . . . . 64.120000000000005 109.134 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.491 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 46.8 t-20 -99.19 137.02 20.34 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 107.428 -1.323 . . . . 55.009999999999998 107.428 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.38 -13.94 31.83 Favored 'Trans proline' 0 CA--C 1.553 1.454 0 C-N-CA 122.556 2.171 . . . . 62.32 113.623 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -61.71 119.35 8.54 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.857 0.863 . . . . 74.230000000000004 110.593 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.423 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 24.7 p -119.22 147.21 44.5 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.249 -0.432 . . . . 75.200000000000003 110.811 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 24.5 tp -89.87 129.41 36.24 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.551 -0.749 . . . . 73.340000000000003 109.132 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -134.89 128.51 32.77 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.524 -0.547 . . . . 72.299999999999997 109.524 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 35' ' ' VAL . 5.6 mp -113.8 128.01 56.24 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.722 -0.672 . . . . 72.140000000000001 109.439 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.538 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 9.3 tp10 -137.3 163.55 30.7 Favored 'General case' 0 C--O 1.195 -1.785 0 N-CA-C 107.618 -1.253 . . . . 61.340000000000003 107.618 177.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -73.24 133.58 44.02 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 119.229 0.922 . . . . 74.120000000000005 110.498 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.36 155.13 39.7 Favored 'General case' 0 N--CA 1.438 -1.051 0 O-C-N 123.688 0.618 . . . . 45.240000000000002 109.739 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -87.48 7.18 30.47 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.784 0.802 . . . . 73.420000000000002 109.88 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.42 126.05 12.54 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.609 -0.723 . . . . 55.409999999999997 109.45 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.593 ' ND2' ' HA ' ' A' ' 30' ' ' VAL . 3.4 m-20 -79.62 124.89 28.95 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.473 -0.936 . . . . 74.519999999999996 108.473 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.9 m . . . . . 0 C--N 1.276 -2.592 0 N-CA-C 106.854 -1.536 . . . . 74.239999999999995 106.854 179.405 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.459 HG12 ' H ' ' B' ' 32' ' ' THR . 34.8 t . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 121.763 0.792 . . . . 63.450000000000003 112.572 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -90.24 6.45 42.78 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.402 -0.817 . . . . 71.129999999999995 112.188 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . 0.459 ' H ' HG12 ' B' ' 30' ' ' VAL . 18.3 m -129.42 128.42 42.94 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 113.4 0.889 . . . . 61.130000000000003 113.4 -175.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.502 HD11 ' O ' ' B' ' 81' ' ' ALA . 76.3 mt -104.0 148.16 26.53 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.633 -1.247 . . . . 70.140000000000001 107.633 172.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 28.2 p90 -105.98 118.02 35.53 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 118.477 -1.289 . . . . 74.519999999999996 107.565 172.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.485 HG22 ' HG ' ' B' ' 103' ' ' LEU . 39.1 t -100.58 124.32 54.07 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.564 0 CA-C-N 114.157 -1.383 . . . . 44.310000000000002 107.849 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 35.7 p -129.16 168.43 16.15 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 115.339 -0.846 . . . . 50.409999999999997 109.89 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.82 12.07 57.14 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 110.543 -1.023 . . . . 25.41 110.543 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 89.8 mt -80.95 123.59 82.03 Favored Pre-proline 0 N--CA 1.432 -1.328 0 C-N-CA 123.634 0.774 . . . . 72.510000000000005 110.046 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.11 155.29 34.9 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.738 2.292 . . . . 72.329999999999998 111.649 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.481 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 7.4 p -70.32 -4.42 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-O 121.906 0.86 . . . . 74.209999999999994 111.046 -177.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -120.19 22.66 11.31 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.883 -0.784 . . . . 71.129999999999995 108.883 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.41 HD11 HD21 ' B' ' 47' ' ' LEU . 6.6 tt -50.44 132.08 10.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-N 115.077 -0.965 . . . . 44.210000000000001 111.609 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.555 ' HE2' ' OD2' ' A' ' 41' ' ' ASP . 39.6 mmtm -108.54 140.1 21.46 Favored Pre-proline 0 C--N 1.29 -1.994 0 CA-C-N 115.316 -0.857 . . . . 70.329999999999998 112.632 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -53.31 -41.75 70.39 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.73 2.287 . . . . 65.340000000000003 112.401 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.542 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -74.42 -22.76 58.99 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 117.718 -1.593 . . . . 72.200000000000003 111.356 -178.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' B' ' 43' ' ' LYS . 36.4 tt0 -66.46 -41.62 88.77 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.628 -0.879 . . . . 74.140000000000001 108.628 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.439 HD11 HD11 ' B' ' 62' ' ' ILE . 90.1 mt -66.42 -41.75 88.76 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.616 -0.72 . . . . 72.140000000000001 110.011 173.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.583 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 71.6 t80 -52.8 -47.74 67.37 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 124.496 1.118 . . . . 75.420000000000002 111.121 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 88.5 mt -64.47 -37.36 87.26 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 123.31 0.381 . . . . 75.450000000000003 111.118 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.452 HD13 HD22 ' A' ' 49' ' ' LEU . 39.3 tp -75.87 -46.44 30.21 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.824 -0.626 . . . . 72.049999999999997 112.054 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -92.03 4.14 53.71 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.413 0.894 . . . . 71.340000000000003 113.413 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.583 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 53.0 ttt-85 -61.03 -48.44 92.42 Favored Pre-proline 0 CA--C 1.563 1.469 0 N-CA-C 112.656 0.613 . . . . 74.530000000000001 112.656 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.76 -1.71 11.83 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.133 1.889 . . . . 73.310000000000002 112.707 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -84.6 98.72 10.32 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.867 0.842 . . . . 72.140000000000001 110.779 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -66.39 113.84 4.96 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 113.783 -1.553 . . . . 74.120000000000005 109.401 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.15 -16.71 5.72 Favored Glycine 0 C--N 1.285 -2.27 0 CA-C-N 115.105 -0.952 . . . . 42.409999999999997 111.905 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -63.56 103.73 0.57 Allowed 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.246 0.546 . . . . 75.099999999999994 110.937 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -84.26 -45.61 12.68 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.746 -0.835 . . . . 61.549999999999997 108.746 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.25 173.63 42.95 Favored Glycine 0 C--N 1.305 -1.18 0 CA-C-N 114.814 -1.085 . . . . 53.409999999999997 111.768 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.3 p -128.68 141.37 51.36 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 122.542 0.337 . . . . 62.420000000000002 110.61 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 61.7 tp -114.5 110.94 20.6 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.919 -1.141 . . . . 52.020000000000003 107.919 175.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.439 HD11 HD11 ' B' ' 47' ' ' LEU . 50.9 mm -94.06 131.4 41.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 109.882 -0.414 . . . . 75.439999999999998 109.882 -176.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' B' ' 69' ' ' PRO . 60.5 tttp -124.38 115.08 20.39 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.159 0.504 . . . . 73.209999999999994 110.178 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.57 124.67 23.88 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.731 -0.668 . . . . 74.409999999999997 110.748 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 11.2 m -130.26 155.34 46.46 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 103.835 -2.654 . . . . 74.439999999999998 103.835 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.45 -35.17 51.81 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.617 0.969 . . . . 71.030000000000001 113.617 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -87.02 -45.92 10.3 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 119.838 -0.745 . . . . 60.039999999999999 112.537 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -155.35 134.79 7.87 Favored Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 114.921 -1.036 . . . . 65.049999999999997 109.654 -168.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 14.3 Cg_exo -72.19 105.0 1.76 Allowed 'Trans proline' 0 C--N 1.298 -2.09 0 C-N-CA 122.283 1.989 . . . . 64.25 108.076 166.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 36.0 m -77.15 151.2 5.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.594 -0.891 . . . . 73.340000000000003 108.594 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.64 120.88 4.31 Favored Glycine 0 CA--C 1.474 -2.492 0 C-N-CA 117.791 -2.147 . . . . 71.299999999999997 113.124 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -88.29 102.52 14.92 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 105.999 -1.852 . . . . 71.340000000000003 105.999 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 70.6 t -95.2 120.25 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.544 0 CA-C-O 122.089 0.947 . . . . 71.439999999999998 109.761 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 58.3 mt -98.0 123.44 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.723 0 CA-C-N 113.099 -1.864 . . . . 65.409999999999997 109.021 -172.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -114.16 161.21 18.09 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-N 114.6 -1.182 . . . . 71.409999999999997 109.894 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -55.7 -41.39 73.72 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 124.684 1.194 . . . . 72.030000000000001 112.667 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 4.0 p -155.81 162.99 40.39 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.92 -0.582 . . . . 74.430000000000007 110.534 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -28.22 64.57 Favored 'General case' 0 C--O 1.202 -1.408 0 C-N-CA 119.865 -0.734 . . . . 74.540000000000006 109.889 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.0 -27.77 69.05 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.491 0.663 . . . . 52.049999999999997 110.196 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.46 -41.21 6.57 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.995 -1.242 . . . . 74.120000000000005 109.995 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.502 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -61.91 -41.26 97.7 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 114.702 -0.749 . . . . 54.149999999999999 111.827 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.8 -36.24 83.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.548 0.213 . . . . 64.329999999999998 111.168 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.71 -39.28 73.52 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.381 -0.599 . . . . 74.340000000000003 109.381 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.86 -42.2 86.04 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.125 -0.943 . . . . 60.149999999999999 110.286 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' B' ' 104' ' ' GLU . 13.3 ttmt -60.71 -47.89 84.26 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.426 -0.806 . . . . 64.230000000000004 109.636 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -60.14 -38.49 83.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.009 -0.541 . . . . 71.310000000000002 111.11 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.42 -30.95 62.13 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 112.538 0.57 . . . . 71.0 112.538 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.604 ' O ' HG22 ' B' ' 91' ' ' ILE . 98.4 mt -108.52 -12.54 14.98 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 116.002 1.853 . . . . 75.340000000000003 116.002 -174.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -79.56 114.55 18.57 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 120.188 -1.57 . . . . 61.310000000000002 112.024 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.98 9.18 28.59 Favored Glycine 0 CA--C 1.485 -1.829 0 C-N-CA 120.619 -0.8 . . . . 73.439999999999998 111.381 173.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.604 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.6 tt -104.81 149.79 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.803 0 N-CA-C 106.904 -1.517 . . . . 75.340000000000003 106.904 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.44 ' CZ ' ' HA ' ' B' ' 98' ' ' PRO . 99.3 mtt180 -81.39 138.71 35.58 Favored 'General case' 0 C--N 1.267 -2.989 0 CA-C-O 121.523 0.677 . . . . 74.409999999999997 112.192 175.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 43.5 t80 -77.97 -28.54 49.43 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.219 -1.355 . . . . 53.210000000000001 108.117 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.23 127.62 14.76 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 106.106 -1.812 . . . . 75.140000000000001 106.106 175.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . 0.506 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 72.7 Cg_endo -71.58 -21.72 25.34 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.089 1.859 . . . . 72.209999999999994 114.761 -176.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.99 -25.43 29.99 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.527 0.679 . . . . 74.109999999999999 109.717 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -97.2 128.77 33.98 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.475 -0.784 . . . . 72.129999999999995 108.983 -176.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.44 ' HA ' ' CZ ' ' B' ' 92' ' ' ARG . 38.1 Cg_exo -60.64 -16.82 45.55 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 123.241 2.627 . . . . 54.299999999999997 113.179 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -55.46 118.86 4.83 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 124.707 1.203 . . . . 71.230000000000004 110.138 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 33.7 p -104.67 157.97 16.82 Favored 'General case' 0 N--CA 1.413 -2.323 0 C-N-CA 120.115 -0.634 . . . . 70.319999999999993 110.505 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 35.5 tp -96.25 124.66 40.33 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.507 -1.664 . . . . 75.409999999999997 106.507 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -129.62 127.46 40.67 Favored 'General case' 0 N--CA 1.422 -1.84 0 C-N-CA 120.161 -0.616 . . . . 71.329999999999998 109.758 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.485 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.8 mp -114.8 140.92 48.53 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.271 -1.011 . . . . 71.129999999999995 108.271 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.477 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 39.1 tt0 -152.24 165.64 34.24 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.535 -1.654 . . . . 75.510000000000005 106.535 176.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -71.32 138.46 49.31 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 120.077 1.308 . . . . 55.329999999999998 110.983 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.47 154.42 30.56 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.434 -0.58 . . . . 75.25 109.434 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -84.43 1.46 45.31 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 122.126 0.965 . . . . 73.230000000000004 109.432 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.82 118.72 12.52 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.302 -0.863 . . . . 65.120000000000005 109.481 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' B' ' 30' ' ' VAL . 3.8 m-20 -73.42 112.59 9.63 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.549 -1.278 . . . . 43.299999999999997 107.549 175.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 C--N 1.278 -2.52 0 N-CA-C 108.97 -0.752 . . . . 65.530000000000001 108.97 -176.56 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.462 ' HA ' HD21 ' A' ' 109' ' ' ASN . 57.3 t . . . . . 0 N--CA 1.434 -1.232 0 N-CA-C 104.108 -2.553 . . . . 54.0 104.108 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -121.29 -4.15 9.44 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 115.174 -0.921 . . . . 64.319999999999993 110.322 -168.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.7 m -101.99 124.54 47.79 Favored 'General case' 0 C--N 1.264 -3.117 0 CA-C-N 115.132 -0.94 . . . . 54.119999999999997 109.213 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 33' ' ' LEU . 3.2 mp -108.13 137.59 45.85 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 107.308 -1.367 . . . . 75.099999999999994 107.308 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 104' ' ' GLU . 24.2 p90 -103.77 109.16 20.77 Favored 'General case' 0 N--CA 1.412 -2.355 0 C-N-CA 118.473 -1.291 . . . . 74.019999999999996 107.621 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.536 HG22 ' HG ' ' A' ' 103' ' ' LEU . 25.0 t -96.57 120.17 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.752 0 CA-C-N 113.772 -1.558 . . . . 72.109999999999999 107.677 -174.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 20.1 p -126.51 166.78 16.63 Favored 'General case' 0 N--CA 1.4 -2.935 0 CA-C-N 114.644 -1.162 . . . . 63.310000000000002 108.305 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 94.89 32.08 7.36 Favored Glycine 0 N--CA 1.417 -2.619 0 N-CA-C 110.671 -0.972 . . . . 64.099999999999994 110.671 -173.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.4 mt -101.0 145.27 30.11 Favored Pre-proline 0 N--CA 1.428 -1.566 0 N-CA-C 109.081 -0.711 . . . . 54.409999999999997 109.081 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.04 157.69 33.17 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.208 1.939 . . . . 62.340000000000003 110.022 173.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.486 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 7.7 p -76.29 -2.15 4.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-O 122.362 1.077 . . . . 61.030000000000001 109.66 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -128.28 35.13 4.46 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 114.437 -1.256 . . . . 65.209999999999994 108.564 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.98 123.86 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 N-CA-C 108.097 -1.075 . . . . 54.049999999999997 108.097 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 43' ' ' LYS . 4.8 mmpt? -93.65 143.98 27.45 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-N 115.358 -0.837 . . . . 61.100000000000001 110.153 -175.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.09 -19.95 35.5 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.472 2.781 . . . . 73.120000000000005 114.617 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.551 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -87.34 -15.67 37.26 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 118.435 -1.306 . . . . 74.310000000000002 111.644 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -67.32 -41.21 85.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.102 0.477 . . . . 62.32 110.244 -177.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.13 -30.31 67.45 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 116.153 -0.476 . . . . 70.340000000000003 109.833 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.692 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 41.2 t80 -61.88 -51.17 69.28 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.484 -0.78 . . . . 72.140000000000001 110.246 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.94 -38.31 90.51 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.073 -0.512 . . . . 75.200000000000003 110.973 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.8 tp -77.91 -43.02 31.27 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.507 -0.77 . . . . 74.530000000000001 112.289 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -97.62 -2.06 42.4 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 114.441 1.274 . . . . 54.43 114.441 -172.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 32.3 ttt-85 -60.69 -46.09 97.07 Favored Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 112.89 0.7 . . . . 64.219999999999999 112.89 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -75.05 -2.68 12.86 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.095 1.863 . . . . 75.25 112.769 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -83.88 106.21 15.38 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.627 0.727 . . . . 74.409999999999997 110.871 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -68.76 109.95 4.08 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.254 -1.339 . . . . 74.239999999999995 110.115 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.24 -14.28 6.97 Favored Glycine 0 N--CA 1.421 -2.306 0 CA-C-N 114.908 -1.042 . . . . 72.349999999999994 111.576 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -65.93 102.89 0.84 Allowed 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.173 0.511 . . . . 54.210000000000001 110.852 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.417 ' HB2' HG13 ' A' ' 74' ' ' ILE . 7.9 mm-40 -81.16 -57.48 3.49 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.543 -0.91 . . . . 75.299999999999997 108.543 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.08 -174.37 35.45 Favored Glycine 0 C--N 1.303 -1.251 0 CA-C-N 114.911 -1.04 . . . . 52.439999999999998 112.439 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.7 p -146.39 137.88 24.61 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 123.407 0.683 . . . . 65.239999999999995 110.297 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.2 tp -112.06 120.05 40.54 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.558 -0.534 . . . . 61.32 109.558 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 mm -94.01 134.49 31.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.851 -0.796 . . . . 62.109999999999999 108.851 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -134.74 114.13 12.36 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 110.006 -0.368 . . . . 72.310000000000002 110.006 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.82 112.82 2.45 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.36 0.6 . . . . 65.310000000000002 109.514 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -113.86 164.32 13.92 Favored 'General case' 0 N--CA 1.404 -2.756 0 N-CA-C 105.479 -2.045 . . . . 75.140000000000001 105.479 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.97 -38.25 10.39 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.246 1.202 . . . . 54.450000000000003 114.246 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.74 -27.73 13.5 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.455 0.539 . . . . 74.329999999999998 112.455 -174.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -169.93 148.49 3.16 Favored Pre-proline 0 N--CA 1.423 -1.822 0 CA-C-N 115.921 -0.581 . . . . 61.109999999999999 110.7 -168.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.486 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 13.8 Cg_exo -70.24 106.2 1.71 Allowed 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 121.999 1.8 . . . . 63.210000000000001 108.417 165.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.1 m -81.48 158.76 4.08 Favored 'Isoleucine or valine' 0 C--O 1.25 1.081 0 N-CA-C 107.883 -1.155 . . . . 53.109999999999999 107.883 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.88 120.9 2.91 Favored Glycine 0 CA--C 1.484 -1.853 0 C-N-CA 117.668 -2.206 . . . . 73.109999999999999 113.077 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -88.03 102.02 14.35 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.532 -1.285 . . . . 72.0 107.532 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 78.4 t -91.34 123.79 43.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 108.814 -0.81 . . . . 54.509999999999998 108.814 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 58' ' ' GLU . 46.9 pt -107.83 123.73 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.329 0 CA-C-O 122.05 0.929 . . . . 63.450000000000003 111.564 -175.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -100.25 163.82 12.23 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 114.243 -1.344 . . . . 72.0 109.84 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -64.52 -39.86 94.55 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.111 -0.95 . . . . 65.109999999999999 112.461 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 56.0 m -145.21 166.0 26.74 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.742 -0.208 . . . . 62.119999999999997 110.48 -172.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -29.49 64.33 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 120.591 -0.444 . . . . 73.239999999999995 112.081 -176.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.23 -18.98 64.7 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 122.222 1.01 . . . . 65.340000000000003 108.88 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.1 -41.29 10.46 Favored Glycine 0 C--N 1.305 -1.184 0 CA-C-N 114.392 -1.276 . . . . 51.100000000000001 110.033 176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.62 -46.17 76.71 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.684 -0.758 . . . . 73.519999999999996 111.6 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -29.41 70.15 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 111.887 0.329 . . . . 71.129999999999995 111.887 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.55 -40.45 56.84 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 111.304 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.18 -43.23 87.47 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.915 -0.584 . . . . 74.510000000000005 110.953 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 103' ' ' LEU . 14.5 ptmm? -72.08 -31.81 66.45 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.93 -0.708 . . . . 74.209999999999994 110.414 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -58.73 -36.72 74.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.038 0.447 . . . . 74.140000000000001 110.453 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.23 -42.2 16.15 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 120.999 0.428 . . . . 61.219999999999999 111.606 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.433 ' O ' HG22 ' A' ' 91' ' ' ILE . 92.3 mt -98.52 -18.61 18.09 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 117.18 2.289 . . . . 72.510000000000005 117.18 -169.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.335 0.2 OUTLIER -72.42 114.63 10.75 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 117.167 -1.813 . . . . 53.049999999999997 111.946 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.68 14.92 10.71 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 110.461 -1.056 . . . . 64.310000000000002 110.461 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.1 tt -93.2 128.19 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 CA-C-O 121.26 0.553 . . . . 74.450000000000003 109.788 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.714 ' HG3' HG22 ' A' ' 100' ' ' THR . 5.9 ttt180 -83.79 124.82 31.32 Favored 'General case' 0 N--CA 1.402 -2.873 0 N-CA-C 107.68 -1.23 . . . . 72.030000000000001 107.68 173.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.44 ' HB2' ' CD1' ' A' ' 101' ' ' LEU . 3.5 t80 -64.18 -34.25 77.66 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 124.572 1.17 . . . . 73.120000000000005 110.012 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.502 ' HB3' ' HB3' ' B' ' 45' ' ' ARG . 2.8 p-10 -151.64 136.92 10.72 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 105.901 -1.889 . . . . 73.25 105.901 175.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.437 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 73.8 Cg_endo -75.48 -1.27 11.11 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.336 2.024 . . . . 65.140000000000001 114.118 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -92.35 -25.17 18.66 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.285 0.564 . . . . 73.129999999999995 110.019 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -99.29 133.77 21.78 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 108.065 -1.087 . . . . 72.420000000000002 108.065 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.63 -16.74 56.53 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.167 1.911 . . . . 42.020000000000003 112.398 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -62.16 122.33 15.32 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.573 1.149 . . . . 55.100000000000001 110.466 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.714 HG22 ' HG3' ' A' ' 92' ' ' ARG . 26.0 p -119.33 149.71 41.36 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.21 -0.663 . . . . 74.239999999999995 109.21 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.8 mp -88.67 124.09 33.76 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-O 120.789 0.328 . . . . 72.519999999999996 110.715 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -120.37 112.9 19.59 Favored 'General case' 0 N--CA 1.4 -2.964 0 N-CA-C 107.518 -1.29 . . . . 74.099999999999994 107.518 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.536 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.4 mp -87.15 116.22 25.07 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.512 -1.222 . . . . 72.319999999999993 107.822 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.416 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 37.7 mt-10 -118.13 164.74 14.7 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.374 -1.343 . . . . 74.540000000000006 107.374 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -81.7 132.16 35.28 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 118.694 0.679 . . . . 73.420000000000002 109.568 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.41 137.79 48.6 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.837 -1.172 . . . . 73.319999999999993 107.837 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -82.95 12.02 5.43 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.215 1.007 . . . . 61.409999999999997 109.892 -175.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -157.5 118.73 3.61 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 114.421 -1.263 . . . . 73.239999999999995 107.614 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.462 HD21 ' HA ' ' A' ' 30' ' ' VAL . 44.9 m-80 -70.68 138.63 50.81 Favored 'General case' 0 CA--C 1.475 -1.935 0 C-N-CA 120.019 -0.672 . . . . 72.129999999999995 110.329 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.281 -2.372 0 CA-C-N 115.567 -0.742 . . . . 72.209999999999994 110.168 -174.037 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 81.0 t . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 103.748 -2.686 . . . . 74.209999999999994 103.748 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -129.02 7.39 5.52 Favored 'General case' 0 CA--C 1.471 -2.078 0 CA-C-N 115.435 -0.802 . . . . 74.530000000000001 111.803 -169.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 56.6 m -109.58 132.34 54.23 Favored 'General case' 0 C--N 1.264 -3.151 0 N-CA-C 107.554 -1.276 . . . . 64.349999999999994 107.554 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 72' ' ' PHE . 3.4 mp -121.98 151.46 40.77 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.482 -0.933 . . . . 72.239999999999995 108.482 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.438 ' CE1' ' HB2' ' B' ' 104' ' ' GLU . 17.9 p90 -108.13 111.47 23.5 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.787 -1.19 . . . . 75.010000000000005 107.787 175.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 57.2 t -97.57 122.16 48.86 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 CA-C-N 114.094 -1.412 . . . . 71.120000000000005 108.197 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 65.4 p -130.05 174.8 9.44 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.532 -0.758 . . . . 64.310000000000002 110.128 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 88.66 22.87 38.14 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.029 -1.228 . . . . 61.229999999999997 110.029 -172.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 88.4 mt -92.37 132.52 31.8 Favored Pre-proline 0 N--CA 1.412 -2.336 0 N-CA-C 106.179 -1.785 . . . . 53.219999999999999 106.179 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.88 160.24 30.2 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 121.639 1.559 . . . . 74.109999999999999 110.95 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 9.4 p -68.62 -7.92 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-O 122.588 1.185 . . . . 63.200000000000003 109.774 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -121.46 31.92 6.11 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 114.042 -1.435 . . . . 51.049999999999997 108.576 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.25 131.65 33.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 109.091 -0.707 . . . . 74.230000000000004 109.091 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -100.52 136.54 19.92 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-N 115.302 -0.863 . . . . 72.319999999999993 109.655 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -54.62 -24.61 37.65 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 C-N-CA 123.716 2.944 . . . . 74.209999999999994 114.121 -173.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.507 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 10.6 ptt180 -82.5 -15.24 53.16 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 122.081 -0.387 . . . . 61.149999999999999 111.954 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.13 -40.83 82.39 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.31 -0.626 . . . . 71.140000000000001 109.31 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 90.8 mt -68.76 -32.26 71.89 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.463 -0.79 . . . . 63.240000000000002 109.633 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.592 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 75.6 t80 -63.53 -48.17 78.62 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.135 -0.939 . . . . 73.239999999999995 110.033 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 84.9 mt -67.16 -39.93 86.58 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.196 0.522 . . . . 73.409999999999997 110.31 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 tp -74.01 -40.39 62.96 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.954 -1.021 . . . . 71.510000000000005 112.473 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -97.97 -4.18 36.8 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.639 0.978 . . . . 72.450000000000003 113.639 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.592 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 67.7 ttt180 -61.55 -45.07 93.78 Favored Pre-proline 0 CA--C 1.555 1.141 0 N-CA-C 112.665 0.617 . . . . 75.310000000000002 112.665 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.62 -12.99 20.3 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 121.373 1.382 . . . . 63.119999999999997 113.021 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -78.01 110.73 13.21 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 121.953 0.882 . . . . 64.439999999999998 111.48 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -72.38 109.46 6.11 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 113.945 -1.479 . . . . 65.129999999999995 109.363 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.69 -13.78 5.83 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-N 115.522 -0.763 . . . . 52.219999999999999 112.317 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -61.57 117.03 5.23 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.33 0.586 . . . . 73.209999999999994 111.638 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.427 ' HB2' HG13 ' B' ' 74' ' ' ILE . 5.7 mm-40 -96.47 -47.47 5.95 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.487 -0.779 . . . . 63.43 111.034 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.23 177.13 46.73 Favored Glycine 0 C--N 1.294 -1.802 0 C-N-CA 120.015 -1.088 . . . . 65.329999999999998 112.457 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.5 p -135.47 137.78 42.5 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 122.852 0.461 . . . . 62.229999999999997 110.999 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 5.5 mp -117.35 124.4 48.84 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.423 -1.325 . . . . 72.420000000000002 107.423 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 47.2 mm -94.28 146.98 5.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 109.671 -0.492 . . . . 71.25 109.671 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -129.59 106.57 8.83 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.234 -1.395 . . . . 53.32 107.234 176.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -72.44 116.57 13.05 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.99 -1.115 . . . . 71.010000000000005 107.99 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 11.5 m -122.84 155.16 37.19 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 104.98 -2.23 . . . . 62.240000000000002 104.98 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.94 -25.79 65.45 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.905 0.383 . . . . 60.399999999999999 111.698 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -82.11 -45.8 14.7 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 116.062 -0.517 . . . . 70.519999999999996 111.695 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -172.34 145.97 1.57 Allowed Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 108.183 -1.044 . . . . 71.519999999999996 108.183 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 8.2 Cg_exo -72.06 106.38 2.02 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.299 2.0 . . . . 71.150000000000006 109.087 168.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 35.8 m -87.6 157.67 3.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.721 -0.844 . . . . 70.239999999999995 108.721 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.31 120.89 3.33 Favored Glycine 0 CA--C 1.481 -2.067 0 C-N-CA 118.62 -1.753 . . . . 73.120000000000005 112.791 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' B' ' 33' ' ' LEU . 98.0 m-85 -88.16 102.37 14.74 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.342 -1.355 . . . . 73.5 107.342 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 88.4 t -94.13 130.15 43.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.298 0 CA-C-N 114.678 -1.146 . . . . 53.119999999999997 109.703 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' B' ' 58' ' ' GLU . 48.6 pt -106.99 138.64 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.241 0 CA-C-O 121.848 0.832 . . . . 72.319999999999993 110.596 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -119.21 166.08 13.42 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 114.116 -1.402 . . . . 72.120000000000005 111.553 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.75 -40.87 80.73 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.023 -1.444 . . . . 72.340000000000003 112.362 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 5.0 p -157.95 167.64 29.38 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.145 -0.48 . . . . 72.129999999999995 111.399 -170.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.58 -30.11 62.82 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 120.219 -0.593 . . . . 71.430000000000007 109.845 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.48 -24.19 63.75 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.766 0.793 . . . . 43.009999999999998 109.579 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.89 -36.85 9.79 Favored Glycine 0 C--N 1.309 -0.963 0 CA-C-N 114.63 -1.168 . . . . 72.430000000000007 110.581 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.444 ' HB1' HD11 ' B' ' 33' ' ' LEU . . . -65.1 -49.07 71.44 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.717 0.807 . . . . 50.539999999999999 111.002 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.29 -38.66 77.47 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 116.092 -0.504 . . . . 74.140000000000001 111.207 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.6 -40.8 72.99 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.716 -0.674 . . . . 52.329999999999998 111.322 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.82 -41.38 83.15 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 116.161 -0.472 . . . . 73.540000000000006 111.459 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' B' ' 103' ' ' LEU . 15.1 ptmm? -72.02 -36.42 69.68 Favored 'General case' 0 C--O 1.2 -1.533 0 C-N-CA 120.153 -0.619 . . . . 52.140000000000001 109.521 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -58.95 -39.22 81.0 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.316 0.646 . . . . 52.409999999999997 110.081 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.45 -31.37 37.47 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 112.615 0.598 . . . . 71.129999999999995 112.615 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.418 ' O ' HG22 ' B' ' 91' ' ' ILE . 96.2 mt -100.21 -31.49 11.35 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.201 1.926 . . . . 72.109999999999999 116.201 -174.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . 0.251 0.2 OUTLIER -65.91 121.96 16.27 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.448 1.277 . . . . 71.230000000000004 114.448 -173.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.23 14.94 15.21 Favored Glycine 0 N--CA 1.428 -1.874 0 C-N-CA 120.744 -0.741 . . . . 73.239999999999995 112.104 174.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.418 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.5 tt -103.98 140.04 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.909 0 N-CA-C 107.123 -1.436 . . . . 64.099999999999994 107.123 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' B' ' 94' ' ' ASP . 89.4 mtt180 -74.15 134.91 42.83 Favored 'General case' 0 C--N 1.263 -3.163 0 CA-C-O 120.869 0.366 . . . . 65.010000000000005 110.051 171.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.0 t80 -65.49 -34.76 79.02 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.436 -1.256 . . . . 75.5 109.171 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.562 ' HB2' ' HB3' ' B' ' 97' ' ' ASN . 3.0 m-20 -131.4 138.35 32.57 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 102.055 -3.313 . . . . 52.219999999999999 102.055 173.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . 0.692 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 22.1 Cg_endo -63.21 -29.25 73.51 Favored 'Trans proline' 0 N--CA 1.486 1.041 0 CA-C-N 121.911 1.718 . . . . 53.229999999999997 111.001 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.5 -17.36 42.21 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.965 -1.47 . . . . 50.399999999999999 110.916 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' ASN . . . . . 0.562 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . 39.5 t30 -100.43 125.67 38.54 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 109.573 -0.528 . . . . 64.519999999999996 109.573 -175.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.72 -10.71 28.35 Favored 'Trans proline' 0 C--O 1.239 0.554 0 C-N-CA 122.795 2.33 . . . . 74.409999999999997 112.586 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' GLN . . . . . 0.433 ' HB3' ' ND2' ' B' ' 97' ' ' ASN . 6.6 tp60 -70.29 113.06 7.08 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.446 -0.946 . . . . 72.140000000000001 108.446 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.492 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 69.6 p -97.37 145.8 25.79 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.03 -0.532 . . . . 70.349999999999994 109.919 -175.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 52.2 tp -87.85 123.71 32.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.881 -1.155 . . . . 71.049999999999997 107.881 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -136.88 123.33 20.8 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-O 121.669 0.747 . . . . 74.319999999999993 110.337 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.469 ' O ' ' HE2' ' B' ' 85' ' ' LYS . 5.4 mp -107.19 122.52 46.69 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.199 -1.364 . . . . 71.340000000000003 109.391 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.438 ' HB2' ' CE1' ' B' ' 34' ' ' PHE . 48.6 mt-10 -126.29 165.56 18.75 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.206 -1.035 . . . . 65.530000000000001 108.206 174.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -73.81 141.15 46.2 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.807 -0.357 . . . . 74.349999999999994 110.039 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.03 158.8 26.4 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.563 -0.903 . . . . 35.009999999999998 108.563 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -92.26 7.75 41.3 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.956 0.884 . . . . 75.0 109.946 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -157.66 132.67 8.72 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.252 -0.885 . . . . 55.520000000000003 108.916 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -85.32 141.28 30.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.574 -0.528 . . . . 53.530000000000001 109.574 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.292 -1.904 0 N-CA-C 108.498 -0.927 . . . . 74.439999999999998 108.498 175.946 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.411 -2.42 0 N-CA-C 105.669 -1.975 . . . . 74.510000000000005 105.669 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 16.8 ptm180 -114.65 7.09 15.9 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.327 -0.851 . . . . 70.329999999999998 110.42 -175.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.9 m -116.41 117.73 30.75 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.919 0.866 . . . . 64.510000000000005 110.686 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.481 HD23 ' HB3' ' A' ' 85' ' ' LYS . 2.9 mp -98.13 140.73 32.01 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.774 -1.565 . . . . 74.200000000000003 106.774 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.538 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 6.8 p90 -107.54 114.64 28.77 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 117.578 -1.649 . . . . 72.140000000000001 107.979 173.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.447 HG22 ' HG ' ' A' ' 103' ' ' LEU . 43.8 t -97.29 121.05 47.41 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.879 0 CA-C-N 114.375 -1.284 . . . . 72.120000000000005 108.492 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.5 p -124.26 170.77 10.44 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 115.544 -0.753 . . . . 64.140000000000001 109.608 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 82.35 41.42 9.24 Favored Glycine 0 N--CA 1.43 -1.725 0 N-CA-C 110.103 -1.199 . . . . 21.440000000000001 110.103 -173.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.451 ' HB3' HD13 ' A' ' 42' ' ' ILE . 96.4 mt -111.31 123.06 35.98 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 114.23 -0.985 . . . . 73.219999999999999 110.16 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.5 144.08 19.61 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.857 2.372 . . . . 71.329999999999998 110.664 173.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.572 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 7.6 p -73.24 4.75 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 CA-C-O 122.475 1.131 . . . . 71.209999999999994 112.088 -173.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -125.66 13.12 8.04 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.885 -1.052 . . . . 70.5 110.904 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.451 HD13 ' HB3' ' A' ' 38' ' ' LEU . 28.0 pt -53.65 135.68 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 113.453 0.909 . . . . 62.119999999999997 113.453 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -97.18 146.0 30.59 Favored Pre-proline 0 C--N 1.292 -1.894 0 CA-C-N 114.625 -1.17 . . . . 72.540000000000006 109.119 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.13 -26.7 52.03 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.171 2.581 . . . . 72.319999999999993 112.861 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.525 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 9.8 ptt180 -70.86 -23.91 62.41 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 120.858 0.361 . . . . 72.420000000000002 111.328 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -72.63 -40.47 66.39 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.633 -0.877 . . . . 41.340000000000003 108.633 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.2 mt -66.73 -36.78 83.28 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.802 -0.814 . . . . 65.340000000000003 108.802 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.525 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 87.8 t80 -58.62 -47.54 84.04 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-N 114.708 -1.133 . . . . 74.140000000000001 110.253 175.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 97.6 mt -70.91 -30.14 66.4 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.072 0.463 . . . . 71.519999999999996 110.563 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.7 tp -68.62 -51.56 40.95 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.213 -0.903 . . . . 65.010000000000005 110.667 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -95.2 10.59 35.43 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.682 0.623 . . . . 72.420000000000002 112.682 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 10.6 ttp180 -52.65 -50.02 83.01 Favored Pre-proline 0 CA--C 1.565 1.539 0 C-N-CA 124.471 1.108 . . . . 74.349999999999994 113.696 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -85.35 -0.88 9.07 Favored 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 121.588 1.525 . . . . 64.049999999999997 112.74 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -88.72 96.04 10.51 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 122.629 1.204 . . . . 70.219999999999999 112.104 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -69.85 113.54 7.18 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 113.068 -1.878 . . . . 65.230000000000004 109.44 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.99 -24.82 3.25 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 114.956 -1.02 . . . . 63.420000000000002 110.661 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -56.62 115.81 2.76 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.251 0.62 . . . . 51.310000000000002 111.352 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -94.26 -56.58 2.78 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 109.209 -0.663 . . . . 55.399999999999999 109.209 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.22 169.93 40.63 Favored Glycine 0 C--N 1.295 -1.743 0 CA-C-N 115.214 -0.903 . . . . 45.299999999999997 111.6 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.411 ' HB3' HG22 ' A' ' 73' ' ' VAL . 10.4 p -130.55 137.36 49.66 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 120.93 0.395 . . . . 72.230000000000004 110.543 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -121.02 109.73 15.4 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.52 -0.919 . . . . 53.020000000000003 108.52 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.587 ' H ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -93.92 130.84 42.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.098 0.475 . . . . 72.530000000000001 111.287 -177.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 69' ' ' PRO . 87.2 tttt -108.84 112.37 24.59 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.505 -0.924 . . . . 55.049999999999997 108.505 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.1 122.77 15.21 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.789 -0.642 . . . . 73.109999999999999 110.226 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 15.5 m -130.39 159.67 36.3 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 105.669 -1.975 . . . . 65.299999999999997 105.669 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -42.64 -41.78 3.21 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.177 1.391 . . . . 72.030000000000001 114.356 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -105.62 -36.47 7.08 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.331 0.586 . . . . 71.030000000000001 112.542 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.574 ' O ' ' HB ' ' A' ' 65' ' ' THR . 8.3 pt20 -147.3 132.29 8.98 Favored Pre-proline 0 C--N 1.291 -1.953 0 CA-C-N 115.357 -0.838 . . . . 75.299999999999997 111.697 -168.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.572 ' HD3' ' HA ' ' A' ' 40' ' ' VAL . 32.3 Cg_endo -73.06 101.87 1.39 Allowed 'Trans proline' 0 N--CA 1.433 -2.082 0 C-N-CA 121.649 1.566 . . . . 72.430000000000007 108.18 167.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.7 m -70.77 139.12 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 108.685 -0.857 . . . . 63.350000000000001 108.685 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 62' ' ' ILE . . . -108.82 119.79 5.7 Favored Glycine 0 CA--C 1.465 -3.056 0 C-N-CA 118.236 -1.935 . . . . 72.329999999999998 112.939 -174.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -88.73 101.91 14.47 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 105.865 -1.902 . . . . 64.439999999999998 105.865 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 60' ' ' SER . 92.4 t -96.78 121.55 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.504 0 CA-C-N 114.735 -1.12 . . . . 63.030000000000001 108.888 -176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.7 mt -102.02 119.85 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.763 0 CA-C-N 114.601 -1.181 . . . . 72.109999999999999 109.854 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 5.2 m-85 -102.07 156.35 17.6 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 114.373 -1.285 . . . . 72.340000000000003 109.916 176.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -64.47 -30.53 71.56 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.201 -1.363 . . . . 62.530000000000001 112.112 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m -156.27 155.84 33.03 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 121.804 -0.56 . . . . 74.109999999999999 112.205 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.641 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -54.16 -39.15 66.29 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 123.953 0.783 . . . . 72.340000000000003 110.91 175.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.71 -29.56 69.42 Favored 'General case' 0 CA--C 1.493 -1.249 0 O-C-N 123.889 0.743 . . . . 75.310000000000002 110.369 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.01 -45.4 5.1 Favored Glycine 0 C--N 1.295 -1.733 0 CA-C-N 114.469 -1.241 . . . . 73.329999999999998 110.69 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.1 -46.32 88.6 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.479 1.112 . . . . 70.120000000000005 113.137 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 10.0 pt-20 -62.51 -37.11 84.77 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.384 -0.371 . . . . 64.340000000000003 111.327 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.31 -37.63 52.21 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 116.267 -0.424 . . . . 65.430000000000007 110.638 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.76 90.37 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.721 -0.672 . . . . 63.130000000000003 111.661 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.481 ' HB3' HD23 ' A' ' 33' ' ' LEU . 16.1 pttp -75.36 -33.71 61.08 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 118.552 -1.259 . . . . 64.219999999999999 111.85 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.6 -17.15 61.21 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.229 0.538 . . . . 55.32 111.509 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.22 -45.03 14.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 120.998 0.427 . . . . 62.210000000000001 110.285 175.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.555 ' O ' HG22 ' A' ' 91' ' ' ILE . 91.9 mt -91.04 -5.42 55.31 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 114.749 1.389 . . . . 73.219999999999999 114.749 -173.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -78.99 114.77 18.21 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.055 -1.028 . . . . 74.310000000000002 112.627 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.13 20.37 10.56 Favored Glycine 0 CA--C 1.479 -2.216 0 C-N-CA 120.408 -0.901 . . . . 55.530000000000001 111.64 174.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 88' ' ' LEU . 16.0 tt -114.3 142.32 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.276 0 N-CA-C 105.461 -2.051 . . . . 70.540000000000006 105.461 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.49 ' CD ' ' HA ' ' A' ' 95' ' ' PRO . 33.3 ptt180 -87.02 130.09 34.61 Favored 'General case' 0 C--N 1.262 -3.227 0 C-N-CA 119.424 -0.91 . . . . 55.039999999999999 111.335 175.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -60.75 -31.48 70.81 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.701 -1.59 . . . . 71.409999999999997 110.207 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.404 ' OD2' ' HB3' ' B' ' 45' ' ' ARG . 9.4 t0 -142.28 113.27 6.18 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 105.512 -2.033 . . . . 74.0 105.512 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.49 ' HA ' ' CD ' ' A' ' 92' ' ' ARG . 53.0 Cg_exo -61.38 -12.85 25.81 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 122.99 2.46 . . . . 43.43 114.846 -178.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -98.21 -14.45 20.33 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.704 -0.623 . . . . 74.010000000000005 110.177 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -94.79 141.97 24.07 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.705 -0.85 . . . . 64.519999999999996 108.705 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.09 2.35 7.25 Favored 'Trans proline' 0 CA--C 1.549 1.248 0 C-N-CA 122.619 2.213 . . . . 75.019999999999996 114.314 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -92.87 127.78 38.5 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 121.558 -0.714 . . . . 72.510000000000005 109.259 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.556 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 50.6 p -107.08 143.64 34.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.916 -0.401 . . . . 55.119999999999997 109.916 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 34.7 tp -89.37 127.98 35.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.382 -0.97 . . . . 74.519999999999996 108.382 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -136.96 124.01 21.56 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 108.545 -0.909 . . . . 64.450000000000003 108.545 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.447 ' HG ' HG22 ' A' ' 35' ' ' VAL . 5.9 mp -112.83 122.72 48.5 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 115.732 -0.667 . . . . 60.530000000000001 109.85 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.538 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 43.3 mt-10 -127.89 177.43 6.85 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.603 -1.258 . . . . 75.140000000000001 107.603 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -91.02 138.57 31.5 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 118.753 0.706 . . . . 64.019999999999996 111.424 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.75 158.79 33.98 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.443 -0.799 . . . . 60.310000000000002 108.865 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -84.8 -1.98 57.11 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.764 0.792 . . . . 75.450000000000003 109.643 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -151.43 132.56 14.4 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.321 -0.854 . . . . 72.109999999999999 109.623 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -78.11 124.29 27.88 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.645 -0.502 . . . . 70.400000000000006 109.645 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 C--N 1.287 -2.15 0 N-CA-C 108.07 -1.085 . . . . 75.439999999999998 108.07 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.522 ' HA ' HD21 ' B' ' 109' ' ' ASN . 48.5 t . . . . . 0 N--CA 1.43 -1.443 0 N-CA-C 108.816 -0.809 . . . . 75.340000000000003 108.816 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' B' ' 75' ' ' PHE . 15.0 ptm180 -114.49 11.65 17.19 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.208 -0.905 . . . . 72.510000000000005 111.232 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 29.6 m -122.19 122.93 40.31 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.514 0.673 . . . . 71.109999999999999 111.096 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' B' ' 85' ' ' LYS . 2.2 mp -101.63 144.75 29.97 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.075 -1.454 . . . . 62.32 107.075 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.591 ' CE2' ' HB2' ' B' ' 104' ' ' GLU . 9.9 p90 -109.2 116.43 31.9 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 117.412 -1.715 . . . . 62.340000000000003 108.179 171.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.46 120.06 46.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 CA-C-N 113.946 -1.479 . . . . 73.439999999999998 108.225 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . 0.459 ' OG ' ' HG3' ' B' ' 102' ' ' ARG . 11.0 p -128.72 163.03 26.02 Favored 'General case' 0 N--CA 1.408 -2.557 0 CA-C-N 115.505 -0.771 . . . . 73.400000000000006 109.984 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 88.83 37.79 7.19 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 110.648 -0.981 . . . . 42.100000000000001 110.648 -173.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.89 135.79 19.37 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 108.069 -1.086 . . . . 73.430000000000007 108.069 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.06 150.64 23.46 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.081 1.854 . . . . 73.040000000000006 110.194 172.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.527 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 8.1 p -76.75 1.73 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 121.999 0.904 . . . . 62.409999999999997 110.5 -174.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -127.73 20.85 6.53 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.509 -0.769 . . . . 50.340000000000003 110.032 -173.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 24.9 pt -52.6 133.77 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 113.871 1.063 . . . . 74.0 113.871 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' B' ' 43' ' ' LYS . 3.2 mptp? -90.86 147.12 35.26 Favored Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 114.58 -1.191 . . . . 75.400000000000006 109.458 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.84 -28.65 59.21 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.855 2.37 . . . . 64.450000000000003 113.286 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.523 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -79.54 -14.38 58.9 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 117.642 -1.623 . . . . 63.25 111.898 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -69.93 -40.53 75.46 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.818 -0.808 . . . . 72.049999999999997 108.818 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 88.6 mt -66.4 -34.03 77.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.376 -0.829 . . . . 72.349999999999994 109.072 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.523 ' HB3' ' O ' ' B' ' 45' ' ' ARG . 78.9 t80 -60.94 -49.28 78.08 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-N 115.112 -0.949 . . . . 72.310000000000002 110.065 176.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 92.0 mt -70.01 -29.14 66.12 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-O 121.117 0.484 . . . . 74.430000000000007 110.677 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 tp -71.78 -51.03 24.7 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.113 -0.949 . . . . 64.010000000000005 111.121 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -96.8 7.5 46.45 Favored 'General case' 0 C--O 1.217 -0.608 0 N-CA-C 113.674 0.99 . . . . 71.239999999999995 113.674 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 10.0 ttp180 -47.93 -50.83 51.53 Favored Pre-proline 0 CA--C 1.568 1.639 0 N-CA-C 114.505 1.298 . . . . 72.120000000000005 114.505 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' B' ' 52' ' ' ARG . 1.0 OUTLIER -87.62 -1.39 7.46 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 121.685 1.59 . . . . 73.209999999999994 112.98 177.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -86.96 97.17 10.55 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.929 1.347 . . . . 71.450000000000003 111.878 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -69.39 113.25 6.53 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 112.169 -2.287 . . . . 72.340000000000003 109.637 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.26 -20.28 4.23 Favored Glycine 0 N--CA 1.422 -2.295 0 CA-C-N 114.72 -1.127 . . . . 71.150000000000006 111.29 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -57.05 114.98 2.36 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.249 0.62 . . . . 73.409999999999997 112.075 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.36 -51.24 4.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.607 0.718 . . . . 65.299999999999997 109.363 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.17 178.59 42.88 Favored Glycine 0 C--N 1.298 -1.55 0 CA-C-N 115.208 -0.905 . . . . 53.43 112.198 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.414 ' HB3' HG22 ' B' ' 73' ' ' VAL . 6.7 p -134.39 141.08 46.73 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 123.508 0.723 . . . . 64.209999999999994 110.082 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -122.91 112.93 18.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.736 -1.579 . . . . 34.420000000000002 106.736 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.579 HD13 ' H ' ' B' ' 62' ' ' ILE . 0.2 OUTLIER -93.84 137.92 21.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.13 0.49 . . . . 72.340000000000003 111.254 -176.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -124.46 112.14 16.54 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.129 -1.063 . . . . 61.210000000000001 108.129 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.48 116.61 7.66 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.661 -0.496 . . . . 70.239999999999995 109.661 -177.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 8.5 m -111.53 167.38 10.37 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.523 -1.658 . . . . 75.540000000000006 106.523 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.78 -33.11 6.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.231 1.197 . . . . 71.439999999999998 114.231 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 58.7 mtt-85 -104.72 -28.68 11.05 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.665 0.987 . . . . 74.319999999999993 113.665 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -170.7 152.86 3.93 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 116.439 -0.346 . . . . 73.439999999999998 110.155 -165.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 51.4 Cg_endo -77.72 108.24 2.52 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 C-N-CA 122.27 1.98 . . . . 54.149999999999999 109.927 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 31.7 m -76.03 140.23 17.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.372 -1.344 . . . . 71.099999999999994 107.372 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.16 120.84 5.46 Favored Glycine 0 C--N 1.282 -2.438 0 C-N-CA 118.753 -1.689 . . . . 74.310000000000002 112.912 -175.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.4 102.29 14.39 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 105.883 -1.895 . . . . 61.43 105.883 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.414 HG22 ' HB3' ' B' ' 60' ' ' SER . 83.3 t -94.94 124.76 47.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 114.789 -1.096 . . . . 55.439999999999998 109.279 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 60.7 mt -107.35 122.08 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.567 0 CA-C-N 114.41 -1.268 . . . . 75.239999999999995 109.81 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' B' ' 31' ' ' ARG . 4.0 m-85 -105.95 157.2 17.67 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.666 -1.152 . . . . 75.430000000000007 109.697 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.76 -36.26 67.64 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.125 -0.943 . . . . 61.409999999999997 109.868 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.91 134.31 54.85 Favored 'General case' 0 N--CA 1.389 -3.485 0 CA-C-N 115.173 -0.921 . . . . 72.530000000000001 109.406 -170.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -25.09 56.71 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.425 -0.807 . . . . 61.210000000000001 111.218 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.3 -19.81 49.54 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 107.451 -1.315 . . . . 73.25 107.451 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.34 -41.98 8.18 Favored Glycine 0 C--N 1.295 -1.705 0 CA-C-N 113.312 -1.767 . . . . 64.409999999999997 109.22 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.23 -46.91 88.16 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.201 1.0 . . . . 65.420000000000002 112.16 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -58.81 -44.72 90.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.257 -0.429 . . . . 73.519999999999996 111.305 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.71 -36.16 75.68 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.705 -0.68 . . . . 60.0 110.578 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.68 -42.37 91.36 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.881 -0.6 . . . . 53.130000000000003 111.444 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.444 ' HB3' HD23 ' B' ' 33' ' ' LEU . 17.1 pttp -74.27 -36.03 63.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 118.171 -1.412 . . . . 63.32 111.147 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -63.49 -27.47 69.29 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.547 0.529 . . . . 74.349999999999994 111.321 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.31 -43.69 17.18 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 120.672 0.272 . . . . 74.109999999999999 111.388 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.538 ' O ' HG22 ' B' ' 91' ' ' ILE . 95.7 mt -86.22 -8.57 57.69 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.164 1.542 . . . . 53.310000000000002 115.164 -174.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.22 114.59 15.06 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.049 -1.06 . . . . 65.219999999999999 112.813 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.49 14.79 26.86 Favored Glycine 0 N--CA 1.428 -1.851 0 C-N-CA 120.301 -0.952 . . . . 53.520000000000003 112.278 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.538 HG22 ' O ' ' B' ' 88' ' ' LEU . 16.3 tt -106.59 134.43 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.211 0 N-CA-C 106.127 -1.805 . . . . 52.240000000000002 106.127 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' B' ' 95' ' ' PRO . 39.4 ptt180 -78.9 133.11 36.97 Favored 'General case' 0 C--N 1.262 -3.223 0 C-N-CA 119.651 -0.82 . . . . 74.230000000000004 111.168 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -69.13 -28.63 66.63 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.769 -1.559 . . . . 74.340000000000003 110.206 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.435 ' OD2' ' HB3' ' A' ' 45' ' ' ARG . 10.6 t70 -146.57 118.25 4.83 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 106.389 -1.708 . . . . 63.130000000000003 106.389 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . 0.496 ' HA ' ' NE ' ' B' ' 92' ' ' ARG . 21.0 Cg_endo -60.69 -21.45 69.58 Favored 'Trans proline' 0 N--CA 1.48 0.726 0 C-N-CA 123.039 2.493 . . . . 72.310000000000002 114.409 -176.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -85.97 -23.25 26.97 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.508 0.671 . . . . 65.340000000000003 110.27 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -100.62 132.29 22.51 Favored Pre-proline 0 C--N 1.29 -2.002 0 CA-C-N 115.499 -0.773 . . . . 73.299999999999997 109.13 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.08 -0.72 6.74 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.852 2.368 . . . . 72.400000000000006 112.505 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -69.72 112.23 6.04 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.888 -0.782 . . . . 72.530000000000001 108.888 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.47 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 70.3 p -103.48 145.57 29.81 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.903 -0.777 . . . . 73.219999999999999 108.903 -177.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 36.7 tp -89.9 130.67 36.09 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.663 -1.236 . . . . 61.450000000000003 107.663 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.459 ' HG3' ' OG ' ' B' ' 36' ' ' SER . 7.7 ptm180 -138.14 122.53 18.32 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 108.694 -0.854 . . . . 70.340000000000003 108.694 -175.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -117.47 132.37 56.56 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.82 -0.627 . . . . 73.540000000000006 110.18 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.591 ' HB2' ' CE2' ' B' ' 34' ' ' PHE . 36.0 mt-10 -136.43 174.28 10.79 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.19 -1.781 . . . . 73.099999999999994 106.19 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -81.84 145.02 30.62 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 119.128 -1.029 . . . . 74.439999999999998 110.941 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.14 151.73 40.0 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 107.906 -1.146 . . . . 72.019999999999996 107.906 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -75.95 -9.66 58.79 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.004 0.907 . . . . 62.509999999999998 109.888 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.8 127.29 9.33 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.076 -0.965 . . . . 73.010000000000005 108.827 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.522 HD21 ' HA ' ' B' ' 30' ' ' VAL . 93.0 m-20 -71.71 143.73 49.55 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.912 -0.585 . . . . 65.310000000000002 110.976 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 N--CA 1.413 -2.291 0 N-CA-C 108.075 -1.083 . . . . 64.420000000000002 108.075 178.55 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 CA--C 1.502 -0.889 0 N-CA-C 107.465 -1.309 . . . . 63.409999999999997 107.465 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 17.0 ptp180 -113.99 -1.7 13.72 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.069 -0.969 . . . . 74.439999999999998 111.172 -172.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.4 m -111.07 130.57 55.57 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 115.538 -0.755 . . . . 44.109999999999999 110.679 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.451 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.0 pt? -127.78 153.31 46.72 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.903 -0.777 . . . . 75.510000000000005 108.903 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -103.0 120.68 41.08 Favored 'General case' 0 N--CA 1.418 -2.075 0 CA-C-O 121.924 0.869 . . . . 74.040000000000006 108.97 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.0 t -97.59 120.94 47.58 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 CA-C-N 114.388 -1.278 . . . . 71.140000000000001 107.659 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.8 p -128.9 157.44 41.58 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 116.295 -0.411 . . . . 64.209999999999994 110.564 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 98.91 17.44 27.84 Favored Glycine 0 C--N 1.299 -1.525 0 O-C-N 123.675 0.609 . . . . 54.340000000000003 112.734 -178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.467 ' HB3' HG21 ' A' ' 42' ' ' ILE . 96.1 mt -78.72 125.65 83.9 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 106.9 -1.519 . . . . 74.319999999999993 106.9 173.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -58.63 154.57 41.88 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.244 1.296 . . . . 52.32 110.117 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.3 p -73.44 4.8 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 CA-C-O 122.33 1.062 . . . . 74.310000000000002 110.785 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.43 ' O ' ' HE2' ' A' ' 43' ' ' LYS . 18.3 t70 -110.34 13.29 22.95 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 114.574 -1.194 . . . . 60.329999999999998 109.155 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.467 HG21 ' HB3' ' A' ' 38' ' ' LEU 0.266 2.4 pp -58.09 141.43 15.08 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 N-CA-C 114.939 1.459 . . . . 74.430000000000007 114.939 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.435 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 61.1 mmtt -106.5 145.93 32.0 Favored Pre-proline 0 C--N 1.283 -2.313 0 CA-C-N 113.548 -1.66 . . . . 73.430000000000007 106.736 176.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.14 -25.93 65.38 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.223 1.949 . . . . 54.240000000000002 111.94 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.501 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 13.9 ptt180 -69.82 -24.73 63.51 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.574 -0.739 . . . . 70.040000000000006 111.521 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 40.6 mt-10 -69.99 -42.89 72.47 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 120.986 0.422 . . . . 75.430000000000007 110.28 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.01 -37.3 86.91 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.85 0.833 . . . . 63.450000000000003 109.099 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.572 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 23.2 t80 -60.88 -50.47 73.29 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.462 -1.245 . . . . 72.340000000000003 110.905 176.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 95.7 mt -64.16 -41.41 97.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.174 0.511 . . . . 64.109999999999999 110.065 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 tp -67.33 -41.96 84.4 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.741 -1.118 . . . . 74.150000000000006 111.52 -176.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -92.07 -1.32 57.27 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 115.194 1.553 . . . . 63.039999999999999 115.194 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.572 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 12.6 mtp180 -61.51 -45.97 94.11 Favored Pre-proline 0 N--CA 1.479 0.992 0 N-CA-C 113.794 1.035 . . . . 74.239999999999995 113.794 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.28 -16.28 43.66 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 121.166 1.244 . . . . 74.120000000000005 112.513 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -92.65 92.33 7.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.296 1.046 . . . . 64.329999999999998 110.203 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -73.35 113.92 10.98 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 113.753 -1.567 . . . . 74.040000000000006 109.544 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.98 -20.93 2.49 Favored Glycine 0 C--N 1.288 -2.123 0 CA-C-N 114.754 -1.112 . . . . 44.200000000000003 111.657 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -54.47 112.73 1.06 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.553 0.741 . . . . 75.299999999999997 111.969 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -94.26 -45.21 7.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.639 -0.71 . . . . 74.329999999999998 110.932 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.43 178.35 48.32 Favored Glycine 0 C--N 1.298 -1.563 0 C-N-CA 120.27 -0.967 . . . . 65.230000000000004 112.791 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.0 p -143.08 142.17 31.45 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 123.069 0.548 . . . . 45.109999999999999 111.297 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.426 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 5.4 mp -118.8 130.21 55.65 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.247 -1.39 . . . . 74.209999999999994 107.247 173.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.5 mm -109.26 131.92 58.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 118.043 0.383 . . . . 70.430000000000007 111.26 -173.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -120.13 106.83 12.34 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.479 -0.934 . . . . 73.409999999999997 108.479 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -63.21 126.24 26.75 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.802 -1.09 . . . . 60.210000000000001 109.517 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 14.8 m -130.1 153.98 47.93 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 105.565 -2.013 . . . . 72.420000000000002 105.565 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.41 -33.64 31.18 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.164 1.172 . . . . 64.439999999999998 114.164 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -104.19 -35.67 7.94 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 112.768 0.655 . . . . 75.109999999999999 112.768 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.532 ' O ' ' HB ' ' A' ' 65' ' ' THR . 5.4 pm0 -156.88 129.45 4.23 Favored Pre-proline 0 C--N 1.302 -1.477 0 C-N-CA 121.071 -0.251 . . . . 75.420000000000002 110.434 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 38' ' ' LEU . 29.0 Cg_exo -64.15 118.64 5.59 Favored 'Trans proline' 0 N--CA 1.441 -1.577 0 C-N-CA 122.305 2.003 . . . . 65.409999999999997 108.99 167.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.0 140.33 15.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.383 -0.969 . . . . 63.520000000000003 108.383 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 61' ' ' LEU . . . -122.33 122.22 4.98 Favored Glycine 0 C--N 1.289 -2.05 0 C-N-CA 119.775 -1.203 . . . . 64.519999999999996 112.699 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -87.89 103.16 15.4 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.429 -1.693 . . . . 75.299999999999997 106.429 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.44 132.19 47.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 CA-C-N 115.118 -0.947 . . . . 74.230000000000004 110.545 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 110' ' ' THR . 4.7 tt -107.68 129.69 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 CA-C-N 114.893 -1.049 . . . . 71.299999999999997 109.98 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.51 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 14.2 m-85 -108.76 158.33 17.73 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 114.897 -1.047 . . . . 73.25 109.22 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.97 -31.95 73.44 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.872 -0.604 . . . . 72.140000000000001 111.256 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.7 p -133.32 152.13 51.91 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 112.492 0.553 . . . . 45.140000000000001 112.492 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.633 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.89 -35.46 80.06 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 108.591 -0.892 . . . . 63.539999999999999 108.591 175.106 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.61 -19.52 62.11 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 122.556 1.169 . . . . 74.120000000000005 108.316 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.96 -45.64 8.93 Favored Glycine 0 C--N 1.294 -1.779 0 CA-C-N 113.937 -1.483 . . . . 70.420000000000002 110.153 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.29 -42.89 74.87 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.99 -0.605 . . . . 64.530000000000001 111.593 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.477 ' HA ' ' HG2' ' A' ' 85' ' ' LYS 0.27 1.4 pp20? -69.67 -30.24 67.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 112.937 0.717 . . . . 74.5 112.937 -177.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.62 -32.81 68.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.316 0.579 . . . . 32.409999999999997 109.992 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.87 -44.87 68.91 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.438 -0.801 . . . . 72.120000000000005 110.828 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 104' ' ' GLU . 14.1 ptmm? -68.88 -33.11 73.25 Favored 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 120.792 -0.363 . . . . 75.409999999999997 110.209 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -59.73 -41.77 91.66 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.403 0.681 . . . . 63.140000000000001 109.913 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.59 -33.39 18.9 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 112.196 0.443 . . . . 64.140000000000001 112.196 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.596 ' O ' HG22 ' A' ' 91' ' ' ILE . 97.1 mt -94.05 -13.25 27.1 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 115.934 1.827 . . . . 54.329999999999998 115.934 -172.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.313 0.2 OUTLIER -78.79 114.39 17.68 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 116.771 -1.972 . . . . 73.430000000000007 112.633 177.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.26 6.85 25.36 Favored Glycine 0 CA--C 1.492 -1.401 0 C-N-CA 120.746 -0.74 . . . . 74.510000000000005 112.335 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 88' ' ' LEU . 9.1 tt -91.96 130.39 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 N-CA-C 107.844 -1.169 . . . . 74.510000000000005 107.844 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.47 ' HG2' HG22 ' A' ' 100' ' ' THR . 98.6 mtt180 -74.9 130.25 39.07 Favored 'General case' 0 C--N 1.275 -2.631 0 C-N-CA 119.523 -0.871 . . . . 65.200000000000003 109.772 171.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -66.73 -30.04 70.16 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.336 -1.302 . . . . 73.540000000000006 108.284 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -141.58 124.9 9.78 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 104.556 -2.387 . . . . 74.450000000000003 104.556 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.472 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 43.1 Cg_endo -65.01 -27.17 58.04 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 122.197 1.931 . . . . 61.039999999999999 114.454 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -81.92 -24.79 35.42 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.422 -0.955 . . . . 63.310000000000002 108.422 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -84.12 129.45 58.42 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.852 -1.166 . . . . 64.530000000000001 107.852 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.08 -18.49 51.48 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.196 1.931 . . . . 73.400000000000006 112.275 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.425 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 6.1 tp60 -66.48 114.83 5.77 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.261 0.553 . . . . 62.200000000000003 110.485 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.481 ' OG1' ' HD2' ' A' ' 102' ' ' ARG . 32.8 p -98.23 161.78 13.53 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 115.678 -0.692 . . . . 74.019999999999996 109.772 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.5 tp -100.8 126.97 47.41 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.53 -1.285 . . . . 74.349999999999994 107.53 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.481 ' HD2' ' OG1' ' A' ' 100' ' ' THR . 0.1 OUTLIER -127.13 117.16 21.84 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.513 -0.921 . . . . 73.349999999999994 108.513 -176.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.15 123.84 49.86 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.814 -0.63 . . . . 64.329999999999998 110.101 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.5 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 9.1 tp10 -140.52 158.02 44.62 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.45 -1.315 . . . . 64.510000000000005 107.45 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -66.14 140.91 58.24 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 118.715 0.689 . . . . 71.420000000000002 112.847 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.71 158.46 24.21 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 108.375 -0.972 . . . . 71.540000000000006 108.375 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -82.35 -7.56 59.63 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.283 0.563 . . . . 74.120000000000005 110.472 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.0 136.41 28.43 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.958 -0.564 . . . . 44.020000000000003 110.905 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -81.88 124.41 29.68 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.779 -0.646 . . . . 73.519999999999996 109.631 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.411 ' O ' HD12 ' A' ' 74' ' ' ILE . 11.3 t . . . . . 0 N--CA 1.416 -2.163 0 N-CA-C 107.338 -1.356 . . . . 63.520000000000003 107.338 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' B' ' 78' ' ' ARG . 55.0 t . . . . . 0 CA--C 1.502 -0.897 0 N-CA-C 108.71 -0.848 . . . . 72.450000000000003 108.71 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -118.71 4.13 11.62 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.985 0.898 . . . . 73.510000000000005 110.325 -172.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . 0.483 ' HB ' ' HA ' ' B' ' 109' ' ' ASN . 63.5 m -111.52 136.06 51.23 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.688 -1.142 . . . . 62.240000000000002 108.345 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.441 HD23 ' H ' ' B' ' 33' ' ' LEU . 2.1 pt? -131.53 154.37 48.87 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.443 -0.577 . . . . 61.039999999999999 109.443 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.563 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 30.6 p90 -101.97 118.1 36.2 Favored 'General case' 0 N--CA 1.416 -2.171 0 CA-C-O 122.04 0.924 . . . . 61.229999999999997 108.718 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 51.0 t -98.42 122.25 49.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 113.901 -1.5 . . . . 73.319999999999993 107.553 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 22.5 p -127.42 164.57 21.58 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.666 -0.697 . . . . 64.349999999999994 109.603 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 93.95 27.81 11.92 Favored Glycine 0 N--CA 1.424 -2.143 0 O-C-N 123.523 0.514 . . . . 71.510000000000005 111.896 -175.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.405 ' HB3' HG12 ' B' ' 42' ' ' ILE . 98.2 mt -96.55 117.78 65.77 Favored Pre-proline 0 C--N 1.292 -1.91 0 N-CA-C 108.629 -0.878 . . . . 73.420000000000002 108.629 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.76 151.74 14.56 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.882 2.388 . . . . 61.229999999999997 112.001 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.49 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 11.9 p -63.62 -6.69 2.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 123.876 0.87 . . . . 74.319999999999993 112.781 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -121.39 26.31 8.93 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.618 -0.676 . . . . 74.150000000000006 109.775 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.411 HD12 ' O ' ' B' ' 42' ' ' ILE . 2.5 pp -58.43 135.76 22.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 113.203 0.816 . . . . 73.239999999999995 113.203 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -102.31 143.34 26.41 Favored Pre-proline 0 C--N 1.278 -2.53 0 CA-C-N 114.718 -1.128 . . . . 64.540000000000006 109.187 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -51.87 -32.18 45.91 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.79 2.327 . . . . 61.43 112.666 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.524 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 10.7 ptt180 -68.44 -25.44 65.02 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 111.886 0.328 . . . . 64.439999999999998 111.886 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -70.5 -39.63 74.02 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.602 0.715 . . . . 71.439999999999998 109.365 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 77.7 mt -67.71 -34.71 77.41 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 115.007 -0.997 . . . . 72.540000000000006 108.637 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.623 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 51.0 t80 -62.49 -48.44 79.56 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.745 -1.116 . . . . 73.239999999999995 110.102 176.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 93.6 mt -66.22 -40.77 90.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.131 0.491 . . . . 64.319999999999993 110.294 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.3 tp -71.57 -43.42 66.36 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.278 -0.874 . . . . 73.439999999999998 112.048 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -100.07 8.24 44.09 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 113.301 0.852 . . . . 74.209999999999994 113.301 -174.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.623 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 28.5 ttt180 -70.54 -43.34 16.14 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-O 119.349 -0.358 . . . . 74.010000000000005 111.798 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -74.96 -12.73 21.61 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 121.532 1.488 . . . . 73.329999999999998 112.623 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -85.72 110.82 19.59 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.655 0.741 . . . . 75.140000000000001 111.668 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -74.55 112.59 10.89 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.489 -1.232 . . . . 74.329999999999998 111.304 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.13 -19.84 3.84 Favored Glycine 0 N--CA 1.429 -1.77 0 CA-C-N 115.018 -0.992 . . . . 62.009999999999998 112.97 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -56.64 112.6 1.33 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.209 0.528 . . . . 75.439999999999998 112.369 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -93.75 -55.03 3.4 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.751 -0.659 . . . . 72.299999999999997 110.756 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.29 170.71 43.72 Favored Glycine 0 C--N 1.296 -1.667 0 C-N-CA 120.309 -0.948 . . . . 51.439999999999998 112.304 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.417 ' HB3' HG22 ' B' ' 73' ' ' VAL . 12.6 p -132.3 137.12 47.34 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.388 0.514 . . . . 75.409999999999997 112.388 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.408 ' O ' ' HA2' ' B' ' 71' ' ' GLY . 54.8 mt -104.3 113.5 27.1 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.353 -0.98 . . . . 73.049999999999997 108.353 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 43.2 mm -94.38 127.02 46.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 109.208 -0.664 . . . . 62.219999999999999 109.208 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -120.2 114.7 22.31 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.517 -0.92 . . . . 71.209999999999994 108.517 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.37 123.23 19.06 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.866 -0.607 . . . . 55.420000000000002 109.638 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.1 m -128.04 150.44 49.94 Favored 'General case' 0 N--CA 1.402 -2.851 0 N-CA-C 103.923 -2.621 . . . . 74.019999999999996 103.923 174.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.09 -40.16 4.71 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.5 1.296 . . . . 73.430000000000007 114.5 -173.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -100.61 -18.52 16.54 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 112.373 0.509 . . . . 74.129999999999995 112.373 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 24.4 pt20 -169.05 127.32 0.88 Allowed Pre-proline 0 C--N 1.308 -1.234 0 C-N-CA 120.878 -0.329 . . . . 73.150000000000006 111.628 -169.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 10.5 Cg_exo -73.33 101.21 1.32 Allowed 'Trans proline' 0 N--CA 1.437 -1.798 0 C-N-CA 122.363 2.042 . . . . 75.530000000000001 107.99 167.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.97 150.36 4.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.022 -0.536 . . . . 64.040000000000006 109.712 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' B' ' 61' ' ' LEU . . . -123.23 120.65 4.29 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 118.402 -1.856 . . . . 74.409999999999997 112.959 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -88.11 102.52 14.86 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.192 -1.781 . . . . 74.120000000000005 106.192 175.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' B' ' 60' ' ' SER . 60.1 t -99.86 130.21 49.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-N 114.677 -1.147 . . . . 75.129999999999995 110.863 -172.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.502 HD12 ' O ' ' B' ' 110' ' ' THR . 3.7 tt -104.05 127.61 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 0 CA-C-N 115.204 -0.907 . . . . 70.010000000000005 109.613 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' B' ' 81' ' ' ALA . 8.9 m-85 -105.33 154.13 20.69 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.43 -1.322 . . . . 73.239999999999995 107.43 171.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -65.19 -37.04 86.08 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.64 -0.504 . . . . 70.540000000000006 109.64 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 4.2 p -114.86 133.21 56.15 Favored 'General case' 0 N--CA 1.386 -3.673 0 CA-C-O 121.722 0.772 . . . . 75.209999999999994 111.304 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' B' ' 30' ' ' VAL . 0.0 OUTLIER -75.65 -24.46 56.39 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 115.241 -0.891 . . . . 72.140000000000001 110.785 177.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.12 -19.82 39.32 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.906 -1.516 . . . . 63.039999999999999 106.906 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.08 -43.43 10.8 Favored Glycine 0 C--N 1.299 -1.507 0 CA-C-N 113.277 -1.783 . . . . 62.340000000000003 109.637 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' B' ' 75' ' ' PHE . . . -62.41 -35.13 78.26 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.52 -0.84 . . . . 53.439999999999998 110.977 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 1.4 pp20? -69.42 -38.28 77.83 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.29 -0.964 . . . . 73.519999999999996 110.405 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.52 78.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.091 0.472 . . . . 74.140000000000001 110.4 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.03 -44.46 72.65 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.824 -0.625 . . . . 24.309999999999999 111.402 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' B' ' 82' ' ' GLU . 13.2 ptmm? -68.45 -34.71 76.44 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.787 -0.365 . . . . 74.299999999999997 110.475 -177.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -62.51 -28.85 70.13 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.063 -0.517 . . . . 73.019999999999996 110.91 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.75 -41.3 13.41 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 112.305 0.483 . . . . 63.299999999999997 112.305 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.548 ' O ' HG22 ' B' ' 91' ' ' ILE . 97.5 mt -98.62 -8.17 26.79 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 116.192 1.923 . . . . 74.340000000000003 116.192 -169.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 36.0 p30 -69.99 116.11 9.98 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 119.504 1.047 . . . . 72.430000000000007 113.208 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.87 7.07 48.31 Favored Glycine 0 CA--C 1.482 -1.994 0 C-N-CA 120.843 -0.694 . . . . 75.129999999999995 113.068 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.548 HG22 ' O ' ' B' ' 88' ' ' LEU . 14.4 tt -101.58 137.24 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.929 0 N-CA-C 108.168 -1.049 . . . . 74.319999999999993 108.168 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -68.78 132.82 47.43 Favored 'General case' 0 C--N 1.266 -3.036 0 CA-C-O 121.776 0.798 . . . . 71.040000000000006 112.161 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -73.42 -28.35 61.94 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.672 -1.604 . . . . 73.230000000000004 107.848 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.446 ' OD2' ' HB3' ' A' ' 45' ' ' ARG . 9.4 t0 -146.14 114.73 4.59 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 105.417 -2.068 . . . . 62.229999999999997 105.417 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . 0.516 ' HD3' ' CZ ' ' A' ' 48' ' ' TYR . 56.7 Cg_endo -68.74 -19.06 41.83 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.328 2.019 . . . . 62.229999999999997 113.961 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -83.14 -24.69 32.44 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.794 -0.817 . . . . 74.099999999999994 108.794 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -95.54 143.35 25.96 Favored Pre-proline 0 C--N 1.309 -1.174 0 N-CA-C 108.57 -0.9 . . . . 71.140000000000001 108.57 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.11 -3.47 13.84 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 122.068 1.845 . . . . 71.420000000000002 114.224 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -75.87 120.65 21.51 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.992 0.425 . . . . 73.450000000000003 110.893 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.544 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 82.4 p -99.44 154.88 17.87 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 109.202 -0.666 . . . . 73.329999999999998 109.202 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 28.8 tp -94.78 127.92 41.12 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.686 -1.227 . . . . 71.540000000000006 107.686 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -125.63 130.28 51.31 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.567 -1.271 . . . . 74.409999999999997 107.567 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -123.61 116.31 22.9 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 123.366 0.416 . . . . 75.310000000000002 110.317 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.563 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 5.0 tp10 -134.37 156.64 48.15 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.918 -1.512 . . . . 73.209999999999994 106.918 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -66.8 143.43 56.9 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.35 0.977 . . . . 73.109999999999999 111.879 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.86 157.36 24.42 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.896 -0.593 . . . . 61.539999999999999 109.903 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -85.65 7.82 21.89 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.626 0.727 . . . . 71.120000000000005 110.712 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.64 138.88 11.13 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.348 -0.982 . . . . 51.420000000000002 108.348 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.483 ' HA ' ' HB ' ' B' ' 32' ' ' THR . 94.3 m-20 -82.88 158.56 22.63 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-O 121.228 0.537 . . . . 63.420000000000002 109.928 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.502 ' O ' HD12 ' B' ' 74' ' ' ILE . 14.2 t . . . . . 0 C--N 1.285 -2.216 0 N-CA-C 106.939 -1.504 . . . . 75.430000000000007 106.939 174.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.663 ' HA ' HD21 ' A' ' 109' ' ' ASN . 98.6 t . . . . . 0 N--CA 1.431 -1.388 0 N-CA-C 105.745 -1.946 . . . . 73.549999999999997 105.745 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 13.7 ptm180 -127.57 15.89 7.04 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.004 -1.453 . . . . 72.420000000000002 110.497 -167.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.4 m -124.7 124.63 42.59 Favored 'General case' 0 C--N 1.272 -2.784 0 C-N-CA 119.467 -0.893 . . . . 73.150000000000006 110.666 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.2 mt -107.16 141.17 38.86 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.352 -0.981 . . . . 63.109999999999999 108.352 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.463 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 16.7 p90 -102.73 115.8 31.31 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 107.088 -1.449 . . . . 64.129999999999995 107.088 173.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.416 HG22 ' HG ' ' A' ' 103' ' ' LEU . 35.4 t -97.65 120.03 46.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 CA-C-N 114.23 -1.35 . . . . 75.099999999999994 108.418 -177.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.9 p -123.8 165.76 16.75 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 116.246 -0.433 . . . . 75.349999999999994 110.008 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.14 11.96 44.05 Favored Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 111.065 -0.814 . . . . 63.109999999999999 111.065 -173.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.6 mt -83.07 130.23 58.11 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 107.608 -1.256 . . . . 74.5 107.608 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.12 161.43 10.98 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.099 1.866 . . . . 71.319999999999993 111.204 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.407 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 7.5 p -62.53 -15.69 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.681 0.753 . . . . 73.099999999999994 110.79 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -121.56 35.69 4.82 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.04 -0.982 . . . . 55.149999999999999 109.231 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.594 HG22 ' HG2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -66.43 131.2 32.22 Favored 'Isoleucine or valine' 0 C--O 1.256 1.44 0 N-CA-C 108.422 -0.955 . . . . 73.219999999999999 108.422 175.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -99.25 143.94 27.33 Favored Pre-proline 0 C--N 1.291 -1.957 0 CA-C-N 115.111 -0.949 . . . . 72.209999999999994 111.627 -177.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.53 -26.53 37.01 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.634 2.889 . . . . 71.319999999999993 114.194 -176.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.54 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -86.5 -10.52 53.94 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 117.159 -1.816 . . . . 71.030000000000001 112.109 -177.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' HG2' ' HG2' ' B' ' 46' ' ' GLU . 35.6 mt-10 -67.42 -40.21 85.52 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.005 -0.739 . . . . 75.319999999999993 109.005 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.38 -27.27 65.17 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.588 -0.733 . . . . 74.010000000000005 110.123 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.54 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 46.9 t80 -65.3 -47.59 76.08 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.371 -0.831 . . . . 70.450000000000003 109.823 176.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.44 -40.37 81.16 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.365 -0.605 . . . . 71.349999999999994 109.365 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.456 HD13 HD22 ' B' ' 49' ' ' LEU . 32.3 tp -64.34 -47.61 78.67 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.819 -1.082 . . . . 74.329999999999998 112.164 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -98.91 0.94 45.14 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 114.609 1.337 . . . . 72.140000000000001 114.609 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.1 ttt85 -63.63 -44.2 79.94 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 112.829 0.677 . . . . 74.439999999999998 112.829 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.77 -6.97 20.3 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 121.28 1.32 . . . . 72.450000000000003 112.713 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -96.59 90.02 5.19 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.516 0.674 . . . . 74.019999999999996 110.698 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -67.65 109.59 3.36 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.969 0.89 . . . . 71.209999999999994 109.882 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.1 -27.01 1.42 Allowed Glycine 0 C--N 1.285 -2.267 0 CA-C-N 114.406 -1.27 . . . . 60.520000000000003 110.155 -173.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -54.91 127.31 28.13 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.139 0.576 . . . . 74.430000000000007 111.934 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -105.92 -53.89 2.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.175 0.512 . . . . 71.109999999999999 110.568 174.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.64 178.12 41.17 Favored Glycine 0 C--N 1.294 -1.793 0 CA-C-N 115.492 -0.776 . . . . 71.209999999999994 111.822 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.4 p -146.72 137.69 24.07 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.64 0.22 . . . . 74.439999999999998 111.054 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.0 mt -115.98 134.64 54.76 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.458 0.703 . . . . 74.319999999999993 109.128 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.9 mm -95.0 144.71 9.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 110.15 -0.315 . . . . 64.540000000000006 110.15 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -136.97 118.88 15.23 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.833 -0.432 . . . . 75.430000000000007 109.833 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.29 110.59 6.02 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.349 0.595 . . . . 75.420000000000002 111.022 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.3 m -99.44 162.76 12.84 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 105.578 -2.008 . . . . 72.420000000000002 105.578 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -43.91 -37.87 3.09 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 114.037 1.125 . . . . 74.439999999999998 114.037 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -103.87 -26.72 12.57 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.211 1.189 . . . . 64.230000000000004 114.211 -177.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -166.79 153.38 8.18 Favored Pre-proline 0 C--N 1.307 -1.261 0 C-N-CA 120.783 -0.367 . . . . 71.420000000000002 110.346 -168.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.594 ' HG2' HG22 ' A' ' 42' ' ' ILE . 56.9 Cg_endo -76.66 118.89 4.98 Favored 'Trans proline' 0 N--CA 1.438 -1.766 0 C-N-CA 122.459 2.106 . . . . 74.329999999999998 110.949 172.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 m -93.93 162.17 2.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.837 -1.171 . . . . 65.430000000000007 107.837 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.41 121.59 3.54 Favored Glycine 0 C--N 1.297 -1.633 0 C-N-CA 118.934 -1.603 . . . . 72.530000000000001 113.332 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -87.8 105.53 17.46 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.414 -1.328 . . . . 65.129999999999995 107.414 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.68 127.43 52.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 115.053 -0.976 . . . . 62.219999999999999 110.164 -176.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 tt -99.79 130.06 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 CA-C-O 121.704 0.764 . . . . 64.019999999999996 110.219 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.598 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 82.0 m-85 -112.01 152.8 27.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 114.228 -1.351 . . . . 74.450000000000003 109.172 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.477 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 35.0 t70 -68.02 -30.1 69.26 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 114.839 -1.073 . . . . 53.539999999999999 112.712 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.4 m -131.95 150.09 52.25 Favored 'General case' 0 N--CA 1.417 -2.1 0 O-C-N 121.776 -0.577 . . . . 73.209999999999994 109.961 -174.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.635 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -80.38 -27.87 38.07 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.499 -0.926 . . . . 74.140000000000001 108.499 178.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.44 -19.46 60.39 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 114.377 -1.283 . . . . 72.349999999999994 107.591 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.41 -42.13 7.09 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 113.393 -1.73 . . . . 34.399999999999999 110.095 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.04 -43.41 98.89 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.135 0.574 . . . . 74.030000000000001 111.599 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.0 -38.26 90.48 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 121.027 -0.269 . . . . 74.439999999999998 111.706 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.08 -38.53 72.44 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 120.701 0.286 . . . . 74.340000000000003 110.478 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.58 90.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.568 -0.742 . . . . 44.32 111.202 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -67.08 -37.78 84.59 Favored 'General case' 0 C--O 1.206 -1.237 0 C-N-CA 120.378 -0.529 . . . . 55.310000000000002 111.262 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -72.91 -17.08 61.54 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 120.853 0.359 . . . . 71.209999999999994 111.753 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.57 -45.93 11.29 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 116.364 -0.38 . . . . 71.239999999999995 110.76 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.476 ' O ' HG22 ' A' ' 91' ' ' ILE . 92.7 mt -98.38 -9.05 25.86 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 115.291 1.589 . . . . 72.040000000000006 115.291 -172.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.55 126.34 30.61 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.075 -1.016 . . . . 74.430000000000007 110.657 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.19 3.37 54.22 Favored Glycine 0 CA--C 1.475 -2.445 0 C-N-CA 120.599 -0.81 . . . . 60.240000000000002 112.5 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 88' ' ' LEU . 16.1 tt -111.18 144.45 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.343 0 N-CA-C 107.058 -1.46 . . . . 75.519999999999996 107.058 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -70.21 135.41 49.02 Favored 'General case' 0 C--N 1.272 -2.786 0 CA-C-O 121.557 0.694 . . . . 73.109999999999999 112.394 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -74.06 -28.54 61.46 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 113.677 -1.601 . . . . 61.109999999999999 109.069 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -144.36 120.26 6.19 Favored Pre-proline 0 C--N 1.314 -0.973 0 N-CA-C 105.906 -1.887 . . . . 64.439999999999998 105.906 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.511 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 57.6 Cg_endo -67.33 -21.63 47.21 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.522 2.148 . . . . 73.150000000000006 114.241 -176.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -82.61 -26.11 32.58 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.5 0.667 . . . . 64.239999999999995 109.255 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -90.27 134.08 32.02 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 108.012 -1.106 . . . . 60.039999999999999 108.012 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -70.18 -9.26 25.56 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 122.351 2.034 . . . . 71.230000000000004 112.181 176.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -68.96 125.69 27.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.559 -0.746 . . . . 60.119999999999997 110.061 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 39.5 p -102.63 156.35 17.68 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 116.496 -0.32 . . . . 72.040000000000006 110.207 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.4 tp -95.54 126.11 40.6 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.798 -0.815 . . . . 74.219999999999999 108.798 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -120.66 127.04 51.7 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.205 -1.035 . . . . 75.099999999999994 108.205 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.416 ' HG ' HG22 ' A' ' 35' ' ' VAL . 7.3 mp -116.37 116.54 27.9 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 123.51 0.506 . . . . 73.109999999999999 109.683 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 39.1 tt0 -128.52 162.88 26.19 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.782 -1.192 . . . . 62.229999999999997 107.782 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -71.36 145.36 49.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 118.728 0.694 . . . . 73.439999999999998 109.23 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.58 157.89 34.65 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.694 -0.854 . . . . 52.539999999999999 108.694 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 13.1 tmtt? -80.24 -9.85 59.74 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.092 0.948 . . . . 75.430000000000007 108.6 -176.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -157.14 126.13 5.88 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.184 -1.371 . . . . 54.039999999999999 107.567 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.663 HD21 ' HA ' ' A' ' 30' ' ' VAL . 91.5 m-20 -72.26 141.15 48.93 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.241 -0.436 . . . . 74.030000000000001 110.243 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.1 t . . . . . 0 C--N 1.295 -1.787 0 C-N-CA 120.367 -0.533 . . . . 74.439999999999998 109.979 -178.659 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.429 ' HA ' HD21 ' B' ' 109' ' ' ASN . 68.3 t . . . . . 0 N--CA 1.42 -1.973 0 N-CA-C 104.766 -2.309 . . . . 23.239999999999998 104.766 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -116.18 10.68 14.98 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.636 -0.711 . . . . 73.120000000000005 110.743 -171.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 57.9 m -120.46 129.8 54.02 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-O 121.5 0.667 . . . . 60.350000000000001 110.657 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.432 ' N ' HD12 ' B' ' 33' ' ' LEU . 2.4 mp -112.34 143.25 43.76 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.611 -1.255 . . . . 75.25 107.611 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.545 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 26.3 p90 -101.3 116.85 33.74 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 107.437 -1.32 . . . . 73.409999999999997 107.437 172.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.444 HG22 ' HG ' ' B' ' 103' ' ' LEU . 41.2 t -98.81 114.98 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.329 0 CA-C-N 114.21 -1.359 . . . . 73.109999999999999 107.468 -177.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.8 p -124.53 154.18 40.97 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 116.285 -0.416 . . . . 73.230000000000004 110.295 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.51 4.29 32.51 Favored Glycine 0 N--CA 1.431 -1.685 0 O-C-N 123.561 0.538 . . . . 42.32 111.969 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 86.3 mt -71.66 132.58 85.21 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 107.372 -1.344 . . . . 74.120000000000005 107.372 175.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . 0.403 ' C ' ' H ' ' B' ' 41' ' ' ASP . 37.4 Cg_endo -65.99 160.89 42.16 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.62 1.546 . . . . 54.539999999999999 111.677 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.467 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 9.4 p -69.91 4.99 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.6 0 CA-C-O 122.148 0.975 . . . . 54.030000000000001 111.274 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' B' ' 39' ' ' PRO . 27.9 t70 -125.51 19.01 8.1 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.616 1.166 . . . . 72.040000000000006 109.19 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.12 127.5 20.87 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 CA-C-O 121.843 0.83 . . . . 62.520000000000003 111.086 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.462 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 70.1 mmtt -98.71 137.35 20.58 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.07 -0.968 . . . . 75.340000000000003 108.936 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -53.74 -32.48 65.93 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.857 2.372 . . . . 73.340000000000003 113.236 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.575 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 0.0 OUTLIER -73.15 -15.8 61.46 Favored 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 119.374 -0.931 . . . . 74.340000000000003 112.324 -179.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.462 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 47.6 mt-10 -69.55 -36.06 75.98 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.893 -0.504 . . . . 75.109999999999999 110.23 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.88 -26.38 64.16 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 121.732 0.777 . . . . 73.5 108.919 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.511 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 58.3 t80 -73.33 -34.91 65.93 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.911 -1.041 . . . . 75.200000000000003 110.215 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 67.1 mt -78.48 -41.51 32.39 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.271 -0.64 . . . . 73.010000000000005 109.271 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.6 tp -66.09 -46.52 77.35 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.21 -0.904 . . . . 62.109999999999999 111.482 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -95.03 14.92 20.28 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 112.221 0.452 . . . . 75.319999999999993 112.221 -176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.486 ' CZ ' ' HA ' ' B' ' 52' ' ' ARG . 0.8 OUTLIER -59.46 -52.12 76.44 Favored Pre-proline 0 CA--C 1.56 1.349 0 CA-C-N 115.864 -0.607 . . . . 63.439999999999998 111.743 178.466 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.3 -1.48 11.12 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 121.607 1.538 . . . . 61.409999999999997 112.728 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -89.54 91.6 8.76 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 122.024 0.916 . . . . 74.530000000000001 110.673 -177.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -75.4 109.85 9.28 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.21 -1.359 . . . . 74.099999999999994 108.785 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.65 -14.04 4.19 Favored Glycine 0 C--N 1.293 -1.813 0 CA-C-N 115.058 -0.974 . . . . 64.099999999999994 111.753 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -59.93 109.89 1.05 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.191 0.52 . . . . 74.510000000000005 110.527 175.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -86.09 -49.35 7.85 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.737 -0.665 . . . . 54.030000000000001 110.435 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.11 -175.69 45.46 Favored Glycine 0 C--N 1.294 -1.797 0 C-N-CA 120.13 -1.033 . . . . 23.510000000000002 112.175 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 21.5 p -148.17 143.27 26.96 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 122.377 0.271 . . . . 60.240000000000002 111.335 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 85.3 mt -116.83 127.21 54.08 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.474 -0.936 . . . . 74.040000000000006 108.474 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 47.4 mm -94.56 136.46 25.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.198 -0.667 . . . . 53.009999999999998 109.198 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -127.58 115.4 18.75 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.016 -0.735 . . . . 74.129999999999995 109.016 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.21 109.46 5.26 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.235 -0.654 . . . . 62.219999999999999 109.235 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 19.6 m -100.6 156.23 17.42 Favored 'General case' 0 N--CA 1.407 -2.611 0 N-CA-C 104.458 -2.423 . . . . 71.319999999999993 104.458 175.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.41 -37.58 17.38 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 113.65 0.981 . . . . 62.32 113.65 -173.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -102.78 -16.54 15.93 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.191 1.182 . . . . 63.43 114.191 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.532 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 4.4 pt20 -173.77 142.45 0.92 Allowed Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 118.167 0.44 . . . . 63.240000000000002 111.731 -174.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.467 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 14.9 Cg_exo -68.77 115.19 3.82 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 123.05 2.5 . . . . 74.019999999999996 111.096 170.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -92.55 167.35 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.038 -1.097 . . . . 70.340000000000003 108.038 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.62 122.68 2.43 Favored Glycine 0 C--O 1.207 -1.585 0 C-N-CA 118.87 -1.633 . . . . 54.509999999999998 113.621 -176.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -88.11 107.73 18.9 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.636 -1.246 . . . . 72.510000000000005 107.636 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 90.2 t -101.17 129.16 52.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 115.185 -0.916 . . . . 73.120000000000005 110.978 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.49 HD12 ' O ' ' B' ' 110' ' ' THR . 3.4 tt -101.85 134.33 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 115.253 -0.885 . . . . 62.210000000000001 110.351 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -113.57 158.35 20.89 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.97 -1.014 . . . . 64.239999999999995 110.738 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.1 -34.66 78.08 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.823 -1.535 . . . . 74.340000000000003 112.4 175.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 46.4 m -135.75 152.14 50.83 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 120.757 -0.377 . . . . 70.019999999999996 110.736 -173.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . 0.567 ' HD3' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -80.08 -26.6 39.52 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.393 0.616 . . . . 63.310000000000002 109.343 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.05 -21.14 51.11 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 107.726 -1.212 . . . . 52.240000000000002 107.726 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.47 -39.58 14.67 Favored Glycine 0 C--N 1.31 -0.884 0 N-CA-C 109.276 -1.529 . . . . 32.009999999999998 109.276 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.02 -42.61 97.06 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.322 -0.939 . . . . 62.329999999999998 111.501 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.84 -37.64 88.29 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.782 0.325 . . . . 61.240000000000002 111.556 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.15 -37.21 69.43 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.054 0.454 . . . . 70.140000000000001 110.336 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.84 -42.96 80.62 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.497 -0.774 . . . . 62.049999999999997 111.027 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.43 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 14.9 ptmm? -68.2 -37.1 80.54 Favored 'General case' 0 C--O 1.206 -1.189 0 C-N-CA 120.585 -0.446 . . . . 73.019999999999996 110.744 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -66.68 -29.53 69.55 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 120.863 0.363 . . . . 62.0 111.427 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.34 -44.42 25.21 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 116.166 -0.47 . . . . 70.310000000000002 111.252 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.581 ' O ' HG22 ' B' ' 91' ' ' ILE . 99.3 mt -94.75 -11.96 28.05 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 115.356 1.613 . . . . 72.400000000000006 115.356 -173.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -76.2 115.64 16.12 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 118.257 -1.377 . . . . 71.219999999999999 109.825 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.99 11.56 24.07 Favored Glycine 0 CA--C 1.482 -2.01 0 C-N-CA 120.463 -0.875 . . . . 74.329999999999998 111.767 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.581 HG22 ' O ' ' B' ' 88' ' ' LEU . 14.4 tt -99.66 140.54 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.624 0 N-CA-C 107.665 -1.235 . . . . 54.509999999999998 107.665 175.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.44 ' CG ' HG22 ' B' ' 100' ' ' THR . 79.3 mtt180 -81.75 128.67 34.23 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-O 120.985 0.421 . . . . 74.219999999999999 110.175 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.74 -34.39 77.77 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.55 -1.205 . . . . 75.109999999999999 110.063 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -144.5 126.1 7.98 Favored Pre-proline 0 C--N 1.312 -1.047 0 N-CA-C 106.405 -1.702 . . . . 70.239999999999995 106.405 174.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . 0.457 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 60.4 Cg_endo -69.84 -0.41 6.93 Favored 'Trans proline' 0 N--CA 1.486 1.031 0 C-N-CA 123.266 2.644 . . . . 74.510000000000005 114.386 -173.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -91.75 -25.65 18.95 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.54 0.686 . . . . 73.409999999999997 109.542 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -91.81 139.16 24.68 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 108.144 -1.058 . . . . 74.400000000000006 108.144 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -69.6 -20.78 35.16 Favored 'Trans proline' 0 C--O 1.247 0.932 0 C-N-CA 121.763 1.642 . . . . 60.130000000000003 111.014 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -55.57 131.17 45.61 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.502 1.121 . . . . 62.43 110.621 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.44 HG22 ' CG ' ' B' ' 92' ' ' ARG . 75.2 p -112.76 160.03 18.36 Favored 'General case' 0 N--CA 1.418 -2.061 0 C-N-CA 120.177 -0.609 . . . . 72.400000000000006 109.78 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 20.2 tp -96.8 121.23 38.43 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.261 -1.014 . . . . 54.509999999999998 108.261 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -112.51 123.13 49.61 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.242 -1.022 . . . . 74.430000000000007 108.242 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.444 ' HG ' HG22 ' B' ' 35' ' ' VAL . 7.1 mp -110.5 115.7 30.1 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 109.381 -0.6 . . . . 74.219999999999999 109.381 172.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.545 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 34.2 tt0 -129.87 157.58 41.86 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.321 -1.362 . . . . 74.329999999999998 107.321 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . 0.417 ' HB3' HG11 ' B' ' 30' ' ' VAL . 25.6 m-85 -66.7 138.46 57.42 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 118.602 0.637 . . . . 75.540000000000006 110.693 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.36 152.26 30.52 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 108.902 -0.777 . . . . 74.129999999999995 108.902 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' B' ' 107' ' ' LYS . 14.4 tmtt? -78.49 -6.93 56.79 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.4 -0.818 . . . . 54.240000000000002 110.053 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.18 132.87 21.0 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.127 -0.942 . . . . 73.219999999999999 108.824 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.429 HD21 ' HA ' ' B' ' 30' ' ' VAL . 91.2 m-20 -87.13 143.09 27.46 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.326 -0.397 . . . . 72.349999999999994 110.249 177.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.49 ' O ' HD12 ' B' ' 74' ' ' ILE . 12.8 t . . . . . 0 N--CA 1.416 -2.132 0 N-CA-C 107.572 -1.27 . . . . 71.540000000000006 107.572 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.4 t . . . . . 0 N--CA 1.431 -1.381 0 CA-C-O 122.252 1.025 . . . . 72.099999999999994 109.636 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -102.52 13.45 34.5 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.194 -1.366 . . . . 73.299999999999997 111.244 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 109' ' ' ASN . 23.8 m -139.02 132.51 30.29 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.917 -0.713 . . . . 70.519999999999996 111.576 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.7 mt -110.73 145.88 37.27 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.341 -0.985 . . . . 73.239999999999995 108.341 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -101.65 111.2 23.37 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 107.29 -1.374 . . . . 62.520000000000003 107.29 173.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.45 HG22 ' HG ' ' A' ' 103' ' ' LEU . 47.2 t -97.44 120.92 47.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.178 -1.374 . . . . 73.040000000000006 108.013 -177.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 p -126.98 168.64 14.27 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 115.335 -0.848 . . . . 72.420000000000002 109.217 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 88.58 39.64 6.62 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 111.085 -0.806 . . . . 71.019999999999996 111.085 -177.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 99.6 mt -105.37 137.97 19.42 Favored Pre-proline 0 N--CA 1.418 -2.041 0 N-CA-C 108.325 -0.991 . . . . 73.510000000000005 108.325 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -56.76 159.43 14.16 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.941 1.761 . . . . 75.439999999999998 109.183 171.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.574 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 8.9 p -80.86 -0.75 4.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 122.435 1.112 . . . . 64.310000000000002 110.677 -168.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -117.42 16.25 14.71 Favored 'General case' 0 N--CA 1.413 -2.276 0 CA-C-N 114.552 -1.204 . . . . 72.140000000000001 110.809 -172.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.482 HG13 ' HG2' ' A' ' 69' ' ' PRO 0.272 2.7 pp -55.82 136.38 18.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 114.47 1.285 . . . . 71.129999999999995 114.47 -177.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.546 ' HD3' ' CD ' ' A' ' 46' ' ' GLU . 6.6 mptt -103.1 149.8 37.24 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 106.689 -1.597 . . . . 74.319999999999993 106.689 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.19 -28.68 88.41 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.361 2.04 . . . . 73.349999999999994 112.0 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.662 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 20.3 ptt180 -68.16 -30.38 69.49 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 116.165 -0.47 . . . . 75.120000000000005 111.712 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.546 ' CD ' ' HD3' ' A' ' 43' ' ' LYS . 46.5 mt-10 -69.0 -42.41 76.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.022 0.439 . . . . 74.519999999999996 110.185 -175.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.56 -43.11 94.94 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.508 -0.923 . . . . 72.219999999999999 108.508 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.544 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 37.4 t80 -57.79 -45.1 86.54 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.414 -1.266 . . . . 72.310000000000002 111.626 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 88.4 mt -64.73 -40.46 95.36 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.366 0.603 . . . . 65.409999999999997 110.305 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 tp -70.08 -43.67 70.65 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.897 -1.047 . . . . 74.340000000000003 111.106 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -84.99 6.82 23.58 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 114.065 1.135 . . . . 64.430000000000007 114.065 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.491 ' HA ' ' NE ' ' A' ' 52' ' ' ARG . 3.2 mmp_? -50.59 -52.23 57.84 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 113.482 0.919 . . . . 74.239999999999995 113.482 177.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.38 -1.36 9.71 Favored 'Trans proline' 0 C--N 1.365 1.436 0 C-N-CA 121.795 1.663 . . . . 72.209999999999994 113.248 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -89.5 107.82 19.29 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 122.1 0.953 . . . . 71.129999999999995 112.38 -175.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -76.78 112.16 13.07 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 113.852 -1.522 . . . . 75.310000000000002 111.054 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 75' ' ' PHE . . . 142.4 -32.04 1.99 Allowed Glycine 0 N--CA 1.424 -2.147 0 CA-C-N 114.653 -1.158 . . . . 73.230000000000004 111.19 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.05 118.25 4.49 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.667 0.787 . . . . 74.349999999999994 112.705 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -108.1 -35.71 6.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.272 0.558 . . . . 61.329999999999998 110.652 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.56 -178.38 48.37 Favored Glycine 0 C--N 1.306 -1.084 0 C-N-CA 120.154 -1.022 . . . . 75.230000000000004 112.441 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.6 p -144.29 137.56 27.31 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.613 0.206 . . . . 70.430000000000007 111.43 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -107.83 114.32 28.19 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 107.725 -1.213 . . . . 73.349999999999994 107.725 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.53 136.59 26.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 110.334 -0.247 . . . . 74.319999999999993 110.334 -175.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 69' ' ' PRO . 63.4 tttp -124.99 106.94 10.33 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 109.353 -0.61 . . . . 62.340000000000003 109.353 176.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.87 109.17 7.16 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.707 -0.849 . . . . 72.450000000000003 108.707 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.4 m -104.97 164.11 12.03 Favored 'General case' 0 N--CA 1.41 -2.455 0 N-CA-C 105.373 -2.084 . . . . 65.200000000000003 105.373 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.02 -33.76 62.9 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.704 0.683 . . . . 70.109999999999999 111.903 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.494 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 1.5 tpm_? -82.18 -52.28 7.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 112.201 0.445 . . . . 71.230000000000004 112.201 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -160.22 152.55 17.28 Favored Pre-proline 0 C--N 1.289 -2.033 0 CA-C-N 115.878 -0.601 . . . . 63.32 109.853 -171.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.574 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 58.3 Cg_endo -80.16 108.73 2.24 Favored 'Trans proline' 0 N--CA 1.431 -2.187 0 C-N-CA 122.546 2.164 . . . . 72.430000000000007 110.051 168.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.5 m -83.04 160.33 3.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.109 -1.071 . . . . 64.439999999999998 108.109 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.41 120.71 2.25 Favored Glycine 0 CA--C 1.474 -2.504 0 C-N-CA 118.042 -2.028 . . . . 55.240000000000002 112.747 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -88.37 102.52 14.95 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 106.622 -1.622 . . . . 75.209999999999994 106.622 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.07 127.28 47.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-N 115.429 -0.805 . . . . 74.209999999999994 109.948 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.9 pt -98.0 135.24 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.301 0 CA-C-N 115.155 -0.929 . . . . 75.129999999999995 110.722 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 87.9 m-85 -121.98 149.53 43.33 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.341 -1.3 . . . . 72.510000000000005 108.559 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -52.64 -44.23 65.97 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 124.486 1.116 . . . . 74.349999999999994 111.585 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.1 m -145.34 158.09 43.9 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.72 -0.673 . . . . 74.329999999999998 110.235 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.456 ' HD3' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.24 -26.68 67.48 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.857 -0.61 . . . . 72.519999999999996 109.872 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.02 -28.05 69.54 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.366 -0.834 . . . . 62.539999999999999 110.15 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.01 -37.07 8.58 Favored Glycine 0 C--N 1.311 -0.812 0 N-CA-C 109.774 -1.33 . . . . 23.210000000000001 109.774 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.67 -44.45 93.73 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.491 -0.854 . . . . 72.25 111.728 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.4 -35.98 82.2 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.862 0.363 . . . . 61.329999999999998 111.832 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.35 -42.04 69.01 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.027 0.441 . . . . 65.420000000000002 110.052 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.62 95.76 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.666 -0.697 . . . . 71.430000000000007 111.258 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.421 ' CE ' ' HA ' ' A' ' 104' ' ' GLU . 14.8 ptmm? -70.56 -33.57 71.27 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 120.538 -0.465 . . . . 64.010000000000005 110.657 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -69.48 -36.49 76.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.887 0.375 . . . . 74.140000000000001 110.839 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.85 -41.93 42.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.07 0.462 . . . . 40.43 111.859 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 91' ' ' ILE . 85.8 mt -93.95 -9.75 36.0 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 115.085 1.513 . . . . 73.230000000000004 115.085 -172.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -74.95 118.39 17.86 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 117.898 -1.521 . . . . 72.040000000000006 108.828 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.23 12.56 48.48 Favored Glycine 0 N--CA 1.424 -2.152 0 CA-C-N 115.468 -0.787 . . . . 40.229999999999997 111.794 176.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.7 tt -100.84 134.46 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.965 0 N-CA-C 108.185 -1.042 . . . . 71.319999999999993 108.185 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.542 ' HG2' HG22 ' A' ' 100' ' ' THR . 82.7 mtt180 -79.41 142.31 36.07 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 115.445 -0.798 . . . . 71.329999999999998 112.448 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -75.88 -28.89 58.29 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.548 -1.66 . . . . 74.209999999999994 108.394 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.597 ' OD2' ' HB3' ' B' ' 45' ' ' ARG . 6.2 m-20 -138.22 127.76 14.83 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 104.138 -2.542 . . . . 71.030000000000001 104.138 173.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.61 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 18.0 Cg_endo -58.92 -26.73 82.26 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.093 1.862 . . . . 73.450000000000003 112.444 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -90.76 -5.14 56.08 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.461 -0.79 . . . . 72.409999999999997 111.82 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.464 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 52.7 t-20 -104.17 125.96 32.95 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 108.171 -1.048 . . . . 73.310000000000002 108.171 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -64.53 -7.07 13.36 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 123.15 2.567 . . . . 62.5 113.349 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -77.44 115.32 17.11 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.691 -0.855 . . . . 65.099999999999994 108.691 176.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.542 HG22 ' HG2' ' A' ' 92' ' ' ARG . 27.7 p -116.12 153.05 32.46 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.158 -1.053 . . . . 71.230000000000004 108.158 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.6 mp -82.85 140.52 32.87 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 118.417 0.553 . . . . 71.549999999999997 111.102 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.6 108.81 10.19 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.659 -1.608 . . . . 75.340000000000003 106.659 176.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.45 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.8 mp -102.61 123.26 46.01 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.951 -0.568 . . . . 60.450000000000003 111.818 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.421 ' HA ' ' CE ' ' A' ' 85' ' ' LYS . 17.2 mm-40 -132.34 164.32 26.72 Favored 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 123.435 0.694 . . . . 75.340000000000003 109.807 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -73.68 143.32 46.27 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.468 -0.567 . . . . 64.109999999999999 109.468 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.46 157.07 37.53 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.146 -1.057 . . . . 75.239999999999995 108.146 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -72.73 -13.32 61.31 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.383 1.087 . . . . 71.549999999999997 110.503 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.81 127.01 3.98 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 105.985 -1.857 . . . . 55.329999999999998 105.985 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.476 ' HA ' ' HB ' ' A' ' 32' ' ' THR . 7.1 p30 -79.19 144.42 34.44 Favored 'General case' 0 CA--C 1.47 -2.104 0 C-N-CA 118.517 -1.273 . . . . 63.420000000000002 108.918 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.395 -3.213 0 C-N-CA 118.544 -1.262 . . . . 74.530000000000001 112.548 -173.234 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--O 1.214 -0.81 0 CA-C-O 121.348 0.594 . . . . 63.109999999999999 110.991 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.697 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 72.2 mtt180 -95.44 -2.59 48.51 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.287 -0.87 . . . . 72.530000000000001 109.921 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 16.0 m -101.03 137.92 38.76 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 114.977 -1.01 . . . . 52.130000000000003 112.265 -174.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 77.2 mt -117.52 146.24 43.69 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.696 -1.224 . . . . 73.209999999999994 107.696 173.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -99.53 118.98 37.29 Favored 'General case' 0 N--CA 1.42 -1.974 0 C-N-CA 118.486 -1.286 . . . . 71.430000000000007 107.811 173.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.467 HG22 ' HG ' ' B' ' 103' ' ' LEU . 35.2 t -97.32 109.09 22.66 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 N-CA-C 106.318 -1.734 . . . . 60.43 106.318 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -116.54 170.34 8.65 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-N 115.094 -0.957 . . . . 64.329999999999998 108.867 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 81.23 46.33 7.04 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.705 -0.958 . . . . 75.099999999999994 110.705 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 91.3 mt -114.37 141.44 26.51 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 107.573 -1.269 . . . . 74.430000000000007 107.573 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -59.99 161.4 19.1 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 121.585 1.523 . . . . 72.349999999999994 110.395 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.618 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 8.8 p -86.07 7.89 2.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 122.477 1.132 . . . . 74.329999999999998 109.752 -171.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -127.9 19.13 6.61 Favored 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 114.79 -1.095 . . . . 72.099999999999994 111.402 -174.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.427 HG12 ' HG2' ' B' ' 69' ' ' PRO . 32.6 pt -58.07 134.81 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 114.424 1.268 . . . . 74.109999999999999 114.424 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -101.44 145.85 31.17 Favored Pre-proline 0 C--N 1.297 -1.707 0 CA-C-N 113.908 -1.496 . . . . 73.140000000000001 110.066 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -55.97 -27.98 66.48 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.258 2.639 . . . . 74.109999999999999 113.484 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.597 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 23.9 ptt180 -70.36 -28.67 65.3 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 121.179 0.514 . . . . 73.010000000000005 111.051 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -69.84 -40.01 76.09 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.839 -0.619 . . . . 75.140000000000001 110.204 -176.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.97 -41.59 95.32 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 108.708 -0.849 . . . . 71.319999999999993 108.708 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.61 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 7.3 t80 -57.1 -47.1 81.87 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.73 -1.123 . . . . 72.25 111.32 177.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 82.5 mt -61.1 -42.7 99.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.11 0.481 . . . . 73.409999999999997 110.789 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.412 HD13 HD22 ' A' ' 49' ' ' LEU . 37.9 tp -73.86 -42.99 60.0 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.198 -0.91 . . . . 64.200000000000003 111.936 -176.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -89.02 -10.49 47.36 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 115.623 1.712 . . . . 75.409999999999997 115.623 -173.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 14.1 mtp180 -54.28 -52.41 69.26 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 113.603 0.964 . . . . 70.319999999999993 113.603 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.3 -21.18 71.03 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 121.668 1.578 . . . . 73.019999999999996 112.304 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -88.42 86.59 7.07 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.662 0.744 . . . . 64.510000000000005 109.564 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -68.5 112.87 5.58 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.282 -1.326 . . . . 70.150000000000006 108.464 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 149.39 -28.52 1.21 Allowed Glycine 0 C--N 1.288 -2.087 0 CA-C-N 114.186 -1.37 . . . . 60.439999999999998 110.16 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -58.83 117.12 4.26 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.471 0.708 . . . . 64.209999999999994 111.568 176.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -102.02 -59.85 1.63 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.995 0.426 . . . . 72.140000000000001 111.212 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.78 172.37 31.17 Favored Glycine 0 C--N 1.295 -1.702 0 C-N-CA 120.559 -0.829 . . . . 71.109999999999999 112.181 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.1 p -135.39 137.04 41.92 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 122.903 0.481 . . . . 54.420000000000002 110.622 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.56 110.17 17.04 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.382 -1.34 . . . . 73.439999999999998 107.382 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.35 138.03 21.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 120.748 0.308 . . . . 73.430000000000007 110.923 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' B' ' 69' ' ' PRO . 0.6 OUTLIER -117.14 106.77 13.69 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.662 -1.607 . . . . 71.239999999999995 106.662 176.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.75 124.17 24.79 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.182 -0.917 . . . . 72.219999999999999 109.04 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 7.8 m -127.09 151.94 47.96 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 103.214 -2.884 . . . . 61.310000000000002 103.214 177.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.33 -33.36 65.54 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.063 0.764 . . . . 74.239999999999995 113.063 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -86.98 -38.7 16.37 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 120.19 -0.604 . . . . 71.0 112.294 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' B' ' 65' ' ' THR . 28.4 pt20 -161.53 135.3 4.91 Favored Pre-proline 0 C--N 1.297 -1.691 0 CA-C-O 120.495 0.188 . . . . 71.510000000000005 111.485 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.618 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 18.0 Cg_endo -80.55 109.8 2.33 Favored 'Trans proline' 0 N--CA 1.427 -2.411 0 C-N-CA 122.064 1.842 . . . . 62.130000000000003 109.508 168.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -84.68 147.9 5.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.436 -0.95 . . . . 51.240000000000002 108.436 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.28 120.56 4.58 Favored Glycine 0 CA--C 1.481 -2.056 0 C-N-CA 118.647 -1.74 . . . . 74.329999999999998 112.847 -175.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -87.74 102.72 14.93 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.628 -1.619 . . . . 70.439999999999998 106.628 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 69.2 t -100.11 128.73 51.75 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 114.923 -1.035 . . . . 70.120000000000005 110.117 -174.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 45.8 pt -101.76 132.67 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 CA-C-O 122.165 0.983 . . . . 65.540000000000006 110.865 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . 0.697 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 79.9 m-85 -111.15 142.64 43.06 Favored 'General case' 0 C--N 1.266 -3.028 0 CA-C-N 113.744 -1.571 . . . . 75.209999999999994 107.9 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.95 -24.92 67.66 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.308 0.575 . . . . 75.349999999999994 110.704 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 3.1 m -129.75 131.82 46.39 Favored 'General case' 0 N--CA 1.386 -3.67 0 N-CA-C 107.429 -1.323 . . . . 74.200000000000003 107.429 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . 0.702 ' NE ' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -80.93 -24.11 38.39 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.952 -0.567 . . . . 73.109999999999999 110.301 179.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.16 -20.52 57.49 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.316 -2.105 . . . . 70.219999999999999 105.316 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.81 -40.31 15.01 Favored Glycine 0 C--N 1.314 -0.65 0 CA-C-N 112.672 -2.058 . . . . 61.119999999999997 109.282 177.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.31 -47.27 86.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.111 -1.045 . . . . 51.420000000000002 110.912 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 10.9 pt-20 -63.7 -31.2 72.3 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.54 -0.464 . . . . 71.010000000000005 112.124 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.64 -42.15 67.92 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.712 0.291 . . . . 70.209999999999994 110.545 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.28 -39.29 82.16 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.55 -0.75 . . . . 63.140000000000001 111.105 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' B' ' 82' ' ' GLU . 14.4 ptmm? -66.06 -37.34 85.59 Favored 'General case' 0 C--O 1.199 -1.554 0 C-N-CA 120.606 -0.438 . . . . 73.129999999999995 110.288 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -55.79 -32.82 63.82 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 120.961 0.41 . . . . 73.420000000000002 111.772 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.09 -36.45 19.62 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 112.406 0.521 . . . . 54.130000000000003 112.406 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.604 ' O ' HG22 ' B' ' 91' ' ' ILE . 97.5 mt -95.69 -22.14 17.74 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 116.019 1.859 . . . . 74.530000000000001 116.019 -173.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . 0.459 ' HB3' ' H ' ' B' ' 103' ' ' LEU . 0.3 OUTLIER -74.99 113.3 12.15 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 118.441 -1.304 . . . . 75.209999999999994 110.514 178.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.46 16.17 16.94 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 120.761 -0.733 . . . . 72.049999999999997 111.344 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.604 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.3 tt -113.37 145.31 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.81 0 N-CA-C 107.844 -1.169 . . . . 74.319999999999993 107.844 175.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.554 ' CG ' HG22 ' B' ' 100' ' ' THR . 97.7 mtt180 -82.31 145.02 30.19 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 113.325 0.861 . . . . 74.519999999999996 113.325 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.411 ' HB2' HD11 ' B' ' 101' ' ' LEU . 22.0 t80 -77.24 -34.87 55.81 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.405 -1.725 . . . . 74.409999999999997 107.264 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' A' ' 45' ' ' ARG . 5.2 m-20 -134.34 120.62 14.91 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 105.249 -2.13 . . . . 73.340000000000003 105.249 176.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . 0.544 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 18.1 Cg_endo -60.78 -24.22 78.38 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 121.897 1.731 . . . . 73.109999999999999 112.21 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -84.71 -14.62 47.84 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 123.725 0.81 . . . . 74.5 110.776 -176.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' ASN . . . . . 0.445 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . 53.7 t-20 -104.52 133.44 20.19 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 107.538 -1.282 . . . . 55.439999999999998 107.538 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.52 -5.39 15.09 Favored 'Trans proline' 0 CA--C 1.55 1.294 0 C-N-CA 122.524 2.149 . . . . 74.439999999999998 112.916 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -72.01 116.97 13.04 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 109.244 -0.65 . . . . 42.109999999999999 109.244 177.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.618 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 67.2 p -115.87 152.17 33.88 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.974 -0.75 . . . . 62.439999999999998 108.974 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' B' ' 93' ' ' PHE . 6.4 mp -84.08 139.69 32.31 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.11 0.481 . . . . 71.310000000000002 110.487 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -125.3 109.49 12.86 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 107.134 -1.432 . . . . 71.209999999999994 107.134 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.467 ' HG ' HG22 ' B' ' 35' ' ' VAL . 6.8 mp -99.39 119.56 38.16 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 108.467 -0.938 . . . . 74.239999999999995 108.467 173.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.406 ' HA ' ' CE ' ' B' ' 85' ' ' LYS . 36.7 mm-40 -136.22 165.37 25.89 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.101 -1.074 . . . . 62.32 108.101 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -71.17 137.04 48.43 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 118.727 0.694 . . . . 74.420000000000002 110.544 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.63 152.92 29.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 116.216 -0.447 . . . . 53.420000000000002 110.032 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -73.17 -12.85 61.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.859 0.838 . . . . 62.439999999999998 110.086 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.97 123.29 20.64 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.243 -0.889 . . . . 72.010000000000005 109.625 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -83.53 100.81 11.01 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.688 -1.597 . . . . 61.299999999999997 106.688 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.6 t . . . . . 0 C--N 1.288 -2.071 0 CA-C-O 121.862 0.839 . . . . 65.239999999999995 112.517 -172.588 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.536 HG12 ' H ' ' A' ' 32' ' ' THR . 37.5 t . . . . . 0 N--CA 1.437 -1.112 0 N-CA-C 108.106 -1.072 . . . . 71.140000000000001 108.106 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 13.1 ptm180 -92.65 8.58 38.48 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.3 0.571 . . . . 75.409999999999997 110.294 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.536 ' H ' HG12 ' A' ' 30' ' ' VAL . 8.7 m -122.45 129.66 52.27 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.804 0.811 . . . . 62.32 111.972 -177.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 33' ' ' LEU . 2.8 mp -110.46 141.29 43.77 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.339 -1.356 . . . . 74.120000000000005 107.339 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.671 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 11.4 p90 -101.51 128.01 47.94 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.252 -1.388 . . . . 63.0 107.252 172.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.4 t -106.76 118.32 54.27 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.623 0 N-CA-C 107.783 -1.191 . . . . 62.310000000000002 107.783 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.8 p -127.46 163.05 24.94 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.106 -0.702 . . . . 51.32 109.106 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.22 33.58 10.51 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.709 -0.956 . . . . 61.210000000000001 110.709 -174.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.7 mt -96.4 140.39 22.18 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.988 -1.116 . . . . 70.319999999999993 107.988 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -65.37 161.4 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 C-N-CA 121.315 1.344 . . . . 64.219999999999999 109.952 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -70.46 -8.77 11.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.79 0.805 . . . . 72.239999999999995 110.315 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -124.27 40.45 3.73 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 108.224 -1.028 . . . . 72.230000000000004 108.224 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.9 tp -60.53 125.34 16.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.115 -0.948 . . . . 74.340000000000003 109.451 173.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.606 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 26.1 mmmt -90.48 138.04 27.08 Favored Pre-proline 0 C--N 1.296 -1.757 0 N-CA-C 106.8 -1.555 . . . . 71.510000000000005 106.8 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.5 -25.07 77.48 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.485 2.123 . . . . 74.120000000000005 112.784 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.4 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 14.5 ptt180 -74.21 -27.66 60.9 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 116.012 -0.54 . . . . 74.530000000000001 111.396 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 30.5 mt-10 -62.87 -47.44 83.32 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.129 0.49 . . . . 73.239999999999995 109.964 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 99.7 mt -62.16 -45.3 94.05 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.283 -0.871 . . . . 63.140000000000001 109.803 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.682 ' CZ ' ' HD3' ' B' ' 95' ' ' PRO . 0.0 OUTLIER -60.01 -43.4 95.24 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.494 -0.776 . . . . 75.409999999999997 112.123 178.616 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 98.6 mt -64.36 -44.24 92.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.071 0.462 . . . . 74.329999999999998 110.221 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.429 ' O ' ' HD2' ' A' ' 53' ' ' PRO . 27.9 tp -66.72 -39.37 87.97 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.92 -1.036 . . . . 71.010000000000005 110.976 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -86.9 -4.49 59.18 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 114.566 1.321 . . . . 74.340000000000003 114.566 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 17.7 mtp180 -60.15 -42.87 92.08 Favored Pre-proline 0 N--CA 1.485 1.29 0 N-CA-C 113.447 0.906 . . . . 74.450000000000003 113.447 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 50' ' ' LEU . 24.5 Cg_exo -69.04 -18.36 40.4 Favored 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 121.693 1.595 . . . . 63.509999999999998 112.018 173.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -89.73 92.26 8.98 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 122.097 0.951 . . . . 74.239999999999995 110.967 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -69.4 111.79 5.51 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.177 -1.374 . . . . 63.539999999999999 109.589 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.84 -26.56 2.07 Favored Glycine 0 C--N 1.291 -1.963 0 CA-C-N 115.469 -0.787 . . . . 72.219999999999999 111.143 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -57.69 116.34 3.36 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.544 0.738 . . . . 74.219999999999999 111.698 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -96.7 -48.85 5.33 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.151 0.5 . . . . 51.149999999999999 110.323 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.69 167.23 40.27 Favored Glycine 0 C--N 1.302 -1.307 0 C-N-CA 120.014 -1.089 . . . . 75.120000000000005 113.246 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.418 ' HB3' HG22 ' A' ' 73' ' ' VAL . 11.5 p -127.27 137.66 52.9 Favored 'General case' 0 C--O 1.251 1.145 0 C-N-CA 123.12 0.568 . . . . 62.030000000000001 111.652 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.1 mp -112.42 150.44 31.14 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.904 -1.147 . . . . 64.200000000000003 107.904 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.0 mm -125.35 142.0 43.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 117.975 0.352 . . . . 73.120000000000005 110.091 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.561 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -133.99 107.73 7.96 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.52 -0.918 . . . . 72.019999999999996 108.52 178.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.2 130.37 43.62 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.315 -0.624 . . . . 75.230000000000004 109.315 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.9 m -129.38 164.0 24.57 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 106.405 -1.702 . . . . 75.340000000000003 106.405 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.41 -37.24 16.53 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.008 1.114 . . . . 74.129999999999995 114.008 -176.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -94.56 -41.6 9.25 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.285 0.565 . . . . 72.310000000000002 112.071 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -163.86 153.88 12.89 Favored Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 115.456 -0.793 . . . . 64.430000000000007 109.367 -170.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -78.27 118.2 4.27 Favored 'Trans proline' 0 N--CA 1.429 -2.309 0 C-N-CA 121.992 1.795 . . . . 71.239999999999995 109.939 170.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.37 159.58 2.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.973 -1.121 . . . . 71.219999999999999 107.973 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.72 157.46 20.45 Favored Glycine 0 C--N 1.298 -1.555 0 C-N-CA 118.688 -1.72 . . . . 61.43 113.683 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.68 109.73 15.56 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.948 -1.501 . . . . 73.439999999999998 106.948 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.418 HG22 ' HB3' ' A' ' 60' ' ' SER . 72.7 t -103.23 128.98 55.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 CA-C-N 116.044 -0.525 . . . . 64.349999999999994 110.155 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 mp -105.85 128.43 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 115.799 -0.637 . . . . 74.239999999999995 109.964 -178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 4.7 m-85 -109.07 153.41 23.7 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.682 -1.145 . . . . 73.340000000000003 110.242 175.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -67.09 -27.98 67.8 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.867 -1.061 . . . . 71.329999999999998 112.066 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.3 m -134.88 144.86 47.76 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 109.537 -0.542 . . . . 64.140000000000001 109.537 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -24.75 55.79 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.959 -0.564 . . . . 73.349999999999994 110.11 -178.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.37 -36.56 71.49 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.817 -0.808 . . . . 64.209999999999994 108.817 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.41 -37.05 62.84 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 114.261 -1.336 . . . . 74.439999999999998 110.195 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.64 78.1 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.012 -0.594 . . . . 63.140000000000001 111.177 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.75 -33.15 74.28 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.698 -0.401 . . . . 74.409999999999997 111.758 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.83 -39.82 66.27 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 120.637 0.256 . . . . 75.319999999999993 111.195 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.31 -43.11 92.08 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 116.275 -0.421 . . . . 74.209999999999994 110.896 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.402 ' CD ' ' HA ' ' A' ' 104' ' ' GLU . 20.3 pttp -70.84 -30.28 66.65 Favored 'General case' 0 C--O 1.198 -1.631 0 C-N-CA 119.03 -1.068 . . . . 72.409999999999997 111.945 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -62.82 -31.4 72.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.381 0.61 . . . . 72.340000000000003 110.096 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.83 -36.57 21.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 116.041 -0.527 . . . . 55.119999999999997 111.427 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.556 ' O ' HG22 ' A' ' 91' ' ' ILE . 96.5 mt -93.98 -10.83 32.36 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 115.361 1.615 . . . . 54.420000000000002 115.361 -174.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -78.77 115.08 18.23 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 118.502 -1.279 . . . . 73.540000000000006 111.202 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.51 19.4 13.92 Favored Glycine 0 N--CA 1.421 -2.331 0 C-N-CA 120.515 -0.85 . . . . 73.219999999999999 111.211 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 88' ' ' LEU . 16.5 tt -102.04 125.33 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.04 0 N-CA-C 106.86 -1.533 . . . . 75.329999999999998 106.86 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -78.28 129.04 34.58 Favored 'General case' 0 C--N 1.257 -3.422 0 N-CA-C 109.303 -0.629 . . . . 55.030000000000001 109.303 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -72.68 -30.22 64.06 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.714 -1.13 . . . . 74.540000000000006 109.824 -172.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.597 ' HB2' ' CB ' ' A' ' 97' ' ' ASN 0.277 9.7 m-20 -150.62 124.63 4.47 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 105.765 -1.939 . . . . 24.449999999999999 105.765 177.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.466 ' HD3' ' CZ ' ' B' ' 48' ' ' TYR . 52.3 Cg_exo -63.0 -19.01 68.09 Favored 'Trans proline' 0 CA--C 1.555 1.535 0 CA-C-N 121.127 1.438 . . . . 72.5 111.272 170.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -78.12 -23.53 47.8 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.272 1.029 . . . . 73.430000000000007 110.707 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.597 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 22.0 t-20 -107.6 141.38 22.92 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 107.336 -1.357 . . . . 75.310000000000002 107.336 -172.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.429 ' HD2' ' OD1' ' A' ' 97' ' ' ASN . 73.5 Cg_endo -76.07 7.25 3.36 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 122.522 2.148 . . . . 72.010000000000005 111.726 176.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -88.31 126.18 35.05 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.141 -0.936 . . . . 74.200000000000003 109.921 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.2 p -115.25 141.92 47.38 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.529 -0.915 . . . . 54.109999999999999 108.529 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.3 tp -89.14 132.58 34.75 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.411 -0.589 . . . . 43.5 109.411 -176.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -134.56 122.53 22.5 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.095 0.558 . . . . 74.519999999999996 109.727 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -116.02 132.82 56.54 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.273 -0.64 . . . . 71.310000000000002 109.273 177.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.671 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 34.7 tt0 -146.24 168.49 20.93 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.223 -1.769 . . . . 71.519999999999996 106.223 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -68.02 138.2 55.66 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 120.133 1.333 . . . . 74.340000000000003 110.646 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.07 160.22 31.42 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.298 -0.864 . . . . 74.299999999999997 111.491 -176.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -63.29 -25.39 68.29 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.521 -1.218 . . . . 64.140000000000001 110.379 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.1 130.66 29.39 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 114.554 -1.203 . . . . 62.350000000000001 108.948 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 30' ' ' VAL . 1.7 m-20 -82.44 121.35 26.62 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.322 -1.732 . . . . 73.400000000000006 106.322 176.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.287 -2.124 0 C-N-CA 119.46 -0.896 . . . . 61.240000000000002 111.293 -178.838 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.512 ' HB ' ' CD1' ' B' ' 105' ' ' PHE . 40.8 t . . . . . 1 N--CA 1.369 -4.513 0 N-CA-C 105.005 -2.22 . . . . 74.239999999999995 105.005 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.468 ' NH2' ' HA ' ' B' ' 76' ' ' ASP . 17.1 ptm180 -101.05 11.72 39.03 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 122.019 0.914 . . . . 72.310000000000002 109.221 -177.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . 0.473 HG21 HG22 ' B' ' 110' ' ' THR . 51.9 m -124.13 114.92 20.31 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.959 -1.019 . . . . 74.25 109.348 172.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' B' ' 85' ' ' LYS . 4.4 mp -96.87 140.48 31.36 Favored 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 107.857 -1.164 . . . . 74.230000000000004 107.857 -176.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' B' ' 104' ' ' GLU 0.262 28.0 p90 -102.83 110.63 22.61 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 117.534 -1.666 . . . . 73.329999999999998 109.127 175.005 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.444 HG22 ' HG ' ' B' ' 103' ' ' LEU . 40.5 t -97.49 125.88 50.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-N 113.736 -1.574 . . . . 74.530000000000001 108.634 -176.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 19.1 p -131.32 170.76 14.19 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.945 -0.571 . . . . 60.409999999999997 109.658 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.36 5.2 57.11 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.721 -0.952 . . . . 41.229999999999997 110.721 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.719 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 63.8 mt -84.34 120.01 73.86 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 106.515 -1.661 . . . . 74.129999999999995 106.515 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.56 175.84 6.56 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.577 1.518 . . . . 75.140000000000001 111.425 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.436 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 13.2 p -65.54 -19.82 26.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.957 0.884 . . . . 31.120000000000001 110.149 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -107.32 39.51 1.88 Allowed 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.141 -0.936 . . . . 74.109999999999999 108.599 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 tp -68.62 121.32 17.67 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 N-CA-C 109.044 -0.724 . . . . 74.109999999999999 109.044 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.418 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 16.3 mmmt -89.11 138.55 28.95 Favored Pre-proline 0 C--N 1.287 -2.112 0 N-CA-C 106.545 -1.65 . . . . 71.0 106.545 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.29 -29.48 86.2 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 122.333 2.022 . . . . 64.040000000000006 112.065 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.576 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 14.2 ptt180 -63.49 -31.94 73.25 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 114.818 -1.083 . . . . 63.43 112.17 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.418 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 36.9 mt-10 -63.02 -49.26 75.31 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.824 0.345 . . . . 74.049999999999997 110.374 -177.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.15 -43.46 91.75 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.724 -0.671 . . . . 75.319999999999993 109.969 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.69 ' O ' ' HG3' ' B' ' 52' ' ' ARG . 0.4 OUTLIER -59.94 -43.38 94.99 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.031 -0.986 . . . . 75.120000000000005 112.298 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.39 -42.51 75.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.854 0.359 . . . . 70.019999999999996 110.274 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 24.6 tp -64.93 -41.45 95.52 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.108 -0.951 . . . . 72.439999999999998 111.087 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -88.67 1.87 54.29 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 113.944 1.09 . . . . 73.549999999999997 113.944 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.69 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 17.4 mtp180 -62.19 -46.38 90.95 Favored Pre-proline 0 CA--C 1.558 1.262 0 N-CA-C 113.593 0.96 . . . . 75.010000000000005 113.593 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -68.0 -19.46 45.75 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 121.853 1.702 . . . . 62.539999999999999 112.421 175.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -81.89 98.15 8.38 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.007 0.908 . . . . 73.530000000000001 110.789 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -70.91 110.11 5.44 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 113.898 -1.501 . . . . 75.120000000000005 110.764 -177.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.38 -15.42 4.18 Favored Glycine 0 N--CA 1.423 -2.233 0 CA-C-N 114.401 -1.272 . . . . 74.200000000000003 111.537 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -56.47 115.66 2.64 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.155 0.502 . . . . 71.120000000000005 111.424 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -93.49 -50.79 5.26 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-N 115.634 -0.712 . . . . 70.319999999999993 109.864 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.33 -179.17 47.5 Favored Glycine 0 C--N 1.29 -2.007 0 C-N-CA 120.527 -0.844 . . . . 53.149999999999999 111.671 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.2 p -136.9 137.99 40.21 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 123.311 0.644 . . . . 61.009999999999998 109.836 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 52.8 tp -120.36 123.81 43.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.591 -1.263 . . . . 73.049999999999997 107.591 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.63 144.96 8.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 109.929 -0.397 . . . . 54.119999999999997 109.929 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.456 ' HE3' ' HA ' ' B' ' 63' ' ' LYS . 1.6 tpmt? -133.43 108.56 8.74 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.039 -1.097 . . . . 74.120000000000005 108.039 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.19 108.85 3.31 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.91 -0.587 . . . . 74.129999999999995 109.603 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 20.9 m -100.06 156.71 17.03 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 105.872 -1.899 . . . . 53.520000000000003 105.872 175.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.09 -37.35 3.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.597 1.159 . . . . 74.099999999999994 113.885 -174.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -101.34 -46.12 5.12 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 119.677 -0.809 . . . . 70.540000000000006 112.469 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.719 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 4.0 pt20 -142.55 136.66 14.72 Favored Pre-proline 0 C--N 1.288 -2.095 0 CA-C-O 120.985 0.422 . . . . 73.340000000000003 112.035 -170.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.436 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 19.1 Cg_exo -64.34 108.88 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.393 2.729 . . . . 55.439999999999998 110.537 170.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 33.8 m -87.64 160.63 2.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.251 -1.018 . . . . 64.340000000000003 108.251 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.55 121.19 2.89 Favored Glycine 0 CA--C 1.481 -2.062 0 C-N-CA 119.163 -1.494 . . . . 64.120000000000005 112.68 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.12 108.83 19.46 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.198 -1.408 . . . . 73.109999999999999 107.198 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 86.0 t -95.9 125.23 48.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-N 115.72 -0.673 . . . . 72.439999999999998 110.396 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 3.5 mp -96.91 127.32 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 CA-C-N 115.064 -0.971 . . . . 73.310000000000002 108.907 -176.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -109.38 158.14 18.22 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.426 -0.806 . . . . 75.310000000000002 110.647 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . 0.468 ' HA ' ' NH2' ' B' ' 31' ' ' ARG . 18.0 t70 -79.93 -29.53 39.77 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 113.941 -1.482 . . . . 73.010000000000005 111.777 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 9.2 m -135.57 153.9 51.53 Favored 'General case' 0 N--CA 1.417 -2.098 0 C-N-CA 119.238 -0.985 . . . . 75.349999999999994 112.107 -168.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 7.3 tpt85 -63.51 -42.62 98.47 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.477 -1.238 . . . . 75.5 109.856 177.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.11 -17.61 62.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.191 -1.368 . . . . 75.340000000000003 109.679 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.69 -47.5 4.52 Favored Glycine 0 CA--C 1.488 -1.646 0 CA-C-N 114.113 -1.403 . . . . 52.240000000000002 109.902 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.22 -46.68 87.81 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 114.498 -0.851 . . . . 70.549999999999997 111.752 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.16 -31.33 72.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.602 0.593 . . . . 74.329999999999998 112.602 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.74 -39.47 24.15 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 120.804 -0.358 . . . . 70.129999999999995 110.691 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.95 -42.36 85.37 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.059 -0.519 . . . . 72.239999999999995 111.427 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.431 ' HB3' HD23 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -73.51 -27.67 61.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 120.308 -0.557 . . . . 73.409999999999997 110.9 -177.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -76.15 -39.73 54.3 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.239 -0.437 . . . . 54.130000000000003 110.362 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.08 -43.89 61.23 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 120.848 0.356 . . . . 52.509999999999998 111.874 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.507 ' O ' HG22 ' B' ' 91' ' ' ILE . 97.1 mt -87.05 -14.11 42.46 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 115.684 1.735 . . . . 74.049999999999997 115.684 -172.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -78.5 113.92 16.95 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 117.729 -1.588 . . . . 73.439999999999998 111.57 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.95 18.22 9.0 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.383 -0.913 . . . . 63.340000000000003 111.353 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.507 HG22 ' O ' ' B' ' 88' ' ' LEU . 15.1 tt -101.59 136.92 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.91 0 N-CA-C 108.086 -1.079 . . . . 61.350000000000001 108.086 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.468 ' NH1' ' HA ' ' B' ' 98' ' ' PRO . 15.6 mmt180 -64.97 130.21 42.56 Favored 'General case' 0 C--N 1.278 -2.541 0 C-N-CA 124.109 0.964 . . . . 61.020000000000003 108.602 175.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -75.13 -27.51 59.8 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.01 -1.478 . . . . 63.310000000000002 107.01 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.62 126.43 3.51 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 103.375 -2.824 . . . . 52.140000000000001 103.375 168.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . 0.682 ' HD3' ' CZ ' ' A' ' 48' ' ' TYR . 69.6 Cg_endo -71.88 -8.4 22.93 Favored 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 122.235 1.957 . . . . 73.140000000000001 114.342 -171.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -84.49 -21.81 30.47 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.05 -0.722 . . . . 64.040000000000006 109.05 -177.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -108.98 142.44 25.52 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.329 -0.989 . . . . 65.340000000000003 108.329 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.468 ' HA ' ' NH1' ' B' ' 92' ' ' ARG . 49.1 Cg_exo -62.25 -3.92 4.63 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 123.151 2.567 . . . . 42.299999999999997 113.525 172.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.93 117.03 6.99 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-O 121.653 0.74 . . . . 75.120000000000005 109.855 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 42.5 p -121.56 150.07 42.19 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.566 -0.743 . . . . 71.319999999999993 109.906 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 22.7 tp -85.95 123.42 31.26 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 106.411 -1.7 . . . . 72.319999999999993 106.411 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.97 113.17 16.14 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.842 -1.17 . . . . 75.409999999999997 107.842 -172.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.444 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.7 mp -112.59 136.62 51.92 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.537 -0.756 . . . . 72.319999999999993 110.271 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.489 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 42.4 tt0 -144.94 167.52 22.44 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.937 -1.505 . . . . 72.25 106.937 175.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . 0.512 ' CD1' ' HB ' ' B' ' 30' ' ' VAL . 40.1 m-85 -76.64 135.07 39.14 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.277 -0.638 . . . . 74.120000000000005 109.277 177.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.53 163.48 26.87 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.462 0.649 . . . . 65.109999999999999 111.194 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -76.57 -20.64 56.6 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 122.187 0.994 . . . . 44.109999999999999 108.895 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.06 124.3 27.36 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.879 -1.055 . . . . 74.430000000000007 110.956 -174.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.479 HD21 ' HA ' ' B' ' 30' ' ' VAL . 81.7 m-20 -82.94 136.21 34.64 Favored 'General case' 0 CA--C 1.475 -1.904 0 N-CA-C 107.68 -1.23 . . . . 74.109999999999999 107.68 173.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.473 HG22 HG21 ' B' ' 32' ' ' THR . 12.0 t . . . . . 0 C--N 1.268 -2.978 0 N-CA-C 108.652 -0.87 . . . . 72.129999999999995 108.652 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.1 t . . . . . 0 N--CA 1.444 -0.773 0 N-CA-C 103.169 -2.901 . . . . 72.430000000000007 103.169 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' A' ' 75' ' ' PHE . 20.4 ptt180 -133.27 9.81 4.08 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 119.788 -0.765 . . . . 73.530000000000001 112.016 -167.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 75.0 m -105.36 119.98 40.43 Favored 'General case' 0 C--N 1.264 -3.149 0 C-N-CA 119.744 -0.782 . . . . 73.430000000000007 109.536 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.512 HD11 ' O ' ' A' ' 81' ' ' ALA . 76.1 mt -99.28 142.11 31.19 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.418 -1.327 . . . . 71.230000000000004 107.418 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 15.8 p90 -103.54 116.79 33.04 Favored 'General case' 0 C--N 1.281 -2.4 0 C-N-CA 117.994 -1.482 . . . . 74.019999999999996 107.989 175.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.423 HG22 ' HG ' ' A' ' 103' ' ' LEU . 29.7 t -97.36 118.98 44.8 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.311 -1.366 . . . . 54.109999999999999 107.311 -178.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 32.7 p -120.92 166.08 14.31 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 109.041 -0.725 . . . . 72.329999999999998 109.041 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA2' ' NE2' ' A' ' 99' ' ' GLN . . . 97.0 18.5 29.19 Favored Glycine 0 N--CA 1.425 -2.038 0 C-N-CA 120.524 -0.846 . . . . 72.310000000000002 111.643 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -93.89 112.0 55.24 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.456 -0.942 . . . . 51.329999999999998 108.456 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.71 156.97 25.15 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.402 2.068 . . . . 72.099999999999994 110.774 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.99 -4.24 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 CA-C-O 122.109 0.957 . . . . 73.420000000000002 112.141 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -100.93 14.19 32.66 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.85 -0.796 . . . . 64.310000000000002 108.85 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.25 129.18 11.95 Favored 'Isoleucine or valine' 0 C--O 1.254 1.297 0 C-N-CA 124.859 1.263 . . . . 64.549999999999997 110.122 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -126.85 104.77 23.19 Favored Pre-proline 0 C--N 1.286 -2.19 0 N-CA-C 106.705 -1.591 . . . . 74.319999999999993 106.705 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -39.98 -17.49 0.05 OUTLIER 'Trans proline' 0 N--CA 1.515 2.777 1 C-N-CA 126.53 4.82 . . . . 62.340000000000003 118.14 -165.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.503 ' HG3' ' CE2' ' B' ' 93' ' ' PHE . 0.0 OUTLIER -60.59 -32.56 71.67 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 112.892 0.701 . . . . 71.109999999999999 112.892 176.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.645 ' HG3' ' CZ ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -69.39 -42.84 74.59 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.371 -0.931 . . . . 75.430000000000007 109.605 -177.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.37 -45.25 94.03 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 115.817 -0.628 . . . . 64.209999999999994 109.394 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.642 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 72.9 t80 -56.52 -49.13 75.67 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.952 -1.022 . . . . 72.310000000000002 111.42 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 93.2 mt -66.8 -35.97 81.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.915 0.388 . . . . 62.100000000000001 110.772 -176.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.5 tp -73.83 -41.97 61.54 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.279 -0.873 . . . . 63.530000000000001 112.327 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -87.81 -11.39 48.11 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 115.936 1.828 . . . . 73.150000000000006 115.936 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 52.8 mtp180 -60.58 -41.97 85.8 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 113.793 1.034 . . . . 75.299999999999997 113.793 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -64.82 -19.23 64.18 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.696 1.597 . . . . 54.340000000000003 112.387 175.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -81.76 89.65 6.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.233 0.539 . . . . 64.239999999999995 110.214 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.29 109.79 1.68 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.746 -0.835 . . . . 64.329999999999998 108.746 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.6 -17.67 3.7 Favored Glycine 0 N--CA 1.419 -2.485 0 CA-C-N 114.823 -1.081 . . . . 71.310000000000002 110.759 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -63.38 112.74 2.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.821 0.31 . . . . 63.409999999999997 110.538 175.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -90.55 -48.07 7.31 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.09 0.471 . . . . 73.409999999999997 110.437 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.8 179.21 48.78 Favored Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.203 -0.999 . . . . 74.439999999999998 112.558 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 p -138.33 136.84 36.8 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.803 0.335 . . . . 73.540000000000006 110.933 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 mp -123.02 121.16 35.39 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.558 -0.904 . . . . 73.530000000000001 108.558 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.76 138.56 20.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 120.853 0.358 . . . . 64.409999999999997 111.204 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -121.14 135.64 55.13 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.527 1.131 . . . . 71.230000000000004 108.254 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.63 126.89 33.31 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.74 0.781 . . . . 75.299999999999997 112.913 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 18.9 m -130.12 148.56 51.97 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 104.254 -2.499 . . . . 65.329999999999998 104.254 172.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -42.24 -48.86 4.99 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.849 1.26 . . . . 72.409999999999997 114.366 -169.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 67' ' ' ARG . 24.1 mtm180 -105.3 -5.05 20.87 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.187 -1.005 . . . . 71.010000000000005 113.184 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.476 ' O ' ' HB ' ' A' ' 65' ' ' THR . 11.2 pt20 -161.79 117.1 1.28 Allowed Pre-proline 0 C--N 1.312 -1.03 0 C-N-CA 120.114 -0.634 . . . . 71.230000000000004 112.515 -171.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -73.53 105.52 2.01 Favored 'Trans proline' 0 N--CA 1.432 -2.089 0 C-N-CA 122.243 1.962 . . . . 72.030000000000001 108.107 169.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.5 152.16 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.119 -0.697 . . . . 71.140000000000001 109.119 -176.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.53 120.4 4.4 Favored Glycine 0 CA--C 1.477 -2.293 0 C-N-CA 118.642 -1.742 . . . . 61.229999999999997 112.805 -175.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.52 103.72 16.15 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.454 -1.313 . . . . 71.409999999999997 107.454 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.2 t -98.09 120.96 48.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 114.888 -1.051 . . . . 72.299999999999997 110.097 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 110' ' ' THR . 5.9 tt -94.96 127.74 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.258 0 CA-C-N 115.019 -0.991 . . . . 71.439999999999998 110.187 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.532 ' O ' ' HD2' ' A' ' 31' ' ' ARG . 84.4 m-85 -107.46 165.86 11.09 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 114.616 -1.175 . . . . 72.340000000000003 110.086 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.95 -48.21 78.88 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 125.209 1.404 . . . . 75.420000000000002 112.48 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 p -143.65 163.88 32.0 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 111.755 0.28 . . . . 74.439999999999998 111.755 -172.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.509 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -68.44 -36.05 78.48 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.216 0.531 . . . . 74.430000000000007 110.65 -177.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.64 -28.87 63.0 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.228 -0.896 . . . . 73.420000000000002 108.962 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.11 -39.5 37.17 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.443 -1.253 . . . . 70.310000000000002 110.407 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.512 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -65.35 -46.1 81.56 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.878 -0.661 . . . . 65.430000000000007 111.534 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -63.38 -37.63 88.03 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.448 -0.501 . . . . 74.239999999999995 112.082 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.2 -38.47 85.38 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.249 -0.432 . . . . 72.120000000000005 110.106 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.86 -39.52 83.77 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.808 -0.633 . . . . 45.009999999999998 110.56 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -59.09 -47.97 83.32 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.685 -0.689 . . . . 62.420000000000002 111.836 177.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -66.1 -25.16 66.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.194 0.521 . . . . 61.43 111.864 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.17 -39.72 32.72 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.872 -0.604 . . . . 43.310000000000002 111.514 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.472 ' O ' HG22 ' A' ' 91' ' ' ILE . 98.2 mt -102.2 -25.33 13.73 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 116.896 2.184 . . . . 73.409999999999997 116.896 -173.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -65.46 114.75 5.06 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-N 120.327 1.421 . . . . 75.25 110.18 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.58 10.18 19.87 Favored Glycine 0 N--CA 1.421 -2.32 0 CA-C-N 115.405 -0.816 . . . . 45.020000000000003 111.606 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 88' ' ' LEU . 14.7 tt -93.9 130.33 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.41 0 N-CA-C 109.107 -0.701 . . . . 64.319999999999993 109.107 177.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.536 ' CG ' HG22 ' A' ' 100' ' ' THR . 79.0 mtt180 -76.15 141.35 41.92 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-O 121.396 0.617 . . . . 73.140000000000001 111.757 173.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.645 ' CZ ' ' HG3' ' A' ' 46' ' ' GLU . 26.3 t80 -70.74 -34.46 71.9 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.509 -1.678 . . . . 60.329999999999998 109.108 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.558 ' HB2' ' CB ' ' A' ' 97' ' ' ASN . 6.5 m-20 -140.41 142.14 28.32 Favored Pre-proline 0 C--N 1.294 -1.821 0 N-CA-C 102.666 -3.087 . . . . 52.329999999999998 102.666 175.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.67 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 28.1 Cg_endo -64.03 -22.7 67.9 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 121.469 1.446 . . . . 75.049999999999997 110.898 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -92.08 -8.16 46.62 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.65 -1.159 . . . . 74.129999999999995 110.545 -176.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.558 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 34.2 t30 -103.51 120.66 51.03 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 108.977 -0.749 . . . . 64.099999999999994 108.977 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.89 -19.55 35.38 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.669 2.246 . . . . 74.120000000000005 111.858 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.429 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 6.9 tp60 -68.09 114.65 6.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.337 -0.986 . . . . 72.450000000000003 108.337 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.536 HG22 ' CG ' ' A' ' 92' ' ' ARG . 69.1 p -107.56 154.83 20.84 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.066 -0.716 . . . . 74.010000000000005 109.066 -175.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.7 mp -86.29 118.29 25.64 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.803 -0.443 . . . . 74.109999999999999 109.803 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -110.76 121.25 44.87 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.725 -1.954 . . . . 74.109999999999999 105.725 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.423 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.5 mp -105.27 138.17 41.89 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.151 -1.055 . . . . 71.25 108.151 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.579 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 32.6 tt0 -146.02 163.38 35.41 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.843 -1.91 . . . . 64.200000000000003 105.843 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -70.55 137.91 50.5 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 119.22 0.918 . . . . 74.439999999999998 110.37 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.9 141.15 40.66 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 108.15 -1.056 . . . . 73.209999999999994 108.15 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -80.19 10.04 4.93 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 122.233 1.016 . . . . 74.200000000000003 110.692 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -162.38 132.17 4.54 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.986 -1.857 . . . . 75.450000000000003 105.986 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -78.36 158.54 28.75 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.413 0.625 . . . . 62.329999999999998 111.648 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.422 ' O ' HD12 ' A' ' 74' ' ' ILE . 6.7 t . . . . . 0 N--CA 1.399 -2.977 0 N-CA-C 104.35 -2.463 . . . . 51.520000000000003 104.35 169.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.526 ' HA ' HD21 ' B' ' 109' ' ' ASN . 57.8 t . . . . . 0 CA--C 1.5 -0.976 0 N-CA-C 106.49 -1.67 . . . . 73.129999999999995 106.49 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -140.04 15.06 2.45 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 115.042 -0.981 . . . . 64.230000000000004 111.855 -171.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' B' ' 74' ' ' ILE . 35.3 m -105.84 125.76 51.37 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 108.727 -0.842 . . . . 65.230000000000004 108.727 174.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.455 HD11 ' O ' ' B' ' 81' ' ' ALA . 85.4 mt -100.83 143.11 31.38 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.75 -0.833 . . . . 71.129999999999995 108.75 178.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.615 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 4.6 p90 -104.44 118.47 36.68 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 106.798 -1.556 . . . . 71.239999999999995 106.798 171.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 39.8 t -97.27 111.95 28.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 N-CA-C 107.206 -1.405 . . . . 64.319999999999993 107.206 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 36.2 p -109.92 162.47 14.48 Favored 'General case' 0 C--N 1.276 -2.59 0 N-CA-C 109.07 -0.715 . . . . 63.350000000000001 109.07 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.83 24.82 12.47 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.428 -0.891 . . . . 70.030000000000001 111.887 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.573 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 83.4 mt -101.78 113.59 65.81 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 107.757 -1.201 . . . . 75.430000000000007 107.757 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.49 169.79 2.14 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.856 2.371 . . . . 54.350000000000001 112.35 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 6.6 p -72.96 -2.41 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 122.115 0.959 . . . . 63.420000000000002 110.458 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' B' ' 43' ' ' LYS . 22.3 t0 -105.01 10.65 34.03 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 114.954 -1.021 . . . . 55.329999999999998 109.563 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.94 129.88 19.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-O 121.811 0.815 . . . . 72.420000000000002 109.449 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' B' ' 45' ' ' ARG . 47.7 mmtm -130.0 107.05 16.56 Favored Pre-proline 0 C--N 1.277 -2.564 0 N-CA-C 106.449 -1.686 . . . . 64.049999999999997 106.449 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -41.48 -16.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.478 1 C-N-CA 126.372 4.715 . . . . 52.420000000000002 117.774 -165.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.557 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 9.8 ptt180 -65.51 -24.72 67.2 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 122.642 0.377 . . . . 75.230000000000004 111.855 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.553 ' HG3' ' CE1' ' B' ' 93' ' ' PHE . 0.0 OUTLIER -76.03 -41.83 49.72 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 119.214 -0.994 . . . . 75.120000000000005 108.888 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.41 ' HG ' ' OE1' ' B' ' 46' ' ' GLU . 96.4 mt -62.17 -37.19 84.28 Favored 'General case' 0 C--O 1.211 -0.939 0 N-CA-C 108.859 -0.793 . . . . 74.219999999999999 108.859 175.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.67 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 63.1 t80 -58.53 -49.78 76.15 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.846 -1.07 . . . . 55.130000000000003 110.488 176.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.62 -33.98 74.97 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.862 0.363 . . . . 64.219999999999999 110.738 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 36.5 tp -74.58 -45.92 42.08 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.566 -0.743 . . . . 72.239999999999995 112.467 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -92.13 -7.31 48.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.951 1.093 . . . . 70.010000000000005 113.951 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.594 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 20.6 ttt180 -65.99 -43.13 56.29 Favored Pre-proline 0 CA--C 1.56 1.333 0 N-CA-C 112.416 0.525 . . . . 71.409999999999997 112.416 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.22 -15.43 46.09 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 121.76 1.64 . . . . 53.420000000000002 111.862 175.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -85.68 88.87 7.6 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.419 -0.585 . . . . 71.409999999999997 109.419 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.1 112.85 5.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.453 -0.794 . . . . 73.109999999999999 109.978 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.84 -26.5 1.62 Allowed Glycine 0 N--CA 1.426 -1.985 0 CA-C-N 113.578 -1.646 . . . . 72.409999999999997 109.49 -174.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -50.89 119.03 3.54 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.413 1.085 . . . . 72.140000000000001 111.905 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.493 ' HB2' HG23 ' B' ' 74' ' ' ILE . 6.6 mm-40 -93.06 -46.69 7.33 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 115.928 -0.578 . . . . 52.420000000000002 109.443 176.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.85 171.99 37.4 Favored Glycine 0 C--N 1.297 -1.614 0 C-N-CA 120.455 -0.879 . . . . 72.200000000000003 112.325 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.9 p -127.11 137.34 52.98 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.192 0.52 . . . . 61.109999999999999 111.061 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . 0.409 HD22 HG22 ' B' ' 110' ' ' THR . 5.1 mp -117.87 109.72 16.88 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.376 -0.972 . . . . 72.219999999999999 108.376 175.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.74 131.95 39.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.729 -0.841 . . . . 60.329999999999998 108.729 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -130.97 119.57 22.27 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 109.293 -0.632 . . . . 75.239999999999995 109.293 -176.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.51 134.63 57.26 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.213 1.005 . . . . 73.409999999999997 110.873 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 2.5 m -130.08 158.58 39.24 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 105.663 -1.977 . . . . 71.040000000000006 105.663 175.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.89 -40.66 10.36 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.065 0.946 . . . . 72.109999999999999 113.29 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 -104.75 -41.66 5.6 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 119.58 -0.848 . . . . 72.349999999999994 112.735 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.573 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 14.1 pt20 -153.36 126.44 4.13 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 120.717 -0.393 . . . . 74.099999999999994 111.55 -173.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' B' ' 38' ' ' LEU . 51.9 Cg_exo -56.85 124.37 16.09 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.004 2.469 . . . . 63.109999999999999 111.393 171.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.24 141.22 14.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 115.114 -0.948 . . . . 72.329999999999998 108.679 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.73 120.31 5.21 Favored Glycine 0 C--O 1.205 -1.702 0 C-N-CA 119.139 -1.505 . . . . 74.239999999999995 112.46 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -90.37 102.94 15.67 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.642 -1.244 . . . . 74.310000000000002 107.642 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.17 112.38 37.49 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 CA-C-N 115.569 -0.741 . . . . 70.310000000000002 109.182 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.493 HG23 ' HB2' ' B' ' 58' ' ' GLU . 12.4 tt -97.18 138.01 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 CA-C-N 115.528 -0.76 . . . . 71.209999999999994 110.549 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -112.61 160.04 18.26 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.04 -0.982 . . . . 75.430000000000007 109.341 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.24 -31.61 72.53 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.863 -0.608 . . . . 63.219999999999999 112.224 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 26.4 p -128.88 152.56 48.38 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 121.74 0.781 . . . . 61.509999999999998 111.904 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . 0.832 ' HD3' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -63.09 -39.05 93.57 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.514 -1.221 . . . . 73.430000000000007 109.954 177.255 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . 0.404 ' N ' ' HG2' ' B' ' 78' ' ' ARG . . . -79.51 -19.9 48.52 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.184 -1.043 . . . . 63.020000000000003 108.184 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.56 -44.75 31.76 Favored Glycine 0 C--N 1.307 -1.067 0 N-CA-C 109.227 -1.549 . . . . 72.400000000000006 109.227 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.455 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -67.97 -37.4 81.48 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.381 -0.909 . . . . 50.310000000000002 109.476 176.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -55.42 -52.51 63.33 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.066 -0.97 . . . . 65.230000000000004 110.576 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.08 89.76 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.525 -0.761 . . . . 74.230000000000004 110.994 -176.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.21 -39.96 82.28 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.351 -0.84 . . . . 44.409999999999997 110.563 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -62.84 -42.49 99.76 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.603 -0.726 . . . . 44.119999999999997 111.841 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -62.37 -37.37 85.42 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.257 0.551 . . . . 74.230000000000004 111.25 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.19 -45.34 33.7 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 115.581 -0.736 . . . . 63.149999999999999 111.767 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.497 ' O ' HG22 ' B' ' 91' ' ' ILE . 90.7 mt -93.33 -21.05 19.8 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 117.477 2.399 . . . . 72.010000000000005 117.477 -170.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -69.86 114.01 7.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 120.787 1.631 . . . . 73.219999999999999 112.343 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 113.9 1.56 24.01 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.885 -0.598 . . . . 64.040000000000006 112.255 176.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.497 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.2 tt -86.02 136.15 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 CA-C-O 121.137 0.494 . . . . 61.240000000000002 110.184 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.516 ' HA ' HG22 ' B' ' 100' ' ' THR . 22.2 mmt180 -59.26 139.02 57.38 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 125.17 1.388 . . . . 72.519999999999996 110.045 173.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.553 ' CE1' ' HG3' ' B' ' 46' ' ' GLU . 34.9 t80 -80.77 -32.28 35.54 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.491 -1.67 . . . . 74.140000000000001 106.491 173.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.667 ' HB2' ' HB3' ' B' ' 97' ' ' ASN . 9.5 m-20 -147.47 143.31 17.83 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 101.493 -3.521 . . . . 73.530000000000001 101.493 174.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . 0.632 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 74.0 Cg_endo -78.33 -15.88 13.98 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 CA-C-N 121.952 1.733 . . . . 61.200000000000003 109.619 175.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -79.63 -25.34 41.43 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.299 -1.319 . . . . 74.129999999999995 109.629 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' ASN . . . . . 0.667 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . 38.0 t30 -109.69 129.9 23.4 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 107.744 -1.206 . . . . 75.109999999999999 107.744 -174.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.73 -2.81 6.97 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 123.156 2.57 . . . . 61.310000000000002 113.241 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -77.45 122.41 25.16 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.723 0.773 . . . . 73.319999999999993 110.267 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.516 HG22 ' HA ' ' B' ' 92' ' ' ARG . 17.9 p -121.72 159.81 25.82 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 115.045 -0.979 . . . . 75.200000000000003 108.582 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.406 HD13 HG23 ' B' ' 91' ' ' ILE . 4.4 mp -93.05 134.81 34.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.405 -0.961 . . . . 75.530000000000001 108.405 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -123.99 116.85 23.52 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.044 -1.836 . . . . 71.219999999999999 106.044 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mp -106.49 136.37 46.38 Favored 'General case' 0 C--N 1.289 -2.034 0 O-C-N 123.752 0.657 . . . . 72.409999999999997 110.354 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.615 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 37.1 tt0 -145.4 163.97 32.95 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 105.744 -1.947 . . . . 74.150000000000006 105.744 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -70.47 144.93 51.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 119.493 1.042 . . . . 71.450000000000003 110.133 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.69 158.18 27.03 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 107.996 -1.113 . . . . 73.120000000000005 107.996 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -81.91 -11.32 58.96 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.009 0.909 . . . . 63.009999999999998 109.523 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -149.06 130.49 14.77 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.664 -1.153 . . . . 52.229999999999997 107.948 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.526 HD21 ' HA ' ' B' ' 30' ' ' VAL . 54.2 m-80 -74.15 113.99 11.98 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.432 0.634 . . . . 72.420000000000002 110.479 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.409 HG22 HD22 ' B' ' 61' ' ' LEU . 23.5 m . . . . . 0 N--CA 1.419 -2.023 0 N-CA-C 107.336 -1.357 . . . . 70.030000000000001 107.336 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 32' ' ' THR . 26.1 t . . . . . 0 N--CA 1.429 -1.51 0 N-CA-C 109.691 -0.485 . . . . 71.030000000000001 109.691 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 40.9 mtm180 -85.97 7.38 24.6 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-O 120.926 0.393 . . . . 72.209999999999994 110.507 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.531 ' H ' HG12 ' A' ' 30' ' ' VAL . 33.6 m -134.2 129.77 36.23 Favored 'General case' 0 C--N 1.259 -3.363 0 CA-C-O 121.821 0.82 . . . . 64.530000000000001 112.054 -173.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.429 HD13 ' HB3' ' A' ' 85' ' ' LYS . 88.4 mt -103.7 139.07 39.46 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.73 -1.211 . . . . 52.350000000000001 107.73 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -98.76 112.14 24.31 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.773 -1.566 . . . . 74.310000000000002 106.773 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.515 HG22 ' HG ' ' A' ' 103' ' ' LEU . 29.1 t -96.99 120.63 46.58 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 CA-C-N 113.79 -1.55 . . . . 71.109999999999999 107.739 -174.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 p -126.38 163.71 22.68 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 115.228 -0.896 . . . . 62.229999999999997 109.548 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.64 27.84 10.14 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.927 -0.869 . . . . 73.25 110.927 -173.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.563 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 96.8 mt -97.26 119.35 63.27 Favored Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 107.96 -1.126 . . . . 73.420000000000002 107.96 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.99 153.22 6.57 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.734 2.289 . . . . 72.140000000000001 111.283 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.512 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 8.6 p -70.07 -1.98 2.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.875 0.845 . . . . 70.109999999999999 112.013 -172.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -127.2 31.34 5.25 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-O 121.553 0.692 . . . . 65.150000000000006 109.974 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.14 149.06 6.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 N-CA-C 113.613 0.968 . . . . 74.019999999999996 113.613 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.529 ' HG2' ' CZ ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -102.74 144.53 28.8 Favored Pre-proline 0 C--N 1.279 -2.476 0 CA-C-N 113.883 -1.508 . . . . 73.409999999999997 109.615 176.091 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.45 -24.98 79.21 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 122.63 2.22 . . . . 74.319999999999993 113.325 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.529 ' CZ ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -84.14 -11.42 56.63 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 118.441 -1.304 . . . . 72.310000000000002 111.427 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.475 ' HG2' ' HG2' ' B' ' 46' ' ' GLU . 35.7 mt-10 -63.77 -39.92 95.44 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.703 0.763 . . . . 75.299999999999997 109.358 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.3 mt -67.32 -31.53 71.88 Favored 'General case' 0 C--O 1.209 -1.064 0 CA-C-N 115.226 -0.897 . . . . 73.450000000000003 110.077 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.6 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 42.0 t80 -65.32 -46.81 78.82 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.786 -0.643 . . . . 74.219999999999999 110.863 178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 69.0 mt -64.92 -40.01 94.39 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.114 -0.494 . . . . 64.310000000000002 110.884 -176.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.6 tp -81.42 -38.96 25.65 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.43 -0.804 . . . . 61.549999999999997 112.543 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -95.43 -3.52 46.79 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.285 1.217 . . . . 72.430000000000007 114.285 -173.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -61.49 -44.55 92.56 Favored Pre-proline 0 CA--C 1.563 1.452 0 N-CA-C 112.799 0.666 . . . . 64.329999999999998 112.799 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.68 -2.39 12.39 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 121.393 1.395 . . . . 53.25 112.854 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -91.53 95.35 9.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 122.336 1.065 . . . . 72.400000000000006 110.945 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -63.79 109.63 1.8 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 113.078 -1.874 . . . . 74.230000000000004 110.519 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.72 -23.56 3.23 Favored Glycine 0 N--CA 1.422 -2.252 0 CA-C-N 114.858 -1.065 . . . . 70.549999999999997 111.002 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -55.32 114.85 1.97 Allowed 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.498 0.719 . . . . 74.519999999999996 111.959 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -97.86 -58.91 1.87 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.661 -0.699 . . . . 75.109999999999999 110.376 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -158.26 -177.0 30.94 Favored Glycine 0 C--N 1.295 -1.726 0 C-N-CA 120.898 -0.668 . . . . 73.450000000000003 111.869 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.7 p -148.76 140.65 23.76 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 123.032 0.533 . . . . 64.340000000000003 110.349 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.3 tp -120.87 122.01 39.33 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.41 -0.589 . . . . 75.239999999999995 109.41 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.403 HG23 ' HB2' ' A' ' 69' ' ' PRO . 44.4 mm -93.57 133.76 33.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 109.233 -0.654 . . . . 74.430000000000007 109.233 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -135.3 113.27 11.1 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 121.021 0.438 . . . . 62.25 110.374 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -67.97 124.43 23.34 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.362 0.601 . . . . 61.399999999999999 110.897 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.8 m -116.7 162.05 18.27 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 105.637 -1.986 . . . . 71.209999999999994 105.637 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.51 -34.95 3.53 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.163 1.172 . . . . 74.109999999999999 114.163 -175.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -95.62 -46.79 6.49 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 112.75 0.648 . . . . 70.430000000000007 112.75 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 4.2 pt20 -156.82 157.08 30.62 Favored Pre-proline 0 C--N 1.295 -1.773 0 CA-C-N 115.792 -0.64 . . . . 64.019999999999996 109.459 -170.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.512 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 74.5 Cg_endo -80.46 120.64 4.05 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 122.667 2.245 . . . . 72.299999999999997 110.711 171.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.91 161.62 2.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.239 -1.022 . . . . 71.540000000000006 108.239 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.91 120.93 2.92 Favored Glycine 0 CA--C 1.484 -1.85 0 C-N-CA 118.762 -1.685 . . . . 74.109999999999999 112.579 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -88.11 104.62 16.85 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.519 -1.289 . . . . 75.409999999999997 107.519 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.6 t -99.25 123.26 51.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 CA-C-N 115.922 -0.581 . . . . 62.32 109.799 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 tt -101.54 131.85 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 115.38 -0.827 . . . . 73.140000000000001 110.962 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 74.2 m-85 -115.51 146.83 41.34 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.434 -1.257 . . . . 74.010000000000005 107.639 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -79.23 -24.07 43.31 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.708 0.766 . . . . 74.420000000000002 110.493 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.6 m -109.96 140.65 43.73 Favored 'General case' 0 N--CA 1.392 -3.373 0 CA-C-N 115.498 -0.774 . . . . 73.239999999999995 108.964 -175.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.1 mmt-85 -73.38 -33.15 64.87 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.417 -1.327 . . . . 73.140000000000001 107.417 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.2 -19.23 61.77 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.499 -1.682 . . . . 44.119999999999997 109.071 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.91 -42.34 6.39 Favored Glycine 0 CA--C 1.487 -1.661 0 N-CA-C 109.606 -1.398 . . . . 63.439999999999998 109.606 -177.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.413 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -64.71 -47.45 78.27 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 114.902 -0.649 . . . . 73.349999999999994 111.115 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.56 -36.11 82.82 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.147 -0.621 . . . . 73.450000000000003 111.991 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.37 78.12 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 120.737 0.303 . . . . 44.350000000000001 110.854 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.36 -42.28 79.45 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.947 -0.569 . . . . 73.430000000000007 110.843 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.429 ' HB3' HD13 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -71.62 -28.78 64.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 120.245 -0.582 . . . . 73.510000000000005 111.801 -178.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -71.31 -41.38 69.97 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 120.592 0.234 . . . . 64.340000000000003 111.542 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.05 -41.42 50.74 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.252 0.464 . . . . 75.239999999999995 112.252 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.477 ' O ' HG22 ' A' ' 91' ' ' ILE . 97.4 mt -95.93 1.71 53.06 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 115.646 1.721 . . . . 70.239999999999995 115.646 -173.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -79.09 114.39 18.0 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 116.822 -1.951 . . . . 75.310000000000002 111.066 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.17 12.18 34.58 Favored Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 110.27 -1.132 . . . . 61.119999999999997 110.27 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.3 tt -82.38 134.46 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.911 0 N-CA-C 109.116 -0.698 . . . . 52.420000000000002 109.116 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.461 ' NH1' ' HA ' ' A' ' 98' ' ' PRO . 26.2 mmt180 -60.91 121.07 11.44 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 107.954 -1.128 . . . . 72.400000000000006 107.954 171.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -75.37 -27.06 58.99 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.856 -1.535 . . . . 73.140000000000001 106.856 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 97' ' ' ASN . 12.0 t70 -148.07 126.1 5.91 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 103.212 -2.884 . . . . 70.239999999999995 103.212 174.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.561 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 69.2 Cg_endo -71.81 -16.44 29.62 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.426 1.417 . . . . 61.32 114.732 -175.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -93.07 -22.14 19.3 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.34 0.591 . . . . 74.129999999999995 110.174 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 48.9 t-20 -91.27 132.49 33.77 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.158 -1.423 . . . . 65.430000000000007 107.158 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.461 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 35.6 Cg_endo -67.75 -1.8 7.43 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.587 2.192 . . . . 70.329999999999998 113.0 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.75 113.74 10.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.793 -0.817 . . . . 62.450000000000003 108.793 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.9 p -115.7 147.53 40.77 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.915 -0.584 . . . . 74.129999999999995 109.687 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.6 tp -94.83 125.04 39.23 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 116.073 -0.512 . . . . 73.439999999999998 109.84 -174.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -120.54 126.35 50.11 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.194 -0.669 . . . . 75.010000000000005 109.194 176.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.515 ' HG ' HG22 ' A' ' 35' ' ' VAL . 7.0 mp -104.5 127.18 52.15 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 107.841 -1.17 . . . . 62.420000000000002 107.841 176.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -136.04 163.29 30.66 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 107.731 -1.211 . . . . 71.030000000000001 107.731 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.505 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 33.0 m-85 -78.7 134.83 37.06 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 119.048 0.84 . . . . 74.439999999999998 110.323 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.39 165.0 25.42 Favored 'General case' 0 N--CA 1.428 -1.532 0 O-C-N 123.668 0.605 . . . . 43.350000000000001 109.403 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -86.79 -6.87 58.68 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-O 121.946 0.879 . . . . 53.109999999999999 109.661 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.5 134.22 23.61 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.073 -0.967 . . . . 75.329999999999998 108.83 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' A' ' 30' ' ' VAL . 3.3 m-20 -76.72 124.97 28.46 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.165 -1.421 . . . . 53.119999999999997 107.165 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.409 -2.476 0 C-N-CA 118.113 -1.435 . . . . 75.530000000000001 108.907 179.326 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.56 HG12 ' H ' ' B' ' 32' ' ' THR . 17.5 t . . . . . 0 N--CA 1.444 -0.727 0 N-CA-C 110.345 -0.243 . . . . 74.430000000000007 110.345 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.572 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 82.8 mtm180 -96.22 0.04 50.52 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-O 121.286 0.565 . . . . 53.340000000000003 110.74 175.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . 0.56 ' H ' HG12 ' B' ' 30' ' ' VAL . 25.0 m -111.24 128.72 56.02 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-O 121.511 0.672 . . . . 72.430000000000007 112.549 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.5 HD11 ' O ' ' B' ' 81' ' ' ALA . 91.1 mt -104.57 146.37 29.0 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.43 -0.952 . . . . 73.420000000000002 108.43 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.6 ' CE1' ' HB2' ' B' ' 104' ' ' GLU . 27.9 p90 -104.6 115.18 29.89 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.187 -1.412 . . . . 51.200000000000003 107.187 172.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.53 115.45 37.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 CA-C-N 113.917 -1.492 . . . . 62.310000000000002 107.859 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 35.7 p -119.53 171.4 8.38 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.272 -0.876 . . . . 74.239999999999995 109.272 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 86.93 25.01 35.83 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.38 -1.088 . . . . 52.509999999999998 110.38 -173.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 95.7 mt -94.77 114.71 64.2 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 107.701 -1.222 . . . . 60.229999999999997 107.701 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.23 157.62 1.86 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.762 2.308 . . . . 74.329999999999998 111.968 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 7.2 p -63.35 -17.52 19.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.424 0.63 . . . . 75.209999999999994 112.111 -173.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -120.35 42.38 2.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.682 0.753 . . . . 62.340000000000003 109.948 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.421 HG12 ' HB3' ' B' ' 38' ' ' LEU . 2.5 pp -60.89 135.02 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.563 -1.255 . . . . 73.299999999999997 110.801 169.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.41 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 23.4 mmmt -94.19 144.14 27.55 Favored Pre-proline 0 C--N 1.266 -3.025 0 N-CA-C 106.68 -1.6 . . . . 71.150000000000006 106.68 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.38 -20.7 69.44 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.352 2.035 . . . . 70.109999999999999 113.176 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.487 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 0.0 OUTLIER -87.34 -10.74 51.38 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 118.966 -1.094 . . . . 71.019999999999996 111.999 -179.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.475 ' HG2' ' HG2' ' A' ' 46' ' ' GLU . 33.5 mt-10 -67.07 -39.0 86.74 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.426 0.631 . . . . 53.229999999999997 109.811 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 90.9 mt -68.86 -29.97 68.39 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-N 115.445 -0.798 . . . . 54.43 109.393 176.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.561 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 39.9 t80 -66.99 -47.99 69.83 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.438 -0.801 . . . . 74.200000000000003 110.682 177.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 82.3 mt -63.69 -39.77 95.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.29 0.567 . . . . 72.209999999999994 110.327 -177.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 33.6 tp -76.82 -39.49 51.16 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.106 -0.952 . . . . 73.0 112.489 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -95.25 -0.87 52.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 114.175 1.176 . . . . 74.409999999999997 114.175 -176.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -63.13 -42.98 79.83 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 112.479 0.548 . . . . 53.450000000000003 112.479 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -65.93 -21.63 56.82 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.09 1.86 . . . . 42.210000000000001 112.226 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -92.24 88.23 6.39 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 121.753 0.787 . . . . 75.209999999999994 109.57 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -80.51 115.49 20.06 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 122.439 1.114 . . . . 71.239999999999995 111.361 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.01 -28.41 0.73 Allowed Glycine 0 C--N 1.284 -2.354 0 CA-C-N 112.657 -2.065 . . . . 71.200000000000003 108.742 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -48.6 121.88 4.99 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.818 1.247 . . . . 75.230000000000004 111.775 174.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.47 ' HB2' HG23 ' B' ' 74' ' ' ILE . 12.0 mm-40 -92.83 -56.71 2.9 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.546 -0.909 . . . . 72.299999999999997 108.546 174.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.54 -175.88 39.57 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 115.063 -0.971 . . . . 72.150000000000006 112.035 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 12.5 p -136.99 138.17 40.24 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 122.735 0.414 . . . . 61.100000000000001 111.086 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 57.8 tp -114.39 127.22 55.73 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.289 -1.004 . . . . 63.340000000000003 108.289 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 50.8 mm -93.99 143.37 11.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.232 -0.655 . . . . 61.450000000000003 109.232 -176.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -137.96 108.23 6.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.645 -0.872 . . . . 63.310000000000002 108.645 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -66.94 128.98 38.4 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.312 0.577 . . . . 74.150000000000006 109.834 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.8 m -125.72 158.15 35.57 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 104.584 -2.376 . . . . 73.140000000000001 104.584 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.68 -29.24 59.02 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.554 0.946 . . . . 74.239999999999995 113.554 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -85.92 -39.28 17.12 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.729 0.64 . . . . 75.400000000000006 112.729 177.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 3.7 pt20 -174.32 155.1 2.16 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 115.886 -0.597 . . . . 74.340000000000003 109.691 -169.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.447 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 58.4 Cg_endo -80.28 115.82 3.25 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 C-N-CA 122.357 2.038 . . . . 74.239999999999995 110.657 171.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -87.92 162.63 2.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.405 -0.961 . . . . 53.039999999999999 108.405 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.06 122.7 3.4 Favored Glycine 0 CA--C 1.491 -1.464 0 C-N-CA 118.689 -1.72 . . . . 73.409999999999997 113.555 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -87.93 108.99 19.46 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.541 -1.281 . . . . 72.120000000000005 107.541 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 67.9 t -103.54 120.66 53.9 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 115.698 -0.683 . . . . 74.329999999999998 110.285 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.526 HD12 ' O ' ' B' ' 110' ' ' THR . 3.6 tt -96.54 130.82 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 115.169 -0.923 . . . . 75.319999999999993 110.06 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . 0.572 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 90.0 m-85 -111.13 156.56 21.18 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.906 -1.043 . . . . 65.439999999999998 108.326 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.74 -36.15 82.91 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.015 0.436 . . . . 60.539999999999999 112.089 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 33.0 p -131.84 163.41 28.33 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.411 0.624 . . . . 73.019999999999996 112.64 -175.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' B' ' 82' ' ' GLU . 4.4 mpt_? -73.94 -34.06 64.17 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 108.734 -0.839 . . . . 75.140000000000001 108.734 176.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.82 -19.84 64.29 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.01 -0.996 . . . . 72.409999999999997 109.564 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.16 -46.12 6.0 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.224 -1.151 . . . . 54.109999999999999 110.224 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.5 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -62.88 -45.1 94.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.3 -0.45 . . . . 63.240000000000002 111.705 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' B' ' 78' ' ' ARG . 9.6 pt-20 -63.56 -36.11 82.71 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 120.916 -0.314 . . . . 72.150000000000006 111.299 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.43 -41.85 79.72 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 120.839 0.352 . . . . 52.140000000000001 110.312 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.44 -42.31 87.84 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.72 -0.673 . . . . 63.409999999999997 111.227 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -70.96 -39.29 72.63 Favored 'General case' 0 C--O 1.203 -1.35 0 C-N-CA 119.407 -0.917 . . . . 72.409999999999997 110.999 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -65.68 -31.9 73.16 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.174 0.511 . . . . 61.43 110.764 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.06 -40.27 17.02 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 112.309 0.485 . . . . 71.0 112.309 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.529 ' O ' HG22 ' B' ' 91' ' ' ILE . 87.3 mt -100.99 -13.11 18.4 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 116.348 1.981 . . . . 70.030000000000001 116.348 -172.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -76.17 113.69 14.0 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 117.401 -1.72 . . . . 73.129999999999995 112.043 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 113.36 6.46 21.91 Favored Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 120.545 -0.836 . . . . 65.310000000000002 112.055 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.529 HG22 ' O ' ' B' ' 88' ' ' LEU . 14.9 tt -97.95 144.67 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.954 0 N-CA-C 107.117 -1.438 . . . . 72.329999999999998 107.117 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.418 ' HG2' HG22 ' B' ' 100' ' ' THR . 81.6 mtt180 -79.42 138.36 37.6 Favored 'General case' 0 C--N 1.26 -3.296 0 CA-C-O 121.244 0.545 . . . . 71.230000000000004 111.471 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -69.17 -35.51 76.37 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 113.811 -1.54 . . . . 74.549999999999997 108.599 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' B' ' 97' ' ' ASN . 1.1 m-20 -129.36 130.13 23.3 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 102.306 -3.22 . . . . 73.040000000000006 102.306 172.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . 0.6 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 27.9 Cg_endo -61.29 -30.66 88.32 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.316 2.011 . . . . 75.329999999999998 113.39 -177.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -94.19 15.21 17.85 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 123.339 0.656 . . . . 65.239999999999995 111.276 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' ASN . . . . . 0.495 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . 46.3 t30 -127.18 128.14 24.16 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.698 -0.853 . . . . 72.340000000000003 108.698 -177.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.55 9.82 1.15 Allowed 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.927 2.418 . . . . 53.329999999999998 113.25 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -83.83 110.34 18.28 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.894 -1.521 . . . . 70.319999999999993 106.894 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.462 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 65.5 p -102.72 141.09 36.11 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.798 -0.761 . . . . 74.299999999999997 110.365 -175.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 24.7 tp -86.17 126.1 33.99 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.272 -1.01 . . . . 72.140000000000001 108.272 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -131.05 121.68 25.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 109.437 -0.579 . . . . 62.439999999999998 109.437 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.68 116.59 32.27 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.126 -0.943 . . . . 72.510000000000005 109.829 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' GLU . . . . . 0.6 ' HB2' ' CE1' ' B' ' 34' ' ' PHE . 40.2 mm-40 -122.51 170.33 10.09 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.545 -1.65 . . . . 73.109999999999999 106.545 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -81.72 137.43 35.38 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 119.184 0.902 . . . . 72.349999999999994 109.738 176.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.66 151.13 27.72 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.176 0.512 . . . . 74.510000000000005 111.41 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -87.23 12.09 12.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.715 0.769 . . . . 41.229999999999997 109.996 177.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -137.69 115.42 11.38 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 107.524 -1.287 . . . . 70.25 107.524 177.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -84.05 106.96 16.11 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.464 -1.68 . . . . 71.340000000000003 106.464 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.526 ' O ' HD12 ' B' ' 74' ' ' ILE . 28.8 m . . . . . 0 C--N 1.3 -1.544 0 CA-C-N 116.245 -0.434 . . . . 51.32 110.834 -173.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 CA--C 1.508 -0.64 0 N-CA-C 109.288 -0.634 . . . . 75.310000000000002 109.288 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.87 136.35 50.6 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.382 -0.969 . . . . 74.430000000000007 108.382 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -52.29 144.45 12.78 Favored 'General case' 0 C--O 1.25 1.083 0 O-C-N 124.229 0.955 . . . . 73.209999999999994 112.842 -175.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.497 ' HA ' ' CD ' ' A' ' 78' ' ' ARG . 1.4 pp20? -78.04 96.01 4.99 Favored 'General case' 0 N--CA 1.385 -3.683 0 CA-C-O 122.318 1.056 . . . . 75.400000000000006 109.685 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' A' ' 105' ' ' PHE . 40.6 t -82.28 111.82 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-N 114.826 -1.079 . . . . 53.340000000000003 108.289 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 88.4 mtt180 -88.53 12.8 13.54 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.676 -0.693 . . . . 72.219999999999999 111.458 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.9 m -136.99 132.74 34.74 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 121.415 0.626 . . . . 60.310000000000002 112.462 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.4 mt -112.11 145.3 40.02 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.358 -0.979 . . . . 71.400000000000006 108.358 173.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.403 ' CE1' ' HB2' ' A' ' 104' ' ' GLU . 21.5 p90 -103.42 114.8 29.36 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 106.956 -1.498 . . . . 73.310000000000002 106.956 172.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.59 HG22 ' HG ' ' A' ' 103' ' ' LEU . 33.5 t -101.05 113.87 38.46 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 CA-C-N 114.144 -1.389 . . . . 64.230000000000004 108.643 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.6 p -111.4 171.61 7.38 Favored 'General case' 0 N--CA 1.41 -2.438 0 N-CA-C 109.104 -0.702 . . . . 64.519999999999996 109.104 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 88.04 29.13 21.27 Favored Glycine 0 N--CA 1.431 -1.652 0 C-N-CA 120.911 -0.661 . . . . 33.240000000000002 112.493 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 96.5 mt -93.07 125.83 53.39 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.671 -1.233 . . . . 72.230000000000004 107.671 173.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -50.21 153.41 6.91 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.484 2.123 . . . . 70.209999999999994 110.783 172.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.453 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 11.3 p -65.94 -12.91 14.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 123.152 0.581 . . . . 62.420000000000002 112.09 -172.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -126.77 41.67 3.47 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.904 0.859 . . . . 53.350000000000001 109.373 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 pp -59.17 145.5 10.84 Favored 'Isoleucine or valine' 0 C--O 1.25 1.115 0 C-N-CA 119.271 -0.972 . . . . 72.310000000000002 112.52 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.451 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 70.6 mmtt -98.94 146.22 31.3 Favored Pre-proline 0 C--N 1.271 -2.813 0 N-CA-C 107.31 -1.367 . . . . 72.030000000000001 107.31 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -59.45 -24.53 75.15 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.381 2.054 . . . . 74.019999999999996 111.866 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.548 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . 13.9 ptt180 -78.13 -20.58 51.83 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.692 -0.686 . . . . 75.129999999999995 112.736 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 42.6 mt-10 -64.6 -38.74 92.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.221 0.534 . . . . 63.43 110.368 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -76.1 -22.17 55.86 Favored 'General case' 0 C--O 1.212 -0.907 0 CA-C-O 121.628 0.727 . . . . 65.450000000000003 109.934 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.508 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 62.9 t80 -73.5 -47.96 37.11 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.065 -0.97 . . . . 72.200000000000003 109.04 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.39 -38.84 74.75 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.655 -0.702 . . . . 75.430000000000007 110.175 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.9 tp -78.52 -37.08 43.92 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.46 -0.791 . . . . 61.420000000000002 112.719 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -97.05 1.04 49.65 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 118.898 -1.121 . . . . 63.229999999999997 113.598 -175.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -67.82 -42.93 36.44 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 114.049 1.129 . . . . 72.200000000000003 114.049 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -63.76 -20.11 68.17 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 121.478 1.452 . . . . 72.120000000000005 111.807 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -90.02 101.11 13.82 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 121.638 0.732 . . . . 74.200000000000003 110.834 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -64.41 110.4 2.26 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.345 -1.298 . . . . 65.200000000000003 110.642 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.47 -17.26 3.1 Favored Glycine 0 N--CA 1.425 -2.087 0 CA-C-N 115.015 -0.993 . . . . 62.149999999999999 113.326 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -62.4 107.9 1.01 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 118.001 0.901 . . . . 74.209999999999994 112.317 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -90.72 -43.92 9.8 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.49 -0.777 . . . . 74.409999999999997 110.648 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.91 171.88 43.29 Favored Glycine 0 C--N 1.301 -1.376 0 C-N-CA 120.797 -0.716 . . . . 54.439999999999998 111.674 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.8 p -138.57 137.34 36.91 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.85 0.325 . . . . 74.239999999999995 111.659 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 112' ' ' MET . 6.6 mp -112.83 121.63 45.27 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.561 -0.903 . . . . 65.349999999999994 108.561 177.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.5 mm -94.27 133.03 36.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 120.892 0.377 . . . . 74.319999999999993 110.14 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -118.06 106.88 13.35 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.708 -1.59 . . . . 73.519999999999996 106.708 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.73 131.19 42.77 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.893 -0.594 . . . . 73.150000000000006 109.663 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.591 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 18.8 m -129.7 153.01 48.58 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 104.486 -2.412 . . . . 72.310000000000002 104.486 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.5 -26.87 45.24 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 114.381 1.252 . . . . 42.450000000000003 114.381 -172.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 30.8 mmt180 -104.48 -25.64 12.71 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 113.268 0.84 . . . . 73.430000000000007 113.268 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.591 ' O ' ' HB ' ' A' ' 65' ' ' THR . 14.3 pt20 -172.55 136.54 0.82 Allowed Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.398 -0.593 . . . . 72.430000000000007 109.398 -173.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.455 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 44.8 Cg_endo -74.58 133.39 17.2 Favored 'Trans proline' 0 N--CA 1.43 -2.232 0 C-N-CA 121.956 1.771 . . . . 70.120000000000005 110.449 170.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m -101.78 143.54 14.5 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 N-CA-C 108.126 -1.065 . . . . 74.310000000000002 108.126 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.5 120.96 4.88 Favored Glycine 0 CA--C 1.479 -2.161 0 C-N-CA 119.807 -1.187 . . . . 73.109999999999999 112.719 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -87.69 102.8 14.99 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.769 -1.567 . . . . 72.519999999999996 106.769 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.9 t -97.69 123.8 50.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-N 114.984 -1.007 . . . . 65.319999999999993 110.036 -175.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' A' ' 112' ' ' MET . 10.9 tt -95.86 131.51 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.108 0 CA-C-N 115.04 -0.982 . . . . 75.129999999999995 109.274 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.45 159.71 18.48 Favored 'General case' 0 N--CA 1.414 -2.25 0 CA-C-N 114.977 -1.01 . . . . 71.329999999999998 110.839 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -53.63 -44.93 69.93 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 125.646 1.578 . . . . 75.010000000000005 110.808 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.3 p -150.8 153.86 36.22 Favored 'General case' 0 N--CA 1.398 -3.067 0 CA-C-N 115.403 -0.817 . . . . 64.329999999999998 111.293 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.497 ' CD ' ' HA ' ' A' ' 29' ' ' GLU . 7.2 ttt-85 -58.74 -42.58 89.12 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 125.158 1.383 . . . . 74.340000000000003 110.2 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.66 -18.73 64.26 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.897 -1.047 . . . . 74.510000000000005 109.394 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.25 -45.26 5.37 Favored Glycine 0 C--N 1.294 -1.766 0 CA-C-N 113.626 -1.625 . . . . 61.299999999999997 110.455 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.54 -45.02 95.39 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.998 0.919 . . . . 51.039999999999999 111.584 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.08 -26.92 68.76 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.286 -0.416 . . . . 63.439999999999998 111.844 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.5 -39.52 27.81 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.16 0.505 . . . . 72.010000000000005 109.878 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.95 85.96 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.684 -0.689 . . . . 43.149999999999999 111.021 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.419 ' CE ' ' HA ' ' A' ' 104' ' ' GLU . 14.0 ptmm? -68.38 -28.08 66.79 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.281 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -64.43 -36.23 83.5 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.658 0.599 . . . . 73.439999999999998 110.904 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.25 -38.64 17.38 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 120.977 0.418 . . . . 63.119999999999997 111.916 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.532 ' O ' HG22 ' A' ' 91' ' ' ILE . 95.6 mt -96.94 -5.43 37.98 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 115.571 1.693 . . . . 60.140000000000001 115.571 -171.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -78.75 114.93 18.1 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 117.086 -1.845 . . . . 54.329999999999998 110.889 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.34 14.65 29.86 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 110.746 -0.942 . . . . 64.239999999999995 110.746 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 88' ' ' LEU . 10.2 tt -84.7 126.04 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.875 0 CA-C-O 121.632 0.73 . . . . 55.140000000000001 109.413 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -63.93 111.78 2.64 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 105.84 -1.911 . . . . 73.310000000000002 105.84 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -71.71 -25.78 62.22 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.947 0.88 . . . . 73.109999999999999 109.262 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -161.29 117.8 1.37 Allowed Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 106.583 -1.636 . . . . 72.310000000000002 106.583 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.08 -28.81 86.39 Favored 'Trans proline' 0 N--CA 1.474 0.349 0 C-N-CA 122.161 1.907 . . . . 74.439999999999998 112.862 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -74.71 -24.7 58.79 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.275 0.56 . . . . 71.129999999999995 110.899 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -102.96 135.64 19.38 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.023 -1.473 . . . . 63.119999999999997 107.023 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.97 15.06 0.62 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.306 2.004 . . . . 72.400000000000006 112.341 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.404 ' HA ' ' OE1' ' A' ' 99' ' ' GLN . 5.9 tp60 -89.96 121.4 32.02 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.922 0.889 . . . . 72.439999999999998 110.334 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.483 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 66.2 p -114.59 142.47 46.39 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.128 -0.693 . . . . 73.010000000000005 109.128 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.9 tp -89.18 135.95 33.29 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.933 -0.766 . . . . 71.150000000000006 108.933 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -135.0 124.79 25.39 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.57 -0.529 . . . . 61.229999999999997 109.57 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.59 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.6 mp -110.84 118.33 35.84 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.059 -0.519 . . . . 63.439999999999998 109.866 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HA ' ' CE ' ' A' ' 85' ' ' LYS . 7.7 mm-40 -126.61 161.29 28.39 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.936 -0.765 . . . . 72.019999999999996 108.936 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.447 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 27.1 m-85 -69.94 139.17 52.84 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.36 -0.536 . . . . 54.539999999999999 109.922 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.52 160.66 29.28 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 121.121 0.486 . . . . 65.019999999999996 110.004 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -77.16 -13.65 59.91 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.454 -0.794 . . . . 73.540000000000006 110.127 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.38 136.67 16.64 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.025 -0.989 . . . . 62.229999999999997 109.449 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -70.96 113.0 7.56 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.239 -1.393 . . . . 43.32 107.239 173.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.4 t -89.29 126.57 35.57 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.486 -0.931 . . . . 64.230000000000004 108.486 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.457 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 54.5 mtmt -90.39 81.88 5.97 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 113.098 0.777 . . . . 72.430000000000007 113.098 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.444 ' HB3' HG21 ' A' ' 74' ' ' ILE . 14.1 tpt -74.77 -53.19 9.64 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 105.439 -2.06 . . . . 70.430000000000007 105.439 171.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.61 115.81 28.01 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 103.707 -2.701 . . . . 70.510000000000005 103.707 168.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 111' ' ' LYS . 95.4 mttt -69.57 110.99 5.1 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 112.863 0.69 . . . . 70.519999999999996 112.863 -170.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.2 m -62.16 113.99 3.18 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.464 -1.244 . . . . 75.319999999999993 112.709 -176.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.03 140.08 6.4 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.408 -1.701 . . . . 71.400000000000006 106.408 172.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.8 tp -114.54 13.53 17.56 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.305 -0.958 . . . . 74.140000000000001 112.624 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 . . . . . 0 C--N 1.305 -1.346 0 N-CA-C 108.243 -1.021 . . . . 71.230000000000004 108.243 175.692 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 12.4 tpt . . . . . 0 CA--C 1.515 -0.404 0 N-CA-C 107.183 -1.414 . . . . 74.209999999999994 107.183 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -105.03 -73.13 0.69 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.802 -0.814 . . . . 54.340000000000003 108.802 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -123.22 105.41 9.86 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.842 -0.617 . . . . 65.120000000000005 109.696 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' B' ' 78' ' ' ARG . 7.9 pt-20 -70.17 96.23 1.06 Allowed 'General case' 0 N--CA 1.387 -3.615 0 CA-C-O 121.142 0.496 . . . . 74.219999999999999 112.238 175.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 60.1 t -79.45 110.05 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 N-CA-C 105.105 -2.183 . . . . 75.200000000000003 105.105 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -84.86 8.2 18.25 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 112.417 0.525 . . . . 61.340000000000003 112.417 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 28.9 m -127.85 129.27 46.66 Favored 'General case' 0 C--N 1.27 -2.857 0 C-N-CA 119.963 -0.695 . . . . 72.409999999999997 112.065 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -104.77 134.39 48.0 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.517 -1.29 . . . . 72.230000000000004 107.517 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.567 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 33.7 p90 -91.75 118.3 30.55 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 107.784 -1.191 . . . . 74.040000000000006 107.784 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.446 HG22 ' HG ' ' B' ' 103' ' ' LEU . 39.6 t -97.44 115.68 37.86 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 114.198 -1.364 . . . . 61.229999999999997 108.137 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 24.0 p -129.44 171.12 12.87 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 115.101 -0.954 . . . . 64.420000000000002 109.224 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 82.03 51.92 4.27 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 110.44 -1.064 . . . . 70.030000000000001 110.44 -173.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 95.7 mt -122.44 129.25 25.14 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.868 -1.16 . . . . 53.240000000000002 107.868 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -52.85 159.59 4.92 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 122.412 2.074 . . . . 72.109999999999999 110.978 171.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.68 -10.54 14.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.628 0.727 . . . . 74.120000000000005 111.301 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -127.02 40.83 3.64 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 122.158 0.98 . . . . 73.329999999999998 109.441 -176.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.451 ' O ' HD12 ' B' ' 42' ' ' ILE . 2.7 pp -64.46 134.19 29.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 118.686 -1.205 . . . . 71.530000000000001 110.666 170.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.416 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 74.1 mmtt -91.42 141.99 26.55 Favored Pre-proline 0 C--N 1.273 -2.734 0 N-CA-C 108.672 -0.862 . . . . 71.430000000000007 108.672 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -51.78 -32.16 44.94 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.85 2.367 . . . . 74.519999999999996 112.429 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.48 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 12.0 ptt180 -68.44 -26.57 65.58 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 112.426 0.528 . . . . 62.240000000000002 112.426 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.416 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 32.7 mt-10 -65.13 -42.7 93.63 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.327 0.584 . . . . 71.209999999999994 109.539 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.38 -36.6 81.68 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 115.397 -0.82 . . . . 74.200000000000003 109.489 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.486 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 76.2 t80 -61.01 -46.82 89.19 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.822 -1.081 . . . . 63.420000000000002 110.867 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 89.0 mt -66.62 -41.66 88.02 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.241 0.544 . . . . 55.049999999999997 109.826 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 29.2 tp -69.73 -44.2 70.77 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.667 -1.151 . . . . 72.329999999999998 112.117 -175.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -94.53 4.42 53.87 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 113.167 0.803 . . . . 61.329999999999998 113.167 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 28.2 ttt180 -69.5 -43.77 23.55 Favored Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 112.976 0.732 . . . . 75.150000000000006 112.976 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -76.23 -2.47 12.66 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 121.45 1.434 . . . . 74.439999999999998 112.033 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -94.6 103.12 15.06 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 121.833 0.825 . . . . 70.319999999999993 111.556 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -68.19 118.17 10.97 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 114.103 -1.408 . . . . 65.150000000000006 110.793 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' B' ' 75' ' ' PHE . . . 133.07 -19.7 4.33 Favored Glycine 0 C--N 1.281 -2.472 0 CA-C-N 115.005 -0.998 . . . . 73.519999999999996 112.695 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -58.4 113.22 1.87 Allowed 'General case' 0 C--O 1.242 0.672 0 CA-C-N 117.301 0.55 . . . . 70.420000000000002 111.663 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -95.46 -58.97 1.98 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.58 -0.736 . . . . 74.010000000000005 110.344 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.6 160.2 32.92 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 120.041 -1.076 . . . . 72.200000000000003 113.095 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.3 p -119.33 137.95 53.37 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 122.702 0.401 . . . . 62.420000000000002 110.814 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 66.9 tp -111.31 111.3 22.25 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.882 -1.155 . . . . 75.540000000000006 107.882 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 51.0 mm -94.61 136.38 26.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 109.732 -0.47 . . . . 63.409999999999997 109.732 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -133.19 114.84 14.3 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.477 -0.935 . . . . 74.439999999999998 108.477 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.06 113.95 8.63 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.959 -1.126 . . . . 75.150000000000006 107.959 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.9 m -105.93 167.56 9.71 Favored 'General case' 0 N--CA 1.403 -2.807 0 N-CA-C 107.023 -1.473 . . . . 72.530000000000001 107.023 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.76 -33.42 23.11 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 113.675 0.991 . . . . 71.120000000000005 113.675 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -105.18 -37.78 6.78 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 119.724 -0.79 . . . . 71.530000000000001 112.424 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -155.25 159.68 31.53 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 110.203 -0.295 . . . . 73.430000000000007 110.203 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.24 123.29 7.09 Favored 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.218 1.945 . . . . 65.329999999999998 109.636 167.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 35.9 m -97.58 156.84 3.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 107.461 -1.311 . . . . 64.239999999999995 107.461 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.03 121.94 2.58 Favored Glycine 0 C--O 1.203 -1.798 0 C-N-CA 118.237 -1.935 . . . . 50.329999999999998 113.492 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -88.42 108.36 19.33 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.78 -1.193 . . . . 60.539999999999999 107.78 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.62 120.11 53.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-N 116.184 -0.462 . . . . 74.109999999999999 110.473 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' B' ' 111' ' ' LYS . 11.8 tt -96.32 134.8 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 115.559 -0.746 . . . . 73.409999999999997 110.478 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' B' ' 56' ' ' GLY . 60.1 m-85 -111.29 149.58 30.87 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 114.621 -1.172 . . . . 74.200000000000003 109.821 179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -56.27 -34.35 66.34 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.727 1.211 . . . . 61.32 111.453 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 9.9 p -144.56 138.3 27.4 Favored 'General case' 0 N--CA 1.398 -3.027 0 CA-C-O 121.953 0.883 . . . . 73.400000000000006 110.634 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -74.9 -25.57 59.03 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 114.494 -1.23 . . . . 75.209999999999994 110.453 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.1 -19.68 64.06 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.532 1.158 . . . . 73.329999999999998 108.654 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.26 -43.2 5.66 Favored Glycine 0 C--N 1.308 -1.0 0 CA-C-N 113.786 -1.552 . . . . 51.200000000000003 109.922 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.41 -37.64 78.55 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.989 0.916 . . . . 52.210000000000001 112.02 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.04 -34.53 76.41 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.864 0.364 . . . . 62.329999999999998 111.44 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.25 -38.12 27.43 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.295 0.569 . . . . 72.430000000000007 109.804 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.2 93.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.872 -1.058 . . . . 61.439999999999998 111.202 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -65.6 -41.01 93.28 Favored 'General case' 0 C--O 1.195 -1.815 0 CA-C-N 116.258 -0.428 . . . . 75.200000000000003 110.647 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -63.68 -24.73 67.9 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 112.359 0.503 . . . . 74.239999999999995 112.359 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.54 -36.02 33.67 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 120.811 0.339 . . . . 64.420000000000002 111.156 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.497 ' O ' HG22 ' B' ' 91' ' ' ILE . 98.6 mt -102.14 -19.92 14.93 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 115.222 1.564 . . . . 74.040000000000006 115.222 -174.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . 0.436 ' HB3' ' H ' ' B' ' 103' ' ' LEU 0.259 0.2 OUTLIER -75.65 113.95 13.67 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 118.92 -1.112 . . . . 62.350000000000001 112.616 -178.807 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.04 14.99 13.51 Favored Glycine 0 N--CA 1.41 -3.035 0 CA-C-N 115.554 -0.748 . . . . 61.399999999999999 111.74 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.497 HG22 ' O ' ' B' ' 88' ' ' LEU . 15.7 tt -95.93 133.89 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.977 0 N-CA-C 108.964 -0.754 . . . . 74.349999999999994 108.964 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' B' ' 92' ' ' ARG . 7.3 tpt180 -62.82 119.3 9.09 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 105.117 -2.179 . . . . 74.329999999999998 105.117 172.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -68.18 -31.12 70.44 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 108.418 -0.956 . . . . 74.310000000000002 108.418 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 45' ' ' ARG . 1.0 OUTLIER -166.47 137.42 2.76 Favored Pre-proline 0 N--CA 1.427 -1.616 0 N-CA-C 106.709 -1.589 . . . . 74.420000000000002 106.709 174.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.1 -2.81 12.88 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.132 1.888 . . . . 71.230000000000004 113.237 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -85.63 -24.92 26.91 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.75 0.786 . . . . 71.540000000000006 109.532 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' ASN . . . . . 0.544 ' OD1' ' HB2' ' B' ' 99' ' ' GLN . 6.6 t-20 -110.45 148.17 37.88 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 106.004 -1.85 . . . . 73.439999999999998 106.004 174.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.05 22.1 0.77 Allowed 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 122.529 2.153 . . . . 65.129999999999995 112.045 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLN . . . . . 0.544 ' HB2' ' OD1' ' B' ' 97' ' ' ASN . 5.5 tp60 -89.41 129.29 35.95 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.948 0.899 . . . . 63.219999999999999 110.802 -176.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.544 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 36.8 p -116.52 138.32 51.49 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.731 -0.47 . . . . 54.229999999999997 109.731 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 49.3 tp -86.09 131.1 34.33 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.045 -0.724 . . . . 73.120000000000005 109.045 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -135.82 122.63 21.15 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-O 120.834 0.35 . . . . 74.019999999999996 110.31 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.446 ' HG ' HG22 ' B' ' 35' ' ' VAL . 6.2 mp -108.27 116.27 31.66 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.841 -1.17 . . . . 74.219999999999999 107.841 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.567 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 7.4 tp10 -131.72 159.6 37.94 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.625 -1.62 . . . . 61.409999999999997 106.625 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -68.93 137.19 53.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 119.561 1.073 . . . . 71.319999999999993 110.859 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.63 164.28 26.46 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.92 -0.582 . . . . 74.439999999999998 110.232 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -84.72 -9.86 57.81 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.76 0.791 . . . . 71.310000000000002 109.114 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.44 130.09 19.09 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.208 -0.905 . . . . 63.240000000000002 109.892 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -70.26 104.55 2.69 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.854 -1.165 . . . . 64.409999999999997 107.854 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 13.0 m -92.37 101.99 14.46 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.665 -0.698 . . . . 62.310000000000002 109.57 -172.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . 0.475 ' HA ' HD12 ' B' ' 74' ' ' ILE . 53.3 mtmt -77.93 83.62 4.24 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.029 0.919 . . . . 72.25 111.284 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 14.7 tpt -96.68 24.04 6.41 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.533 -1.212 . . . . 72.219999999999999 107.888 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -140.31 119.08 12.45 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.491 -1.231 . . . . 63.130000000000003 107.791 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -71.99 108.51 5.27 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.642 0.589 . . . . 73.430000000000007 109.977 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 41.9 p -142.14 139.55 32.18 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.405 -0.361 . . . . 54.149999999999999 110.263 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -130.89 159.13 38.32 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.468 -0.938 . . . . 74.519999999999996 108.468 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 33.3 tp -108.13 20.05 19.18 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.922 -0.77 . . . . 72.150000000000006 108.922 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 . . . . . 0 C--N 1.318 -0.794 0 N-CA-C 108.038 -1.097 . . . . 52.310000000000002 108.038 177.024 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.583 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 96.2 mmm . . . . . 0 C--O 1.207 -1.153 0 N-CA-C 110.472 -0.196 . . . . 75.310000000000002 110.472 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 44.6 mt-10 -89.57 62.04 5.75 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 121.067 -1.021 . . . . 54.140000000000001 112.197 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 27' ' ' GLU . 15.1 mt-10 -171.12 30.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 126.304 1.842 . . . . 64.200000000000003 110.572 175.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 26' ' ' MET . 43.0 mm-40 -70.61 106.74 3.61 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.603 -1.18 . . . . 72.109999999999999 108.934 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.3 t -77.49 109.02 11.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 103.859 -2.645 . . . . 54.009999999999998 103.859 167.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 75' ' ' PHE . 26.6 ptt180 -129.64 7.97 5.32 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.793 -0.64 . . . . 73.519999999999996 112.461 -168.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.3 m -104.89 124.48 49.55 Favored 'General case' 0 C--N 1.266 -3.04 0 C-N-CA 119.77 -0.772 . . . . 70.120000000000005 109.236 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 93.7 mt -104.75 136.78 43.63 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.745 -1.205 . . . . 64.140000000000001 107.745 176.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.501 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 20.4 p90 -98.32 118.98 36.18 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.27 -1.382 . . . . 74.239999999999995 107.27 174.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.461 HG22 ' HG ' ' A' ' 103' ' ' LEU . 19.5 t -99.79 111.01 28.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 114.531 -1.213 . . . . 61.530000000000001 108.365 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.7 p -110.01 175.33 5.48 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 108.57 -0.9 . . . . 73.109999999999999 108.57 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 97.42 1.33 59.2 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 120.757 -0.735 . . . . 54.210000000000001 111.659 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.5 mt -77.06 139.05 65.03 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 108.373 -0.973 . . . . 42.32 108.373 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 170.38 16.69 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.726 1.617 . . . . 75.530000000000001 111.383 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 p -78.69 7.54 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-O 122.67 1.224 . . . . 60.409999999999997 109.403 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -115.93 7.94 14.55 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.042 -1.436 . . . . 75.519999999999996 109.481 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.32 125.3 18.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.962 0.887 . . . . 55.25 110.813 -176.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -109.96 142.04 25.05 Favored Pre-proline 0 C--N 1.289 -2.043 0 CA-C-N 114.198 -1.365 . . . . 75.049999999999997 109.356 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.48 -25.08 30.72 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.63 2.886 . . . . 51.240000000000002 113.56 -176.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' HB3' ' OD2' ' B' ' 94' ' ' ASP . 23.7 ptt180 -66.63 -28.17 68.26 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 121.067 0.461 . . . . 75.420000000000002 111.464 -178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -71.48 -38.2 71.23 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.143 0.497 . . . . 70.510000000000005 110.666 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.76 -38.65 73.47 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 108.544 -0.91 . . . . 73.010000000000005 108.544 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.573 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 12.2 t80 -57.93 -49.05 78.08 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.756 -1.111 . . . . 73.409999999999997 111.087 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 97.1 mt -62.84 -41.31 99.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.075 0.464 . . . . 54.310000000000002 110.707 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.9 tp -73.46 -40.92 63.78 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.315 -0.857 . . . . 62.539999999999999 111.609 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -90.79 -5.69 55.31 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 114.543 1.312 . . . . 73.109999999999999 114.543 -175.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 13.1 mtp180 -58.36 -48.38 97.09 Favored Pre-proline 0 N--CA 1.481 1.091 0 N-CA-C 113.417 0.895 . . . . 73.239999999999995 113.417 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.57 -16.84 52.05 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 121.472 1.448 . . . . 72.549999999999997 112.494 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -91.03 86.31 6.21 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.327 0.584 . . . . 63.25 110.147 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -70.48 115.99 10.29 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 122.213 1.006 . . . . 71.109999999999999 109.544 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.14 -23.08 2.08 Favored Glycine 0 C--N 1.287 -2.172 0 CA-C-N 113.81 -1.541 . . . . 70.340000000000003 109.556 -173.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -57.37 109.55 0.7 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.206 1.002 . . . . 62.310000000000002 111.343 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -88.15 -47.52 8.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.525 0.679 . . . . 54.229999999999997 109.679 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.46 170.95 44.08 Favored Glycine 0 C--N 1.297 -1.618 0 C-N-CA 120.147 -1.025 . . . . 71.120000000000005 112.833 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.4 p -131.59 138.03 48.68 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 122.653 0.381 . . . . 75.329999999999998 110.144 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -115.66 118.29 32.66 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.468 -1.678 . . . . 72.319999999999993 106.468 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -93.52 133.84 33.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.881 -1.155 . . . . 73.209999999999994 107.881 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -127.97 117.74 22.29 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.191 -1.04 . . . . 73.230000000000004 108.191 -175.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.37 111.31 4.56 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.055 -1.091 . . . . 75.109999999999999 108.055 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.8 m -116.03 168.24 10.26 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.826 -0.805 . . . . 53.32 108.826 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.28 -29.93 10.76 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.789 1.235 . . . . 72.219999999999999 114.196 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -104.11 -47.2 4.23 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.989 -0.684 . . . . 74.540000000000006 111.16 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -155.93 153.24 25.41 Favored Pre-proline 0 N--CA 1.413 -2.324 0 CA-C-N 115.48 -0.782 . . . . 65.109999999999999 109.527 -167.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -68.72 105.65 1.34 Allowed 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 122.047 1.832 . . . . 74.010000000000005 108.765 167.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -86.08 162.8 2.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 108.206 -1.035 . . . . 71.129999999999995 108.206 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.33 120.2 3.3 Favored Glycine 0 CA--C 1.486 -1.751 0 C-N-CA 117.91 -2.091 . . . . 64.230000000000004 113.072 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -89.0 104.8 17.32 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.39 -1.337 . . . . 72.230000000000004 107.39 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.3 t -99.9 118.34 46.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 115.765 -0.652 . . . . 73.409999999999997 110.289 -176.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 tt -97.69 127.6 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 CA-C-O 121.909 0.861 . . . . 64.5 110.32 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.421 ' O ' ' HD2' ' A' ' 31' ' ' ARG . 73.2 m-85 -102.86 166.18 10.62 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 114.515 -1.22 . . . . 73.239999999999995 110.144 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.03 -47.73 74.34 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.972 -1.013 . . . . 73.329999999999998 112.565 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 p -146.13 165.12 30.06 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.615 -0.721 . . . . 51.340000000000003 111.082 -172.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.504 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -70.35 -32.12 69.69 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.628 -0.508 . . . . 74.019999999999996 109.628 -178.016 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.63 -20.41 65.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 122.199 1.0 . . . . 53.130000000000003 109.552 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.06 -42.43 6.3 Favored Glycine 0 C--N 1.299 -1.492 0 CA-C-N 114.253 -1.34 . . . . 75.299999999999997 110.417 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.22 -42.86 88.12 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 123.167 0.587 . . . . 75.120000000000005 111.48 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.18 -42.76 91.59 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 111.637 0.236 . . . . 74.109999999999999 111.637 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.4 -36.85 68.77 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-O 121.031 0.444 . . . . 72.019999999999996 111.098 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.42 -39.64 77.75 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.491 -0.777 . . . . 54.119999999999997 111.346 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -68.18 -37.13 80.63 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 120.1 -0.64 . . . . 74.299999999999997 110.147 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -58.27 -38.16 76.41 Favored 'General case' 0 CA--C 1.507 -0.686 0 O-C-N 123.47 0.481 . . . . 73.340000000000003 111.286 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.66 -41.66 26.42 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 116.387 -0.37 . . . . 64.109999999999999 111.601 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.48 ' O ' HG22 ' A' ' 91' ' ' ILE . 99.0 mt -88.97 -22.17 23.17 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 116.212 1.93 . . . . 73.420000000000002 116.212 -173.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.436 ' HB3' ' H ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -71.78 113.15 8.52 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 117.904 -1.519 . . . . 65.239999999999995 109.888 176.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.77 11.98 13.53 Favored Glycine 0 N--CA 1.408 -3.222 0 CA-C-N 115.411 -0.813 . . . . 44.119999999999997 111.478 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.5 tt -94.45 133.75 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 N-CA-C 107.441 -1.318 . . . . 63.329999999999998 107.441 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 59.5 ttt180 -97.43 126.86 42.93 Favored 'General case' 0 C--N 1.251 -3.696 0 N-CA-C 109.15 -0.685 . . . . 72.109999999999999 109.15 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.13 -32.84 74.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.593 -1.185 . . . . 75.530000000000001 110.418 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.62 ' HB2' ' HB3' ' A' ' 97' ' ' ASN . 1.5 m-20 -147.73 126.49 6.2 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 103.938 -2.616 . . . . 61.530000000000001 103.938 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.649 ' HD3' ' CZ ' ' B' ' 48' ' ' TYR . 30.6 Cg_endo -67.69 -12.76 36.63 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 CA-C-N 121.279 1.492 . . . . 75.519999999999996 111.217 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -91.46 -0.65 57.65 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.194 -0.912 . . . . 73.310000000000002 111.01 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 18.7 t30 -117.41 127.14 26.87 Favored Pre-proline 0 C--O 1.213 -0.853 0 N-CA-C 108.387 -0.968 . . . . 65.120000000000005 108.387 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.07 -12.18 33.42 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.398 2.732 . . . . 62.219999999999999 114.927 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -94.68 158.63 15.43 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 119.804 -0.758 . . . . 73.430000000000007 110.209 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.439 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 49.6 p -135.95 161.09 36.62 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.712 -1.218 . . . . 74.420000000000002 107.712 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 mp -90.43 129.74 36.58 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.186 0.517 . . . . 74.129999999999995 110.42 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -124.37 110.52 14.67 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.178 -1.416 . . . . 64.109999999999999 107.178 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.6 mp -98.58 122.51 41.88 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.405 -0.816 . . . . 74.019999999999996 109.846 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.501 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 37.3 tt0 -130.94 157.57 42.6 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.864 -1.532 . . . . 64.109999999999999 106.864 176.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -65.71 139.97 58.42 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 118.458 0.572 . . . . 73.519999999999996 109.586 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.14 157.27 32.98 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.958 -0.756 . . . . 73.310000000000002 108.958 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -88.61 0.69 56.13 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 122.124 0.964 . . . . 75.319999999999993 109.216 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.35 124.97 3.76 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.749 -1.114 . . . . 64.310000000000002 108.113 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -64.78 124.15 21.21 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.463 0.649 . . . . 63.450000000000003 110.891 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.8 m -103.26 102.57 12.54 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 108.097 -1.075 . . . . 71.430000000000007 108.097 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -72.88 154.48 40.57 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.612 -1.177 . . . . 62.530000000000001 113.231 -174.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -84.54 169.28 14.6 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 104.876 -2.268 . . . . 74.5 104.876 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.76 102.75 0.07 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.182 0.901 . . . . 40.229999999999997 110.673 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -144.82 116.67 8.24 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.7 -0.852 . . . . 74.019999999999996 108.7 -174.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 37.1 t -88.25 106.06 17.96 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.775 -0.824 . . . . 71.109999999999999 108.775 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -90.24 -20.34 23.1 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.028 -0.73 . . . . 75.219999999999999 109.028 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.6 tp 67.32 99.12 0.05 Allowed 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.775 1.23 . . . . 63.219999999999999 110.723 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 . . . . . 0 C--N 1.321 -0.65 0 C-N-CA 124.612 1.165 . . . . 52.25 109.877 -179.924 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 110.384 -0.228 . . . . 73.099999999999994 110.384 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -89.97 104.52 17.08 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.217 -0.66 . . . . 63.32 109.217 -174.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 56.72 61.81 2.5 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.931 0.892 . . . . 73.030000000000001 113.363 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.42 ' CD ' HH11 ' B' ' 78' ' ' ARG . 9.6 mm-40 -66.01 115.11 5.72 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 105.644 -1.984 . . . . 74.010000000000005 105.644 170.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 97.5 t -70.81 109.07 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 103.692 -2.707 . . . . 70.349999999999994 103.692 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.596 ' HB2' ' O ' ' B' ' 75' ' ' PHE . 16.1 ptm180 -123.53 17.9 9.65 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-N 114.655 -1.157 . . . . 63.310000000000002 110.974 -164.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 29.9 m -124.67 121.56 35.04 Favored 'General case' 0 C--N 1.273 -2.739 0 C-N-CA 119.554 -0.858 . . . . 73.219999999999999 110.104 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 87.9 mt -103.48 137.23 41.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.196 -1.039 . . . . 75.340000000000003 108.196 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -98.88 113.99 26.37 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 106.762 -1.57 . . . . 73.219999999999999 106.762 175.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.595 HG22 ' HG ' ' B' ' 103' ' ' LEU . 22.0 t -99.69 112.56 32.42 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.665 0 CA-C-N 114.429 -1.259 . . . . 55.340000000000003 108.4 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' B' ' 101' ' ' LEU . 48.9 p -111.48 169.46 8.79 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 108.626 -0.879 . . . . 73.140000000000001 108.626 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.541 ' HA2' ' CD ' ' B' ' 99' ' ' GLN . . . 109.68 -6.65 31.49 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 120.421 -0.895 . . . . 70.049999999999997 111.655 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 55.1 mt -75.8 133.71 72.84 Favored Pre-proline 0 N--CA 1.428 -1.572 0 CA-C-N 114.253 -0.974 . . . . 64.530000000000001 108.812 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.49 170.68 16.87 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.095 1.863 . . . . 51.009999999999998 110.715 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.508 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 8.2 p -70.92 -11.51 15.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.446 0.641 . . . . 73.340000000000003 111.623 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -112.55 27.28 9.77 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.961 0.886 . . . . 65.129999999999995 108.894 -177.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.513 HG22 ' HG2' ' B' ' 69' ' ' PRO . 0.1 OUTLIER -74.58 126.59 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-O 121.566 0.698 . . . . 73.530000000000001 109.4 179.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -101.34 141.53 22.78 Favored Pre-proline 0 C--N 1.299 -1.608 0 CA-C-N 115.707 -0.678 . . . . 60.43 111.08 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -51.0 -25.42 16.18 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.628 2.886 . . . . 61.229999999999997 114.199 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.508 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 15.3 ptt-85 -66.35 -32.27 73.57 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 120.864 0.364 . . . . 75.049999999999997 111.019 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -69.24 -34.48 74.88 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.923 -0.58 . . . . 72.349999999999994 109.973 -174.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.407 ' O ' ' HD2' ' B' ' 51' ' ' PHE . 97.3 mt -74.65 -44.07 52.2 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.47 0.652 . . . . 62.109999999999999 109.454 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.649 ' CZ ' ' HD3' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -57.81 -43.32 85.61 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.976 -1.011 . . . . 74.040000000000006 112.071 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 96.9 mt -63.55 -42.81 98.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.891 0.377 . . . . 73.310000000000002 111.015 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.3 tp -71.65 -42.68 67.25 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.284 -0.871 . . . . 65.049999999999997 111.657 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . 0.407 ' HD2' ' O ' ' B' ' 47' ' ' LEU . 81.4 m-85 -85.42 -4.74 59.25 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.993 1.479 . . . . 73.329999999999998 114.993 -175.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 26.2 mtp180 -51.81 -50.05 80.01 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 114.16 1.17 . . . . 75.25 114.16 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.51 -0.88 10.64 Favored 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 121.873 1.715 . . . . 74.120000000000005 114.046 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . 0.264 69.8 m-85 -87.67 134.92 33.57 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 115.519 1.674 . . . . 71.120000000000005 115.519 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -67.12 109.24 2.96 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.262 -1.79 . . . . 72.519999999999996 112.455 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' B' ' 75' ' ' PHE . . . 106.38 -7.59 40.14 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 115.531 -0.759 . . . . 44.520000000000003 113.467 171.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -59.94 106.98 0.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.406 0.622 . . . . 72.409999999999997 112.54 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -99.24 -44.58 6.19 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.692 -0.686 . . . . 72.209999999999994 110.849 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.91 -178.88 41.78 Favored Glycine 0 C--N 1.302 -1.318 0 C-N-CA 119.429 -1.367 . . . . 71.25 113.569 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.7 p -139.86 137.67 35.09 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.162 0.585 . . . . 74.25 111.158 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.51 116.51 28.31 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.301 -1.0 . . . . 73.310000000000002 108.301 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.51 133.27 35.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.663 -0.866 . . . . 33.340000000000003 108.663 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' B' ' 69' ' ' PRO . 12.1 tmtt? -125.31 115.29 20.12 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.364 -1.347 . . . . 53.329999999999998 107.364 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.15 130.74 39.71 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.09 -0.504 . . . . 73.109999999999999 109.872 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 3.4 m -124.52 164.82 18.97 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.885 -1.154 . . . . 74.329999999999998 107.885 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.58 -31.5 36.49 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.53 0.937 . . . . 63.229999999999997 113.53 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -99.22 -52.41 3.53 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.897 -0.721 . . . . 74.230000000000004 111.484 176.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -154.16 145.86 16.85 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 115.781 -0.645 . . . . 75.120000000000005 111.156 -170.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.513 ' HG2' HG22 ' B' ' 42' ' ' ILE . 60.2 Cg_endo -75.62 124.8 8.49 Favored 'Trans proline' 0 N--CA 1.436 -1.88 0 C-N-CA 122.93 2.42 . . . . 60.219999999999999 111.621 174.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 m -93.84 155.11 3.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 114.977 -1.011 . . . . 65.120000000000005 108.442 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.32 120.51 4.23 Favored Glycine 0 CA--C 1.486 -1.756 0 C-N-CA 119.032 -1.556 . . . . 61.420000000000002 112.811 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -89.7 102.77 15.46 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.608 -1.256 . . . . 72.209999999999994 107.608 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 68.8 t -92.67 123.94 44.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 115.79 -0.641 . . . . 64.430000000000007 109.584 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' B' ' 111' ' ' LYS . 13.7 tt -101.53 129.21 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.328 0 CA-C-O 122.297 1.046 . . . . 75.150000000000006 111.074 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.596 ' O ' ' HB2' ' B' ' 31' ' ' ARG . 91.9 m-85 -109.81 160.43 16.35 Favored 'General case' 0 N--CA 1.404 -2.759 0 CA-C-N 113.217 -1.81 . . . . 71.099999999999994 107.993 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . 0.479 ' HA ' ' NH2' ' B' ' 31' ' ' ARG . 34.7 t70 -73.09 -33.31 65.53 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.276 0.56 . . . . 72.400000000000006 111.843 176.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 12.4 p -128.73 158.81 37.56 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 116.258 -0.428 . . . . 52.310000000000002 111.641 -174.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . 0.436 ' HD3' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -80.48 -27.78 37.73 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.476 -0.889 . . . . 63.450000000000003 108.662 177.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' B' ' 82' ' ' GLU . . . -72.07 -24.91 61.58 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.977 0.894 . . . . 61.219999999999999 108.764 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.12 -44.75 28.3 Favored Glycine 0 C--N 1.31 -0.895 0 N-CA-C 109.62 -1.392 . . . . 35.229999999999997 109.62 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.6 -44.95 95.03 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.766 -0.717 . . . . 73.319999999999993 111.736 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' B' ' 79' ' ' ALA . 2.0 pp20? -66.96 -28.28 68.15 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.495 0.554 . . . . 74.109999999999999 112.495 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.95 -46.84 32.9 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.119 -0.491 . . . . 71.099999999999994 110.172 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.97 92.6 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.53 -0.759 . . . . 74.040000000000006 111.678 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.457 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 14.2 ptmm? -69.49 -34.38 74.24 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 120.024 -0.67 . . . . 74.109999999999999 110.147 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -62.84 -32.24 73.42 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 121.129 0.49 . . . . 74.420000000000002 110.405 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.78 -32.48 19.07 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 112.541 0.571 . . . . 74.400000000000006 112.541 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.47 ' O ' HG22 ' B' ' 91' ' ' ILE . 91.7 mt -101.66 -25.19 13.95 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 116.603 2.075 . . . . 72.310000000000002 116.603 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . 0.268 0.2 OUTLIER -68.69 113.92 6.6 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 118.06 -1.456 . . . . 61.530000000000001 112.615 -176.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.2 6.47 15.82 Favored Glycine 0 N--CA 1.419 -2.451 0 C-N-CA 120.791 -0.719 . . . . 54.409999999999997 111.872 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.47 HG22 ' O ' ' B' ' 88' ' ' LEU . 12.2 tt -96.61 146.73 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.361 0 N-CA-C 107.735 -1.209 . . . . 42.409999999999997 107.735 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.451 ' HG3' HG22 ' B' ' 100' ' ' THR . 97.7 mtt180 -89.47 140.89 29.07 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-O 121.333 0.587 . . . . 72.319999999999993 112.342 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -73.27 -31.41 64.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.834 -1.53 . . . . 73.120000000000005 109.182 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.537 ' OD2' ' HB3' ' A' ' 45' ' ' ARG 0.266 4.8 m-20 -142.67 137.27 15.1 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 104.113 -2.551 . . . . 74.140000000000001 104.113 176.343 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . 0.573 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 19.0 Cg_endo -64.09 -19.51 66.32 Favored 'Trans proline' 0 CA--C 1.55 1.291 0 CA-C-N 121.064 1.416 . . . . 72.040000000000006 109.631 168.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -72.14 -24.98 61.54 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.109 1.764 . . . . 74.209999999999994 109.609 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -94.91 126.84 45.37 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 115.189 -0.914 . . . . 73.239999999999995 109.769 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.19 -6.25 14.76 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.937 2.425 . . . . 74.510000000000005 112.689 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' GLN . . . . . 0.541 ' CD ' ' HA2' ' B' ' 37' ' ' GLY . 8.7 tt0 -99.0 162.11 13.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.571 -0.9 . . . . 74.030000000000001 108.571 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.5 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 82.6 p -125.64 164.25 21.0 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.513 -0.551 . . . . 74.430000000000007 109.513 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' B' ' 36' ' ' SER . 5.3 mp -85.8 117.33 24.6 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 107.012 -1.477 . . . . 54.43 107.012 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -113.44 107.34 15.71 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 107.725 -1.213 . . . . 73.310000000000002 107.725 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.595 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.0 mp -90.22 116.45 28.21 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.572 -1.27 . . . . 61.119999999999997 107.572 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.457 ' HA ' ' CE ' ' B' ' 85' ' ' LYS . 12.1 tp10 -135.22 162.88 31.29 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.88 -1.156 . . . . 72.329999999999998 107.88 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -69.07 137.28 53.41 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 118.71 0.687 . . . . 75.010000000000005 111.84 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.95 156.03 32.27 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 109.169 -0.678 . . . . 71.030000000000001 109.169 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -78.13 -8.61 58.48 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.908 0.861 . . . . 42.450000000000003 109.624 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.2 130.98 9.95 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.164 -0.925 . . . . 75.239999999999995 108.77 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.411 ' ND2' ' HG2' ' B' ' 31' ' ' ARG . 6.5 m-20 -63.74 132.49 51.16 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.549 -0.75 . . . . 62.229999999999997 110.003 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 33.4 m -120.4 116.36 25.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.357 -0.979 . . . . 53.219999999999999 108.357 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . 0.593 ' HD3' ' H ' ' B' ' 111' ' ' LYS . 0.0 OUTLIER -89.21 158.15 17.98 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.66 -0.7 . . . . 73.129999999999995 110.543 -177.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -93.03 99.76 12.31 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 110.014 -0.365 . . . . 73.530000000000001 110.014 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . 39.5 72.28 0.15 Allowed 'General case' 0 C--O 1.246 0.921 0 C-N-CA 125.347 1.459 . . . . 72.400000000000006 113.247 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -130.48 130.91 44.81 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 116.112 -0.495 . . . . 74.319999999999993 109.671 -173.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 33.1 t -126.65 104.46 8.11 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.127 -1.434 . . . . 73.319999999999993 107.127 175.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -83.08 -16.1 48.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.093 -0.503 . . . . 54.420000000000002 112.236 -175.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 tt 58.74 32.58 22.34 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.567 1.147 . . . . 72.319999999999993 109.922 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 . . . . . 0 C--N 1.317 -0.807 0 N-CA-C 106.603 -1.629 . . . . 74.439999999999998 106.603 179.275 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 CA--C 1.501 -0.917 0 CA-C-O 121.212 0.53 . . . . 75.310000000000002 109.928 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -117.64 141.34 48.49 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 106.144 -1.798 . . . . 71.319999999999993 106.144 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -84.2 78.0 9.86 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.389 1.09 . . . . 72.150000000000006 111.066 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -96.33 -177.41 3.95 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.717 -1.583 . . . . 74.140000000000001 110.373 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.529 ' HA ' HD21 ' A' ' 109' ' ' ASN . 17.8 t -56.66 111.39 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 113.184 0.809 . . . . 74.329999999999998 113.184 -164.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 42.4 mtt180 -99.43 -25.16 14.55 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-O 122.363 1.078 . . . . 71.230000000000004 109.349 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.4 m -98.11 138.24 35.7 Favored 'General case' 0 C--N 1.26 -3.291 0 CA-C-N 113.549 -1.659 . . . . 71.450000000000003 113.6 -167.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.8 mt -124.57 142.8 51.08 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 114.018 -1.447 . . . . 74.140000000000001 108.325 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 104' ' ' GLU . 32.0 p90 -101.48 112.23 24.71 Favored 'General case' 0 N--CA 1.423 -1.825 0 C-N-CA 118.956 -1.097 . . . . 75.040000000000006 108.074 172.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.481 HG12 HD11 ' A' ' 101' ' ' LEU . 41.7 t -97.05 114.01 32.89 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.828 0 N-CA-C 106.898 -1.519 . . . . 55.439999999999998 106.898 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.6 p -124.46 154.44 40.48 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.288 -0.869 . . . . 74.209999999999994 111.177 -175.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.62 4.65 34.44 Favored Glycine 0 N--CA 1.425 -2.07 0 CA-C-N 115.939 -0.573 . . . . 33.539999999999999 111.856 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.56 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 94.4 mt -66.28 131.67 94.35 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.23 -0.655 . . . . 54.310000000000002 109.23 175.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.04 157.55 3.92 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.416 2.077 . . . . 70.409999999999997 110.283 171.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.496 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 9.8 p -83.44 6.97 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 122.787 1.28 . . . . 72.439999999999998 109.847 -170.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -127.87 17.04 6.82 Favored 'General case' 0 N--CA 1.406 -2.659 0 CA-C-N 114.323 -1.308 . . . . 54.420000000000002 110.322 -175.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 pp -54.06 133.75 16.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 114.62 1.341 . . . . 71.230000000000004 114.62 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.539 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.33 143.03 26.03 Favored Pre-proline 0 C--N 1.285 -2.199 0 CA-C-N 114.174 -1.376 . . . . 54.219999999999999 108.279 177.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.88 -24.64 65.58 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.913 2.408 . . . . 73.019999999999996 113.853 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.545 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -82.35 -15.34 53.16 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 118.094 -1.442 . . . . 70.109999999999999 111.882 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.49 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 30.0 mt-10 -69.66 -37.76 76.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.803 0.811 . . . . 74.129999999999995 108.932 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.9 mt -65.67 -35.92 82.16 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 114.773 -1.103 . . . . 75.209999999999994 108.828 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.545 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 73.7 t80 -63.95 -47.37 80.76 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.572 -1.194 . . . . 74.519999999999996 110.227 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 81.9 mt -65.02 -35.68 81.95 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.815 0.341 . . . . 71.510000000000005 111.809 -176.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.0 tp -86.23 -36.25 19.53 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 112.581 0.585 . . . . 65.140000000000001 112.581 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -98.56 -11.12 22.5 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 114.337 1.236 . . . . 73.510000000000005 114.337 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.5 ttt-85 -66.79 -42.71 45.67 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 119.987 -0.685 . . . . 71.329999999999998 111.693 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -58.11 -25.35 70.74 Favored 'Trans proline' 0 C--N 1.398 3.167 0 C-N-CA 121.711 1.608 . . . . 72.120000000000005 111.553 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -84.8 84.42 7.7 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.777 0.799 . . . . 72.200000000000003 110.112 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -67.93 108.74 3.15 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.333 -1.303 . . . . 75.099999999999994 109.905 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.94 -25.5 1.29 Allowed Glycine 0 N--CA 1.424 -2.133 0 CA-C-N 113.996 -1.457 . . . . 64.209999999999994 109.67 -172.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -55.45 118.72 4.71 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.085 0.554 . . . . 72.430000000000007 110.538 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -93.65 -60.09 1.85 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 120.121 -0.632 . . . . 61.229999999999997 109.363 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.56 175.15 38.15 Favored Glycine 0 C--N 1.298 -1.546 0 C-N-CA 120.848 -0.691 . . . . 65.310000000000002 112.075 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.3 p -134.79 143.88 47.34 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 122.488 0.315 . . . . 75.530000000000001 111.002 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.437 HD21 ' O ' ' A' ' 112' ' ' MET . 80.5 mt -115.98 119.91 37.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.09 -0.707 . . . . 74.209999999999994 109.09 174.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.17 133.3 35.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 110.137 -0.319 . . . . 71.540000000000006 110.137 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -117.82 106.66 13.23 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.27 -1.381 . . . . 72.239999999999995 107.27 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.4 124.6 25.48 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.246 -1.02 . . . . 71.219999999999999 108.246 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 5.9 m -128.89 150.79 50.2 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 105.155 -2.165 . . . . 72.239999999999995 105.155 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.05 -40.34 10.53 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 114.42 1.267 . . . . 63.32 114.42 -173.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -96.01 -26.76 15.42 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.877 1.065 . . . . 73.439999999999998 113.877 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.56 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -172.23 143.05 1.27 Allowed Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 110.202 -0.296 . . . . 70.439999999999998 110.202 -177.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.496 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 59.5 Cg_endo -77.37 124.64 7.23 Favored 'Trans proline' 0 N--CA 1.432 -2.092 0 C-N-CA 122.491 2.127 . . . . 65.019999999999996 110.102 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.7 m -96.36 147.49 6.1 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 N-CA-C 108.222 -1.029 . . . . 53.240000000000002 108.222 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.22 120.86 4.59 Favored Glycine 0 CA--C 1.479 -2.204 0 C-N-CA 118.879 -1.629 . . . . 71.129999999999995 112.907 -175.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.44 103.65 15.71 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 106.849 -1.538 . . . . 75.409999999999997 106.849 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.5 t -94.34 128.07 45.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.363 0 CA-C-N 115.071 -0.968 . . . . 74.129999999999995 110.284 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.67 114.24 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.369 0 N-CA-C 107.991 -1.114 . . . . 62.219999999999999 107.991 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.476 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 36.1 m-85 -93.96 162.65 13.81 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.329 -0.85 . . . . 74.200000000000003 109.584 174.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.36 -41.21 51.31 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 124.317 1.011 . . . . 75.510000000000005 111.876 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.6 p -164.9 166.08 19.85 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.571 -0.741 . . . . 70.540000000000006 111.986 -174.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.687 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -56.05 -39.5 72.11 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.236 1.014 . . . . 72.120000000000005 112.105 177.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.82 -28.17 69.38 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.625 0.726 . . . . 73.319999999999993 109.731 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.56 -38.71 9.46 Favored Glycine 0 C--N 1.309 -0.922 0 CA-C-N 114.648 -1.16 . . . . 65.310000000000002 110.897 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.67 -45.87 77.48 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.546 0.738 . . . . 52.219999999999999 112.032 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -34.82 78.8 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.007 0.432 . . . . 75.150000000000006 111.439 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.6 -41.21 65.84 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.992 -0.549 . . . . 62.109999999999999 110.563 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.89 -41.72 86.73 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.747 -0.66 . . . . 62.5 110.821 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -69.42 -28.46 66.16 Favored 'General case' 0 C--O 1.199 -1.585 0 CA-C-N 116.292 -0.413 . . . . 70.019999999999996 111.297 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -78.11 -21.07 50.99 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.27 0.557 . . . . 75.349999999999994 111.751 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.91 -44.02 11.36 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.278 -0.419 . . . . 72.439999999999998 111.378 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.467 ' O ' HG22 ' A' ' 91' ' ' ILE . 96.0 mt -93.78 -12.64 28.66 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 115.456 1.65 . . . . 74.519999999999996 115.456 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -67.56 114.6 6.34 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 119.559 1.072 . . . . 55.020000000000003 112.169 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.37 16.37 14.86 Favored Glycine 0 N--CA 1.429 -1.83 0 C-N-CA 119.73 -1.224 . . . . 63.340000000000003 111.789 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 88' ' ' LEU . 11.4 tt -90.81 128.19 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.73 0 N-CA-C 107.669 -1.234 . . . . 75.230000000000004 107.669 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -75.1 121.73 22.5 Favored 'General case' 0 C--N 1.269 -2.898 0 N-CA-C 107.87 -1.159 . . . . 71.099999999999994 107.87 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.43 -32.81 69.03 Favored 'General case' 0 C--N 1.312 -1.033 0 O-C-N 124.357 1.036 . . . . 70.150000000000006 109.04 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.419 ' HB3' ' HB3' ' B' ' 45' ' ' ARG . 3.1 p-10 -148.06 115.18 3.99 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 107.077 -1.453 . . . . 75.430000000000007 107.077 171.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -62.37 -9.59 15.89 Favored 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 122.685 2.257 . . . . 70.239999999999995 113.185 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -74.46 -19.21 60.47 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.483 0.658 . . . . 74.510000000000005 109.453 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -118.08 146.52 39.4 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.202 -1.036 . . . . 74.019999999999996 108.202 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.19 -16.61 52.53 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.182 1.921 . . . . 74.230000000000004 113.159 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -52.83 125.35 16.62 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.199 1.4 . . . . 73.120000000000005 111.823 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.3 p -112.26 150.3 31.13 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 120.153 -0.619 . . . . 45.420000000000002 110.823 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.481 HD11 HG12 ' A' ' 35' ' ' VAL . 22.2 tp -98.34 127.01 44.08 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.469 -0.938 . . . . 73.420000000000002 108.469 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -122.38 136.03 54.82 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.09 0.471 . . . . 74.349999999999994 109.822 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.448 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.6 mp -110.38 116.25 31.11 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.378 -0.828 . . . . 73.040000000000006 108.965 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.478 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 5.3 tp10 -127.19 161.99 27.22 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.73 -0.841 . . . . 73.519999999999996 108.73 -177.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -70.75 139.29 51.03 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 118.514 0.597 . . . . 65.25 110.436 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.16 150.5 31.7 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 109.233 -0.655 . . . . 60.340000000000003 109.233 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -74.18 -6.65 49.03 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.589 -0.732 . . . . 74.530000000000001 111.961 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.16 133.65 7.88 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.772 -0.825 . . . . 31.41 108.772 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.529 HD21 ' HA ' ' A' ' 30' ' ' VAL . 84.1 m-20 -74.78 108.31 7.44 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.99 -1.115 . . . . 72.239999999999995 107.99 172.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.7 t -101.05 126.76 47.76 Favored 'General case' 0 C--N 1.289 -2.054 0 C-N-CA 119.11 -1.036 . . . . 41.020000000000003 109.823 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.556 ' HE2' ' N ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -60.99 138.28 58.19 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.927 -0.397 . . . . 63.340000000000003 109.927 175.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.437 ' O ' HD21 ' A' ' 61' ' ' LEU . 1.3 tmt? -69.13 -25.95 64.65 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.591 -0.732 . . . . 73.219999999999999 110.599 -176.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.03 93.14 2.69 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.309 -0.626 . . . . 65.120000000000005 109.309 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -78.0 123.92 27.39 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.587 -0.733 . . . . 73.150000000000006 110.258 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 75.1 m -86.3 144.61 27.3 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.341 0.591 . . . . 72.129999999999995 112.542 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -139.44 118.96 12.97 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.977 -1.49 . . . . 72.239999999999995 106.977 174.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.513 ' HG ' ' OE2' ' A' ' 118' ' ' GLU . 22.3 tp -102.11 -68.38 0.83 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.549 -0.908 . . . . 73.450000000000003 108.549 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.513 ' OE2' ' HG ' ' A' ' 117' ' ' LEU . 9.3 mp0 . . . . . 0 C--N 1.307 -1.249 0 N-CA-C 106.399 -1.704 . . . . 73.25 106.399 168.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.293 0 CA-C-O 120.83 0.348 . . . . 62.509999999999998 110.166 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -135.91 163.37 30.4 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.739 -1.208 . . . . 64.409999999999997 107.739 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -87.94 47.58 1.52 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.777 0.798 . . . . 71.510000000000005 110.944 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.584 ' HB2' ' HD2' ' B' ' 78' ' ' ARG . 26.9 mm-40 -81.72 -179.97 7.6 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 114.561 -1.199 . . . . 64.019999999999996 110.948 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 32.2 t -83.0 111.66 19.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.003 0.43 . . . . 71.329999999999998 111.754 -166.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 86.6 mtt180 -91.64 -3.52 56.26 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.124 0.488 . . . . 75.239999999999995 111.634 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.9 m -115.55 128.2 55.81 Favored 'General case' 0 C--N 1.263 -3.16 0 CA-C-O 121.675 0.75 . . . . 53.240000000000002 112.759 -172.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 71.3 mt -110.1 142.41 41.6 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.184 -0.916 . . . . 71.099999999999994 108.697 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -99.38 113.69 26.17 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 106.992 -1.484 . . . . 74.430000000000007 106.992 173.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.478 HG22 ' HG ' ' B' ' 103' ' ' LEU . 53.4 t -102.49 125.67 56.73 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.984 0 CA-C-N 113.953 -1.476 . . . . 72.439999999999998 107.509 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.2 p -139.17 169.56 17.55 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.732 -0.667 . . . . 74.030000000000001 110.219 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 90.56 42.66 5.08 Favored Glycine 0 N--CA 1.422 -2.295 0 N-CA-C 109.465 -1.454 . . . . 71.219999999999999 109.465 -172.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.33 138.25 20.13 Favored Pre-proline 0 N--CA 1.418 -2.066 0 CA-C-N 114.039 -1.08 . . . . 75.310000000000002 108.437 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -54.53 155.83 15.87 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.401 2.068 . . . . 55.149999999999999 110.094 171.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.498 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 8.1 p -83.06 3.93 2.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 122.627 1.203 . . . . 65.030000000000001 108.796 -174.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.93 21.93 6.3 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 114.136 -1.393 . . . . 64.150000000000006 111.056 -173.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 35.2 pt -54.0 137.03 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 113.88 1.067 . . . . 75.310000000000002 113.88 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.583 ' HA ' ' HE3' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -93.36 141.38 23.88 Favored Pre-proline 0 C--N 1.279 -2.467 0 N-CA-C 107.054 -1.461 . . . . 73.420000000000002 107.054 174.425 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.24 -25.53 78.53 Favored 'Trans proline' 0 N--CA 1.478 0.616 0 C-N-CA 122.644 2.229 . . . . 71.129999999999995 113.093 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.471 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 16.7 ptt180 -79.7 -18.0 52.3 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 112.166 0.432 . . . . 63.030000000000001 112.166 -176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.503 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 31.2 mt-10 -65.31 -40.29 93.56 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.815 0.817 . . . . 75.140000000000001 108.993 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 74.2 mt -67.92 -35.93 79.28 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.556 -1.202 . . . . 73.439999999999998 109.634 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -61.16 -48.18 82.79 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.43 -0.804 . . . . 74.099999999999994 111.144 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 79.8 mt -63.1 -44.31 96.04 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 123.837 0.71 . . . . 63.100000000000001 110.054 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.9 tp -73.02 -41.55 64.11 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.894 -1.048 . . . . 71.239999999999995 111.861 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -96.03 10.03 38.83 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.323 0.861 . . . . 73.010000000000005 113.323 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -70.48 -48.65 17.3 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 120.615 -0.434 . . . . 64.219999999999999 111.725 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.75 -3.85 14.42 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 121.376 1.384 . . . . 72.439999999999998 112.128 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -91.42 94.69 9.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.416 1.103 . . . . 74.319999999999993 111.439 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -64.2 113.24 3.43 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 112.922 -1.944 . . . . 55.409999999999997 110.047 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.88 -21.97 3.68 Favored Glycine 0 C--N 1.287 -2.156 0 CA-C-N 115.097 -0.956 . . . . 63.009999999999998 111.403 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -62.26 105.8 0.65 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.329 0.585 . . . . 73.519999999999996 111.99 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -87.52 -48.6 7.8 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.787 -0.642 . . . . 63.420000000000002 109.609 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.57 170.93 43.55 Favored Glycine 0 C--N 1.298 -1.529 0 C-N-CA 120.741 -0.742 . . . . 53.229999999999997 112.0 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.7 p -128.8 138.1 51.89 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 122.684 0.394 . . . . 63.439999999999998 110.432 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 87.6 mt -112.99 112.88 24.64 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.526 -0.916 . . . . 71.310000000000002 108.526 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 50.4 mm -93.81 133.05 36.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.651 -0.499 . . . . 74.230000000000004 109.651 -176.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -128.3 126.69 41.32 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.097 -1.446 . . . . 74.5 107.097 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.72 125.88 29.93 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.698 0.761 . . . . 65.129999999999995 112.758 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.3 m -113.6 155.89 24.65 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 103.811 -2.663 . . . . 54.229999999999997 103.811 173.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.88 -35.15 31.36 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 114.322 1.23 . . . . 54.130000000000003 114.322 -172.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -104.91 -14.57 15.42 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 113.237 0.829 . . . . 75.019999999999996 113.237 -175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -172.81 147.85 1.65 Allowed Pre-proline 0 N--CA 1.468 0.473 0 CA-C-O 120.753 0.311 . . . . 61.119999999999997 110.258 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 46.2 Cg_endo -78.63 122.85 5.65 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 C-N-CA 122.347 2.032 . . . . 74.129999999999995 110.263 169.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 35.2 m -94.03 155.05 3.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.082 -1.081 . . . . 71.219999999999999 108.082 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.49 121.65 3.55 Favored Glycine 0 CA--C 1.474 -2.501 0 C-N-CA 118.868 -1.634 . . . . 63.329999999999998 113.301 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -88.17 102.46 14.82 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.754 -1.572 . . . . 75.329999999999998 106.754 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.18 122.9 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 CA-C-N 115.195 -0.911 . . . . 64.030000000000001 109.539 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 62.6 mt -102.68 120.71 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.418 0 CA-C-N 113.846 -1.525 . . . . 53.43 109.448 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.42 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 71.5 m-85 -105.06 161.21 14.43 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 114.112 -1.404 . . . . 73.219999999999999 109.846 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.57 -29.97 71.0 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.21 -0.904 . . . . 73.439999999999998 111.807 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 29.7 p -161.67 165.87 27.58 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.045 0.538 . . . . 73.519999999999996 110.072 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . 0.584 ' HD2' ' HB2' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -70.63 -22.58 62.51 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.529 -0.468 . . . . 43.439999999999998 110.314 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.15 -28.12 69.54 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.452 0.644 . . . . 54.409999999999997 110.383 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.38 -39.91 7.1 Favored Glycine 0 C--N 1.308 -1.023 0 N-CA-C 110.2 -1.16 . . . . 53.039999999999999 110.2 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.49 -43.68 98.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.503 -0.849 . . . . 62.5 111.825 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.93 -39.69 90.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 74.310000000000002 111.472 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.11 -37.83 64.01 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.082 0.468 . . . . 74.109999999999999 110.135 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.36 -40.54 77.43 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.48 -0.782 . . . . 53.310000000000002 111.083 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.528 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 14.5 ptmm? -68.18 -40.77 82.15 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 120.303 -0.559 . . . . 74.239999999999995 110.668 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -66.79 -25.26 66.38 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 120.71 -0.396 . . . . 74.239999999999995 111.925 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.67 -41.51 17.67 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 120.839 0.352 . . . . 75.519999999999996 111.281 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.548 ' O ' HG22 ' B' ' 91' ' ' ILE . 96.9 mt -96.26 -14.0 22.98 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 115.623 1.712 . . . . 62.100000000000001 115.623 -173.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.43 116.06 12.42 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 118.803 -1.159 . . . . 74.25 112.523 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.82 26.64 7.45 Favored Glycine 0 N--CA 1.428 -1.877 0 C-N-CA 120.49 -0.862 . . . . 71.239999999999995 111.373 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.548 HG22 ' O ' ' B' ' 88' ' ' LEU . 16.5 tt -114.95 133.71 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.551 0 N-CA-C 107.325 -1.361 . . . . 74.219999999999999 107.325 174.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.414 ' HG2' HG22 ' B' ' 100' ' ' THR . 99.2 mtt180 -67.66 134.47 51.18 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-O 121.086 0.469 . . . . 72.540000000000006 110.634 172.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -70.8 -30.35 66.78 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.529 -1.214 . . . . 63.030000000000001 109.039 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' B' ' 97' ' ' ASN . 8.5 t70 -144.31 118.97 5.93 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 104.544 -2.391 . . . . 74.010000000000005 104.544 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . 0.516 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 31.8 Cg_endo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.907 2.405 . . . . 74.319999999999993 113.819 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -94.21 4.46 53.86 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.609 0.719 . . . . 74.530000000000001 111.123 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' ASN . . . . . 0.474 ' HB3' ' HB3' ' B' ' 94' ' ' ASP . 56.2 t30 -118.84 130.34 24.88 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 107.514 -1.291 . . . . 74.310000000000002 107.514 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.44 -13.43 33.01 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 123.046 2.497 . . . . 75.549999999999997 113.972 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -67.33 116.53 8.19 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-O 121.379 0.609 . . . . 75.010000000000005 110.28 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.595 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 58.2 p -106.48 145.17 32.14 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.824 -0.625 . . . . 54.310000000000002 109.916 -176.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 33.4 tp -94.13 128.97 40.85 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 110.025 -0.361 . . . . 71.329999999999998 110.025 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.447 HH21 ' CD ' ' B' ' 104' ' ' GLU . 6.0 ptm180 -129.02 127.44 41.61 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.914 -0.402 . . . . 54.109999999999999 109.914 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.478 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.7 mp -115.06 118.84 34.51 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.608 -0.723 . . . . 74.540000000000006 110.034 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.528 ' HA ' ' CE ' ' B' ' 85' ' ' LYS . 34.3 mt-10 -137.81 162.0 35.1 Favored 'General case' 0 C--O 1.199 -1.574 0 C-N-CA 122.739 0.415 . . . . 74.140000000000001 110.378 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -69.39 132.91 47.12 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 118.295 0.498 . . . . 74.510000000000005 111.355 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.59 154.47 34.39 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.413 -0.588 . . . . 65.310000000000002 109.413 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -84.28 9.15 13.73 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 120.876 0.369 . . . . 75.430000000000007 111.567 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.81 130.41 11.5 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.638 -0.504 . . . . 60.530000000000001 109.638 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -76.68 121.45 23.28 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 108.676 -0.861 . . . . 70.329999999999998 108.676 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 7.0 m -113.3 134.33 54.66 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.225 -0.657 . . . . 74.140000000000001 109.225 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.16 153.62 21.1 Favored 'General case' 0 C--O 1.247 0.948 0 N-CA-C 107.612 -1.255 . . . . 72.209999999999994 107.612 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.31 77.39 8.96 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.856 0.836 . . . . 62.229999999999997 109.3 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -163.62 103.84 0.93 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.34 -1.3 . . . . 64.219999999999999 109.8 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -86.06 81.5 8.45 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 122.454 1.121 . . . . 73.120000000000005 108.491 173.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 41.8 m -120.76 127.17 51.72 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 114.459 -1.246 . . . . 44.229999999999997 110.524 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -140.67 158.49 43.91 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.677 -0.86 . . . . 72.519999999999996 108.677 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 53.7 tp -80.87 -45.28 17.08 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.847 -0.798 . . . . 73.420000000000002 108.847 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.431 -1.39 0 CA-C-N 115.646 -0.707 . . . . 73.530000000000001 109.912 -178.673 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.417 ' N ' ' HG ' ' A' ' 77' ' ' SER . 1.8 mpt? . . . . . 0 C--O 1.224 -0.251 0 CA-C-O 121.005 0.431 . . . . 75.310000000000002 110.362 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -115.15 177.64 4.58 Favored 'General case' 0 C--O 1.252 1.194 0 CA-C-N 116.461 -0.336 . . . . 73.310000000000002 110.738 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -75.34 104.89 6.1 Favored 'General case' 0 N--CA 1.432 -1.365 0 O-C-N 124.233 0.958 . . . . 73.329999999999998 111.722 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.445 ' HB2' ' HD2' ' A' ' 78' ' ' ARG . 34.4 mt-10 -150.75 179.86 7.85 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.791 -1.929 . . . . 74.040000000000006 105.791 174.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.58 111.1 12.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 121.363 0.602 . . . . 71.120000000000005 110.917 -170.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.644 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 69.0 mtt180 -91.93 -22.63 19.93 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 122.352 1.072 . . . . 73.340000000000003 109.518 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 18.1 m -96.07 122.7 39.18 Favored 'General case' 0 C--N 1.258 -3.396 0 CA-C-N 113.471 -1.695 . . . . 73.340000000000003 112.018 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.544 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.1 pt? -115.59 142.11 47.17 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 107.554 -1.276 . . . . 75.540000000000006 107.554 175.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 104' ' ' GLU . 26.2 p90 -96.57 122.18 39.2 Favored 'General case' 0 N--CA 1.417 -2.091 0 C-N-CA 118.779 -1.168 . . . . 71.230000000000004 109.272 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.415 HG22 ' HG ' ' A' ' 103' ' ' LEU . 41.6 t -97.27 108.78 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.586 0 N-CA-C 106.419 -1.697 . . . . 62.399999999999999 106.419 178.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 32.2 p -115.76 172.95 6.81 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 108.93 -0.767 . . . . 74.030000000000001 108.93 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 87.13 41.38 6.64 Favored Glycine 0 N--CA 1.418 -2.56 0 N-CA-C 109.897 -1.281 . . . . 74.099999999999994 109.897 -174.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.9 mt -114.81 145.14 33.32 Favored Pre-proline 0 N--CA 1.423 -1.777 0 N-CA-C 107.201 -1.407 . . . . 72.129999999999995 107.201 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.43 171.26 15.01 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.558 1.505 . . . . 72.430000000000007 110.199 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.5 p -71.31 -7.53 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 CA-C-O 122.574 1.178 . . . . 71.349999999999994 109.932 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -103.3 20.02 18.55 Favored 'General case' 0 C--O 1.203 -1.392 0 CA-C-N 114.035 -1.439 . . . . 65.200000000000003 109.386 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.98 123.51 27.95 Favored 'Isoleucine or valine' 0 C--O 1.253 1.261 0 CA-C-O 121.622 0.725 . . . . 73.219999999999999 110.715 178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -101.18 145.76 30.98 Favored Pre-proline 0 C--N 1.307 -1.244 0 C-N-CA 124.831 1.252 . . . . 74.019999999999996 111.44 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.56 -17.86 60.55 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.295 2.664 . . . . 70.450000000000003 114.557 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.555 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -86.73 -17.24 34.1 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 117.71 -1.596 . . . . 71.319999999999993 110.961 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -66.7 -42.16 86.86 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.133 0.492 . . . . 74.010000000000005 110.155 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.19 -37.35 87.04 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.191 -0.67 . . . . 55.420000000000002 109.191 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.667 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 61.0 t80 -59.38 -48.72 80.56 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.13 -0.941 . . . . 61.420000000000002 110.732 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 86.6 mt -61.59 -41.61 97.68 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.918 0.761 . . . . 73.510000000000005 110.32 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.9 tp -70.61 -42.19 71.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.286 -0.87 . . . . 71.329999999999998 111.79 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -86.72 7.13 28.03 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.851 1.056 . . . . 75.549999999999997 113.851 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.523 ' HA ' ' NE ' ' A' ' 52' ' ' ARG . 3.9 mmp_? -52.83 -50.33 81.94 Favored Pre-proline 0 N--CA 1.486 1.326 0 N-CA-C 113.924 1.083 . . . . 74.420000000000002 113.924 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -76.5 -0.91 10.92 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 121.914 1.743 . . . . 54.340000000000003 113.863 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' CE2' ' HA ' ' A' ' 84' ' ' ALA . 60.6 m-85 -98.76 115.33 28.53 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-O 121.945 0.879 . . . . 64.530000000000001 112.364 -174.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HD3' ' H ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -80.08 120.93 24.89 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 113.814 -1.539 . . . . 61.240000000000002 109.511 179.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.7 -14.0 6.09 Favored Glycine 0 C--N 1.276 -2.791 0 CA-C-N 114.958 -1.019 . . . . 73.319999999999993 113.037 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -58.33 107.31 0.48 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.044 0.422 . . . . 73.010000000000005 111.003 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.497 ' OE2' ' HA ' ' A' ' 76' ' ' ASP . 22.5 mt-10 -96.21 -33.96 11.83 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 120.579 -0.449 . . . . 74.430000000000007 110.987 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.77 -179.22 48.39 Favored Glycine 0 C--N 1.302 -1.334 0 C-N-CA 120.131 -1.033 . . . . 30.399999999999999 112.418 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.7 p -145.74 138.17 25.63 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.201 0.6 . . . . 73.040000000000006 110.409 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.0 mp -120.5 124.75 46.16 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.373 -0.973 . . . . 75.510000000000005 108.373 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.2 mm -93.96 138.02 21.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.983 -0.747 . . . . 65.209999999999994 108.983 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -126.39 112.09 15.24 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.091 -1.077 . . . . 75.150000000000006 108.091 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.92 116.41 13.39 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.671 -0.695 . . . . 75.109999999999999 110.746 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -109.03 152.2 25.32 Favored 'General case' 0 N--CA 1.396 -3.156 0 N-CA-C 102.296 -3.224 . . . . 74.549999999999997 102.296 171.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.82 -40.53 29.58 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.981 0.734 . . . . 42.299999999999997 112.981 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -85.16 -49.24 8.4 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.31 0.576 . . . . 74.349999999999994 112.019 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -138.47 127.07 14.18 Favored Pre-proline 0 C--N 1.283 -2.297 0 CA-C-N 115.718 -0.674 . . . . 71.409999999999997 112.334 -168.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.84 101.5 1.2 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.585 2.19 . . . . 64.329999999999998 108.689 166.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.39 152.16 3.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.773 -0.825 . . . . 71.329999999999998 108.773 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.76 119.99 4.53 Favored Glycine 0 CA--C 1.473 -2.555 0 C-N-CA 118.632 -1.746 . . . . 61.100000000000001 111.989 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -87.83 106.18 17.91 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 106.675 -1.602 . . . . 75.549999999999997 106.675 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 32' ' ' THR . 98.5 t -96.14 130.56 44.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 115.326 -0.852 . . . . 74.120000000000005 109.659 -177.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.8 mp -102.95 117.91 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.606 0 CA-C-N 115.079 -0.964 . . . . 63.109999999999999 108.945 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.644 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 7.4 m-85 -98.48 163.38 12.71 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.854 -1.066 . . . . 75.340000000000003 108.992 172.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.497 ' HA ' ' OE2' ' A' ' 58' ' ' GLU . 10.7 t70 -51.27 -39.27 56.37 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 123.944 0.778 . . . . 74.019999999999996 111.65 176.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.417 ' HG ' ' N ' ' A' ' 26' ' ' MET . 66.8 m -160.7 166.17 29.24 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.181 -0.918 . . . . 43.009999999999998 110.428 -175.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.572 ' HD3' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -55.28 -32.66 62.57 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.975 0.91 . . . . 74.109999999999999 111.029 176.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.45 ' HA ' ' OE2' ' A' ' 82' ' ' GLU . . . -64.35 -26.07 68.31 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.825 0.821 . . . . 53.039999999999999 110.534 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.77 -44.27 5.51 Favored Glycine 0 C--N 1.285 -2.284 0 N-CA-C 109.855 -1.298 . . . . 62.439999999999998 109.855 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.95 -39.23 91.4 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.379 -0.91 . . . . 71.030000000000001 110.932 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.45 ' OE2' ' HA ' ' A' ' 79' ' ' ALA . 14.8 pt-20 -62.75 -41.48 99.23 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 123.139 0.274 . . . . 64.340000000000003 110.764 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.32 -37.41 80.53 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-O 121.28 0.562 . . . . 73.049999999999997 110.673 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HA ' ' CE2' ' A' ' 54' ' ' PHE . . . -69.54 -42.7 74.26 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.618 -0.719 . . . . 74.25 111.411 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 82' ' ' GLU . 14.9 ptmm? -70.08 -33.45 71.92 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.331 -0.548 . . . . 73.049999999999997 110.8 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.12 -44.11 95.14 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 123.432 0.458 . . . . 72.340000000000003 110.921 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.72 -41.5 23.5 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 120.288 -0.565 . . . . 72.219999999999999 112.009 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.411 ' O ' HG22 ' A' ' 91' ' ' ILE . 94.3 mt -89.08 -20.66 24.04 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 116.335 1.976 . . . . 75.430000000000007 116.335 -170.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -67.58 115.01 6.69 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 120.1 1.318 . . . . 55.310000000000002 110.083 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.43 13.72 16.32 Favored Glycine 0 N--CA 1.415 -2.75 0 CA-C-N 115.69 -0.686 . . . . 75.540000000000006 111.472 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 88' ' ' LEU . 14.5 tt -92.12 132.86 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.652 0 CA-C-O 121.411 0.624 . . . . 72.200000000000003 110.068 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.435 ' HB3' ' O ' ' A' ' 94' ' ' ASP . 30.2 mmt180 -63.81 137.23 57.96 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.854 -1.066 . . . . 65.219999999999999 108.248 172.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.499 ' CD1' HD11 ' A' ' 101' ' ' LEU . 7.1 t80 -77.32 -30.77 54.2 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.872 -1.529 . . . . 72.140000000000001 106.872 174.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.617 ' OD2' ' HB3' ' B' ' 45' ' ' ARG 0.294 5.0 m-20 -144.66 136.92 13.24 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 100.823 -3.769 . . . . 61.520000000000003 100.823 171.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.586 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 49.3 Cg_endo -71.88 -5.9 18.02 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 CA-C-N 121.943 1.729 . . . . 74.230000000000004 109.815 172.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -94.94 6.43 49.07 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.986 1.314 . . . . 75.420000000000002 109.154 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.611 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 48.4 t-20 -129.21 131.25 23.56 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 108.825 -0.806 . . . . 74.319999999999993 108.825 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -70.44 -6.46 18.98 Favored 'Trans proline' 0 C--O 1.25 1.121 0 C-N-CA 123.361 2.707 . . . . 75.450000000000003 113.082 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.414 ' HA ' ' OE1' ' A' ' 99' ' ' GLN . 5.9 tp60 -84.54 118.72 24.5 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 108.927 -0.768 . . . . 73.0 108.927 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.474 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 37.0 p -120.4 146.39 46.24 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.558 -0.746 . . . . 73.019999999999996 109.138 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.499 HD11 ' CD1' ' A' ' 93' ' ' PHE . 7.5 mp -80.8 137.79 36.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.442 0.639 . . . . 64.040000000000006 111.637 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -129.63 105.75 8.26 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 107.263 -1.384 . . . . 73.409999999999997 107.263 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.1 mp -97.94 117.17 31.69 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.047 -0.978 . . . . 63.539999999999999 108.784 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.558 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 32.9 tt0 -136.61 160.43 38.83 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.572 -1.64 . . . . 71.040000000000006 106.572 -177.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -70.0 139.43 52.75 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 119.263 0.938 . . . . 74.230000000000004 110.492 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.28 145.07 46.36 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.337 -0.616 . . . . 71.549999999999997 109.337 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.52 2.19 14.54 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.78 -0.645 . . . . 73.230000000000004 111.536 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.26 115.78 4.78 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.162 -1.051 . . . . 61.210000000000001 108.162 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -69.13 123.21 20.48 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 107.876 -1.157 . . . . 74.510000000000005 107.876 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.6 m -103.97 101.53 11.31 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 120.99 -0.284 . . . . 72.140000000000001 110.636 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -68.02 128.77 37.75 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.202 -0.666 . . . . 74.430000000000007 109.202 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 84.0 mtp -68.56 -42.1 78.8 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.042 -0.725 . . . . 71.329999999999998 109.042 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.45 117.88 27.69 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.005 -0.998 . . . . 75.129999999999995 108.668 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -83.19 104.53 13.45 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.099 -0.5 . . . . 73.120000000000005 110.065 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.8 m -70.69 100.59 1.89 Allowed 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.721 -0.672 . . . . 62.420000000000002 110.201 177.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -122.61 101.2 7.33 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 105.058 -2.201 . . . . 65.239999999999995 105.058 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.0 tp -76.66 76.55 3.32 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.585 0.957 . . . . 51.149999999999999 113.585 -171.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--N 1.316 -0.877 0 C-N-CA 126.424 1.89 . . . . 64.329999999999998 107.064 171.891 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 19.8 mmt . . . . . 0 CA--C 1.494 -1.184 0 N-CA-C 107.363 -1.347 . . . . 38.039999999999999 107.363 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -104.23 155.2 18.93 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.681 -0.408 . . . . 63.549999999999997 110.109 -174.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -86.41 100.45 12.35 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.174 -1.788 . . . . 63.039999999999999 106.174 168.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.64 -179.45 6.57 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 106.894 -1.521 . . . . 74.109999999999999 106.894 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.26 111.91 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.52 0.676 . . . . 75.439999999999998 112.155 -169.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -96.3 -17.38 20.74 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 115.066 -0.97 . . . . 64.219999999999999 110.363 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 13.6 m -99.2 129.65 45.45 Favored 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 114.991 -1.004 . . . . 71.340000000000003 112.83 -170.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.466 HD23 ' H ' ' B' ' 33' ' ' LEU . 2.4 pt? -123.87 151.39 43.52 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 107.241 -1.392 . . . . 71.340000000000003 107.241 174.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.603 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 18.3 p90 -105.4 123.98 48.78 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 121.896 0.855 . . . . 74.439999999999998 109.585 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.463 HG22 ' HG ' ' B' ' 103' ' ' LEU . 43.5 t -97.79 115.41 37.67 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 107.004 -1.48 . . . . 73.140000000000001 107.004 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 23.8 p -119.04 168.36 10.9 Favored 'General case' 0 C--N 1.274 -2.703 0 CA-C-N 115.309 -0.86 . . . . 61.520000000000003 108.786 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 89.69 31.13 11.7 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.749 -0.94 . . . . 72.420000000000002 110.749 -175.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 88.9 mt -104.2 114.31 64.44 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.076 -1.453 . . . . 63.450000000000003 107.076 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.15 156.85 19.09 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.102 1.868 . . . . 74.219999999999999 110.43 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 11.9 p -65.22 -10.51 9.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 122.174 0.988 . . . . 74.409999999999997 111.27 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -98.04 8.3 44.98 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 114.869 -1.059 . . . . 72.010000000000005 110.054 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.49 121.53 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 CA-C-O 121.583 0.706 . . . . 64.420000000000002 111.489 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.48 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 3.2 mptp? -85.58 145.81 42.79 Favored Pre-proline 0 C--N 1.315 -0.906 0 C-N-CA 124.39 1.076 . . . . 74.209999999999994 109.923 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.19 -23.53 74.16 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.526 2.151 . . . . 64.549999999999997 112.972 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.617 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 13.2 ptt180 -77.46 -24.48 50.24 Favored 'General case' 0 N--CA 1.425 -1.681 0 O-C-N 122.279 -0.263 . . . . 63.119999999999997 111.126 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.48 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 43.3 mt-10 -68.09 -33.63 74.9 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.276 0.56 . . . . 74.209999999999994 110.001 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 48.8 mt -63.09 -47.11 84.25 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.281 -1.007 . . . . 70.230000000000004 108.281 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.594 ' O ' ' HG3' ' B' ' 52' ' ' ARG . 11.5 t80 -58.83 -44.62 90.95 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.431 -1.259 . . . . 74.329999999999998 111.175 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 93.5 mt -65.24 -39.14 92.31 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.007 0.432 . . . . 73.319999999999993 110.884 -178.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 34.7 tp -78.97 -40.52 31.49 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 115.931 -0.577 . . . . 71.319999999999993 112.121 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -89.88 0.91 56.78 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 115.519 1.674 . . . . 64.040000000000006 115.519 -174.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 14.3 mtp180 -61.36 -47.52 93.62 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 114.459 1.281 . . . . 73.219999999999999 114.459 176.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -72.08 -4.24 14.79 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.257 1.305 . . . . 73.209999999999994 112.377 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -92.42 93.4 8.57 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.915 0.864 . . . . 72.120000000000005 111.428 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.567 ' HD3' ' H ' ' B' ' 55' ' ' LYS . 0.1 OUTLIER -65.35 111.76 3.19 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.085 -1.416 . . . . 72.049999999999997 110.143 178.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.14 -15.54 4.24 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.331 -0.85 . . . . 75.099999999999994 112.702 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -61.9 109.39 1.24 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 117.099 0.45 . . . . 75.329999999999998 110.747 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -86.56 -38.2 17.4 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.175 -1.046 . . . . 72.239999999999995 108.175 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.7 178.9 40.58 Favored Glycine 0 C--N 1.311 -0.826 0 CA-C-N 115.014 -0.994 . . . . 34.240000000000002 112.023 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.6 p -135.1 148.74 49.9 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 122.456 0.302 . . . . 63.020000000000003 110.973 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 54.3 tp -126.31 111.74 14.89 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.974 -1.121 . . . . 72.400000000000006 107.974 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.43 ' CG2' ' HB2' ' B' ' 69' ' ' PRO . 46.5 mm -94.24 134.34 32.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 110.228 -0.286 . . . . 73.5 110.228 -175.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -124.35 114.91 20.16 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.219 -0.66 . . . . 52.219999999999999 109.219 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.08 125.34 26.36 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.216 0.531 . . . . 74.010000000000005 109.58 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 16.0 m -125.04 159.38 31.48 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 106.145 -1.798 . . . . 61.219999999999999 106.145 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.04 -40.54 15.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.17 0.988 . . . . 44.219999999999999 112.946 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -88.93 -47.7 7.97 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 112.857 0.688 . . . . 50.299999999999997 112.857 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 26.4 pt20 -155.68 149.0 18.49 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 116.041 -0.527 . . . . 72.400000000000006 110.048 -170.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 49.9 Cg_endo -79.07 108.58 2.41 Favored 'Trans proline' 0 N--CA 1.436 -1.899 0 C-N-CA 122.146 1.898 . . . . 55.119999999999997 109.981 170.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.03 151.32 4.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.5 -0.773 . . . . 53.439999999999998 109.061 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.13 120.69 4.73 Favored Glycine 0 CA--C 1.478 -2.244 0 C-N-CA 118.162 -1.97 . . . . 51.310000000000002 113.681 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -88.41 105.44 17.6 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 106.467 -1.679 . . . . 63.43 106.467 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.417 ' O ' HD23 ' B' ' 33' ' ' LEU . 74.6 t -100.15 130.67 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 CA-C-O 121.421 0.629 . . . . 74.219999999999999 110.3 -176.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.52 119.77 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 CA-C-N 114.708 -1.133 . . . . 74.430000000000007 108.724 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -102.78 168.37 9.28 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 115.208 -0.906 . . . . 62.539999999999999 111.358 174.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.96 -43.67 50.28 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.289 -1.323 . . . . 75.109999999999999 110.792 172.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 11.5 p -166.03 169.68 14.35 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.045 -0.98 . . . . 75.510000000000005 110.894 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . 0.507 ' HD3' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -63.24 -30.53 71.65 Favored 'General case' 0 C--O 1.213 -0.822 0 O-C-N 123.194 0.309 . . . . 75.310000000000002 110.182 176.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.98 67.38 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 122.361 1.077 . . . . 71.0 109.469 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.5 -43.69 5.45 Favored Glycine 0 C--N 1.294 -1.791 0 CA-C-N 113.536 -1.665 . . . . 64.340000000000003 110.678 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.79 -36.9 85.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.556 -0.822 . . . . 72.540000000000006 111.798 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 9.9 pt-20 -60.75 -41.23 94.99 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 120.747 0.308 . . . . 73.329999999999998 110.64 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.72 -39.4 80.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.998 0.428 . . . . 63.229999999999997 110.162 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.29 82.39 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.371 -0.831 . . . . 75.030000000000001 111.198 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' B' ' 82' ' ' GLU . 13.1 ptmm? -69.54 -32.19 70.86 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 116.233 -0.44 . . . . 65.310000000000002 110.861 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -70.95 -28.83 64.76 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 111.987 0.366 . . . . 74.439999999999998 111.987 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.71 -32.8 25.33 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 120.436 -0.505 . . . . 65.439999999999998 111.694 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.558 ' O ' HG22 ' B' ' 91' ' ' ILE . 92.7 mt -107.8 -4.39 18.11 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 115.443 1.645 . . . . 74.530000000000001 115.443 -173.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -79.03 114.78 18.25 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 117.786 -1.566 . . . . 74.209999999999994 110.272 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.9 3.96 48.64 Favored Glycine 0 CA--C 1.479 -2.211 0 C-N-CA 120.564 -0.827 . . . . 73.099999999999994 111.911 174.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.558 HG22 ' O ' ' B' ' 88' ' ' LEU . 15.5 tt -96.5 137.61 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.056 0 N-CA-C 107.312 -1.366 . . . . 73.239999999999995 107.312 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.428 ' HG2' HG22 ' B' ' 100' ' ' THR . 99.4 mtt180 -77.28 142.14 39.62 Favored 'General case' 0 C--N 1.265 -3.071 0 CA-C-O 121.35 0.595 . . . . 62.229999999999997 112.537 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.459 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 39.8 t80 -67.69 -37.0 81.72 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.798 -1.546 . . . . 71.409999999999997 108.991 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.57 ' HB2' ' HB2' ' B' ' 97' ' ' ASN 0.277 3.9 m-20 -131.13 133.81 25.1 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 101.831 -3.396 . . . . 60.340000000000003 101.831 174.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . 0.667 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 18.7 Cg_endo -61.04 -29.9 88.56 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 CA-C-N 121.993 1.748 . . . . 62.509999999999998 112.026 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -94.91 15.93 17.38 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.544 -0.753 . . . . 52.399999999999999 111.133 -175.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' B' ' 94' ' ' ASP . 57.7 t-20 -122.82 131.86 24.33 Favored Pre-proline 0 C--N 1.312 -1.054 0 N-CA-C 107.225 -1.398 . . . . 60.409999999999997 107.225 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.91 -3.42 13.58 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.279 1.986 . . . . 73.200000000000003 112.57 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' GLN . . . . . 0.471 ' HA ' ' OE1' ' B' ' 99' ' ' GLN . 5.8 tp60 -76.59 112.23 12.92 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.958 -0.756 . . . . 74.329999999999998 108.958 177.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.508 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 81.6 p -105.49 144.85 31.68 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.647 -0.706 . . . . 65.109999999999999 110.278 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 81.0 mt -79.53 135.97 36.76 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.431 -0.952 . . . . 64.120000000000005 108.431 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -131.42 112.79 13.01 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.744 -1.206 . . . . 73.420000000000002 107.744 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.463 ' HG ' HG22 ' B' ' 35' ' ' VAL . 7.6 mp -103.12 118.21 36.28 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.601 -0.727 . . . . 64.140000000000001 109.61 177.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.603 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 6.5 tp10 -135.29 157.12 47.71 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 105.684 -1.969 . . . . 74.0 105.684 -177.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -69.33 142.24 54.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 119.74 1.154 . . . . 65.420000000000002 110.961 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.47 153.11 25.79 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.888 -1.153 . . . . 53.520000000000003 107.888 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -94.3 13.01 24.89 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.908 -1.117 . . . . 73.219999999999999 109.235 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.4 114.86 10.44 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.71 -1.218 . . . . 55.509999999999998 107.71 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -85.01 104.44 14.94 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.236 -1.394 . . . . 74.409999999999997 107.236 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 16.3 m -102.38 96.79 7.17 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 116.07 -0.514 . . . . 74.230000000000004 110.895 -170.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -61.74 141.67 57.73 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 116.451 -0.34 . . . . 71.219999999999999 110.094 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 89.0 mtp -88.55 -57.6 2.86 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.71 -0.848 . . . . 73.439999999999998 108.71 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.34 116.59 32.68 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.033 -1.469 . . . . 71.150000000000006 107.033 175.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -109.59 137.99 46.61 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 116.241 -0.436 . . . . 72.439999999999998 109.975 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 10.5 p -68.35 126.79 30.71 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.544 -0.539 . . . . 72.230000000000004 109.544 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -75.11 150.54 38.77 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.426 -0.583 . . . . 73.230000000000004 109.426 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 40.4 tp -78.58 65.95 3.99 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.29 -1.004 . . . . 73.209999999999994 108.29 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.446 -0.653 0 C-N-CA 125.941 1.696 . . . . 72.450000000000003 107.577 -177.856 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 CA--C 1.487 -1.457 0 N-CA-C 107.2 -1.407 . . . . 75.310000000000002 107.2 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -111.25 -167.9 1.24 Allowed 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.928 -0.767 . . . . 73.129999999999995 108.928 -169.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.24 62.39 3.6 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.981 0.896 . . . . 74.530000000000001 109.099 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.483 ' OE1' ' HD3' ' A' ' 78' ' ' ARG . 39.5 mt-10 -72.13 150.31 43.94 Favored 'General case' 0 N--CA 1.4 -2.933 0 C-N-CA 126.09 1.756 . . . . 71.439999999999998 108.531 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.7 110.0 8.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 105.941 -1.874 . . . . 74.340000000000003 105.941 173.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 24.2 mtt180 -104.02 0.88 30.41 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.778 -0.769 . . . . 64.409999999999997 111.066 -172.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.1 m -104.69 125.49 50.84 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-O 121.391 0.615 . . . . 73.25 112.597 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.413 HD12 ' CE1' ' A' ' 75' ' ' PHE . 73.5 mt -109.73 138.03 46.68 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.554 -0.906 . . . . 55.530000000000001 108.554 173.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -96.31 110.55 22.86 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 107.345 -1.354 . . . . 74.030000000000001 107.345 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.523 HG22 ' HG ' ' A' ' 103' ' ' LEU . 40.5 t -97.67 124.51 50.68 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.767 0 CA-C-N 114.168 -1.378 . . . . 72.530000000000001 108.623 -176.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.7 p -129.45 164.72 23.08 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.166 -0.924 . . . . 75.150000000000006 110.111 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 92.85 29.89 10.13 Favored Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.924 -0.87 . . . . 50.549999999999997 110.924 -173.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.9 mt -95.23 122.19 60.32 Favored Pre-proline 0 N--CA 1.425 -1.699 0 N-CA-C 106.04 -1.837 . . . . 71.209999999999994 106.04 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -55.41 153.32 28.73 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.161 1.908 . . . . 74.239999999999995 111.7 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.5 p -61.34 -12.91 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.918 0.887 . . . . 74.120000000000005 111.423 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -127.94 40.74 3.63 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.623 -0.88 . . . . 74.120000000000005 108.623 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.7 tt -72.08 132.02 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.459 -0.791 . . . . 72.519999999999996 109.087 172.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.444 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 29.3 mmmt -90.26 145.8 33.47 Favored Pre-proline 0 C--N 1.276 -2.619 0 N-CA-C 108.584 -0.895 . . . . 71.230000000000004 108.584 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.66 -29.3 84.92 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.478 2.119 . . . . 73.239999999999995 111.728 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.522 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 13.2 ptt180 -70.85 -22.06 62.36 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 115.44 -0.8 . . . . 72.409999999999997 111.738 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 38.8 mt-10 -69.47 -38.27 77.66 Favored 'General case' 0 CA--C 1.506 -0.729 0 O-C-N 122.058 -0.401 . . . . 45.109999999999999 110.451 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.22 -34.0 76.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 122.042 0.925 . . . . 55.149999999999999 108.768 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.576 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 56.5 t80 -65.46 -48.83 71.34 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.573 -1.194 . . . . 71.129999999999995 110.169 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 95.5 mt -65.17 -43.57 91.32 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 123.606 0.566 . . . . 71.099999999999994 110.045 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.407 HD13 HD22 ' B' ' 49' ' ' LEU . 34.2 tp -65.59 -43.14 90.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.034 -0.985 . . . . 54.299999999999997 111.147 -176.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -95.73 14.88 21.71 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 113.156 0.799 . . . . 72.239999999999995 113.156 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 3.2 mmp_? -55.37 -51.14 82.4 Favored Pre-proline 0 N--CA 1.486 1.351 0 N-CA-C 112.452 0.538 . . . . 62.020000000000003 112.452 174.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 52' ' ' ARG . 5.4 Cg_exo -81.33 -1.61 11.17 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 121.859 1.706 . . . . 65.439999999999998 112.918 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -93.63 89.74 6.35 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.52 0.676 . . . . 73.209999999999994 111.867 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -65.45 112.22 3.45 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.716 -1.129 . . . . 64.230000000000004 108.597 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 75' ' ' PHE . . . 132.96 -10.56 5.14 Favored Glycine 0 C--N 1.286 -2.206 0 C-N-CA 119.306 -1.426 . . . . 73.409999999999997 112.943 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -69.09 94.81 0.69 Allowed 'General case' 0 C--O 1.243 0.712 0 CA-C-N 117.626 0.713 . . . . 74.310000000000002 109.162 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -84.59 -44.35 13.6 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.032 -0.531 . . . . 62.25 109.879 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -168.8 179.43 41.64 Favored Glycine 0 C--N 1.296 -1.658 0 C-N-CA 120.645 -0.788 . . . . 73.099999999999994 111.867 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.8 p -151.44 140.72 21.37 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 122.801 0.44 . . . . 72.329999999999998 109.844 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.1 tp -111.96 109.56 19.41 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.322 -0.992 . . . . 72.219999999999999 108.322 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.41 129.65 44.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.563 -0.532 . . . . 74.409999999999997 109.563 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -123.4 123.09 39.89 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.37 -0.974 . . . . 74.099999999999994 108.37 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.69 118.06 21.17 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.406 0.622 . . . . 71.109999999999999 110.56 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.2 m -107.99 155.41 20.37 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 104.577 -2.379 . . . . 75.109999999999999 104.577 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.38 -33.71 31.11 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.265 1.209 . . . . 70.25 114.265 -172.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -105.07 -17.45 14.49 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 118.923 -1.111 . . . . 64.319999999999993 113.138 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -164.56 148.73 7.99 Favored Pre-proline 0 C--N 1.321 -0.654 0 C-N-CA 120.662 -0.415 . . . . 72.340000000000003 110.725 -173.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -80.94 121.7 4.1 Favored 'Trans proline' 0 N--CA 1.429 -2.292 0 C-N-CA 121.856 1.704 . . . . 70.530000000000001 109.671 168.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.82 146.94 5.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 107.676 -1.231 . . . . 72.209999999999994 107.676 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.33 120.77 3.13 Favored Glycine 0 CA--C 1.48 -2.13 0 C-N-CA 118.363 -1.875 . . . . 65.239999999999995 113.238 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -88.0 101.82 14.14 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.534 -1.654 . . . . 62.210000000000001 106.534 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.6 t -92.18 126.23 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 CA-C-N 115.688 -0.687 . . . . 65.329999999999998 110.031 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.6 mt -100.83 111.28 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.406 0 CA-C-N 114.287 -1.324 . . . . 55.229999999999997 108.32 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.533 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 80.8 m-85 -95.84 169.17 10.19 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 114.926 -1.034 . . . . 62.140000000000001 110.994 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.6 -44.13 97.08 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.304 -1.316 . . . . 72.230000000000004 112.561 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.9 p -152.78 165.71 34.5 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 122.427 -0.171 . . . . 72.420000000000002 111.016 -172.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.483 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -78.28 -27.95 47.51 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.246 -1.02 . . . . 74.030000000000001 108.246 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.44 -26.18 65.38 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.245 -0.888 . . . . 63.130000000000003 108.766 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.46 -40.46 8.38 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.324 -1.11 . . . . 61.439999999999998 110.324 176.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.15 92.92 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.286 0.635 . . . . 54.200000000000003 112.528 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.47 -31.47 70.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 119.769 -0.772 . . . . 64.430000000000007 112.11 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.4 -42.52 68.23 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.148 0.499 . . . . 52.240000000000002 110.018 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.01 -42.36 97.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.651 -0.704 . . . . 74.319999999999993 111.295 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.441 ' CE ' ' HA ' ' A' ' 104' ' ' GLU . 13.8 ptmm? -67.97 -36.9 80.84 Favored 'General case' 0 C--O 1.198 -1.648 0 C-N-CA 120.248 -0.581 . . . . 73.409999999999997 109.85 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -67.15 -19.79 65.65 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 112.974 0.731 . . . . 74.540000000000006 112.974 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.34 -45.57 10.45 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-O 121.276 0.56 . . . . 65.409999999999997 110.236 175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.526 ' O ' HG22 ' A' ' 91' ' ' ILE . 93.8 mt -94.13 -19.16 21.05 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 116.17 1.915 . . . . 73.209999999999994 116.17 -171.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.439 ' HB3' ' H ' ' A' ' 103' ' ' LEU 0.293 0.2 OUTLIER -76.55 116.99 17.75 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 120.662 -1.273 . . . . 54.130000000000003 113.335 -177.196 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.75 19.83 9.39 Favored Glycine 0 N--CA 1.423 -2.225 0 C-N-CA 120.689 -0.767 . . . . 62.329999999999998 112.142 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 88' ' ' LEU . 18.1 tt -112.91 135.84 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.212 0 N-CA-C 108.166 -1.05 . . . . 72.129999999999995 108.166 176.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.486 ' HG2' HG22 ' A' ' 100' ' ' THR . 63.5 mtt180 -72.75 128.11 34.57 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 116.242 -0.435 . . . . 73.209999999999994 109.901 174.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.4 ' CD2' ' HG3' ' B' ' 45' ' ' ARG . 8.6 t80 -57.57 -32.26 66.97 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 124.983 1.427 . . . . 70.420000000000002 109.932 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.611 ' HB2' ' HB2' ' A' ' 97' ' ' ASN 0.284 8.8 m-20 -133.53 140.27 36.39 Favored Pre-proline 0 CA--C 1.496 -1.132 0 N-CA-C 103.326 -2.842 . . . . 54.0 103.326 170.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.513 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 34.7 Cg_endo -70.89 -17.28 32.57 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 CA-C-N 121.229 1.475 . . . . 74.420000000000002 111.771 173.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -86.66 -12.47 48.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.132 0.491 . . . . 62.350000000000001 110.096 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.611 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 44.7 t-20 -103.76 131.98 21.49 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 109.078 -0.712 . . . . 72.219999999999999 109.078 -172.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.421 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 45.1 Cg_endo -70.43 -14.56 34.09 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.465 2.11 . . . . 71.230000000000004 112.407 176.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -65.24 115.89 6.03 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 109.458 -0.571 . . . . 61.219999999999999 109.458 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.486 HG22 ' HG2' ' A' ' 92' ' ' ARG . 60.6 p -102.62 139.92 37.57 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 119.946 -0.701 . . . . 72.519999999999996 110.026 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.9 tp -94.78 123.25 38.13 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.669 -0.864 . . . . 64.120000000000005 108.669 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 102' ' ' ARG . 0.3 OUTLIER -137.32 128.4 27.67 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 119.607 -0.837 . . . . 74.120000000000005 110.473 178.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.523 ' HG ' HG22 ' A' ' 35' ' ' VAL . 5.3 mp -106.65 125.29 50.81 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.315 -1.312 . . . . 63.530000000000001 108.38 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.441 ' HA ' ' CE ' ' A' ' 85' ' ' LYS . 26.0 tt0 -136.32 155.36 50.18 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.818 -1.179 . . . . 60.009999999999998 107.818 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -66.57 132.13 47.53 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 119.028 0.831 . . . . 73.329999999999998 111.822 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.09 152.6 36.76 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.19 -1.041 . . . . 73.019999999999996 108.19 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -93.24 15.59 15.12 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.66 1.219 . . . . 73.239999999999995 110.319 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -153.86 125.83 7.8 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.738 -1.119 . . . . 72.439999999999998 108.373 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.12 123.56 21.0 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.033 -1.099 . . . . 75.129999999999995 108.033 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.0 m -105.88 138.3 42.31 Favored 'General case' 0 C--N 1.269 -2.916 0 N-CA-C 107.327 -1.361 . . . . 61.420000000000002 107.327 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -111.7 167.71 10.13 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.294 -1.002 . . . . 74.239999999999995 108.294 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 85.6 mtp -77.39 177.21 8.15 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.047 -0.723 . . . . 61.039999999999999 109.047 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.02 85.32 4.25 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.178 0.513 . . . . 45.200000000000003 111.087 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -112.69 98.34 7.16 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.638 -1.616 . . . . 73.0 106.638 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.0 m -83.35 107.74 16.07 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.228 0.537 . . . . 72.140000000000001 110.708 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -83.11 78.04 9.66 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.014 -1.476 . . . . 71.049999999999997 107.014 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.7 tp -101.72 -35.65 9.0 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.346 -1.353 . . . . 51.450000000000003 107.346 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 . . . . . 0 N--CA 1.413 -2.309 0 N-CA-C 106.19 -1.782 . . . . 75.230000000000004 106.19 179.044 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.465 0.307 0 N-CA-C 111.965 0.357 . . . . 52.420000000000002 111.965 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -107.72 -163.1 0.87 Allowed 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.312 -0.995 . . . . 71.109999999999999 108.312 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -78.83 76.58 5.32 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 122.55 1.167 . . . . 71.420000000000002 112.217 177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.464 ' OE1' ' HD3' ' B' ' 78' ' ' ARG . 32.6 mt-10 -77.29 163.72 26.23 Favored 'General case' 0 N--CA 1.399 -2.977 0 CA-C-N 113.675 -1.602 . . . . 74.209999999999994 107.956 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 45.6 t -78.78 110.47 14.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 106.203 -1.777 . . . . 65.400000000000006 106.203 173.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.523 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 66.5 mtt180 -99.47 -15.7 18.6 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-N 115.567 -0.742 . . . . 62.409999999999997 111.427 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' B' ' 73' ' ' VAL . 31.0 m -105.4 129.16 53.78 Favored 'General case' 1 C--N 1.243 -4.026 0 N-CA-C 113.581 0.956 . . . . 53.340000000000003 113.581 -170.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.492 HD11 ' O ' ' B' ' 81' ' ' ALA . 79.2 mt -106.64 145.78 31.53 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.479 -1.237 . . . . 73.329999999999998 107.883 171.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' B' ' 104' ' ' GLU . 25.5 p90 -104.15 116.28 31.91 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 119.077 -1.049 . . . . 62.32 108.346 173.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.37 118.09 43.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 114.03 -1.441 . . . . 53.299999999999997 107.602 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.5 p -126.37 163.15 23.91 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 109.44 -0.578 . . . . 72.109999999999999 109.44 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 99.5 19.99 18.77 Favored Glycine 0 N--CA 1.423 -2.215 0 N-CA-C 111.826 -0.51 . . . . 41.0 111.826 -172.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 72.4 mt -93.89 120.21 66.1 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 107.915 -1.143 . . . . 73.239999999999995 107.915 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.34 159.6 22.48 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.576 2.184 . . . . 53.240000000000002 111.643 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 7.9 p -70.04 -6.11 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-O 121.94 0.876 . . . . 62.420000000000002 110.922 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -114.48 30.08 7.56 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.108 -1.071 . . . . 72.530000000000001 108.108 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.402 HG22 ' HG2' ' B' ' 69' ' ' PRO . 9.4 tt -58.8 140.32 17.28 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 CA-C-O 121.745 0.783 . . . . 72.329999999999998 111.627 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.636 ' HG2' ' CZ ' ' B' ' 45' ' ' ARG . 0.1 OUTLIER -101.18 143.34 26.4 Favored Pre-proline 0 C--N 1.293 -1.872 0 C-N-CA 125.712 1.605 . . . . 74.239999999999995 108.525 175.056 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -61.79 -27.91 81.15 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.451 2.1 . . . . 63.020000000000003 113.437 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.636 ' CZ ' ' HG2' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -82.7 -10.65 58.82 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 118.228 -1.389 . . . . 65.150000000000006 111.909 -177.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -65.09 -39.4 93.14 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 120.101 -0.639 . . . . 72.510000000000005 109.708 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.31 -33.71 74.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.538 -0.755 . . . . 71.049999999999997 109.806 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.513 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 66.5 t80 -61.94 -50.81 70.63 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.674 -0.694 . . . . 74.230000000000004 110.184 177.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 81.4 mt -62.04 -44.17 97.27 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 124.085 0.865 . . . . 44.009999999999998 109.548 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 20.6 tp -63.17 -44.64 94.88 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.45 -1.25 . . . . 71.019999999999996 110.965 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -93.59 11.39 28.96 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 113.902 1.075 . . . . 74.329999999999998 113.902 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' B' ' 52' ' ' ARG . 5.2 mmp_? -55.25 -51.86 76.21 Favored Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 113.276 0.843 . . . . 75.319999999999993 113.276 175.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' B' ' 52' ' ' ARG . 2.9 Cg_exo -79.26 -1.0 11.2 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.011 1.808 . . . . 74.420000000000002 112.937 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -99.81 99.76 10.61 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-O 122.5 1.143 . . . . 65.109999999999999 112.516 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -73.67 116.09 13.85 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 113.02 -1.9 . . . . 61.219999999999999 109.076 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' B' ' 75' ' ' PHE . . . 143.19 -24.73 2.22 Favored Glycine 0 C--N 1.284 -2.312 0 CA-C-N 114.822 -1.081 . . . . 60.520000000000003 112.103 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -55.67 110.07 0.66 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.512 0.725 . . . . 61.039999999999999 112.488 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -96.11 -49.27 5.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.489 -0.778 . . . . 50.130000000000003 110.368 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -169.68 172.41 43.65 Favored Glycine 0 C--N 1.299 -1.477 0 CA-C-N 115.162 -0.926 . . . . 71.219999999999999 111.413 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.9 p -141.17 137.63 32.83 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 122.531 0.332 . . . . 74.25 110.627 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 28.5 tp -120.33 115.35 23.37 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.897 -1.149 . . . . 75.129999999999995 107.897 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.95 131.47 42.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 109.684 -0.488 . . . . 72.030000000000001 109.684 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -118.55 114.35 22.68 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.309 -0.997 . . . . 72.0 108.309 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.6 119.74 12.86 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.956 -0.757 . . . . 64.319999999999993 108.956 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 25.6 m -114.65 155.25 26.93 Favored 'General case' 0 N--CA 1.401 -2.913 0 N-CA-C 104.662 -2.347 . . . . 64.340000000000003 104.662 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.78 -38.01 14.73 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.69 0.996 . . . . 71.439999999999998 113.69 -173.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -104.29 -15.78 15.36 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 113.239 0.829 . . . . 72.299999999999997 113.239 -174.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.493 ' O ' ' HB ' ' B' ' 65' ' ' THR . 29.4 pt20 -172.64 140.05 0.97 Allowed Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 110.135 -0.32 . . . . 71.530000000000001 110.135 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 68' ' ' GLN . 6.4 Cg_exo -74.54 112.99 3.68 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.846 2.364 . . . . 71.310000000000002 109.672 168.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -90.8 145.31 7.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.648 -0.871 . . . . 75.400000000000006 108.648 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.19 120.1 4.43 Favored Glycine 0 CA--C 1.483 -1.914 0 C-N-CA 118.917 -1.611 . . . . 60.219999999999999 112.775 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.91 103.06 15.82 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.579 -1.267 . . . . 75.219999999999999 107.579 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' B' ' 32' ' ' THR . 59.3 t -98.25 127.36 50.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-N 115.725 -0.67 . . . . 71.299999999999997 110.687 -175.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 53.3 mt -98.44 128.76 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 CA-C-N 114.842 -1.072 . . . . 63.130000000000003 108.814 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.523 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 85.3 m-85 -109.03 159.47 16.82 Favored 'General case' 0 C--N 1.271 -2.837 0 N-CA-C 107.799 -1.185 . . . . 64.209999999999994 107.799 174.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.13 -40.09 94.77 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 112.469 0.544 . . . . 75.340000000000003 112.469 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 2.9 p -143.69 155.61 44.27 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 116.046 -0.524 . . . . 63.030000000000001 111.707 -174.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . 0.597 ' HD3' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -59.69 -35.18 73.98 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 123.398 0.436 . . . . 73.030000000000001 110.898 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.6 -32.31 73.74 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 122.008 0.909 . . . . 64.439999999999998 109.49 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.47 -37.44 35.76 Favored Glycine 0 C--N 1.31 -0.864 0 CA-C-N 114.021 -1.445 . . . . 73.230000000000004 110.493 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.492 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -70.03 -45.3 67.47 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.848 -0.676 . . . . 55.119999999999997 111.517 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.94 -37.19 85.37 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.289 -0.564 . . . . 71.140000000000001 111.425 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.46 -35.99 81.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.853 0.359 . . . . 44.219999999999999 110.268 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.65 74.74 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.716 -0.675 . . . . 73.310000000000002 111.464 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.407 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 13.8 ptmm? -66.65 -40.18 88.56 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 119.743 -0.783 . . . . 72.239999999999995 110.619 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -60.53 -30.62 69.87 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.173 0.435 . . . . 53.299999999999997 112.173 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.18 -36.36 19.54 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.33 -0.548 . . . . 41.229999999999997 111.969 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.457 ' O ' HG22 ' B' ' 91' ' ' ILE . 91.2 mt -96.97 -23.38 16.33 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 116.042 1.867 . . . . 53.399999999999999 116.042 -172.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . 0.48 ' HB3' ' H ' ' B' ' 103' ' ' LEU . 0.2 OUTLIER -76.34 123.11 25.43 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.202 1.186 . . . . 73.409999999999997 114.202 -175.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.34 27.13 6.27 Favored Glycine 0 CA--C 1.483 -1.907 0 C-N-CA 120.316 -0.945 . . . . 74.019999999999996 111.582 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.457 HG22 ' O ' ' B' ' 88' ' ' LEU . 18.8 tt -124.44 142.96 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.395 0 N-CA-C 106.316 -1.735 . . . . 74.349999999999994 106.316 175.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.587 ' HG2' HG22 ' B' ' 100' ' ' THR . 96.3 mtt180 -74.21 145.82 43.83 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-O 121.098 0.475 . . . . 73.129999999999995 111.164 176.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -74.03 -33.24 63.68 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.166 -1.379 . . . . 74.140000000000001 108.199 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.575 ' HB2' ' CB ' ' B' ' 97' ' ' ASN . 4.8 m-20 -136.08 130.32 18.37 Favored Pre-proline 0 CA--C 1.511 -0.533 0 N-CA-C 103.456 -2.794 . . . . 75.430000000000007 103.456 173.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . 0.576 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 17.5 Cg_endo -58.26 -34.82 98.97 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.024 1.816 . . . . 52.119999999999997 112.479 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.17 1.57 39.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.816 -0.629 . . . . 75.209999999999994 111.782 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' ASN . . . . . 0.575 ' CB ' ' HB2' ' B' ' 94' ' ' ASP . 48.1 t30 -114.12 128.07 26.18 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 109.575 -0.528 . . . . 74.450000000000003 109.575 -175.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.12 -7.16 20.48 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 122.82 2.347 . . . . 71.319999999999993 112.016 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' GLN . . . . . 0.543 ' HB3' ' ND2' ' B' ' 97' ' ' ASN . 6.4 tp60 -75.01 112.12 10.91 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.099 -1.074 . . . . 71.25 108.099 174.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.587 HG22 ' HG2' ' B' ' 92' ' ' ARG . 82.2 p -101.96 151.88 21.6 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.76 -0.655 . . . . 74.209999999999994 109.398 -174.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 42.0 tp -98.81 121.0 40.19 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.958 -1.127 . . . . 71.329999999999998 107.958 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -131.93 138.53 48.4 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-O 121.344 0.593 . . . . 64.329999999999998 109.511 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' B' ' 89' ' ' ASN . 5.9 mp -122.36 118.41 28.36 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.944 -1.026 . . . . 71.420000000000002 109.137 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.451 ' HB2' ' CE2' ' B' ' 34' ' ' PHE . 9.3 mm-40 -124.21 168.43 12.94 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.966 -1.124 . . . . 43.219999999999999 107.966 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -74.35 141.95 45.15 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 109.191 -0.67 . . . . 60.439999999999998 109.191 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.46 144.22 42.22 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 108.163 -1.051 . . . . 64.140000000000001 108.163 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -80.44 6.74 11.45 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.787 0.803 . . . . 71.049999999999997 110.827 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -167.26 131.93 1.95 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.856 -1.905 . . . . 63.32 105.856 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -66.34 145.65 55.48 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 109.041 -0.725 . . . . 73.439999999999998 109.041 176.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 7.6 t -102.03 156.13 17.74 Favored 'General case' 0 N--CA 1.411 -2.412 0 C-N-CA 119.059 -1.056 . . . . 71.540000000000006 109.15 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -111.01 154.89 23.53 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 107.826 -1.176 . . . . 72.010000000000005 107.826 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 86.5 mtp -90.15 155.46 19.02 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.169 -1.419 . . . . 71.409999999999997 107.169 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.66 94.14 1.32 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.045 0.45 . . . . 75.299999999999997 111.07 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -119.27 125.76 49.88 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 107.268 -1.382 . . . . 73.209999999999994 107.268 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 17.9 m -74.87 104.32 5.44 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 123.499 0.5 . . . . 62.409999999999997 110.623 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . 0.42 ' HE3' ' C ' ' B' ' 116' ' ' LYS . 0.1 OUTLIER -107.92 78.72 1.21 Allowed 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 122.132 0.967 . . . . 74.109999999999999 109.805 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 33.2 tp -118.72 -61.11 1.69 Allowed 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 104.806 -2.294 . . . . 73.510000000000005 104.806 171.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 . . . . . 0 N--CA 1.437 -1.115 0 N-CA-C 105.425 -2.065 . . . . 73.439999999999998 105.425 170.389 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 110.691 -0.114 . . . . 75.310000000000002 110.691 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.58 -47.21 10.07 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.357 0.599 . . . . 50.32 110.113 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.49 101.44 11.32 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.688 0.756 . . . . 74.310000000000002 111.867 -175.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.543 ' OE1' ' HG3' ' A' ' 78' ' ' ARG . 1.6 tm-20 -117.16 -179.1 3.61 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 105.117 -2.179 . . . . 55.229999999999997 105.117 173.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 17.2 t -92.59 109.76 22.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 C-N-CA 118.324 -1.351 . . . . 74.200000000000003 109.84 -171.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NH2' ' HA ' ' A' ' 76' ' ' ASP . 17.1 ptm180 -111.08 9.68 22.01 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.215 -0.902 . . . . 71.319999999999993 111.459 -172.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.1 m -121.0 125.83 48.37 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.652 -0.704 . . . . 74.430000000000007 109.85 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' A' ' 85' ' ' LYS . 89.7 mt -107.35 152.85 23.6 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.239 -0.891 . . . . 73.519999999999996 108.846 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.59 ' CE1' ' HB2' ' A' ' 104' ' ' GLU . 21.8 p90 -115.18 118.16 32.53 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 117.883 -1.527 . . . . 75.319999999999993 109.056 172.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.8 t -97.63 123.08 49.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 113.797 -1.547 . . . . 74.319999999999993 107.679 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 60.0 p -124.31 175.37 7.12 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.986 -1.116 . . . . 71.030000000000001 107.986 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 88.5 27.21 25.5 Favored Glycine 0 N--CA 1.422 -2.279 0 N-CA-C 111.169 -0.772 . . . . 74.310000000000002 111.169 -176.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.4 mt -103.68 131.64 21.83 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 107.623 -1.251 . . . . 71.340000000000003 107.623 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.86 168.01 21.56 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.791 1.661 . . . . 72.319999999999993 111.094 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.71 -6.2 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-O 122.063 0.935 . . . . 60.509999999999998 110.524 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -124.78 40.4 3.75 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.176 -1.046 . . . . 52.439999999999998 108.176 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.49 125.03 34.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 106.589 -1.634 . . . . 62.420000000000002 106.589 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -93.91 142.24 24.77 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 109.223 -0.658 . . . . 72.010000000000005 109.223 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.24 -21.16 50.71 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.887 2.391 . . . . 62.240000000000002 113.217 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.576 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.3 ptt180 -77.21 -24.48 51.31 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 116.233 -0.439 . . . . 74.519999999999996 110.743 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -70.41 -41.27 73.18 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.0 0.428 . . . . 64.25 110.513 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.47 -39.97 94.82 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 108.728 -0.842 . . . . 74.150000000000006 108.728 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.65 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 30.7 t80 -57.13 -48.24 79.15 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.408 -1.269 . . . . 64.310000000000002 111.292 178.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 88.1 mt -61.53 -40.77 95.88 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.238 0.542 . . . . 73.540000000000006 110.77 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.8 tp -77.23 -40.93 43.13 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.0 -1.0 . . . . 72.019999999999996 111.926 -176.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -88.3 -8.13 55.64 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 115.398 1.629 . . . . 74.409999999999997 115.398 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 54.8 mtp85 -57.79 -43.78 98.94 Favored Pre-proline 0 N--CA 1.48 1.075 0 N-CA-C 114.896 1.443 . . . . 72.040000000000006 114.896 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -67.91 -17.45 46.6 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 121.344 1.362 . . . . 75.129999999999995 112.101 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -86.32 89.6 7.91 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.923 0.868 . . . . 74.230000000000004 110.962 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -65.03 110.76 2.6 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.367 -1.288 . . . . 74.310000000000002 109.769 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.88 -24.72 2.42 Favored Glycine 0 C--N 1.281 -2.522 0 CA-C-N 114.682 -1.144 . . . . 61.409999999999997 111.193 -176.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -58.29 113.03 1.76 Allowed 'General case' 0 C--O 1.242 0.664 0 C-N-CA 122.799 0.44 . . . . 72.340000000000003 111.355 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -91.65 -59.76 2.05 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.37 -0.832 . . . . 51.350000000000001 109.614 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -167.43 -178.45 39.64 Favored Glycine 0 C--N 1.298 -1.583 0 CA-C-N 115.276 -0.874 . . . . 55.329999999999998 111.449 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.2 p -135.66 137.97 42.36 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 122.532 0.333 . . . . 74.409999999999997 111.345 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.6 tt -107.7 119.97 40.93 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.742 -1.577 . . . . 53.329999999999998 106.742 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -95.66 128.97 46.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 109.661 -0.496 . . . . 64.439999999999998 109.661 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -119.06 109.35 15.81 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 106.51 -1.663 . . . . 73.239999999999995 106.51 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.84 127.78 33.66 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.514 -0.767 . . . . 74.540000000000006 109.777 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 7.1 m -130.32 151.04 51.25 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 105.54 -2.022 . . . . 63.43 105.54 175.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.74 -41.65 10.94 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 114.529 1.307 . . . . 72.420000000000002 114.529 -172.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -105.41 -11.58 16.38 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 114.988 1.477 . . . . 74.150000000000006 114.988 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.417 ' O ' ' HB ' ' A' ' 65' ' ' THR . 29.1 pt20 -166.1 125.69 1.19 Allowed Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 120.95 0.405 . . . . 55.310000000000002 111.671 -175.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.81 108.17 2.64 Favored 'Trans proline' 0 N--CA 1.439 -1.682 0 C-N-CA 122.371 2.047 . . . . 65.540000000000006 108.945 169.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.16 146.92 5.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.639 -0.874 . . . . 62.039999999999999 108.639 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.77 120.72 4.59 Favored Glycine 0 CA--C 1.486 -1.732 0 C-N-CA 118.868 -1.634 . . . . 61.530000000000001 113.499 -176.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -87.74 103.77 15.92 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.999 -1.482 . . . . 74.420000000000002 106.999 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.9 t -94.68 121.8 45.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 114.781 -1.1 . . . . 60.350000000000001 110.818 -174.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 tt -93.33 124.92 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.962 0 CA-C-N 114.822 -1.081 . . . . 74.420000000000002 109.978 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -103.59 155.57 18.44 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 114.817 -1.083 . . . . 72.140000000000001 108.424 173.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.499 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 22.5 t70 -67.98 -34.52 76.69 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.815 -0.63 . . . . 74.319999999999993 110.4 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.7 m -132.49 145.87 51.49 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 107.984 -1.117 . . . . 73.019999999999996 107.984 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.676 ' HB2' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -78.22 -24.38 47.07 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.66 -0.866 . . . . 71.239999999999995 108.66 -179.178 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.13 -25.45 68.36 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.028 0.918 . . . . 53.229999999999997 109.098 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.7 -42.59 6.78 Favored Glycine 0 C--N 1.297 -1.627 0 CA-C-N 113.533 -1.667 . . . . 64.5 109.724 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.28 -49.01 79.48 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.306 0.642 . . . . 70.120000000000005 111.239 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.19 -35.58 73.84 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.264 0.626 . . . . 62.299999999999997 112.234 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.05 -32.23 39.42 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.166 0.508 . . . . 63.399999999999999 111.014 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.73 -46.05 69.91 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.147 -0.479 . . . . 72.420000000000002 111.052 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HB3' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -68.8 -28.08 66.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.135 -0.484 . . . . 64.150000000000006 111.525 -177.2 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -70.28 -40.7 74.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.212 -0.449 . . . . 74.209999999999994 110.496 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.66 -36.99 36.89 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.279 0.474 . . . . 31.32 112.279 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.55 ' O ' HG22 ' A' ' 91' ' ' ILE . 98.5 mt -89.39 -4.48 58.02 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 115.484 1.661 . . . . 71.319999999999993 115.484 -175.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -78.55 118.05 20.3 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 117.86 -1.536 . . . . 74.340000000000003 110.803 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.13 6.53 31.82 Favored Glycine 0 CA--C 1.483 -1.934 0 CA-C-N 115.73 -0.668 . . . . 63.32 112.729 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.9 tt -88.36 121.43 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 109.244 -0.651 . . . . 72.219999999999999 109.244 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.529 ' CG ' HG22 ' A' ' 100' ' ' THR . 71.3 mtt180 -74.53 135.28 42.16 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 116.166 -0.47 . . . . 72.230000000000004 110.311 173.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.516 ' CD1' HD11 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -63.54 -39.23 93.86 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.367 -1.288 . . . . 54.039999999999999 107.697 177.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' A' ' 97' ' ' ASN . 8.2 m-20 -135.41 128.47 18.24 Favored Pre-proline 0 CA--C 1.485 -1.547 0 N-CA-C 104.413 -2.44 . . . . 62.43 104.413 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -56.96 -26.24 66.9 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 121.748 1.632 . . . . 52.039999999999999 111.07 173.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -74.88 -20.68 59.63 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.544 1.138 . . . . 72.310000000000002 110.569 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 36.4 t30 -106.69 124.59 35.06 Favored Pre-proline 0 C--N 1.308 -1.217 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 110.491 -173.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.65 -12.04 33.33 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 123.248 2.632 . . . . 74.340000000000003 113.25 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.497 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 6.5 tp60 -74.09 113.49 11.34 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.31 -0.996 . . . . 72.439999999999998 108.31 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.529 HG22 ' CG ' ' A' ' 92' ' ' ARG . 68.0 p -110.76 145.18 38.55 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.518 -0.764 . . . . 62.149999999999999 110.2 -173.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.561 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.1 mp -78.39 120.51 23.23 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.431 0.634 . . . . 55.43 109.652 175.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 104' ' ' GLU . 0.3 OUTLIER -123.43 112.56 17.68 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 107.224 -1.399 . . . . 74.109999999999999 107.224 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -106.94 127.31 53.33 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.2 -0.909 . . . . 72.129999999999995 110.31 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.59 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 47.3 mt-10 -132.67 174.07 10.68 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.351 -1.351 . . . . 75.409999999999997 107.351 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.469 ' HB3' HG11 ' A' ' 30' ' ' VAL . 61.8 m-85 -79.51 138.62 37.59 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.34 -0.615 . . . . 73.030000000000001 109.34 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.36 152.28 40.93 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.256 -0.646 . . . . 52.329999999999998 109.256 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.539 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 14.0 tmtt? -74.29 -8.15 55.22 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.45 0.643 . . . . 75.140000000000001 110.198 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.54 131.23 9.82 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.733 -0.667 . . . . 73.420000000000002 109.722 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.46 HD21 ' HA ' ' A' ' 30' ' ' VAL . 93.0 m-20 -75.68 143.27 42.24 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.925 -0.579 . . . . 71.230000000000004 110.217 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 t -117.1 146.81 42.91 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.855 -0.794 . . . . 75.510000000000005 108.855 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -110.4 157.34 19.65 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.269 -0.641 . . . . 64.219999999999999 109.269 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 15.9 mmt -87.8 -17.4 31.66 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.376 0.608 . . . . 74.420000000000002 109.876 173.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.1 99.86 2.89 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.617 -1.623 . . . . 64.040000000000006 106.617 170.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -159.87 146.99 16.45 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.588 -0.523 . . . . 75.25 109.588 -172.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.5 m 61.42 39.8 14.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.007 0.923 . . . . 60.409999999999997 113.236 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -71.92 102.27 2.87 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.911 -0.774 . . . . 71.400000000000006 108.911 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.02 73.44 6.82 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.345 -0.983 . . . . 53.109999999999999 108.345 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.426 -1.652 0 N-CA-C 105.569 -2.012 . . . . 73.409999999999997 105.569 -179.471 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 40.4 tpp . . . . . 0 CA--C 1.543 0.697 0 CA-C-O 121.842 0.83 . . . . 74.030000000000001 110.82 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -111.15 20.97 16.87 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.097 -1.075 . . . . 70.549999999999997 108.097 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -112.32 22.69 14.44 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.696 -1.594 . . . . 74.319999999999993 106.696 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.434 ' HB2' ' HD2' ' B' ' 78' ' ' ARG . 22.8 mm-40 -94.8 -179.76 4.97 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 112.354 -2.203 . . . . 71.319999999999993 109.803 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.472 HG11 ' HB3' ' B' ' 105' ' ' PHE . 16.0 t -97.52 111.77 28.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-O 121.48 0.657 . . . . 74.030000000000001 110.157 -168.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -104.08 -2.62 25.64 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.446 -0.797 . . . . 75.209999999999994 110.59 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 23.2 m -113.54 127.62 56.15 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 115.507 -0.769 . . . . 71.420000000000002 110.645 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.469 HD13 ' HB3' ' B' ' 85' ' ' LYS . 94.9 mt -104.96 148.3 26.86 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.735 -0.839 . . . . 73.430000000000007 108.735 176.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.435 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 37.1 p90 -105.01 115.66 30.65 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 118.126 -1.429 . . . . 64.25 107.757 171.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.414 HG22 ' HG ' ' B' ' 103' ' ' LEU . 43.5 t -97.05 114.75 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-N 113.99 -1.459 . . . . 65.230000000000004 107.812 -177.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 21.3 p -123.72 174.34 7.54 Favored 'General case' 0 N--CA 1.401 -2.908 0 CA-C-N 114.704 -1.134 . . . . 73.439999999999998 108.72 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 87.92 32.98 11.55 Favored Glycine 0 N--CA 1.421 -2.325 0 N-CA-C 110.241 -1.143 . . . . 61.340000000000003 110.241 -172.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 85.9 mt -105.68 142.87 25.69 Favored Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 107.767 -1.198 . . . . 61.25 107.767 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -75.68 164.3 32.35 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.977 1.784 . . . . 72.140000000000001 110.151 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.432 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 13.8 p -71.23 -8.51 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-O 122.457 1.123 . . . . 63.420000000000002 109.869 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.429 ' O ' ' HD2' ' B' ' 43' ' ' LYS . 13.0 t70 -99.43 10.95 40.43 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.24 -1.345 . . . . 73.129999999999995 109.472 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.402 ' HA ' ' OE2' ' B' ' 46' ' ' GLU . 0.0 OUTLIER -66.65 125.01 23.05 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 CA-C-O 121.886 0.851 . . . . 72.430000000000007 109.79 -178.274 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.519 ' HG3' ' NE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -105.53 142.55 24.98 Favored Pre-proline 0 C--N 1.291 -1.976 0 CA-C-N 114.65 -1.159 . . . . 71.319999999999993 109.517 177.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.75 -26.67 24.3 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 123.762 2.975 . . . . 73.349999999999994 113.632 -174.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.559 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 19.2 ptt180 -66.74 -26.17 66.86 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.879 -0.6 . . . . 73.319999999999993 112.057 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.478 ' HG3' ' HG2' ' B' ' 43' ' ' LYS . 42.3 mt-10 -70.3 -42.85 71.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.784 0.326 . . . . 61.509999999999998 110.945 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -68.01 -33.83 75.35 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 108.71 -0.848 . . . . 72.510000000000005 108.71 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.528 ' O ' ' HG3' ' B' ' 52' ' ' ARG . 62.8 t80 -60.97 -51.38 69.49 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.653 -1.158 . . . . 61.020000000000003 110.098 175.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 92.7 mt -62.84 -40.95 99.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.321 0.582 . . . . 64.099999999999994 110.216 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 25.4 tp -69.63 -41.59 75.42 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.781 -1.1 . . . . 61.340000000000003 111.674 -176.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -94.69 -2.25 51.55 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 114.954 1.464 . . . . 73.109999999999999 114.954 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 30.6 mtp180 -60.94 -43.25 90.71 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.292 0.849 . . . . 60.450000000000003 113.292 173.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.93 -19.93 70.17 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 121.378 1.385 . . . . 74.019999999999996 112.188 174.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -92.53 90.11 7.02 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 122.364 1.078 . . . . 74.25 110.191 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -76.45 109.35 10.1 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.684 -1.144 . . . . 75.420000000000002 110.05 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.42 -27.51 1.36 Allowed Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 108.986 -1.645 . . . . 65.340000000000003 108.986 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -51.86 123.32 9.99 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.542 1.137 . . . . 73.019999999999996 111.789 173.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -97.2 -60.39 1.59 Allowed 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 109.719 -0.475 . . . . 72.129999999999995 109.719 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -161.42 168.46 36.64 Favored Glycine 0 C--N 1.292 -1.915 0 C-N-CA 119.567 -1.301 . . . . 51.030000000000001 113.141 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.5 p -126.15 138.06 53.64 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.33 0.586 . . . . 71.450000000000003 110.747 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 49.5 tp -116.27 116.67 28.19 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.47 -0.937 . . . . 51.32 108.47 176.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mp -94.33 131.89 39.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 109.154 -0.684 . . . . 63.039999999999999 109.154 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -130.47 125.96 35.7 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.546 -0.909 . . . . 74.510000000000005 108.546 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -77.39 130.5 37.16 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.013 0.435 . . . . 41.119999999999997 110.774 -175.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.7 m -129.71 151.74 49.97 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 104.244 -2.502 . . . . 75.420000000000002 104.244 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.17 -45.46 8.35 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.376 1.07 . . . . 63.32 113.541 -174.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -88.96 -29.2 19.71 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.624 0.972 . . . . 74.409999999999997 113.624 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.407 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 26.1 pt20 -165.06 132.56 2.39 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-O 120.871 0.367 . . . . 72.319999999999993 111.797 -169.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.432 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 12.0 Cg_exo -71.89 109.96 2.8 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.659 2.24 . . . . 73.329999999999998 108.747 167.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 33.3 m -87.21 151.56 3.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.2 -0.667 . . . . 71.340000000000003 109.2 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.98 121.09 4.59 Favored Glycine 0 C--N 1.297 -1.638 0 C-N-CA 119.271 -1.442 . . . . 54.310000000000002 112.726 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -87.91 104.32 16.5 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.818 -1.549 . . . . 55.509999999999998 106.818 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 98.9 t -100.31 117.35 45.38 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-N 115.028 -0.987 . . . . 64.439999999999998 109.697 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 tt -101.83 131.61 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-N 115.37 -0.832 . . . . 74.430000000000007 110.466 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -108.7 158.12 17.9 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.438 -1.255 . . . . 74.310000000000002 109.174 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -59.26 -27.12 65.52 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 123.758 0.661 . . . . 75.519999999999996 112.055 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 21.3 m -154.43 157.26 38.19 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.625 -0.672 . . . . 73.340000000000003 110.943 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . 0.627 ' HD3' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -57.97 -32.24 67.67 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.113 0.565 . . . . 73.510000000000005 110.623 175.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.25 -27.69 67.43 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.804 0.812 . . . . 74.219999999999999 110.062 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.88 -37.19 8.64 Favored Glycine 0 C--N 1.301 -1.374 0 N-CA-C 110.244 -1.142 . . . . 72.099999999999994 110.244 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.413 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -67.16 -47.3 71.43 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.455 -0.872 . . . . 51.030000000000001 111.182 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -57.52 -40.7 79.34 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.948 0.351 . . . . 71.310000000000002 111.948 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.05 -35.31 66.69 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 120.944 0.402 . . . . 61.130000000000003 110.945 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.93 -44.19 73.57 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.104 -0.498 . . . . 70.439999999999998 111.254 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.469 ' HB3' HD13 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -71.2 -32.14 68.49 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.146 -0.479 . . . . 71.109999999999999 110.648 -177.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -64.46 -38.78 92.22 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.797 -0.638 . . . . 70.200000000000003 111.092 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.97 -40.06 25.01 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 120.573 -0.451 . . . . 72.140000000000001 112.053 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.575 ' O ' HG22 ' B' ' 91' ' ' ILE . 94.5 mt -93.12 -11.99 31.53 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 116.593 2.072 . . . . 73.439999999999998 116.593 -172.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -78.66 117.64 20.01 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 117.911 -1.516 . . . . 64.319999999999993 110.488 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.04 7.83 37.46 Favored Glycine 0 CA--C 1.485 -1.836 0 C-N-CA 120.434 -0.889 . . . . 53.350000000000001 112.188 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.575 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.5 tt -105.46 140.2 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 107.907 -1.146 . . . . 71.25 107.907 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.559 ' HG3' HG22 ' B' ' 100' ' ' THR . 43.7 mtt85 -70.65 139.9 51.43 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 113.843 1.053 . . . . 74.420000000000002 113.843 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.475 ' CD1' HD21 ' B' ' 101' ' ' LEU . 54.6 t80 -83.43 -25.07 31.58 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.141 -1.845 . . . . 73.319999999999993 108.321 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -149.31 122.71 4.52 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 106.883 -1.525 . . . . 73.519999999999996 106.883 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . 0.65 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 36.8 Cg_endo -62.84 -23.44 74.33 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.057 2.505 . . . . 63.119999999999997 113.993 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -98.18 1.7 47.67 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.266 0.555 . . . . 62.219999999999999 112.126 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -116.71 133.76 23.0 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 108.059 -1.089 . . . . 64.329999999999998 108.059 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.421 ' HA ' HH21 ' B' ' 92' ' ' ARG . 31.8 Cg_exo -64.0 -9.46 19.29 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.796 2.331 . . . . 65.409999999999997 113.061 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' GLN . . . . . 0.455 ' HA ' ' OE1' ' B' ' 99' ' ' GLN . 6.1 tp60 -69.81 111.38 5.52 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.795 0.807 . . . . 72.239999999999995 109.934 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.559 HG22 ' HG3' ' B' ' 92' ' ' ARG . 41.7 p -110.43 145.31 37.84 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.181 -0.918 . . . . 73.040000000000006 109.34 -176.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.475 HD21 ' CD1' ' B' ' 93' ' ' PHE . 91.7 mt -71.18 146.55 49.03 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.295 0.569 . . . . 55.420000000000002 110.521 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -143.84 106.26 4.41 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.338 -1.356 . . . . 74.450000000000003 107.338 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.426 ' O ' ' HE2' ' B' ' 85' ' ' LYS . 6.7 mp -107.67 116.26 31.63 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.486 -0.779 . . . . 73.230000000000004 109.608 177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.435 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 9.6 tp10 -129.26 161.55 29.93 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.231 -1.396 . . . . 70.540000000000006 107.231 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . 0.472 ' HB3' HG11 ' B' ' 30' ' ' VAL . 72.3 m-85 -70.06 136.37 50.23 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 118.262 0.483 . . . . 74.030000000000001 110.687 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.48 153.7 43.12 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.068 -0.515 . . . . 73.349999999999994 110.571 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -82.37 5.09 21.44 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 122.184 0.993 . . . . 62.310000000000002 110.054 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -169.6 131.62 1.14 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.507 -1.664 . . . . 62.219999999999999 106.507 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -65.6 97.79 0.33 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.434 -0.58 . . . . 75.349999999999994 109.434 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 9.5 m -85.88 120.01 26.82 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 114.792 -1.095 . . . . 55.030000000000001 108.545 -176.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -84.31 141.94 30.56 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.706 -0.679 . . . . 60.340000000000003 110.286 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -82.28 -37.36 25.97 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.323 -1.362 . . . . 73.519999999999996 107.323 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.74 104.72 17.26 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.291 -1.322 . . . . 23.530000000000001 108.325 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.552 ' HG2' ' H ' ' B' ' 115' ' ' SER . 33.1 ttpt -145.67 -174.8 4.5 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.304 -1.739 . . . . 65.409999999999997 106.304 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.552 ' H ' ' HG2' ' B' ' 114' ' ' LYS . 19.5 m 79.62 20.96 0.61 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.686 1.195 . . . . 64.340000000000003 110.529 177.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -87.34 95.83 10.14 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.344 -0.984 . . . . 71.540000000000006 108.344 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 tt -88.3 81.46 7.28 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.37 -0.974 . . . . 73.030000000000001 108.37 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 . . . . . 0 N--CA 1.472 0.668 0 C-N-CA 129.678 3.191 . . . . 63.219999999999999 106.28 178.712 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 108.394 -0.965 . . . . 75.310000000000002 108.394 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -167.11 121.4 1.02 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.275 -1.009 . . . . 63.329999999999998 108.275 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -131.14 104.01 6.83 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.518 0.675 . . . . 73.329999999999998 110.311 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.592 ' HB3' ' HD2' ' A' ' 78' ' ' ARG . 1.9 tm-20 -141.99 -178.32 5.64 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 105.169 -2.16 . . . . 65.030000000000001 105.169 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.593 ' HA ' ' ND2' ' A' ' 109' ' ' ASN . 47.6 t -58.34 125.62 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 113.048 0.758 . . . . 74.140000000000001 113.048 -169.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 75' ' ' PHE . 6.6 mpt_? -106.04 6.08 30.85 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-N 115.859 -0.609 . . . . 63.310000000000002 112.104 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.459 ' H ' HG12 ' A' ' 30' ' ' VAL . 18.1 m -135.82 132.46 36.7 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 114.35 1.241 . . . . 72.099999999999994 114.35 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.467 HD11 ' O ' ' A' ' 81' ' ' ALA . 68.9 mt -110.42 151.56 27.35 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.043 -1.095 . . . . 74.329999999999998 108.043 171.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -107.39 114.21 28.08 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 118.808 -1.157 . . . . 63.43 108.036 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.489 HG22 ' HG ' ' A' ' 103' ' ' LEU . 42.2 t -97.99 119.96 46.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.749 0 CA-C-N 113.791 -1.55 . . . . 44.049999999999997 107.9 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.7 p -123.26 165.1 17.5 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 115.204 -0.907 . . . . 73.5 109.628 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 96.36 18.67 30.19 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 111.5 -0.64 . . . . 71.319999999999993 111.5 -174.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.451 HD22 HG13 ' A' ' 42' ' ' ILE . 82.3 mt -89.83 128.87 48.57 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 107.337 -1.357 . . . . 65.439999999999998 107.337 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.41 165.22 32.43 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.684 1.589 . . . . 54.130000000000003 110.991 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 8.9 p -69.32 -5.42 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 122.151 0.976 . . . . 64.340000000000003 110.751 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.555 ' OD2' ' HE2' ' B' ' 43' ' ' LYS . 24.5 t70 -113.56 13.8 18.84 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.207 -0.906 . . . . 74.310000000000002 109.647 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.451 HG13 HD22 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -61.08 129.23 23.57 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 CA-C-O 121.693 0.758 . . . . 75.209999999999994 109.38 -178.221 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 46.1 mmtm -93.59 145.8 30.62 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 115.477 -0.783 . . . . 71.329999999999998 113.031 -176.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.34 -29.02 87.95 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.589 2.193 . . . . 63.299999999999997 112.202 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.623 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -86.37 -12.11 50.15 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 118.885 -1.126 . . . . 64.450000000000003 110.491 177.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 43' ' ' LYS . 43.7 tt0 -77.1 -40.57 45.41 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.377 -0.601 . . . . 71.519999999999996 109.377 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.34 -33.23 75.36 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.684 0.754 . . . . 71.430000000000007 109.221 172.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.623 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 57.2 t80 -61.17 -48.87 79.59 Favored 'General case' 0 C--O 1.202 -1.432 0 CA-C-N 114.467 -1.242 . . . . 73.540000000000006 110.467 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 83.2 mt -66.88 -35.78 80.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.582 0.706 . . . . 60.119999999999997 110.031 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.3 tp -67.25 -51.31 54.64 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.787 -1.097 . . . . 71.230000000000004 111.287 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -96.41 11.95 33.05 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.493 0.923 . . . . 73.540000000000006 113.493 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 31.8 ttt-85 -70.36 -42.79 16.31 Favored Pre-proline 0 C--N 1.312 -1.061 0 C-N-CA 120.653 -0.419 . . . . 73.109999999999999 112.052 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -77.29 -4.39 14.7 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 121.521 1.48 . . . . 61.210000000000001 111.879 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -89.73 107.18 18.94 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 122.076 0.941 . . . . 60.219999999999999 111.533 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -75.29 110.56 9.74 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 113.707 -1.588 . . . . 54.310000000000002 108.905 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.22 -10.83 5.33 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.457 -0.878 . . . . 72.439999999999998 113.339 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -66.7 112.52 4.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.553 0.677 . . . . 71.439999999999998 111.141 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -90.1 -41.49 11.63 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.238 0.542 . . . . 62.140000000000001 110.424 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.46 -176.93 42.7 Favored Glycine 0 C--N 1.307 -1.066 0 CA-C-N 115.186 -0.915 . . . . 51.439999999999998 111.325 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.467 ' HB3' HG22 ' A' ' 73' ' ' VAL . 20.6 p -148.03 137.9 22.55 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.475 0.546 . . . . 45.200000000000003 112.475 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.4 mp -111.24 126.35 54.78 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.741 -0.837 . . . . 64.430000000000007 108.741 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.2 mm -94.97 143.57 11.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 C-N-CA 122.301 0.24 . . . . 55.340000000000003 110.637 -174.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 69' ' ' PRO . 64.0 tttp -125.95 106.19 9.46 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.847 -0.797 . . . . 71.209999999999994 108.847 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.36 112.79 9.76 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.49 -0.777 . . . . 75.319999999999993 110.443 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 66' ' ' ALA . 2.3 m -110.99 173.21 6.44 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 107.912 -1.144 . . . . 53.32 107.912 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.427 ' H ' HG22 ' A' ' 65' ' ' THR . . . -50.87 -38.51 49.81 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.099 0.959 . . . . 73.109999999999999 112.911 -177.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -104.19 -49.1 3.68 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.48 0.657 . . . . 64.219999999999999 111.467 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -136.92 136.05 20.75 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 114.789 -1.096 . . . . 65.030000000000001 112.316 -166.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 55.7 Cg_endo -81.1 102.36 1.35 Allowed 'Trans proline' 0 N--CA 1.429 -2.287 0 C-N-CA 122.723 2.282 . . . . 72.019999999999996 109.43 168.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -80.22 157.1 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 N-CA-C 109.291 -0.633 . . . . 75.409999999999997 109.291 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.09 123.49 4.83 Favored Glycine 0 CA--C 1.48 -2.144 0 C-N-CA 118.536 -1.792 . . . . 72.510000000000005 113.294 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -87.23 103.01 15.03 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 105.621 -1.992 . . . . 73.209999999999994 105.621 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 60' ' ' SER . 76.1 t -97.8 127.12 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 CA-C-N 115.084 -0.962 . . . . 72.219999999999999 110.495 -174.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 3.0 mp -94.46 129.77 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 CA-C-N 114.482 -1.235 . . . . 74.319999999999993 108.575 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.459 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 89.4 m-85 -117.7 152.24 35.63 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.483 -0.932 . . . . 64.439999999999998 108.483 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -49.89 -38.05 34.05 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 124.548 1.139 . . . . 54.25 112.697 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.5 p -157.04 163.74 38.72 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.528 -0.76 . . . . 61.100000000000001 110.346 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.592 ' HD2' ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -71.99 -28.54 63.48 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.208 -0.597 . . . . 73.200000000000003 109.925 -178.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.83 -29.71 70.22 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-O 121.793 0.806 . . . . 74.150000000000006 109.424 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.08 -32.14 26.87 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.585 -1.006 . . . . 74.310000000000002 110.585 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.467 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -67.05 -48.61 67.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 123.506 0.723 . . . . 74.010000000000005 110.976 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.01 -28.68 69.96 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.345 -0.222 . . . . 71.010000000000005 111.301 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.31 -41.02 73.84 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.965 0.412 . . . . 72.310000000000002 110.032 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.99 -42.22 90.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.813 -0.631 . . . . 42.200000000000003 109.64 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 104' ' ' GLU . 34.7 ttmt -59.92 -45.62 92.0 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.558 -0.746 . . . . 75.299999999999997 110.269 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.59 -31.58 69.59 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.819 -0.628 . . . . 72.530000000000001 111.871 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.16 -35.18 17.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 113.025 0.75 . . . . 64.540000000000006 113.025 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 91' ' ' ILE . 97.9 mt -110.72 -5.31 15.02 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 116.724 2.12 . . . . 62.439999999999998 116.724 -170.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -78.7 114.57 17.74 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 117.358 -1.737 . . . . 74.349999999999994 111.199 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.65 12.93 33.78 Favored Glycine 0 CA--C 1.48 -2.132 0 N-CA-C 110.509 -1.036 . . . . 41.409999999999997 110.509 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 88' ' ' LEU . 9.6 tt -90.76 141.08 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.004 0 N-CA-C 108.969 -0.752 . . . . 75.109999999999999 108.969 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -63.21 117.05 6.01 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 108.122 -1.066 . . . . 74.209999999999994 108.122 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' B' ' 45' ' ' ARG . 64.9 t80 -73.86 -28.65 61.69 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.648 -1.612 . . . . 72.129999999999995 106.648 176.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 97' ' ' ASN . 20.8 t0 -144.27 117.03 5.63 Favored Pre-proline 0 N--CA 1.422 -1.843 0 N-CA-C 102.833 -3.025 . . . . 74.540000000000006 102.833 176.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.459 ' HD3' ' CZ ' ' B' ' 48' ' ' TYR . 74.2 Cg_endo -71.81 -20.76 25.75 Favored 'Trans proline' 0 C--N 1.327 -0.554 0 CA-C-N 120.608 1.253 . . . . 64.209999999999994 113.5 -177.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -87.06 -21.1 26.28 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 121.634 0.73 . . . . 64.120000000000005 109.134 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.491 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 46.8 t-20 -99.19 137.02 20.34 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 107.428 -1.323 . . . . 55.009999999999998 107.428 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.38 -13.94 31.83 Favored 'Trans proline' 0 CA--C 1.553 1.454 0 C-N-CA 122.556 2.171 . . . . 62.32 113.623 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -61.71 119.35 8.54 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.857 0.863 . . . . 74.230000000000004 110.593 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.423 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 24.7 p -119.22 147.21 44.5 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.249 -0.432 . . . . 75.200000000000003 110.811 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 24.5 tp -89.87 129.41 36.24 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.551 -0.749 . . . . 73.340000000000003 109.132 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -134.89 128.51 32.77 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.524 -0.547 . . . . 72.299999999999997 109.524 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 35' ' ' VAL . 5.6 mp -113.8 128.01 56.24 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.722 -0.672 . . . . 72.140000000000001 109.439 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.538 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 9.3 tp10 -137.3 163.55 30.7 Favored 'General case' 0 C--O 1.195 -1.785 0 N-CA-C 107.618 -1.253 . . . . 61.340000000000003 107.618 177.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -73.24 133.58 44.02 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 119.229 0.922 . . . . 74.120000000000005 110.498 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.36 155.13 39.7 Favored 'General case' 0 N--CA 1.438 -1.051 0 O-C-N 123.688 0.618 . . . . 45.240000000000002 109.739 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -87.48 7.18 30.47 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.784 0.802 . . . . 73.420000000000002 109.88 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.42 126.05 12.54 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.609 -0.723 . . . . 55.409999999999997 109.45 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.593 ' ND2' ' HA ' ' A' ' 30' ' ' VAL . 3.4 m-20 -79.62 124.89 28.95 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.473 -0.936 . . . . 74.519999999999996 108.473 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.9 m -122.18 143.24 49.69 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 106.854 -1.536 . . . . 74.239999999999995 106.854 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -129.66 147.87 51.49 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.306 -0.558 . . . . 60.43 111.629 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 94.2 mmm -81.98 -57.62 3.33 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.504 -0.771 . . . . 73.319999999999993 109.239 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.1 106.41 5.76 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.627 -1.249 . . . . 50.409999999999997 107.627 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -124.5 113.18 17.77 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.491 -0.777 . . . . 71.519999999999996 109.54 -173.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.6 m -93.22 128.08 39.05 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.106 -0.497 . . . . 74.310000000000002 109.88 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -68.18 103.71 1.63 Allowed 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 109.162 -0.681 . . . . 64.129999999999995 109.162 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.53 14.49 9.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.769 0.795 . . . . 71.099999999999994 110.692 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 N--CA 1.403 -2.82 0 N-CA-C 105.955 -1.869 . . . . 65.439999999999998 105.955 174.224 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 108.893 -0.78 . . . . 63.25 108.893 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -106.69 130.13 54.47 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.566 -0.902 . . . . 65.230000000000004 108.566 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.449 ' HA ' HH12 ' B' ' 31' ' ' ARG . 41.3 tt0 -79.93 80.62 6.32 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 118.671 -1.212 . . . . 74.450000000000003 110.075 174.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.52 ' CB ' ' HD2' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -94.18 -179.64 5.01 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.612 -1.631 . . . . 72.030000000000001 107.693 177.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.459 HG12 ' H ' ' B' ' 32' ' ' THR . 34.8 t -76.38 112.78 14.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-O 121.763 0.792 . . . . 63.450000000000003 112.572 -170.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.449 HH12 ' HA ' ' B' ' 28' ' ' GLU . 6.3 mpt_? -90.24 6.45 42.78 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.402 -0.817 . . . . 71.129999999999995 112.188 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . 0.459 ' H ' HG12 ' B' ' 30' ' ' VAL . 18.3 m -129.42 128.42 42.94 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 113.4 0.889 . . . . 61.130000000000003 113.4 -175.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.502 HD11 ' O ' ' B' ' 81' ' ' ALA . 76.3 mt -104.0 148.16 26.53 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.633 -1.247 . . . . 70.140000000000001 107.633 172.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 28.2 p90 -105.98 118.02 35.53 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 118.477 -1.289 . . . . 74.519999999999996 107.565 172.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.485 HG22 ' HG ' ' B' ' 103' ' ' LEU . 39.1 t -100.58 124.32 54.07 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.564 0 CA-C-N 114.157 -1.383 . . . . 44.310000000000002 107.849 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 35.7 p -129.16 168.43 16.15 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 115.339 -0.846 . . . . 50.409999999999997 109.89 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.82 12.07 57.14 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 110.543 -1.023 . . . . 25.41 110.543 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 89.8 mt -80.95 123.59 82.03 Favored Pre-proline 0 N--CA 1.432 -1.328 0 C-N-CA 123.634 0.774 . . . . 72.510000000000005 110.046 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.11 155.29 34.9 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.738 2.292 . . . . 72.329999999999998 111.649 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.481 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 7.4 p -70.32 -4.42 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-O 121.906 0.86 . . . . 74.209999999999994 111.046 -177.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -120.19 22.66 11.31 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.883 -0.784 . . . . 71.129999999999995 108.883 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.41 HD11 HD21 ' B' ' 47' ' ' LEU . 6.6 tt -50.44 132.08 10.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-N 115.077 -0.965 . . . . 44.210000000000001 111.609 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.555 ' HE2' ' OD2' ' A' ' 41' ' ' ASP . 39.6 mmtm -108.54 140.1 21.46 Favored Pre-proline 0 C--N 1.29 -1.994 0 CA-C-N 115.316 -0.857 . . . . 70.329999999999998 112.632 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -53.31 -41.75 70.39 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.73 2.287 . . . . 65.340000000000003 112.401 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.542 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -74.42 -22.76 58.99 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 117.718 -1.593 . . . . 72.200000000000003 111.356 -178.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' B' ' 43' ' ' LYS . 36.4 tt0 -66.46 -41.62 88.77 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.628 -0.879 . . . . 74.140000000000001 108.628 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.439 HD11 HD11 ' B' ' 62' ' ' ILE . 90.1 mt -66.42 -41.75 88.76 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.616 -0.72 . . . . 72.140000000000001 110.011 173.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.583 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 71.6 t80 -52.8 -47.74 67.37 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 124.496 1.118 . . . . 75.420000000000002 111.121 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 88.5 mt -64.47 -37.36 87.26 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 123.31 0.381 . . . . 75.450000000000003 111.118 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.452 HD13 HD22 ' A' ' 49' ' ' LEU . 39.3 tp -75.87 -46.44 30.21 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.824 -0.626 . . . . 72.049999999999997 112.054 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -92.03 4.14 53.71 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.413 0.894 . . . . 71.340000000000003 113.413 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.583 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 53.0 ttt-85 -61.03 -48.44 92.42 Favored Pre-proline 0 CA--C 1.563 1.469 0 N-CA-C 112.656 0.613 . . . . 74.530000000000001 112.656 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.76 -1.71 11.83 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.133 1.889 . . . . 73.310000000000002 112.707 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -84.6 98.72 10.32 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.867 0.842 . . . . 72.140000000000001 110.779 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -66.39 113.84 4.96 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 113.783 -1.553 . . . . 74.120000000000005 109.401 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.15 -16.71 5.72 Favored Glycine 0 C--N 1.285 -2.27 0 CA-C-N 115.105 -0.952 . . . . 42.409999999999997 111.905 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -63.56 103.73 0.57 Allowed 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.246 0.546 . . . . 75.099999999999994 110.937 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -84.26 -45.61 12.68 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.746 -0.835 . . . . 61.549999999999997 108.746 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.25 173.63 42.95 Favored Glycine 0 C--N 1.305 -1.18 0 CA-C-N 114.814 -1.085 . . . . 53.409999999999997 111.768 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.3 p -128.68 141.37 51.36 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 122.542 0.337 . . . . 62.420000000000002 110.61 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 61.7 tp -114.5 110.94 20.6 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.919 -1.141 . . . . 52.020000000000003 107.919 175.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.439 HD11 HD11 ' B' ' 47' ' ' LEU . 50.9 mm -94.06 131.4 41.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 109.882 -0.414 . . . . 75.439999999999998 109.882 -176.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' B' ' 69' ' ' PRO . 60.5 tttp -124.38 115.08 20.39 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.159 0.504 . . . . 73.209999999999994 110.178 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.57 124.67 23.88 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.731 -0.668 . . . . 74.409999999999997 110.748 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 11.2 m -130.26 155.34 46.46 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 103.835 -2.654 . . . . 74.439999999999998 103.835 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.45 -35.17 51.81 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.617 0.969 . . . . 71.030000000000001 113.617 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -87.02 -45.92 10.3 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 119.838 -0.745 . . . . 60.039999999999999 112.537 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -155.35 134.79 7.87 Favored Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 114.921 -1.036 . . . . 65.049999999999997 109.654 -168.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 14.3 Cg_exo -72.19 105.0 1.76 Allowed 'Trans proline' 0 C--N 1.298 -2.09 0 C-N-CA 122.283 1.989 . . . . 64.25 108.076 166.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 36.0 m -77.15 151.2 5.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.594 -0.891 . . . . 73.340000000000003 108.594 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.64 120.88 4.31 Favored Glycine 0 CA--C 1.474 -2.492 0 C-N-CA 117.791 -2.147 . . . . 71.299999999999997 113.124 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -88.29 102.52 14.92 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 105.999 -1.852 . . . . 71.340000000000003 105.999 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 70.6 t -95.2 120.25 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.544 0 CA-C-O 122.089 0.947 . . . . 71.439999999999998 109.761 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 58.3 mt -98.0 123.44 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.723 0 CA-C-N 113.099 -1.864 . . . . 65.409999999999997 109.021 -172.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -114.16 161.21 18.09 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-N 114.6 -1.182 . . . . 71.409999999999997 109.894 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -55.7 -41.39 73.72 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 124.684 1.194 . . . . 72.030000000000001 112.667 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 4.0 p -155.81 162.99 40.39 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.92 -0.582 . . . . 74.430000000000007 110.534 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . 0.52 ' HD2' ' CB ' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -70.71 -28.22 64.57 Favored 'General case' 0 C--O 1.202 -1.408 0 C-N-CA 119.865 -0.734 . . . . 74.540000000000006 109.889 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.0 -27.77 69.05 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.491 0.663 . . . . 52.049999999999997 110.196 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.46 -41.21 6.57 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.995 -1.242 . . . . 74.120000000000005 109.995 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.502 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -61.91 -41.26 97.7 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 114.702 -0.749 . . . . 54.149999999999999 111.827 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.8 -36.24 83.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.548 0.213 . . . . 64.329999999999998 111.168 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.71 -39.28 73.52 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.381 -0.599 . . . . 74.340000000000003 109.381 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.86 -42.2 86.04 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.125 -0.943 . . . . 60.149999999999999 110.286 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' B' ' 104' ' ' GLU . 13.3 ttmt -60.71 -47.89 84.26 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.426 -0.806 . . . . 64.230000000000004 109.636 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -60.14 -38.49 83.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.009 -0.541 . . . . 71.310000000000002 111.11 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.42 -30.95 62.13 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 112.538 0.57 . . . . 71.0 112.538 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.604 ' O ' HG22 ' B' ' 91' ' ' ILE . 98.4 mt -108.52 -12.54 14.98 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 116.002 1.853 . . . . 75.340000000000003 116.002 -174.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -79.56 114.55 18.57 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 120.188 -1.57 . . . . 61.310000000000002 112.024 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.98 9.18 28.59 Favored Glycine 0 CA--C 1.485 -1.829 0 C-N-CA 120.619 -0.8 . . . . 73.439999999999998 111.381 173.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.604 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.6 tt -104.81 149.79 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.803 0 N-CA-C 106.904 -1.517 . . . . 75.340000000000003 106.904 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.44 ' CZ ' ' HA ' ' B' ' 98' ' ' PRO . 99.3 mtt180 -81.39 138.71 35.58 Favored 'General case' 0 C--N 1.267 -2.989 0 CA-C-O 121.523 0.677 . . . . 74.409999999999997 112.192 175.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 43.5 t80 -77.97 -28.54 49.43 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.219 -1.355 . . . . 53.210000000000001 108.117 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.23 127.62 14.76 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 106.106 -1.812 . . . . 75.140000000000001 106.106 175.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . 0.506 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 72.7 Cg_endo -71.58 -21.72 25.34 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.089 1.859 . . . . 72.209999999999994 114.761 -176.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.99 -25.43 29.99 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.527 0.679 . . . . 74.109999999999999 109.717 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -97.2 128.77 33.98 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.475 -0.784 . . . . 72.129999999999995 108.983 -176.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.44 ' HA ' ' CZ ' ' B' ' 92' ' ' ARG . 38.1 Cg_exo -60.64 -16.82 45.55 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 123.241 2.627 . . . . 54.299999999999997 113.179 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -55.46 118.86 4.83 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 124.707 1.203 . . . . 71.230000000000004 110.138 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 33.7 p -104.67 157.97 16.82 Favored 'General case' 0 N--CA 1.413 -2.323 0 C-N-CA 120.115 -0.634 . . . . 70.319999999999993 110.505 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 35.5 tp -96.25 124.66 40.33 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.507 -1.664 . . . . 75.409999999999997 106.507 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -129.62 127.46 40.67 Favored 'General case' 0 N--CA 1.422 -1.84 0 C-N-CA 120.161 -0.616 . . . . 71.329999999999998 109.758 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.485 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.8 mp -114.8 140.92 48.53 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.271 -1.011 . . . . 71.129999999999995 108.271 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.477 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 39.1 tt0 -152.24 165.64 34.24 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.535 -1.654 . . . . 75.510000000000005 106.535 176.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -71.32 138.46 49.31 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 120.077 1.308 . . . . 55.329999999999998 110.983 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.47 154.42 30.56 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.434 -0.58 . . . . 75.25 109.434 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -84.43 1.46 45.31 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 122.126 0.965 . . . . 73.230000000000004 109.432 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.82 118.72 12.52 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.302 -0.863 . . . . 65.120000000000005 109.481 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' B' ' 30' ' ' VAL . 3.8 m-20 -73.42 112.59 9.63 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.549 -1.278 . . . . 43.299999999999997 107.549 175.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 20.0 m -105.07 126.43 52.06 Favored 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 108.97 -0.752 . . . . 65.530000000000001 108.97 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -84.03 148.96 26.57 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.928 -0.768 . . . . 72.510000000000005 108.928 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -86.34 -37.14 18.77 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.268 -0.641 . . . . 74.319999999999993 109.268 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.24 112.95 25.08 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.345 -0.843 . . . . 72.109999999999999 110.032 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -111.77 116.07 30.11 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.262 -1.755 . . . . 73.340000000000003 106.262 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 7.9 t -150.63 158.95 44.75 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 109.511 -0.552 . . . . 40.520000000000003 109.511 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -102.87 101.14 11.17 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.756 -1.201 . . . . 74.450000000000003 107.756 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 89.3 mt -73.31 -23.31 60.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.087 0.47 . . . . 70.299999999999997 111.482 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.42 -1.961 0 N-CA-C 107.706 -1.22 . . . . 72.129999999999995 107.706 176.434 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 CA--C 1.498 -1.048 0 N-CA-C 108.986 -0.746 . . . . 75.310000000000002 108.986 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.09 -48.17 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.408 0.623 . . . . 70.430000000000007 110.029 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -109.78 80.92 1.36 Allowed 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 107.817 -1.179 . . . . 75.329999999999998 107.817 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' HA ' ' HD2' ' A' ' 78' ' ' ARG . 8.7 mm-40 -113.77 101.71 9.55 Favored 'General case' 0 N--CA 1.4 -2.954 0 CA-C-N 114.376 -1.283 . . . . 72.349999999999994 107.655 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.462 ' HA ' HD21 ' A' ' 109' ' ' ASN . 57.3 t -74.59 108.83 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 104.108 -2.553 . . . . 54.0 104.108 168.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -121.29 -4.15 9.44 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 115.174 -0.921 . . . . 64.319999999999993 110.322 -168.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.7 m -101.99 124.54 47.79 Favored 'General case' 0 C--N 1.264 -3.117 0 CA-C-N 115.132 -0.94 . . . . 54.119999999999997 109.213 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 33' ' ' LEU . 3.2 mp -108.13 137.59 45.85 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 107.308 -1.367 . . . . 75.099999999999994 107.308 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 104' ' ' GLU . 24.2 p90 -103.77 109.16 20.77 Favored 'General case' 0 N--CA 1.412 -2.355 0 C-N-CA 118.473 -1.291 . . . . 74.019999999999996 107.621 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.536 HG22 ' HG ' ' A' ' 103' ' ' LEU . 25.0 t -96.57 120.17 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.752 0 CA-C-N 113.772 -1.558 . . . . 72.109999999999999 107.677 -174.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 20.1 p -126.51 166.78 16.63 Favored 'General case' 0 N--CA 1.4 -2.935 0 CA-C-N 114.644 -1.162 . . . . 63.310000000000002 108.305 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 94.89 32.08 7.36 Favored Glycine 0 N--CA 1.417 -2.619 0 N-CA-C 110.671 -0.972 . . . . 64.099999999999994 110.671 -173.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.4 mt -101.0 145.27 30.11 Favored Pre-proline 0 N--CA 1.428 -1.566 0 N-CA-C 109.081 -0.711 . . . . 54.409999999999997 109.081 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.04 157.69 33.17 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.208 1.939 . . . . 62.340000000000003 110.022 173.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.486 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 7.7 p -76.29 -2.15 4.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-O 122.362 1.077 . . . . 61.030000000000001 109.66 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -128.28 35.13 4.46 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 114.437 -1.256 . . . . 65.209999999999994 108.564 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.98 123.86 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 N-CA-C 108.097 -1.075 . . . . 54.049999999999997 108.097 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 43' ' ' LYS . 4.8 mmpt? -93.65 143.98 27.45 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-N 115.358 -0.837 . . . . 61.100000000000001 110.153 -175.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.09 -19.95 35.5 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.472 2.781 . . . . 73.120000000000005 114.617 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.551 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -87.34 -15.67 37.26 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 118.435 -1.306 . . . . 74.310000000000002 111.644 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -67.32 -41.21 85.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.102 0.477 . . . . 62.32 110.244 -177.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.13 -30.31 67.45 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 116.153 -0.476 . . . . 70.340000000000003 109.833 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.692 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 41.2 t80 -61.88 -51.17 69.28 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.484 -0.78 . . . . 72.140000000000001 110.246 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.94 -38.31 90.51 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.073 -0.512 . . . . 75.200000000000003 110.973 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.8 tp -77.91 -43.02 31.27 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.507 -0.77 . . . . 74.530000000000001 112.289 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -97.62 -2.06 42.4 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 114.441 1.274 . . . . 54.43 114.441 -172.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 32.3 ttt-85 -60.69 -46.09 97.07 Favored Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 112.89 0.7 . . . . 64.219999999999999 112.89 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -75.05 -2.68 12.86 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.095 1.863 . . . . 75.25 112.769 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -83.88 106.21 15.38 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.627 0.727 . . . . 74.409999999999997 110.871 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -68.76 109.95 4.08 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.254 -1.339 . . . . 74.239999999999995 110.115 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.24 -14.28 6.97 Favored Glycine 0 N--CA 1.421 -2.306 0 CA-C-N 114.908 -1.042 . . . . 72.349999999999994 111.576 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -65.93 102.89 0.84 Allowed 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.173 0.511 . . . . 54.210000000000001 110.852 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.417 ' HB2' HG13 ' A' ' 74' ' ' ILE . 7.9 mm-40 -81.16 -57.48 3.49 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.543 -0.91 . . . . 75.299999999999997 108.543 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.08 -174.37 35.45 Favored Glycine 0 C--N 1.303 -1.251 0 CA-C-N 114.911 -1.04 . . . . 52.439999999999998 112.439 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.7 p -146.39 137.88 24.61 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 123.407 0.683 . . . . 65.239999999999995 110.297 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.41 ' HB2' ' SD ' ' A' ' 112' ' ' MET . 65.2 tp -112.06 120.05 40.54 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.558 -0.534 . . . . 61.32 109.558 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 mm -94.01 134.49 31.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.851 -0.796 . . . . 62.109999999999999 108.851 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -134.74 114.13 12.36 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 110.006 -0.368 . . . . 72.310000000000002 110.006 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.82 112.82 2.45 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.36 0.6 . . . . 65.310000000000002 109.514 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -113.86 164.32 13.92 Favored 'General case' 0 N--CA 1.404 -2.756 0 N-CA-C 105.479 -2.045 . . . . 75.140000000000001 105.479 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.97 -38.25 10.39 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.246 1.202 . . . . 54.450000000000003 114.246 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.74 -27.73 13.5 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.455 0.539 . . . . 74.329999999999998 112.455 -174.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -169.93 148.49 3.16 Favored Pre-proline 0 N--CA 1.423 -1.822 0 CA-C-N 115.921 -0.581 . . . . 61.109999999999999 110.7 -168.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.486 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 13.8 Cg_exo -70.24 106.2 1.71 Allowed 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 121.999 1.8 . . . . 63.210000000000001 108.417 165.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.1 m -81.48 158.76 4.08 Favored 'Isoleucine or valine' 0 C--O 1.25 1.081 0 N-CA-C 107.883 -1.155 . . . . 53.109999999999999 107.883 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.88 120.9 2.91 Favored Glycine 0 CA--C 1.484 -1.853 0 C-N-CA 117.668 -2.206 . . . . 73.109999999999999 113.077 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -88.03 102.02 14.35 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.532 -1.285 . . . . 72.0 107.532 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 78.4 t -91.34 123.79 43.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 108.814 -0.81 . . . . 54.509999999999998 108.814 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 58' ' ' GLU . 46.9 pt -107.83 123.73 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.329 0 CA-C-O 122.05 0.929 . . . . 63.450000000000003 111.564 -175.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -100.25 163.82 12.23 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 114.243 -1.344 . . . . 72.0 109.84 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -64.52 -39.86 94.55 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.111 -0.95 . . . . 65.109999999999999 112.461 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 56.0 m -145.21 166.0 26.74 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.742 -0.208 . . . . 62.119999999999997 110.48 -172.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -71.94 -29.49 64.33 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 120.591 -0.444 . . . . 73.239999999999995 112.081 -176.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.23 -18.98 64.7 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 122.222 1.01 . . . . 65.340000000000003 108.88 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.1 -41.29 10.46 Favored Glycine 0 C--N 1.305 -1.184 0 CA-C-N 114.392 -1.276 . . . . 51.100000000000001 110.033 176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.62 -46.17 76.71 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.684 -0.758 . . . . 73.519999999999996 111.6 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -29.41 70.15 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 111.887 0.329 . . . . 71.129999999999995 111.887 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.55 -40.45 56.84 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 111.304 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.18 -43.23 87.47 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.915 -0.584 . . . . 74.510000000000005 110.953 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 103' ' ' LEU . 14.5 ptmm? -72.08 -31.81 66.45 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.93 -0.708 . . . . 74.209999999999994 110.414 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -58.73 -36.72 74.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.038 0.447 . . . . 74.140000000000001 110.453 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.23 -42.2 16.15 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 120.999 0.428 . . . . 61.219999999999999 111.606 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.433 ' O ' HG22 ' A' ' 91' ' ' ILE . 92.3 mt -98.52 -18.61 18.09 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 117.18 2.289 . . . . 72.510000000000005 117.18 -169.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.335 0.2 OUTLIER -72.42 114.63 10.75 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 117.167 -1.813 . . . . 53.049999999999997 111.946 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.68 14.92 10.71 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 110.461 -1.056 . . . . 64.310000000000002 110.461 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.1 tt -93.2 128.19 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 CA-C-O 121.26 0.553 . . . . 74.450000000000003 109.788 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.714 ' HG3' HG22 ' A' ' 100' ' ' THR . 5.9 ttt180 -83.79 124.82 31.32 Favored 'General case' 0 N--CA 1.402 -2.873 0 N-CA-C 107.68 -1.23 . . . . 72.030000000000001 107.68 173.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.44 ' HB2' ' CD1' ' A' ' 101' ' ' LEU . 3.5 t80 -64.18 -34.25 77.66 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 124.572 1.17 . . . . 73.120000000000005 110.012 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.502 ' HB3' ' HB3' ' B' ' 45' ' ' ARG . 2.8 p-10 -151.64 136.92 10.72 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 105.901 -1.889 . . . . 73.25 105.901 175.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.437 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 73.8 Cg_endo -75.48 -1.27 11.11 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.336 2.024 . . . . 65.140000000000001 114.118 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -92.35 -25.17 18.66 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.285 0.564 . . . . 73.129999999999995 110.019 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -99.29 133.77 21.78 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 108.065 -1.087 . . . . 72.420000000000002 108.065 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.63 -16.74 56.53 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.167 1.911 . . . . 42.020000000000003 112.398 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -62.16 122.33 15.32 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.573 1.149 . . . . 55.100000000000001 110.466 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.714 HG22 ' HG3' ' A' ' 92' ' ' ARG . 26.0 p -119.33 149.71 41.36 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.21 -0.663 . . . . 74.239999999999995 109.21 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.8 mp -88.67 124.09 33.76 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-O 120.789 0.328 . . . . 72.519999999999996 110.715 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -120.37 112.9 19.59 Favored 'General case' 0 N--CA 1.4 -2.964 0 N-CA-C 107.518 -1.29 . . . . 74.099999999999994 107.518 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.536 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.4 mp -87.15 116.22 25.07 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.512 -1.222 . . . . 72.319999999999993 107.822 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.416 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . 37.7 mt-10 -118.13 164.74 14.7 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.374 -1.343 . . . . 74.540000000000006 107.374 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -81.7 132.16 35.28 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 118.694 0.679 . . . . 73.420000000000002 109.568 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.41 137.79 48.6 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.837 -1.172 . . . . 73.319999999999993 107.837 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -82.95 12.02 5.43 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.215 1.007 . . . . 61.409999999999997 109.892 -175.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -157.5 118.73 3.61 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 114.421 -1.263 . . . . 73.239999999999995 107.614 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.462 HD21 ' HA ' ' A' ' 30' ' ' VAL . 44.9 m-80 -70.68 138.63 50.81 Favored 'General case' 0 CA--C 1.475 -1.935 0 C-N-CA 120.019 -0.672 . . . . 72.129999999999995 110.329 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.3 m -118.37 142.84 47.13 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.567 -0.742 . . . . 72.209999999999994 110.168 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -115.44 158.32 22.69 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.03 -1.1 . . . . 71.310000000000002 108.03 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.41 ' SD ' ' HB2' ' A' ' 61' ' ' LEU . 96.7 mmm -89.17 -33.75 16.93 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.893 -0.78 . . . . 73.129999999999995 108.893 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -115.26 114.84 25.73 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.335 -0.848 . . . . 65.530000000000001 110.073 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -128.3 118.87 24.0 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.323 -0.991 . . . . 62.0 108.323 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.1 m -132.69 109.17 9.51 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.259 -0.645 . . . . 73.25 109.259 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -85.84 127.71 34.64 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.871 -1.159 . . . . 74.120000000000005 107.871 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.3 tp -84.02 -40.87 17.87 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.32 -0.4 . . . . 73.310000000000002 111.331 -174.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.3 -1.556 0 N-CA-C 107.051 -1.462 . . . . 65.540000000000006 107.051 -175.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 121.123 0.487 . . . . 55.439999999999998 111.166 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.44 -53.68 2.64 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 123.341 0.657 . . . . 75.129999999999995 110.886 -172.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -130.77 86.25 2.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.191 -1.04 . . . . 75.040000000000006 108.191 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' B' ' 31' ' ' ARG . 23.0 mm-40 -76.3 102.32 5.83 Favored 'General case' 0 N--CA 1.399 -3.014 0 CA-C-N 114.243 -1.344 . . . . 74.420000000000002 109.989 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 81.0 t -72.38 109.02 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 103.748 -2.686 . . . . 74.209999999999994 103.748 168.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' B' ' 29' ' ' GLU . 16.4 ptt180 -129.02 7.39 5.52 Favored 'General case' 0 CA--C 1.471 -2.078 0 CA-C-N 115.435 -0.802 . . . . 74.530000000000001 111.803 -169.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 56.6 m -109.58 132.34 54.23 Favored 'General case' 0 C--N 1.264 -3.151 0 N-CA-C 107.554 -1.276 . . . . 64.349999999999994 107.554 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 72' ' ' PHE . 3.4 mp -121.98 151.46 40.77 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.482 -0.933 . . . . 72.239999999999995 108.482 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.438 ' CE1' ' HB2' ' B' ' 104' ' ' GLU . 17.9 p90 -108.13 111.47 23.5 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.787 -1.19 . . . . 75.010000000000005 107.787 175.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 57.2 t -97.57 122.16 48.86 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 CA-C-N 114.094 -1.412 . . . . 71.120000000000005 108.197 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 65.4 p -130.05 174.8 9.44 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.532 -0.758 . . . . 64.310000000000002 110.128 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 88.66 22.87 38.14 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.029 -1.228 . . . . 61.229999999999997 110.029 -172.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 88.4 mt -92.37 132.52 31.8 Favored Pre-proline 0 N--CA 1.412 -2.336 0 N-CA-C 106.179 -1.785 . . . . 53.219999999999999 106.179 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.88 160.24 30.2 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 121.639 1.559 . . . . 74.109999999999999 110.95 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 9.4 p -68.62 -7.92 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-O 122.588 1.185 . . . . 63.200000000000003 109.774 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -121.46 31.92 6.11 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 114.042 -1.435 . . . . 51.049999999999997 108.576 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.25 131.65 33.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 109.091 -0.707 . . . . 74.230000000000004 109.091 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -100.52 136.54 19.92 Favored Pre-proline 0 C--N 1.287 -2.123 0 CA-C-N 115.302 -0.863 . . . . 72.319999999999993 109.655 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -54.62 -24.61 37.65 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 C-N-CA 123.716 2.944 . . . . 74.209999999999994 114.121 -173.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.507 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 10.6 ptt180 -82.5 -15.24 53.16 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 122.081 -0.387 . . . . 61.149999999999999 111.954 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.13 -40.83 82.39 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.31 -0.626 . . . . 71.140000000000001 109.31 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 90.8 mt -68.76 -32.26 71.89 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.463 -0.79 . . . . 63.240000000000002 109.633 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.592 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 75.6 t80 -63.53 -48.17 78.62 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.135 -0.939 . . . . 73.239999999999995 110.033 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 84.9 mt -67.16 -39.93 86.58 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.196 0.522 . . . . 73.409999999999997 110.31 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 tp -74.01 -40.39 62.96 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.954 -1.021 . . . . 71.510000000000005 112.473 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -97.97 -4.18 36.8 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.639 0.978 . . . . 72.450000000000003 113.639 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.592 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 67.7 ttt180 -61.55 -45.07 93.78 Favored Pre-proline 0 CA--C 1.555 1.141 0 N-CA-C 112.665 0.617 . . . . 75.310000000000002 112.665 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.62 -12.99 20.3 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 121.373 1.382 . . . . 63.119999999999997 113.021 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -78.01 110.73 13.21 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 121.953 0.882 . . . . 64.439999999999998 111.48 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -72.38 109.46 6.11 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 113.945 -1.479 . . . . 65.129999999999995 109.363 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.69 -13.78 5.83 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-N 115.522 -0.763 . . . . 52.219999999999999 112.317 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -61.57 117.03 5.23 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.33 0.586 . . . . 73.209999999999994 111.638 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.427 ' HB2' HG13 ' B' ' 74' ' ' ILE . 5.7 mm-40 -96.47 -47.47 5.95 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.487 -0.779 . . . . 63.43 111.034 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.23 177.13 46.73 Favored Glycine 0 C--N 1.294 -1.802 0 C-N-CA 120.015 -1.088 . . . . 65.329999999999998 112.457 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.5 p -135.47 137.78 42.5 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 122.852 0.461 . . . . 62.229999999999997 110.999 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 5.5 mp -117.35 124.4 48.84 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.423 -1.325 . . . . 72.420000000000002 107.423 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 47.2 mm -94.28 146.98 5.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 109.671 -0.492 . . . . 71.25 109.671 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -129.59 106.57 8.83 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.234 -1.395 . . . . 53.32 107.234 176.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -72.44 116.57 13.05 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.99 -1.115 . . . . 71.010000000000005 107.99 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 11.5 m -122.84 155.16 37.19 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 104.98 -2.23 . . . . 62.240000000000002 104.98 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.94 -25.79 65.45 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.905 0.383 . . . . 60.399999999999999 111.698 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -82.11 -45.8 14.7 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 116.062 -0.517 . . . . 70.519999999999996 111.695 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -172.34 145.97 1.57 Allowed Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 108.183 -1.044 . . . . 71.519999999999996 108.183 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 8.2 Cg_exo -72.06 106.38 2.02 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.299 2.0 . . . . 71.150000000000006 109.087 168.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 35.8 m -87.6 157.67 3.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.721 -0.844 . . . . 70.239999999999995 108.721 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.31 120.89 3.33 Favored Glycine 0 CA--C 1.481 -2.067 0 C-N-CA 118.62 -1.753 . . . . 73.120000000000005 112.791 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' B' ' 33' ' ' LEU . 98.0 m-85 -88.16 102.37 14.74 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.342 -1.355 . . . . 73.5 107.342 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 88.4 t -94.13 130.15 43.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.298 0 CA-C-N 114.678 -1.146 . . . . 53.119999999999997 109.703 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' B' ' 58' ' ' GLU . 48.6 pt -106.99 138.64 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.241 0 CA-C-O 121.848 0.832 . . . . 72.319999999999993 110.596 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -119.21 166.08 13.42 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 114.116 -1.402 . . . . 72.120000000000005 111.553 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.75 -40.87 80.73 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.023 -1.444 . . . . 72.340000000000003 112.362 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 5.0 p -157.95 167.64 29.38 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.145 -0.48 . . . . 72.129999999999995 111.399 -170.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.58 -30.11 62.82 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 120.219 -0.593 . . . . 71.430000000000007 109.845 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.48 -24.19 63.75 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.766 0.793 . . . . 43.009999999999998 109.579 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.89 -36.85 9.79 Favored Glycine 0 C--N 1.309 -0.963 0 CA-C-N 114.63 -1.168 . . . . 72.430000000000007 110.581 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.444 ' HB1' HD11 ' B' ' 33' ' ' LEU . . . -65.1 -49.07 71.44 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.717 0.807 . . . . 50.539999999999999 111.002 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.29 -38.66 77.47 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 116.092 -0.504 . . . . 74.140000000000001 111.207 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.6 -40.8 72.99 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.716 -0.674 . . . . 52.329999999999998 111.322 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.82 -41.38 83.15 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 116.161 -0.472 . . . . 73.540000000000006 111.459 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' B' ' 103' ' ' LEU . 15.1 ptmm? -72.02 -36.42 69.68 Favored 'General case' 0 C--O 1.2 -1.533 0 C-N-CA 120.153 -0.619 . . . . 52.140000000000001 109.521 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -58.95 -39.22 81.0 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.316 0.646 . . . . 52.409999999999997 110.081 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.45 -31.37 37.47 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 112.615 0.598 . . . . 71.129999999999995 112.615 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.418 ' O ' HG22 ' B' ' 91' ' ' ILE . 96.2 mt -100.21 -31.49 11.35 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.201 1.926 . . . . 72.109999999999999 116.201 -174.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . 0.251 0.2 OUTLIER -65.91 121.96 16.27 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.448 1.277 . . . . 71.230000000000004 114.448 -173.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.23 14.94 15.21 Favored Glycine 0 N--CA 1.428 -1.874 0 C-N-CA 120.744 -0.741 . . . . 73.239999999999995 112.104 174.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.418 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.5 tt -103.98 140.04 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.909 0 N-CA-C 107.123 -1.436 . . . . 64.099999999999994 107.123 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' B' ' 94' ' ' ASP . 89.4 mtt180 -74.15 134.91 42.83 Favored 'General case' 0 C--N 1.263 -3.163 0 CA-C-O 120.869 0.366 . . . . 65.010000000000005 110.051 171.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.0 t80 -65.49 -34.76 79.02 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.436 -1.256 . . . . 75.5 109.171 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.562 ' HB2' ' HB3' ' B' ' 97' ' ' ASN . 3.0 m-20 -131.4 138.35 32.57 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 102.055 -3.313 . . . . 52.219999999999999 102.055 173.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . 0.692 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 22.1 Cg_endo -63.21 -29.25 73.51 Favored 'Trans proline' 0 N--CA 1.486 1.041 0 CA-C-N 121.911 1.718 . . . . 53.229999999999997 111.001 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.5 -17.36 42.21 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.965 -1.47 . . . . 50.399999999999999 110.916 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' ASN . . . . . 0.562 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . 39.5 t30 -100.43 125.67 38.54 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 109.573 -0.528 . . . . 64.519999999999996 109.573 -175.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.72 -10.71 28.35 Favored 'Trans proline' 0 C--O 1.239 0.554 0 C-N-CA 122.795 2.33 . . . . 74.409999999999997 112.586 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' GLN . . . . . 0.433 ' HB3' ' ND2' ' B' ' 97' ' ' ASN . 6.6 tp60 -70.29 113.06 7.08 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.446 -0.946 . . . . 72.140000000000001 108.446 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.492 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 69.6 p -97.37 145.8 25.79 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.03 -0.532 . . . . 70.349999999999994 109.919 -175.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 52.2 tp -87.85 123.71 32.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.881 -1.155 . . . . 71.049999999999997 107.881 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -136.88 123.33 20.8 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-O 121.669 0.747 . . . . 74.319999999999993 110.337 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.469 ' O ' ' HE2' ' B' ' 85' ' ' LYS . 5.4 mp -107.19 122.52 46.69 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.199 -1.364 . . . . 71.340000000000003 109.391 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.438 ' HB2' ' CE1' ' B' ' 34' ' ' PHE . 48.6 mt-10 -126.29 165.56 18.75 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.206 -1.035 . . . . 65.530000000000001 108.206 174.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -73.81 141.15 46.2 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.807 -0.357 . . . . 74.349999999999994 110.039 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.03 158.8 26.4 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.563 -0.903 . . . . 35.009999999999998 108.563 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -92.26 7.75 41.3 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.956 0.884 . . . . 75.0 109.946 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -157.66 132.67 8.72 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.252 -0.885 . . . . 55.520000000000003 108.916 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -85.32 141.28 30.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.574 -0.528 . . . . 53.530000000000001 109.574 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -123.25 145.8 48.38 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.498 -0.927 . . . . 74.439999999999998 108.498 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -114.08 160.37 18.99 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 120.732 0.301 . . . . 73.420000000000002 110.754 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' MET . . . . . 0.404 ' HG2' HD11 ' B' ' 74' ' ' ILE . 14.1 mmt -94.01 -31.48 14.23 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.869 -0.605 . . . . 60.149999999999999 111.03 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -127.54 114.62 17.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 116.004 -0.543 . . . . 75.299999999999997 110.596 -177.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -160.32 94.42 1.08 Allowed 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.664 -1.236 . . . . 60.009999999999998 107.664 175.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.2 m -86.39 101.22 12.92 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.856 0.836 . . . . 73.439999999999998 111.229 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -93.6 90.66 6.73 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.177 -1.416 . . . . 73.120000000000005 107.177 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 51.7 tp -64.64 -32.59 74.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.825 0.821 . . . . 72.129999999999995 109.191 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 N--CA 1.404 -2.736 0 N-CA-C 107.096 -1.446 . . . . 74.040000000000006 107.096 177.915 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 CA--C 1.51 -0.571 0 N-CA-C 108.959 -0.756 . . . . 75.310000000000002 108.959 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -175.44 -167.34 0.25 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 101.874 -3.38 . . . . 73.319999999999993 101.874 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -98.58 36.93 1.55 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.561 -2.014 . . . . 74.340000000000003 105.561 172.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.714 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 9.6 pt-20 -55.43 151.68 9.82 Favored 'General case' 0 N--CA 1.397 -3.078 0 CA-C-N 112.395 -2.184 . . . . 73.450000000000003 114.777 -173.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.5 t -104.58 114.64 44.72 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.549 0 N-CA-C 105.669 -1.975 . . . . 74.510000000000005 105.669 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 16.8 ptm180 -114.65 7.09 15.9 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.327 -0.851 . . . . 70.329999999999998 110.42 -175.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.9 m -116.41 117.73 30.75 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.919 0.866 . . . . 64.510000000000005 110.686 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.481 HD23 ' HB3' ' A' ' 85' ' ' LYS . 2.9 mp -98.13 140.73 32.01 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.774 -1.565 . . . . 74.200000000000003 106.774 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.538 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 6.8 p90 -107.54 114.64 28.77 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 117.578 -1.649 . . . . 72.140000000000001 107.979 173.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.447 HG22 ' HG ' ' A' ' 103' ' ' LEU . 43.8 t -97.29 121.05 47.41 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.879 0 CA-C-N 114.375 -1.284 . . . . 72.120000000000005 108.492 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.5 p -124.26 170.77 10.44 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 115.544 -0.753 . . . . 64.140000000000001 109.608 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 82.35 41.42 9.24 Favored Glycine 0 N--CA 1.43 -1.725 0 N-CA-C 110.103 -1.199 . . . . 21.440000000000001 110.103 -173.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.451 ' HB3' HD13 ' A' ' 42' ' ' ILE . 96.4 mt -111.31 123.06 35.98 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 114.23 -0.985 . . . . 73.219999999999999 110.16 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.5 144.08 19.61 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.857 2.372 . . . . 71.329999999999998 110.664 173.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.572 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 7.6 p -73.24 4.75 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 CA-C-O 122.475 1.131 . . . . 71.209999999999994 112.088 -173.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -125.66 13.12 8.04 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.885 -1.052 . . . . 70.5 110.904 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.451 HD13 ' HB3' ' A' ' 38' ' ' LEU . 28.0 pt -53.65 135.68 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 113.453 0.909 . . . . 62.119999999999997 113.453 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -97.18 146.0 30.59 Favored Pre-proline 0 C--N 1.292 -1.894 0 CA-C-N 114.625 -1.17 . . . . 72.540000000000006 109.119 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.13 -26.7 52.03 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.171 2.581 . . . . 72.319999999999993 112.861 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.525 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 9.8 ptt180 -70.86 -23.91 62.41 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 120.858 0.361 . . . . 72.420000000000002 111.328 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -72.63 -40.47 66.39 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.633 -0.877 . . . . 41.340000000000003 108.633 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.2 mt -66.73 -36.78 83.28 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.802 -0.814 . . . . 65.340000000000003 108.802 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.525 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 87.8 t80 -58.62 -47.54 84.04 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-N 114.708 -1.133 . . . . 74.140000000000001 110.253 175.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 97.6 mt -70.91 -30.14 66.4 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.072 0.463 . . . . 71.519999999999996 110.563 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.7 tp -68.62 -51.56 40.95 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.213 -0.903 . . . . 65.010000000000005 110.667 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -95.2 10.59 35.43 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.682 0.623 . . . . 72.420000000000002 112.682 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 10.6 ttp180 -52.65 -50.02 83.01 Favored Pre-proline 0 CA--C 1.565 1.539 0 C-N-CA 124.471 1.108 . . . . 74.349999999999994 113.696 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -85.35 -0.88 9.07 Favored 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 121.588 1.525 . . . . 64.049999999999997 112.74 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -88.72 96.04 10.51 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 122.629 1.204 . . . . 70.219999999999999 112.104 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -69.85 113.54 7.18 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 113.068 -1.878 . . . . 65.230000000000004 109.44 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.99 -24.82 3.25 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 114.956 -1.02 . . . . 63.420000000000002 110.661 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -56.62 115.81 2.76 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.251 0.62 . . . . 51.310000000000002 111.352 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -94.26 -56.58 2.78 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 109.209 -0.663 . . . . 55.399999999999999 109.209 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.22 169.93 40.63 Favored Glycine 0 C--N 1.295 -1.743 0 CA-C-N 115.214 -0.903 . . . . 45.299999999999997 111.6 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.411 ' HB3' HG22 ' A' ' 73' ' ' VAL . 10.4 p -130.55 137.36 49.66 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 120.93 0.395 . . . . 72.230000000000004 110.543 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -121.02 109.73 15.4 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.52 -0.919 . . . . 53.020000000000003 108.52 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.587 ' H ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -93.92 130.84 42.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.098 0.475 . . . . 72.530000000000001 111.287 -177.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 69' ' ' PRO . 87.2 tttt -108.84 112.37 24.59 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.505 -0.924 . . . . 55.049999999999997 108.505 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.1 122.77 15.21 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.789 -0.642 . . . . 73.109999999999999 110.226 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 15.5 m -130.39 159.67 36.3 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 105.669 -1.975 . . . . 65.299999999999997 105.669 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -42.64 -41.78 3.21 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.177 1.391 . . . . 72.030000000000001 114.356 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -105.62 -36.47 7.08 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.331 0.586 . . . . 71.030000000000001 112.542 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.574 ' O ' ' HB ' ' A' ' 65' ' ' THR . 8.3 pt20 -147.3 132.29 8.98 Favored Pre-proline 0 C--N 1.291 -1.953 0 CA-C-N 115.357 -0.838 . . . . 75.299999999999997 111.697 -168.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.572 ' HD3' ' HA ' ' A' ' 40' ' ' VAL . 32.3 Cg_endo -73.06 101.87 1.39 Allowed 'Trans proline' 0 N--CA 1.433 -2.082 0 C-N-CA 121.649 1.566 . . . . 72.430000000000007 108.18 167.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.7 m -70.77 139.12 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 108.685 -0.857 . . . . 63.350000000000001 108.685 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 62' ' ' ILE . . . -108.82 119.79 5.7 Favored Glycine 0 CA--C 1.465 -3.056 0 C-N-CA 118.236 -1.935 . . . . 72.329999999999998 112.939 -174.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -88.73 101.91 14.47 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 105.865 -1.902 . . . . 64.439999999999998 105.865 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 60' ' ' SER . 92.4 t -96.78 121.55 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.504 0 CA-C-N 114.735 -1.12 . . . . 63.030000000000001 108.888 -176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.7 mt -102.02 119.85 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.763 0 CA-C-N 114.601 -1.181 . . . . 72.109999999999999 109.854 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 5.2 m-85 -102.07 156.35 17.6 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 114.373 -1.285 . . . . 72.340000000000003 109.916 176.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -64.47 -30.53 71.56 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.201 -1.363 . . . . 62.530000000000001 112.112 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m -156.27 155.84 33.03 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 121.804 -0.56 . . . . 74.109999999999999 112.205 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.714 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -54.16 -39.15 66.29 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 123.953 0.783 . . . . 72.340000000000003 110.91 175.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.71 -29.56 69.42 Favored 'General case' 0 CA--C 1.493 -1.249 0 O-C-N 123.889 0.743 . . . . 75.310000000000002 110.369 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.01 -45.4 5.1 Favored Glycine 0 C--N 1.295 -1.733 0 CA-C-N 114.469 -1.241 . . . . 73.329999999999998 110.69 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.1 -46.32 88.6 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.479 1.112 . . . . 70.120000000000005 113.137 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 10.0 pt-20 -62.51 -37.11 84.77 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.384 -0.371 . . . . 64.340000000000003 111.327 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.31 -37.63 52.21 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 116.267 -0.424 . . . . 65.430000000000007 110.638 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.76 90.37 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.721 -0.672 . . . . 63.130000000000003 111.661 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.481 ' HB3' HD23 ' A' ' 33' ' ' LEU . 16.1 pttp -75.36 -33.71 61.08 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 118.552 -1.259 . . . . 64.219999999999999 111.85 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.6 -17.15 61.21 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.229 0.538 . . . . 55.32 111.509 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.22 -45.03 14.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 120.998 0.427 . . . . 62.210000000000001 110.285 175.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.555 ' O ' HG22 ' A' ' 91' ' ' ILE . 91.9 mt -91.04 -5.42 55.31 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 114.749 1.389 . . . . 73.219999999999999 114.749 -173.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -78.99 114.77 18.21 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.055 -1.028 . . . . 74.310000000000002 112.627 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.13 20.37 10.56 Favored Glycine 0 CA--C 1.479 -2.216 0 C-N-CA 120.408 -0.901 . . . . 55.530000000000001 111.64 174.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 88' ' ' LEU . 16.0 tt -114.3 142.32 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.276 0 N-CA-C 105.461 -2.051 . . . . 70.540000000000006 105.461 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.49 ' CD ' ' HA ' ' A' ' 95' ' ' PRO . 33.3 ptt180 -87.02 130.09 34.61 Favored 'General case' 0 C--N 1.262 -3.227 0 C-N-CA 119.424 -0.91 . . . . 55.039999999999999 111.335 175.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -60.75 -31.48 70.81 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.701 -1.59 . . . . 71.409999999999997 110.207 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.404 ' OD2' ' HB3' ' B' ' 45' ' ' ARG . 9.4 t0 -142.28 113.27 6.18 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 105.512 -2.033 . . . . 74.0 105.512 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.49 ' HA ' ' CD ' ' A' ' 92' ' ' ARG . 53.0 Cg_exo -61.38 -12.85 25.81 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 122.99 2.46 . . . . 43.43 114.846 -178.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -98.21 -14.45 20.33 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.704 -0.623 . . . . 74.010000000000005 110.177 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -94.79 141.97 24.07 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.705 -0.85 . . . . 64.519999999999996 108.705 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.09 2.35 7.25 Favored 'Trans proline' 0 CA--C 1.549 1.248 0 C-N-CA 122.619 2.213 . . . . 75.019999999999996 114.314 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -92.87 127.78 38.5 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 121.558 -0.714 . . . . 72.510000000000005 109.259 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.556 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 50.6 p -107.08 143.64 34.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.916 -0.401 . . . . 55.119999999999997 109.916 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 34.7 tp -89.37 127.98 35.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.382 -0.97 . . . . 74.519999999999996 108.382 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -136.96 124.01 21.56 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 108.545 -0.909 . . . . 64.450000000000003 108.545 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.447 ' HG ' HG22 ' A' ' 35' ' ' VAL . 5.9 mp -112.83 122.72 48.5 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 115.732 -0.667 . . . . 60.530000000000001 109.85 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.538 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 43.3 mt-10 -127.89 177.43 6.85 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.603 -1.258 . . . . 75.140000000000001 107.603 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -91.02 138.57 31.5 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 118.753 0.706 . . . . 64.019999999999996 111.424 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.75 158.79 33.98 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.443 -0.799 . . . . 60.310000000000002 108.865 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -84.8 -1.98 57.11 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.764 0.792 . . . . 75.450000000000003 109.643 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -151.43 132.56 14.4 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.321 -0.854 . . . . 72.109999999999999 109.623 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -78.11 124.29 27.88 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.645 -0.502 . . . . 70.400000000000006 109.645 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.7 m -92.68 139.14 30.87 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.07 -1.085 . . . . 75.439999999999998 108.07 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -86.07 123.08 30.98 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.868 -0.79 . . . . 75.400000000000006 108.868 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -86.52 -63.72 1.27 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.433 -0.951 . . . . 74.209999999999994 108.433 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -150.28 93.31 1.98 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.218 0.533 . . . . 45.5 110.331 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -143.47 117.89 9.68 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.752 -0.658 . . . . 72.010000000000005 109.483 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 m -85.41 89.85 7.79 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.67 -0.492 . . . . 62.039999999999999 109.67 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -94.17 76.38 4.03 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.267 -1.753 . . . . 74.040000000000006 106.267 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.42 HD23 ' HG3' ' A' ' 118' ' ' GLU . 4.7 tt -87.61 127.31 35.27 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.058 -1.83 . . . . 60.109999999999999 106.058 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.42 ' HG3' HD23 ' A' ' 117' ' ' LEU . 47.8 mt-10 . . . . . 0 N--CA 1.475 0.81 0 C-N-CA 124.928 1.291 . . . . 75.209999999999994 109.765 -175.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 67.1 mtm . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 120.925 0.393 . . . . 72.409999999999997 109.968 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' B' ' 29' ' ' GLU . 2.1 mp0 -108.15 -170.69 1.72 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.994 -0.743 . . . . 65.200000000000003 108.994 -174.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -83.58 43.69 0.92 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.425 -1.324 . . . . 62.109999999999999 107.425 172.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' B' ' 27' ' ' GLU . 8.3 pt-20 -64.7 127.59 32.21 Favored 'General case' 0 N--CA 1.41 -2.467 0 C-N-CA 125.969 1.707 . . . . 74.010000000000005 111.217 -176.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.522 ' HA ' HD21 ' B' ' 109' ' ' ASN . 48.5 t -95.72 110.55 24.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.816 -0.809 . . . . 75.340000000000003 108.816 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' B' ' 75' ' ' PHE . 15.0 ptm180 -114.49 11.65 17.19 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.208 -0.905 . . . . 72.510000000000005 111.232 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 29.6 m -122.19 122.93 40.31 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.514 0.673 . . . . 71.109999999999999 111.096 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' B' ' 85' ' ' LYS . 2.2 mp -101.63 144.75 29.97 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.075 -1.454 . . . . 62.32 107.075 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.591 ' CE2' ' HB2' ' B' ' 104' ' ' GLU . 9.9 p90 -109.2 116.43 31.9 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 117.412 -1.715 . . . . 62.340000000000003 108.179 171.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.46 120.06 46.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 CA-C-N 113.946 -1.479 . . . . 73.439999999999998 108.225 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.459 ' OG ' ' HG3' ' B' ' 102' ' ' ARG . 11.0 p -128.72 163.03 26.02 Favored 'General case' 0 N--CA 1.408 -2.557 0 CA-C-N 115.505 -0.771 . . . . 73.400000000000006 109.984 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 88.83 37.79 7.19 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 110.648 -0.981 . . . . 42.100000000000001 110.648 -173.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.89 135.79 19.37 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 108.069 -1.086 . . . . 73.430000000000007 108.069 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -53.06 150.64 23.46 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.081 1.854 . . . . 73.040000000000006 110.194 172.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.527 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 8.1 p -76.75 1.73 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 121.999 0.904 . . . . 62.409999999999997 110.5 -174.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -127.73 20.85 6.53 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.509 -0.769 . . . . 50.340000000000003 110.032 -173.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 24.9 pt -52.6 133.77 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 113.871 1.063 . . . . 74.0 113.871 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' B' ' 43' ' ' LYS . 3.2 mptp? -90.86 147.12 35.26 Favored Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 114.58 -1.191 . . . . 75.400000000000006 109.458 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.84 -28.65 59.21 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.855 2.37 . . . . 64.450000000000003 113.286 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.523 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 0.0 OUTLIER -79.54 -14.38 58.9 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 117.642 -1.623 . . . . 63.25 111.898 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -69.93 -40.53 75.46 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.818 -0.808 . . . . 72.049999999999997 108.818 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 88.6 mt -66.4 -34.03 77.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.376 -0.829 . . . . 72.349999999999994 109.072 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.523 ' HB3' ' O ' ' B' ' 45' ' ' ARG . 78.9 t80 -60.94 -49.28 78.08 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-N 115.112 -0.949 . . . . 72.310000000000002 110.065 176.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 92.0 mt -70.01 -29.14 66.12 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-O 121.117 0.484 . . . . 74.430000000000007 110.677 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 tp -71.78 -51.03 24.7 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.113 -0.949 . . . . 64.010000000000005 111.121 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -96.8 7.5 46.45 Favored 'General case' 0 C--O 1.217 -0.608 0 N-CA-C 113.674 0.99 . . . . 71.239999999999995 113.674 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 10.0 ttp180 -47.93 -50.83 51.53 Favored Pre-proline 0 CA--C 1.568 1.639 0 N-CA-C 114.505 1.298 . . . . 72.120000000000005 114.505 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' B' ' 52' ' ' ARG . 1.0 OUTLIER -87.62 -1.39 7.46 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 121.685 1.59 . . . . 73.209999999999994 112.98 177.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -86.96 97.17 10.55 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.929 1.347 . . . . 71.450000000000003 111.878 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -69.39 113.25 6.53 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 112.169 -2.287 . . . . 72.340000000000003 109.637 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.26 -20.28 4.23 Favored Glycine 0 N--CA 1.422 -2.295 0 CA-C-N 114.72 -1.127 . . . . 71.150000000000006 111.29 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -57.05 114.98 2.36 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.249 0.62 . . . . 73.409999999999997 112.075 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.36 -51.24 4.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.607 0.718 . . . . 65.299999999999997 109.363 175.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.17 178.59 42.88 Favored Glycine 0 C--N 1.298 -1.55 0 CA-C-N 115.208 -0.905 . . . . 53.43 112.198 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.414 ' HB3' HG22 ' B' ' 73' ' ' VAL . 6.7 p -134.39 141.08 46.73 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 123.508 0.723 . . . . 64.209999999999994 110.082 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -122.91 112.93 18.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.736 -1.579 . . . . 34.420000000000002 106.736 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.579 HD13 ' H ' ' B' ' 62' ' ' ILE . 0.2 OUTLIER -93.84 137.92 21.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.13 0.49 . . . . 72.340000000000003 111.254 -176.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -124.46 112.14 16.54 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.129 -1.063 . . . . 61.210000000000001 108.129 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.48 116.61 7.66 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.661 -0.496 . . . . 70.239999999999995 109.661 -177.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 8.5 m -111.53 167.38 10.37 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.523 -1.658 . . . . 75.540000000000006 106.523 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.78 -33.11 6.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.231 1.197 . . . . 71.439999999999998 114.231 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 58.7 mtt-85 -104.72 -28.68 11.05 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.665 0.987 . . . . 74.319999999999993 113.665 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -170.7 152.86 3.93 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 116.439 -0.346 . . . . 73.439999999999998 110.155 -165.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 51.4 Cg_endo -77.72 108.24 2.52 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 C-N-CA 122.27 1.98 . . . . 54.149999999999999 109.927 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 31.7 m -76.03 140.23 17.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.372 -1.344 . . . . 71.099999999999994 107.372 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.16 120.84 5.46 Favored Glycine 0 C--N 1.282 -2.438 0 C-N-CA 118.753 -1.689 . . . . 74.310000000000002 112.912 -175.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.4 102.29 14.39 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 105.883 -1.895 . . . . 61.43 105.883 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.414 HG22 ' HB3' ' B' ' 60' ' ' SER . 83.3 t -94.94 124.76 47.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 114.789 -1.096 . . . . 55.439999999999998 109.279 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 60.7 mt -107.35 122.08 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.567 0 CA-C-N 114.41 -1.268 . . . . 75.239999999999995 109.81 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' B' ' 31' ' ' ARG . 4.0 m-85 -105.95 157.2 17.67 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.666 -1.152 . . . . 75.430000000000007 109.697 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.76 -36.26 67.64 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 115.125 -0.943 . . . . 61.409999999999997 109.868 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.91 134.31 54.85 Favored 'General case' 0 N--CA 1.389 -3.485 0 CA-C-N 115.173 -0.921 . . . . 72.530000000000001 109.406 -170.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -25.09 56.71 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.425 -0.807 . . . . 61.210000000000001 111.218 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.3 -19.81 49.54 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 107.451 -1.315 . . . . 73.25 107.451 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.34 -41.98 8.18 Favored Glycine 0 C--N 1.295 -1.705 0 CA-C-N 113.312 -1.767 . . . . 64.409999999999997 109.22 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.23 -46.91 88.16 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.201 1.0 . . . . 65.420000000000002 112.16 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -58.81 -44.72 90.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.257 -0.429 . . . . 73.519999999999996 111.305 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.71 -36.16 75.68 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.705 -0.68 . . . . 60.0 110.578 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.68 -42.37 91.36 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.881 -0.6 . . . . 53.130000000000003 111.444 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.444 ' HB3' HD23 ' B' ' 33' ' ' LEU . 17.1 pttp -74.27 -36.03 63.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 118.171 -1.412 . . . . 63.32 111.147 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -63.49 -27.47 69.29 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.547 0.529 . . . . 74.349999999999994 111.321 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.31 -43.69 17.18 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 120.672 0.272 . . . . 74.109999999999999 111.388 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.538 ' O ' HG22 ' B' ' 91' ' ' ILE . 95.7 mt -86.22 -8.57 57.69 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.164 1.542 . . . . 53.310000000000002 115.164 -174.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.22 114.59 15.06 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.049 -1.06 . . . . 65.219999999999999 112.813 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.49 14.79 26.86 Favored Glycine 0 N--CA 1.428 -1.851 0 C-N-CA 120.301 -0.952 . . . . 53.520000000000003 112.278 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.538 HG22 ' O ' ' B' ' 88' ' ' LEU . 16.3 tt -106.59 134.43 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.211 0 N-CA-C 106.127 -1.805 . . . . 52.240000000000002 106.127 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' B' ' 95' ' ' PRO . 39.4 ptt180 -78.9 133.11 36.97 Favored 'General case' 0 C--N 1.262 -3.223 0 C-N-CA 119.651 -0.82 . . . . 74.230000000000004 111.168 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -69.13 -28.63 66.63 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.769 -1.559 . . . . 74.340000000000003 110.206 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.435 ' OD2' ' HB3' ' A' ' 45' ' ' ARG . 10.6 t70 -146.57 118.25 4.83 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 106.389 -1.708 . . . . 63.130000000000003 106.389 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . 0.496 ' HA ' ' NE ' ' B' ' 92' ' ' ARG . 21.0 Cg_endo -60.69 -21.45 69.58 Favored 'Trans proline' 0 N--CA 1.48 0.726 0 C-N-CA 123.039 2.493 . . . . 72.310000000000002 114.409 -176.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -85.97 -23.25 26.97 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.508 0.671 . . . . 65.340000000000003 110.27 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -100.62 132.29 22.51 Favored Pre-proline 0 C--N 1.29 -2.002 0 CA-C-N 115.499 -0.773 . . . . 73.299999999999997 109.13 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.08 -0.72 6.74 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.852 2.368 . . . . 72.400000000000006 112.505 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -69.72 112.23 6.04 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.888 -0.782 . . . . 72.530000000000001 108.888 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.47 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 70.3 p -103.48 145.57 29.81 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.903 -0.777 . . . . 73.219999999999999 108.903 -177.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 36.7 tp -89.9 130.67 36.09 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.663 -1.236 . . . . 61.450000000000003 107.663 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.459 ' HG3' ' OG ' ' B' ' 36' ' ' SER . 7.7 ptm180 -138.14 122.53 18.32 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 108.694 -0.854 . . . . 70.340000000000003 108.694 -175.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -117.47 132.37 56.56 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.82 -0.627 . . . . 73.540000000000006 110.18 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.591 ' HB2' ' CE2' ' B' ' 34' ' ' PHE . 36.0 mt-10 -136.43 174.28 10.79 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.19 -1.781 . . . . 73.099999999999994 106.19 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -81.84 145.02 30.62 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 119.128 -1.029 . . . . 74.439999999999998 110.941 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.14 151.73 40.0 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 107.906 -1.146 . . . . 72.019999999999996 107.906 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -75.95 -9.66 58.79 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 122.004 0.907 . . . . 62.509999999999998 109.888 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.8 127.29 9.33 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.076 -0.965 . . . . 73.010000000000005 108.827 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.522 HD21 ' HA ' ' B' ' 30' ' ' VAL . 93.0 m-20 -71.71 143.73 49.55 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.912 -0.585 . . . . 65.310000000000002 110.976 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 22.5 m -110.33 129.58 55.72 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 108.075 -1.083 . . . . 64.420000000000002 108.075 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -92.13 110.73 22.11 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.178 -1.045 . . . . 64.239999999999995 108.178 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -67.98 -60.62 2.36 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.672 -0.694 . . . . 60.43 111.361 -171.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -147.27 101.24 3.37 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.221 -0.592 . . . . 72.150000000000006 112.133 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -154.62 129.11 9.15 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.235 -1.024 . . . . 63.229999999999997 108.235 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 48.4 m -80.1 109.82 14.92 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.337 0.589 . . . . 63.5 109.43 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -144.47 83.39 1.72 Allowed 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 106.222 -1.77 . . . . 71.340000000000003 106.222 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 4.6 tt -110.08 76.59 1.0 Allowed 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.548 -0.751 . . . . 65.510000000000005 109.71 -175.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 C--N 1.306 -1.294 0 N-CA-C 105.476 -2.046 . . . . 74.0 105.476 175.503 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.368 0.128 . . . . 75.310000000000002 111.012 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -149.09 -70.58 0.2 Allowed 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.519 -1.289 . . . . 38.009999999999998 107.519 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -141.67 105.33 4.7 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.789 -1.189 . . . . 73.439999999999998 107.789 175.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.42 ' HB3' ' HD2' ' A' ' 78' ' ' ARG . 7.7 mp0 -86.66 137.86 32.13 Favored 'General case' 0 N--CA 1.394 -3.23 0 N-CA-C 106.861 -1.533 . . . . 53.119999999999997 106.861 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.86 110.12 14.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.465 -1.309 . . . . 63.409999999999997 107.465 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 17.0 ptp180 -113.99 -1.7 13.72 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.069 -0.969 . . . . 74.439999999999998 111.172 -172.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.4 m -111.07 130.57 55.57 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 115.538 -0.755 . . . . 44.109999999999999 110.679 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.451 ' H ' HD23 ' A' ' 33' ' ' LEU . 2.0 pt? -127.78 153.31 46.72 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.903 -0.777 . . . . 75.510000000000005 108.903 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -103.0 120.68 41.08 Favored 'General case' 0 N--CA 1.418 -2.075 0 CA-C-O 121.924 0.869 . . . . 74.040000000000006 108.97 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.0 t -97.59 120.94 47.58 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 CA-C-N 114.388 -1.278 . . . . 71.140000000000001 107.659 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.8 p -128.9 157.44 41.58 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 116.295 -0.411 . . . . 64.209999999999994 110.564 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 98.91 17.44 27.84 Favored Glycine 0 C--N 1.299 -1.525 0 O-C-N 123.675 0.609 . . . . 54.340000000000003 112.734 -178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.467 ' HB3' HG21 ' A' ' 42' ' ' ILE . 96.1 mt -78.72 125.65 83.9 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 106.9 -1.519 . . . . 74.319999999999993 106.9 173.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -58.63 154.57 41.88 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.244 1.296 . . . . 52.32 110.117 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.3 p -73.44 4.8 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 CA-C-O 122.33 1.062 . . . . 74.310000000000002 110.785 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.43 ' O ' ' HE2' ' A' ' 43' ' ' LYS . 18.3 t70 -110.34 13.29 22.95 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 114.574 -1.194 . . . . 60.329999999999998 109.155 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.467 HG21 ' HB3' ' A' ' 38' ' ' LEU 0.266 2.4 pp -58.09 141.43 15.08 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 N-CA-C 114.939 1.459 . . . . 74.430000000000007 114.939 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.435 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 61.1 mmtt -106.5 145.93 32.0 Favored Pre-proline 0 C--N 1.283 -2.313 0 CA-C-N 113.548 -1.66 . . . . 73.430000000000007 106.736 176.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.14 -25.93 65.38 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.223 1.949 . . . . 54.240000000000002 111.94 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.501 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 13.9 ptt180 -69.82 -24.73 63.51 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.574 -0.739 . . . . 70.040000000000006 111.521 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 40.6 mt-10 -69.99 -42.89 72.47 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 120.986 0.422 . . . . 75.430000000000007 110.28 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.01 -37.3 86.91 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.85 0.833 . . . . 63.450000000000003 109.099 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.572 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 23.2 t80 -60.88 -50.47 73.29 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.462 -1.245 . . . . 72.340000000000003 110.905 176.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 95.7 mt -64.16 -41.41 97.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.174 0.511 . . . . 64.109999999999999 110.065 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 tp -67.33 -41.96 84.4 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.741 -1.118 . . . . 74.150000000000006 111.52 -176.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -92.07 -1.32 57.27 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 115.194 1.553 . . . . 63.039999999999999 115.194 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.572 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 12.6 mtp180 -61.51 -45.97 94.11 Favored Pre-proline 0 N--CA 1.479 0.992 0 N-CA-C 113.794 1.035 . . . . 74.239999999999995 113.794 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.28 -16.28 43.66 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 121.166 1.244 . . . . 74.120000000000005 112.513 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -92.65 92.33 7.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.296 1.046 . . . . 64.329999999999998 110.203 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -73.35 113.92 10.98 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 113.753 -1.567 . . . . 74.040000000000006 109.544 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.98 -20.93 2.49 Favored Glycine 0 C--N 1.288 -2.123 0 CA-C-N 114.754 -1.112 . . . . 44.200000000000003 111.657 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -54.47 112.73 1.06 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.553 0.741 . . . . 75.299999999999997 111.969 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -94.26 -45.21 7.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.639 -0.71 . . . . 74.329999999999998 110.932 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.43 178.35 48.32 Favored Glycine 0 C--N 1.298 -1.563 0 C-N-CA 120.27 -0.967 . . . . 65.230000000000004 112.791 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.0 p -143.08 142.17 31.45 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 123.069 0.548 . . . . 45.109999999999999 111.297 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.426 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 5.4 mp -118.8 130.21 55.65 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.247 -1.39 . . . . 74.209999999999994 107.247 173.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.5 mm -109.26 131.92 58.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 118.043 0.383 . . . . 70.430000000000007 111.26 -173.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -120.13 106.83 12.34 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.479 -0.934 . . . . 73.409999999999997 108.479 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -63.21 126.24 26.75 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.802 -1.09 . . . . 60.210000000000001 109.517 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 14.8 m -130.1 153.98 47.93 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 105.565 -2.013 . . . . 72.420000000000002 105.565 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.41 -33.64 31.18 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.164 1.172 . . . . 64.439999999999998 114.164 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -104.19 -35.67 7.94 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 112.768 0.655 . . . . 75.109999999999999 112.768 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.532 ' O ' ' HB ' ' A' ' 65' ' ' THR . 5.4 pm0 -156.88 129.45 4.23 Favored Pre-proline 0 C--N 1.302 -1.477 0 C-N-CA 121.071 -0.251 . . . . 75.420000000000002 110.434 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 38' ' ' LEU . 29.0 Cg_exo -64.15 118.64 5.59 Favored 'Trans proline' 0 N--CA 1.441 -1.577 0 C-N-CA 122.305 2.003 . . . . 65.409999999999997 108.99 167.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.0 140.33 15.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.383 -0.969 . . . . 63.520000000000003 108.383 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 61' ' ' LEU . . . -122.33 122.22 4.98 Favored Glycine 0 C--N 1.289 -2.05 0 C-N-CA 119.775 -1.203 . . . . 64.519999999999996 112.699 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -87.89 103.16 15.4 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.429 -1.693 . . . . 75.299999999999997 106.429 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.44 132.19 47.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 CA-C-N 115.118 -0.947 . . . . 74.230000000000004 110.545 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 110' ' ' THR . 4.7 tt -107.68 129.69 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 CA-C-N 114.893 -1.049 . . . . 71.299999999999997 109.98 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.51 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 14.2 m-85 -108.76 158.33 17.73 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 114.897 -1.047 . . . . 73.25 109.22 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.97 -31.95 73.44 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.872 -0.604 . . . . 72.140000000000001 111.256 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.7 p -133.32 152.13 51.91 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 112.492 0.553 . . . . 45.140000000000001 112.492 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.633 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.89 -35.46 80.06 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 108.591 -0.892 . . . . 63.539999999999999 108.591 175.106 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.61 -19.52 62.11 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 122.556 1.169 . . . . 74.120000000000005 108.316 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.96 -45.64 8.93 Favored Glycine 0 C--N 1.294 -1.779 0 CA-C-N 113.937 -1.483 . . . . 70.420000000000002 110.153 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.29 -42.89 74.87 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.99 -0.605 . . . . 64.530000000000001 111.593 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.477 ' HA ' ' HG2' ' A' ' 85' ' ' LYS 0.27 1.4 pp20? -69.67 -30.24 67.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 112.937 0.717 . . . . 74.5 112.937 -177.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.62 -32.81 68.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.316 0.579 . . . . 32.409999999999997 109.992 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.87 -44.87 68.91 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.438 -0.801 . . . . 72.120000000000005 110.828 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 104' ' ' GLU . 14.1 ptmm? -68.88 -33.11 73.25 Favored 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 120.792 -0.363 . . . . 75.409999999999997 110.209 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -59.73 -41.77 91.66 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.403 0.681 . . . . 63.140000000000001 109.913 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.59 -33.39 18.9 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 112.196 0.443 . . . . 64.140000000000001 112.196 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.596 ' O ' HG22 ' A' ' 91' ' ' ILE . 97.1 mt -94.05 -13.25 27.1 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 115.934 1.827 . . . . 54.329999999999998 115.934 -172.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.313 0.2 OUTLIER -78.79 114.39 17.68 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 116.771 -1.972 . . . . 73.430000000000007 112.633 177.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.26 6.85 25.36 Favored Glycine 0 CA--C 1.492 -1.401 0 C-N-CA 120.746 -0.74 . . . . 74.510000000000005 112.335 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 88' ' ' LEU . 9.1 tt -91.96 130.39 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 N-CA-C 107.844 -1.169 . . . . 74.510000000000005 107.844 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.47 ' HG2' HG22 ' A' ' 100' ' ' THR . 98.6 mtt180 -74.9 130.25 39.07 Favored 'General case' 0 C--N 1.275 -2.631 0 C-N-CA 119.523 -0.871 . . . . 65.200000000000003 109.772 171.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -66.73 -30.04 70.16 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.336 -1.302 . . . . 73.540000000000006 108.284 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -141.58 124.9 9.78 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 104.556 -2.387 . . . . 74.450000000000003 104.556 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.472 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 43.1 Cg_endo -65.01 -27.17 58.04 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 122.197 1.931 . . . . 61.039999999999999 114.454 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -81.92 -24.79 35.42 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.422 -0.955 . . . . 63.310000000000002 108.422 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -84.12 129.45 58.42 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.852 -1.166 . . . . 64.530000000000001 107.852 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.08 -18.49 51.48 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.196 1.931 . . . . 73.400000000000006 112.275 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.425 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 6.1 tp60 -66.48 114.83 5.77 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.261 0.553 . . . . 62.200000000000003 110.485 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.481 ' OG1' ' HD2' ' A' ' 102' ' ' ARG . 32.8 p -98.23 161.78 13.53 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 115.678 -0.692 . . . . 74.019999999999996 109.772 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.5 tp -100.8 126.97 47.41 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.53 -1.285 . . . . 74.349999999999994 107.53 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.481 ' HD2' ' OG1' ' A' ' 100' ' ' THR . 0.1 OUTLIER -127.13 117.16 21.84 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.513 -0.921 . . . . 73.349999999999994 108.513 -176.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.15 123.84 49.86 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.814 -0.63 . . . . 64.329999999999998 110.101 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.5 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 9.1 tp10 -140.52 158.02 44.62 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.45 -1.315 . . . . 64.510000000000005 107.45 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -66.14 140.91 58.24 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 118.715 0.689 . . . . 71.420000000000002 112.847 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.71 158.46 24.21 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 108.375 -0.972 . . . . 71.540000000000006 108.375 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -82.35 -7.56 59.63 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.283 0.563 . . . . 74.120000000000005 110.472 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.0 136.41 28.43 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.958 -0.564 . . . . 44.020000000000003 110.905 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -81.88 124.41 29.68 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.779 -0.646 . . . . 73.519999999999996 109.631 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.411 ' O ' HD12 ' A' ' 74' ' ' ILE . 11.3 t -87.77 138.98 30.99 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 107.338 -1.356 . . . . 63.520000000000003 107.338 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -112.35 109.97 19.91 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.28 0.562 . . . . 64.430000000000007 111.875 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 14.7 mmt -87.89 -32.94 18.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.566 -0.743 . . . . 74.349999999999994 109.631 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -129.13 107.89 9.93 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.199 -0.91 . . . . 60.450000000000003 109.622 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -101.86 90.3 3.95 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.151 -0.685 . . . . 65.340000000000003 109.151 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.2 m -88.88 80.72 7.06 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.911 0.862 . . . . 60.240000000000002 108.999 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 154.2 24.69 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.864 -1.062 . . . . 61.020000000000003 112.994 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.8 mt -85.48 125.67 33.22 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.506 -0.924 . . . . 65.329999999999998 108.506 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--N 1.293 -1.889 0 N-CA-C 107.763 -1.199 . . . . 73.420000000000002 107.763 -177.708 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 109.897 -0.408 . . . . 62.009999999999998 109.897 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -68.88 -73.01 0.16 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 116.422 -0.354 . . . . 75.319999999999993 111.556 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -122.27 91.67 3.56 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.039 0.755 . . . . 70.400000000000006 113.039 -173.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -95.45 122.28 38.01 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 106.06 -1.83 . . . . 55.119999999999997 106.06 170.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' B' ' 78' ' ' ARG . 55.0 t -78.4 109.48 13.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.71 -0.848 . . . . 72.450000000000003 108.71 -174.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -118.71 4.13 11.62 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.985 0.898 . . . . 73.510000000000005 110.325 -172.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . 0.483 ' HB ' ' HA ' ' B' ' 109' ' ' ASN . 63.5 m -111.52 136.06 51.23 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.688 -1.142 . . . . 62.240000000000002 108.345 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.441 HD23 ' H ' ' B' ' 33' ' ' LEU . 2.1 pt? -131.53 154.37 48.87 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.443 -0.577 . . . . 61.039999999999999 109.443 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.563 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 30.6 p90 -101.97 118.1 36.2 Favored 'General case' 0 N--CA 1.416 -2.171 0 CA-C-O 122.04 0.924 . . . . 61.229999999999997 108.718 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 51.0 t -98.42 122.25 49.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 113.901 -1.5 . . . . 73.319999999999993 107.553 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 22.5 p -127.42 164.57 21.58 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 115.666 -0.697 . . . . 64.349999999999994 109.603 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 93.95 27.81 11.92 Favored Glycine 0 N--CA 1.424 -2.143 0 O-C-N 123.523 0.514 . . . . 71.510000000000005 111.896 -175.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.405 ' HB3' HG12 ' B' ' 42' ' ' ILE . 98.2 mt -96.55 117.78 65.77 Favored Pre-proline 0 C--N 1.292 -1.91 0 N-CA-C 108.629 -0.878 . . . . 73.420000000000002 108.629 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.76 151.74 14.56 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.882 2.388 . . . . 61.229999999999997 112.001 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.49 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 11.9 p -63.62 -6.69 2.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 123.876 0.87 . . . . 74.319999999999993 112.781 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -121.39 26.31 8.93 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.618 -0.676 . . . . 74.150000000000006 109.775 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.411 HD12 ' O ' ' B' ' 42' ' ' ILE . 2.5 pp -58.43 135.76 22.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 113.203 0.816 . . . . 73.239999999999995 113.203 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -102.31 143.34 26.41 Favored Pre-proline 0 C--N 1.278 -2.53 0 CA-C-N 114.718 -1.128 . . . . 64.540000000000006 109.187 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -51.87 -32.18 45.91 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.79 2.327 . . . . 61.43 112.666 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.524 ' O ' ' HB3' ' B' ' 48' ' ' TYR . 10.7 ptt180 -68.44 -25.44 65.02 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 111.886 0.328 . . . . 64.439999999999998 111.886 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -70.5 -39.63 74.02 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.602 0.715 . . . . 71.439999999999998 109.365 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 77.7 mt -67.71 -34.71 77.41 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 115.007 -0.997 . . . . 72.540000000000006 108.637 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.623 ' O ' ' HB2' ' B' ' 52' ' ' ARG . 51.0 t80 -62.49 -48.44 79.56 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.745 -1.116 . . . . 73.239999999999995 110.102 176.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 93.6 mt -66.22 -40.77 90.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.131 0.491 . . . . 64.319999999999993 110.294 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.3 tp -71.57 -43.42 66.36 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.278 -0.874 . . . . 73.439999999999998 112.048 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -100.07 8.24 44.09 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 113.301 0.852 . . . . 74.209999999999994 113.301 -174.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.623 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 28.5 ttt180 -70.54 -43.34 16.14 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-O 119.349 -0.358 . . . . 74.010000000000005 111.798 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -74.96 -12.73 21.61 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 121.532 1.488 . . . . 73.329999999999998 112.623 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -85.72 110.82 19.59 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.655 0.741 . . . . 75.140000000000001 111.668 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -74.55 112.59 10.89 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.489 -1.232 . . . . 74.329999999999998 111.304 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.13 -19.84 3.84 Favored Glycine 0 N--CA 1.429 -1.77 0 CA-C-N 115.018 -0.992 . . . . 62.009999999999998 112.97 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -56.64 112.6 1.33 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.209 0.528 . . . . 75.439999999999998 112.369 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -93.75 -55.03 3.4 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.751 -0.659 . . . . 72.299999999999997 110.756 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.29 170.71 43.72 Favored Glycine 0 C--N 1.296 -1.667 0 C-N-CA 120.309 -0.948 . . . . 51.439999999999998 112.304 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.417 ' HB3' HG22 ' B' ' 73' ' ' VAL . 12.6 p -132.3 137.12 47.34 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.388 0.514 . . . . 75.409999999999997 112.388 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.408 ' O ' ' HA2' ' B' ' 71' ' ' GLY . 54.8 mt -104.3 113.5 27.1 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.353 -0.98 . . . . 73.049999999999997 108.353 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 43.2 mm -94.38 127.02 46.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 109.208 -0.664 . . . . 62.219999999999999 109.208 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -120.2 114.7 22.31 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.517 -0.92 . . . . 71.209999999999994 108.517 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.37 123.23 19.06 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.866 -0.607 . . . . 55.420000000000002 109.638 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.1 m -128.04 150.44 49.94 Favored 'General case' 0 N--CA 1.402 -2.851 0 N-CA-C 103.923 -2.621 . . . . 74.019999999999996 103.923 174.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.09 -40.16 4.71 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.5 1.296 . . . . 73.430000000000007 114.5 -173.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -100.61 -18.52 16.54 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 112.373 0.509 . . . . 74.129999999999995 112.373 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 24.4 pt20 -169.05 127.32 0.88 Allowed Pre-proline 0 C--N 1.308 -1.234 0 C-N-CA 120.878 -0.329 . . . . 73.150000000000006 111.628 -169.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 10.5 Cg_exo -73.33 101.21 1.32 Allowed 'Trans proline' 0 N--CA 1.437 -1.798 0 C-N-CA 122.363 2.042 . . . . 75.530000000000001 107.99 167.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.97 150.36 4.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.022 -0.536 . . . . 64.040000000000006 109.712 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' B' ' 61' ' ' LEU . . . -123.23 120.65 4.29 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 118.402 -1.856 . . . . 74.409999999999997 112.959 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -88.11 102.52 14.86 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.192 -1.781 . . . . 74.120000000000005 106.192 175.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' B' ' 60' ' ' SER . 60.1 t -99.86 130.21 49.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-N 114.677 -1.147 . . . . 75.129999999999995 110.863 -172.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.502 HD12 ' O ' ' B' ' 110' ' ' THR . 3.7 tt -104.05 127.61 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 0 CA-C-N 115.204 -0.907 . . . . 70.010000000000005 109.613 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' B' ' 81' ' ' ALA . 8.9 m-85 -105.33 154.13 20.69 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.43 -1.322 . . . . 73.239999999999995 107.43 171.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -65.19 -37.04 86.08 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.64 -0.504 . . . . 70.540000000000006 109.64 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 4.2 p -114.86 133.21 56.15 Favored 'General case' 0 N--CA 1.386 -3.673 0 CA-C-O 121.722 0.772 . . . . 75.209999999999994 111.304 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' B' ' 30' ' ' VAL . 0.0 OUTLIER -75.65 -24.46 56.39 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 115.241 -0.891 . . . . 72.140000000000001 110.785 177.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.12 -19.82 39.32 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.906 -1.516 . . . . 63.039999999999999 106.906 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.08 -43.43 10.8 Favored Glycine 0 C--N 1.299 -1.507 0 CA-C-N 113.277 -1.783 . . . . 62.340000000000003 109.637 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' B' ' 75' ' ' PHE . . . -62.41 -35.13 78.26 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.52 -0.84 . . . . 53.439999999999998 110.977 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 1.4 pp20? -69.42 -38.28 77.83 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.29 -0.964 . . . . 73.519999999999996 110.405 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.52 78.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.091 0.472 . . . . 74.140000000000001 110.4 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.03 -44.46 72.65 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.824 -0.625 . . . . 24.309999999999999 111.402 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' B' ' 82' ' ' GLU . 13.2 ptmm? -68.45 -34.71 76.44 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.787 -0.365 . . . . 74.299999999999997 110.475 -177.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -62.51 -28.85 70.13 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.063 -0.517 . . . . 73.019999999999996 110.91 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.75 -41.3 13.41 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 112.305 0.483 . . . . 63.299999999999997 112.305 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.548 ' O ' HG22 ' B' ' 91' ' ' ILE . 97.5 mt -98.62 -8.17 26.79 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 116.192 1.923 . . . . 74.340000000000003 116.192 -169.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 36.0 p30 -69.99 116.11 9.98 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 119.504 1.047 . . . . 72.430000000000007 113.208 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.87 7.07 48.31 Favored Glycine 0 CA--C 1.482 -1.994 0 C-N-CA 120.843 -0.694 . . . . 75.129999999999995 113.068 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.548 HG22 ' O ' ' B' ' 88' ' ' LEU . 14.4 tt -101.58 137.24 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.929 0 N-CA-C 108.168 -1.049 . . . . 74.319999999999993 108.168 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -68.78 132.82 47.43 Favored 'General case' 0 C--N 1.266 -3.036 0 CA-C-O 121.776 0.798 . . . . 71.040000000000006 112.161 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -73.42 -28.35 61.94 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.672 -1.604 . . . . 73.230000000000004 107.848 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.446 ' OD2' ' HB3' ' A' ' 45' ' ' ARG . 9.4 t0 -146.14 114.73 4.59 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 105.417 -2.068 . . . . 62.229999999999997 105.417 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . 0.516 ' HD3' ' CZ ' ' A' ' 48' ' ' TYR . 56.7 Cg_endo -68.74 -19.06 41.83 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.328 2.019 . . . . 62.229999999999997 113.961 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -83.14 -24.69 32.44 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.794 -0.817 . . . . 74.099999999999994 108.794 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -95.54 143.35 25.96 Favored Pre-proline 0 C--N 1.309 -1.174 0 N-CA-C 108.57 -0.9 . . . . 71.140000000000001 108.57 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.11 -3.47 13.84 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 122.068 1.845 . . . . 71.420000000000002 114.224 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -75.87 120.65 21.51 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.992 0.425 . . . . 73.450000000000003 110.893 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.544 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 82.4 p -99.44 154.88 17.87 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 109.202 -0.666 . . . . 73.329999999999998 109.202 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 28.8 tp -94.78 127.92 41.12 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.686 -1.227 . . . . 71.540000000000006 107.686 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -125.63 130.28 51.31 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.567 -1.271 . . . . 74.409999999999997 107.567 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -123.61 116.31 22.9 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 123.366 0.416 . . . . 75.310000000000002 110.317 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.563 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 5.0 tp10 -134.37 156.64 48.15 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.918 -1.512 . . . . 73.209999999999994 106.918 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -66.8 143.43 56.9 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.35 0.977 . . . . 73.109999999999999 111.879 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.86 157.36 24.42 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.896 -0.593 . . . . 61.539999999999999 109.903 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -85.65 7.82 21.89 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.626 0.727 . . . . 71.120000000000005 110.712 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.64 138.88 11.13 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.348 -0.982 . . . . 51.420000000000002 108.348 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.483 ' HA ' ' HB ' ' B' ' 32' ' ' THR . 94.3 m-20 -82.88 158.56 22.63 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-O 121.228 0.537 . . . . 63.420000000000002 109.928 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.502 ' O ' HD12 ' B' ' 74' ' ' ILE . 14.2 t -123.47 164.06 19.66 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.939 -1.504 . . . . 75.430000000000007 106.939 174.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' B' ' 111' ' ' LYS . 0.0 OUTLIER -134.96 144.66 47.54 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.427 -0.953 . . . . 71.319999999999993 108.427 177.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 26.0 mmt -104.6 -58.72 1.84 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.253 -0.647 . . . . 73.329999999999998 109.253 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.39 94.02 6.82 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.617 -0.72 . . . . 61.450000000000003 109.951 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -83.85 116.13 22.6 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.034 -0.728 . . . . 63.350000000000001 109.034 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 6.7 m -107.11 135.83 47.99 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 106.855 -1.535 . . . . 74.409999999999997 106.855 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -86.57 102.64 14.32 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 119.056 -1.058 . . . . 70.010000000000005 110.021 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 67.5 mt -104.79 88.74 2.98 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.362 -1.718 . . . . 70.109999999999999 106.362 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 . . . . . 0 C--N 1.297 -1.689 0 N-CA-C 108.431 -0.951 . . . . 73.530000000000001 108.431 -175.917 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.47 0.538 0 CA-C-O 120.487 0.184 . . . . 75.310000000000002 111.313 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -74.2 -67.67 0.59 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.206 -1.035 . . . . 61.350000000000001 108.206 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -116.37 147.1 41.95 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.838 -1.912 . . . . 71.209999999999994 105.838 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.1 mp0 -62.76 109.46 1.43 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 105.363 -2.088 . . . . 71.420000000000002 105.363 171.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.663 ' HA ' HD21 ' A' ' 109' ' ' ASN . 98.6 t -69.63 109.28 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 105.745 -1.946 . . . . 73.549999999999997 105.745 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 13.7 ptm180 -127.57 15.89 7.04 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.004 -1.453 . . . . 72.420000000000002 110.497 -167.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.4 m -124.7 124.63 42.59 Favored 'General case' 0 C--N 1.272 -2.784 0 C-N-CA 119.467 -0.893 . . . . 73.150000000000006 110.666 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.2 mt -107.16 141.17 38.86 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.352 -0.981 . . . . 63.109999999999999 108.352 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.463 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 16.7 p90 -102.73 115.8 31.31 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 107.088 -1.449 . . . . 64.129999999999995 107.088 173.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.416 HG22 ' HG ' ' A' ' 103' ' ' LEU . 35.4 t -97.65 120.03 46.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 CA-C-N 114.23 -1.35 . . . . 75.099999999999994 108.418 -177.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.9 p -123.8 165.76 16.75 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 116.246 -0.433 . . . . 75.349999999999994 110.008 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.14 11.96 44.05 Favored Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 111.065 -0.814 . . . . 63.109999999999999 111.065 -173.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.6 mt -83.07 130.23 58.11 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 107.608 -1.256 . . . . 74.5 107.608 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.12 161.43 10.98 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.099 1.866 . . . . 71.319999999999993 111.204 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.407 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 7.5 p -62.53 -15.69 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.681 0.753 . . . . 73.099999999999994 110.79 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -121.56 35.69 4.82 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.04 -0.982 . . . . 55.149999999999999 109.231 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.594 HG22 ' HG2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -66.43 131.2 32.22 Favored 'Isoleucine or valine' 0 C--O 1.256 1.44 0 N-CA-C 108.422 -0.955 . . . . 73.219999999999999 108.422 175.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -99.25 143.94 27.33 Favored Pre-proline 0 C--N 1.291 -1.957 0 CA-C-N 115.111 -0.949 . . . . 72.209999999999994 111.627 -177.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.53 -26.53 37.01 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.634 2.889 . . . . 71.319999999999993 114.194 -176.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.54 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -86.5 -10.52 53.94 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 117.159 -1.816 . . . . 71.030000000000001 112.109 -177.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' HG2' ' HG2' ' B' ' 46' ' ' GLU . 35.6 mt-10 -67.42 -40.21 85.52 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.005 -0.739 . . . . 75.319999999999993 109.005 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.38 -27.27 65.17 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.588 -0.733 . . . . 74.010000000000005 110.123 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.54 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 46.9 t80 -65.3 -47.59 76.08 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.371 -0.831 . . . . 70.450000000000003 109.823 176.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.44 -40.37 81.16 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.365 -0.605 . . . . 71.349999999999994 109.365 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.456 HD13 HD22 ' B' ' 49' ' ' LEU . 32.3 tp -64.34 -47.61 78.67 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.819 -1.082 . . . . 74.329999999999998 112.164 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -98.91 0.94 45.14 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 114.609 1.337 . . . . 72.140000000000001 114.609 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.1 ttt85 -63.63 -44.2 79.94 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 112.829 0.677 . . . . 74.439999999999998 112.829 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.77 -6.97 20.3 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 121.28 1.32 . . . . 72.450000000000003 112.713 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -96.59 90.02 5.19 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.516 0.674 . . . . 74.019999999999996 110.698 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -67.65 109.59 3.36 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.969 0.89 . . . . 71.209999999999994 109.882 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.1 -27.01 1.42 Allowed Glycine 0 C--N 1.285 -2.267 0 CA-C-N 114.406 -1.27 . . . . 60.520000000000003 110.155 -173.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -54.91 127.31 28.13 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.139 0.576 . . . . 74.430000000000007 111.934 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -105.92 -53.89 2.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.175 0.512 . . . . 71.109999999999999 110.568 174.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.64 178.12 41.17 Favored Glycine 0 C--N 1.294 -1.793 0 CA-C-N 115.492 -0.776 . . . . 71.209999999999994 111.822 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.4 p -146.72 137.69 24.07 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.64 0.22 . . . . 74.439999999999998 111.054 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.0 mt -115.98 134.64 54.76 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.458 0.703 . . . . 74.319999999999993 109.128 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.9 mm -95.0 144.71 9.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 110.15 -0.315 . . . . 64.540000000000006 110.15 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -136.97 118.88 15.23 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.833 -0.432 . . . . 75.430000000000007 109.833 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.29 110.59 6.02 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.349 0.595 . . . . 75.420000000000002 111.022 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.3 m -99.44 162.76 12.84 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 105.578 -2.008 . . . . 72.420000000000002 105.578 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -43.91 -37.87 3.09 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 114.037 1.125 . . . . 74.439999999999998 114.037 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -103.87 -26.72 12.57 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.211 1.189 . . . . 64.230000000000004 114.211 -177.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -166.79 153.38 8.18 Favored Pre-proline 0 C--N 1.307 -1.261 0 C-N-CA 120.783 -0.367 . . . . 71.420000000000002 110.346 -168.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.594 ' HG2' HG22 ' A' ' 42' ' ' ILE . 56.9 Cg_endo -76.66 118.89 4.98 Favored 'Trans proline' 0 N--CA 1.438 -1.766 0 C-N-CA 122.459 2.106 . . . . 74.329999999999998 110.949 172.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 m -93.93 162.17 2.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.837 -1.171 . . . . 65.430000000000007 107.837 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.41 121.59 3.54 Favored Glycine 0 C--N 1.297 -1.633 0 C-N-CA 118.934 -1.603 . . . . 72.530000000000001 113.332 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -87.8 105.53 17.46 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.414 -1.328 . . . . 65.129999999999995 107.414 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.68 127.43 52.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 115.053 -0.976 . . . . 62.219999999999999 110.164 -176.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 tt -99.79 130.06 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 CA-C-O 121.704 0.764 . . . . 64.019999999999996 110.219 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.598 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 82.0 m-85 -112.01 152.8 27.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 114.228 -1.351 . . . . 74.450000000000003 109.172 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.477 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 35.0 t70 -68.02 -30.1 69.26 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 114.839 -1.073 . . . . 53.539999999999999 112.712 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.4 m -131.95 150.09 52.25 Favored 'General case' 0 N--CA 1.417 -2.1 0 O-C-N 121.776 -0.577 . . . . 73.209999999999994 109.961 -174.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.635 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -80.38 -27.87 38.07 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.499 -0.926 . . . . 74.140000000000001 108.499 178.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.44 -19.46 60.39 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 114.377 -1.283 . . . . 72.349999999999994 107.591 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.41 -42.13 7.09 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 113.393 -1.73 . . . . 34.399999999999999 110.095 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.04 -43.41 98.89 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.135 0.574 . . . . 74.030000000000001 111.599 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.0 -38.26 90.48 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 121.027 -0.269 . . . . 74.439999999999998 111.706 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.08 -38.53 72.44 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 120.701 0.286 . . . . 74.340000000000003 110.478 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.58 90.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.568 -0.742 . . . . 44.32 111.202 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -67.08 -37.78 84.59 Favored 'General case' 0 C--O 1.206 -1.237 0 C-N-CA 120.378 -0.529 . . . . 55.310000000000002 111.262 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -72.91 -17.08 61.54 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 120.853 0.359 . . . . 71.209999999999994 111.753 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.57 -45.93 11.29 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 116.364 -0.38 . . . . 71.239999999999995 110.76 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.476 ' O ' HG22 ' A' ' 91' ' ' ILE . 92.7 mt -98.38 -9.05 25.86 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 115.291 1.589 . . . . 72.040000000000006 115.291 -172.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.55 126.34 30.61 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.075 -1.016 . . . . 74.430000000000007 110.657 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.19 3.37 54.22 Favored Glycine 0 CA--C 1.475 -2.445 0 C-N-CA 120.599 -0.81 . . . . 60.240000000000002 112.5 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 88' ' ' LEU . 16.1 tt -111.18 144.45 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.343 0 N-CA-C 107.058 -1.46 . . . . 75.519999999999996 107.058 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -70.21 135.41 49.02 Favored 'General case' 0 C--N 1.272 -2.786 0 CA-C-O 121.557 0.694 . . . . 73.109999999999999 112.394 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -74.06 -28.54 61.46 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 113.677 -1.601 . . . . 61.109999999999999 109.069 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -144.36 120.26 6.19 Favored Pre-proline 0 C--N 1.314 -0.973 0 N-CA-C 105.906 -1.887 . . . . 64.439999999999998 105.906 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.511 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 57.6 Cg_endo -67.33 -21.63 47.21 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.522 2.148 . . . . 73.150000000000006 114.241 -176.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -82.61 -26.11 32.58 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.5 0.667 . . . . 64.239999999999995 109.255 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -90.27 134.08 32.02 Favored Pre-proline 0 C--N 1.299 -1.627 0 N-CA-C 108.012 -1.106 . . . . 60.039999999999999 108.012 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -70.18 -9.26 25.56 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 122.351 2.034 . . . . 71.230000000000004 112.181 176.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -68.96 125.69 27.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.559 -0.746 . . . . 60.119999999999997 110.061 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 39.5 p -102.63 156.35 17.68 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 116.496 -0.32 . . . . 72.040000000000006 110.207 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.4 tp -95.54 126.11 40.6 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.798 -0.815 . . . . 74.219999999999999 108.798 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -120.66 127.04 51.7 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.205 -1.035 . . . . 75.099999999999994 108.205 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.416 ' HG ' HG22 ' A' ' 35' ' ' VAL . 7.3 mp -116.37 116.54 27.9 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 123.51 0.506 . . . . 73.109999999999999 109.683 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 39.1 tt0 -128.52 162.88 26.19 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.782 -1.192 . . . . 62.229999999999997 107.782 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -71.36 145.36 49.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 118.728 0.694 . . . . 73.439999999999998 109.23 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.58 157.89 34.65 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.694 -0.854 . . . . 52.539999999999999 108.694 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 13.1 tmtt? -80.24 -9.85 59.74 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.092 0.948 . . . . 75.430000000000007 108.6 -176.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -157.14 126.13 5.88 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.184 -1.371 . . . . 54.039999999999999 107.567 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.663 HD21 ' HA ' ' A' ' 30' ' ' VAL . 91.5 m-20 -72.26 141.15 48.93 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.241 -0.436 . . . . 74.030000000000001 110.243 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.1 t -94.96 134.43 37.64 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.367 -0.533 . . . . 74.439999999999998 109.979 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -94.85 92.02 6.73 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.575 -0.898 . . . . 72.409999999999997 108.575 175.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.1 tpt -67.24 -57.66 6.27 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.799 -1.091 . . . . 53.310000000000002 110.545 -176.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -112.79 89.88 3.19 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 121.288 0.566 . . . . 71.409999999999997 111.001 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -152.31 97.98 2.35 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.959 -0.756 . . . . 62.509999999999998 108.959 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.3 m -107.05 114.85 29.18 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.865 -1.531 . . . . 75.109999999999999 106.865 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -134.46 137.69 44.16 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 110.355 -0.239 . . . . 73.430000000000007 110.355 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.9 tp -73.67 -69.73 0.42 Allowed 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.825 -0.625 . . . . 75.109999999999999 109.522 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 C--N 1.307 -1.258 0 CA-C-N 116.135 -0.484 . . . . 54.439999999999998 110.459 -178.297 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 21.7 ptp . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 110.301 -0.259 . . . . 71.150000000000006 110.301 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.29 -49.15 58.62 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 112.38 0.511 . . . . 60.409999999999997 112.38 -171.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -126.9 131.02 51.24 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 120.843 0.354 . . . . 74.340000000000003 110.082 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.551 ' H ' ' CD ' ' B' ' 29' ' ' GLU . 1.3 mp0 -68.07 96.05 0.6 Allowed 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 108.241 -1.022 . . . . 75.140000000000001 108.241 173.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.429 ' HA ' HD21 ' B' ' 109' ' ' ASN . 68.3 t -84.49 109.52 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 104.766 -2.309 . . . . 23.239999999999998 104.766 171.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -116.18 10.68 14.98 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.636 -0.711 . . . . 73.120000000000005 110.743 -171.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 57.9 m -120.46 129.8 54.02 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-O 121.5 0.667 . . . . 60.350000000000001 110.657 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.432 ' N ' HD12 ' B' ' 33' ' ' LEU . 2.4 mp -112.34 143.25 43.76 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.611 -1.255 . . . . 75.25 107.611 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.545 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 26.3 p90 -101.3 116.85 33.74 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 107.437 -1.32 . . . . 73.409999999999997 107.437 172.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.444 HG22 ' HG ' ' B' ' 103' ' ' LEU . 41.2 t -98.81 114.98 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.329 0 CA-C-N 114.21 -1.359 . . . . 73.109999999999999 107.468 -177.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.8 p -124.53 154.18 40.97 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 116.285 -0.416 . . . . 73.230000000000004 110.295 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.51 4.29 32.51 Favored Glycine 0 N--CA 1.431 -1.685 0 O-C-N 123.561 0.538 . . . . 42.32 111.969 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 86.3 mt -71.66 132.58 85.21 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 107.372 -1.344 . . . . 74.120000000000005 107.372 175.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . 0.403 ' C ' ' H ' ' B' ' 41' ' ' ASP . 37.4 Cg_endo -65.99 160.89 42.16 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.62 1.546 . . . . 54.539999999999999 111.677 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.467 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 9.4 p -69.91 4.99 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.6 0 CA-C-O 122.148 0.975 . . . . 54.030000000000001 111.274 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' B' ' 39' ' ' PRO . 27.9 t70 -125.51 19.01 8.1 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.616 1.166 . . . . 72.040000000000006 109.19 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.12 127.5 20.87 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 CA-C-O 121.843 0.83 . . . . 62.520000000000003 111.086 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.462 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 70.1 mmtt -98.71 137.35 20.58 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.07 -0.968 . . . . 75.340000000000003 108.936 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -53.74 -32.48 65.93 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.857 2.372 . . . . 73.340000000000003 113.236 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.575 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 0.0 OUTLIER -73.15 -15.8 61.46 Favored 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 119.374 -0.931 . . . . 74.340000000000003 112.324 -179.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.462 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 47.6 mt-10 -69.55 -36.06 75.98 Favored 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 121.893 -0.504 . . . . 75.109999999999999 110.23 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.88 -26.38 64.16 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 121.732 0.777 . . . . 73.5 108.919 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.511 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 58.3 t80 -73.33 -34.91 65.93 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.911 -1.041 . . . . 75.200000000000003 110.215 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 67.1 mt -78.48 -41.51 32.39 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.271 -0.64 . . . . 73.010000000000005 109.271 177.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 30.6 tp -66.09 -46.52 77.35 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.21 -0.904 . . . . 62.109999999999999 111.482 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -95.03 14.92 20.28 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 112.221 0.452 . . . . 75.319999999999993 112.221 -176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.486 ' CZ ' ' HA ' ' B' ' 52' ' ' ARG . 0.8 OUTLIER -59.46 -52.12 76.44 Favored Pre-proline 0 CA--C 1.56 1.349 0 CA-C-N 115.864 -0.607 . . . . 63.439999999999998 111.743 178.466 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.3 -1.48 11.12 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 121.607 1.538 . . . . 61.409999999999997 112.728 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -89.54 91.6 8.76 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 122.024 0.916 . . . . 74.530000000000001 110.673 -177.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -75.4 109.85 9.28 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.21 -1.359 . . . . 74.099999999999994 108.785 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.65 -14.04 4.19 Favored Glycine 0 C--N 1.293 -1.813 0 CA-C-N 115.058 -0.974 . . . . 64.099999999999994 111.753 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -59.93 109.89 1.05 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.191 0.52 . . . . 74.510000000000005 110.527 175.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -86.09 -49.35 7.85 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.737 -0.665 . . . . 54.030000000000001 110.435 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.11 -175.69 45.46 Favored Glycine 0 C--N 1.294 -1.797 0 C-N-CA 120.13 -1.033 . . . . 23.510000000000002 112.175 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 21.5 p -148.17 143.27 26.96 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 122.377 0.271 . . . . 60.240000000000002 111.335 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 85.3 mt -116.83 127.21 54.08 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.474 -0.936 . . . . 74.040000000000006 108.474 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 47.4 mm -94.56 136.46 25.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.198 -0.667 . . . . 53.009999999999998 109.198 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -127.58 115.4 18.75 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.016 -0.735 . . . . 74.129999999999995 109.016 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.21 109.46 5.26 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.235 -0.654 . . . . 62.219999999999999 109.235 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 19.6 m -100.6 156.23 17.42 Favored 'General case' 0 N--CA 1.407 -2.611 0 N-CA-C 104.458 -2.423 . . . . 71.319999999999993 104.458 175.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.41 -37.58 17.38 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 113.65 0.981 . . . . 62.32 113.65 -173.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -102.78 -16.54 15.93 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.191 1.182 . . . . 63.43 114.191 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.532 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 4.4 pt20 -173.77 142.45 0.92 Allowed Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-N 118.167 0.44 . . . . 63.240000000000002 111.731 -174.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.467 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 14.9 Cg_exo -68.77 115.19 3.82 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 123.05 2.5 . . . . 74.019999999999996 111.096 170.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -92.55 167.35 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.038 -1.097 . . . . 70.340000000000003 108.038 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.62 122.68 2.43 Favored Glycine 0 C--O 1.207 -1.585 0 C-N-CA 118.87 -1.633 . . . . 54.509999999999998 113.621 -176.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -88.11 107.73 18.9 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.636 -1.246 . . . . 72.510000000000005 107.636 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 90.2 t -101.17 129.16 52.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 115.185 -0.916 . . . . 73.120000000000005 110.978 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.49 HD12 ' O ' ' B' ' 110' ' ' THR . 3.4 tt -101.85 134.33 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 115.253 -0.885 . . . . 62.210000000000001 110.351 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -113.57 158.35 20.89 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.97 -1.014 . . . . 64.239999999999995 110.738 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.1 -34.66 78.08 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.823 -1.535 . . . . 74.340000000000003 112.4 175.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 46.4 m -135.75 152.14 50.83 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 120.757 -0.377 . . . . 70.019999999999996 110.736 -173.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . 0.567 ' HD3' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -80.08 -26.6 39.52 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.393 0.616 . . . . 63.310000000000002 109.343 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.05 -21.14 51.11 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 107.726 -1.212 . . . . 52.240000000000002 107.726 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.47 -39.58 14.67 Favored Glycine 0 C--N 1.31 -0.884 0 N-CA-C 109.276 -1.529 . . . . 32.009999999999998 109.276 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.02 -42.61 97.06 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.322 -0.939 . . . . 62.329999999999998 111.501 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.84 -37.64 88.29 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.782 0.325 . . . . 61.240000000000002 111.556 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.15 -37.21 69.43 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.054 0.454 . . . . 70.140000000000001 110.336 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.84 -42.96 80.62 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.497 -0.774 . . . . 62.049999999999997 111.027 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.43 ' CE ' ' HA ' ' B' ' 104' ' ' GLU . 14.9 ptmm? -68.2 -37.1 80.54 Favored 'General case' 0 C--O 1.206 -1.189 0 C-N-CA 120.585 -0.446 . . . . 73.019999999999996 110.744 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -66.68 -29.53 69.55 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 120.863 0.363 . . . . 62.0 111.427 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.34 -44.42 25.21 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 116.166 -0.47 . . . . 70.310000000000002 111.252 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.581 ' O ' HG22 ' B' ' 91' ' ' ILE . 99.3 mt -94.75 -11.96 28.05 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 115.356 1.613 . . . . 72.400000000000006 115.356 -173.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -76.2 115.64 16.12 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 118.257 -1.377 . . . . 71.219999999999999 109.825 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.99 11.56 24.07 Favored Glycine 0 CA--C 1.482 -2.01 0 C-N-CA 120.463 -0.875 . . . . 74.329999999999998 111.767 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.581 HG22 ' O ' ' B' ' 88' ' ' LEU . 14.4 tt -99.66 140.54 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.624 0 N-CA-C 107.665 -1.235 . . . . 54.509999999999998 107.665 175.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.44 ' CG ' HG22 ' B' ' 100' ' ' THR . 79.3 mtt180 -81.75 128.67 34.23 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-O 120.985 0.421 . . . . 74.219999999999999 110.175 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.74 -34.39 77.77 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.55 -1.205 . . . . 75.109999999999999 110.063 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -144.5 126.1 7.98 Favored Pre-proline 0 C--N 1.312 -1.047 0 N-CA-C 106.405 -1.702 . . . . 70.239999999999995 106.405 174.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . 0.457 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 60.4 Cg_endo -69.84 -0.41 6.93 Favored 'Trans proline' 0 N--CA 1.486 1.031 0 C-N-CA 123.266 2.644 . . . . 74.510000000000005 114.386 -173.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -91.75 -25.65 18.95 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.54 0.686 . . . . 73.409999999999997 109.542 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -91.81 139.16 24.68 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 108.144 -1.058 . . . . 74.400000000000006 108.144 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -69.6 -20.78 35.16 Favored 'Trans proline' 0 C--O 1.247 0.932 0 C-N-CA 121.763 1.642 . . . . 60.130000000000003 111.014 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -55.57 131.17 45.61 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.502 1.121 . . . . 62.43 110.621 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.44 HG22 ' CG ' ' B' ' 92' ' ' ARG . 75.2 p -112.76 160.03 18.36 Favored 'General case' 0 N--CA 1.418 -2.061 0 C-N-CA 120.177 -0.609 . . . . 72.400000000000006 109.78 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 20.2 tp -96.8 121.23 38.43 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.261 -1.014 . . . . 54.509999999999998 108.261 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -112.51 123.13 49.61 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.242 -1.022 . . . . 74.430000000000007 108.242 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.444 ' HG ' HG22 ' B' ' 35' ' ' VAL . 7.1 mp -110.5 115.7 30.1 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 109.381 -0.6 . . . . 74.219999999999999 109.381 172.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.545 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 34.2 tt0 -129.87 157.58 41.86 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.321 -1.362 . . . . 74.329999999999998 107.321 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . 0.417 ' HB3' HG11 ' B' ' 30' ' ' VAL . 25.6 m-85 -66.7 138.46 57.42 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 118.602 0.637 . . . . 75.540000000000006 110.693 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.36 152.26 30.52 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 108.902 -0.777 . . . . 74.129999999999995 108.902 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' B' ' 107' ' ' LYS . 14.4 tmtt? -78.49 -6.93 56.79 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.4 -0.818 . . . . 54.240000000000002 110.053 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.18 132.87 21.0 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.127 -0.942 . . . . 73.219999999999999 108.824 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.429 HD21 ' HA ' ' B' ' 30' ' ' VAL . 91.2 m-20 -87.13 143.09 27.46 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.326 -0.397 . . . . 72.349999999999994 110.249 177.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.49 ' O ' HD12 ' B' ' 74' ' ' ILE . 12.8 t -112.15 151.63 29.26 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 107.572 -1.27 . . . . 71.540000000000006 107.572 176.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -107.01 140.82 39.2 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.972 -1.121 . . . . 74.230000000000004 107.972 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -64.93 1.08 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.958 -1.497 . . . . 64.209999999999994 106.958 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.34 97.07 6.11 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.902 -0.59 . . . . 52.549999999999997 110.642 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -153.79 100.61 2.39 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.287 -0.635 . . . . 71.209999999999994 109.287 175.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 18.9 m -112.28 90.2 3.28 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.79 -0.819 . . . . 62.439999999999998 108.79 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -106.62 104.64 14.37 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.918 -1.141 . . . . 62.25 107.918 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 56.9 tp -78.11 -37.48 46.23 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.62 0.724 . . . . 62.109999999999999 109.194 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.418 -2.046 0 CA-C-N 114.904 -1.044 . . . . 55.350000000000001 108.883 177.327 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 48.6 ttm . . . . . 0 C--O 1.222 -0.391 0 CA-C-O 120.491 0.186 . . . . 75.310000000000002 111.29 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -123.48 27.94 7.22 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 110.349 -0.241 . . . . 75.019999999999996 110.349 -172.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 65.82 84.11 0.16 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.228 0.955 . . . . 73.430000000000007 109.594 -173.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -80.03 -178.63 6.6 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.974 -1.012 . . . . 74.400000000000006 108.867 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.4 t -74.74 110.3 8.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 118.942 -1.103 . . . . 72.099999999999994 109.636 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -102.52 13.45 34.5 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.194 -1.366 . . . . 73.299999999999997 111.244 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 109' ' ' ASN . 23.8 m -139.02 132.51 30.29 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.917 -0.713 . . . . 70.519999999999996 111.576 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.7 mt -110.73 145.88 37.27 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.341 -0.985 . . . . 73.239999999999995 108.341 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -101.65 111.2 23.37 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 107.29 -1.374 . . . . 62.520000000000003 107.29 173.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.45 HG22 ' HG ' ' A' ' 103' ' ' LEU . 47.2 t -97.44 120.92 47.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.178 -1.374 . . . . 73.040000000000006 108.013 -177.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 p -126.98 168.64 14.27 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 115.335 -0.848 . . . . 72.420000000000002 109.217 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 100' ' ' THR . . . 88.58 39.64 6.62 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 111.085 -0.806 . . . . 71.019999999999996 111.085 -177.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 99.6 mt -105.37 137.97 19.42 Favored Pre-proline 0 N--CA 1.418 -2.041 0 N-CA-C 108.325 -0.991 . . . . 73.510000000000005 108.325 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -56.76 159.43 14.16 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.941 1.761 . . . . 75.439999999999998 109.183 171.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.574 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 8.9 p -80.86 -0.75 4.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 122.435 1.112 . . . . 64.310000000000002 110.677 -168.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -117.42 16.25 14.71 Favored 'General case' 0 N--CA 1.413 -2.276 0 CA-C-N 114.552 -1.204 . . . . 72.140000000000001 110.809 -172.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.482 HG13 ' HG2' ' A' ' 69' ' ' PRO 0.272 2.7 pp -55.82 136.38 18.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 114.47 1.285 . . . . 71.129999999999995 114.47 -177.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.546 ' HD3' ' CD ' ' A' ' 46' ' ' GLU . 6.6 mptt -103.1 149.8 37.24 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 106.689 -1.597 . . . . 74.319999999999993 106.689 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.19 -28.68 88.41 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.361 2.04 . . . . 73.349999999999994 112.0 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.662 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 20.3 ptt180 -68.16 -30.38 69.49 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 116.165 -0.47 . . . . 75.120000000000005 111.712 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.546 ' CD ' ' HD3' ' A' ' 43' ' ' LYS . 46.5 mt-10 -69.0 -42.41 76.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.022 0.439 . . . . 74.519999999999996 110.185 -175.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.56 -43.11 94.94 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.508 -0.923 . . . . 72.219999999999999 108.508 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.544 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 37.4 t80 -57.79 -45.1 86.54 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.414 -1.266 . . . . 72.310000000000002 111.626 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 88.4 mt -64.73 -40.46 95.36 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.366 0.603 . . . . 65.409999999999997 110.305 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 tp -70.08 -43.67 70.65 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.897 -1.047 . . . . 74.340000000000003 111.106 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -84.99 6.82 23.58 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 114.065 1.135 . . . . 64.430000000000007 114.065 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.491 ' HA ' ' NE ' ' A' ' 52' ' ' ARG . 3.2 mmp_? -50.59 -52.23 57.84 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 113.482 0.919 . . . . 74.239999999999995 113.482 177.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.38 -1.36 9.71 Favored 'Trans proline' 0 C--N 1.365 1.436 0 C-N-CA 121.795 1.663 . . . . 72.209999999999994 113.248 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -89.5 107.82 19.29 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 122.1 0.953 . . . . 71.129999999999995 112.38 -175.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -76.78 112.16 13.07 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 113.852 -1.522 . . . . 75.310000000000002 111.054 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 75' ' ' PHE . . . 142.4 -32.04 1.99 Allowed Glycine 0 N--CA 1.424 -2.147 0 CA-C-N 114.653 -1.158 . . . . 73.230000000000004 111.19 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.05 118.25 4.49 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.667 0.787 . . . . 74.349999999999994 112.705 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -108.1 -35.71 6.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.272 0.558 . . . . 61.329999999999998 110.652 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.56 -178.38 48.37 Favored Glycine 0 C--N 1.306 -1.084 0 C-N-CA 120.154 -1.022 . . . . 75.230000000000004 112.441 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.6 p -144.29 137.56 27.31 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.613 0.206 . . . . 70.430000000000007 111.43 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -107.83 114.32 28.19 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 107.725 -1.213 . . . . 73.349999999999994 107.725 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.53 136.59 26.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 110.334 -0.247 . . . . 74.319999999999993 110.334 -175.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 69' ' ' PRO . 63.4 tttp -124.99 106.94 10.33 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 109.353 -0.61 . . . . 62.340000000000003 109.353 176.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.87 109.17 7.16 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.707 -0.849 . . . . 72.450000000000003 108.707 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.4 m -104.97 164.11 12.03 Favored 'General case' 0 N--CA 1.41 -2.455 0 N-CA-C 105.373 -2.084 . . . . 65.200000000000003 105.373 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.02 -33.76 62.9 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.704 0.683 . . . . 70.109999999999999 111.903 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.494 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 1.5 tpm_? -82.18 -52.28 7.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 112.201 0.445 . . . . 71.230000000000004 112.201 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -160.22 152.55 17.28 Favored Pre-proline 0 C--N 1.289 -2.033 0 CA-C-N 115.878 -0.601 . . . . 63.32 109.853 -171.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.574 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 58.3 Cg_endo -80.16 108.73 2.24 Favored 'Trans proline' 0 N--CA 1.431 -2.187 0 C-N-CA 122.546 2.164 . . . . 72.430000000000007 110.051 168.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.5 m -83.04 160.33 3.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.109 -1.071 . . . . 64.439999999999998 108.109 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.41 120.71 2.25 Favored Glycine 0 CA--C 1.474 -2.504 0 C-N-CA 118.042 -2.028 . . . . 55.240000000000002 112.747 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -88.37 102.52 14.95 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 106.622 -1.622 . . . . 75.209999999999994 106.622 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.07 127.28 47.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-N 115.429 -0.805 . . . . 74.209999999999994 109.948 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.9 pt -98.0 135.24 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.301 0 CA-C-N 115.155 -0.929 . . . . 75.129999999999995 110.722 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 87.9 m-85 -121.98 149.53 43.33 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.341 -1.3 . . . . 72.510000000000005 108.559 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -52.64 -44.23 65.97 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 124.486 1.116 . . . . 74.349999999999994 111.585 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.1 m -145.34 158.09 43.9 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.72 -0.673 . . . . 74.329999999999998 110.235 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.456 ' HD3' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -66.24 -26.68 67.48 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.857 -0.61 . . . . 72.519999999999996 109.872 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.02 -28.05 69.54 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.366 -0.834 . . . . 62.539999999999999 110.15 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.01 -37.07 8.58 Favored Glycine 0 C--N 1.311 -0.812 0 N-CA-C 109.774 -1.33 . . . . 23.210000000000001 109.774 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.67 -44.45 93.73 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.491 -0.854 . . . . 72.25 111.728 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.4 -35.98 82.2 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.862 0.363 . . . . 61.329999999999998 111.832 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.35 -42.04 69.01 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.027 0.441 . . . . 65.420000000000002 110.052 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.62 95.76 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.666 -0.697 . . . . 71.430000000000007 111.258 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.421 ' CE ' ' HA ' ' A' ' 104' ' ' GLU . 14.8 ptmm? -70.56 -33.57 71.27 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 120.538 -0.465 . . . . 64.010000000000005 110.657 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -69.48 -36.49 76.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.887 0.375 . . . . 74.140000000000001 110.839 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.85 -41.93 42.09 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.07 0.462 . . . . 40.43 111.859 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 91' ' ' ILE . 85.8 mt -93.95 -9.75 36.0 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 115.085 1.513 . . . . 73.230000000000004 115.085 -172.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -74.95 118.39 17.86 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 117.898 -1.521 . . . . 72.040000000000006 108.828 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.23 12.56 48.48 Favored Glycine 0 N--CA 1.424 -2.152 0 CA-C-N 115.468 -0.787 . . . . 40.229999999999997 111.794 176.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.7 tt -100.84 134.46 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.965 0 N-CA-C 108.185 -1.042 . . . . 71.319999999999993 108.185 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.542 ' HG2' HG22 ' A' ' 100' ' ' THR . 82.7 mtt180 -79.41 142.31 36.07 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 115.445 -0.798 . . . . 71.329999999999998 112.448 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -75.88 -28.89 58.29 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.548 -1.66 . . . . 74.209999999999994 108.394 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.597 ' OD2' ' HB3' ' B' ' 45' ' ' ARG . 6.2 m-20 -138.22 127.76 14.83 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 104.138 -2.542 . . . . 71.030000000000001 104.138 173.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.61 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 18.0 Cg_endo -58.92 -26.73 82.26 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.093 1.862 . . . . 73.450000000000003 112.444 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -90.76 -5.14 56.08 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.461 -0.79 . . . . 72.409999999999997 111.82 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.464 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 52.7 t-20 -104.17 125.96 32.95 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 108.171 -1.048 . . . . 73.310000000000002 108.171 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -64.53 -7.07 13.36 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 123.15 2.567 . . . . 62.5 113.349 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -77.44 115.32 17.11 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.691 -0.855 . . . . 65.099999999999994 108.691 176.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.542 HG22 ' HG2' ' A' ' 92' ' ' ARG . 27.7 p -116.12 153.05 32.46 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.158 -1.053 . . . . 71.230000000000004 108.158 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.6 mp -82.85 140.52 32.87 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 118.417 0.553 . . . . 71.549999999999997 111.102 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.6 108.81 10.19 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.659 -1.608 . . . . 75.340000000000003 106.659 176.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.45 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.8 mp -102.61 123.26 46.01 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.951 -0.568 . . . . 60.450000000000003 111.818 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.421 ' HA ' ' CE ' ' A' ' 85' ' ' LYS . 17.2 mm-40 -132.34 164.32 26.72 Favored 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 123.435 0.694 . . . . 75.340000000000003 109.807 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -73.68 143.32 46.27 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.468 -0.567 . . . . 64.109999999999999 109.468 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.46 157.07 37.53 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.146 -1.057 . . . . 75.239999999999995 108.146 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -72.73 -13.32 61.31 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.383 1.087 . . . . 71.549999999999997 110.503 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.81 127.01 3.98 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 105.985 -1.857 . . . . 55.329999999999998 105.985 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.476 ' HA ' ' HB ' ' A' ' 32' ' ' THR . 7.1 p30 -79.19 144.42 34.44 Favored 'General case' 0 CA--C 1.47 -2.104 0 C-N-CA 118.517 -1.273 . . . . 63.420000000000002 108.918 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.0 t -124.1 115.11 20.61 Favored 'General case' 0 N--CA 1.395 -3.213 0 C-N-CA 118.544 -1.262 . . . . 74.530000000000001 112.548 -173.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -41.83 124.45 2.6 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.045 -1.889 . . . . 65.329999999999998 109.02 168.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -45.79 -60.53 2.17 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.335 1.054 . . . . 74.549999999999997 110.357 -175.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -99.27 92.39 5.41 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 107.87 -1.159 . . . . 73.019999999999996 107.87 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.1 102.79 0.53 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.38 -0.827 . . . . 71.450000000000003 109.613 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.5 t -92.58 -164.75 1.22 Allowed 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 114.702 -1.135 . . . . 64.540000000000006 108.186 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.2 tttm 69.32 67.88 0.26 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.899 1.333 . . . . 63.409999999999997 109.177 -174.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.8 tp -134.58 -31.49 1.06 Allowed 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 113.046 -1.888 . . . . 64.409999999999997 107.271 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 N--CA 1.429 -1.511 0 N-CA-C 108.177 -1.046 . . . . 74.129999999999995 108.177 177.623 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 94.1 mmm . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 114.038 1.125 . . . . 71.319999999999993 114.038 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -69.33 102.97 1.85 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.665 0.617 . . . . 45.409999999999997 112.665 -170.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 56.18 37.85 29.25 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.707 0.803 . . . . 71.0 109.406 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -85.44 154.45 21.81 Favored 'General case' 0 N--CA 1.409 -2.51 0 CA-C-N 114.883 -1.053 . . . . 63.340000000000003 111.396 -171.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.0 112.1 4.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-N 114.441 -1.254 . . . . 63.109999999999999 110.991 -171.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.697 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 72.2 mtt180 -95.44 -2.59 48.51 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.287 -0.87 . . . . 72.530000000000001 109.921 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 16.0 m -101.03 137.92 38.76 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 114.977 -1.01 . . . . 52.130000000000003 112.265 -174.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 77.2 mt -117.52 146.24 43.69 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.696 -1.224 . . . . 73.209999999999994 107.696 173.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -99.53 118.98 37.29 Favored 'General case' 0 N--CA 1.42 -1.974 0 C-N-CA 118.486 -1.286 . . . . 71.430000000000007 107.811 173.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.467 HG22 ' HG ' ' B' ' 103' ' ' LEU . 35.2 t -97.32 109.09 22.66 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 N-CA-C 106.318 -1.734 . . . . 60.43 106.318 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -116.54 170.34 8.65 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-N 115.094 -0.957 . . . . 64.329999999999998 108.867 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 81.23 46.33 7.04 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.705 -0.958 . . . . 75.099999999999994 110.705 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 91.3 mt -114.37 141.44 26.51 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 107.573 -1.269 . . . . 74.430000000000007 107.573 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -59.99 161.4 19.1 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 121.585 1.523 . . . . 72.349999999999994 110.395 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.618 ' HA ' ' HD3' ' B' ' 69' ' ' PRO . 8.8 p -86.07 7.89 2.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 122.477 1.132 . . . . 74.329999999999998 109.752 -171.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -127.9 19.13 6.61 Favored 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 114.79 -1.095 . . . . 72.099999999999994 111.402 -174.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.427 HG12 ' HG2' ' B' ' 69' ' ' PRO . 32.6 pt -58.07 134.81 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 114.424 1.268 . . . . 74.109999999999999 114.424 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -101.44 145.85 31.17 Favored Pre-proline 0 C--N 1.297 -1.707 0 CA-C-N 113.908 -1.496 . . . . 73.140000000000001 110.066 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -55.97 -27.98 66.48 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.258 2.639 . . . . 74.109999999999999 113.484 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.597 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 23.9 ptt180 -70.36 -28.67 65.3 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 121.179 0.514 . . . . 73.010000000000005 111.051 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -69.84 -40.01 76.09 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.839 -0.619 . . . . 75.140000000000001 110.204 -176.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.97 -41.59 95.32 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 108.708 -0.849 . . . . 71.319999999999993 108.708 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.61 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 7.3 t80 -57.1 -47.1 81.87 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.73 -1.123 . . . . 72.25 111.32 177.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 82.5 mt -61.1 -42.7 99.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.11 0.481 . . . . 73.409999999999997 110.789 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.412 HD13 HD22 ' A' ' 49' ' ' LEU . 37.9 tp -73.86 -42.99 60.0 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.198 -0.91 . . . . 64.200000000000003 111.936 -176.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -89.02 -10.49 47.36 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 115.623 1.712 . . . . 75.409999999999997 115.623 -173.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 14.1 mtp180 -54.28 -52.41 69.26 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 113.603 0.964 . . . . 70.319999999999993 113.603 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.3 -21.18 71.03 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 121.668 1.578 . . . . 73.019999999999996 112.304 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -88.42 86.59 7.07 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.662 0.744 . . . . 64.510000000000005 109.564 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -68.5 112.87 5.58 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.282 -1.326 . . . . 70.150000000000006 108.464 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 149.39 -28.52 1.21 Allowed Glycine 0 C--N 1.288 -2.087 0 CA-C-N 114.186 -1.37 . . . . 60.439999999999998 110.16 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -58.83 117.12 4.26 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.471 0.708 . . . . 64.209999999999994 111.568 176.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -102.02 -59.85 1.63 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.995 0.426 . . . . 72.140000000000001 111.212 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.78 172.37 31.17 Favored Glycine 0 C--N 1.295 -1.702 0 C-N-CA 120.559 -0.829 . . . . 71.109999999999999 112.181 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.1 p -135.39 137.04 41.92 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 122.903 0.481 . . . . 54.420000000000002 110.622 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.56 110.17 17.04 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.382 -1.34 . . . . 73.439999999999998 107.382 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.35 138.03 21.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 120.748 0.308 . . . . 73.430000000000007 110.923 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' B' ' 69' ' ' PRO . 0.6 OUTLIER -117.14 106.77 13.69 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.662 -1.607 . . . . 71.239999999999995 106.662 176.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.75 124.17 24.79 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.182 -0.917 . . . . 72.219999999999999 109.04 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 7.8 m -127.09 151.94 47.96 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 103.214 -2.884 . . . . 61.310000000000002 103.214 177.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.33 -33.36 65.54 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.063 0.764 . . . . 74.239999999999995 113.063 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -86.98 -38.7 16.37 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 120.19 -0.604 . . . . 71.0 112.294 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' B' ' 65' ' ' THR . 28.4 pt20 -161.53 135.3 4.91 Favored Pre-proline 0 C--N 1.297 -1.691 0 CA-C-O 120.495 0.188 . . . . 71.510000000000005 111.485 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.618 ' HD3' ' HA ' ' B' ' 40' ' ' VAL . 18.0 Cg_endo -80.55 109.8 2.33 Favored 'Trans proline' 0 N--CA 1.427 -2.411 0 C-N-CA 122.064 1.842 . . . . 62.130000000000003 109.508 168.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -84.68 147.9 5.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.436 -0.95 . . . . 51.240000000000002 108.436 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.28 120.56 4.58 Favored Glycine 0 CA--C 1.481 -2.056 0 C-N-CA 118.647 -1.74 . . . . 74.329999999999998 112.847 -175.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -87.74 102.72 14.93 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.628 -1.619 . . . . 70.439999999999998 106.628 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 69.2 t -100.11 128.73 51.75 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 114.923 -1.035 . . . . 70.120000000000005 110.117 -174.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 45.8 pt -101.76 132.67 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 CA-C-O 122.165 0.983 . . . . 65.540000000000006 110.865 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.697 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 79.9 m-85 -111.15 142.64 43.06 Favored 'General case' 0 C--N 1.266 -3.028 0 CA-C-N 113.744 -1.571 . . . . 75.209999999999994 107.9 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.95 -24.92 67.66 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.308 0.575 . . . . 75.349999999999994 110.704 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 3.1 m -129.75 131.82 46.39 Favored 'General case' 0 N--CA 1.386 -3.67 0 N-CA-C 107.429 -1.323 . . . . 74.200000000000003 107.429 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . 0.702 ' NE ' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -80.93 -24.11 38.39 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.952 -0.567 . . . . 73.109999999999999 110.301 179.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.16 -20.52 57.49 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 105.316 -2.105 . . . . 70.219999999999999 105.316 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.81 -40.31 15.01 Favored Glycine 0 C--N 1.314 -0.65 0 CA-C-N 112.672 -2.058 . . . . 61.119999999999997 109.282 177.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.31 -47.27 86.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.111 -1.045 . . . . 51.420000000000002 110.912 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 10.9 pt-20 -63.7 -31.2 72.3 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.54 -0.464 . . . . 71.010000000000005 112.124 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.64 -42.15 67.92 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.712 0.291 . . . . 70.209999999999994 110.545 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.28 -39.29 82.16 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.55 -0.75 . . . . 63.140000000000001 111.105 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' B' ' 82' ' ' GLU . 14.4 ptmm? -66.06 -37.34 85.59 Favored 'General case' 0 C--O 1.199 -1.554 0 C-N-CA 120.606 -0.438 . . . . 73.129999999999995 110.288 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -55.79 -32.82 63.82 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 120.961 0.41 . . . . 73.420000000000002 111.772 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.09 -36.45 19.62 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 112.406 0.521 . . . . 54.130000000000003 112.406 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.604 ' O ' HG22 ' B' ' 91' ' ' ILE . 97.5 mt -95.69 -22.14 17.74 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 116.019 1.859 . . . . 74.530000000000001 116.019 -173.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . 0.459 ' HB3' ' H ' ' B' ' 103' ' ' LEU . 0.3 OUTLIER -74.99 113.3 12.15 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 118.441 -1.304 . . . . 75.209999999999994 110.514 178.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.46 16.17 16.94 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 120.761 -0.733 . . . . 72.049999999999997 111.344 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.604 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.3 tt -113.37 145.31 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.81 0 N-CA-C 107.844 -1.169 . . . . 74.319999999999993 107.844 175.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.554 ' CG ' HG22 ' B' ' 100' ' ' THR . 97.7 mtt180 -82.31 145.02 30.19 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 113.325 0.861 . . . . 74.519999999999996 113.325 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.411 ' HB2' HD11 ' B' ' 101' ' ' LEU . 22.0 t80 -77.24 -34.87 55.81 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.405 -1.725 . . . . 74.409999999999997 107.264 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' A' ' 45' ' ' ARG . 5.2 m-20 -134.34 120.62 14.91 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 105.249 -2.13 . . . . 73.340000000000003 105.249 176.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . 0.544 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 18.1 Cg_endo -60.78 -24.22 78.38 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 121.897 1.731 . . . . 73.109999999999999 112.21 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -84.71 -14.62 47.84 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 123.725 0.81 . . . . 74.5 110.776 -176.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' ASN . . . . . 0.445 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . 53.7 t-20 -104.52 133.44 20.19 Favored Pre-proline 0 C--N 1.31 -1.142 0 N-CA-C 107.538 -1.282 . . . . 55.439999999999998 107.538 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.52 -5.39 15.09 Favored 'Trans proline' 0 CA--C 1.55 1.294 0 C-N-CA 122.524 2.149 . . . . 74.439999999999998 112.916 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -72.01 116.97 13.04 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 109.244 -0.65 . . . . 42.109999999999999 109.244 177.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.618 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 67.2 p -115.87 152.17 33.88 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.974 -0.75 . . . . 62.439999999999998 108.974 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' B' ' 93' ' ' PHE . 6.4 mp -84.08 139.69 32.31 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.11 0.481 . . . . 71.310000000000002 110.487 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -125.3 109.49 12.86 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 107.134 -1.432 . . . . 71.209999999999994 107.134 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.467 ' HG ' HG22 ' B' ' 35' ' ' VAL . 6.8 mp -99.39 119.56 38.16 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 108.467 -0.938 . . . . 74.239999999999995 108.467 173.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.406 ' HA ' ' CE ' ' B' ' 85' ' ' LYS . 36.7 mm-40 -136.22 165.37 25.89 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.101 -1.074 . . . . 62.32 108.101 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -71.17 137.04 48.43 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 118.727 0.694 . . . . 74.420000000000002 110.544 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.63 152.92 29.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 116.216 -0.447 . . . . 53.420000000000002 110.032 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -73.17 -12.85 61.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.859 0.838 . . . . 62.439999999999998 110.086 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.97 123.29 20.64 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.243 -0.889 . . . . 72.010000000000005 109.625 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -83.53 100.81 11.01 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.688 -1.597 . . . . 61.299999999999997 106.688 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 5.6 t -100.77 92.97 5.32 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.862 0.839 . . . . 65.239999999999995 112.517 -172.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -61.03 129.92 43.82 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.566 -1.197 . . . . 72.439999999999998 108.843 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.53 -48.42 67.05 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.422 -0.955 . . . . 73.010000000000005 108.422 -177.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.84 71.38 10.66 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.523 -0.917 . . . . 75.439999999999998 108.523 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -74.28 123.72 25.08 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.337 -1.301 . . . . 75.230000000000004 108.262 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.2 t -90.22 -166.62 1.63 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.183 -0.673 . . . . 71.420000000000002 109.183 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 57.6 tttm 74.73 81.33 0.11 Allowed 'General case' 0 C--O 1.244 0.764 0 C-N-CA 125.308 1.443 . . . . 75.040000000000006 110.886 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 41.4 tp -159.44 -48.55 0.05 Allowed 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.061 -1.829 . . . . 74.400000000000006 106.061 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 N--CA 1.436 -1.15 0 CA-C-N 114.208 -1.36 . . . . 74.200000000000003 107.645 174.333 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 47.2 ttp . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 107.094 -1.447 . . . . 75.310000000000002 107.094 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 74.07 155.28 0.16 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.583 1.153 . . . . 55.520000000000003 112.264 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 30' ' ' VAL . 43.7 mt-10 61.12 -164.99 0.23 Allowed 'General case' 0 C--N 1.341 0.215 0 O-C-N 124.325 1.016 . . . . 70.430000000000007 110.092 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.557 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -49.09 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 125.766 1.627 . . . . 75.140000000000001 110.254 168.263 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.536 HG12 ' H ' ' A' ' 32' ' ' THR . 37.5 t -104.41 113.76 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 108.106 -1.072 . . . . 71.140000000000001 108.106 177.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 13.1 ptm180 -92.65 8.58 38.48 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.3 0.571 . . . . 75.409999999999997 110.294 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.536 ' H ' HG12 ' A' ' 30' ' ' VAL . 8.7 m -122.45 129.66 52.27 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.804 0.811 . . . . 62.32 111.972 -177.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 33' ' ' LEU . 2.8 mp -110.46 141.29 43.77 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.339 -1.356 . . . . 74.120000000000005 107.339 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.671 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 11.4 p90 -101.51 128.01 47.94 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.252 -1.388 . . . . 63.0 107.252 172.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.4 t -106.76 118.32 54.27 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.623 0 N-CA-C 107.783 -1.191 . . . . 62.310000000000002 107.783 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.8 p -127.46 163.05 24.94 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.106 -0.702 . . . . 51.32 109.106 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.22 33.58 10.51 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.709 -0.956 . . . . 61.210000000000001 110.709 -174.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.7 mt -96.4 140.39 22.18 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.988 -1.116 . . . . 70.319999999999993 107.988 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -65.37 161.4 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 C-N-CA 121.315 1.344 . . . . 64.219999999999999 109.952 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 p -70.46 -8.77 11.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.79 0.805 . . . . 72.239999999999995 110.315 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -124.27 40.45 3.73 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 108.224 -1.028 . . . . 72.230000000000004 108.224 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.9 tp -60.53 125.34 16.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.115 -0.948 . . . . 74.340000000000003 109.451 173.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.606 ' HB2' ' HG3' ' A' ' 46' ' ' GLU . 26.1 mmmt -90.48 138.04 27.08 Favored Pre-proline 0 C--N 1.296 -1.757 0 N-CA-C 106.8 -1.555 . . . . 71.510000000000005 106.8 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.5 -25.07 77.48 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.485 2.123 . . . . 74.120000000000005 112.784 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 14.5 ptt180 -74.21 -27.66 60.9 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 116.012 -0.54 . . . . 74.530000000000001 111.396 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' A' ' 43' ' ' LYS . 30.5 mt-10 -62.87 -47.44 83.32 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.129 0.49 . . . . 73.239999999999995 109.964 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 99.7 mt -62.16 -45.3 94.05 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.283 -0.871 . . . . 63.140000000000001 109.803 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.682 ' CZ ' ' HD3' ' B' ' 95' ' ' PRO . 0.0 OUTLIER -60.01 -43.4 95.24 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.494 -0.776 . . . . 75.409999999999997 112.123 178.616 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 98.6 mt -64.36 -44.24 92.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.071 0.462 . . . . 74.329999999999998 110.221 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.429 ' O ' ' HD2' ' A' ' 53' ' ' PRO . 27.9 tp -66.72 -39.37 87.97 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.92 -1.036 . . . . 71.010000000000005 110.976 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -86.9 -4.49 59.18 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 114.566 1.321 . . . . 74.340000000000003 114.566 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 17.7 mtp180 -60.15 -42.87 92.08 Favored Pre-proline 0 N--CA 1.485 1.29 0 N-CA-C 113.447 0.906 . . . . 74.450000000000003 113.447 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 50' ' ' LEU . 24.5 Cg_exo -69.04 -18.36 40.4 Favored 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 121.693 1.595 . . . . 63.509999999999998 112.018 173.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -89.73 92.26 8.98 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 122.097 0.951 . . . . 74.239999999999995 110.967 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -69.4 111.79 5.51 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.177 -1.374 . . . . 63.539999999999999 109.589 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.84 -26.56 2.07 Favored Glycine 0 C--N 1.291 -1.963 0 CA-C-N 115.469 -0.787 . . . . 72.219999999999999 111.143 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -57.69 116.34 3.36 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.544 0.738 . . . . 74.219999999999999 111.698 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -96.7 -48.85 5.33 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.151 0.5 . . . . 51.149999999999999 110.323 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.69 167.23 40.27 Favored Glycine 0 C--N 1.302 -1.307 0 C-N-CA 120.014 -1.089 . . . . 75.120000000000005 113.246 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.418 ' HB3' HG22 ' A' ' 73' ' ' VAL . 11.5 p -127.27 137.66 52.9 Favored 'General case' 0 C--O 1.251 1.145 0 C-N-CA 123.12 0.568 . . . . 62.030000000000001 111.652 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.1 mp -112.42 150.44 31.14 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.904 -1.147 . . . . 64.200000000000003 107.904 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.0 mm -125.35 142.0 43.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 117.975 0.352 . . . . 73.120000000000005 110.091 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.561 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -133.99 107.73 7.96 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.52 -0.918 . . . . 72.019999999999996 108.52 178.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.2 130.37 43.62 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.315 -0.624 . . . . 75.230000000000004 109.315 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.9 m -129.38 164.0 24.57 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 106.405 -1.702 . . . . 75.340000000000003 106.405 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.41 -37.24 16.53 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.008 1.114 . . . . 74.129999999999995 114.008 -176.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -94.56 -41.6 9.25 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.285 0.565 . . . . 72.310000000000002 112.071 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -163.86 153.88 12.89 Favored Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 115.456 -0.793 . . . . 64.430000000000007 109.367 -170.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -78.27 118.2 4.27 Favored 'Trans proline' 0 N--CA 1.429 -2.309 0 C-N-CA 121.992 1.795 . . . . 71.239999999999995 109.939 170.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.37 159.58 2.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.973 -1.121 . . . . 71.219999999999999 107.973 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -126.72 157.46 20.45 Favored Glycine 0 C--N 1.298 -1.555 0 C-N-CA 118.688 -1.72 . . . . 61.43 113.683 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.68 109.73 15.56 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.948 -1.501 . . . . 73.439999999999998 106.948 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.418 HG22 ' HB3' ' A' ' 60' ' ' SER . 72.7 t -103.23 128.98 55.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 CA-C-N 116.044 -0.525 . . . . 64.349999999999994 110.155 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 mp -105.85 128.43 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 115.799 -0.637 . . . . 74.239999999999995 109.964 -178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 4.7 m-85 -109.07 153.41 23.7 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.682 -1.145 . . . . 73.340000000000003 110.242 175.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -67.09 -27.98 67.8 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.867 -1.061 . . . . 71.329999999999998 112.066 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.3 m -134.88 144.86 47.76 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 109.537 -0.542 . . . . 64.140000000000001 109.537 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.557 ' NE ' ' HA ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -75.85 -24.75 55.79 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.959 -0.564 . . . . 73.349999999999994 110.11 -178.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.37 -36.56 71.49 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.817 -0.808 . . . . 64.209999999999994 108.817 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.41 -37.05 62.84 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 114.261 -1.336 . . . . 74.439999999999998 110.195 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.64 78.1 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.012 -0.594 . . . . 63.140000000000001 111.177 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.75 -33.15 74.28 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.698 -0.401 . . . . 74.409999999999997 111.758 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.83 -39.82 66.27 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 120.637 0.256 . . . . 75.319999999999993 111.195 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.31 -43.11 92.08 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 116.275 -0.421 . . . . 74.209999999999994 110.896 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.402 ' CD ' ' HA ' ' A' ' 104' ' ' GLU . 20.3 pttp -70.84 -30.28 66.65 Favored 'General case' 0 C--O 1.198 -1.631 0 C-N-CA 119.03 -1.068 . . . . 72.409999999999997 111.945 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -62.82 -31.4 72.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.381 0.61 . . . . 72.340000000000003 110.096 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.83 -36.57 21.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 116.041 -0.527 . . . . 55.119999999999997 111.427 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.556 ' O ' HG22 ' A' ' 91' ' ' ILE . 96.5 mt -93.98 -10.83 32.36 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 115.361 1.615 . . . . 54.420000000000002 115.361 -174.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -78.77 115.08 18.23 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 118.502 -1.279 . . . . 73.540000000000006 111.202 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.51 19.4 13.92 Favored Glycine 0 N--CA 1.421 -2.331 0 C-N-CA 120.515 -0.85 . . . . 73.219999999999999 111.211 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 88' ' ' LEU . 16.5 tt -102.04 125.33 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.04 0 N-CA-C 106.86 -1.533 . . . . 75.329999999999998 106.86 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -78.28 129.04 34.58 Favored 'General case' 0 C--N 1.257 -3.422 0 N-CA-C 109.303 -0.629 . . . . 55.030000000000001 109.303 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -72.68 -30.22 64.06 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.714 -1.13 . . . . 74.540000000000006 109.824 -172.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.597 ' HB2' ' CB ' ' A' ' 97' ' ' ASN 0.277 9.7 m-20 -150.62 124.63 4.47 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 105.765 -1.939 . . . . 24.449999999999999 105.765 177.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.466 ' HD3' ' CZ ' ' B' ' 48' ' ' TYR . 52.3 Cg_exo -63.0 -19.01 68.09 Favored 'Trans proline' 0 CA--C 1.555 1.535 0 CA-C-N 121.127 1.438 . . . . 72.5 111.272 170.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -78.12 -23.53 47.8 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.272 1.029 . . . . 73.430000000000007 110.707 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.597 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 22.0 t-20 -107.6 141.38 22.92 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 107.336 -1.357 . . . . 75.310000000000002 107.336 -172.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.429 ' HD2' ' OD1' ' A' ' 97' ' ' ASN . 73.5 Cg_endo -76.07 7.25 3.36 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 122.522 2.148 . . . . 72.010000000000005 111.726 176.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -88.31 126.18 35.05 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.141 -0.936 . . . . 74.200000000000003 109.921 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.2 p -115.25 141.92 47.38 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.529 -0.915 . . . . 54.109999999999999 108.529 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.3 tp -89.14 132.58 34.75 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.411 -0.589 . . . . 43.5 109.411 -176.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -134.56 122.53 22.5 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.095 0.558 . . . . 74.519999999999996 109.727 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mp -116.02 132.82 56.54 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.273 -0.64 . . . . 71.310000000000002 109.273 177.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.671 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 34.7 tt0 -146.24 168.49 20.93 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.223 -1.769 . . . . 71.519999999999996 106.223 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -68.02 138.2 55.66 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 120.133 1.333 . . . . 74.340000000000003 110.646 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.07 160.22 31.42 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.298 -0.864 . . . . 74.299999999999997 111.491 -176.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -63.29 -25.39 68.29 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.521 -1.218 . . . . 64.140000000000001 110.379 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.1 130.66 29.39 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 114.554 -1.203 . . . . 62.350000000000001 108.948 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 30' ' ' VAL . 1.7 m-20 -82.44 121.35 26.62 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.322 -1.732 . . . . 73.400000000000006 106.322 176.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.4 t -132.91 151.99 51.96 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 119.46 -0.896 . . . . 61.240000000000002 111.293 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -77.55 153.99 32.81 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.841 -1.54 . . . . 75.5 106.841 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.13 -40.2 86.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.051 -0.722 . . . . 72.420000000000002 109.051 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.89 100.54 8.09 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.493 -0.776 . . . . 53.25 110.38 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.7 107.11 4.99 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 105.668 -1.975 . . . . 63.329999999999998 105.668 174.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.1 m -70.87 126.31 29.22 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 123.615 0.572 . . . . 72.219999999999999 110.529 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.83 145.21 40.79 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.146 -0.479 . . . . 72.019999999999996 110.042 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.0 mt -123.03 145.11 48.8 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.79 -0.641 . . . . 64.430000000000007 109.729 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--N 1.301 -1.51 0 N-CA-C 108.615 -0.883 . . . . 54.149999999999999 108.615 178.604 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 49.1 ttm . . . . . 0 CA--C 1.51 -0.565 0 N-CA-C 107.72 -1.215 . . . . 73.019999999999996 107.72 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -104.5 112.01 24.9 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 114.026 1.121 . . . . 61.020000000000003 114.026 -168.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -149.13 -173.99 4.52 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 103.316 -2.846 . . . . 72.140000000000001 103.316 173.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.608 ' HA ' ' HD3' ' B' ' 78' ' ' ARG . 33.3 mt-10 -74.55 91.92 2.34 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 105.907 -1.886 . . . . 71.209999999999994 105.907 171.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.512 ' HB ' ' CD1' ' B' ' 105' ' ' PHE . 40.8 t -105.77 110.19 30.39 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.513 0 N-CA-C 105.005 -2.22 . . . . 74.239999999999995 105.005 176.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.468 ' NH2' ' HA ' ' B' ' 76' ' ' ASP . 17.1 ptm180 -101.05 11.72 39.03 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 122.019 0.914 . . . . 72.310000000000002 109.221 -177.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . 0.473 HG21 HG22 ' B' ' 110' ' ' THR . 51.9 m -124.13 114.92 20.31 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.959 -1.019 . . . . 74.25 109.348 172.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' B' ' 85' ' ' LYS . 4.4 mp -96.87 140.48 31.36 Favored 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 107.857 -1.164 . . . . 74.230000000000004 107.857 -176.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' B' ' 104' ' ' GLU 0.262 28.0 p90 -102.83 110.63 22.61 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 117.534 -1.666 . . . . 73.329999999999998 109.127 175.005 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.444 HG22 ' HG ' ' B' ' 103' ' ' LEU . 40.5 t -97.49 125.88 50.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-N 113.736 -1.574 . . . . 74.530000000000001 108.634 -176.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 19.1 p -131.32 170.76 14.19 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.945 -0.571 . . . . 60.409999999999997 109.658 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.36 5.2 57.11 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.721 -0.952 . . . . 41.229999999999997 110.721 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.719 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 63.8 mt -84.34 120.01 73.86 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 106.515 -1.661 . . . . 74.129999999999995 106.515 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.56 175.84 6.56 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.577 1.518 . . . . 75.140000000000001 111.425 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.436 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 13.2 p -65.54 -19.82 26.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.957 0.884 . . . . 31.120000000000001 110.149 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -107.32 39.51 1.88 Allowed 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.141 -0.936 . . . . 74.109999999999999 108.599 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 tp -68.62 121.32 17.67 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 N-CA-C 109.044 -0.724 . . . . 74.109999999999999 109.044 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.418 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 16.3 mmmt -89.11 138.55 28.95 Favored Pre-proline 0 C--N 1.287 -2.112 0 N-CA-C 106.545 -1.65 . . . . 71.0 106.545 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.29 -29.48 86.2 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 122.333 2.022 . . . . 64.040000000000006 112.065 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.576 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 14.2 ptt180 -63.49 -31.94 73.25 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 114.818 -1.083 . . . . 63.43 112.17 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.418 ' HG3' ' HB2' ' B' ' 43' ' ' LYS . 36.9 mt-10 -63.02 -49.26 75.31 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.824 0.345 . . . . 74.049999999999997 110.374 -177.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.15 -43.46 91.75 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.724 -0.671 . . . . 75.319999999999993 109.969 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.69 ' O ' ' HG3' ' B' ' 52' ' ' ARG . 0.4 OUTLIER -59.94 -43.38 94.99 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.031 -0.986 . . . . 75.120000000000005 112.298 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.39 -42.51 75.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.854 0.359 . . . . 70.019999999999996 110.274 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 24.6 tp -64.93 -41.45 95.52 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.108 -0.951 . . . . 72.439999999999998 111.087 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -88.67 1.87 54.29 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 113.944 1.09 . . . . 73.549999999999997 113.944 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.69 ' HG3' ' O ' ' B' ' 48' ' ' TYR . 17.4 mtp180 -62.19 -46.38 90.95 Favored Pre-proline 0 CA--C 1.558 1.262 0 N-CA-C 113.593 0.96 . . . . 75.010000000000005 113.593 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -68.0 -19.46 45.75 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 121.853 1.702 . . . . 62.539999999999999 112.421 175.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -81.89 98.15 8.38 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.007 0.908 . . . . 73.530000000000001 110.789 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -70.91 110.11 5.44 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 113.898 -1.501 . . . . 75.120000000000005 110.764 -177.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.38 -15.42 4.18 Favored Glycine 0 N--CA 1.423 -2.233 0 CA-C-N 114.401 -1.272 . . . . 74.200000000000003 111.537 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -56.47 115.66 2.64 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.155 0.502 . . . . 71.120000000000005 111.424 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -93.49 -50.79 5.26 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-N 115.634 -0.712 . . . . 70.319999999999993 109.864 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.33 -179.17 47.5 Favored Glycine 0 C--N 1.29 -2.007 0 C-N-CA 120.527 -0.844 . . . . 53.149999999999999 111.671 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.2 p -136.9 137.99 40.21 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 123.311 0.644 . . . . 61.009999999999998 109.836 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 52.8 tp -120.36 123.81 43.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.591 -1.263 . . . . 73.049999999999997 107.591 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.63 144.96 8.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 109.929 -0.397 . . . . 54.119999999999997 109.929 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.456 ' HE3' ' HA ' ' B' ' 63' ' ' LYS . 1.6 tpmt? -133.43 108.56 8.74 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.039 -1.097 . . . . 74.120000000000005 108.039 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.19 108.85 3.31 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.91 -0.587 . . . . 74.129999999999995 109.603 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 20.9 m -100.06 156.71 17.03 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 105.872 -1.899 . . . . 53.520000000000003 105.872 175.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -44.09 -37.35 3.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.597 1.159 . . . . 74.099999999999994 113.885 -174.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -101.34 -46.12 5.12 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 119.677 -0.809 . . . . 70.540000000000006 112.469 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.719 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 4.0 pt20 -142.55 136.66 14.72 Favored Pre-proline 0 C--N 1.288 -2.095 0 CA-C-O 120.985 0.422 . . . . 73.340000000000003 112.035 -170.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.436 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 19.1 Cg_exo -64.34 108.88 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.393 2.729 . . . . 55.439999999999998 110.537 170.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 33.8 m -87.64 160.63 2.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.251 -1.018 . . . . 64.340000000000003 108.251 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.55 121.19 2.89 Favored Glycine 0 CA--C 1.481 -2.062 0 C-N-CA 119.163 -1.494 . . . . 64.120000000000005 112.68 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.12 108.83 19.46 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.198 -1.408 . . . . 73.109999999999999 107.198 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 86.0 t -95.9 125.23 48.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-N 115.72 -0.673 . . . . 72.439999999999998 110.396 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 3.5 mp -96.91 127.32 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 CA-C-N 115.064 -0.971 . . . . 73.310000000000002 108.907 -176.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -109.38 158.14 18.22 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.426 -0.806 . . . . 75.310000000000002 110.647 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . 0.468 ' HA ' ' NH2' ' B' ' 31' ' ' ARG . 18.0 t70 -79.93 -29.53 39.77 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 113.941 -1.482 . . . . 73.010000000000005 111.777 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 9.2 m -135.57 153.9 51.53 Favored 'General case' 0 N--CA 1.417 -2.098 0 C-N-CA 119.238 -0.985 . . . . 75.349999999999994 112.107 -168.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . 0.608 ' HD3' ' HA ' ' B' ' 29' ' ' GLU . 7.3 tpt85 -63.51 -42.62 98.47 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.477 -1.238 . . . . 75.5 109.856 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.11 -17.61 62.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.191 -1.368 . . . . 75.340000000000003 109.679 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.69 -47.5 4.52 Favored Glycine 0 CA--C 1.488 -1.646 0 CA-C-N 114.113 -1.403 . . . . 52.240000000000002 109.902 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.22 -46.68 87.81 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 114.498 -0.851 . . . . 70.549999999999997 111.752 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.16 -31.33 72.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.602 0.593 . . . . 74.329999999999998 112.602 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.74 -39.47 24.15 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 120.804 -0.358 . . . . 70.129999999999995 110.691 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.95 -42.36 85.37 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.059 -0.519 . . . . 72.239999999999995 111.427 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.431 ' HB3' HD23 ' B' ' 33' ' ' LEU . 0.0 OUTLIER -73.51 -27.67 61.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 120.308 -0.557 . . . . 73.409999999999997 110.9 -177.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -76.15 -39.73 54.3 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.239 -0.437 . . . . 54.130000000000003 110.362 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.08 -43.89 61.23 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 120.848 0.356 . . . . 52.509999999999998 111.874 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.507 ' O ' HG22 ' B' ' 91' ' ' ILE . 97.1 mt -87.05 -14.11 42.46 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 115.684 1.735 . . . . 74.049999999999997 115.684 -172.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -78.5 113.92 16.95 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 117.729 -1.588 . . . . 73.439999999999998 111.57 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.95 18.22 9.0 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.383 -0.913 . . . . 63.340000000000003 111.353 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.507 HG22 ' O ' ' B' ' 88' ' ' LEU . 15.1 tt -101.59 136.92 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.91 0 N-CA-C 108.086 -1.079 . . . . 61.350000000000001 108.086 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.468 ' NH1' ' HA ' ' B' ' 98' ' ' PRO . 15.6 mmt180 -64.97 130.21 42.56 Favored 'General case' 0 C--N 1.278 -2.541 0 C-N-CA 124.109 0.964 . . . . 61.020000000000003 108.602 175.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -75.13 -27.51 59.8 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.01 -1.478 . . . . 63.310000000000002 107.01 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.62 126.43 3.51 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 103.375 -2.824 . . . . 52.140000000000001 103.375 168.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . 0.682 ' HD3' ' CZ ' ' A' ' 48' ' ' TYR . 69.6 Cg_endo -71.88 -8.4 22.93 Favored 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 122.235 1.957 . . . . 73.140000000000001 114.342 -171.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -84.49 -21.81 30.47 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.05 -0.722 . . . . 64.040000000000006 109.05 -177.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -108.98 142.44 25.52 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.329 -0.989 . . . . 65.340000000000003 108.329 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.468 ' HA ' ' NH1' ' B' ' 92' ' ' ARG . 49.1 Cg_exo -62.25 -3.92 4.63 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 123.151 2.567 . . . . 42.299999999999997 113.525 172.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -64.93 117.03 6.99 Favored 'General case' 0 C--O 1.251 1.15 0 CA-C-O 121.653 0.74 . . . . 75.120000000000005 109.855 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 42.5 p -121.56 150.07 42.19 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.566 -0.743 . . . . 71.319999999999993 109.906 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 22.7 tp -85.95 123.42 31.26 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 106.411 -1.7 . . . . 72.319999999999993 106.411 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.97 113.17 16.14 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.842 -1.17 . . . . 75.409999999999997 107.842 -172.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.444 ' HG ' HG22 ' B' ' 35' ' ' VAL . 5.7 mp -112.59 136.62 51.92 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.537 -0.756 . . . . 72.319999999999993 110.271 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.489 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 42.4 tt0 -144.94 167.52 22.44 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.937 -1.505 . . . . 72.25 106.937 175.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . 0.512 ' CD1' ' HB ' ' B' ' 30' ' ' VAL . 40.1 m-85 -76.64 135.07 39.14 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.277 -0.638 . . . . 74.120000000000005 109.277 177.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.53 163.48 26.87 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.462 0.649 . . . . 65.109999999999999 111.194 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 57.2 tttp -76.57 -20.64 56.6 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 122.187 0.994 . . . . 44.109999999999999 108.895 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.06 124.3 27.36 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.879 -1.055 . . . . 74.430000000000007 110.956 -174.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.479 HD21 ' HA ' ' B' ' 30' ' ' VAL . 81.7 m-20 -82.94 136.21 34.64 Favored 'General case' 0 CA--C 1.475 -1.904 0 N-CA-C 107.68 -1.23 . . . . 74.109999999999999 107.68 173.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.473 HG22 HG21 ' B' ' 32' ' ' THR . 12.0 t -135.25 152.51 51.6 Favored 'General case' 0 C--N 1.268 -2.978 0 N-CA-C 108.652 -0.87 . . . . 72.129999999999995 108.652 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -93.65 147.82 22.67 Favored 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 104.867 -2.271 . . . . 74.099999999999994 104.867 169.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -43.65 97.35 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.763 -0.829 . . . . 43.439999999999998 108.763 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.16 93.97 9.52 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.296 -1.372 . . . . 73.409999999999997 107.296 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -93.93 113.05 24.98 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.57 -1.641 . . . . 72.340000000000003 106.57 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -62.74 125.75 25.0 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-O 121.317 0.579 . . . . 54.520000000000003 111.458 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' B' ' 116' ' ' LYS . 0.1 OUTLIER -83.89 112.9 20.56 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.518 -0.764 . . . . 71.310000000000002 109.582 -177.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 71.3 mt -86.79 95.64 9.91 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.987 -1.116 . . . . 71.519999999999996 107.987 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--N 1.297 -1.702 0 CA-C-N 115.535 -0.757 . . . . 71.439999999999998 109.255 -175.436 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.511 -0.553 0 CA-C-O 121.009 0.433 . . . . 75.310000000000002 109.958 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -108.53 -69.04 0.87 Allowed 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 116.41 -0.359 . . . . 73.319999999999993 111.067 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.251 32.8 mt-10 -92.23 71.59 5.33 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 118.355 -1.338 . . . . 71.219999999999999 113.539 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.429 ' HB2' ' HD3' ' A' ' 31' ' ' ARG 0.311 9.2 mm-40 -57.72 135.3 56.75 Favored 'General case' 0 N--CA 1.406 -2.643 0 CA-C-N 113.321 -1.763 . . . . 74.099999999999994 106.457 169.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.89 107.89 3.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 103.169 -2.901 . . . . 72.430000000000007 103.169 168.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' A' ' 75' ' ' PHE . 20.4 ptt180 -133.27 9.81 4.08 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 119.788 -0.765 . . . . 73.530000000000001 112.016 -167.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 75.0 m -105.36 119.98 40.43 Favored 'General case' 0 C--N 1.264 -3.149 0 C-N-CA 119.744 -0.782 . . . . 73.430000000000007 109.536 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.512 HD11 ' O ' ' A' ' 81' ' ' ALA . 76.1 mt -99.28 142.11 31.19 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.418 -1.327 . . . . 71.230000000000004 107.418 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 104' ' ' GLU . 15.8 p90 -103.54 116.79 33.04 Favored 'General case' 0 C--N 1.281 -2.4 0 C-N-CA 117.994 -1.482 . . . . 74.019999999999996 107.989 175.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.423 HG22 ' HG ' ' A' ' 103' ' ' LEU . 29.7 t -97.36 118.98 44.8 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.311 -1.366 . . . . 54.109999999999999 107.311 -178.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 32.7 p -120.92 166.08 14.31 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 109.041 -0.725 . . . . 72.329999999999998 109.041 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA2' ' NE2' ' A' ' 99' ' ' GLN . . . 97.0 18.5 29.19 Favored Glycine 0 N--CA 1.425 -2.038 0 C-N-CA 120.524 -0.846 . . . . 72.310000000000002 111.643 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -93.89 112.0 55.24 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.456 -0.942 . . . . 51.329999999999998 108.456 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.71 156.97 25.15 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.402 2.068 . . . . 72.099999999999994 110.774 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.99 -4.24 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 CA-C-O 122.109 0.957 . . . . 73.420000000000002 112.141 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -100.93 14.19 32.66 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.85 -0.796 . . . . 64.310000000000002 108.85 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.25 129.18 11.95 Favored 'Isoleucine or valine' 0 C--O 1.254 1.297 0 C-N-CA 124.859 1.263 . . . . 64.549999999999997 110.122 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -126.85 104.77 23.19 Favored Pre-proline 0 C--N 1.286 -2.19 0 N-CA-C 106.705 -1.591 . . . . 74.319999999999993 106.705 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -39.98 -17.49 0.05 OUTLIER 'Trans proline' 0 N--CA 1.515 2.777 1 C-N-CA 126.53 4.82 . . . . 62.340000000000003 118.14 -165.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.503 ' HG3' ' CE2' ' B' ' 93' ' ' PHE . 0.0 OUTLIER -60.59 -32.56 71.67 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 112.892 0.701 . . . . 71.109999999999999 112.892 176.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.645 ' HG3' ' CZ ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -69.39 -42.84 74.59 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.371 -0.931 . . . . 75.430000000000007 109.605 -177.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.37 -45.25 94.03 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 115.817 -0.628 . . . . 64.209999999999994 109.394 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.642 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 72.9 t80 -56.52 -49.13 75.67 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.952 -1.022 . . . . 72.310000000000002 111.42 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 93.2 mt -66.8 -35.97 81.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.915 0.388 . . . . 62.100000000000001 110.772 -176.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.5 tp -73.83 -41.97 61.54 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.279 -0.873 . . . . 63.530000000000001 112.327 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -87.81 -11.39 48.11 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 115.936 1.828 . . . . 73.150000000000006 115.936 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' A' ' 48' ' ' TYR . 52.8 mtp180 -60.58 -41.97 85.8 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 113.793 1.034 . . . . 75.299999999999997 113.793 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -64.82 -19.23 64.18 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.696 1.597 . . . . 54.340000000000003 112.387 175.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -81.76 89.65 6.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.233 0.539 . . . . 64.239999999999995 110.214 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.29 109.79 1.68 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.746 -0.835 . . . . 64.329999999999998 108.746 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.6 -17.67 3.7 Favored Glycine 0 N--CA 1.419 -2.485 0 CA-C-N 114.823 -1.081 . . . . 71.310000000000002 110.759 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -63.38 112.74 2.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.821 0.31 . . . . 63.409999999999997 110.538 175.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -90.55 -48.07 7.31 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.09 0.471 . . . . 73.409999999999997 110.437 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.8 179.21 48.78 Favored Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.203 -0.999 . . . . 74.439999999999998 112.558 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.4 p -138.33 136.84 36.8 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.803 0.335 . . . . 73.540000000000006 110.933 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 mp -123.02 121.16 35.39 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.558 -0.904 . . . . 73.530000000000001 108.558 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.76 138.56 20.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 120.853 0.358 . . . . 64.409999999999997 111.204 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -121.14 135.64 55.13 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.527 1.131 . . . . 71.230000000000004 108.254 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.63 126.89 33.31 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.74 0.781 . . . . 75.299999999999997 112.913 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 68' ' ' GLN . 18.9 m -130.12 148.56 51.97 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 104.254 -2.499 . . . . 65.329999999999998 104.254 172.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -42.24 -48.86 4.99 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.849 1.26 . . . . 72.409999999999997 114.366 -169.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 67' ' ' ARG . 24.1 mtm180 -105.3 -5.05 20.87 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.187 -1.005 . . . . 71.010000000000005 113.184 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.476 ' O ' ' HB ' ' A' ' 65' ' ' THR . 11.2 pt20 -161.79 117.1 1.28 Allowed Pre-proline 0 C--N 1.312 -1.03 0 C-N-CA 120.114 -0.634 . . . . 71.230000000000004 112.515 -171.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -73.53 105.52 2.01 Favored 'Trans proline' 0 N--CA 1.432 -2.089 0 C-N-CA 122.243 1.962 . . . . 72.030000000000001 108.107 169.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.5 152.16 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.119 -0.697 . . . . 71.140000000000001 109.119 -176.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.53 120.4 4.4 Favored Glycine 0 CA--C 1.477 -2.293 0 C-N-CA 118.642 -1.742 . . . . 61.229999999999997 112.805 -175.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.52 103.72 16.15 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.454 -1.313 . . . . 71.409999999999997 107.454 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.2 t -98.09 120.96 48.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 114.888 -1.051 . . . . 72.299999999999997 110.097 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 110' ' ' THR . 5.9 tt -94.96 127.74 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.258 0 CA-C-N 115.019 -0.991 . . . . 71.439999999999998 110.187 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.532 ' O ' ' HD2' ' A' ' 31' ' ' ARG . 84.4 m-85 -107.46 165.86 11.09 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 114.616 -1.175 . . . . 72.340000000000003 110.086 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.95 -48.21 78.88 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 125.209 1.404 . . . . 75.420000000000002 112.48 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 p -143.65 163.88 32.0 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 111.755 0.28 . . . . 74.439999999999998 111.755 -172.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.509 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -68.44 -36.05 78.48 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.216 0.531 . . . . 74.430000000000007 110.65 -177.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.64 -28.87 63.0 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.228 -0.896 . . . . 73.420000000000002 108.962 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.11 -39.5 37.17 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.443 -1.253 . . . . 70.310000000000002 110.407 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.512 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -65.35 -46.1 81.56 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.878 -0.661 . . . . 65.430000000000007 111.534 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -63.38 -37.63 88.03 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.448 -0.501 . . . . 74.239999999999995 112.082 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.2 -38.47 85.38 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.249 -0.432 . . . . 72.120000000000005 110.106 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.86 -39.52 83.77 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.808 -0.633 . . . . 45.009999999999998 110.56 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -59.09 -47.97 83.32 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.685 -0.689 . . . . 62.420000000000002 111.836 177.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -66.1 -25.16 66.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.194 0.521 . . . . 61.43 111.864 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.17 -39.72 32.72 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.872 -0.604 . . . . 43.310000000000002 111.514 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.472 ' O ' HG22 ' A' ' 91' ' ' ILE . 98.2 mt -102.2 -25.33 13.73 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 116.896 2.184 . . . . 73.409999999999997 116.896 -173.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -65.46 114.75 5.06 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-N 120.327 1.421 . . . . 75.25 110.18 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.58 10.18 19.87 Favored Glycine 0 N--CA 1.421 -2.32 0 CA-C-N 115.405 -0.816 . . . . 45.020000000000003 111.606 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 88' ' ' LEU . 14.7 tt -93.9 130.33 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.41 0 N-CA-C 109.107 -0.701 . . . . 64.319999999999993 109.107 177.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.536 ' CG ' HG22 ' A' ' 100' ' ' THR . 79.0 mtt180 -76.15 141.35 41.92 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-O 121.396 0.617 . . . . 73.140000000000001 111.757 173.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.645 ' CZ ' ' HG3' ' A' ' 46' ' ' GLU . 26.3 t80 -70.74 -34.46 71.9 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.509 -1.678 . . . . 60.329999999999998 109.108 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.558 ' HB2' ' CB ' ' A' ' 97' ' ' ASN . 6.5 m-20 -140.41 142.14 28.32 Favored Pre-proline 0 C--N 1.294 -1.821 0 N-CA-C 102.666 -3.087 . . . . 52.329999999999998 102.666 175.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.67 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 28.1 Cg_endo -64.03 -22.7 67.9 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 121.469 1.446 . . . . 75.049999999999997 110.898 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -92.08 -8.16 46.62 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.65 -1.159 . . . . 74.129999999999995 110.545 -176.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.558 ' CB ' ' HB2' ' A' ' 94' ' ' ASP . 34.2 t30 -103.51 120.66 51.03 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 108.977 -0.749 . . . . 64.099999999999994 108.977 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.89 -19.55 35.38 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.669 2.246 . . . . 74.120000000000005 111.858 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.429 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 6.9 tp60 -68.09 114.65 6.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.337 -0.986 . . . . 72.450000000000003 108.337 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.536 HG22 ' CG ' ' A' ' 92' ' ' ARG . 69.1 p -107.56 154.83 20.84 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.066 -0.716 . . . . 74.010000000000005 109.066 -175.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 36' ' ' SER . 9.7 mp -86.29 118.29 25.64 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.803 -0.443 . . . . 74.109999999999999 109.803 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -110.76 121.25 44.87 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.725 -1.954 . . . . 74.109999999999999 105.725 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.423 ' HG ' HG22 ' A' ' 35' ' ' VAL . 6.5 mp -105.27 138.17 41.89 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.151 -1.055 . . . . 71.25 108.151 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.579 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 32.6 tt0 -146.02 163.38 35.41 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.843 -1.91 . . . . 64.200000000000003 105.843 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -70.55 137.91 50.5 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 119.22 0.918 . . . . 74.439999999999998 110.37 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.9 141.15 40.66 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 108.15 -1.056 . . . . 73.209999999999994 108.15 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -80.19 10.04 4.93 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 122.233 1.016 . . . . 74.200000000000003 110.692 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -162.38 132.17 4.54 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.986 -1.857 . . . . 75.450000000000003 105.986 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -78.36 158.54 28.75 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.413 0.625 . . . . 62.329999999999998 111.648 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.422 ' O ' HD12 ' A' ' 74' ' ' ILE . 6.7 t -110.47 149.53 30.17 Favored 'General case' 0 N--CA 1.399 -2.977 0 N-CA-C 104.35 -2.463 . . . . 51.520000000000003 104.35 169.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -133.11 137.68 46.41 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 108.935 -0.765 . . . . 62.5 108.935 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 92.3 mmm -79.6 -15.56 57.42 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.017 0.437 . . . . 73.140000000000001 110.897 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.48 112.35 22.84 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.196 -0.911 . . . . 54.020000000000003 109.247 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.38 110.23 1.38 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.162 -1.051 . . . . 74.409999999999997 108.162 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.8 m -68.87 99.96 1.12 Allowed 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 123.697 0.623 . . . . 55.200000000000003 110.148 -176.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -66.87 141.49 57.64 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.183 -0.917 . . . . 51.149999999999999 111.779 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.9 mt -87.83 -20.32 26.23 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.094 -0.957 . . . . 74.219999999999999 108.47 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.422 -1.833 0 CA-C-N 114.912 -1.04 . . . . 60.020000000000003 108.241 178.052 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 48.8 ttm . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.851 0.358 . . . . 73.540000000000006 110.773 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -95.5 -77.6 0.47 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.339 0.59 . . . . 63.409999999999997 111.696 -175.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -116.14 99.51 7.29 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.103 -0.499 . . . . 64.040000000000006 111.047 -176.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -88.8 132.9 34.44 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 105.189 -2.152 . . . . 72.010000000000005 105.189 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.526 ' HA ' HD21 ' B' ' 109' ' ' ASN . 57.8 t -80.41 109.09 14.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.49 -1.67 . . . . 73.129999999999995 106.49 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -140.04 15.06 2.45 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 115.042 -0.981 . . . . 64.230000000000004 111.855 -171.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' B' ' 74' ' ' ILE . 35.3 m -105.84 125.76 51.37 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 108.727 -0.842 . . . . 65.230000000000004 108.727 174.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.455 HD11 ' O ' ' B' ' 81' ' ' ALA . 85.4 mt -100.83 143.11 31.38 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.75 -0.833 . . . . 71.129999999999995 108.75 178.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.615 ' CE1' ' HB3' ' B' ' 104' ' ' GLU . 4.6 p90 -104.44 118.47 36.68 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 106.798 -1.556 . . . . 71.239999999999995 106.798 171.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 39.8 t -97.27 111.95 28.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 N-CA-C 107.206 -1.405 . . . . 64.319999999999993 107.206 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 36.2 p -109.92 162.47 14.48 Favored 'General case' 0 C--N 1.276 -2.59 0 N-CA-C 109.07 -0.715 . . . . 63.350000000000001 109.07 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.83 24.82 12.47 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.428 -0.891 . . . . 70.030000000000001 111.887 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.573 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 83.4 mt -101.78 113.59 65.81 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 107.757 -1.201 . . . . 75.430000000000007 107.757 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.49 169.79 2.14 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.856 2.371 . . . . 54.350000000000001 112.35 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 6.6 p -72.96 -2.41 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 122.115 0.959 . . . . 63.420000000000002 110.458 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' B' ' 43' ' ' LYS . 22.3 t0 -105.01 10.65 34.03 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 114.954 -1.021 . . . . 55.329999999999998 109.563 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.94 129.88 19.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-O 121.811 0.815 . . . . 72.420000000000002 109.449 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' B' ' 45' ' ' ARG . 47.7 mmtm -130.0 107.05 16.56 Favored Pre-proline 0 C--N 1.277 -2.564 0 N-CA-C 106.449 -1.686 . . . . 64.049999999999997 106.449 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -41.48 -16.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.478 1 C-N-CA 126.372 4.715 . . . . 52.420000000000002 117.774 -165.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.557 ' HB3' ' OD2' ' A' ' 94' ' ' ASP . 9.8 ptt180 -65.51 -24.72 67.2 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 122.642 0.377 . . . . 75.230000000000004 111.855 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.553 ' HG3' ' CE1' ' B' ' 93' ' ' PHE . 0.0 OUTLIER -76.03 -41.83 49.72 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 119.214 -0.994 . . . . 75.120000000000005 108.888 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.41 ' HG ' ' OE1' ' B' ' 46' ' ' GLU . 96.4 mt -62.17 -37.19 84.28 Favored 'General case' 0 C--O 1.211 -0.939 0 N-CA-C 108.859 -0.793 . . . . 74.219999999999999 108.859 175.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.67 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 63.1 t80 -58.53 -49.78 76.15 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.846 -1.07 . . . . 55.130000000000003 110.488 176.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.62 -33.98 74.97 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.862 0.363 . . . . 64.219999999999999 110.738 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 36.5 tp -74.58 -45.92 42.08 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.566 -0.743 . . . . 72.239999999999995 112.467 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -92.13 -7.31 48.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.951 1.093 . . . . 70.010000000000005 113.951 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.594 ' HB2' ' O ' ' B' ' 48' ' ' TYR . 20.6 ttt180 -65.99 -43.13 56.29 Favored Pre-proline 0 CA--C 1.56 1.333 0 N-CA-C 112.416 0.525 . . . . 71.409999999999997 112.416 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.22 -15.43 46.09 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 121.76 1.64 . . . . 53.420000000000002 111.862 175.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -85.68 88.87 7.6 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.419 -0.585 . . . . 71.409999999999997 109.419 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.1 112.85 5.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.453 -0.794 . . . . 73.109999999999999 109.978 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.84 -26.5 1.62 Allowed Glycine 0 N--CA 1.426 -1.985 0 CA-C-N 113.578 -1.646 . . . . 72.409999999999997 109.49 -174.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -50.89 119.03 3.54 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.413 1.085 . . . . 72.140000000000001 111.905 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.493 ' HB2' HG23 ' B' ' 74' ' ' ILE . 6.6 mm-40 -93.06 -46.69 7.33 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 115.928 -0.578 . . . . 52.420000000000002 109.443 176.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.85 171.99 37.4 Favored Glycine 0 C--N 1.297 -1.614 0 C-N-CA 120.455 -0.879 . . . . 72.200000000000003 112.325 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 11.9 p -127.11 137.34 52.98 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.192 0.52 . . . . 61.109999999999999 111.061 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . 0.409 HD22 HG22 ' B' ' 110' ' ' THR . 5.1 mp -117.87 109.72 16.88 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.376 -0.972 . . . . 72.219999999999999 108.376 175.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.74 131.95 39.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.729 -0.841 . . . . 60.329999999999998 108.729 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -130.97 119.57 22.27 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 109.293 -0.632 . . . . 75.239999999999995 109.293 -176.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.51 134.63 57.26 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.213 1.005 . . . . 73.409999999999997 110.873 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' B' ' 68' ' ' GLN . 2.5 m -130.08 158.58 39.24 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 105.663 -1.977 . . . . 71.040000000000006 105.663 175.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.89 -40.66 10.36 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.065 0.946 . . . . 72.109999999999999 113.29 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 -104.75 -41.66 5.6 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 119.58 -0.848 . . . . 72.349999999999994 112.735 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.573 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 14.1 pt20 -153.36 126.44 4.13 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 120.717 -0.393 . . . . 74.099999999999994 111.55 -173.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' B' ' 38' ' ' LEU . 51.9 Cg_exo -56.85 124.37 16.09 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.004 2.469 . . . . 63.109999999999999 111.393 171.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.24 141.22 14.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 115.114 -0.948 . . . . 72.329999999999998 108.679 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.73 120.31 5.21 Favored Glycine 0 C--O 1.205 -1.702 0 C-N-CA 119.139 -1.505 . . . . 74.239999999999995 112.46 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -90.37 102.94 15.67 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.642 -1.244 . . . . 74.310000000000002 107.642 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.17 112.38 37.49 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 CA-C-N 115.569 -0.741 . . . . 70.310000000000002 109.182 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.493 HG23 ' HB2' ' B' ' 58' ' ' GLU . 12.4 tt -97.18 138.01 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 CA-C-N 115.528 -0.76 . . . . 71.209999999999994 110.549 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -112.61 160.04 18.26 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.04 -0.982 . . . . 75.430000000000007 109.341 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.24 -31.61 72.53 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.863 -0.608 . . . . 63.219999999999999 112.224 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 26.4 p -128.88 152.56 48.38 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-O 121.74 0.781 . . . . 61.509999999999998 111.904 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . 0.832 ' HD3' ' H ' ' B' ' 78' ' ' ARG . 0.0 OUTLIER -63.09 -39.05 93.57 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.514 -1.221 . . . . 73.430000000000007 109.954 177.255 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . 0.404 ' N ' ' HG2' ' B' ' 78' ' ' ARG . . . -79.51 -19.9 48.52 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.184 -1.043 . . . . 63.020000000000003 108.184 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.56 -44.75 31.76 Favored Glycine 0 C--N 1.307 -1.067 0 N-CA-C 109.227 -1.549 . . . . 72.400000000000006 109.227 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.455 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -67.97 -37.4 81.48 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.381 -0.909 . . . . 50.310000000000002 109.476 176.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -55.42 -52.51 63.33 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.066 -0.97 . . . . 65.230000000000004 110.576 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.08 89.76 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.525 -0.761 . . . . 74.230000000000004 110.994 -176.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.21 -39.96 82.28 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.351 -0.84 . . . . 44.409999999999997 110.563 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -62.84 -42.49 99.76 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.603 -0.726 . . . . 44.119999999999997 111.841 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -62.37 -37.37 85.42 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.257 0.551 . . . . 74.230000000000004 111.25 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.19 -45.34 33.7 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 115.581 -0.736 . . . . 63.149999999999999 111.767 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.497 ' O ' HG22 ' B' ' 91' ' ' ILE . 90.7 mt -93.33 -21.05 19.8 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 117.477 2.399 . . . . 72.010000000000005 117.477 -170.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -69.86 114.01 7.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 120.787 1.631 . . . . 73.219999999999999 112.343 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 113.9 1.56 24.01 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.885 -0.598 . . . . 64.040000000000006 112.255 176.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.497 HG22 ' O ' ' B' ' 88' ' ' LEU . 13.2 tt -86.02 136.15 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 CA-C-O 121.137 0.494 . . . . 61.240000000000002 110.184 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.516 ' HA ' HG22 ' B' ' 100' ' ' THR . 22.2 mmt180 -59.26 139.02 57.38 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 125.17 1.388 . . . . 72.519999999999996 110.045 173.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.553 ' CE1' ' HG3' ' B' ' 46' ' ' GLU . 34.9 t80 -80.77 -32.28 35.54 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.491 -1.67 . . . . 74.140000000000001 106.491 173.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.667 ' HB2' ' HB3' ' B' ' 97' ' ' ASN . 9.5 m-20 -147.47 143.31 17.83 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 101.493 -3.521 . . . . 73.530000000000001 101.493 174.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . 0.632 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 74.0 Cg_endo -78.33 -15.88 13.98 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 CA-C-N 121.952 1.733 . . . . 61.200000000000003 109.619 175.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -79.63 -25.34 41.43 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.299 -1.319 . . . . 74.129999999999995 109.629 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' ASN . . . . . 0.667 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . 38.0 t30 -109.69 129.9 23.4 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 107.744 -1.206 . . . . 75.109999999999999 107.744 -174.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.73 -2.81 6.97 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 123.156 2.57 . . . . 61.310000000000002 113.241 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -77.45 122.41 25.16 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.723 0.773 . . . . 73.319999999999993 110.267 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.516 HG22 ' HA ' ' B' ' 92' ' ' ARG . 17.9 p -121.72 159.81 25.82 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 115.045 -0.979 . . . . 75.200000000000003 108.582 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.406 HD13 HG23 ' B' ' 91' ' ' ILE . 4.4 mp -93.05 134.81 34.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.405 -0.961 . . . . 75.530000000000001 108.405 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -123.99 116.85 23.52 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.044 -1.836 . . . . 71.219999999999999 106.044 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mp -106.49 136.37 46.38 Favored 'General case' 0 C--N 1.289 -2.034 0 O-C-N 123.752 0.657 . . . . 72.409999999999997 110.354 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.615 ' HB3' ' CE1' ' B' ' 34' ' ' PHE . 37.1 tt0 -145.4 163.97 32.95 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 105.744 -1.947 . . . . 74.150000000000006 105.744 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -70.47 144.93 51.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 119.493 1.042 . . . . 71.450000000000003 110.133 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.69 158.18 27.03 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 107.996 -1.113 . . . . 73.120000000000005 107.996 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -81.91 -11.32 58.96 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.009 0.909 . . . . 63.009999999999998 109.523 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -149.06 130.49 14.77 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.664 -1.153 . . . . 52.229999999999997 107.948 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.526 HD21 ' HA ' ' B' ' 30' ' ' VAL . 54.2 m-80 -74.15 113.99 11.98 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.432 0.634 . . . . 72.420000000000002 110.479 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.409 HG22 HD22 ' B' ' 61' ' ' LEU . 23.5 m -96.2 102.17 13.92 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.336 -1.357 . . . . 70.030000000000001 107.336 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -93.73 146.59 23.74 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.964 -1.016 . . . . 75.109999999999999 111.196 -169.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 92.3 mmm -73.15 -53.3 11.34 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 108.25 -1.018 . . . . 23.350000000000001 108.25 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.9 90.14 8.22 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 107.738 -1.208 . . . . 72.109999999999999 107.738 176.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -53.31 122.87 10.44 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.265 -0.88 . . . . 74.019999999999996 111.263 -175.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 39.3 m -58.61 119.84 7.79 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.555 0.693 . . . . 70.430000000000007 109.531 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -101.48 121.5 42.07 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.713 -1.13 . . . . 73.209999999999994 111.139 -167.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 4.5 tt -71.85 -59.27 2.84 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 106.714 -1.588 . . . . 73.340000000000003 106.714 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 C--N 1.306 -1.313 0 N-CA-C 107.785 -1.191 . . . . 54.420000000000002 107.785 175.767 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 109.211 -0.662 . . . . 75.310000000000002 109.211 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -69.0 -56.77 6.75 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 113.596 0.961 . . . . 74.420000000000002 113.596 -162.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -103.05 31.97 3.96 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.797 0.808 . . . . 65.299999999999997 112.101 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -90.97 151.38 21.1 Favored 'General case' 0 N--CA 1.411 -2.39 0 N-CA-C 107.072 -1.455 . . . . 74.310000000000002 107.072 175.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 32' ' ' THR . 26.1 t -91.61 121.88 42.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.693 0 CA-C-N 116.13 -0.486 . . . . 71.030000000000001 109.691 -170.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.519 ' NH2' ' HG2' ' A' ' 111' ' ' LYS . 40.9 mtm180 -85.97 7.38 24.6 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-O 120.926 0.393 . . . . 72.209999999999994 110.507 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.531 ' H ' HG12 ' A' ' 30' ' ' VAL . 33.6 m -134.2 129.77 36.23 Favored 'General case' 0 C--N 1.259 -3.363 0 CA-C-O 121.821 0.82 . . . . 64.530000000000001 112.054 -173.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.429 HD13 ' HB3' ' A' ' 85' ' ' LYS . 88.4 mt -103.7 139.07 39.46 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.73 -1.211 . . . . 52.350000000000001 107.73 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -98.76 112.14 24.31 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.773 -1.566 . . . . 74.310000000000002 106.773 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.515 HG22 ' HG ' ' A' ' 103' ' ' LEU . 29.1 t -96.99 120.63 46.58 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 CA-C-N 113.79 -1.55 . . . . 71.109999999999999 107.739 -174.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 p -126.38 163.71 22.68 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 115.228 -0.896 . . . . 62.229999999999997 109.548 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.64 27.84 10.14 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.927 -0.869 . . . . 73.25 110.927 -173.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.563 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 96.8 mt -97.26 119.35 63.27 Favored Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 107.96 -1.126 . . . . 73.420000000000002 107.96 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.99 153.22 6.57 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.734 2.289 . . . . 72.140000000000001 111.283 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.512 ' HA ' ' CD ' ' A' ' 69' ' ' PRO . 8.6 p -70.07 -1.98 2.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.875 0.845 . . . . 70.109999999999999 112.013 -172.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -127.2 31.34 5.25 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-O 121.553 0.692 . . . . 65.150000000000006 109.974 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.14 149.06 6.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 N-CA-C 113.613 0.968 . . . . 74.019999999999996 113.613 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.529 ' HG2' ' CZ ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -102.74 144.53 28.8 Favored Pre-proline 0 C--N 1.279 -2.476 0 CA-C-N 113.883 -1.508 . . . . 73.409999999999997 109.615 176.091 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.45 -24.98 79.21 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 122.63 2.22 . . . . 74.319999999999993 113.325 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.529 ' CZ ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -84.14 -11.42 56.63 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 118.441 -1.304 . . . . 72.310000000000002 111.427 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.475 ' HG2' ' HG2' ' B' ' 46' ' ' GLU . 35.7 mt-10 -63.77 -39.92 95.44 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.703 0.763 . . . . 75.299999999999997 109.358 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.3 mt -67.32 -31.53 71.88 Favored 'General case' 0 C--O 1.209 -1.064 0 CA-C-N 115.226 -0.897 . . . . 73.450000000000003 110.077 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.6 ' CE1' ' HD3' ' B' ' 95' ' ' PRO . 42.0 t80 -65.32 -46.81 78.82 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.786 -0.643 . . . . 74.219999999999999 110.863 178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 69.0 mt -64.92 -40.01 94.39 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.114 -0.494 . . . . 64.310000000000002 110.884 -176.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.6 tp -81.42 -38.96 25.65 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.43 -0.804 . . . . 61.549999999999997 112.543 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -95.43 -3.52 46.79 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.285 1.217 . . . . 72.430000000000007 114.285 -173.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -61.49 -44.55 92.56 Favored Pre-proline 0 CA--C 1.563 1.452 0 N-CA-C 112.799 0.666 . . . . 64.329999999999998 112.799 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.68 -2.39 12.39 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 121.393 1.395 . . . . 53.25 112.854 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -91.53 95.35 9.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 122.336 1.065 . . . . 72.400000000000006 110.945 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -63.79 109.63 1.8 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 113.078 -1.874 . . . . 74.230000000000004 110.519 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.72 -23.56 3.23 Favored Glycine 0 N--CA 1.422 -2.252 0 CA-C-N 114.858 -1.065 . . . . 70.549999999999997 111.002 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -55.32 114.85 1.97 Allowed 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.498 0.719 . . . . 74.519999999999996 111.959 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -97.86 -58.91 1.87 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.661 -0.699 . . . . 75.109999999999999 110.376 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -158.26 -177.0 30.94 Favored Glycine 0 C--N 1.295 -1.726 0 C-N-CA 120.898 -0.668 . . . . 73.450000000000003 111.869 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.7 p -148.76 140.65 23.76 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 123.032 0.533 . . . . 64.340000000000003 110.349 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.3 tp -120.87 122.01 39.33 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.41 -0.589 . . . . 75.239999999999995 109.41 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.403 HG23 ' HB2' ' A' ' 69' ' ' PRO . 44.4 mm -93.57 133.76 33.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 109.233 -0.654 . . . . 74.430000000000007 109.233 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -135.3 113.27 11.1 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 121.021 0.438 . . . . 62.25 110.374 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -67.97 124.43 23.34 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.362 0.601 . . . . 61.399999999999999 110.897 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.8 m -116.7 162.05 18.27 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 105.637 -1.986 . . . . 71.209999999999994 105.637 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -45.51 -34.95 3.53 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.163 1.172 . . . . 74.109999999999999 114.163 -175.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -95.62 -46.79 6.49 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 112.75 0.648 . . . . 70.430000000000007 112.75 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 4.2 pt20 -156.82 157.08 30.62 Favored Pre-proline 0 C--N 1.295 -1.773 0 CA-C-N 115.792 -0.64 . . . . 64.019999999999996 109.459 -170.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.512 ' CD ' ' HA ' ' A' ' 40' ' ' VAL . 74.5 Cg_endo -80.46 120.64 4.05 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 122.667 2.245 . . . . 72.299999999999997 110.711 171.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.91 161.62 2.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.239 -1.022 . . . . 71.540000000000006 108.239 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.91 120.93 2.92 Favored Glycine 0 CA--C 1.484 -1.85 0 C-N-CA 118.762 -1.685 . . . . 74.109999999999999 112.579 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -88.11 104.62 16.85 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.519 -1.289 . . . . 75.409999999999997 107.519 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.6 t -99.25 123.26 51.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 CA-C-N 115.922 -0.581 . . . . 62.32 109.799 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 tt -101.54 131.85 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 115.38 -0.827 . . . . 73.140000000000001 110.962 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 74.2 m-85 -115.51 146.83 41.34 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.434 -1.257 . . . . 74.010000000000005 107.639 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -79.23 -24.07 43.31 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.708 0.766 . . . . 74.420000000000002 110.493 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.6 m -109.96 140.65 43.73 Favored 'General case' 0 N--CA 1.392 -3.373 0 CA-C-N 115.498 -0.774 . . . . 73.239999999999995 108.964 -175.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.1 mmt-85 -73.38 -33.15 64.87 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.417 -1.327 . . . . 73.140000000000001 107.417 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.2 -19.23 61.77 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.499 -1.682 . . . . 44.119999999999997 109.071 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.91 -42.34 6.39 Favored Glycine 0 CA--C 1.487 -1.661 0 N-CA-C 109.606 -1.398 . . . . 63.439999999999998 109.606 -177.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.413 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -64.71 -47.45 78.27 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 114.902 -0.649 . . . . 73.349999999999994 111.115 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.56 -36.11 82.82 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.147 -0.621 . . . . 73.450000000000003 111.991 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.37 78.12 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 120.737 0.303 . . . . 44.350000000000001 110.854 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.36 -42.28 79.45 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.947 -0.569 . . . . 73.430000000000007 110.843 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.429 ' HB3' HD13 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -71.62 -28.78 64.02 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 120.245 -0.582 . . . . 73.510000000000005 111.801 -178.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -71.31 -41.38 69.97 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 120.592 0.234 . . . . 64.340000000000003 111.542 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.05 -41.42 50.74 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.252 0.464 . . . . 75.239999999999995 112.252 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.477 ' O ' HG22 ' A' ' 91' ' ' ILE . 97.4 mt -95.93 1.71 53.06 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 115.646 1.721 . . . . 70.239999999999995 115.646 -173.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -79.09 114.39 18.0 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 116.822 -1.951 . . . . 75.310000000000002 111.066 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.17 12.18 34.58 Favored Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 110.27 -1.132 . . . . 61.119999999999997 110.27 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 88' ' ' LEU . 13.3 tt -82.38 134.46 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.911 0 N-CA-C 109.116 -0.698 . . . . 52.420000000000002 109.116 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.461 ' NH1' ' HA ' ' A' ' 98' ' ' PRO . 26.2 mmt180 -60.91 121.07 11.44 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 107.954 -1.128 . . . . 72.400000000000006 107.954 171.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -75.37 -27.06 58.99 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.856 -1.535 . . . . 73.140000000000001 106.856 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 97' ' ' ASN . 12.0 t70 -148.07 126.1 5.91 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 103.212 -2.884 . . . . 70.239999999999995 103.212 174.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.561 ' HD3' ' CE1' ' B' ' 48' ' ' TYR . 69.2 Cg_endo -71.81 -16.44 29.62 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.426 1.417 . . . . 61.32 114.732 -175.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -93.07 -22.14 19.3 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.34 0.591 . . . . 74.129999999999995 110.174 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 48.9 t-20 -91.27 132.49 33.77 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.158 -1.423 . . . . 65.430000000000007 107.158 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.461 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 35.6 Cg_endo -67.75 -1.8 7.43 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.587 2.192 . . . . 70.329999999999998 113.0 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.75 113.74 10.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.793 -0.817 . . . . 62.450000000000003 108.793 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.9 p -115.7 147.53 40.77 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.915 -0.584 . . . . 74.129999999999995 109.687 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.6 tp -94.83 125.04 39.23 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 116.073 -0.512 . . . . 73.439999999999998 109.84 -174.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -120.54 126.35 50.11 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.194 -0.669 . . . . 75.010000000000005 109.194 176.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.515 ' HG ' HG22 ' A' ' 35' ' ' VAL . 7.0 mp -104.5 127.18 52.15 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 107.841 -1.17 . . . . 62.420000000000002 107.841 176.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -136.04 163.29 30.66 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 107.731 -1.211 . . . . 71.030000000000001 107.731 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.505 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 33.0 m-85 -78.7 134.83 37.06 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 119.048 0.84 . . . . 74.439999999999998 110.323 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.39 165.0 25.42 Favored 'General case' 0 N--CA 1.428 -1.532 0 O-C-N 123.668 0.605 . . . . 43.350000000000001 109.403 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -86.79 -6.87 58.68 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-O 121.946 0.879 . . . . 53.109999999999999 109.661 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.5 134.22 23.61 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.073 -0.967 . . . . 75.329999999999998 108.83 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' A' ' 30' ' ' VAL . 3.3 m-20 -76.72 124.97 28.46 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.165 -1.421 . . . . 53.119999999999997 107.165 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.9 t -88.01 163.22 16.41 Favored 'General case' 0 N--CA 1.409 -2.476 0 C-N-CA 118.113 -1.435 . . . . 75.530000000000001 108.907 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.519 ' HG2' ' NH2' ' A' ' 31' ' ' ARG . 51.3 mtmt -130.09 132.16 46.04 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.303 -1.369 . . . . 72.329999999999998 107.303 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 91.9 mtp -67.32 116.13 7.75 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.374 -0.602 . . . . 73.120000000000005 109.374 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.69 104.11 15.78 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.685 -0.689 . . . . 61.340000000000003 111.369 -175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -88.67 93.77 9.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 107.429 -1.323 . . . . 71.299999999999997 107.429 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.2 m -61.11 133.0 55.55 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.609 -1.178 . . . . 71.25 112.782 -173.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -111.3 70.17 0.71 Allowed 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 114.909 -1.041 . . . . 64.140000000000001 110.327 175.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.7 tp -88.35 -33.08 18.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.026 -1.842 . . . . 65.230000000000004 106.026 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.416 -2.153 0 N-CA-C 104.857 -2.275 . . . . 65.109999999999999 104.857 173.272 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.565 0.222 . . . . 73.409999999999997 110.412 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.84 -34.15 51.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.442 0.639 . . . . 63.240000000000002 111.009 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -95.86 74.79 3.12 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.807 -0.812 . . . . 74.540000000000006 108.807 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.591 ' HB3' ' HG2' ' B' ' 78' ' ' ARG . 2.6 mm-40 -161.04 -179.36 7.45 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.551 -0.907 . . . . 62.43 108.551 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.56 HG12 ' H ' ' B' ' 32' ' ' THR . 17.5 t -105.74 127.53 60.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 123.132 0.27 . . . . 74.430000000000007 110.345 -169.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.572 ' HB3' ' O ' ' B' ' 75' ' ' PHE . 82.8 mtm180 -96.22 0.04 50.52 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-O 121.286 0.565 . . . . 53.340000000000003 110.74 175.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . 0.56 ' H ' HG12 ' B' ' 30' ' ' VAL . 25.0 m -111.24 128.72 56.02 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-O 121.511 0.672 . . . . 72.430000000000007 112.549 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.5 HD11 ' O ' ' B' ' 81' ' ' ALA . 91.1 mt -104.57 146.37 29.0 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.43 -0.952 . . . . 73.420000000000002 108.43 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.6 ' CE1' ' HB2' ' B' ' 104' ' ' GLU . 27.9 p90 -104.6 115.18 29.89 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.187 -1.412 . . . . 51.200000000000003 107.187 172.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.53 115.45 37.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 CA-C-N 113.917 -1.492 . . . . 62.310000000000002 107.859 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 35.7 p -119.53 171.4 8.38 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.272 -0.876 . . . . 74.239999999999995 109.272 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' B' ' 100' ' ' THR . . . 86.93 25.01 35.83 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.38 -1.088 . . . . 52.509999999999998 110.38 -173.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 95.7 mt -94.77 114.71 64.2 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 107.701 -1.222 . . . . 60.229999999999997 107.701 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.23 157.62 1.86 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.762 2.308 . . . . 74.329999999999998 111.968 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' CD ' ' B' ' 69' ' ' PRO . 7.2 p -63.35 -17.52 19.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.424 0.63 . . . . 75.209999999999994 112.111 -173.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -120.35 42.38 2.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.682 0.753 . . . . 62.340000000000003 109.948 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.421 HG12 ' HB3' ' B' ' 38' ' ' LEU . 2.5 pp -60.89 135.02 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.563 -1.255 . . . . 73.299999999999997 110.801 169.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.41 ' HB2' ' HG3' ' B' ' 46' ' ' GLU . 23.4 mmmt -94.19 144.14 27.55 Favored Pre-proline 0 C--N 1.266 -3.025 0 N-CA-C 106.68 -1.6 . . . . 71.150000000000006 106.68 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.38 -20.7 69.44 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.352 2.035 . . . . 70.109999999999999 113.176 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.487 ' O ' ' HG ' ' B' ' 49' ' ' LEU . 0.0 OUTLIER -87.34 -10.74 51.38 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 118.966 -1.094 . . . . 71.019999999999996 111.999 -179.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.475 ' HG2' ' HG2' ' A' ' 46' ' ' GLU . 33.5 mt-10 -67.07 -39.0 86.74 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.426 0.631 . . . . 53.229999999999997 109.811 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 90.9 mt -68.86 -29.97 68.39 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-N 115.445 -0.798 . . . . 54.43 109.393 176.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.561 ' CE1' ' HD3' ' A' ' 95' ' ' PRO . 39.9 t80 -66.99 -47.99 69.83 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.438 -0.801 . . . . 74.200000000000003 110.682 177.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' B' ' 45' ' ' ARG . 82.3 mt -63.69 -39.77 95.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.29 0.567 . . . . 72.209999999999994 110.327 -177.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 33.6 tp -76.82 -39.49 51.16 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.106 -0.952 . . . . 73.0 112.489 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -95.25 -0.87 52.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 114.175 1.176 . . . . 74.409999999999997 114.175 -176.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -63.13 -42.98 79.83 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 112.479 0.548 . . . . 53.450000000000003 112.479 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -65.93 -21.63 56.82 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.09 1.86 . . . . 42.210000000000001 112.226 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -92.24 88.23 6.39 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 121.753 0.787 . . . . 75.209999999999994 109.57 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -80.51 115.49 20.06 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 122.439 1.114 . . . . 71.239999999999995 111.361 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.01 -28.41 0.73 Allowed Glycine 0 C--N 1.284 -2.354 0 CA-C-N 112.657 -2.065 . . . . 71.200000000000003 108.742 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -48.6 121.88 4.99 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.818 1.247 . . . . 75.230000000000004 111.775 174.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.47 ' HB2' HG23 ' B' ' 74' ' ' ILE . 12.0 mm-40 -92.83 -56.71 2.9 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.546 -0.909 . . . . 72.299999999999997 108.546 174.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.54 -175.88 39.57 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 115.063 -0.971 . . . . 72.150000000000006 112.035 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 12.5 p -136.99 138.17 40.24 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 122.735 0.414 . . . . 61.100000000000001 111.086 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' LEU . . . . . . . . . . . . . 57.8 tp -114.39 127.22 55.73 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.289 -1.004 . . . . 63.340000000000003 108.289 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 50.8 mm -93.99 143.37 11.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.232 -0.655 . . . . 61.450000000000003 109.232 -176.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -137.96 108.23 6.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.645 -0.872 . . . . 63.310000000000002 108.645 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -66.94 128.98 38.4 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.312 0.577 . . . . 74.150000000000006 109.834 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.8 m -125.72 158.15 35.57 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 104.584 -2.376 . . . . 73.140000000000001 104.584 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.68 -29.24 59.02 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.554 0.946 . . . . 74.239999999999995 113.554 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -85.92 -39.28 17.12 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.729 0.64 . . . . 75.400000000000006 112.729 177.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' B' ' 38' ' ' LEU . 3.7 pt20 -174.32 155.1 2.16 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 115.886 -0.597 . . . . 74.340000000000003 109.691 -169.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.447 ' CD ' ' HA ' ' B' ' 40' ' ' VAL . 58.4 Cg_endo -80.28 115.82 3.25 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 C-N-CA 122.357 2.038 . . . . 74.239999999999995 110.657 171.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -87.92 162.63 2.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.405 -0.961 . . . . 53.039999999999999 108.405 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.06 122.7 3.4 Favored Glycine 0 CA--C 1.491 -1.464 0 C-N-CA 118.689 -1.72 . . . . 73.409999999999997 113.555 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -87.93 108.99 19.46 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.541 -1.281 . . . . 72.120000000000005 107.541 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 67.9 t -103.54 120.66 53.9 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 115.698 -0.683 . . . . 74.329999999999998 110.285 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.526 HD12 ' O ' ' B' ' 110' ' ' THR . 3.6 tt -96.54 130.82 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 115.169 -0.923 . . . . 75.319999999999993 110.06 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . 0.572 ' O ' ' HB3' ' B' ' 31' ' ' ARG . 90.0 m-85 -111.13 156.56 21.18 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.906 -1.043 . . . . 65.439999999999998 108.326 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.74 -36.15 82.91 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.015 0.436 . . . . 60.539999999999999 112.089 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' SER . . . . . . . . . . . . . 33.0 p -131.84 163.41 28.33 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.411 0.624 . . . . 73.019999999999996 112.64 -175.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' ARG . . . . . 0.591 ' HG2' ' HB3' ' B' ' 29' ' ' GLU . 4.4 mpt_? -73.94 -34.06 64.17 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 108.734 -0.839 . . . . 75.140000000000001 108.734 176.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.82 -19.84 64.29 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.01 -0.996 . . . . 72.409999999999997 109.564 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.16 -46.12 6.0 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.224 -1.151 . . . . 54.109999999999999 110.224 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.5 ' O ' HD11 ' B' ' 33' ' ' LEU . . . -62.88 -45.1 94.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.3 -0.45 . . . . 63.240000000000002 111.705 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' B' ' 78' ' ' ARG . 9.6 pt-20 -63.56 -36.11 82.71 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 120.916 -0.314 . . . . 72.150000000000006 111.299 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.43 -41.85 79.72 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 120.839 0.352 . . . . 52.140000000000001 110.312 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.44 -42.31 87.84 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.72 -0.673 . . . . 63.409999999999997 111.227 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -70.96 -39.29 72.63 Favored 'General case' 0 C--O 1.203 -1.35 0 C-N-CA 119.407 -0.917 . . . . 72.409999999999997 110.999 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -65.68 -31.9 73.16 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.174 0.511 . . . . 61.43 110.764 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.06 -40.27 17.02 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 112.309 0.485 . . . . 71.0 112.309 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.529 ' O ' HG22 ' B' ' 91' ' ' ILE . 87.3 mt -100.99 -13.11 18.4 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 116.348 1.981 . . . . 70.030000000000001 116.348 -172.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -76.17 113.69 14.0 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 117.401 -1.72 . . . . 73.129999999999995 112.043 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 113.36 6.46 21.91 Favored Glycine 0 N--CA 1.423 -2.17 0 C-N-CA 120.545 -0.836 . . . . 65.310000000000002 112.055 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.529 HG22 ' O ' ' B' ' 88' ' ' LEU . 14.9 tt -97.95 144.67 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.954 0 N-CA-C 107.117 -1.438 . . . . 72.329999999999998 107.117 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.418 ' HG2' HG22 ' B' ' 100' ' ' THR . 81.6 mtt180 -79.42 138.36 37.6 Favored 'General case' 0 C--N 1.26 -3.296 0 CA-C-O 121.244 0.545 . . . . 71.230000000000004 111.471 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -69.17 -35.51 76.37 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 113.811 -1.54 . . . . 74.549999999999997 108.599 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' B' ' 97' ' ' ASN . 1.1 m-20 -129.36 130.13 23.3 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 102.306 -3.22 . . . . 73.040000000000006 102.306 172.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . 0.6 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 27.9 Cg_endo -61.29 -30.66 88.32 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.316 2.011 . . . . 75.329999999999998 113.39 -177.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -94.19 15.21 17.85 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 123.339 0.656 . . . . 65.239999999999995 111.276 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' ASN . . . . . 0.495 ' HB3' ' HB2' ' B' ' 94' ' ' ASP . 46.3 t30 -127.18 128.14 24.16 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.698 -0.853 . . . . 72.340000000000003 108.698 -177.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.55 9.82 1.15 Allowed 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.927 2.418 . . . . 53.329999999999998 113.25 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -83.83 110.34 18.28 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.894 -1.521 . . . . 70.319999999999993 106.894 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.462 ' O ' ' HA3' ' B' ' 37' ' ' GLY . 65.5 p -102.72 141.09 36.11 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.798 -0.761 . . . . 74.299999999999997 110.365 -175.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 24.7 tp -86.17 126.1 33.99 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.272 -1.01 . . . . 72.140000000000001 108.272 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -131.05 121.68 25.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 109.437 -0.579 . . . . 62.439999999999998 109.437 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.68 116.59 32.27 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.126 -0.943 . . . . 72.510000000000005 109.829 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.6 ' HB2' ' CE1' ' B' ' 34' ' ' PHE . 40.2 mm-40 -122.51 170.33 10.09 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.545 -1.65 . . . . 73.109999999999999 106.545 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -81.72 137.43 35.38 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 119.184 0.902 . . . . 72.349999999999994 109.738 176.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.66 151.13 27.72 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.176 0.512 . . . . 74.510000000000005 111.41 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -87.23 12.09 12.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.715 0.769 . . . . 41.229999999999997 109.996 177.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -137.69 115.42 11.38 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 107.524 -1.287 . . . . 70.25 107.524 177.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -84.05 106.96 16.11 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.464 -1.68 . . . . 71.340000000000003 106.464 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.526 ' O ' HD12 ' B' ' 74' ' ' ILE . 28.8 m -75.82 139.23 41.64 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.245 -0.434 . . . . 51.32 110.834 -173.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -114.55 90.73 3.41 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.053 0.454 . . . . 61.030000000000001 110.64 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' MET . . . . . . . . . . . . . 86.4 mtp -85.09 90.28 7.82 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.901 -0.59 . . . . 64.239999999999995 110.633 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.41 148.85 22.54 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.722 -1.214 . . . . 71.530000000000001 107.722 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -73.75 112.0 9.44 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.177 -0.675 . . . . 72.219999999999999 109.177 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 36.1 t -81.87 111.03 17.7 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 115.836 -0.62 . . . . 72.0 109.932 -177.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -71.69 133.38 45.6 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.275 -0.875 . . . . 63.329999999999998 111.231 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 48.2 tp -73.84 -54.94 6.88 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 104.856 -2.275 . . . . 72.209999999999994 104.856 172.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 N--CA 1.431 -1.388 0 C-N-CA 127.447 2.299 . . . . 75.530000000000001 105.86 170.08 . . . . . . . . 0 0 . 1 stop_ save_